Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NOTCH2NLC, (GGC)n REPEAT EXPANSION	NOTCH2NLC		Neuronal intranuclear inclusion disease	Pathogenic(Last reviewed: Oct 24, 2019)	no assertion criteria provided	VCV000691867					691867	679582		
NM_001004434.3(SLC30A2):c.259G>A (p.Gly87Arg)	SLC30A2	G87R	Zinc deficiency, transient neonatal	Pathogenic(Last reviewed: Aug 24, 2012)	no assertion criteria provided	VCV000039553	1	26371500	1	26045009	39553	48152		NC_000001.11:26045008:C:T
NM_001004434.3(SLC30A2):c.161A>G (p.His54Arg)	SLC30A2	H54R	Zinc deficiency, transient neonatal	Pathogenic(Last reviewed: Dec 22, 2006)	no assertion criteria provided	VCV000039552	1	26371598	1	26045107	39552	48151	rs587776926	NC_000001.11:26045106:T:C
NM_003094.4(SNRPE):c.133G>A (p.Gly45Ser)	SNRPE	G45S, G37S, G43S, G32S	Hypotrichosis 11	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039506	1	203832842	1	203863714	39506	48105	rs587776925	NC_000001.11:203863713:G:A
NM_016058.4(TPRKB):c.446A>G (p.Tyr149Cys)	TPRKB	Y149C, Y131C, Y188C, Y116C	GALLOWAY-MOWAT SYNDROME 5	Pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000444885	2	73957152	2	73730025	444885	438527	rs1233885358	NC_000002.12:73730024:T:C
NM_016058.4(TPRKB):c.407T>C (p.Leu136Pro)	TPRKB	L136P, L103P, L175P, L118P	GALLOWAY-MOWAT SYNDROME 5	Pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000444884	2	73957721	2	73730594	444884	438526	rs1553433412	NC_000002.12:73730593:A:G
NM_006556.4(PMVK):c.550del (p.Asn183_Leu184insTer)	PMVK		Porokeratosis of Mibelli	Pathogenic(Last reviewed: Jul 23, 2015)	no assertion criteria provided	VCV000253042	1	154897634	1	154925158	253042	247453	rs879255607	NC_000001.11:154925157:GG:G
NM_006556.4(PMVK):c.412C>T (p.Arg138Ter)	PMVK	R138*, R124*, R63*	Porokeratosis of Mibelli	Pathogenic(Last reviewed: Jul 23, 2015)	no assertion criteria provided	VCV000253041	1	154898860	1	154926384	253041	247452	rs745983207	NC_000001.11:154926383:G:A
NM_017686.4(GDAP2):c.1198_1199insG (p.His400fs)	GDAP2		SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27	Pathogenic(Last reviewed: Mar 28, 2019)	no assertion criteria provided	VCV000624620	1	118426158 - 118426159	1	117883536 - 117883537	624620	613439	rs547792505	NC_000001.11:117883536::C
NM_017686.4(GDAP2):c.1305dup (p.Ser436fs)	GDAP2		SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27	Pathogenic(Last reviewed: Mar 28, 2019)	no assertion criteria provided	VCV000624619	1	118420771 - 118420772	1	117878149 - 117878150	624619	613438	rs1557794465	NC_000001.11:117878149:C:CC
NM_017686.4(GDAP2):c.946C>T (p.Gln316Ter)	GDAP2	Q316*	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27	Pathogenic(Last reviewed: Mar 28, 2019)	no assertion criteria provided	VCV000624618	1	118439462	1	117896840	624618	613437	rs752352896	NC_000001.11:117896839:G:A
NM_022821.4(ELOVL1):c.494C>T (p.Ser165Phe)	ELOVL1	S165F, S138F, S84F	ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES	Pathogenic(Last reviewed: Aug 9, 2019)	no assertion criteria provided	VCV000652597	1	43830119	1	43364448	652597	653802		NC_000001.11:43364447:G:A
NM_014176.4(UBE2T):c.179+5G>A	UBE2T		Fanconi anemia, complementation group T	Pathogenic(Last reviewed: Jun 4, 2015)	no assertion criteria provided	VCV000199437	1	202304112	1	202334984	199437	196428	rs796052212	NC_000001.11:202334983:C:T
NM_014176.4(UBE2T):c.4C>G (p.Gln2Glu)	UBE2T	Q2E	Fanconi anemia, complementation group T	Pathogenic(Last reviewed: Jun 4, 2015)	no assertion criteria provided	VCV000199436	1	202304879	1	202335751	199436	196427	rs774357609	NC_000001.11:202335750:G:C
IGKC, CYS194GLY	IGKC	C194G	Immunoglobulin kappa light chain deficiency	Pathogenic(Last reviewed: Oct 25, 1985)	no assertion criteria provided	VCV000029759					29759	38714		
IGKC, TRP148ARG	IGKC	W148R	Immunoglobulin kappa light chain deficiency	Pathogenic(Last reviewed: Oct 25, 1985)	no assertion criteria provided	VCV000029758					29758	38713		
NC_000001.10:g.(155160963_155162030)insC	MUC1		Medullary cystic kidney disease 1	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000055830					55830	70488		
NM_199342.4(SVBP):c.39_42del (p.Lys13fs)	SVBP	K13fs	NEURODEVELOPMENTAL DISORDER WITH ATAXIA, HYPOTONIA, AND MICROCEPHALY|Lower limb spasticity|Microcephaly|Intellectual disability	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000635969	1	43282174 - 43282177	1	42816503 - 42816506	635969	623783		NC_000001.11:42816502:TTCTTT:TT
NM_199342.4(SVBP):c.82C>T (p.Gln28Ter)	SVBP	Q28*	NEURODEVELOPMENTAL DISORDER WITH ATAXIA, HYPOTONIA, AND MICROCEPHALY|Lower limb spasticity|Microcephaly|Intellectual disability	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000635968	1	43282134	1	42816463	635968	623782		NC_000001.11:42816462:G:A
NM_016406.4(UFC1):c.68G>A (p.Arg23Gln)	UFC1	R23Q	NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH	Pathogenic(Last reviewed: Aug 6, 2018)	no assertion criteria provided	VCV000559448	1	161123855	1	161154065	559448	550172	rs1181612302	NC_000001.11:161154064:G:A
NM_001242908.2(RSPO1):c.286+1G>A	RSPO1		Palmoplantar hyperkeratosis and true hermaphroditism	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000001605	1	38082155	1	37616483	1605	16644		NC_000001.11:37616482:C:T
RSPO1, EX4 DEL	RSPO1		Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and 46,XX sex reversal	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000001604					1604	16643		
NM_016406.4(UFC1):c.317C>T (p.Thr106Ile)	UFC1	T106I	NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH	Pathogenic(Last reviewed: Aug 6, 2018)	no assertion criteria provided	VCV000559447	1	161127468	1	161157678	559447	550171	rs1553232770	NC_000001.11:161157677:C:T
RSPO1, 1-BP INS, 896G	RSPO1		Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and 46,XX sex reversal	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000001603					1603	16642		
NM_024494.3(WNT2B):c.205C>T (p.Arg69Ter)	WNT2B	R50*, R69*	Failure to thrive in infancy|Impaired feeding ability|Diarrhea|Failure to thrive|Chronic diarrhea|DIARRHEA 9	Pathogenic(Last reviewed: Oct 31, 2018)	no assertion criteria provided	VCV000545432	1	113057518	1	112514896	545432	535693	rs370244148	NC_000001.11:112514895:C:T
NM_001294347.2(COL8A2):c.1168_1169delinsGT (p.Gln390Val)	COL8A2	Q455V	Corneal dystrophy, Fuchs endothelial 1	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000167868	1	36563918 - 36563919	1	36098317 - 36098318	167868	178168	rs727504229	NC_000001.11:36098316:TG:AC
NM_005202.4(COL8A2):c.1363C>A (p.Gln455Lys)	COL8A2	Q455K, Q390K	Corneal dystrophy, Fuchs endothelial 1|Corneal dystrophy, posterior polymorphous, 2	Pathogenic(Last reviewed: Jan 15, 2012)	no assertion criteria provided	VCV000017147	1	36563919	1	36098318	17147	32186	rs80358191	NC_000001.11:36098317:G:T
NM_005202.4(COL8A2):c.1349T>G (p.Leu450Trp)	COL8A2	L450W, L385W	Corneal dystrophy, Fuchs endothelial 1|Corneal dystrophy, posterior polymorphous, 2	Pathogenic(Last reviewed: Mar 28, 2013)	no assertion criteria provided	VCV000017148	1	36563933	1	36098332	17148	32187	rs80358192	NC_000001.11:36098331:A:C
NM_006759.4(UGP2):c.34A>G	UGP2	M1V, M12V	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 83	Pathogenic(Last reviewed: Feb 4, 2020)	no assertion criteria provided	VCV000805980	2	64083454	2	63856320	805980	794316		NC_000002.12:63856319:A:G
NM_023077.3(COA7):c.431del (p.Gly144fs)	COA7	G144fs	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3	Pathogenic(Last reviewed: Apr 15, 2019)	no assertion criteria provided	VCV000625461	1	53153657	1	52687985	625461	613766	rs1558102464	NC_000001.11:52687984:CC:C
NM_023077.3(COA7):c.17A>G (p.Asp6Gly)	COA7	D6G	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3	Pathogenic(Last reviewed: Apr 16, 2019)	no assertion criteria provided	VCV000625460	1	53163982	1	52698310	625460	613765	rs780572767	NC_000001.11:52698309:T:C
NM_023077.3(COA7):c.446G>T (p.Ser149Ile)	COA7	S149I	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3	Pathogenic(Last reviewed: Apr 15, 2019)	no assertion criteria provided	VCV000625459	1	53153642	1	52687970	625459	613764	rs1558102448	NC_000001.11:52687969:C:A
NM_003944.4(SELENBP1):c.481+1G>A	SELENBP1		EXTRAORAL HALITOSIS DUE TO METHANETHIOL OXIDASE DEFICIENCY	Pathogenic(Last reviewed: Oct 12, 2018)	no assertion criteria provided	VCV000585260	1	151340674	1	151368198	585260	576310	rs1357490520	NC_000001.11:151368197:C:T
NM_015991.4(C1QA):c.648G>A (p.Trp216Ter)	C1QA	W194*, W216*	C1q deficiency	Pathogenic(Last reviewed: Sep 28, 2017)	no assertion criteria provided	VCV000440740	1	22965810	1	22639317	440740	434365	rs34139950	NC_000001.11:22639316:G:A
NM_002143.3(HPCA):c.568G>A (p.Ala190Thr)	HPCA	A190T	Torsion dystonia 2	Pathogenic(Last reviewed: Apr 2, 2015)	no assertion criteria provided	VCV000190120	1	33359449	1	32893848	190120	187952	rs550921485	NC_000001.11:32893847:G:A
NM_002143.3(HPCA):c.212C>A (p.Thr71Asn)	HPCA	T71N	Torsion dystonia 2	Pathogenic(Last reviewed: Apr 2, 2015)	no assertion criteria provided	VCV000190119	1	33354711	1	32889110	190119	187951	rs775863165	NC_000001.11:32889109:C:A
NM_172369.5(C1QC):c.213del (p.Gln74fs)	C1QC	Q74fs	C1q deficiency	Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	VCV000017069	1	22973749	1	22647256	17069	32108	rs761681612	NC_000001.11:22647255:CCC:CC
NM_023077.3(COA7):c.247+1G>T	COA7		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3	Pathogenic(Last reviewed: Apr 18, 2019)	no assertion criteria provided	VCV000438351	1	53158398	1	52692726	438351	431982	rs1197945739	NC_000001.11:52692725:C:A
NM_023077.3(COA7):c.410A>G (p.Tyr137Cys)	COA7	Y137C	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3	Pathogenic(Last reviewed: Apr 18, 2019)	no assertion criteria provided	VCV000438350	1	53153678	1	52688006	438350	431981	rs961876891	NC_000001.11:52688005:T:C
NM_172369.5(C1QC):c.100G>A (p.Gly34Arg)	C1QC	G6R, G34R	C1q deficiency	Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	VCV000017071	1	22970616	1	22644123	17071	32110	rs200206736	NC_000001.11:22644122:G:A
NM_172369.5(C1QC):c.205C>T (p.Arg69Ter)	C1QC	R41*, R69*	C1q deficiency	Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	VCV000017070	1	22973743	1	22647250	17070	32109	rs377549148	NC_000001.11:22647249:C:T
NM_172369.5(C1QC):c.490G>A (p.Gly164Ser)	C1QC	G164S, G75S	C1q deficiency	Pathogenic(Last reviewed: Jan 29, 2019)	no assertion criteria provided	VCV000440743	1	22974028	1	22647535	440743	434368	rs752596663	NC_000001.11:22647534:G:A
NM_002143.3(HPCA):c.225C>A (p.Asn75Lys)	HPCA	N75K	Torsion dystonia 2	Pathogenic(Last reviewed: Apr 2, 2015)	no assertion criteria provided	VCV000190118	1	33354724	1	32889123	190118	187950	rs786205675	NC_000001.11:32889122:C:A
NM_015991.4(C1QA):c.622C>T (p.Gln208Ter)	C1QA	Q186*, Q208*	C1q deficiency	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000017073	1	22965784	1	22639291	17073	32112	rs121909581	NC_000001.11:22639290:C:T
NM_000427.3(LORICRIN):c.684dup (p.Ser229fs)	LORICRIN		not provided	Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000279841	1	153234103 - 153234104	1	153261627 - 153261628	279841	263978	rs886041212	NC_000001.11:153261627:GGGGGG:GGGGGGG
NM_033505.4(SELENOI):c.732-2A>G	SELENOI		SPASTIC PARAPLEGIA 81, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Feb 14, 2020)	no assertion criteria provided	VCV000812575	2	26607825	2	26384957	812575	800823		NC_000002.12:26384956:A:G
NM_033505.4(SELENOI):c.335G>C (p.Arg112Pro)	SELENOI	R112P	SPASTIC PARAPLEGIA 81, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Feb 14, 2020)	no assertion criteria provided	VCV000812574	2	26596259	2	26373391	812574	800822		NC_000002.12:26373390:G:C
LOR, 1-BP INS, 709C	LORICRIN		Vohwinkel syndrome, variant form	Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	VCV000014419					14419	29458		
LOR, 1-BP INS, 730G	LORICRIN		Vohwinkel syndrome, variant form	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000014418					14418	29457		
NM_002249.6(KCNN3):c.1049G>A (p.Gly350Asp)	KCNN3	G350D, G37D, G45D	ZIMMERMANN-LABAND SYNDROME 3	Pathogenic(Last reviewed: Nov 11, 2019)	no assertion criteria provided	VCV000804202	1	154744850	1	154772374	804202	792565		NC_000001.11:154772373:C:T
NM_002249.6(KCNN3):c.805A>G (p.Lys269Glu)	KCNN3	K269E	ZIMMERMANN-LABAND SYNDROME 3	Pathogenic(Last reviewed: Nov 11, 2019)	no assertion criteria provided	VCV000804201	1	154841636	1	154869160	804201	792564		NC_000001.11:154869159:T:C
NM_002249.6(KCNN3):c.1306A>T (p.Ser436Cys)	KCNN3	S436C, S123C, S131C	ZIMMERMANN-LABAND SYNDROME 3	Pathogenic(Last reviewed: Nov 11, 2019)	no assertion criteria provided	VCV000804200	1	154744593	1	154772117	804200	792563		NC_000001.11:154772116:T:A
NM_079420.3(MYL1):c.479-2A>G	MYL1		Congenital myopathy with reduced type 2 muscle fibers	Pathogenic(Last reviewed: May 8, 2019)	no assertion criteria provided	VCV000627413	2	211158526	2	210293802	627413	615768	rs1559659233	NC_000002.12:210293801:T:C
NM_177398.4(LMX1A):c.290G>C (p.Cys97Ser)	LMX1A	C97S	Deafness, autosomal dominant 7	Pathogenic(Last reviewed: Feb 12, 2020)	no assertion criteria provided	VCV000812516	1	165218851	1	165249614	812516	800759		NC_000001.11:165249613:C:G
NM_000491.5(C1QB):c.187+1G>T	C1QB		C1q deficiency	Pathogenic(Last reviewed: Sep 28, 2017)	no assertion criteria provided	VCV000440741	1	22986137	1	22659644	440741	434366	rs1361922961	NC_000001.11:22659643:G:T
c.455G-A	C1QB		C1q deficiency	Pathogenic(Last reviewed: Jan 1, 1988)	no assertion criteria provided	VCV000017072					17072	32111		
MCM6, EX17, T/C	MCM6		Lactase persistence	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000007690					7690	22729		
NM_000491.5(C1QB):c.730G>A (p.Gly244Arg)	C1QB	G217R, G244R	C1q deficiency	Pathogenic(Last reviewed: Sep 28, 2017)	no assertion criteria provided	VCV000440742	1	22987847	1	22661354	440742	434367	rs34813378	NC_000001.11:22661353:G:A
NM_001085487.3(MYSM1):c.869C>G (p.Ser290Ter)	MYSM1	S290*	BONE MARROW FAILURE SYNDROME 4	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000807637	1	59147847	1	58682175	807637	798477		NC_000001.11:58682174:G:C
NM_001085487.3(MYSM1):c.1967A>G (p.His656Arg)	MYSM1	H656R	BONE MARROW FAILURE SYNDROME 4	Pathogenic(Last reviewed: Sep 13, 2018)	no assertion criteria provided	VCV000561194	1	59132774	1	58667102	561194	552301	rs1557507208	NC_000001.11:58667101:T:C
NM_006496.4(GNAI3):c.141C>A (p.Ser47Arg)	GNAI3	S47R	Auriculocondylar syndrome 1	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000064691	1	110116381	1	109573759	64691	75620	rs397514768	NC_000001.11:109573758:C:A
NM_001277991.1(TSHB):c.-490G>T	TSHB	E12*, E32*	Secondary hypothyroidism	Pathogenic(Last reviewed: May 1, 1990)	no assertion criteria provided	VCV000012685	1	115576077	1	115033456	12685	27724	rs121918669	NC_000001.11:115033455:G:T
NM_001277991.1(TSHB):c.-439G>A	TSHB	G29R, G49R	Secondary hypothyroidism	Pathogenic(Last reviewed: Aug 1, 1989)	no assertion criteria provided	VCV000012684	1	115576128	1	115033507	12684	27723	rs121918668	NC_000001.11:115033506:G:A
NM_000549.4:c.162+5G>A	TSHB		Secondary hypothyroidism	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000012688	1	115576150	1	115033529	12688	27727		NC_000001.11:115033528:G:A
NM_001085487.3(MYSM1):c.1168G>T (p.Glu390Ter)	MYSM1	E390*	BONE MARROW FAILURE SYNDROME 4	Pathogenic(Last reviewed: Sep 13, 2018)	no assertion criteria provided	VCV000561193	1	59147548	1	58681876	561193	552300	rs1557518298	NC_000001.11:58681875:C:A
NM_000549.4(TSHB):c.373delT (p.Cys125Valfs)	TSHB	C125fs, C80fs	not provided|Secondary hypothyroidism	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000437070	1	115576804	1	115034183	437070	427630	rs755485552	NC_000001.11:115034182:T:
NM_006496.4(GNAI3):c.118G>C (p.Gly40Arg)	GNAI3	G40R	Auriculocondylar syndrome 1	Pathogenic(Last reviewed: Sep 17, 2012)	criteria provided, single submitter	VCV000031636	1	110091460	1	109548838	31636	40313	rs387907178	NC_000001.11:109548837:G:C
TSHB, 1-BP DEL, 313T	TSHB		Secondary hypothyroidism	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000012686					12686	27725		
NM_014168.4(METTL5):c.344_345del (p.Arg115fs)	METTL5	R115fs	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 72|Intellectual disability, severe	Pathogenic	criteria provided, single submitter	VCV000689379	2	170677663 - 170677664	2	169821153 - 169821154	689379	676971		NC_000002.12:169821152:TCT:T
NM_014168.4(METTL5):c.571_572del (p.Lys191fs)	METTL5	K191fs	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 72|Intellectual disability, severe	Pathogenic	criteria provided, single submitter	VCV000689363	2	170668986 - 170668987	2	169812476 - 169812477	689363	676955		NC_000002.12:169812475:TT:
NM_017825.3(ADPRS):c.416_426del (p.Ala139fs)	ADPRS	A139fs	not provided	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000852549	1	36557325 - 36557335	1	36091724 - 36091734	852549	823926		NC_000001.11:36091723:GCCCGGGCCCAG:G
NM_001378.3(DYNC1I2):c.868C>T (p.Gln290Ter)	DYNC1I2	Q290*, Q282*, Q284*, Q264*	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES	Pathogenic(Last reviewed: Jul 2, 2019)	no assertion criteria provided	VCV000635401	2	172582801	2	171726291	635401	623227		NC_000002.12:171726290:C:T
NM_001378.3(DYNC1I2):c.740A>G (p.Tyr247Cys)	DYNC1I2	Y247C, Y239C, Y241C, Y221C	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES	Pathogenic(Last reviewed: Jul 2, 2019)	no assertion criteria provided	VCV000635400	2	172582561	2	171726051	635400	623226		NC_000002.12:171726050:A:G
NM_001378.3(DYNC1I2):c.607+1G>A	DYNC1I2		NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES	Pathogenic(Last reviewed: Jul 2, 2019)	no assertion criteria provided	VCV000635399	2	172582224	2	171725714	635399	623225		NC_000002.12:171725713:G:A
NM_017825.3(ADPRS):c.292del (p.Val98fs)	ADPRS	V98fs	NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES	Pathogenic(Last reviewed: Jan 9, 2019)	no assertion criteria provided	VCV000599344	1	36556924	1	36091323	599344	590641	rs1557733367	NC_000001.11:36091322:GG:G
NM_017825.3(ADPRS):c.100G>A (p.Asp34Asn)	ADPRS	D34N	NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES	Pathogenic(Last reviewed: Nov 8, 2018)	no assertion criteria provided	VCV000590303	1	36554605	1	36089004	590303	581244	rs1557732234	NC_000001.11:36089003:G:A
NM_017825.3(ADPRS):c.530C>T (p.Ser177Leu)	ADPRS	S177L	NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES	Pathogenic(Last reviewed: Nov 8, 2018)	no assertion criteria provided	VCV000590302	1	36557524	1	36091923	590302	581243	rs200626873	NC_000001.11:36091922:C:T
NM_017825.3(ADPRS):c.414_418del (p.Ala139fs)	ADPRS	A139fs	NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES	Pathogenic(Last reviewed: Nov 8, 2018)	no assertion criteria provided	VCV000590301	1	36557322 - 36557326	1	36091721 - 36091725	590301	581242	rs1557733597	NC_000001.11:36091720:CCTGCCC:CC
NM_017825.3(ADPRS):c.235A>C (p.Thr79Pro)	ADPRS	T79P	NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES	Pathogenic(Last reviewed: Nov 8, 2018)	no assertion criteria provided	VCV000590300	1	36556868	1	36091267	590300	581241	rs1557733311	NC_000001.11:36091266:A:C
NM_017825.3(ADPRS):c.1000C>T (p.Gln334Ter)	ADPRS	Q334*	NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES	Pathogenic(Last reviewed: Nov 8, 2018)	no assertion criteria provided	VCV000590298	1	36558895	1	36093294	590298	581239	rs1557734377	NC_000001.11:36093293:C:T
NM_021222.3(PRUNE1):c.196C>T (p.Arg66Ter)	PRUNE1	R66*	not provided	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000430526	1	150991006	1	151018530	430526	421165	rs137929776	NC_000001.11:151018529:C:T
PUM1, THR1035SER	PUM1	T1035S	SPINOCEREBELLAR ATAXIA 47	Pathogenic(Last reviewed: May 1, 2018)	no assertion criteria provided	VCV000523131					523131	513757		
PUM1, ARG1147TRP	PUM1	R1147W	SPINOCEREBELLAR ATAXIA 47, EARLY-ONSET	Pathogenic(Last reviewed: May 1, 2018)	no assertion criteria provided	VCV000523130					523130	513756		
PUM1, ARG1139TRP	PUM1	R1139W	SPINOCEREBELLAR ATAXIA 47, EARLY-ONSET	Pathogenic(Last reviewed: May 1, 2018)	no assertion criteria provided	VCV000523129					523129	513755		
NM_021222.3(PRUNE1):c.889C>T (p.Arg297Trp)	PRUNE1	R297W, R96W, R115W	Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies	Pathogenic(Last reviewed: Sep 19, 2017)	no assertion criteria provided	VCV000427232	1	151001376	1	151028900	427232	416153	rs752599948	NC_000001.11:151028899:C:T
NM_021222.3(PRUNE1):c.160C>A (p.Pro54Thr)	PRUNE1	P54T	Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies	Pathogenic(Last reviewed: Sep 19, 2017)	no assertion criteria provided	VCV000427231	1	150990970	1	151018494	427231	416152	rs1085308033	NC_000001.11:151018493:C:A
NM_207421.4(PADI6):c.1618G>A (p.Gly540Arg)	PADI6	G540R	Preimplantation embryonic lethality 2	Pathogenic(Last reviewed: Dec 2, 2016)	no assertion criteria provided	VCV000372232	1	17722159	1	17395663	372232	359137	rs1057517684	NC_000001.11:17395662:G:A
NM_207421.4(PADI6):c.970C>T (p.Gln324Ter)	PADI6	Q324*	Preimplantation embryonic lethality 2	Pathogenic(Last reviewed: Dec 2, 2016)	no assertion criteria provided	VCV000372231	1	17718616	1	17392121	372231	359136	rs1057517683	NC_000001.11:17392120:C:T
NM_207421.4(PADI6):c.633T>A (p.His211Gln)	PADI6	H211Q	Preimplantation embryonic lethality 2	Pathogenic(Last reviewed: Dec 2, 2016)	no assertion criteria provided	VCV000372230	1	17708541	1	17382046	372230	359135	rs775156958	NC_000001.11:17382045:T:A
NM_207421.4(PADI6):c.2007_2008AG[1] (p.Glu670fs)	PADI6		Preimplantation embryonic lethality 2	Pathogenic(Last reviewed: Dec 2, 2016)	no assertion criteria provided	VCV000372229	1	17727856 - 17727857	1	17401360 - 17401361	372229	359134	rs1057517682	NC_000001.11:17401359:AGAG:AG
NM_207421.4(PADI6):c.1141C>T (p.Gln381Ter)	PADI6	Q381*	Preimplantation embryonic lethality 2	Pathogenic(Last reviewed: Dec 2, 2016)	no assertion criteria provided	VCV000372228	1	17720537	1	17394041	372228	359133	rs1057517681	NC_000001.11:17394040:C:T
NM_001017975.5(HFM1):c.3929_3930delinsG (p.Pro1310fs)	HFM1		Premature ovarian failure 9	Pathogenic(Last reviewed: Mar 6, 2014)	no assertion criteria provided	VCV000126431	1	91731618 - 91731619	1	91266061 - 91266062	126431	131964	rs587777270	NC_000001.11:91266060:GG:C
NM_001017975.5(HFM1):c.2206G>A (p.Gly736Ser)	HFM1	G736S	Premature ovarian failure 9	Pathogenic(Last reviewed: Mar 6, 2014)	no assertion criteria provided	VCV000126430	1	91816295	1	91350738	126430	131963	rs587777269	NC_000001.11:91350737:C:T
NM_001017975.5(HFM1):c.2651T>G (p.Ile884Ser)	HFM1	I884S	Premature ovarian failure 9	Pathogenic(Last reviewed: Mar 6, 2014)	no assertion criteria provided	VCV000126429	1	91784879	1	91319322	126429	131962	rs587777268	NC_000001.11:91319321:A:C
NM_001017975.5(HFM1):c.1686G>C (p.Arg562Ser)	HFM1	R562S	Premature ovarian failure 9	Pathogenic(Last reviewed: Mar 6, 2014)	no assertion criteria provided	VCV000126428	1	91818856	1	91353299	126428	131961	rs730880018	NC_000001.11:91353298:C:G
LAMTOR2, IVS4DS, C-A, +23, 3-PRIME UTR	LAMTOR2		Immunodeficiency due to defect in mapbp-interacting protein	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000001239					1239	16278		
NM_001287491.2(TET3):c.1215del (p.Trp406fs)	TET3	W313fs, W406fs	BECK-FAHRNER SYNDROME	Pathogenic(Last reviewed: Mar 4, 2020)	no assertion criteria provided	VCV000816638	2	74274259	2	74047132	816638	804843		NC_000002.12:74047131:A:
NM_001287491.2(TET3):c.4977_4983del (p.His1660fs)	TET3	H1567fs, H1660fs	BECK-FAHRNER SYNDROME	Pathogenic(Last reviewed: Mar 4, 2020)	no assertion criteria provided	VCV000816637	2	74328890 - 74328896	2	74101763 - 74101769	816637	804842		NC_000002.12:74101762:GCCCACGGC:GC
NM_001287491.2(TET3):c.5083C>T (p.Gln1695Ter)	TET3	Q1695*, Q1602*	BECK-FAHRNER SYNDROME	Pathogenic(Last reviewed: Mar 4, 2020)	no assertion criteria provided	VCV000816636	2	74328998	2	74101871	816636	804841		NC_000002.12:74101870:C:T
NM_001287491.2(TET3):c.2552C>T (p.Thr851Met)	TET3	T851M, T758M	BECK-FAHRNER SYNDROME	Pathogenic(Last reviewed: Mar 4, 2020)	no assertion criteria provided	VCV000816635	2	74300733	2	74073606	816635	804840		NC_000002.12:74073605:C:T
NM_001287491.2(TET3):c.2722G>T (p.Val908Leu)	TET3	V908L, V815L	BECK-FAHRNER SYNDROME	Pathogenic(Last reviewed: Mar 4, 2020)	no assertion criteria provided	VCV000816634	2	74314999	2	74087872	816634	804839		NC_000002.12:74087871:G:T
NM_001287491.2(TET3):c.3226G>A (p.Ala1076Thr)	TET3	A1076T, A983T	BECK-FAHRNER SYNDROME	Pathogenic(Last reviewed: Mar 4, 2020)	no assertion criteria provided	VCV000816633	2	74320752	2	74093625	816633	804838		NC_000002.12:74093624:G:A
NM_001287491.2(TET3):c.3215T>G (p.Phe1072Cys)	TET3	F1072C, F979C	BECK-FAHRNER SYNDROME	Pathogenic(Last reviewed: Mar 4, 2020)	no assertion criteria provided	VCV000816632	2	74320741	2	74093614	816632	804837		NC_000002.12:74093613:T:G
NM_001287491.2(TET3):c.2254C>T (p.Arg752Cys)	TET3	R752C, R659C	BECK-FAHRNER SYNDROME	Pathogenic(Last reviewed: Mar 4, 2020)	no assertion criteria provided	VCV000816631	2	74275298	2	74048171	816631	804836		NC_000002.12:74048170:C:T
NM_001287491.2(TET3):c.3265G>A (p.Val1089Met)	TET3	V1089M, V996M	BECK-FAHRNER SYNDROME	Pathogenic(Last reviewed: Mar 4, 2020)	no assertion criteria provided	VCV000816630	2	74320791	2	74093664	816630	804835		NC_000002.12:74093663:G:A
GRCh37/hg19 2p21(chr2:46844284-46844565)	CRIPT		Short stature with microcephaly and distinctive facies	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625543	2	46844284 - 46844565			625543	613847		
NM_014171.6(CRIPT):c.141del (p.Phe47fs)	CRIPT	F47fs	Short stature with microcephaly and distinctive facies|Ateleiotic dwarfism	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000127250	2	46850904	2	46623765	127250	132706	rs587779348	NC_000002.12:46623764:TTT:TT
NM_014171.6(CRIPT):c.133_134insGG (p.Ala45fs)	CRIPT		Short stature with microcephaly and distinctive facies|Ateleiotic dwarfism	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000127249	2	46846815 - 46846816	2	46619676 - 46619677	127249	132705	rs587779356	NC_000002.12:46619676:G:GGG
NM_021222.3(PRUNE1):c.316G>A (p.Asp106Asn)	PRUNE1	D106N	Abnormality of brain morphology|Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies	Pathogenic/Likely pathogenic(Last reviewed: May 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000402131	1	150991126	1	151018650	402131	389107	rs773618224	NC_000001.11:151018649:G:A
NM_015331.3(NCSTN):c.17del (p.Gly6fs)	NCSTN	G6fs	not provided	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000504025	1	160313199	1	160343409	504025	495062	rs1266104510	NC_000001.11:160343408:GGGGG:GGGG
NM_015331.3(NCSTN):c.1101+1G>A	NCSTN		Familial acne inversa 1	Pathogenic(Last reviewed: Dec 1, 2017)	no assertion criteria provided	VCV000446481	1	160322782	1	160352992	446481	439996	rs1347055289	NC_000001.11:160352991:G:A
NM_015331.3(NCSTN):c.1551+1G>A	NCSTN		Familial acne inversa 1	Pathogenic(Last reviewed: Nov 19, 2010)	no assertion criteria provided	VCV000030453	1	160325749	1	160355959	30453	39410	rs1553210984	NC_000001.11:160355958:G:A
NM_015331.3(NCSTN):c.1752del (p.Glu584fs)	NCSTN	E564fs, E584fs, E446fs	Familial acne inversa 1	Pathogenic(Last reviewed: Nov 19, 2010)	no assertion criteria provided	VCV000030452	1	160326502	1	160356712	30452	39409	rs1553211087	NC_000001.11:160356711:G:
NM_015331.3(NCSTN):c.1300C>T (p.Arg434Ter)	NCSTN	R434*, R414*, R296*	Familial acne inversa 1	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000225419	1	160324028	1	160354238	225419	227203	rs1085307081	NC_000001.11:160354237:C:T
NM_015331.3(NCSTN):c.349C>T (p.Arg117Ter)	NCSTN	R117*, R97*	Familial acne inversa 1	Pathogenic	criteria provided, single submitter	VCV000030454	1	160319373	1	160349583	30454	39411	rs387906896	NC_000001.11:160349582:C:T
NM_145167.2(PIGM):c.-270C>G	PIGM		Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency	Pathogenic(Last reviewed: Apr 19, 2007)	no assertion criteria provided	VCV000001288	1	160001799	1	160032009	1288	16327	rs587776528	NC_000001.11:160032008:G:C
NM_030916.3(NECTIN4):c.229C>T (p.Gln77Ter)	NECTIN4	Q77*	Ectodermal dysplasia-syndactyly syndrome 1	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000807665	1	161049590	1	161079800	807665	798457		NC_000001.11:161079799:G:A
NM_001135254.2(PAX7):c.166C>T (p.Arg56Cys)	PAX7	R56C	MYOPATHY, CONGENITAL, PROGRESSIVE, WITH SCOLIOSIS	Pathogenic(Last reviewed: Sep 12, 2019)	no assertion criteria provided	VCV000689509	1	18960877	1	18634383	689509	677187		NC_000001.11:18634382:C:T
NM_001135254.2(PAX7):c.86-1G>A	PAX7		MYOPATHY, CONGENITAL, PROGRESSIVE, WITH SCOLIOSIS	Pathogenic(Last reviewed: Sep 12, 2019)	no assertion criteria provided	VCV000689507	1	18960796	1	18634302	689507	677185		NC_000001.11:18634301:G:A
NM_001135254.2(PAX7):c.433C>T (p.Arg145Ter)	PAX7	R145*	MYOPATHY, CONGENITAL, PROGRESSIVE, WITH SCOLIOSIS	Pathogenic(Last reviewed: Sep 12, 2019)	no assertion criteria provided	VCV000689506	1	18961716	1	18635222	689506	677184		NC_000001.11:18635221:C:T
NM_001350776.1(MSTO1):c.-266G>A	MSTO1	V8M	Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome	Pathogenic(Last reviewed: Sep 22, 2017)	no assertion criteria provided	VCV000438835	1	155580061	1	155610270	438835	432468	rs762798018	NC_000001.11:155610269:G:A
NM_018116.3(MSTO1):c.966+1G>A	MSTO1		Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome	Pathogenic(Last reviewed: Sep 22, 2017)	no assertion criteria provided	VCV000438834	1	155582362	1	155612571	438834	432467	rs771965165	NC_000001.11:155612570:G:A
NM_018116.3(MSTO1):c.1128C>A (p.Phe376Leu)	MSTO1	F376L, F195L, F199L, F198L, F321L	Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome	Pathogenic(Last reviewed: Sep 22, 2017)	no assertion criteria provided	VCV000438832	1	155582869	1	155613078	438832	432465	rs1553295536	NC_000001.11:155613077:C:A
NM_018116.3(MSTO1):c.1033C>T (p.Arg345Cys)	MSTO1	R345C, R164C, R167C, R290C, R168C	Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome	Pathogenic(Last reviewed: Sep 22, 2017)	no assertion criteria provided	VCV000438831	1	155582701	1	155612910	438831	432464	rs749922789	NC_000001.11:155612909:C:T
NM_024700.4(SNIP1):c.331C>T (p.Arg111Cys)	SNIP1	R111C	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433084	1	38006353	1	37540752	433084	426647	rs202020647	NC_000001.11:37540751:G:A
NM_030916.3(NECTIN4):c.181C>T (p.Gln61Ter)	NECTIN4	Q61*	Ectodermal dysplasia-syndactyly syndrome 1	Pathogenic(Last reviewed: Jan 24, 2018)	no assertion criteria provided	VCV000425552	1	161049638	1	161079848	425552	413893	rs1085307125	NC_000001.11:161079847:G:A
NM_030916.3(NECTIN4):c.724G>A (p.Val242Met)	NECTIN4	V242M	Ectodermal dysplasia-syndactyly syndrome 1	Pathogenic(Last reviewed: Jan 24, 2018)	no assertion criteria provided	VCV000425551	1	161047249	1	161077459	425551	413892	rs1085307124	NC_000001.11:161077458:C:T
NM_201269.3(ZNF644):c.*592G>A	ZNF644		Myopia 21, autosomal dominant	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000031109	1	91381763	1	90916206	31109	40066	rs587776903	NC_000001.11:90916205:C:T
NM_201269.3(ZNF644):c.1759A>G (p.Ile587Val)	ZNF644	I587V	Myopia 21, autosomal dominant	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000031108	1	91405152	1	90939595	31108	40065	rs146936371	NC_000001.11:90939594:T:C
NM_201269.3(ZNF644):c.2014A>G (p.Ser672Gly)	ZNF644	S672G	Myopia 21, autosomal dominant	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000031107	1	91404897	1	90939340	31107	40064	rs387907109	NC_000001.11:90939339:T:C
NM_030916.3(NECTIN4):c.635C>G (p.Pro212Arg)	NECTIN4	P212R	Ectodermal dysplasia-syndactyly syndrome 1	Pathogenic(Last reviewed: May 1, 2011)	no assertion criteria provided	VCV000030794	1	161047338	1	161077548	30794	39751	rs387907014	NC_000001.11:161077547:G:C
NM_024700.4(SNIP1):c.1097A>G (p.Glu366Gly)	SNIP1	E366G	Psychomotor retardation, epilepsy, and craniofacial dysmorphism	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000030717	1	38003443	1	37537842	30717	39674	rs387906986	NC_000001.11:37537841:T:C
NM_001004311.3(FIGLA):c.416_418ACA[1] (p.Asn140del)	FIGLA	N140del	Premature ovarian failure 6	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000002138	2	71012735 - 71012737	2	70785603 - 70785605	2138	17177	rs71647804	NC_000002.12:70785602:TGTTGTT:TGTT
NM_001004311.3(FIGLA):c.15_36del (p.Gly6fs)	FIGLA	G6fs	Premature ovarian failure 6	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000002137	2	71017735 - 71017756	2	70790603 - 70790624	2137	17176	rs587776535	NC_000002.12:70790602:GGCGCGGGGATCTAGGACGCCGGGCGCGGGG:GGCGCGGGG
NM_030916.3(NECTIN4):c.906del (p.Pro304fs)	NECTIN4	P304fs	Ectodermal dysplasia-syndactyly syndrome 1	Pathogenic(Last reviewed: Aug 13, 2010)	no assertion criteria provided	VCV000001602	1	161044495	1	161074705	1602	16641	rs730880260	NC_000001.11:161074704:AAA:AA
NM_030916.3(NECTIN4):c.851G>A (p.Arg284Gln)	NECTIN4	R284Q	Ectodermal dysplasia-syndactyly syndrome 1	Pathogenic(Last reviewed: Aug 13, 2010)	no assertion criteria provided	VCV000001600	1	161046145	1	161076355	1600	16639	rs267606991	NC_000001.11:161076354:C:T
NM_001004311.3(FIGLA):c.2T>C (p.Met1Thr)	FIGLA	M1T	Premature ovarian failure 6	Pathogenic(Last reviewed: Jun 21, 2019)	no assertion criteria provided	VCV000635131	2	71017769	2	70790637	635131	622966	rs1001164504	NC_000002.12:70790636:A:G
NM_030916.3(NECTIN4):c.554C>T (p.Thr185Met)	NECTIN4	T185M	Ectodermal dysplasia-syndactyly syndrome 1	Pathogenic(Last reviewed: Aug 13, 2010)	no assertion criteria provided	VCV000001601	1	161047419	1	161077629	1601	16640	rs267606992	NC_000001.11:161077628:G:A
NM_005645.4(TAF13):c.92T>A (p.Leu31His)	TAF13	L31H	Mental retardation, autosomal recessive 60|not provided	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	VCV000375727	1	109617623	1	109075001	375727	362617	rs1060505030	NC_000001.11:109075000:A:T
NM_005645.4(TAF13):c.119T>A (p.Met40Lys)	TAF13	M40K	Mental retardation, autosomal recessive 60|not provided	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	VCV000375726	1	109608842	1	109066220	375726	362616	rs1060505029	NC_000001.11:109066219:A:T
NM_144772.3(NAXE):c.468_478delinsATCCCTTTCCTTGGGG (p.Gln157fs)	NAXE		not provided	Pathogenic(Last reviewed: Feb 13, 2017)	criteria provided, single submitter	VCV000423748	1	156562414 - 156562424	1	156592622 - 156592632	423748	404955	rs1064796609	NC_000001.11:156592621:CCAGTGTCAGA:ATCCCTTTCCTTGGGG
NM_016233.2(PADI3):c.628C>T (p.Arg210Trp)	PADI3	R210W	Central centrifugal cicatricial alopecia	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000599199	1	17594433	1	17267938	599199	590371	rs139876092	NC_000001.11:17267937:C:T
NM_016233.2(PADI3):c.1955G>A (p.Arg652Lys)	PADI3	R652K	Central centrifugal cicatricial alopecia	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000599198	1	17609534	1	17283039	599198	590376	rs1437225536	NC_000001.11:17283038:G:A
NM_016233.2(PADI3):c.832-2A>G	PADI3		Central centrifugal cicatricial alopecia	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000599197	1	17597372	1	17270877	599197	590372	rs1557508308	NC_000001.11:17270876:A:G
NM_016233.2(PADI3):c.1669C>T (p.Arg557Trp)	PADI3	R557W	Central centrifugal cicatricial alopecia	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000599196	1	17607199	1	17280704	599196	590374	rs140482516	NC_000001.11:17280703:C:T
NM_016233.2(PADI3):c.1744G>A (p.Ala582Thr)	PADI3	A582T	Central centrifugal cicatricial alopecia	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000599195	1	17607274	1	17280779	599195	590375	rs34097903	NC_000001.11:17280778:G:A
NM_016233.2(PADI3):c.1813C>A (p.Pro605Thr)	PADI3	P605T	Uncombable hair syndrome	Pathogenic(Last reviewed: Mar 7, 2019)	no assertion criteria provided	VCV000374869	1	17609392	1	17282897	374869	361774	rs144944758	NC_000001.11:17282896:C:A
NM_144772.3(NAXE):c.653A>T (p.Asp218Val)	NAXE	D218V	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy 1	Pathogenic(Last reviewed: Nov 14, 2016)	no assertion criteria provided	VCV000268121	1	156563336	1	156593544	268121	263647	rs886041064	NC_000001.11:156593543:A:T
NM_144772.3(NAXE):c.804_807delinsA (p.Lys270del)	NAXE		Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy 1	Pathogenic(Last reviewed: Nov 14, 2016)	no assertion criteria provided	VCV000268119	1	156563813 - 156563816	1	156594021 - 156594024	268119	263645	rs886041062	NC_000001.11:156594020:GAAG:A
NM_144772.3(NAXE):c.516+1G>A	NAXE		Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy 1	Pathogenic(Last reviewed: Nov 14, 2016)	no assertion criteria provided	VCV000268118	1	156562463	1	156592671	268118	263644	rs139093330	NC_000001.11:156592670:G:A
NM_144772.3(NAXE):c.196C>T (p.Gln66Ter)	NAXE	Q66*	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy 1	Pathogenic(Last reviewed: Nov 14, 2016)	no assertion criteria provided	VCV000268117	1	156561906	1	156592114	268117	263643	rs759251812	NC_000001.11:156592113:C:T
NM_144772.3(NAXE):c.177C>A (p.Tyr59Ter)	NAXE	Y59*	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy 1	Pathogenic(Last reviewed: Nov 14, 2016)	no assertion criteria provided	VCV000268116	1	156561773	1	156591981	268116	263642	rs371872027	NC_000001.11:156591980:C:A
NM_144772.3(NAXE):c.281C>A (p.Ala94Asp)	NAXE	A94D	Infantile encephalopathy	Pathogenic(Last reviewed: Nov 14, 2016)	no assertion criteria provided	VCV000253145	1	156561991	1	156592199	253145	247557	rs879255647	NC_000001.11:156592198:C:A
NM_052965.4(TSEN15):c.346C>T (p.His116Tyr)	TSEN15	H116Y	Pontocerebellar hypoplasia, type 2f	Pathogenic(Last reviewed: Sep 26, 2016)	no assertion criteria provided	VCV000243001	1	184023990	1	184054856	243001	244081	rs879253780	NC_000001.11:184054855:C:T
NM_052965.4(TSEN15):c.455A>G (p.Tyr152Cys)	TSEN15	Y152C	Pontocerebellar hypoplasia, type 2f	Pathogenic(Last reviewed: Sep 26, 2016)	no assertion criteria provided	VCV000243000	1	184041392	1	184072258	243000	244080	rs879253779	NC_000001.11:184072257:A:G
NM_016233.2(PADI3):c.856A>G (p.Thr286Ala)	PADI3	T286A	Central centrifugal cicatricial alopecia	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000599194	1	17597398	1	17270903	599194	590373	rs139426141	NC_000001.11:17270902:A:G
NM_016233.2(PADI3):c.335T>A (p.Leu112His)	PADI3	L112H	Uncombable hair syndrome	Pathogenic(Last reviewed: Jan 6, 2020)	no assertion criteria provided	VCV000374868	1	17588689	1	17262194	374868	361773	rs142129409	NC_000001.11:17262193:T:A
NM_144772.3(NAXE):c.743del (p.Ala248fs)	NAXE	A248fs	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy 1	Pathogenic(Last reviewed: Nov 14, 2016)	no assertion criteria provided	VCV000268120	1	156563752	1	156593960	268120	263646	rs886041063	NC_000001.11:156593959:C:
NM_016233.2(PADI3):c.881C>T (p.Ala294Val)	PADI3	A294V	Uncombable hair syndrome	Pathogenic(Last reviewed: Jan 6, 2020)	no assertion criteria provided	VCV000374867	1	17597423	1	17270928	374867	361772	rs144080386	NC_000001.11:17270927:C:T
NM_052965.4(TSEN15):c.226T>G (p.Trp76Gly)	TSEN15	W76G	Pontocerebellar hypoplasia, type 2f|Global developmental delay|Primary microcephaly|Seizures	Pathogenic/Likely pathogenic(Last reviewed: Jan 13, 2015)	no assertion criteria provided	VCV000183315	1	184023870	1	184054736	183315	181398	rs730882223	NC_000001.11:184054735:T:G
NM_001105537.4(ZNF142):c.4002del (p.Leu1335fs)	ZNF142	L1172fs, L1335fs, L1535fs	Intellectual disability|Seizures	Pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000635279	2	219507237	2	218642514	635279	623113		NC_000002.12:218642513:CCC:CC
NM_000701.8(ATP1A1):c.907G>C (p.Gly303Arg)	ATP1A1	G303R, G272R	Hypomagnesemia, seizures, and mental retardation 2	Pathogenic(Last reviewed: Feb 4, 2019)	no assertion criteria provided	VCV000617642	1	116932213	1	116389591	617642	609045	rs1557785503	NC_000001.11:116389590:G:C
NM_000701.8(ATP1A1):c.905T>C (p.Leu302Pro)	ATP1A1	L302R, L302P, L271P	Hypomagnesemia, seizures, and mental retardation 2	Pathogenic(Last reviewed: Feb 4, 2019)	no assertion criteria provided	VCV000617641	1	116932211	1	116389589	617641	609044	rs1557785499	NC_000001.11:116389588:T:C
NM_000701.8(ATP1A1):c.143T>G (p.Leu48Arg)	ATP1A1	L48R, L17R	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD	Pathogenic(Last reviewed: Jun 28, 2018)	no assertion criteria provided	VCV000545677	1	116927424	1	116384802	545677	536169	rs1553190285	NC_000001.11:116384801:T:G
NM_000701.8(ATP1A1):c.995T>G (p.Val332Gly)	ATP1A1	V332G, V301G		Pathogenic(Last reviewed: Feb 17, 2013)	no assertion criteria provided	VCV000162468	1	116932301	1	116389679	162468	172141	rs724160010	NC_000001.11:116389678:T:G
NM_000701.8(ATP1A1):c.311T>G (p.Leu104Arg)	ATP1A1	L104R, L73R		Pathogenic(Last reviewed: Feb 17, 2013)	no assertion criteria provided	VCV000162466	1	116930037	1	116387415	162466	172140	rs11540945	NC_000001.11:116387414:T:G
NM_000701.8(ATP1A1):c.299_313del (p.Phe100_Leu104del)	ATP1A1			Pathogenic(Last reviewed: Feb 17, 2013)	no assertion criteria provided	VCV000162465	1	116930023 - 116930037	1	116387401 - 116387415	162465	172139	rs724160008	NC_000001.11:116387400:GTTCTCAATGTTACTGT:GT
NM_001256165.1(TMCO1):c.-252_-251GA[1]	TMCO1		Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	Pathogenic(Last reviewed: Jan 5, 2010)	no assertion criteria provided	VCV000031100	1	165738001 - 165738002	1	165768764 - 165768765	31100	40057	rs397518448	NC_000001.11:165768763:TCTCT:TCT
NM_032545.3(CFC1):c.361_362+18dup	CFC1		Heterotaxy, visceral, 2, autosomal	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000005190	2	131355422 - 131355423	2	130597849 - 130597850	5190	20229	rs863223280	NC_000002.12:130597849:GCGCACCCCTGTGCCCACCTGCGC:GCGCACCCCTGTGCCCACCTGCGCACCCCTGTGCCCACCTGCGC
NM_001270420.1(CFC1):c.248-293C>T	CFC1	R112C	Heterotaxy, visceral, 2, autosomal	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000005187	2	131355469	2	130597896	5187	20226	rs104893611	NC_000002.12:130597895:G:A
NM_001791.4(CDC42):c.476C>T (p.Ala159Val)	CDC42	A159V	not provided	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000487653	1	22413349	1	22086856	487653	480737	rs1553196134	NC_000001.11:22086855:C:T
NM_032545.3(CFC1):c.522del (p.Ala175fs)	CFC1	A136fs, A100fs, A175fs	Heterotaxy, visceral, 2, autosomal	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000005188	2	131350600	2	130593027	5188	20227	rs746231039	NC_000002.12:130593026:G:
NM_001105537.3(ZNF142):c.817_818delAA (p.Lys273Glufs)	ZNF142	K110fs, K273fs, K473fs	NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000627543	2	219513813 - 219513814	2	218649090 - 218649091	627543	615898	rs1447313633	NC_000002.12:218649089:TT:
NM_001105537.3(ZNF142):c.1292delG (p.Cys431Leufs)	ZNF142	C268fs, C431fs, C631fs	NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000627542	2	219511053	2	218646330	627542	615897	rs1559296368	NC_000002.12:218646329:C:
NM_001791.4(CDC42):c.203G>A (p.Arg68Gln)	CDC42	R68Q	not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000450370	1	22412956	1	22086463	450370	442723	rs1553196096	NC_000001.11:22086462:G:A
NM_001256164.1(TMCO1):c.188_189AG[1] (p.Gln63_Ser64insTer)	TMCO1		Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome|not provided	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000420165	1	165737437 - 165737438	1	165768200 - 165768201	420165	404973	rs752176040	NC_000001.11:165768199:CTCT:CT
NM_019026.4(TMCO1):c.476+3G>C	TMCO1		Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	Pathogenic(Last reviewed: Jan 15, 2014)	criteria provided, single submitter	VCV000218899	1	165721336	1	165752099	218899	215660	rs372701032	NC_000001.11:165752098:C:G
NM_019026.4(TMCO1):c.412C>T (p.Arg138Ter)	TMCO1	R87*, R138*, R75*, R104*	Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000088739	1	165721403	1	165752166	88739	94316	rs201213306	NC_000001.11:165752165:G:A
NM_001791.4(CDC42):c.511G>A (p.Glu171Lys)	CDC42	E171K	Noonan-Like Syndrome Disorder|Takenouchi-Kosaki syndrome	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000487654	1	22417945	1	22091452	487654	480738	rs1553196539	NC_000001.11:22091451:G:A
NM_001791.4(CDC42):c.247T>C (p.Ser83Pro)	CDC42	S83P	Takenouchi-Kosaki syndrome|not provided	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000487652	1	22413000	1	22086507	487652	480736	rs1553196101	NC_000001.11:22086506:T:C
NM_001256164.1(TMCO1):c.147-9_147-6del	TMCO1	V30fs, V81fs, V18fs	Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	Pathogenic(Last reviewed: Jul 15, 2014)	criteria provided, single submitter	VCV000189248	1	165737487 - 165737490	1	165768250 - 165768253	189248	187105	rs786204789	NC_000001.11:165768249:AACCA:A
NM_203342.2(EPB41):c.39T>G (p.Tyr13Ter)	EPB41	Y13*, Y222*	not provided	Pathogenic(Last reviewed: Nov 23, 2018)	criteria provided, single submitter	VCV000620455	1	29320039	1	28993527	620455	611519	rs1557948590	NC_000001.11:28993526:T:G
NM_203342.2(EPB41):c.1A>G (p.Met1Val)	EPB41	M1V, M210V	not provided	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000618091	1	29320001	1	28993489	618091	609421	rs1557948192	NC_000001.11:28993488:A:G
NC_000001.11:g.29203234del	MECR		Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000807442	1	29529743	1	29203231	807442	798471		NC_000001.11:29203230:CCCC:CCC
NM_032793.5(MFSD2A):c.229-25_229-23del	MFSD2A	V82del	Intrauterine growth retardation|Intellectual disability|Delayed gross motor development|Microcephaly|Febrile seizures|Functional abnormality of male internal genitalia|Cryptorchidism|Hyperammonemia	Pathogenic	no assertion criteria provided	VCV000684729	1	40424346 - 40424348	1	39958674 - 39958676	684729	672321		NC_000001.11:39958673:GTTGT:GT
NG_050967.1:g.291668_510915del	EXOC6B		SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3	Pathogenic(Last reviewed: Apr 17, 2019)	no assertion criteria provided	VCV000625846					625846	614150		
NM_015189.3(EXOC6B):c.906T>A (p.Tyr302Ter)	EXOC6B	Y302*, Y189*	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3	Pathogenic(Last reviewed: Apr 17, 2019)	no assertion criteria provided	VCV000625845	2	72786591	2	72559462	625845	614149	rs1294100541	NC_000002.12:72559461:A:T
NM_001005388.2(NFASC):c.3365T>A (p.Val1122Glu)	NFASC	V1122E, V1051E, V1071E, V944E, V1056E	NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION	Pathogenic(Last reviewed: Mar 14, 2019)	no assertion criteria provided	VCV000620657	1	204978760	1	205009632	620657	612043	rs754724304	NC_000001.11:205009631:T:A
NM_001005388.2(NFASC):c.2470+2039C>T	NFASC	R846*, R831*	NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION	Pathogenic(Last reviewed: Jan 3, 2020)	no assertion criteria provided	VCV000620656	1	204953187	1	204984059	620656	612042	rs755160624	NC_000001.11:204984058:C:T
NM_001005388.2(NFASC):c.1076G>C (p.Arg359Pro)	NFASC	R370P, R359P, R353P	NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION	Pathogenic(Last reviewed: Mar 14, 2019)	no assertion criteria provided	VCV000620655	1	204939816	1	204970688	620655	612041	rs767453033	NC_000001.11:204970687:G:C
NM_030650.3(LNPK):c.751C>T (p.Arg251Ter)	LNPK	R251*, R282*, R128*, R253*, R317*	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM	Pathogenic(Last reviewed: Aug 17, 2018)	no assertion criteria provided	VCV000559607	2	176804341	2	175939613	559607	550328	rs1391644554	NC_000002.12:175939612:G:A
NM_030650.3(LNPK):c.726del (p.Pro243fs)	LNPK	P120fs, P243fs, P309fs, P245fs, P274fs	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM	Pathogenic(Last reviewed: Aug 17, 2018)	no assertion criteria provided	VCV000559606	2	176804366	2	175939638	559606	550327	rs1553498948	NC_000002.12:175939637:T:
NM_032793.5(MFSD2A):c.1016C>T (p.Ser339Leu)	MFSD2A	S339L, S352L, S300L, S183L, S224L, S337L	Primary autosomal recessive microcephaly 15	Pathogenic(Last reviewed: Jan 23, 2018)	no assertion criteria provided	VCV000372262	1	40433304	1	39967632	372262	359167	rs1057519087	NC_000001.11:39967631:C:T
NM_032793.5(MFSD2A):c.497C>T (p.Ser166Leu)	MFSD2A	S166L, S179L, S10L, S129L, S164L, S51L	Primary autosomal recessive microcephaly 15	Pathogenic(Last reviewed: Jan 23, 2018)	no assertion criteria provided	VCV000372261	1	40431162	1	39965490	372261	359166	rs1057517689	NC_000001.11:39965489:C:T
NM_032793.5(MFSD2A):c.476C>T (p.Thr159Met)	MFSD2A	T159M, T172M, T122M, T157M, T44M, T3M	Primary autosomal recessive microcephaly 15	Pathogenic(Last reviewed: Jan 23, 2018)	no assertion criteria provided	VCV000372260	1	40431005	1	39965333	372260	359165	rs1057517688	NC_000001.11:39965332:C:T
NM_203342.2(EPB41):c.444_450del (p.Asn149fs)	EPB41	N323fs, N149fs, N358fs	Hereditary elliptocytosis	Pathogenic(Last reviewed: Dec 25, 2015)	no assertion criteria provided	VCV000221297	1	29344901 - 29344907	1	29018389 - 29018395	221297	223026	rs869025285	NC_000001.11:29018388:GAATCAG:
NM_203342.2(EPB41):c.2T>C (p.Met1Thr)	EPB41	M1T, M210T	Elliptocytosis 1	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000016715	1	29320002	1	28993490	16715	31754	rs121434564	NC_000001.11:28993489:T:C
NM_203342.2(EPB41):c.2T>G (p.Met1Arg)	EPB41	M1R, M210R	Elliptocytosis 1	Pathogenic(Last reviewed: Nov 1, 1992)	no assertion criteria provided	VCV000016714	1	29320002	1	28993490	16714	31753	rs121434564	NC_000001.11:28993489:T:G
NM_022716.4(PRRX1):c.266_269dup (p.Arg92fs)	PRRX1			Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000050497	1	170688887 - 170688888	1	170719746 - 170719747	50497	59534	rs398122375	NC_000001.11:170719746:AAAAAAA:AAAAAAAAAAA
NM_022716.4(PRRX1):c.269del (p.Lys90fs)	PRRX1	K90fs		Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000050496	1	170688888	1	170719747	50496	59533	rs398122375	NC_000001.11:170719746:AAAAAAA:AAAAAA
NM_022716.4(PRRX1):c.691G>C (p.Ala231Pro)	PRRX1	A231P		Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000029826	1	170705280	1	170736139	29826	38781		NC_000001.11:170736138:G:C
NM_022716.4(PRRX1):c.338T>C (p.Phe113Ser)	PRRX1	F113S		Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000029825	1	170688963	1	170719822	29825	38780	rs387906667	NC_000001.11:170719821:T:C
NM_004437.3(EPB41):c.1219_1458del	EPB41		Elliptocytosis 1	Pathogenic(Last reviewed: Jan 1, 1993)	no assertion criteria provided	VCV000016713					16713	31752		
NM_004437.3(EPB41):c.1219_1587del	EPB41		Elliptocytosis 1	Pathogenic(Last reviewed: Jan 1, 1993)	no assertion criteria provided	VCV000016712					16712	31751		
NM_016011.5(MECR):c.247_250del (p.Asn83fs)	MECR	N111fs, N33fs, N83fs, N118fs, N7fs	Childhood Onset Dystonias|Optic atrophy|Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2017)	no assertion criteria provided	VCV000374883	1	29543124 - 29543127	1	29216612 - 29216615	374883	361788	rs1057519287	NC_000001.11:29216611:GATTGAT:GAT
NM_016011.5(MECR):c.854A>G (p.Tyr285Cys)	MECR	Y285C, Y235C, Y209C, Y313C, Y320C	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities|Childhood Onset Dystonias|Optic atrophy	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2017)	no assertion criteria provided	VCV000374881	1	29522747	1	29196235	374881	361786	rs759218713	NC_000001.11:29196234:T:C
NM_016011.5(MECR):c.855T>G (p.Tyr285Ter)	MECR	Y285*, Y235*, Y209*, Y313*, Y320*	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities|Childhood Onset Dystonias|Optic atrophy	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2017)	no assertion criteria provided	VCV000374879	1	29522746	1	29196234	374879	361784	rs1057519286	NC_000001.11:29196233:A:C
NM_016011.4(MECR):c.772C>T (p.Arg258Trp)	MECR	R258W, R182W, R286W, R208W, R293W	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities|Childhood Onset Dystonias|Optic atrophy	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000374882	1	29527086	1	29200574	374882	361787	rs145192716	NC_000001.11:29200573:G:A
NM_019026.4(TMCO1):c.616C>T (p.Arg206Ter)	TMCO1	R206*, R155*, R172*, R143*	Global developmental delay|Delayed speech and language development|Rib fusion|Bilateral cleft lip and palate|Renal agenesis|Severe visual impairment|Bilateral cleft lip|Unilateral renal agenesis|Relative macrocephaly|Hemivertebrae|Abnormality of the sternum|Cleft palate|Cryptorchidism|Scoliosis|Autistic disorder of childhood onset|Pulmonic stenosis (disease)|Sensorineural hearing loss|Strabismus|Bilateral cleft palate|Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	Pathogenic	criteria provided, single submitter	VCV000598963	1	165712409	1	165743172	598963	590035	rs765379963	NC_000001.11:165743171:G:A
NM_203342.2(EPB41):c.-159_159del	EPB41		Elliptocytosis 1	Pathogenic(Last reviewed: Aug 1, 1990)	no assertion criteria provided	VCV000016711					16711	31750		
NM_001031725.6(DDX59):c.185del (p.Phe62fs)	DDX59	F62fs	Orofaciodigital syndrome V	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801603	1	200635684	1	200666556	801603	789911		NC_000001.11:200666555:AAA:AA
NM_015836.3(WARS2):c.134G>T (p.Gly45Val)	WARS2	G45V	NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES	Pathogenic(Last reviewed: Oct 10, 2017)	no assertion criteria provided	VCV000440919	1	119619187	1	119076564	440919	434547	rs1553241795	NC_000001.11:119076563:C:A
NM_015836.3(WARS2):c.325del (p.Ser109fs)	WARS2	S109fs	NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES	Pathogenic(Last reviewed: Oct 10, 2017)	no assertion criteria provided	VCV000440914	1	119618996	1	119076373	440914	434542	rs1253426801	NC_000001.11:119076372:TTTTTT:TTTTT
NM_001031725.6(DDX59):c.1600G>A (p.Gly534Arg)	DDX59	G534R, G356R, G420R, G450R, G491R	Orofaciodigital syndrome V	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000088654	1	200613642	1	200644514	88654	94242	rs886037652	NC_000001.11:200644513:C:T
NM_015836.3(WARS2):c.532G>C (p.Val178Leu)	WARS2	V178L	NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000440920	1	119576820	1	119034197	440920	434548	rs912133959	NC_000001.11:119034196:C:G
NM_032833.4(PPP1R15B):c.1972C>T (p.Arg658Cys)	PPP1R15B	R658C	Microcephaly, short stature, and impaired glucose metabolism 2	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000222030	1	204375390	1	204406262	222030	223738	rs869025335	NC_000001.11:204406261:G:A
NM_001031725.6(DDX59):c.1100T>G (p.Val367Gly)	DDX59	V367G	not provided|Orofaciodigital syndrome V	Pathogenic(Last reviewed: Mar 16, 2015)	criteria provided, single submitter	VCV000088653	1	200619767	1	200650639	88653	94241	rs587777067	NC_000001.11:200650638:A:C
NM_001791.4(CDC42):c.191A>G (p.Tyr64Cys)	CDC42	Y64C	Takenouchi-Kosaki syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000218950	1	22412944	1	22086451	218950	215784	rs864309721	NC_000001.11:22086450:A:G
NM_002585.4(PBX1):c.392del (p.Ala131fs)	PBX1	A131fs, A48fs	not provided	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000817451	1	164761857	1	164792620	817451	805187		NC_000001.11:164792619:C:
NM_002585.4(PBX1):c.370_371dup (p.Gly125fs)	PBX1		not provided	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000817312	1	164761834 - 164761835	1	164792597 - 164792598	817312	805186		NC_000001.11:164792597:GG:GGGG
NM_002585.4(PBX1):c.661G>T (p.Glu221Ter)	PBX1	E221*, E138*	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000807456	1	164769086	1	164799849	807456	798458		NC_000001.11:164799848:G:T
NM_002585.3(PBX1):c.422C>G (p.Ser141Ter)	PBX1	S141*, S58*	not provided	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, single submitter	VCV000620254	1	164761887	1	164792650	620254	611496	rs866426234	NC_000001.11:164792649:C:G
NM_002585.3(PBX1):c.783dup (p.Ser262fs)	PBX1		CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY	Pathogenic(Last reviewed: Apr 26, 2018)	no assertion criteria provided	VCV000523091	1	164776856 - 164776857	1	164807619 - 164807620	523091	513703	rs1553249146	NC_000001.11:164807619:CCCC:CCCCC
NM_002585.3(PBX1):c.704G>A (p.Arg235Gln)	PBX1	R235Q, R152Q	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY	Pathogenic(Last reviewed: Apr 26, 2018)	no assertion criteria provided	VCV000523090	1	164776781	1	164807544	523090	513702	rs1553249136	NC_000001.11:164807543:G:A
NM_002585.3(PBX1):c.701G>C (p.Arg234Pro)	PBX1	R234P, R151P	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY	Pathogenic(Last reviewed: Apr 26, 2018)	no assertion criteria provided	VCV000523089	1	164769126	1	164799889	523089	513701	rs1553248112	NC_000001.11:164799888:G:C
NM_002585.3(PBX1):c.680G>C (p.Arg227Pro)	PBX1	R227P, R144P	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY	Pathogenic(Last reviewed: Apr 26, 2018)	no assertion criteria provided	VCV000523088	1	164769105	1	164799868	523088	513700	rs1553248110	NC_000001.11:164799867:G:C
NM_002585.3(PBX1):c.413_419del (p.Gly138fs)	PBX1	G138fs, G55fs	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	VCV000488567	1	164761877 - 164761883	1	164792640 - 164792646	488567	481435	rs1553247020	NC_000001.11:164792639:GGGGCAGG:G
NM_002585.3(PBX1):c.511-2A>G	PBX1		CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY	Pathogenic(Last reviewed: Aug 25, 2017)	no assertion criteria provided	VCV000437837	1	164768934	1	164799697	437837	431427	rs1553248075	NC_000001.11:164799696:A:G
NM_002585.3(PBX1):c.550C>T (p.Arg184Ter)	PBX1	R184*, R101*	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY	Pathogenic(Last reviewed: Aug 25, 2017)	no assertion criteria provided	VCV000437836	1	164768975	1	164799738	437836	431426	rs1553248081	NC_000001.11:164799737:C:T
NM_002585.3(PBX1):c.428del (p.Asn143fs)	PBX1	N143fs, N60fs	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY	Pathogenic(Last reviewed: Aug 25, 2017)	no assertion criteria provided	VCV000437835	1	164761892	1	164792655	437835	431425	rs1553247028	NC_000001.11:164792654:AA:A
NM_000066.4(C8B):c.1041_1047dup (p.Leu350fs)	C8B			Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000035597	1	57411551 - 57411552	1	56945878 - 56945879	35597	44262	rs398122868	NC_000001.11:56945878:CACAGCC:CACAGCCCACAGCC
NM_000066.4(C8B):c.605del (p.Pro202fs)	C8B	P140fs, P202fs, P150fs		Pathogenic(Last reviewed: Nov 15, 1995)	no assertion criteria provided	VCV000035596	1	57417782	1	56952109	35596	44261	rs398122867	NC_000001.11:56952108:GGGG:GGG
NM_000066.4(C8B):c.336del (p.Asn113fs)	C8B	N51fs, N61fs, N113fs		Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000035595	1	57422497	1	56956824	35595	44260	rs372968576	NC_000001.11:56956823:GG:G
NM_000066.4(C8B):c.820C>T (p.Arg274Ter)	C8B	R274*, R222*, R212*		Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000035592	1	57415272	1	56949599	35592	44257	rs140813121	NC_000001.11:56949598:G:A
NM_000066.4(C8B):c.361C>T (p.Arg121Ter)	C8B	R121*, R69*, R59*		Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000035593	1	57422472	1	56956799	35593	44258	rs150022116	NC_000001.11:56956798:G:A
NM_000066.4(C8B):c.271C>T (p.Gln91Ter)	C8B	Q91*, Q39*, Q29*	Complement component 6 deficiency|	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000035594	1	57422562	1	56956889	35594	44259	rs146187042	NC_000001.11:56956888:G:A
NM_006236.3(POU3F3):c.398_407del (p.Pro133fs)	POU3F3	P133fs	SNIJDERS BLOK-FISHER SYNDROME	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000807662	2	105472360 - 105472369	2	104855902 - 104855911	807662	798479		NC_000002.12:104855901:GCAGCCCCCAGCAGCC:GCAGCC
NM_005687.5(FARSB):c.226T>C (p.Cys76Arg)	FARSB	C76R	Cirrhosis of liver|Cerebral calcification|Dilatation|Interstitial pneumonitis	Pathogenic	criteria provided, single submitter	VCV000545695	2	223507613	2	222642894	545695	536187	rs1419129874	NC_000002.12:222642893:A:G
NM_005687.5(FARSB):c.784A>G (p.Lys262Glu)	FARSB	K262E	Cirrhosis of liver|Cerebral calcification|Dilatation|Interstitial pneumonitis	Pathogenic(Last reviewed: May 28, 2018)	criteria provided, single submitter	VCV000545655	2	223496325	2	222631606	545655	536151	rs1553554543	NC_000002.12:222631605:T:C
NM_006236.3(POU3F3):c.1284C>A (p.Cys428Ter)	POU3F3	C428*	SNIJDERS BLOK-FISHER SYNDROME	Pathogenic(Last reviewed: Jan 3, 2020)	no assertion criteria provided	VCV000691587	2	105473252	2	104856794	691587	679287		NC_000002.12:104856793:C:A
NM_006236.3(POU3F3):c.668C>A (p.Ser223Ter)	POU3F3	S223*	SNIJDERS BLOK-FISHER SYNDROME	Pathogenic(Last reviewed: Oct 3, 2019)	no assertion criteria provided	VCV000691586	2	105472636	2	104856178	691586	679286		NC_000002.12:104856177:C:A
NM_006236.3(POU3F3):c.196_197delinsT (p.Asp66fs)	POU3F3		SNIJDERS BLOK-FISHER SYNDROME	Pathogenic(Last reviewed: Oct 3, 2019)	no assertion criteria provided	VCV000691585	2	105472164 - 105472165	2	104855706 - 104855707	691585	679285		NC_000002.12:104855705:GA:T
NM_006236.3(POU3F3):c.1367A>G (p.Asn456Ser)	POU3F3	N456S	SNIJDERS BLOK-FISHER SYNDROME	Pathogenic(Last reviewed: Oct 3, 2019)	no assertion criteria provided	VCV000691584	2	105473335	2	104856877	691584	679284		NC_000002.12:104856876:A:G
NM_006236.3(POU3F3):c.1220G>T (p.Arg407Leu)	POU3F3	R407L	SNIJDERS BLOK-FISHER SYNDROME	Pathogenic(Last reviewed: Oct 3, 2019)	no assertion criteria provided	VCV000691583	2	105473188	2	104856730	691583	679283		NC_000002.12:104856729:G:T
NM_006236.3(POU3F3):c.1085G>T (p.Arg362Leu)	POU3F3	R362L	SNIJDERS BLOK-FISHER SYNDROME	Pathogenic(Last reviewed: Oct 3, 2019)	no assertion criteria provided	VCV000691582	2	105473053	2	104856595	691582	679282		NC_000002.12:104856594:G:T
NM_020832.3(ZNF687):c.725G>T (p.Ser242Ile)	ZNF687	S242I	Paget disease of bone 6	Pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	VCV000222988	1	151259492	1	151287016	222988	224709	rs869025582	NC_000001.11:151287015:G:T
NM_006492.3(ALX3):c.586C>T (p.Arg196Trp)	ALX3	R196W	Frontonasal dysplasia 1	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000004648	1	110607217	1	110064595	4648	19687	rs121908170	NC_000001.11:110064594:G:A
NM_006492.3(ALX3):c.574_577CTGA[1] (p.Thr193fs)	ALX3		Frontonasal dysplasia 1	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000004647	1	110607222 - 110607225	1	110064600 - 110064603	4647	19686	rs387906319	NC_000001.11:110064599:TCAGTCAG:TCAG
NM_006492.3(ALX3):c.543T>A (p.Tyr181Ter)	ALX3	Y181*	Frontonasal dysplasia 1	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000004646	1	110607260	1	110064638	4646	19685	rs121908169	NC_000001.11:110064637:A:T
NM_006492.3(ALX3):c.547C>T (p.Arg183Trp)	ALX3	R183W	Frontonasal dysplasia 1	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000004645	1	110607256	1	110064634	4645	19684	rs121908168	NC_000001.11:110064633:G:A
NM_006492.3(ALX3):c.608A>G (p.Asn203Ser)	ALX3	N203S	Frontonasal dysplasia 1	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000004643	1	110604172	1	110061550	4643	19682	rs121908166	NC_000001.11:110061549:T:C
NM_006492.3(ALX3):c.595-2A>T	ALX3		Frontonasal dysplasia 1	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000004642	1	110604187	1	110061565	4642	19681		NC_000001.11:110061564:T:A
NM_006492.3(ALX3):c.502C>G (p.Leu168Val)	ALX3	L168V	Frontonasal dysplasia 1	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000004644	1	110607301	1	110064679	4644	19683	rs121908167	NC_000001.11:110064678:G:C
NM_005687.5(FARSB):c.755T>C (p.Phe252Ser)	FARSB	F252S	Rajab interstitial lung disease with brain calcifications|Cirrhosis of liver|Cerebral calcification|Dilatation|Interstitial pneumonitis	Pathogenic(Last reviewed: Feb 8, 2019)	no assertion criteria provided	VCV000545694	2	223496354	2	222631635	545694	536186	rs1466642025	NC_000002.12:222631634:A:G
NM_005687.5(FARSB):c.1202G>A (p.Arg401Gln)	FARSB	R401Q	Rajab interstitial lung disease with brain calcifications|Cirrhosis of liver|Cerebral calcification|Dilatation|Interstitial pneumonitis	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000545664	2	223488418	2	222623699	545664	536160	rs1553553086	NC_000002.12:222623698:C:T
NM_005687.5(FARSB):c.1381A>C (p.Thr461Pro)	FARSB	T461P	Rajab interstitial lung disease with brain calcifications|Cirrhosis of liver|Cerebral calcification|Dilatation|Interstitial pneumonitis	Pathogenic(Last reviewed: May 28, 2018)	criteria provided, single submitter	VCV000545642	2	223478611	2	222613892	545642	536138	rs1396171148	NC_000002.12:222613891:T:G
NM_005687.5(FARSB):c.848+1G>A	FARSB		Rajab interstitial lung disease with brain calcifications|not provided	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	VCV000545501	2	223494831	2	222630112	545501	536007	rs777071414	NC_000002.12:222630111:C:T
NM_005687.5(FARSB):c.767C>T (p.Thr256Met)	FARSB	T256M	Rajab interstitial lung disease with brain calcifications|Interstitial lung and liver disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2019)	no assertion criteria provided	VCV000487455	2	223496342	2	222631623	487455	480513	rs753710639	NC_000002.12:222631622:G:A
NM_020832.3(ZNF687):c.2810C>G (p.Pro937Arg)	ZNF687	P937R	Paget disease of bone 6	Pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	VCV000222987	1	151262329	1	151289853	222987	224708	rs148402804	NC_000001.11:151289852:C:G
NM_005687.5(FARSB):c.1486delinsAA (p.His496fs)	FARSB		not provided|Rajab interstitial lung disease with brain calcifications|Interstitial lung and liver disease	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000487456	2	223464779	2	222600060	487456	480514	rs1553549333	NC_000002.12:222600059:G:TT
NM_013386.5(SLC25A24):c.649C>T (p.Arg217Cys)	SLC25A24	R198C, R217C	Fontaine progeroid syndrome	Pathogenic	criteria provided, single submitter	VCV000369980	1	108700104	1	108157482	369980	354197	rs1553253990	NC_000001.11:108157481:G:A
NM_016011.4(MECR):c.830+2dup	MECR		Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities|Childhood Onset Dystonias|Optic atrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449055	1	29527026	1	29200513 - 29200514	449055	442819	rs756421370	NC_000001.11:29200513:A:AA
NM_016653.3(MAP3K20):c.282dup (p.Asn95Ter)	MAP3K20		MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000446160	2	174047614 - 174047615	2	173182886 - 173182887	446160	439507	rs1553576774	NC_000002.12:173182886:TT:TTT
NM_016653.3(MAP3K20):c.490_491del (p.Met164fs)	MAP3K20	M164fs	MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000446158	2	174055813 - 174055814	2	173191085 - 173191086	446158	439505	rs1293675104	NC_000002.12:173191084:AT:
NM_006000.3(TUBA4A):c.643C>T (p.Arg215Cys)	TUBA4A	R215C, R200C	Amyotrophic lateral sclerosis 22 with frontotemporal dementia	Pathogenic(Last reviewed: Oct 22, 2014)	no assertion criteria provided	VCV000180185	2	220115778	2	219251056	180185	178368	rs730880028	NC_000002.12:219251055:G:A
NM_033440.3(CELA2A):c.209C>T (p.Thr70Met)	CELA2A	T70M	Coronary artery disease|Hypertriglyceridemia|Diabetes|Hypertensive disorder	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000633595	1	15788135	1	15461640	633595	622024		NC_000001.11:15461639:C:T
NM_016653.3(MAP3K20):c.515G>A (p.Trp172Ter)	MAP3K20	W172*	MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000446159	2	174055838	2	173191110	446159	439506	rs1553578407	NC_000002.12:173191109:G:A
NM_006000.3(TUBA4A):c.433A>C (p.Thr145Pro)	TUBA4A	T145P, T130P	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	Pathogenic(Last reviewed: Oct 22, 2014)	no assertion criteria provided	VCV000180187	2	220115988	2	219251266	180187	178370	rs730880029	NC_000002.12:219251265:T:G
NM_006000.3(TUBA4A):c.1147G>A (p.Ala383Thr)	TUBA4A	A383T, A368T	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	Pathogenic(Last reviewed: Oct 22, 2014)	no assertion criteria provided	VCV000180186	2	220115274	2	219250552	180186	178369	rs368743618	NC_000002.12:219250551:C:T
NM_006000.3(TUBA4A):c.1220G>A (p.Trp407Ter)	TUBA4A	W407*, W392*	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	Pathogenic(Last reviewed: Oct 22, 2014)	no assertion criteria provided	VCV000180184	2	220115201	2	219250479	180184	178367	rs730880027	NC_000002.12:219250478:C:T
NM_006000.3(TUBA4A):c.959G>A (p.Arg320His)	TUBA4A	R320H, R305H	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	Pathogenic(Last reviewed: Oct 22, 2014)	no assertion criteria provided	VCV000180183	2	220115462	2	219250740	180183	178366	rs730880026	NC_000002.12:219250739:C:T
NM_006000.3(TUBA4A):c.958C>T (p.Arg320Cys)	TUBA4A	R320C, R305C	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	Pathogenic(Last reviewed: Oct 22, 2014)	no assertion criteria provided	VCV000180182	2	220115463	2	219250741	180182	178365	rs730880025	NC_000002.12:219250740:G:A
NM_177402.5(SYT2):c.923C>T (p.Pro308Leu)	SYT2	P308L	Myasthenic syndrome, congenital, 7, presynaptic	Pathogenic(Last reviewed: Sep 4, 2014)	no assertion criteria provided	VCV000156369	1	202568476	1	202599348	156369	166148	rs587777782	NC_000001.11:202599347:G:A
NM_177402.5(SYT2):c.920A>C (p.Asp307Ala)	SYT2	D307A	Myasthenic syndrome, congenital, 7, presynaptic	Pathogenic(Last reviewed: Sep 4, 2014)	no assertion criteria provided	VCV000156368	1	202568479	1	202599351	156368	166147	rs587777781	NC_000001.11:202599350:T:G
NM_019885.3(CYP26B1):c.436T>C (p.Ser146Pro)	CYP26B1	S146P, S71P	not provided|Radiohumeral fusions with other skeletal and craniofacial anomalies	Pathogenic(Last reviewed: Nov 11, 2011)	no assertion criteria provided	VCV000030448	2	72362542	2	72135413	30448	39405	rs281875232	NC_000002.12:72135412:A:G
NM_019885.3(CYP26B1):c.1088G>T (p.Arg363Leu)	CYP26B1	R363L, R288L	not provided|Radiohumeral fusions with other skeletal and craniofacial anomalies	Pathogenic(Last reviewed: Nov 11, 2011)	no assertion criteria provided	VCV000030447	2	72360210	2	72133081	30447	39404	rs281875231	NC_000002.12:72133080:C:A
NM_033440.3(CELA2A):c.639+1G>C	CELA2A		Familial partial lipodystrophy 6|Coronary artery disease|Hypertriglyceridemia|Diabetes|Hypertensive disorder	Pathogenic(Last reviewed: Oct 11, 2019)	no assertion criteria provided	VCV000633594	1	15792640	1	15466145	633594	622027		NC_000001.11:15466144:G:C
NM_033440.3(CELA2A):c.253C>A (p.Leu85Met)	CELA2A	L85M	Coronary artery disease|Hypertriglyceridemia|Diabetes|Hypertensive disorder|Familial partial lipodystrophy 6	Pathogenic(Last reviewed: Oct 10, 2019)	no assertion criteria provided	VCV000633593	1	15789253	1	15462758	633593	622025		NC_000001.11:15462757:C:A
NM_033440.3(CELA2A):c.361G>A (p.Asp121Asn)	CELA2A	D121N	Coronary artery disease|Hypertriglyceridemia|Diabetes|Hypertensive disorder|Familial partial lipodystrophy 6	Pathogenic(Last reviewed: Oct 10, 2019)	no assertion criteria provided	VCV000633592	1	15789885	1	15463390	633592	622026		NC_000001.11:15463389:G:A
NM_002709.3(PPP1CB):c.166G>C (p.Ala56Pro)	PPP1CB	A56P	Noonan syndrome-like disorder with loose anagen hair 2	Pathogenic(Last reviewed: May 31, 2017)	no assertion criteria provided	VCV000427633	2	28999830	2	28776964	427633	417069	rs1114167429	NC_000002.12:28776963:G:C
TBX15, 1-BP DEL, 1044A	TBX15		Pelviscapular dysplasia	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000005823					5823	20862		
TBX15, 1-BP DEL, 1042A	TBX15		Pelviscapular dysplasia	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000005822					5822	20861		
NM_001009999.3(KDM1A):c.1207G>A (p.Glu403Lys)	KDM1A	E403K, E379K	Cleft palate, psychomotor retardation, and distinctive facial features	Pathogenic(Last reviewed: Sep 30, 2015)	criteria provided, single submitter	VCV000218912	1	23395059	1	23068566	218912	215724	rs864309715	NC_000001.11:23068565:G:A
NM_021133.4(RNASEL):c.3G>A (p.Met1Ile)	RNASEL	M1I	Prostate cancer, hereditary, 1	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000013005	1	182555939	1	182586804	13005	28044	rs74315365	NC_000001.11:182586803:C:T
NM_002709.3(PPP1CB):c.548A>C (p.Glu183Ala)	PPP1CB	E183A	not provided|Noonan syndrome-like disorder with loose anagen hair 2	Pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	VCV000254652	2	29006800	2	28783934	254652	249187	rs886037954	NC_000002.12:28783933:A:C
NM_002709.3(PPP1CB):c.548A>T (p.Glu183Val)	PPP1CB	E183V	not provided|Noonan syndrome-like disorder with loose anagen hair 2	Pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	VCV000254651	2	29006800	2	28783934	254651	249188	rs886037954	NC_000002.12:28783933:A:T
NM_001009999.3(KDM1A):c.2353T>C (p.Tyr785His)	KDM1A	Y785H, Y761H, Y767H	Cleft palate, psychomotor retardation, and distinctive facial features	Pathogenic(Last reviewed: Sep 30, 2015)	criteria provided, single submitter	VCV000218911	1	23408767	1	23082274	218911	215723	rs864309714	NC_000001.11:23082273:T:C
NM_001009999.3(KDM1A):c.1739A>G (p.Asp580Gly)	KDM1A	D580G, D556G, D562G	Cleft palate, psychomotor retardation, and distinctive facial features	Pathogenic(Last reviewed: Sep 30, 2015)	criteria provided, single submitter	VCV000218913	1	23403725	1	23077232	218913	215725	rs864309716	NC_000001.11:23077231:A:G
NM_013386.5(SLC25A24):c.650G>A (p.Arg217His)	SLC25A24	R198H, R217H	Fontaine progeroid syndrome	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370032	1	108700103	1	108157481	370032	354272	rs1553253989	NC_000001.11:108157480:C:T
NC_000001.11:g.(?_111120496)_(111120713_?)del	DRAM2		not provided	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000833095	1	111663118 - 111663335			833095	818838		
NM_194302.4(CFAP65):c.2675G>A (p.Trp892Ter)	CFAP65	W892*	SPERMATOGENIC FAILURE 40	Pathogenic(Last reviewed: Nov 21, 2019)	no assertion criteria provided	VCV000694583	2	219888074	2	219023352	694583	682656		NC_000002.12:219023351:C:T
NM_194302.4(CFAP65):c.1580del (p.Leu527fs)	CFAP65	L462fs, L516fs, L527fs	SPERMATOGENIC FAILURE 40	Pathogenic(Last reviewed: Nov 21, 2019)	no assertion criteria provided	VCV000694536	2	219894195	2	219029473	694536	682587		NC_000002.12:219029472:A:
NM_194302.4(CFAP65):c.2284C>T (p.Arg762Ter)	CFAP65	R762*	SPERMATOGENIC FAILURE 40	Pathogenic(Last reviewed: Nov 20, 2019)	no assertion criteria provided	VCV000694535	2	219890809	2	219026087	694535	682586		NC_000002.12:219026086:G:A
NM_178454.5(DRAM2):c.217_225del (p.Val73_Tyr75del)	DRAM2		Retinal dystrophy	Pathogenic(Last reviewed: Nov 1, 2014)	criteria provided, single submitter	VCV000192236	1	111667478 - 111667486	1	111124856 - 111124864	192236	190035	rs786205663	NC_000001.11:111124855:ATAACGAACATAA:ATAA
NM_178454.5(DRAM2):c.79T>C (p.Tyr27His)	DRAM2	Y27H	Retinal dystrophy	Pathogenic(Last reviewed: Nov 1, 2014)	criteria provided, single submitter	VCV000192235	1	111674098	1	111131476	192235	190038	rs786205662	NC_000001.11:111131475:A:G
NM_178454.5(DRAM2):c.494G>A (p.Trp165Ter)	DRAM2	W165*, W75*, W35*	Cone-rod dystrophy 21|Retinal dystrophy	Pathogenic(Last reviewed: Nov 1, 2014)	criteria provided, single submitter	VCV000192239	1	111663161	1	111120539	192239	190033	rs201422368	NC_000001.11:111120538:C:T
NM_178454.5(DRAM2):c.131G>A (p.Ser44Asn)	DRAM2	S44N	Cone-rod dystrophy 21|Retinal dystrophy	Pathogenic(Last reviewed: Nov 1, 2014)	criteria provided, single submitter	VCV000192238	1	111674046	1	111131424	192238	190037	rs786205665	NC_000001.11:111131423:C:T
NM_178454.5(DRAM2):c.362A>T (p.His121Leu)	DRAM2	H121L, H31L	Cone-rod dystrophy 21|Retinal dystrophy	Pathogenic(Last reviewed: Nov 1, 2014)	criteria provided, single submitter	VCV000192237	1	111663293	1	111120671	192237	190034	rs786205664	NC_000001.11:111120670:T:A
NM_178454.5(DRAM2):c.61_63GCT[1] (p.Ala22del)	DRAM2	A22del	Cone-rod dystrophy 21|Retinal dystrophy	Pathogenic(Last reviewed: Nov 1, 2014)	criteria provided, single submitter	VCV000192234	1	111674111 - 111674113	1	111131489 - 111131491	192234	190039	rs786205661	NC_000001.11:111131488:AGCAGCAG:AGCAG
NM_178454.5(DRAM2):c.140del (p.Gly47fs)	DRAM2	G47fs	Cone-rod dystrophy 21|Retinal dystrophy	Pathogenic(Last reviewed: Nov 1, 2014)	criteria provided, single submitter	VCV000192233	1	111668908	1	111126286	192233	190036	rs746559651	NC_000001.11:111126285:CC:C
NC_000001.10:g.57832716_57832797ins[(ATTTT)60-79(ATTTC)31-75(ATTTT)58-90]	DAB1		Spinocerebellar ataxia 37	Pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000430691	1	57832716 - 57832797			430691	424219		
NM_212552.3(BOLA3):c.220_222del (p.Glu74del)	BOLA3	E74del	Multiple mitochondrial dysfunctions syndrome 2	Pathogenic(Last reviewed: Mar 9, 2020)	no assertion criteria provided	VCV000816938	2	74369435 - 74369437	2	74142308 - 74142310	816938	805142		NC_000002.12:74142307:CTCCT:CT
NM_153741.2(DPM3):c.254T>A (p.Leu85Ter)	DPM3	L85*, L115*	Congenital disorder of glycosylation type 1O	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000694278	1	155112463	1	155139987	694278	682123		NC_000001.11:155139986:A:T
NM_173651.4(FSIP2):c.910del (p.Gln304fs)	FSIP2	Q304fs	SPERMATOGENIC FAILURE 34	Pathogenic(Last reviewed: Oct 22, 2018)	no assertion criteria provided	VCV000586972	2	186618488	2	185753761	586972	578018	rs773975635	NC_000002.12:185753760:C:
NM_173651.4(FSIP2):c.16389_16392AATA[1] (p.Asn5465fs)	FSIP2		SPERMATOGENIC FAILURE 34	Pathogenic(Last reviewed: Oct 22, 2018)	no assertion criteria provided	VCV000586971	2	186670421 - 186670424	2	185805694 - 185805697	586971	578017	rs1559034750	NC_000002.12:185805693:AAATAAATA:AAATA
NM_198173.3(GRHL3):c.899G>A (p.Trp300Ter)	GRHL3	W254*, W300*, W305*	Van der Woude syndrome 2	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000465251	1	24664540	1	24338050	465251	448069	rs1553172687	NC_000001.11:24338049:G:A
NM_212552.3(BOLA3):c.136C>T (p.Arg46Ter)	BOLA3	R46*	Multiple mitochondrial dysfunctions syndrome 2	Pathogenic(Last reviewed: Dec 22, 2017)	no assertion criteria provided	VCV000224514	2	74372349	2	74145222	224514	226292	rs143492730	NC_000002.12:74145221:G:A
NM_198173.3(GRHL3):c.1285+2del	GRHL3		nonsyndromic cleft palate	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000219246	1	24669264	1	24342774	219246	217267	rs886037770	NC_000001.11:24342773:T:
NM_198173.2(GRHL3):c.916delCinsCC (p.Arg306Profs)	GRHL3		nonsyndromic cleft palate	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000219245	1	24664554 - 24664555	1	24338064 - 24338065	219245	217266	rs886037769	NC_000001.11:24338064:CCC:CCCC
NM_198173.3(GRHL3):c.840+1G>T	GRHL3		nonsyndromic cleft palate	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000219244	1	24664280	1	24337790	219244	217265	rs886037768	NC_000001.11:24337789:G:T
NM_198173.3(GRHL3):c.738C>T (p.Gly246=)	GRHL3		nonsyndromic cleft palate	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000219243	1	24664177	1	24337687	219243	217264	rs886037767	NC_000001.11:24337686:C:T
NM_198173.3(GRHL3):c.1171C>T (p.Arg391Cys)	GRHL3	R391C, R396C, R345C	Van der Woude syndrome 2	Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000101520	1	24668728	1	24342238	101520	107263	rs879255245	NC_000001.11:24342237:C:T
NM_198173.3(GRHL3):c.1419+1G>T	GRHL3		Van der Woude syndrome 2	Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000101519	1	24669516	1	24343026	101519	107262	rs879255244	NC_000001.11:24343025:G:T
NM_212552.3(BOLA3):c.200T>A (p.Ile67Asn)	BOLA3	I67N	Multiple mitochondrial dysfunctions syndrome 2	Pathogenic(Last reviewed: Mar 9, 2020)	no assertion criteria provided	VCV000816698	2	74369457	2	74142330	816698	804904		NC_000002.12:74142329:A:T
NM_198173.3(GRHL3):c.893G>A (p.Arg298His)	GRHL3	R298H, R252H, R303H	Van der Woude syndrome 2	Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000101518	1	24664534	1	24338044	101518	107261	rs752673677	NC_000001.11:24338043:G:A
NM_198173.3(GRHL3):c.1559_1562GGAG[1] (p.Glu522fs)	GRHL3		Van der Woude syndrome 2	Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000101517	1	24673973 - 24673976	1	24347483 - 24347486	101517	107260	rs879255243	NC_000001.11:24347482:GGAGGGAG:GGAG
NM_198173.3(GRHL3):c.970_971insGT (p.Phe324fs)	GRHL3		Van der Woude syndrome 2	Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000101516	1	24666174 - 24666175	1	24339684 - 24339685	101516	107259	rs879255573	NC_000001.11:24339684:T:TGT
NM_212552.3(BOLA3):c.123dup (p.Glu42fs)	BOLA3		Multiple mitochondrial dysfunctions syndrome 2	Pathogenic(Last reviewed: Oct 7, 2011)	no assertion criteria provided	VCV000031020	2	74372361 - 74372362	2	74145234 - 74145235	31020	39977	rs869320737	NC_000002.12:74145234:TTT:TTTT
NM_001231.5(CASQ1):c.731A>G (p.Asp244Gly)	CASQ1	D244G	Myopathy, vacuolar, with casq1 aggregates	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000183021	1	160165766	1	160195976	183021	181172	rs730882052	NC_000001.11:160195975:A:G
NM_153741.2(DPM3):c.254T>C (p.Leu85Ser)	DPM3	L85S, L115S	Congenital disorder of glycosylation type 1O	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000004702	1	155112463	1	155139987	4702	19741	rs121908155	NC_000001.11:155139986:A:G
NM_153741.2(DPM3):c.41T>C (p.Leu14Pro)	DPM3	L44P, L14P	Congenital disorder of glycosylation type 1O	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000585021	1	155112676	1	155140200	585021	576073	rs778481307	NC_000001.11:155140199:A:G
NM_001010898.4(SLC6A17):c.1898C>G (p.Pro633Arg)	SLC6A17	P633R	Mental retardation, autosomal recessive 48	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000187770	1	110740780	1	110198158	187770	185668	rs375380880	NC_000001.11:110198157:C:G
NM_001010898.4(SLC6A17):c.484G>A (p.Gly162Arg)	SLC6A17	G162R	Mental retardation, autosomal recessive 48	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000187769	1	110716634	1	110174012	187769	185667	rs775085213	NC_000001.11:110174011:G:A
NM_001658.4(ARF1):c.296G>A (p.Arg99His)	ARF1	R99H	PERIVENTRICULAR NODULAR HETEROTOPIA 8	Pathogenic(Last reviewed: Nov 13, 2018)	no assertion criteria provided	VCV000590334	1	228285328	1	228097627	590334	581272	rs1558087712	NC_000001.11:228097626:G:A
NM_001658.4(ARF1):c.379A>G (p.Lys127Glu)	ARF1	K127E	PERIVENTRICULAR NODULAR HETEROTOPIA 8	Pathogenic(Last reviewed: Nov 13, 2018)	no assertion criteria provided	VCV000590333	1	228285411	1	228097710	590333	581271	rs1558087795	NC_000001.11:228097709:A:G
NM_001658.4(ARF1):c.103T>C (p.Tyr35His)	ARF1	Y35H	PERIVENTRICULAR NODULAR HETEROTOPIA 8	Pathogenic(Last reviewed: Nov 13, 2018)	no assertion criteria provided	VCV000590332	1	228284918	1	228097217	590332	581270	rs879036238	NC_000001.11:228097216:T:C
NM_004425.4(ECM1):c.826C>T (p.Gln276Ter)	ECM1	Q276*, Q303*	Lipid proteinosis	Pathogenic(Last reviewed: Nov 19, 2015)	no assertion criteria provided	VCV000222944	1	150484050	1	150511574	222944	224663	rs869025563	NC_000001.11:150511573:C:T
NM_004425.4(ECM1):c.1393-1G>T	ECM1		Lipid proteinosis	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000587581	1	150485712	1	150513236	587581	578361	rs1560267428	NC_000001.11:150513235:G:T
NM_004425.4(ECM1):c.93_94delinsTT (p.Arg31_Gln32delinsSerTer)	ECM1		Lipid proteinosis	Pathogenic(Last reviewed: Nov 19, 2015)	no assertion criteria provided	VCV000222949	1	150482029 - 150482030	1	150509553 - 150509554	222949	224664	rs869025567	NC_000001.11:150509552:GC:TT
NM_004425.4(ECM1):c.658T>G (p.Cys220Gly)	ECM1	C220G, C247G	Lipid proteinosis	Pathogenic(Last reviewed: Nov 19, 2015)	no assertion criteria provided	VCV000222948	1	150483624	1	150511148	222948	224661	rs869025566	NC_000001.11:150511147:T:G
NM_004425.4(ECM1):c.727C>T (p.Arg243Ter)	ECM1	R243*, R270*	Lipid proteinosis	Pathogenic(Last reviewed: Nov 19, 2015)	no assertion criteria provided	VCV000222946	1	150483951	1	150511475	222946	224662	rs746217361	NC_000001.11:150511474:C:T
NM_004425.4(ECM1):c.480G>A (p.Trp160Ter)	ECM1	W160*, W187*	Lipid proteinosis	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000007477	1	150483446	1	150510970	7477	22516	rs1560265435	NC_000001.11:150510969:G:A
NM_004425.4(ECM1):c.499T>A (p.Phe167Ile)	ECM1	F167I, F194I	Lipid proteinosis	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000007476	1	150483465	1	150510989	7476	22515	rs121909116	NC_000001.11:150510988:T:A
NM_004425.4(ECM1):c.157C>T (p.Arg53Ter)	ECM1	R53*	Lipid proteinosis	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000007475	1	150482172	1	150509696	7475	22514	rs121909115	NC_000001.11:150509695:C:T
ECM1, 1163-BP DEL	ECM1		Lipid proteinosis	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000007473					7473	22512		
NM_004425.4(ECM1):c.1036C>T (p.Gln346Ter)	ECM1	Q346*, Q373*	Lipid proteinosis	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000007472	1	150484260	1	150511784	7472	22511	rs121909114	NC_000001.11:150511783:C:T
NM_004425.4(ECM1):c.1019del (p.Gln340fs)	ECM1	Q340fs, Q367fs	Lipid proteinosis	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000007471	1	150484243	1	150511767	7471	22510	rs778473713	NC_000001.11:150511766:A:
NM_004425.4(ECM1):c.506dup (p.Gly170fs)	ECM1		Lipid proteinosis	Pathogenic(Last reviewed: Nov 19, 2015)	no assertion criteria provided	VCV000222945	1	150483466 - 150483467	1	150510990 - 150510991	222945	224659	rs869025564	NC_000001.11:150510990:CCCCCC:CCCCCCC
NM_152515.5(CKAP2L):c.1092_1093del (p.Gln364fs)	CKAP2L	Q364fs, Q199fs	not provided	Pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	VCV000451430	2	113513855 - 113513856	2	112756278 - 112756279	451430	442906	rs755184431	NC_000002.12:112756277:TCT:T
NM_144563.3(RPIA):c.627G>C (p.Trp209Cys)	RPIA	W209C	Deficiency of ribose-5-phosphate isomerase	Pathogenic(Last reviewed: Jun 21, 2019)	no assertion criteria provided	VCV000635118	2	89036082	2	88736565	635118	622953	rs1558699183	NC_000002.12:88736564:G:C
NM_004446.3(EPRS1):c.3377T>C (p.Met1126Thr)	EPRS1	M1126T	LEUKODYSTROPHY, HYPOMYELINATING, 15	Pathogenic(Last reviewed: May 3, 2018)	no assertion criteria provided	VCV000523137	1	220154796	1	219981454	523137	513763	rs1474000585	NC_000001.11:219981453:A:G
NM_004446.3(EPRS1):c.3667del (p.Thr1223fs)	EPRS1	T1223fs	LEUKODYSTROPHY, HYPOMYELINATING, 15	Pathogenic(Last reviewed: May 3, 2018)	no assertion criteria provided	VCV000523136	1	220153471	1	219980129	523136	513762	rs1553318956	NC_000001.11:219980128:TT:T
NM_004446.3(EPRS1):c.3478C>T (p.Pro1160Ser)	EPRS1	P1160S	LEUKODYSTROPHY, HYPOMYELINATING, 15	Pathogenic(Last reviewed: May 3, 2018)	no assertion criteria provided	VCV000523135	1	220154175	1	219980833	523135	513761	rs898824971	NC_000001.11:219980832:G:A
NM_004446.3(EPRS1):c.1015C>T (p.Arg339Ter)	EPRS1	R339*	LEUKODYSTROPHY, HYPOMYELINATING, 15	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000523134	1	220195789	1	220022447	523134	513760	rs763737931	NC_000001.11:220022446:G:A
NM_004446.3(EPRS1):c.3344C>G (p.Pro1115Arg)	EPRS1	P1115R	LEUKODYSTROPHY, HYPOMYELINATING, 15	Pathogenic(Last reviewed: Aug 20, 2019)	no assertion criteria provided	VCV000523133	1	220156143	1	219982801	523133	513759	rs1288116010	NC_000001.11:219982800:G:C
NM_152515.5(CKAP2L):c.554_555del (p.Lys185fs)	CKAP2L	K185fs, K20fs	Filippi syndrome	Pathogenic(Last reviewed: Nov 6, 2014)	no assertion criteria provided	VCV000162389	2	113514393 - 113514394	2	112756816 - 112756817	162389	172092	rs727502805	NC_000002.12:112756815:TTT:T
NM_001304361.2(CKAP2L):c.-280-59_-11del	CKAP2L		Filippi syndrome	Pathogenic(Last reviewed: Nov 6, 2014)	no assertion criteria provided	VCV000162388	2	113514463 - 113514791	2	112756886 - 112757214	162388	172091	rs1553442237	
NM_152515.5(CKAP2L):c.751del (p.Ser251fs)	CKAP2L	S86fs, S251fs	Filippi syndrome	Pathogenic(Last reviewed: Nov 6, 2014)	no assertion criteria provided	VCV000162387	2	113514197	2	112756620	162387	172090	rs727502804	NC_000002.12:112756619:TTT:TT
C8A, ARG394TER	C8A	R394*		Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000029661					29661	38616		
C8A, IVS2, G-T, +1	C8A			Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000029660					29660	38615		
NM_144563.3(RPIA):c.404C>T (p.Ala135Val)	RPIA	A61V, A135V	Deficiency of ribose-5-phosphate isomerase	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000013008	2	89028797	2	88729279	13008	28047	rs121918591	NC_000002.12:88729278:C:T
NM_152515.5(CKAP2L):c.78_79insTT (p.Gly27fs)	CKAP2L		Filippi syndrome	Pathogenic(Last reviewed: Nov 6, 2014)	no assertion criteria provided	VCV000162386	2	113520105 - 113520106	2	112762528 - 112762529	162386	172089	rs727502803	NC_000002.12:112762528::AA
NM_152515.5(CKAP2L):c.2T>C (p.Met1Thr)	CKAP2L	M1T	Filippi syndrome	Pathogenic(Last reviewed: Nov 6, 2014)	no assertion criteria provided	VCV000162385	2	113522174	2	112764597	162385	172088	rs548949031	NC_000002.12:112764596:A:G
NM_152515.5(CKAP2L):c.571dup (p.Ile191fs)	CKAP2L		Filippi syndrome	Pathogenic(Last reviewed: Nov 6, 2014)	no assertion criteria provided	VCV000162384	2	113514376 - 113514377	2	112756799 - 112756800	162384	172087	rs727502802	NC_000002.12:112756799:T:TT
NM_004425.4(ECM1):c.507del (p.Arg171fs)	ECM1	R171fs, R198fs	Lipid proteinosis	Pathogenic(Last reviewed: Nov 19, 2015)	no assertion criteria provided	VCV000222947	1	150483473	1	150510997	222947	224660	rs869025565	NC_000001.11:150510996:T:
NM_144563.3(RPIA):c.762del (p.Asn255fs)	RPIA	N255fs	Deficiency of ribose-5-phosphate isomerase	Pathogenic(Last reviewed: Sep 1, 2010)	no assertion criteria provided	VCV000013007	2	89037515	2	88737998	13007	28046	rs730880316	NC_000002.12:88737997:GGG:GG
NM_014698.3(TMEM63A):c.1699G>A (p.Gly567Ser)	TMEM63A	G567S	LEUKODYSTROPHY, HYPOMYELINATING, 19, TRANSIENT INFANTILE|Leukodystrophy	Pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, single submitter	VCV000689461	1	226041428	1	225853727	689461	677054		NC_000001.11:225853726:C:T
NM_014698.3(TMEM63A):c.1385T>A (p.Ile462Asn)	TMEM63A	I462N	LEUKODYSTROPHY, HYPOMYELINATING, 19, TRANSIENT INFANTILE|Leukodystrophy	Pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, single submitter	VCV000689460	1	226044710	1	225857010	689460	677053		NC_000001.11:225857009:A:T
NM_014698.3(TMEM63A):c.503G>A (p.Gly168Glu)	TMEM63A	G168E	LEUKODYSTROPHY, HYPOMYELINATING, 19, TRANSIENT INFANTILE|Leukodystrophy	Pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, single submitter	VCV000689459	1	226055599	1	225867899	689459	677052		NC_000001.11:225867898:C:T
NM_000066.4(C8B):c.1282C>T (p.Arg428Ter)	C8B	R428*, R376*, R366*	|Complement component 6 deficiency|not provided	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017038	1	57406638	1	56940965	17038	32077	rs41286844	NC_000001.11:56940964:G:A
NM_001311193.2(PLA2G4A):c.378+17114dup	PLA2G4A		GASTROINTESTINAL ULCERATION, RECURRENT, WITH DYSFUNCTIONAL PLATELETS	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807464	1	186880456 - 186880457	1	186911324 - 186911325	807464	798461		NC_000001.11:186911324:T:TT
NM_003038.5(SLC1A4):c.1035-381_1230-73del	SLC1A4		Spastic tetraplegia, thin corpus callosum, and progressive microcephaly	Pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000488671	2	65244824 - 65245606	2	65017690 - 65018472	488671	481555	rs1553375174	
NM_024420.2(PLA2G4A):c.2118+4_2118+7del	PLA2G4A		GASTROINTESTINAL ULCERATION, RECURRENT, WITH DYSFUNCTIONAL PLATELETS	Pathogenic(Last reviewed: Mar 29, 2019)	no assertion criteria provided	VCV000624622	1	186948605 - 186948608	1	186979473 - 186979476	624622	613441	rs1557901999	NC_000001.11:186979472:GTAAGTA:GTA
NM_024420.2(PLA2G4A):c.1723G>C (p.Asp575His)	PLA2G4A	D575H, D515H	GASTROINTESTINAL ULCERATION, RECURRENT, WITH DYSFUNCTIONAL PLATELETS	Pathogenic(Last reviewed: Mar 29, 2019)	no assertion criteria provided	VCV000624621	1	186934684	1	186965552	624621	613440	rs1557895416	NC_000001.11:186965551:G:C
NM_003038.5(SLC1A4):c.1364+1G>A	SLC1A4		Spastic tetraplegia, thin corpus callosum, and progressive microcephaly	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000587615	2	65245814	2	65018680	587615	578404	rs1558529034	NC_000002.12:65018679:G:A
NM_024420.2(PLA2G4A):c.1454G>A (p.Arg485His)	PLA2G4A	R485H, R425H	GASTROINTESTINAL ULCERATION, RECURRENT, WITH DYSFUNCTIONAL PLATELETS	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000009080	1	186925351	1	186956219	9080	24119	rs121434635	NC_000001.11:186956218:G:A
NM_024420.2(PLA2G4A):c.331T>C (p.Ser111Pro)	PLA2G4A	S111P	GASTROINTESTINAL ULCERATION, RECURRENT, WITH DYSFUNCTIONAL PLATELETS	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000009079	1	186863296	1	186894164	9079	24118	rs121434634	NC_000001.11:186894163:T:C
NC_000002.12:g.(?_71109950)_(71130239_?)del	MCEE		Methylmalonyl-CoA epimerase deficiency	Pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, single submitter	VCV000833393	2	71337080 - 71357369			833393	819268		
NM_003038.5(SLC1A4):c.944_945del (p.Leu315fs)	SLC1A4	L95fs, L315fs	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly	Pathogenic(Last reviewed: Nov 25, 2015)	no assertion criteria provided	VCV000372157	2	65243717 - 65243718	2	65016583 - 65016584	372157	359062	rs1057517664	NC_000002.12:65016582:TT:
NM_004389.3(CTNNA2):c.1480C>T (p.Arg494Ter)	CTNNA2	R494*, R528*, R126*, R173*	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9	Pathogenic(Last reviewed: Nov 5, 2018)	no assertion criteria provided	VCV000590261	2	80773128	2	80546003	590261	581203	rs778294237	NC_000002.12:80546002:C:T
NM_001164883.1(CTNNA2):c.2295+4050C>T	CTNNA2	R781*, R460*, R815*, R413*	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9	Pathogenic(Last reviewed: Nov 5, 2018)	no assertion criteria provided	VCV000590260	2	80835354	2	80608229	590260	581202	rs1413537928	NC_000002.12:80608228:C:T
NM_004389.3(CTNNA2):c.2644C>T (p.Arg882Ter)	CTNNA2	R882*, R916*, R930*, R514*, R562*, R837*, R561*	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9	Pathogenic(Last reviewed: Nov 5, 2018)	no assertion criteria provided	VCV000590259	2	80874923	2	80647798	590259	581201	rs760139097	NC_000002.12:80647797:C:T
NM_031942.5(CDCA7):c.1148G>A (p.Arg383His)	CDCA7	R304H, R383H	Immunodeficiency-centromeric instability-facial anomalies syndrome 3	Pathogenic(Last reviewed: Apr 5, 2019)	no assertion criteria provided	VCV000225531	2	174231123	2	173366395	225531	227438	rs772929976	NC_000002.12:173366394:G:A
NM_031942.5(CDCA7):c.1118del (p.Gly373fs)	CDCA7	G294V, G373fs, G294fs	Immunodeficiency-centromeric instability-facial anomalies syndrome 3	Pathogenic(Last reviewed: Apr 5, 2019)	no assertion criteria provided	VCV000225530	2	174231092	2	173366364	225530	227437	rs876657409	NC_000002.12:173366363:GG:G
NM_031942.5(CDCA7):c.1058G>A (p.Arg353His)	CDCA7	R274H, R353H	Immunodeficiency-centromeric instability-facial anomalies syndrome 3	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000225532	2	174231033	2	173366305	225532	227439	rs370384522	NC_000002.12:173366304:G:A
NM_003038.5(SLC1A4):c.766G>A (p.Glu256Lys)	SLC1A4	E256K, E36K	not provided|Spastic tetraplegia, thin corpus callosum, and progressive microcephaly	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265259	2	65237863	2	65010729	265259	259742	rs201278558	NC_000002.12:65010728:G:A
NM_031942.5(CDCA7):c.1057C>T (p.Arg353Cys)	CDCA7	R274C, R353C	Immunodeficiency-centromeric instability-facial anomalies syndrome 3	Pathogenic(Last reviewed: Apr 10, 2019)	no assertion criteria provided	VCV000225529	2	174231032	2	173366304	225529	227436	rs879253738	NC_000002.12:173366303:C:T
GRCh37/hg19 2p25.3(chr2:3385474-3418641)x1	TRAPPC12		not provided	Pathogenic(Last reviewed: Oct 13, 2017)	no assertion criteria provided	VCV000688945	2	3385474 - 3418641			688945	676537		
NM_017951.4(SMPD4):c.1473_1479del (p.Leu492fs)	SMPD4	L390fs, L463fs, L492fs	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIES	Pathogenic(Last reviewed: Oct 16, 2019)	no assertion criteria provided	VCV000691973	2	130912760 - 130912766	2	130155187 - 130155193	691973	679719		NC_000002.12:130155186:GCGGAGCGCG:GCG
NM_017951.4(SMPD4):c.1337C>T (p.Pro446Leu)	SMPD4	P446L, P344L, P417L	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIES	Pathogenic(Last reviewed: Oct 16, 2019)	no assertion criteria provided	VCV000691972	2	130913677	2	130156104	691972	679718		NC_000002.12:130156103:G:A
NM_017951.4(SMPD4):c.199C>T (p.Gln67Ter)	SMPD4	Q67*	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIES	Pathogenic(Last reviewed: Oct 16, 2019)	no assertion criteria provided	VCV000691971	2	130932531	2	130174958	691971	679717		NC_000002.12:130174957:G:A
NM_017951.4(SMPD4):c.462+1G>T	SMPD4		NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIES	Pathogenic(Last reviewed: Oct 16, 2019)	no assertion criteria provided	VCV000691970	2	130930851	2	130173278	691970	679716		NC_000002.12:130173277:C:A
NM_017951.4(SMPD4):c.1570+1G>A	SMPD4		NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIES	Pathogenic(Last reviewed: Oct 16, 2019)	no assertion criteria provided	VCV000691969	2	130912668	2	130155095	691969	679715		NC_000002.12:130155094:C:T
NM_017951.4(SMPD4):c.1407-9G>A	SMPD4		NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIES	Pathogenic(Last reviewed: Oct 16, 2019)	no assertion criteria provided	VCV000691968	2	130912841	2	130155268	691968	679714		NC_000002.12:130155267:C:T
NM_032018.7(SPRTN):c.350A>G (p.Tyr117Cys)	SPRTN	Y117C	Ruijs-Aalfs syndrome	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000143916	1	231483571	1	231347825	143916	153639	rs527236213	NC_000001.11:231347824:A:G
NM_032018.7(SPRTN):c.723del (p.Lys241fs)	SPRTN	K241fs	Ruijs-Aalfs syndrome	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000162628	1	231488358	1	231352612	162628	172306	rs527236212	NC_000001.11:231352611:AAA:AA
NM_016030.6(TRAPPC12):c.1880C>T (p.Ala627Val)	TRAPPC12	A627V	Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome|Progressive childhood encephalopathy	Pathogenic(Last reviewed: May 1, 2017)	criteria provided, single submitter	VCV000430823	2	3482619	2	3478848	430823	424367	rs768950892	NC_000002.12:3478847:C:T
NM_016030.6(TRAPPC12):c.360dup (p.Glu121fs)	TRAPPC12		Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome|Progressive childhood encephalopathy	Pathogenic(Last reviewed: May 1, 2017)	criteria provided, single submitter	VCV000430822	2	3391749 - 3391750	2	3387978 - 3387979	430822	424366	rs1135401749	NC_000002.12:3387978:CCCCC:CCCCCC
NM_032018.7(SPRTN):c.718_718+3del	SPRTN	G197fs, G240fs	Ruijs-Aalfs syndrome|not provided	Pathogenic	criteria provided, single submitter	VCV000143915	1	231487316 - 231487319	1	231351571 - 231351574	143915	153638	rs587593493	NC_000001.11:231351569:AGGTA:A
NM_213622.4(STAMBP):c.503_524del (p.Met168fs)	STAMBP	M168fs, M33fs	not provided	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000503843	2	74074638 - 74074659	2	73847511 - 73847532	503843	495160	rs1553381934	NC_000002.12:73847510:AGATGATCCGGAACCAGGAGCTAGA:AGA
NM_213622.4(STAMBP):c.938C>T (p.Thr313Ile)	STAMBP	T313I, T178I	not provided	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	VCV000420170	2	74077573	2	73850446	420170	406034	rs202100019	NC_000002.12:73850445:C:T
NM_213622.4(STAMBP):c.106_108delinsAA (p.Tyr36fs)	STAMBP		not provided	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000286829	2	74058089 - 74058091	2	73830962 - 73830964	286829	271066	rs886043494	NC_000002.12:73830961:TAC:AA
NM_213622.4(STAMBP):c.418C>T (p.Gln140Ter)	STAMBP	Q140*, Q5*	not provided	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000837152	2	74074556	2	73847429	837152	827028		NC_000002.12:73847428:C:T
NM_001198903.1(YY1AP1):c.997+23T>G	YY1AP1		Grange syndrome	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000523661	1	155642328	1	155672537	523661	514309	rs1558307853	NC_000001.11:155672536:A:C
NM_001198903.1(YY1AP1):c.826-1G>A	YY1AP1		Grange syndrome	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000523660	1	155642523	1	155672732	523660	514308	rs199653824	NC_000001.11:155672731:C:T
NM_018253.3(YY1AP1):c.217C>T (p.Gln73Ter)	YY1AP1	Q222*, Q84*, Q150*, Q18*, Q73*	Grange syndrome	Pathogenic(Last reviewed: Feb 14, 2017)	no assertion criteria provided	VCV000375642	1	155646413	1	155676622	375642	362483	rs1057519599	NC_000001.11:155676621:G:A
NM_153212.3(GJB4):c.566T>A (p.Phe189Tyr)	GJB4	F189Y	Erythrokeratodermia variabilis et progressiva 2	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000005009	1	35227421	1	34761820	5009	20048	rs80358213	NC_000001.11:34761819:T:A
NM_153212.3(GJB4):c.65G>A (p.Arg22His)	GJB4	R22H	Erythrokeratodermia variabilis et progressiva 2	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000005008	1	35226920	1	34761319	5008	20047	rs80358212	NC_000001.11:34761318:G:A
NM_001198906.2(YY1AP1):c.*428_*431TCTG[1]	YY1AP1		Grange syndrome	Pathogenic(Last reviewed: Feb 14, 2017)	no assertion criteria provided	VCV000375641	1	155630209 - 155630212	1	155660418 - 155660421	375641	362482	rs759089960	NC_000001.11:155660417:CAGACAGA:CAGA
NM_001198906.2(YY1AP1):c.*930G>T	YY1AP1	E801*, E643*, E652*, E597*, E709*, E781*, E663*	Grange syndrome	Pathogenic(Last reviewed: Feb 14, 2017)	no assertion criteria provided	VCV000375640	1	155629714	1	155659923	375640	362481	rs1057519598	NC_000001.11:155659922:C:A
NM_001198903.1(YY1AP1):c.2390T>A (p.Leu797Ter)	YY1AP1	L797*, L593*, L648*, L705*, L777*, L639*, L659*	Grange syndrome	Pathogenic(Last reviewed: Feb 14, 2017)	no assertion criteria provided	VCV000375639	1	155629725	1	155659934	375639	362480	rs1057519597	NC_000001.11:155659933:A:T
NM_152268.4(PARS2):c.1130dup (p.Pro377_Lys378insTer)	PARS2		EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000183148	1	55223704 - 55223705	1	54758031 - 54758032	183148	181284	rs730882152	NC_000001.11:54758031:GGGGGG:GGGGGGG
NM_213622.4(STAMBP):c.411del (p.Ile138fs)	STAMBP	I3fs, I138fs	Microcephaly-capillary malformation syndrome	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000050797	2	74074548	2	73847421	50797	59806	rs886037633	NC_000002.12:73847420:CC:C
NM_213622.4(STAMBP):c.532C>T (p.Arg178Ter)	STAMBP	R178*, R43*	Microcephaly-capillary malformation syndrome	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000050792	2	74074670	2	73847543	50792	59801	rs397509388	NC_000002.12:73847542:C:T
CRYGC, 5-BP DUP, NT226	CRYGC		Cataract, coppock-like	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000016944					16944	31983		
NM_153212.3(GJB4):c.35G>A (p.Gly12Asp)	GJB4	G12D	Erythrokeratodermia variabilis et progressiva 2	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000005007	1	35226890	1	34761289	5007	20046	rs80358211	NC_000001.11:34761288:G:A
NM_153212.3(GJB4):c.411C>A (p.Phe137Leu)	GJB4	F137L	Erythrokeratodermia variabilis et progressiva 2	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000005005	1	35227266	1	34761665	5005	20044	rs80358206	NC_000001.11:34761664:C:A
NM_213622.4(STAMBP):c.707C>T (p.Ser236Phe)	STAMBP	S236F, S101F	Microcephaly-capillary malformation syndrome	Pathogenic(Last reviewed: Jan 2, 2018)	no assertion criteria provided	VCV000492960	2	74074845	2	73847718	492960	485890	rs766580482	NC_000002.12:73847717:C:T
NM_213622.4(STAMBP):c.649C>T (p.Gln217Ter)	STAMBP	Q217*, Q82*	Microcephaly-capillary malformation syndrome	Pathogenic(Last reviewed: Apr 19, 2017)	criteria provided, single submitter	VCV000436881	2	74074787	2	73847660	436881	428099	rs1553382055	NC_000002.12:73847659:C:T
NM_001198903.1(YY1AP1):c.724C>T (p.Gln242Ter)	YY1AP1	Q242*, Q104*, Q170*, Q93*, Q38*	Grange syndrome	Pathogenic(Last reviewed: Feb 14, 2017)	no assertion criteria provided	VCV000375638	1	155646353	1	155676562	375638	362479	rs749232831	NC_000001.11:155676561:G:A
NM_153212.3(GJB4):c.253A>C (p.Thr85Pro)	GJB4	T85P	not provided|Erythrokeratodermia variabilis et progressiva 2	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000005006	1	35227108	1	34761507	5006	20045	rs80358210	NC_000001.11:34761506:A:C
NM_153212.3(GJB4):c.409T>C (p.Phe137Leu)	GJB4	F137L	Erythrokeratodermia variabilis et progressiva 2	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000005004	1	35227264	1	34761663	5004	20043	rs80358207	NC_000001.11:34761662:T:C
NM_213622.4(STAMBP):c.299T>A (p.Phe100Tyr)	STAMBP	F100Y	Microcephaly-capillary malformation syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000050796	2	74072313	2	73845186	50796	59805	rs397514697	NC_000002.12:73845185:T:A
NM_213622.4(STAMBP):c.1270C>T (p.Arg424Ter)	STAMBP	R424*, R424del, R289*	Microcephaly-capillary malformation syndrome|not provided	Pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, single submitter	VCV000050795	2	74089381	2	73862254	50795	59804	rs397509390	NC_000002.12:73862253:C:T
NM_015375.3(DSTYK):c.24G>A (p.Trp8Ter)	DSTYK	W8*	Congenital anomalies of kidney and urinary tract 1, susceptibility to	Pathogenic(Last reviewed: Aug 15, 2013)	no assertion criteria provided	VCV000060685	1	205180640	1	205211512	60685	75259	rs879255515	NC_000001.11:205211511:C:T
DSTYK, 4-KB DEL AND 20-BP INS	DSTYK		Hereditary spastic paraplegia 23	Pathogenic(Last reviewed: May 13, 2019)	no assertion criteria provided	VCV000417786					417786	404687		
NM_032357.4(CCDC115):c.92T>C (p.Leu31Ser)	CCDC115	L31S	CCDC115-CDG|Congenital disorders of glycosylation type II	Pathogenic(Last reviewed: Jun 21, 2019)	no assertion criteria provided	VCV000218967	2	131099607	2	130342034	218967	216019	rs751325113	NC_000002.12:130342033:A:G
NM_032357.4(CCDC115):c.31G>T (p.Asp11Tyr)	CCDC115	D11Y	CCDC115-CDG|Congenital disorders of glycosylation type II	Pathogenic(Last reviewed: Jun 21, 2019)	no assertion criteria provided	VCV000218963	2	131099668	2	130342095	218963	216009	rs869025583	NC_000002.12:130342094:C:A
NM_001615.4(ACTG2):c.584C>T (p.Thr195Ile)	ACTG2	T195I, T152I	not provided	Pathogenic(Last reviewed: May 26, 2015)	criteria provided, single submitter	VCV000379697	2	74140744	2	73913617	379697	367936	rs1057520694	NC_000002.12:73913616:C:T
NM_003676.4(DEGS1):c.604del (p.Tyr202fs)	DEGS1	Y166fs, Y202fs	LEUKODYSTROPHY, HYPOMYELINATING, 18	Pathogenic(Last reviewed: Apr 30, 2019)	no assertion criteria provided	VCV000626328	1	224377799	1	224190097	626328	614660	rs1558210191	NC_000001.11:224190096:TT:T
NM_003676.4(DEGS1):c.341_342del (p.Leu114fs)	DEGS1	L78fs, L114fs	LEUKODYSTROPHY, HYPOMYELINATING, 18	Pathogenic(Last reviewed: Apr 30, 2019)	no assertion criteria provided	VCV000626327	1	224377537 - 224377538	1	224189835 - 224189836	626327	614659	rs1558209947	NC_000001.11:224189834:TT:
NM_001615.4(ACTG2):c.113G>A (p.Arg38His)	ACTG2	R38H	Chronic intestinal pseudoobstruction	Pathogenic(Last reviewed: May 2, 2015)	no assertion criteria provided	VCV000217521	2	74128551	2	73901424	217521	214167	rs869312168	NC_000002.12:73901423:G:A
NM_001615.4(ACTG2):c.188G>A (p.Arg63Gln)	ACTG2	R63Q	Visceral myopathy	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000694269	2	74129548	2	73902421	694269	682115		NC_000002.12:73902420:G:A
NM_001615.4(ACTG2):c.116C>T (p.Pro39Leu)	ACTG2	P39L	Visceral myopathy	Pathogenic(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000694268	2	74128554	2	73901427	694268	682114		NC_000002.12:73901426:C:T
NM_001615.4(ACTG2):c.806_807delinsAA (p.Gly269Glu)	ACTG2		Visceral myopathy	Pathogenic	no assertion criteria provided	VCV000156554	2	74143711 - 74143712	2	73916584 - 73916585	156554	166358	rs587777870	NC_000002.12:73916583:GC:AA
NM_001615.4(ACTG2):c.613G>A (p.Ala205Thr)	ACTG2	A205T, A162T	Visceral myopathy	Pathogenic(Last reviewed: Aug 21, 2015)	criteria provided, single submitter	VCV000369682	2	74140773	2	73913646	369682	353891	rs1057516046	NC_000002.12:73913645:G:A
NM_001615.4(ACTG2):c.134T>C (p.Met45Thr)	ACTG2	M45T	Visceral myopathy	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	VCV000218309	2	74129494	2	73902367	218309	215005	rs864309490	NC_000002.12:73902366:T:C
NM_020151.3(STARD7):c.291-4766_291-1517CATTT[274]ATTTT[376]	STARD7		Epilepsy, familial adult myoclonic 2	Pathogenic(Last reviewed: Jun 3, 2019)	no assertion criteria provided	VCV000635132	2	96862804 - 96866053	2	96197066 - 96200315	635132	622967		
STARD7, (ATTTC)n REPEAT EXPANSION	STARD7		Epilepsy, familial adult myoclonic 2	Pathogenic(Last reviewed: Nov 14, 2019)	no assertion criteria provided	VCV000694447					694447	682371		
NM_003672.4(CDC14A):c.1351_1352del (p.Ala451fs)	CDC14A	A158fs, A393fs, A451fs	Sensorineural hearing loss	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000691620	1	100963693 - 100963694	1	100498137 - 100498138	691620	679341		NC_000001.11:100498136:GC:
NM_003672.4(CDC14A):c.839-3C>G	CDC14A		Deafness, autosomal recessive 32	Pathogenic(Last reviewed: Aug 3, 2018)	no assertion criteria provided	VCV000559438	1	100933509	1	100467953	559438	550162	rs1553191001	NC_000001.11:100467952:C:G
NM_003672.4(CDC14A):c.376del (p.Tyr126fs)	CDC14A	Y126fs, Y68fs	Deafness, autosomal recessive 32	Pathogenic(Last reviewed: Aug 3, 2018)	no assertion criteria provided	VCV000559437	1	100889844	1	100424288	559437	550161	rs759201338	NC_000001.11:100424287:T:
NM_003672.4(CDC14A):c.417C>G (p.Tyr139Ter)	CDC14A	Y139*, Y81*	Deafness, autosomal recessive 32	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000638290	1	100905515	1	100439959	638290	626071		NC_000001.11:100439958:C:G
NM_003672.4(CDC14A):c.1015C>T (p.Arg339Ter)	CDC14A	R339*, R281*, R46*	Deafness, autosomal recessive 32	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000235146	1	100949885	1	100484329	235146	236878	rs777112652	NC_000001.11:100484328:C:T
NM_003676.4(DEGS1):c.764A>G (p.Asn255Ser)	DEGS1	N255S, N219S	Leukodystrophy|LEUKODYSTROPHY, HYPOMYELINATING, 18	Pathogenic(Last reviewed: Sep 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000625852	1	224377960	1	224190258	625852	614156	rs768180196	NC_000001.11:224190257:A:G
NM_001615.4(ACTG2):c.255+210C>A	ACTG2	F110L	Visceral myopathy	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	VCV000218311	2	74129825	2	73902698	218311	215007	rs768290597	NC_000002.12:73902697:C:A
NM_001615.4(ACTG2):c.400T>A (p.Tyr134Asn)	ACTG2	Y134N, Y91N	Visceral myopathy	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	VCV000132805	2	74136215	2	73909088	132805	136554	rs587777388	NC_000002.12:73909087:T:A
NM_003672.4(CDC14A):c.1033C>T (p.Arg345Ter)	CDC14A	R345*, R52*, R287*	Deafness, autosomal recessive 32|Sensorineural hearing loss	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000559439	1	100949903	1	100484347	559439	550163	rs549556142	NC_000001.11:100484346:C:T
NM_003467.3(CXCR4):c.950_953del (p.Leu317fs)	CXCR4	L317fs, L350fs, L321fs, L388fs, L302fs	Inherited Immunodeficiency Diseases	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827702	2	136872545 - 136872548	2	136114975 - 136114978	827702	815884		NC_000002.12:136114974:GTGAGTG:GTG
NM_000374.5(UROD):c.346C>T (p.Gln116Ter)	UROD	Q116*	Porphyria cutanea tarda	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000064679	1	45479335	1	45013663	64679	75614	rs397514765	NC_000001.11:45013662:C:T
NM_000374.5(UROD):c.6_15del (p.Glu2fs)	UROD	E2fs	Porphyria cutanea tarda	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000064678	1	45477943 - 45477952	1	45012271 - 45012280	64678	75613	rs397514764	NC_000001.11:45012270:AGCGAATGGG:
NM_003467.2(CXCR4):c.1027G>T (p.Glu343Ter)	CXCR4	E343*, E347*, E328*, E376*, E414*	Warts, hypogammaglobulinemia, infections, and myelokathexis	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000014022	2	136872471	2	136114901	14022	29061	rs104893625	NC_000002.12:136114900:C:A
NM_000374.5(UROD):c.904C>T (p.Gln302Ter)	UROD	Q302*	Familial porphyria cutanea tarda	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801474	1	45480640	1	45014968	801474	789972		NC_000001.11:45014967:C:T
NM_000374.5(UROD):c.185C>T (p.Pro62Leu)	UROD	P62L	Hepatoerythropoietic porphyria	Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	VCV000000070	1	45478859	1	45013187	70	15109	rs121918060	NC_000001.11:45013186:C:T
NM_000374.5(UROD):c.874C>G (p.Arg292Gly)	UROD	R292G	Hepatoerythropoietic porphyria	Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000000069	1	45480507	1	45014835	69	15108	rs121918059	NC_000001.11:45014834:C:G
NM_000374.5(UROD):c.499G>A (p.Glu167Lys)	UROD	E167K	Hepatoerythropoietic porphyria	Pathogenic(Last reviewed: Apr 1, 1991)	no assertion criteria provided	VCV000000068	1	45479605	1	45013933	68	15107	rs121918058	NC_000001.11:45013932:G:A
NM_000374.5(UROD):c.578G>C (p.Arg193Pro)	UROD	R193P	Familial porphyria cutanea tarda	Pathogenic(Last reviewed: Sep 8, 2016)	no assertion criteria provided	VCV000254172	1	45479684	1	45014012	254172	248651	rs143823335	NC_000001.11:45014011:G:C
NM_000374.5(UROD):c.995G>A (p.Arg332His)	UROD	R332H	Familial porphyria cutanea tarda	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000000076	1	45481061	1	45015389	76	15115	rs121918066	NC_000001.11:45015388:G:A
NM_000374.5(UROD):c.912C>A (p.Asn304Lys)	UROD	N304K	Familial porphyria cutanea tarda	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000000075	1	45480648	1	45014976	75	15114	rs121918065	NC_000001.11:45014975:C:A
NM_000374.5(UROD):c.583C>T (p.Leu195Phe)	UROD	L195F	Familial porphyria cutanea tarda	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000000074	1	45479689	1	45014017	74	15113	rs121918064	NC_000001.11:45014016:C:T
NM_000374.5(UROD):c.494T>G (p.Met165Arg)	UROD	M165R	Familial porphyria cutanea tarda	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000000073	1	45479600	1	45013928	73	15112	rs121918063	NC_000001.11:45013927:T:G
NM_000374.5(UROD):c.942G>A (p.Glu314=)	UROD	E314E	Familial porphyria cutanea tarda	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000000072	1	45480678	1	45015006	72	15111	rs121918062	NC_000001.11:45015005:G:A
NM_000374.5(UROD):c.842G>T (p.Gly281Val)	UROD	G281V	Familial porphyria cutanea tarda	Pathogenic(Last reviewed: Mar 1, 1989)	no assertion criteria provided	VCV000000065	1	45480475	1	45014803	65	15104	rs121918057	NC_000001.11:45014802:G:T
NM_001615.4(ACTG2):c.593G>A (p.Gly198Asp)	ACTG2	G198D, G155D	Visceral myopathy	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000218312	2	74140753	2	73913626	218312	215008	rs864309492	NC_000002.12:73913625:G:A
NM_001615.4(ACTG2):c.187C>G (p.Arg63Gly)	ACTG2	R63G	Visceral myopathy	Pathogenic(Last reviewed: Dec 20, 2016)	criteria provided, multiple submitters, no conflicts	VCV000218310	2	74129547	2	73902420	218310	215006	rs864309491	NC_000002.12:73902419:C:G
NM_003672.4(CDC14A):c.1126C>T (p.Arg376Ter)	CDC14A	R376*, R318*, R83*	Deafness, autosomal recessive 32|Sensorineural hearing loss	Pathogenic(Last reviewed: May 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235145	1	100949996	1	100484440	235145	236877	rs876661408	NC_000001.11:100484439:C:T
NM_003467.2(CXCR4):c.1013C>G (p.Ser338Ter)	CXCR4	S338*, S323*, S371*, S409*, S342*	Warts, hypogammaglobulinemia, infections, and myelokathexis	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000014023	2	136872485	2	136114915	14023	29062	rs104893626	NC_000002.12:136114914:G:C
NM_000374.5(UROD):c.636+1G>C	UROD		Familial porphyria cutanea tarda	Pathogenic(Last reviewed: Sep 8, 2016)	no assertion criteria provided	VCV000000067	1	45479743	1	45014071	67	15106	rs145195562	NC_000001.11:45014070:G:C
NM_000374.5(UROD):c.932A>G (p.Tyr311Cys)	UROD	Y311C	Porphyria cutanea tarda, type I|Hepatoerythropoietic porphyria	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000000071	1	45480668	1	45014996	71	15110	rs121918061	NC_000001.11:45014995:A:G
NM_025207.5(FLAD1):c.745C>T (p.Arg249Ter)	FLAD1	R150*, R152*, R249*	Glutaric aciduria, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801554	1	154960953	1	154988477	801554	789852		NC_000001.11:154988476:C:T
NM_025207.5(FLAD1):c.408C>A (p.Cys136Ter)	FLAD1	C136*, C37*, C39*	not provided	Pathogenic(Last reviewed: Oct 19, 2016)	criteria provided, single submitter	VCV000373037	1	154960616	1	154988140	373037	359254	rs1057518160	NC_000001.11:154988139:C:A
NM_022786.3(ARV1):c.518dup (p.Pro174fs)	ARV1		not provided	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000839151	1	231131566 - 231131567	1	230995820 - 230995821	839151	823524		NC_000001.11:230995820:AAAAAAAAA:AAAAAAAAAA
NM_025207.5(FLAD1):c.498del (p.Ser167fs)	FLAD1	S167fs, S68fs, S70fs	Glutaric aciduria, type 2	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000224734	1	154960706	1	154988230	224734	226512	rs876661315	NC_000001.11:154988229:C:
NM_025207.5(FLAD1):c.324del (p.Arg109fs)	FLAD1	R109fs, R12fs	Glutaric aciduria, type 2	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000224733	1	154956491	1	154984015	224733	226510	rs876661314	NC_000001.11:154984014:GGGG:GGG
NM_015139.3(SLC35D1):c.193A>C (p.Thr65Pro)	SLC35D1	T65P	Schneckenbecken dysplasia	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000001129	1	67519504	1	67053821	1129	16168	rs267607062	NC_000001.11:67053820:T:G
SLC35D1, 4.9-KB DEL, EX7	SLC35D1		Schneckenbecken dysplasia	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000001128					1128	16167		
NM_015139.3(SLC35D1):c.392+3A>G	SLC35D1		Schneckenbecken dysplasia	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000001127	1	67517692	1	67052009	1127	16166		NC_000001.11:67052008:T:C
NM_015139.3(SLC35D1):c.319C>T (p.Arg107Ter)	SLC35D1	R107*	Schneckenbecken dysplasia	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000001126	1	67518459	1	67052776	1126	16165	rs267607063	NC_000001.11:67052775:G:A
NM_015139.3(SLC35D1):c.636+1G>T	SLC35D1		Schneckenbecken dysplasia	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000001125	1	67512947	1	67047264	1125	16164		NC_000001.11:67047263:C:A
NM_015139.3(SLC35D1):c.932G>A (p.Trp311Ter)	SLC35D1	W311*	Schneckenbecken dysplasia	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000001124	1	67474795	1	67009112	1124	16163	rs137853111	NC_000001.11:67009111:C:T
SLC35D1, 1-BP DEL, 125A	SLC35D1		Schneckenbecken dysplasia	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000001123					1123	16162		
NM_025207.5(FLAD1):c.526_537delinsCA (p.Ala176fs)	FLAD1		Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency|Glutaric aciduria, type 2	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000224731	1	154960734 - 154960745	1	154988258 - 154988269	224731	226514	rs876661312	NC_000001.11:154988257:GCAGGGGGCATC:CA
NM_025207.5(FLAD1):c.836del (p.Phe279fs)	FLAD1	F180fs, F182fs, F279fs	Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency|Glutaric aciduria, type 2	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000224730	1	154961043	1	154988567	224730	226516	rs876661311	NC_000001.11:154988566:TT:T
NM_025207.5(FLAD1):c.568_569dup (p.Val191fs)	FLAD1		Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency|Glutaric aciduria, type 2	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000224728	1	154960775 - 154960776	1	154988299 - 154988300	224728	226515	rs876661310	NC_000001.11:154988299:GC:GCGC
NM_025207.5(FLAD1):c.1484_1486del (p.Ser495del)	FLAD1	S495del, S398del	Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency|Glutaric aciduria, type 2	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000224727	1	154962932 - 154962934	1	154990456 - 154990458	224727	226517	rs876661309	NC_000001.11:154990455:CTCCT:CT
NM_022786.3(ARV1):c.294+1G>A	ARV1		Epileptic encephalopathy, early infantile, 38|ARV1-related condition	Pathogenic(Last reviewed: Feb 13, 2015)	criteria provided, single submitter	VCV000224496	1	231124186	1	230988440	224496	226233	rs150619347	NC_000001.11:230988439:G:A
NM_021222.3(PRUNE1):c.661del (p.Ala221fs)	PRUNE1	A221fs, A39fs	Inborn genetic diseases	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000521740	1	150998130	1	151025654	521740	511165	rs1553253812	NC_000001.11:151025653:GG:G
NM_021222.3(PRUNE1):c.3_7dup (p.Asp3fs)	PRUNE1		Inborn genetic diseases	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000521739	1	150981110 - 150981111	1	151008634 - 151008635	521739	511164	rs1553251507	NC_000001.11:151008634:GGAGG:GGAGGGGAGG
NM_213622.4(STAMBP):c.112C>T (p.Arg38Cys)	STAMBP	R38C	Microcephaly-capillary malformation syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000050793	2	74058095	2	73830968	50793	59802	rs143739249	NC_000002.12:73830967:C:T
NM_022786.3(ARV1):c.565G>A (p.Gly189Arg)	ARV1	G189R, G222R	Epileptic encephalopathy, early infantile, 38|Neurodegeneration|Blindness	Pathogenic/Likely pathogenic(Last reviewed: Jan 13, 2015)	no assertion criteria provided	VCV000183341	1	231131622	1	230995876	183341	181401	rs730882241	NC_000001.11:230995875:G:A
NM_001615.4(ACTG2):c.118C>T (p.Arg40Cys)	ACTG2	R40C	Visceral myopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 24, 2015)	criteria provided, multiple submitters, no conflicts	VCV000132799	2	74128556	2	73901429	132799	136548	rs587777385	NC_000002.12:73901428:C:T
NM_025207.5(FLAD1):c.397_400TTCT[1] (p.Phe134fs)	FLAD1		Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency|Glutaric aciduria, type 2	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000224732	1	154960605 - 154960608	1	154988129 - 154988132	224732	226511	rs876661313	NC_000001.11:154988128:TTCTTTCT:TTCT
NM_025207.5(FLAD1):c.1588C>T (p.Arg530Cys)	FLAD1	R530C, R433C	Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency|Glutaric aciduria, type 2|not provided	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000224729	1	154965222	1	154992746	224729	226518	rs771466122	NC_000001.11:154992745:C:T
NM_005807.6(PRG4):c.3139_3140del (p.Lys1047fs)	PRG4	K1006fs, K1047fs, K913fs, K954fs, K1004fs		Pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000800914	1	186277989 - 186277990	1	186308857 - 186308858	800914	788732		NC_000001.11:186308856:AAA:A
NM_005807.5(PRG4):c.849del (p.Val284fs)	PRG4	V191fs, V284fs, V241fs, V243fs, V150fs		Pathogenic(Last reviewed: Feb 4, 2018)	no assertion criteria provided	VCV000684672	1	186275700	1	186306568	684672	672209		NC_000001.11:186306567:A:
NM_005807.5(PRG4):c.2841_2842del (p.Lys947fs)	PRG4	K904fs, K813fs, K854fs, K906fs, K947fs		Pathogenic(Last reviewed: Feb 4, 2018)	no assertion criteria provided	VCV000684671	1	186277688 - 186277689	1	186308556 - 186308557	684671	672214		NC_000001.11:186308555:AAAAAA:AAAA
NM_005807.5(PRG4):c.1910_1911del (p.Pro637fs)	PRG4	P637fs, P503fs, P544fs, P594fs, P596fs		Pathogenic(Last reviewed: Feb 4, 2018)	no assertion criteria provided	VCV000684670	1	186276761 - 186276762	1	186307629 - 186307630	684670	672211		NC_000001.11:186307628:CT:
NM_005807.5(PRG4):c.1911del (p.Glu638fs)	PRG4	E504fs, E545fs, E595fs, E638fs, E597fs		Pathogenic(Last reviewed: Feb 4, 2018)	no assertion criteria provided	VCV000684669	1	186276762	1	186307630	684669	672212		NC_000001.11:186307629:T:
NM_005807.5(PRG4):c.2215A>T (p.Lys739Ter)	PRG4	K698*, K646*, K696*, K605*, K739*		Pathogenic(Last reviewed: Feb 4, 2018)	no assertion criteria provided	VCV000684668	1	186277066	1	186307934	684668	672213		NC_000001.11:186307933:A:T
NM_005807.5(PRG4):c.3277_3278del (p.Lys1093fs)	PRG4	K1050fs, K1093fs, K959fs, K1000fs, K1052fs		Pathogenic(Last reviewed: Feb 4, 2018)	no assertion criteria provided	VCV000684666	1	186278127 - 186278128	1	186308995 - 186308996	684666	672215		NC_000001.11:186308994:AAA:A
NM_005807.5(PRG4):c.1194del (p.Thr399fs)	PRG4	T265fs, T358fs, T399fs, T306fs, T356fs		Pathogenic(Last reviewed: Feb 4, 2018)	no assertion criteria provided	VCV000684664	1	186276043	1	186306911	684664	672210		NC_000001.11:186306910:CCC:CC
PRG4, EX1DEL	PRG4			Pathogenic(Last reviewed: Jan 11, 2019)	no assertion criteria provided	VCV000599362					599362	590697		
PRG4, IVS6, 41-BP INS	PRG4			Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000005656					5656	20695		
PRG4, 5-BP DEL, NT3690	PRG4			Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000005654					5654	20693		
PRG4, 2-BP DEL, NT3023	PRG4			Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000005653					5653	20692		
PRG4, 7-BP DEL, NT3240	PRG4			Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000005652					5652	20691		
PRG4, 5-BP DEL, NT2805	PRG4			Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000005651					5651	20690		
NM_001024845.3(SLC6A9):c.832C>T (p.Gln278Ter)	SLC6A9	Q351*, Q278*, Q282*, Q213*, Q257*, Q297*, Q167*	Glycine encephalopathy with normal serum glycine	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000568191	1	44468210	1	44002538	568191	557286	rs201437896	NC_000001.11:44002537:G:A
NM_012090.5(MACF1):c.14116G>C (p.Gly4706Arg)	MACF1	G4706R	LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION|Lissencephaly	Pathogenic(Last reviewed: Feb 15, 2019)	no assertion criteria provided	VCV000586953	1	39916758	1	39451086	586953	577997	rs1488808726	NC_000001.11:39451085:G:C
NM_012090.5(MACF1):c.15689G>T (p.Cys5230Phe)	MACF1	C5230F	LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION|Lissencephaly with decussation defect	Pathogenic(Last reviewed: Feb 15, 2019)	no assertion criteria provided	VCV000586951	1	39934399	1	39468727	586951	578001	rs1557670520	NC_000001.11:39468726:G:T
NM_012090.5(MACF1):c.15688T>G (p.Cys5230Gly)	MACF1	C5230G	LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION|Lissencephaly with decussation defect	Pathogenic(Last reviewed: Feb 15, 2019)	no assertion criteria provided	VCV000586950	1	39934398	1	39468726	586950	578000	rs1557670515	NC_000001.11:39468725:T:G
NM_012090.5(MACF1):c.15682G>T (p.Asp5228Tyr)	MACF1	D5228Y	LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION|Lissencephaly with decussation defect	Pathogenic(Last reviewed: Feb 15, 2019)	no assertion criteria provided	VCV000586949	1	39934392	1	39468720	586949	577999	rs1557670503	NC_000001.11:39468719:G:T
NM_012090.5(MACF1):c.15530G>T (p.Cys5177Phe)	MACF1	C5177F	LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION|Lissencephaly with decussation defect	Pathogenic(Last reviewed: Feb 15, 2019)	no assertion criteria provided	VCV000586948	1	39929312	1	39463640	586948	577998	rs1557668270	NC_000001.11:39463639:G:T
NM_001024845.3(SLC6A9):c.709_713del (p.Lys237fs)	SLC6A9	K126fs, K172fs, K216fs, K237fs, K241fs, K256fs, K310fs	Glycine encephalopathy with normal serum glycine	Pathogenic(Last reviewed: Sep 19, 2017)	no assertion criteria provided	VCV000374988	1	44468535 - 44468539	1	44002863 - 44002867	374988	361896	rs1057519315	NC_000001.11:44002862:GACTTGAC:GAC
NM_001024845.3(SLC6A9):c.1498C>T (p.Gln500Ter)	SLC6A9	Q573*, Q500*, Q479*, Q504*, Q389*, Q435*, Q519*	Glycine encephalopathy with normal serum glycine	Pathogenic(Last reviewed: Sep 19, 2017)	no assertion criteria provided	VCV000374987	1	44466477	1	44000805	374987	361895	rs1057519314	NC_000001.11:44000804:G:A
NM_001024845.3(SLC6A9):c.1000A>G (p.Ser334Gly)	SLC6A9	S407G, S334G, S223G, S269G, S353G, S313G, S338G	Glycine encephalopathy with normal serum glycine	Pathogenic(Last reviewed: Sep 19, 2017)	no assertion criteria provided	VCV000374986	1	44467262	1	44001590	374986	361894	rs1057519313	NC_000001.11:44001589:T:C
NM_012090.5(MACF1):c.10617+444_15577-288del	MACF1		LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION|Lissencephaly with decussation defect	Pathogenic(Last reviewed: Feb 15, 2019)	no assertion criteria provided	VCV000586952	1	39894403 - 39933999	1	39428731 - 39468327	586952	577996		
NM_003467.2(CXCR4):c.1000C>T (p.Arg334Ter)	CXCR4	R334*, R338*, R367*, R319*, R405*	Myelokathexis, isolated|Warts, hypogammaglobulinemia, infections, and myelokathexis	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000014020	2	136872498	2	136114928	14020	29059	rs104893624	NC_000002.12:136114927:G:A
NM_004044.7(ATIC):c.1654A>T (p.Lys552Ter)	ATIC	K552*	AICAR transformylase/IMP cyclohydrolase deficiency	Pathogenic	no assertion criteria provided	VCV000666360	2	216213967	2	215349244	666360	653852		NC_000002.12:215349243:A:T
NM_005401.5(PTPN14):c.401_402insTT (p.Leu135fs)	PTPN14		Choanal atresia and lymphedema	Pathogenic(Last reviewed: Jan 4, 2019)	no assertion criteria provided	VCV000599260	1	214588012 - 214588013	1	214414669 - 214414670	599260	590481	rs1558092113	NC_000001.11:214414669::AA
NM_006618.5(KDM5B):c.551T>G (p.Leu184Ter)	KDM5B	L184*	not provided	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000859886	1	202742271	1	202773143	859886	823240		NC_000001.11:202773142:A:C
NM_001314042.1(KDM5B):c.622dup (p.Tyr208fs)	KDM5B		Intellectual disability, autosomal recessive 65	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560604	1	202736142 - 202736143	1	202767014 - 202767015	560604	551679	rs1558501648	NC_000001.11:202767014:A:AA
NM_001314042.1(KDM5B):c.3907del (p.Gln1303fs)	KDM5B	Q1303fs, Q1222fs, Q1267fs	Intellectual disability, autosomal recessive 65	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560603	1	202702639	1	202733511	560603	551678	rs1558479778	NC_000001.11:202733510:GGG:GG
NM_001314042.1(KDM5B):c.895C>T (p.Pro299Ser)	KDM5B	R299*, P299S, P218S, P263S	Intellectual disability, autosomal recessive 65	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560602	1	202733198	1	202764070	560602	551677	rs375695605	NC_000001.11:202764069:G:A
c.2475-2A-G	KDM5B		Intellectual disability, autosomal recessive 65	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560601					560601	551676		
NM_006164.5(NFE2L2):c.241G>A (p.Gly81Ser)	NFE2L2	G81S, G65S	IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA	Pathogenic(Last reviewed: Oct 30, 2017)	no assertion criteria provided	VCV000445149	2	178098804	2	177234076	445149	438545	rs1553487942	NC_000002.12:177234075:C:T
NM_006164.5(NFE2L2):c.239C>A (p.Thr80Lys)	NFE2L2	T80K, Q4K, T64K	IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA	Pathogenic(Last reviewed: Oct 30, 2017)	no assertion criteria provided	VCV000445148	2	178098806	2	177234078	445148	438544	rs1553487947	NC_000002.12:177234077:G:T
ATIC, 125-129DUP, 130-132DEL	ATIC		AICAR transformylase/IMP cyclohydrolase deficiency	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000007811					7811	22850		
NM_004044.7(ATIC):c.1277A>G (p.Lys426Arg)	ATIC	K426R	AICAR transformylase/IMP cyclohydrolase deficiency	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000007810	2	216209551	2	215344828	7810	22849	rs121434478	NC_000002.12:215344827:A:G
PTPN14, 2,016-BP DEL	PTPN14		Choanal atresia and lymphedema	Pathogenic(Last reviewed: Sep 10, 2010)	no assertion criteria provided	VCV000006620					6620	21659		
NM_004736.4(XPR1):c.653T>C (p.Leu218Ser)	XPR1	L218S	Basal ganglia calcification, idiopathic, 6	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000192306	1	180775665	1	180806529	192306	190099	rs786205904	NC_000001.11:180806528:T:C
NM_004736.4(XPR1):c.419T>C (p.Leu140Pro)	XPR1	L140P	Basal ganglia calcification, idiopathic, 6	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000192305	1	180772719	1	180803583	192305	190098	rs786205903	NC_000001.11:180803582:T:C
NM_004736.4(XPR1):c.407G>A (p.Ser136Asn)	XPR1	S136N	Basal ganglia calcification, idiopathic, 6	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000192304	1	180772707	1	180803571	192304	190097	rs786205902	NC_000001.11:180803570:G:A
NM_014813.2(LRIG2):c.1980_1981insJX891452.1:g.1_371 (p.Ile662Phefs)	LRIG2		Urofacial syndrome 2	Pathogenic(Last reviewed: Feb 7, 2013)	no assertion criteria provided	VCV000040209	1	113655282 - 113655283	1	113112660 - 113112661	40209	48696		
NM_014813.3(LRIG2):c.2088del (p.Ser697fs)	LRIG2	S697fs, S594fs	Urofacial syndrome 2	Pathogenic(Last reviewed: Feb 7, 2013)	no assertion criteria provided	VCV000040208	1	113657054	1	113114432	40208	48695	rs587776947	NC_000001.11:113114431:CCC:CC
NM_014813.3(LRIG2):c.2125C>T (p.Arg709Ter)	LRIG2	R709*, R606*	Urofacial syndrome 2	Pathogenic(Last reviewed: Feb 7, 2013)	no assertion criteria provided	VCV000040207	1	113657093	1	113114471	40207	48694	rs587776946	NC_000001.11:113114470:C:T
NM_014813.3(LRIG2):c.1230del (p.Glu410fs)	LRIG2	E307fs, E410fs	Urofacial syndrome 2	Pathogenic(Last reviewed: Feb 7, 2013)	no assertion criteria provided	VCV000040206	1	113642889	1	113100267	40206	48693	rs587776945	NC_000001.11:113100266:AA:A
NM_006164.5(NFE2L2):c.91G>A (p.Gly31Arg)	NFE2L2	G31R, G15R	IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA|Colorectal cancer	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2018)	no assertion criteria provided	VCV000445150	2	178098954	2	177234226	445150	438546	rs1553488015	NC_000002.12:177234225:C:T
NM_004736.4(XPR1):c.434T>C (p.Leu145Pro)	XPR1	L145P	Basal ganglia calcification, idiopathic, 6	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000192303	1	180772734	1	180803598	192303	190096	rs786205901	NC_000001.11:180803597:T:C
NM_000975.5(RPL11):c.391_392insSVAelement	RPL11		not provided	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000694738	1	24021276 - 24021277	1	23694786 - 23694787	694738	682857		
NM_000975.5(RPL11):c.143_144del (p.Pro48fs)	RPL11	P48fs, P47fs	not provided	Pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, single submitter	VCV000451147	1	24019235 - 24019236	1	23692745 - 23692746	451147	442762	rs1553121689	NC_000001.11:23692744:CT:
NM_000975.5(RPL11):c.116dup (p.Leu40fs)	RPL11		not provided	Pathogenic(Last reviewed: Jan 25, 2016)	criteria provided, single submitter	VCV000280297	1	24019207 - 24019208	1	23692717 - 23692718	280297	263980	rs886041528	NC_000001.11:23692717:T:TT
NM_001349.4(DARS1):c.839A>T (p.His280Leu)	DARS1	H280L, H180L	Hypomyelination with brainstem and spinal cord involvement and leg spasticity	Pathogenic	no assertion criteria provided	VCV000143190	2	136678143	2	135920573	143190	152908	rs527236040	NC_000002.12:135920572:T:A
NM_001349.4(DARS1):c.1481G>A (p.Arg494His)	DARS1	R494H, R394H	Hypomyelination with brainstem and spinal cord involvement and leg spasticity	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522693	2	136664911	2	135907341	522693	513247	rs967111310	NC_000002.12:135907340:C:T
NM_001349.4(DARS1):c.1480C>G (p.Arg494Gly)	DARS1	R494G, R394G	Hypomyelination with brainstem and spinal cord involvement and leg spasticity	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000050991	2	136664912	2	135907342	50991	65662	rs147077598	NC_000002.12:135907341:G:C
NM_001349.4(DARS1):c.1379G>A (p.Arg460His)	DARS1	R460H, R360H	Hypomyelination with brainstem and spinal cord involvement and leg spasticity	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000050990	2	136668744	2	135911174	50990	65661	rs587776985	NC_000002.12:135911173:C:T
NM_001349.4(DARS1):c.766A>C (p.Met256Leu)	DARS1	M256L, M156L	Hypomyelination with brainstem and spinal cord involvement and leg spasticity	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000050988	2	136680399	2	135922829	50988	65659	rs886037635	NC_000002.12:135922828:T:G
NM_001349.4(DARS1):c.821C>T (p.Ala274Val)	DARS1	A274V, A174V	Hypomyelination with brainstem and spinal cord involvement and leg spasticity	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000050987	2	136678161	2	135920591	50987	65658	rs369152939	NC_000002.12:135920590:G:A
NM_001349.4(DARS1):c.1099G>T (p.Asp367Tyr)	DARS1	D367Y, D267Y	Hypomyelination with brainstem and spinal cord involvement and leg spasticity	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000050986	2	136673803	2	135916233	50986	65657	rs370064817	NC_000002.12:135916232:C:A
COLEC11, 3-BP DEL, 648CTC	COLEC11			Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030971					30971	39928		
NM_024027.4(COLEC11):c.610G>A (p.Gly204Ser)	COLEC11	G204S, G201S, G156S, G218S, G130S, G178S, G180S, G154S		Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030970	2	3691502	2	3643912	30970	39927	rs387907076	NC_000002.12:3643911:G:A
NM_199235.3(COLEC11):c.-44del	COLEC11	F16fs, F30fs		Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030969	2	3651974	2	3604384	30969	39926		NC_000002.12:3604383:CC:C
NM_024027.4(COLEC11):c.505T>C (p.Ser169Pro)	COLEC11	S169P, S166P, S121P, S143P, S183P, S119P, S145P, S95P		Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030968	2	3691397	2	3643807	30968	39925	rs387907075	NC_000002.12:3643806:T:C
NM_000975.5(RPL11):c.62_63del (p.Cys21fs)	RPL11	C21fs, C20fs	Diamond-Blackfan anemia	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000643018	1	24019153 - 24019154	1	23692663 - 23692664	643018	627541		NC_000001.11:23692662:TGT:T
NC_000001.10:g.(?_24022278)_(24022873_?)del	RPL11		Diamond-Blackfan anemia	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000642046	1	24022278 - 24022873	1	23695788 - 23696383	642046	650544		
NM_000975.5(RPL11):c.508-2A>G	RPL11		Diamond-Blackfan anemia	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000639774	1	24022832	1	23696342	639774	650701		NC_000001.11:23696341:A:G
NC_000001.10:g.(?_24018304)_(24022873_?)del	RPL11		Diamond-Blackfan anemia	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000583762	1	24018304 - 24022873	1	23691814 - 23696383	583762	556497		
NM_000975.5(RPL11):c.111del (p.Lys38fs)	RPL11	K37fs, K38fs	Diamond-Blackfan anemia	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000532180	1	24019202	1	23692712	532180	515705	rs1553121684	NC_000001.11:23692711:CC:C
NM_000975.5(RPL11):c.43_49del (p.Leu15fs)	RPL11	L14fs, L15fs	Diamond-Blackfan anemia 7	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522687	1	24019134 - 24019140	1	23692644 - 23692650	522687	513403	rs1553121678	NC_000001.11:23692643:ACTTCGCA:A
NM_000975.5(RPL11):c.204del (p.Ile68fs)	RPL11	I68fs, I67fs	Diamond-Blackfan anemia 7	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000100641	1	24020342	1	23693852	100641	106513	rs587777120	NC_000001.11:23693851:TT:T
NM_000975.5(RPL11):c.476_477del (p.Lys159fs)	RPL11	K158fs, K159fs	Diamond-Blackfan anemia 7	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000100640	1	24022366 - 24022367	1	23695876 - 23695877	100640	106512	rs587777119	NC_000001.11:23695875:AAA:A
NM_002246.3(KCNK3):c.575A>G (p.Tyr192Cys)	KCNK3	Y192C	Primary pulmonary hypertension 4	Pathogenic(Last reviewed: Jul 25, 2013)	no assertion criteria provided	VCV000060483	2	26950826	2	26727958	60483	75078	rs398123043	NC_000002.12:26727957:A:G
NM_002246.3(KCNK3):c.544G>A (p.Glu182Lys)	KCNK3	E182K	Primary pulmonary hypertension 4	Pathogenic(Last reviewed: Jul 25, 2013)	no assertion criteria provided	VCV000060482	2	26950795	2	26727927	60482	75077	rs398123042	NC_000002.12:26727926:G:A
NM_002246.3(KCNK3):c.661G>C (p.Val221Leu)	KCNK3	V221L	Primary pulmonary hypertension 4	Pathogenic(Last reviewed: Jul 25, 2013)	no assertion criteria provided	VCV000060481	2	26950912	2	26728044	60481	75076	rs398123041	NC_000002.12:26728043:G:C
NM_002246.3(KCNK3):c.289G>A (p.Gly97Arg)	KCNK3	G97R	Primary pulmonary hypertension 4	Pathogenic(Last reviewed: Jul 25, 2013)	no assertion criteria provided	VCV000060480	2	26950540	2	26727672	60480	75075	rs398123040	NC_000002.12:26727671:G:A
COLEC11, EX1-3DEL	COLEC11			Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030973					30973	39930		
COLEC11, 1-BP DEL, 300T	COLEC11			Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030972					30972	39929		
NM_000975.5(RPL11):c.158-1G>A	RPL11		Diamond-Blackfan anemia 7	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000005754	1	24020296	1	23693806	5754	20793		NC_000001.11:23693805:G:A
NM_000975.5(RPL11):c.479_481AGG[1] (p.Glu161del)	RPL11		Diamond-Blackfan anemia 7	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000005753	1	24022369 - 24022371	1	23695879 - 23695881	5753	20792		NC_000001.11:23695878:GAGGAGG:GAGG
NM_000975.5(RPL11):c.58_59CT[1] (p.Cys21fs)	RPL11		Diamond-Blackfan anemia 7	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000005752	1	24019150 - 24019151	1	23692660 - 23692661	5752	20791		NC_000001.11:23692659:CTCT:CT
NM_001615.4(ACTG2):c.442C>A (p.Arg148Ser)	ACTG2	R148S, R105S	Chronic intestinal pseudoobstruction|Visceral myopathy	Pathogenic(Last reviewed: May 2, 2015)	no assertion criteria provided	VCV000132797	2	74136257	2	73909130	132797	136546	rs587777383	NC_000002.12:73909129:C:A
NM_000975.5(RPL11):c.160dup (p.Arg54fs)	RPL11		Diamond-Blackfan anemia	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000856991	1	24020298 - 24020299	1	23693808 - 23693809	856991	823641		NC_000001.11:23693808:A:AA
NC_000001.11:g.(?_23691824)_(23696373_?)del	RPL11		Diamond-Blackfan anemia	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000832897	1	24018314 - 24022863			832897	818936		
NM_002246.3(KCNK3):c.23C>A (p.Thr8Lys)	KCNK3	T8K	Primary pulmonary hypertension 4	Pathogenic	no assertion criteria provided	VCV000426049	2	26915766	2	26692898	426049	414373	rs1085307438	NC_000002.12:26692897:C:A
NM_002246.3(KCNK3):c.608G>A (p.Gly203Asp)	KCNK3	G203D	Primary pulmonary hypertension 4|Primary pulmonary hypertension	Pathogenic(Last reviewed: Jul 11, 2016)	no assertion criteria provided	VCV000060479	2	26950859	2	26727991	60479	75074	rs398123039	NC_000002.12:26727990:G:A
NM_000975.5(RPL11):c.223C>T (p.Arg75Ter)	RPL11	R75*, R74*	Diamond-Blackfan anemia|Diamond-Blackfan anemia 7	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000005751	1	24020362	1	23693872	5751	20790	rs121434389	NC_000001.11:23693871:C:T
NM_025133.4(FBXO11):c.1249C>T (p.Gln417Ter)	FBXO11	Q417*, Q501*	not provided	Pathogenic(Last reviewed: Sep 15, 2018)	criteria provided, single submitter	VCV000620354	2	48050397	2	47823258	620354	611571	rs1558414256	NC_000002.12:47823257:G:A
NM_001190274.2(FBXO11):c.2685_2686del (p.Leu895_Ser896insTer)	FBXO11		INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000804255	2	48035355 - 48035356	2	47808216 - 47808217	804255	792598		NC_000002.12:47808215:ACA:A
NM_001190274.1(FBXO11):c.442+1dup	FBXO11		INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: Aug 17, 2018)	no assertion criteria provided	VCV000559605	2	48066556 - 48066557	2	47839417 - 47839418	559605	550326	rs1553342101	NC_000002.12:47839417:CC:CCC
NM_025133.4(FBXO11):c.2457dup (p.Glu820Ter)	FBXO11		INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: Aug 17, 2018)	no assertion criteria provided	VCV000559603	2	48035331 - 48035332	2	47808192 - 47808193	559603	550324	rs1553334874	NC_000002.12:47808192:A:AA
NM_025133.4(FBXO11):c.2266T>C (p.Ser756Pro)	FBXO11	S840P, S756P	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: Aug 17, 2018)	no assertion criteria provided	VCV000559602	2	48036334	2	47809195	559602	550323	rs1553335247	NC_000002.12:47809194:A:G
NM_025133.4(FBXO11):c.162A>T (p.Arg54Ser)	FBXO11	R138S, R54S	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: Aug 17, 2018)	no assertion criteria provided	VCV000559601	2	48066586	2	47839447	559601	550322	rs1553342109	NC_000002.12:47839446:T:A
NM_025133.4(FBXO11):c.1360A>G (p.Ile454Val)	FBXO11	I538V, I454V	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: Aug 17, 2018)	no assertion criteria provided	VCV000559600	2	48050286	2	47823147	559600	550321	rs1553338592	NC_000002.12:47823146:T:C
NM_001080397.2(SLC45A1):c.628C>T (p.Arg210Trp)	SLC45A1	R176W, R210W	INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000428599	1	8385913	1	8325853	428599	420285	rs781036625	NC_000001.11:8325852:C:T
NM_001080397.2(SLC45A1):c.731C>T (p.Ala244Val)	SLC45A1	A210V, A244V	INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES	Pathogenic(Last reviewed: Jun 26, 2017)	no assertion criteria provided	VCV000428598	1	8386016	1	8325956	428598	420284	rs150539474	NC_000001.11:8325955:C:T
NM_000888.5(ITGB6):c.586C>A (p.Pro196Thr)	ITGB6	P196T, P154T, P58T, P101T, P123T	Amelogenesis imperfecta, type IH	Pathogenic(Last reviewed: Apr 15, 2014)	no assertion criteria provided	VCV000180686	2	161051887	2	160195376	180686	178851	rs730880298	NC_000002.12:160195375:G:T
NM_000888.5(ITGB6):c.1846C>T (p.Arg616Ter)	ITGB6	R616*, R521*, R574*, R543*, R478*	Amelogenesis imperfecta, type IH	Pathogenic(Last reviewed: Apr 15, 2014)	no assertion criteria provided	VCV000180685	2	160982927	2	160126416	180685	178850	rs730880297	NC_000002.12:160126415:G:A
NM_000888.5(ITGB6):c.825T>A (p.His275Gln)	ITGB6	H275Q, H137Q, H202Q, H233Q, H180Q	Amelogenesis imperfecta, type IH	Pathogenic(Last reviewed: Apr 15, 2014)	no assertion criteria provided	VCV000180684	2	161029176	2	160172665	180684	178849	rs730882118	NC_000002.12:160172664:A:T
NM_000888.5(ITGB6):c.427G>A (p.Ala143Thr)	ITGB6	A143T, A48T, A101T, A5T, A70T	Amelogenesis imperfecta, type IH	Pathogenic(Last reviewed: Apr 15, 2014)	no assertion criteria provided	VCV000180683	2	161052046	2	160195535	180683	178848	rs140015315	NC_000002.12:160195534:C:T
NM_002353.3(TACSTD2):c.557T>C (p.Leu186Pro)	TACSTD2	L186P	Lattice corneal dystrophy Type III	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000016189	1	59042272	1	58576600	16189	31228	rs80358228	NC_000001.11:58576599:A:G
TACSTD2, 12-BP DEL/1-BP INS, NT772	TACSTD2		Lattice corneal dystrophy Type III	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000016188					16188	31227		
NM_002353.3(TACSTD2):c.355T>A (p.Cys119Ser)	TACSTD2	C119S	Lattice corneal dystrophy Type III	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000016187	1	59042474	1	58576802	16187	31226	rs80358227	NC_000001.11:58576801:A:T
NM_002353.3(TACSTD2):c.2T>G (p.Met1Arg)	TACSTD2	M1R	Lattice corneal dystrophy Type III	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000016186	1	59042827	1	58577155	16186	31225	rs80358226	NC_000001.11:58577154:A:C
NM_002353.3(TACSTD2):c.632del (p.Gln211fs)	TACSTD2	Q211fs	Lattice corneal dystrophy Type III	Pathogenic(Last reviewed: Apr 1, 1999)	no assertion criteria provided	VCV000016185	1	59042197	1	58576525	16185	31224		NC_000001.11:58576524:T:
NM_002353.3(TACSTD2):c.509C>A (p.Ser170Ter)	TACSTD2	S170*	Lattice corneal dystrophy Type III	Pathogenic(Last reviewed: Apr 1, 1999)	no assertion criteria provided	VCV000016184	1	59042320	1	58576648	16184	31223	rs80358225	NC_000001.11:58576647:G:T
NM_002353.3(TACSTD2):c.619C>T (p.Gln207Ter)	TACSTD2	Q207*	Lattice corneal dystrophy Type III	Pathogenic(Last reviewed: Apr 1, 1999)	no assertion criteria provided	VCV000016183	1	59042210	1	58576538	16183	31222	rs80358224	NC_000001.11:58576537:G:A
NM_002353.3(TACSTD2):c.352C>T (p.Gln118Ter)	TACSTD2	Q118*	Lattice corneal dystrophy Type III	Pathogenic(Last reviewed: Apr 1, 1999)	no assertion criteria provided	VCV000016182	1	59042477	1	58576805	16182	31221	rs80358223	NC_000001.11:58576804:G:A
NM_000888.5(ITGB6):c.898G>A (p.Glu300Lys)	ITGB6	E300K, E205K, E227K, E258K, E162K	Adolescent alopeciam dentogingival abnormalitites and intellectual disability	Pathogenic	no assertion criteria provided	VCV000217305	2	161029103	2	160172592	217305	213951	rs779692470	NC_000002.12:160172591:C:T
NM_015978.2:c.1615A>G	TNNI3K		Cardiac conduction disease with or without dilated cardiomyopathy	Pathogenic(Last reviewed: Apr 23, 2019)	no assertion criteria provided	VCV000590304					590304	581245		
NM_025133.4(FBXO11):c.2484_2485AT[1] (p.Leu828_Tyr829insTer)	FBXO11		INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: Aug 17, 2018)	no assertion criteria provided	VCV000559604	2	48035302 - 48035303	2	47808163 - 47808164	559604	550325	rs1553334863	NC_000002.12:47808162:ATATA:ATA
NM_001206641.3(COA6):c.286T>C (p.Trp96Arg)	COA6	W66R, W96R, W20R	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000204622	1	234510049	1	234374303	204622	201016	rs875989827	NC_000001.11:234374302:T:C
NM_001206641.3(COA6):c.349G>T (p.Glu117Ter)	COA6	E87*, E117*, E41*	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4	Pathogenic(Last reviewed: Jul 1, 2014)	no assertion criteria provided	VCV000144037	1	234510112	1	234374366	144037	153776	rs146440690	NC_000001.11:234374365:G:T
NM_001768.6(CD8A):c.331G>A (p.Gly111Ser)	CD8A	G90S, G111S	Cd8 deficiency, familial	Pathogenic(Last reviewed: Jul 1, 2001)	no assertion criteria provided	VCV000012742	2	87017523	2	86790400	12742	27781	rs121918660	NC_000002.12:86790399:C:T
NM_001206641.3(COA6):c.267G>C (p.Trp89Cys)	COA6	W59C, W89C, W13C	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4	Pathogenic(Last reviewed: Jul 9, 2015)	no assertion criteria provided	VCV000144036	1	234510030	1	234374284	144036	153775	rs1558123786	NC_000001.11:234374283:G:C
NM_025160.6(WDR26):c.1023_1024delinsTT (p.Arg341_Gln342delinsSerTer)	WDR26		not provided	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000817912	1	224599263 - 224599264	1	224411561 - 224411562	817912	805207		NC_000001.11:224411560:GC:AA
NM_025160.6(WDR26):c.959del (p.Asn320fs)	WDR26	N304fs, N320fs	not provided	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000545954	1	224606022	1	224418320	545954	536227	rs1553358993	NC_000001.11:224418319:TT:T
NM_013328.4(PYCR2):c.138+1G>T	PYCR2		not provided	Pathogenic(Last reviewed: Jun 28, 2016)	no assertion criteria provided	VCV000545033	1	226111400	1	225923700	545033	535292	rs1473859981	NC_000001.11:225923699:C:A
NM_025160.6(WDR26):c.327del (p.Glu109fs)	WDR26	E109fs	not provided	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000504158	1	224621481	1	224433779	504158	495075	rs1553363770	NC_000001.11:224433778:TT:T
NM_025160.6(WDR26):c.56del (p.Gly19fs)	WDR26	G19fs	not provided	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000452733	1	224621752	1	224434050	452733	442727	rs1553364049	NC_000001.11:224434049:CC:C
NM_025160.6(WDR26):c.1672_1673AG[1] (p.Arg558fs)	WDR26		SKRABAN-DEARDORFF SYNDROME	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801625	1	224585898 - 224585899	1	224398196 - 224398197	801625	789935		NC_000001.11:224398195:CTCT:CT
NM_025160.6(WDR26):c.73_74insA (p.Gly25fs)	WDR26		Intellectual disability, seizures, abnormal gait and distinctive facial features	Pathogenic(Last reviewed: Aug 4, 2017)	no assertion criteria provided	VCV000488458	1	224621734 - 224621735	1	224434032 - 224434033	488458	481308	rs1553364018	NC_000001.11:224434032::T
NM_013328.4(PYCR2):c.753_754CT[4] (p.Leu254fs)	PYCR2		not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000286401	1	226108946 - 226108947	1	225921246 - 225921247	286401	270638	rs886043378	NC_000001.11:225921246:AGAGAG:AGAGAGAG
NM_013328.4(PYCR2):c.694T>G (p.Cys232Gly)	PYCR2	C232G, C158G	Leukodystrophy, hypomyelinating, 10	Pathogenic(Last reviewed: Sep 16, 2016)	no assertion criteria provided	VCV000254250	1	226109011	1	225921311	254250	248764	rs886037933	NC_000001.11:225921310:A:C
NM_013328.4(PYCR2):c.595C>T (p.Arg199Trp)	PYCR2	R199W, R125W	Leukodystrophy, hypomyelinating, 10	Pathogenic(Last reviewed: Sep 16, 2016)	no assertion criteria provided	VCV000254249	1	226109290	1	225921590	254249	248763	rs758595075	NC_000001.11:225921589:G:A
NM_013328.4(PYCR2):c.773T>C (p.Val258Ala)	PYCR2	V184A, V258A	Leukodystrophy, hypomyelinating, 10	Pathogenic(Last reviewed: Sep 16, 2016)	no assertion criteria provided	VCV000254248	1	226108932	1	225921232	254248	248762	rs886037932	NC_000001.11:225921231:A:G
NM_013328.4(PYCR2):c.751C>T (p.Arg251Cys)	PYCR2	R251C, R177C	Leukodystrophy, hypomyelinating, 10	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000192394	1	226108954	1	225921254	192394	190180	rs876657403	NC_000001.11:225921253:G:A
NM_025160.6(WDR26):c.154del (p.Asp52fs)	WDR26	D52fs	SKRABAN-DEARDORFF SYNDROME	Pathogenic(Last reviewed: Aug 26, 2019)	no assertion criteria provided	VCV000827809	1	224621654	1	224433952	827809	815976		NC_000001.11:224433951:CCCCC:CCCC
NM_025160.6(WDR26):c.762T>G (p.Ser254Arg)	WDR26	S254R, S238R	SKRABAN-DEARDORFF SYNDROME	Pathogenic(Last reviewed: Aug 15, 2017)	no assertion criteria provided	VCV000433011	1	224612222	1	224424520	433011	426513	rs150512167	NC_000001.11:224424519:A:C
NM_025160.6(WDR26):c.850G>A (p.Asp284Asn)	WDR26	D284N, D268N	SKRABAN-DEARDORFF SYNDROME	Pathogenic(Last reviewed: Aug 15, 2017)	no assertion criteria provided	VCV000433010	1	224607232	1	224419530	433010	426512	rs1553359384	NC_000001.11:224419529:C:T
NM_025160.6(WDR26):c.904_905del (p.Gln302fs)	WDR26	Q302fs, Q286fs	SKRABAN-DEARDORFF SYNDROME	Pathogenic(Last reviewed: Aug 16, 2017)	no assertion criteria provided	VCV000433009	1	224606076 - 224606077	1	224418374 - 224418375	433009	426511	rs1553359034	NC_000001.11:224418373:TGT:T
NM_025160.6(WDR26):c.1457del (p.Val486fs)	WDR26	V486fs, V470fs	SKRABAN-DEARDORFF SYNDROME	Pathogenic(Last reviewed: Aug 15, 2017)	no assertion criteria provided	VCV000433008	1	224586699	1	224398997	433008	426510	rs1553353378	NC_000001.11:224398996:A:
NM_025160.6(WDR26):c.1161_1162del (p.His389fs)	WDR26	H373fs, H389fs	SKRABAN-DEARDORFF SYNDROME	Pathogenic(Last reviewed: Aug 15, 2017)	no assertion criteria provided	VCV000433007	1	224592269 - 224592270	1	224404567 - 224404568	433007	426509	rs1553354980	NC_000001.11:224404566:TAT:T
NM_025160.6(WDR26):c.1276G>T (p.Glu426Ter)	WDR26	E426*, E410*	SKRABAN-DEARDORFF SYNDROME	Pathogenic(Last reviewed: Aug 15, 2017)	no assertion criteria provided	VCV000433006	1	224592155	1	224404453	433006	426508	rs1553354926	NC_000001.11:224404452:C:A
NM_013328.4(PYCR2):c.355C>T (p.Arg119Cys)	PYCR2	R119C	Leukodystrophy, hypomyelinating, 10	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	VCV000192393	1	226109743	1	225922043	192393	190179	rs372781135	NC_000001.11:225922042:G:A
NM_002709.3(PPP1CB):c.146C>G (p.Pro49Arg)	PPP1CB	P49R	not provided|Noonan syndrome-like disorder with loose anagen hair 2	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000254648	2	28999810	2	28776944	254648	249186	rs886037952	NC_000002.12:28776943:C:G
NM_001277062.2(MFF):c.284del (p.Thr95fs)	MFF	T45fs, T121fs, T95fs	Encephalopathy due to defective mitochondrial and peroxisomal fission 2	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000545568	2	228197237	2	227332521	545568	536071	rs1285225437	NC_000002.12:227332520:C:
NM_001277062.2(MFF):c.375_376del (p.Glu127fs)	MFF	E77fs, E153fs, E127fs	Encephalopathy due to defective mitochondrial and peroxisomal fission 2	Pathogenic(Last reviewed: Aug 25, 2016)	no assertion criteria provided	VCV000253270	2	228205028 - 228205029	2	227340312 - 227340313	253270	247692	rs879255690	NC_000002.12:227340311:AAAAA:AAA
NM_001277062.2(MFF):c.739C>T (p.Arg247Ter)	MFF	R194*, R298*, R174*, R199*, R208*, R247*, R177*	Encephalopathy due to defective mitochondrial and peroxisomal fission 2	Pathogenic(Last reviewed: Aug 25, 2016)	no assertion criteria provided	VCV000253269	2	228220472	2	227355756	253269	247691	rs753829320	NC_000002.12:227355755:C:T
NM_001277062.2(MFF):c.106dup (p.Leu36fs)	MFF		Encephalopathy due to defective mitochondrial and peroxisomal fission 2	Pathogenic(Last reviewed: Aug 25, 2016)	no assertion criteria provided	VCV000253268	2	228195485 - 228195486	2	227330769 - 227330770	253268	247690	rs886037862	NC_000002.12:227330769:CC:CCC
NM_002936.5(RNASEH1):c.554C>T (p.Ala185Val)	RNASEH1	A185V, A68V, A159V	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2	Pathogenic(Last reviewed: Jul 29, 2015)	no assertion criteria provided	VCV000372199	2	3596658	2	3549068	372199	359104	rs1057517675	NC_000002.12:3549067:G:A
NM_002936.5(RNASEH1):c.469C>T (p.Arg157Ter)	RNASEH1	R157*, R40*, R131*	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2	Pathogenic(Last reviewed: Jul 29, 2015)	no assertion criteria provided	VCV000372198	2	3598003	2	3550413	372198	359103	rs373442996	NC_000002.12:3550412:G:A
NM_002936.5(RNASEH1):c.424G>A (p.Val142Ile)	RNASEH1	V142I, V25I, V116I	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2	Pathogenic(Last reviewed: Jul 29, 2015)	no assertion criteria provided	VCV000372197	2	3598048	2	3550458	372197	359102	rs766294940	NC_000002.12:3550457:C:T
NM_022173.4(TIA1):c.1150G>A (p.Glu384Lys)	TIA1	E384K, E243K, E308K, E336K, E244K, E372K, E373K, E383K, E283K, E338K, E347K, E375K	Welander distal myopathy|not provided	Pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000041480	2	70439862	2	70212730	41480	49919	rs747068278	NC_000002.12:70212729:C:T
NM_013328.4(PYCR2):c.796C>T (p.Arg266Ter)	PYCR2	R266*, R192*	Leukodystrophy, hypomyelinating, 10|not provided	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000254247	1	226108909	1	225921209	254247	248761	rs886037931	NC_000001.11:225921208:G:A
NM_001277062.2(MFF):c.112C>T (p.Gln38Ter)	MFF	Q64*, Q38*	Encephalopathy due to defective mitochondrial and peroxisomal fission 2|Global developmental delay|Mitochondrial encephalomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000039831	2	228195493	2	227330777	39831	48430	rs397514615	NC_000002.12:227330776:C:T
NM_007348.4(ATF6):c.1108A>T (p.Lys370Ter)	ATF6	K370*	not provided	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000620421	1	161790872	1	161821082	620421	611495	rs367613392	NC_000001.11:161821081:A:T
NM_007348.4(ATF6):c.709C>T (p.Gln237Ter)	ATF6	Q237*	Achromatopsia 7	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801569	1	161771862	1	161802072	801569	789873		NC_000001.11:161802071:C:T
NM_004698.4(PRPF3):c.1285G>T (p.Asp429Tyr)	PRPF3	D294Y, D429Y	Retinitis pigmentosa 18	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812123	1	150315787	1	150343311	812123	800347		NC_000001.11:150343310:G:T
NM_007348.3(ATF6):c.160dup (p.Glu54Glyfs)	ATF6		Achromatopsia	Pathogenic(Last reviewed: May 15, 2016)	criteria provided, single submitter	VCV000505015	1	161751700 - 161751701	1	161781910 - 161781911	505015	496144	rs1553227755	NC_000001.11:161781910:GG:GGG
NM_007348.4(ATF6):c.1187+5G>C	ATF6		Achromatopsia 7	Pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	VCV000209098	1	161790956	1	161821166	209098	205697	rs761129859	NC_000001.11:161821165:G:C
NM_007348.4(ATF6):c.353del (p.Pro118fs)	ATF6	P118fs	Achromatopsia 7	Pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	VCV000209097	1	161753884	1	161784094	209097	205694	rs797045171	NC_000001.11:161784093:CC:C
NM_007348.4(ATF6):c.82+5G>T	ATF6		Achromatopsia 7	Pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	VCV000209096	1	161736237	1	161766447	209096	205693	rs797045170	NC_000001.11:161766446:G:T
NM_007348.4(ATF6):c.355dup (p.Glu119Glyfs)	ATF6		Achromatopsia 7	Pathogenic(Last reviewed: Sep 1, 2015)	no assertion criteria provided	VCV000208171	1	161761196 - 161761197	1	161791406 - 161791407	208171	204433	rs869320751	NC_000001.11:161791406:GG:GGG
NM_020365.5(EIF2B3):c.80T>A (p.Leu27Gln)	EIF2B3	L27Q	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000040179	1	45446761	1	44981089	40179	48676	rs397514647	NC_000001.11:44981088:A:T
EIF2B3, 2-BP DEL, 1295TG	EIF2B3		Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000004438					4438	19477		
NM_020365.5(EIF2B3):c.674G>A (p.Arg225Gln)	EIF2B3	R225Q	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000004437	1	45347394	1	44881722	4437	19476	rs113994024	NC_000001.11:44881721:C:T
NM_004698.4(PRPF3):c.1466C>A (p.Ala489Asp)	PRPF3	A489D, A354D	Retinitis pigmentosa 18	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000003354	1	150316677	1	150344201	3354	18393	rs121434243	NC_000001.11:150344200:C:A
NM_004698.4(PRPF3):c.1477C>T (p.Pro493Ser)	PRPF3	P493S, P358S	Retinitis pigmentosa 18	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000003353	1	150316688	1	150344212	3353	18392	rs121434242	NC_000001.11:150344211:C:T
NM_007348.3:c.355_356dupG	ATF6		Achromatopsia 7	Pathogenic	no assertion criteria provided	VCV000217302					217302	213956		
NM_007348.4(ATF6):c.1110dup (p.Val371fs)	ATF6		Achromatopsia 7	Pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	VCV000209101	1	161790871 - 161790872	1	161821081 - 161821082	209101	205696	rs797045174	NC_000001.11:161821081:AAA:AAAA
NM_007348.4(ATF6):c.797dup (p.Pro266_Asn267insTer)	ATF6		Achromatopsia 7	Pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	VCV000209100	1	161771947 - 161771948	1	161802157 - 161802158	209100	205695	rs797045173	NC_000001.11:161802157:CCC:CCCC
NM_007348.4(ATF6):c.1699T>A (p.Tyr567Asn)	ATF6	Y567N	Achromatopsia 7	Pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	VCV000208176	1	161833082	1	161863292	208176	204438	rs796065053	NC_000001.11:161863291:T:A
NM_002491.3(NDUFB3):c.200del (p.Phe67fs)	NDUFB3	F67fs	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 1, 2016)	criteria provided, single submitter	VCV000520909	2	201950240	2	201085517	520909	511388	rs1553535063	NC_000002.12:201085516:TT:T
NM_007348.4(ATF6):c.1533+1G>C	ATF6		Achromatopsia 7	Pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	VCV000209099	1	161823114	1	161853324	209099	205698	rs797045172	NC_000001.11:161853323:G:C
NM_007348.4(ATF6):c.970C>T (p.Arg324Cys)	ATF6	R324C	Achromatopsia 7	Pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	VCV000208172	1	161789483	1	161819693	208172	204434	rs761357250	NC_000001.11:161819692:C:T
NM_020365.5(EIF2B3):c.1037T>C (p.Ile346Thr)	EIF2B3	I346T	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Apr 1, 2019)	no assertion criteria provided	VCV000004440	1	45341306	1	44875634	4440	19479	rs119474039	NC_000001.11:44875633:A:G
NM_020365.5(EIF2B3):c.260C>T (p.Ala87Val)	EIF2B3	A87V	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Apr 1, 2019)	no assertion criteria provided	VCV000004439	1	45444021	1	44978349	4439	19478	rs113994022	NC_000001.11:44978348:G:A
NM_053274.3(GLMN):c.743dup (p.Leu248fs)	GLMN		not provided	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000618144	1	92737201 - 92737202	1	92271644 - 92271645	618144	609436	rs754756178	NC_000001.11:92271644:AAAAAA:AAAAAAA
NM_053274.3(GLMN):c.1630G>T (p.Glu544Ter)	GLMN	E544*, E530*	Blue rubber bleb nevus	Pathogenic	criteria provided, single submitter	VCV000549853	1	92712657	1	92247100	549853	540578	rs1557497881	NC_000001.11:92247099:C:A
NM_053274.3(GLMN):c.1208T>G (p.Leu403Ter)	GLMN	L403*, L389*	not provided	Pathogenic(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	VCV000420033	1	92731982	1	92266425	420033	405247	rs1064794247	NC_000001.11:92266424:A:C
NM_053274.3(GLMN):c.39+2T>C	GLMN		not provided	Pathogenic(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	VCV000379875	1	92763516	1	92297959	379875	365512	rs1057520767	NC_000001.11:92297958:A:G
NM_053274.3(GLMN):c.1323dup (p.Thr442fs)	GLMN		not provided	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000660874	1	92729265 - 92729266	1	92263708 - 92263709	660874	628275		NC_000001.11:92263708:AAA:AAAA
NM_053274.3(GLMN):c.108C>A (p.Cys36Ter)	GLMN	C36*	Venous malformation	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523551	1	92763018	1	92297461	523551	513903	rs770780171	NC_000001.11:92297460:G:T
GLMN, 5-BP DEL, 980CAGAA	GLMN		Glomuvenous malformations	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000007805					7805	22844		
NM_053274.2(GLMN):c.736-2886_1214+254delinsGG	GLMN		Glomuvenous malformations	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000007804	1	92731722 - 92740095	1	92266165 - 92274538	7804	22843		
NM_053274.3(GLMN):c.1179_1181del (p.Asn393del)	GLMN	N393del, N379del	Glomuvenous malformations|not specified	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000007807	1	92732009 - 92732011	1	92266452 - 92266454	7807	22846	rs773442562	NC_000001.11:92266451:TTGTT:TT
NM_053274.3(GLMN):c.157_161del (p.Glu52_Lys53insTer)	GLMN		Glomuvenous malformations|not provided	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000007806	1	92762965 - 92762969	1	92297408 - 92297412	7806	22845	rs762515373	NC_000001.11:92297407:TTCTTTTC:TTC
NM_019026.4(TMCO1):c.544C>T (p.Arg182Ter)	TMCO1	R182*, R148*, R119*, R131*	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, single submitter	VCV000521929	1	165712481	1	165743244	521929	511188	rs1247427997	NC_000001.11:165743243:G:A
NM_019026.4(TMCO1):c.525C>A (p.Tyr175Ter)	TMCO1	Y175*, Y124*, Y141*, Y112*	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 6, 2017)	criteria provided, single submitter	VCV000521850	1	165712500	1	165743263	521850	511189	rs1553249737	NC_000001.11:165743262:G:T
NM_018489.3(ASH1L):c.1880_1881dup (p.Gly628fs)	ASH1L		not provided	Pathogenic(Last reviewed: Aug 25, 2019)	criteria provided, single submitter	VCV000817705	1	155450779 - 155450780	1	155480988 - 155480989	817705	805179		NC_000001.11:155480988:TTT:TTTTT
NM_018489.3(ASH1L):c.4224_4225del (p.Tyr1409fs)	ASH1L	Y1409fs	not provided	Pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, single submitter	VCV000817414	1	155448436 - 155448437	1	155478645 - 155478646	817414	805178		NC_000001.11:155478644:AAA:A
NM_018489.3(ASH1L):c.2422_2423delinsT (p.Lys808fs)	ASH1L		Intellectual disability, autosomal dominant 52	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000544684	1	155450238 - 155450239	1	155480447 - 155480448	544684	535229	rs1553265703	NC_000001.11:155480446:TT:A
NM_018489.3(ASH1L):c.2991_2992del (p.Leu998fs)	ASH1L	L998fs	not provided	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000662987	1	155449669 - 155449670	1	155479878 - 155479879	662987	626897		NC_000001.11:155479877:ACA:A
NM_018489.3(ASH1L):c.5506C>T (p.Gln1836Ter)	ASH1L	Q1836*	not provided	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000633576	1	155408440	1	155438649	633576	621934	rs1558105796	NC_000001.11:155438648:G:A
NM_018489.3(ASH1L):c.1632del (p.Lys544fs)	ASH1L	K544fs	not provided	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000633562	1	155451029	1	155481238	633562	621935	rs1558151861	NC_000001.11:155481237:TTT:TT
NM_018489.3(ASH1L):c.3664_3667del (p.Lys1222fs)	ASH1L	K1222fs	Intellectual disability, autosomal dominant 52	Pathogenic(Last reviewed: Sep 26, 2018)	no assertion criteria provided	VCV000625522	1	155448994 - 155448997	1	155479203 - 155479206	625522	613826	rs1558148010	NC_000001.11:155479202:TCTTT:T
NM_018489.3(ASH1L):c.6803_6804delinsTTCTCA (p.Cys2268fs)	ASH1L		Intellectual disability, autosomal dominant 52	Pathogenic(Last reviewed: Jun 13, 2018)	no assertion criteria provided	VCV000559655	1	155327532 - 155327533	1	155357741 - 155357742	559655	550346	rs1553245038	NC_000001.11:155357740:AC:TGAGAA
NM_018489.3(ASH1L):c.8356G>C (p.Ala2786Pro)	ASH1L	A2786P, A2791P	Intellectual disability, autosomal dominant 52	Pathogenic(Last reviewed: Dec 5, 2017)	no assertion criteria provided	VCV000446517	1	155311831	1	155342040	446517	440035	rs1553241570	NC_000001.11:155342039:C:G
NM_018489.3(ASH1L):c.3705del (p.Glu1236fs)	ASH1L	E1236fs	Intellectual disability, autosomal dominant 52	Pathogenic(Last reviewed: Dec 5, 2017)	no assertion criteria provided	VCV000446514	1	155448956	1	155479165	446514	440032	rs1553265189	NC_000001.11:155479164:A:
NM_018489.3(ASH1L):c.8854dup (p.Arg2952fs)	ASH1L		Intellectual disability, autosomal dominant 52	Pathogenic(Last reviewed: Dec 5, 2017)	no assertion criteria provided	VCV000446513	1	155307491 - 155307492	1	155337700 - 155337701	446513	440031	rs775592405	NC_000001.11:155337700:TT:TTT
ASH1L, VAL2080ILE	ASH1L	V2080I	Intellectual disability, autosomal dominant 52	Pathogenic(Last reviewed: Dec 5, 2017)	no assertion criteria provided	VCV000446512					446512	440030		
NM_018489.3(ASH1L):c.2170G>T (p.Ala724Ser)	ASH1L	A724S	Intellectual disability, autosomal dominant 52	Pathogenic(Last reviewed: Nov 15, 2012)	no assertion criteria provided	VCV000446511	1	155450491	1	155480700	446511	440029	rs1293246328	NC_000001.11:155480699:C:A
NM_018489.3(ASH1L):c.6427G>T (p.Glu2143Ter)	ASH1L	E2143*, E2148*	Intellectual disability, autosomal dominant 52	Pathogenic(Last reviewed: Dec 5, 2017)	no assertion criteria provided	VCV000446516	1	155340680	1	155370889	446516	440034	rs1553247374	NC_000001.11:155370888:C:A
NM_018489.3(ASH1L):c.7764_7768dup (p.Asp2590fs)	ASH1L		Intellectual disability, autosomal dominant 52	Pathogenic(Last reviewed: Dec 5, 2017)	no assertion criteria provided	VCV000446515	1	155317481 - 155317482	1	155347690 - 155347691	446515	440033	rs1553242856	NC_000001.11:155347690:CCTTG:CCTTGCCTTG
NM_148960.3(CLDN19):c.388G>T (p.Gly130Cys)	CLDN19	G130C	Hypomagnesemia 5, renal, with ocular involvement	Pathogenic	no assertion criteria provided	VCV000560599	1	43204092	1	42738421	560599	551674	rs1557551678	NC_000001.11:42738420:C:A
NM_001205293.3(CACNA1E):c.2101A>G (p.Ile701Val)	CACNA1E	I701V	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69	Pathogenic(Last reviewed: Jan 18, 2019)	no assertion criteria provided	VCV000617451	1	181693632	1	181724496	617451	608799	rs1558308998	NC_000001.11:181724495:A:G
NM_148960.3(CLDN19):c.269T>G (p.Leu90Arg)	CLDN19	L90R	Hypomagnesemia 5, renal, with ocular involvement	Pathogenic(Last reviewed: Jul 10, 2018)	no assertion criteria provided	VCV000548636	1	43204211	1	42738540	548636	539120	rs118203981	NC_000001.11:42738539:A:C
NM_001994.2(F13B):c.1498del (p.Glu500fs)	F13B	E500fs		Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000016522	1	197021821	1	197052691	16522	31561	rs797044453	NC_000001.11:197052690:C:
F13B, 3-BP INS, AAC	F13B			Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	VCV000016521					16521	31560		
NM_001994.2(F13B):c.1349G>T (p.Cys450Phe)	F13B	C430F, C450F		Pathogenic(Last reviewed: Jul 1, 1993)	no assertion criteria provided	VCV000016519	1	197024850	1	197055720	16519	31558	rs121913075	NC_000001.11:197055719:C:A
NM_148960.3(CLDN19):c.269T>C (p.Leu90Pro)	CLDN19	L90P	Hypomagnesemia 5, renal, with ocular involvement	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000001363	1	43204211	1	42738540	1363	16402	rs118203981	NC_000001.11:42738539:A:G
NM_148960.3(CLDN19):c.169C>G (p.Gln57Glu)	CLDN19	Q57E	Hypomagnesemia 5, renal, with ocular involvement	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000001362	1	43205566	1	42739895	1362	16401	rs118203980	NC_000001.11:42739894:G:C
NM_001994.2(F13B):c.299_300insAAC (p.Tyr100Ter)	F13B		Coagulation factor deficiency syndrome	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627055	1	197031065 - 197031066	1	197061935 - 197061936	627055	615309		NC_000001.11:197061935::GTT
NM_148960.3(CLDN19):c.169C>T (p.Gln57Ter)	CLDN19	Q57*	Hypomagnesemia 5, renal, with ocular involvement	Pathogenic(Last reviewed: Jul 10, 2018)	no assertion criteria provided	VCV000548637	1	43205566	1	42739895	548637	539121	rs118203980	NC_000001.11:42739894:G:A
F13B, 1-BP DEL, IVS1AS, A, -2	F13B			Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000016518					16518	31557		
NM_001205293.3(CACNA1E):c.1054G>A (p.Gly352Arg)	CACNA1E	G352R	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69|not provided	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265066	1	181620576	1	181651440	265066	259636	rs886039323	NC_000001.11:181651439:G:A
NM_003108.4(SOX11):c.353A>C (p.Tyr118Ser)	SOX11	Y118S	Mental retardation, autosomal dominant 27	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000807694	2	5833206	2	5693074	807694	798510		NC_000002.12:5693073:A:C
NM_003108.4(SOX11):c.299G>C (p.Arg100Pro)	SOX11	R100P	not provided	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, single submitter	VCV000420675	2	5833152	2	5693020	420675	405998	rs1064794628	NC_000002.12:5693019:G:C
NM_003108.4(SOX11):c.1286G>A (p.Trp429Ter)	SOX11	W429*	Mental retardation, autosomal dominant 27	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000374396	2	5834139	2	5694007	374396	361177	rs1057518672	NC_000002.12:5694006:G:A
NM_003108.4(SOX11):c.594C>A (p.Tyr198Ter)	SOX11	Y198*	not provided	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000373066	2	5833447	2	5693315	373066	359459	rs1057518187	NC_000002.12:5693314:C:A
NM_003108.4(SOX11):c.178T>C (p.Ser60Pro)	SOX11	S60P	Mental retardation, autosomal dominant 27	Pathogenic(Last reviewed: Jun 2, 2014)	no assertion criteria provided	VCV000139530	2	5833031	2	5692899	139530	143174	rs587777480	NC_000002.12:5692898:T:C
NM_003108.4(SOX11):c.347A>G (p.Tyr116Cys)	SOX11	Y116C	Mental retardation, autosomal dominant 27	Pathogenic(Last reviewed: Jun 2, 2014)	no assertion criteria provided	VCV000139529	2	5833200	2	5693068	139529	143173	rs587777479	NC_000002.12:5693067:A:G
NM_006593.4(TBR1):c.1731dup (p.Ala578fs)	TBR1		Autism 5	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000807510	2	162280419 - 162280420	2	161423908 - 161423909	807510	798486		NC_000002.12:161423908:C:CC
NM_006593.4(TBR1):c.1165A>G (p.Lys389Glu)	TBR1	K389E	Autism 5	Pathogenic(Last reviewed: Dec 19, 2018)	no assertion criteria provided	VCV000599053	2	162276743	2	161420232	599053	590230	rs1553510677	NC_000002.12:161420231:A:G
NM_006593.4(TBR1):c.813G>T (p.Trp271Cys)	TBR1	W271C	Autism 5	Pathogenic(Last reviewed: Jan 2, 2019)	no assertion criteria provided	VCV000599052	2	162274307	2	161417796	599052	590229	rs1559060428	NC_000002.12:161417795:G:T
TBR1, ASN374HIS	TBR1	N374H	Autism 5	Pathogenic(Last reviewed: Dec 19, 2018)	no assertion criteria provided	VCV000599051					599051	590228		
TBR1, LYS228GLU	TBR1	K228E	Autism 5	Pathogenic(Last reviewed: Dec 19, 2018)	no assertion criteria provided	VCV000599050					599050	590227		
TBR1, 1-BP INS, C	TBR1		Autism 5	Pathogenic(Last reviewed: Dec 19, 2018)	no assertion criteria provided	VCV000599049					599049	590226		
TBR1, 1-BP DEL, C	TBR1		Autism 5	Pathogenic(Last reviewed: Dec 19, 2018)	no assertion criteria provided	VCV000599048					599048	590225		
NM_022469.4(GREM2):c.408G>T (p.Glu136Asp)	GREM2	E136D	Tooth agenesis, selective, 9	Pathogenic(Last reviewed: Dec 29, 2016)	no assertion criteria provided	VCV000374885	1	240656368	1	240493068	374885	361790	rs1057519288	NC_000001.11:240493067:C:A
NM_022469.4(GREM2):c.38C>T (p.Ala13Val)	GREM2	A13V	Tooth agenesis, selective, 9	Pathogenic(Last reviewed: Dec 29, 2016)	no assertion criteria provided	VCV000374884	1	240656738	1	240493438	374884	361789	rs373941682	NC_000001.11:240493437:G:A
NM_006593.4(TBR1):c.1118A>G (p.Gln373Arg)	TBR1	Q373R	Moderate global developmental delay|Seizures|Aplasia/Hypoplasia of the corpus callosum|Moderate global developmental delay|Behavioral abnormality	Pathogenic/Likely pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000523679	2	162275551	2	161419040	523679	514327	rs1553510492	NC_000002.12:161419039:A:G
NM_000374.5(UROD):c.842G>A (p.Gly281Glu)	UROD	G281E	Porphyria cutanea tarda|Hepatoerythropoietic porphyria|Familial porphyria cutanea tarda	Pathogenic(Last reviewed: Sep 8, 2016)	no assertion criteria provided	VCV000000066	1	45480475	1	45014803	66	15105	rs121918057	NC_000001.11:45014802:G:A
NM_001905.4(CTPS1):c.1692-1G>C	CTPS1		Immunodeficiency 24|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000140454	1	41475832	1	41010160	140454	150138	rs145092287	NC_000001.11:41010159:G:C
NM_148960.3(CLDN19):c.59G>A (p.Gly20Asp)	CLDN19	G20D	not provided|Hypomagnesemia 5, renal, with ocular involvement	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000001361	1	43205676	1	42740005	1361	16400	rs118203979	NC_000001.11:42740004:C:T
NM_001011.4(RPS7):c.76-1G>T	RPS7		Diamond-Blackfan anemia 8	Pathogenic(Last reviewed: Jul 18, 2017)	no assertion criteria provided	VCV000372193	2	3623406	2	3575816	372193	359098	rs1057519624	NC_000002.12:3575815:G:T
NM_001011.4(RPS7):c.147+1G>A	RPS7		Diamond-Blackfan anemia 8	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000006150	2	3623479	2	3575889	6150	21189	rs397507554	NC_000002.12:3575888:G:A
NM_015636.3(EIF2B4):c.1462T>C (p.Tyr488His)	EIF2B4	Y489H, Y510H, Y458H, Y283H, Y474H, Y509H, Y294H, Y488H	Ovarioleukodystrophy	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000004122	2	27587374	2	27364507	4122	19161	rs113994040	NC_000002.12:27364506:A:G
NM_015636.3(EIF2B4):c.1390T>C (p.Cys464Arg)	EIF2B4	C465R, C259R, C434R, C486R, C485R, C270R, C450R, C464R	Ovarioleukodystrophy	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000004121	2	27587446	2	27364579	4121	19160	rs113994038	NC_000002.12:27364578:A:G
NM_001034116.1(EIF2B4):c.683C>T (p.Ala228Val)	EIF2B4	A228V, A213V, A249V, A197V, A22V, A248V, A33V, A227V	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000004120	2	27590914	2	27368047	4120	19159	rs113994027	NC_000002.12:27368046:G:A
NM_001034116.1(EIF2B4):c.1191+1G>A	EIF2B4		Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000004119	2	27589625	2	27366758	4119	19158	rs113994037	NC_000002.12:27366757:C:T
NM_001034116.1(EIF2B4):c.1120C>T (p.Arg374Cys)	EIF2B4	R374C, R179C, R343C, R394C, R395C, R168C, R359C, R373C	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000004118	2	27589697	2	27366830	4118	19157	rs113994035	NC_000002.12:27366829:G:A
NM_032601.4(MCEE):c.139C>T (p.Arg47Ter)	MCEE	R47*	not provided|Methylmalonyl-CoA epimerase deficiency	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002343	2	71351575	2	71124445	2343	17382	rs111033538	NC_000002.12:71124444:G:A
NM_024782.2(NHEJ1):c.350del (p.Phe117fs)	NHEJ1	F117fs	not provided	Pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, single submitter	VCV000424561	2	220022234	2	219157512	424561	405622	rs1064797042	NC_000002.12:219157511:AA:A
NM_024782.2(NHEJ1):c.530-2A>T	NHEJ1		not provided	Pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	VCV000419273	2	220011462	2	219146740	419273	405620	rs1064793763	NC_000002.12:219146739:T:A
NM_024782.2(NHEJ1):c.570_573dup (p.Gln192fs)	NHEJ1		not provided	Pathogenic(Last reviewed: Mar 30, 2015)	criteria provided, single submitter	VCV000418719	2	220011416 - 220011417	2	219146694 - 219146695	418719	405618	rs1553548393	NC_000002.12:219146694:TTCC:TTCCTTCC
NM_024782.2(NHEJ1):c.324dup (p.Arg109fs)	NHEJ1		not provided	Pathogenic(Last reviewed: Sep 6, 2016)	criteria provided, single submitter	VCV000280838	2	220022259 - 220022260	2	219157537 - 219157538	280838	264088	rs886041973	NC_000002.12:219157537:C:CC
NM_024782.3(NHEJ1):c.369C>A (p.Cys123Ter)	NHEJ1	C123*	Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000845632	2	220022215	2	219157493	845632	825753		NC_000002.12:219157492:G:T
NM_024782.2(NHEJ1):c.643C>T (p.Gln215Ter)	NHEJ1	Q215*	Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000536739	2	219942874	2	219078152	536739	517726	rs1553542017	NC_000002.12:219078151:G:A
NM_001743.6(CALM2):c.414C>G (p.Asn138Lys)	CALM2	N102K, N186K, N138K	Long QT syndrome 15	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000488476	2	47388869	2	47161730	488476	481344	rs1553431702	NC_000002.12:47161729:G:C
NM_001902.6(CTH):c.718C>G (p.Gln240Glu)	CTH	Q240E, Q196E, Q208E	Cystathioninuria	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000002940	1	70896071	1	70430388	2940	17979	rs28941786	NC_000001.11:70430387:C:G
CTH, 1-BP DEL, 1220C	CTH		Cystathioninuria	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000002938					2938	17977		
CTH, 2-BP DEL, 940CT	CTH		Cystathioninuria	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000002937					2937	17976		
NM_024782.2(NHEJ1):c.177+1_177+3delinsTT	NHEJ1		Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation	Pathogenic(Last reviewed: Jan 27, 2006)	no assertion criteria provided	VCV000000984	2	220022905 - 220022907	2	219158183 - 219158185	984	16023	rs886037606	NC_000002.12:219158182:TAC:AA
NM_024782.2(NHEJ1):c.367T>C (p.Cys123Arg)	NHEJ1	C123R	Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation	Pathogenic(Last reviewed: Jan 27, 2006)	no assertion criteria provided	VCV000000982	2	220022217	2	219157495	982	16021	rs118204452	NC_000002.12:219157494:A:G
NM_024782.2(NHEJ1):c.169C>G (p.Arg57Gly)	NHEJ1	R57G	Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation	Pathogenic(Last reviewed: Jan 27, 2006)	no assertion criteria provided	VCV000000981	2	220022916	2	219158194	981	16020	rs118204451	NC_000002.12:219158193:G:C
NM_002148.3(HOXD10):c.956T>A (p.Met319Lys)	HOXD10	M319K	Vertical talus, congenital	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000014878	2	176983892	2	176119164	14878	29917	rs104893634	NC_000002.12:176119163:T:A
NM_001743.6(CALM2):c.389A>G (p.Asp130Gly)	CALM2	D130G, D178G, D94G	Long QT syndrome 15	Pathogenic(Last reviewed: Feb 21, 2020)	no assertion criteria provided	VCV000812710	2	47388894	2	47161755	812710	800961		NC_000002.12:47161754:T:C
NM_001743.6(CALM2):c.287A>T (p.Asp96Val)	CALM2	D96V, D60V, D144V	Long QT syndrome 15	Pathogenic(Last reviewed: Mar 5, 2013)	no assertion criteria provided	VCV000183233	2	47388996	2	47161857	183233	181366	rs730882254	NC_000002.12:47161856:T:A
NM_024782.2(NHEJ1):c.11dup (p.Glu5fs)	NHEJ1		Severe combined immunodeficiency with sensitivity to ionizing radiation due to nhej1 deficiency	Pathogenic(Last reviewed: May 19, 2006)	no assertion criteria provided	VCV000000985	2	220023073 - 220023074	2	219158351 - 219158352	985	16024	rs886037607	NC_000002.12:219158351:A:AA
NM_024782.2(NHEJ1):c.532C>T (p.Arg178Ter)	NHEJ1	R178*	not provided|Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000000983	2	220011458	2	219146736	983	16022	rs118204453	NC_000002.12:219146735:G:A
NM_012433.3(SF3B1):c.1998G>T (p.Lys666Asn)	SF3B1	K666N	Myelodysplastic syndrome progressed to acute myeloid leukemia|Myelodysplastic syndrome|Acute myeloid leukemia	Pathogenic(Last reviewed: Jan 8, 2016)	criteria provided, single submitter	VCV000219098	2	198267359	2	197402635	219098	216787	rs377023736	NC_000002.12:197402634:C:A
NM_005850.5(SF3B4):c.1153_1159dup (p.Gly387fs)	SF3B4		not provided	Pathogenic(Last reviewed: Aug 17, 2015)	criteria provided, single submitter	VCV000419756	1	149895549 - 149895550	1	149923657 - 149923658	419756	404904	rs1553765608	NC_000001.11:149923657:CAGTGTA:CAGTGTACAGTGTA
NM_005850.5(SF3B4):c.811del (p.Ala271fs)	SF3B4	A271fs	not provided	Pathogenic(Last reviewed: Feb 23, 2016)	criteria provided, single submitter	VCV000280303	1	149897830	1	149925938	280303	263949	rs886041532	NC_000001.11:149925937:C:
NM_005850.5(SF3B4):c.731_743del (p.Pro244fs)	SF3B4	P244fs	Nager syndrome	Pathogenic(Last reviewed: Aug 6, 2014)	criteria provided, single submitter	VCV000212159	1	149897898 - 149897910	1	149926006 - 149926018	212159	206715	rs797045957	NC_000001.11:149926005:GGCACTGGGGGTGGG:GG
NM_005850.5(SF3B4):c.43_44GT[1] (p.Tyr16fs)	SF3B4		Nager syndrome	Pathogenic(Last reviewed: Dec 26, 2014)	criteria provided, single submitter	VCV000212158	1	149899175 - 149899176	1	149927283 - 149927284	212158	206718	rs797045956	NC_000001.11:149927282:ACACA:ACA
NM_005850.5(SF3B4):c.193G>T (p.Glu65Ter)	SF3B4	E65*	Nager syndrome	Pathogenic(Last reviewed: Nov 25, 2014)	criteria provided, single submitter	VCV000212157	1	149898781	1	149926889	212157	206717	rs797045955	NC_000001.11:149926888:C:A
NM_005850.5(SF3B4):c.88del (p.Trp30fs)	SF3B4	W30fs	Nager syndrome	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000208841	1	149899133	1	149927241	208841	205403	rs797045134	NC_000001.11:149927240:A:
NM_005850.5(SF3B4):c.452C>A (p.Ser151Ter)	SF3B4	S151*	Nager syndrome	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000208840	1	149898522	1	149926630	208840	205402	rs797045133	NC_000001.11:149926629:G:T
NM_005850.5(SF3B4):c.625C>T (p.Gln209Ter)	SF3B4	Q209*	Nager syndrome	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000208839	1	149898349	1	149926457	208839	205401	rs797045132	NC_000001.11:149926456:G:A
NM_005850.5(SF3B4):c.661_664dup (p.Asn222fs)	SF3B4		Nager syndrome	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000208838	1	149898309 - 149898310	1	149926417 - 149926418	208838	205400	rs797045131	NC_000001.11:149926417:TGGG:TGGGTGGG
NM_005850.5(SF3B4):c.769del (p.Ile257fs)	SF3B4	I257fs	Nager syndrome	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000208837	1	149897872	1	149925980	208837	205399	rs797045130	NC_000001.11:149925979:T:
NM_005850.5(SF3B4):c.796dup (p.Met266fs)	SF3B4		Nager syndrome	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000208836	1	149897844 - 149897845	1	149925952 - 149925953	208836	205398	rs797045129	NC_000001.11:149925952:T:TT
NM_005850.5(SF3B4):c.827dup (p.Ser277fs)	SF3B4		Nager syndrome	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000208835	1	149897813 - 149897814	1	149925921 - 149925922	208835	205397	rs797045128	NC_000001.11:149925921:GGGGGG:GGGGGGG
NM_005850.5(SF3B4):c.836_837insGGGTATG (p.Thr280fs)	SF3B4		Nager syndrome	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000208834	1	149897804 - 149897805	1	149925912 - 149925913	208834	205396	rs797045127	NC_000001.11:149925912:C:CATACCCC
NM_005850.5(SF3B4):c.864del (p.His288fs)	SF3B4	H288fs	Nager syndrome	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000208833	1	149897777	1	149925885	208833	205395	rs797045126	NC_000001.11:149925884:A:
NM_005850.5(SF3B4):c.1060dup (p.Arg354fs)	SF3B4		Nager syndrome	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000208831	1	149895759 - 149895760	1	149923867 - 149923868	208831	205393	rs782357237	NC_000001.11:149923867:GGGGGGG:GGGGGGGG
NM_005850.5(SF3B4):c.1148dup (p.His383fs)	SF3B4		Nager syndrome	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000208830	1	149895560 - 149895561	1	149923668 - 149923669	208830	205392	rs797045124	NC_000001.11:149923668:T:TT
NM_005850.5(SF3B4):c.1199del (p.Pro400fs)	SF3B4	P400fs	Nager syndrome	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000208829	1	149895510	1	149923618	208829	205391	rs797045123	NC_000001.11:149923617:GG:G
NM_005850.5(SF3B4):c.1232del (p.Pro411fs)	SF3B4	P411fs	Nager syndrome	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000208828	1	149895477	1	149923585	208828	205390	rs797045122	NC_000001.11:149923584:GG:G
NM_005850.5(SF3B4):c.1252_1258del (p.Leu418fs)	SF3B4	L418fs	Nager syndrome	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000208827	1	149895451 - 149895457	1	149923559 - 149923565	208827	205389	rs797045121	NC_000001.11:149923558:CTCGAAG:
GMPPA, TRP214TER	GMPPA	W214*	Alacrima, achalasia, and mental retardation syndrome	Pathogenic(Last reviewed: Oct 3, 2013)	no assertion criteria provided	VCV000088695					88695	94275		
NM_005850.5(SF3B4):c.1006C>T (p.Arg336Ter)	SF3B4	R336*	Nager syndrome	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065407	1	149895814	1	149923922	65407	76338	rs397515324	NC_000001.11:149923921:G:A
NM_005850.5(SF3B4):c.913+1G>A	SF3B4		Nager syndrome	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000031653	1	149897727	1	149925835	31653	40329	rs797045125	NC_000001.11:149925834:C:T
NM_005850.5(SF3B4):c.1A>G (p.Met1Val)	SF3B4	M1V	Nager syndrome	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000031650	1	149899651	1	149927759	31650	40326	rs387907185	NC_000001.11:149927758:T:C
NM_005850.5(SF3B4):c.1230_1249del (p.Pro411fs)	SF3B4	P411fs	Stenosis of the external auditory canal|Midface retrusion|Micrognathia|Malar flattening|Nager syndrome	Pathogenic(Last reviewed: Mar 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000212156	1	149895460 - 149895479	1	149923568 - 149923587	212156	206712	rs797045954	NC_000001.11:149923567:GGCCTCGAGGGGGAACTGGTGGCC:GGCC
NM_015700.4(NFU1):c.472C>T (p.Arg158Trp)	NFU1	R182W, R158W, R41W	Multiple mitochondrial dysfunctions syndrome 1	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000488564	2	69633155	2	69406023	488564	481432	rs1354126704	NC_000002.12:69406022:G:A
NM_015700.4(NFU1):c.473+5G>A	NFU1		Multiple mitochondrial dysfunctions syndrome 1	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000488563	2	69633149	2	69406017	488563	481431	rs756085990	NC_000002.12:69406016:C:T
NM_001002755.3(NFU1):c.303-2A>T	NFU1		not provided	Pathogenic(Last reviewed: Mar 13, 2014)	criteria provided, single submitter	VCV000214869	2	69646738	2	69419606	214869	210889	rs371546359	NC_000002.12:69419605:T:A
NM_005272.4(GNAT2):c.591-2A>C	GNAT2		Achromatopsia 4	Pathogenic(Last reviewed: Jun 12, 2018)	no assertion criteria provided	VCV000623276	1	110148723	1	109606101	623276	612250	rs1557918638	NC_000001.11:109606100:T:G
NM_005272.4(GNAT2):c.313C>T (p.Arg105Ter)	GNAT2	R105*	Achromatopsia 4	Pathogenic(Last reviewed: Jun 12, 2018)	no assertion criteria provided	VCV000623274	1	110151401	1	109608779	623274	612245	rs1403825722	NC_000001.11:109608778:G:A
NC_000001.10:g.110150279_110152297dup	GNAT2		Achromatopsia 4	Pathogenic(Last reviewed: Jun 12, 2018)	no assertion criteria provided	VCV000623272	1	110150279 - 110152297	1	109607813 - 109609831	623272	612244		
NM_005060.4(RORC):c.1321C>T (p.Gln441Ter)	RORC	Q441*, Q420*	Immunodeficiency 42	Pathogenic(Last reviewed: Aug 7, 2015)	no assertion criteria provided	VCV000217447	1	151783875	1	151811399	217447	214087	rs863225092	NC_000001.11:151811398:G:A
NM_005060.4(RORC):c.985C>T (p.Gln329Ter)	RORC	Q329*, Q308*	Immunodeficiency 42	Pathogenic(Last reviewed: Aug 7, 2015)	no assertion criteria provided	VCV000217446	1	151786045	1	151813569	217446	214086	rs863225091	NC_000001.11:151813568:G:A
NM_005060.4(RORC):c.113C>T (p.Ser38Leu)	RORC	S38L, S17L	Immunodeficiency 42	Pathogenic(Last reviewed: Aug 7, 2015)	no assertion criteria provided	VCV000217445	1	151789714	1	151817238	217445	214085	rs774357869	NC_000001.11:151817237:G:A
NC_000001.11:g.109606085C>T	GNAT2	G202E	Achromatopsia 4	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812114	1	110148707	1	109606085	812114	800346		NC_000001.11:109606084:C:T
NM_005272.4(GNAT2):c.955del (p.Ile319fs)	GNAT2	I319fs	Achromatopsia 4	Pathogenic(Last reviewed: Jun 12, 2018)	no assertion criteria provided	VCV000623287	1	110146086	1	109603464	623287	612232	rs1557917535	NC_000001.11:109603463:TTT:TT
NM_005272.4(GNAT2):c.803_806dup (p.Lys270fs)	GNAT2		Achromatopsia 4	Pathogenic(Last reviewed: Jun 12, 2018)	no assertion criteria provided	VCV000623282	1	110146640 - 110146641	1	109604018 - 109604019	623282	612237	rs1557917899	NC_000001.11:109604018:TTGA:TTGATTGA
NM_005272.4(GNAT2):c.503dup (p.Pro169_Ser170insTer)	GNAT2		Achromatopsia 4	Pathogenic(Last reviewed: Jun 12, 2018)	no assertion criteria provided	VCV000623275	1	110149016 - 110149017	1	109606394 - 109606395	623275	612242	rs1557918911	NC_000001.11:109606394:A:AA
NM_005272.4(GNAT2):c.303+365_461+974del	GNAT2		Achromatopsia 4	Pathogenic(Last reviewed: Jun 12, 2018)	no assertion criteria provided	VCV000623273	1	110150279 - 110152297	1	109607657 - 109609675	623273	612243		
NM_005272.4(GNAT2):c.285_291delinsCTGTAT (p.Ala96fs)	GNAT2		Achromatopsia 4	Pathogenic(Last reviewed: Jun 12, 2018)	no assertion criteria provided	VCV000623271	1	110152674 - 110152680	1	109610052 - 109610058	623271	612246	rs1557920291	NC_000001.11:109610051:TTCAGCA:ATACAG
GNAT2, 4-BP INS, 842TCAG	GNAT2		Achromatopsia 4	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000015923					15923	30962		
NM_001002755.3(NFU1):c.622G>T (p.Gly208Cys)	NFU1	G208C, G67C, G184C	not provided|Multiple mitochondrial dysfunctions syndrome 1	Pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000030700	2	69627594	2	69400462	30700	39657	rs374514431	NC_000002.12:69400461:C:A
NFU1, 545G-A	NFU1		Multiple mitochondrial dysfunctions syndrome 1	Pathogenic(Last reviewed: Nov 11, 2011)	no assertion criteria provided	VCV000030699					30699	39656		
GNAT2, NT285, 7-BP DEL/6-BP INS	GNAT2		Achromatopsia 4	Pathogenic(Last reviewed: Dec 1, 2004)	no assertion criteria provided	VCV000015924					15924	30963		
NM_005272.4(GNAT2):c.235C>T (p.Gln79Ter)	GNAT2	Q79*	Achromatopsia 4	Pathogenic(Last reviewed: Jun 12, 2018)	no assertion criteria provided	VCV000015922	1	110152730	1	109610108	15922	30961	rs121434585	NC_000001.11:109610107:G:A
NM_005850.5(SF3B4):c.827del (p.Pro276fs)	SF3B4	P276fs	not provided|Hereditary hearing loss and deafness	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000446295	1	149897814	1	149925922	446295	439700	rs797045128	NC_000001.11:149925921:GGGGGG:GGGGG
NM_004522.3(KIF5C):c.265_267TCA[1] (p.Ser90del)	KIF5C	S90del	not provided	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000504269	2	149686897 - 149686899	2	148929328 - 148929330	504269	495118	rs1553463778	NC_000002.12:148929327:TCATCA:TCA
NM_004522.3(KIF5C):c.710A>T (p.Glu237Val)	KIF5C	E237V	Cortical dysplasia, complex, with other brain malformations 2	Pathogenic(Last reviewed: Jun 1, 2013)	no assertion criteria provided	VCV000065402	2	149803533	2	148947019	65402	76335	rs587777035	NC_000002.12:148947018:A:T
NM_022787.4(NMNAT1):c.293T>G (p.Val98Gly)	NMNAT1	V98G	Retinal dystrophy	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000866255	1	10035827	1	9975769	866255	856129		NC_000001.11:9975768:T:G
NM_018713.2(SLC30A10):c.1006C>T (p.His336Tyr)	SLC30A10	H336Y	Hypermanganesemia with dystonia 1	Pathogenic(Last reviewed: Feb 9, 2017)	no assertion criteria provided	VCV000375609	1	220089243	1	219915901	375609	362420	rs770740586	NC_000001.11:219915900:G:A
NR_046437.1(SLC30A10):n.707_764del	SLC30A10	A166fs	Hypermanganesemia with dystonia 1	Pathogenic(Last reviewed: Feb 9, 2017)	no assertion criteria provided	VCV000375608	1	220101230 - 220101287	1	219927888 - 219927945	375608	362421	rs1553313783	
NM_018713.2(SLC30A10):c.492del (p.Gly165fs)	SLC30A10	G165fs	Hypermanganesemia with dystonia 1	Pathogenic(Last reviewed: Feb 9, 2017)	no assertion criteria provided	VCV000375607	1	220101291	1	219927949	375607	362422	rs1057519590	NC_000001.11:219927948:GGGG:GGG
NM_018713.2(SLC30A10):c.460C>T (p.Gln154Ter)	SLC30A10	Q154*	Hypermanganesemia with dystonia 1	Pathogenic(Last reviewed: Feb 9, 2017)	no assertion criteria provided	VCV000375606	1	220101323	1	219927981	375606	362423	rs1057519589	NC_000001.11:219927980:G:A
NM_018713.2(SLC30A10):c.922C>T (p.Gln308Ter)	SLC30A10	Q308*	Hypermanganesemia with dystonia 1	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000038410	1	220091633	1	219918291	38410	46969	rs281860290	NC_000001.11:219918290:G:A
NR_046437.1(SLC30A10):n.1014_1016del	SLC30A10	V256del	Hypermanganesemia with dystonia 1	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000038409	1	220091788 - 220091790	1	219918446 - 219918448	38409	46968	rs281860289	NC_000001.11:219918445:ACCAC:AC
NM_018713.2(SLC30A10):c.500T>C (p.Phe167Ser)	SLC30A10	F167S	Hypermanganesemia with dystonia 1	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000038408	1	220101283	1	219927941	38408	46967	rs281860286	NC_000001.11:219927940:A:G
NR_046437.1(SLC30A10):n.503_613del	SLC30A10		Hypermanganesemia with dystonia 1	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000038407	1	220101381 - 220101491	1	219928039 - 219928149	38407	46966	rs1553313839	
NM_018713.2(SLC30A10):c.1046T>C (p.Leu349Pro)	SLC30A10	L349P	Hypermanganesemia with dystonia 1	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000038406	1	220089203	1	219915861	38406	46965	rs281860291	NC_000001.11:219915860:A:G
nsv1067840	SLC30A10		Hypermanganesemia with dystonia 1	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000038295	1	219990803 - 220091941	1	219817461 - 219918599	38295	46862		
NM_022787.4(NMNAT1):c.716T>C (p.Leu239Ser)	NMNAT1	L239S	Leber congenital amaurosis 9	Pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000464670	1	10042635	1	9982577	464670	448406	rs778606847	NC_000001.11:9982576:T:C
NC_000001.10:g.(?_10041069)_(10042779_?)del	NMNAT1		Leber congenital amaurosis 9	Pathogenic(Last reviewed: Apr 15, 2017)	criteria provided, single submitter	VCV000464669	1	10041069 - 10042779	1	9981011 - 9982721	464669	446968		
NM_022787.4(NMNAT1):c.53A>G (p.Asn18Ser)	NMNAT1	N18S	Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000190977	1	10032184	1	9972126	190977	188783	rs748902766	NC_000001.11:9972125:A:G
NM_022787.4(NMNAT1):c.25G>A (p.Val9Met)	NMNAT1	V9M	Leber congenital amaurosis 9	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000037140	1	10032156	1	9972098	37140	45801	rs387907294	NC_000001.11:9972097:G:A
NM_022787.4(NMNAT1):c.457C>G (p.Leu153Val)	NMNAT1	L153V	Leber congenital amaurosis 9	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000037139	1	10042376	1	9982318	37139	45800	rs387907293	NC_000001.11:9982317:C:G
NM_022787.4(NMNAT1):c.710G>T (p.Arg237Leu)	NMNAT1	R237L	Leber congenital amaurosis 9	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000037138	1	10042629	1	9982571	37138	45799	rs368062092	NC_000001.11:9982570:G:T
NM_018713.2(SLC30A10):c.1235del (p.Gln412fs)	SLC30A10	Q412fs	Hypermanganesemia with dystonia 1	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000030889	1	220089014	1	219915672	30889	39846	rs281860292	NC_000001.11:219915671:T:
NM_018713.2(SLC30A10):c.507del (p.Pro170fs)	SLC30A10	P170fs	Hypermanganesemia with dystonia 1	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000030888	1	220101276	1	219927934	30888	39845	rs281860287	NC_000001.11:219927933:CCCCCC:CCCCC
NM_018713.2(SLC30A10):c.266T>C (p.Leu89Pro)	SLC30A10	L89P	Hypermanganesemia with dystonia 1	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000030886	1	220101517	1	219928175	30886	39843	rs281860284	NC_000001.11:219928174:A:G
NM_022787.4(NMNAT1):c.451G>T (p.Val151Phe)	NMNAT1	V151F	Leber congenital amaurosis 9	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000037136	1	10042370	1	9982312	37136	45797	rs387907292	NC_000001.11:9982311:G:T
NM_022787.4(NMNAT1):c.817A>G (p.Asn273Asp)	NMNAT1	N273D	Leber congenital amaurosis 9	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000037135	1	10042736	1	9982678	37135	45796	rs387907291	NC_000001.11:9982677:A:G
NM_022787.4(NMNAT1):c.838T>C (p.Ter280Gln)	NMNAT1	*280Q	Leber congenital amaurosis 9	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000037132	1	10042757	1	9982699	37132	45793	rs387907290	NC_000001.11:9982698:T:C
NM_001743.6(CALM2):c.407A>C (p.Gln136Pro)	CALM2	Q136P, Q100P, Q184P	Long QT syndrome 1|Long QT syndrome 15	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000096724	2	47388876	2	47161737	96724	102611	rs398124649	NC_000002.12:47161736:T:G
NM_001743.6(CALM2):c.400G>C (p.Asp134His)	CALM2	D134H, D98H, D182H	Long QT syndrome 1|Long QT syndrome 15	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000096723	2	47388883	2	47161744	96723	102610	rs398124650	NC_000002.12:47161743:C:G
NM_001743.6(CALM2):c.293A>T (p.Asn98Ile)	CALM2	N98I, N62I, N146I	Long QT syndrome 1|Long QT syndrome 15	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000096721	2	47388990	2	47161851	96721	102608	rs398124647	NC_000002.12:47161850:T:A
NR_046437.1(SLC30A10):n.525_533del	SLC30A10		Hypermanganesemia with dystonia 1	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000030885	1	220101461 - 220101469	1	219928119 - 219928127	30885	39842	rs281860285	NC_000001.11:219928118:CGGGCCGGGC:C
NM_021831.6(AGBL5):c.826C>T (p.Arg276Trp)	AGBL5	R276W	Retinitis pigmentosa 75	Pathogenic(Last reviewed: Sep 6, 2017)	no assertion criteria provided	VCV000242933	2	27278039	2	27055171	242933	244035	rs879253769	NC_000002.12:27055170:C:T
NM_021831.6(AGBL5):c.883G>A (p.Asp295Asn)	AGBL5	D295N	Retinitis pigmentosa 75	Pathogenic(Last reviewed: Sep 6, 2017)	no assertion criteria provided	VCV000242932	2	27278096	2	27055228	242932	244034	rs879253768	NC_000002.12:27055227:G:A
NM_021831.6(AGBL5):c.1787_1788del (p.His596fs)	AGBL5	H596fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812217	2	27281383 - 27281384	2	27058515 - 27058516	812217	800466		NC_000002.12:27058514:AT:
NR_046437.1(SLC30A10):n.796del	SLC30A10	T196fs	not provided|Hypermanganesemia with dystonia 1	Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000030887	1	220101198	1	219927856	30887	39844	rs281860288	NC_000001.11:219927855:CCCCC:CCCC
NM_152384.3(BBS5):c.258+2T>C	BBS5		Bardet-Biedl syndrome 5	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560431	2	170344367	2	169487857	560431	551525	rs1559122157	NC_000002.12:169487856:T:C
NM_152384.3(BBS5):c.209-2A>G	BBS5		Bardet-Biedl syndrome 5	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560430	2	170344314	2	169487804	560430	551524	rs1477098739	NC_000002.12:169487803:A:G
NM_152384.3(BBS5):c.413G>A (p.Arg138His)	BBS5	R138H	Bardet-Biedl syndrome	Pathogenic	no assertion criteria provided	VCV000068066	2	170349410	2	169492900	68066	78957	rs179363897	NC_000002.12:169492899:G:A
NM_152384.3(BBS5):c.567G>A (p.Trp189Ter)	BBS5	W189*	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000854247	2	170350295	2	169493785	854247	825199		NC_000002.12:169493784:G:A
NM_152384.3(BBS5):c.2T>A (p.Met1Lys)	BBS5	M1K	Bardet-Biedl syndrome 5	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812118	2	170336065	2	169479555	812118	800350		NC_000002.12:169479554:T:A
NM_152384.3(BBS5):c.166A>G (p.Arg56Gly)	BBS5	R56G	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585188	2	170343602	2	169487092	585188	576216	rs1559121920	NC_000002.12:169487091:A:G
NM_152384.3(BBS5):c.123del (p.Gly42fs)	BBS5	G42fs	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585187	2	170338822	2	169482312	585187	576215	rs1272140892	NC_000002.12:169482311:AAA:AA
NM_152384.3(BBS5):c.547A>G (p.Thr183Ala)	BBS5	T183A	Bardet-Biedl syndrome 5	Pathogenic(Last reviewed: Feb 15, 2008)	no assertion criteria provided	VCV000006162	2	170350275	2	169493765	6162	21201	rs121908582	NC_000002.12:169493764:A:G
NM_152384.3(BBS5):c.177G>A (p.Trp59Ter)	BBS5	W59*	Bardet-Biedl syndrome 5	Pathogenic(Last reviewed: May 14, 2004)	no assertion criteria provided	VCV000006160	2	170343613	2	169487103	6160	21199	rs767221160	NC_000002.12:169487102:G:A
BBS5, 8-BP DEL/7-BP INS, NT263	BBS5		Bardet-Biedl syndrome 5	Pathogenic(Last reviewed: May 14, 2004)	no assertion criteria provided	VCV000006159					6159	21198		
NM_152384.3(BBS5):c.425T>A (p.Leu142Ter)	BBS5	L142*	Bardet-Biedl syndrome 5	Pathogenic(Last reviewed: May 14, 2004)	no assertion criteria provided	VCV000006158	2	170349422	2	169492912	6158	21197		NC_000002.12:169492911:T:A
NM_152384.3(BBS5):c.522+3A>G	BBS5		Bardet-Biedl syndrome 5	Pathogenic(Last reviewed: May 14, 2004)	no assertion criteria provided	VCV000006157	2	170349522	2	169493012	6157	21196	rs587777828	NC_000002.12:169493011:A:G
NM_152384.3(BBS5):c.143-1G>A	BBS5		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000854552	2	170343578	2	169487068	854552	851358		NC_000002.12:169487067:G:A
NC_000002.12:g.(?_169492874)_(169493836_?)del	BBS5		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000832168	2	170349384 - 170350346			832168	819080		
NM_152384.3(BBS5):c.265C>T (p.Arg89Ter)	BBS5	R89*	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000531823	2	170344503	2	169487993	531823	516815	rs772757329	NC_000002.12:169487992:C:T
NM_152384.3(BBS5):c.214G>A (p.Gly72Ser)	BBS5	G72S	Bardet-Biedl syndrome 5|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000006161	2	170344321	2	169487811	6161	21200	rs121908581	NC_000002.12:169487810:G:A
NM_001615.4(ACTG2):c.532C>T (p.Arg178Cys)	ACTG2	R178C, R135C	Visceral myopathy|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000132800	2	74140692	2	73913565	132800	136549	rs78001248	NC_000002.12:73913564:C:T
GRCh37/hg19 1p31.3(chr1:61551732-61620930)x1	NFIA		not provided	Pathogenic(Last reviewed: Mar 22, 2018)	no assertion criteria provided	VCV000685456	1	61551732 - 61620930			685456	673048		
NM_001134673.4(NFIA):c.1270C>T (p.Gln424Ter)	NFIA	Q416*, Q424*, Q469*	not provided	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000620518	1	61872249	1	61406577	620518	611526	rs1557762822	NC_000001.11:61406576:C:T
NM_001134673.4(NFIA):c.586C>T (p.Gln196Ter)	NFIA	Q188*, Q196*, Q241*	not provided	Pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	VCV000504296	1	61743218	1	61277546	504296	495336	rs1553167851	NC_000001.11:61277545:C:T
NM_001134673.4(NFIA):c.1008_1009dup (p.Ser337fs)	NFIA		not provided	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000452925	1	61848969 - 61848970	1	61383297 - 61383298	452925	442869	rs1553180342	NC_000001.11:61383297:TT:TTTT
NM_001134673.4(NFIA):c.361C>T (p.Arg121Cys)	NFIA	R113C, R121C, R166C	not provided	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000265253	1	61554154	1	61088482	265253	259674	rs886039429	NC_000001.11:61088481:C:T
NM_001134673.4(NFIA):c.220C>T (p.Arg74Ter)	NFIA	R66*, R74*, R119*	NFIA-related disorders|not provided	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000523874	1	61554013	1	61088341	523874	514432	rs1553149182	NC_000001.11:61088340:C:T
NFIA, 109-KB DEL	NFIA		Brain malformations and urinary tract defects	Pathogenic(Last reviewed: Oct 30, 2017)	no assertion criteria provided	VCV000445152					445152	438548		
NM_001134673.4(NFIA):c.1094del (p.Pro365fs)	NFIA	P357fs, P365fs, P410fs	Brain malformations and urinary tract defects	Pathogenic(Last reviewed: Apr 20, 2017)	no assertion criteria provided	VCV000417968	1	61869793	1	61404121	417968	404855	rs1060505054	NC_000001.11:61404120:CC:C
NG_011787.1:g.(205313_260238)_(334455_354191)del	NFIA		Brain malformations and urinary tract defects	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000417967			1	61277586 - 61426464	417967	404854		
NM_022787.4(NMNAT1):c.507G>A (p.Trp169Ter)	NMNAT1	W169*	not provided|Leber congenital amaurosis 9	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000265453	1	10042426	1	9982368	265453	259687	rs371526758	NC_000001.11:9982367:G:A
NM_001134673.4(NFIA):c.70C>T (p.Arg24Ter)	NFIA	R16*, R24*, R69*	not provided|Brain malformations and urinary tract defects	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000420999	1	61553863	1	61088191	420999	405220	rs1064794841	NC_000001.11:61088190:C:T
NM_001743.6(CALM2):c.396T>G (p.Asp132Glu)	CALM2	D132E, D96E, D180E	Long QT syndrome 1|Long QT syndrome 15	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000096722	2	47388887	2	47161748	96722	102609	rs398124648	NC_000002.12:47161747:A:C
NM_001743.6(CALM2):c.293A>G (p.Asn98Ser)	CALM2	N98S, N62S, N146S	Long QT syndrome 1|Long QT syndrome 15	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000096720	2	47388990	2	47161851	96720	102607	rs398124647	NC_000002.12:47161850:T:C
NM_020738.4(KIDINS220):c.4276del (p.Ser1426fs)	KIDINS220	S1408fs, S1370fs, S1407fs, S1427fs, S1327fs, S1369fs, S1426fs	not provided	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000817924	2	8871890	2	8731760	817924	806280		NC_000002.12:8731759:A:
NM_020738.4(KIDINS220):c.4417dup (p.Leu1473fs)	KIDINS220		not provided	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000817641	2	8871748 - 8871749	2	8731618 - 8731619	817641	806281		NC_000002.12:8731618:GGGGGG:GGGGGGG
NM_022893.4(BCL11A):c.314dup (p.Thr106fs)	BCL11A		not provided	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000817487	2	60773176 - 60773177	2	60546041 - 60546042	817487	805315		NC_000002.12:60546041:A:AA
NM_018263.6(ASXL2):c.1879dup (p.Ser627fs)	ASXL2		not provided	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000817477	2	25967326 - 25967327	2	25744457 - 25744458	817477	805303		NC_000002.12:25744457:A:AA
NM_022893.4(BCL11A):c.417_421del (p.Pro140fs)	BCL11A	P140fs	not provided	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000817215	2	60695933 - 60695937	2	60468798 - 60468802	817215	805314		NC_000002.12:60468797:GAGGGGAGG:GAGG
NM_022893.4(BCL11A):c.1285_1286CA[4] (p.Lys430fs)	BCL11A		not provided	Pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000524144	2	60688758 - 60688759	2	60461623 - 60461624	524144	514473	rs1553403363	NC_000002.12:60461623:TGTG:TGTGTGTG
NM_018263.6(ASXL2):c.2606del (p.Pro868_Ser869insTer)	ASXL2		not provided	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000523922	2	25966600	2	25743731	523922	514465	rs1553691555	NC_000002.12:25743730:G:
NM_022893.4(BCL11A):c.1831G>T (p.Glu611Ter)	BCL11A	E611*, E577*	not provided	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000523833	2	60688216	2	60461081	523833	514472	rs1303665345	NC_000002.12:60461080:C:A
NM_022893.4(BCL11A):c.1735_1741del (p.Glu579fs)	BCL11A	E545fs, E579fs	not provided	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000504051	2	60688306 - 60688312	2	60461171 - 60461177	504051	495158	rs1553403049	NC_000002.12:60461170:GGCCCTCGGCC:GGCC
NM_022893.4(BCL11A):c.952A>T (p.Arg318Ter)	BCL11A	R318*, R284*	not provided	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000488995	2	60689095	2	60461960	488995	481659	rs1553403551	NC_000002.12:60461959:T:A
NM_022893.4(BCL11A):c.12_15CAAG[4] (p.Gly7fs)	BCL11A		not provided	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000452149	2	60780386 - 60780387	2	60553251 - 60553252	452149	443284	rs1553354668	NC_000002.12:60553251:CTTGCTTGC:CTTGCTTGCTTGCTTGC
NM_020738.4(KIDINS220):c.5079_5080del (p.Asn1693fs)	KIDINS220	N1637fs, N1674fs, N1675fs, N1693fs, N1636fs, N1594fs, N1694fs	Spastic paraplegia, intellectual disability, nystagmus, and obesity	Pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000430805	2	8871086 - 8871087	2	8730956 - 8730957	430805	424350	rs1131692229	NC_000002.12:8730955:TGT:T
NM_022893.4(BCL11A):c.1078dup (p.Leu360fs)	BCL11A		not provided	Pathogenic(Last reviewed: Mar 28, 2017)	criteria provided, single submitter	VCV000426886	2	60688968 - 60688969	2	60461833 - 60461834	426886	414892	rs768799046	NC_000002.12:60461833:GGGGGGG:GGGGGGGG
NM_022893.4(BCL11A):c.633_643del (p.Gly212fs)	BCL11A	G178fs, G212fs	not provided	Pathogenic(Last reviewed: Feb 16, 2017)	criteria provided, single submitter	VCV000423454	2	60689404 - 60689414	2	60462269 - 60462279	423454	406000	rs1553403688	NC_000002.12:60462268:AAGGGATACCAA:A
NM_022893.4(BCL11A):c.793dup (p.Leu265fs)	BCL11A		not provided	Pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000420316	2	60689253 - 60689254	2	60462118 - 60462119	420316	405999	rs761909641	NC_000002.12:60462118:GGGGGGG:GGGGGGGG
NM_022893.4(BCL11A):c.263C>A (p.Ser88Ter)	BCL11A	S88*	not provided	Pathogenic(Last reviewed: Dec 20, 2016)	criteria provided, single submitter	VCV000391343	2	60773228	2	60546093	391343	366657	rs1057524042	NC_000002.12:60546092:G:T
NM_001122764.3(PPOX):c.1281G>A (p.Trp427Ter)	PPOX	W427*, W265*, W291*, W394*, W390*	Abnormal blistering of the skin|Porphyrinuria|Abdominal colic	Pathogenic(Last reviewed: Mar 22, 2016)	no assertion criteria provided	VCV000373956	1	161140729	1	161170939	373956	360805	rs1057518798	NC_000001.11:161170938:G:A
NM_018263.6(ASXL2):c.1240_1241GT[1] (p.Ser415fs)	ASXL2		Shashi-Pena syndrome	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000666592	2	25973182 - 25973183	2	25750313 - 25750314	666592	654120		NC_000002.12:25750312:ACACA:ACA
NM_018263.6(ASXL2):c.1228A>T (p.Lys410Ter)	ASXL2	K410*, K352*, K150*	Shashi-Pena syndrome	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, single submitter	VCV000666552	2	25973197	2	25750328	666552	654121		NC_000002.12:25750327:T:A
NM_022893.4(BCL11A):c.295del (p.Val99fs)	BCL11A	V99fs	|Cerebellar vermis hypoplasia|Intellectual developmental disorder with persistence of fetal hemoglobin	Pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000632586	2	60773196	2	60546061	632586	621021	rs1558519119	NC_000002.12:60546060:C:
NM_022893.4(BCL11A):c.1601_1631del (p.Val534fs)	BCL11A	V500fs, V534fs	Intellectual developmental disorder with persistence of fetal hemoglobin	Pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000632585	2	60688416 - 60688446	2	60461281 - 60461311	632585	621020	rs1558612412	NC_000002.12:60461280:GGCAGGGCGCGGCTCTCGTCGCCCACGCCCA:
NM_000542.5(SFTPB):c.1084-1G>A	SFTPB		Surfactant metabolism dysfunction, pulmonary, 1	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000587605	2	85888659	2	85661536	587605	578406	rs1558572491	NC_000002.12:85661535:C:T
NM_001122764.3(PPOX):c.1353T>G (p.Tyr451Ter)	PPOX	Y451*, Y289*, Y414*, Y315*, Y418*	Migraine|Abnormal blistering of the skin|Constipation|Abnormal urinary color	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523355	1	161140885	1	161171095	523355	513896	rs148292941	NC_000001.11:161171094:T:G
NM_020738.4(KIDINS220):c.4520dup (p.Leu1507fs)	KIDINS220		Spastic paraplegia, intellectual disability, nystagmus, and obesity	Pathogenic(Last reviewed: Jan 11, 2017)	no assertion criteria provided	VCV000374910	2	8871645 - 8871646	2	8731515 - 8731516	374910	361815	rs1057519302	NC_000002.12:8731515:AAA:AAAA
NM_020738.4(KIDINS220):c.4096C>T (p.Gln1366Ter)	KIDINS220	Q1366*, Q1347*, Q1267*, Q1310*, Q1367*, Q1309*, Q1348*	Spastic paraplegia, intellectual disability, nystagmus, and obesity	Pathogenic(Last reviewed: Jan 11, 2017)	no assertion criteria provided	VCV000374909	2	8872070	2	8731940	374909	361814	rs1057519301	NC_000002.12:8731939:G:A
NM_020738.4(KIDINS220):c.4050G>A (p.Trp1350Ter)	KIDINS220	W1350*, W1251*, W1331*, W1293*, W1351*, W1294*, W1332*	Spastic paraplegia, intellectual disability, nystagmus, and obesity	Pathogenic(Last reviewed: Jan 11, 2017)	no assertion criteria provided	VCV000374908	2	8873577	2	8733447	374908	361813	rs1057519300	NC_000002.12:8733446:C:T
NM_018263.6(ASXL2):c.1288G>T (p.Glu430Ter)	ASXL2	E430*, E170*, E372*	Shashi-Pena syndrome	Pathogenic(Last reviewed: Nov 11, 2016)	no assertion criteria provided	VCV000268127	2	25973137	2	25750268	268127	263653	rs886041070	NC_000002.12:25750267:C:A
NM_018263.6(ASXL2):c.2971_2974del (p.Gly991fs)	ASXL2	G731fs, G933fs, G991fs	Shashi-Pena syndrome	Pathogenic(Last reviewed: Nov 11, 2016)	no assertion criteria provided	VCV000268126	2	25966232 - 25966235	2	25743363 - 25743366	268126	263652	rs886041069	NC_000002.12:25743362:CTCCC:C
NM_018263.6(ASXL2):c.2472del (p.Ser825fs)	ASXL2	S825fs, S565fs, S767fs	Shashi-Pena syndrome	Pathogenic(Last reviewed: Jan 25, 2018)	no assertion criteria provided	VCV000268125	2	25966734	2	25743865	268125	263651	rs886041068	NC_000002.12:25743864:GGG:GG
NM_018263.6(ASXL2):c.1225_1228del (p.Pro409fs)	ASXL2	P409fs, P149fs, P351fs	Shashi-Pena syndrome	Pathogenic(Last reviewed: Nov 11, 2016)	no assertion criteria provided	VCV000268124	2	25973197 - 25973200	2	25750328 - 25750331	268124	263650	rs886041067	NC_000002.12:25750327:TTGGTTG:TTG
NM_018263.6(ASXL2):c.2081dup (p.Gly696fs)	ASXL2		Shashi-Pena syndrome	Pathogenic(Last reviewed: Nov 11, 2016)	no assertion criteria provided	VCV000268123	2	25967124 - 25967125	2	25744255 - 25744256	268123	263649	rs886041066	NC_000002.12:25744255:CC:CCC
NM_000542.5(SFTPB):c.465G>T (p.Gly155=)	SFTPB		Surfactant metabolism dysfunction, pulmonary, 1	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000013205	2	85892846	2	85665723	13205	28244	rs1553380888	NC_000002.12:85665722:C:A
NM_000542.5(SFTPB):c.706C>T (p.Arg236Cys)	SFTPB	R236C, R248C	Surfactant metabolism dysfunction, pulmonary, 1	Pathogenic(Last reviewed: Dec 1, 1995)	no assertion criteria provided	VCV000013204	2	85890937	2	85663814	13204	28243	rs137853202	NC_000002.12:85663813:G:A
SFTPB, 1-BP DEL, 457C	SFTPB		Surfactant metabolism dysfunction, pulmonary, 1	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000013203					13203	28242		
SFTPB, 1-BP DEL, 1553T	SFTPB		Surfactant metabolism dysfunction, pulmonary, 1	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	VCV000013202					13202	28241		
PPOX, IVS11DS, G-A, -1	PPOX		Variegate porphyria, homozygous	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000008702					8702	23741		
PPOX, 12-BP INS, NT657	PPOX		Variegate porphyria, homozygous	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000008701					8701	23740		
NM_001122764.3(PPOX):c.1046A>C (p.Asp349Ala)	PPOX	D349A, D187A, D213A, D316A	Variegate porphyria, homozygous	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000008698	1	161140257	1	161170467	8698	23737	rs28936676	NC_000001.11:161170466:A:C
NM_022893.4(BCL11A):c.1065_1083dup (p.Pro362fs)	BCL11A		not provided	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000834294	2	60688963 - 60688964	2	60461828 - 60461829	834294	826862		NC_000002.12:60461828:AGGGAGGGGGGGCGTCGCCAGG:AGGGAGGGGGGGCGTCGCCAGGGAGGGGGGGCGTCGCCAGG
NM_001122764.3(PPOX):c.745dup (p.Val249fs)	PPOX		not provided	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000664759	1	161138905 - 161138906	1	161169115 - 161169116	664759	627018		NC_000001.11:161169115:GGGGGG:GGGGGGG
NM_001122764.3(PPOX):c.454C>T (p.Arg152Cys)	PPOX	R152C	not provided	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000664272	1	161137900	1	161168110	664272	627015		NC_000001.11:161168109:C:T
NM_001122764.3(PPOX):c.565C>T (p.Gln189Ter)	PPOX	Q156*, Q189*, Q27*, Q53*	not provided	Pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, single submitter	VCV000651549	1	161138315	1	161168525	651549	627016		NC_000001.11:161168524:C:T
NM_001122764.3(PPOX):c.78C>A (p.Cys26Ter)	PPOX	C26*	not provided	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000649718	1	161136715	1	161166925	649718	627014		NC_000001.11:161166924:C:A
NM_001122764.3(PPOX):c.1090_1091AG[1] (p.Arg364fs)	PPOX		not provided	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000643192	1	161140301 - 161140302	1	161170511 - 161170512	643192	627019		NC_000001.11:161170510:AGAG:AG
NM_018263.6(ASXL2):c.2424del (p.Thr809fs)	ASXL2	T809fs, T549fs, T751fs	Shashi-Pena syndrome	Pathogenic(Last reviewed: Jan 16, 2017)	criteria provided, single submitter	VCV000268122	2	25966782	2	25743913	268122	263648	rs886041065	NC_000002.12:25743912:GGGG:GGG
NM_022893.4(BCL11A):c.1775_1776insTGG (p.Gly592dup)	BCL11A		Intellectual developmental disorder with persistence of fetal hemoglobin	Pathogenic(Last reviewed: Sep 8, 2016)	no assertion criteria provided	VCV000253304	2	60688271 - 60688272	2	60461136 - 60461137	253304	247747	rs886037867	NC_000002.12:60461136:CC:CCACC
NM_022893.4(BCL11A):c.198C>A (p.His66Gln)	BCL11A	H66Q	Intellectual developmental disorder with persistence of fetal hemoglobin	Pathogenic(Last reviewed: Sep 8, 2016)	no assertion criteria provided	VCV000253302	2	60773293	2	60546158	253302	247745	rs886037866	NC_000002.12:60546157:G:T
NM_022893.4(BCL11A):c.143G>T (p.Cys48Phe)	BCL11A	C48F	Intellectual developmental disorder with persistence of fetal hemoglobin	Pathogenic(Last reviewed: Sep 8, 2016)	no assertion criteria provided	VCV000253301	2	60773348	2	60546213	253301	247744	rs886037865	NC_000002.12:60546212:C:A
NM_022893.4(BCL11A):c.139A>C (p.Thr47Pro)	BCL11A	T47P	Intellectual developmental disorder with persistence of fetal hemoglobin	Pathogenic(Last reviewed: Sep 8, 2016)	no assertion criteria provided	VCV000253300	2	60773352	2	60546217	253300	247743	rs886037864	NC_000002.12:60546216:T:G
NM_001122764.3(PPOX):c.199del (p.Ala66_Leu67insTer)	PPOX		Variegate porphyria	Pathogenic(Last reviewed: Mar 24, 2014)	criteria provided, single submitter	VCV000189241	1	161136999	1	161167209	189241	187104	rs786204784	NC_000001.11:161167208:CCC:CC
PPOX, 5-BP DEL, NT1239	PPOX		Variegate porphyria	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000008700					8700	23739		
NM_001122764.3(PPOX):c.538_539del (p.Ile180fs)	PPOX	I44fs, I180fs, I18fs, I147fs	Variegate porphyria	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000008699	1	161138288 - 161138289	1	161168498 - 161168499	8699	23738		NC_000001.11:161168497:AT:
NM_001122764.3(PPOX):c.59A>C (p.His20Pro)	PPOX	H20P	Variegate porphyria	Pathogenic(Last reviewed: Jul 1, 1996)	no assertion criteria provided	VCV000008695	1	161136696	1	161166906	8695	23734	rs121918326	NC_000001.11:161166905:A:C
NM_001122764.3(PPOX):c.502C>T (p.Arg168Cys)	PPOX	R168C, R32C, R135C, R6C	Variegate porphyria	Pathogenic(Last reviewed: Jul 1, 1996)	no assertion criteria provided	VCV000008694	1	161138252	1	161168462	8694	23733	rs121918325	NC_000001.11:161168461:C:T
PPOX, 1-BP INS, 1022G	PPOX		Variegate porphyria	Pathogenic(Last reviewed: Mar 1, 1996)	no assertion criteria provided	VCV000008692					8692	23731		
ICOS, 1,815-BP DEL	ICOS		Common variable immunodeficiency 1	Pathogenic(Last reviewed: Dec 1, 2004)	no assertion criteria provided	VCV000005501					5501	20540		
NM_022787.4(NMNAT1):c.619C>T (p.Arg207Trp)	NMNAT1	R207W	Leber congenital amaurosis 9	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000037133	1	10042538	1	9982480	37133	45794	rs142968179	NC_000001.11:9982479:C:T
NM_001122764.3(PPOX):c.338+1G>A	PPOX		not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000834524	1	161137277	1	161167487	834524	850740		NC_000001.11:161167486:G:A
NM_001122764.3(PPOX):c.35T>C (p.Ile12Thr)	PPOX	I12T	Variegate porphyria, homozygous	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000008703	1	161136672	1	161166882	8703	23742	rs28936677	NC_000001.11:161166881:T:C
NM_152384.3(BBS5):c.619-1G>C	BBS5		Bardet-Biedl syndrome|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000812227	2	170354136	2	169497626	812227	800686		NC_000002.12:169497625:G:C
NM_001122764.3(PPOX):c.2T>C (p.Met1Thr)	PPOX	M1T	not provided	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000655883	1	161136639	1	161166849	655883	627012		NC_000001.11:161166848:T:C
NM_000542.5(SFTPB):c.361_362insAA (p.Pro121fs)	SFTPB		Surfactant metabolism dysfunction, pulmonary, 1	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000631868	2	85893771 - 85893772	2	85666648 - 85666649	631868	620097	rs779795223	NC_000002.12:85666648::TT
NM_022893.4(BCL11A):c.529C>T (p.Gln177Ter)	BCL11A	Q177*, Q143*	not provided|Intellectual developmental disorder with persistence of fetal hemoglobin	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000503758	2	60689518	2	60462383	503758	495129	rs1553403736	NC_000002.12:60462382:G:A
NM_000542.5(SFTPB):c.361delinsGAA (p.Pro121fs)	SFTPB		Surfactant metabolism dysfunction, pulmonary, 1	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000013201	2	85893772	2	85666649	13201	28240	rs35328240	NC_000002.12:85666648:G:TTC
NM_022662.4(ANAPC1):c.4373+1G>A	ANAPC1		Rothmund-Thomson syndrome type 1	Pathogenic(Last reviewed: Oct 17, 2019)	no assertion criteria provided	VCV000692106	2	112552394	2	111794817	692106	679850		NC_000002.12:111794816:C:T
NM_022662.4(ANAPC1):c.1778dup (p.Asn593fs)	ANAPC1		Rothmund-Thomson syndrome type 1	Pathogenic(Last reviewed: Oct 17, 2019)	no assertion criteria provided	VCV000692105	2	112605314 - 112605315	2	111847737 - 111847738	692105	679849		NC_000002.12:111847737:TT:TTT
NM_001256864.2(DNAJC6):c.2536C>T (p.Gln846Ter)	DNAJC6	Q789*, Q776*, Q846*	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: Oct 13, 2016)	no assertion criteria provided	VCV000265964	1	65874368	1	65408685	265964	260693	rs886039854	NC_000001.11:65408684:C:T
NM_001256864.2(DNAJC6):c.2223A>T (p.Thr741=)	DNAJC6		Parkinson disease 19b, early-onset	Pathogenic(Last reviewed: Aug 9, 2016)	no assertion criteria provided	VCV000253095	1	65867559	1	65401876	253095	247506	rs879255554	NC_000001.11:65401875:A:T
NM_001256864.2(DNAJC6):c.2779A>G (p.Arg927Gly)	DNAJC6	R927G, R857G, R870G	Parkinson disease 19b, early-onset	Pathogenic(Last reviewed: Aug 9, 2016)	no assertion criteria provided	VCV000253094	1	65877077	1	65411394	253094	247505	rs879255630	NC_000001.11:65411393:A:G
NM_001256864.2(DNAJC6):c.2410C>T (p.Gln804Ter)	DNAJC6	Q734*, Q747*, Q804*	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000088855	1	65871735	1	65406052	88855	94424	rs398122405	NC_000001.11:65406051:C:T
NM_022662.4(ANAPC1):c.2705-198C>T	ANAPC1		Rothmund-Thomson syndrome type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2019)	no assertion criteria provided	VCV000692104	2	112582942	2	111825365	692104	679848		NC_000002.12:111825364:G:A
NM_001122764.3(PPOX):c.175C>T (p.Arg59Trp)	PPOX	R59W	Variegate porphyria	Pathogenic(Last reviewed: Feb 14, 2013)	no assertion criteria provided	VCV000008696	1	161136977	1	161167187	8696	23735	rs121918324	NC_000001.11:161167186:C:T
NM_020699.4(GATAD2B):c.562_563del (p.Gln188fs)	GATAD2B	Q188fs	not provided	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000817498	1	153791301 - 153791302	1	153818825 - 153818826	817498	805171		NC_000001.11:153818824:TGT:T
NM_020699.4(GATAD2B):c.252del (p.Arg84fs)	GATAD2B	R84fs	not provided	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000817388	1	153800572	1	153828096	817388	805172		NC_000001.11:153828095:CC:C
NM_020699.4(GATAD2B):c.574C>T (p.Gln192Ter)	GATAD2B	Q192*	Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801547	1	153791290	1	153818814	801547	789845		NC_000001.11:153818813:G:A
NM_000198.4(HSD3B2):c.1003C>T (p.Arg335Ter)	HSD3B2	R335*	not provided	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000597649	1	119965127	1	119422504	597649	588710	rs148200568	NC_000001.11:119422503:C:T
NM_020699.4(GATAD2B):c.335+1G>A	GATAD2B		not provided	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000546280	1	153800488	1	153828012	546280	536564	rs1553189681	NC_000001.11:153828011:C:T
NM_020699.4(GATAD2B):c.1261dup (p.Ala421fs)	GATAD2B		not provided	Pathogenic(Last reviewed: Jun 1, 2016)	no assertion criteria provided	VCV000545032	1	153785883 - 153785884	1	153813407 - 153813408	545032	535290	rs1553187583	NC_000001.11:153813407:C:CC
NM_020699.4(GATAD2B):c.186_194delinsTGGTG (p.Glu62fs)	GATAD2B		not provided	Pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, single submitter	VCV000504174	1	153800630 - 153800638	1	153828154 - 153828162	504174	495077	rs1553189700	NC_000001.11:153828153:GTGGGTAAC:CACCA
NM_020699.4(GATAD2B):c.153del (p.Lys52fs)	GATAD2B	K52fs	not provided	Pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, single submitter	VCV000451832	1	153800671	1	153828195	451832	442631	rs1553189704	NC_000001.11:153828194:CC:C
NM_020699.4(GATAD2B):c.709C>T (p.Gln237Ter)	GATAD2B	Q237*	not provided	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000432992	1	153790536	1	153818060	432992	425312	rs1553188314	NC_000001.11:153818059:G:A
NM_020699.4(GATAD2B):c.1414del (p.Glu472fs)	GATAD2B	E472fs	not provided	Pathogenic(Last reviewed: Feb 20, 2017)	criteria provided, single submitter	VCV000423772	1	153785731	1	153813255	423772	404921	rs1064796622	NC_000001.11:153813254:CC:C
NM_020699.4(GATAD2B):c.973C>T (p.Gln325Ter)	GATAD2B	Q325*	not provided	Pathogenic(Last reviewed: Sep 12, 2015)	criteria provided, single submitter	VCV000419723	1	153788992	1	153816516	419723	404922	rs1064794066	NC_000001.11:153816515:G:A
NM_020699.4(GATAD2B):c.495dup (p.Ile166fs)	GATAD2B		not provided	Pathogenic(Last reviewed: Jul 17, 2015)	criteria provided, single submitter	VCV000419264	1	153791368 - 153791369	1	153818892 - 153818893	419264	404924	rs1064793756	NC_000001.11:153818892:AA:AAA
NM_020699.4(GATAD2B):c.1045C>T (p.Gln349Ter)	GATAD2B	Q349*	not provided	Pathogenic(Last reviewed: Jan 11, 2017)	criteria provided, single submitter	VCV000391977	1	153788920	1	153816444	391977	364430	rs1057524308	NC_000001.11:153816443:G:A
NM_020699.4(GATAD2B):c.658C>T (p.Gln220Ter)	GATAD2B	Q220*	not provided	Pathogenic(Last reviewed: Apr 24, 2015)	criteria provided, single submitter	VCV000379456	1	153790587	1	153818111	379456	364395	rs1057520600	NC_000001.11:153818110:G:A
NM_020699.4(GATAD2B):c.694C>T (p.Gln232Ter)	GATAD2B	Q232*	Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: Apr 30, 2014)	no assertion criteria provided	VCV000374387	1	153790551	1	153818075	374387	361157	rs1057518674	NC_000001.11:153818074:G:A
NM_020699.4(GATAD2B):c.428_431AAGA[1] (p.Glu144fs)	GATAD2B		not provided	Pathogenic(Last reviewed: Dec 12, 2016)	criteria provided, single submitter	VCV000373815	1	153792112 - 153792115	1	153819636 - 153819639	373815	359246	rs1057518629	NC_000001.11:153819635:TCTTTCTT:TCTT
NM_020699.4(GATAD2B):c.1331del (p.Cys444fs)	GATAD2B	C444fs	not provided	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000373041	1	153785814	1	153813338	373041	359243	rs1057518163	NC_000001.11:153813337:C:
NM_020699.4(GATAD2B):c.335+1G>T	GATAD2B		not provided	Pathogenic(Last reviewed: Aug 18, 2016)	criteria provided, single submitter	VCV000280788	1	153800488	1	153828012	280788	263943	rs1553189681	NC_000001.11:153828011:C:A
NM_020699.4(GATAD2B):c.335+2T>G	GATAD2B		not provided	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000280149	1	153800487	1	153828011	280149	263972	rs1553189680	NC_000001.11:153828010:A:C
NM_020699.4(GATAD2B):c.1217-2A>G	GATAD2B		not provided	Pathogenic(Last reviewed: Aug 22, 2016)	criteria provided, single submitter	VCV000280108	1	153785930	1	153813454	280108	263967	rs1553187606	NC_000001.11:153813453:T:C
NC_000001.11:g.(?_119415410)_(119422630_?)del	HSD3B2		not provided	Pathogenic(Last reviewed: May 17, 2019)	criteria provided, single submitter	VCV000832762	1	119958033 - 119965253			832762	818842		
NM_020699.4(GATAD2B):c.667_670del (p.Lys224fs)	GATAD2B	K224fs	Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000638585	1	153790575 - 153790578	1	153818099 - 153818102	638585	626365		NC_000001.11:153818098:TAGATAG:TAG
NM_020699.4(GATAD2B):c.185del (p.Glu62fs)	GATAD2B	E62fs	Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000638011	1	153800639	1	153828163	638011	625784		NC_000001.11:153828162:T:
NM_020699.4(GATAD2B):c.1411C>T (p.Gln471Ter)	GATAD2B	Q471*	Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, single submitter	VCV000620074	1	153785734	1	153813258	620074	611374	rs1557778985	NC_000001.11:153813257:G:A
NM_020699.4(GATAD2B):c.1075C>T (p.Gln359Ter)	GATAD2B	Q359*	Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000584436	1	153788890	1	153816414	584436	575485	rs1557781252	NC_000001.11:153816413:G:A
NM_020699.4(GATAD2B):c.1426G>T (p.Glu476Ter)	GATAD2B	E476*	Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: May 29, 2017)	criteria provided, single submitter	VCV000448968	1	153784602	1	153812126	448968	442546	rs1553187446	NC_000001.11:153812125:C:A
NM_001625.4(AK2):c.523del (p.Arg175fs)	AK2	R167fs, R175fs, R133fs, R127fs	Reticular dysgenesis	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000446366	1	33478979	1	33013378	446366	439807	rs1553150995	NC_000001.11:33013377:G:
NM_020699.4(GATAD2B):c.655C>T (p.Gln219Ter)	GATAD2B	Q219*	not provided	Pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, single submitter	VCV000445996	1	153790590	1	153818114	445996	439268	rs1553188335	NC_000001.11:153818113:G:A
NM_020699.4(GATAD2B):c.1429C>T (p.Gln477Ter)	GATAD2B	Q477*	Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: Jul 8, 2016)	criteria provided, single submitter	VCV000435288	1	153784599	1	153812123	435288	427639	rs1553187443	NC_000001.11:153812122:G:A
NM_020699.4(GATAD2B):c.552_555del (p.Lys184fs)	GATAD2B	K184fs	Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000430625	1	153791309 - 153791312	1	153818833 - 153818836	430625	423708	rs1131692165	NC_000001.11:153818832:TTTCTTT:TTT
NM_020699.4(GATAD2B):c.76_80dup (p.Leu28fs)	GATAD2B		Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: Jul 7, 2017)	no assertion criteria provided	VCV000430624	1	153800743 - 153800744	1	153828267 - 153828268	430624	423707	rs1131692164	NC_000001.11:153828267:ACATCA:ACATCACATCA
NM_020699.4(GATAD2B):c.981del (p.Thr328fs)	GATAD2B	T328fs	Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: Oct 31, 2014)	criteria provided, single submitter	VCV000211069	1	153788984	1	153816508	211069	206722	rs797045594	NC_000001.11:153816507:CCC:CC
NM_020699.4(GATAD2B):c.563_564AG[1] (p.Gln190fs)	GATAD2B		Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065423	1	153791298 - 153791299	1	153818822 - 153818823	65423	76353	rs886037647	NC_000001.11:153818821:CTCT:CT
GATAD2B, ASN195LYSfsTER30	GATAD2B		Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: Nov 15, 2012)	no assertion criteria provided	VCV000039666					39666	48265		
NM_020699.4(GATAD2B):c.1408C>T (p.Gln470Ter)	GATAD2B	Q470*	Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: Nov 15, 2012)	no assertion criteria provided	VCV000039665	1	153785737	1	153813261	39665	48264	rs587776931	NC_000001.11:153813260:G:A
NM_001625.4(AK2):c.25G>T (p.Glu9Ter)	AK2	E9*	Reticular dysgenesis	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000018262	1	33502405	1	33036804	18262	33301	rs267606647	NC_000001.11:33036803:C:A
NM_001625.4(AK2):c.697A>T (p.Lys233Ter)	AK2	K233*, K185*	Reticular dysgenesis	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000018261	1	33478805	1	33013204	18261	33300	rs267606646	NC_000001.11:33013203:T:A
AK2, EX2 DEL	AK2		Reticular dysgenesis	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000018259					18259	33298		
NM_001625.4(AK2):c.556C>T (p.Arg186Cys)	AK2	R186C, R144C, R178C, R138C	Reticular dysgenesis	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000018258	1	33478946	1	33013345	18258	33297	rs267606645	NC_000001.11:33013344:G:A
NM_001625.4(AK2):c.494A>G (p.Asp165Gly)	AK2	D165G, D123G, D157G, D117G	Reticular dysgenesis	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000018256	1	33480127	1	33014526	18256	33295	rs267606643	NC_000001.11:33014525:T:C
NM_001625.4(AK2):c.498+1G>A	AK2		Reticular dysgenesis	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000018255	1	33480122	1	33014521	18255	33294		NC_000001.11:33014520:C:T
NM_001625.4(AK2):c.453del (p.Tyr152fs)	AK2	Y104fs, Y152fs, L120fs, Y110fs, Y144fs	Reticular dysgenesis	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000018254	1	33480168	1	33014567	18254	33293	rs1553151177	NC_000001.11:33014566:GG:G
NM_001625.4(AK2):c.331-1G>A	AK2		Reticular dysgenesis	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000018253	1	33487063	1	33021462	18253	33292		NC_000001.11:33021461:C:T
NM_001625.4(AK2):c.1A>G (p.Met1Val)	AK2	M1V	Reticular dysgenesis	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000018252	1	33502429	1	33036828	18252	33291	rs137853206	NC_000001.11:33036827:T:C
NM_001625.4(AK2):c.118del (p.Cys40fs)	AK2	C40fs	Reticular dysgenesis	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000018251	1	33490144	1	33024543	18251	33290	rs387906581	NC_000001.11:33024542:A:
NM_013411.4(AK2):c.636_*2601del	AK2		Reticular dysgenesis	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000018250					18250	33289		
NM_000198.4(HSD3B2):c.1022C>T (p.Pro341Leu)	HSD3B2	P341L	3 beta-Hydroxysteroid dehydrogenase deficiency	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000012194	1	119965146	1	119422523	12194	27233	rs121964897	NC_000001.11:119422522:C:T
NM_000198.4(HSD3B2):c.867del (p.Met290fs)	HSD3B2	M290fs	3 beta-Hydroxysteroid dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000012193	1	119964991	1	119422368	12193	27232		NC_000001.11:119422367:G:
NM_000198.4(HSD3B2):c.664C>A (p.Pro222Thr)	HSD3B2	P222T	3 beta-Hydroxysteroid dehydrogenase deficiency	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000012191	1	119964788	1	119422165	12191	27230	rs80358220	NC_000001.11:119422164:C:A
NM_000198.4(HSD3B2):c.424G>A (p.Glu142Lys)	HSD3B2	E142K	3 beta-Hydroxysteroid dehydrogenase deficiency	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000012190	1	119964548	1	119421925	12190	27229	rs80358219	NC_000001.11:119421924:G:A
NM_000198.4(HSD3B2):c.1119A>C (p.Ter373Cys)	HSD3B2	*373C	3 beta-Hydroxysteroid dehydrogenase deficiency	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000012189	1	119965243	1	119422620	12189	27228	rs80358218	NC_000001.11:119422619:A:C
NM_000198.4(HSD3B2):c.29C>A (p.Ala10Glu)	HSD3B2	A10E	3 beta-Hydroxysteroid dehydrogenase deficiency	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000012188	1	119958071	1	119415448	12188	27227	rs28934880	NC_000001.11:119415447:C:A
NM_000198.4(HSD3B2):c.742_743delinsAA (p.Val248Asn)	HSD3B2		3 beta-Hydroxysteroid dehydrogenase deficiency	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000012186	1	119964866 - 119964867	1	119422243 - 119422244	12186	27225	rs121964896	NC_000001.11:119422242:GT:AA
NM_000198.4(HSD3B2):c.558dup (p.Thr187fs)	HSD3B2		3 beta-Hydroxysteroid dehydrogenase deficiency	Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000012185	1	119964679 - 119964680	1	119422056 - 119422057	12185	27224		NC_000001.11:119422056:CCC:CCCC
NM_002181.4(IHH):c.389C>A (p.Thr130Asn)	IHH	T130N	Type A1 brachydactyly	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000008876	2	219922343	2	219057621	8876	23915	rs267606872	NC_000002.12:219057620:G:T
NM_002181.4(IHH):c.383G>A (p.Arg128Gln)	IHH	R128Q	Type A1 brachydactyly	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000008875	2	219922349	2	219057627	8875	23914	rs267606873	NC_000002.12:219057626:C:T
IHH, 3-BP DEL, 283GAG	IHH		Type A1 brachydactyly	Pathogenic(Last reviewed: Aug 15, 2008)	no assertion criteria provided	VCV000008874					8874	23913		
NM_002181.4(IHH):c.461C>T (p.Thr154Ile)	IHH	T154I	Type A1 brachydactyly	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000008873	2	219922271	2	219057549	8873	23912	rs121917861	NC_000002.12:219057548:G:A
NM_002181.4(IHH):c.569T>C (p.Val190Ala)	IHH	V190A	Acrocapitofemoral dysplasia	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000008871	2	219922163	2	219057441	8871	23910	rs121917857	NC_000002.12:219057440:A:G
NM_002181.4(IHH):c.137C>T (p.Pro46Leu)	IHH	P46L	Acrocapitofemoral dysplasia	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000008870	2	219925053	2	219060331	8870	23909	rs121917856	NC_000002.12:219060330:G:A
NM_002181.4(IHH):c.300C>A (p.Asp100Glu)	IHH	D100E	Type A1 brachydactyly	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000008868	2	219924890	2	219060168	8868	23907	rs121917854	NC_000002.12:219060167:G:T
NM_000198.4(HSD3B2):c.462C>A (p.Tyr154Ter)	HSD3B2	Y154*	not provided	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000848651	1	119964586	1	119421963	848651	822601		NC_000001.11:119421962:C:A
NM_000198.4(HSD3B2):c.818_819del (p.Lys273fs)	HSD3B2	K273fs	not provided	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000586031	1	119964941 - 119964942	1	119422318 - 119422319	586031	576403	rs754609778	NC_000001.11:119422317:AAA:A
NM_020699.4(GATAD2B):c.1196del (p.Gln399fs)	GATAD2B	Q399fs	not provided|GATAD2B-Related Disorder	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000450045	1	153788769	1	153816293	450045	442630	rs1553188054	NC_000001.11:153816292:T:
NM_020699.4(GATAD2B):c.1241G>A (p.Arg414Gln)	GATAD2B	R414Q	not provided|Mental retardation, autosomal dominant 18	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000381463	1	153785904	1	153813428	381463	364424	rs1057521041	NC_000001.11:153813427:C:T
NM_020699.4(GATAD2B):c.346C>T (p.Arg116Ter)	GATAD2B	R116*	GATAD2B-Related Disorder|not provided	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000280408	1	153792201	1	153819725	280408	263969	rs886041621	NC_000001.11:153819724:G:A
NM_000198.4(HSD3B2):c.512G>A (p.Trp171Ter)	HSD3B2	W171*	3 beta-Hydroxysteroid dehydrogenase deficiency	Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000012184	1	119964636	1	119422013	12184	27223	rs80358216	NC_000001.11:119422012:G:A
NM_002181.4(IHH):c.284A>G (p.Glu95Gly)	IHH	E95G	Type A1 brachydactyly	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000008872	2	219924906	2	219060184	8872	23911	rs121917859	NC_000002.12:219060183:T:C
NM_002181.4(IHH):c.391G>A (p.Glu131Lys)	IHH	E131K	Type A1 brachydactyly	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000008867	2	219922341	2	219057619	8867	23906	rs121917853	NC_000002.12:219057618:C:T
NM_020699.4(GATAD2B):c.535C>T (p.Arg179Ter)	GATAD2B	R179*	not provided|Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000435290	1	153791329	1	153818853	435290	427641	rs1553188463	NC_000001.11:153818852:G:A
NM_000198.4(HSD3B2):c.745C>T (p.Arg249Ter)	HSD3B2	R249*	not provided	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000012187	1	119964869	1	119422246	12187	27226	rs80358217	NC_000001.11:119422245:C:T
NM_002181.4(IHH):c.283G>A (p.Glu95Lys)	IHH	E95K	Type A1 brachydactyly	Pathogenic(Last reviewed: Apr 30, 2009)	no assertion criteria provided	VCV000008866	2	219924907	2	219060185	8866	23905	rs121917852	NC_000002.12:219060184:C:T
NM_020699.4(GATAD2B):c.918del (p.Pro307fs)	GATAD2B	P307fs	not provided|Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: Feb 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000419376	1	153789047	1	153816571	419376	404923	rs1064793829	NC_000001.11:153816570:AA:A
NM_020699.4(GATAD2B):c.1432C>T (p.Arg478Ter)	GATAD2B	R478*	not provided|Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265610	1	153784596	1	153812120	265610	259631	rs761820222	NC_000001.11:153812119:G:A
NM_001256864.2(DNAJC6):c.801-2A>G	DNAJC6		Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus|Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: Aug 1, 2019)	no assertion criteria provided	VCV000088854	1	65851393	1	65385710	88854	94423	rs398122404	NC_000001.11:65385709:A:G
NM_022787.4(NMNAT1):c.709C>T (p.Arg237Cys)	NMNAT1	R237C	Retinal dystrophy|Leber congenital amaurosis 9	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000845745	1	10042628	1	9982570	845745	824565		NC_000001.11:9982569:C:T
NM_002181.4(IHH):c.298G>A (p.Asp100Asn)	IHH	D100N	Type A1 brachydactyly	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000008869	2	219924892	2	219060170	8869	23908	rs121917855	NC_000002.12:219060169:C:T
NM_014362.4(HIBCH):c.488G>T (p.Cys163Phe)	HIBCH	C163F	not provided	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000430548	2	191125911	2	190261185	430548	421352	rs74832989	NC_000002.12:190261184:C:A
NM_014362.4(HIBCH):c.852del (p.Leu284fs)	HIBCH	L284fs	not provided	Pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	VCV000430547	2	191109652	2	190244926	430547	421351	rs1131692017	NC_000002.12:190244925:T:
NM_014362.4(HIBCH):c.609del (p.Gly204fs)	HIBCH	G204fs	Beta-hydroxyisobutyryl-CoA deacylase deficiency	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000654855	2	191116942	2	190252216	654855	629239		NC_000002.12:190252215:TTTT:TTT
NM_014362.4(HIBCH):c.1128dup (p.Lys377Ter)	HIBCH		Beta-hydroxyisobutyryl-CoA deacylase deficiency	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000217316	2	191069875 - 191069876	2	190205149 - 190205150	217316	213970	rs863225062	NC_000002.12:190205149:AAA:AAAA
NM_014362.4(HIBCH):c.1033G>A (p.Gly345Ser)	HIBCH	G345S	Beta-hydroxyisobutyryl-CoA deacylase deficiency	Pathogenic(Last reviewed: Aug 1, 2015)	no assertion criteria provided	VCV000208532	2	191073618	2	190208892	208532	205050	rs770114459	NC_000002.12:190208891:C:T
NM_014362.4(HIBCH):c.129dup (p.Gly44fs)	HIBCH		Beta-hydroxyisobutyryl-CoA deacylase deficiency	Pathogenic(Last reviewed: Aug 1, 2015)	no assertion criteria provided	VCV000208531	2	191161628 - 191161629	2	190296902 - 190296903	208531	205049	rs767597690	NC_000002.12:190296902:TTTTTTTT:TTTTTTTTT
NM_014362.4(HIBCH):c.950G>A (p.Gly317Glu)	HIBCH	G317E	Beta-hydroxyisobutyryl-CoA deacylase deficiency	Pathogenic(Last reviewed: Dec 4, 2013)	no assertion criteria provided	VCV000187864	2	191077743	2	190213017	187864	185756	rs786204004	NC_000002.12:190213016:C:T
NM_014362.4(HIBCH):c.79-3C>G	HIBCH		Beta-hydroxyisobutyryl-CoA deacylase deficiency	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000001146	2	191161682	2	190296956	1146	16185	rs778922921	NC_000002.12:190296955:G:C
NM_014362.4(HIBCH):c.517+1G>A	HIBCH		Beta-hydroxyisobutyryl-CoA deacylase deficiency	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689764	2	191125881	2	190261155	689764	677411		NC_000002.12:190261154:C:T
NM_007262.5(PARK7):c.115G>T (p.Ala39Ser)	PARK7	A39S	Parkinson disease, autosomal recessive early-onset, digenic, PINK1/DJ1	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000007069	1	8025408	1	7965348	7069	22108	rs137853051	NC_000001.11:7965347:G:T
NM_014362.4(HIBCH):c.220-9T>G	HIBCH		Beta-hydroxyisobutyryl-CoA deacylase deficiency	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000001144	2	191159365	2	190294639	1144	16183	rs786200864	NC_000002.12:190294638:A:C
NM_007262.5(PARK7):c.105dup (p.Ala36fs)	PARK7		Parkinson disease 7	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	VCV000573287	1	8025396 - 8025397	1	7965336 - 7965337	573287	557376	rs781600849	NC_000001.11:7965336:TT:TTT
NM_007262.5(PARK7):c.192G>C (p.Glu64Asp)	PARK7	E64D	Parkinson disease 7	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000007067	1	8025485	1	7965425	7067	22106	rs74315353	NC_000001.11:7965424:G:C
NM_007262.5(PARK7):c.446A>C (p.Asp149Ala)	PARK7	D149A	Parkinson disease 7	Pathogenic(Last reviewed: Aug 2, 2013)	no assertion criteria provided	VCV000007066	1	8044990	1	7984930	7066	22105	rs74315352	NC_000001.11:7984929:A:C
NM_007262.5(PARK7):c.78G>A (p.Met26Ile)	PARK7	M26I	Parkinson disease 7	Pathogenic(Last reviewed: Jul 1, 2012)	no assertion criteria provided	VCV000007065	1	8022923	1	7962863	7065	22104	rs74315351	NC_000001.11:7962862:G:A
nsv513788	PARK7		Parkinson disease 7	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000007063	1	8018845 - 8044954			7063	22102		
NM_007262.5(PARK7):c.189_190AG[1] (p.Glu64fs)	PARK7		Parkinson disease 7|not provided	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000447914	1	8025482 - 8025483	1	7965422 - 7965423	447914	440521	rs1553122929	NC_000001.11:7965421:AGAG:AG
NM_007262.5(PARK7):c.497T>C (p.Leu166Pro)	PARK7	L166P	Parkinson disease 7	Pathogenic(Last reviewed: Jul 1, 2012)	no assertion criteria provided	VCV000007064	1	8045041	1	7984981	7064	22103	rs28938172	NC_000001.11:7984980:T:C
NM_001284214.2(TRIP12):c.3995del (p.Gly1332fs)	TRIP12	G1285fs, G1325fs, G1360fs, G1014fs, G1317fs, G1333fs, G1355fs, G1284fs, G1312fs, G1332fs, G1354fs, G1359fs	not provided	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000817916	2	230657754	2	229793038	817916	805293		NC_000002.12:229793037:CCC:CC
NM_001284214.2(TRIP12):c.1782_1806del (p.Glu595fs)	TRIP12	E547fs, E553fs, E595fs, E250fs, E566fs	not provided	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000817739	2	230678967 - 230678991	2	229814251 - 229814275	817739	805297		NC_000002.12:229814250:ACTATGTCTCCGTGACAACATCTCCA:A
NM_001284214.2(TRIP12):c.3676del (p.Asp1226fs)	TRIP12	D1178fs, D1224fs, D1253fs, D1254fs, D908fs, D1184fs, D1211fs, D1226fs, D1227fs	not provided	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000817326	2	230661366	2	229796650	817326	805295		NC_000002.12:229796649:CC:C
NM_001284214.2(TRIP12):c.3835C>T (p.Gln1279Ter)	TRIP12	Q961*, Q1237*, Q1264*, Q1279*, Q1307*, Q1231*, Q1306*, Q1277*, Q1280*	not provided	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000816957	2	230659947	2	229795231	816957	805294		NC_000002.12:229795230:G:A
NM_001284214.2(TRIP12):c.3085C>T (p.Gln1029Ter)	TRIP12	Q1057*, Q987*, Q1014*, Q1027*, Q981*, Q1056*, Q1029*, Q1030*, Q711*	Clark-Baraitser syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801907	2	230667008	2	229802292	801907	790207		NC_000002.12:229802291:G:A
NM_001284214.2(TRIP12):c.1651C>T (p.Arg551Ter)	TRIP12	R503*, R551*, R206*, R509*, R522*	not provided	Pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, single submitter	VCV000489242	2	230679895	2	229815179	489242	481645	rs1553636520	NC_000002.12:229815178:G:A
NM_001284214.2(TRIP12):c.1599+2T>C	TRIP12		not provided	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000489099	2	230683078	2	229818362	489099	481646	rs1553639854	NC_000002.12:229818361:A:G
NM_001284214.2(TRIP12):c.3955C>T (p.Gln1319Ter)	TRIP12	Q1271*, Q1319*, Q1347*, Q1272*, Q1304*, Q1001*, Q1299*, Q1320*, Q1341*, Q1346*, Q1312*, Q1342*	not provided	Pathogenic(Last reviewed: Nov 24, 2017)	criteria provided, single submitter	VCV000488911	2	230657794	2	229793078	488911	481644	rs1553610240	NC_000002.12:229793077:G:A
NM_001284214.2(TRIP12):c.4914+2T>C	TRIP12		not provided	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000424206	2	230652219	2	229787503	424206	405653	rs1064796861	NC_000002.12:229787502:A:G
NM_000261.2(MYOC):c.1111T>C (p.Tyr371His)	MYOC	Y371H	Primary open angle glaucoma	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000242274	1	171605469	1	171636329	242274	243828	rs878854408	NC_000001.11:171636328:A:G
NM_000261.2(MYOC):c.1091G>T (p.Gly364Val)	MYOC	G364V	Glaucoma 1, open angle, A	Pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	VCV000007947	1	171605489	1	171636349	7947	22986	rs121909193	NC_000001.11:171636348:C:A
NM_001284214.2(TRIP12):c.4237C>T (p.Gln1413Ter)	TRIP12	Q1413*, Q1393*, Q1414*, Q1436*, Q1441*, Q1435*, Q1095*, Q1365*, Q1366*, Q1440*, Q1398*, Q1406*	Clark-Baraitser syndrome	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000619982	2	230656679	2	229791963	619982	611382	rs1559428905	NC_000002.12:229791962:G:A
NM_001284214.2(TRIP12):c.1279del (p.Ser427fs)	TRIP12	S385fs, S398fs, S427fs, S82fs	TRIP12 associated autism with facial dysmorphology	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000522807	2	230695547	2	229830831	522807	513412	rs1553655558	NC_000002.12:229830830:AA:A
NM_001284214.2(TRIP12):c.3887+1G>A	TRIP12		Clark-Baraitser syndrome	Pathogenic(Last reviewed: Apr 15, 2020)	no assertion criteria provided	VCV000446141	2	230659894	2	229795178	446141	439488	rs1553612358	NC_000002.12:229795177:C:T
NM_001284214.2(TRIP12):c.3123dup (p.Gly1042fs)	TRIP12		Clark-Baraitser syndrome	Pathogenic(Last reviewed: Apr 15, 2020)	no assertion criteria provided	VCV000446140	2	230666969 - 230666970	2	229802253 - 229802254	446140	439487	rs1553620494	NC_000002.12:229802253:TT:TTT
NM_001284214.2(TRIP12):c.3590_3591del (p.Val1196_Ser1197insTer)	TRIP12		Clark-Baraitser syndrome	Pathogenic(Last reviewed: Apr 15, 2020)	no assertion criteria provided	VCV000446139	2	230661451 - 230661452	2	229796735 - 229796736	446139	439486	rs1553614300	NC_000002.12:229796734:TG:
NM_001284214.2(TRIP12):c.3401+1G>A	TRIP12		Clark-Baraitser syndrome	Pathogenic(Last reviewed: Apr 15, 2020)	no assertion criteria provided	VCV000446137	2	230663590	2	229798874	446137	439484	rs1553616463	NC_000002.12:229798873:C:T
NM_181741.4(ORC4):c.1226del (p.Thr409fs)	ORC4	T409fs, T325fs, T335fs	Meier-Gorlin syndrome 2	Pathogenic(Last reviewed: Sep 16, 2014)	criteria provided, single submitter	VCV000211805	2	148693164	2	147935595	211805	206853	rs797045852	NC_000002.12:147935594:G:
NM_181742.3(ORC4):c.(-18+1_-17-1)_(762+1_773-1)del	ORC4		Meier-Gorlin syndrome 2	Pathogenic(Last reviewed: Feb 27, 2011)	no assertion criteria provided	VCV000030297	2	148701092 - 148778176	2	147943523 - 148020607	30297	39253		
NM_004153.4(ORC1):c.1996C>T (p.Arg666Trp)	ORC1	R666W, R661W	Meier-Gorlin syndrome 1	Pathogenic(Last reviewed: Feb 27, 2011)	no assertion criteria provided	VCV000030236	1	52849109	1	52383437	30236	39192	rs201253919	NC_000001.11:52383436:G:A
NM_004153.4(ORC1):c.1482-2A>G	ORC1		Meier-Gorlin syndrome 1	Pathogenic(Last reviewed: Feb 27, 2011)	no assertion criteria provided	VCV000030235	1	52850936	1	52385264	30235	39191	rs1378348220	NC_000001.11:52385263:T:C
NM_004153.4(ORC1):c.1999_2000delinsA (p.Val667fs)	ORC1		Meier-Gorlin syndrome 1	Pathogenic(Last reviewed: Feb 27, 2011)	no assertion criteria provided	VCV000030234	1	52849105 - 52849106	1	52383433 - 52383434	30234	39190	rs1557573504	NC_000001.11:52383432:AC:T
NM_004153.4(ORC1):c.2159G>A (p.Arg720Gln)	ORC1	R720Q, R715Q	Meier-Gorlin syndrome 1	Pathogenic(Last reviewed: Feb 27, 2011)	no assertion criteria provided	VCV000030233	1	52841246	1	52375574	30233	39189	rs387906828	NC_000001.11:52375573:C:T
NM_004153.4(ORC1):c.266T>C (p.Phe89Ser)	ORC1	F89S	Meier-Gorlin syndrome 1	Pathogenic(Last reviewed: Feb 27, 2011)	no assertion criteria provided	VCV000030231	1	52863493	1	52397821	30231	39187	rs387906827	NC_000001.11:52397820:A:G
NM_004153.4(ORC1):c.380A>G (p.Glu127Gly)	ORC1	E127G	Meier-Gorlin syndrome 1	Pathogenic(Last reviewed: Feb 27, 2011)	no assertion criteria provided	VCV000030230	1	52863379	1	52397707	30230	39186	rs387906826	NC_000001.11:52397706:T:C
NM_000261.2(MYOC):c.1430T>A (p.Ile477Asn)	MYOC	I477N	Glaucoma 1, open angle, A	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000030205	1	171605150	1	171636010	30205	39161	rs74315331	NC_000001.11:171636009:A:T
NM_000261.2(MYOC):c.1138G>C (p.Asp380His)	MYOC	D380H	Glaucoma 1, open angle, A	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000007961	1	171605442	1	171636302	7961	23000	rs121909194	NC_000001.11:171636301:C:G
NM_000261.2(MYOC):c.734G>A (p.Cys245Tyr)	MYOC	C245Y	Glaucoma 1, open angle, A	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000007959	1	171605846	1	171636706	7959	22998	rs74315340	NC_000001.11:171636705:C:T
NM_000261.2(MYOC):c.1196G>T (p.Gly399Val)	MYOC	G399V	Glaucoma 1, open angle, a, digenic	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000007957	1	171605384	1	171636244	7957	22996	rs28936694	NC_000001.11:171636243:C:A
NM_000261.2(MYOC):c.1297T>C (p.Cys433Arg)	MYOC	C433R	Glaucoma 1, open angle, A	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000007956	1	171605283	1	171636143	7956	22995	rs74315338	NC_000001.11:171636142:A:G
NM_000261.2(MYOC):c.1430T>G (p.Ile477Ser)	MYOC	I477S	Glaucoma 1, open angle, A	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000007950	1	171605150	1	171636010	7950	22989	rs74315331	NC_000001.11:171636009:A:C
NM_001284214.2(TRIP12):c.4928G>A (p.Arg1643Gln)	TRIP12	R1628Q, R1643Q, R1325Q, R1596Q, R1665Q, R1595Q, R1623Q, R1636Q, R1666Q, R1644Q, R1670Q, R1671Q	Clark-Baraitser syndrome	Pathogenic(Last reviewed: Apr 15, 2020)	no assertion criteria provided	VCV000446138	2	230650558	2	229785842	446138	439485	rs1553602821	NC_000002.12:229785841:C:T
NM_001284214.2(TRIP12):c.582_583AG[2] (p.Ser196fs)	TRIP12		Clark-Baraitser syndrome	Pathogenic(Last reviewed: Apr 15, 2020)	no assertion criteria provided	VCV000446136	2	230723928 - 230723929	2	229859212 - 229859213	446136	439483	rs1553704327	NC_000002.12:229859211:CTCTCT:CTCT
NM_181741.4(ORC4):c.870_873dup (p.Ala292fs)	ORC4		Meier-Gorlin syndrome 2	Pathogenic(Last reviewed: Feb 27, 2011)	no assertion criteria provided	VCV000030296	2	148696793 - 148696794	2	147939224 - 147939225	30296	39252	rs797044461	NC_000002.12:147939224:TGTT:TGTTTGTT
NM_000261.2(MYOC):c.1267A>G (p.Lys423Glu)	MYOC	K423E	Glaucoma 1, open angle, A	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000007954	1	171605313	1	171636173	7954	22993	rs74315336	NC_000001.11:171636172:T:C
NM_000261.2(MYOC):c.1440C>A (p.Asn480Lys)	MYOC	N480K	Glaucoma 1, open angle, A	Pathogenic(Last reviewed: Apr 13, 1998)	no assertion criteria provided	VCV000007951	1	171605140	1	171636000	7951	22990	rs74315332	NC_000001.11:171635999:G:T
NM_000261.2(MYOC):c.1309T>C (p.Tyr437His)	MYOC	Y437H	Glaucoma 1, open angle, A	Pathogenic(Last reviewed: Apr 9, 1998)	no assertion criteria provided	VCV000007946	1	171605271	1	171636131	7946	22985	rs74315328	NC_000001.11:171636130:A:G
NM_003690.5(PRKRA):c.267_268del (p.His89fs)	PRKRA	H64fs, H78fs, H89fs	Dystonia 16	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000006347	2	179312281 - 179312282	2	178447554 - 178447555	6347	21386	rs730880307	NC_000002.12:178447553:TAT:T
NM_001284214.2(TRIP12):c.1684C>T (p.Arg562Ter)	TRIP12	R217*, R520*, R562*, R514*, R533*	Clark-Baraitser syndrome	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000812668	2	230679862	2	229815146	812668	800918		NC_000002.12:229815145:G:A
NM_181741.4(ORC4):c.1A>G (p.Met1Val)	ORC4	M1V	Meier-Gorlin syndrome 2	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000225427	2	148733527	2	147975958	225427	227220	rs1085307083	NC_000002.12:147975957:T:C
NM_000261.2(MYOC):c.754G>A (p.Gly252Arg)	MYOC	G252R	Glaucoma 1, open angle, A	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000007960	1	171605826	1	171636686	7960	22999	rs74315341	NC_000001.11:171636685:C:T
NM_000261.2(MYOC):c.1010A>G (p.Gln337Arg)	MYOC	Q337R	Glaucoma 1, open angle, A	Pathogenic(Last reviewed: Sep 1, 1997)	no assertion criteria provided	VCV000007953	1	171605570	1	171636430	7953	22992	rs74315335	NC_000001.11:171636429:T:C
NM_000261.2(MYOC):c.1099G>A (p.Gly367Arg)	MYOC	G367R	not provided|Glaucoma 1, open angle, A	Pathogenic(Last reviewed: Aug 16, 2016)	criteria provided, single submitter	VCV000007952	1	171605481	1	171636341	7952	22991	rs74315334	NC_000001.11:171636340:C:T
NM_000261.2(MYOC):c.1109C>T (p.Pro370Leu)	MYOC	P370L	Glaucoma 1, open angle, A|not provided	Pathogenic(Last reviewed: Apr 7, 2016)	criteria provided, single submitter	VCV000007948	1	171605471	1	171636331	7948	22987	rs74315330	NC_000001.11:171636330:G:A
NM_172362.3(KCNH1):c.1465C>T (p.Leu489Phe)	KCNH1	L489F, L462F	not provided	Pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	VCV000449572	1	210977506	1	210804164	449572	442707	rs1553345948	NC_000001.11:210804163:G:A
NM_172362.3(KCNH1):c.1055C>A (p.Ser352Tyr)	KCNH1	S325Y, S352Y	Zimmermann-Laband syndrome 1	Pathogenic	no assertion criteria provided	VCV000183419	1	211093389	1	210920047	183419	181521	rs730882172	NC_000001.11:210920046:G:T
NM_172362.3(KCNH1):c.1147G>C (p.Val383Leu)	KCNH1	V356L, V383L	Zimmermann-Laband syndrome 1	Pathogenic	no assertion criteria provided	VCV000183417	1	211093297	1	210919955	183417	181518	rs730882173	NC_000001.11:210919954:C:G
NM_000396.4(CTSK):c.891-1G>T	CTSK		Pyknodysostosis	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623333	1	150769375	1	150796899	623333	612342	rs1557823855	NC_000001.11:150796898:C:A
NM_172362.3(KCNH1):c.1546C>T (p.Leu516Phe)	KCNH1	L489F, L516F	Temple-Baraitser syndrome	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000162521	1	210977425	1	210804083	162521	172194	rs727502820	NC_000001.11:210804082:G:A
NM_000396.4(CTSK):c.154A>T (p.Lys52Ter)	CTSK	K52*	Pyknodysostosis	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000008425	1	150778667	1	150806191	8425	23464	rs74315306	NC_000001.11:150806190:T:A
NM_000396.4(CTSK):c.236G>A (p.Gly79Glu)	CTSK	G79E	Pyknodysostosis	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000008424	1	150778585	1	150806109	8424	23463	rs74315305	NC_000001.11:150806108:C:T
NM_000396.4(CTSK):c.990A>G (p.Ter330Trp)	CTSK	*330W	Pyknodysostosis	Pathogenic(Last reviewed: Aug 30, 1996)	no assertion criteria provided	VCV000008420	1	150769275	1	150796799	8420	23459	rs74315301	NC_000001.11:150796798:T:C
NM_172362.3(KCNH1):c.651G>C (p.Lys217Asn)	KCNH1	K217N	Temple-Baraitser syndrome	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000162523	1	211192506	1	211019164	162523	172196	rs727502822	NC_000001.11:211019163:C:G
NM_172362.3(KCNH1):c.1508A>G (p.Gln503Arg)	KCNH1	Q503R, Q476R	Temple-Baraitser syndrome	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000162522	1	210977463	1	210804121	162522	172195	rs727502821	NC_000001.11:210804120:T:C
NM_001615.4(ACTG2):c.119G>A (p.Arg40His)	ACTG2	R40H	Visceral neuropathy, familial, autosomal dominant|Chronic intestinal pseudoobstruction|Visceral myopathy	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000132802	2	74128557	2	73901430	132802	136551	rs587777386	NC_000002.12:73901429:G:A
NM_172362.3(KCNH1):c.1135C>G (p.Leu379Val)	KCNH1	L352V, L379V	Zimmermann-Laband syndrome 1	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000183416	1	211093309	1	210919967	183416	181519	rs730882176	NC_000001.11:210919966:G:C
NM_172362.3(KCNH1):c.1123G>A (p.Gly375Arg)	KCNH1	G348R, G375R	Zimmermann-Laband syndrome 1	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000183415	1	211093321	1	210919979	183415	181520	rs730882174	NC_000001.11:210919978:C:T
NM_000396.4(CTSK):c.121-1G>A	CTSK		not provided	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000859435	1	150778701	1	150806225	859435	850725		NC_000001.11:150806224:C:T
NM_000396.4(CTSK):c.953G>A (p.Cys318Tyr)	CTSK	C318Y	not provided	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000649051	1	150769312	1	150796836	649051	626802		NC_000001.11:150796835:C:T
NM_025160.6(WDR26):c.1625_1634del (p.Ala541_Leu542insTer)	WDR26		Inborn genetic diseases	Pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, single submitter	VCV000522095	1	224586227 - 224586236	1	224398525 - 224398534	522095	511231	rs1553353206	NC_000001.11:224398524:ACATTTAACAA:A
NM_001256864.2(DNAJC6):c.454C>T (p.Arg152Ter)	DNAJC6	R82*, R152*, R95*	Parkinson disease 19a, juvenile-onset|Malignant tumor of prostate	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000219301	1	65831790	1	65366107	219301	220990	rs864622011	NC_000001.11:65366106:C:T
NM_006063.3(KLHL41):c.1296del (p.Lys432fs)	KLHL41	K432fs	Nemaline myopathy 9	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000646196	2	170371385	2	169514875	646196	628985		NC_000002.12:169514874:AAAAAAA:AAAAAA
NM_006063.3(KLHL41):c.930_939del (p.Asn310fs)	KLHL41	N310fs	Nemaline myopathy 9	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000645750	2	170367217 - 170367226	2	169510707 - 169510716	645750	628982		NC_000002.12:169510706:ATGACACAGCA:A
NM_006063.3(KLHL41):c.168_175del (p.Pro56_Tyr57insTer)	KLHL41		Nemaline myopathy 9	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000581470	2	170366453 - 170366460	2	169509943 - 169509950	581470	559392	rs1247404453	NC_000002.12:169509942:TCCTTACTTCC:TCC
NM_006063.3(KLHL41):c.215dup (p.Glu73fs)	KLHL41		Nemaline myopathy 9	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000566091	2	170366495 - 170366496	2	169509985 - 169509986	566091	558909	rs775513051	NC_000002.12:169509985:AAAAAAAA:AAAAAAAAA
NM_006063.3(KLHL41):c.1238C>T (p.Ser413Leu)	KLHL41	S413L	Nemaline myopathy 9	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000183245	2	170371211	2	169514701	183245	181378	rs730882260	NC_000002.12:169514700:C:T
NM_006063.3(KLHL41):c.575_577AAG[2] (p.Glu194del)	KLHL41	E194del	Nemaline myopathy 9	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000183244	2	170366863 - 170366865	2	169510353 - 169510355	183244	181377	rs730882259	NC_000002.12:169510352:AAGAAGAAG:AAGAAG
NM_006063.3(KLHL41):c.1748_1755del (p.Lys583fs)	KLHL41	K583fs	Nemaline myopathy 9	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000183242	2	170382132 - 170382139	2	169525622 - 169525629	183242	181375	rs730882258	NC_000002.12:169525621:AAGGAAATA:A
NM_006063.3(KLHL41):c.459delinsACTC (p.Ala154_Arg155insLeu)	KLHL41		Nemaline myopathy 9	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000183241	2	170366747	2	169510237	183241	181374	rs730882257	NC_000002.12:169510236:T:ACTC
RPL5, 5-BP DEL/39-BP INS, NT498	RPL5		Diamond-Blackfan anemia 6	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000006183					6183	21222		
NM_014362.4(HIBCH):c.809+1G>A	HIBCH		Beta-hydroxyisobutyryl-CoA deacylase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000424160	2	191110879	2	190246153	424160	405524	rs143746450	NC_000002.12:190246152:C:T
NM_000198.4(HSD3B2):c.776C>T (p.Thr259Met)	HSD3B2	T259M	3 beta-Hydroxysteroid dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000012192	1	119964900	1	119422277	12192	27231	rs80358221	NC_000001.11:119422276:C:T
NM_000396.4(CTSK):c.136C>T (p.Arg46Trp)	CTSK	R46W	not provided|Pyknodysostosis	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553560	1	150778685	1	150806209	553560	540645	rs371277428	NC_000001.11:150806208:G:A
NM_000147.4(FUCA1):c.564G>A (p.Trp188Ter)	FUCA1	W188*	Fucosidosis	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000488519	1	24189722	1	23863232	488519	481387	rs189315801	NC_000001.11:23863231:C:T
NM_000147.4(FUCA1):c.393T>A (p.Tyr131Ter)	FUCA1	Y131*	not provided	Pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, single submitter	VCV000265438	1	24192112	1	23865622	265438	259658	rs781230182	NC_000001.11:23865621:A:T
NM_000147.4(FUCA1):c.1082G>A (p.Trp361Ter)	FUCA1	W361*	not provided	Pathogenic(Last reviewed: Apr 14, 2015)	criteria provided, single submitter	VCV000218428	1	24175217	1	23848727	218428	215197	rs864309551	NC_000001.11:23848726:C:T
NM_000147.4(FUCA1):c.790C>T (p.Arg264Ter)	FUCA1	R264*	Fucosidosis	Pathogenic	no assertion criteria provided	VCV000100721	1	24181029	1	23854539	100721	106586	rs587779399	NC_000001.11:23854538:G:A
NM_000147.4(FUCA1):c.464C>T (p.Ser155Phe)	FUCA1	S155F	Fucosidosis	Pathogenic	no assertion criteria provided	VCV000100720	1	24192041	1	23865551	100720	106585	rs587779398	NC_000001.11:23865550:G:A
NM_006063.3(KLHL41):c.641del (p.Asn214fs)	KLHL41	N214fs	Nemaline myopathy|Nemaline myopathy 9	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183243	2	170366925	2	169510415	183243	181376	rs730882235	NC_000002.12:169510414:AAAAA:AAAA
NC_000001.10:g.(?_24186268)_(24186413_?)del	FUCA1		Fucosidosis	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000656837	1	24186268 - 24186413	1	23859778 - 23859923	656837	650558		
NM_000147.4(FUCA1):c.810del (p.Cys271fs)	FUCA1	C271fs	Fucosidosis	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000633222	1	24181009	1	23854519	633222	621079	rs1557510081	NC_000001.11:23854518:GG:G
NM_001105.5(ACVR1):c.1124G>C (p.Arg375Pro)	ACVR1	R375P	Progressive myositis ossificans	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000029596	2	158617532	2	157761020	29596	38550	rs387906590	NC_000002.12:157761019:C:G
NM_001105.5(ACVR1):c.774G>C (p.Arg258Ser)	ACVR1	R258S	Progressive myositis ossificans	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000018311	2	158626896	2	157770384	18311	33350	rs121912680	NC_000002.12:157770383:C:G
FUCA1, 1-BP DEL, EX3	FUCA1		Fucosidosis	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000000690					690	15729		
FUCA1, 1-BP DEL, EX5	FUCA1		Fucosidosis	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000000689					689	15728		
FUCA1, 1-BP DEL, EX2	FUCA1		Fucosidosis	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000000688					688	15727		
NM_000147.4(FUCA1):c.648C>A (p.Tyr216Ter)	FUCA1	Y216*	Fucosidosis	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000000687	1	24189638	1	23863148	687	15726	rs80358198	NC_000001.11:23863147:G:T
NM_000147.4(FUCA1):c.1160G>A (p.Trp387Ter)	FUCA1	W387*	Fucosidosis	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000000686	1	24175139	1	23848649	686	15725	rs80358197	NC_000001.11:23848648:C:T
NM_000147.4(FUCA1):c.244C>T (p.Gln82Ter)	FUCA1	Q82*	Fucosidosis	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000000685	1	24194533	1	23868043	685	15724	rs80358196	NC_000001.11:23868042:G:A
NM_000147.4(FUCA1):c.969+1G>A	FUCA1		Fucosidosis	Pathogenic(Last reviewed: Mar 1, 1993)	no assertion criteria provided	VCV000000684	1	24180849	1	23854359	684	15723		NC_000001.11:23854358:C:T
FUCA1, 2-EX DEL	FUCA1		Fucosidosis	Pathogenic(Last reviewed: Jan 1, 1991)	no assertion criteria provided	VCV000000682					682	15721		
NM_001105.5(ACVR1):c.605G>T (p.Arg202Ile)	ACVR1	R202I	Progressive myositis ossificans	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000029597	2	158630638	2	157774126	29597	38551	rs387906591	NC_000002.12:157774125:C:A
NM_001105.5(ACVR1):c.982G>T (p.Gly328Trp)	ACVR1	G328W	Progressive myositis ossificans	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000029594	2	158622517	2	157766005	29594	38548	rs387906588	NC_000002.12:157766004:C:A
NM_001105.5(ACVR1):c.982G>A (p.Gly328Arg)	ACVR1	G328R	Progressive myositis ossificans	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000029593	2	158622517	2	157766005	29593	38547	rs387906588	NC_000002.12:157766004:C:T
NM_001105.5(ACVR1):c.1067G>A (p.Gly356Asp)	ACVR1	G356D	Progressive myositis ossificans	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000018310	2	158617589	2	157761077	18310	33349	rs121912679	NC_000002.12:157761076:C:T
NM_000147.4(FUCA1):c.1229T>G (p.Leu410Arg)	FUCA1	L410R	Fucosidosis	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000000692	1	24172595	1	23846105	692	15731	rs80358199	NC_000001.11:23846104:A:C
NM_001105.5(ACVR1):c.587T>C (p.Leu196Pro)	ACVR1	L196P	Progressive myositis ossificans	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000208843	2	158630656	2	157774144	208843	205405	rs797045135	NC_000002.12:157774143:A:G
NM_006118.4(HAX1):c.337G>T (p.Glu113Ter)	HAX1	E113*, E65*	Severe congenital neutropenia 3, autosomal recessive	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000864562	1	154246270	1	154273794	864562	822751		NC_000001.11:154273793:G:T
NM_006118.4(HAX1):c.407del (p.His136fs)	HAX1	H136fs, H88fs	Severe congenital neutropenia 3, autosomal recessive	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000659562	1	154246340	1	154273864	659562	626852		NC_000001.11:154273863:A:
NM_001822.5(CHN1):c.661T>C (p.Tyr221His)	CHN1	Y221H, Y195H, Y96H	Duane retraction syndrome 2	Pathogenic(Last reviewed: Apr 10, 2017)	criteria provided, single submitter	VCV000559835	2	175689213	2	174824485	559835	550557	rs1553475005	NC_000002.12:174824484:A:G
HAX1, 1-BP DEL, 91G	HAX1		Severe congenital neutropenia 3, autosomal recessive	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000004657					4657	19696		
HAX1, 59-BP DEL, NT376	HAX1		Severe congenital neutropenia 3, autosomal recessive	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000004655					4655	19694		
NM_001018837.2(HAX1):c.54-25dup	HAX1		Severe congenital neutropenia 3, autosomal recessive	Pathogenic(Last reviewed: May 15, 2008)	no assertion criteria provided	VCV000004653	1	154245925 - 154245926	1	154273449 - 154273450	4653	19692		NC_000001.11:154273449:CCCCCC:CCCCCCC
HAX1, 1-BP INS, 431G	HAX1		Severe congenital neutropenia 3, autosomal recessive	Pathogenic(Last reviewed: May 15, 2008)	no assertion criteria provided	VCV000004652					4652	19691		
NM_000147.4(FUCA1):c.1125G>A (p.Trp375Ter)	FUCA1	W375*	not provided|Fucosidosis	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000198046	1	24175174	1	23848684	198046	195207	rs794727774	NC_000001.11:23848683:C:T
NM_000147.4(FUCA1):c.1279C>T (p.Gln427Ter)	FUCA1	Q427*	Fucosidosis	Pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, single submitter	VCV000000681	1	24172327	1	23845837	681	15720	rs118204450	NC_000001.11:23845836:G:A
NM_001039348.3(EFEMP1):c.615T>A (p.Tyr205Ter)	EFEMP1	Y205*	Generalized hypotonia|Posterolateral diaphragmatic hernia|Dural ectasia|Arachnodactyly|Severe Myopia|Ectropion of lower eyelids|Joint hypermobility|Accelerated skeletal maturation|Pulmonary bulla|Tall stature|Inguinal hernia|Diverticulum of bladder|Scoliosis|Dolichocephaly	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000691885	2	56108772	2	55881637	691885	679598		NC_000002.12:55881636:A:T
NM_001039348.3(EFEMP1):c.320_324del (p.Met107fs)	EFEMP1	M107fs	Generalized hypotonia|Posterolateral diaphragmatic hernia|Dural ectasia|Arachnodactyly|Severe Myopia|Ectropion of lower eyelids|Joint hypermobility|Accelerated skeletal maturation|Pulmonary bulla|Tall stature|Inguinal hernia|Diverticulum of bladder|Scoliosis|Dolichocephaly	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000691884	2	56144993 - 56144997	2	55917858 - 55917862	691884	679599		NC_000002.12:55917857:TGCCATGC:TGC
NM_006118.3(HAX1):c.383C>G (p.Ser128Ter)	HAX1	S128*, S80*	Severe congenital neutropenia 3, autosomal recessive	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561028	1	154246316	1	154273840	561028	552034	rs1398108109	NC_000001.11:154273839:C:G
NM_001822.5(CHN1):c.754C>T (p.Pro252Ser)	CHN1	P252S, P226S, P127S	Duane retraction syndrome 2	Pathogenic(Last reviewed: May 1, 2011)	no assertion criteria provided	VCV000029624	2	175677169	2	174812441	29624	38578	rs387906600	NC_000002.12:174812440:G:A
NM_001822.5(CHN1):c.422C>T (p.Pro141Leu)	CHN1	P141L	Duane retraction syndrome 2	Pathogenic(Last reviewed: May 1, 2011)	no assertion criteria provided	VCV000029623	2	175742695	2	174877967	29623	38577	rs387906599	NC_000002.12:174877966:G:A
NM_001822.5(CHN1):c.937G>A (p.Glu313Lys)	CHN1	E313K, E188K, E287K	Duane retraction syndrome 2	Pathogenic(Last reviewed: Aug 8, 2008)	no assertion criteria provided	VCV000017556	2	175676266	2	174811538	17556	32595	rs121912798	NC_000002.12:174811537:C:T
NM_001822.5(CHN1):c.682G>A (p.Gly228Ser)	CHN1	G228S, G202S, G103S	Duane retraction syndrome 2	Pathogenic(Last reviewed: Aug 8, 2008)	no assertion criteria provided	VCV000017554	2	175689192	2	174824464	17554	32593	rs121912796	NC_000002.12:174824463:C:T
NM_001822.5(CHN1):c.378T>G (p.Ile126Met)	CHN1	I126M	Duane retraction syndrome 2	Pathogenic(Last reviewed: Aug 8, 2008)	no assertion criteria provided	VCV000017551	2	175742739	2	174878011	17551	32590	rs121912793	NC_000002.12:174878010:A:C
NM_001822.5(CHN1):c.755C>A (p.Pro252Gln)	CHN1	P252Q, P127Q, P226Q	Duane retraction syndrome 2	Pathogenic(Last reviewed: Aug 8, 2008)	no assertion criteria provided	VCV000017555	2	175677168	2	174812440	17555	32594	rs121912797	NC_000002.12:174812439:G:T
NM_001822.5(CHN1):c.668C>T (p.Ala223Val)	CHN1	A223V, A197V, A98V	Duane retraction syndrome 2	Pathogenic(Last reviewed: Aug 8, 2008)	no assertion criteria provided	VCV000017553	2	175689206	2	174824478	17553	32592	rs121912795	NC_000002.12:174824477:G:A
NM_001822.5(CHN1):c.427T>C (p.Tyr143His)	CHN1	Y143H	Duane retraction syndrome 2	Pathogenic(Last reviewed: Aug 8, 2008)	no assertion criteria provided	VCV000017552	2	175742690	2	174877962	17552	32591	rs121912794	NC_000002.12:174877961:A:G
NM_001822.5(CHN1):c.60A>T (p.Leu20Phe)	CHN1	L20F	Duane retraction syndrome 2	Pathogenic(Last reviewed: Aug 8, 2008)	no assertion criteria provided	VCV000017550	2	175809670	2	174944942	17550	32589	rs121912792	NC_000002.12:174944941:T:A
NM_001018837.2(HAX1):c.54-73dup	HAX1		Severe congenital neutropenia 3, autosomal recessive	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV000004656	1	154245878 - 154245879	1	154273402 - 154273403	4656	19695		NC_000001.11:154273402:GGGGG:GGGGGG
NM_001018837.2(HAX1):c.54-68_54-67insA	HAX1		Severe congenital neutropenia 3, autosomal recessive	Pathogenic(Last reviewed: May 15, 2008)	no assertion criteria provided	VCV000004651	1	154245888 - 154245889	1	154273412 - 154273413	4651	19690		NC_000001.11:154273412::A
NM_001018837.2(HAX1):c.54-107del	HAX1	E31fs	not provided|Severe congenital neutropenia 3, autosomal recessive	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419887	1	154245849	1	154273373	419887	404926	rs764082747	NC_000001.11:154273372:G:
NM_006118.3(HAX1):c.568C>T (p.Gln190Ter)	HAX1	Q190*, Q142*	Severe congenital neutropenia 3, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000004650	1	154247641	1	154275165	4650	19689	rs74315322	NC_000001.11:154275164:C:T
NM_004522.3(KIF5C):c.709G>A (p.Glu237Lys)	KIF5C	E237K	Cortical dysplasia, complex, with other brain malformations 2|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000140740	2	149803532	2	148947018	140740	150453	rs587777570	NC_000002.12:148947017:G:A
NM_181741.4(ORC4):c.521A>G (p.Tyr174Cys)	ORC4	Y174C, Y100C, Y90C	not provided|Meier-Gorlin syndrome 2	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000030295	2	148710009	2	147952440	30295	39251	rs387906847	NC_000002.12:147952439:T:C
GRCh37/hg19 2p16.3(chr2:49113632-49255072)x1	FSHR		not provided	Pathogenic(Last reviewed: Oct 24, 2017)	no assertion criteria provided	VCV000689110	2	49113632 - 49255072			689110	676702		
GRCh37/hg19 2p16.3(chr2:49158272-49209034)x1	FSHR		not provided	Pathogenic(Last reviewed: Aug 23, 2017)	no assertion criteria provided	VCV000686634	2	49158272 - 49209034			686634	674226		
GRCh37/hg19 2p16.3(chr2:49016672-49229962)x1	FSHR		not provided	Pathogenic(Last reviewed: May 18, 2018)	no assertion criteria provided	VCV000685315	2	49016672 - 49229962			685315	672907		
NM_000145.3(FSHR):c.2T>C (p.Met1Thr)	FSHR	M1T	Amenorrhea	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523337	2	49381555	2	49154416	523337	513928	rs955385021	NC_000002.12:49154415:A:G
NM_000145.3(FSHR):c.383C>A (p.Ser128Tyr)	FSHR	S128Y	Ovarian hyperstimulation syndrome	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000016254	2	49217768	2	48990629	16254	31293	rs121909665	NC_000002.12:48990628:G:T
NM_000145.3(FSHR):c.1634T>C (p.Ile545Thr)	FSHR	I545T, I519T	Ovarian hyperstimulation syndrome	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000016253	2	49190326	2	48963187	16253	31292	rs121909664	NC_000002.12:48963186:A:G
NM_000145.3(FSHR):c.1555C>A (p.Pro519Thr)	FSHR	P519T, P493T	Ovarian dysgenesis 1	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000016251	2	49190405	2	48963266	16251	31290	rs121909662	NC_000002.12:48963265:G:T
NM_000145.3(FSHR):c.1346C>T (p.Thr449Ile)	FSHR	T449I, T423I	Ovarian hyperstimulation syndrome	Pathogenic(Last reviewed: Aug 21, 2003)	no assertion criteria provided	VCV000016249	2	49190614	2	48963475	16249	31288	rs28928870	NC_000002.12:48963474:G:A
NM_000145.3(FSHR):c.1255G>A (p.Ala419Thr)	FSHR	A393T, A419T	Ovarian dysgenesis 1	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000016248	2	49190705	2	48963566	16248	31287	rs121909661	NC_000002.12:48963565:C:T
NM_000145.3(FSHR):c.1717C>T (p.Arg573Cys)	FSHR	R573C, R547C	Ovarian dysgenesis 1	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000016245	2	49190243	2	48963104	16245	31284	rs121909660	NC_000002.12:48963103:G:A
NM_006118.3(HAX1):c.430dup (p.Val144fs)	HAX1		Severe congenital neutropenia 3, autosomal recessive	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000578906	1	154246356 - 154246357	1	154273880 - 154273881	578906	556600	rs770288337	NC_000001.11:154273880:GGGGGGG:GGGGGGGG
NM_000145.3(FSHR):c.1760C>A (p.Pro587His)	FSHR	P587H, P561H	Ovarian dysgenesis 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000029704	2	49190200	2	48963061	29704	38659	rs386833512	NC_000002.12:48963060:G:T
NM_000145.3(FSHR):c.1345A>G (p.Thr449Ala)	FSHR	T449A, T423A	Ovarian hyperstimulation syndrome	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000016252	2	49190615	2	48963476	16252	31291	rs121909663	NC_000002.12:48963475:T:C
NM_000145.3(FSHR):c.1699G>A (p.Asp567Asn)	FSHR	D567N, D541N	Ovarian hyperstimulation syndrome	Pathogenic(Last reviewed: Aug 21, 2003)	no assertion criteria provided	VCV000016250	2	49190261	2	48963122	16250	31289	rs28928871	NC_000002.12:48963121:C:T
NM_000147.4(FUCA1):c.1138G>T (p.Glu380Ter)	FUCA1	E380*	Fucosidosis	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000683	1	24175161	1	23848671	683	15722	rs80358195	NC_000001.11:23848670:C:A
NM_000298.6(PKLR):c.101-1G>A	PKLR		not specified	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000811711	1	155270072	1	155300281	811711	799126		NC_000001.11:155300280:C:T
NM_000298.6(PKLR):c.1075C>T (p.Arg359Cys)	PKLR	R328C, R359C	not specified	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000811313	1	155264067	1	155294276	811313	799120		NC_000001.11:155294275:G:A
NM_000298.6(PKLR):c.169C>T (p.Gln57Ter)	PKLR	Q26*, Q57*	not specified	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000811249	1	155270003	1	155300212	811249	799125		NC_000001.11:155300211:G:A
NM_000298.6(PKLR):c.507+1G>A	PKLR		not specified	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000811116	1	155265227	1	155295436	811116	799121		NC_000001.11:155295435:C:T
NM_000298.6(PKLR):c.994G>A (p.Gly332Ser)	PKLR	G332S, G301S	not provided	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000618827	1	155264148	1	155294357	618827	609356	rs773626254	NC_000001.11:155294356:C:T
NM_005413.4(SIX3):c.288T>A (p.Cys96Ter)	SIX3	C96*	not provided	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000489225	2	45169531	2	44942392	489225	481655	rs1553337648	NC_000002.12:44942391:T:A
NM_005413.4(SIX3):c.396_397GC[5] (p.Ala136fs)	SIX3		not provided	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	VCV000449840	2	45169639 - 45169640	2	44942500 - 44942501	449840	443252	rs753473749	NC_000002.12:44942499:GCGCGCGCGCGC:GCGCGCGCGC
NM_001002294.3(FMO3):c.859G>T (p.Glu287Ter)	FMO3	E287*, E267*, E224*	not provided	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000379574	1	171083178	1	171114038	379574	364540	rs1057520649	NC_000001.11:171114037:G:T
NM_005413.4(SIX3):c.357del (p.Ala121fs)	SIX3	A121fs	not provided	Pathogenic(Last reviewed: Mar 9, 2016)	criteria provided, single submitter	VCV000280334	2	45169596	2	44942457	280334	264103	rs886041560	NC_000002.12:44942456:CCCCC:CCCC
NM_015425.6(POLR1A):c.2527C>T (p.Arg843Ter)	POLR1A	R843*	Acrofacial dysostosis, Cincinnati type	Pathogenic	no assertion criteria provided	VCV000626284	2	86276114	2	86048991	626284	614600	rs1377622831	NC_000002.12:86048990:G:A
NM_000298.6(PKLR):c.331G>A (p.Gly111Arg)	PKLR	G111R, G80R	Pyruvate kinase deficiency of red cells	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522658	1	155265500	1	155295709	522658	513235	rs918627824	NC_000001.11:155295708:C:T
NM_015425.6(POLR1A):c.3649del (p.Gln1217fs)	POLR1A	Q1217fs	Acrofacial dysostosis, Cincinnati type	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000203464	2	86267606	2	86040483	203464	199875	rs875989814	NC_000002.12:86040482:GGG:GG
NM_015425.6(POLR1A):c.1777G>C (p.Glu593Gln)	POLR1A	E593Q	Acrofacial dysostosis, Cincinnati type	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000203463	2	86297230	2	86070107	203463	199874	rs794729674	NC_000002.12:86070106:C:G
NM_007259.5(VPS45):c.712G>A (p.Glu238Lys)	VPS45	E238K, E133K, E202K	Severe congenital neutropenia 5, autosomal recessive	Pathogenic(Last reviewed: Jul 4, 2013)	no assertion criteria provided	VCV000055907	1	150053448	1	150081366	55907	70550	rs782269909	NC_000001.11:150081365:G:A
NM_005413.4(SIX3):c.499G>T (p.Ala167Ser)	SIX3	A167S	SCHIZENCEPHALY	Pathogenic(Last reviewed: Mar 1, 2010)	no assertion criteria provided	VCV000030382	2	45169742	2	44942603	30382	39339	rs387906868	NC_000002.12:44942602:G:T
NM_001002294.3(FMO3):c.442G>T (p.Gly148Ter)	FMO3	G148*, G85*, G128*	FMO3 activity, decreased	Pathogenic(Last reviewed: Apr 1, 1999)	no assertion criteria provided	VCV000016310	1	171076936	1	171107795	16310	31349	rs72549325	NC_000001.11:171107794:G:T
PKLR, 1-BP DEL, 823G	PKLR		Pyruvate kinase deficiency of red cells	Pathogenic(Last reviewed: Apr 24, 2008)	no assertion criteria provided	VCV000001518					1518	16557		
NM_000298.6(PKLR):c.1269G>A (p.Ala423=)	PKLR		Pyruvate kinase deficiency of red cells	Pathogenic(Last reviewed: Apr 24, 2008)	no assertion criteria provided	VCV000001517	1	155263229	1	155293438	1517	16556	rs774652817	NC_000001.11:155293437:C:T
NM_000298.6(PKLR):c.1318G>T (p.Glu440Ter)	PKLR	E440*, E409*	Pyruvate kinase deficiency of red cells	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000001516	1	155263086	1	155293295	1516	16555	rs771145576	NC_000001.11:155293294:C:A
PKLR, -83G-C	PKLR		Pyruvate kinase deficiency of red cells	Pathogenic(Last reviewed: Feb 15, 2003)	no assertion criteria provided	VCV000001515					1515	16554		
NM_000298.6(PKLR):c.389C>A (p.Ser130Tyr)	PKLR	S130Y, S99Y	Pyruvate kinase deficiency of red cells	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000001514	1	155265346	1	155295555	1514	16553	rs118204089	NC_000001.11:155295554:G:T
NM_000298.6(PKLR):c.1261C>A (p.Gln421Lys)	PKLR	Q421K, Q390K	Pyruvate kinase deficiency of red cells	Pathogenic(Last reviewed: Mar 1, 1992)	no assertion criteria provided	VCV000001509	1	155263237	1	155293446	1509	16548	rs118204084	NC_000001.11:155293445:G:T
NM_000298.6(PKLR):c.1151C>T (p.Thr384Met)	PKLR	T353M, T384M	Pyruvate kinase deficiency of red cells	Pathogenic(Last reviewed: Sep 15, 1991)	no assertion criteria provided	VCV000001507	1	155263347	1	155293556	1507	16546	rs74315362	NC_000001.11:155293555:G:A
NM_000298.6(PKLR):c.487C>T (p.Arg163Cys)	PKLR	R132C, R163C	Pyruvate kinase deficiency of red cells	Pathogenic(Last reviewed: May 1, 1991)	no assertion criteria provided	VCV000001506	1	155265248	1	155295457	1506	16545	rs118204083	NC_000001.11:155295456:G:A
PKLR, 1-BP DEL	PKLR		Pyruvate kinase deficiency of red cells	Pathogenic(Last reviewed: Jan 1, 1991)	no assertion criteria provided	VCV000001505					1505	16544		
NM_005413.4(SIX3):c.507G>A (p.Trp169Ter)	SIX3	W169*	Holoprosencephaly 2	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000579427	2	45169750	2	44942611	579427	558472	rs1558420022	NC_000002.12:44942610:G:A
NM_005413.4(SIX3):c.441_451del (p.Leu148fs)	SIX3	L148fs	Holoprosencephaly 2	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000545576	2	45169683 - 45169693	2	44942544 - 44942554	545576	536076	rs1553337688	NC_000002.12:44942543:ACCTCTACCACA:A
NM_005413.4(SIX3):c.696_705del (p.Asn232fs)	SIX3	N232fs	Holoprosencephaly 2	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000065501	2	45169939 - 45169948	2	44942800 - 44942809	65501	76409	rs397515502	NC_000002.12:44942799:CCCCAGCAAG:
NM_007259.5(VPS45):c.671C>A (p.Thr224Asn)	VPS45	T224N, T119N, T188N	Severe congenital neutropenia 5, autosomal recessive	Pathogenic(Last reviewed: Jul 4, 2013)	no assertion criteria provided	VCV000055906	1	150049841	1	150077763	55906	70549	rs879255237	NC_000001.11:150077762:C:A
NM_005413.4(SIX3):c.556_557dup (p.Pro187fs)	SIX3		Holoprosencephaly 2	Pathogenic(Last reviewed: Oct 1, 2000)	no assertion criteria provided	VCV000006096	2	45169798 - 45169799	2	44942659 - 44942660	6096	21135		NC_000002.12:44942659:GG:GGGG
NM_000298.6(PKLR):c.110G>A (p.Gly37Glu)	PKLR	G37Q, G37E, G6E	Adenosine triphosphate, elevated, of erythrocytes	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000001512	1	155270062	1	155300271	1512	16551	rs118204087	NC_000001.11:155300270:C:T
FMO3, 1-BP DEL, 191A	FMO3		Trimethylaminuria	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000016317					16317	31356		
NM_001002294.3(FMO3):c.94G>A (p.Glu32Lys)	FMO3	E32K	Trimethylaminuria	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000016316	1	171061893	1	171092752	16316	31355	rs72549320	NC_000001.11:171092751:G:A
FMO3, 2-EX DEL	FMO3		Trimethylaminuria	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000016315					16315	31354		
NM_001002294.3(FMO3):c.940G>T (p.Glu314Ter)	FMO3	E314*, E251*, E294*	Trimethylaminuria	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000016312	1	171083259	1	171114119	16312	31351	rs72549330	NC_000001.11:171114118:G:T
NM_001002294.3(FMO3):c.1160G>T (p.Arg387Leu)	FMO3	R387L, R324L, R367L	Trimethylaminuria	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000016311	1	171083479	1	171114339	16311	31350	rs72549331	NC_000001.11:171114338:G:T
NM_001002294.3(FMO3):c.154G>A (p.Ala52Thr)	FMO3	A52T, A32T	Trimethylaminuria	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000016307	1	171072947	1	171103806	16307	31346	rs72549321	NC_000001.11:171103805:G:A
NM_001002294.3(FMO3):c.198G>T (p.Met66Ile)	FMO3	M66I, M46I	Trimethylaminuria	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000016306	1	171072991	1	171103850	16306	31345	rs72549323	NC_000001.11:171103849:G:T
NM_001122764.3(PPOX):c.503G>A (p.Arg168His)	PPOX	R168H, R135H, R32H, R6H	Variegate porphyria|not provided	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008697	1	161138253	1	161168463	8697	23736	rs41270025	NC_000001.11:161168462:G:A
NM_001002294.3(FMO3):c.182A>G (p.Asn61Ser)	FMO3	N61S, N41S	Trimethylaminuria	Pathogenic(Last reviewed: Oct 1, 2015)	no assertion criteria provided	VCV000016313	1	171072975	1	171103834	16313	31352	rs72549322	NC_000001.11:171103833:A:G
NM_005413.4(SIX3):c.339G>T (p.Trp113Cys)	SIX3	W113C	Holoprosencephaly 2|not specified	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000006099	2	45169582	2	44942443	6099	21138	rs137853021	NC_000002.12:44942442:G:T
NM_005413.4(SIX3):c.749T>C (p.Val250Ala)	SIX3	V250A	Holoprosencephaly 2	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000006095	2	45169992	2	44942853	6095	21134	rs121917880	NC_000002.12:44942852:T:C
NM_005413.4(SIX3):c.770G>C (p.Arg257Pro)	SIX3	R257P	Holoprosencephaly 2	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000006094	2	45170013	2	44942874	6094	21133	rs121917879	NC_000002.12:44942873:G:C
NM_005413.4(SIX3):c.676C>G (p.Leu226Val)	SIX3	L226V	Holoprosencephaly 2	Pathogenic(Last reviewed: Aug 29, 2013)	no assertion criteria provided	VCV000006093	2	45169919	2	44942780	6093	21132	rs121917878	NC_000002.12:44942779:C:G
NM_006118.3(HAX1):c.256C>T (p.Arg86Ter)	HAX1	R86*, R38*	Severe congenital neutropenia 3, autosomal recessive	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000004654	1	154246014	1	154273538	4654	19693	rs121908165	NC_000001.11:154273537:C:T
NM_005149.3(TBX19):c.665+1del	TBX19		Adrenocorticotropic hormone deficiency	Pathogenic(Last reviewed: Jun 12, 2014)	no assertion criteria provided	VCV000560675	1	168267023	1	168297785	560675	551686	rs1558192351	NC_000001.11:168297784:GG:G
NM_005149.3(TBX19):c.265del (p.Leu89fs)	TBX19	L89fs	Adrenocorticotropic hormone deficiency	Pathogenic(Last reviewed: Oct 22, 2012)	no assertion criteria provided	VCV000560673	1	168260457	1	168291219	560673	551684	rs1558190339	NC_000001.11:168291218:CCC:CC
NM_005149.3(TBX19):c.568C>T (p.Gln190Ter)	TBX19	Q190*	Adrenocorticotropic hormone deficiency	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000488619	1	168262481	1	168293243	488619	481487	rs1553289042	NC_000001.11:168293242:C:T
NM_005149.3(TBX19):c.156_157GA[1] (p.Arg53fs)	TBX19		Adrenocorticotropic hormone deficiency	Pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	VCV000560672	1	168250483 - 168250484	1	168281245 - 168281246	560672	551683	rs763818059	NC_000001.11:168281244:AGAGA:AGA
TBX19, LYS146ARG	TBX19	K146R	Adrenocorticotropic hormone deficiency	Pathogenic(Last reviewed: Mar 8, 2018)	no assertion criteria provided	VCV000495297					495297	486794		
NM_173170.1(IL36RN):c.304C>T (p.Arg102Trp)	IL36RN	R102W	Pustular psoriasis, generalized	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000160374	2	113820090	2	113062513	160374	170218	rs199932303	NC_000002.12:113062512:C:T
NM_173170.1(IL36RN):c.104A>G (p.Lys35Arg)	IL36RN	K35R	Pustular psoriasis, generalized	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000160373	2	113818503	2	113060926	160373	170217	rs187015338	NC_000002.12:113060925:A:G
NM_006182.4(DDR2):c.337G>A (p.Glu113Lys)	DDR2	E113K	Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000060759	1	162724565	1	162754775	60759	75297	rs397514747	NC_000001.11:162754774:G:A
NM_173170.1(IL36RN):c.368C>G (p.Thr123Arg)	IL36RN	T123R	Pustular psoriasis, generalized	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000040006	2	113820154	2	113062577	40006	48519	rs397514629	NC_000002.12:113062576:C:G
NM_173170.1(IL36RN):c.142C>T (p.Arg48Trp)	IL36RN	R48W	Pustular psoriasis, generalized	Pathogenic(Last reviewed: Sep 9, 2011)	no assertion criteria provided	VCV000030491	2	113819727	2	113062150	30491	39448	rs151325121	NC_000002.12:113062149:C:T
NM_005149.3(TBX19):c.627C>G (p.Tyr209Ter)	TBX19	Y209*	Adrenocorticotropic hormone deficiency	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561125	1	168266985	1	168297747	561125	552037	rs140528998	NC_000001.11:168297746:C:G
NM_006182.4(DDR2):c.2283+1G>A	DDR2		Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000012316	1	162746161	1	162776371	12316	27355		NC_000001.11:162776370:G:A
NM_006182.4(DDR2):c.2138C>T (p.Thr713Ile)	DDR2	T713I	Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000012315	1	162746015	1	162776225	12315	27354	rs121964865	NC_000001.11:162776224:C:T
NM_006182.4(DDR2):c.2177T>G (p.Ile726Arg)	DDR2	I726R	Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000012314	1	162746054	1	162776264	12314	27353	rs121964864	NC_000001.11:162776263:T:G
NM_005149.3(TBX19):c.257T>G (p.Met86Arg)	TBX19	M86R	Adrenocorticotropic hormone deficiency	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000005442	1	168260451	1	168291213	5442	20481	rs74315378	NC_000001.11:168291212:T:G
NM_005149.3(TBX19):c.383C>T (p.Ser128Phe)	TBX19	S128F	Adrenocorticotropic hormone deficiency	Pathogenic(Last reviewed: Mar 23, 2001)	no assertion criteria provided	VCV000005441	1	168260577	1	168291339	5441	20480	rs74315377	NC_000001.11:168291338:C:T
NM_001002294.3(FMO3):c.589_590TG[1] (p.Cys197_Asp198delinsTer)	FMO3		Trimethylaminuria	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000225364	1	171077324 - 171077325	1	171108183 - 171108184	225364	227206	rs3832024	NC_000001.11:171108182:TGTG:TG
NM_000145.3(FSHR):c.566C>T (p.Ala189Val)	FSHR	A189V, A163V	Ovarian dysgenesis 1	Pathogenic(Last reviewed: Jan 6, 2020)	no assertion criteria provided	VCV000016243	2	49210264	2	48983125	16243	31282	rs121909658	NC_000002.12:48983124:G:A
NM_006182.4(DDR2):c.1829T>C (p.Leu610Pro)	DDR2	L610P	Warburg-Cinotti syndrome	Pathogenic(Last reviewed: Feb 13, 2019)	no assertion criteria provided	VCV000587365	1	162743359	1	162773569	587365	578314	rs1558079436	NC_000001.11:162773568:T:C
NM_006182.4(DDR2):c.2219A>G (p.Tyr740Cys)	DDR2	Y740C	Warburg-Cinotti syndrome	Pathogenic(Last reviewed: Feb 13, 2019)	no assertion criteria provided	VCV000586979	1	162746096	1	162776306	586979	578025	rs1558081627	NC_000001.11:162776305:A:G
NM_173170.1(IL36RN):c.80T>C (p.Leu27Pro)	IL36RN	L27P	Pustular psoriasis, generalized	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000030489	2	113818479	2	113060902	30489	39446	rs387906914	NC_000002.12:113060901:T:C
NM_006182.4(DDR2):c.2254C>T (p.Arg752Cys)	DDR2	R752C	Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000012313	1	162746131	1	162776341	12313	27352	rs121964863	NC_000001.11:162776340:C:T
NM_005149.3(TBX19):c.856C>T (p.Arg286Ter)	TBX19	R286*	Adrenocorticotropic hormone deficiency	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000005440	1	168274374	1	168305136	5440	20479	rs74315376	NC_000001.11:168305135:C:T
NM_005149.3(TBX19):c.782del (p.Asn261fs)	TBX19	N261fs	Adrenocorticotropic hormone deficiency|not provided	Pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000005443	1	168274299	1	168305061	5443	20482	rs730880274	NC_000001.11:168305060:AA:A
NM_015378.4(VPS13D):c.2020C>T (p.Arg674Ter)	VPS13D	R674*	Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000807523	1	12331098	1	12271041	807523	798454		NC_000001.11:12271040:C:T
NM_002299.4(LCT):c.804G>C (p.Gln268His)	LCT	Q268H	Congenital lactase deficiency	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000006588	2	136587163	2	135829593	6588	21627	rs121908937	NC_000002.12:135829592:C:G
LCT, 4-BP DEL, NT4998	LCT		Congenital lactase deficiency	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000006587					6587	21626		
NM_015378.4(VPS13D):c.12683G>A (p.Arg4228Gln)	VPS13D	R4228Q, R4203Q	Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome	Pathogenic(Last reviewed: Sep 17, 2018)	no assertion criteria provided	VCV000561204	1	12557574	1	12497520	561204	552311	rs1557478316	NC_000001.11:12497519:G:A
NM_015378.4(VPS13D):c.10562A>G (p.Asn3521Ser)	VPS13D	N3521S, N3496S	Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome	Pathogenic(Last reviewed: Sep 17, 2018)	no assertion criteria provided	VCV000561203	1	12428636	1	12368581	561203	552310	rs1557737087	NC_000001.11:12368580:A:G
NM_015378.4(VPS13D):c.7332_7333TG[1] (p.Val2445fs)	VPS13D		Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome	Pathogenic(Last reviewed: Sep 17, 2018)	no assertion criteria provided	VCV000561202	1	12378312 - 12378313	1	12318255 - 12318256	561202	552309	rs1557705968	NC_000001.11:12318254:TGTG:TG
NM_015378.4(VPS13D):c.5409C>A (p.Tyr1803Ter)	VPS13D	Y1803*	Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome	Pathogenic(Last reviewed: Sep 14, 2018)	no assertion criteria provided	VCV000561201	1	12343568	1	12283511	561201	552308	rs1557684974	NC_000001.11:12283510:C:A
NM_015378.4(VPS13D):c.12629C>T (p.Ala4210Val)	VPS13D	A4210V, A4185V	Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome	Pathogenic(Last reviewed: Sep 14, 2018)	no assertion criteria provided	VCV000561200	1	12520418	1	12460363	561200	552307	rs746736545	NC_000001.11:12460362:C:T
NM_015378.4(VPS13D):c.3316C>T (p.Gln1106Ter)	VPS13D	Q1106*	Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome	Pathogenic(Last reviewed: Sep 14, 2018)	no assertion criteria provided	VCV000561199	1	12336961	1	12276904	561199	552306	rs1557680710	NC_000001.11:12276903:C:T
NM_002299.4(LCT):c.4170T>A (p.Tyr1390Ter)	LCT	Y1390*	Congenital lactase deficiency	Pathogenic(Last reviewed: Jan 6, 2020)	no assertion criteria provided	VCV000006586	2	136564701	2	135807131	6586	21625	rs121908936	NC_000002.12:135807130:A:T
NM_005413.4(SIX3):c.385G>T (p.Glu129Ter)	SIX3	E129*	SCHIZENCEPHALY|Holoprosencephaly 2	Pathogenic(Last reviewed: Mar 1, 2010)	no assertion criteria provided	VCV000030380	2	45169628	2	44942489	30380	39337	rs387906867	NC_000002.12:44942488:G:T
NM_015378.4(VPS13D):c.3569G>A (p.Gly1190Asp)	VPS13D	G1190D	Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome	Pathogenic(Last reviewed: Sep 14, 2018)	no assertion criteria provided	VCV000561198	1	12337214	1	12277157	561198	552305	rs1557680919	NC_000001.11:12277156:G:A
NGF, 680C-A AND 2-BP DEL, 681GG	NGF		Congenital sensory neuropathy with selective loss of small myelinated fibers	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000029802					29802	38757		
NM_006912.6(RIT1):c.229G>T (p.Ala77Ser)	RIT1	A77S, A41S, A94S	not provided	Pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000561621	1	155874530	1	155904739	561621	552494	rs869025191	NC_000001.11:155904738:C:A
NM_006912.6(RIT1):c.245T>G (p.Phe82Cys)	RIT1	F82C, F99C, F46C	not provided	Pathogenic(Last reviewed: Oct 31, 2016)	criteria provided, single submitter	VCV000372863	1	155874286	1	155904495	372863	359228	rs868208063	NC_000001.11:155904494:A:C
NM_006912.6(RIT1):c.259G>C (p.Asp87His)	RIT1	D87H, D104H, D51H	not provided	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000280151	1	155874272	1	155904481	280151	263956	rs886041414	NC_000001.11:155904480:C:G
NM_004285.4(H6PD):c.325del (p.Arg109fs)	H6PD	R120fs, R109fs	Cortisone reductase deficiency 1	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000031587	1	9305317	1	9245258	31587	40271	rs398122818	NC_000001.11:9245257:CC:C
NM_004285.4(H6PD):c.948C>G (p.Tyr316Ter)	H6PD	Y316*, Y327*	Cortisone reductase deficiency 1	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000031586	1	9322320	1	9262261	31586	40270	rs398122817	NC_000001.11:9262260:C:G
NM_004285.4(H6PD):c.1076G>A (p.Gly359Asp)	H6PD	G359D, G370D	Cortisone reductase deficiency 1	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000031585	1	9323628	1	9263569	31585	40269	rs387907167	NC_000001.11:9263568:G:A
NM_004285.4(H6PD):c.960G>A (p.Val320=)	H6PD		Cortisone reductase deficiency 1	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000031584	1	9322332	1	9262273	31584	40268	rs398122816	NC_000001.11:9262272:G:A
NM_006912.6(RIT1):c.270G>T (p.Met90Ile)	RIT1	M90I, M107I, M54I	Noonan syndrome 8|not provided	Pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	VCV000265328	1	155874261	1	155904470	265328	259632	rs483352822	NC_000001.11:155904469:C:A
NM_006912.6(RIT1):c.241G>C (p.Glu81Gln)	RIT1	E81Q, E45Q, E98Q	Noonan syndrome	Pathogenic	no assertion criteria provided	VCV000183404	1	155874290	1	155904499	183404	181512	rs869025192	NC_000001.11:155904498:C:G
NM_004285.4(H6PD):c.1860_1861insACAGGTGGTTGACCTGTGGCCGGGTCTGA (p.Glu621delinsThrGlyGlyTer)	H6PD		Cortisone reductase deficiency 1	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000016130	1	9324412 - 9324413	1	9264353 - 9264354	16130	31169	rs606231222	NC_000001.11:9264353::ACAGGTGGTTGACCTGTGGCCGGGTCTGA
NM_006912.6(RIT1):c.91G>C (p.Gly31Arg)	RIT1	G31R, G48R	Noonan syndrome 1	Pathogenic	criteria provided, single submitter	VCV000694723	1	155880462	1	155910671	694723	682797		NC_000001.11:155910670:C:G
NM_006912.6(RIT1):c.245T>C (p.Phe82Ser)	RIT1	F46S, F82S, F99S	Noonan syndrome 1	Pathogenic	criteria provided, single submitter	VCV000694696	1	155874286	1	155904495	694696	682796		NC_000001.11:155904494:A:G
NM_006912.6(RIT1):c.268A>G (p.Met90Val)	RIT1	M90V, M107V, M54V	Noonan syndrome 8|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000561681	1	155874263	1	155904472	561681	552492	rs1557960039	NC_000001.11:155904471:T:C
NM_000298.6(PKLR):c.1436G>A (p.Arg479His)	PKLR	R479H, R448H	Pyruvate kinase deficiency of red cells|not specified	Pathogenic(Last reviewed: Apr 14, 2017)	criteria provided, single submitter	VCV000001510	1	155262968	1	155293177	1510	16549	rs118204085	NC_000001.11:155293176:C:T
NM_006912.6(RIT1):c.365G>T (p.Arg122Leu)	RIT1	R122L, R139L, R86L	Noonan syndrome 8|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280609	1	155874166	1	155904375	280609	263951	rs777520196	NC_000001.11:155904374:C:A
NM_006912.6(RIT1):c.244T>C (p.Phe82Leu)	RIT1	F82L, F99L, F46L	not provided|Noonan syndrome	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000183407	1	155874287	1	155904496	183407	181509	rs869025194	NC_000001.11:155904495:A:G
NM_017837.3(PIGV):c.494C>A (p.Ala165Glu)	PIGV	A165E	Hyperphosphatasia with mental retardation syndrome 1	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000135662	1	27121019	1	26794528	135662	139380	rs376328153	NC_000001.11:26794527:C:A
NM_017837.3(PIGV):c.1022C>T (p.Ala341Val)	PIGV	A341V	Hyperphosphatasia with mental retardation syndrome 1	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000001287	1	27121547	1	26795056	1287	16326	rs139073416	NC_000001.11:26795055:C:T
NM_017837.3(PIGV):c.1154A>C (p.His385Pro)	PIGV	H385P	Hyperphosphatasia with mental retardation syndrome 1	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000001285	1	27121679	1	26795188	1285	16324	rs267606951	NC_000001.11:26795187:A:C
NM_017837.3(PIGV):c.766C>A (p.Gln256Lys)	PIGV	Q256K	Hyperphosphatasia with mental retardation syndrome 1	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000001286	1	27121291	1	26794800	1286	16325	rs267606952	NC_000001.11:26794799:C:A
NM_001122764.3(PPOX):c.694G>C (p.Gly232Arg)	PPOX	G232R, G70R, G96R, G199R	Variegate porphyria|not provided	Pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV000008693	1	161138860	1	161169070	8693	23732	rs121918323	NC_000001.11:161169069:G:C
NM_152281.3(GORAB):c.231dup (p.Pro78fs)	GORAB		Geroderma osteodysplastica	Pathogenic(Last reviewed: Jan 29, 2019)	no assertion criteria provided	VCV000800784	1	170508515 - 170508516	1	170539374 - 170539375	800784	788730		NC_000001.11:170539374:AAAAA:AAAAAA
NM_152281.2(GORAB):c.495-2A>T	GORAB		not provided	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000597291	1	170511630	1	170542489	597291	588352	rs1558006532	NC_000001.11:170542488:A:T
NM_001008216.2(GALE):c.796-1G>T	GALE		not provided	Pathogenic(Last reviewed: Jul 16, 2015)	criteria provided, single submitter	VCV000281922	1	24123077	1	23796587	281922	266159	rs779828095	NC_000001.11:23796586:C:A
NM_001008216.2(GALE):c.272del (p.Leu91fs)	GALE	L91fs	not provided	Pathogenic(Last reviewed: Jun 11, 2014)	criteria provided, single submitter	VCV000197665	1	24124686	1	23798196	197665	194826	rs794727702	NC_000001.11:23798195:A:
NM_001008216.2(GALE):c.408C>A (p.Tyr136Ter)	GALE	Y136*	not provided	Pathogenic(Last reviewed: Jan 21, 2014)	criteria provided, single submitter	VCV000167124	1	24124305	1	23797815	167124	177739	rs727503943	NC_000001.11:23797814:G:T
NM_152281.2(GORAB):c.733G>C (p.Ala245Pro)	GORAB	A220P, A245P, A65P	Geroderma osteodysplastica	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000218115	1	170513982	1	170544841	218115	214774	rs183596463	NC_000001.11:170544840:G:C
NM_001008216.2(GALE):c.905G>A (p.Gly302Asp)	GALE	G302D	UDPglucose-4-epimerase deficiency	Pathogenic(Last reviewed: Jan 25, 2011)	no assertion criteria provided	VCV000021173	1	24122724	1	23796234	21173	34025	rs137853861	NC_000001.11:23796233:C:T
GORAB, 1-BP DEL, 257C	GORAB		Geroderma osteodysplastica	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000002654					2654	17693		
NM_152281.2(GORAB):c.737+5G>C	GORAB		Geroderma osteodysplastica	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000002653	1	170513991	1	170544850	2653	17692		NC_000001.11:170544849:G:C
NM_152281.2(GORAB):c.859C>T (p.Arg287Ter)	GORAB	R287*, R107*	Geroderma osteodysplastica	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000002652	1	170521277	1	170552136	2652	17691	rs119455952	NC_000001.11:170552135:C:T
GORAB, 2-BP DEL/2-BP INS, NT-1	GORAB		Geroderma osteodysplastica	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000002651					2651	17690		
NM_001008216.2(GALE):c.749del (p.Gly250fs)	GALE	G250fs	UDPglucose-4-epimerase deficiency	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000664655	1	24123233	1	23796743	664655	627619		NC_000001.11:23796742:CCC:CC
NM_001008216.2(GALE):c.937C>A (p.Leu313Met)	GALE	L313M	UDPglucose-4-epimerase deficiency	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000003680	1	24122692	1	23796202	3680	18719	rs3180383	NC_000001.11:23796201:G:T
NM_001008216.2(GALE):c.308A>G (p.Asp103Gly)	GALE	D103G	UDPglucose-4-epimerase deficiency	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000003678	1	24124650	1	23798160	3678	18717	rs28940883	NC_000001.11:23798159:T:C
NM_001320252.2(GORAB):c.-99G>T	GORAB	E148*	Geroderma osteodysplastica	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000002650	1	170508656	1	170539515	2650	17689	rs119455951	NC_000001.11:170539514:G:T
NM_001008216.2(GALE):c.269G>A (p.Gly90Glu)	GALE	G90E	UDPglucose-4-epimerase deficiency	Pathogenic(Last reviewed: Jan 25, 2011)	no assertion criteria provided	VCV000003677	1	24124689	1	23798199	3677	18716	rs28940882	NC_000001.11:23798198:C:T
NM_001008216.2(GALE):c.548T>C (p.Leu183Pro)	GALE	L183P	UDPglucose-4-epimerase deficiency	Pathogenic(Last reviewed: Jan 25, 2011)	no assertion criteria provided	VCV000003675	1	24123618	1	23797128	3675	18714	rs121908045	NC_000001.11:23797127:A:G
NM_006912.6(RIT1):c.230C>G (p.Ala77Gly)	RIT1	A41G, A94G, A77G	Noonan syndrome 8	Pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, single submitter	VCV000850519	1	155874529	1	155904738	850519	822786		NC_000001.11:155904737:G:C
NM_033343.4(LHX4):c.295del (p.Thr99fs)	LHX4	T99fs	not provided	Pathogenic(Last reviewed: Dec 16, 2015)	criteria provided, single submitter	VCV000280160	1	180235572	1	180266437	280160	263957	rs886041420	NC_000001.11:180266436:AA:A
NM_024989.4(PGAP1):c.427C>T (p.Gln143Ter)	PGAP1	Q143*	Mental retardation, autosomal recessive 42	Pathogenic(Last reviewed: Sep 11, 2016)	criteria provided, single submitter	VCV000474992	2	197781192	2	196916468	474992	450375	rs1410587479	NC_000002.12:196916467:G:A
NM_024989.4(PGAP1):c.1390_1393TACA[1] (p.Ile465fs)	PGAP1		Mental retardation, autosomal recessive 42	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000474988	2	197740499 - 197740502	2	196875775 - 196875778	474988	450176	rs781325598	NC_000002.12:196875774:TGTATGTAT:TGTAT
NM_024989.4(PGAP1):c.927+1G>A	PGAP1		Mental retardation, autosomal recessive 42	Pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000436299	2	197761854	2	196897130	436299	427977	rs750079325	NC_000002.12:196897129:C:T
NM_024989.4(PGAP1):c.1090-2A>G	PGAP1		Mental retardation, autosomal recessive 42	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000222981	2	197755637	2	196890913	222981	224702	rs869025581	NC_000002.12:196890912:T:C
NM_024989.4(PGAP1):c.1396C>T (p.Gln466Ter)	PGAP1	Q466*, Q292*, Q77*	Mental retardation, autosomal recessive 42	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000222978	2	197740500	2	196875776	222978	224699	rs143038880	NC_000002.12:196875775:G:A
NM_024989.4(PGAP1):c.1572T>A (p.Tyr524Ter)	PGAP1	Y524*, Y135*, Y350*	Mental retardation, autosomal recessive 42	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000222977	2	197737731	2	196873007	222977	224698	rs869025578	NC_000002.12:196873006:A:T
NM_024989.4(PGAP1):c.586_588CTT[1] (p.Leu197del)	PGAP1	L197del	Mental retardation, autosomal recessive 42	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000132084	2	197777664 - 197777666	2	196912940 - 196912942	132084	136319	rs587777378	NC_000002.12:196912939:AAGAAGA:AAGA
NM_024989.4(PGAP1):c.1952+1G>T	PGAP1		Mental retardation, autosomal recessive 42	Pathogenic(Last reviewed: Jan 31, 2014)	no assertion criteria provided	VCV000101081	2	197712670	2	196847946	101081	106842	rs587777202	NC_000002.12:196847945:C:A
NM_033343.4(LHX4):c.293dup (p.Thr99fs)	LHX4		Short stature-pituitary and cerebellar defects-small sella turcica syndrome	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000018444	1	180235565 - 180235566	1	180266430 - 180266431	18444	33483	rs587776662	NC_000001.11:180266430:CCCCCC:CCCCCCC
NM_001008216.2(GALE):c.505C>T (p.Arg169Trp)	GALE	R169W	not provided|UDPglucose-4-epimerase deficiency	Pathogenic(Last reviewed: Jun 11, 2014)	criteria provided, single submitter	VCV000021171	1	24124208	1	23797718	21171	34023	rs137853859	NC_000001.11:23797717:G:A
NM_001008216.2(GALE):c.101A>G (p.Asn34Ser)	GALE	N34S	not provided|UDPglucose-4-epimerase deficiency	Pathogenic(Last reviewed: Apr 30, 2014)	criteria provided, single submitter	VCV000003676	1	24125397	1	23798907	3676	18715	rs121908046	NC_000001.11:23798906:T:C
NM_172362.3(KCNH1):c.1480A>G (p.Ile494Val)	KCNH1	I494V, I467V	Temple-Baraitser syndrome|Zimmermann-Laband syndrome 1|Zimmermann-Laband syndrome 1|Temple-Baraitser syndrome	Pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	VCV000162520	1	210977491	1	210804149	162520	172193	rs727502819	NC_000001.11:210804148:T:C
NM_024989.4(PGAP1):c.921_925del (p.Lys308fs)	PGAP1	K134fs, K308fs	Mental retardation, autosomal recessive 42|Cerebral visual impairment and intellectual disability	Pathogenic(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	VCV000222980	2	197761857 - 197761861	2	196897133 - 196897137	222980	224701	rs869025580	NC_000002.12:196897132:GTTTAGT:GT
NM_024989.4(PGAP1):c.274_276del (p.Pro92del)	PGAP1	P92del	Mental retardation, autosomal recessive 42|Cerebral visual impairment and intellectual disability	Pathogenic(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	VCV000222979	2	197784746 - 197784748	2	196920022 - 196920024	222979	224700	rs869025579	NC_000002.12:196920021:AGGA:A
NM_005235.3(ERBB4):c.3823C>T (p.Arg1275Trp)	ERBB4	R1275W, R1259W	Amyotrophic lateral sclerosis 19|not provided	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000064626	2	212248444	2	211383719	64626	75590	rs397514263	NC_000002.12:211383718:G:A
NM_005235.3(ERBB4):c.2780G>A (p.Arg927Gln)	ERBB4	R927Q	Amyotrophic lateral sclerosis 19|not provided	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000064625	2	212288966	2	211424241	64625	75589	rs397514262	NC_000002.12:211424240:C:T
NM_005378.6(MYCN):c.1132del (p.Glu378fs)	MYCN	E167fs, E378fs	not provided	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000817427	2	16085955	2	15945833	817427	805249		NC_000002.12:15945832:GG:G
NM_005378.6(MYCN):c.788C>G (p.Ser263Ter)	MYCN	S263*	not provided	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000620521	2	16082974	2	15942852	620521	611534	rs1558534492	NC_000002.12:15942851:C:G
NM_001042702.4(PJVK):c.406C>T (p.Arg136Ter)	PJVK	R136*, R139*, R171*	Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560905	2	179319253	2	178454526	560905	551997	rs367688416	NC_000002.12:178454525:C:T
NM_001042702.4(PJVK):c.162_172del (p.Pro55fs)	PJVK	P55fs, P58fs, P90fs	Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560904	2	179318296 - 179318306	2	178453569 - 178453579	560904	551996	rs1559366084	NC_000002.12:178453568:ACACCTTTTACAC:AC
NM_001042702.4(PJVK):c.158C>G (p.Ser53Ter)	PJVK	S53*, S88*, S56*	Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560903	2	179318294	2	178453567	560903	551995	rs538027448	NC_000002.12:178453566:C:G
NM_001042702.4(PJVK):c.515_516del (p.Ser172fs)	PJVK	S175fs, S172fs, S207fs, S13fs	not provided	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000497396	2	179320843 - 179320844	2	178456116 - 178456117	497396	488820	rs1553601319	NC_000002.12:178456115:TCT:T
NM_005378.6(MYCN):c.790+1G>T	MYCN		not provided	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000453036	2	16082977	2	15942855	453036	442978	rs1553370518	NC_000002.12:15942854:G:T
NM_005378.6(MYCN):c.817G>T (p.Glu273Ter)	MYCN	E273*, E62*	not provided	Pathogenic(Last reviewed: Jun 18, 2015)	criteria provided, single submitter	VCV000281398	2	16085641	2	15945519	281398	265635	rs886042150	NC_000002.12:15945518:G:T
NM_005378.6(MYCN):c.1122_1123CT[1] (p.Asn374_Ser375insTer)	MYCN		not provided	Pathogenic(Last reviewed: Jun 8, 2015)	criteria provided, single submitter	VCV000265251	2	16085946 - 16085947	2	15945824 - 15945825	265251	259699	rs886039428	NC_000002.12:15945823:CTCT:CT
NM_005378.6(MYCN):c.511_551del (p.Ala171fs)	MYCN	A171fs	not provided	Pathogenic(Last reviewed: Mar 16, 2015)	criteria provided, single submitter	VCV000265250	2	16082689 - 16082729	2	15942567 - 15942607	265250	259698	rs886039427	NC_000002.12:15942566:CCGGCCGCGCCGGGGCCGCCCTGCCCGCCGAGCTCGCCCACCCGGCCGC:CCGGCCGC
NM_001353775.1(PJVK):c.914_916ACA[1] (p.Asn306del)	PJVK	N303del	Deafness, autosomal recessive 59	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562095	2	179325847 - 179325849	2	178461120 - 178461122	562095	553250	rs1559372512	NC_000002.12:178461119:ACAACA:ACA
NM_001042702.5(PJVK):c.122del (p.Lys41fs)	PJVK	K41fs, K76fs, K44fs	Deafness, autosomal recessive 59	Pathogenic(Last reviewed: Feb 28, 2007)	no assertion criteria provided	VCV000001303	2	179318257	2	178453530	1303	16342	rs1559366000	NC_000002.12:178453529:AA:A
NM_001042702.5(PJVK):c.988del (p.Val330fs)	PJVK	V171fs, V332fs, V333fs, V330fs	Deafness, autosomal recessive 59	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000001302	2	179325930	2	178461203	1302	16341	rs1559372640	NC_000002.12:178461202:G:
NM_001042702.5(PJVK):c.726del (p.Phe242fs)	PJVK	F83fs, F242fs, F245fs	Deafness, autosomal recessive 59	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000001301	2	179325131	2	178460404	1301	16340	rs1559371613	NC_000002.12:178460403:TTT:TT
NM_001042702.5(PJVK):c.113dup (p.Lys41fs)	PJVK		Deafness, autosomal recessive 59	Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000001299	2	179318248 - 179318249	2	178453521 - 178453522	1299	16338	rs1559365985	NC_000002.12:178453521:T:TT
NM_001042702.5(PJVK):c.161C>T (p.Thr54Ile)	PJVK	T54I, T57I, T89I	Deafness, autosomal recessive 59	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000001298	2	179318297	2	178453570	1298	16337	rs118203988	NC_000002.12:178453569:C:T
NM_024989.4(PGAP1):c.2357_2358insTA (p.Arg786fs)	PGAP1		Mental retardation, autosomal recessive 42|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000503954	2	197708779 - 197708780	2	196844055 - 196844056	503954	495391	rs767774867	NC_000002.12:196844055::TA
NM_005378.6(MYCN):c.1103_1104AG[3] (p.Ser369fs)	MYCN		Feingold syndrome 1	Pathogenic(Last reviewed: Apr 4, 2019)	no assertion criteria provided	VCV000695119	2	16085926 - 16085927	2	15945804 - 15945805	695119	683223		NC_000002.12:15945804:AGAG:AGAGAG
NM_005378.6(MYCN):c.900_901TG[1] (p.Val301fs)	MYCN		Feingold syndrome 1	Pathogenic(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	VCV000433154	2	16085724 - 16085725	2	15945602 - 15945603	433154	426708	rs1553370918	NC_000002.12:15945601:TGTG:TG
NM_005378.6(MYCN):c.1061dup (p.Ser355fs)	MYCN		Feingold syndrome 1	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000433152	2	16085884 - 16085885	2	15945762 - 15945763	433152	426711	rs1553370963	NC_000002.12:15945762:C:CC
NM_005378.6(MYCN):c.1014C>A (p.Tyr338Ter)	MYCN	Y338*, Y127*	Feingold syndrome 1	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000433149	2	16085838	2	15945716	433149	426710	rs367962377	NC_000002.12:15945715:C:A
NM_005378.6(MYCN):c.1145G>A (p.Arg382His)	MYCN	R382H, R171H	Feingold syndrome 1	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000013898	2	16085969	2	15945847	13898	28937	rs121913666	NC_000002.12:15945846:G:A
NM_005378.6(MYCN):c.626dup (p.Ala210fs)	MYCN		Feingold syndrome 1	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000013897	2	16082808 - 16082809	2	15942686 - 15942687	13897	28936	rs1558534266	NC_000002.12:15942686:CCCC:CCCCC
NM_005378.6(MYCN):c.1177C>A (p.Arg393Ser)	MYCN	R393S, R182S	Feingold syndrome 1	Pathogenic(Last reviewed: May 1, 2005)	no assertion criteria provided	VCV000013893	2	16086001	2	15945879	13893	28932	rs104893647	NC_000002.12:15945878:C:A
NM_001042702.5(PJVK):c.547C>T (p.Arg183Trp)	PJVK	R183W, R186W, R218W, R24W	Deafness, autosomal recessive 59	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000001297	2	179320876	2	178456149	1297	16336	rs111706634	NC_000002.12:178456148:C:T
NM_024009.3(GJB3):c.497A>G (p.Asn166Ser)	GJB3	N166S	Deafness, digenic, GJB2/GJB3	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000006492	1	35250860	1	34785259	6492	21531	rs121908851	NC_000001.11:34785258:A:G
NM_024009.3(GJB3):c.101T>C (p.Leu34Pro)	GJB3	L34P	Erythrokeratodermia variabilis et progressiva 1	Pathogenic(Last reviewed: May 15, 2002)	no assertion criteria provided	VCV000006491	1	35250464	1	34784863	6491	21530	rs28937583	NC_000001.11:34784862:T:C
NM_024009.3(GJB3):c.256T>A (p.Cys86Ser)	GJB3	C86S	Erythrokeratodermia variabilis et progressiva 1	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000006484	1	35250619	1	34785018	6484	21523	rs74315317	NC_000001.11:34785017:T:A
NM_024009.3(GJB3):c.35G>A (p.Gly12Asp)	GJB3	G12D	Erythrokeratodermia variabilis et progressiva 1	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000006483	1	35250398	1	34784797	6483	21522	rs74315316	NC_000001.11:34784796:G:A
NM_024009.3(GJB3):c.34G>C (p.Gly12Arg)	GJB3	G12R	Erythrokeratodermia variabilis et progressiva 1	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000006482	1	35250397	1	34784796	6482	21521	rs74315315	NC_000001.11:34784795:G:C
NM_024009.3(GJB3):c.8G>A (p.Trp3Ter)	GJB3	W3*	Deafness, autosomal recessive 1A	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627448	1	35250371	1	34784770	627448	615784	rs1557659237	NC_000001.11:34784769:G:A
NM_024009.3(GJB3):c.125G>C (p.Arg42Pro)	GJB3	R42P	Erythrokeratodermia variabilis et progressiva 1	Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	VCV000006489	1	35250488	1	34784887	6489	21528	rs74315321	NC_000001.11:34784886:G:C
NM_024009.3(GJB3):c.421A>G (p.Ile141Val)	GJB3	I141V	Deafness, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000006488	1	35250784	1	34785183	6488	21527	rs74315320	NC_000001.11:34785182:A:G
NM_024009.3(GJB3):c.421_423del (p.Ile141del)	GJB3	I141del	Deafness, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000006487	1	35250784 - 35250786	1	34785183 - 34785185	6487	21526	rs770247378	NC_000001.11:34785182:ATT:
NM_005378.6(MYCN):c.1117C>T (p.Arg373Ter)	MYCN	R373*, R162*	not provided|Feingold syndrome 1	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, single submitter	VCV000545970	2	16085941	2	15945819	545970	536234	rs754137452	NC_000002.12:15945818:C:T
NM_005378.6(MYCN):c.1181G>A (p.Arg394His)	MYCN	R394H, R183H	Feingold syndrome 1	Pathogenic(Last reviewed: Apr 4, 2019)	no assertion criteria provided	VCV000013894	2	16086005	2	15945883	13894	28933	rs104893648	NC_000002.12:15945882:G:A
NM_005378.6(MYCN):c.1178G>A (p.Arg393His)	MYCN	R393H, R182H	Feingold syndrome 1	Pathogenic(Last reviewed: Apr 4, 2019)	no assertion criteria provided	VCV000013892	2	16086002	2	15945880	13892	28931	rs104893646	NC_000002.12:15945879:G:A
NM_006912.6(RIT1):c.69A>C (p.Lys23Asn)	RIT1	K23N, K40N	Noonan syndrome 1|Noonan syndrome 8	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000581105	1	155880484	1	155910693	581105	556612	rs1557962794	NC_000001.11:155910692:T:G
NM_001166107.1(HMGCS2):c.646del (p.Ser216fs)	HMGCS2	S216fs, S258fs	mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000488533	1	120301819	1	119759196	488533	481401	rs1553240525	NC_000001.11:119759195:AAA:AA
NM_001166107.1(HMGCS2):c.891-2del	HMGCS2		mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000488532	1	120298222	1	119755599	488532	481400	rs1553240165	NC_000001.11:119755598:T:
NM_001166107.1(HMGCS2):c.1036G>A (p.Gly346Arg)	HMGCS2	G346R, G388R	not provided	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000449457	1	120298075	1	119755452	449457	442602	rs752626288	NC_000001.11:119755451:C:T
NM_001166107.1(HMGCS2):c.736C>T (p.Arg246Ter)	HMGCS2	R246*, R288*	not provided	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000280473	1	120300050	1	119757427	280473	263940	rs142637231	NC_000001.11:119757426:G:A
NC_000001.11:g.(?_119768721)_(119768864_?)del	HMGCS2		mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000832206	1	120311344 - 120311487			832206	818844		
NC_000001.10:g.(?_120311364)_(120311467_?)del	HMGCS2		mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000650721	1	120311364 - 120311467	1	119768741 - 119768844	650721	650519		
NM_030787.3(CFHR5):c.678del (p.Glu226fs)	CFHR5	E226fs	CFHR5 deficiency	Pathogenic(Last reviewed: Mar 17, 2016)	criteria provided, single submitter	VCV000226110	1	196964916	1	196995786	226110	227915	rs368209619	NC_000001.11:196995785:AA:A
CFHR5, EX2-3DUP	CFHR5		CFHR5 deficiency	Pathogenic(Last reviewed: Sep 4, 2010)	no assertion criteria provided	VCV000037236					37236	45831		
NM_001166107.1(HMGCS2):c.500A>G (p.Tyr167Cys)	HMGCS2	Y167C	mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000009262	1	120306854	1	119764231	9262	24301	rs137852640	NC_000001.11:119764230:T:C
NM_001166107.1(HMGCS2):c.160G>A (p.Val54Met)	HMGCS2	V54M	mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000009261	1	120307194	1	119764571	9261	24300	rs28937320	NC_000001.11:119764570:C:T
NM_005378.6(MYCN):c.964C>T (p.Arg322Ter)	MYCN	R322*, R111*	Feingold syndrome 1	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000433151	2	16085788	2	15945666	433151	426709	rs759103701	NC_000002.12:15945665:C:T
NM_001042702.5(PJVK):c.499C>T (p.Arg167Ter)	PJVK	R167*, R170*, R202*, R8*	Deafness, autosomal recessive 59|Rare genetic deafness	Pathogenic(Last reviewed: May 22, 2015)	criteria provided, single submitter	VCV000001300	2	179320828	2	178456101	1300	16339	rs118203989	NC_000002.12:178456100:C:T
NM_001166107.1(HMGCS2):c.724+2T>C	HMGCS2		mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000644135	1	120301739	1	119759116	644135	650617		NC_000001.11:119759115:A:G
NM_006182.4(DDR2):c.2304T>A (p.Ser768Arg)	DDR2	S768R	Non-small cell lung cancer|Squamous cell carcinoma	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375878	1	162748390	1	162778600	375878	362757	rs267598140	NC_000001.11:162778599:T:A
NM_003597.5(KLF11):c.1039G>T (p.Ala347Ser)	KLF11	A349S, A330S, A347S		Pathogenic(Last reviewed: Mar 29, 2005)	no assertion criteria provided	VCV000006498	2	10188503	2	10048376	6498	21537	rs121912645	NC_000002.12:10048375:G:T
NM_002491.3(NDUFB3):c.208G>T (p.Gly70Ter)	NDUFB3	G70*	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25|Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039836	2	201950249	2	201085526	39836	48435	rs200800978	NC_000002.12:201085525:G:T
NM_015702.3(MMADHC):c.472C>T (p.Arg158Ter)	MMADHC	R158*	not provided	Pathogenic(Last reviewed: Jun 23, 2016)	criteria provided, single submitter	VCV000265247	2	150432957	2	149576443	265247	259695	rs886039425	NC_000002.12:149576442:G:A
NM_000122.2(ERCC3):c.460C>T (p.Gln154Ter)	ERCC3	Q154*, Q90*	Xeroderma pigmentosum, complementation group b	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801749	2	128050197	2	127292621	801749	790042		NC_000002.12:127292620:G:A
NM_000122.1(ERCC3):c.583C>T (p.Arg195Ter)	ERCC3	R195*, R131*	Xeroderma pigmentosum, complementation group b	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627443	2	128047339	2	127289763	627443	615785	rs138385061	NC_000002.12:127289762:G:A
NM_004836.7(EIF2AK3):c.1564_1565del (p.Trp522fs)	EIF2AK3	W522fs, W371fs	Wolcott-Rallison dysplasia	Pathogenic(Last reviewed: Nov 18, 2014)	criteria provided, single submitter	VCV000210932	2	88885444 - 88885445	2	88585926 - 88585927	210932	207029	rs797045558	NC_000002.12:88585925:CAC:C
NM_004836.7(EIF2AK3):c.1192C>T (p.Gln398Ter)	EIF2AK3	Q398*, Q247*	Wolcott-Rallison dysplasia	Pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	VCV000208168	2	88888393	2	88588875	208168	204423	rs864621972	NC_000002.12:88588874:G:A
NM_000122.1(ERCC3):c.355A>C (p.Thr119Pro)	ERCC3	T119P, T55P	Trichothiodystrophy 2, photosensitive	Pathogenic(Last reviewed: Feb 1, 1997)	no assertion criteria provided	VCV000016584	2	128050302	2	127292726	16584	31623	rs121913046	NC_000002.12:127292725:T:G
NM_004836.7(EIF2AK3):c.994G>T (p.Glu332Ter)	EIF2AK3	E331*, E332*, E181*	Wolcott-Rallison dysplasia	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000005878	2	88890344	2	88590826	5878	20917	rs121908570	NC_000002.12:88590825:C:A
NM_004836.7(EIF2AK3):c.1566_1569GAAA[1] (p.Lys523_Glu524insTer)	EIF2AK3		Wolcott-Rallison dysplasia	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000005877	2	88885436 - 88885439	2	88585918 - 88585921	5877	20916	rs1558652941	NC_000002.12:88585917:TTTCTTTC:TTTC
NM_004836.7(EIF2AK3):c.1763G>A (p.Arg588Gln)	EIF2AK3	R587Q, R588Q, R437Q	Wolcott-Rallison dysplasia	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000005875	2	88882948	2	88583430	5875	20914	rs121908569	NC_000002.12:88583429:C:T
NM_004836.7(EIF2AK3):c.1035dup (p.Lys346Ter)	EIF2AK3		Wolcott-Rallison dysplasia	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000005874	2	88890090 - 88890091	2	88590572 - 88590573	5874	20913	rs869025178	NC_000002.12:88590572:AA:AAA
NM_015702.3(MMADHC):c.746A>G (p.Tyr249Cys)	MMADHC	Y249C	Homocystinuria, cblD type, variant 1	Pathogenic(Last reviewed: Apr 3, 2008)	no assertion criteria provided	VCV000000763	2	150426633	2	149570119	763	15802	rs118204046	NC_000002.12:149570118:T:C
NM_015702.3(MMADHC):c.545C>A (p.Thr182Asn)	MMADHC	T182N	Homocystinuria, cblD type, variant 1	Pathogenic(Last reviewed: Apr 3, 2008)	no assertion criteria provided	VCV000000762	2	150432289	2	149575775	762	15801	rs118204045	NC_000002.12:149575774:G:T
NM_015702.3(MMADHC):c.455dup (p.Cys153fs)	MMADHC		Methylmalonic acidemia with homocystinuria cblD	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000219002	2	150432973 - 150432974	2	149576459 - 149576460	219002	216021	rs864309743	NC_000002.12:149576459:G:GG
NM_015702.3(MMADHC):c.60_61insAT (p.Leu21fs)	MMADHC		Methylmalonic acidemia with homocystinuria cblD	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000219001	2	150438734 - 150438735	2	149582220 - 149582221	219001	216024	rs864309742	NC_000002.12:149582220:A:ATA
NM_000122.1(ERCC3):c.1633C>T (p.Gln545Ter)	ERCC3	Q545*, Q481*	Xeroderma pigmentosum, complementation group b	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016588	2	128036846	2	127279270	16588	31627	rs121913048	NC_000002.12:127279269:G:A
NM_000122.1(ERCC3):c.1273C>T (p.Arg425Ter)	ERCC3	R425*, R361*	Xeroderma pigmentosum, complementation group b	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016585	2	128044348	2	127286772	16585	31624	rs121913047	NC_000002.12:127286771:G:A
NM_004482.4(GALNT3):c.1720T>G (p.Cys574Gly)	GALNT3	C574G	Hyperphosphatemic familial tumoral calcinosis 1	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000007803	2	166606311	2	165749801	7803	22842	rs267606841	NC_000002.12:165749800:A:C
NM_004482.4(GALNT3):c.677del (p.Ala226fs)	GALNT3	A226fs	Hyperphosphatemic familial tumoral calcinosis 1	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000007802	2	166621405	2	165764895	7802	22841	rs786205250	NC_000002.12:165764894:G:
NM_004482.4(GALNT3):c.1626+1G>A	GALNT3		Hyperphosphatemic familial tumoral calcinosis 1	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000007801	2	166611136	2	165754626	7801	22840	rs760830864	NC_000002.12:165754625:C:T
NM_004482.4(GALNT3):c.803dup (p.Thr269fs)	GALNT3		Hyperphosphatemic familial tumoral calcinosis 1	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000007800	2	166618449 - 166618450	2	165761939 - 165761940	7800	22839	rs766750282	NC_000002.12:165761939:G:GG
NM_004482.4(GALNT3):c.815C>A (p.Thr272Lys)	GALNT3	T272K	Hyperphosphatemic familial tumoral calcinosis 1	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000007799	2	166618438	2	165761928	7799	22838	rs137853090	NC_000002.12:165761927:G:T
NM_004482.4(GALNT3):c.1441C>T (p.Gln481Ter)	GALNT3	Q481*	Hyperphosphatemic familial tumoral calcinosis 1	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000007798	2	166611525	2	165755015	7798	22837	rs137853089	NC_000002.12:165755014:G:A
NM_004482.4(GALNT3):c.966T>G (p.Tyr322Ter)	GALNT3	Y322*	Hyperphosphatemic familial tumoral calcinosis 1	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000007797	2	166615953	2	165759443	7797	22836	rs137853088	NC_000002.12:165759442:A:C
NM_004482.4(GALNT3):c.1076C>A (p.Thr359Lys)	GALNT3	T359K	Hyperphosphatemic familial tumoral calcinosis 1	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000007796	2	166615372	2	165758862	7796	22835	rs137853091	NC_000002.12:165758861:G:T
NM_004482.4(GALNT3):c.1774C>T (p.Gln592Ter)	GALNT3	Q592*	Hyperphosphatemic familial tumoral calcinosis 1	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000007795	2	166606257	2	165749747	7795	22834	rs137853087	NC_000002.12:165749746:G:A
NM_004482.4(GALNT3):c.1524+5G>A	GALNT3		Hyperphosphatemic familial tumoral calcinosis 1	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000007793	2	166611437	2	165754927	7793	22832	rs375879489	NC_000002.12:165754926:C:T
NM_015702.3(MMADHC):c.776T>C (p.Leu259Pro)	MMADHC	L259P	Homocystinuria, cblD type, variant 1	Pathogenic(Last reviewed: Apr 3, 2008)	no assertion criteria provided	VCV000000761	2	150426603	2	149570089	761	15800	rs118204044	NC_000002.12:149570088:A:G
NM_015702.3(MMADHC):c.554_555AT[1] (p.Met186fs)	MMADHC		Methylmalonic acidemia with homocystinuria cblD	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000848430	2	150432277 - 150432278	2	149575763 - 149575764	848430	824813		NC_000002.12:149575762:ATAT:AT
NM_015702.3(MMADHC):c.544dup (p.Thr182fs)	MMADHC		Methylmalonic acidemia with homocystinuria cblD	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000837579	2	150432289 - 150432290	2	149575775 - 149575776	837579	824814		NC_000002.12:149575775:TTTTTT:TTTTTTT
NC_000002.12:g.(?_149569954)_(149587117_?)del	MMADHC		Methylmalonic acidemia with homocystinuria cblD	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000832146	2	150426468 - 150443631			832146	819051		
NC_000002.12:g.(?_149569964)_(149587107_?)del	MMADHC		Methylmalonic acidemia with homocystinuria cblD	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000831549	2	150426478 - 150443621			831549	819052		
NM_015702.3(MMADHC):c.295_296del (p.Leu99fs)	MMADHC	L99fs	Methylmalonic acidemia with homocystinuria cblD	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000639047	2	150436021 - 150436022	2	149579507 - 149579508	639047	628489		NC_000002.12:149579506:AAA:A
NM_004482.4(GALNT3):c.505C>T (p.Arg169Ter)	GALNT3	R169*	Hyperphosphatemic familial tumoral calcinosis 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561015	2	166626706	2	165770196	561015	552053	rs775341386	NC_000002.12:165770195:G:A
NM_015702.3(MMADHC):c.22_23AG[1] (p.Arg8fs)	MMADHC		Methylmalonic acidemia with homocystinuria cblD	Pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, single submitter	VCV000487521	2	150438770 - 150438771	2	149582256 - 149582257	487521	480572	rs1553454436	NC_000002.12:149582255:CTCT:CT
NM_015702.3(MMADHC):c.228dup (p.Asn77fs)	MMADHC		Methylmalonic acidemia with homocystinuria cblD	Pathogenic(Last reviewed: Dec 1, 2016)	no assertion criteria provided	VCV000219000	2	150436088 - 150436089	2	149579574 - 149579575	219000	216022	rs864309741	NC_000002.12:149579574:CCC:CCCC
NM_015702.3(MMADHC):c.133dup (p.Ala45fs)	MMADHC		Methylmalonic acidemia with homocystinuria cblD	Pathogenic(Last reviewed: Dec 1, 2016)	no assertion criteria provided	VCV000218999	2	150438661 - 150438662	2	149582147 - 149582148	218999	216023	rs864309740	NC_000002.12:149582147:CC:CCC
NM_000122.1(ERCC3):c.471+1G>A	ERCC3		Xeroderma pigmentosum, complementation group b	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016589	2	128050185	2	127292609	16589	31628	rs1558964705	NC_000002.12:127292608:C:T
NM_000122.1(ERCC3):c.809_810del (p.Ser269_Phe270insTer)	ERCC3		Xeroderma pigmentosum, complementation group b	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016586	2	128046925 - 128046926	2	127289349 - 127289350	16586	31625	rs866379139	NC_000002.12:127289348:AAAA:AA
NM_015702.3(MMADHC):c.696+3_696+6del	MMADHC		Methylmalonic acidemia with homocystinuria cblD	Pathogenic(Last reviewed: Apr 3, 2008)	no assertion criteria provided	VCV000000769	2	150427593 - 150427596	2	149571079 - 149571082	769	15808	rs397509364	NC_000002.12:149571078:ACTCACT:ACT
NM_015702.3(MMADHC):c.419dup (p.Tyr140Ter)	MMADHC		Methylmalonic acidemia with homocystinuria cblD	Pathogenic(Last reviewed: Apr 3, 2008)	no assertion criteria provided	VCV000000768	2	150433009 - 150433010	2	149576495 - 149576496	768	15807	rs397509363	NC_000002.12:149576495:T:TT
NM_000122.1(ERCC3):c.325C>T (p.Arg109Ter)	ERCC3	R109*, R45*	not provided|Xeroderma pigmentosum, complementation group b	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265515	2	128050332	2	127292756	265515	259693	rs34295337	NC_000002.12:127292755:G:A
NM_004482.4(GALNT3):c.1524+1G>A	GALNT3		Hyperphosphatemic familial tumoral calcinosis 1	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000007791	2	166611441	2	165754931	7791	22830	rs745655924	NC_000002.12:165754930:C:T
NM_057176.3(BSND):c.262G>T (p.Glu88Ter)	BSND	E88*	not provided	Pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	VCV000620144	1	55470779	1	55005106	620144	611525	rs771232166	NC_000001.11:55005105:G:T
NM_057176.3(BSND):c.452del (p.Pro151fs)	BSND	P151fs	Bartter disease type 4a	Pathogenic	no assertion criteria provided	VCV000590851	1	55472847	1	55007174	590851	581790	rs765135576	NC_000001.11:55007173:CCC:CC
NM_057176.3(BSND):c.470G>A (p.Trp157Ter)	BSND	W157*	not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000858780	1	55472867	1	55007194	858780	824252		NC_000001.11:55007193:G:A
NC_000001.10:g.(?_115231162)_(115238211_?)del	AMPD1		Muscle AMP deaminase deficiency	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000653528	1	115231162 - 115238211	1	114688541 - 114695590	653528	650518		
NM_057176.3(BSND):c.10G>T (p.Glu4Ter)	BSND	E4*	Sensorineural deafness with mild renal dysfunction	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000004389	1	55464869	1	54999196	4389	19428	rs121908145	NC_000001.11:54999195:G:T
NM_057176.3(BSND):c.23G>T (p.Arg8Leu)	BSND	R8L	Bartter disease type 4a	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000004386	1	55464882	1	54999209	4386	19425	rs74315288	NC_000001.11:54999208:G:T
BSND, EX3-EX4 DEL	BSND		Bartter disease type 4a	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000004383					4383	19422		
BSND, IVS1, 41-BP DEL	BSND		Bartter disease type 4a	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000004382					4382	19421		
NM_057176.3(BSND):c.1A>T (p.Met1Leu)	BSND	M1L	Bartter disease type 4a	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000004380	1	55464860	1	54999187	4380	19419	rs74315284	NC_000001.11:54999186:A:T
NM_057176.3(BSND):c.28G>A (p.Gly10Ser)	BSND	G10S	Bartter disease type 4a	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000004385	1	55464887	1	54999214	4385	19424	rs74315287	NC_000001.11:54999213:G:A
NM_000122.1(ERCC3):c.296T>C (p.Phe99Ser)	ERCC3	F99S, F35S	Xeroderma pigmentosum, complementation group b	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016583	2	128050361	2	127292785	16583	31622	rs121913045	NC_000002.12:127292784:A:G
ERCC3, IVS14AS, C-A, -6	ERCC3		Xeroderma pigmentosum, complementation group b	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016582					16582	31621		
NM_015702.3(MMADHC):c.307_324dup (p.Leu103_Ser108dup)	MMADHC		Methylmalonic aciduria, cblD type, variant 2|Methylmalonic acidemia with homocystinuria cblD	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000000766	2	150435992 - 150435993	2	149579478 - 149579479	766	15805	rs397509362	NC_000002.12:149579478:TGATAAAGGTTCTGCTAG:TGATAAAGGTTCTGCTAGTGATAAAGGTTCTGCTAG
NM_015702.3(MMADHC):c.160C>T (p.Arg54Ter)	MMADHC	R54*	Methylmalonic acidemia with homocystinuria cblD|Methylmalonic aciduria, cblD type, variant 2	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000000765	2	150436157	2	149579643	765	15804	rs118204047	NC_000002.12:149579642:G:A
NM_000298.6(PKLR):c.721G>T (p.Glu241Ter)	PKLR	E241*, E210*	Pyruvate kinase deficiency of red cells|Adenosine triphosphate, elevated, of erythrocytes|Pyruvate kinase deficiency of red cells|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280113	1	155264517	1	155294726	280113	263974	rs201953584	NC_000001.11:155294725:C:A
NM_015702.3(MMADHC):c.57_64del (p.Cys19_Ser20insTer)	MMADHC	S20*	Methylmalonic acidemia with homocystinuria cblD|Methylmalonic aciduria, cblD type, variant 2	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000000764	2	150438731 - 150438738	2	149582217 - 149582224	764	15803	rs397509361	NC_000002.12:149582216:CTAAAGAGC:C
NM_001003679.3(LEPR):c.2296A>T (p.Lys766Ter)	LEPR	K766*	not provided	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000596614	1	66083730	1	65618047	596614	587675	rs765551290	NC_000001.11:65618046:A:T
Single allele	LEPR		Leptin receptor deficiency	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000666597	1	66038010 - 66067366			666597	654157		
NM_001003679.3(LEPR):c.464A>C (p.Tyr155Ser)	LEPR	Y155*, Y155S	Leptin receptor deficiency	Pathogenic(Last reviewed: May 1, 2019)	no assertion criteria provided	VCV000619954	1	66038102	1	65572419	619954	611351	rs1557670950	NC_000001.11:65572418:A:C
NM_001003679.3(LEPR):c.479del (p.His160fs)	LEPR	H160fs	not provided	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000596629	1	66038117	1	65572434	596629	587690	rs1557670990	NC_000001.11:65572433:A:
NM_002303.5(LEPR):c.3260_3261AG[6] (p.Ser1090fs)	LEPR		Leptin receptor deficiency	Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000453309	1	66102459 - 66102460	1	65636776 - 65636777	453309	446902	rs1553174844	NC_000001.11:65636776:AGAGAGAGAG:AGAGAGAGAGAG
NM_002303.6(LEPR):c.2597+1G>A	LEPR		Leptin receptor deficiency	Pathogenic(Last reviewed: Mar 26, 1998)	no assertion criteria provided	VCV000008522	1	66087142	1	65621459	8522	23561		NC_000001.11:65621458:G:A
NM_001003679.3(LEPR):c.93G>A (p.Trp31Ter)	LEPR	W31*	not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000421140	1	66036208	1	65570525	421140	405229	rs945135468	NC_000001.11:65570524:G:A
NM_000449.3(RFX5):c.609del (p.Ala204fs)	RFX5	A204fs	Bare lymphocyte syndrome 2	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000649396	1	151316305	1	151343829	649396	626815		NC_000001.11:151343828:T:
NM_000449.3(RFX5):c.312dup (p.Asp105Ter)	RFX5		Bare lymphocyte syndrome 2	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000648114	1	151317244 - 151317245	1	151344768 - 151344769	648114	626816		NC_000001.11:151344768:A:AA
RFX5, 4-BP DEL, IVS-AS, G-A, -1	RFX5		Bare lymphocyte syndrome, type II, complementation group c	Pathogenic(Last reviewed: Apr 1, 1999)	no assertion criteria provided	VCV000007647					7647	22686		
NM_000449.3(RFX5):c.116+5G>A	RFX5		Bare lymphocyte syndrome, type II, complementation group c	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000007644	1	151318676	1	151346200	7644	22683		NC_000001.11:151346199:C:T
NM_000449.3(RFX5):c.1032C>T (p.Ile344=)	RFX5		Bare lymphocyte syndrome, type II, complementation group c	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000007645	1	151315481	1	151343005	7645	22684	rs1557831362	NC_000001.11:151343004:G:A
NM_000122.1(ERCC3):c.1421dup (p.Asp474fs)	ERCC3		Xeroderma pigmentosum, complementation group b|not specified|not provided	Pathogenic(Last reviewed: Feb 10, 2017)	criteria provided, single submitter	VCV000134130	2	128038128 - 128038129	2	127280552 - 127280553	134130	137869	rs587778281	NC_000002.12:127280552:T:TT
NM_000449.3(RFX5):c.234-1G>A	RFX5		not provided|Bare lymphocyte syndrome, type II, complementation group c	Pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, single submitter	VCV000007646	1	151317324	1	151344848	7646	22685	rs748270285	NC_000001.11:151344847:C:T
NM_022367.4(SEMA4A):c.1049T>G (p.Phe350Cys)	SEMA4A	F350C, F218C, F251C, F181C	Retinitis pigmentosa 35|Cone-rod dystrophy 10	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000003361	1	156132800	1	156163009	3361	18400	rs267607034	NC_000001.11:156163008:T:G
NM_022367.4(SEMA4A):c.1033G>C (p.Asp345His)	SEMA4A	D345H, D176H, D213H, D246H	Retinitis pigmentosa 35|Cone-rod dystrophy 10	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000003360	1	156132784	1	156162993	3360	18399	rs267607033	NC_000001.11:156162992:G:C
NM_003051.3(SLC16A1):c.218delG	SLC16A1		not provided	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000450708	1	113464755	1	112922133	450708	442585	rs1553208520	NC_000001.11:112922132:CC:C
NM_003051.3(SLC16A1):c.490dup (p.Leu164fs)	SLC16A1		Monocarboxylate transporter 1 deficiency, autosomal dominant	Pathogenic(Last reviewed: Nov 13, 2014)	no assertion criteria provided	VCV000160372	1	113460537 - 113460538	1	112917915 - 112917916	160372	170216	rs606231312	NC_000001.11:112917915:GGGGGG:GGGGGGG
NM_003051.3(SLC16A1):c.747_750del (p.Asn250fs)	SLC16A1	N250fs	Monocarboxylate transporter 1 deficiency, autosomal dominant	Pathogenic(Last reviewed: Nov 13, 2014)	no assertion criteria provided	VCV000160371	1	113460278 - 113460281	1	112917656 - 112917659	160371	170215	rs606231311	NC_000001.11:112917655:ATTAATT:ATT
NM_003051.3(SLC16A1):c.41dup (p.Asp15fs)	SLC16A1		Monocarboxylate transporter 1 deficiency, autosomal recessive	Pathogenic(Last reviewed: Nov 13, 2014)	no assertion criteria provided	VCV000160369	1	113471889 - 113471890	1	112929267 - 112929268	160369	170213	rs606231309	NC_000001.11:112929267:GGGGGGG:GGGGGGGG
NM_003051.3(SLC16A1):c.938G>A (p.Arg313Gln)	SLC16A1	R313Q	Monocarboxylate transporter 1 deficiency, autosomal dominant	Pathogenic(Last reviewed: Nov 13, 2014)	no assertion criteria provided	VCV000158085	1	113460090	1	112917468	158085	167936	rs606231302	NC_000001.11:112917467:C:T
NM_003051.3(SLC16A1):c.499del (p.Val167fs)	SLC16A1	V167fs	Monocarboxylate transporter 1 deficiency, autosomal dominant	Pathogenic(Last reviewed: Nov 13, 2014)	no assertion criteria provided	VCV000158083	1	113460529	1	112917907	158083	167933	rs606231301	NC_000001.11:112917906:CC:C
NM_003051.3(SLC16A1):c.586C>T (p.Arg196Ter)	SLC16A1	R196*	Monocarboxylate transporter 1 deficiency, autosomal dominant	Pathogenic(Last reviewed: Nov 13, 2014)	no assertion criteria provided	VCV000158081	1	113460442	1	112917820	158081	167930	rs606231300	NC_000001.11:112917819:G:A
NM_003051.3(SLC16A1):c.937C>T (p.Arg313Ter)	SLC16A1	R313*	Monocarboxylate transporter 1 deficiency, autosomal recessive	Pathogenic(Last reviewed: Nov 13, 2014)	no assertion criteria provided	VCV000158079	1	113460091	1	112917469	158079	167927	rs606231299	NC_000001.11:112917468:G:A
NM_003051.3(SLC16A1):c.-391_-390insACGCCGGTCACGTGGCGGGGTGGGG	SLC16A1		Exercise-induced hyperinsulinism	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000008917	1	113499002 - 113499003	1	112956380 - 112956381	8917	23956	rs606231172	NC_000001.11:112956380::CCCCACCCCGCCACGTGACCGGCGT
NM_003051.3(SLC16A1):c.610A>G (p.Lys204Glu)	SLC16A1	K204E	Erythrocyte lactate transporter defect	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000008914	1	113460418	1	112917796	8914	23953	rs80358222	NC_000001.11:112917795:T:C
NM_003051.3(SLC16A1):c.-202G>A	SLC16A1		Exercise-induced hyperinsulinism	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000008916	1	113498814	1	112956192	8916	23955	rs387906403	NC_000001.11:112956191:C:T
NM_006912.6(RIT1):c.246T>A (p.Phe82Leu)	RIT1	F82L, F99L, F46L	Noonan syndrome 8|Noonan syndrome 1|not provided	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000370035	1	155874285	1	155904494	370035	354275	rs730881014	NC_000001.11:155904493:A:T
NM_003051.3(SLC16A1):c.982C>T (p.Arg328Ter)	SLC16A1	R328*	Exercise-induced hyperinsulinism|Monocarboxylate transporter 1 deficiency, autosomal recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000160370	1	113460046	1	112917424	160370	170214	rs606231310	NC_000001.11:112917423:G:A
NM_014762.4(DHCR24):c.1438G>A (p.Glu480Lys)	DHCR24	E480K	Desmosterolosis	Pathogenic(Last reviewed: Jul 1, 2011)	no assertion criteria provided	VCV000030578	1	55318019	1	54852346	30578	39535	rs387906940	NC_000001.11:54852345:C:T
NM_014762.4(DHCR24):c.281G>A (p.Arg94His)	DHCR24	R94H	Desmosterolosis	Pathogenic(Last reviewed: Jul 1, 2011)	no assertion criteria provided	VCV000030577	1	55349397	1	54883724	30577	39534	rs387906939	NC_000001.11:54883723:C:T
NM_014762.4(DHCR24):c.307C>T (p.Arg103Cys)	DHCR24	R103C	Desmosterolosis	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000030576	1	55349371	1	54883698	30576	39533	rs387906938	NC_000001.11:54883697:G:A
LHCGR, EX10DEL	LHCGR		Leydig cell hypoplasia, partial	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000014404					14404	29443		
NM_014762.4(DHCR24):c.1412A>C (p.Tyr471Ser)	DHCR24	Y471S	Desmosterolosis	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000004367	1	55318045	1	54852372	4367	19406	rs28939092	NC_000001.11:54852371:T:G
LHCGR, 33-BP INS, NT54	LHCGR		Leydig cell agenesis	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000014405					14405	29444		
LHCGR, 6-BP DEL, NT1822	LHCGR		Luteinizing hormone resistance, female|Leydig cell agenesis	Pathogenic(Last reviewed: Mar 1, 1998)	no assertion criteria provided	VCV000014399					14399	29438		
LHCGR, LEU-GLN INS, CODON 19-20	LHCGR		Luteinizing hormone/choriogonadotropin receptor, lq variant	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000014401					14401	29440		
NM_004336.5(BUB1):c.1475C>A (p.Ser492Tyr)	BUB1	S492Y, S472Y	Carcinoma of colon	Pathogenic(Last reviewed: Mar 19, 1998)	no assertion criteria provided	VCV000007083	2	111416028	2	110658451	7083	22122	rs121909055	NC_000002.12:110658450:G:T
NM_004336.5(BUB1):c.422+1G>A	BUB1		Carcinoma of colon	Pathogenic(Last reviewed: Mar 19, 1998)	no assertion criteria provided	VCV000007082	2	111430237	2	110672660	7082	22121	rs794729661	NC_000002.12:110672659:C:T
NM_004336.5(BUB1):c.3069del (p.His1024fs)	BUB1	H1024fs, H1004fs, H967fs	Carcinoma of colon	Pathogenic(Last reviewed: Mar 19, 1998)	no assertion criteria provided	VCV000006759	2	111395730	2	110638153	6759	21798	rs587776642	NC_000002.12:110638152:A:
NM_001002294.3(FMO3):c.458C>T (p.Pro153Leu)	FMO3	P153L, P90L, P133L	Trimethylaminuria	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016308	1	171076952	1	171107811	16308	31347	rs72549326	NC_000001.11:171107810:C:T
NM_001002294.3(FMO3):c.913G>T (p.Glu305Ter)	FMO3	E305*, E242*, E285*	not provided|Trimethylaminuria	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016304	1	171083232	1	171114092	16304	31343	rs61753344	NC_000001.11:171114091:G:T
HSPD1, GLN461GLU	HSPD1	Q461E	Hereditary spastic paraplegia 13	Pathogenic(Last reviewed: Sep 13, 2018)	no assertion criteria provided	VCV000561192					561192	552299		
NM_002857.3(PEX19):c.320del (p.Lys107fs)	PEX19	K107fs	Peroxisome biogenesis disorder 12A	Pathogenic(Last reviewed: Sep 1, 2010)	no assertion criteria provided	VCV000030062	1	160252760	1	160282970	30062	39017		NC_000001.11:160282969:TTTT:TTT
NM_002857.3(PEX19):c.763dup (p.Met255fs)	PEX19		Peroxisome biogenesis disorder 12A	Pathogenic(Last reviewed: Mar 2, 1999)	no assertion criteria provided	VCV000009217	1	160249867 - 160249868	1	160280077 - 160280078	9217	24256		NC_000001.11:160280077:T:TT
NM_002156.5(HSPD1):c.86A>G (p.Asp29Gly)	HSPD1	D29G	Leukodystrophy, hypomyelinating, 4	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000017558	2	198363487	2	197498763	17558	32597	rs72466451	NC_000002.12:197498762:T:C
NM_002156.5(HSPD1):c.292G>A (p.Val98Ile)	HSPD1	V72I, V98I	Hereditary spastic paraplegia 13	Pathogenic(Last reviewed: Sep 13, 2018)	no assertion criteria provided	VCV000017557	2	198361999	2	197497275	17557	32596	rs66468541	NC_000002.12:197497274:C:T
NM_014585.5(SLC40A1):c.-205A>C	SLC40A1		Hemochromatosis type 4	Pathogenic(Last reviewed: Nov 17, 2009)	no assertion criteria provided	VCV000488156	2	190445391	2	189580665	488156	481111	rs1553495699	NC_000002.12:189580664:T:G
NM_014585.5(SLC40A1):c.544C>G (p.Gln182Glu)	SLC40A1	Q182E	Hemochromatosis type 4	Pathogenic(Last reviewed: Nov 29, 2012)	no assertion criteria provided	VCV000488155	2	190430296	2	189565570	488155	481108	rs1553493479	NC_000002.12:189565569:G:C
NM_014585.5(SLC40A1):c.1049C>A (p.Ala350Asp)	SLC40A1	A350D	Hemochromatosis type 4	Pathogenic(Last reviewed: Mar 8, 2013)	no assertion criteria provided	VCV000488154	2	190428663	2	189563937	488154	481107	rs1553493234	NC_000002.12:189563936:G:T
NM_014585.5(SLC40A1):c.1481G>A (p.Gly494Asp)	SLC40A1	G494D	Hemochromatosis type 4	Pathogenic(Last reviewed: May 14, 2012)	no assertion criteria provided	VCV000488153	2	190426839	2	189562113	488153	481106	rs1553492997	NC_000002.12:189562112:C:T
NM_014585.5(SLC40A1):c.541G>A (p.Asp181Asn)	SLC40A1	D181N	Hemochromatosis type 4	Pathogenic(Last reviewed: Jul 15, 2013)	no assertion criteria provided	VCV000488152	2	190430299	2	189565573	488152	481109	rs1553493481	NC_000002.12:189565572:C:T
NM_014585.5(SLC40A1):c.479T>C (p.Val160Ala)	SLC40A1	V160A	Hemochromatosis type 4	Pathogenic(Last reviewed: Jun 24, 2015)	no assertion criteria provided	VCV000488151	2	190436476	2	189571750	488151	481110	rs1553494286	NC_000002.12:189571749:A:G
NM_014585.5(SLC40A1):c.1469G>A (p.Gly490Asp)	SLC40A1	G490D	Hemochromatosis type 4	Pathogenic(Last reviewed: Mar 4, 2017)	criteria provided, single submitter	VCV000406376	2	190426851	2	189562125	406376	392453	rs1060501102	NC_000002.12:189562124:C:T
NM_004550.4(NDUFS2):c.686C>A (p.Pro229Gln)	NDUFS2	P229Q	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6	Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	VCV000006710	1	161179705	1	161209915	6710	21749	rs121434428	NC_000001.11:161209914:C:A
NM_004550.4(NDUFS2):c.683G>A (p.Arg228Gln)	NDUFS2	R228Q	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6	Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	VCV000006709	1	161179702	1	161209912	6709	21748	rs121434427	NC_000001.11:161209911:G:A
NM_014585.5(SLC40A1):c.800G>A (p.Gly267Asp)	SLC40A1	G267D	Hemochromatosis type 4	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000005418	2	190428912	2	189564186	5418	20457	rs104893664	NC_000002.12:189564185:C:T
NM_014585.5(SLC40A1):c.239G>T (p.Gly80Val)	SLC40A1	G80V	Hemochromatosis type 4	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000005417	2	190439919	2	189575193	5417	20456	rs104893673	NC_000002.12:189575192:C:A
NM_014585.5(SLC40A1):c.542A>T (p.Asp181Val)	SLC40A1	D181V	Hemochromatosis type 4	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000005416	2	190430298	2	189565572	5416	20455	rs104893672	NC_000002.12:189565571:T:A
NM_014585.5(SLC40A1):c.968G>T (p.Gly323Val)	SLC40A1	G323V	Hemochromatosis type 4	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000005415	2	190428744	2	189564018	5415	20454	rs104893671	NC_000002.12:189564017:C:A
NM_014585.5(SLC40A1):c.546G>T (p.Gln182His)	SLC40A1	Q182H	Hemochromatosis type 4	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000005413	2	190430294	2	189565568	5413	20452	rs104893670	NC_000002.12:189565567:C:A
NM_014585.5(SLC40A1):c.470A>G (p.Asp157Gly)	SLC40A1	D157G	Hemochromatosis type 4	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000005412	2	190436485	2	189571759	5412	20451	rs104893663	NC_000002.12:189571758:T:C
NM_014585.5(SLC40A1):c.430A>C (p.Asn144His)	SLC40A1	N144H	Hemochromatosis type 4	Pathogenic(Last reviewed: Jul 1, 2001)	no assertion criteria provided	VCV000005410	2	190436525	2	189571799	5410	20449	rs104893662	NC_000002.12:189571798:T:G
NM_014585.6(SLC40A1):c.430A>G (p.Asn144Asp)	SLC40A1	N144D	Hemochromatosis type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801843	2	190436525	2	189571799	801843	790140		NC_000002.12:189571798:T:C
NM_014585.5(SLC40A1):c.809A>T (p.Asp270Val)	SLC40A1	D270V	Hemochromatosis type 4	Pathogenic(Last reviewed: Sep 17, 2015)	no assertion criteria provided	VCV000208987	2	190428903	2	189564177	208987	205544	rs368420430	NC_000002.12:189564176:T:A
NM_014585.5(SLC40A1):c.230C>A (p.Ala77Asp)	SLC40A1	A77D	Hemochromatosis type 4	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000005411	2	190439928	2	189575202	5411	20450	rs28939076	NC_000002.12:189575201:G:T
NM_004550.4(NDUFS2):c.268G>A (p.Ala90Thr)	NDUFS2	A90T	Leber's optic atrophy	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522715	1	161176262	1	161206472	522715	513236	rs1553249704	NC_000001.11:161206471:G:A
NP_055400.1(SLC40A1):p.Gln248His	SLC40A1		Hemochromatosis type 4	Pathogenic(Last reviewed: Sep 17, 2015)	no assertion criteria provided	VCV000208986					208986	205546		
NM_004550.4(NDUFS2):c.1237T>C (p.Ser413Pro)	NDUFS2	S413P	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6|not provided	Pathogenic(Last reviewed: Mar 20, 2014)	criteria provided, single submitter	VCV000006711	1	161183463	1	161213673	6711	21750	rs121434429	NC_000001.11:161213672:T:C
NM_014585.5(SLC40A1):c.476_478TTG[3] (p.Val162del)	SLC40A1	V162del	Hemochromatosis type 4	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000005414	2	190436468 - 190436470	2	189571742 - 189571744	5414	20453		NC_000002.12:189571741:CAACAACAACAA:CAACAACAA
NM_003108.4(SOX11):c.791C>A (p.Ser264Ter)	SOX11	S264*	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	VCV000520936	2	5833644	2	5693512	520936	511429	rs1553327954	NC_000002.12:5693511:C:A
NM_003108.4(SOX11):c.1164_1176del (p.Asn389fs)	SOX11	N389fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000520896	2	5834016 - 5834028	2	5693884 - 5693896	520896	511430	rs1553328057	NC_000002.12:5693883:GGAACCTGTCCCTG:G
NM_002437.5(MPV17):c.461+2T>C	MPV17		not provided	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000598353	2	27534765	2	27311897	598353	589414	rs138199394	NC_000002.12:27311896:A:G
NM_002437.5(MPV17):c.409-1G>C	MPV17		not provided	Pathogenic(Last reviewed: Jul 26, 2016)	criteria provided, single submitter	VCV000289822	2	27534820	2	27311952	289822	274059	rs886044280	NC_000002.12:27311951:C:G
NM_002437.5(MPV17):c.370C>T (p.Gln124Ter)	MPV17	Q124*	not provided	Pathogenic(Last reviewed: Feb 11, 2015)	criteria provided, single submitter	VCV000214664	2	27535366	2	27312499	214664	210808	rs863224074	NC_000002.12:27312498:G:A
NM_002437.5(MPV17):c.155_167del (p.Leu52fs)	MPV17	L52fs	not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000841778	2	27535880 - 27535892	2	27313013 - 27313025	841778	826165		NC_000002.12:27313012:GACACCATGGTCAGA:GA
NC_000002.11:g.(?_27534757)_(27545394_?)del	MPV17		not provided	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000832772	2	27534757 - 27545394			832772	819017		
NM_004974.4(KCNA2):c.1223T>C (p.Val408Ala)	KCNA2	V408A	Epileptic encephalopathy, early infantile, 32	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000666316	1	111146182	1	110603560	666316	653844		NC_000001.11:110603559:A:G
NM_004974.4(KCNA2):c.894G>T (p.Leu298Phe)	KCNA2	L298F	Epileptic encephalopathy, early infantile, 32	Pathogenic(Last reviewed: Apr 1, 2015)	no assertion criteria provided	VCV000190327	1	111146511	1	110603889	190327	188154	rs876657390	NC_000001.11:110603888:C:A
NC_000001.11:g.(?_110593873)_(110604802_?)del	KCNA2		Epileptic encephalopathy, early infantile, 32	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000830850	1	111136495 - 111147424			830850	818837		
NC_000001.11:g.110604194del	KCNA2		Seizures|Intellectual disability	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000816892					816892	805071		
NM_004974.4(KCNA2):c.1120A>G (p.Thr374Ala)	KCNA2	T374A	Epileptic encephalopathy, early infantile, 32	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000559647	1	111146285	1	110603663	559647	550344	rs1553181280	NC_000001.11:110603662:T:C
NM_002437.5(MPV17):c.106C>T (p.Gln36Ter)	MPV17	Q36*	Navajo neurohepatopathy	Pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000242902	2	27535941	2	27313074	242902	244007	rs754051090	NC_000002.12:27313073:G:A
NM_002437.5(MPV17):c.70+5G>A	MPV17		Navajo neurohepatopathy	Pathogenic(Last reviewed: May 17, 2012)	no assertion criteria provided	VCV000038359	2	27545310	2	27322443	38359	46922	rs267607268	NC_000002.12:27322442:C:T
NM_002437.5(MPV17):c.485C>A (p.Ala162Asp)	MPV17	A162D	Navajo neurohepatopathy	Pathogenic(Last reviewed: May 17, 2012)	no assertion criteria provided	VCV000038357	2	27532826	2	27309958	38357	46920	rs267607259	NC_000002.12:27309957:G:T
NM_002437.5(MPV17):c.280G>C (p.Gly94Arg)	MPV17	G94R	Navajo neurohepatopathy	Pathogenic(Last reviewed: May 17, 2012)	no assertion criteria provided	VCV000038354	2	27535456	2	27312589	38354	46917	rs267607257	NC_000002.12:27312588:C:G
NM_002437.5(MPV17):c.262A>G (p.Lys88Glu)	MPV17	K88E	Navajo neurohepatopathy	Pathogenic(Last reviewed: May 17, 2012)	no assertion criteria provided	VCV000038351	2	27535564	2	27312697	38351	46914	rs267607256	NC_000002.12:27312696:T:C
NM_002437.5(MPV17):c.22dup (p.Gln8fs)	MPV17		Navajo neurohepatopathy	Pathogenic(Last reviewed: May 17, 2012)	no assertion criteria provided	VCV000038349	2	27545362 - 27545363	2	27322495 - 27322496	38349	46912	rs267607266	NC_000002.12:27322495:GG:GGG
NM_002437.5(MPV17):c.122_147del (p.Arg41fs)	MPV17	R41fs	Navajo neurohepatopathy	Pathogenic(Last reviewed: May 17, 2012)	no assertion criteria provided	VCV000038346	2	27535900 - 27535925	2	27313033 - 27313058	38346	46909	rs397507438	NC_000002.12:27313032:GCCTCTCTGGTGTTCCTGCAGACCCCGCCTCTC:GCCTCTC
NM_002437.5(MPV17):c.279+1G>T	MPV17		Navajo neurohepatopathy	Pathogenic	criteria provided, single submitter	VCV000691983	2	27535546	2	27312679	691983	679728		NC_000002.12:27312678:C:A
NM_002437.4(MPV17):c.71-2_79delins4	MPV17		Navajo neurohepatopathy	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000522377	2	27535968 - 27535978	2	27313101 - 27313111	522377	512988		
NM_002437.5(MPV17):c.376-1G>A	MPV17		Navajo neurohepatopathy	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000522376	2	27535115	2	27312247	522376	512982	rs1423840146	NC_000002.12:27312246:C:T
NM_002437.5(MPV17):c.376-2A>C	MPV17		Navajo neurohepatopathy	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000522375	2	27535116	2	27312248	522375	512983	rs113055360	NC_000002.12:27312247:T:G
NM_002437.5(MPV17):c.293del (p.Pro98fs)	MPV17	P98fs	Navajo neurohepatopathy	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000522374	2	27535443	2	27312576	522374	512985	rs1553383480	NC_000002.12:27312575:GGGG:GGG
MPV17, 26-BP DEL, NT116	MPV17		Navajo neurohepatopathy	Pathogenic(Last reviewed: May 1, 2006)	no assertion criteria provided	VCV000016163					16163	31202		
NM_014585.6(SLC40A1):c.533G>A (p.Arg178Gln)	SLC40A1	R178Q	Hemochromatosis type 4	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000839124	2	190430307	2	189565581	839124	825517		NC_000002.12:189565580:C:T
NM_002437.5(MPV17):c.414dup (p.Pro139fs)	MPV17		Navajo neurohepatopathy	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635346	2	27534813 - 27534814	2	27311945 - 27311946	635346	623131		NC_000002.12:27311945:CC:CCC
NM_002437.5(MPV17):c.186+2T>C	MPV17		not provided|Navajo neurohepatopathy	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000038347	2	27535859	2	27312992	38347	46910	rs147952488	NC_000002.12:27312991:A:G
NM_002437.5(MPV17):c.462-903_0delinsCCTG	MPV17		Navajo neurohepatopathy	Pathogenic(Last reviewed: May 17, 2012)	no assertion criteria provided	VCV000016166	2	27532179 - 27533752	2	27309311 - 27310884	16166	31205		
NM_002437.5(MPV17):c.498C>A (p.Asn166Lys)	MPV17	N166K	Navajo neurohepatopathy	Pathogenic(Last reviewed: May 17, 2012)	no assertion criteria provided	VCV000016161	2	27532813	2	27309945	16161	31200	rs121909722	NC_000002.12:27309944:G:T
NM_004482.4(GALNT3):c.516-2A>T	GALNT3		not provided|Hyperphosphatemic familial tumoral calcinosis 1	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000007794	2	166621568	2	165765058	7794	22833	rs761396172	NC_000002.12:165765057:T:A
NM_015702.3(MMADHC):c.748C>T (p.Arg250Ter)	MMADHC	R250*	Methylmalonic acidemia with homocystinuria cblD	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000000767	2	150426631	2	149570117	767	15806	rs118204048	NC_000002.12:149570116:G:A
NM_006996.3(SLC19A2):c.1082G>A (p.Trp361Ter)	SLC19A2	W361*, W160*	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Aug 8, 2016)	no assertion criteria provided	VCV000492807	1	169438023	1	169468785	492807	485690	rs1553211899	NC_000001.11:169468784:C:T
NM_006996.3(SLC19A2):c.428C>T (p.Ser143Phe)	SLC19A2	S143F	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Sep 3, 2013)	no assertion criteria provided	VCV000492806	1	169446772	1	169477534	492806	485691	rs761957186	NC_000001.11:169477533:G:A
NM_006996.3(SLC19A2):c.64_70del (p.Thr22fs)	SLC19A2	T22fs	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Mar 16, 2012)	no assertion criteria provided	VCV000599230	1	169454935 - 169454941	1	169485697 - 169485703	599230	590455	rs1557894839	NC_000001.11:169485696:GAGCGGT:
NM_006996.3(SLC19A2):c.584_585del (p.Leu195fs)	SLC19A2	L195fs	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Jul 22, 2011)	no assertion criteria provided	VCV000599229	1	169446615 - 169446616	1	169477377 - 169477378	599229	590454	rs763099442	NC_000001.11:169477376:AA:
NM_006996.3(SLC19A2):c.152C>T (p.Pro51Leu)	SLC19A2	P51L	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Mar 15, 2004)	no assertion criteria provided	VCV000005964	1	169454853	1	169485615	5964	21003	rs121908540	NC_000001.11:169485614:G:A
NM_006996.3(SLC19A2):c.1074G>A (p.Trp358Ter)	SLC19A2	W358*, W157*	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000005963	1	169438031	1	169468793	5963	21002	rs74315375	NC_000001.11:169468792:C:T
NM_006996.3(SLC19A2):c.429_430del (p.Ile145fs)	SLC19A2	I145fs	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000005962	1	169446770 - 169446771	1	169477532 - 169477533	5962	21001		NC_000001.11:169477531:AA:
NM_006996.3(SLC19A2):c.242dup (p.Tyr81Ter)	SLC19A2		Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000005961	1	169446957 - 169446958	1	169477719 - 169477720	5961	21000		NC_000001.11:169477719:T:TT
NM_006996.3(SLC19A2):c.1146_1147TG[1] (p.Val383fs)	SLC19A2		Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000005960	1	169437956 - 169437957	1	169468718 - 169468719	5960	20999		NC_000001.11:169468717:CACA:CA
NM_006996.3(SLC19A2):c.750G>A (p.Trp250Ter)	SLC19A2	W250*	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000005958	1	169446450	1	169477212	5958	20997	rs74315374	NC_000001.11:169477211:C:T
NM_006996.3(SLC19A2):c.725del (p.Pro242fs)	SLC19A2	P242fs	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000005956	1	169446475	1	169477237	5956	20995		NC_000001.11:169477236:GGGG:GGG
NM_006996.3(SLC19A2):c.484C>T (p.Arg162Ter)	SLC19A2	R162*	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000005955	1	169446716	1	169477478	5955	20994	rs74315373	NC_000001.11:169477477:G:A
NM_006996.3(SLC19A2):c.885del (p.Leu296fs)	SLC19A2	L95fs, L296fs	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000005959	1	169439347	1	169470109	5959	20998		NC_000001.11:169470108:AA:A
NM_002437.5(MPV17):c.135del (p.Glu45fs)	MPV17	E45fs	Navajo neurohepatopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000214662	2	27535912	2	27313045	214662	210810	rs777604559	NC_000002.12:27313044:TT:T
NM_057176.3(BSND):c.3G>A (p.Met1Ile)	BSND	M1I	Bartter disease type 4a|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004384	1	55464862	1	54999189	4384	19423	rs74315286	NC_000001.11:54999188:G:A
NM_020435.4(GJC2):c.23_24delinsAA (p.Phe8Ter)	GJC2		not provided	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000817577	1	228345482 - 228345483	1	228157781 - 228157782	817577	805208		NC_000001.11:228157780:TC:AA
NM_080916.3(DGUOK):c.254_255delinsT (p.Lys85fs)	DGUOK		not provided	Pathogenic(Last reviewed: Aug 24, 2018)	criteria provided, single submitter	VCV000598562	2	74166148 - 74166149	2	73939021 - 73939022	598562	589623	rs1558650352	NC_000002.12:73939020:AA:T
NM_080916.3(DGUOK):c.494A>T (p.Glu165Val)	DGUOK	E165V, E62V, E68V	not provided	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000595262	2	74177762	2	73950635	595262	586324	rs770950831	NC_000002.12:73950634:A:T
NM_080916.3(DGUOK):c.356dup (p.Lys120fs)	DGUOK		not provided	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000503980	2	74173945 - 74173946	2	73946818 - 73946819	503980	495130	rs1553403687	NC_000002.12:73946818:T:TT
NM_080916.3(DGUOK):c.658G>T (p.Glu220Ter)	DGUOK	E220*, E117*, E123*	not provided	Pathogenic(Last reviewed: Jun 18, 2013)	criteria provided, single submitter	VCV000214287	2	74184318	2	73957191	214287	210899	rs863223948	NC_000002.12:73957190:G:T
NM_080916.3(DGUOK):c.195G>A (p.Trp65Ter)	DGUOK	W65*	not provided	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449312	2	74166089	2	73938962	449312	443310	rs140307681	NC_000002.12:73938961:G:A
NM_080916.3(DGUOK):c.443+1G>A	DGUOK		not provided	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000393268	2	74174034	2	73946907	393268	367060	rs1057524864	NC_000002.12:73946906:G:A
NM_080916.3(DGUOK):c.186C>A (p.Tyr62Ter)	DGUOK	Y62*	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4	Pathogenic(Last reviewed: Aug 18, 2016)	no assertion criteria provided	VCV000253068	2	74166080	2	73938953	253068	247479	rs879255617	NC_000002.12:73938952:C:A
NM_080916.3(DGUOK):c.130G>A (p.Glu44Lys)	DGUOK	E44K	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4	Pathogenic(Last reviewed: Aug 18, 2016)	no assertion criteria provided	VCV000253066	2	74154167	2	73927040	253066	247477	rs762550967	NC_000002.12:73927039:G:A
NM_001171506.2(MCFD2):c.241G>T (p.Asp81Tyr)	MCFD2	D81Y, D62Y, D29Y	Factor v and factor viii, combined deficiency of, 2	Pathogenic(Last reviewed: Jun 15, 2008)	no assertion criteria provided	VCV000002872	2	47135017	2	46907878	2872	17911	rs78289603	NC_000002.12:46907877:C:A
NM_001171506.2(MCFD2):c.407T>C (p.Ile136Thr)	MCFD2	I136T, I84T, I117T	Factor v and factor viii, combined deficiency of, 2	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000002871	2	47132636	2	46905497	2871	17910	rs137852914	NC_000002.12:46905496:A:G
NM_001171506.2(MCFD2):c.387C>G (p.Asp129Glu)	MCFD2	D129E, D110E, D77E	Factor v and factor viii, combined deficiency of, 2	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000002870	2	47132656	2	46905517	2870	17909	rs137852913	NC_000002.12:46905516:G:C
NM_001171506.2(MCFD2):c.265_272del (p.Asp89fs)	MCFD2	D70fs, D37fs, D89fs	Factor v and factor viii, combined deficiency of, 2	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000002869	2	47134986 - 47134993	2	46907847 - 46907854	2869	17908	rs1558461545	NC_000002.12:46907846:AAGCCATCAAGC:AAGC
NM_001171506.2(MCFD2):c.249del (p.Asp83fs)	MCFD2	D31fs, D64fs, D83fs	Factor v and factor viii, combined deficiency of, 2	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000002868	2	47135009	2	46907870	2868	17907	rs1294221028	NC_000002.12:46907869:A:
NM_001171506.2(MCFD2):c.103del (p.Gln35fs)	MCFD2	Q35fs	Factor v and factor viii, combined deficiency of, 2	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000002867	2	47136208	2	46909069	2867	17906	rs1253799389	NC_000002.12:46909068:GGG:GG
NM_001171506.2(MCFD2):c.309+1G>A	MCFD2		Factor v and factor viii, combined deficiency of, 2	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000002866	2	47134948	2	46907809	2866	17905	rs387906287	NC_000002.12:46907808:C:T
NM_020435.4(GJC2):c.778C>T (p.Arg260Cys)	GJC2	R260C	Lymphatic malformation 3	Pathogenic(Last reviewed: Jun 11, 2010)	no assertion criteria provided	VCV000002080	1	228346237	1	228158536	2080	17119	rs267606846	NC_000001.11:228158535:C:T
NM_020435.4(GJC2):c.108C>G (p.Ile36Met)	GJC2	I33M, I36M	Spastic paraplegia 44, autosomal recessive	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000002078	1	228345567	1	228157866	2078	17117	rs75469429	NC_000001.11:228157865:C:G
NM_020435.4(GJC2):c.787G>A (p.Glu263Lys)	GJC2	E263K	Leukodystrophy, hypomyelinating, 2	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000060683	1	228346246	1	228158545	60683	75257	rs397514734	NC_000001.11:228158544:G:A
NM_020435.4(GJC2):c.143C>T (p.Ser48Leu)	GJC2	S48L	Lymphatic malformation 3	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000002079	1	228345602	1	228157901	2079	17118	rs267606847	NC_000001.11:228157900:C:T
NM_020435.4(GJC2):c.695_696insG (p.Tyr232Ter)	GJC2		Leukodystrophy, hypomyelinating, 2	Pathogenic(Last reviewed: Mar 4, 2008)	no assertion criteria provided	VCV000002077	1	228346154 - 228346155	1	228158453 - 228158454	2077	17116	rs796065029	NC_000001.11:228158453::G
NM_020435.4(GJC2):c.989del (p.Pro330fs)	GJC2	P330fs	Leukodystrophy, hypomyelinating, 2	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000002073	1	228346446	1	228158745	2073	17112	rs796065027	NC_000001.11:228158744:CCC:CC
NM_080916.3(DGUOK):c.679G>A (p.Glu227Lys)	DGUOK	E227K, E124K, E130K	Mitochondrial DNA-depletion syndrome 3, hepatocerebral	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000008158	2	74184339	2	73957212	8158	23197	rs104893632	NC_000002.12:73957211:G:A
NM_080916.3(DGUOK):c.425G>A (p.Arg142Lys)	DGUOK	R142K, R45K	Mitochondrial DNA-depletion syndrome 3, hepatocerebral	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000008157	2	74174015	2	73946888	8157	23196	rs104893631	NC_000002.12:73946887:G:A
NM_080916.3(DGUOK):c.609_610del (p.Tyr204fs)	DGUOK	Y204fs, Y107fs, Y101fs	Mitochondrial DNA-depletion syndrome 3, hepatocerebral	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000008156	2	74184268 - 74184269	2	73957141 - 73957142	8156	23195	rs886037615	NC_000002.12:73957140:TGT:T
NM_080916.3(DGUOK):c.313C>T (p.Arg105Ter)	DGUOK	R105*, R8*	Mitochondrial DNA-depletion syndrome 3, hepatocerebral	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000008154	2	74173903	2	73946776	8154	23193	rs104893630	NC_000002.12:73946775:C:T
NM_020435.4(GJC2):c.914_947del (p.Pro305fs)	GJC2	P305fs	Leukodystrophy, hypomyelinating, 2	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000002076	1	228346360 - 228346393	1	228158659 - 228158692	2076	17115	rs796065028	NC_000001.11:228158658:CGCCGCGGCCCCCCGGCCTCCGCCCCCGCCCCCGCGCCGCGGCCCCC:CGCCGCGGCCCCC
NM_020435.4(GJC2):c.814T>G (p.Tyr272Asp)	GJC2	Y272D	Leukodystrophy, hypomyelinating, 2	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000002075	1	228346273	1	228158572	2075	17114	rs74315314	NC_000001.11:228158571:T:G
NM_020435.4(GJC2):c.268C>T (p.Pro90Ser)	GJC2	P90S	Leukodystrophy, hypomyelinating, 2	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000002072	1	228345727	1	228158026	2072	17111	rs74315312	NC_000001.11:228158025:C:T
NM_020435.4(GJC2):c.857T>C (p.Met286Thr)	GJC2	M286T	Leukodystrophy, hypomyelinating, 2	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000002071	1	228346316	1	228158615	2071	17110	rs74315311	NC_000001.11:228158614:T:C
NM_002437.5(MPV17):c.280-1dup	MPV17		not provided|Navajo neurohepatopathy	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000290443	2	27535451 - 27535452	2	27312584 - 27312585	290443	274680	rs766160589	NC_000002.12:27312584:CCCCCC:CCCCCCC
NM_020435.3(GJC2):c.-170A>G	GJC2		Leukodystrophy, hypomyelinating, 2	Pathogenic(Last reviewed: Jun 6, 2017)	no assertion criteria provided	VCV000139577	1	228337558	1	228149857	139577	143207	rs587777496	
NM_001330350.1(UBIAD1):c.530-9229G>A	UBIAD1	G177E	Schnyder crystalline corneal dystrophy	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000041408	1	11345701	1	11285644	41408	49835	rs397514669	NC_000001.11:11285643:G:A
NM_001330349.1(UBIAD1):c.618+90C>G	UBIAD1	D236E	Schnyder crystalline corneal dystrophy	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000000864	1	11345879	1	11285822	864	15903	rs118203953	NC_000001.11:11285821:C:G
NM_013319.2(UBIAD1):c.335A>G (p.Asp112Gly)	UBIAD1	D112G	Schnyder crystalline corneal dystrophy	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000000861	1	11333923	1	11273866	861	15900	rs118203950	NC_000001.11:11273865:A:G
NM_013319.2(UBIAD1):c.355A>G (p.Arg119Gly)	UBIAD1	R119G	Schnyder crystalline corneal dystrophy	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000000858	1	11333943	1	11273886	858	15897	rs118203947	NC_000001.11:11273885:A:G
NM_001330350.1(UBIAD1):c.530-9203G>A	UBIAD1	G186R	Schnyder crystalline corneal dystrophy	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000000863	1	11345727	1	11285670	863	15902	rs118203952	NC_000001.11:11285669:G:A
NM_013319.2(UBIAD1):c.511T>C (p.Ser171Pro)	UBIAD1	S171P	Schnyder crystalline corneal dystrophy	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000000862	1	11334099	1	11274042	862	15901	rs118203951	NC_000001.11:11274041:T:C
NM_001330349.1(UBIAD1):c.618+77A>G	UBIAD1	N232S	Schnyder crystalline corneal dystrophy	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000000860	1	11345866	1	11285809	860	15899	rs118203949	NC_000001.11:11285808:A:G
NM_013319.2(UBIAD1):c.524C>T (p.Thr175Ile)	UBIAD1	T175I	Schnyder crystalline corneal dystrophy	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000000859	1	11334112	1	11274055	859	15898	rs118203948	NC_000001.11:11274054:C:T
NM_013319.2(UBIAD1):c.529G>C (p.Gly177Arg)	UBIAD1	G177R, V177L	Schnyder crystalline corneal dystrophy	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000000857	1	11334117	1	11274060	857	15896	rs118203946	NC_000001.11:11274059:G:C
NM_020435.4(GJC2):c.1134_1144del (p.Ala379fs)	GJC2	A379fs	Spastic paraplegia|Leukodystrophy, hypomyelinating, 2	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000656694	1	228346584 - 228346594	1	228158883 - 228158893	656694	627401		NC_000001.11:228158882:CGGCCTCCCTGCGGCCTCCC:CGGCCTCCC
NM_020435.4(GJC2):c.107del (p.Ile36fs)	GJC2	I36fs	Dystonia|Intellectual disability	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000625200	1	228345566	1	228157865	625200	613533		NC_000001.11:228157864:T:
NM_080916.3(DGUOK):c.444-11C>G	DGUOK		Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000253069	2	74177701	2	73950574	253069	247480	rs536746349	NC_000002.12:73950573:C:G
NM_080916.3(DGUOK):c.255del (p.Ala86fs)	DGUOK	A86fs	not provided|Mitochondrial DNA-depletion syndrome 3, hepatocerebral	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000008153	2	74166145	2	73939018	8153	23192	rs886037613	NC_000002.12:73939017:AAAAA:AAAA
NM_001166107.1(HMGCS2):c.560-633G>A	HMGCS2	G212R	mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000009259	1	120302538	1	119759915	9259	24298	rs137852638	NC_000001.11:119759914:C:T
NM_025077.4(TOE1):c.938_939CA[1] (p.Gln314fs)	TOE1		not provided	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, single submitter	VCV000524117	1	45808779 - 45808780	1	45343107 - 45343108	524117	514430	rs780563835	NC_000001.11:45343106:CACA:CA
NM_025077.4(TOE1):c.733G>T (p.Glu245Ter)	TOE1	E245*	not provided	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000523872	1	45808296	1	45342624	523872	514429	rs1393167436	NC_000001.11:45342623:G:T
NM_025077.4(TOE1):c.448C>T (p.Gln150Ter)	TOE1	Q150*	not provided	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000849146	1	45807735	1	45342063	849146	824198		NC_000001.11:45342062:C:T
NM_003849.4(SUCLG1):c.457_458delinsTA (p.Val153Ter)	SUCLG1		Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Pathogenic(Last reviewed: Feb 16, 2020)	criteria provided, single submitter	VCV000818207	2	84668444 - 84668445	2	84441320 - 84441321	818207	806417		NC_000002.12:84441319:AC:TA
NM_003849.4(SUCLG1):c.201+1G>T	SUCLG1		Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801730	2	84676772	2	84449648	801730	790300		NC_000002.12:84449647:C:A
NM_003849.4(SUCLG1):c.548T>C (p.Ile183Thr)	SUCLG1	I183T	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801727	2	84668212	2	84441088	801727	790297		NC_000002.12:84441087:A:G
NM_000191.3(HMGCL):c.499T>A (p.Tyr167Asn)	HMGCL	Y167N	Deficiency of hydroxymethylglutaryl-CoA lyase	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000523024	1	24137288	1	23810798	523024	513508	rs1553132209	NC_000001.11:23810797:A:T
NM_025077.4(TOE1):c.957C>A (p.His319Gln)	TOE1	H319Q	Pontocerebellar hypoplasia, type 7	Pathogenic(Last reviewed: Apr 15, 2017)	no assertion criteria provided	VCV000417751	1	45808798	1	45343126	417751	404652		NC_000001.11:45343125:C:A
TOE1, 2-BP DEL	TOE1		Pontocerebellar hypoplasia, type 7	Pathogenic(Last reviewed: Apr 15, 2017)	no assertion criteria provided	VCV000417750					417750	404651		
NM_000191.3(HMGCL):c.835G>A (p.Glu279Lys)	HMGCL	E279K, E208K	Deficiency of hydroxymethylglutaryl-CoA lyase	Pathogenic(Last reviewed: Oct 1, 2000)	no assertion criteria provided	VCV000011958	1	24130931	1	23804441	11958	26997	rs121964998	NC_000001.11:23804440:C:T
HMGCL, 930-BP DEL, EX3-6DEL	HMGCL		Deficiency of hydroxymethylglutaryl-CoA lyase	Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	VCV000011956					11956	26995		
NM_000191.3(HMGCL):c.27del (p.Arg10fs)	HMGCL	R10fs	Deficiency of hydroxymethylglutaryl-CoA lyase	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000557324	1	24151879	1	23825389	557324	541121	rs1409716731	NC_000001.11:23825388:C:
NM_025077.4(TOE1):c.307G>A (p.Ala103Thr)	TOE1	A103T	Pontocerebellar hypoplasia, type 7	Pathogenic/Likely pathogenic(Last reviewed: Jul 16, 2017)	no assertion criteria provided	VCV000417748	1	45807215	1	45341543	417748	404649	rs371848318	NC_000001.11:45341542:G:A
NM_025077.4(TOE1):c.443T>A (p.Phe148Tyr)	TOE1	F148Y	Pontocerebellar hypoplasia, type 7	Pathogenic/Likely pathogenic(Last reviewed: Jul 16, 2017)	no assertion criteria provided	VCV000417747	1	45807730	1	45342058	417747	404648		NC_000001.11:45342057:T:A
NM_025077.4(TOE1):c.658G>A (p.Glu220Lys)	TOE1	E220K	Pontocerebellar hypoplasia, type 7	Pathogenic/Likely pathogenic(Last reviewed: Jul 16, 2017)	no assertion criteria provided	VCV000417746	1	45808221	1	45342549	417746	404647		NC_000001.11:45342548:G:A
NM_003849.4(SUCLG1):c.507del (p.Asn171fs)	SUCLG1	N171fs	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Pathogenic(Last reviewed: Jul 7, 2015)	criteria provided, single submitter	VCV000212328	2	84668395	2	84441271	212328	207028	rs797046017	NC_000002.12:84441270:CCC:CC
NM_003849.4(SUCLG1):c.448C>T (p.Gln150Ter)	SUCLG1	Q150*	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000018412	2	84668454	2	84441330	18412	33451	rs267607098	NC_000002.12:84441329:G:A
NM_003849.4(SUCLG1):c.97+3G>C	SUCLG1		Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000018411	2	84686294	2	84459170	18411	33450	rs786205871	NC_000002.12:84459169:C:G
NM_003849.4(SUCLG1):c.509C>G (p.Pro170Arg)	SUCLG1	P170R	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000018410	2	84668393	2	84441269	18410	33449	rs267607099	NC_000002.12:84441268:G:C
NM_003849.4(SUCLG1):c.254G>C (p.Gly85Ala)	SUCLG1	G72A, G85A	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Pathogenic(Last reviewed: Feb 1, 2010)	no assertion criteria provided	VCV000018409	2	84670472	2	84443348	18409	33448	rs267607097	NC_000002.12:84443347:C:G
SUCLG1, 2-BP DEL, 113AT	SUCLG1		Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000000988					988	16027		
NM_025077.4(TOE1):c.518T>G (p.Val173Gly)	TOE1	V173G	Pontocerebellar hypoplasia, type 7	Pathogenic/Likely pathogenic(Last reviewed: Jul 16, 2017)	no assertion criteria provided	VCV000417749	1	45808081	1	45342409	417749	404650		NC_000001.11:45342408:T:G
NM_002437.5(MPV17):c.206G>A (p.Trp69Ter)	MPV17	W69*	MPV17-related mitochondrial DNA maintenance defect|Navajo neurohepatopathy	Pathogenic/Likely pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000038348	2	27535620	2	27312753	38348	46911	rs267607261	NC_000002.12:27312752:C:T
NM_080916.3(DGUOK):c.591G>A (p.Gln197=)	DGUOK		not provided|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4|Portal hypertension, noncirrhotic|Mitochondrial DNA-depletion syndrome 3, hepatocerebral	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000214286	2	74177859	2	73950732	214286	210897	rs748597500	NC_000002.12:73950731:G:A
NM_020435.4(GJC2):c.718C>T (p.Arg240Ter)	GJC2	R240*	Leukodystrophy, hypomyelinating, 2	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000002074	1	228346177	1	228158476	2074	17113	rs74315313	NC_000001.11:228158475:C:T
NM_003849.4(SUCLG1):c.40A>T (p.Met14Leu)	SUCLG1	M14L	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561158	2	84686354	2	84459230	561158	552068	rs796052053	NC_000002.12:84459229:T:A
NM_000191.3(HMGCL):c.602C>A (p.Ser201Tyr)	HMGCL	S201Y, S130Y	Deficiency of hydroxymethylglutaryl-CoA lyase|not provided	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000449033	1	24134773	1	23808283	449033	442782	rs760106433	NC_000001.11:23808282:G:T
NM_000191.3(HMGCL):c.202_203CT[2] (p.Ser69fs)	HMGCL		Deficiency of hydroxymethylglutaryl-CoA lyase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000011954	1	24144011 - 24144012	1	23817521 - 23817522	11954	26993	rs752137615	NC_000001.11:23817520:AGAGAG:AGAG
NM_001079818.3(ITGA6):c.3115-2267del	ITGA6	K1041fs, K1056fs, K937fs	Epidermolysis bullosa junctionalis with pyloric atresia	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000623184	2	173366551	2	172501823	623184	612187	rs1559159868	NC_000002.12:172501822:AA:A
ITGA6, 1-BP DEL, 791C	ITGA6		Epidermolysis bullosa junctionalis with pyloric atresia	Pathogenic(Last reviewed: Jun 15, 1997)	no assertion criteria provided	VCV000014745					14745	29784		
NM_000261.2(MYOC):c.144G>T (p.Gln48His)	MYOC	Q48H	Glaucoma 3, primary congenital, a, digenic|Glaucoma 1, open angle, A|MYOC-Related Disorders	Pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, single submitter	VCV000007958	1	171621608	1	171652468	7958	22997	rs74315339	NC_000001.11:171652467:C:A
NM_006164.5(NFE2L2):c.235G>A (p.Glu79Lys)	NFE2L2	E63K, E79K	Uterine cervical neoplasms|Squamous cell carcinoma of the head and neck|Transitional cell carcinoma of the bladder|IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA|Squamous cell lung carcinoma|Lung adenocarcinoma|Hepatocellular carcinoma	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2018)	no assertion criteria provided	VCV000376466	2	178098810	2	177234082	376466	363345	rs1057519922	NC_000002.12:177234081:C:T
NM_005857.5(ZMPSTE24):c.1060-6_1085del	ZMPSTE24		Lethal tight skin contracture syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801467	1	40756519 - 40756550	1	40290847 - 40290878	801467	789965		NC_000001.11:40290846:TTTCTAGATGAATTCTTTCCTGTGTTTTTTTTT:T
NM_005857.5(ZMPSTE24):c.1097T>G (p.Leu366Ter)	ZMPSTE24	L366*	not provided	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000620353	1	40756563	1	40290891	620353	611520	rs1431637197	NC_000001.11:40290890:T:G
NM_005857.5(ZMPSTE24):c.818del (p.Lys273fs)	ZMPSTE24	K273fs	not provided	Pathogenic(Last reviewed: Jul 21, 2016)	criteria provided, single submitter	VCV000288995	1	40747062	1	40281390	288995	273232	rs886044057	NC_000001.11:40281389:AA:A
NM_005857.5(ZMPSTE24):c.1263dup (p.Ala422fs)	ZMPSTE24		not provided	Pathogenic(Last reviewed: Jan 28, 2015)	criteria provided, single submitter	VCV000140517	1	40758173 - 40758174	1	40292501 - 40292502	140517	150195	rs281875375	NC_000001.11:40292501:TTT:TTTT
NM_005857.5(ZMPSTE24):c.1204-1G>A	ZMPSTE24		not provided	Pathogenic(Last reviewed: May 26, 2015)	criteria provided, single submitter	VCV000140513	1	40758116	1	40292444	140513	150191	rs61751009	NC_000001.11:40292443:G:A
NM_005857.5(ZMPSTE24):c.584_585del (p.Tyr195fs)	ZMPSTE24	Y195fs	Lethal tight skin contracture syndrome	Pathogenic(Last reviewed: Feb 1, 2010)	no assertion criteria provided	VCV000041412	1	40735755 - 40735756	1	40270083 - 40270084	41412	49844	rs786205123	NC_000001.11:40270082:TAT:T
NM_005857.5(ZMPSTE24):c.1349G>A (p.Trp450Ter)	ZMPSTE24	W450*	Mandibuloacral dysplasia with type B lipodystrophy|not provided	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000030586	1	40758262	1	40292590	30586	39543	rs281875376	NC_000001.11:40292589:G:A
NM_005857.5(ZMPSTE24):c.591dup (p.Ile198fs)	ZMPSTE24		Lethal tight skin contracture syndrome|not provided	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000030585	1	40735756 - 40735757	1	40270084 - 40270085	30585	39542	rs281875367	NC_000001.11:40270084:TTTTTTT:TTTTTTTT
NM_005857.5(ZMPSTE24):c.715G>T (p.Glu239Ter)	ZMPSTE24	E239*	Lethal tight skin contracture syndrome|not provided	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000004276	1	40737653	1	40271981	4276	19315	rs267607181	NC_000001.11:40271980:G:T
NM_005857.5(ZMPSTE24):c.121C>T (p.Gln41Ter)	ZMPSTE24	Q41*	Mandibuloacral dysplasia with type B lipodystrophy|not provided	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000004274	1	40724064	1	40258392	4274	19313	rs121908094	NC_000001.11:40258391:C:T
NM_005857.5(ZMPSTE24):c.1018T>C (p.Trp340Arg)	ZMPSTE24	W340R	Mandibuloacral dysplasia with type B lipodystrophy|not provided	Pathogenic(Last reviewed: Aug 15, 2003)	no assertion criteria provided	VCV000004272	1	40751660	1	40285988	4272	19311	rs121908093	NC_000001.11:40285987:T:C
NM_005857.5(ZMPSTE24):c.50del (p.Lys17fs)	ZMPSTE24	K17fs	not provided|Lethal tight skin contracture syndrome	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, single submitter	VCV000041411	1	40723992	1	40258320	41411	49843	rs281875360	NC_000001.11:40258319:AA:A
NM_005857.5(ZMPSTE24):c.743C>T (p.Pro248Leu)	ZMPSTE24	P248L	Mandibuloacral dysplasia with type B lipodystrophy|not provided	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000004275	1	40737681	1	40272009	4275	19314	rs121908095	NC_000001.11:40272008:C:T
NM_000396.4(CTSK):c.721C>T (p.Arg241Ter)	CTSK	R241*	Pyknodysostosis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008422	1	150772083	1	150799607	8422	23461	rs74315303	NC_000001.11:150799606:G:A
NM_005149.3(TBX19):c.75_78del (p.Glu26fs)	TBX19	E26fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000520566	1	168250400 - 168250403	1	168281162 - 168281165	520566	511190	rs760520604	NC_000001.11:168281161:GAGTGAG:GAG
NM_013319.2(UBIAD1):c.305A>G (p.Asn102Ser)	UBIAD1	N102S	Schnyder crystalline corneal dystrophy	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000000856	1	11333893	1	11273836	856	15895	rs118203945	NC_000001.11:11273835:A:G
NM_006912.6(RIT1):c.270G>C (p.Met90Ile)	RIT1	M90I, M107I, M54I	Noonan syndrome 8|not provided	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000190305	1	155874261	1	155904470	190305	188134	rs483352822	NC_000001.11:155904469:C:G
NM_006912.6(RIT1):c.265T>C (p.Tyr89His)	RIT1	Y89H, Y53H, Y106H	Noonan syndrome|not provided|Noonan syndrome 8	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183411	1	155874266	1	155904475	183411	181505	rs869025197	NC_000001.11:155904474:A:G
NM_005857.5(ZMPSTE24):c.54dup (p.Ile19fs)	ZMPSTE24		Lethal tight skin contracture syndrome|not provided	Pathogenic(Last reviewed: Oct 5, 2012)	no assertion criteria provided	VCV000030584	1	40723996 - 40723997	1	40258324 - 40258325	30584	39541	rs281875361	NC_000001.11:40258324:T:TT
NM_002026.3(FN1):c.4139_4141CTC[1] (p.Pro1381del)	FN1	P1472del	Glomerulopathy with fibronectin deposits 2	Pathogenic	no assertion criteria provided	VCV000192246	2	216251607 - 216251609	2	215386884 - 215386886	192246	190046	rs869025199	NC_000002.12:215386883:GAGGAG:GAG
NM_212482.3(FN1):c.5921T>C (p.Leu1974Pro)	FN1	L1974P, L1883P, L1793P, L1884P	Glomerulopathy with fibronectin deposits 2	Pathogenic	no assertion criteria provided	VCV000192245	2	216240408	2	215375685	192245	190044	rs137854487	NC_000002.12:215375684:A:G
NM_212482.3(FN1):c.5775G>C (p.Trp1925Cys)	FN1	W1925C, W1834C, W1835C, W1744C	Glomerulopathy with fibronectin deposits 2	Pathogenic	no assertion criteria provided	VCV000192244	2	216241333	2	215376610	192244	190045	rs869025198	NC_000002.12:215376609:C:G
NM_002026.3(FN1):c.5648T>G (p.Leu1883Arg)	FN1	L1974R, L1793R, L1884R, L1883R	Glomerulopathy with fibronectin deposits 2	Pathogenic(Last reviewed: Feb 19, 2008)	no assertion criteria provided	VCV000016324	2	216240408	2	215375685	16324	31363	rs137854487	NC_000002.12:215375684:A:C
NM_002026.3(FN1):c.685+1G>C	FN1		Spondylometaphyseal dysplasia - Sutcliffe type	Pathogenic	criteria provided, single submitter	VCV000638046	2	216295437	2	215430714	638046	625867		NC_000002.12:215430713:C:G
NM_002026.3(FN1):c.5500T>A (p.Trp1834Arg)	FN1	W1925R, W1834R, W1744R, W1835R	Glomerulopathy with fibronectin deposits 2	Pathogenic(Last reviewed: Feb 19, 2008)	no assertion criteria provided	VCV000016323	2	216241335	2	215376612	16323	31362	rs137854486	NC_000002.12:215376611:A:T
NM_002437.5(MPV17):c.122G>A (p.Arg41Gln)	MPV17	R41Q	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000626263	2	27535925	2	27313058	626263	614556	rs140992482	NC_000002.12:27313057:C:T
NM_004974.4(KCNA2):c.1214C>T (p.Pro405Leu)	KCNA2	P405L	Epileptic encephalopathy, early infantile, 32|not provided	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000190325	1	111146191	1	110603569	190325	188152	rs876657389	NC_000001.11:110603568:G:A
NM_002026.3(FN1):c.2918A>G (p.Tyr973Cys)	FN1	Y983C, Y973C	Glomerulopathy with fibronectin deposits 2	Pathogenic(Last reviewed: Feb 19, 2008)	no assertion criteria provided	VCV000016325	2	216271029	2	215406306	16325	31364	rs137854488	NC_000002.12:215406305:T:C
NM_000191.3(HMGCL):c.914_915del (p.Phe305fs)	HMGCL	F305fs, F234fs	Deficiency of hydroxymethylglutaryl-CoA lyase|not provided	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031084	1	24129016 - 24129017	1	23802526 - 23802527	31084	40041	rs786205431	NC_000001.11:23802525:AAA:A
NM_001039550.2(DNAJB2):c.394C>T (p.Arg132Ter)	DNAJB2	R132*	Spinal muscular atrophy, distal, autosomal recessive, 5	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000864789	2	220147600	2	219282878	864789	825763		NC_000002.12:219282877:C:T
NM_001039550.2(DNAJB2):c.89G>A (p.Trp30Ter)	DNAJB2	W30*	Spinal muscular atrophy, distal, autosomal recessive, 5	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000856608	2	220145323	2	219280601	856608	825756		NC_000002.12:219280600:G:A
NM_001039550.2(DNAJB2):c.0_229+18del	DNAJB2		Spinal muscular atrophy, distal, autosomal recessive, 5	Pathogenic	criteria provided, single submitter	VCV000254212	2	220142659 - 220146510	2	219277937 - 219281788	254212	248727		
DNAJB2, IVS5DS, G-A, +1	DNAJB2		Spinal muscular atrophy, distal, autosomal recessive, 5	Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	VCV000039697					39697	48296		
NM_001039550.2(DNAJB2):c.343G>T (p.Glu115Ter)	DNAJB2	E115*	Charcot-Marie-Tooth disease, axonal, type 2T	Pathogenic(Last reviewed: Oct 25, 2013)	criteria provided, single submitter	VCV000209147	2	220146774	2	219282052	209147	205729	rs797045039	NC_000002.12:219282051:G:T
NM_001039550.2(DNAJB2):c.620-1G>A	DNAJB2		Spinal muscular atrophy, distal, autosomal recessive, 5	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	VCV000246691	2	220149353	2	219284631	246691	245298	rs764813110	NC_000002.12:219284630:G:A
NM_003896.4(ST3GAL5):c.1024G>A (p.Gly342Ser)	ST3GAL5	G101S, G319S, G214S, G289S, G342S, G314S	Salt and pepper developmental regression syndrome	Pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000828145	2	86067500	2	85840377	828145	816446		NC_000002.12:85840376:C:T
GRCh37/hg19 2p25.3(chr2:2164149-2396499)x1	MYT1L		not provided	Pathogenic(Last reviewed: Jan 26, 2018)	no assertion criteria provided	VCV000688210	2	2164149 - 2396499			688210	675802		
GRCh37/hg19 2p25.3(chr2:2033726-2832894)x1	MYT1L		not provided	Pathogenic(Last reviewed: Mar 28, 2018)	no assertion criteria provided	VCV000685325	2	2033726 - 2832894			685325	672917		
NM_001303052.2(MYT1L):c.1585G>A (p.Gly529Arg)	MYT1L	G529R, G527R	Mental retardation, autosomal dominant 39	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000592088	2	1921010	2	1917238	592088	583083	rs1275489527	NC_000002.12:1917237:C:T
NM_001303052.2(MYT1L):c.2412del (p.Met804fs)	MYT1L	M804fs, M802fs	not provided	Pathogenic(Last reviewed: Apr 4, 2018)	criteria provided, single submitter	VCV000524075	2	1893121	2	1889349	524075	514452	rs1553297209	NC_000002.12:1889348:C:
NM_001303052.2(MYT1L):c.606del (p.Lys203fs)	MYT1L	K203fs	not provided	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000504402	2	1926935	2	1923163	504402	495388	rs1553324762	NC_000002.12:1923162:GG:G
NM_001303052.2(MYT1L):c.2554G>T (p.Glu852Ter)	MYT1L	E850*, E852*	not provided	Pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	VCV000489036	2	1891348	2	1887576	489036	481634	rs1553295440	NC_000002.12:1887575:C:A
NM_001303052.2(MYT1L):c.1068del (p.Asn356fs)	MYT1L	N356fs	not provided	Pathogenic(Last reviewed: May 18, 2015)	criteria provided, single submitter	VCV000419088	2	1926473	2	1922701	419088	405531	rs1064793635	NC_000002.12:1922700:G:
NM_001303052.2(MYT1L):c.1221_1222delinsT (p.Glu407fs)	MYT1L		not provided	Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	VCV000418814	2	1926319 - 1926320	2	1922547 - 1922548	418814	405530	rs1064793449	NC_000002.12:1922546:GC:A
NM_001303052.2(MYT1L):c.2123dup (p.Ser709fs)	MYT1L		not provided	Pathogenic(Last reviewed: Aug 17, 2016)	criteria provided, single submitter	VCV000280803	2	1895968 - 1895969	2	1892196 - 1892197	280803	264064	rs886041944	NC_000002.12:1892196:CCCCC:CCCCCC
NM_001303052.2(MYT1L):c.1705C>T (p.Arg569Ter)	MYT1L	R567*, R569*	not provided	Pathogenic(Last reviewed: Jul 18, 2016)	criteria provided, single submitter	VCV000280701	2	1915796	2	1912024	280701	264073	rs886041858	NC_000002.12:1912023:G:A
NM_001303052.2(MYT1L):c.487G>T (p.Glu163Ter)	MYT1L	E163*	not provided	Pathogenic(Last reviewed: Mar 21, 2016)	criteria provided, single submitter	VCV000280449	2	1946772	2	1943000	280449	264075	rs886041655	NC_000002.12:1942999:C:A
NM_003896.4(ST3GAL5):c.124del (p.Cys42fs)	ST3GAL5	C14fs, C19fs, C42fs	Salt and pepper developmental regression syndrome	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000856273	2	86090567	2	85863444	856273	827084		NC_000002.12:85863443:AA:A
NM_001303052.2(MYT1L):c.1678C>T (p.His560Tyr)	MYT1L	H560Y, H558Y	Mental retardation, autosomal dominant 39	Pathogenic(Last reviewed: Jan 24, 2019)	no assertion criteria provided	VCV000617493	2	1915823	2	1912051	617493	608860	rs1558371790	NC_000002.12:1912050:G:A
NM_001303052.2(MYT1L):c.2221_2230del (p.Thr741fs)	MYT1L	T739fs, T741fs	Mental retardation, autosomal dominant 39	Pathogenic(Last reviewed: Jan 18, 2019)	no assertion criteria provided	VCV000617454	2	1895862 - 1895871	2	1892090 - 1892099	617454	608802	rs1253072668	NC_000002.12:1892089:GGCAGCGCGTGG:GG
NM_003896.4(ST3GAL5):c.353del (p.Lys118fs)	ST3GAL5	K118fs, K90fs, K95fs	Salt and pepper developmental regression syndrome	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000577410	2	86075293	2	85848170	577410	560987	rs754643632	NC_000002.12:85848169:TT:T
NM_003896.4(ST3GAL5):c.147G>A (p.Trp49Ter)	ST3GAL5	W49*, W21*, W26*	Salt and pepper developmental regression syndrome	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000572904	2	86090544	2	85863421	572904	559191	rs778265926	NC_000002.12:85863420:C:T
NM_003896.4(ST3GAL5):c.369_381delinsTG (p.Lys123fs)	ST3GAL5		Salt and pepper developmental regression syndrome	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000533027	2	86075265 - 86075277	2	85848142 - 85848154	533027	518648	rs1553405470	NC_000002.12:85848141:TGTCTTGGCAAAC:CA
NM_001303052.2(MYT1L):c.760dup (p.Asp254fs)	MYT1L		Mental retardation, autosomal dominant 39	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000488449	2	1926780 - 1926781	2	1923008 - 1923009	488449	481309	rs1553324416	NC_000002.12:1923008:C:CC
NM_003896.4(ST3GAL5):c.584G>C (p.Cys195Ser)	ST3GAL5	C195S, C167S, C172S, C67S	Salt and pepper developmental regression syndrome	Pathogenic(Last reviewed: Sep 16, 2016)	no assertion criteria provided	VCV000254245	2	86075062	2	85847939	254245	248759	rs886037930	NC_000002.12:85847938:C:G
NM_001303052.2(MYT1L):c.1923T>G (p.Tyr641Ter)	MYT1L	Y639*, Y641*	Mental retardation, autosomal dominant 39	Pathogenic(Last reviewed: Aug 30, 2016)	no assertion criteria provided	VCV000208429	2	1906961	2	1903189	208429	204647	rs869320676	NC_000002.12:1903188:A:C
NM_001303052.2(MYT1L):c.2642+1G>A	MYT1L		Mental retardation, autosomal dominant 39|not provided	Pathogenic(Last reviewed: May 26, 2016)	criteria provided, single submitter	VCV000208428	2	1891259	2	1887487	208428	204646	rs869320675	NC_000002.12:1887486:C:T
NM_003590.5(CUL3):c.1377+3A>G	CUL3		Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100526	2	225368366	2	224503649	100526	106403	rs199469661	NC_000002.12:224503648:T:C
NM_003590.5(CUL3):c.1377+1G>C	CUL3		Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100525	2	225368368	2	224503651	100525	106402	rs199469660	NC_000002.12:224503650:C:G
NM_003590.4(CUL3):c.1376_1377insG (p.Thr460Aspfs)	CUL3	K459fs	Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100524	2	225368367 - 225368368	2	224503650 - 224503651	100524	106401	rs199469659	NC_000002.12:224503650:CC:CCC
NM_003590.5(CUL3):c.1376_1377+4del	CUL3	K459fs	Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100523	2	225368365 - 225368370	2	224503648 - 224503653	100523	106400	rs199469657	NC_000002.12:224503647:TTACCTTTA:TTA
NM_003590.5(CUL3):c.1376A>G (p.Lys459Arg)	CUL3	K459R, K393R, K465R	Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100522	2	225368370	2	224503653	100522	106399	rs199469658	NC_000002.12:224503652:T:C
NM_003590.5(CUL3):c.1236G>A (p.Leu412=)	CUL3	L412L	Pseudohypoaldosteronism type 2A	Pathogenic	no assertion criteria provided	VCV000100521	2	225368510	2	224503793	100521	106398	rs199469655	NC_000002.12:224503792:C:T
NM_003590.5(CUL3):c.1207-5T>A	CUL3		Pseudohypoaldosteronism type 2E|Pseudohypoaldosteronism type 2A	Pathogenic(Last reviewed: Jan 22, 2012)	no assertion criteria provided	VCV000100520	2	225368544	2	224503827	100520	106397	rs199469652	NC_000002.12:224503826:A:T
NM_003590.5(CUL3):c.1207-3C>T	CUL3		Pseudohypoaldosteronism type 2E|Pseudohypoaldosteronism type 2A	Pathogenic(Last reviewed: Jan 22, 2012)	no assertion criteria provided	VCV000100519	2	225368542	2	224503825	100519	106396	rs199469653	NC_000002.12:224503824:G:A
NM_003590.5(CUL3):c.1207-28T>G	CUL3		Pseudohypoaldosteronism type 2E|Pseudohypoaldosteronism type 2A	Pathogenic(Last reviewed: Jan 22, 2012)	no assertion criteria provided	VCV000100518	2	225368567	2	224503850	100518	106395	rs199469649	NC_000002.12:224503849:A:C
NM_003590.5(CUL3):c.1207-26A>G	CUL3		Pseudohypoaldosteronism type 2E|Pseudohypoaldosteronism type 2A	Pathogenic(Last reviewed: Jan 22, 2012)	no assertion criteria provided	VCV000100517	2	225368565	2	224503848	100517	106394	rs199469650	NC_000002.12:224503847:T:C
NM_003590.5(CUL3):c.1207-1G>A	CUL3		Pseudohypoaldosteronism type 2E|Pseudohypoaldosteronism type 2A	Pathogenic(Last reviewed: Jan 22, 2012)	no assertion criteria provided	VCV000100516	2	225368540	2	224503823	100516	106393	rs199469654	NC_000002.12:224503822:C:T
NM_003590.5(CUL3):c.1207-12T>G	CUL3		Pseudohypoaldosteronism type 2E|Pseudohypoaldosteronism type 2A	Pathogenic(Last reviewed: Jan 22, 2012)	no assertion criteria provided	VCV000100515	2	225368551	2	224503834	100515	106392	rs199469651	NC_000002.12:224503833:A:C
NM_003590.5(CUL3):c.1238A>G (p.Asp413Gly)	CUL3	D413G, D419G, D347G	Pseudohypoaldosteronism type 2A|Pseudohypoaldosteronism type 2E	Pathogenic(Last reviewed: Jan 22, 2012)	no assertion criteria provided	VCV000030323	2	225368508	2	224503791	30323	39279	rs199469656	NC_000002.12:224503790:T:C
NM_006623.4(PHGDH):c.958_968del (p.Ala320fs)	PHGDH	A320fs	Phosphoglycerate dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000848472	1	120283017 - 120283027	1	119740394 - 119740404	848472	822616		NC_000001.11:119740393:CCAGGCCCTTACCAG:CCAG
NM_006623.4(PHGDH):c.797C>T (p.Pro266Leu)	PHGDH	P266L	Phosphoglycerate dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522677	1	120279741	1	119737118	522677	513230	rs775936961	NC_000001.11:119737117:C:T
NM_006623.4(PHGDH):c.856G>C (p.Ala286Pro)	PHGDH	A286P	Neu-Laxova syndrome 1	Pathogenic(Last reviewed: Sep 4, 2014)	no assertion criteria provided	VCV000156361	1	120279800	1	119737177	156361	166141	rs587777775	NC_000001.11:119737176:G:C
NM_006623.4(PHGDH):c.793G>A (p.Glu265Lys)	PHGDH	E265K	Neu-Laxova syndrome 1	Pathogenic(Last reviewed: Sep 4, 2014)	no assertion criteria provided	VCV000156360	1	120279737	1	119737114	156360	166140	rs587777774	NC_000001.11:119737113:G:A
NM_014236.4(GNPAT):c.1937+5G>A	GNPAT		Rhizomelic chondrodysplasia punctata type 2	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000035468	1	231411249	1	231275503	35468	44137		NC_000001.11:231275502:G:A
NM_014236.4(GNPAT):c.1429_1430del (p.Met477fs)	GNPAT	M416fs, M477fs	Rhizomelic chondrodysplasia punctata type 2	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000035467	1	231406653 - 231406654	1	231270907 - 231270908	35467	44136		NC_000001.11:231270906:AT:
NM_014236.4(GNPAT):c.1575del (p.Phe525fs)	GNPAT	F464fs, F525fs	Rhizomelic chondrodysplasia punctata type 2	Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000006845	1	231408110	1	231272364	6845	21884		NC_000001.11:231272363:C:
NM_014236.4(GNPAT):c.780del (p.Asn261fs)	GNPAT	N200fs, N261fs	Rhizomelic chondrodysplasia punctata type 2	Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000006844	1	231401767	1	231266021	6844	21883		NC_000001.11:231266020:G:
NM_014236.4(GNPAT):c.631C>T (p.Arg211Cys)	GNPAT	R211C, R150C	Rhizomelic chondrodysplasia punctata type 2	Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000006842	1	231401101	1	231265355	6842	21881	rs121434440	NC_000001.11:231265354:C:T
NM_006623.4(PHGDH):c.714del (p.Ile239fs)	PHGDH	I239fs	Phosphoglycerate dehydrogenase deficiency	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000003869	1	120277986	1	119735363	3869	18908	rs730882181	NC_000001.11:119735362:GGG:GG
NM_014236.4(GNPAT):c.849_850dup (p.Tyr284fs)	GNPAT		Rhizomelic chondrodysplasia punctata type 2	Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000006843	1	231401835 - 231401836	1	231266089 - 231266090	6843	21882		NC_000001.11:231266089:TT:TTTT
NM_006623.4(PHGDH):c.1273G>A (p.Val425Met)	PHGDH	V425M	Phosphoglycerate dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 1, 2000)	no assertion criteria provided	VCV000003868	1	120285493	1	119742870	3868	18907	rs121907988	NC_000001.11:119742869:G:A
NM_006623.4(PHGDH):c.290+2T>C	PHGDH		not provided|Epileptic encephalopathy|Seizures	Pathogenic/Likely pathogenic(Last reviewed: Jul 6, 2016)	criteria provided, multiple submitters, no conflicts	VCV000280721	1	120263946	1	119721323	280721	263935	rs886041874	NC_000001.11:119721322:T:C
NM_014236.4(GNPAT):c.1280-3T>G	GNPAT		Rhizomelic chondrodysplasia punctata type 2	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000035466	1	231406501	1	231270755	35466	44135		NC_000001.11:231270754:T:G
NM_014236.4(GNPAT):c.632G>A (p.Arg211His)	GNPAT	R211H, R150H	Rhizomelic chondrodysplasia punctata type 2	Pathogenic(Last reviewed: Jan 15, 2001)	no assertion criteria provided	VCV000006841	1	231401102	1	231265356	6841	21880	rs121434439	NC_000001.11:231265355:G:A
NM_006623.4(PHGDH):c.1030C>T (p.Arg344Ter)	PHGDH	R344*	Neu-Laxova syndrome 1|Phosphoglycerate dehydrogenase deficiency	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000522743	1	120283093	1	119740470	522743	513231	rs769256568	NC_000001.11:119740469:C:T
NM_006623.4(PHGDH):c.418G>A (p.Gly140Arg)	PHGDH	G140R	Neu-Laxova syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2014)	no assertion criteria provided	VCV000139534	1	120269633	1	119727010	139534	143178	rs587777770	NC_000001.11:119727009:G:A
NM_006623.4(PHGDH):c.1129G>A (p.Gly377Ser)	PHGDH	G377S	Phosphoglycerate dehydrogenase deficiency|Phosphoglycerate dehydrogenase deficiency|Neu-Laxova syndrome 1	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000003871	1	120284440	1	119741817	3871	18910	rs267606948	NC_000001.11:119741816:G:A
NM_025000.4(DCAF17):c.289dup (p.Ile97fs)	DCAF17		Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Apr 15, 2014)	criteria provided, single submitter	VCV000216916	2	172300085 - 172300086	2	171443575 - 171443576	216916	213527	rs863224865	NC_000002.12:171443575:AAAAAA:AAAAAAA
NM_025000.4(DCAF17):c.127-3_127-1delinsAA	DCAF17		Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000031583	2	172291590 - 172291592	2	171435080 - 171435082	31583	40267		NC_000002.12:171435079:TAG:AA
NM_025000.4(DCAF17):c.341C>A (p.Ser114Ter)	DCAF17	S114*	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000031582	2	172305210	2	171448700	31582	40266	rs760978794	NC_000002.12:171448699:C:A
NM_025000.4(DCAF17):c.387G>A (p.Trp129Ter)	DCAF17	W129*	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000031580	2	172305256	2	171448746	31580	40264	rs1559264135	NC_000002.12:171448745:G:A
NM_025000.4(DCAF17):c.906G>A (p.Trp302Ter)	DCAF17	W302*	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000031581	2	172325465	2	171468955	31581	40265	rs761229686	NC_000002.12:171468954:G:A
NM_025000.4(DCAF17):c.1091+6T>G	DCAF17		Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000000533	2	172330491	2	171473981	533	15572	rs1559289651	NC_000002.12:171473980:T:G
NM_025000.4(DCAF17):c.1422+5G>T	DCAF17		Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000000532	2	172336708	2	171480198	532	15571	rs1314048356	NC_000002.12:171480197:G:T
NM_001039550.2(DNAJB2):c.352+1G>A	DNAJB2		Charcot-Marie-Tooth disease|Spinal muscular atrophy, distal, autosomal recessive, 5	Pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000217886	2	220146784	2	219282062	217886	214533	rs756614404	NC_000002.12:219282061:G:A
NM_019032.5(ADAMTSL4):c.2087C>A (p.Ser696Ter)	ADAMTSL4	S696*, S657*, S719*	not provided	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000620489	1	150530009	1	150557533	620489	611482	rs115937511	NC_000001.11:150557532:C:A
NM_019032.5(ADAMTSL4):c.2375G>A (p.Trp792Ter)	ADAMTSL4	W792*, W753*, W815*	not provided	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000489012	1	150530618	1	150558142	489012	481560	rs377384434	NC_000001.11:150558141:G:A
NM_145861.3(EDARADD):c.196C>T (p.Arg66Ter)	EDARADD	R66*, R56*	not provided	Pathogenic(Last reviewed: May 2, 2016)	criteria provided, single submitter	VCV000280481	1	236590727	1	236427427	280481	264009	rs766500689	NC_000001.11:236427426:C:T
NM_080738.4(EDARADD):c.337G>A (p.Asp113Asn)	EDARADD	D123N, D113N	ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT	Pathogenic(Last reviewed: Aug 9, 2016)	no assertion criteria provided	VCV000253092	1	236645668	1	236482368	253092	247503	rs879255629	NC_000001.11:236482367:G:A
NM_003748.4(ALDH4A1):c.1055C>T (p.Ser352Leu)	ALDH4A1	S352L, S292L	Deficiency of pyrroline-5-carboxylate reductase	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000004003	1	19203992	1	18877498	4003	19042	rs137852937	NC_000001.11:18877497:G:A
NM_080738.4(EDARADD):c.90+1G>A	EDARADD		Ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive	Pathogenic(Last reviewed: Aug 9, 2016)	no assertion criteria provided	VCV000253093	1	236572575	1	236409275	253093	247504	rs879255553	NC_000001.11:236409274:G:A
NM_080738.4(EDARADD):c.372_377del (p.Thr125_Val126del)	EDARADD		Autosomal recessive hypohidrotic ectodermal dysplasia syndrome	Pathogenic(Last reviewed: Dec 29, 2011)	no assertion criteria provided	VCV000065754	1	236645703 - 236645708	1	236482403 - 236482408	65754	76662	rs397515575	NC_000001.11:236482402:AACGGT:
NM_019032.5(ADAMTSL4):c.2008C>T (p.Arg670Ter)	ADAMTSL4	R670*, R631*, R693*		Pathogenic(Last reviewed: Aug 1, 2010)	no assertion criteria provided	VCV000039557	1	150529772	1	150557296	39557	48156	rs368482584	NC_000001.11:150557295:C:T
NM_003748.4(ALDH4A1):c.1560dup (p.Gly521fs)	ALDH4A1		Deficiency of pyrroline-5-carboxylate reductase	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000004002	1	19200975 - 19200976	1	18874481 - 18874482	4002	19041	rs779536510	NC_000001.11:18874481:AAA:AAAA
NM_002437.5(MPV17):c.191C>G (p.Pro64Arg)	MPV17	P64R	not provided|Navajo neurohepatopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000381523	2	27535635	2	27312768	381523	366592	rs375401970	NC_000002.12:27312767:G:C
NM_019032.5(ADAMTSL4):c.1785T>G (p.Tyr595Ter)	ADAMTSL4	Y595*, Y618*		Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000001349	1	150529450	1	150556974	1349	16388	rs118203985	NC_000001.11:150556973:T:G
NM_019032.5(ADAMTSL4):c.2270dup (p.Gly758fs)	ADAMTSL4		not provided|Ectopia lentis et pupillae	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	VCV000039559	1	150530505 - 150530506	1	150558029 - 150558030	39559	48158	rs747160538	NC_000001.11:150558029:GGGGGGGG:GGGGGGGGG
NM_080738.4(EDARADD):c.335T>G (p.Leu112Arg)	EDARADD	L112R, L122R	Autosomal dominant hypohidrotic ectodermal dysplasia|Ectodermal dysplasia 11a, hypohidrotic/hair/tooth type, autosomal dominant	Pathogenic(Last reviewed: Dec 29, 2011)	no assertion criteria provided	VCV000004189	1	236645666	1	236482366	4189	19228	rs121908116	NC_000001.11:236482365:T:G
NM_006623.4(PHGDH):c.1468G>A (p.Val490Met)	PHGDH	V490M	Phosphoglycerate dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003867	1	120286529	1	119743906	3867	18906	rs121907987	NC_000001.11:119743905:G:A
GRCh37/hg19 1q32.3(chr1:211618004-211660264)x1	RD3		not provided	Pathogenic(Last reviewed: Jul 31, 2017)	no assertion criteria provided	VCV000688555	1	211618004 - 211660264			688555	676147		
NM_000760.4(CSF3R):c.203_221del (p.Glu68fs)	CSF3R	E68fs	Neutropenia, severe congenital, 7, autosomal recessive	Pathogenic(Last reviewed: Dec 15, 2018)	criteria provided, single submitter	VCV000655386	1	36941118 - 36941136	1	36475517 - 36475535	655386	627822		NC_000001.11:36475516:CTGCCCCCGGGCTGAAGCTCTGC:CTGC
NM_000760.4(CSF3R):c.935_963del (p.Arg311_Trp312insTer)	CSF3R		Neutropenia, severe congenital, 7, autosomal recessive	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000649220	1	36937873 - 36937901	1	36472272 - 36472300	649220	627817		NC_000001.11:36472271:CCAGTCGCTCCAGTGGCCAGGCAGGGGCC:
NM_000760.4(CSF3R):c.799del (p.Glu267fs)	CSF3R	E267fs	Neutropenia, severe congenital, 7, autosomal recessive	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000542856	1	36938162	1	36472561	542856	515880	rs759302795	NC_000001.11:36472560:C:
NM_000760.4(CSF3R):c.1216dup (p.Val406fs)	CSF3R		Neutropenia, severe congenital, 7, autosomal recessive	Pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, single submitter	VCV000542855	1	36937102 - 36937103	1	36471501 - 36471502	542855	515878	rs890101650	NC_000001.11:36471501:CC:CCC
NM_000760.4(CSF3R):c.998-2A>T	CSF3R		Neutropenia, severe congenital, 7, autosomal recessive	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000242835	1	36937742	1	36472141	242835	243939	rs879253750	NC_000001.11:36472140:T:A
NM_000760.4(CSF3R):c.1245del (p.Thr416fs)	CSF3R	T416fs	Neutropenia, severe congenital, 7, autosomal recessive	Pathogenic(Last reviewed: Jun 12, 2014)	no assertion criteria provided	VCV000242630	1	36937074	1	36471473	242630	171705	rs606231474	NC_000001.11:36471472:CCC:CC
NM_000760.4(CSF3R):c.948_963del (p.His317fs)	CSF3R	H317fs	Neutropenia, severe congenital, 7, autosomal recessive	Pathogenic(Last reviewed: Jun 12, 2014)	no assertion criteria provided	VCV000242629	1	36937873 - 36937888	1	36472272 - 36472287	242629	171706	rs606231475	NC_000001.11:36472271:CCAGTCGCTCCAGTGGCCAG:CCAG
NM_004700.4(KCNQ4):c.261_269del (p.Tyr88_Val90del)	KCNQ4		Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Dec 7, 2017)	no assertion criteria provided	VCV000625441	1	41250024 - 41250032	1	40784352 - 40784360	625441	613748	rs1557977732	NC_000001.11:40784351:GTCTACAACGT:GT
NM_004700.4(KCNQ4):c.796G>T (p.Asp266Tyr)	KCNQ4	D266Y	Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Dec 7, 2017)	no assertion criteria provided	VCV000591002	1	41285106	1	40819434	591002	581958	rs1558014576	NC_000001.11:40819433:G:T
NM_004700.4(KCNQ4):c.140T>C (p.Leu47Pro)	KCNQ4	L47P	Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Oct 20, 2017)	no assertion criteria provided	VCV000585006	1	41249905	1	40784233	585006	576062	rs1271250198	NC_000001.11:40784232:T:C
NM_004700.4(KCNQ4):c.459del (p.Ala154fs)	KCNQ4	A154fs	Rare genetic deafness	Pathogenic(Last reviewed: Aug 14, 2013)	criteria provided, single submitter	VCV000179111	1	41283888	1	40818216	179111	172583	rs727504635	NC_000001.11:40818215:CC:C
NM_000760.4(CSF3R):c.1919C>A (p.Thr640Asn)	CSF3R	T617N, T640N	Hereditary neutrophilia	Pathogenic(Last reviewed: Aug 3, 2009)	no assertion criteria provided	VCV000016005	1	36933198	1	36467597	16005	31044	rs121918426	NC_000001.11:36467596:G:T
NM_006996.3(SLC19A2):c.515G>A (p.Gly172Asp)	SLC19A2	G172D	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness|not provided	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000005957	1	169446685	1	169477447	5957	20996	rs28937595	NC_000001.11:169477446:C:T
NM_004700.4(KCNQ4):c.2039C>T (p.Ser680Phe)	KCNQ4	S680F, S626F	Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000208373	1	41304146	1	40838474	208373	204602	rs772135867	NC_000001.11:40838473:C:T
NM_004700.3(KCNQ4):c.1044_1051delTGCCTGGC (p.Ala349Profs)	KCNQ4		Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000208372	1	41287988 - 41287995	1	40822313 - 40822320	208372	204601	rs797044972	
NM_004700.4(KCNQ4):c.891G>T (p.Arg297Ser)	KCNQ4	R297S	Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000208371	1	41285603	1	40819931	208371	204600	rs797044971	NC_000001.11:40819930:G:T
NM_004700.4(KCNQ4):c.872C>T (p.Pro291Leu)	KCNQ4	P291L	Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000208370	1	41285584	1	40819912	208370	204599	rs797044970	NC_000001.11:40819911:C:T
NM_004700.4(KCNQ4):c.871C>T (p.Pro291Ser)	KCNQ4	P291S	Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000208369	1	41285583	1	40819911	208369	204598	rs797044969	NC_000001.11:40819910:C:T
NM_004700.4(KCNQ4):c.823T>C (p.Trp275Arg)	KCNQ4	W275R	Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000208368	1	41285133	1	40819461	208368	204597	rs797044968	NC_000001.11:40819460:T:C
NM_004700.4(KCNQ4):c.808T>C (p.Tyr270His)	KCNQ4	Y270H	Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000208367	1	41285118	1	40819446	208367	204596	rs797044967	NC_000001.11:40819445:T:C
NM_004700.4(KCNQ4):c.689T>A (p.Val230Glu)	KCNQ4	V230E	Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000208365	1	41284333	1	40818661	208365	204594	rs797044965	NC_000001.11:40818660:T:A
NM_004700.4(KCNQ4):c.226_227GC[3] (p.His77fs)	KCNQ4		Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000208364	1	41249989 - 41249990	1	40784317 - 40784318	208364	204593	rs1553165199	NC_000001.11:40784317:CGCGC:CGCGCGC
NM_183059.2(RD3):c.136G>T (p.Glu46Ter)	RD3	E46*	Leber congenital amaurosis 12	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000189794	1	211654622	1	211481280	189794	187664	rs786205150	NC_000001.11:211481279:C:A
NM_183059.2(RD3):c.137_138del (p.Glu46fs)	RD3	E46fs	Leber congenital amaurosis 12	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000189793	1	211654620 - 211654621	1	211481278 - 211481279	189793	187663	rs786205149	NC_000001.11:211481277:CTC:C
NM_000760.4(CSF3R):c.922C>T (p.Arg308Cys)	CSF3R	R308C	Neutropenia, severe congenital, 7, autosomal recessive|Severe congenital neutropenia	Pathogenic(Last reviewed: Jun 1, 2013)	criteria provided, single submitter	VCV000161982	1	36937914	1	36472313	161982	171707	rs606231473	NC_000001.11:36472312:G:A
NM_004700.4(KCNQ4):c.785A>T (p.Asp262Val)	KCNQ4	D262V	Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000021427	1	41285095	1	40819423	21427	34279	rs80358275	NC_000001.11:40819422:A:T
NM_004700.4(KCNQ4):c.778G>A (p.Glu260Lys)	KCNQ4	E260K	Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000021426	1	41285088	1	40819416	21426	34278	rs80358274	NC_000001.11:40819415:G:A
NM_004700.4(KCNQ4):c.546C>G (p.Phe182Leu)	KCNQ4	F182L	Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000021424	1	41284190	1	40818518	21424	34276	rs80358273	NC_000001.11:40818517:C:G
NM_183059.2(RD3):c.180C>A (p.Tyr60Ter)	RD3	Y60*	Leber congenital amaurosis 12	Pathogenic(Last reviewed: Jun 8, 2012)	no assertion criteria provided	VCV000189791	1	211654578	1	211481236	189791	187661	rs762631020	NC_000001.11:211481235:G:T
NM_183059.2(RD3):c.296+1G>A	RD3		Leber congenital amaurosis 12	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000013121	1	211654461	1	211481119	13121	28160	rs386834260	NC_000001.11:211481118:C:T
NM_004700.4(KCNQ4):c.211del (p.Gln71fs)	KCNQ4	Q71fs	Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Feb 17, 2011)	no assertion criteria provided	VCV000006248	1	41249975	1	40784303	6248	21287	rs80358272	NC_000001.11:40784302:CC:C
NM_006912.6(RIT1):c.229G>C (p.Ala77Pro)	RIT1	A77P, A94P, A41P	Noonan syndrome|Noonan syndrome 8	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228289	1	155874530	1	155904739	228289	228269	rs869025191	NC_000001.11:155904738:C:G
NM_205768.3(ZBTB18):c.1350_1351del (p.Gln451fs)	ZBTB18	Q442fs, Q451fs	not provided	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000817434	1	244218425 - 244218426	1	244055123 - 244055124	817434	805215		NC_000001.11:244055122:CCC:C
NM_000183.3(HADHB):c.1206C>G (p.Tyr402Ter)	HADHB	Y402*, Y387*, Y380*	Mitochondrial trifunctional protein deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801656	2	26507807	2	26284939	801656	790225		NC_000002.12:26284938:C:G
NM_006352.4(ZBTB18):c.940_941insG (p.Leu314fs)	ZBTB18		Mental retardation, autosomal dominant 22	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801642	1	244218043 - 244218044	1	244054741 - 244054742	801642	789954		NC_000001.11:244054741::G
NM_205768.2(ZBTB18):c.1342dup (p.Thr448fs)	ZBTB18		not provided	Pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, single submitter	VCV000504179	1	244218417 - 244218418	1	244055115 - 244055116	504179	495076	rs1553270611	NC_000001.11:244055115:A:AA
NM_000183.3(HADHB):c.693_696dup (p.Ala233fs)	HADHB		not provided	Pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000431822	2	26502064 - 26502065	2	26279196 - 26279197	431822	425487	rs745646607	NC_000002.12:26279196:CGCT:CGCTCGCT
NM_000183.3(HADHB):c.1211dup (p.Gly404_Arg405insTer)	HADHB		not provided	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000424253	2	26507809 - 26507810	2	26284941 - 26284942	424253	405703	rs1553323072	NC_000002.12:26284941:GGG:GGGG
NM_205768.2(ZBTB18):c.800dup (p.Tyr267Ter)	ZBTB18		not provided	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000424193	1	244217875 - 244217876	1	244054573 - 244054574	424193	405132	rs1553270470	NC_000001.11:244054573:A:AA
NM_000183.3(HADHB):c.1A>G (p.Met1Val)	HADHB	M1V	not provided	Pathogenic(Last reviewed: Feb 21, 2017)	criteria provided, single submitter	VCV000418241	2	26477123	2	26254255	418241	405698	rs763333945	NC_000002.12:26254254:A:G
NM_001253852.3(AP4B1):c.530_531insA (p.Asn178fs)	AP4B1		not provided	Pathogenic(Last reviewed: Nov 8, 2015)	criteria provided, single submitter	VCV000252668	1	114443944 - 114443945	1	113901322 - 113901323	252668	246860	rs879255397	NC_000001.11:113901322::T
NM_001253852.3(AP4B1):c.114-2A>C	AP4B1		not provided	Pathogenic(Last reviewed: Nov 8, 2015)	criteria provided, single submitter	VCV000252667	1	114445486	1	113902864	252667	246861	rs879255396	NC_000001.11:113902863:T:G
NM_000183.3(HADHB):c.1059del (p.Gly354fs)	HADHB	G339fs, G354fs, G332fs	not provided	Pathogenic(Last reviewed: Jul 11, 2014)	criteria provided, single submitter	VCV000203752	2	26505916	2	26283048	203752	200010	rs796051974	NC_000002.12:26283047:TT:T
NM_205768.2(ZBTB18):c.1444C>T (p.Arg482Cys)	ZBTB18	R482C, R473C	Mental retardation, autosomal dominant 22	Pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, single submitter	VCV000548012	1	244218520	1	244055218	548012	538333	rs1553270634	NC_000001.11:244055217:C:T
NM_006352.4(ZBTB18):c.1363C>T (p.Arg455Cys)	ZBTB18	R464C, R455C	Mental retardation, autosomal dominant 22	Pathogenic(Last reviewed: Oct 4, 2017)	no assertion criteria provided	VCV000440857	1	244218466	1	244055164	440857	434502	rs750922282	NC_000001.11:244055163:C:T
NM_205768.2(ZBTB18):c.142C>T (p.Arg48Ter)	ZBTB18	R48*, R39*	Mental retardation, autosomal dominant 22	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000431091	1	244217218	1	244053916	431091	424614	rs1135401770	NC_000001.11:244053915:C:T
NM_006352.4(ZBTB18):c.556C>T (p.Arg186Ter)	ZBTB18	R186*, R195*	Mental retardation, autosomal dominant 22	Pathogenic(Last reviewed: Apr 14, 2017)	no assertion criteria provided	VCV000417741	1	244217659	1	244054357	417741	404642	rs1064792999	NC_000001.11:244054356:C:T
NM_006352.4(ZBTB18):c.572del (p.Asp190_Ser191insTer)	ZBTB18		Mental retardation, autosomal dominant 22	Pathogenic(Last reviewed: Sep 16, 2016)	criteria provided, single submitter	VCV000397517	1	244217675	1	244054373	397517	384399	rs1060499655	NC_000001.11:244054372:C:
NM_000183.3(HADHB):c.357dup (p.Ala120fs)	HADHB		Mitochondrial trifunctional protein deficiency	Pathogenic(Last reviewed: Aug 16, 2016)	no assertion criteria provided	VCV000253049	2	26499942 - 26499943	2	26277074 - 26277075	253049	247460	rs886037844	NC_000002.12:26277074:T:TT
NM_001348768.2(HECW2):c.3577T>G (p.Phe1193Val)	HECW2	F1193V, F837V	Neurodevelopmental disorder with hypotonia, seizures, and absent language	Pathogenic(Last reviewed: Jan 10, 2018)	no assertion criteria provided	VCV000242324	2	197106881	2	196242157	242324	243876	rs878854422	NC_000002.12:196242156:A:C
NM_001348768.2(HECW2):c.3988C>T (p.Arg1330Trp)	HECW2	R1330W, R974W	Neurodevelopmental disorder with hypotonia, seizures, and absent language	Pathogenic(Last reviewed: Jan 10, 2018)	no assertion criteria provided	VCV000242318	2	197090524	2	196225800	242318	243879	rs878854417	NC_000002.12:196225799:G:A
NM_205768.2(ZBTB18):c.133C>T (p.Arg45Ter)	ZBTB18	R45*, R36*	not provided	Pathogenic(Last reviewed: Feb 9, 2016)	criteria provided, single submitter	VCV000225923	1	244217209	1	244053907	225923	227733	rs1085307109	NC_000001.11:244053906:C:T
NM_000183.3(HADHB):c.1175C>T (p.Ala392Val)	HADHB	A392V, A370V, A377V	Mitochondrial trifunctional protein deficiency	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000190379	2	26507776	2	26284908	190379	188207	rs764623179	NC_000002.12:26284907:C:T
NM_006352.4(ZBTB18):c.370G>T (p.Glu124Ter)	ZBTB18	E133*, E124*	Mental retardation, autosomal dominant 22	Pathogenic(Last reviewed: Nov 6, 2013)	no assertion criteria provided	VCV000088856	1	244217473	1	244054171	88856	94425	rs398122406	NC_000001.11:244054170:G:T
NM_000183.3(HADHB):c.1364T>G (p.Val455Gly)	HADHB	V422G, V433G, V440G, V455G	Mitochondrial trifunctional protein deficiency	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000014849	2	26508414	2	26285546	14849	29888	rs267606859	NC_000002.12:26285545:T:G
HADHB, 1-BP INS, 36-BP DEL	HADHB		Mitochondrial trifunctional protein deficiency	Pathogenic(Last reviewed: Aug 1, 1997)	no assertion criteria provided	VCV000014848					14848	29887		
NM_000183.3(HADHB):c.685C>T (p.Arg229Ter)	HADHB	R229*, R214*, R207*	Mitochondrial trifunctional protein deficiency	Pathogenic(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	VCV000579455	2	26502057	2	26279189	579455	561250	rs759136382	NC_000002.12:26279188:C:T
NM_000183.3(HADHB):c.1331G>A (p.Arg444Lys)	HADHB	R411K, R422K, R429K, R444K	Mitochondrial trifunctional protein deficiency	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000014847	2	26508381	2	26285513	14847	29886	rs121913134	NC_000002.12:26285512:G:A
NM_000183.3(HADHB):c.788A>G (p.Asp263Gly)	HADHB	D263G, D248G, D241G	Mitochondrial trifunctional protein deficiency	Pathogenic(Last reviewed: May 1, 1996)	no assertion criteria provided	VCV000014844	2	26502160	2	26279292	14844	29883	rs121913131	NC_000002.12:26279291:A:G
NM_006352.4(ZBTB18):c.1364G>A (p.Arg455His)	ZBTB18	R464H, R455H	Mental retardation, autosomal dominant 22	Pathogenic(Last reviewed: Jan 18, 2019)	no assertion criteria provided	VCV000617452	1	244218467	1	244055165	617452	608800	rs1558149913	NC_000001.11:244055164:G:A
NM_000183.3(HADHB):c.254+1G>A	HADHB		not provided|Mitochondrial trifunctional protein deficiency	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000431987	2	26492866	2	26269998	431987	425486	rs776172237	NC_000002.12:26269997:G:A
NM_001348768.2(HECW2):c.3572G>A (p.Arg1191Gln)	HECW2	R1191Q, R835Q	not provided|Neurodevelopmental disorder with hypotonia, seizures, and absent language	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000242317	2	197106886	2	196242162	242317	243874	rs878854416	NC_000002.12:196242161:C:T
NM_006352.4(ZBTB18):c.916_917del (p.Arg306fs)	ZBTB18	R306fs, R315fs	Mental retardation, autosomal dominant 22|not provided	Pathogenic(Last reviewed: Apr 28, 2016)	criteria provided, single submitter	VCV000225922	1	244218019 - 244218020	1	244054717 - 244054718	225922	227734	rs1085307108	NC_000001.11:244054716:AG:
NM_001253852.3(AP4B1):c.311_312delinsC (p.Leu104fs)	AP4B1		Spastic paraplegia 47, autosomal recessive	Pathogenic(Last reviewed: Feb 19, 2014)	criteria provided, single submitter	VCV000210195	1	114445286 - 114445287	1	113902664 - 113902665	210195	206709	rs797045244	NC_000001.11:113902663:CA:G
AP4B1, 1-BP DEL, 869C	AP4B1		Spastic paraplegia 47, autosomal recessive	Pathogenic(Last reviewed: Jul 1, 2014)	no assertion criteria provided	VCV000209982					209982	206568		
NM_001253852.3(AP4B1):c.313del (p.Ala105fs)	AP4B1	A6fs, A105fs	Spastic paraplegia 47, autosomal recessive	Pathogenic(Last reviewed: Aug 8, 2013)	criteria provided, single submitter	VCV000157721	1	114445285	1	113902663	157721	167569	rs587783179	NC_000001.11:113902662:CC:C
AP4B1, 1-BP DEL, 664C	AP4B1		Spastic paraplegia 47, autosomal recessive	Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000030663					30663	39620		
AP4B1, 3-BP INS, 487TAT	AP4B1		Spastic paraplegia 47, autosomal recessive	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000030662					30662	39619		
NM_080916.3(DGUOK):c.137A>G (p.Asn46Ser)	DGUOK	N46S	Portal hypertension, noncirrhotic|MITOCHONDRIAL DNA DEPLETION SYNDROME 3|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4	Pathogenic/Likely pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000253062	2	74154174	2	73927047	253062	247473	rs763615602	NC_000002.12:73927046:A:G
NM_183059.2(RD3):c.112C>T (p.Arg38Ter)	RD3	R38*	Leber congenital amaurosis 12	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000189792	1	211654646	1	211481304	189792	187662	rs786205148	NC_000001.11:211481303:G:A
NM_004700.4(KCNQ4):c.859G>C (p.Gly287Arg)	KCNQ4	G287R	Autosomal dominant nonsyndromic deafness 2A|not provided	Pathogenic(Last reviewed: Jun 20, 2013)	no assertion criteria provided	VCV000156337	1	41285571	1	40819899	156337	166117	rs137853969	NC_000001.11:40819898:G:C
NM_004700.4(KCNQ4):c.886G>A (p.Gly296Ser)	KCNQ4	G296S	Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000006249	1	41285598	1	40819926	6249	21288	rs80358279	NC_000001.11:40819925:G:A
NM_004700.4(KCNQ4):c.212_224del (p.Gln71fs)	KCNQ4	Q71fs	Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Nov 22, 2019)	no assertion criteria provided	VCV000006245	1	41249976 - 41249988	1	40784304 - 40784316	6245	21284	rs80358271	NC_000001.11:40784303:CAGCGCTCCTCGGC:C
NM_080738.4(EDARADD):c.424G>A (p.Glu142Lys)	EDARADD	E142K, E152K	Autosomal recessive hypohidrotic ectodermal dysplasia syndrome|Ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive	Pathogenic(Last reviewed: Dec 29, 2011)	no assertion criteria provided	VCV000004188	1	236645755	1	236482455	4188	19227	rs74315309	NC_000001.11:236482454:G:A
NM_004698.4(PRPF3):c.1481C>T (p.Thr494Met)	PRPF3	T494M, T359M	not provided|Retinal dystrophy|Retinitis pigmentosa|Retinitis pigmentosa 18	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003352	1	150316692	1	150344216	3352	18391	rs121434241	NC_000001.11:150344215:C:T
NM_004482.4(GALNT3):c.484C>T (p.Arg162Ter)	GALNT3	R162*	not provided|Hyperphosphatemic familial tumoral calcinosis 1	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000007792	2	166626727	2	165770217	7792	22831	rs137853086	NC_000002.12:165770216:G:A
NM_000760.4(CSF3R):c.1640G>A (p.Trp547Ter)	CSF3R	W547*	Inherited Immunodeficiency Diseases|Neutropenia, severe congenital, 7, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000570920	1	36933759	1	36468158	570920	557045	rs138156467	NC_000001.11:36468157:C:T
NM_004700.4(KCNQ4):c.821T>A (p.Leu274His)	KCNQ4	L274H	Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000006247	1	41285131	1	40819459	6247	21286	rs80358276	NC_000001.11:40819458:T:A
NM_004700.4(KCNQ4):c.842T>C (p.Leu281Ser)	KCNQ4	L281S	Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000006246	1	41285554	1	40819882	6246	21285	rs80358278	NC_000001.11:40819881:T:C
NM_004700.4(KCNQ4):c.853G>T (p.Gly285Cys)	KCNQ4	G285C	Autosomal dominant nonsyndromic deafness 2A	Pathogenic(Last reviewed: Feb 17, 2011)	no assertion criteria provided	VCV000006244	1	41285565	1	40819893	6244	21283	rs28937588	NC_000001.11:40819892:G:T
NM_004700.4(KCNQ4):c.961G>A (p.Gly321Ser)	KCNQ4	G321S	Autosomal dominant nonsyndromic deafness 2A	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2019)	no assertion criteria provided	VCV000006243	1	41285852	1	40820180	6243	21282	rs28939710	NC_000001.11:40820179:G:A
NM_025000.4(DCAF17):c.270del (p.Lys90fs)	DCAF17	K90fs	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Sep 22, 2015)	no assertion criteria provided	VCV000212711	2	172300069	2	171443559	212711	209327	rs879253799	NC_000002.12:171443558:AAAA:AAA
NM_003896.4(ST3GAL5):c.862C>T (p.Arg288Ter)	ST3GAL5	R288*, R260*, R47*, R160*, R265*	Salt and pepper developmental regression syndrome	Pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005556	2	86071665	2	85844542	5556	20595	rs104893668	NC_000002.12:85844541:G:A
NM_001033044.4(GLUL):c.970C>A (p.Arg324Ser)	GLUL	R324S	Congenital brain dysgenesis due to glutamine synthetase deficiency	Pathogenic(Last reviewed: May 1, 2011)	no assertion criteria provided	VCV000029734	1	182353692	1	182384557	29734	38689	rs80358214	NC_000001.11:182384556:G:T
NM_001033044.4(GLUL):c.1021C>T (p.Arg341Cys)	GLUL	R341C	Congenital brain dysgenesis due to glutamine synthetase deficiency	Pathogenic(Last reviewed: Nov 3, 2005)	no assertion criteria provided	VCV000016084	1	182353641	1	182384506	16084	31123	rs80358215	NC_000001.11:182384505:G:A
NM_001033044.4(GLUL):c.970C>T (p.Arg324Cys)	GLUL	R324C	Congenital brain dysgenesis due to glutamine synthetase deficiency	Pathogenic(Last reviewed: Nov 3, 2005)	no assertion criteria provided	VCV000016083	1	182353692	1	182384557	16083	31122	rs80358214	NC_000001.11:182384556:G:A
NM_000299.3(PKP1):c.1903C>T (p.Gln635Ter)	PKP1	Q614*, Q635*	not provided	Pathogenic(Last reviewed: Oct 14, 2015)	criteria provided, single submitter	VCV000429879	1	201294074	1	201324946	429879	421198	rs1131691647	NC_000001.11:201324945:C:T
NM_016343.4(CENPF):c.8033dup (p.Asp2679fs)	CENPF		not provided	Pathogenic(Last reviewed: Dec 12, 2015)	criteria provided, single submitter	VCV000280183	1	214825101 - 214825102	1	214651758 - 214651759	280183	263998	rs886041436	NC_000001.11:214651758:T:TT
NM_016343.4(CENPF):c.7219C>T (p.Arg2407Ter)	CENPF	R2407*	not provided	Pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	VCV000280153	1	214820132	1	214646789	280153	264005	rs376076886	NC_000001.11:214646788:C:T
NM_001005337.3(PKP1):c.1233-2A>G	PKP1		Epidermolysis bullosa simplex due to plakophilin deficiency	Pathogenic(Last reviewed: Feb 14, 2020)	no assertion criteria provided	VCV000812570	1	201289393	1	201320265	812570	800818		NC_000001.11:201320264:A:G
NM_001005337.3(PKP1):c.889del (p.Arg297fs)	PKP1	R297fs	Epidermolysis bullosa simplex due to plakophilin deficiency	Pathogenic(Last reviewed: Feb 14, 2020)	no assertion criteria provided	VCV000812569	1	201286741	1	201317613	812569	800817		NC_000001.11:201317612:CC:C
NM_001005337.3(PKP1):c.2021+1G>A	PKP1		Epidermolysis bullosa simplex due to plakophilin deficiency	Pathogenic(Last reviewed: Feb 17, 2020)	no assertion criteria provided	VCV000812568	1	201294256	1	201325128	812568	800816		NC_000001.11:201325127:G:A
NM_016343.4(CENPF):c.5920dup (p.Thr1974fs)	CENPF		Stromme syndrome	Pathogenic(Last reviewed: Feb 27, 2019)	no assertion criteria provided	VCV000619138	1	214818825 - 214818826	1	214645482 - 214645483	619138	610533	rs757531591	NC_000001.11:214645482:AAAAAAAA:AAAAAAAAA
NM_016343.4(CENPF):c.9280C>T (p.Arg3094Ter)	CENPF	R3094*	Stromme syndrome	Pathogenic(Last reviewed: Aug 25, 2017)	no assertion criteria provided	VCV000224502	1	214837072	1	214663729	224502	226241	rs869312748	NC_000001.11:214663728:C:T
NM_016343.4(CENPF):c.171_199del (p.Asn57fs)	CENPF	N57fs	Stromme syndrome	Pathogenic(Last reviewed: Aug 25, 2017)	no assertion criteria provided	VCV000224501	1	214788177 - 214788205	1	214614834 - 214614862	224501	226240	rs757575602	NC_000001.11:214614833:TGAAAATGAAAAAACCGAGGGTACAAACCTGAAAA:TGAAAA
NM_016343.4(CENPF):c.8692C>T (p.Arg2898Ter)	CENPF	R2898*	Stromme syndrome	Pathogenic(Last reviewed: Mar 1, 2015)	no assertion criteria provided	VCV000190387	1	214830482	1	214657139	190387	188214	rs786205697	NC_000001.11:214657138:C:T
NM_016343.4(CENPF):c.574-2A>C	CENPF		Stromme syndrome	Pathogenic(Last reviewed: Mar 1, 2015)	no assertion criteria provided	VCV000190386	1	214793996	1	214620653	190386	188213	rs376767238	NC_000001.11:214620652:A:C
NM_001005337.3(PKP1):c.1233-2A>T	PKP1		Epidermolysis bullosa simplex due to plakophilin deficiency	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000007605	1	201289393	1	201320265	7605	22644	rs1558193923	NC_000001.11:201320264:A:T
PKP1, 28-BP DUP, NT1132	PKP1		Epidermolysis bullosa simplex due to plakophilin deficiency	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000007604					7604	22643		
NM_001005337.3(PKP1):c.910C>T (p.Gln304Ter)	PKP1	Q304*	Epidermolysis bullosa simplex due to plakophilin deficiency	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000007603	1	201286763	1	201317635	7603	22642	rs121918354	NC_000001.11:201317634:C:T
NM_016343.4(CENPF):c.2734G>T (p.Glu912Ter)	CENPF	E912*	Stromme syndrome	Pathogenic(Last reviewed: Oct 20, 2017)	no assertion criteria provided	VCV000224500	1	214814415	1	214641072	224500	226239	rs200976140	NC_000001.11:214641071:G:T
NM_016343.4(CENPF):c.1744G>T (p.Glu582Ter)	CENPF	E582*	Stromme syndrome	Pathogenic(Last reviewed: Mar 1, 2015)	no assertion criteria provided	VCV000190385	1	214813425	1	214640082	190385	188212	rs367624766	NC_000001.11:214640081:G:T
NM_001430.5(EPAS1):c.1609G>T (p.Gly537Trp)	EPAS1	G537W	Erythrocytosis, familial, 4	Pathogenic(Last reviewed: Jan 10, 2008)	no assertion criteria provided	VCV000006468	2	46607420	2	46380281	6468	21507	rs137853036	NC_000002.12:46380280:G:T
NM_001430.5(EPAS1):c.1603A>G (p.Met535Val)	EPAS1	M535V	Erythrocytosis, familial, 4	Pathogenic(Last reviewed: Apr 3, 2009)	no assertion criteria provided	VCV000006470	2	46607414	2	46380275	6470	21509	rs137853037	NC_000002.12:46380274:A:G
NM_001430.5(EPAS1):c.1609G>A (p.Gly537Arg)	EPAS1	G537R	Erythrocytosis, familial, 4	Pathogenic(Last reviewed: Apr 3, 2009)	no assertion criteria provided	VCV000006469	2	46607420	2	46380281	6469	21508	rs137853036	NC_000002.12:46380280:G:A
NM_001615.4(ACTG2):c.770G>A (p.Arg257His)	ACTG2	R257H, R214H	Chronic intestinal pseudoobstruction|Megacystis|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 16, 2012)	criteria provided, single submitter	VCV000208792	2	74141963	2	73914836	208792	205237	rs797044959	NC_000002.12:73914835:G:A
NM_002633.3(PGM1):c.87_88del (p.Phe29fs)	PGM1	F29fs	Congenital disorder of glycosylation type 1t	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000663105	1	64059246 - 64059247	1	63593575 - 63593576	663105	628208		NC_000001.11:63593574:CC:
NM_002633.3(PGM1):c.1086dup (p.Gly363fs)	PGM1		Congenital disorder of glycosylation type 1t	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000654351	1	64104407 - 64104408	1	63638736 - 63638737	654351	628210		NC_000001.11:63638736:TTTTTT:TTTTTTT
NM_002633.3(PGM1):c.1376_1377TC[1] (p.Ala461fs)	PGM1		Congenital disorder of glycosylation type 1t	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000645088	1	64117435 - 64117436	1	63651764 - 63651765	645088	628211		NC_000001.11:63651763:TCTC:TC
NM_032409.3(PINK1):c.502G>C (p.Ala168Pro)	PINK1	A168P	PINK1-Related Parkinsonism|not provided	Pathogenic(Last reviewed: Sep 22, 2015)	criteria provided, single submitter	VCV000429877	1	20964449	1	20637956	429877	421201	rs768091663	NC_000001.11:20637955:G:C
NM_002633.3(PGM1):c.661del (p.Arg221fs)	PGM1	R221fs, R24fs, R239fs	Congenital disorder of glycosylation type 1t	Pathogenic(Last reviewed: Feb 6, 2014)	no assertion criteria provided	VCV000133290	1	64097431	1	63631760	133290	137029	rs587777405	NC_000001.11:63631759:CC:C
NM_002633.3(PGM1):c.787G>T (p.Asp263Tyr)	PGM1	D263Y, D66Y, D281Y	Congenital disorder of glycosylation type 1t	Pathogenic(Last reviewed: Feb 6, 2014)	no assertion criteria provided	VCV000133289	1	64100604	1	63634933	133289	137028	rs587777404	NC_000001.11:63634932:G:T
NM_002633.3(PGM1):c.112A>T (p.Asn38Tyr)	PGM1	N38Y	Congenital disorder of glycosylation type 1t	Pathogenic(Last reviewed: Feb 6, 2014)	no assertion criteria provided	VCV000133287	1	64059271	1	63593600	133287	137026	rs587777402	NC_000001.11:63593599:A:T
NM_002633.3(PGM1):c.1547T>C (p.Leu516Pro)	PGM1	L516P, L319P, L534P	Congenital disorder of glycosylation type 1t	Pathogenic(Last reviewed: Feb 6, 2014)	no assertion criteria provided	VCV000133286	1	64120085	1	63654414	133286	137025	rs587777401	NC_000001.11:63654413:T:C
NM_002633.3(PGM1):c.361G>C (p.Gly121Arg)	PGM1	G121R, G139R	Congenital disorder of glycosylation type 1t	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000039771	1	64095210	1	63629539	39771	48370	rs398122912	NC_000001.11:63629538:G:C
NM_002633.3(PGM1):c.1145-1G>C	PGM1		Congenital disorder of glycosylation type 1t	Pathogenic(Last reviewed: Jul 23, 2009)	no assertion criteria provided	VCV000013651	1	64114187	1	63648516	13651	28690	rs587776801	NC_000001.11:63648515:G:C
NM_002633.3(PGM1):c.343A>G (p.Thr115Ala)	PGM1	T115A, T133A	Congenital disorder of glycosylation type 1t	Pathogenic(Last reviewed: Feb 6, 2014)	no assertion criteria provided	VCV000013650	1	64095192	1	63629521	13650	28689	rs121918371	NC_000001.11:63629520:A:G
NM_032409.3(PINK1):c.273del (p.Cys92fs)	PINK1	C92fs	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000664114	1	20960314	1	20633821	664114	627314		NC_000001.11:20633820:C:
NM_032409.3(PINK1):c.13C>T (p.Gln5Ter)	PINK1	Q5*	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000661098	1	20960054	1	20633561	661098	627313		NC_000001.11:20633560:C:T
NM_032409.3(PINK1):c.599del (p.Ala200fs)	PINK1	A200fs	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000581272	1	20964546	1	20638053	581272	556768	rs1557561340	NC_000001.11:20638052:C:
NM_002633.3(PGM1):c.1091del (p.Asn364fs)	PGM1	N167fs, N364fs, N382fs	Congenital disorder of glycosylation type 1t	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000579973	1	64104417	1	63638746	579973	557354	rs1557437034	NC_000001.11:63638745:AA:A
NM_002633.3(PGM1):c.649C>T (p.Arg217Ter)	PGM1	R217*, R20*, R235*	Congenital disorder of glycosylation type 1t|not provided	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000499573	1	64097420	1	63631749	499573	490997	rs770066171	NC_000001.11:63631748:C:T
NM_032409.3(PINK1):c.620del (p.Arg207fs)	PINK1	R207fs	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Jun 9, 2014)	criteria provided, single submitter	VCV000189240	1	20964567	1	20638074	189240	187107	rs756677845	NC_000001.11:20638073:G:
NM_002633.3(PGM1):c.1507C>T (p.Arg503Ter)	PGM1	R503*, R521*, R306*	Congenital disorder of glycosylation type 1t	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000039772	1	64120045	1	63654374	39772	48371	rs397515423	NC_000001.11:63654373:C:T
NM_032409.3(PINK1):c.650C>A (p.Ala217Asp)	PINK1	A217D	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000002414	1	20964597	1	20638104	2414	17453	rs74315360	NC_000001.11:20638103:C:A
NM_002633.3(PGM1):c.184G>C (p.Asp62His)	PGM1	D62H	not provided|Congenital disorder of glycosylation type 1t	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	VCV000133288	1	64059343	1	63593672	133288	137027	rs587777403	NC_000001.11:63593671:G:C
NM_080916.3(DGUOK):c.603_604GA[1] (p.Arg202fs)	DGUOK		not provided|Mitochondrial DNA depletion syndrome, hepatocerebral form due to DGUOK deficiency|Mitochondrial DNA-depletion syndrome 3, hepatocerebral|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000214288	2	74184262 - 74184263	2	73957135 - 73957136	214288	210898	rs863223949	NC_000002.12:73957134:AGAGA:AGA
NM_020184.4(CNNM4):c.613_621delinsA (p.Gly205fs)	CNNM4		Retinal dystrophy	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000867091	2	97427349 - 97427357	2	96761612 - 96761620	867091	856223		NC_000002.12:96761611:GGGCTTATG:A
NM_020184.4(CNNM4):c.1494C>A (p.Asp498Glu)	CNNM4	D498E	Jalili syndrome	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812291	2	97462840	2	96797103	812291	800477		NC_000002.12:96797102:C:A
NM_020184.4(CNNM4):c.1547-1G>A	CNNM4		Jalili syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801734	2	97463249	2	96797512	801734	790304		NC_000002.12:96797511:G:A
NM_020184.4(CNNM4):c.1312del (p.Leu438fs)	CNNM4	L438fs	Jalili syndrome	Pathogenic(Last reviewed: Feb 22, 2019)	no assertion criteria provided	VCV000635490	2	97428043	2	96762306	635490	623272		NC_000002.12:96762305:CCCCCC:CCCCC
NM_020184.4(CNNM4):c.1743C>G (p.Tyr581Ter)	CNNM4	Y581*	Jalili syndrome	Pathogenic	criteria provided, single submitter	VCV000518456	2	97464855	2	96799118	518456	509046	rs1432600424	NC_000002.12:96799117:C:G
NM_020184.4(CNNM4):c.1682-1G>C	CNNM4		Jalili syndrome	Pathogenic	no assertion criteria provided	VCV000252931	2	97464793	2	96799056	252931	247333	rs879255500	NC_000002.12:96799055:G:C
NM_020184.4(CNNM4):c.1220G>T (p.Arg407Leu)	CNNM4	R407L	Jalili syndrome	Pathogenic(Last reviewed: Aug 16, 2017)	no assertion criteria provided	VCV000627568	2	97427956	2	96762219	627568	615923		NC_000002.12:96762218:G:T
NM_020184.4(CNNM4):c.1555C>T (p.Arg519Ter)	CNNM4	R519*	Jalili syndrome	Pathogenic(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	VCV000434794	2	97463258	2	96797521	434794	428105	rs1455470131	NC_000002.12:96797520:C:T
CNNM4, 83-BP DEL, NT62	CNNM4		Jalili syndrome	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000002853					2853	17892		
NM_020184.4(CNNM4):c.2149C>T (p.Gln717Ter)	CNNM4	Q717*	Jalili syndrome	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000002852	2	97475075	2	96809338	2852	17891	rs75559353	NC_000002.12:96809337:C:T
NM_020184.4(CNNM4):c.1690C>T (p.Gln564Ter)	CNNM4	Q564*	Jalili syndrome	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000002850	2	97464802	2	96799065	2850	17889	rs80100937	NC_000002.12:96799064:C:T
NM_014704.4(CEP104):c.89del (p.Thr30fs)	CEP104	T30fs	Global developmental delay|Cerebellar ataxia|Dystonia	Pathogenic	no assertion criteria provided	VCV000812756	1	3768883	1	3852319	812756	800984		NC_000001.11:3852318:G:
NC_000001.10:g.(?_3731946)_(3768991_?)del	CEP104		Joubert syndrome 25	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000665628	1	3731946 - 3768991	1	3815382 - 3852427	665628	650546		
NM_014704.4(CEP104):c.1082_1091del (p.Pro361fs)	CEP104	P361fs	Joubert syndrome 25	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000542193	1	3753884 - 3753893	1	3837320 - 3837329	542193	515891	rs776094913	NC_000001.11:3837319:GGGAGTAACGGG:GG
NM_014704.4(CEP104):c.759T>G (p.Tyr253Ter)	CEP104	Y253*	Joubert syndrome 25	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000542192	1	3755660	1	3839096	542192	515879	rs372048855	NC_000001.11:3839095:A:C
NM_014704.4(CEP104):c.2572-2A>G	CEP104		Joubert syndrome 25	Pathogenic(Last reviewed: Feb 2, 2016)	no assertion criteria provided	VCV000221277	1	3732936	1	3816372	221277	222988	rs869025278	NC_000001.11:3816371:T:C
NM_014704.4(CEP104):c.496C>T (p.Arg166Ter)	CEP104	R166*	Joubert syndrome 25	Pathogenic(Last reviewed: Feb 2, 2016)	no assertion criteria provided	VCV000221276	1	3761541	1	3844977	221276	222987	rs374574638	NC_000001.11:3844976:G:A
NM_014704.4(CEP104):c.1328_1329insT (p.Tyr444fs)	CEP104		Joubert syndrome 25	Pathogenic(Last reviewed: Feb 2, 2016)	no assertion criteria provided	VCV000221275	1	3751645 - 3751646	1	3835081 - 3835082	221275	222986	rs869025277	NC_000001.11:3835081::A
NM_014704.4(CEP104):c.735+2T>C	CEP104		Joubert syndrome 25	Pathogenic(Last reviewed: Feb 2, 2016)	no assertion criteria provided	VCV000221274	1	3756170	1	3839606	221274	222985	rs869025276	NC_000001.11:3839605:A:G
NM_020184.4(CNNM4):c.599C>A (p.Ser200Tyr)	CNNM4	S200Y	Jalili syndrome	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000002851	2	97427335	2	96761598	2851	17890	rs79424354	NC_000002.12:96761597:C:A
NM_020184.4(CNNM4):c.971T>C (p.Leu324Pro)	CNNM4	L324P	Jalili syndrome	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000002849	2	97427707	2	96761970	2849	17888	rs74552543	NC_000002.12:96761969:T:C
NM_020184.4(CNNM4):c.707G>A (p.Arg236Gln)	CNNM4	R236Q	Jalili syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000002848	2	97427443	2	96761706	2848	17887	rs75267011	NC_000002.12:96761705:G:A
CNNM4, 1-BP DUP, 1312C	CNNM4		Jalili syndrome	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000002847					2847	17886		
NC_000001.10:g.(?_227069589)_(227083300_?)del	PSEN2		Alzheimer disease, type 4	Pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000533784	1	227069589 - 227083300	1	226881888 - 226895599	533784	514880		
NM_015627.2(LDLRAP1):c.429C>A (p.Cys143Ter)	LDLRAP1	C143*	not provided	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000620519	1	25883728	1	25557237	620519	611516	rs777648532	NC_000001.11:25557236:C:A
NM_015627.3(LDLRAP1):c.571del (p.Asp191fs)	LDLRAP1	D191fs	Familial hypercholesterolemia 4	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000860136	1	25889596	1	25563105	860136	823847		NC_000001.11:25563104:GGGG:GGG
NC_000001.11:g.(?_25543689)_(25557277_?)del	LDLRAP1		Familial hypercholesterolemia 4	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000830746	1	25870180 - 25883768			830746	818959		
NM_004431.5(EPHA2):c.759G>A (p.Trp253Ter)	EPHA2	W253*, W199*	Cataract 6, multiple types	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000665755	1	16474937	1	16148442	665755	627055		NC_000001.11:16148441:C:T
NM_015627.2(LDLRAP1):c.863C>T (p.Ser288Leu)	LDLRAP1	S288L	Familial hypercholesterolemia 4	Pathogenic(Last reviewed: Jun 19, 2019)	no assertion criteria provided	VCV000520396	1	25893419	1	25566928	520396	511000	rs753151497	NC_000001.11:25566927:C:T
NM_004431.5(EPHA2):c.2819C>T (p.Thr940Ile)	EPHA2	T940I, T886I	Cataract 6, multiple types	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000013259	1	16455935	1	16129440	13259	28298	rs137853200	NC_000001.11:16129439:G:A
NM_004431.5(EPHA2):c.2842G>T (p.Gly948Trp)	EPHA2	G948W, G894W	Cataract 6, multiple types	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000013258	1	16451799	1	16125304	13258	28297	rs137853199	NC_000001.11:16125303:C:A
NM_015627.2(LDLRAP1):c.459+2T>G	LDLRAP1		Familial hypercholesterolemia 4	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000004780	1	25883760	1	25557269	4780	19819	rs1461905374	NC_000001.11:25557268:T:G
NM_015627.3(LDLRAP1):c.74dup (p.Gly26fs)	LDLRAP1		Familial hypercholesterolemia 4	Pathogenic(Last reviewed: May 18, 2001)	no assertion criteria provided	VCV000004777	1	25870261 - 25870262	1	25543770 - 25543771	4777	19816	rs1553170279	NC_000001.11:25543770:GG:GGG
NM_032409.3(PINK1):c.736C>T (p.Arg246Ter)	PINK1	R246*	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000002407	1	20966445	1	20639952	2407	17446	rs74315357	NC_000001.11:20639951:C:T
NM_018062.4(FANCL):c.296_297del (p.Gln99fs)	FANCL	Q99fs	Fanconi anemia, complementation group A	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801717	2	58449154 - 58449155	2	58222019 - 58222020	801717	790287		NC_000002.12:58222018:TT:
NM_001114636.1(FANCL):c.430del (p.Ser144fs)	FANCL	S144fs	Fanconi anemia, complementation group L	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000209077	2	58431306	2	58204171	209077	205672	rs869320685	NC_000002.12:58204170:AA:A
NM_001114636.1(FANCL):c.268del (p.Leu90fs)	FANCL	L90fs	Fanconi anemia, complementation group L	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000209076	2	58453868	2	58226733	209076	205671	rs869320684	NC_000002.12:58226732:G:
FANCL, 4-BP DUP, 1095AATT	FANCL		Fanconi anemia, complementation group L	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000030702					30702	39659		
FANCL, 3-BP DEL, 1007TAT	FANCL		Fanconi anemia, complementation group L	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000030701					30701	39658		
NM_015627.2(LDLRAP1):c.432_433insA (p.Ala145fs)	LDLRAP1		Familial hypercholesterolemia 4	Pathogenic(Last reviewed: May 18, 2001)	no assertion criteria provided	VCV000004774	1	25883731 - 25883732	1	25557240 - 25557241	4774	19813	rs1557703339	NC_000001.11:25557240::A
NM_015627.2(LDLRAP1):c.65G>A (p.Trp22Ter)	LDLRAP1	W22*	Familial hypercholesterolemia 4	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000004773	1	25870254	1	25543763	4773	19812	rs121908324	NC_000001.11:25543762:G:A
NM_018062.4(FANCL):c.36C>A (p.Cys12Ter)	FANCL	C12*	Fanconi anemia	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000841734	2	58468413	2	58241278	841734	826859		NC_000002.12:58241277:G:T
NM_015627.3(LDLRAP1):c.431dup (p.His144fs)	LDLRAP1		Familial hypercholesterolemia 4	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000662264	1	25883729 - 25883730	1	25557238 - 25557239	662264	627723		NC_000001.11:25557238:A:AA
NM_001114636.1(FANCL):c.40dup (p.Leu14fs)	FANCL		Fanconi anemia	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000575609	2	58468408 - 58468409	2	58241273 - 58241274	575609	558249	rs761039364	NC_000002.12:58241273:GGGGG:GGGGGG
NM_001114636.1(FANCL):c.211C>T (p.Gln71Ter)	FANCL	Q71*	Fanconi anemia	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000526347	2	58456954	2	58229819	526347	518505	rs753105795	NC_000002.12:58229818:G:A
NM_001114636.1(FANCL):c.426_438del (p.Asp142fs)	FANCL	D142fs	Fanconi anemia	Pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, single submitter	VCV000241250	2	58431298 - 58431310	2	58204163 - 58204175	241250	238967	rs878855046	NC_000002.12:58204162:TCTACCAGAAGCATCT:TCT
EPHA2, IVS16, G-A, -9	EPHA2		Cataract 6, multiple types	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000013261					13261	28300		
EPHA2, 2-BP DEL, 2915TG	EPHA2		Cataract 6, multiple types	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000013260					13260	28299		
NM_004153.4(ORC1):c.314G>A (p.Arg105Gln)	ORC1	R105Q	Meier-Gorlin syndrome|Meier-Gorlin syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000030232	1	52863445	1	52397773	30232	39188	rs143141689	NC_000001.11:52397772:C:T
NM_004341.5(CAD):c.571C>T (p.Arg191Ter)	CAD	R191*	Epileptic encephalopathy, early infantile, 50	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801658	2	27445462	2	27222594	801658	790227		NC_000002.12:27222593:C:T
NM_013296.5(GPSM2):c.138C>A (p.Phe46Leu)	GPSM2	F46L	Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560890	1	109439567	1	108896945	560890	551992	rs755804651	NC_000001.11:108896944:C:A
NM_004341.5(CAD):c.5296_5308del (p.Phe1766fs)	CAD	F1766fs, F1703fs	not provided	Pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, single submitter	VCV000430523	2	27462237 - 27462249	2	27239369 - 27239381	430523	421387	rs1019263242	NC_000002.12:27239368:GCCCTTCTCCAAGGCCC:GCCC
NM_004341.5(CAD):c.2617_2620del (p.Asp873fs)	CAD	D810fs, D873fs	not provided	Pathogenic(Last reviewed: Apr 3, 2017)	criteria provided, single submitter	VCV000426813	2	27455062 - 27455065	2	27232194 - 27232197	426813	414884	rs1085307810	NC_000002.12:27232193:CAGACA:CA
NM_001692.4(ATP6V1B1):c.1123del (p.Arg375fs)	ATP6V1B1	R375fs	not provided	Pathogenic(Last reviewed: Mar 29, 2017)	criteria provided, single submitter	VCV000424584	2	71190764	2	70963634	424584	406006	rs1064797052	NC_000002.12:70963633:A:
NM_013296.5(GPSM2):c.1600+3_1600+6del	GPSM2		not provided	Pathogenic(Last reviewed: Jul 22, 2015)	criteria provided, single submitter	VCV000419262	1	109465197 - 109465200	1	108922575 - 108922578	419262	404877	rs750981446	NC_000001.11:108922574:AAGTAAGT:AAGT
NM_013296.5(GPSM2):c.1093C>T (p.Arg365Ter)	GPSM2	R365*	not provided	Pathogenic(Last reviewed: Jul 22, 2015)	criteria provided, single submitter	VCV000419261	1	109446777	1	108904155	419261	404876	rs367682612	NC_000001.11:108904154:C:T
NM_013296.5(GPSM2):c.977G>A (p.Trp326Ter)	GPSM2	W326*	Autosomal recessive non-syndromic sensorineural deafness type DFNB	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402258	1	109445771	1	108903149	402258	389218	rs1060499797	NC_000001.11:108903148:G:A
NM_013296.5(GPSM2):c.1501del (p.Ser501fs)	GPSM2	S501fs	Chudley-McCullough syndrome	Pathogenic(Last reviewed: Jan 1, 2020)	criteria provided, single submitter	VCV000864860	1	109465097	1	108922475	864860	855104		NC_000001.11:108922474:AAA:AA
NM_001692.4(ATP6V1B1):c.235C>T (p.Gln79Ter)	ATP6V1B1	Q79*	not provided	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000852126	2	71185236	2	70958106	852126	826920		NC_000002.12:70958105:C:T
NM_001692.4(ATP6V1B1):c.607C>T (p.Gln203Ter)	ATP6V1B1	Q203*	not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000845388	2	71188072	2	70960942	845388	826923		NC_000002.12:70960941:C:T
NC_000002.12:g.(?_70959008)_(70961703_?)del	ATP6V1B1		not provided	Pathogenic(Last reviewed: Sep 1, 2019)	criteria provided, single submitter	VCV000830934	2	71186138 - 71188833			830934	819267		
NM_001692.4(ATP6V1B1):c.175-1G>C	ATP6V1B1		Nephrocalcinosis|Postaxial polydactyly type A1	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000638151	2	71185175	2	70958045	638151	625971		NC_000002.12:70958044:G:C
NM_001692.4(ATP6V1B1):c.497del (p.Thr166fs)	ATP6V1B1	T166fs	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562411	2	71187120	2	70959990	562411	553595	rs782152033	NC_000002.12:70959989:C:
NM_013296.5(GPSM2):c.485del (p.Pro162fs)	GPSM2	P162fs	not provided	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000500059	1	109440649	1	108898027	500059	491483	rs766556930	NC_000001.11:108898026:CCC:CC
NM_013296.5(GPSM2):c.1063-1G>T	GPSM2		Rare genetic deafness	Pathogenic(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	VCV000228354	1	109446746	1	108904124	228354	228256	rs773068151	NC_000001.11:108904123:G:T
NM_004341.5(CAD):c.6071G>A (p.Arg2024Gln)	CAD	R2024Q, R1961Q	Epileptic encephalopathy, early infantile, 50	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000203466	2	27464966	2	27242098	203466	199877		NC_000002.12:27242097:G:A
NM_004341.5(CAD):c.1843-1G>A	CAD		Epileptic encephalopathy, early infantile, 50	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000203465	2	27448998	2	27226130	203465	199876	rs769567624	NC_000002.12:27226129:G:A
GPSM2, 1-BP DEL, 1473G	GPSM2		Chudley-McCullough syndrome	Pathogenic(Last reviewed: Jun 8, 2012)	no assertion criteria provided	VCV000035491					35491	44164		
ATP6V1B1, IVS12DS, G-C, +1	ATP6V1B1		Renal tubular acidosis, distal, with progressive deafness	Pathogenic(Last reviewed: Oct 15, 2008)	no assertion criteria provided	VCV000012230					12230	27269		
NM_001692.4(ATP6V1B1):c.585+1G>A	ATP6V1B1		Renal tubular acidosis, distal, with progressive deafness	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000012227	2	71187209	2	70960079	12227	27266		NC_000002.12:70960078:G:A
ATP6V1B1, 1-BP DEL	ATP6V1B1		Renal tubular acidosis, distal, with progressive deafness	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000012226					12226	27265		
NM_001692.4(ATP6V1B1):c.91C>T (p.Arg31Ter)	ATP6V1B1	R31*	Renal tubular acidosis, distal, with progressive deafness	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000012225	2	71163175	2	70936045	12225	27264	rs121964879	NC_000002.12:70936044:C:T
NM_004341.5(CAD):c.5365C>T (p.Arg1789Ter)	CAD	R1789*, R1726*	Epileptic encephalopathy, early infantile, 50	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000374831	2	27462310	2	27239442	374831	361736	rs62130681	NC_000002.12:27239441:C:T
NM_013296.5(GPSM2):c.459_460del (p.Ala154fs)	GPSM2	A154fs	Rare genetic deafness	Pathogenic(Last reviewed: Oct 19, 2014)	criteria provided, single submitter	VCV000180034	1	109440625 - 109440626	1	108898003 - 108898004	180034	172467	rs727505300	NC_000001.11:108898002:TG:
NM_013296.5(GPSM2):c.1684C>T (p.Gln562Ter)	GPSM2	Q562*	Chudley-McCullough syndrome	Pathogenic(Last reviewed: Jun 8, 2012)	no assertion criteria provided	VCV000030781	1	109466705	1	108924083	30781	39738	rs387907010	NC_000001.11:108924082:C:T
NM_013296.5(GPSM2):c.1062+1G>T	GPSM2		not specified|Chudley-McCullough syndrome	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000035494	1	109445857	1	108903235	35494	44167	rs777695770	NC_000001.11:108903234:G:T
NM_013296.5(GPSM2):c.1661C>A (p.Ser554Ter)	GPSM2	S554*	Chudley-McCullough syndrome|not provided	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000035493	1	109466682	1	108924060	35493	44166	rs145191476	NC_000001.11:108924059:C:A
NM_004431.5(EPHA2):c.2913_2914TG[1] (p.Val972fs)	EPHA2		Cataract 6, multiple types	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000849920	1	16451725 - 16451726	1	16125230 - 16125231	849920	822930		NC_000001.11:16125229:CACA:CA
NM_015627.2(LDLRAP1):c.71del (p.Gly24fs)	LDLRAP1	G24fs	not provided|Familial hypercholesterolemia 4	Pathogenic/Likely pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000468290	1	25870254	1	25543763	468290	447723	rs1201229554	NC_000001.11:25543762:GGGGGGG:GGGGGG
NM_004431.5(EPHA2):c.2826-9G>A	EPHA2		Cataract 6, multiple types|not provided	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280146	1	16451824	1	16125329	280146	263955	rs886041412	NC_000001.11:16125328:C:T
NM_015627.2(LDLRAP1):c.406C>T (p.Gln136Ter)	LDLRAP1	Q136*	Familial hypercholesterolemia 4	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000004775	1	25883705	1	25557214	4775	19814	rs121908325	NC_000001.11:25557213:C:T
NM_001692.4(ATP6V1B1):c.1248+1G>C	ATP6V1B1		Renal tubular acidosis with progressive nerve deafness	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000555327	2	71191673	2	70964543	555327	542147	rs1553420702	NC_000002.12:70964542:G:C
NM_004341.5(CAD):c.98T>G (p.Met33Arg)	CAD	M33R	not provided|Epileptic encephalopathy, early infantile, 50	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000374829	2	27440760	2	27217892	374829	361734	rs751610198	NC_000002.12:27217891:T:G
NM_001692.4(ATP6V1B1):c.1037C>G (p.Pro346Arg)	ATP6V1B1	P346R	not provided|Renal tubular acidosis with progressive nerve deafness	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280139	2	71190419	2	70963289	280139	264108	rs781838938	NC_000002.12:70963288:C:G
NM_013296.5(GPSM2):c.379C>T (p.Arg127Ter)	GPSM2	R127*	Chudley-McCullough syndrome|Autosomal recessive non-syndromic sensorineural deafness type DFNB	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000001823	1	109440214	1	108897592	1823	16862	rs267606854	NC_000001.11:108897591:C:T
NM_007375.3(TARDBP):c.1043G>T (p.Gly348Val)	TARDBP	G348V	Motor neuron disease	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, single submitter	VCV000266064	1	11082509	1	11022452	266064	260865	rs1131690782	NC_000001.11:11022451:G:T
NM_007375.3(TARDBP):c.787A>G (p.Lys263Glu)	TARDBP	K263E	FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED	Pathogenic(Last reviewed: Sep 15, 2009)	no assertion criteria provided	VCV000005238	1	11082253	1	11022196	5238	20277	rs267607102	NC_000001.11:11022195:A:G
NM_007375.3(TARDBP):c.1153T>G (p.Trp385Gly)	TARDBP	W385G	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000190400	1	11082619	1	11022562	190400	188226	rs797044595	NC_000001.11:11022561:T:G
NM_007375.3(TARDBP):c.800A>G (p.Asn267Ser)	TARDBP	N267S	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000021482	1	11082266	1	11022209	21482	34334	rs80356718	NC_000001.11:11022208:A:G
NM_007375.3(TARDBP):c.1147A>G (p.Ile383Val)	TARDBP	I383V	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000021476	1	11082613	1	11022556	21476	34328	rs80356740	NC_000001.11:11022555:A:G
NM_007375.3(TARDBP):c.881G>T (p.Gly294Val)	TARDBP	G294V	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Apr 23, 2009)	no assertion criteria provided	VCV000021484	1	11082347	1	11022290	21484	34336	rs80356721	NC_000001.11:11022289:G:T
NM_007375.3(TARDBP):c.*83T>C	TARDBP		Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Apr 23, 2009)	no assertion criteria provided	VCV000021465	1	11082794	1	11022737	21465	34317	rs80356744	NC_000001.11:11022736:T:C
NM_007375.3(TARDBP):c.1028A>G (p.Gln343Arg)	TARDBP	Q343R	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000005235	1	11082494	1	11022437	5235	20274	rs80356731	NC_000001.11:11022436:A:G
NM_007375.3(TARDBP):c.991C>A (p.Gln331Lys)	TARDBP	Q331K	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Mar 21, 2008)	no assertion criteria provided	VCV000005229	1	11082457	1	11022400	5229	20268	rs80356727	NC_000001.11:11022399:C:A
NM_032409.3(PINK1):c.774C>A (p.Tyr258Ter)	PINK1	Y258*	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000631591	1	20966483	1	20639990	631591	619987	rs756783990	NC_000001.11:20639989:C:A
NM_001692.4(ATP6V1B1):c.469C>T (p.Arg157Cys)	ATP6V1B1	R157C	not provided	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000850234	2	71187092	2	70959962	850234	826921		NC_000002.12:70959961:C:T
NM_001692.4(ATP6V1B1):c.1356del (p.Phe452fs)	ATP6V1B1	F452fs	not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000848844	2	71191971	2	70964841	848844	826926		NC_000002.12:70964840:TTT:TT
NM_001692.4(ATP6V1B1):c.242T>C (p.Leu81Pro)	ATP6V1B1	L81P	Renal tubular acidosis, distal, with progressive deafness|Nephrolithiasis|Nephrocalcinosis	Pathogenic/Likely pathogenic(Last reviewed: Sep 8, 2017)	no assertion criteria provided	VCV000012228	2	71185243	2	70958113	12228	27267	rs121964880	NC_000002.12:70958112:T:C
NM_007375.3(TARDBP):c.943G>A (p.Ala315Thr)	TARDBP	A315T	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000005236	1	11082409	1	11022352	5236	20275	rs80356726	NC_000001.11:11022351:G:A
NM_007375.3(TARDBP):c.881G>C (p.Gly294Ala)	TARDBP	G294A	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000005230	1	11082347	1	11022290	5230	20269	rs80356721	NC_000001.11:11022289:G:C
NM_002857.3(PEX19):c.775C>T (p.Gln259Ter)	PEX19	Q259*	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 20, 2013)	criteria provided, single submitter	VCV000225039	1	160249632	1	160279842	225039	226867	rs869312934	NC_000001.11:160279841:G:A
NM_015627.3(LDLRAP1):c.603dup (p.Ser202fs)	LDLRAP1		Familial hypercholesterolemia 4	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000004781	1	25889626 - 25889627	1	25563135 - 25563136	4781	19820	rs781585299	NC_000001.11:25563135:CCCCC:CCCCCC
NM_007375.3(TARDBP):c.883G>A (p.Gly295Ser)	TARDBP	G295S	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000021485	1	11082349	1	11022292	21485	34337	rs80356723	NC_000001.11:11022291:G:A
NM_007375.3(TARDBP):c.*697G>A	TARDBP		Amyotrophic lateral sclerosis type 10|FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000005239	1	11083408	1	11023351	5239	20278	rs387906334	NC_000001.11:11023350:G:A
NM_002618.4(PEX13):c.465T>G (p.Tyr155Ter)	PEX13	Y155*	Peroxisome biogenesis disorder 11A	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000582828	2	61258926	2	61031791	582828	558251	rs369851185	NC_000002.12:61031790:T:G
NM_002618.4(PEX13):c.508C>T (p.Arg170Ter)	PEX13	R170*	Peroxisome biogenesis disorder 11A	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000575270	2	61258969	2	61031834	575270	558624	rs553968959	NC_000002.12:61031833:C:T
NM_002618.4(PEX13):c.586C>T (p.Gln196Ter)	PEX13	Q196*	Peroxisome biogenesis disorder 11A	Pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	VCV000573201	2	61259047	2	61031912	573201	561861	rs1559035738	NC_000002.12:61031911:C:T
NM_002618.4(PEX13):c.937T>G (p.Trp313Gly)	PEX13	W313G	Peroxisome biogenesis disorder 11B	Pathogenic(Last reviewed: Aug 13, 2018)	no assertion criteria provided	VCV000375270	2	61275630	2	61048495	375270	362041	rs61752113	NC_000002.12:61048494:T:G
PEX13, 14-BP DEL, EXON 2	PEX13		Peroxisome biogenesis disorder 11A	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000030227					30227	39183		
PEX13, 147-KB DEL	PEX13		Peroxisome biogenesis disorder 11A	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000030226					30226	39182		
NM_002618.4(PEX13):c.702G>A (p.Trp234Ter)	PEX13	W234*	Peroxisome biogenesis disorder 11A	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	VCV000007703	2	61259163	2	61032028	7703	22742	rs104893661	NC_000002.12:61032027:G:A
NM_001692.4(ATP6V1B1):c.943C>T (p.Arg315Ter)	ATP6V1B1	R315*	not provided|Renal tubular acidosis with progressive nerve deafness	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000554499	2	71190325	2	70963195	554499	542319	rs145536062	NC_000002.12:70963194:C:T
NM_002618.4(PEX13):c.977T>C (p.Ile326Thr)	PEX13	I326T	Peroxisome biogenesis disorder 11B	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000007704	2	61275670	2	61048535	7704	22743	rs61752115	NC_000002.12:61048534:T:C
NM_001105.5(ACVR1):c.617G>A (p.Arg206His)	ACVR1	R206H	not provided|Progressive myositis ossificans	Pathogenic(Last reviewed: Jan 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000018309	2	158630626	2	157774114	18309	33348	rs121912678	NC_000002.12:157774113:C:T
GRCh37/hg19 1q42.3(chr1:235584727-235591045)x1	TBCE		not provided	Pathogenic(Last reviewed: May 1, 2018)	no assertion criteria provided	VCV000685753	1	235584727 - 235591045			685753	673345		
NM_018122.5(DARS2):c.223C>T (p.Arg75Ter)	DARS2	R75*	not provided	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000597308	1	173795920	1	173826782	597308	588369	rs1557852998	NC_000001.11:173826781:C:T
NM_018122.5(DARS2):c.1272_1273delinsC (p.Glu425fs)	DARS2		not provided	Pathogenic(Last reviewed: Mar 2, 2018)	criteria provided, single submitter	VCV000503692	1	173819545 - 173819546	1	173850407 - 173850408	503692	495205	rs1553204327	NC_000001.11:173850406:GG:C
NM_018122.5(DARS2):c.1196del (p.Ile399fs)	DARS2	I399fs	Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801580	1	173819469	1	173850331	801580	789886		NC_000001.11:173850330:T:
Single allele	TBCE			Pathogenic(Last reviewed: Apr 8, 2016)	criteria provided, single submitter	VCV000402240	1	235575072 - 235583424			402240	389211		
NM_003193.5(TBCE):c.464T>A (p.Ile155Asn)	TBCE	I155N, I42N	Encephalopathy, progressive, with amyotrophy and optic atrophy	Pathogenic(Last reviewed: Nov 29, 2016)	no assertion criteria provided	VCV000372201	1	235590458	1	235427143	372201	359106	rs780472451	NC_000001.11:235427142:T:A
NM_003193.5(TBCE):c.924del (p.Ser308_Leu309insTer)	TBCE		Encephalopathy, progressive, with amyotrophy and optic atrophy	Pathogenic(Last reviewed: Nov 29, 2016)	no assertion criteria provided	VCV000372200	1	235599883	1	235436568	372200	359105	rs750781063	NC_000001.11:235436567:CC:C
NM_003193.5(TBCE):c.1113T>A (p.Cys371Ter)	TBCE	C371*, C422*, C258*		Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000005292	1	235600786	1	235437471	5292	20331	rs121908384	NC_000001.11:235437470:T:A
NM_145038.5(DRC1):c.1325del (p.Asn442fs)	DRC1	N442fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000837206	2	26667744	2	26444876	837206	826129		NC_000002.12:26444875:AA:A
NM_145038.5(DRC1):c.109dup (p.Gln37fs)	DRC1		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000663966	2	26624964 - 26624965	2	26402096 - 26402097	663966	629768		NC_000002.12:26402096:CC:CCC
NC_000002.11:g.(?_26663226)_(26667244_?)del	DRC1		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000659594	2	26663226 - 26667244	2	26440358 - 26444376	659594	650749		
NM_018122.5(DARS2):c.20T>A (p.Leu7Ter)	DARS2	L7*	Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000522973	1	173794387	1	173825249	522973	513498	rs1553200766	NC_000001.11:173825248:T:A
NM_018122.5(DARS2):c.1825C>T (p.Arg609Trp)	DARS2	R609W, R558W	Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome	Pathogenic(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000030863	1	173826730	1	173857592	30863	39820	rs200670286	NC_000001.11:173857591:C:T
NM_018122.5(DARS2):c.228-22T>A	DARS2		Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000030862	1	173797449	1	173828311	30862	39819	rs1557853625	NC_000001.11:173828310:T:A
NM_003193.5(TBCE):c.66_67del (p.Val23fs)	TBCE	V23fs		Pathogenic(Last reviewed: Sep 5, 2006)	no assertion criteria provided	VCV000005291	1	235543430 - 235543431	1	235380115 - 235380116	5291	20330		NC_000001.11:235380114:AG:
NM_018122.5(DARS2):c.1877T>A (p.Leu626Gln)	DARS2	L626Q, L575Q	Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000001067	1	173826782	1	173857644	1067	16106	rs121918213	NC_000001.11:173857643:T:A
NM_018122.5(DARS2):c.1837C>T (p.Leu613Phe)	DARS2	L613F, L562F	Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000001066	1	173826742	1	173857604	1066	16105	rs121918212	NC_000001.11:173857603:C:T
NM_018122.5(DARS2):c.1273G>T (p.Glu425Ter)	DARS2	E425*	Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000001065	1	173819546	1	173850408	1065	16104	rs121918211	NC_000001.11:173850407:G:T
NM_018122.5(DARS2):c.536G>A (p.Arg179His)	DARS2	R179H	Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000001064	1	173802557	1	173833419	1064	16103	rs121918210	NC_000001.11:173833418:G:A
NM_018122.5(DARS2):c.133A>G (p.Ser45Gly)	DARS2	S45G	Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000001063	1	173795830	1	173826692	1063	16102	rs121918209	NC_000001.11:173826691:A:G
NM_018122.5(DARS2):c.787C>T (p.Arg263Ter)	DARS2	R263*	Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000001059	1	173807344	1	173838206	1059	16098	rs121918206	NC_000001.11:173838205:C:T
NM_018122.5(DARS2):c.1876C>G (p.Leu626Val)	DARS2	L626V, L575V	Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000001058	1	173826781	1	173857643	1058	16097	rs121918205	NC_000001.11:173857642:C:G
NM_013296.5(GPSM2):c.1492C>T (p.Arg498Ter)	GPSM2	R498*	not provided|Rare genetic deafness|GPSM2-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000504591	1	109465090	1	108922468	504591	496561	rs370907055	NC_000001.11:108922467:C:T
NM_001692.4(ATP6V1B1):c.785+1G>A	ATP6V1B1		Rare genetic deafness|not provided	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000179259	2	71188824	2	70961694	179259	178267	rs727504746	NC_000002.12:70961693:G:A
NM_018122.5(DARS2):c.396+2T>G	DARS2		not provided|Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449386	1	173799901	1	173830763	449386	442667	rs759123043	NC_000001.11:173830762:T:G
NM_145038.5(DRC1):c.2056A>T (p.Lys686Ter)	DRC1	K686*, Q118*	Ciliary dyskinesia, primary, 21|Kartagener syndrome	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000055839	2	26677651	2	26454783	55839	70497	rs587776997	NC_000002.12:26454782:A:T
PEX14, 41-KB DEL	PEX14		Peroxisome biogenesis disorder 13A	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000007702					7702	22741		
NM_004565.3(PEX14):c.553C>T (p.Gln185Ter)	PEX14	Q185*	Peroxisome biogenesis disorder 13A	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000007701	1	10684462	1	10624405	7701	22740	rs61752116	NC_000001.11:10624404:C:T
NM_000447.3(PSEN2):c.254C>T (p.Ala85Val)	PSEN2	A85V	not provided|Alzheimer disease, type 4	Pathogenic(Last reviewed: Apr 22, 2008)	no assertion criteria provided	VCV000008853	1	227071518	1	226883817	8853	23892	rs63750048	NC_000001.11:226883816:C:T
NM_000447.3(PSEN2):c.365C>G (p.Thr122Arg)	PSEN2	T122R	not provided|Alzheimer disease, type 4	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000008851	1	227073247	1	226885546	8851	23890	rs28936380	NC_000001.11:226885545:C:G
NM_000447.3(PSEN2):c.1289C>T (p.Thr430Met)	PSEN2	T430M, T429M	not provided|Alzheimer disease, type 4	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000008848	1	227083222	1	226895521	8848	23887	rs63750666	NC_000001.11:226895520:C:T
NM_000447.3(PSEN2):c.715A>G (p.Met239Val)	PSEN2	M239V	Alzheimer disease, type 4|not provided	Pathogenic(Last reviewed: Aug 31, 1995)	no assertion criteria provided	VCV000008846	1	227076678	1	226888977	8846	23885	rs28936379	NC_000001.11:226888976:A:G
NM_018122.5(DARS2):c.455G>T (p.Cys152Phe)	DARS2	C152F	Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|not provided	Pathogenic(Last reviewed: Dec 6, 2017)	no assertion criteria provided	VCV000001061	1	173800731	1	173831593	1061	16100	rs121918208	NC_000001.11:173831592:G:T
GRCh37/hg19 2q31.1(chr2:172644081-172644457)	SLC25A12		Hypomyelination, global cerebral	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000813326	2	172644081 - 172644457			813326	801574		
NM_003705.5(SLC25A12):c.1058G>A (p.Arg353Gln)	SLC25A12	R353Q	Hypomyelination, global cerebral	Pathogenic(Last reviewed: Aug 1, 2016)	no assertion criteria provided	VCV000253136	2	172669962	2	171813452	253136	247548	rs886037851	NC_000002.12:171813451:C:T
NM_003705.5(SLC25A12):c.1769A>G (p.Gln590Arg)	SLC25A12	Q590R	Hypomyelination, global cerebral	Pathogenic(Last reviewed: Jul 30, 2009)	no assertion criteria provided	VCV000006148	2	172644147	2	171787637	6148	21187	rs121434396	NC_000002.12:171787636:T:C
NM_022552.5(DNMT3A):c.2469dup (p.Ile824fs)	DNMT3A		not provided	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000817820	2	25459813 - 25459814	2	25236944 - 25236945	817820	805301		NC_000002.12:25236944:CC:CCC
NM_022552.5(DNMT3A):c.2162_2168del (p.Lys721fs)	DNMT3A	K498fs, K532fs, K721fs, K569fs	not provided	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000817110	2	25463514 - 25463520	2	25240645 - 25240651	817110	805302		NC_000002.12:25240644:AGGCCCT:
GRCh37/hg19 2p24.3(chr2:15338744-15670360)x1	NBAS		not provided	Pathogenic(Last reviewed: Jul 12, 2018)	no assertion criteria provided	VCV000688670	2	15338744 - 15670360			688670	676262		
GRCh37/hg19 2p23.3(chr2:25464105-25581265)x1	DNMT3A		not provided	Pathogenic(Last reviewed: May 10, 2017)	no assertion criteria provided	VCV000686121	2	25464105 - 25581265			686121	673713		
NM_153759.3(DNMT3A):c.1300del (p.Tyr434fs)	DNMT3A	Y434fs, Y471fs, Y623fs, Y400fs	Tatton-Brown-rahman syndrome	Pathogenic	no assertion criteria provided	VCV000631520	2	25466836	2	25243967	631520	619907	rs1553412022	NC_000002.12:25243966:AAA:AA
NM_175629.2(DNMT3A):c.617G>A (p.Trp206Ter)	DNMT3A	W206*	not provided	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000620247	2	25497832	2	25274963	620247	611568	rs1558697970	NC_000002.12:25274962:C:T
NM_015909.4(NBAS):c.6840G>A (p.Thr2280=)	NBAS		Infantile liver failure syndrome 2	Pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	VCV000617879	2	15319112	2	15178988	617879	609276	rs776597537	NC_000002.12:15178987:C:T
NM_015909.4(NBAS):c.1501C>T (p.Arg501Ter)	NBAS	R501*	Infantile liver failure syndrome 2	Pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	VCV000617878	2	15614289	2	15474165	617878	609275	rs759960319	NC_000002.12:15474164:G:A
NM_153759.3(DNMT3A):c.1061dup (p.Arg355fs)	DNMT3A		Tatton-Brown-rahman syndrome	Pathogenic(Last reviewed: Aug 3, 2018)	no assertion criteria provided	VCV000559440	2	25467447 - 25467448	2	25244578 - 25244579	559440	550164	rs1164367418	NC_000002.12:25244578:CCCCC:CCCCCC
NM_022552.4(DNMT3A):c.1015-3_1015-1delinsAA	DNMT3A		not provided	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000504067	2	25470028 - 25470030	2	25247159 - 25247161	504067	495150	rs1553413823	NC_000002.12:25247158:CTG:TT
NM_015909.4(NBAS):c.2882T>G (p.Leu961Ter)	NBAS	L961*	not provided	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000451096	2	15555725	2	15415601	451096	442973	rs1553308501	NC_000002.12:15415600:A:C
NM_175629.2(DNMT3A):c.340dup (p.Ala114fs)	DNMT3A		not provided	Pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, single submitter	VCV000423491	2	25505417 - 25505418	2	25282548 - 25282549	423491	405695	rs1553423604	NC_000002.12:25282548:CCCC:CCCCC
NM_153759.3(DNMT3A):c.1744C>T (p.Arg582Ter)	DNMT3A	R582*, R771*, R619*	not provided	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000419534	2	25463182	2	25240313	419534	405690	rs779626155	NC_000002.12:25240312:G:A
NM_153759.3(DNMT3A):c.807del (p.Lys270fs)	DNMT3A	K307fs, K270fs, K459fs	not provided	Pathogenic(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	VCV000280432	2	25469084	2	25246215	280432	264098	rs886041641	NC_000002.12:25246214:CC:C
NM_153759.3(DNMT3A):c.1041C>G (p.Tyr347Ter)	DNMT3A	Y536*, Y347*, Y384*	not provided	Pathogenic(Last reviewed: Feb 22, 2016)	criteria provided, single submitter	VCV000280341	2	25467468	2	25244599	280341	264079	rs370376334	NC_000002.12:25244598:G:C
NM_153759.3(DNMT3A):c.637C>T (p.Gln213Ter)	DNMT3A	Q213*, Q402*, Q250*	Early T cell progenitor acute lymphoblastic leukemia	Pathogenic	no assertion criteria provided	VCV000208338	2	25469564	2	25246695	208338	204573	rs796065342	NC_000002.12:25246694:G:A
NM_015909.4(NBAS):c.17C>A (p.Ser6Ter)	NBAS	S6*	not provided	Pathogenic(Last reviewed: Apr 10, 2019)	criteria provided, single submitter	VCV000838205	2	15701412	2	15561288	838205	824977		NC_000002.12:15561287:G:T
NM_153759.3(DNMT3A):c.430G>A (p.Asp144Asn)	DNMT3A	D333N, D110N, D144N, D181N	HEYN-SPROUL-JACKSON SYNDROME	Pathogenic(Last reviewed: Jan 2, 2020)	no assertion criteria provided	VCV000801332	2	25470477	2	25247608	801332	789714		NC_000002.12:25247607:C:T
NM_153759.3(DNMT3A):c.421T>C (p.Trp141Arg)	DNMT3A	W330R, W107R, W141R, W178R	HEYN-SPROUL-JACKSON SYNDROME	Pathogenic(Last reviewed: Jan 2, 2020)	no assertion criteria provided	VCV000801331	2	25470486	2	25247617	801331	789713		NC_000002.12:25247616:A:G
NM_153759.3(DNMT3A):c.1818G>A (p.Trp606Ter)	DNMT3A	W643*, W795*, W606*	Tatton-Brown-rahman syndrome	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000656461	2	25462022	2	25239153	656461	629752		NC_000002.12:25239152:C:T
NM_153759.3(DNMT3A):c.676del (p.Gln226fs)	DNMT3A	Q263fs, Q226fs, Q415fs	Tatton-Brown-rahman syndrome	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000574227	2	25469525	2	25246656	574227	560553	rs1558669964	NC_000002.12:25246655:GG:G
NM_153759.3(DNMT3A):c.493_502del (p.Phe165fs)	DNMT3A	F354fs, F202fs, F165fs	Tatton-Brown-rahman syndrome	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000569775	2	25469973 - 25469982	2	25247104 - 25247113	569775	557984	rs1558671136	NC_000002.12:25247103:CCTGGTGGAAC:C
NM_153759.3(DNMT3A):c.943del (p.Leu315fs)	DNMT3A	L315fs, L352fs, L504fs	Tatton-Brown-rahman syndrome	Pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, single submitter	VCV000541936	2	25468166	2	25245297	541936	517998	rs1553412880	NC_000002.12:25245296:GGG:GG
NM_153759.3(DNMT3A):c.168del (p.Ala57fs)	DNMT3A	A57fs, A246fs, A94fs	Tatton-Brown-rahman syndrome	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000475178	2	25471026	2	25248157	475178	450755	rs1553414406	NC_000002.12:25248156:A:
NM_015909.4(NBAS):c.2167C>T (p.Gln723Ter)	NBAS	Q723*	not provided	Pathogenic(Last reviewed: Mar 29, 2017)	criteria provided, single submitter	VCV000445960	2	15601846	2	15461722	445960	439232	rs1278049478	NC_000002.12:15461721:G:A
NM_015909.4(NBAS):c.586C>T (p.Gln196Ter)	NBAS	Q196*	Short stature, optic nerve atrophy, and Pelger-Huet anomaly	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000430659	2	15676603	2	15536479	430659	424188	rs1131692171	NC_000002.12:15536478:G:A
NM_015909.4(NBAS):c.1749G>A (p.Trp583Ter)	NBAS	W583*	Infantile liver failure syndrome 2	Pathogenic	no assertion criteria provided	VCV000424842	2	15608634	2	15468510	424842	411605	rs770446752	NC_000002.12:15468509:C:T
NM_015040.3(PIKFYVE):c.2008_2190del (p.Ile670_Gln730del)	PIKFYVE		Fleck corneal dystrophy	Pathogenic(Last reviewed: Mar 9, 2016)	no assertion criteria provided	VCV000223249					223249	224981		
NM_015040.4(PIKFYVE):c.3150dup (p.Asp1051fs)	PIKFYVE		Fleck corneal dystrophy	Pathogenic(Last reviewed: Mar 9, 2016)	no assertion criteria provided	VCV000223248	2	209190681 - 209190682	2	208325957 - 208325958	223248	224980	rs869312464	NC_000002.12:208325957:AAAA:AAAAA
NM_015909.4(NBAS):c.603_605del (p.Leu202del)	NBAS	L202del	Infantile liver failure syndrome 2	Pathogenic(Last reviewed: Jul 2, 2015)	no assertion criteria provided	VCV000204583	2	15676584 - 15676586	2	15536460 - 15536462	204583	200973	rs796065038	NC_000002.12:15536459:AGGAG:AG
NM_015909.4(NBAS):c.2708T>G (p.Leu903Arg)	NBAS	L903R	Infantile liver failure syndrome 2	Pathogenic(Last reviewed: Jul 2, 2015)	no assertion criteria provided	VCV000204582	2	15557706	2	15417582	204582	200972	rs368196005	NC_000002.12:15417581:A:C
NM_015909.4(NBAS):c.558_560del (p.Ile187del)	NBAS	I187del	Infantile liver failure syndrome 2	Pathogenic(Last reviewed: Jul 2, 2015)	no assertion criteria provided	VCV000204580	2	15676629 - 15676631	2	15536505 - 15536507	204580	200970	rs796065037	NC_000002.12:15536504:ATCA:A
NM_153759.3(DNMT3A):c.2138T>C (p.Phe713Ser)	DNMT3A	F902S, F713S, F750S	Tatton-Brown-rahman syndrome	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000139619	2	25457182	2	25234313	139619	143242	rs587777510	NC_000002.12:25234312:A:G
NM_153759.3(DNMT3A):c.1076T>A (p.Met359Lys)	DNMT3A	M548K, M359K, M396K	Tatton-Brown-rahman syndrome	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000139618	2	25467433	2	25244564	139618	143241	rs587777509	NC_000002.12:25244563:A:T
NM_153759.3(DNMT3A):c.362T>A (p.Ile121Asn)	DNMT3A	I310N, I121N, I158N	Tatton-Brown-rahman syndrome	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000139617	2	25470545	2	25247676	139617	143240	rs587777508	NC_000002.12:25247675:A:T
NM_153759.3(DNMT3A):c.1376T>C (p.Leu459Pro)	DNMT3A	L648P, L459P, L496P	Tatton-Brown-rahman syndrome	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000139616	2	25464570	2	25241701	139616	143239	rs587777507	NC_000002.12:25241700:A:G
NM_153759.3(DNMT3A):c.322_324del (p.Trp108del)	DNMT3A	W108del, W297del, W145del	Tatton-Brown-rahman syndrome	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000139615	2	25470583 - 25470585	2	25247714 - 25247716	139615	143238	rs587777506	NC_000002.12:25247713:CCAC:C
NM_015040.4(PIKFYVE):c.4167_4170del (p.Glu1389fs)	PIKFYVE	E1389fs	Fleck corneal dystrophy	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000041924	2	209200054 - 209200057	2	208335329 - 208335332	41924	51092	rs387907335	NC_000002.12:208335328:AAGTA:A
NM_000821.7(GGCX):c.763G>A (p.Val255Met)	GGCX	V255M, V198M	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000016206	2	85781392	2	85554269	16206	31245	rs121909683	NC_000002.12:85554268:C:T
NM_000821.7(GGCX):c.1427G>A (p.Arg476His)	GGCX	R476H, R419H	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000016205	2	85779551	2	85552428	16205	31244	rs121909682	NC_000002.12:85552427:C:T
NM_000821.7(GGCX):c.1426C>T (p.Arg476Cys)	GGCX	R476C, R419C	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000016204	2	85779552	2	85552429	16204	31243	rs121909681	NC_000002.12:85552428:G:A
GGCX, GLY537TYR	GGCX	G537Y	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000016203					16203	31242		
NM_000821.7(GGCX):c.1120C>T (p.Gln374Ter)	GGCX	Q374*, Q317*	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000016202	2	85780390	2	85553267	16202	31241	rs121909680	NC_000002.12:85553266:G:A
NM_000821.7(GGCX):c.1478G>C (p.Trp493Ser)	GGCX	W493S, W436S	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000016201	2	85779066	2	85551943	16201	31240	rs121909679	NC_000002.12:85551942:C:G
NM_000821.7(GGCX):c.1672G>A (p.Gly558Arg)	GGCX	G558R, G501R	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000016200	2	85778671	2	85551548	16200	31239	rs121909678	NC_000002.12:85551547:C:T
NM_000821.7(GGCX):c.215-1G>T	GGCX		Vitamin K-dependent clotting factors, combined deficiency of, 1	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000016198	2	85786199	2	85559076	16198	31237	rs786205096	NC_000002.12:85559075:C:A
NM_000821.7(GGCX):c.1454G>C (p.Arg485Pro)	GGCX	R485P, R428P	Vitamin K-dependent clotting factors, combined deficiency of, 1	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000016197	2	85779090	2	85551967	16197	31236	rs121909676	NC_000002.12:85551966:C:G
NM_000821.7(GGCX):c.899C>T (p.Ser300Phe)	GGCX	S300F, S243F	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000016196	2	85780611	2	85553488	16196	31235	rs121909684	NC_000002.12:85553487:G:A
NM_000821.7(GGCX):c.1502G>C (p.Trp501Ser)	GGCX	W501S, W444S	Vitamin K-dependent clotting factors, combined deficiency of, 1	Pathogenic(Last reviewed: Nov 15, 2000)	no assertion criteria provided	VCV000016195	2	85779042	2	85551919	16195	31234	rs28928872	NC_000002.12:85551918:C:G
NM_015040.4(PIKFYVE):c.2962C>T (p.Gln988Ter)	PIKFYVE	Q988*	Fleck corneal dystrophy	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000001699	2	209190497	2	208325773	1699	16738	rs121918337	NC_000002.12:208325772:C:T
NM_015909.4(NBAS):c.409C>T (p.Arg137Trp)	NBAS	R137W	Infantile liver failure syndrome 2	Pathogenic(Last reviewed: Oct 18, 2015)	criteria provided, single submitter	VCV000218416	2	15679451	2	15539327	218416	215173	rs368085185	NC_000002.12:15539326:G:A
NM_000821.7(GGCX):c.896T>C (p.Phe299Ser)	GGCX	F299S, F242S	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000016199	2	85780614	2	85553491	16199	31238	rs121909677	NC_000002.12:85553490:A:G
NM_015040.4(PIKFYVE):c.3308A>G (p.Lys1103Arg)	PIKFYVE	K1103R	Fleck corneal dystrophy	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000001698	2	209190843	2	208326119	1698	16737	rs121918336	NC_000002.12:208326118:A:G
NM_015627.2(LDLRAP1):c.89-1G>C	LDLRAP1		Familial hypercholesterolemia 4	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000004779	1	25880412	1	25553921	4779	19818	rs755104973	NC_000001.11:25553920:G:C
NM_018122.5(DARS2):c.788G>A (p.Arg263Gln)	DARS2	R263Q	Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation|Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome	Pathogenic(Last reviewed: Feb 17, 2016)	criteria provided, single submitter	VCV000001060	1	173807345	1	173838207	1060	16099	rs121918207	NC_000001.11:173838206:G:A
NM_000821.7(GGCX):c.1181T>G (p.Leu394Arg)	GGCX	L394R, L337R	Vitamin K-dependent clotting factors, combined deficiency of, 1	Pathogenic(Last reviewed: Oct 20, 2000)	no assertion criteria provided	VCV000016194	2	85780168	2	85553045	16194	31233	rs121909675	NC_000002.12:85553044:A:C
NM_015909.4(NBAS):c.686dup (p.Ser230fs)	NBAS		Infantile liver failure syndrome 2|not provided	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000204581	2	15674726 - 15674727	2	15534602 - 15534603	204581	200971	rs759315662	NC_000002.12:15534602:AAA:AAAA
NM_001201543.2(FAM161A):c.379C>T (p.Gln127Ter)	FAM161A	Q127*	not provided	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000862775	2	62069300	2	61842165	862775	826886		NC_000002.12:61842164:G:A
NM_001201543.2(FAM161A):c.1060C>T (p.Arg354Ter)	FAM161A	R354*	not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000854879	2	62067079	2	61839944	854879	826879		NC_000002.12:61839943:G:A
NM_001201543.2(FAM161A):c.969_972del (p.Lys323fs)	FAM161A	K323fs	not provided	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000844843	2	62067167 - 62067170	2	61840032 - 61840035	844843	826881		NC_000002.12:61840031:TGGCT:T
NM_001201543.2(FAM161A):c.336del (p.Lys112fs)	FAM161A	K112fs	not provided	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000647059	2	62069343	2	61842208	647059	630406		NC_000002.12:61842207:TTTT:TTT
NM_001201543.2(FAM161A):c.943A>T (p.Lys315Ter)	FAM161A	K315*	Retinitis pigmentosa 28	Pathogenic(Last reviewed: Mar 26, 2020)	no assertion criteria provided	VCV000828065	2	62067196	2	61840061	828065	816401		NC_000002.12:61840060:T:A
NM_001201543.2(FAM161A):c.1321dup (p.His441fs)	FAM161A		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812322	2	62066817 - 62066818	2	61839682 - 61839683	812322	800473		NC_000002.12:61839682:G:GG
NM_153759.3(DNMT3A):c.2077C>G (p.Arg693Gly)	DNMT3A	R693G, R882G, R730G	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375883	2	25457243	2	25234374	375883	362762	rs377577594	NC_000002.12:25234373:G:C
NM_153759.3(DNMT3A):c.2078G>T (p.Arg693Leu)	DNMT3A	R693L, R882L, R730L	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375879	2	25457242	2	25234373	375879	362758	rs147001633	NC_000002.12:25234372:C:A
NM_000348.4(SRD5A2):c.598G>A (p.Glu200Lys)	SRD5A2	E200K	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 26, 2012)	no assertion criteria provided	VCV000492905	2	31754477	2	31529407	492905	485697	rs756853742	NC_000002.12:31529406:C:T
NM_000348.4(SRD5A2):c.534C>A (p.Tyr178Ter)	SRD5A2	Y178*	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 27, 2014)	no assertion criteria provided	VCV000492902	2	31756454	2	31531384	492902	485700	rs1200261940	NC_000002.12:31531383:G:T
NM_000348.4(SRD5A2):c.282-2A>G	SRD5A2		3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Jul 27, 2017)	no assertion criteria provided	VCV000492900	2	31758838	2	31533768	492900	485702	rs1340425455	NC_000002.12:31533767:T:C
NM_000348.4(SRD5A2):c.271T>G (p.Tyr91Asp)	SRD5A2	Y91D	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Sep 27, 2010)	no assertion criteria provided	VCV000492898	2	31805700	2	31580630	492898	485703	rs201175894	NC_000002.12:31580629:A:C
NM_000348.4(SRD5A2):c.205G>T (p.Ala69Ser)	SRD5A2	A69S	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Apr 19, 2011)	no assertion criteria provided	VCV000492897	2	31805766	2	31580696	492897	485705	rs1553329443	NC_000002.12:31580695:C:A
NM_000348.4(SRD5A2):c.169G>C (p.Glu57Gln)	SRD5A2	E57Q	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Sep 23, 2013)	no assertion criteria provided	VCV000492896	2	31805802	2	31580732	492896	485706	rs750444774	NC_000002.12:31580731:C:G
NM_000348.4(SRD5A2):c.59T>C (p.Leu20Pro)	SRD5A2	L20P	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 5, 2011)	no assertion criteria provided	VCV000492895	2	31805911	2	31580842	492895	485707	rs761824859	NC_000002.12:31580841:A:G
NM_000348.4(SRD5A2):c.542C>T (p.Pro181Leu)	SRD5A2	P181L	not provided	Pathogenic(Last reviewed: Mar 23, 2015)	criteria provided, single submitter	VCV000372520	2	31756446	2	31531376	372520	359421	rs1057517829	NC_000002.12:31531375:G:A
NM_000348.4(SRD5A2):c.100G>A (p.Gly34Arg)	SRD5A2	G34R	not provided	Pathogenic(Last reviewed: May 10, 2016)	criteria provided, single submitter	VCV000372518	2	31805871	2	31580801	372518	359355	rs782032018	NC_000002.12:31580800:C:T
NM_000348.4(SRD5A2):c.2T>C (p.Met1Thr)	SRD5A2	M1T	not provided	Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000265705	2	31805968	2	31580899	265705	259735	rs886039748	NC_000002.12:31580898:A:G
NM_152263.4(TPM3):c.547C>T (p.Arg183Ter)	TPM3	R146*, R183*, R56*, R80*	not provided	Pathogenic(Last reviewed: Feb 3, 2014)	criteria provided, single submitter	VCV000167744	1	154145403	1	154172927	167744	177187	rs727504181	NC_000001.11:154172926:G:A
NM_001042681.2(RERE):c.62_63GA[7] (p.Lys25fs)	RERE		not provided	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000856683	1	8716283 - 8716284	1	8656224 - 8656225	856683	824430		NC_000001.11:8656224:TCTCTCTCTCTC:TCTCTCTCTCTCTC
NM_000348.4(SRD5A2):c.100G>C (p.Gly34Arg)	SRD5A2	G34R	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000830332	2	31805871	2	31580801	830332	818724	rs782032018	NC_000002.12:31580800:C:G
GRCh37/hg19 2p23.1(chr2:31758677-31805700)	SRD5A2		3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625673	2	31758677 - 31805700			625673	613977		
NC_000002.11:g.31757164_31770106del12943insCA	SRD5A2		3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Sep 15, 2018)	criteria provided, single submitter	VCV000562141	2	31757164 - 31770106	2	31532094 - 31545036	562141	553315		
NM_000348.4(SRD5A2):c.729del (p.Lys244fs)	SRD5A2	K244fs	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000549757	2	31751302	2	31526232	549757	540523	rs1553323033	NC_000002.12:31526231:GGGG:GGG
NM_000348.4(SRD5A2):c.211C>T (p.Gln71Ter)	SRD5A2	Q71*	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	VCV000403724	2	31805760	2	31580690	403724	390701	rs1060499834	NC_000002.12:31580689:G:A
NM_021815.5(SLC5A7):c.143A>G (p.Asp48Gly)	SLC5A7	D48G	Myasthenic syndrome, congenital, 20, presynaptic	Pathogenic(Last reviewed: Oct 7, 2016)	no assertion criteria provided	VCV000265765	2	108604754	2	107988298	265765	260411	rs886039768	NC_000002.12:107988297:A:G
NM_021815.5(SLC5A7):c.1082G>A (p.Arg361Gln)	SLC5A7	R361Q, R114Q, R256Q	Myasthenic syndrome, congenital, 20, presynaptic	Pathogenic(Last reviewed: Oct 7, 2016)	no assertion criteria provided	VCV000265763	2	108625107	2	108008651	265763	260409	rs147656110	NC_000002.12:108008650:G:A
NM_000348.4(SRD5A2):c.656del (p.Phe219fs)	SRD5A2	F219fs	not provided	Pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000097381	2	31754419	2	31529349	97381	103273	rs61748127	NC_000002.12:31529348:AAAAA:AAAA
NM_000348.4(SRD5A2):c.78C>G (p.Tyr26Ter)	SRD5A2	Y26*	Micropenis	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000003350	2	31805892	2	31580823	3350	18389	rs104893667	NC_000002.12:31580822:G:C
NM_000348.4(SRD5A2):c.591G>T (p.Glu197Asp)	SRD5A2	E197D	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000003349	2	31754484	2	31529414	3349	18388	rs121434253	NC_000002.12:31529413:C:A
NM_000348.4(SRD5A2):c.753del (p.Phe252fs)	SRD5A2	P251del, F252fs	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000003343	2	31751278	2	31526208	3343	18382	rs587776567	NC_000002.12:31526207:T:
NM_000348.4(SRD5A2):c.468_470del (p.Met157del)	SRD5A2	M157del	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Aug 1, 1995)	no assertion criteria provided	VCV000003338	2	31756518 - 31756520	2	31531448 - 31531450	3338	18377	rs587776566	NC_000002.12:31531447:ATT:
NC_000002.12:g.(?_31524586)_(31580971_?)del	SRD5A2		3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Nov 14, 1991)	no assertion criteria provided	VCV000003336			2	31524586 - 31580971	3336	18375		
NM_001042681.2(RERE):c.4319A>G (p.Gln1440Arg)	RERE	Q1440R, Q886R	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	VCV000562007	1	8418276	1	8358216	562007	553144	rs1321809020	NC_000001.11:8358215:T:C
NM_001042681.2(RERE):c.4303C>T (p.His1435Tyr)	RERE	H1435Y, H881Y	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	VCV000562005	1	8418292	1	8358232	562005	553145	rs1557582259	NC_000001.11:8358231:G:A
NM_001042681.2(RERE):c.4300T>C (p.Ser1434Pro)	RERE	S1434P, S880P	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	VCV000562004	1	8418295	1	8358235	562004	553146	rs1557582271	NC_000001.11:8358234:A:G
NM_001042681.2(RERE):c.248dup (p.Ser84fs)	RERE		Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	VCV000562003	1	8716108 - 8716109	1	8656049 - 8656050	562003	553148	rs1557461427	NC_000001.11:8656049:TTTTTTTT:TTTTTTTTT
Single allele	RERE		Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	VCV000562002	1	8497191 - 8813784			562002	553149		
NM_000348.4(SRD5A2):c.586G>C (p.Gly196Arg)	SRD5A2	G196R	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000548153	2	31754489	2	31529419	548153	538637	rs121434250	NC_000002.12:31529418:C:G
NM_000348.4(SRD5A2):c.218del (p.Leu73fs)	SRD5A2	L73fs	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000548143	2	31805753	2	31580683	548143	538628	rs1553329427	NC_000002.12:31580682:A:
NM_000348.4(SRD5A2):c.737G>A (p.Arg246Gln)	SRD5A2	R246Q	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Sep 2, 2016)	criteria provided, single submitter	VCV000459645	2	31751294	2	31526224	459645	451158	rs9332967	NC_000002.12:31526223:C:T
NM_001042681.2(RERE):c.2249_2270dup (p.Thr758fs)	RERE		Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	Pathogenic(Last reviewed: Jan 8, 2018)	no assertion criteria provided	VCV000236219	1	8421296 - 8421297	1	8361236 - 8361237	236219	237787	rs878853252	NC_000001.11:8361236:CCTGGAGGAGCTGAGGAGGGAGC:CCTGGAGGAGCTGAGGAGGGAGCCTGGAGGAGCTGAGGAGGGAGC
NM_001042681.2(RERE):c.3466G>A (p.Gly1156Arg)	RERE	G1156R, G602R	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	Pathogenic(Last reviewed: Jan 8, 2018)	no assertion criteria provided	VCV000236216	1	8419976	1	8359916	236216	237784	rs766951273	NC_000001.11:8359915:C:T
NM_000348.4(SRD5A2):c.547G>A (p.Gly183Ser)	SRD5A2	G183S	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Sep 23, 2013)	no assertion criteria provided	VCV000003341	2	31756441	2	31531371	3341	18380	rs121434247	NC_000002.12:31531370:C:T
NM_000348.4(SRD5A2):c.344G>A (p.Gly115Asp)	SRD5A2	G115D	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Jun 12, 2017)	no assertion criteria provided	VCV000003340	2	31758774	2	31533704	3340	18379	rs121434246	NC_000002.12:31533703:C:T
NM_020699.4(GATAD2B):c.1444C>T (p.Gln482Ter)	GATAD2B	Q482*	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 26, 2016)	criteria provided, single submitter	VCV000521258	1	153784584	1	153812108	521258	511174	rs946006593	NC_000001.11:153812107:G:A
NM_000348.4(SRD5A2):c.704A>T (p.Tyr235Phe)	SRD5A2	Y235F	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000459644	2	31751327	2	31526257	459644	450852	rs772283403	NC_000002.12:31526256:T:A
NM_000348.4(SRD5A2):c.578A>G (p.Asn193Ser)	SRD5A2	N193S	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000459638	2	31754497	2	31529427	459638	451173	rs763296857	NC_000002.12:31529426:T:C
NM_152263.4(TPM3):c.654_656AGA[1] (p.Glu219del)	TPM3	E182del, E219del	Nemaline myopathy 1	Pathogenic(Last reviewed: Jun 2, 2016)	no assertion criteria provided	VCV000235144	1	154143171 - 154143173	1	154170695 - 154170697	235144	236876	rs876661407	NC_000001.11:154170694:TCTTCTT:TCTT
NM_152263.4(TPM3):c.670_672GAA[1] (p.Glu225del)	TPM3	E188del, E225del	Nemaline myopathy 1	Pathogenic(Last reviewed: Jun 2, 2016)	no assertion criteria provided	VCV000235143	1	154143155 - 154143157	1	154170679 - 154170681	235143	236875	rs876661406	NC_000001.11:154170678:TTCTTC:TTC
NM_000348.4(SRD5A2):c.307C>T (p.Arg103Ter)	SRD5A2	R103*	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Nov 18, 2017)	criteria provided, single submitter	VCV000074593	2	31758811	2	31533741	74593	85484	rs267599353	NC_000002.12:31533740:G:A
NM_000348.4(SRD5A2):c.164T>A (p.Leu55Gln)	SRD5A2	L55Q	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: May 30, 2016)	criteria provided, single submitter	VCV000003339	2	31805807	2	31580737	3339	18378	rs121434245	NC_000002.12:31580736:A:T
NM_001201543.2(FAM161A):c.1003C>T (p.Arg335Ter)	FAM161A	R335*	not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000497934	2	62067136	2	61840001	497934	489358	rs777678022	NC_000002.12:61840000:G:A
NM_001201543.2(FAM161A):c.685C>T (p.Arg229Ter)	FAM161A	R229*	Retinitis pigmentosa 28|Retinal dystrophy	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000000035	2	62067454	2	61840319	35	15074	rs267606794	NC_000002.12:61840318:G:A
NM_001042681.2(RERE):c.4304A>G (p.His1435Arg)	RERE	H1435R, H881R	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000522858	1	8418291	1	8358231	522858	513409	rs1553154130	NC_000001.11:8358230:T:C
NM_152263.4(TPM3):c.758C>A (p.Thr253Lys)	TPM3	T253K, T216K, T150K, T126K, T195K	Congenital myopathy with fiber type disproportion|Nemaline myopathy 1	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000462142	1	154142893	1	154170417	462142	447294	rs1553248515	NC_000001.11:154170416:G:T
NM_152263.4(TPM3):c.733A>G (p.Arg245Gly)	TPM3	R208G, R245G, R142G, R118G, R187G	Congenital myopathy with fiber type disproportion|not provided	Pathogenic(Last reviewed: Apr 11, 2013)	no assertion criteria provided	VCV000042117	1	154142918	1	154170442	42117	51283	rs199474718	NC_000001.11:154170441:T:C
NM_152263.4(TPM3):c.721G>A (p.Glu241Lys)	TPM3	E204K, E241K, E183K, E114K, E138K	Congenital myopathy with fiber type disproportion|not provided	Pathogenic(Last reviewed: Apr 11, 2013)	no assertion criteria provided	VCV000042116	1	154142930	1	154170454	42116	51282	rs199474717	NC_000001.11:154170453:C:T
NM_152263.4(TPM3):c.505A>G (p.Lys169Glu)	TPM3	K132E, K169E, K42E, K66E	Congenital myopathy with fiber type disproportion|not provided	Pathogenic(Last reviewed: Apr 11, 2013)	no assertion criteria provided	VCV000042115	1	154145445	1	154172969	42115	51281	rs199474715	NC_000001.11:154172968:T:C
NM_152263.4(TPM3):c.272G>C (p.Arg91Pro)	TPM3	R54P, R91P	Congenital myopathy with fiber type disproportion|not provided	Pathogenic(Last reviewed: Apr 11, 2013)	no assertion criteria provided	VCV000042114	1	154148696	1	154176220	42114	51280	rs199474713	NC_000001.11:154176219:C:G
NM_152263.4(TPM3):c.11C>T (p.Ala4Val)	TPM3	A4V	Congenital myopathy with fiber type disproportion|not provided	Pathogenic(Last reviewed: Apr 11, 2013)	no assertion criteria provided	VCV000042113	1	154164484	1	154192008	42113	51279	rs199474711	NC_000001.11:154192007:G:A
NM_000348.4(SRD5A2):c.635C>G (p.Pro212Arg)	SRD5A2	P212R	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000003348	2	31754440	2	31529370	3348	18387	rs121434252	NC_000002.12:31529369:G:C
NM_015909.4(NBAS):c.2950del (p.Ile984fs)	NBAS	I984fs	Fever-associated acute infantile liver failure syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000501319	2	15542413	2	15402289	501319	492743	rs776797592	NC_000002.12:15402288:TTTTTT:TTTTT
NM_001042681.2(RERE):c.3146C>T (p.Pro1049Leu)	RERE	P1049L, P495L	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000235329	1	8420421	1	8360361	235329	237016	rs878853011	NC_000001.11:8360360:G:A
NM_152263.4(TPM3):c.298C>A (p.Leu100Met)	TPM3	L100M, L63M	not provided|Congenital myopathy with fiber type disproportion	Pathogenic(Last reviewed: Apr 11, 2013)	no assertion criteria provided	VCV000012452	1	154148670	1	154176194	12452	27491	rs121964853	NC_000001.11:154176193:G:T
NM_152263.4(TPM3):c.855del (p.Ter286AsnextTer?)	TPM3	*249fs, *286fs	Nemaline myopathy 1|not provided	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000012451	1	154140416	1	154167940	12451	27490	rs199474719	NC_000001.11:154167939:T:
NM_001048166.1(STIL):c.1092dup (p.Glu365fs)	STIL		not provided	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000546578	1	47753263 - 47753264	1	47287591 - 47287592	546578	536595	rs767408811	NC_000001.11:47287591:T:TT
NM_000312.3(PROC):c.340G>T (p.Gly114Cys)	PROC	G114C	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522437	2	128180687	2	127423111	522437	513020	rs374476971	NC_000002.12:127423110:G:T
NM_001048166.1(STIL):c.703dup (p.Tyr235fs)	STIL		not provided	Pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, single submitter	VCV000450838	1	47761518 - 47761519	1	47295846 - 47295847	450838	442865	rs1553180057	NC_000001.11:47295846:A:AA
NM_001048166.1(STIL):c.2830-2A>G	STIL		not provided	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000423587	1	47726213	1	47260541	423587	405215	rs1064796510	NC_000001.11:47260540:T:C
NM_006302.3(MOGS):c.1801C>T (p.Arg601Ter)	MOGS	R601*, R495*	not provided	Pathogenic(Last reviewed: Mar 12, 2015)	criteria provided, single submitter	VCV000379238	2	74689115	2	74461988	379238	367062	rs1057520537	NC_000002.12:74461987:G:A
NM_000312.4(PROC):c.321_325GCACG[3] (p.Cys111fs)	PROC		Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000838069	2	128180666 - 128180667	2	127423090 - 127423091	838069	824737		NC_000002.12:127423090:GGCACGGCACG:GGCACGGCACGGCACG
NM_006302.3(MOGS):c.1862dup (p.Ala621_Glu622insTer)	MOGS		Congenital disorder of glycosylation type 2B	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000807445	2	74689053 - 74689054	2	74461926 - 74461927	807445	798514		NC_000002.12:74461926:G:GG
NM_000312.3(PROC):c.446A>C (p.His149Pro)	PROC	H107P, H149P	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000000679	2	128180895	2	127423319	679	15718	rs121918159	NC_000002.12:127423318:A:C
NM_000312.3(PROC):c.1015G>A (p.Val339Met)	PROC	V297M, V339M	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000000677	2	128186151	2	127428575	677	15716	rs121918158	NC_000002.12:127428574:G:A
NM_000312.3(PROC):c.1335C>G (p.Ile445Met)	PROC	I403M, I445M	Thrombophilia, hereditary, due to protein C deficiency, autosomal recessive	Pathogenic(Last reviewed: Nov 15, 1993)	no assertion criteria provided	VCV000000676	2	128186471	2	127428895	676	15715	rs121918157	NC_000002.12:127428894:C:G
NM_000312.3(PROC):c.678G>C (p.Gln226His)	PROC	Q184H, Q226H	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic(Last reviewed: Oct 15, 1993)	no assertion criteria provided	VCV000000674	2	128183803	2	127426227	674	15713	rs121918155	NC_000002.12:127426226:G:C
NM_000312.3(PROC):c.552_553insTT (p.Arg185fs)	PROC		Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000000672	2	128183677 - 128183678	2	127426101 - 127426102	672	15711	rs1558715857	NC_000002.12:127426101::TT
NM_000312.3(PROC):c.658C>T (p.Arg220Trp)	PROC	R178W, R220W	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic(Last reviewed: Dec 25, 1989)	no assertion criteria provided	VCV000000668	2	128183783	2	127426207	668	15707	rs121918152	NC_000002.12:127426206:C:T
NM_000312.3(PROC):c.866C>T (p.Pro289Leu)	PROC	P247L, P289L	Thrombophilia, hereditary, due to protein C deficiency, autosomal recessive	Pathogenic(Last reviewed: Aug 31, 1991)	no assertion criteria provided	VCV000000667	2	128186002	2	127428426	667	15706	rs121918151	NC_000002.12:127428425:C:T
NM_000312.3(PROC):c.185A>C (p.Glu62Ala)	PROC	E20A, E62A	Thrombophilia, hereditary, due to protein C deficiency, autosomal recessive	Pathogenic(Last reviewed: Mar 15, 1992)	no assertion criteria provided	VCV000000664	2	128178973	2	127421397	664	15703	rs121918148	NC_000002.12:127421396:A:C
NM_000312.3(PROC):c.1027G>A (p.Gly343Ser)	PROC	G301S, G343S	Thrombophilia, hereditary, due to protein C deficiency, autosomal recessive	Pathogenic(Last reviewed: Mar 21, 1992)	no assertion criteria provided	VCV000000663	2	128186163	2	127428587	663	15702	rs121918147	NC_000002.12:127428586:G:A
NM_000312.3(PROC):c.902C>T (p.Ala301Val)	PROC	A259V, A301V	Thrombophilia, hereditary, due to protein C deficiency, autosomal recessive	Pathogenic(Last reviewed: Mar 1, 1992)	no assertion criteria provided	VCV000000660	2	128186038	2	127428462	660	15699	rs121918144	NC_000002.12:127428461:C:T
PROC, ARG12TRP	PROC	R12W	Thrombophilia, hereditary, due to protein C deficiency, autosomal recessive	Pathogenic(Last reviewed: Nov 10, 1988)	no assertion criteria provided	VCV000000658					658	15697		
NM_000312.3(PROC):c.1332G>C (p.Trp444Cys)	PROC	W402C, W444C	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic(Last reviewed: May 1, 1987)	no assertion criteria provided	VCV000000657	2	128186468	2	127428892	657	15696	rs121918142	NC_000002.12:127428891:G:C
NC_000002.12:g.(?_74461255)_(74465267_?)del	MOGS		Congenital disorder of glycosylation type 2B	Pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, single submitter	VCV000831030	2	74688382 - 74692394			831030	819276		
NM_006302.3(MOGS):c.646del (p.Val216fs)	MOGS	V110fs, V216fs	Congenital disorder of glycosylation type 2B	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000565387	2	74690447	2	74463320	565387	559187	rs777654978	NC_000002.12:74463319:C:
NM_001048166.1(STIL):c.453+5G>A	STIL		Primary autosomal recessive microcephaly 7	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000218244	1	47767228	1	47301556	218244	214880	rs863225464	NC_000001.11:47301555:C:T
NM_001048166.1(STIL):c.2393T>G (p.Leu798Trp)	STIL	L798W, L751W	Primary autosomal recessive microcephaly 7	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000091843	1	47735529	1	47269857	91843	97320	rs398122976	NC_000001.11:47269856:A:C
NM_006302.3(MOGS):c.1954T>C (p.Phe652Leu)	MOGS	F652L, F546L	Congenital disorder of glycosylation type 2B	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000008194	2	74688962	2	74461835	8194	23233	rs121909292	NC_000002.12:74461834:A:G
NM_006302.3(MOGS):c.1457G>C (p.Arg486Thr)	MOGS	R486T, R380T	Congenital disorder of glycosylation type 2B	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000008193	2	74689459	2	74462332	8193	23232	rs121909291	NC_000002.12:74462331:C:G
PROC, -14T-C	PROC		Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic(Last reviewed: Apr 24, 1998)	no assertion criteria provided	VCV000000678					678	15717		
NM_000312.3(PROC):c.678+9C>T	PROC		Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000000673	2	128183812	2	127426236	673	15712	rs1053253907	NC_000002.12:127426235:C:T
PROC, 1-BP DEL, 8857G	PROC		Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic(Last reviewed: May 15, 1996)	no assertion criteria provided	VCV000000670					670	15709		
NM_000312.3(PROC):c.1042C>T (p.Arg348Ter)	PROC	R306*, R348*	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic(Last reviewed: Aug 1, 1992)	no assertion criteria provided	VCV000000656	2	128186178	2	127428602	656	15695	rs121918141	NC_000002.12:127428601:C:T
NM_001048166.1(STIL):c.2829+1G>A	STIL		Primary autosomal recessive microcephaly 7	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000012950	1	47728574	1	47262902	12950	27989	rs199422206	NC_000001.11:47262901:C:T
NM_001048166.1(STIL):c.3658del (p.Leu1219_Val1220insTer)	STIL		Primary autosomal recessive microcephaly 7	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000012949	1	47717017	1	47251345	12949	27988	rs199422207	NC_000001.11:47251344:C:
NM_001048166.1(STIL):c.3718C>T (p.Gln1240Ter)	STIL	Q1239*, Q1240*, Q1193*, Q1175*, Q1222*	Primary autosomal recessive microcephaly 7	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000012948	1	47716957	1	47251285	12948	27987	rs121918609	NC_000001.11:47251284:G:A
NM_001201543.2(FAM161A):c.1786C>T (p.Arg596Ter)	FAM161A	R596*, R540*	Retinitis pigmentosa 28|not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000000039	2	62063210	2	61836075	39	15078	rs267606793	NC_000002.12:61836074:G:A
NM_000312.4(PROC):c.595C>T (p.Arg199Ter)	PROC	R191*, R197*, R254*, R220*, R233*, R260*, R180*, R199*, R255*, R261*	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000839161	2	128183720	2	127426144	839161	824738		NC_000002.12:127426143:C:T
NM_000312.3(PROC):c.400+1G>A	PROC		Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic(Last reviewed: Nov 17, 2018)	criteria provided, single submitter	VCV000661205	2	128180748	2	127423172	661205	650813		NC_000002.12:127423171:G:A
NM_000312.3(PROC):c.1212dup (p.Pro405fs)	PROC		Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000407370	2	128186342 - 128186343	2	127428766 - 127428767	407370	391596	rs1333329860	NC_000002.12:127428766:GGGGGG:GGGGGGG
NM_000312.3(PROC):c.925G>A (p.Ala309Thr)	PROC	A267T, A309T	Thrombophilia, hereditary, due to protein C deficiency, autosomal recessive|Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000000662	2	128186061	2	127428485	662	15701	rs121918146	NC_000002.12:127428484:G:A
NM_000348.4(SRD5A2):c.620C>A (p.Ala207Asp)	SRD5A2	A207D	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Nov 18, 2017)	criteria provided, single submitter	VCV000529238	2	31754455	2	31529385	529238	518178	rs767564684	NC_000002.12:31529384:G:T
NM_000312.3(PROC):c.1000G>A (p.Gly334Ser)	PROC	G292S, G334S	Thrombophilia, hereditary, due to protein C deficiency, autosomal recessive|Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000000666	2	128186136	2	127428560	666	15705	rs121918150	NC_000002.12:127428559:G:A
NM_000312.3(PROC):c.226G>A (p.Val76Met)	PROC	V34M, V76M	Thrombophilia, hereditary, due to protein C deficiency, autosomal recessive|Abnormal thrombosis	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000000665	2	128179014	2	127421438	665	15704	rs121918149	NC_000002.12:127421437:G:A
GRCh37/hg19 1q43(chr1:240224262-240317038)x1	FMN2		not provided	Pathogenic(Last reviewed: May 29, 2018)	no assertion criteria provided	VCV000687934	1	240224262 - 240317038			687934	675526		
NM_000104.3(CYP1B1):c.1330C>T (p.Arg444Ter)	CYP1B1	R444*	not provided	Pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000523782	2	38298167	2	38071024	523782	514467	rs377049098	NC_000002.12:38071023:G:A
NM_006015.6(ARID1A):c.3948_3950delinsCTAGGA (p.Gly1317Ter)	ARID1A		not provided	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000451207	1	27100152 - 27100154	1	26773661 - 26773663	451207	442806	rs1553153130	NC_000001.11:26773660:GGG:CTAGGA
NM_006015.6(ARID1A):c.5262del (p.Ser1755fs)	ARID1A	S1538fs, S1755fs	not provided	Pathogenic(Last reviewed: Dec 28, 2016)	criteria provided, single submitter	VCV000422806	1	27105651	1	26779160	422806	405147	rs1064796010	NC_000001.11:26779159:T:
NM_006015.6(ARID1A):c.5351del (p.Asn1784fs)	ARID1A	N1567fs, N1784fs	not provided	Pathogenic(Last reviewed: Sep 18, 2015)	criteria provided, single submitter	VCV000419853	1	27105737	1	26779246	419853	405148	rs1064794151	NC_000001.11:26779245:AAAA:AAA
NM_006015.6(ARID1A):c.1390C>T (p.Gln464Ter)	ARID1A	Q464*	not provided	Pathogenic(Last reviewed: Apr 3, 2015)	criteria provided, single submitter	VCV000379359	1	27057682	1	26731191	379359	365204	rs1057520585	NC_000001.11:26731190:C:T
NM_006015.6(ARID1A):c.2988+1G>A	ARID1A		not provided	Pathogenic(Last reviewed: Oct 11, 2016)	criteria provided, single submitter	VCV000280918	1	27093058	1	26766567	280918	264021	rs886042036	NC_000001.11:26766566:G:A
NM_020066.5(FMN2):c.2363_2364del (p.Ile788fs)	FMN2	I792fs, I788fs	not provided	Pathogenic(Last reviewed: Mar 23, 2016)	criteria provided, single submitter	VCV000280455	1	240370475 - 240370476	1	240207175 - 240207176	280455	263981	rs886041659	NC_000001.11:240207174:TT:
NM_005006.7(NDUFS1):c.699_700del (p.Lys234fs)	NDUFS1	K123fs, K177fs, K234fs, K248fs, K198fs	not provided	Pathogenic(Last reviewed: Sep 17, 2013)	criteria provided, single submitter	VCV000214780	2	207011664 - 207011665	2	206146940 - 206146941	214780	210746	rs1553506655	NC_000002.12:206146939:TA:
NM_005006.7(NDUFS1):c.1393-2A>C	NDUFS1		not provided	Pathogenic(Last reviewed: Jun 12, 2014)	criteria provided, single submitter	VCV000214772	2	206997831	2	206133107	214772	210743	rs370009373	NC_000002.12:206133106:T:G
NC_000001.11:g.26779591del	ARID1A		Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000816871					816871	805073		
NM_005006.7(NDUFS1):c.64C>T (p.Arg22Ter)	NDUFS1	R22*, R36*	Mitochondrial complex I deficiency, nuclear type 1	Pathogenic	no assertion criteria provided	VCV000626277	2	207017232	2	206152508	626277	614599	rs750971390	NC_000002.12:206152507:G:A
NM_006015.6(ARID1A):c.750_771dup (p.Ser258fs)	ARID1A		Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000623658	1	27023643 - 27023644	1	26697152 - 26697153	623658	612472	rs1557570794	NC_000001.11:26697152:GCCGCCTCCCTCCTCCAGCGCC:GCCGCCTCCCTCCTCCAGCGCCGCCGCCTCCCTCCTCCAGCGCC
NM_006015.6(ARID1A):c.5164C>T (p.Arg1722Ter)	ARID1A	R1722*, R1505*	Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Dec 30, 2015)	criteria provided, single submitter	VCV000434343	1	27105553	1	26779062	434343	427794	rs1485978447	NC_000001.11:26779061:C:T
NM_006015.6(ARID1A):c.921_940del (p.Tyr308fs)	ARID1A	Y308fs	Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Jun 8, 2016)	criteria provided, single submitter	VCV000434335	1	27023808 - 27023827	1	26697317 - 26697336	434335	427777	rs1553146165	NC_000001.11:26697316:CCCGGGGCTACCAGGGCTACCCCGGGG:CCCGGGG
NM_006015.6(ARID1A):c.1207C>T (p.Gln403Ter)	ARID1A	Q403*	not provided	Pathogenic(Last reviewed: Apr 22, 2016)	criteria provided, single submitter	VCV000235660	1	27056211	1	26729720	235660	237340	rs878853088	NC_000001.11:26729719:C:T
NM_006015.6(ARID1A):c.3679G>T (p.Glu1227Ter)	ARID1A	E1227*	Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Mar 9, 2017)	no assertion criteria provided	VCV000225844	1	27099442	1	26772951	225844	227658	rs875989849	NC_000001.11:26772950:G:T
NM_006015.6(ARID1A):c.1113del (p.Gln372fs)	ARID1A	Q372fs	Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Mar 9, 2017)	no assertion criteria provided	VCV000225843	1	27024002	1	26697511	225843	227657	rs875989848	NC_000001.11:26697510:GGGGGG:GGGGG
NM_006015.6(ARID1A):c.5965C>T (p.Arg1989Ter)	ARID1A	R1989*, R1772*	Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Dec 20, 2013)	no assertion criteria provided	VCV000225842	1	27106354	1	26779863	225842	227656	rs879255270	NC_000001.11:26779862:C:T
NM_006015.6(ARID1A):c.394del (p.Val132fs)	ARID1A	V132fs	Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Feb 28, 2014)	criteria provided, single submitter	VCV000210259	1	27023285	1	26696794	210259	206790	rs797045263	NC_000001.11:26696793:GGGG:GGG
NM_020066.5(FMN2):c.2515del (p.Thr839fs)	FMN2	T843fs, T839fs	Mental retardation, autosomal recessive 47	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000162608	1	240370625	1	240207325	162608	172284	rs727502861	NC_000001.11:240207324:AAA:AA
NM_020066.5(FMN2):c.1394dup (p.Ala466fs)	FMN2		Mental retardation, autosomal recessive 47	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000162607	1	240256799 - 240256800	1	240093499 - 240093500	162607	172283	rs727502860	NC_000001.11:240093499:CCCC:CCCCC
NM_005006.7(NDUFS1):c.1669C>T (p.Arg557Ter)	NDUFS1	R557*, R500*, R521*, R446*, R571*	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5	Pathogenic(Last reviewed: Jul 1, 2010)	no assertion criteria provided	VCV000050923	2	206994851	2	206130127	50923	65582	rs372691318	NC_000002.12:206130126:G:A
NM_005006.7(NDUFS1):c.1855G>A (p.Asp619Asn)	NDUFS1	D619N, D583N, D562N, D633N, D508N	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5	Pathogenic(Last reviewed: Jul 1, 2010)	no assertion criteria provided	VCV000050922	2	206992550	2	206127826	50922	65581	rs397515447	NC_000002.12:206127825:C:T
NM_005006.7(NDUFS1):c.1783A>G (p.Thr595Ala)	NDUFS1	T595A, T538A, T559A, T484A, T609A	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000031914	2	206992622	2	206127898	31914	40569	rs387907199	NC_000002.12:206127897:T:C
NM_006015.6(ARID1A):c.2758C>T (p.Gln920Ter)	ARID1A	Q920*	Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Mar 18, 2012)	no assertion criteria provided	VCV000030293	1	27092737	1	26766246	30293	39249	rs387906845	NC_000001.11:26766245:C:T
NM_005006.7(NDUFS1):c.691C>G (p.Leu231Val)	NDUFS1	L231V, L245V, L174V, L120V, L195V	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5	Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	VCV000014233	2	207011673	2	206146949	14233	29272	rs199422226	NC_000002.12:206146948:G:C
NM_005006.7(NDUFS1):c.721C>T (p.Arg241Trp)	NDUFS1	R241W, R184W, R205W, R255W, R130W	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000014232	2	207011643	2	206146919	14232	29271	rs199422225	NC_000002.12:206146918:G:A
NM_005006.7(NDUFS1):c.666_668del (p.Ile223del)	NDUFS1	I223del, I112del, I166del, I187del, I237del	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000014230	2	207011696 - 207011698	2	206146972 - 206146974	14230	29269	rs397515383	NC_000002.12:206146971:ATGAT:AT
NM_000104.3(CYP1B1):c.2T>C (p.Met1Thr)	CYP1B1	M1T	Anterior segment dysgenesis 6	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000007736	2	38302530	2	38075387	7736	22775	rs72549389	NC_000002.12:38075386:A:G
NM_000104.3(CYP1B1):c.-285C>T	CYP1B1		Glaucoma 3, primary congenital, A	Pathogenic	criteria provided, single submitter	VCV000813357	2	38303205	2	38076063	813357	801604		NC_000002.12:38076062:G:A
NM_000104.3(CYP1B1):c.1536_1541del (p.Pro513_Lys514del)	CYP1B1		Glaucoma 3, primary congenital, A	Pathogenic	criteria provided, single submitter	VCV000813355	2	38297956 - 38297961	2	38070813 - 38070818	813355	801602		NC_000002.12:38070812:TTGGGTTT:TT
NM_006015.6(ARID1A):c.6134_6138del (p.Lys2045fs)	ARID1A	K1828fs, K2045fs	Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560947	1	27106523 - 27106527	1	26780032 - 26780036	560947	552044	rs1557620758	NC_000001.11:26780031:AAGTG:
NM_006015.6(ARID1A):c.1348C>T (p.Gln450Ter)	ARID1A	Q450*	Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560946	1	27056352	1	26729861	560946	552043	rs1557591264	NC_000001.11:26729860:C:T
NM_000104.3(CYP1B1):c.1345del (p.Asp449fs)	CYP1B1	D449fs	Glaucoma 3, primary congenital, A	Pathogenic(Last reviewed: Apr 1, 2017)	criteria provided, single submitter	VCV000456639	2	38298152	2	38071009	456639	451210	rs749073455	NC_000002.12:38071008:CC:C
NM_000104.3(CYP1B1):c.1302G>A (p.Trp434Ter)	CYP1B1	W434*	Glaucoma 3, primary congenital, A	Pathogenic(Last reviewed: May 3, 2017)	criteria provided, single submitter	VCV000456638	2	38298195	2	38071052	456638	451194	rs893198212	NC_000002.12:38071051:C:T
NM_000104.3(CYP1B1):c.1063_1075del (p.Arg355fs)	CYP1B1	R355fs	Glaucoma 3, primary congenital, A|Irido-corneo-trabecular dysgenesis	Pathogenic(Last reviewed: Nov 21, 2014)	no assertion criteria provided	VCV000417858	2	38298422 - 38298434	2	38071279 - 38071291	417858	404760	rs1064792896	NC_000002.12:38071278:CTGCCTGCACTCG:
NM_000104.3(CYP1B1):c.694G>C (p.Gly232Arg)	CYP1B1	G232R	Glaucoma 3, primary congenital, A	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000007740	2	38301838	2	38074695	7740	22779	rs104893628	NC_000002.12:38074694:C:G
CYP1B1, 1-BP DEL, 4339G	CYP1B1		Glaucoma 3, primary congenital, A	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000007738					7738	22777		
NM_000104.3(CYP1B1):c.1093G>T (p.Gly365Trp)	CYP1B1	G365W	Glaucoma 3, primary congenital, A	Pathogenic(Last reviewed: Mar 1, 1998)	no assertion criteria provided	VCV000007732	2	38298404	2	38071261	7732	22771	rs55771538	NC_000002.12:38071260:C:A
CYP1B1, 10-BP DUP, NT1546	CYP1B1		Glaucoma 3, primary congenital, A	Pathogenic(Last reviewed: Mar 1, 1998)	no assertion criteria provided	VCV000007731					7731	22770		
CYP1B1, 1-BP INS, 1209C	CYP1B1		Glaucoma 3, primary congenital, A	Pathogenic(Last reviewed: Apr 1, 1997)	no assertion criteria provided	VCV000007729					7729	22768		
CYP1B1, 13-BP DEL, NT1410	CYP1B1		Glaucoma 3, primary congenital, A	Pathogenic(Last reviewed: Apr 1, 1997)	no assertion criteria provided	VCV000007728					7728	22767		
NM_000104.3(CYP1B1):c.783C>A (p.Phe261Leu)	CYP1B1	F261L	Glaucoma 3, primary congenital, A	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000030223	2	38301749	2	38074606	30223	39179	rs1558603396	NC_000002.12:38074605:G:T
NM_000104.3(CYP1B1):c.1267A>T (p.Asn423Tyr)	CYP1B1	N423Y	Glaucoma 3, primary congenital, A|Glaucoma, primary open angle, juvenile-onset	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000007743	2	38298230	2	38071087	7743	22782	rs104893629	NC_000002.12:38071086:T:A
CYP1B1, 1-BP DEL, 3979A	CYP1B1		Glaucoma 3, primary congenital, A|Glaucoma, primary open angle, juvenile-onset	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000007742					7742	22781		
NM_000104.3(CYP1B1):c.1405C>T (p.Arg469Trp)	CYP1B1	R469W	Glaucoma 3, primary congenital, A|not provided	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000007733	2	38298092	2	38070949	7733	22772	rs28936701	NC_000002.12:38070948:G:A
NM_001079.3(ZAP70):c.117C>A (p.Cys39Ter)	ZAP70	C39*	not provided	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000489150	2	98340616	2	97724153	489150	481666	rs897972295	NC_000002.12:97724152:C:A
NM_001079.3(ZAP70):c.1280del (p.Val427fs)	ZAP70	V427fs, V120fs	not provided	Pathogenic(Last reviewed: Mar 4, 2015)	criteria provided, single submitter	VCV000418647	2	98351910	2	97735447	418647	406050	rs1064793340	NC_000002.12:97735446:T:
NM_001079.4(ZAP70):c.283C>T (p.Pro95Ser)	ZAP70	P95S	Congenital combined immunodeficiency	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827753	2	98340782	2	97724319	827753	815897		NC_000002.12:97724318:C:T
NM_001079.3(ZAP70):c.1247dup (p.Met416fs)	ZAP70		ZAP70-Related Severe Combined Immunodeficiency	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000567226	2	98351876 - 98351877	2	97735413 - 97735414	567226	558698	rs1559328006	NC_000002.12:97735413:T:TT
NM_001079.3(ZAP70):c.838-80G>A	ZAP70		Combined immunodeficiency due to ZAP70 deficiency	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000041039	2	98349927	2	97733464	41039	49461	rs113994173	NC_000002.12:97733463:G:A
NM_001079.3(ZAP70):c.239C>A (p.Pro80Gln)	ZAP70	P80Q	Cd8 deficiency, familial	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000038914	2	98340738	2	97724275	38914	47517	rs113994172	NC_000002.12:97724274:C:A
NM_001079.3(ZAP70):c.1714A>T (p.Met572Leu)	ZAP70	M572L, M265L	Cd8 deficiency, familial	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000038913	2	98354548	2	97738085	38913	47516	rs113994175	NC_000002.12:97738084:A:T
NM_001079.3(ZAP70):c.1393C>T (p.Arg465Cys)	ZAP70	R465C, R158C	Combined immunodeficiency due to ZAP70 deficiency	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000038912	2	98354039	2	97737576	38912	47515	rs113994174	NC_000002.12:97737575:C:T
NM_001079.3(ZAP70):c.1394G>A (p.Arg465His)	ZAP70	R465H, R158H	Combined immunodeficiency due to ZAP70 deficiency	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000013257	2	98354040	2	97737577	13257	28296	rs137853201	NC_000002.12:97737576:G:A
NM_001079.3(ZAP70):c.1510_1522del (p.Lys504fs)	ZAP70	K504fs, K197fs	Combined immunodeficiency due to ZAP70 deficiency	Pathogenic(Last reviewed: Jun 10, 1994)	no assertion criteria provided	VCV000013256	2	98354246 - 98354258	2	97737783 - 97737795	13256	28295	rs730880319	NC_000002.12:97737782:CAAGTGGTACGCAC:C
NM_001079.3(ZAP70):c.1554C>A (p.Ser518Arg)	ZAP70	S518R, S211R	Combined immunodeficiency due to ZAP70 deficiency	Pathogenic(Last reviewed: Jun 10, 1994)	no assertion criteria provided	VCV000013255	2	98354291	2	97737828	13255	28294	rs104893674	NC_000002.12:97737827:C:A
NM_000312.3(PROC):c.889G>C (p.Asp297His)	PROC	D297H	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic(Last reviewed: Sep 3, 2018)	criteria provided, single submitter	VCV000663591	2	128186025	2	127428449	663591	628434		NC_000002.12:127428448:G:C
NM_006302.3(MOGS):c.370C>T (p.Gln124Ter)	MOGS	Q124*, Q18*	Congenital disorder of glycosylation type 2B	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000127098	2	74691832	2	74464705	127098	132607	rs587777323	NC_000002.12:74464704:G:A
NM_002437.5(MPV17):c.148C>T (p.Arg50Trp)	MPV17	R50W	not provided|Navajo neurohepatopathy	Pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016162	2	27535899	2	27313032	16162	31201	rs121909723	NC_000002.12:27313031:G:A
NM_000104.3(CYP1B1):c.1169G>A (p.Arg390His)	CYP1B1	R390H	not provided	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000592512	2	38298328	2	38071185	592512	583549	rs56010818	NC_000002.12:38071184:C:T
NM_005006.7(NDUFS1):c.683T>C (p.Val228Ala)	NDUFS1	V228A, V171A, V242A, V192A, V117A	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000429933	2	207011681	2	206146957	429933	421356	rs370411488	NC_000002.12:206146956:A:G
NM_000104.3(CYP1B1):c.830del (p.Phe276_Leu277insTer)	CYP1B1		Glaucoma, congenital|not provided	Pathogenic(Last reviewed: Mar 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265390	2	38301702	2	38074559	265390	259737	rs766425037	NC_000002.12:38074558:AA:A
NM_006015.6(ARID1A):c.31_56del (p.Ser11fs)	ARID1A	S11fs	not provided|Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000030292	1	27022913 - 27022938	1	26696422 - 26696447	30292	39248	rs797045262	NC_000001.11:26696421:CCCGCCGCCGCCAGCAGCCTGGGCAACCCGCCGCCGCC:CCCGCCGCCGCC
NM_005006.7(NDUFS1):c.755A>G (p.Asp252Gly)	NDUFS1	D252G, D141G, D216G, D195G, D266G	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5|not provided	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000014231	2	207009733	2	206145009	14231	29270	rs199422224	NC_000002.12:206145008:T:C
NM_001079.3(ZAP70):c.574C>T (p.Arg192Trp)	ZAP70	R192W	Autoimmune disease, multisystem, infantile-onset, 2|Congenital combined immunodeficiency	Pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	VCV000222951	2	98349356	2	97732893	222951	224665	rs199840952	NC_000002.12:97732892:C:T
NM_001079.3(ZAP70):c.1079G>C (p.Arg360Pro)	ZAP70	R360P, R53P	Autoimmune disease, multisystem, infantile-onset, 2|Congenital combined immunodeficiency	Pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	VCV000222950	2	98351172	2	97734709	222950	224666	rs869025224	NC_000002.12:97734708:G:C
NM_006912.6(RIT1):c.270G>A (p.Met90Ile)	RIT1	M90I, M107I, M54I	Noonan syndrome 8|not provided|Noonan syndrome	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000120250	1	155874261	1	155904470	120250	125844	rs483352822	NC_000001.11:155904469:C:T
NM_152263.4(TPM3):c.94C>T (p.Gln32Ter)	TPM3	Q32*	Nemaline myopathy 1|not provided	Pathogenic(Last reviewed: Sep 18, 2014)	no assertion criteria provided	VCV000012449	1	154164401	1	154191925	12449	27488	rs80358248	NC_000001.11:154191924:G:A
NM_000348.4(SRD5A2):c.679C>T (p.Arg227Ter)	SRD5A2	R227*	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000003342	2	31754396	2	31529326	3342	18381	rs121434248	NC_000002.12:31529325:G:A
NM_001044385.3(TMEM237):c.73dup (p.Ser25fs)	TMEM237		not provided	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000596040	2	202505616 - 202505617	2	201640893 - 201640894	596040	587101	rs1559590832	NC_000002.12:201640893:TT:TTT
NM_016008.4(DYNC2LI1):c.655-9del	DYNC2LI1		Short-rib thoracic dysplasia 15 with polydactyly	Pathogenic(Last reviewed: Apr 6, 2018)	no assertion criteria provided	VCV000518440	2	44027969	2	43800830	518440	509032	rs752971070	NC_000002.12:43800829:TTT:TT
NM_016008.4(DYNC2LI1):c.123_124insA (p.Gly42fs)	DYNC2LI1		Short-rib thoracic dysplasia 15 with polydactyly	Pathogenic(Last reviewed: Apr 6, 2018)	no assertion criteria provided	VCV000518439	2	44004035 - 44004036	2	43776896 - 43776897	518439	509031	rs1553359373	NC_000002.12:43776896::A
NM_016008.4(DYNC2LI1):c.420del (p.Lys140_Val141insTer)	DYNC2LI1		Short-rib thoracic dysplasia 15 with polydactyly	Pathogenic(Last reviewed: Apr 6, 2018)	no assertion criteria provided	VCV000518438	2	44021693	2	43794554	518438	509030	rs770155116	NC_000002.12:43794553:AAA:AA
NM_016008.4(DYNC2LI1):c.619C>T (p.Arg207Ter)	DYNC2LI1	R208*, R207*	Short-rib thoracic dysplasia 15 with polydactyly	Pathogenic(Last reviewed: Apr 6, 2018)	no assertion criteria provided	VCV000253218	2	44023899	2	43796760	253218	247637	rs745930390	NC_000002.12:43796759:C:T
NM_001044385.3(TMEM237):c.275-2A>G	TMEM237		Joubert syndrome 14	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000692024	2	202498156	2	201633433	692024	679821		NC_000002.12:201633432:T:C
NM_001044385.3(TMEM237):c.901C>T (p.Arg301Ter)	TMEM237	R301*, R293*	Joubert syndrome 14	Pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000647195	2	202492841	2	201628118	647195	629291		NC_000002.12:201628117:G:A
NM_016008.4(DYNC2LI1):c.2T>C (p.Met1Thr)	DYNC2LI1	M1T	Short-rib thoracic dysplasia 15 with polydactyly	Pathogenic(Last reviewed: Apr 6, 2018)	no assertion criteria provided	VCV000518437	2	44001279	2	43774140	518437	509029	rs200859699	NC_000002.12:43774139:T:C
NM_001044385.3(TMEM237):c.1066dup (p.Gln356fs)	TMEM237		Joubert syndrome 14	Pathogenic(Last reviewed: Dec 9, 2011)	no assertion criteria provided	VCV000031182	2	202490841 - 202490842	2	201626118 - 201626119	31182	40139	rs751952525	NC_000002.12:201626118:GG:GGG
NM_057176.3(BSND):c.139G>A (p.Gly47Arg)	BSND	G47R	Bartter disease type 4a|not provided	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004387	1	55464998	1	54999325	4387	19426	rs74315289	NC_000001.11:54999324:G:A
NM_001044385.3(TMEM237):c.677+1G>A	TMEM237		Joubert syndrome 14	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000654117	2	202494451	2	201629728	654117	650936		NC_000002.12:201629727:C:T
NM_016008.4(DYNC2LI1):c.659C>T (p.Thr220Ile)	DYNC2LI1	T221I, T220I	Short-rib thoracic dysplasia 15 with polydactyly	Pathogenic(Last reviewed: Apr 7, 2018)	no assertion criteria provided	VCV000253219	2	44027984	2	43800845	253219	247638	rs886037860	NC_000002.12:43800844:C:T
NM_016008.4(DYNC2LI1):c.993+3A>G	DYNC2LI1		Short-rib thoracic dysplasia 1 with or without polydactyly|Short-rib thoracic dysplasia 15 with polydactyly	Pathogenic(Last reviewed: Jun 16, 2015)	no assertion criteria provided	VCV000212768	2	44032388	2	43805249	212768	209390	rs879255656	NC_000002.12:43805248:A:G
NM_016008.4(DYNC2LI1):c.372G>A (p.Trp124Ter)	DYNC2LI1	W124*	Short-rib thoracic dysplasia 1 with or without polydactyly|Short-rib thoracic dysplasia 15 with polydactyly	Pathogenic(Last reviewed: Jun 16, 2015)	no assertion criteria provided	VCV000212766	2	44021647	2	43794508	212766	209388	rs769975073	NC_000002.12:43794507:G:A
NM_016008.4(DYNC2LI1):c.993+1G>A	DYNC2LI1		Short-rib thoracic dysplasia 1 with or without polydactyly|Short-rib thoracic dysplasia 15 with polydactyly	Pathogenic(Last reviewed: Jun 16, 2015)	no assertion criteria provided	VCV000212764	2	44032386	2	43805247	212764	209389	rs374356079	NC_000002.12:43805246:G:A
NM_001044385.3(TMEM237):c.677+1G>T	TMEM237		Joubert syndrome 14	Pathogenic(Last reviewed: Dec 9, 2011)	no assertion criteria provided	VCV000031181	2	202494451	2	201629728	31181	40138	rs793888505	NC_000002.12:201629727:C:A
NM_001079.3(ZAP70):c.1624-11G>A	ZAP70		not provided|Combined immunodeficiency due to ZAP70 deficiency	Pathogenic(Last reviewed: Feb 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000013253	2	98354447	2	97737984	13253	28292	rs730880318	NC_000002.12:97737983:G:A
NM_001044385.3(TMEM237):c.553+1G>A	TMEM237		Joubert syndrome 14	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000841287	2	202496773	2	201632050	841287	851143		NC_000002.12:201632049:C:T
NM_016008.4(DYNC2LI1):c.349C>G (p.Leu117Val)	DYNC2LI1	L117V	Short-rib thoracic dysplasia 1 with or without polydactyly|Short-rib thoracic dysplasia 15 with polydactyly	Pathogenic(Last reviewed: Jun 16, 2015)	no assertion criteria provided	VCV000212765	2	44021624	2	43794485	212765	209387	rs201948500	NC_000002.12:43794484:C:G
NM_001044385.3(TMEM237):c.943+1G>T	TMEM237		Joubert syndrome 14	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000031184	2	202492798	2	201628075	31184	40141	rs748510210	NC_000002.12:201628074:C:A
NM_001044385.3(TMEM237):c.76C>T (p.Gln26Ter)	TMEM237	Q26*, Q18*	Joubert syndrome 14	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000031183	2	202504987	2	201640264	31183	40140	rs387907131	NC_000002.12:201640263:G:A
NM_025216.3(WNT10A):c.1199G>A (p.Cys400Tyr)	WNT10A	C400Y	Odonto-onycho-dermal dysplasia	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000807721	2	219757938	2	218893216	807721	798498		NC_000002.12:218893215:G:A
NM_025216.3(WNT10A):c.949del (p.Ala317fs)	WNT10A	A317fs	Odonto-onycho-dermal dysplasia	Pathogenic(Last reviewed: Jun 4, 2018)	no assertion criteria provided	VCV000559394	2	219757684	2	218892962	559394	550121	rs775990266	NC_000002.12:218892961:GGGGG:GGGG
NM_025216.3(WNT10A):c.826T>A (p.Cys276Ser)	WNT10A	C276S	Odonto-onycho-dermal dysplasia	Pathogenic(Last reviewed: Jun 4, 2018)	no assertion criteria provided	VCV000559393	2	219757565	2	218892843	559393	550123	rs1011303295	NC_000002.12:218892842:T:A
NM_025216.3(WNT10A):c.898_899del (p.Ile300fs)	WNT10A	I300fs	Odonto-onycho-dermal dysplasia	Pathogenic(Last reviewed: Jun 4, 2018)	no assertion criteria provided	VCV000559392	2	219757637 - 219757638	2	218892915 - 218892916	559392	550120	rs1553623281	NC_000002.12:218892914:AT:
NM_025216.3(WNT10A):c.1176C>A (p.Cys392Ter)	WNT10A	C392*	Odonto-onycho-dermal dysplasia	Pathogenic(Last reviewed: Jun 4, 2018)	no assertion criteria provided	VCV000559391	2	219757915	2	218893193	559391	550122	rs1553623389	NC_000002.12:218893192:C:A
NM_025216.3(WNT10A):c.650A>G (p.Asp217Gly)	WNT10A	D217G	not provided	Pathogenic(Last reviewed: Apr 24, 2015)	criteria provided, single submitter	VCV000379584	2	219754979	2	218890257	379584	367004	rs1057520655	NC_000002.12:218890256:A:G
NM_005373.2(MPL):c.1468+2T>C	MPL		not provided	Pathogenic(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	VCV000372410	1	43814675	1	43349004	372410	359250	rs1057517761	NC_000001.11:43349003:T:C
NM_025216.3(WNT10A):c.985dup (p.Arg329fs)	WNT10A		not provided	Pathogenic(Last reviewed: Mar 7, 2016)	criteria provided, single submitter	VCV000280404	2	219757722 - 219757723	2	218893000 - 218893001	280404	264061	rs886041618	NC_000002.12:218893000:CC:CCC
NM_025216.3(WNT10A):c.803C>G (p.Ser268Ter)	WNT10A	S268*	not provided	Pathogenic(Last reviewed: Jul 4, 2016)	criteria provided, single submitter	VCV000265294	2	219757542	2	218892820	265294	259732	rs886039454	NC_000002.12:218892819:C:G
NM_005373.3(MPL):c.793del (p.Leu265fs)	MPL	L265fs	Congenital amegakaryocytic thrombocytopenia|essential thrombocytemia	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000839594	1	43805735	1	43340064	839594	823992		NC_000001.11:43340063:CCC:CC
NC_000001.10:g.(?_43814924)_(43815040_?)del	MPL		Congenital amegakaryocytic thrombocytopenia|essential thrombocytemia	Pathogenic(Last reviewed: Jul 25, 2019)	criteria provided, single submitter	VCV000665044	1	43814924 - 43815040	1	43349253 - 43349369	665044	650583		
NM_005373.2(MPL):c.1194G>A (p.Trp398Ter)	MPL	W398*	essential thrombocytemia|Congenital amegakaryocytic thrombocytopenia	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, single submitter	VCV000660831	1	43812491	1	43346820	660831	627885		NC_000001.11:43346819:G:A
NM_005373.2(MPL):c.1462G>T (p.Glu488Ter)	MPL	E488*	Congenital amegakaryocytic thrombocytopenia|essential thrombocytemia	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000656664	1	43814667	1	43348996	656664	627886		NC_000001.11:43348995:G:T
NC_000002.11:g.(?_219745698)_(219758013_?)del	WNT10A		Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000464177	2	219745698 - 219758013	2	218880976 - 218893291	464177	448382		
NM_005373.2(MPL):c.972del (p.Arg325fs)	MPL	R325fs	Congenital amegakaryocytic thrombocytopenia	Pathogenic(Last reviewed: Oct 8, 2015)	criteria provided, single submitter	VCV000435886	1	43806173	1	43340502	435886	427821	rs770457041	NC_000001.11:43340501:CCCC:CCC
WNT10A, GLY95LYS	WNT10A	G95K	Tooth agenesis, selective, 4	Pathogenic(Last reviewed: May 1, 2012)	no assertion criteria provided	VCV000036972					36972	45629		
NM_005373.2(MPL):c.1543_1544delinsAA (p.Trp515Lys)	MPL	W515K	Myelofibrosis with myeloid metaplasia	Pathogenic(Last reviewed: Nov 15, 2006)	no assertion criteria provided	VCV000014165	1	43815008 - 43815009	1	43349337 - 43349338	14165	29204	rs121913616	NC_000001.11:43349336:TG:AA
NM_005373.2(MPL):c.823C>A (p.Pro275Thr)	MPL	P275T	Congenital amegakaryocytic thrombocytopenia	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000014161	1	43805767	1	43340096	14161	29200	rs28928908	NC_000001.11:43340095:C:A
NM_005373.2:c.1566-1G>T	MPL		Congenital amegakaryocytic thrombocytopenia	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000014160	1	43817886	1	43352215	14160	29199		NC_000001.11:43352214:G:T
NM_005373.2(MPL):c.1473G>A (p.Trp491Ter)	MPL	W491*	Congenital amegakaryocytic thrombocytopenia	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000014159	1	43814938	1	43349267	14159	29198	rs121913613	NC_000001.11:43349266:G:A
NM_005373.2:c.1499delT	MPL	L500fs	Congenital amegakaryocytic thrombocytopenia	Pathogenic(Last reviewed: Mar 16, 1999)	no assertion criteria provided	VCV000014155	1	43814964	1	43349293	14155	29194		NC_000001.11:43349292:T:
NM_005373.2(MPL):c.556C>T (p.Gln186Ter)	MPL	Q186*	Congenital amegakaryocytic thrombocytopenia	Pathogenic(Last reviewed: Mar 16, 1999)	no assertion criteria provided	VCV000014154	1	43805106	1	43339435	14154	29193	rs121913610	NC_000001.11:43339434:C:T
NM_025216.3(WNT10A):c.27G>A (p.Trp9Ter)	WNT10A	W9*	Odonto-onycho-dermal dysplasia	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000004465	2	219745744	2	218881022	4465	19504	rs121908123	NC_000002.12:218881021:G:A
NM_025216.3(WNT10A):c.1128C>A (p.Cys376Ter)	WNT10A	C376*	Odonto-onycho-dermal dysplasia	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000004464	2	219757867	2	218893145	4464	19503	rs121908122	NC_000002.12:218893144:C:A
NM_025216.3(WNT10A):c.697G>T (p.Glu233Ter)	WNT10A	E233*	Odonto-onycho-dermal dysplasia	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000004460	2	219755026	2	218890304	4460	19499	rs121908118	NC_000002.12:218890303:G:T
NM_005373.3(MPL):c.1247G>A (p.Trp416Ter)	MPL	W416*	essential thrombocytemia|Congenital amegakaryocytic thrombocytopenia	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000855899	1	43812544	1	43346873	855899	823994		NC_000001.11:43346872:G:A
NM_025216.3(WNT10A):c.717del (p.His239fs)	WNT10A	H239fs	Tooth agenesis, selective, 4|Odonto-onycho-dermal dysplasia	Pathogenic(Last reviewed: Dec 7, 2019)	criteria provided, single submitter	VCV000841780	2	219755046	2	218890324	841780	825745		NC_000002.12:218890323:C:
NM_025216.3(WNT10A):c.814C>T (p.Gln272Ter)	WNT10A	Q272*	Tooth agenesis, selective, 4|Odonto-onycho-dermal dysplasia	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000841749	2	219757553	2	218892831	841749	825747		NC_000002.12:218892830:C:T
NM_005373.2(MPL):c.1904C>T (p.Pro635Leu)	MPL	P635L	Congenital amegakaryocytic thrombocytopenia	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000014157	1	43818439	1	43352768	14157	29196	rs121913612	NC_000001.11:43352767:C:T
NM_025216.3(WNT10A):c.909_916del (p.His303fs)	WNT10A	H303fs	Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4	Pathogenic(Last reviewed: Apr 14, 2019)	criteria provided, single submitter	VCV000844473	2	219757643 - 219757650	2	218892921 - 218892928	844473	825748		NC_000002.12:218892920:CCGCACAACCGCA:CCGCA
NM_025216.3(WNT10A):c.949dup (p.Ala317fs)	WNT10A		Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4	Pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, single submitter	VCV000661181	2	219757683 - 219757684	2	218892961 - 218892962	661181	629471		NC_000002.12:218892961:GGGGG:GGGGGG
NM_005373.2(MPL):c.1069C>T (p.Arg357Ter)	MPL	R357*	essential thrombocytemia|Congenital amegakaryocytic thrombocytopenia	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000660904	1	43812204	1	43346533	660904	627884		NC_000001.11:43346532:C:T
NM_025216.3(WNT10A):c.694del (p.Arg232fs)	WNT10A	R232fs	Tooth agenesis, selective, 4|Odonto-onycho-dermal dysplasia	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000639357	2	219755021	2	218890299	639357	629469		NC_000002.12:218890298:CCC:CC
NM_025216.3(WNT10A):c.310C>T (p.Arg104Cys)	WNT10A	R104C	Tooth agenesis, selective, 4|Odonto-onycho-dermal dysplasia	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000532827	2	219747079	2	218882357	532827	517834	rs764658964	NC_000002.12:218882356:C:T
NM_001114748.2(TMEM240):c.343G>A (p.Val115Met)	TMEM240	V115M		Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000523023	1	1470999	1	1535619	523023	513493	rs1045410944	NC_000001.11:1535618:C:T
NM_001114748.2(TMEM240):c.511C>T (p.Arg171Trp)	TMEM240	R171W		Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000161196	1	1470750	1	1535370	161196	171043	rs606231455	NC_000001.11:1535369:G:A
NM_001114748.2(TMEM240):c.239C>T (p.Thr80Met)	TMEM240	T80M		Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000161195	1	1471103	1	1535723	161195	171042	rs606231454	NC_000001.11:1535722:G:A
NM_001114748.2(TMEM240):c.346C>T (p.Arg116Cys)	TMEM240	R116C		Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000161194	1	1470996	1	1535616	161194	171041	rs606231453	NC_000001.11:1535615:G:A
NM_001114748.2(TMEM240):c.489C>G (p.Tyr163Ter)	TMEM240	Y163*		Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000161193	1	1470772	1	1535392	161193	171040	rs606231452	NC_000001.11:1535391:G:C
NM_006015.6(ARID1A):c.4003C>T (p.Arg1335Ter)	ARID1A	R1335*	Coffin-Siris syndrome 1|Mental retardation, autosomal dominant 14	Pathogenic	criteria provided, single submitter	VCV000030294	1	27100207	1	26773716	30294	39250	rs387906846	NC_000001.11:26773715:C:T
NM_153759.3(DNMT3A):c.2077C>A (p.Arg693Ser)	DNMT3A	R693S, R882S, R730S	Acute myeloid leukemia	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375884	2	25457243	2	25234374	375884	362763	rs377577594	NC_000002.12:25234373:G:T
NM_005373.2(MPL):c.413del (p.Ile138fs)	MPL	I138fs	Thrombocythemia 1|Congenital amegakaryocytic thrombocytopenia|Congenital amegakaryocytic thrombocytopenia	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000528088	1	43804963	1	43339292	528088	515914	rs1343123940	NC_000001.11:43339291:T:
NM_000085.4(CLCNKB):c.73del (p.Cys25fs)	CLCNKB	C25fs	not provided	Pathogenic(Last reviewed: Apr 15, 2016)	criteria provided, single submitter	VCV000447106	1	16371060	1	16044565	447106	440381	rs1553127141	NC_000001.11:16044564:T:
CLCNKB, DEL	CLCNKB		BARTTER SYNDROME, TYPE 4B, WITH SENSORINEURAL DEAFNESS	Pathogenic(Last reviewed: Mar 25, 2004)	no assertion criteria provided	VCV000007598					7598	22637		
NM_212482.3(FN1):c.3051G>T (p.Trp1017Cys)	FN1	W1017C	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 28, 2013)	criteria provided, single submitter	VCV000208716	2	216269314	2	215404591	208716	205230	rs797044906	NC_000002.12:215404590:C:A
NM_004980.4(KCND3):c.1153T>C (p.Ser385Pro)	KCND3	S385P	Spinocerebellar ataxia type 19/22	Pathogenic	no assertion criteria provided	VCV000375399	1	112329682	1	111787060	375399	362133	rs1057519453	NC_000001.11:111787059:A:G
CLCNKB, DEL	CLCNKB		Bartter syndrome type 3	Pathogenic(Last reviewed: Dec 1, 2000)	no assertion criteria provided	VCV000007596					7596	22635		
NM_020435.3(GJC2):c.-167A>G	GJC2		Spastic paraplegia|Leukodystrophy, hypomyelinating, 2	Pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	VCV000030759	1	228337561	1	228149860	30759	39716	rs587776888	
NM_004980.4(KCND3):c.1130C>T (p.Thr377Met)	KCND3	T377M	Spinocerebellar ataxia type 19/22	Pathogenic(Last reviewed: Apr 20, 2019)	criteria provided, single submitter	VCV000626319	1	112329705	1	111787083	626319	614648		NC_000001.11:111787082:G:A
NM_004980.4(KCND3):c.1123C>T (p.Pro375Ser)	KCND3	P375S	Spinocerebellar ataxia type 19/22	Pathogenic(Last reviewed: Apr 20, 2019)	criteria provided, single submitter	VCV000626318	1	112329712	1	111787090	626318	614649		NC_000001.11:111787089:G:A
NM_004980.4(KCND3):c.1013T>A (p.Val338Glu)	KCND3	V338E	Spinocerebellar ataxia type 19/22	Pathogenic(Last reviewed: Apr 20, 2019)	criteria provided, single submitter	VCV000626317	1	112524336	1	111981714	626317	614650		NC_000001.11:111981713:A:T
NM_004980.4(KCND3):c.950G>A (p.Cys317Tyr)	KCND3	C317Y	Spinocerebellar ataxia type 19/22	Pathogenic(Last reviewed: Apr 20, 2019)	criteria provided, single submitter	VCV000626316	1	112524399	1	111981777	626316	614651		NC_000001.11:111981776:C:T
NM_004980.4(KCND3):c.1034G>T (p.Gly345Val)	KCND3	G345V	Spinocerebellar ataxia type 19/22	Pathogenic(Last reviewed: Jun 27, 2014)	criteria provided, single submitter	VCV000211216	1	112524315	1	111981693	211216	206701	rs797045634	NC_000001.11:111981692:C:A
NM_005373.3(MPL):c.1474_1477dup (p.Ser493fs)	MPL		essential thrombocytemia|Congenital amegakaryocytic thrombocytopenia	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000834305	1	43814938 - 43814939	1	43349267 - 43349268	834305	823995		NC_000001.11:43349267:ATCT:ATCTATCT
NM_005373.2(MPL):c.127C>T (p.Arg43Ter)	MPL	R43*	MPL-Related Disorders|Congenital amegakaryocytic thrombocytopenia	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371574	1	43803817	1	43338146	371574	357085	rs148434485	NC_000001.11:43338145:C:T
NM_005373.2(MPL):c.317C>T (p.Pro106Leu)	MPL	P106L	essential thrombocytemia|Congenital amegakaryocytic thrombocytopenia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265248	1	43804317	1	43338646	265248	259670	rs750046020	NC_000001.11:43338645:C:T
NM_004980.4(KCND3):c.1054A>C (p.Thr352Pro)	KCND3	T352P	Spinocerebellar ataxia type 19/22	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000066062	1	112524295	1	111981673	66062	76966	rs397515476	NC_000001.11:111981672:T:G
NM_172198.2(KCND3):c.677_679TCT[1] (p.Phe227del)	KCND3	F227del	Spinocerebellar ataxia type 19/22	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000066061	1	112524667 - 112524669	1	111982045 - 111982047	66061	76965	rs397515475	NC_000001.11:111982044:AGAAGAAG:AGAAG
NM_018122.5(DARS2):c.228-21_228-20delinsC	DARS2		Clubfoot|Abnormality of the foot|EMG: axonal abnormality|Hypertensive disorder|Gout|Sensorimotor neuropathy|CNS demyelination|Impaired vibration sensation in the lower limbs|Cerebral cortical atrophy|Difficulty walking|Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|Gait ataxia|Gait imbalance|Dysmetria	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000001057	1	173797450 - 173797451	1	173828312 - 173828313	1057	16096	rs1553201258	NC_000001.11:173828311:TT:C
NM_004980.4(KCND3):c.1111G>A (p.Gly371Arg)	KCND3	G371R	not provided|Spinocerebellar ataxia type 19/22	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000383943	1	112329724	1	111787102	383943	364367	rs1057521793	NC_000001.11:111787101:C:T
NM_000104.3(CYP1B1):c.1331G>A (p.Arg444Gln)	CYP1B1	R444Q	Glaucoma, congenital	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000845455	2	38298166	2	38071023	845455	826466		NC_000002.12:38071022:C:T
NM_006015.6(ARID1A):c.2879-1G>A	ARID1A		Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000812670	1	27092947	1	26766456	812670	800921		NC_000001.11:26766455:G:A
NM_005373.2(MPL):c.304C>T (p.Arg102Cys)	MPL	R102C	essential thrombocytemia|Congenital amegakaryocytic thrombocytopenia	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000644406	1	43804304	1	43338633	644406	627882		NC_000001.11:43338632:C:T
NM_001008216.2(GALE):c.280G>A (p.Val94Met)	GALE	V94M	not provided|UDPglucose-4-epimerase deficiency|Galactose epimerase deficiency, severe	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000003682	1	24124678	1	23798188	3682	18721	rs121908047	NC_000001.11:23798187:C:T
NM_013296.5(GPSM2):c.1473del (p.Phe492fs)	GPSM2	F492fs	Rare genetic deafness|GPSM2-Related Disorders|not provided	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000291707	1	109465069	1	108922447	291707	275828	rs772372530	NC_000001.11:108922446:GGG:GG
NM_000433.3(NCF2):c.835_836del (p.Thr279fs)	NCF2	T234fs, T198fs, T279fs	not provided	Pathogenic(Last reviewed: Nov 24, 2017)	criteria provided, single submitter	VCV000420120	1	183536358 - 183536359	1	183567223 - 183567224	420120	404992	rs1064794299	NC_000001.11:183567222:GTG:G
NM_000433.3(NCF2):c.366+1G>C	NCF2		not provided	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000372772	1	183546733	1	183577598	372772	359241	rs796065032	NC_000001.11:183577597:C:G
NM_000433.3(NCF2):c.257+1G>A	NCF2		not provided	Pathogenic(Last reviewed: Jun 29, 2015)	criteria provided, single submitter	VCV000372431	1	183556029	1	183586894	372431	359221	rs990043411	NC_000001.11:183586893:C:T
NM_001190789.1(NCF2):c.367-2390C>T	NCF2	Q189*, Q144*	not provided	Pathogenic(Last reviewed: Apr 10, 2015)	criteria provided, single submitter	VCV000197669	1	183542364	1	183573229	197669	194830	rs755796920	NC_000001.11:183573228:G:A
NM_000433.3(NCF2):c.1120C>T (p.Gln374Ter)	NCF2	Q293*, Q329*, Q374*	Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000659851	1	183532627	1	183563492	659851	627152		NC_000001.11:183563491:G:A
NM_000433.3(NCF2):c.1321_1325del (p.Lys440_Glu441insTer)	NCF2		Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2	Pathogenic(Last reviewed: Nov 25, 2018)	criteria provided, single submitter	VCV000657832	1	183529374 - 183529378	1	183560239 - 183560243	657832	627150		NC_000001.11:183560238:CTTTCCTT:CTT
NM_000433.3(NCF2):c.904del (p.His302fs)	NCF2	H221fs, H302fs, H257fs	Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000579352	1	183536075	1	183566940	579352	556761	rs777621636	NC_000001.11:183566939:GG:G
NM_000433.3(NCF2):c.40del (p.Val14fs)	NCF2	V14fs	Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000573574	1	183559425	1	183590290	573574	556714	rs1290169467	NC_000001.11:183590289:CCCC:CCC
NM_001190789.1(NCF2):c.366+3093del	NCF2	K161fs	Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000569407	1	183543641	1	183574506	569407	556712	rs1558098982	NC_000001.11:183574505:TT:T
NM_000433.3(NCF2):c.298C>T (p.Gln100Ter)	NCF2	Q100*	Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000002244	1	183546802	1	183577667	2244	17283	rs119103276	NC_000001.11:183577666:G:A
NM_000433.3(NCF2):c.1171_1175del (p.Lys391fs)	NCF2	K310fs, K346fs, K391fs	Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000002242	1	183532572 - 183532576	1	183563437 - 183563441	2242	17281	rs796065031	NC_000001.11:183563436:AGCTTAG:AG
NM_000433.3(NCF2):c.304C>T (p.Arg102Ter)	NCF2	R102*	Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000002241	1	183546796	1	183577661	2241	17280	rs374402066	NC_000001.11:183577660:G:A
NM_001190789.1(NCF2):c.366+3010_366+3011dup	NCF2		Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2	Pathogenic(Last reviewed: Jul 1, 1995)	no assertion criteria provided	VCV000002239	1	183543722 - 183543723	1	183574587 - 183574588	2239	17278	rs796065030	NC_000001.11:183574587:TCT:TCTCT
NC_000001.10:g.(?_183536035)_(183536500_?)dup	NCF2		Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2	Pathogenic(Last reviewed: Oct 19, 2019)	criteria provided, single submitter	VCV000534658	1	183536035 - 183536500	1	183566900 - 183567365	534658	514875		
NM_000433.3(NCF2):c.230G>A (p.Arg77Gln)	NCF2	R77Q	Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000002247	1	183556057	1	183586922	2247	17286	rs119103275	NC_000001.11:183586921:C:T
NM_000433.3(NCF2):c.383C>T (p.Ala128Val)	NCF2	A128V	Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000002246	1	183543740	1	183574605	2246	17285	rs119103274	NC_000001.11:183574604:G:A
NM_000085.4(CLCNKB):c.18dup (p.Leu7fs)	CLCNKB		Bartter syndrome type 3|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000585704	1	16371001 - 16371002	1	16044506 - 16044507	585704	576426	rs953686324	NC_000001.11:16044506:GGGG:GGGGG
NM_181458.4(PAX3):c.619dup (p.Ile207fs)	PAX3		not provided	Pathogenic(Last reviewed: Jul 5, 2019)	criteria provided, single submitter	VCV000817322	2	223096969 - 223096970	2	222232250 - 222232251	817322	805289		NC_000002.12:222232250:T:TT
NM_181457.4(PAX3):c.821G>A (p.Trp274Ter)	PAX3	W274*, W273*	not provided	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000620105	2	223086078	2	222221359	620105	611564	rs1559264524	NC_000002.12:222221358:C:T
NM_181457.4(PAX3):c.667C>T (p.Arg223Ter)	PAX3	R223*, R222*	not provided	Pathogenic(Last reviewed: Feb 22, 2018)	criteria provided, single submitter	VCV000503680	2	223096922	2	222232203	503680	495125	rs772241382	NC_000002.12:222232202:G:A
NM_181457.4(PAX3):c.583C>T (p.Arg195Ter)	PAX3	R195*, R194*	not provided	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000488795	2	223158889	2	222294170	488795	481643	rs1220219700	NC_000002.12:222294169:G:A
NM_033109.5(PNPT1):c.1172_1173CA[1] (p.Gln392fs)	PNPT1		not provided	Pathogenic(Last reviewed: May 27, 2015)	criteria provided, single submitter	VCV000419024	2	55894127 - 55894128	2	55666992 - 55666993	419024	405995	rs1064793593	NC_000002.12:55666991:TGTGT:TGT
NM_181457.4(PAX3):c.602C>G (p.Ser201Ter)	PAX3	S201*, S200*	not provided	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000392483	2	223096987	2	222232268	392483	366459	rs1057524511	NC_000002.12:222232267:G:C
NM_181458.4(PAX3):c.748dup (p.Glu250fs)	PAX3		Albinism, ocular, with sensorineural deafness	Pathogenic	criteria provided, single submitter	VCV000694721	2	223096840 - 223096841	2	222232121 - 222232122	694721	682800		NC_000002.12:222232121:CCC:CCCC
NM_181458.4(PAX3):c.1166C>G (p.Ser389Ter)	PAX3	S389*, S388*	Rare genetic deafness	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000667018	2	223084866	2	222220147	667018	654244		NC_000002.12:222220146:G:C
NM_033109.5(PNPT1):c.1495G>C (p.Gly499Arg)	PNPT1	G499R	Combined oxidative phosphorylation deficiency 13	Pathogenic(Last reviewed: Jan 23, 2019)	no assertion criteria provided	VCV000587378	2	55882035	2	55654900	587378	578335	rs1559094461	NC_000002.12:55654899:C:G
NM_033109.5(PNPT1):c.2137G>T (p.Asp713Tyr)	PNPT1	D713Y	Combined oxidative phosphorylation deficiency 13	Pathogenic(Last reviewed: Jan 23, 2019)	no assertion criteria provided	VCV000587377	2	55867773	2	55640638	587377	578334	rs752550279	NC_000002.12:55640637:C:A
NM_033109.5(PNPT1):c.208T>C (p.Ser70Pro)	PNPT1	S70P	Combined oxidative phosphorylation deficiency 13	Pathogenic(Last reviewed: Jan 23, 2019)	no assertion criteria provided	VCV000587376	2	55914794	2	55687659	587376	578333	rs1559114055	NC_000002.12:55687658:A:G
NM_033109.5(PNPT1):c.407G>A (p.Arg136His)	PNPT1	R136H	Combined oxidative phosphorylation deficiency 13	Pathogenic(Last reviewed: Oct 30, 2018)	no assertion criteria provided	VCV000587375	2	55910966	2	55683831	587375	578332	rs746356243	NC_000002.12:55683830:C:T
NM_033109.5(PNPT1):c.760C>A (p.Gln254Lys)	PNPT1	Q254K	Combined oxidative phosphorylation deficiency 13	Pathogenic	criteria provided, single submitter	VCV000253225	2	55900134	2	55672999	253225	247642	rs778100619	NC_000002.12:55672998:G:T
NM_033109.5(PNPT1):c.1528G>C (p.Ala510Pro)	PNPT1	A510P	Combined oxidative phosphorylation deficiency 13	Pathogenic	criteria provided, single submitter	VCV000253224	2	55874556	2	55647421	253224	247641	rs879255657	NC_000002.12:55647420:C:G
NM_033109.5(PNPT1):c.404-1G>A	PNPT1		Combined oxidative phosphorylation deficiency 13	Pathogenic(Last reviewed: Nov 1, 2015)	no assertion criteria provided	VCV000218175	2	55910970	2	55683835	218175	214827	rs863225449	NC_000002.12:55683834:C:T
NM_033109.5(PNPT1):c.1424A>G (p.Glu475Gly)	PNPT1	E475G	Deafness, autosomal recessive 70	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039802	2	55883283	2	55656148	39802	48401	rs397514599	NC_000002.12:55656147:T:C
NM_181458.4(PAX3):c.268T>C (p.Tyr90His)	PAX3	Y90H	Klein-Waardenberg's syndrome	Pathogenic(Last reviewed: Sep 15, 2003)	no assertion criteria provided	VCV000004216	2	223161750	2	222297031	4216	19255	rs104893654	NC_000002.12:222297030:A:G
NM_181458.4(PAX3):c.386_398del (p.Phe129fs)	PAX3	F128fs, F129fs	Klein-Waardenberg's syndrome	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000004215	2	223160300 - 223160312	2	222295581 - 222295593	4215	19254	rs1559318494	NC_000002.12:222295580:ATTTCCCAGCTGAA:A
NM_181458.4(PAX3):c.127G>T (p.Gly43Cys)	PAX3	G43C	Waardenburg syndrome type 1	Pathogenic(Last reviewed: Feb 26, 2020)	no assertion criteria provided	VCV000827652	2	223161891	2	222297172	827652	815856		NC_000002.12:222297171:C:A
NM_181458.4(PAX3):c.1076_1077del (p.Thr359fs)	PAX3	T359fs, T358fs	Waardenburg syndrome type 1	Pathogenic(Last reviewed: Dec 26, 2019)	no assertion criteria provided	VCV000800731	2	223084955 - 223084956	2	222220236 - 222220237	800731	789351		NC_000002.12:222220235:GG:
NM_181458.4(PAX3):c.1230C>G (p.Tyr410Ter)	PAX3	Y410*, Y409*	Waardenburg syndrome type 1	Pathogenic(Last reviewed: May 15, 2018)	no assertion criteria provided	VCV000545017	2	223066853	2	222202134	545017	535281	rs147111779	NC_000002.12:222202133:G:C
NM_181457.4(PAX3):c.873dup (p.Gly292fs)	PAX3		Rare genetic deafness	Pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, single submitter	VCV000517263	2	223086025 - 223086026	2	222221306 - 222221307	517263	496266	rs1553572976	NC_000002.12:222221306:GGG:GGGG
NM_181458.4(PAX3):c.415A>T (p.Lys139Ter)	PAX3	K139*, K138*	Waardenburg syndrome type 1	Pathogenic(Last reviewed: Mar 10, 2016)	no assertion criteria provided	VCV000235094	2	223160283	2	222295564	235094	236857	rs876661317	NC_000002.12:222295563:T:A
NM_033109.5(PNPT1):c.1160A>G (p.Gln387Arg)	PNPT1	Q387R	Combined oxidative phosphorylation deficiency 13	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039801	2	55894142	2	55667007	39801	48400	rs397514598	NC_000002.12:55667006:T:C
NM_181458.4(PAX3):c.141C>G (p.Asn47Lys)	PAX3	N47K		Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000004213	2	223161877	2	222297158	4213	19252	rs104893652	NC_000002.12:222297157:G:C
NM_181458.4(PAX3):c.811C>T (p.Arg271Cys)	PAX3	R271C, R270C	Waardenburg syndrome type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547748	2	223086088	2	222221369	547748	537715	rs1380858784	NC_000002.12:222221368:G:A
NM_181458.4(PAX3):c.808C>T (p.Arg270Cys)	PAX3	R270C, R269C	Waardenburg syndrome type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547747	2	223086091	2	222221372	547747	537716	rs1228590199	NC_000002.12:222221371:G:A
NM_181458.4(PAX3):c.218C>T (p.Ser73Leu)	PAX3	S73L	Waardenburg syndrome type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547733	2	223161800	2	222297081	547733	537730	rs1553593928	NC_000002.12:222297080:G:A
NM_181458.4(PAX3):c.139A>C (p.Asn47His)	PAX3	N47H	Klein-Waardenberg's syndrome	Pathogenic(Last reviewed: Mar 1, 1993)	no assertion criteria provided	VCV000004214	2	223161879	2	222297160	4214	19253	rs104893653	NC_000002.12:222297159:T:G
PAX3, 1-BP DEL	PAX3		Waardenburg syndrome type 1	Pathogenic(Last reviewed: Jan 1, 1993)	no assertion criteria provided	VCV000004208					4208	19247		
NM_181458.4(PAX3):c.268_281del (p.Tyr90fs)	PAX3	Y90fs	Waardenburg syndrome type 1	Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000004207	2	223161737 - 223161750	2	222297018 - 222297031	4207	19246	rs1559320252	NC_000002.12:222297017:CCAGTCTCCTGGTACC:CC
NM_181458.4(PAX3):c.185_202del (p.Met62_Ile67del)	PAX3		Waardenburg syndrome type 1	Pathogenic(Last reviewed: Feb 13, 1992)	no assertion criteria provided	VCV000004205	2	223161816 - 223161833	2	222297097 - 222297114	4205	19244	rs1559320436	NC_000002.12:222297096:GGATGCCGTGGTGGGCCA:
NM_001039348.3(EFEMP1):c.1033C>T (p.Arg345Trp)	EFEMP1	R345W	Retinal dystrophy|Malattia leventinese|Doyne honeycomb retinal dystrophy|not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008072	2	56098226	2	55871091	8072	23111	rs121434491	NC_000002.12:55871090:G:A
NM_181458.4(PAX3):c.668G>A (p.Arg223Gln)	PAX3	R222Q, R223Q	Rare genetic deafness|Waardenburg syndrome	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000228387	2	223096921	2	222232202	228387	228932	rs876657717	NC_000002.12:222232201:C:T
NM_181458.4(PAX3):c.556del (p.His186fs)	PAX3	H186fs, H185fs	Waardenburg syndrome type 1	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000030596	2	223158916	2	222294197	30596	39553	rs1559316542	NC_000002.12:222294196:G:
NM_181458.4(PAX3):c.238C>G (p.His80Asp)	PAX3	H80D	Waardenburg syndrome type 1	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000030595	2	223161780	2	222297061	30595	39552	rs387906947	NC_000002.12:222297060:G:C
NM_181458.4(PAX3):c.167G>T (p.Arg56Leu)	PAX3	R56L	Waardenburg syndrome type 1	Pathogenic(Last reviewed: Mar 1, 1993)	no assertion criteria provided	VCV000004217	2	223161851	2	222297132	4217	19256	rs267606931	NC_000002.12:222297131:C:A
NM_181458.4(PAX3):c.149C>T (p.Pro50Leu)	PAX3	P50L	Waardenburg syndrome type 1	Pathogenic(Last reviewed: Feb 13, 1992)	no assertion criteria provided	VCV000004206	2	223161869	2	222297150	4206	19245	rs104893650	NC_000002.12:222297149:G:A
NM_025216.3(WNT10A):c.742C>T (p.Arg248Ter)	WNT10A	R248*	Odonto-onycho-dermal dysplasia|not provided|Tooth agenesis, selective, 4|Odonto-onycho-dermal dysplasia	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265293	2	219755071	2	218890349	265293	259731	rs886039453	NC_000002.12:218890348:C:T
NM_025216.3(WNT10A):c.391G>A (p.Ala131Thr)	WNT10A	A131T	not provided|Tooth agenesis, selective, 4|Odonto-onycho-dermal dysplasia	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000265292	2	219754720	2	218889998	265292	259730	rs372993798	NC_000002.12:218889997:G:A
NC_000002.12:g.(?_222201051)_(222295679_?)del	PAX3		Rare genetic deafness	Pathogenic(Last reviewed: Aug 24, 2018)	criteria provided, single submitter	VCV000667019	2	223065770 - 223160398			667019	654974		
NM_181458.4(PAX3):c.142G>C (p.Gly48Arg)	PAX3	G48R	Waardenburg syndrome type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000488038	2	223161876	2	222297157	488038	481053	rs1419548558	NC_000002.12:222297156:C:G
NM_181458.4(PAX3):c.784C>T (p.Arg262Ter)	PAX3	R262*, R261*	Waardenburg syndrome type 1|not provided	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280007	2	223096805	2	222232086	280007	264092	rs886041319	NC_000002.12:222232085:G:A
NM_181458.4(PAX3):c.812G>A (p.Arg271His)	PAX3	R271H, R270H	Waardenburg syndrome type 1|not provided	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000279964	2	223086087	2	222221368	279964	264095	rs774528745	NC_000002.12:222221367:C:T
NM_181458.4(PAX3):c.365_369del (p.Lys122fs)	PAX3	K122fs, K121fs	Waardenburg syndrome type 1	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000004211	2	223160329 - 223160333	2	222295610 - 222295614	4211	19250	rs1559318562	NC_000002.12:222295609:TCTTTT:T
NM_000104.3(CYP1B1):c.1064_1076del (p.Arg355fs)	CYP1B1	R355fs	not provided|Glaucoma, congenital	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000282564	2	38298421 - 38298433	2	38071278 - 38071290	282564	266801	rs72549380	NC_000002.12:38071277:TCTGCCTGCACTC:
NM_012233.3(RAB3GAP1):c.982_988delinsTTA (p.Val328fs)	RAB3GAP1		not provided	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000817251	2	135887573 - 135887579	2	135130003 - 135130009	817251	805234		NC_000002.12:135130002:GTCACTG:TTA
NM_000341.4(SLC3A1):c.1332+2T>A	SLC3A1		Cystine urolithiasis	Pathogenic	no assertion criteria provided	VCV000804196	2	44531479	2	44304340	804196	792560		NC_000002.12:44304339:T:A
NM_000341.4(SLC3A1):c.1012-1G>A	SLC3A1		Cystine urolithiasis	Pathogenic	no assertion criteria provided	VCV000804192	2	44528141	2	44301002	804192	792559		NC_000002.12:44301001:G:A
NM_000341.4(SLC3A1):c.1084C>G (p.Arg362Gly)	SLC3A1	R362G	Cystine urolithiasis	Pathogenic	no assertion criteria provided	VCV000804186	2	44528214	2	44301075	804186	792539		NC_000002.12:44301074:C:G
NM_000341.4(SLC3A1):c.1365del (p.Arg456fs)	SLC3A1	R456fs	Cystine urolithiasis	Pathogenic	no assertion criteria provided	VCV000804185	2	44539757	2	44312618	804185	792545		NC_000002.12:44312617:G:
NM_000341.4(SLC3A1):c.1113C>A (p.Tyr371Ter)	SLC3A1	Y371*	Cystine urolithiasis	Pathogenic	no assertion criteria provided	VCV000804184	2	44528243	2	44301104	804184	792542		NC_000002.12:44301103:C:A
NM_000341.4(SLC3A1):c.1414C>T (p.Leu472Phe)	SLC3A1	L472F	Cystine urolithiasis	Pathogenic	no assertion criteria provided	VCV000804183	2	44539806	2	44312667	804183	792546		NC_000002.12:44312666:C:T
NM_000341.4(SLC3A1):c.1084C>T (p.Arg362Cys)	SLC3A1	R362C	Cystine urolithiasis	Pathogenic	no assertion criteria provided	VCV000804176	2	44528214	2	44301075	804176	792540		NC_000002.12:44301074:C:T
NM_000341.4(SLC3A1):c.163del (p.Gln55fs)	SLC3A1	Q55fs	not provided	Pathogenic(Last reviewed: May 17, 2017)	criteria provided, single submitter	VCV000502014	2	44502835	2	44275696	502014	493438	rs779932118	NC_000002.12:44275695:CCC:CC
NM_001172435.2(RAB3GAP1):c.2103G>A (p.Trp701Ter)	RAB3GAP1	W701*	not provided	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000488840	2	135911260	2	135153690	488840	481604	rs772842361	NC_000002.12:135153689:G:A
NM_001172435.2(RAB3GAP1):c.475_478del (p.Thr159fs)	RAB3GAP1	T159fs	not provided	Pathogenic(Last reviewed: Jan 8, 2016)	criteria provided, single submitter	VCV000285764	2	135870833 - 135870836	2	135113263 - 135113266	285764	270001	rs886043202	NC_000002.12:135113262:ACTG:
NM_001172435.2(RAB3GAP1):c.612del (p.Leu205fs)	RAB3GAP1	L205fs	not provided	Pathogenic(Last reviewed: Jan 8, 2016)	criteria provided, single submitter	VCV000285763	2	135872915	2	135115345	285763	270000	rs886043201	NC_000002.12:135115344:C:
NM_001079866.2(BCS1L):c.625_626del (p.Ile209fs)	BCS1L	I209fs, I89fs	not provided	Pathogenic(Last reviewed: Sep 3, 2014)	criteria provided, single submitter	VCV000214164	2	219526646 - 219526647	2	218661923 - 218661924	214164	210778	rs863223915	NC_000002.12:218661922:AT:
NM_001172435.2(RAB3GAP1):c.2343_2347del (p.Pro782fs)	RAB3GAP1	P782fs	not provided	Pathogenic(Last reviewed: Apr 15, 2015)	criteria provided, single submitter	VCV000195506	2	135920176 - 135920180	2	135162606 - 135162610	195506	192667	rs794727324	NC_000002.12:135162605:TTACCTT:TT
NM_001079866.2(BCS1L):c.355C>T (p.Arg119Ter)	BCS1L	R119*	not provided	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000863524	2	219526163	2	218661440	863524	825742		NC_000002.12:218661439:C:T
NM_001079866.2(BCS1L):c.652_653AG[1] (p.Gly219fs)	BCS1L		not provided	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000649381	2	219526673 - 219526674	2	218661950 - 218661951	649381	629465		NC_000002.12:218661949:AGAG:AG
NM_001079866.2(BCS1L):c.430C>T (p.Arg144Ter)	BCS1L	R144*, R24*	not provided	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000646751	2	219526238	2	218661515	646751	629464		NC_000002.12:218661514:C:T
NM_000341.4(SLC3A1):c.1069_1084dup (p.Arg362fs)	SLC3A1		Cystinuria	Pathogenic	no assertion criteria provided	VCV000431486	2	44528198 - 44528199	2	44301059 - 44301060	431486	424992	rs1553344107	NC_000002.12:44301059:ATGCACGACATTGTCC:ATGCACGACATTGTCCATGCACGACATTGTCC
GRCh38/hg38 2p21(chr2:44307367-44316296)x0	SLC3A1		See cases	Pathogenic(Last reviewed: Jul 18, 2014)	no assertion criteria provided	VCV000155566	2	44534506 - 44543435	2	44307367 - 44316296	155566	165320		
NM_001079866.2(BCS1L):c.901T>A (p.Tyr301Asn)	BCS1L	Y301N, Y181N	Pili torti-deafness syndrome	Pathogenic(Last reviewed: Dec 1, 2013)	no assertion criteria provided	VCV000126497	2	219527617	2	218662894	126497	132021	rs587777278	NC_000002.12:218662893:T:A
NM_001318836.2(BCS1L):c.-40-271A>G	BCS1L	T50A	Mitochondrial complex III deficiency, nuclear type 1	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000006173	2	219525858	2	218661135	6173	21212	rs121908580	NC_000002.12:218661134:A:G
NM_001318836.2(BCS1L):c.-40-316G>C	BCS1L	G35R	Bjornstad syndrome with mild mitochondrial complex III deficiency	Pathogenic(Last reviewed: Feb 22, 2007)	no assertion criteria provided	VCV000006172	2	219525813	2	218661090	6172	21211	rs121908579	NC_000002.12:218661089:G:C
NM_001079866.2(BCS1L):c.1057G>A (p.Val353Met)	BCS1L	V353M, V233M	Mitochondrial complex III deficiency, nuclear type 1	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000006166	2	219527906	2	218663183	6166	21205	rs121908574	NC_000002.12:218663182:G:A
NM_001079866.2(BCS1L):c.464G>C (p.Arg155Pro)	BCS1L	R155P, R35P	Mitochondrial complex III deficiency, nuclear type 1	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000006165	2	219526485	2	218661762	6165	21204	rs121908573	NC_000002.12:218661761:G:C
NM_001079866.2(BCS1L):c.830G>A (p.Ser277Asn)	BCS1L	S277N, S157N	Mitochondrial complex III deficiency, nuclear type 1	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000006163	2	219527343	2	218662620	6163	21202	rs121908571	NC_000002.12:218662619:G:A
NM_012233.3(RAB3GAP1):c.2491G>T (p.Glu831Ter)	RAB3GAP1	E831*	Warburg micro syndrome 1	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623319	2	135920556	2	135162986	623319	612347	rs1558805900	NC_000002.12:135162985:G:T
NM_012233.3(RAB3GAP1):c.1237-2A>G	RAB3GAP1		Warburg micro syndrome 1	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623318	2	135890463	2	135132893	623318	612346	rs1558792168	NC_000002.12:135132892:A:G
NM_012233.3(RAB3GAP1):c.560G>C (p.Arg187Pro)	RAB3GAP1	R187P	Warburg micro syndrome 1	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000545409	2	135872863	2	135115293	545409	535674	rs1553444935	NC_000002.12:135115292:G:C
NM_012233.3(RAB3GAP1):c.9del (p.Asp4fs)	RAB3GAP1	D4fs	Cataract-intellectual disability-hypogonadism syndrome	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000545408	2	135809885	2	135052315	545408	535673	rs1553437083	NC_000002.12:135052314:CC:C
NM_012233.3(RAB3GAP1):c.429dup (p.Lys144Ter)	RAB3GAP1		Warburg micro syndrome 1	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522788	2	135870786 - 135870787	2	135113216 - 135113217	522788	513246	rs1553444644	NC_000002.12:135113216:T:TT
NM_001079866.2(BCS1L):c.889+1G>T	BCS1L		not provided|GRACILE syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000370247	2	219527403	2	218662680	370247	357243	rs1057516346	NC_000002.12:218662679:G:T
NM_012233.3(RAB3GAP1):c.2037_2055dup (p.Phe686fs)	RAB3GAP1		Warburg micro syndrome 1	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000100770	2	135908047 - 135908048	2	135150477 - 135150478	100770	106636	rs587777153	NC_000002.12:135150477:GTCTGCTCTCAGATATGGAGTCT:GTCTGCTCTCAGATATGGAGTCTGCTCTCAGATATGGAGTCT
NM_000341.4(SLC3A1):c.1597T>A (p.Tyr533Asn)	SLC3A1	Y533N	Cystinuria	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000037080	2	44541070	2	44313931	37080	45755	rs387907276	NC_000002.12:44313930:T:A
NM_000341.4(SLC3A1):c.542G>A (p.Arg181Gln)	SLC3A1	R181Q	Cystinuria	Pathogenic(Last reviewed: Apr 1, 1994)	no assertion criteria provided	VCV000018118	2	44507966	2	44280827	18118	33157	rs121912694	NC_000002.12:44280826:G:A
NM_012233.3(RAB3GAP1):c.264_270delinsTTATTA (p.Lys89fs)	RAB3GAP1		Warburg micro syndrome 1	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000007062	2	135848681 - 135848687	2	135091111 - 135091117	7062	22101	rs730882184	NC_000002.12:135091110:AAAGGAT:TTATTA
NM_012233.3(RAB3GAP1):c.1410C>A (p.Tyr470Ter)	RAB3GAP1	Y470*	Warburg micro syndrome 1	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000007061	2	135891514	2	135133944	7061	22100	rs267606996	NC_000002.12:135133943:C:A
NM_001318836.2(BCS1L):c.-40-286C>T	BCS1L	R45C	Mitochondrial complex III deficiency, nuclear type 1	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000006168	2	219525843	2	218661120	6168	21207	rs121908575	NC_000002.12:218661119:C:T
NC_000002.12:g.(?_44280696)_(44286177_?)del	SLC3A1		Cystinuria	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000832572	2	44507835 - 44513316			832572	819169		
NM_012233.3(RAB3GAP1):c.1555-1G>A	RAB3GAP1		Warburg micro syndrome 1	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000800519	2	135893133	2	135135563	800519	789110		NC_000002.12:135135562:G:A
NC_000002.11:g.(?_44527090)_(44541110_?)dup	SLC3A1		Cystinuria	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000648524	2	44527090 - 44541110	2	44299951 - 44313971	648524	650756		
NM_012233.3(RAB3GAP1):c.1908C>G (p.Tyr636Ter)	RAB3GAP1	Y636*	Warburg micro syndrome 1	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635325	2	135893487	2	135135917	635325	623129		NC_000002.12:135135916:C:G
NM_012233.3(RAB3GAP1):c.469G>T (p.Gly157Ter)	RAB3GAP1	G157*	Warburg micro syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561095	2	135870827	2	135113257	561095	552048	rs1558782178	NC_000002.12:135113256:G:T
NM_012233.3(RAB3GAP1):c.1310C>G (p.Ser437Ter)	RAB3GAP1	S437*	Warburg micro syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560923	2	135890538	2	135132968	560923	552049	rs1558792256	NC_000002.12:135132967:C:G
NM_012233.3(RAB3GAP1):c.1039C>T (p.Arg347Ter)	RAB3GAP1	R347*	Warburg micro syndrome 1	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000545410	2	135887630	2	135130060	545410	535675	rs532964185	NC_000002.12:135130059:C:T
NM_001079866.2(BCS1L):c.607dup (p.Arg203fs)	BCS1L		not provided|GRACILE syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370128	2	219526627 - 219526628	2	218661904 - 218661905	370128	357241	rs1057516255	NC_000002.12:218661904:A:AA
NM_012233.3(RAB3GAP1):c.71A>T (p.Glu24Val)	RAB3GAP1	E24V	Warburg micro syndrome 1	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000100772	2	135810052	2	135052482	100772	106638	rs587777155	NC_000002.12:135052481:A:T
NM_012233.3(RAB3GAP1):c.52A>C (p.Thr18Pro)	RAB3GAP1	T18P	Warburg micro syndrome 1	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000100771	2	135810033	2	135052463	100771	106637	rs587777154	NC_000002.12:135052462:A:C
NM_000341.4(SLC3A1):c.1085G>A (p.Arg362His)	SLC3A1	R362H	Cystinuria	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000018122	2	44528215	2	44301076	18122	33161	rs121912697	NC_000002.12:44301075:G:A
SLC3A1, EX5-9DUP	SLC3A1		Cystinuria	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000018121					18121	33160		
NM_012233.3(RAB3GAP1):c.1734G>A (p.Trp578Ter)	RAB3GAP1	W578*	Warburg micro syndrome 1	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000007060	2	135893313	2	135135743	7060	22099	rs137853053	NC_000002.12:135135742:G:A
NM_000433.3(NCF2):c.366+1G>A	NCF2		not provided|Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2	Pathogenic(Last reviewed: Dec 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002243	1	183546733	1	183577598	2243	17282	rs796065032	NC_000001.11:183577597:C:T
NM_000341.4(SLC3A1):c.1601_1602AC[1] (p.Thr535fs)	SLC3A1		Cystinuria	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000858369	2	44541073 - 44541074	2	44313934 - 44313935	858369	826489		NC_000002.12:44313933:CACAC:CAC
NM_012233.3(RAB3GAP1):c.630_631insC (p.Ile211fs)	RAB3GAP1		not provided|Warburg micro syndrome 1	Pathogenic(Last reviewed: Feb 22, 2016)	criteria provided, multiple submitters, no conflicts	VCV000420527	2	135872933 - 135872934	2	135115363 - 135115364	420527	405294	rs1064794536	NC_000002.12:135115363::C
NM_001079866.2(BCS1L):c.598C>T (p.Arg200Ter)	BCS1L	R200*, R80*	not provided|Mitochondrial complex III deficiency, nuclear type 1	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000374395	2	219526619	2	218661896	374395	361172	rs776838028	NC_000002.12:218661895:C:T
NM_001079866.2(BCS1L):c.556C>T (p.Arg186Ter)	BCS1L	R186*, R66*	GRACILE syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371250	2	219526577	2	218661854	371250	357240	rs779331797	NC_000002.12:218661853:C:T
NM_012233.3(RAB3GAP1):c.1009C>T (p.Arg337Ter)	RAB3GAP1	R337*	Warburg micro syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000191126	2	135887600	2	135130030	191126	188929	rs766629205	NC_000002.12:135130029:C:T
NM_012233.3(RAB3GAP1):c.2011C>T (p.Arg671Ter)	RAB3GAP1	R671*	Warburg micro syndrome 1	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000007059	2	135908026	2	135150456	7059	22098	rs137853052	NC_000002.12:135150455:C:T
NM_012233.3(RAB3GAP1):c.649-2A>G	RAB3GAP1		Warburg micro syndrome 1	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000007057	2	135878387	2	135120817	7057	22096	rs730882183	NC_000002.12:135120816:A:G
NM_000348.4(SRD5A2):c.271T>C (p.Tyr91His)	SRD5A2	Y91H	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000492899	2	31805700	2	31580630	492899	485704	rs201175894	NC_000002.12:31580629:A:G
NM_181458.4(PAX3):c.251C>T (p.Ser84Phe)	PAX3	S84F	Klein-Waardenberg's syndrome|Waardenburg syndrome type 1	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000004212	2	223161767	2	222297048	4212	19251	rs104893651	NC_000002.12:222297047:G:A
NM_181457.3(PAX3):c.242G>C (p.Gly81Ala)	PAX3	G81A	Waardenburg syndrome type 1	Pathogenic(Last reviewed: Nov 1, 1995)	no assertion criteria provided	VCV000004210	2	223161776	2	222297057	4210	19249	rs587776586	NC_000002.12:222297056:C:G
NM_181458.4(PAX3):c.556_557CA[1] (p.His186fs)	PAX3		Waardenburg syndrome type 1	Pathogenic(Last reviewed: Nov 1, 1995)	no assertion criteria provided	VCV000004209	2	223158913 - 223158914	2	222294194 - 222294195	4209	19248	rs1559316535	NC_000002.12:222294193:TGTGT:TGT
NM_005465.7(AKT3):c.964G>A (p.Asp322Asn)	AKT3	D322N	not provided	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	VCV000422166	1	243716230	1	243552928	422166	405130	rs1064795602	NC_000001.11:243552927:C:T
GRCh38/hg38 1q44(chr1:243786629-243870496)x1	AKT3		See cases	Pathogenic(Last reviewed: Nov 30, 2010)	no assertion criteria provided	VCV000144805	1	243949931 - 244033798	1	243786629 - 243870496	144805	154556		
NM_005465.7(AKT3):c.49G>A (p.Glu17Lys)	AKT3	E17K	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2	Pathogenic(Last reviewed: Jun 24, 2012)	no assertion criteria provided	VCV000039816	1	243859016	1	243695714	39816	48415	rs397514606	NC_000001.11:243695713:C:T
NM_013339.4(ALG6):c.316C>T (p.Gln106Ter)	ALG6	Q106*	Congenital disorder of glycosylation type 1C	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000856276	1	63870182	1	63404511	856276	824348		NC_000001.11:63404510:C:T
NM_013339.4(ALG6):c.492dup (p.Gln165fs)	ALG6		Congenital disorder of glycosylation type 1C	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000849281	1	63872791 - 63872792	1	63407120 - 63407121	849281	824349		NC_000001.11:63407120:TTTT:TTTTT
NM_013339.4(ALG6):c.290del (p.Leu97fs)	ALG6	L97fs	Congenital disorder of glycosylation type 1C	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000842549	1	63870156	1	63404485	842549	824347		NC_000001.11:63404484:T:
NC_000001.10:g.(?_63862174)_(63862278_?)del	ALG6		Congenital disorder of glycosylation type 1C	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000661749	1	63862174 - 63862278	1	63396503 - 63396607	661749	650614		
NM_013339.4(ALG6):c.146_147del (p.Thr48_Phe49insTer)	ALG6		Congenital disorder of glycosylation type 1C	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000651010	1	63862245 - 63862246	1	63396574 - 63396575	651010	628205		NC_000001.11:63396573:TTTT:TT
NM_013339.4(ALG6):c.999dup (p.Leu334fs)	ALG6		Congenital disorder of glycosylation type 1C	Pathogenic(Last reviewed: Oct 20, 2018)	criteria provided, single submitter	VCV000644709	1	63885051 - 63885052	1	63419380 - 63419381	644709	628207		NC_000001.11:63419380:G:GG
NM_013339.4(ALG6):c.894_896AAT[1] (p.Ile299del)	ALG6	I299del	Congenital disorder of glycosylation type 1C	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000030420	1	63879808 - 63879810	1	63414137 - 63414139	30420	39377	rs387906338	NC_000001.11:63414136:TAATAAT:TAAT
NM_025216.3(WNT10A):c.382C>T (p.Arg128Ter)	WNT10A	R128*	Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4|Schopf-Schulz-Passarge syndrome|Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000464181	2	219754711	2	218889989	464181	450717	rs762739726	NC_000002.12:218889988:C:T
NM_001114748.2(TMEM240):c.509C>T (p.Pro170Leu)	TMEM240	P170L	|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000161192	1	1470752	1	1535372	161192	171039	rs606231451	NC_000001.11:1535371:G:A
NM_013339.4(ALG6):c.167+5G>A	ALG6		Congenital disorder of glycosylation type 1C	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000005499	1	63862273	1	63396602	5499	20538	rs1557585860	NC_000001.11:63396601:G:A
NM_013339.4(ALG6):c.1432T>C (p.Ser478Pro)	ALG6	S478P	Congenital disorder of glycosylation type 1C	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000005498	1	63902599	1	63436928	5498	20537	rs121908444	NC_000001.11:63436927:T:C
NM_000298.6(PKLR):c.1529G>A (p.Arg510Gln)	PKLR	R510Q, R479Q	Pyruvate kinase deficiency of red cells|not specified|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001511	1	155261636	1	155291845	1511	16550	rs113403872	NC_000001.11:155291844:C:T
NM_013339.4(ALG6):c.1338dup (p.Val447fs)	ALG6		Congenital disorder of glycosylation type 1C	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000851522	1	63902504 - 63902505	1	63436833 - 63436834	851522	824350		NC_000001.11:63436833:A:AA
NC_000001.11:g.(?_63428723)_(63429136_?)del	ALG6		Congenital disorder of glycosylation type 1C	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000830956	1	63894394 - 63894807			830956	818988		
NM_013339.4(ALG6):c.171T>A (p.Tyr57Ter)	ALG6	Y57*	Congenital disorder of glycosylation type 1C	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000557002	1	63867928	1	63402257	557002	541250	rs780528545	NC_000001.11:63402256:T:A
NM_001371928.1(AHDC1):c.1289del (p.Pro430fs)	AHDC1	P430fs	not provided	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000817789	1	27877338	1	27550827	817789	805220		NC_000001.11:27550826:GGGGG:GGGG
NM_001371928.1(AHDC1):c.3145_3146del (p.Ala1050fs)	AHDC1	A1050fs	not provided	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000817369	1	27875481 - 27875482	1	27548970 - 27548971	817369	805218		NC_000001.11:27548969:GA:
NM_001371928.1(AHDC1):c.621dup (p.Pro208fs)	AHDC1		not provided	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000817130	1	27878005 - 27878006	1	27551494 - 27551495	817130	805221		NC_000001.11:27551494:A:AA
NM_001371928.1(AHDC1):c.3623G>A (p.Trp1208Ter)	AHDC1	W1208*	Xia-Gibbs syndrome	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000807539	1	27875004	1	27548493	807539	798470		NC_000001.11:27548492:C:T
NM_001371928.1(AHDC1):c.2191_2194del (p.Val731fs)	AHDC1	V731fs	Xia-Gibbs syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801465	1	27876433 - 27876436	1	27549922 - 27549925	801465	789963		NC_000001.11:27549921:CTACCT:CT
NM_001029882.3(AHDC1):c.997del (p.Ala333fs)	AHDC1	A333fs	Cerebellar vermis hypoplasia|Xia-Gibbs syndrome	Pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000632597	1	27877630	1	27551119	632597	621017	rs1557667078	NC_000001.11:27551118:CC:C
NM_001029882.3(AHDC1):c.3466C>T (p.Gln1156Ter)	AHDC1	Q1156*	not provided	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000620243	1	27875161	1	27548650	620243	611517	rs1557658942	NC_000001.11:27548649:G:A
NM_001029882.3(AHDC1):c.3204C>G (p.Tyr1068Ter)	AHDC1	Y1068*	not provided	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000546264	1	27875423	1	27548912	546264	536587	rs1036650716	NC_000001.11:27548911:G:C
NM_001029882.3(AHDC1):c.2026delinsTT (p.Gly676fs)	AHDC1		not provided	Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000545027	1	27876601	1	27550090	545027	535294	rs1553159175	NC_000001.11:27550089:C:AA
NM_001029882.3(AHDC1):c.4429_4430delinsT (p.Pro1477fs)	AHDC1		not provided	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000503934	1	27874197 - 27874198	1	27547686 - 27547687	503934	495090	rs1553157912	NC_000001.11:27547685:GG:A
NM_001029882.3(AHDC1):c.1519A>T (p.Lys507Ter)	AHDC1	K507*	Xia-Gibbs syndrome	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000488466	1	27877108	1	27550597	488466	481334	rs1553159383	NC_000001.11:27550596:T:A
NM_001029882.3(AHDC1):c.2327G>A (p.Trp776Ter)	AHDC1	W776*	not provided	Pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, single submitter	VCV000452095	1	27876300	1	27549789	452095	442815	rs1553159009	NC_000001.11:27549788:C:T
NM_001029882.3(AHDC1):c.2881del (p.His961fs)	AHDC1	H961fs	not provided	Pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, single submitter	VCV000451682	1	27875746	1	27549235	451682	442812	rs1553158679	NC_000001.11:27549234:GGG:GG
NM_001029882.3(AHDC1):c.1810del (p.Asp604fs)	AHDC1	D604fs	not provided	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000451608	1	27876817	1	27550306	451608	442816	rs1553159284	NC_000001.11:27550305:C:
NM_001029882.3(AHDC1):c.2375_2376del (p.Gly792fs)	AHDC1	G792fs	not provided	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000451272	1	27876251 - 27876252	1	27549740 - 27549741	451272	442814	rs1553158952	NC_000001.11:27549739:CCC:C
NM_001029882.3(AHDC1):c.2628del (p.Ser877fs)	AHDC1	S877fs	not provided	Pathogenic(Last reviewed: Jul 5, 2017)	criteria provided, single submitter	VCV000450320	1	27875999	1	27549488	450320	442813	rs1553158807	NC_000001.11:27549487:GG:G
NM_001029882.3(AHDC1):c.3315_3319del (p.Ser1106fs)	AHDC1	S1106fs	not provided	Pathogenic(Last reviewed: Sep 18, 2015)	criteria provided, single submitter	VCV000429816	1	27875308 - 27875312	1	27548797 - 27548801	429816	421239	rs1131691609	NC_000001.11:27548796:GAGAAG:G
NM_001029882.3(AHDC1):c.2746del (p.Ser916fs)	AHDC1	S916fs	not provided	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, single submitter	VCV000429248	1	27875881	1	27549370	429248	421240	rs1131691276	NC_000001.11:27549369:A:
NM_001029882.3(AHDC1):c.1755_1758del (p.Lys585fs)	AHDC1	K585fs	not provided	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	VCV000424562	1	27876869 - 27876872	1	27550358 - 27550361	424562	405155	rs1064797043	NC_000001.11:27550357:TTTTTTT:TTT
NM_001029882.3(AHDC1):c.1153_1154insCGCCGCAA (p.Arg385fs)	AHDC1		not provided	Pathogenic(Last reviewed: May 16, 2016)	criteria provided, single submitter	VCV000421238	1	27877473 - 27877474	1	27550962 - 27550963	421238	405156	rs1064795000	NC_000001.11:27550962::TTGCGGCG
NM_001029882.3(AHDC1):c.4482del (p.Thr1495fs)	AHDC1	T1495fs	not provided	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000419512	1	27874145	1	27547634	419512	405153	rs1064793924	NC_000001.11:27547633:CC:C
NM_001029882.3(AHDC1):c.2693dup (p.Ala899fs)	AHDC1		not provided	Pathogenic(Last reviewed: Aug 4, 2016)	criteria provided, single submitter	VCV000280775	1	27875933 - 27875934	1	27549422 - 27549423	280775	263990	rs886041920	NC_000001.11:27549422:A:AA
NM_001029882.3(AHDC1):c.2908C>T (p.Gln970Ter)	AHDC1	Q970*	not provided	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000280607	1	27875719	1	27549208	280607	264026	rs886041781	NC_000001.11:27549207:G:A
NM_001029882.3(AHDC1):c.2691del (p.Val898fs)	AHDC1	V898fs	not provided	Pathogenic(Last reviewed: Apr 6, 2016)	criteria provided, single submitter	VCV000280482	1	27875936	1	27549425	280482	264029	rs886041676	NC_000001.11:27549424:T:
NM_001029882.3(AHDC1):c.1759C>T (p.Arg587Ter)	AHDC1	R587*	not provided	Pathogenic(Last reviewed: Feb 10, 2017)	criteria provided, single submitter	VCV000280407	1	27876868	1	27550357	280407	264018	rs886041620	NC_000001.11:27550356:G:A
NM_001029882.3(AHDC1):c.2229del (p.Ser744fs)	AHDC1	S744fs	Xia-Gibbs syndrome	Pathogenic(Last reviewed: Aug 11, 2016)	criteria provided, single submitter	VCV000266028	1	27876398	1	27549887	266028	260851	rs886039900	NC_000001.11:27549886:CC:C
NM_001029882.3(AHDC1):c.1945del (p.Ala649fs)	AHDC1	A649fs	not provided	Pathogenic(Last reviewed: Oct 28, 2014)	criteria provided, single submitter	VCV000208158	1	27876682	1	27550171	208158	204416	rs796065042	NC_000001.11:27550170:CC:C
NM_001029882.3(AHDC1):c.3809del (p.Gln1270fs)	AHDC1	Q1270fs	not provided	Pathogenic(Last reviewed: Mar 25, 2015)	criteria provided, single submitter	VCV000208157	1	27874818	1	27548307	208157	204414	rs796065041	NC_000001.11:27548306:T:
NM_001029882.3(AHDC1):c.1881del (p.Gln627fs)	AHDC1	Q627fs	not provided	Pathogenic(Last reviewed: Aug 15, 2014)	criteria provided, single submitter	VCV000208156	1	27876746	1	27550235	208156	204417	rs796065040	NC_000001.11:27550234:C:
NM_001029882.3(AHDC1):c.1122dup (p.Gly375fs)	AHDC1		not provided	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000208155	1	27877504 - 27877505	1	27550993 - 27550994	208155	204419	rs749294057	NC_000001.11:27550993:GGGGGGG:GGGGGGGG
NM_001371928.1(AHDC1):c.2365C>T (p.Arg789Ter)	AHDC1	R789*	Xia-Gibbs syndrome	Pathogenic(Last reviewed: May 4, 2019)	no assertion criteria provided	VCV000827795	1	27876262	1	27549751	827795	815977		NC_000001.11:27549750:G:A
NM_001029882.3(AHDC1):c.1758dupA	AHDC1		Xia-Gibbs syndrome	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000816930					816930	805074		
NM_001371928.1(AHDC1):c.944dup (p.Ala316fs)	AHDC1		Xia-Gibbs syndrome	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000666567	1	27877682 - 27877683	1	27551171 - 27551172	666567	654115		NC_000001.11:27551171:T:TT
NM_001371928.1(AHDC1):c.2948dup (p.Thr984fs)	AHDC1		Xia-Gibbs syndrome	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000638358	1	27875678 - 27875679	1	27549167 - 27549168	638358	626107		NC_000001.11:27549167:GGGG:GGGGG
NM_001029882.3(AHDC1):c.550del (p.Ala184fs)	AHDC1	A184fs	Xia-Gibbs syndrome	Pathogenic(Last reviewed: Apr 16, 2018)	no assertion criteria provided	VCV000559645	1	27878077	1	27551566	559645	550348	rs1553159979	NC_000001.11:27551565:CCC:CC
NM_001029882.3(AHDC1):c.3497C>G (p.Ser1166Ter)	AHDC1	S1166*	Xia-Gibbs syndrome	Pathogenic(Last reviewed: Sep 21, 2017)	no assertion criteria provided	VCV000559626	1	27875130	1	27548619	559626	550347	rs1553158393	NC_000001.11:27548618:G:C
NM_001029882.3(AHDC1):c.979C>T (p.Gln327Ter)	AHDC1	Q327*	not provided	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000450264	1	27877648	1	27551137	450264	442817	rs1553159753	NC_000001.11:27551136:G:A
NM_001029882.3(AHDC1):c.3814C>T (p.Arg1272Ter)	AHDC1	R1272*	Xia-Gibbs syndrome	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000431102	1	27874813	1	27548302	431102	424625	rs1135401761	NC_000001.11:27548301:G:A
NM_001029882.3(AHDC1):c.1402dup (p.Cys468fs)	AHDC1		Cerebral visual impairment and intellectual disability	Pathogenic(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	VCV000224806	1	27877224 - 27877225	1	27550713 - 27550714	224806	226643	rs869312858	NC_000001.11:27550713:A:AA
NM_001029882.3(AHDC1):c.2529_2545del (p.Asp845fs)	AHDC1	D845fs	not provided	Pathogenic(Last reviewed: Jan 7, 2015)	criteria provided, single submitter	VCV000208159	1	27876082 - 27876098	1	27549571 - 27549587	208159	204415	rs796065043	NC_000001.11:27549570:AGTCATCCGAATCGAGCAG:AG
NM_001029882.3(AHDC1):c.2062C>T (p.Arg688Ter)	AHDC1	R688*	Xia-Gibbs syndrome	Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000438276	1	27876565	1	27550054	438276	431902	rs1165205177	NC_000001.11:27550053:G:A
NM_001029882.3(AHDC1):c.2773C>T (p.Arg925Ter)	AHDC1	R925*	Abdominal obesity-metabolic syndrome 3|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000496678	1	27875854	1	27549343	496678	488150	rs777736953	NC_000001.11:27549342:G:A
NM_013339.4(ALG6):c.680+2T>G	ALG6		Congenital disorder of glycosylation type 1C	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000030421	1	63877004	1	63411333	30421	39378	rs868768232	NC_000001.11:63411332:T:G
NM_002074.5(GNB1):c.239T>G (p.Ile80Ser)	GNB1	I80S	not provided	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000391609	1	1737942	1	1806503	391609	364646	rs752746786	NC_000001.11:1806502:A:C
NM_002074.5(GNB1):c.274G>A (p.Ala92Thr)	GNB1	A92T	not provided	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000633546	1	1736014	1	1804575	633546	621936	rs1557889974	NC_000001.11:1804574:C:T
NM_000488.3(SERPINC1):c.624+1G>A	SERPINC1		Antithrombin III deficiency	Pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, single submitter	VCV000694627	1	173880936	1	173911798	694627	682730		NC_000001.11:173911797:C:T
NM_000488.3(SERPINC1):c.448dup (p.Gln150fs)	SERPINC1		Antithrombin III deficiency	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000661606	1	173881112 - 173881113	1	173911974 - 173911975	661606	627127		NC_000001.11:173911974:G:GG
NM_000488.3(SERPINC1):c.415_420del (p.Lys139_Phe140del)	SERPINC1		Antithrombin III deficiency	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000661362	1	173881141 - 173881146	1	173912003 - 173912008	661362	627128		NC_000001.11:173912002:AAACTTAAA:AAA
NM_000488.3(SERPINC1):c.766del (p.Leu256fs)	SERPINC1	L256fs, L208fs	Antithrombin III deficiency	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000645305	1	173879077	1	173909939	645305	627124		NC_000001.11:173909938:GG:G
NM_000488.3(SERPINC1):c.159C>A (p.Cys53Ter)	SERPINC1	C53*, C5*	Deep venous thrombosis	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627247	1	173883940	1	173914802	627247	615307		NC_000001.11:173914801:G:T
NC_000001.10:g.(?_173872942)_(173886516_?)del	SERPINC1		Antithrombin III deficiency	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000417521	1	173872942 - 173886516	1	173903804 - 173917378	417521	390735		
NM_000488.3(SERPINC1):c.1060del (p.Arg354fs)	SERPINC1	R354fs, R306fs	Antithrombin III deficiency	Pathogenic(Last reviewed: Jul 2, 2015)	criteria provided, single submitter	VCV000216071	1	173878783	1	173909645	216071	212078	rs863224495	NC_000001.11:173909644:GGGG:GGG
NM_001365052.1(SERPINC1):c.312_314CTT[2] (p.Phe107del)	SERPINC1	F155del	Antithrombin III deficiency	Pathogenic(Last reviewed: Jun 6, 2015)	criteria provided, single submitter	VCV000188092	1	173881097 - 173881099	1	173911959 - 173911961	188092	185953	rs786204063	NC_000001.11:173911958:AAGAAGAAG:AAGAAG
SERPINC1, 9-BP DEL, NT13395	SERPINC1		Antithrombin III deficiency	Pathogenic(Last reviewed: Dec 1, 1994)	no assertion criteria provided	VCV000018046					18046	33085		
SERPINC1, 3-BP DEL	SERPINC1		Antithrombin III deficiency	Pathogenic(Last reviewed: Apr 18, 2003)	no assertion criteria provided	VCV000018045					18045	33084		
NM_000488.3(SERPINC1):c.667T>C (p.Ser223Pro)	SERPINC1	S191P, S223P, S175P	Antithrombin III deficiency	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000018043	1	173879987	1	173910849	18043	33082	rs121909572	NC_000001.11:173910848:A:G
NM_000488.3(SERPINC1):c.655A>G (p.Asn219Asp)	SERPINC1	N187D, N219D, N171D	Antithrombin III deficiency	Pathogenic(Last reviewed: Dec 1, 1994)	no assertion criteria provided	VCV000018042	1	173879999	1	173910861	18042	33081	rs121909571	NC_000001.11:173910860:T:C
NM_000488.3(SERPINC1):c.500A>C (p.Asn167Thr)	SERPINC1	N135T, N167T, N119T	Antithrombin III deficiency	Pathogenic(Last reviewed: Jun 15, 1999)	no assertion criteria provided	VCV000018041	1	173881061	1	173911923	18041	33080	rs121909570	NC_000001.11:173911922:T:G
NM_000488.3(SERPINC1):c.68T>C (p.Leu23Pro)	SERPINC1	L23P	Antithrombin III deficiency	Pathogenic(Last reviewed: Dec 15, 1998)	no assertion criteria provided	VCV000018040	1	173884031	1	173914893	18040	33079	rs387906575	NC_000001.11:173914892:A:G
NM_000488.3(SERPINC1):c.442T>C (p.Ser148Pro)	SERPINC1	S116P, S148P, S100P	Antithrombin III deficiency	Pathogenic(Last reviewed: Mar 1, 1993)	no assertion criteria provided	VCV000018039	1	173881119	1	173911981	18039	33078	rs121909569	NC_000001.11:173911980:A:G
SERPINC1, 1-BP DEL, A, CODON 370	SERPINC1		Antithrombin III deficiency	Pathogenic(Last reviewed: May 4, 1992)	no assertion criteria provided	VCV000018037					18037	33076		
SERPINC1, 1-BP INS, A, CODON 208	SERPINC1		Antithrombin III deficiency	Pathogenic(Last reviewed: May 4, 1992)	no assertion criteria provided	VCV000018036					18036	33075		
SERPINC1, 1-BP INS, T, CODON 48	SERPINC1		Antithrombin III deficiency	Pathogenic(Last reviewed: May 4, 1992)	no assertion criteria provided	VCV000018035					18035	33074		
NM_000488.3(SERPINC1):c.1271G>A (p.Gly424Asp)	SERPINC1	G392D, G424D, G376D	Antithrombin III deficiency	Pathogenic(Last reviewed: Nov 1, 1992)	no assertion criteria provided	VCV000018033	1	173873151	1	173904013	18033	33072	rs121909566	NC_000001.11:173904012:C:T
NM_000488.3(SERPINC1):c.1141T>C (p.Ser381Pro)	SERPINC1	S349P, S381P, S333P	Antithrombin III deficiency	Pathogenic(Last reviewed: Mar 1, 1992)	no assertion criteria provided	VCV000018032	1	173878702	1	173909564	18032	33071	rs121909565	NC_000001.11:173909563:A:G
NM_000488.3(SERPINC1):c.1382C>T (p.Pro461Leu)	SERPINC1	P429L, P461L, P413L	Antithrombin III deficiency	Pathogenic(Last reviewed: Sep 6, 2017)	no assertion criteria provided	VCV000018031	1	173873040	1	173903902	18031	33070	rs121909564	NC_000001.11:173903901:G:A
NM_000488.3(SERPINC1):c.1021_1024del (p.Asp341fs)	SERPINC1	D309K, D293fs, D341fs	Antithrombin III deficiency	Pathogenic(Last reviewed: Nov 1, 1991)	no assertion criteria provided	VCV000018028	1	173878819 - 173878822	1	173909681 - 173909684	18028	33067	rs121909561	NC_000001.11:173909680:CATCCA:CA
NM_000488.3(SERPINC1):c.965_966AG[1] (p.Ser323fs)	SERPINC1	S291P	Antithrombin III deficiency	Pathogenic(Last reviewed: Nov 1, 1991)	no assertion criteria provided	VCV000018027	1	173878875 - 173878876	1	173909737 - 173909738	18027	33066	rs121909560	NC_000001.11:173909736:CTCT:CT
SERPINC1, 2-BP DEL, AG	SERPINC1		Antithrombin III deficiency	Pathogenic(Last reviewed: Aug 15, 1991)	no assertion criteria provided	VCV000018025					18025	33064		
SERPINC1, 1-BP DEL, A	SERPINC1		Antithrombin III deficiency	Pathogenic(Last reviewed: Aug 15, 1991)	no assertion criteria provided	VCV000018024					18024	33063		
NM_000488.3(SERPINC1):c.235C>A (p.Arg79Ser)	SERPINC1	R47S, R79S, R31S	Antithrombin III deficiency	Pathogenic(Last reviewed: Jun 18, 1990)	no assertion criteria provided	VCV000018015	1	173883864	1	173914726	18015	33054	rs121909547	NC_000001.11:173914725:G:T
AT-III Barcelona	SERPINC1		Antithrombin III deficiency	Pathogenic(Last reviewed: Feb 25, 1988)	no assertion criteria provided	VCV000018013					18013	33052		
AT-III Fontainebleu	SERPINC1		Antithrombin III deficiency	Pathogenic(Last reviewed: Aug 20, 1986)	no assertion criteria provided	VCV000018008					18008	33047		
NM_000488.3(SERPINC1):c.379T>C (p.Cys127Arg)	SERPINC1	C95R, C127R, C79R	Antithrombin III deficiency	Pathogenic(Last reviewed: Dec 27, 2002)	no assertion criteria provided	VCV000018044	1	173883720	1	173914582	18044	33083	rs121909573	NC_000001.11:173914581:A:G
NM_000488.3(SERPINC1):c.779dup (p.Phe261fs)	SERPINC1		Antithrombin III deficiency	Pathogenic(Last reviewed: Nov 1, 1991)	no assertion criteria provided	VCV000018026	1	173879063 - 173879064	1	173909925 - 173909926	18026	33065		NC_000001.11:173909925:TTT:TTTT
NM_000488.3(SERPINC1):c.1316C>T (p.Pro439Leu)	SERPINC1	P407L, P439L, P391L	Antithrombin III deficiency	Pathogenic(Last reviewed: Aug 9, 1988)	no assertion criteria provided	VCV000018017	1	173873106	1	173903968	18017	33056	rs121909555	NC_000001.11:173903967:G:A
NM_000488.3(SERPINC1):c.1274G>C (p.Arg425Pro)	SERPINC1	R393P, R425P, R377P	Antithrombin III deficiency	Pathogenic(Last reviewed: Jan 1, 1989)	no assertion criteria provided	VCV000018009	1	173873148	1	173904010	18009	33048	rs121909549	NC_000001.11:173904009:C:G
AT-III Trento	SERPINC1		Antithrombin III deficiency	Pathogenic(Last reviewed: Jan 1, 1986)	no assertion criteria provided	VCV000018006					18006	33045		
AT-III Roma	SERPINC1		Antithrombin III deficiency	Pathogenic(Last reviewed: Nov 1, 1983)	no assertion criteria provided	VCV000018005					18005	33044		
NM_000104.3(CYP1B1):c.535del (p.Ala179fs)	CYP1B1	A179fs	not provided|Congenital glaucoma	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523943	2	38301997	2	38074854	523943	514468	rs771076928	NC_000002.12:38074853:CC:C
NM_000488.3(SERPINC1):c.341G>A (p.Ser114Asn)	SERPINC1	S66N, S114N	Antithrombin III deficiency	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000843350	1	173883758	1	173914620	843350	823020		NC_000001.11:173914619:C:T
NM_002074.5(GNB1):c.976G>A (p.Ala326Thr)	GNB1	A326T, A226T	Neurodevelopmental Disability|hypotonia|Seizures|Intellectual disability|Muscular hypotonia|Generalized tonic-clonic seizures|Global developmental delay|Seizures	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2016)	no assertion criteria provided	VCV000224718	1	1718817	1	1787378	224718	226495	rs869312826	NC_000001.11:1787377:C:T
NM_002074.5(GNB1):c.284T>C (p.Leu95Pro)	GNB1	L95P	hypotonia|Seizures|Neurodevelopmental Disability|Growth delay|Global developmental delay|Failure to thrive|Limb hypertonia|Multifocal epileptiform discharges|Nystagmus|Seizures|Inability to walk|Strabismus|Muscular hypotonia|Expressive language delay|Intellectual disability|Feeding difficulties|Cortical visual impairment	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2016)	no assertion criteria provided	VCV000224716	1	1736004	1	1804565	224716	226497	rs869312824	NC_000001.11:1804564:A:G
NM_002074.5(GNB1):c.228T>G (p.Asp76Glu)	GNB1	D76E	hypotonia|Seizures|Neurodevelopmental Disability|Global developmental delay|Failure to thrive|Limb hypertonia|Focal seizures with impairment of consciousness or awareness|Seizures|Strabismus	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2016)	no assertion criteria provided	VCV000224712	1	1737953	1	1806514	224712	226501	rs869312822	NC_000001.11:1806513:A:C
NM_000488.3(SERPINC1):c.116T>A (p.Ile39Asn)	SERPINC1	I7N, I39N	Antithrombin III deficiency	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000018021	1	173883983	1	173914845	18021	33060	rs121909558	NC_000001.11:173914844:A:T
NM_000488.3(SERPINC1):c.1240G>A (p.Ala414Thr)	SERPINC1	A382T, A414T, A366T	Antithrombin III deficiency	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000018020	1	173873182	1	173904044	18020	33059	rs121909557	NC_000001.11:173904043:C:T
NM_012233.3(RAB3GAP1):c.899+1G>A	RAB3GAP1		Warburg micro syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000100769	2	135883820	2	135126250	100769	106635	rs587777152	NC_000002.12:135126249:G:A
NM_000488.3(SERPINC1):c.1277C>T (p.Ser426Leu)	SERPINC1	S394L, S426L, S378L	Antithrombin III deficiency	Pathogenic(Last reviewed: Apr 6, 1992)	no assertion criteria provided	VCV000018010	1	173873145	1	173904007	18010	33049	rs121909550	NC_000001.11:173904006:G:A
NM_001349206.2(LPIN1):c.942del (p.Pro315fs)	LPIN1	P314fs, P285fs, P328fs, P364fs, P345fs, P279fs, P315fs	Myoglobinuria, acute recurrent, autosomal recessive	Pathogenic(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000807626	2	11919756	2	11779630	807626	798480		NC_000002.12:11779629:G:
NM_145693.4(LPIN1):c.1253_1254GA[3] (p.Asp419fs)	LPIN1		not provided	Pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	VCV000280315	2	11925013 - 11925014	2	11784887 - 11784888	280315	264027	rs886041544	NC_000002.12:11784887:GAGA:GAGAGA
NM_001349206.2(LPIN1):c.1549+2T>C	LPIN1		Myoglobinuria, acute recurrent, autosomal recessive	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000004914	2	11925204	2	11785078	4914	19953	rs730880306	NC_000002.12:11785077:T:C
NM_145693.3(LPIN1):c.2295-?_2513+?del	LPIN1		Myoglobinuria, acute recurrent, autosomal recessive	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000004913	2	11959610 - 11960640	2	11819484 - 11820514	4913	19952		
NM_001349206.2(LPIN1):c.643G>T (p.Glu215Ter)	LPIN1	E215*, E221*, E245*, E264*	Myoglobinuria, acute recurrent, autosomal recessive	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000004910	2	11913792	2	11773666	4910	19949	rs119480071	NC_000002.12:11773665:G:T
NC_000002.12:g.(?_11819484)_(11819598_?)del	LPIN1		not provided	Pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000832773	2	11959610 - 11959724			832773	819045		
NM_001349206.2(LPIN1):c.2509C>T (p.Arg837Ter)	LPIN1	R801*, R827*, R836*, R837*, R886*, R807*, R867*, R850*	not provided|Myoglobinuria, acute recurrent, autosomal recessive	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000004912	2	11959716	2	11819590	4912	19951	rs119480073	NC_000002.12:11819589:C:T
NM_001349206.2(LPIN1):c.1270C>T (p.Arg424Ter)	LPIN1	R388*, R394*, R437*, R454*, R473*, R423*, R424*	not provided|Myoglobinuria, acute recurrent, autosomal recessive	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000004911	2	11923960	2	11783834	4911	19950	rs119480072	NC_000002.12:11783833:C:T
NM_000433.3(NCF2):c.55_63del (p.Lys19_Asp21del)	NCF2		not provided|Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002245	1	183559402 - 183559410	1	183590267 - 183590275	2245	17284	rs796065033	NC_000001.11:183590266:GTCCTTCTTGTCC:GTCC
NM_000447.3(PSEN2):c.717G>A (p.Met239Ile)	PSEN2	M239I	not provided|Alzheimer disease, type 4	Pathogenic(Last reviewed: Dec 23, 2010)	no assertion criteria provided	VCV000008850	1	227076680	1	226888979	8850	23889	rs63749884	NC_000001.11:226888978:G:A
NM_000348.4(SRD5A2):c.16C>T (p.Gln6Ter)	SRD5A2	Q6*	not provided|3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000436859	2	31805954	2	31580885	436859	428054	rs9332960	NC_000002.12:31580884:G:A
NM_000348.4(SRD5A2):c.682G>A (p.Ala228Thr)	SRD5A2	A228T	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003344	2	31754393	2	31529323	3344	18383	rs121434249	NC_000002.12:31529322:C:T
NM_181458.4(PAX3):c.879dup (p.Phe294fs)	PAX3		Waardenburg syndrome type 1|Waardenburg syndrome|Rare genetic deafness	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000505425	2	223086019 - 223086020	2	222221300 - 222221301	505425	496265	rs1553572967	NC_000002.12:222221300:CCCCCC:CCCCCCC
NM_005373.2(MPL):c.1544G>T (p.Trp515Leu)	MPL	W515L	Myelofibrosis with myeloid metaplasia|Congenital amegakaryocytic thrombocytopenia|Thrombocythemia 2, somatic|Hematologic neoplasm	Pathogenic(Last reviewed: Oct 14, 2016)	criteria provided, single submitter	VCV000014164	1	43815009	1	43349338	14164	29203	rs121913615	NC_000001.11:43349337:G:T
NM_005373.2(MPL):c.769C>T (p.Arg257Cys)	MPL	R257C	Congenital amegakaryocytic thrombocytopenia|Congenital amegakaryocytic thrombocytopenia|essential thrombocytemia	Pathogenic(Last reviewed: Sep 28, 2019)	criteria provided, single submitter	VCV000014156	1	43805713	1	43340042	14156	29195	rs121913611	NC_000001.11:43340041:C:T
NM_025216.3(WNT10A):c.383G>A (p.Arg128Gln)	WNT10A	R128Q	Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4|Odonto-onycho-dermal dysplasia|not provided|Tooth agenesis, selective, 4	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000004463	2	219754712	2	218889990	4463	19502	rs121908121	NC_000002.12:218889989:G:A
NM_000488.3(SERPINC1):c.481C>T (p.Arg161Ter)	SERPINC1	R129*, R161*, R113*	Antithrombin III deficiency	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000018029	1	173881080	1	173911942	18029	33068	rs121909562	NC_000001.11:173911941:G:A
NM_014625.4(NPHS2):c.576_577del (p.Ile192fs)	NPHS2	I192fs	Nephrotic syndrome, idiopathic, steroid-resistant	Pathogenic(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000807638	1	179526323 - 179526324	1	179557188 - 179557189	807638	798459		NC_000001.11:179557187:AAA:A
NM_022436.3(ABCG5):c.403-2A>G	ABCG5		not provided	Pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000502521	2	44059008	2	43831869	502521	493945	rs1553372935	NC_000002.12:43831868:T:C
NM_022436.3(ABCG5):c.403-1G>A	ABCG5		not provided	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000501710	2	44059007	2	43831868	501710	493134	rs1158082114	NC_000002.12:43831867:C:T
NM_014625.3(NPHS2):c.452-1G>A	NPHS2		Nephrotic syndrome, idiopathic, steroid-resistant	Pathogenic	no assertion criteria provided	VCV000397592	1	179528897	1	179559762	397592	384472	rs1060499703	NC_000001.11:179559761:C:T
NM_014625.3(NPHS2):c.385C>T (p.Gln129Ter)	NPHS2	Q129*	Nephrotic syndrome, idiopathic, steroid-resistant	Pathogenic(Last reviewed: Nov 12, 2017)	criteria provided, single submitter	VCV000555037	1	179530490	1	179561355	555037	540667	rs755972674	NC_000001.11:179561354:G:A
NM_014625.3(NPHS2):c.115C>T (p.Gln39Ter)	NPHS2	Q39*	Nephrotic syndrome, idiopathic, steroid-resistant	Pathogenic(Last reviewed: Aug 7, 2019)	no assertion criteria provided	VCV000224481	1	179544885	1	179575750	224481	226221	rs869312746	NC_000001.11:179575749:G:A
NM_014625.3(NPHS2):c.479A>G (p.Asp160Gly)	NPHS2	D160G	Nephrotic syndrome, idiopathic, steroid-resistant	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000005367	1	179528869	1	179559734	5367	20406	rs74315346	NC_000001.11:179559733:T:C
NC_000001.11:g.(?_179564680)_(179564803_?)del	NPHS2		not provided	Pathogenic(Last reviewed: May 22, 2019)	criteria provided, single submitter	VCV000832763	1	179533815 - 179533938			832763	818874		
NM_014625.3(NPHS2):c.378+1G>A	NPHS2		Nephrotic syndrome, idiopathic, steroid-resistant	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000553168	1	179533824	1	179564689	553168	540703	rs762631237	NC_000001.11:179564688:C:T
NM_014625.3(NPHS2):c.274G>T (p.Gly92Cys)	NPHS2	G92C	Nephrotic syndrome, idiopathic, steroid-resistant	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000005366	1	179544726	1	179575591	5366	20405	rs74315345	NC_000001.11:179575590:C:A
NPHS2, 1-BP DEL, 419G	NPHS2		Nephrotic syndrome, idiopathic, steroid-resistant	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000005363					5363	20402		
NM_014625.3(NPHS2):c.211C>T (p.Arg71Ter)	NPHS2	R71*	Nephrotic syndrome, idiopathic, steroid-resistant	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000549953	1	179544789	1	179575654	549953	540695	rs1462028977	NC_000001.11:179575653:G:A
NM_014625.3(NPHS2):c.156del (p.Thr53fs)	NPHS2	T53fs	Nephrotic syndrome, idiopathic, steroid-resistant	Pathogenic/Likely pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000495108	1	179544844	1	179575709	495108	486663	rs1272948499	NC_000001.11:179575708:CCCC:CCC
NM_005101.4(ISG15):c.163C>T (p.Gln55Ter)	ISG15	Q55*	Immunodeficiency 38 with basal ganglia calcification	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000183381	1	949523	1	1014143	183381	181485	rs786201005	NC_000001.11:1014142:C:T
NM_005101.4(ISG15):c.339dup (p.Leu114fs)	ISG15		Immunodeficiency 38 with basal ganglia calcification	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000161455	1	949696 - 949697	1	1014316 - 1014317	161455	171289	rs672601345	NC_000001.11:1014316:GGG:GGGG
NM_005101.4(ISG15):c.379G>T (p.Glu127Ter)	ISG15	E127*	Immunodeficiency 38 with basal ganglia calcification	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000161454	1	949739	1	1014359	161454	171288	rs672601312	NC_000001.11:1014358:G:T
NM_000341.4(SLC3A1):c.1354C>T (p.Arg452Trp)	SLC3A1	R452W	Cystinuria	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000336205	2	44539746	2	44312607	336205	289949	rs201502095	NC_000002.12:44312606:C:T
NM_014625.3(NPHS2):c.104dup (p.Arg36fs)	NPHS2		not provided|Nephrotic syndrome, idiopathic, steroid-resistant	Pathogenic(Last reviewed: Sep 11, 2014)	criteria provided, single submitter	VCV000447876	1	179544895 - 179544896	1	179575760 - 179575761	447876	440418	rs1320543506	NC_000001.11:179575760:CC:CCC
NM_000191.3(HMGCL):c.122G>A (p.Arg41Gln)	HMGCL	R41Q	Deficiency of hydroxymethylglutaryl-CoA lyase|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011957	1	24147022	1	23820532	11957	26996	rs121964997	NC_000001.11:23820531:C:T
NC_000001.11:g.(?_173903889)_(173917430_?)del	SERPINC1		Antithrombin III deficiency	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000833112	1	173873027 - 173886568			833112	818873		
NM_000488.3(SERPINC1):c.391C>T (p.Leu131Phe)	SERPINC1	L99F, L131F, L83F	Deep venous thrombosis|Antithrombin III deficiency	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000018034	1	173883708	1	173914570	18034	33073	rs121909567	NC_000001.11:173914569:G:A
NM_000488.3(SERPINC1):c.1274G>A (p.Arg425His)	SERPINC1	R393H, R425H, R377H	Antithrombin III deficiency	Pathogenic(Last reviewed: Oct 1, 1989)	no assertion criteria provided	VCV000018019	1	173873148	1	173904010	18019	33058	rs121909549	NC_000001.11:173904009:C:T
NM_000488.3(SERPINC1):c.1246G>C (p.Ala416Pro)	SERPINC1	A384P, A416P, A368P	Antithrombin III deficiency	Pathogenic(Last reviewed: Aug 15, 1990)	no assertion criteria provided	VCV000018007	1	173873176	1	173904038	18007	33046	rs121909548	NC_000001.11:173904037:C:G
NM_000488.3(SERPINC1):c.1306G>A (p.Ala436Thr)	SERPINC1	A404T, A436T, A388T	Antithrombin III deficiency	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000018003	1	173873116	1	173903978	18003	33042	rs121909546	NC_000001.11:173903977:C:T
NM_000379.4(XDH):c.3520-1G>C	XDH		Deficiency of xanthine oxidase	Pathogenic(Last reviewed: Nov 23, 2018)	no assertion criteria provided	VCV000635517	2	31564261	2	31341395	635517	623270		NC_000002.12:31341394:C:G
NM_000379.4(XDH):c.140dup (p.Cys48fs)	XDH			Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000641114	2	31625970 - 31625971	2	31403104 - 31403105	641114	629952		NC_000002.12:31403104:CCCCCC:CCCCCCC
NM_000379.4(XDH):c.2274del (p.Glu760fs)	XDH	E760fs		Pathogenic(Last reviewed: Apr 10, 2019)	criteria provided, single submitter	VCV000579351	2	31589784	2	31366918	579351	560617	rs760186813	NC_000002.12:31366917:T:
NM_000379.4(XDH):c.3507del (p.Gly1170fs)	XDH	G1170fs		Pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000570826	2	31565061	2	31342195	570826	561464	rs1558674294	NC_000002.12:31342194:T:
NM_000379.4(XDH):c.445C>T (p.Arg149Cys)	XDH	R149C	Deficiency of xanthine oxidase	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000002956	2	31620584	2	31397718	2956	17995	rs72549369	NC_000002.12:31397717:G:A
NM_000379.4(XDH):c.2567del (p.Thr856fs)	XDH	T856fs	Deficiency of xanthine oxidase	Pathogenic(Last reviewed: May 15, 1997)	no assertion criteria provided	VCV000002955	2	31587088	2	31364222	2955	17994		NC_000002.12:31364221:G:
NM_000379.4(XDH):c.682C>T (p.Arg228Ter)	XDH	R228*	Deficiency of xanthine oxidase	Pathogenic(Last reviewed: May 15, 1997)	no assertion criteria provided	VCV000002954	2	31609391	2	31386525	2954	17993	rs119460972	NC_000002.12:31386524:G:A
NM_014625.4(NPHS2):c.535-1G>T	NPHS2		Nephrotic syndrome, idiopathic, steroid-resistant|Hereditary nephrotic syndrome	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000504890	1	179526366	1	179557231	504890	496597	rs1291398331	NC_000001.11:179557230:C:A
NM_012293.3(PXDN):c.1A>G (p.Met1Val)	PXDN	M1V	Anterior segment dysgenesis 7	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000694379	2	1748227	2	1744455	694379	682306		NC_000002.12:1744454:T:C
NM_012293.3(PXDN):c.693_697dup (p.Val233fs)	PXDN		Anterior segment dysgenesis 7	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000694378	2	1683997 - 1683998	2	1680225 - 1680226	694378	682305		NC_000002.12:1680225:CTGAGC:CTGAGCTGAGC
NM_012293.3(PXDN):c.2569del (p.Cys857fs)	PXDN	C857fs	Anterior segment dysgenesis 7	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000694377	2	1652983	2	1649211	694377	682303		NC_000002.12:1649210:A:
NM_012293.3(PXDN):c.4216_4225dup (p.Arg1409delinsProTer)	PXDN		Anterior segment dysgenesis 7	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000694376	2	1639274 - 1639275	2	1635502 - 1635503	694376	682302		NC_000002.12:1635502:GTGATTCAAG:GTGATTCAAGGTGATTCAAG
NM_012293.3(PXDN):c.2276C>T (p.Ser759Leu)	PXDN	S759L	Anterior segment dysgenesis 7	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000694375	2	1653276	2	1649504	694375	682304		NC_000002.12:1649503:G:A
NM_012293.3(PXDN):c.2375_2397del (p.Leu792fs)	PXDN	L792fs	Anterior segment dysgenesis 7	Pathogenic(Last reviewed: Jun 18, 2014)	no assertion criteria provided	VCV000140744	2	1653155 - 1653177	2	1649383 - 1649405	140744	150457	rs587777573	NC_000002.12:1649382:GGACACCAGGCGCGGCATGGGAAGG:GG
NM_012293.3(PXDN):c.2638C>T (p.Arg880Cys)	PXDN	R880C	Anterior segment dysgenesis 7	Pathogenic(Last reviewed: Sep 9, 2011)	no assertion criteria provided	VCV000140742	2	1652914	2	1649142	140742	150455	rs587777572	NC_000002.12:1649141:G:A
NM_012293.3(PXDN):c.1021C>T (p.Arg341Ter)	PXDN	R341*	Anterior segment dysgenesis 7	Pathogenic(Last reviewed: Jun 18, 2014)	no assertion criteria provided	VCV000140743	2	1670256	2	1666484	140743	150456	rs369535598	NC_000002.12:1666483:G:A
NM_012293.3(PXDN):c.2568del (p.Cys857fs)	PXDN	C857fs	Anterior segment dysgenesis 7	Pathogenic(Last reviewed: Sep 9, 2011)	no assertion criteria provided	VCV000140741	2	1652984	2	1649212	140741	150454	rs558163499	NC_000002.12:1649211:GGGGGGG:GGGGGG
NM_001029882.3(AHDC1):c.2898del (p.Tyr967fs)	AHDC1	Y967fs	Global developmental delay|Delayed speech and language development|Intellectual disability|Neonatal hypotonia|Sleep apnea|Delayed speech and language development|Muscular hypotonia|Sleep apnea|Xia-Gibbs syndrome	Pathogenic(Last reviewed: May 1, 2014)	criteria provided, single submitter	VCV000133327	1	27875729	1	27549218	133327	137064	rs587779767	NC_000001.11:27549217:GG:G
NM_014625.3(NPHS2):c.353C>T (p.Pro118Leu)	NPHS2	P118L	Proteinuria|Nephrotic syndrome, idiopathic, steroid-resistant	Pathogenic(Last reviewed: Sep 28, 2015)	criteria provided, single submitter	VCV000222762	1	179533850	1	179564715	222762	224184	rs869025495	NC_000001.11:179564714:G:A
NM_013296.5(GPSM2):c.742del (p.Gly249fs)	GPSM2	G249fs	GPSM2-Related Disorders|not provided|Chudley-McCullough syndrome|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000035492	1	109441560	1	108898938	35492	44165	rs528069912	NC_000001.11:108898937:CC:C
NM_032976.3(CASP10):c.*128_*129insA	CASP10		Non-Hodgkin lymphoma	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000007767	2	202073912 - 202073913	2	201209189 - 201209190	7767	22806	rs398122800	NC_000002.12:201209189::A
NM_032976.3(CASP10):c.*327C>T	CASP10	A414V, A347V, A371V	Non-Hodgkin lymphoma	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000007765	2	202074111	2	201209388	7765	22804	rs28936699	NC_000002.12:201209387:C:T
NM_032977.3(CASP10):c.853C>T (p.Leu285Phe)	CASP10	L285F, P254L, L242F	Autoimmune lymphoproliferative syndrome, type 2A	Pathogenic(Last reviewed: Sep 8, 2011)	no assertion criteria provided	VCV000007764	2	202072837	2	201208114	7764	22803	rs17860403	NC_000002.12:201208113:C:T
NM_000348.4(SRD5A2):c.607G>A (p.Gly203Ser)	SRD5A2	G203S	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000459640	2	31754468	2	31529398	459640	450863	rs9332961	NC_000002.12:31529397:C:T
NM_000348.4(SRD5A2):c.377A>G (p.Gln126Arg)	SRD5A2	Q126R	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372519	2	31758741	2	31533671	372519	359429	rs368386747	NC_000002.12:31533670:T:C
NM_152263.4(TPM3):c.502C>G (p.Arg168Gly)	TPM3	R168G, R131G, R65G, R41G	Nemaline myopathy 1|not provided|Congenital myopathy with fiber type disproportion	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000012453	1	154145448	1	154172972	12453	27492	rs121964854	NC_000001.11:154172971:G:C
NM_000348.4(SRD5A2):c.692A>G (p.His231Arg)	SRD5A2	H231R	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000003346	2	31754383	2	31529313	3346	18385	rs121434251	NC_000002.12:31529312:T:C
NM_001230.5(CASP10):c.685-2146C>T	CASP10	Q257*	Neoplasm of stomach|Non-Hodgkin lymphoma	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000007766	2	202070652	2	201205929	7766	22805	rs121909775	NC_000002.12:201205928:C:T
NM_001298.3(CNGA3):c.1694C>T (p.Thr565Met)	CNGA3	T565M, T547M	Retinal dystrophy	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000867082	2	99013327	2	98396864	867082	856239		NC_000002.12:98396863:C:T
NM_001298.3(CNGA3):c.572G>A (p.Cys191Tyr)	CNGA3	C173Y, C191Y	Retinal dystrophy	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000866560	2	99008332	2	98391869	866560	856226		NC_000002.12:98391868:G:A
NM_001298.3(CNGA3):c.1021T>C (p.Ser341Pro)	CNGA3	S323P, S341P	Retinal dystrophy	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000866559	2	99012654	2	98396191	866559	856231		NC_000002.12:98396190:T:C
NM_001298.3(CNGA3):c.668G>A (p.Arg223Gln)	CNGA3	R205Q, R223Q	Retinal dystrophy	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000865874	2	99008428	2	98391965	865874	856228		NC_000002.12:98391964:G:A
NM_001079878.2(CNGA3):c.1266del (p.Trp422fs)	CNGA3	W440fs, W422fs	not provided	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000498767	2	99012952	2	98396489	498767	490191	rs1553450762	NC_000002.12:98396488:GG:G
NM_001079878.2(CNGA3):c.459G>A (p.Trp153Ter)	CNGA3	W171*, W153*	not provided	Pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	VCV000488683	2	99006184	2	98389721	488683	481667	rs762773298	NC_000002.12:98389720:G:A
NM_001298.3(CNGA3):c.340G>T (p.Glu114Ter)	CNGA3	E114*	not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000860884	2	98996762	2	98380299	860884	827189		NC_000002.12:98380298:G:T
NM_001298.3(CNGA3):c.1294del (p.Asp432fs)	CNGA3	D414fs, D432fs	Achromatopsia	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812282	2	99012926	2	98396463	812282	800483		NC_000002.12:98396462:GG:G
NM_001298.3(CNGA3):c.667C>G (p.Arg223Gly)	CNGA3	R223G, R205G	Achromatopsia	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812278	2	99008427	2	98391964	812278	800479		NC_000002.12:98391963:C:G
NM_001298.3(CNGA3):c.1768G>A (p.Glu590Lys)	CNGA3	E572K, E590K	Achromatopsia 2	Pathogenic(Last reviewed: Jan 29, 2019)	no assertion criteria provided	VCV000800759	2	99013401	2	98396938	800759	788759		NC_000002.12:98396937:G:A
NM_001079878.2(CNGA3):c.1256_1258delinsAG (p.Val419fs)	CNGA3		Achromatopsia 2	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560440	2	99012943 - 99012945	2	98396480 - 98396482	560440	551526	rs1558820471	NC_000002.12:98396479:TTA:AG
NM_001298.3(CNGA3):c.560T>C (p.Ile187Thr)	CNGA3	I169T, I187T	Achromatopsia 2	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812122	2	99006231	2	98389768	812122	800351		NC_000002.12:98389767:T:C
NM_001079878.2(CNGA3):c.931G>T (p.Gly311Cys)	CNGA3	G329C, G311C	Achromatopsia	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000635157	2	99012618	2	98396155	635157	622994	rs1558820134	NC_000002.12:98396154:G:T
NM_001079878.2(CNGA3):c.1266G>A (p.Trp422Ter)	CNGA3	W440*, W422*	Achromatopsia	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000503563	2	99012953	2	98396490	503563	494984	rs1553450764	NC_000002.12:98396489:G:A
NM_001079878.2(CNGA3):c.434C>T (p.Pro145Leu)	CNGA3	P163L, P145L	Achromatopsia 2	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000009473	2	99006159	2	98389696	9473	24512	rs104893612	NC_000002.12:98389695:C:T
NM_001298.3(CNGA3):c.830G>A (p.Arg277His)	CNGA3	R277H, R259H	Retinal dystrophy|Achromatopsia 2	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000800983	2	99012463	2	98396000	800983	788758		NC_000002.12:98395999:G:A
NM_001079878.2(CNGA3):c.1723G>A (p.Glu575Lys)	CNGA3	E593K, E575K	Achromatopsia	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000503564	2	99013410	2	98396947	503564	494985	rs774676415	NC_000002.12:98396946:G:A
NM_001079878.2(CNGA3):c.880_882ATC[2] (p.Ile296del)	CNGA3		Retinal dystrophy|Achromatopsia	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000635158	2	99012565 - 99012567	2	98396102 - 98396104	635158	622993		NC_000002.12:98396101:TCATCATCATC:TCATCATC
NM_001079878.2(CNGA3):c.818C>G (p.Thr273Arg)	CNGA3	T291R, T273R	Retinal dystrophy|Achromatopsia 2	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000009477	2	99012505	2	98396042	9477	24516	rs104893616	NC_000002.12:98396041:C:G
NM_014625.3(NPHS2):c.643C>T (p.Gln215Ter)	NPHS2	Q215*	Nephrotic syndrome, idiopathic, steroid-resistant|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000370159	1	179526257	1	179557122	370159	357003	rs778055996	NC_000001.11:179557121:G:A
NM_002241.5(KCNJ10):c.601G>A (p.Ala201Thr)	KCNJ10	A201T	SeSAME-like syndrome	Pathogenic	no assertion criteria provided	VCV000692217	1	160011722	1	160041932	692217	679959		NC_000001.11:160041931:C:T
NM_002241.5(KCNJ10):c.626T>C (p.Ile209Thr)	KCNJ10	I209T	SeSAME-like syndrome	Pathogenic	no assertion criteria provided	VCV000692216	1	160011697	1	160041907	692216	679958		NC_000001.11:160041906:A:G
NM_002241.5(KCNJ10):c.775del (p.Val258_Val259insTer)	KCNJ10			Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000030253	1	160011548	1	160041758	30253	39209	rs1557967748	NC_000001.11:160041757:CC:C
NM_002241.5(KCNJ10):c.225T>G (p.Phe75Leu)	KCNJ10	F75L		Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000030252	1	160012098	1	160042308	30252	39208	rs757159382	NC_000001.11:160042307:A:C
NM_002241.5(KCNJ10):c.193C>T (p.Arg65Cys)	KCNJ10	R65C		Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000030251	1	160012130	1	160042340	30251	39207	rs387906834	NC_000001.11:160042339:G:A
NM_002241.5(KCNJ10):c.491C>T (p.Thr164Ile)	KCNJ10	T164I		Pathogenic(Last reviewed: Nov 12, 2010)	no assertion criteria provided	VCV000007465	1	160011832	1	160042042	7465	22504	rs137853069	NC_000001.11:160042041:G:A
NM_002241.5(KCNJ10):c.418T>C (p.Cys140Arg)	KCNJ10	C140R		Pathogenic(Last reviewed: Nov 12, 2010)	no assertion criteria provided	VCV000007464	1	160011905	1	160042115	7464	22503	rs137853068	NC_000001.11:160042114:A:G
NM_002241.5(KCNJ10):c.581C>A (p.Pro194His)	KCNJ10	P194H	Enlarged vestibular aqueduct	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000007469	1	160011742	1	160041952	7469	22508	rs137853073	NC_000001.11:160041951:G:T
NM_002241.5(KCNJ10):c.229G>C (p.Gly77Arg)	KCNJ10	G77R		Pathogenic(Last reviewed: Nov 12, 2010)	no assertion criteria provided	VCV000007468	1	160012094	1	160042304	7468	22507	rs137853072	NC_000001.11:160042303:C:G
NM_002241.5(KCNJ10):c.500C>T (p.Ala167Val)	KCNJ10	A167V		Pathogenic(Last reviewed: Nov 12, 2010)	no assertion criteria provided	VCV000007466	1	160011823	1	160042033	7466	22505	rs137853070	NC_000001.11:160042032:G:A
NM_001079878.2(CNGA3):c.901T>C (p.Cys301Arg)	CNGA3	C319R, C301R	not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000191120	2	99012588	2	98396125	191120	188923	rs753625117	NC_000002.12:98396124:T:C
NM_002074.5(GNB1):c.239T>A (p.Ile80Asn)	GNB1	I80N	Mental retardation, autosomal dominant 42|Neurodevelopmental Disability|hypotonia|Seizures|Failure to thrive|Limb hypertonia|Multifocal epileptiform discharges|Infantile muscular hypotonia|Feeding difficulties|Muscular hypotonia|Global developmental delay|Growth delay|Cortical visual impairment|Seizures|Focal seizures with impairment of consciousness or awareness|Acute lymphoid leukemia	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2016)	no assertion criteria provided	VCV000224715	1	1737942	1	1806503	224715	226498	rs752746786	NC_000001.11:1806502:A:T
NM_002074.5(GNB1):c.233A>G (p.Lys78Arg)	GNB1	K78R	Mental retardation, autosomal dominant 42|hypotonia|Seizures|Neurodevelopmental Disability|Growth delay|Global developmental delay|EEG with generalized epileptiform discharges|Seizures|Strabismus|Muscular hypotonia|Infantile muscular hypotonia|Feeding difficulties|not provided	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000224714	1	1737948	1	1806509	224714	226499	rs869312823	NC_000001.11:1806508:T:C
NM_002074.5(GNB1):c.227A>G (p.Asp76Gly)	GNB1	D76G	Mental retardation, autosomal dominant 42|Neurodevelopmental Disability|hypotonia|Seizures|Intellectual disability|Infantile muscular hypotonia|Muscular hypotonia|Global developmental delay|Acute lymphoid leukemia	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2016)	no assertion criteria provided	VCV000224711	1	1737954	1	1806515	224711	226502	rs869312821	NC_000001.11:1806514:T:C
NM_000488.3(SERPINC1):c.1273C>T (p.Arg425Cys)	SERPINC1	R393C, R425C, R377C	Antithrombin III deficiency	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000018016	1	173873149	1	173904011	18016	33055	rs121909554	NC_000001.11:173904010:G:A
NM_002241.5(KCNJ10):c.889C>T (p.Arg297Cys)	KCNJ10	R297C	not provided|	Pathogenic(Last reviewed: May 10, 2017)	criteria provided, single submitter	VCV000007467	1	160011434	1	160041644	7467	22506	rs137853071	NC_000001.11:160041643:G:A
NM_018122.5(DARS2):c.127+1G>A	DARS2		Inborn genetic diseases	Pathogenic(Last reviewed: Nov 12, 2013)	criteria provided, single submitter	VCV000224993	1	173794495	1	173825357	224993	226868	rs869312918	NC_000001.11:173825356:G:A
NM_003193.4(TBCE):c.155_166delGCCACGAAGGGA (p.Ser52_Gly55del)	TBCE		not provided||	Pathogenic/Likely pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000005290	1	235564868 - 235564879	1	235401553 - 235401564	5290	20329	rs767004810	NC_000001.11:235401552:GGGAGCCACGAAGGGA:GGGA
NM_001298.3(CNGA3):c.1315C>T (p.Arg439Trp)	CNGA3	R439W, R421W	Retinal dystrophy|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000860883	2	99012948	2	98396485	860883	827192		NC_000002.12:98396484:C:T
NM_001079878.2(CNGA3):c.1634G>A (p.Arg545His)	CNGA3	R563H, R545H	Retinal dystrophy|not provided|Abnormality of the eye	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000265467	2	99013321	2	98396858	265467	259747	rs552069173	NC_000002.12:98396857:G:A
NM_002241.5(KCNJ10):c.194G>C (p.Arg65Pro)	KCNJ10	R65P	|Spastic diplegia|Bilateral sensorineural hearing impairment|Microcephaly|Cerebellar ataxia|Renal tubular dysfunction	Pathogenic(Last reviewed: Nov 12, 2010)	no assertion criteria provided	VCV000007462	1	160012129	1	160042339	7462	22501	rs137853066	NC_000001.11:160042338:C:G
NM_000341.4(SLC3A1):c.1500+1G>T	SLC3A1		not provided|Cystinuria	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000284275	2	44539893	2	44312754	284275	268512	rs886042834	NC_000002.12:44312753:G:T
NM_012233.3(RAB3GAP1):c.748+1G>A	RAB3GAP1		not provided|Warburg micro syndrome 1	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000007058	2	135878489	2	135120919	7058	22097	rs587776651	NC_000002.12:135120918:G:A
NM_201548.5(CERKL):c.375C>G (p.Cys125Trp)	CERKL	C125W	Retinal dystrophy	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV000866659	2	182468670	2	181603943	866659	856153		NC_000002.12:181603942:G:C
NM_201548.5(CERKL):c.1404del (p.Glu468_Val469insTer)	CERKL		Retinal dystrophy	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000866631	2	182403953	2	181539226	866631	856148		NC_000002.12:181539225:TT:T
NM_201548.5(CERKL):c.1347T>A (p.Tyr449Ter)	CERKL	Y475*, Y336*, Y449*, Y380*, Y431*	not provided	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000291001	2	182409445	2	181544718	291001	275238	rs770284500	NC_000002.12:181544717:A:T
NM_201548.5(CERKL):c.1012C>T (p.Arg338Ter)	CERKL	R364*, R338*, R225*, R269*, R320*	not provided	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000280382	2	182413468	2	181548741	280382	264085	rs748394238	NC_000002.12:181548740:G:A
NM_201548.5(CERKL):c.199_202dup (p.Leu68fs)	CERKL		not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000859926	2	182521531 - 182521532	2	181656804 - 181656805	859926	825456		NC_000002.12:181656804:GTGC:GTGCGTGC
NM_201548.5(CERKL):c.222del (p.Gln74fs)	CERKL	Q74fs	not provided	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000857117	2	182521512	2	181656785	857117	825455		NC_000002.12:181656784:C:
NM_201548.5(CERKL):c.1145del (p.Gly382fs)	CERKL	G269fs, G408fs, G313fs, G364fs, G382fs	not provided	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000842936	2	182412563	2	181547836	842936	825449		NC_000002.12:181547835:CCC:CC
NM_201548.5(CERKL):c.1431_1432insAGTA (p.Gly478fs)	CERKL		not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000841438	2	182403925 - 182403926	2	181539198 - 181539199	841438	825446		NC_000002.12:181539198::TACT
NM_201548.5(CERKL):c.760G>T (p.Glu254Ter)	CERKL	E236*, E254*, E280*	not provided	Pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000838239	2	182423353	2	181558626	838239	825452		NC_000002.12:181558625:C:A
NC_000002.12:g.(?_181544690)_(181544806_?)del	CERKL		not provided	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000831889	2	182409417 - 182409533			831889	819089		
NC_000002.12:g.(?_181565423)_(181566131_?)del	CERKL		not provided	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000830611	2	182430150 - 182430858			830611	819090		
NM_201548.5(CERKL):c.334C>T (p.Gln112Ter)	CERKL	Q112*	not provided	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000656222	2	182468711	2	181603984	656222	629178		NC_000002.12:181603983:G:A
NM_201548.5(CERKL):c.239-2A>G	CERKL		Retinitis pigmentosa 26	Pathogenic(Last reviewed: Oct 11, 2017)	no assertion criteria provided	VCV000522512	2	182468808	2	181604081	522512	513023	rs776886395	NC_000002.12:181604080:T:C
NM_005026.5(PIK3CD):c.1246T>C (p.Cys416Arg)	PIK3CD	C416R, C387R	Immunodeficiency 14	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000132808	1	9779982	1	9719924	132808	136557	rs587777390	NC_000001.11:9719923:T:C
NM_005026.5(PIK3CD):c.1002C>A (p.Asn334Lys)	PIK3CD	N334K, N305K	Immunodeficiency 14	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000132806	1	9777666	1	9717608	132806	136555	rs28730670	NC_000001.11:9717607:C:A
NM_003659.4(AGPS):c.1703C>T (p.Thr568Met)	AGPS	T568M	Rhizomelic chondrodysplasia punctata type 3	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000035469	2	178386002	2	177521274	35469	44138	rs387907214	NC_000002.12:177521273:C:T
NM_003659.4(AGPS):c.1406T>C (p.Leu469Pro)	AGPS	L469P	Rhizomelic chondrodysplasia punctata type 3	Pathogenic(Last reviewed: Jan 15, 2001)	no assertion criteria provided	VCV000006647	2	178364389	2	177499661	6647	21686	rs121434413	NC_000002.12:177499660:T:C
NM_003659.4(AGPS):c.926C>T (p.Thr309Ile)	AGPS	T309I	Rhizomelic chondrodysplasia punctata type 3	Pathogenic(Last reviewed: Jan 15, 2001)	no assertion criteria provided	VCV000006646	2	178326676	2	177461948	6646	21685	rs121434412	NC_000002.12:177461947:C:T
NM_005026.5(PIK3CD):c.1573G>A (p.Glu525Lys)	PIK3CD	E525K, E496K, E524K	Immunodeficiency 14	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000132807	1	9780851	1	9720793	132807	136556	rs587777389	NC_000001.11:9720792:G:A
NM_201548.5(CERKL):c.780del (p.Pro261fs)	CERKL	P261fs, P243fs, P287fs	Retinitis pigmentosa 26	Pathogenic(Last reviewed: Oct 1, 2013)	no assertion criteria provided	VCV000091394	2	182423333	2	181558606	91394	96870	rs398122964	NC_000002.12:181558605:A:
NM_201548.5(CERKL):c.598A>T (p.Lys200Ter)	CERKL	K200*	Retinitis pigmentosa 26	Pathogenic(Last reviewed: Oct 1, 2013)	no assertion criteria provided	VCV000091393	2	182438495	2	181573768	91393	96869	rs398122963	NC_000002.12:181573767:T:A
NM_201548.5(CERKL):c.420del (p.Ile141fs)	CERKL	I141fs	Retinitis pigmentosa 26	Pathogenic(Last reviewed: Oct 1, 2013)	no assertion criteria provided	VCV000091392	2	182468625	2	181603898	91392	96868	rs398122962	NC_000002.12:181603897:AA:A
NM_003659.4(AGPS):c.1256G>A (p.Arg419His)	AGPS	R419H	Rhizomelic chondrodysplasia punctata type 3	Pathogenic(Last reviewed: Apr 24, 1998)	no assertion criteria provided	VCV000006645	2	178357898	2	177493170	6645	21684	rs121434411	NC_000002.12:177493169:G:A
NM_201548.5(CERKL):c.1462G>T (p.Glu488Ter)	CERKL	E419*, E488*, E514*, E470*, E375*	Retinal dystrophy|not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000860317	2	182403895	2	181539168	860317	825444		NC_000002.12:181539167:C:A
NM_201548.5(CERKL):c.98T>G (p.Leu33Ter)	CERKL	L33*	Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000839961	2	182521636	2	181656909	839961	825459		NC_000002.12:181656908:A:C
NM_201548.5(CERKL):c.448_449AT[1] (p.Ile150fs)	CERKL		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812265	2	182468594 - 182468595	2	181603867 - 181603868	812265	800465		NC_000002.12:181603866:ATAT:AT
NM_001044385.3(TMEM237):c.52C>T (p.Arg18Ter)	TMEM237	R18*, R10*	Joubert syndrome 14|Joubert syndrome	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031180	2	202505638	2	201640915	31180	40137	rs199469707	NC_000002.12:201640914:G:A
NM_001079878.2(CNGA3):c.1531G>A (p.Val511Met)	CNGA3	V529M, V511M	not provided|Achromatopsia 2|Achromatopsia	Pathogenic(Last reviewed: May 4, 2016)	criteria provided, single submitter	VCV000009480	2	99013218	2	98396755	9480	24519	rs104893619	NC_000002.12:98396754:G:A
NM_005465.7(AKT3):c.686A>G (p.Asn229Ser)	AKT3	N229S	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2|	Pathogenic(Last reviewed: Aug 8, 2016)	no assertion criteria provided	VCV000039815	1	243776983	1	243613681	39815	48414	rs397514605	NC_000001.11:243613680:T:C
NM_153759.3(DNMT3A):c.325G>T (p.Gly109Trp)	DNMT3A	G109W, G298W, G146W	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 9, 2013)	criteria provided, single submitter	VCV000208714	2	25470582	2	25247713	208714	205233	rs797044904	NC_000002.12:25247712:C:A
NM_015909.4(NBAS):c.5741G>A (p.Arg1914His)	NBAS	R1914H	not provided|Short stature, optic nerve atrophy, and Pelger-Huet anomaly	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000037042	2	15378794	2	15238670	37042	45728	rs369698072	NC_000002.12:15238669:C:T
NM_032504.1(UNC80):c.6695G>A (p.Trp2232Ter)	UNC80	W2232*, W2227*	not provided	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	VCV000424333	2	210806191	2	209941467	424333	405549	rs1064796916	NC_000002.12:209941466:G:A
NM_001371986.1(UNC80):c.3853C>T (p.Arg1285Ter)	UNC80	R1282*, R1287*, R1285*	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801863	2	210742690	2	209877966	801863	790162		NC_000002.12:209877965:C:T
NM_001371986.1(UNC80):c.3358-1G>C	UNC80		Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801862	2	210707073	2	209842349	801862	790161		NC_000002.12:209842348:G:C
NM_032504.1(UNC80):c.8573_8574del (p.Lys2858fs)	UNC80	K2853fs, K2858fs	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000488633	2	210841026 - 210841027	2	209976302 - 209976303	488633	481501	rs1553621490	NC_000002.12:209976301:AG:
NM_002241.5(KCNJ10):c.321_322del (p.Val109fs)	KCNJ10	V109fs		Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000841424	1	160012001 - 160012002	1	160042211 - 160042212	841424	822885		NC_000001.11:160042210:AG:
NM_032504.1(UNC80):c.601-1G>A	UNC80		Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	Pathogenic(Last reviewed: Aug 23, 2018)	no assertion criteria provided	VCV000684717	2	210650789	2	209786065	684717	672301		NC_000002.12:209786064:G:A
NM_032504.1(UNC80):c.5671C>T (p.Arg1891Ter)	UNC80	R1886*, R1891*	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	Pathogenic(Last reviewed: Aug 23, 2018)	no assertion criteria provided	VCV000684715	2	210794657	2	209929933	684715	672220		NC_000002.12:209929932:C:T
NM_182587.4(UNC80):c.1679_1680AC[1] (p.Thr561fs)	UNC80		Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	Pathogenic(Last reviewed: Aug 23, 2018)	no assertion criteria provided	VCV000684714	2	210682662 - 210682663	2	209817938 - 209817939	684714	672219		NC_000002.12:209817937:ACAC:AC
NM_032504.1(UNC80):c.520C>T (p.Arg174Ter)	UNC80	R174*	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	Pathogenic(Last reviewed: Aug 23, 2018)	no assertion criteria provided	VCV000684713	2	210642203	2	209777479	684713	672218		NC_000002.12:209777478:C:T
NM_032504.1(UNC80):c.8116C>T (p.Arg2706Ter)	UNC80	R2701*, R2706*	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	Pathogenic(Last reviewed: Aug 23, 2018)	no assertion criteria provided	VCV000684712	2	210836982	2	209972258	684712	672221		NC_000002.12:209972257:C:T
NM_032504.1(UNC80):c.2527C>T (p.Arg843Ter)	UNC80	R843*, R838*	not provided|UNC80-Related Disorder	Pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000432358	2	210694004	2	209829280	432358	425462	rs74517001	NC_000002.12:209829279:C:T
NM_032504.1(UNC80):c.151C>T (p.Arg51Ter)	UNC80	R51*	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	Pathogenic(Last reviewed: Jun 14, 2016)	no assertion criteria provided	VCV000222017	2	210640622	2	209775898	222017	223707	rs869025320	NC_000002.12:209775897:C:T
NC_000002.12:g.(?_27462701)_(27463181_?)del	IFT172		Retinitis pigmentosa 71|Short-rib thoracic dysplasia 10 with or without polydactyly	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000831594	2	27685568 - 27686048			831594	819150		
NM_015662.3(IFT172):c.811C>T (p.Arg271Ter)	IFT172	R271*	Short-rib thoracic dysplasia 10 with or without polydactyly|Retinitis pigmentosa 71	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000579128	2	27702991	2	27480124	579128	560569	rs1250676888	NC_000002.12:27480123:G:A
NM_015662.3(IFT172):c.3112-5T>A	IFT172		Retinitis pigmentosa 71	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000191370	2	27680627	2	27457760	191370	189175	rs786205858	NC_000002.12:27457759:A:T
NM_015662.3(IFT172):c.770T>C (p.Leu257Pro)	IFT172	L257P	Retinitis pigmentosa 71	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000191369	2	27703928	2	27481061	191369	189174	rs786205857	NC_000002.12:27481060:A:G
NM_015662.3(IFT172):c.1525-1G>A	IFT172		Retinitis pigmentosa 71	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000191367	2	27693963	2	27471096	191367	189172	rs370540673	NC_000002.12:27471095:C:T
NM_015662.3(IFT172):c.3907C>T (p.Arg1303Ter)	IFT172	R1303*	Short-rib thoracic dysplasia 10 with polydactyly	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000097033	2	27676295	2	27453428	97033	102938	rs587777087	NC_000002.12:27453427:G:A
NM_015662.3(IFT172):c.2158del (p.Arg720fs)	IFT172	R720fs	Short-rib thoracic dysplasia 10 without polydactyly	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000097032	2	27684661	2	27461794	97032	102937	rs587777086	NC_000002.12:27461793:GG:G
NM_015662.3(IFT172):c.1232T>A (p.Ile411Asn)	IFT172	I411N	Short-rib thoracic dysplasia 10 with or without polydactyly	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000097031	2	27700177	2	27477310	97031	102936	rs587777085	NC_000002.12:27477309:A:T
NM_015662.3(IFT172):c.1390_1395del (p.Asp464_Ile465del)	IFT172		Short-rib thoracic dysplasia 10 without polydactyly	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000097030	2	27699524 - 27699529	2	27476657 - 27476662	97030	102935	rs587777084	NC_000002.12:27476656:AATATCAATA:AATA
NM_015662.3(IFT172):c.1667_1668AG[4] (p.Val558fs)	IFT172		Short-rib thoracic dysplasia 10 with polydactyly	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000097029	2	27693814 - 27693815	2	27470947 - 27470948	97029	102934	rs587777083	NC_000002.12:27470947:CTCTCTC:CTCTCTCTC
NM_015662.3(IFT172):c.886C>T (p.Arg296Trp)	IFT172	R296W	Short-rib thoracic dysplasia 10 without polydactyly	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000097028	2	27702916	2	27480049	97028	102933	rs145541911	NC_000002.12:27480048:G:A
NM_015662.3(IFT172):c.3228+1G>A	IFT172		Short-rib thoracic dysplasia 10 without polydactyly	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000097027	2	27680505	2	27457638	97027	102932	rs587777082	NC_000002.12:27457637:C:T
NM_015662.3(IFT172):c.2716C>T (p.Gln906Ter)	IFT172	Q906*	Short-rib thoracic dysplasia 10 without polydactyly	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000097026	2	27682316	2	27459449	97026	102931	rs587777081	NC_000002.12:27459448:G:A
NM_015662.3(IFT172):c.4607T>C (p.Leu1536Pro)	IFT172	L1536P	Short-rib thoracic dysplasia 10 without polydactyly	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000097025	2	27670434	2	27447567	97025	102930	rs587777080	NC_000002.12:27447566:A:G
NM_025000.4(DCAF17):c.436del (p.Ala147fs)	DCAF17	A147fs	not provided|Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000209146	2	172305305	2	171448795	209146	205728	rs797045038	NC_000002.12:171448794:C:
NM_001029882.3(AHDC1):c.2547del (p.Ser850fs)	AHDC1	S850fs	Global developmental delay|Delayed speech and language development|Intellectual disability|Neonatal hypotonia|Sleep apnea|Xia-Gibbs syndrome|Delayed speech and language development|Muscular hypotonia|Sleep apnea	Pathogenic(Last reviewed: Oct 29, 2014)	criteria provided, multiple submitters, no conflicts	VCV000133328	1	27876080	1	27549569	133328	137065	rs587779768	NC_000001.11:27549568:GG:G
NM_001029882.3(AHDC1):c.2371_2372TG[1] (p.Cys791fs)	AHDC1		Global developmental delay|Delayed speech and language development|Intellectual disability|Neonatal hypotonia|Sleep apnea|Xia-Gibbs syndrome|not provided|Delayed speech and language development|Muscular hypotonia|Sleep apnea	Pathogenic(Last reviewed: Mar 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000133326	1	27876253 - 27876254	1	27549742 - 27549743	133326	137063	rs587779766	NC_000001.11:27549741:CACA:CA
NM_015662.3(IFT172):c.2765dup (p.Tyr922Ter)	IFT172		Retinitis pigmentosa 71|Short-rib thoracic dysplasia 10 with or without polydactyly|Short rib-polydactyly syndrome, Majewski type	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000446697	2	27682266 - 27682267	2	27459399 - 27459400	446697	440069	rs750338419	NC_000002.12:27459399:T:TT
NM_005876.5(SPEG):c.2915_2916delinsA (p.Ala972fs)	SPEG		Myopathy, centronuclear, 5	Pathogenic(Last reviewed: Aug 7, 2014)	no assertion criteria provided	VCV000144080	2	220331929 - 220331930	2	219467207 - 219467208	144080	153831	rs587777675	NC_000002.12:219467206:CC:A
NM_005876.5(SPEG):c.3709_3715+29del	SPEG		Myopathy, centronuclear, 5	Pathogenic(Last reviewed: Aug 7, 2014)	no assertion criteria provided	VCV000144079	2	220334093 - 220334128	2	219469371 - 219469406	144079	153830	rs587777674	NC_000002.12:219469370:TGACACAGTGTACGTGTCTGGGAAGTTCCCCGGGAGTG:TG
NM_005876.5(SPEG):c.4276C>T (p.Arg1426Ter)	SPEG	R1426*	Myopathy, centronuclear, 5	Pathogenic(Last reviewed: Aug 7, 2014)	no assertion criteria provided	VCV000144078	2	220338454	2	219473732	144078	153829	rs587777673	NC_000002.12:219473731:C:T
NM_032504.1(UNC80):c.4150G>T (p.Glu1384Ter)	UNC80	E1384*, E1379*	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431144	2	210752852	2	209888128	431144	424644	rs981874506	NC_000002.12:209888127:G:T
NM_032504.1(UNC80):c.2399del (p.Leu800fs)	UNC80	L800fs	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431143	2	210690696	2	209825972	431143	424643	rs1135401813	NC_000002.12:209825971:TTT:TT
NM_006912.6(RIT1):c.244T>G (p.Phe82Val)	RIT1	F82V, F99V, F46V	not provided|Noonan syndrome 8|Noonan syndrome	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000183408	1	155874287	1	155904496	183408	181508	rs869025194	NC_000001.11:155904495:A:C
NM_002074.5(GNB1):c.301A>G (p.Met101Val)	GNB1	M101V, M1V	Mental retardation, autosomal dominant 42|not provided|Neurodevelopmental Disability|hypotonia|Seizures|Developmental regression|Expressive language delay|Multifocal epileptiform discharges|Intellectual disability|Muscular hypotonia|Generalized tonic-clonic seizures|Global developmental delay|Seizures|Focal seizures with impairment of consciousness or awareness|EEG with generalized epileptiform discharges	Pathogenic/Likely pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000224717	1	1735987	1	1804548	224717	226496	rs869312825	NC_000001.11:1804547:T:C
NM_001298.3(CNGA3):c.1706G>A (p.Arg569His)	CNGA3	R569H, R551H	Retinal dystrophy|not provided	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000861698	2	99013339	2	98396876	861698	827196		NC_000002.12:98396875:G:A
NM_001079878.2(CNGA3):c.775C>T (p.Arg259Cys)	CNGA3	R277C, R259C	Macular degeneration|Abnormality of color vision|Photophobia|Achromatopsia 2|Achromatopsia	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000009481	2	99012462	2	98395999	9481	24520	rs104893620	NC_000002.12:98395998:C:T
NM_002241.5(KCNJ10):c.595C>T (p.Arg199Ter)	KCNJ10	R199*		Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000007463	1	160011728	1	160041938	7463	22502	rs137853067	NC_000001.11:160041937:G:A
NM_015662.3(IFT172):c.4630C>T (p.Arg1544Cys)	IFT172	R1544C	Joubert syndrome|Short-rib thoracic dysplasia 10 with or without polydactyly	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000097024	2	27670411	2	27447544	97024	102929	rs587777079	NC_000002.12:27447543:G:A
NM_003680.3(YARS1):c.237C>G (p.Tyr79Ter)	YARS1	Y79*	recessive ARS-related multisystem disease	Pathogenic	no assertion criteria provided	VCV000635008	1	33276335	1	32810734	635008	622852		NC_000001.11:32810733:G:C
NM_014053.4(FLVCR1):c.1377dup (p.Gly460fs)	FLVCR1		not provided	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000450232	1	213061898 - 213061899	1	212888556 - 212888557	450232	442711	rs751415272	NC_000001.11:212888556:AA:AAA
NM_007315.3(STAT1):c.1063A>G (p.Asn355Asp)	STAT1	N355D	not provided	Pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000449830	2	191854375	2	190989649	449830	443122	rs1553495184	NC_000002.12:190989648:T:C
NM_014053.4(FLVCR1):c.1093-1G>A	FLVCR1		not provided	Pathogenic(Last reviewed: Apr 24, 2015)	criteria provided, single submitter	VCV000379610	1	213058634	1	212885292	379610	364854	rs1057520666	NC_000001.11:212885291:G:A
NM_007315.4(STAT1):c.1165G>C (p.Val389Leu)	STAT1	V389L	Immunodeficiency 31C	Pathogenic(Last reviewed: Jan 10, 2020)	no assertion criteria provided	VCV000804296	2	191851636	2	190986910	804296	792652		NC_000002.12:190986909:C:G
NM_007315.3(STAT1):c.1151G>A (p.Gly384Asp)	STAT1	G384D	Immunodeficiency 31C	Pathogenic(Last reviewed: Nov 15, 2014)	no assertion criteria provided	VCV000208142	2	191851650	2	190986924	208142	204403	rs796065052	NC_000002.12:190986923:C:T
NM_139266.2(STAT1):c.832A>G (p.Lys278Glu)	STAT1	K278E	Immunodeficiency 31C	Pathogenic(Last reviewed: Nov 15, 2014)	no assertion criteria provided	VCV000208141	2	191859899	2	190995173	208141	204402	rs863223398	NC_000002.12:190995172:T:C
NM_003680.3(YARS1):c.241_242delinsAT (p.Asp81Ile)	YARS1	D81I	Charcot-Marie-Tooth disease, dominant intermediate C	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000187863	1	33276330 - 33276331	1	32810729 - 32810730	187863	185755	rs786204003	NC_000001.11:32810728:TC:AT
NM_007315.3(STAT1):c.1909A>G (p.Lys637Glu)	STAT1	K637E	Immunodeficiency 31a	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000155908	2	191841716	2	190976990	155908	165690	rs587777705	NC_000002.12:190976989:T:C
NM_007315.3(STAT1):c.2018A>G (p.Lys673Arg)	STAT1	K673R	Immunodeficiency 31a	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000155907	2	191841607	2	190976881	155907	165689	rs587777704	NC_000002.12:190976880:T:C
NM_007315.3(STAT1):c.854A>G (p.Gln285Arg)	STAT1	Q285R	Immunodeficiency 31C	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000144005	2	191859877	2	190995151	144005	153736	rs587777629	NC_000002.12:190995150:T:C
NM_007315.3(STAT1):c.537C>A (p.Asn179Lys)	STAT1	N179K	Immunodeficiency 31C	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000144004	2	191864356	2	190999630	144004	153735	rs587777628	NC_000002.12:190999629:G:T
NM_014053.4(FLVCR1):c.1477G>C (p.Gly493Arg)	FLVCR1	G493R	Posterior column ataxia-retinitis pigmentosa syndrome	Pathogenic(Last reviewed: May 1, 2011)	no assertion criteria provided	VCV000030775	1	213062551	1	212889209	30775	39732	rs1558121050	NC_000001.11:212889208:G:C
NM_007315.3(STAT1):c.812A>C (p.Gln271Pro)	STAT1	Q271P	Immunodeficiency 31C	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000030094	2	191859919	2	190995193	30094	39049	rs387906768	NC_000002.12:190995192:T:G
NM_007315.3(STAT1):c.606G>A (p.Met202Ile)	STAT1	M202I	Immunodeficiency 31C	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000030093	2	191862970	2	190998244	30093	39048	rs1559019204	NC_000002.12:190998243:C:T
NM_007315.3(STAT1):c.493G>C (p.Asp165His)	STAT1	D165H	Immunodeficiency 31C	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000030092	2	191864400	2	190999674	30092	39047	rs387906767	NC_000002.12:190999673:C:G
NM_007315.3(STAT1):c.508T>A (p.Tyr170Asn)	STAT1	Y170N	Immunodeficiency 31C	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000030091	2	191864385	2	190999659	30091	39046	rs387906766	NC_000002.12:190999658:A:T
NM_007315.3(STAT1):c.862A>G (p.Thr288Ala)	STAT1	T288A	Immunodeficiency 31C	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000030090	2	191859869	2	190995143	30090	39045	rs387906765	NC_000002.12:190995142:T:C
NM_007315.3(STAT1):c.494A>G (p.Asp165Gly)	STAT1	D165G	Immunodeficiency 31C	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000030089	2	191864399	2	190999673	30089	39044	rs387906764	NC_000002.12:190999672:T:C
NM_007315.3(STAT1):c.604A>G (p.Met202Val)	STAT1	M202V	Immunodeficiency 31C	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000030087	2	191862972	2	190998246	30087	39042	rs387906762	NC_000002.12:190998245:T:C
NM_007315.3(STAT1):c.857A>T (p.Lys286Ile)	STAT1	K286I	Immunodeficiency 31C	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000030086	2	191859874	2	190995148	30086	39041	rs387906761	NC_000002.12:190995147:T:A
NM_007315.3(STAT1):c.603G>T (p.Lys201Asn)	STAT1	K201N	Mycobacterial and viral infections, susceptibility to, autosomal recessive	Pathogenic(Last reviewed: Dec 23, 2010)	no assertion criteria provided	VCV000030082	2	191862973	2	190998247	30082	39037	rs587776870	NC_000002.12:190998246:C:A
NM_014053.4(FLVCR1):c.574T>C (p.Cys192Arg)	FLVCR1	C192R	Posterior column ataxia-retinitis pigmentosa syndrome	Pathogenic(Last reviewed: Nov 12, 2010)	no assertion criteria provided	VCV000018420	1	213032368	1	212859026	18420	33459	rs267606821	NC_000001.11:212859025:T:C
NM_007315.3(STAT1):c.1927dup (p.Thr643fs)	STAT1		Mycobacterial and viral infections, susceptibility to, autosomal recessive	Pathogenic(Last reviewed: Apr 15, 2006)	no assertion criteria provided	VCV000009048	2	191841697 - 191841698	2	190976971 - 190976972	9048	24087	rs587776714	NC_000002.12:190976971:T:TT
NM_007315.3(STAT1):c.958G>C (p.Glu320Gln)	STAT1	E320Q	Immunodeficiency 31a	Pathogenic(Last reviewed: Aug 18, 2006)	no assertion criteria provided	VCV000009047	2	191856033	2	190991307	9047	24086	rs137852680	NC_000002.12:190991306:C:G
NM_007315.3(STAT1):c.1389G>T (p.Gln463His)	STAT1	Q463H	Immunodeficiency 31a	Pathogenic(Last reviewed: Aug 18, 2006)	no assertion criteria provided	VCV000009046	2	191848425	2	190983699	9046	24085	rs137852679	NC_000002.12:190983698:C:A
NM_007315.3(STAT1):c.1799T>C (p.Leu600Pro)	STAT1	L600P	Mycobacterial and viral infections, susceptibility to, autosomal recessive	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000009045	2	191843656	2	190978930	9045	24084	rs137852678	NC_000002.12:190978929:A:G
NM_139266.2(STAT1):c.1758_1759AG[1] (p.Glu587fs)	STAT1		Mycobacterial and viral infections, susceptibility to, autosomal recessive	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000009044	2	191843694 - 191843695	2	190978968 - 190978969	9044	24083	rs587776713	NC_000002.12:190978967:CTCTC:CTC
NM_007315.3(STAT1):c.2117T>C (p.Leu706Ser)	STAT1	L706S	Immunodeficiency 31a	Pathogenic(Last reviewed: Jul 13, 2001)	no assertion criteria provided	VCV000009043	2	191840556	2	190975830	9043	24082	rs137852677	NC_000002.12:190975829:A:G
NM_003680.3(YARS1):c.458_469del (p.Val153_Val156del)	YARS1		Charcot-Marie-Tooth disease, dominant intermediate C	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000006190	1	33272124 - 33272135	1	32806523 - 32806534	6190	21229	rs786200893	NC_000001.11:32806522:CCACCTGCTTTACCACCT:CCACCT
NM_014053.4(FLVCR1):c.721G>A (p.Ala241Thr)	FLVCR1	A241T	Posterior column ataxia-retinitis pigmentosa syndrome	Pathogenic(Last reviewed: Nov 12, 2010)	no assertion criteria provided	VCV000018419	1	213032515	1	212859173	18419	33458	rs267606819	NC_000001.11:212859172:G:A
NM_000341.4(SLC3A1):c.808C>T (p.Arg270Ter)	SLC3A1	R270*	Cystinuria	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000336195	2	44513213	2	44286074	336195	286483	rs200483989	NC_000002.12:44286073:C:T
NM_001079866.2(BCS1L):c.296C>T (p.Pro99Leu)	BCS1L	P99L	not provided|Leigh syndrome due to mitochondrial complex III deficiency|GRACILE syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006164	2	219526006	2	218661283	6164	21203	rs121908572	NC_000002.12:218661282:C:T
NM_152490.5(B3GALNT2):c.770dup (p.Ala259fs)	B3GALNT2		not provided	Pathogenic(Last reviewed: Jun 11, 2015)	criteria provided, single submitter	VCV000419141	1	235629023 - 235629024	1	235465706 - 235465707	419141	405084	rs1064793673	NC_000001.11:235465706:T:TT
NM_152490.5(B3GALNT2):c.199C>T (p.Arg67Ter)	B3GALNT2	R108*, R67*	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000847124	1	235658052	1	235494742	847124	823545		NC_000001.11:235494741:G:A
NM_152490.5(B3GALNT2):c.699del (p.Val234fs)	B3GALNT2	V234fs, V275fs	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000648191	1	235634227	1	235470913	648191	627443		NC_000001.11:235470912:AA:A
NM_152490.5(B3GALNT2):c.448C>T (p.Arg150Ter)	B3GALNT2	R150*, R191*	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11	Pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	VCV000578921	1	235647745	1	235484429	578921	557130	rs1282726649	NC_000001.11:235484428:G:A
NC_000001.10:g.(?_235628916)_(235629051_?)del	B3GALNT2		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000540919	1	235628916 - 235629051	1	235465599 - 235465734	540919	514886		
NM_152490.5(B3GALNT2):c.1223del (p.Pro408fs)	B3GALNT2	P408fs	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000540913	1	235617556	1	235454244	540913	515634	rs1553342786	NC_000001.11:235454243:GGG:GG
NM_152490.5(B3GALNT2):c.763-1G>A	B3GALNT2		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560963	1	235629032	1	235465715	560963	552041	rs780433836	NC_000001.11:235465714:C:T
NM_152490.5(B3GALNT2):c.51_73dup (p.Ser25fs)	B3GALNT2		not provided|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000132979	1	235667479 - 235667480	1	235504179 - 235504180	132979	136728	rs367543069	NC_000001.11:235504179:AGCGCAGCCGCAGCCAGAGGTGCAGCGC:AGCGCAGCCGCAGCCAGAGGTGCAGCGCAGCCGCAGCCAGAGGTGCAGCGC
NM_152490.5(B3GALNT2):c.306_307TG[1] (p.Val103fs)	B3GALNT2		Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11|not provided	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000041936	1	235652525 - 235652526	1	235489220 - 235489221	41936	51102	rs367543070	NC_000001.11:235489219:CACA:CA
NM_152490.5(B3GALNT2):c.755T>G (p.Val252Gly)	B3GALNT2	V252G, V293G	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000041937	1	235634171	1	235470857	41937	51103	rs367543073	NC_000001.11:235470856:A:C
NM_152490.5(B3GALNT2):c.875G>C (p.Arg292Pro)	B3GALNT2	R292P	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000041935	1	235622061	1	235458753	41935	51101	rs367543076	NC_000001.11:235458752:C:G
NM_152490.5(B3GALNT2):c.740G>A (p.Gly247Glu)	B3GALNT2	G247E, G288E	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000041934	1	235634186	1	235470872	41934	51100	rs367543072	NC_000001.11:235470871:C:T
NM_007315.3(STAT1):c.88del (p.Ile30fs)	STAT1	I30fs	not provided|Mycobacterial and viral infections, susceptibility to, autosomal recessive	Pathogenic(Last reviewed: Dec 16, 2015)	criteria provided, multiple submitters, no conflicts	VCV000285493	2	191874642	2	191009916	285493	269730	rs886043118	NC_000002.12:191009915:TTT:TT
NM_005105.4(RBM8A):c.487C>T (p.Arg163Ter)	RBM8A	R163*	Radial aplasia-thrombocytopenia syndrome	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000030467	1	145509173	1	145925920	30467	39424	rs397515389	NC_000001.11:145925919:G:A
NM_005105.5(RBM8A):c.207_208insAGCG (p.Val70fs)	RBM8A		Radial aplasia-thrombocytopenia syndrome	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000030466	1	145508476 - 145508477	1	145926616 - 145926617	30466	39423	rs397515388	NC_000001.11:145926616::CGCT
NM_201548.5(CERKL):c.967_968del (p.Met323fs)	CERKL	M349fs, M323fs, M210fs, M305fs, M254fs	not provided|Retinal dystrophy	Pathogenic(Last reviewed: Oct 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000236491	2	182413512 - 182413513	2	181548785 - 181548786	236491	238003	rs750151209	NC_000002.12:181548784:AT:
NM_005105.5(RBM8A):c.205+3_205+6del	RBM8A		Radial aplasia-thrombocytopenia syndrome	Pathogenic(Last reviewed: Nov 2, 2019)	no assertion criteria provided	VCV000864872	1	145508285 - 145508288	1	145926803 - 145926806	864872	855120		NC_000001.11:145926802:ACTCAC:AC
NM_005105.5(RBM8A):c.206-13C>A	RBM8A		Radial aplasia-thrombocytopenia syndrome	Pathogenic(Last reviewed: Nov 2, 2019)	no assertion criteria provided	VCV000864871	1	145508462	1	145926631	864871	855119		NC_000001.11:145926630:G:T
NM_001298.3(CNGA3):c.1114C>T (p.Pro372Ser)	CNGA3	P372S, P354S	not provided|Achromatopsia	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, single submitter	VCV000812281	2	99012747	2	98396284	812281	800482		NC_000002.12:98396283:C:T
NM_001298.3(CNGA3):c.778G>A (p.Asp260Asn)	CNGA3	D260N, D242N	Achromatopsia 2|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000689726	2	99012411	2	98395948	689726	677413		NC_000002.12:98395947:G:A
NM_001079878.2(CNGA3):c.67C>T (p.Arg23Ter)	CNGA3	R23*	Achromatopsia|Achromatopsia 2	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000337652	2	98986505	2	98370042	337652	291347	rs777509481	NC_000002.12:98370041:C:T
NC_000001.10:g.(?_145507647)_(145509231_?)del	RBM8A		Radial aplasia-thrombocytopenia syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000528377	1	145507647 - 145509231			528377	514860		
NM_005373.2(MPL):c.235_236del (p.Leu79fs)	MPL	L79fs	essential thrombocytemia|Congenital amegakaryocytic thrombocytopenia|Congenital amegakaryocytic thrombocytopenia|not specified	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000134822	1	43804235 - 43804236	1	43338564 - 43338565	134822	138561	rs587778514	NC_000001.11:43338563:CT:
NM_015215.4(CAMTA1):c.4099_4100AG[2] (p.Glu1368fs)	CAMTA1		not provided	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000817198	1	7798459 - 7798460	1	7738399 - 7738400	817198	805229		NC_000001.11:7738398:AGAGAG:AGAG
GRCh37/hg19 1p36.23(chr1:7235627-7605511)x1	CAMTA1		not provided	Pathogenic(Last reviewed: May 31, 2019)	no assertion criteria provided	VCV000814049	1	7235627 - 7605511			814049	802262		
NM_015215.4(CAMTA1):c.2639G>A (p.Trp880Ter)	CAMTA1	W880*, W850*	Cerebellar ataxia, nonprogressive, with mental retardation	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801430	1	7725246	1	7665186	801430	789998		NC_000001.11:7665185:G:A
NM_015215.4(CAMTA1):c.2446del (p.Gln816fs)	CAMTA1	Q786fs, Q816fs	not provided	Pathogenic(Last reviewed: Apr 4, 2018)	criteria provided, single submitter	VCV000524037	1	7725051	1	7664991	524037	514433	rs1553240332	NC_000001.11:7664990:CCC:CC
NM_015215.4(CAMTA1):c.613G>T (p.Glu205Ter)	CAMTA1	E205*, E175*	not provided	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000450600	1	7700562	1	7640502	450600	442886	rs1553231167	NC_000001.11:7640501:G:T
NM_015215.4(CAMTA1):c.627del (p.Lys208_Trp209insTer)	CAMTA1		not provided	Pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, single submitter	VCV000426685	1	7700575	1	7640515	426685	414810	rs1085307743	NC_000001.11:7640514:GG:G
NM_015215.4(CAMTA1):c.882_883insCG (p.Gly295fs)	CAMTA1		not provided	Pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	VCV000421507	1	7723489 - 7723490	1	7663429 - 7663430	421507	405236	rs1064795180	NC_000001.11:7663429::CG
NM_015215.4(CAMTA1):c.1132dup (p.Val378fs)	CAMTA1		not provided	Pathogenic(Last reviewed: Jan 3, 2017)	criteria provided, single submitter	VCV000418106	1	7723737 - 7723738	1	7663677 - 7663678	418106	405237	rs1553239242	NC_000001.11:7663677:GG:GGG
NM_015215.4(CAMTA1):c.882del (p.Tyr297fs)	CAMTA1	Y267fs, Y297fs	not provided	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000280872	1	7723489	1	7663429	280872	264028	rs886041999	NC_000001.11:7663428:A:
NM_015215.4(CAMTA1):c.4231C>T (p.Arg1411Ter)	CAMTA1	R1411*, R322*, R1298*, R1268*, R435*, R1381*, R454*	not provided	Pathogenic(Last reviewed: Mar 9, 2016)	criteria provided, single submitter	VCV000280426	1	7804943	1	7744883	280426	264023	rs886041635	NC_000001.11:7744882:C:T
NM_015215.4(CAMTA1):c.4210del (p.Ile1404fs)	CAMTA1	I1261fs, I1404fs, I1291fs, I1374fs, I315fs, I428fs, I447fs	not provided	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000658467	1	7804922	1	7744862	658467	628259		NC_000001.11:7744861:A:
CAMTA1, 49-KB DEL, EX2-3	CAMTA1		Cerebellar ataxia, nonprogressive, with mental retardation	Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	VCV000037008					37008	45674		
CAMTA1, 539-KB DUP, EX3-5	CAMTA1		Cerebellar ataxia, nonprogressive, with mental retardation	Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	VCV000037007					37007	45673		
CAMTA1, 81-KB DEL, EX4	CAMTA1		Cerebellar ataxia, nonprogressive, with mental retardation	Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	VCV000037006					37006	45672		
NM_015215.4(CAMTA1):c.511-18459_511-15460del	CAMTA1		Cerebellar ataxia, nonprogressive, with mental retardation	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000599309	1	7682001 - 7685000	1	7621941 - 7624940	599309	590571		
NM_003680.3(YARS1):c.586G>C (p.Glu196Gln)	YARS1	E196Q	Charcot-Marie-Tooth disease, dominant intermediate C	Pathogenic/Likely pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000243071	1	33263369	1	32797768	243071	244151	rs121908834	NC_000001.11:32797767:C:G
GRCh37/hg19 2q31.1(chr2:175578577-175617380)x1	CHRNA1		not provided	Pathogenic(Last reviewed: Mar 13, 2018)	no assertion criteria provided	VCV000688740	2	175578577 - 175617380			688740	676332		
GRCh37/hg19 2q31.1(chr2:175578577-175617380)x1	CHRNA1		not provided	Pathogenic(Last reviewed: Jun 15, 2018)	no assertion criteria provided	VCV000687895	2	175578577 - 175617380			687895	675487		
NM_001039523.3(CHRNA1):c.175C>T (p.Gln59Ter)	CHRNA1	Q59*	not provided	Pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, single submitter	VCV000429993	2	175624230	2	174759502	429993	421322	rs750329103	NC_000002.12:174759501:G:A
NM_000079.4(CHRNA1):c.370A>T (p.Lys124Ter)	CHRNA1	K124*, K149*	Lethal multiple pterygium syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000863215	2	175619117	2	174754389	863215	825251		NC_000002.12:174754388:T:A
Single allele	CHRNA1		Lethal multiple pterygium syndrome	Pathogenic(Last reviewed: Dec 14, 2016)	criteria provided, single submitter	VCV000466174			2	174747592 - 174754414	466174	448551		
NM_001039523.3(CHRNA1):c.812C>A (p.Ser271Tyr)	CHRNA1	S271Y, S246Y	Myasthenic syndrome, slow-channel congenital	Pathogenic(Last reviewed: Jun 15, 1999)	no assertion criteria provided	VCV000135654	2	175618272	2	174753544	135654	139372	rs483353046	NC_000002.12:174753543:G:T
CHRNA1, 17-BP DUP, NT117	CHRNA1		Lethal multiple pterygium syndrome	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000018389					18389	33428		
NM_001039523.3(CHRNA1):c.761G>T (p.Arg254Leu)	CHRNA1	R254L, R229L	Lethal multiple pterygium syndrome	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000018388	2	175618323	2	174753595	18388	33427	rs137852809	NC_000002.12:174753594:C:A
CHRNA1, IVS3AS, G-A, -8	CHRNA1		Congenital myasthenic syndrome 1B, fast-channel	Pathogenic(Last reviewed: Dec 15, 2008)	no assertion criteria provided	VCV000029581					29581	38535		
NM_001039523.3(CHRNA1):c.1389C>G (p.Cys463Trp)	CHRNA1	C418W, C438W, C463W	Myasthenic syndrome, slow-channel congenital	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000018387	2	175612912	2	174748184	18387	33426	rs137852808	NC_000002.12:174748183:G:C
CHRNA1, 1-BP DEL, 381C	CHRNA1		Congenital myasthenic syndrome 1B, fast-channel	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000018386					18386	33425		
NM_001039523.3(CHRNA1):c.529G>C (p.Val177Leu)	CHRNA1	V132L, V152L, V177L	Congenital myasthenic syndrome 1B, fast-channel	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000018385	2	175619033	2	174754305	18385	33424	rs137852807	NC_000002.12:174754304:C:G
NM_001039523.3(CHRNA1):c.832T>G (p.Phe278Val)	CHRNA1	F233V, F253V, F278V	Congenital myasthenic syndrome 1B, fast-channel	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000018383	2	175618252	2	174753524	18383	33422	rs137852805	NC_000002.12:174753523:A:C
NM_001039523.3(CHRNA1):c.988G>A (p.Val330Ile)	CHRNA1	V285I, V305I, V330I	Congenital myasthenic syndrome 1B, fast-channel	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000018382	2	175614763	2	174750035	18382	33421	rs137852804	NC_000002.12:174750034:C:T
NM_001039523.3(CHRNA1):c.601G>A (p.Val201Met)	CHRNA1	V156M, V176M, V201M	Myasthenic syndrome, slow-channel congenital	Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	VCV000018377	2	175618961	2	174754233	18377	33416	rs137852799	NC_000002.12:174754232:C:T
NM_001039523.3(CHRNA1):c.786C>G (p.Asn262Lys)	CHRNA1	N217K, N237K, N262K	Myasthenic syndrome, slow-channel congenital	Pathogenic(Last reviewed: Sep 1, 1996)	no assertion criteria provided	VCV000018376	2	175618298	2	174753570	18376	33415	rs137852798	NC_000002.12:174753569:G:C
NM_001039523.3(CHRNA1):c.786C>A (p.Asn262Lys)	CHRNA1	N237K, N262K	Lethal multiple pterygium syndrome	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000466184	2	175618298	2	174753570	466184	448991	rs137852798	NC_000002.12:174753569:G:T
NM_001039523.3(CHRNA1):c.901T>C (p.Phe301Leu)	CHRNA1	F256L, F276L, F301L	Congenital myasthenic syndrome 1B, fast-channel	Pathogenic(Last reviewed: Apr 13, 2004)	no assertion criteria provided	VCV000018384	2	175614850	2	174750122	18384	33423	rs137852806	NC_000002.12:174750121:A:G
NM_001039523.3(CHRNA1):c.941G>T (p.Ser314Ile)	CHRNA1	S269I, S289I, S314I	Myasthenic syndrome, slow-channel congenital	Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	VCV000018380	2	175614810	2	174750082	18380	33419	rs137852802	NC_000002.12:174750081:C:A
NM_001039523.3(CHRNA1):c.896C>T (p.Thr299Ile)	CHRNA1	T254I, T274I, T299I	Myasthenic syndrome, slow-channel congenital	Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	VCV000018378	2	175614855	2	174750127	18378	33417	rs137852800	NC_000002.12:174750126:G:A
NM_002437.5(MPV17):c.149G>A (p.Arg50Gln)	MPV17	R50Q	not provided|Navajo neurohepatopathy	Pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016160	2	27535898	2	27313031	16160	31199	rs121909721	NC_000002.12:27313030:C:T
NM_014140.3(SMARCAL1):c.1483C>T (p.Gln495Ter)	SMARCAL1	Q495*	not provided	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000504092	2	217297589	2	216432866	504092	495123	rs1553526228	NC_000002.12:216432865:C:T
NM_001127207.2(SMARCAL1):c.723C>A (p.Cys241Ter)	SMARCAL1	C241*	Atrioventricular septal defect|Decreased body weight|Small for gestational age|Disproportionate short-trunk short stature|Microcephaly|Short stature|Focal segmental glomerulosclerosis|Congenital microcephaly|Steroid-resistant nephrotic syndrome	Pathogenic(Last reviewed: Mar 4, 2014)	criteria provided, single submitter	VCV000374208	2	217280150	2	216415427	374208	360834	rs748106387	NC_000002.12:216415426:C:A
NM_014140.3(SMARCAL1):c.1132G>T (p.Glu378Ter)	SMARCAL1	E378*	Schimke immuno-osseous dysplasia	Pathogenic(Last reviewed: Dec 15, 2015)	criteria provided, single submitter	VCV000218374	2	217288391	2	216423668	218374	215101	rs864309531	NC_000002.12:216423667:G:T
NM_014140.4(SMARCAL1):c.786dup (p.Lys263Ter)	SMARCAL1		Schimke immuno-osseous dysplasia	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000857239	2	217280210 - 217280211	2	216415487 - 216415488	857239	825719		NC_000002.12:216415487:TTT:TTTT
NC_000002.11:g.(?_217279418)_(217281040_?)del	SMARCAL1		Schimke immuno-osseous dysplasia	Pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000652386	2	217279418 - 217281040	2	216414695 - 216416317	652386	650796		
NM_001127207.2(SMARCAL1):c.268_269CA[1] (p.His90fs)	SMARCAL1		Schimke immuno-osseous dysplasia	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000642307	2	217279695 - 217279696	2	216414972 - 216414973	642307	629437		NC_000002.12:216414971:CACA:CA
NM_014140.3(SMARCAL1):c.2321C>A (p.Ser774Ter)	SMARCAL1	S774*	Schimke immuno-osseous dysplasia	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	VCV000463148	2	217340068	2	216475345	463148	450693	rs149425324	NC_000002.12:216475344:C:A
SMARCAL1, 4-BP DEL, 1146AAGT	SMARCAL1		Schimke immuno-osseous dysplasia	Pathogenic(Last reviewed: Dec 1, 2004)	no assertion criteria provided	VCV000004177					4177	19216		
NM_014140.3(SMARCAL1):c.1643T>A (p.Ile548Asn)	SMARCAL1	I548N	Schimke immuno-osseous dysplasia	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000004174	2	217300218	2	216435495	4174	19213	rs119473036	NC_000002.12:216435494:T:A
NM_014140.3(SMARCAL1):c.100C>T (p.Gln34Ter)	SMARCAL1	Q34*	Schimke immuno-osseous dysplasia	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000004173	2	217279527	2	216414804	4173	19212	rs119473035	NC_000002.12:216414803:C:T
NM_201548.5(CERKL):c.238+1G>A	CERKL		Retinitis pigmentosa|not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000812266	2	182521495	2	181656768	812266	800687		NC_000002.12:181656767:C:T
NM_014140.4(SMARCAL1):c.1248dup (p.Thr417fs)	SMARCAL1		Schimke immuno-osseous dysplasia	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000649815	2	217293418 - 217293419	2	216428695 - 216428696	649815	629442		NC_000002.12:216428695:C:CC
NM_014140.3(SMARCAL1):c.1190del (p.Leu397fs)	SMARCAL1	L397fs	Schimke immuno-osseous dysplasia	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000577921	2	217293361	2	216428638	577921	557925	rs766291662	NC_000002.12:216428637:T:
NM_014140.3(SMARCAL1):c.1756C>T (p.Arg586Trp)	SMARCAL1	R586W	Schimke immuno-osseous dysplasia	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000004176	2	217311786	2	216447063	4176	19215	rs119473038	NC_000002.12:216447062:C:T
NM_014140.3(SMARCAL1):c.49C>T (p.Arg17Ter)	SMARCAL1	R17*	Schimke immuno-osseous dysplasia	Pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, single submitter	VCV000004172	2	217279476	2	216414753	4172	19211	rs119473034	NC_000002.12:216414752:C:T
NM_001042681.2(RERE):c.4307_4312TCCACC[3] (p.1436_1437LH[3])	RERE		not provided|CHARGE association|Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	Pathogenic(Last reviewed: Feb 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000418456	1	8418276 - 8418277	1	8358216 - 8358217	418456	405245	rs1064793252	NC_000001.11:8358216:GGTGGAGGTGGAGGTGG:GGTGGAGGTGGAGGTGGAGGTGG
NM_152263.4(TPM3):c.26T>G (p.Met9Arg)	TPM3	M9R	Nemaline myopathy 1|not provided	Pathogenic(Last reviewed: Mar 15, 2012)	no assertion criteria provided	VCV000012446	1	154164469	1	154191993	12446	27485	rs80358247	NC_000001.11:154191992:A:C
NM_015100.4(POGZ):c.375dup (p.Leu126fs)	POGZ		not provided	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000818061	1	151403225 - 151403226	1	151430749 - 151430750	818061	805159		NC_000001.11:151430749:T:TT
NM_015100.4(POGZ):c.2164dup (p.Met722fs)	POGZ		not provided	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000817871	1	151380954 - 151380955	1	151408478 - 151408479	817871	805156		NC_000001.11:151408478:TT:TTT
NM_015100.4(POGZ):c.3321del (p.Phe1107fs)	POGZ	F1012fs, F1045fs, F1054fs, F1098fs, F1107fs	not provided	Pathogenic(Last reviewed: Jul 16, 2019)	criteria provided, single submitter	VCV000817848	1	151378190	1	151405714	817848	805152		NC_000001.11:151405713:AAAA:AAA
NM_015100.4(POGZ):c.1558_1559delinsT (p.Asp520fs)	POGZ		not provided	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000817835	1	151395992 - 151395993	1	151423516 - 151423517	817835	805158		NC_000001.11:151423515:TC:A
NM_015100.4(POGZ):c.3307_3308CT[1] (p.Phe1104fs)	POGZ		not provided	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000817667	1	151378201 - 151378202	1	151405725 - 151405726	817667	805153		NC_000001.11:151405724:AGAG:AG
NM_015100.4(POGZ):c.1809dup (p.Glu604Ter)	POGZ		not provided	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000817576	1	151384217 - 151384218	1	151411741 - 151411742	817576	805157		NC_000001.11:151411741:A:AA
NM_015100.4(POGZ):c.3621del (p.Trp1208fs)	POGZ	W1113fs, W1199fs, W1208fs, W1146fs, W1155fs	not provided	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	VCV000817105	1	151377890	1	151405414	817105	805151		NC_000001.11:151405413:C:
NM_015100.4(POGZ):c.125-1G>T	POGZ		White-sutton syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801546	1	151413563	1	151441087	801546	789844		NC_000001.11:151441086:C:A
NM_015100.4(POGZ):c.460-1G>A	POGZ		White-sutton syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801545	1	151402188	1	151429712	801545	789843		NC_000001.11:151429711:C:T
NM_015100.4(POGZ):c.1522C>T (p.Arg508Ter)	POGZ	R508*, R455*, R446*, R413*, R499*	not provided	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000620444	1	151396426	1	151423950	620444	611484	rs1557901051	NC_000001.11:151423949:G:A
NM_015100.4(POGZ):c.712C>T (p.Arg238Ter)	POGZ	R238*, R185*, R143*	not provided	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000620406	1	151400746	1	151428270	620406	611486	rs1557910873	NC_000001.11:151428269:G:A
NM_015100.4(POGZ):c.2914C>T (p.Gln972Ter)	POGZ	Q972*, Q910*, Q877*, Q919*, Q963*	not provided	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000620278	1	151378597	1	151406121	620278	611483	rs1557866540	NC_000001.11:151406120:G:A
NM_015100.4(POGZ):c.1048dup (p.Arg350fs)	POGZ		not provided	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000593228	1	151400328 - 151400329	1	151427852 - 151427853	593228	584292	rs1557909170	NC_000001.11:151427852:TTT:TTTT
NM_015100.4(POGZ):c.2556G>A (p.Trp852Ter)	POGZ	W852*, W757*, W790*, W799*, W843*	not provided	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000523834	1	151379097	1	151406621	523834	514414	rs1553213268	NC_000001.11:151406620:C:T
NM_015100.4(POGZ):c.2817_2830del (p.Cys939_Asp944delinsTer)	POGZ		not provided	Pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, single submitter	VCV000497355	1	151378681 - 151378694	1	151406205 - 151406218	497355	488779	rs1553212757	NC_000001.11:151406204:CATCAACATTCAGACAT:CAT
NM_015100.4(POGZ):c.2419A>T (p.Lys807Ter)	POGZ	K807*, K745*, K712*, K754*, K798*	not provided	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000489263	1	151379724	1	151407248	489263	481562	rs1553213659	NC_000001.11:151407247:T:A
NM_015100.4(POGZ):c.2567C>G (p.Ser856Ter)	POGZ	S856*, S847*, S761*, S794*, S803*	not provided	Pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	VCV000489073	1	151379086	1	151406610	489073	481561	rs1553213240	NC_000001.11:151406609:G:C
NM_015100.4(POGZ):c.1608C>A (p.Tyr536Ter)	POGZ	Y536*, Y441*, Y527*, Y474*, Y483*	not provided	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	VCV000451792	1	151395943	1	151423467	451792	442618	rs1553223544	NC_000001.11:151423466:G:T
NM_015100.4(POGZ):c.3022C>T (p.Arg1008Ter)	POGZ	R1008*, R999*, R946*, R913*, R955*	not provided	Pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000426598	1	151378489	1	151406013	426598	414728	rs1085307702	NC_000001.11:151406012:G:A
NM_015100.4(POGZ):c.2922_2923TG[1] (p.Val975fs)	POGZ		not provided	Pathogenic(Last reviewed: Sep 18, 2015)	criteria provided, single submitter	VCV000419828	1	151378586 - 151378587	1	151406110 - 151406111	419828	404907	rs1064794134	NC_000001.11:151406109:CACA:CA
NM_015100.4(POGZ):c.2616del (p.Asn872fs)	POGZ	N777fs, N819fs, N863fs, N810fs, N872fs	not provided	Pathogenic(Last reviewed: Sep 3, 2015)	criteria provided, single submitter	VCV000419656	1	151378895	1	151406419	419656	404908	rs1064794021	NC_000001.11:151406418:A:
NM_015100.4(POGZ):c.2518_2519CA[1] (p.His840fs)	POGZ		not provided	Pathogenic(Last reviewed: Oct 11, 2017)	criteria provided, single submitter	VCV000280908	1	151379411 - 151379412	1	151406935 - 151406936	280908	263958	rs886042027	NC_000001.11:151406934:TGTG:TG
NM_015100.4(POGZ):c.2350C>T (p.Arg784Ter)	POGZ	R784*, R689*, R731*, R722*, R775*	not provided	Pathogenic(Last reviewed: Mar 30, 2016)	criteria provided, single submitter	VCV000280468	1	151380601	1	151408125	280468	263961	rs886041669	NC_000001.11:151408124:G:A
NM_015100.4(POGZ):c.2806G>T (p.Gly936Ter)	POGZ	G936*, G883*, G841*, G874*, G927*	White-sutton syndrome	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000620052	1	151378705	1	151406229	620052	611372	rs1557867134	NC_000001.11:151406228:C:A
NM_015100.4(POGZ):c.2646_2647del (p.Asn882fs)	POGZ	N829fs, N873fs, N882fs, N787fs, N820fs	White-sutton syndrome	Pathogenic(Last reviewed: Jul 21, 2017)	criteria provided, single submitter	VCV000559853	1	151378864 - 151378865	1	151406388 - 151406389	559853	550575	rs1553213060	NC_000001.11:151406387:TGT:T
NM_015100.4(POGZ):c.2771del (p.Pro924fs)	POGZ	P924fs, P829fs, P862fs, P871fs, P915fs	Downturned corners of mouth|Anteverted nares|Inability to walk by childhood/adolescence|Wide mouth|Seizures|Generalized hypotonia|Brachycephaly|Hypertelorism|Abnormality of the nail|High palate|Absent speech|Hypoplasia of the corpus callosum|Decreased lacrimation|Severe global developmental delay|Sensorineural hearing loss|Microcephaly|Strabismus	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523510	1	151378740	1	151406264	523510	513890	rs1553212868	NC_000001.11:151406263:GGG:GG
NM_015100.4(POGZ):c.3259C>T (p.Arg1087Ter)	POGZ	R1087*, R992*, R1034*, R1078*, R1025*	not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252690	1	151378252	1	151405776	252690	246863	rs879255404	NC_000001.11:151405775:G:A
NM_015100.4(POGZ):c.3847C>T (p.Gln1283Ter)	POGZ	Q1283*, Q1221*, Q1230*, Q1188*, Q1274*	White-sutton syndrome	Pathogenic(Last reviewed: Mar 23, 2016)	no assertion criteria provided	VCV000224725	1	151377664	1	151405188	224725	226508	rs869312834	NC_000001.11:151405187:G:A
NM_015100.4(POGZ):c.2590C>T (p.Arg864Ter)	POGZ	R864*, R811*, R769*, R855*, R802*	White-sutton syndrome	Pathogenic(Last reviewed: Mar 24, 2016)	no assertion criteria provided	VCV000224723	1	151378921	1	151406445	224723	226506	rs756659230	NC_000001.11:151406444:G:A
NM_015100.4(POGZ):c.1277dup (p.Pro426_Glu427insTer)	POGZ		White-sutton syndrome	Pathogenic(Last reviewed: Mar 23, 2016)	no assertion criteria provided	VCV000224722	1	151396670 - 151396671	1	151424194 - 151424195	224722	226505	rs869320763	NC_000001.11:151424194:GGGG:GGGGG
NM_015100.4(POGZ):c.2750dup (p.Pro918fs)	POGZ		not provided	Pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	VCV000207797	1	151378760 - 151378761	1	151406284 - 151406285	207797	204034	rs796052216	NC_000001.11:151406284:GGGG:GGGGG
NM_015100.4(POGZ):c.1810G>T (p.Glu604Ter)	POGZ	E604*, E551*, E595*, E509*, E542*	White-sutton syndrome	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431126	1	151384217	1	151411741	431126	424637	rs1135401798	NC_000001.11:151411740:C:A
NM_015100.4(POGZ):c.1180_1181del (p.Met394fs)	POGZ	M332fs, M385fs, M299fs, M341fs, M394fs	not provided|dysmorphy|intellectual deficiency	Pathogenic(Last reviewed: Oct 27, 2016)	criteria provided, single submitter	VCV000373048	1	151397435 - 151397436	1	151424959 - 151424960	373048	359214	rs1057518170	NC_000001.11:151424958:AT:
NM_015100.4(POGZ):c.2780dup (p.Leu927fs)	POGZ		White-sutton syndrome	Pathogenic(Last reviewed: Nov 10, 2015)	no assertion criteria provided	VCV000218150	1	151378730 - 151378731	1	151406254 - 151406255	218150	214795	rs864321675	NC_000001.11:151406254:AAA:AAAA
NM_015100.4(POGZ):c.2711T>A (p.Leu904Ter)	POGZ	L904*, L809*, L895*, L842*, L851*	White-sutton syndrome	Pathogenic(Last reviewed: Jan 6, 2016)	no assertion criteria provided	VCV000190308	1	151378800	1	151406324	190308	188137	rs864321668	NC_000001.11:151406323:A:T
NM_015100.4(POGZ):c.3354del (p.Leu1119fs)	POGZ	L1057fs, L1024fs, L1066fs, L1110fs, L1119fs	White-sutton syndrome	Pathogenic(Last reviewed: Jan 6, 2016)	no assertion criteria provided	VCV000190307	1	151378157	1	151405681	190307	188136	rs864321667	NC_000001.11:151405680:GGG:GG
NM_014140.3(SMARCAL1):c.415_416del (p.Leu139fs)	SMARCAL1	L139fs	not provided|Schimke immuno-osseous dysplasia	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000598612	2	217279842 - 217279843	2	216415119 - 216415120	598612	589673	rs781023326	NC_000002.12:216415118:TT:
NM_015100.4(POGZ):c.3001C>T (p.Arg1001Ter)	POGZ	R1001*, R992*, R906*, R939*, R948*	White-sutton syndrome|not provided	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000224724	1	151378510	1	151406034	224724	226507	rs869312833	NC_000001.11:151406033:G:A
NM_015100.4(POGZ):c.833C>G (p.Ser278Ter)	POGZ	S278*, S183*, S225*	White-sutton syndrome	Pathogenic(Last reviewed: Jan 6, 2016)	no assertion criteria provided	VCV000218148	1	151400625	1	151428149	218148	214798	rs864321673	NC_000001.11:151428148:G:C
NM_014625.3(NPHS2):c.714G>T (p.Arg238Ser)	NPHS2	R238S	Nephrotic syndrome, idiopathic, steroid-resistant|Idiopathic nephrotic syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000556556	1	179526186	1	179557051	556556	540658	rs748812981	NC_000001.11:179557050:C:A
NM_015100.4(POGZ):c.3041del (p.Gln1014fs)	POGZ	Q1014fs, Q919fs, Q952fs, Q961fs, Q1005fs	not provided|Global developmental delay|Speech apraxia	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000207798	1	151378470	1	151405994	207798	204032	rs796052217	NC_000001.11:151405993:T:
NM_001206744.2(TPO):c.764dup (p.Gly256fs)	TPO		Deficiency of iodide peroxidase	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623381	2	1459994 - 1459995	2	1456222 - 1456223	623381	612258	rs1558307375	NC_000002.12:1456222:GGGGG:GGGGGG
NM_001206744.2(TPO):c.2421del (p.Cys808fs)	TPO	C808fs, C751fs, C635fs	Deficiency of iodide peroxidase	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623380	2	1507748	2	1503976	623380	612259	rs760307139	NC_000002.12:1503975:CCCCCCC:CCCCCC
NM_000547.5(TPO):c.1496del (p.Pro499fs)	TPO	P326fs, P499fs	Deficiency of iodide peroxidase	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000004052	2	1488523	2	1484751	4052	19091		NC_000002.12:1484750:CCC:CC
NM_000547.5(TPO):c.2512del (p.Cys838fs)	TPO	C665fs, C781fs, C838fs	Deficiency of iodide peroxidase	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000004049	2	1507845	2	1504073	4049	19088		NC_000002.12:1504072:T:
NM_000547.5(TPO):c.1943G>A (p.Arg648Gln)	TPO	R648Q, R475Q, R591Q	Deficiency of iodide peroxidase	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000004048	2	1497748	2	1493976	4048	19087	rs121908086	NC_000002.12:1493975:G:A
NM_000547.5(TPO):c.1768G>A (p.Gly590Ser)	TPO	G590S, G417S	Deficiency of iodide peroxidase	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000004045	2	1491763	2	1487991	4045	19084	rs121908084	NC_000002.12:1487990:G:A
NM_000547.5(TPO):c.1339A>T (p.Ile447Phe)	TPO	I447F, I274F	Deficiency of iodide peroxidase	Pathogenic(Last reviewed: Feb 1, 1997)	no assertion criteria provided	VCV000004043	2	1488368	2	1484596	4043	19082	rs104893669	NC_000002.12:1484595:A:T
TPO, 20-BP DUP	TPO		Deficiency of iodide peroxidase	Pathogenic(Last reviewed: Jul 1, 1994)	no assertion criteria provided	VCV000004041					4041	19080		
NM_000547.5(TPO):c.1994G>A (p.Arg665Gln)	TPO	R665Q, R492Q, R608Q	Deficiency of iodide peroxidase	Pathogenic(Last reviewed: Jun 10, 2015)	no assertion criteria provided	VCV000374344	2	1497799	2	1494027	374344	361166	rs140124953	NC_000002.12:1494026:G:A
NM_000547.5(TPO):c.2077C>T (p.Arg693Trp)	TPO	R693W, R520W, R636W	Deficiency of iodide peroxidase	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000004051	2	1499831	2	1496059	4051	19090	rs121908087	NC_000002.12:1496058:C:T
TPO, 1-BP INS, 2505C	TPO		Deficiency of iodide peroxidase	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000004047					4047	19086		
TPO, 4-BP INS, NT1227	TPO		Deficiency of iodide peroxidase	Pathogenic(Last reviewed: Oct 1, 2000)	no assertion criteria provided	VCV000004040					4040	19079		
NM_015100.4(POGZ):c.3456_3457del (p.Glu1154fs)	POGZ	E1145fs, E1154fs, E1059fs, E1092fs, E1101fs	White-sutton syndrome|not provided	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000224726	1	151378054 - 151378055	1	151405578 - 151405579	224726	226509	rs869320764	NC_000001.11:151405577:CT:
NM_015100.4(POGZ):c.2763dup (p.Thr922fs)	POGZ		White-sutton syndrome|not provided	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000218147	1	151378747 - 151378748	1	151406271 - 151406272	218147	214796	rs864321672	NC_000001.11:151406271:GGGGG:GGGGGG
NM_015100.4(POGZ):c.2319_2320CT[1] (p.Ser774fs)	POGZ		Smith-Magenis Syndrome-like|White-sutton syndrome	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000218146	1	151380627 - 151380630	1	151408151 - 151408154	218146	214797	rs864321671	NC_000001.11:151408150:AGAGAG:AG
NM_000312.3(PROC):c.169C>T (p.Arg57Trp)	PROC	R57W	not provided|Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188230	2	128178957	2	127421381	188230	185963	rs757583846	NC_000002.12:127421380:C:T
NM_000312.3(PROC):c.659G>A (p.Arg220Gln)	PROC	R178Q, R220Q	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant|Reduced protein C activity	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000669	2	128183784	2	127426208	669	15708	rs121918153	NC_000002.12:127426207:G:A
NM_000312.3(PROC):c.631C>T (p.Arg211Trp)	PROC	R169W, R211W	Thrombophilia, hereditary, due to protein C deficiency, autosomal recessive|Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant|Reduced protein C activity	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000659	2	128183756	2	127426180	659	15698	rs121918143	NC_000002.12:127426179:C:T
NM_000547.5(TPO):c.1955dup (p.Phe653fs)	TPO		Deficiency of iodide peroxidase|not provided	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000004054	2	1497759 - 1497760	2	1493987 - 1493988	4054	19093		NC_000002.12:1493987:T:TT
NM_000547.5(TPO):c.2268dup (p.Glu757Ter)	TPO		Deficiency of iodide peroxidase|not provided	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000004050	2	1500418 - 1500419	2	1496646 - 1496647	4050	19089		NC_000002.12:1496646:T:TT
NM_000547.5(TPO):c.1618C>T (p.Arg540Ter)	TPO	R540*, R367*	Deficiency of iodide peroxidase|not provided	Pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV000004042	2	1491613	2	1487841	4042	19081	rs121908082	NC_000002.12:1487840:C:T
NM_152490.5(B3GALNT2):c.824_825dup (p.Ile276fs)	B3GALNT2		not provided|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11	Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000132981	1	235628968 - 235628969	1	235465651 - 235465652	132981	136730	rs367543075	NC_000001.11:235465651:AAAA:AAAAAA
NM_001079866.2(BCS1L):c.548G>A (p.Arg183His)	BCS1L	R183H, R63H	Leigh syndrome|Pili torti-deafness syndrome	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000006170	2	219526569	2	218661846	6170	21209	rs121908577	NC_000002.12:218661845:G:A
NM_000547.5(TPO):c.2422del (p.Cys808fs)	TPO	C635fs, C751fs, C808fs	Deficiency of iodide peroxidase	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000632332	2	1507755	2	1503983	632332	620033	rs763662774	NC_000002.12:1503982:T:
NM_000547.5(TPO):c.2395G>A (p.Glu799Lys)	TPO	E799K, E742K, E626K	Deficiency of iodide peroxidase	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000004046	2	1507728	2	1503956	4046	19085	rs121908085	NC_000002.12:1503955:G:A
NM_007375.3(TARDBP):c.1055A>G (p.Asn352Ser)	TARDBP	N352S	not provided|Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000021468	1	11082521	1	11022464	21468	34320	rs80356734	NC_000001.11:11022463:A:G
NM_000191.3(HMGCL):c.109G>T (p.Glu37Ter)	HMGCL	E37*	not provided|Deficiency of hydroxymethylglutaryl-CoA lyase	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000195033	1	24147035	1	23820545	195033	192195	rs763494292	NC_000001.11:23820544:C:A
NM_000191.3(HMGCL):c.698A>G (p.His233Arg)	HMGCL	H233R, H162R	Deficiency of hydroxymethylglutaryl-CoA lyase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000167180	1	24134677	1	23808187	167180	176929	rs727503963	NC_000001.11:23808186:T:C
NM_001039523.3(CHRNA1):c.1396G>A (p.Gly466Arg)	CHRNA1	G441R, G466R	Seizures|Autism|not provided|Lethal multiple pterygium syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449923	2	175612905	2	174748177	449923	443058	rs768407867	NC_000002.12:174748176:C:T
NM_000104.3(CYP1B1):c.1200_1209dup (p.Thr404fs)	CYP1B1		Congenital glaucoma|not provided|Irido-corneo-trabecular dysgenesis	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000068466	2	38298287 - 38298288	2	38071144 - 38071145	68466	79358	rs587778873	NC_000002.12:38071144:GGTGGCATGAGG:GGTGGCATGAGGTGGCATGAGG
NM_000104.3(CYP1B1):c.182G>A (p.Gly61Glu)	CYP1B1	G61E	Glaucoma 3, primary infantile, b|Glaucoma 3, primary congenital, A|Anterior segment dysgenesis 6|not provided|Glaucoma 3, primary congenital, A	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000007730	2	38302350	2	38075207	7730	22769	rs28936700	NC_000002.12:38075206:C:T
NM_014140.3(SMARCAL1):c.863-2A>G	SMARCAL1		Schimke immuno-osseous dysplasia|not provided	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000562358	2	217285020	2	216420297	562358	553542	rs761546902	NC_000002.12:216420296:A:G
NM_014140.3(SMARCAL1):c.1933C>T (p.Arg645Cys)	SMARCAL1	R645C	Schimke immuno-osseous dysplasia	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000004175	2	217315650	2	216450927	4175	19214	rs119473037	NC_000002.12:216450926:C:T
NM_004700.4(KCNQ4):c.853G>A (p.Gly285Ser)	KCNQ4	G285S	Nonsyndromic hearing loss and deafness|Autosomal dominant nonsyndromic deafness 2A|Rare genetic deafness	Pathogenic(Last reviewed: Sep 11, 2018)	reviewed by expert panel	VCV000006241	1	41285565	1	40819893	6241	21280	rs28937588	NC_000001.11:40819892:G:A
NM_006642.5(SDCCAG8):c.1714C>T (p.Gln572Ter)	SDCCAG8	Q474*, Q572*, Q271*, Q604*	Senior Loken syndrome	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812430	1	243579101	1	243415799	812430	800445		NC_000001.11:243415798:C:T
GRCh37/hg19 1q43(chr1:243572906-243615328)x1	SDCCAG8		not provided	Pathogenic(Last reviewed: Jul 31, 2017)	no assertion criteria provided	VCV000687288	1	243572906 - 243615328			687288	674880		
GRCh37/hg19 1q43(chr1:243427293-243483754)x1	SDCCAG8		not provided	Pathogenic(Last reviewed: Mar 30, 2018)	no assertion criteria provided	VCV000685796	1	243427293 - 243483754			685796	673388		
NM_006642.5(SDCCAG8):c.1159del (p.Ala387fs)	SDCCAG8	A86fs, A289fs, A387fs, A419fs	not provided	Pathogenic(Last reviewed: May 26, 2016)	criteria provided, single submitter	VCV000287667	1	243493930	1	243330628	287667	271904	rs778900414	NC_000001.11:243330627:GGG:GG
NM_006642.5(SDCCAG8):c.567G>A (p.Trp189Ter)	SDCCAG8	W189*, W91*	Senior-Loken syndrome 7	Pathogenic(Last reviewed: Jul 17, 2015)	criteria provided, single submitter	VCV000212141	1	243456413	1	243293111	212141	206783	rs797045948	NC_000001.11:243293110:G:A
NM_006642.5(SDCCAG8):c.481C>T (p.Gln161Ter)	SDCCAG8	Q161*, Q63*	Senior-Loken syndrome 7	Pathogenic(Last reviewed: Apr 9, 2015)	criteria provided, single submitter	VCV000212140	1	243449634	1	243286332	212140	206782	rs797045947	NC_000001.11:243286331:C:T
NM_006642.5(SDCCAG8):c.1944_1945GT[1] (p.Cys649fs)	SDCCAG8		Senior-Loken syndrome 7	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000000059	1	243589819 - 243589822	1	243426517 - 243426520	59	15098	rs397515336	NC_000001.11:243426516:GTGTGT:GT
NM_006642.5(SDCCAG8):c.1339dup (p.Glu447fs)	SDCCAG8		Senior-Loken syndrome 7	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000000058	1	243504455 - 243504456	1	243341153 - 243341154	58	15097	rs387906218	NC_000001.11:243341153:GGG:GGGG
NM_014053.4(FLVCR1):c.361A>G (p.Asn121Asp)	FLVCR1	N121D	not provided|Posterior column ataxia-retinitis pigmentosa syndrome	Pathogenic(Last reviewed: Jan 14, 2020)	criteria provided, single submitter	VCV000018418	1	213032155	1	212858813	18418	33457	rs267606820	NC_000001.11:212858812:A:G
NM_006642.5(SDCCAG8):c.1763T>A (p.Leu588Ter)	SDCCAG8	L287*, L490*, L588*, L620*	Bardet-Biedl syndrome 16|Senior-Loken syndrome 7	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV000838639	1	243581288	1	243417986	838639	823820		NC_000001.11:243417985:T:A
NC_000001.11:g.(?_243415682)_(243415849_?)del	SDCCAG8		Bardet-Biedl syndrome 16|Senior-Loken syndrome 7	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000831973	1	243578984 - 243579151			831973	818956		
NM_006642.5(SDCCAG8):c.1628_1631del (p.Asp543fs)	SDCCAG8	D543fs, D575fs, D242fs, D445fs	Bardet-Biedl syndrome 16	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000156528	1	243579013 - 243579016	1	243415711 - 243415714	156528	166292	rs587777846	NC_000001.11:243415710:AGATAG:AG
NM_006642.5(SDCCAG8):c.679A>T (p.Lys227Ter)	SDCCAG8	K227*, K129*, K259*	Bardet-Biedl syndrome 16	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000000061	1	243468018	1	243304716	61	15100	rs267607031	NC_000001.11:243304715:A:T
NM_003038.5(SLC1A4):c.1369C>T (p.Arg457Trp)	SLC1A4	R457W, R237W, R159W	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly|Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000372158	2	65248050	2	65020916	372158	359063	rs761533681	NC_000002.12:65020915:C:T
NM_005373.2(MPL):c.378del (p.Phe126fs)	MPL	F126fs	Congenital amegakaryocytic thrombocytopenia|not specified|essential thrombocytemia|Congenital amegakaryocytic thrombocytopenia|not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265249	1	43804376	1	43338705	265249	259671	rs587778515	NC_000001.11:43338704:TTT:TT
NM_005373.2(MPL):c.1514G>A (p.Ser505Asn)	MPL	S505N	Myelofibrosis|Myeloproliferative Neoplasm|Thrombocytosis, benign familial microcytic|Thrombocythemia 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000014163	1	43814979	1	43349308	14163	29202	rs121913614	NC_000001.11:43349307:G:A
NM_022356.4(P3H1):c.232del (p.Gln78fs)	P3H1	Q78fs	not provided	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000817615	1	43232411	1	42766740	817615	805224		NC_000001.11:42766739:GGG:GG
NM_001146289.1(P3H1):c.570_571del (p.Gly191fs)	P3H1	G191fs	Osteogenesis imperfecta type 8	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522436	1	43228041 - 43228042	1	42762370 - 42762371	522436	513014	rs1553143741	NC_000001.11:42762369:CA:
NM_001146289.1(P3H1):c.1120G>T (p.Glu374Ter)	P3H1	E374*	not provided	Pathogenic(Last reviewed: Sep 22, 2016)	criteria provided, single submitter	VCV000291047	1	43221269	1	42755598	291047	275284	rs140468248	NC_000001.11:42755597:C:A
NM_001146289.1(P3H1):c.1569+1G>A	P3H1		not provided	Pathogenic(Last reviewed: Apr 20, 2016)	criteria provided, single submitter	VCV000280529	1	43217944	1	42752273	280529	264042	rs369651701	NC_000001.11:42752272:C:T
NM_001146289.1(P3H1):c.392C>A (p.Ser131Ter)	P3H1	S131*	not provided	Pathogenic(Last reviewed: Aug 26, 2016)	criteria provided, single submitter	VCV000265432	1	43232251	1	42766580	265432	259666	rs72659347	NC_000001.11:42766579:G:T
NM_022356.4(P3H1):c.1226C>G (p.Ser409Ter)	P3H1	S409*	Osteogenesis imperfecta type 8	Pathogenic(Last reviewed: May 18, 2019)	criteria provided, single submitter	VCV000860818	1	43220659	1	42754988	860818	823976		NC_000001.11:42754987:G:C
NM_001146289.1(P3H1):c.1459C>T (p.Gln487Ter)	P3H1	Q487*	Osteogenesis imperfecta type 8	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000664730	1	43218222	1	42752551	664730	627847		NC_000001.11:42752550:G:A
NM_001146289.1(P3H1):c.1060A>T (p.Arg354Ter)	P3H1	R354*	Osteogenesis imperfecta type 8	Pathogenic(Last reviewed: Dec 9, 2018)	criteria provided, single submitter	VCV000655208	1	43223474	1	42757803	655208	627851		NC_000001.11:42757802:T:A
NM_022356.4(P3H1):c.1856del (p.Asn619fs)	P3H1	N619fs	Osteogenesis imperfecta type 8	Pathogenic(Last reviewed: Dec 9, 2018)	criteria provided, single submitter	VCV000653499	1	43213452	1	42747781	653499	627845		NC_000001.11:42747780:TTT:TT
NM_001146289.1(P3H1):c.1222A>T (p.Lys408Ter)	P3H1	K408*	Osteogenesis imperfecta type 8	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000566925	1	43220837	1	42755166	566925	557321	rs1557569037	NC_000001.11:42755165:T:A
NM_001146289.1(P3H1):c.646_650del (p.Tyr216fs)	P3H1	Y216fs	Osteogenesis imperfecta type 8	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522681	1	43225030 - 43225034	1	42759359 - 42759363	522681	513243	rs1553143142	NC_000001.11:42759358:GAGTAGAGT:GAGT
NM_001146289.1(P3H1):c.1365_1366delinsC (p.Glu455fs)	P3H1		Osteogenesis imperfecta type 8	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000001257	1	43218315 - 43218316	1	42752644 - 42752645	1257	16296	rs137853952	NC_000001.11:42752643:CT:G
NM_001146289.1(P3H1):c.1656C>A (p.Tyr552Ter)	P3H1	Y552*	Osteogenesis imperfecta type 8	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000001256	1	43215921	1	42750250	1256	16295	rs72659355	NC_000001.11:42750249:G:T
NM_001146289.1(P3H1):c.747del (p.Tyr250fs)	P3H1	Y250fs	Osteogenesis imperfecta type 8	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000001255	1	43224933	1	42759262	1255	16294	rs72659348	NC_000001.11:42759261:GGG:GG
NM_001146289.1(P3H1):c.1473+1G>T	P3H1		Osteogenesis imperfecta type 8	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000001254	1	43218207	1	42752536	1254	16293	rs72659354	NC_000001.11:42752535:C:A
NM_006642.5(SDCCAG8):c.696T>G (p.Tyr232Ter)	SDCCAG8	Y264*, Y134*, Y232*	Bardet-Biedl syndrome 16|Senior-Loken syndrome 7	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000846611	1	243468035	1	243304733	846611	823809		NC_000001.11:243304732:T:G
NM_006642.5(SDCCAG8):c.221-2A>G	SDCCAG8		Senior-Loken syndrome 7|Bardet-Biedl syndrome 16	Pathogenic(Last reviewed: Dec 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000212139	1	243434278	1	243270976	212139	206781	rs797045946	NC_000001.11:243270975:A:G
NM_001146289.1(P3H1):c.541C>T (p.Gln181Ter)	P3H1	Q181*	Osteogenesis imperfecta	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635343	1	43228071	1	42762400	635343	623126		NC_000001.11:42762399:G:A
NM_006912.6(RIT1):c.242A>G (p.Glu81Gly)	RIT1	E81G, E98G, E45G	Noonan syndrome 8|not provided|Noonan syndrome|not specified	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183405	1	155874289	1	155904498	183405	181511	rs869025193	NC_000001.11:155904497:T:C
NM_006912.6(RIT1):c.229G>A (p.Ala77Thr)	RIT1	A77T, A41T, A94T	Noonan syndrome|Noonan syndrome 1|Noonan syndrome 8|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183403	1	155874530	1	155904739	183403	181513	rs869025191	NC_000001.11:155904738:C:T
NM_001039523.3(CHRNA1):c.592G>A (p.Gly198Ser)	CHRNA1	G153S, G173S, G198S	Myasthenic syndrome, slow-channel congenital|Lethal multiple pterygium syndrome	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000018379	2	175618970	2	174754242	18379	33418	rs137852801	NC_000002.12:174754241:C:T
NM_000547.5(TPO):c.1978C>G (p.Gln660Glu)	TPO	Q660E, Q603E, Q487E	Deficiency of iodide peroxidase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004053	2	1497783	2	1494011	4053	19092	rs121908088	NC_000002.12:1494010:C:G
NM_000547.5(TPO):c.1357T>G (p.Tyr453Asp)	TPO	Y453D, Y280D	Deficiency of iodide peroxidase|not provided	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004044	2	1488386	2	1484614	4044	19083	rs121908083	NC_000002.12:1484613:T:G
NM_001244710.2(GFPT1):c.89_90del (p.Leu30fs)	GFPT1	L30fs	Congenital myasthenic syndrome 12	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000836225	2	69601163 - 69601164	2	69374031 - 69374032	836225	826910		NC_000002.12:69374030:CA:
NM_002056.4(GFPT1):c.452C>A (p.Thr151Lys)	GFPT1	T151K	Congenital myasthenic syndrome 12	Pathogenic(Last reviewed: May 17, 2019)	no assertion criteria provided	VCV000631478	2	69585552	2	69358420	631478	619841	rs1558761046	NC_000002.12:69358419:G:T
NM_002056.4(GFPT1):c.41G>T (p.Arg14Leu)	GFPT1	R14L	Congenital myasthenic syndrome 12	Pathogenic(Last reviewed: May 17, 2019)	no assertion criteria provided	VCV000631477	2	69601212	2	69374080	631477	619840	rs922548333	NC_000002.12:69374079:C:A
NM_002056.4(GFPT1):c.197_201del (p.Val66fs)	GFPT1	V66fs	Congenital myasthenic syndrome 12	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000583230	2	69597155 - 69597159	2	69370023 - 69370027	583230	558628	rs1558773839	NC_000002.12:69370022:CTTAACTT:CTT
NM_002056.4(GFPT1):c.928C>T (p.Gln310Ter)	GFPT1	Q310*, Q328*	Congenital myasthenic syndrome 12	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000570975	2	69575330	2	69348198	570975	558255	rs1558749457	NC_000002.12:69348197:G:A
NM_002056.4(GFPT1):c.621del (p.Leu207_Leu208insTer)	GFPT1		Congenital myasthenic syndrome 12	Pathogenic(Last reviewed: Feb 11, 2011)	no assertion criteria provided	VCV000029740	2	69581685	2	69354553	29740	38695		NC_000002.12:69354552:C:
NM_002056.4(GFPT1):c.1042G>T (p.Asp348Tyr)	GFPT1	D348Y, D366Y	Congenital myasthenic syndrome 12	Pathogenic(Last reviewed: Feb 11, 2011)	no assertion criteria provided	VCV000029738	2	69573045	2	69345913	29738	38693		NC_000002.12:69345912:C:A
NM_002056.4(GFPT1):c.685+210G>A	GFPT1	W240*	Congenital myasthenic syndrome 12	Pathogenic(Last reviewed: Feb 11, 2011)	no assertion criteria provided	VCV000029737	2	69581411	2	69354279	29737	38692		NC_000002.12:69354278:C:T
NM_002056.3:c.223dupA	GFPT1		Congenital myasthenic syndrome 12	Pathogenic(Last reviewed: Feb 11, 2011)	no assertion criteria provided	VCV000029736					29736	38691		
NM_001146289.1(P3H1):c.1102C>T (p.Arg368Ter)	P3H1	R368*	not provided|Osteogenesis imperfecta type 8	Pathogenic(Last reviewed: Oct 2, 2014)	criteria provided, single submitter	VCV000001258	1	43221287	1	42755616	1258	16297	rs118203996	NC_000001.11:42755615:G:A
NM_001244710.2(GFPT1):c.964C>T (p.Arg322Ter)	GFPT1	R304*, R322*	Congenital myasthenic syndrome 12	Pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000859066	2	69575348	2	69348216	859066	826906		NC_000002.12:69348215:G:A
NM_002056.4(GFPT1):c.43A>G (p.Thr15Ala)	GFPT1	T15A	Congenital myasthenic syndrome 12	Pathogenic(Last reviewed: Feb 11, 2011)	no assertion criteria provided	VCV000029739	2	69601210	2	69374078	29739	38694	rs387906638	NC_000002.12:69374077:T:C
NM_006642.5(SDCCAG8):c.696del (p.Thr231_Tyr232insTer)	SDCCAG8		Senior-Loken syndrome 7|Bardet-Biedl syndrome 16	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000654015	1	243468035	1	243304733	654015	627688		NC_000001.11:243304732:T:
NM_006642.5(SDCCAG8):c.1444del (p.Thr482fs)	SDCCAG8	T384fs, T482fs, T514fs, T181fs	not provided|Bardet-Biedl syndrome 16	Pathogenic(Last reviewed: Feb 21, 2017)	criteria provided, single submitter	VCV000156529	1	243507600	1	243344298	156529	166293	rs587777847	NC_000001.11:243344297:AAAAA:AAAA
NM_014140.4(SMARCAL1):c.2459G>A (p.Arg820His)	SMARCAL1	R820H	Schimke immuno-osseous dysplasia|Inherited Immunodeficiency Diseases	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000827737	2	217341863	2	216477140	827737	815895		NC_000002.12:216477139:G:A
NM_015488.5(PNKD):c.26C>T (p.Ala9Val)	PNKD	A9V	Paroxysmal dyskinesia|Paroxysmal dystonia|Episodic hemiplegia|Paroxysmal nonkinesigenic dyskinesia 1	Pathogenic(Last reviewed: Mar 27, 2019)	no assertion criteria provided	VCV000001892	2	219135284	2	218270561	1892	16931	rs121434511	NC_000002.12:218270560:C:T
NM_014362.4(HIBCH):c.595G>T (p.Gly199Ter)	HIBCH	G199*	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 23, 2015)	criteria provided, single submitter	VCV000520645	2	191116956	2	190252230	520645	511373	rs755786597	NC_000002.12:190252229:C:A
NM_001079878.2(CNGA3):c.613C>T (p.Arg205Trp)	CNGA3	R223W, R205W	not provided|Retinal dystrophy|Achromatopsia	Pathogenic(Last reviewed: Mar 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000498768	2	99008427	2	98391964	498768	490192	rs138958917	NC_000002.12:98391963:C:T
NM_080605.4(B3GALT6):c.556T>C (p.Phe186Leu)	B3GALT6	F186L	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522415	1	1168214	1	1232834	522415	513007	rs1553151294	NC_000001.11:1232833:T:C
NM_080605.4(B3GALT6):c.588dup (p.Arg197fs)	B3GALT6		not provided	Pathogenic(Last reviewed: May 22, 2015)	criteria provided, single submitter	VCV000427130	1	1168239 - 1168240	1	1232859 - 1232860	427130	414727	rs533071750	NC_000001.11:1232859:GGGGGGG:GGGGGGGG
NM_080605.4(B3GALT6):c.545A>G (p.Tyr182Cys)	B3GALT6	Y182C	Ehlers-Danlos syndrome, progeroid type, 2	Pathogenic(Last reviewed: Mar 29, 2019)	no assertion criteria provided	VCV000624636	1	1168203	1	1232823	624636	613455	rs1314046622	NC_000001.11:1232822:A:G
NM_080605.4(B3GALT6):c.323_344del (p.Ala108fs)	B3GALT6	A108fs	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with fractures	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000060497	1	1167975 - 1167996	1	1232595 - 1232616	60497	75092	rs786200943	NC_000001.11:1232594:GGCGCGCCCTGGAGCGGGAGCAGGCGCG:GGCGCG
NM_080605.4(B3GALT6):c.649G>A (p.Gly217Ser)	B3GALT6	G217S	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with fractures	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000060496	1	1168307	1	1232927	60496	75091	rs397514724	NC_000001.11:1232926:G:A
NM_080605.4(B3GALT6):c.619G>C (p.Asp207His)	B3GALT6	D207H	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with fractures	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000060495	1	1168277	1	1232897	60495	75090	rs397514723	NC_000001.11:1232896:G:C
NM_080605.4(B3GALT6):c.415_423del (p.Met139_Ala141del)	B3GALT6		Ehlers-Danlos syndrome, progeroid type, 2	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000060494	1	1168065 - 1168073	1	1232685 - 1232693	60494	75089	rs786200942	NC_000001.11:1232684:TGCTGGCCATGCTGGCC:TGCTGGCC
NM_080605.4(B3GALT6):c.16C>T (p.Arg6Trp)	B3GALT6	R6W	Ehlers-Danlos syndrome, progeroid type, 2	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000060493	1	1167674	1	1232294	60493	75088	rs397514722	NC_000001.11:1232293:C:T
NM_080605.4(B3GALT6):c.588del (p.Arg197fs)	B3GALT6	R197fs	Ehlers-Danlos syndrome, progeroid type, 2	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000060492	1	1168240	1	1232860	60492	75087	rs533071750	NC_000001.11:1232859:GGGGGGG:GGGGGG
NM_080605.4(B3GALT6):c.925T>A (p.Ser309Thr)	B3GALT6	S309T	Ehlers-Danlos syndrome, progeroid type, 2	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000060491	1	1168583	1	1233203	60491	75086	rs397514721	NC_000001.11:1233202:T:A
NM_080605.4(B3GALT6):c.353del (p.Asp118fs)	B3GALT6	D118fs	Ehlers-Danlos syndrome, progeroid type, 2	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000060490	1	1168011	1	1232631	60490	75085	rs750088530	NC_000001.11:1232630:A:
NM_080605.4(B3GALT6):c.200C>T (p.Pro67Leu)	B3GALT6	P67L	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000060489	1	1167858	1	1232478	60489	75084	rs397514720	NC_000001.11:1232477:C:T
NM_080605.4(B3GALT6):c.193A>G (p.Ser65Gly)	B3GALT6	S65G	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000060488	1	1167851	1	1232471	60488	75083	rs397514719	NC_000001.11:1232470:A:G
NM_080605.4(B3GALT6):c.899G>C (p.Cys300Ser)	B3GALT6	C300S	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000060487	1	1168557	1	1233177	60487	75082	rs786200939	NC_000001.11:1233176:G:C
NM_080605.4(B3GALT6):c.466G>A (p.Asp156Asn)	B3GALT6	D156N	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000060486	1	1168124	1	1232744	60486	75081	rs397514718	NC_000001.11:1232743:G:A
NM_080605.4(B3GALT6):c.694C>T (p.Arg232Cys)	B3GALT6	R232C	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000060485	1	1168352	1	1232972	60485	75080	rs397514717	NC_000001.11:1232971:C:T
NM_080605.4(B3GALT6):c.1A>G (p.Met1Val)	B3GALT6	M1V	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000060484	1	1167659	1	1232279	60484	75079	rs786200938	NC_000001.11:1232278:A:G
NM_153759.3(DNMT3A):c.2078G>C (p.Arg693Pro)	DNMT3A	R693P, R882P, R730P	Acute myeloid leukemia|Myelodysplastic syndrome|Lung adenocarcinoma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000375880	2	25457242	2	25234373	375880	362759	rs147001633	NC_000002.12:25234372:C:G
NM_000547.5(TPO):c.1184_1187dup (p.Ala397fs)	TPO		Deficiency of iodide peroxidase|not provided	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000429301	2	1481219 - 1481220	2	1477447 - 1477448	429301	421275	rs763941231	NC_000002.12:1477447:CGGCCG:CGGCCGGCCG
NM_001201543.2(FAM161A):c.1567C>T (p.Arg523Ter)	FAM161A	R523*	Retinitis pigmentosa 28|Retinal dystrophy|Retinitis pigmentosa|not provided	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000038	2	62066572	2	61839437	38	15077	rs202193201	NC_000002.12:61839436:G:A
NM_006642.5(SDCCAG8):c.740+356C>T	SDCCAG8		Bardet-Biedl syndrome 16|Senior-Loken syndrome 7	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000060	1	243468435	1	243305133	60	15099	rs397515337	NC_000001.11:243305132:C:T
NM_000348.4(SRD5A2):c.736C>T (p.Arg246Trp)	SRD5A2	R246W	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000003337	2	31751295	2	31526225	3337	18376	rs121434244	NC_000002.12:31526224:G:A
NM_173076.3(ABCA12):c.305del (p.Leu102fs)	ABCA12	L102fs	not provided	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000817150	2	215928801	2	215064078	817150	805284		NC_000002.12:215064077:A:
NM_001171603.1(PREPL):c.1282_1285del (p.Phe428fs)	PREPL	F339fs, F366fs, F428fs	Myasthenic syndrome, congenital, 22	Pathogenic(Last reviewed: Sep 23, 2019)	no assertion criteria provided	VCV000691883	2	44559666 - 44559669	2	44332527 - 44332530	691883	679597		NC_000002.12:44332526:CAAACA:CA
NM_173076.3(ABCA12):c.596G>A (p.Trp199Ter)	ABCA12	W199*	not provided	Pathogenic(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000596779	2	215914447	2	215049723	596779	587840	rs1187032187	NC_000002.12:215049722:C:T
NM_001171603.1(PREPL):c.1248dup (p.Tyr417fs)	PREPL		not provided	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000524111	2	44559702 - 44559703	2	44332563 - 44332564	524111	514470	rs1553354962	NC_000002.12:44332563:TTTT:TTTTT
NM_173076.3(ABCA12):c.5231G>A (p.Trp1744Ter)	ABCA12	W1744*, W1426*	not provided	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000523765	2	215840659	2	214975935	523765	514458	rs1553523093	NC_000002.12:214975934:C:T
NM_001171603.1(PREPL):c.1793del (p.Pro598fs)	PREPL	P509fs, P532fs, P598fs, P536fs	not provided	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	VCV000503804	2	44550504	2	44323365	503804	495424	rs1553351355	NC_000002.12:44323364:GG:G
NM_173076.3(ABCA12):c.4108G>T (p.Glu1370Ter)	ABCA12	E1370*, E1052*	not provided	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000489320	2	215851321	2	214986597	489320	481641	rs1553526002	NC_000002.12:214986596:C:A
NM_001171603.1(PREPL):c.1530-1G>C	PREPL		not provided	Pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, single submitter	VCV000489148	2	44554068	2	44326929	489148	481654	rs1316112168	NC_000002.12:44326928:C:G
NM_173076.3(ABCA12):c.5381+1G>C	ABCA12		not provided	Pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	VCV000488673	2	215840508	2	214975784	488673	481640	rs1553523037	NC_000002.12:214975783:C:G
NM_173076.3(ABCA12):c.5414C>G (p.Ser1805Ter)	ABCA12	S1805*, S1487*	not provided	Pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	VCV000448978	2	215839556	2	214974832	448978	443162	rs1553522866	NC_000002.12:214974831:G:C
NM_173076.3(ABCA12):c.2593-1G>A	ABCA12		not provided	Pathogenic(Last reviewed: Sep 28, 2015)	criteria provided, single submitter	VCV000429818	2	215869024	2	215004300	429818	421362	rs1131691611	NC_000002.12:215004299:C:T
NM_173076.3(ABCA12):c.2121+2T>G	ABCA12		not provided	Pathogenic(Last reviewed: Jun 25, 2015)	criteria provided, single submitter	VCV000379926	2	215876693	2	215011969	379926	366355	rs763182554	NC_000002.12:215011968:A:C
NM_173076.3(ABCA12):c.5787T>G (p.Tyr1929Ter)	ABCA12	Y1929*, Y1611*	not provided	Pathogenic(Last reviewed: Nov 23, 2015)	criteria provided, single submitter	VCV000280169	2	215831669	2	214966945	280169	264093	rs761557390	NC_000002.12:214966944:A:C
NM_173076.3(ABCA12):c.3889C>T (p.Arg1297Ter)	ABCA12	R1297*, R979*	not provided	Pathogenic(Last reviewed: Jun 8, 2015)	criteria provided, single submitter	VCV000265005	2	215852458	2	214987734	265005	259720	rs114863111	NC_000002.12:214987733:G:A
NM_173076.3(ABCA12):c.3256A>T (p.Lys1086Ter)	ABCA12	K1086*, K768*	not provided	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000265004	2	215862457	2	214997733	265004	259721	rs755391236	NC_000002.12:214997732:T:A
NM_173076.3(ABCA12):c.2140C>T (p.Arg714Ter)	ABCA12	R714*, R396*	not provided	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000265001	2	215876355	2	215011631	265001	259723	rs763481375	NC_000002.12:215011630:G:A
NM_173076.3(ABCA12):c.1300C>T (p.Arg434Ter)	ABCA12	R434*, R116*	not provided	Pathogenic(Last reviewed: Apr 21, 2016)	criteria provided, single submitter	VCV000265000	2	215884508	2	215019784	265000	259725	rs757520757	NC_000002.12:215019783:G:A
NM_173076.3(ABCA12):c.178C>T (p.Arg60Ter)	ABCA12	R60*	not provided	Pathogenic(Last reviewed: Apr 6, 2016)	criteria provided, single submitter	VCV000264997	2	215928928	2	215064205	264997	259728	rs767707248	NC_000002.12:215064204:G:A
NC_000002.12:g.(?_44359487)_(44359725_?)del	PREPL		Myasthenic syndrome, congenital, 22	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000832630	2	44586626 - 44586864			832630	819173		
NM_001171603.1(PREPL):c.715_718del (p.Lys239fs)	PREPL	K150fs, K239fs	Myasthenic syndrome, congenital, 22	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000653242	2	44569590 - 44569593	2	44342451 - 44342454	653242	630024		NC_000002.12:44342450:GTTTGTT:GTT
NM_001171603.1(PREPL):c.881_955delinsTTTTA (p.Lys294fs)	PREPL		Premature ovarian insufficiency	Pathogenic(Last reviewed: Jan 10, 2018)	no assertion criteria provided	VCV000619046	2	44566300 - 44566374	2	44339161 - 44339235	619046	610446	rs1558502635	
NM_173076.3(ABCA12):c.5743dup (p.Ile1915fs)	ABCA12		Autosomal recessive congenital ichthyosis 4B	Pathogenic(Last reviewed: Jan 17, 2019)	no assertion criteria provided	VCV000617618	2	215833478 - 215833479	2	214968754 - 214968755	617618	609014	rs1559120651	NC_000002.12:214968754:T:TT
NM_001171603.1(PREPL):c.694C>T (p.Arg232Ter)	PREPL	R232*, R143*	Myasthenic syndrome, congenital, 22	Pathogenic(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000573441	2	44569614	2	44342475	573441	558466	rs1361739547	NC_000002.12:44342474:G:A
NM_001171603.1(PREPL):c.1604T>G (p.Leu535Ter)	PREPL	L535*, L469*, L473*, L446*	Myasthenic syndrome, congenital, 22	Pathogenic(Last reviewed: Jul 11, 2018)	no assertion criteria provided	VCV000548712	2	44553993	2	44326854	548712	539199	rs1553352792	NC_000002.12:44326853:A:C
NM_001171603.1(PREPL):c.361_364del (p.Val121fs)	PREPL	V121fs, V32fs	Myasthenic syndrome, congenital, 22	Pathogenic(Last reviewed: Jul 11, 2018)	no assertion criteria provided	VCV000548711	2	44571704 - 44571707	2	44344565 - 44344568	548711	539198	rs1436090495	NC_000002.12:44344564:AAACAAA:AAA
PREPL, EX10-15 DEL	PREPL		Myasthenic syndrome, congenital, 22	Pathogenic(Last reviewed: Jul 11, 2018)	no assertion criteria provided	VCV000548710					548710	539197		
NM_001171603.1(PREPL):c.807del (p.Ile269_Met270insTer)	PREPL	M270*	Myasthenic syndrome, congenital, 22	Pathogenic(Last reviewed: Jul 11, 2018)	no assertion criteria provided	VCV000390242	2	44566448	2	44339309	390242	380153	rs1057523690	NC_000002.12:44339308:AA:A
NM_001171613.2(PREPL):c.75del (p.Val26fs)	PREPL	V115fs, V26fs	Myasthenic syndrome, congenital, 22	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV000850079	2	44573407	2	44346268	850079	826509		NC_000002.12:44346267:TT:T
NC_000002.12:g.(?_44321346)_(44359725_?)del	PREPL		Myasthenic syndrome, congenital, 22	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000830511	2	44548485 - 44586864			830511	819172		
NM_001171603.1(PREPL):c.434del (p.Leu145fs)	PREPL	L145fs, L56fs	Myasthenic syndrome, congenital, 22	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000583046	2	44571066	2	44343927	583046	558468	rs775517492	NC_000002.12:44343926:AAAA:AAA
NM_001171603.1(PREPL):c.1155+1G>A	PREPL		Myasthenic syndrome, congenital, 22	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000569764	2	44565489	2	44338350	569764	558103	rs758019788	NC_000002.12:44338349:C:T
NM_173076.3(ABCA12):c.3535G>A (p.Gly1179Arg)	ABCA12	G1179R, G861R	Autosomal recessive congenital ichthyosis 4B	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000002863	2	215855515	2	214990791	2863	17902	rs267606622	NC_000002.12:214990790:C:T
NM_015657.3(ABCA12):c.4058del (p.Asn1353fs)	ABCA12	N1353fs, N1671fs	Autosomal recessive congenital ichthyosis 4B	Pathogenic(Last reviewed: May 1, 2005)	no assertion criteria provided	VCV000002860	2	215843156	2	214978432	2860	17899	rs387906285	NC_000002.12:214978431:TTTTTTT:TTTTTT
NM_173076.3(ABCA12):c.4615G>A (p.Glu1539Lys)	ABCA12	E1539K, E1221K	Autosomal recessive congenital ichthyosis 4A	Pathogenic(Last reviewed: Sep 15, 2003)	no assertion criteria provided	VCV000002858	2	215845332	2	214980608	2858	17897	rs28940271	NC_000002.12:214980607:C:T
NM_173076.3(ABCA12):c.4541G>A (p.Arg1514His)	ABCA12	R1514H, R1196H	Autosomal recessive congenital ichthyosis 4A	Pathogenic(Last reviewed: Sep 15, 2003)	no assertion criteria provided	VCV000002857	2	215846949	2	214982225	2857	17896	rs28940270	NC_000002.12:214982224:C:T
NM_001244710.1(GFPT1):c.686-2A>G	GFPT1		Congenital myasthenic syndrome|Congenital myasthenic syndrome 12	Pathogenic(Last reviewed: Nov 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000540353	2	69581446	2	69354314	540353	518516	rs1011196447	NC_000002.12:69354313:T:C
NM_002056.4(GFPT1):c.331C>T (p.Arg111Cys)	GFPT1	R111C	Congenital myasthenic syndrome 12	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000029735	2	69590695	2	69363563	29735	38690	rs201322234	NC_000002.12:69363562:G:A
NM_001171603.1(PREPL):c.883C>T (p.Arg295Ter)	PREPL	R295*, R206*	Myasthenic syndrome, congenital, 22	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000548713	2	44566372	2	44339233	548713	539200	rs145356495	NC_000002.12:44339232:G:A
NM_173076.2(ABCA12):c.986-?_1061+?del (p.Asp330_Gln354delinsSerfs)	ABCA12		Autosomal recessive congenital ichthyosis 4B	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000002864	2	215891663 - 215901676	2	215026939 - 215036952	2864	17903		
NM_173076.3(ABCA12):c.4951G>A (p.Gly1651Ser)	ABCA12	G1651S, G1333S	Autosomal recessive congenital ichthyosis 4A	Pathogenic(Last reviewed: Sep 15, 2003)	no assertion criteria provided	VCV000002856	2	215843554	2	214978830	2856	17895	rs28940568	NC_000002.12:214978829:C:T
NM_173076.3(ABCA12):c.4142G>A (p.Gly1381Glu)	ABCA12	G1381E, G1063E	Autosomal recessive congenital ichthyosis 4A	Pathogenic(Last reviewed: Sep 15, 2003)	no assertion criteria provided	VCV000002854	2	215851287	2	214986563	2854	17893	rs28940268	NC_000002.12:214986562:C:T
NM_145277.5(HJV):c.358del (p.Gln120fs)	HJV	Q120fs, Q233fs, Q7fs	Hemochromatosis type 2A	Pathogenic(Last reviewed: Nov 9, 2018)	no assertion criteria provided	VCV000590920	1	145416352	1	146018661	590920	581864	rs1559279177	NC_000001.11:146018660:G:
NM_213653.3(HJV):c.1006G>T (p.Gly336Ter)	HJV	G336*, G223*, G110*	Hemochromatosis type 2A	Pathogenic(Last reviewed: Jun 6, 2018)	no assertion criteria provided	VCV000560162	1	145416661	1	146018352	560162	550878	rs1553769428	NC_000001.11:146018351:C:A
NC_000001.10:g.(?_145414693)_(145417545_?)del	HJV		Hemochromatosis type 2A	Pathogenic(Last reviewed: Jan 8, 2017)	criteria provided, single submitter	VCV000417403	1	145414693 - 145417545			417403	390720		
NM_145277.5(HJV):c.-180A>T	HJV	R54*	Hemochromatosis type 2A	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000002373	1	145415341	1	146019672	2373	17412	rs121434375	NC_000001.11:146019671:T:A
NM_145277.5(HJV):c.641_642TC[1] (p.Ser215fs)	HJV		Hemochromatosis type 2A	Pathogenic(Last reviewed: May 1, 2005)	no assertion criteria provided	VCV000002372	1	145416634 - 145416637	1	146018373 - 146018376	2372	17411	rs786205063	NC_000001.11:146018372:GAGAGAG:GAG
NM_145277.5(HJV):c.490C>T (p.Gln164Ter)	HJV	Q164*, Q277*, Q51*	not provided	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000855259	1	145416484	1	146018529	855259	822670		NC_000001.11:146018528:G:A
NC_000001.10:g.(?_145414772)_(145416946_?)del	HJV		not provided	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000832621	1	145414772 - 145416946			832621	818805		
NM_145277.5(HJV):c.-102T>C	HJV	C80R	Hemochromatosis type 2A	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000002369	1	145415419	1	146019594	2369	17408	rs28940586	NC_000001.11:146019593:A:G
NM_145277.5(HJV):c.503T>C (p.Ile168Thr)	HJV	I281T, I168T, I55T	Hemochromatosis type 2A	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000002368	1	145416497	1	146018516	2368	17407	rs74315326	NC_000001.11:146018515:A:G
NM_213653.3(HJV):c.220del (p.Val74fs)	HJV	V74fs	not provided	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000646197	1	145415398	1	146019612	646197	626781		NC_000001.11:146019611:CCCC:CCC
NM_002491.3(NDUFB3):c.64T>C (p.Trp22Arg)	NDUFB3	W22R	Inborn genetic diseases|not provided|Mitochondrial complex I deficiency|MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25|Mitochondrial complex I deficiency, nuclear type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000252575	2	201943669	2	201078946	252575	246907	rs142609245	NC_000002.12:201078945:T:C
NM_001146289.1(P3H1):c.1346-1G>C	P3H1		Osteogenesis imperfecta type 8|not provided	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000284532	1	43218336	1	42752665	284532	268769	rs886042897	NC_000001.11:42752664:C:G
NM_173076.3(ABCA12):c.859C>T (p.Arg287Ter)	ABCA12	R287*	Autosomal recessive congenital ichthyosis 4A|Autosomal recessive congenital ichthyosis 4B|not provided	Pathogenic(Last reviewed: Jul 26, 2016)	criteria provided, single submitter	VCV000264999	2	215910574	2	215045850	264999	259726	rs11891778	NC_000002.12:215045849:G:A
NM_000104.3(CYP1B1):c.868dup (p.Arg290fs)	CYP1B1		Congenital glaucoma|CYP1B1-Related Disorders|not provided|Congenital ocular coloboma	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000068468	2	38301663 - 38301664	2	38074520 - 38074521	68468	79360	rs587778875	NC_000002.12:38074520:GGGGGG:GGGGGGG
NM_020458.4(TTC7A):c.793C>T (p.Arg265Trp)	TTC7A	R231W, R265W	Common variable immunodeficiency	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827752	2	47220617	2	46993478	827752	815896		NC_000002.12:46993477:C:T
NM_020458.4(TTC7A):c.1802+3G>C	TTC7A		Common variable immunodeficiency	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827747	2	47256526	2	47029387	827747	815946		NC_000002.12:47029386:G:C
NM_020458.4(TTC7A):c.1039dup (p.Leu347fs)	TTC7A		Multiple gastrointestinal atresias	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000659629	2	47222310 - 47222311	2	46995171 - 46995172	659629	630050		NC_000002.12:46995171:CC:CCC
NM_020458.4(TTC7A):c.1072C>T (p.Arg358Ter)	TTC7A	R358*, R4*, R324*	Multiple gastrointestinal atresias	Pathogenic(Last reviewed: Aug 26, 2018)	criteria provided, single submitter	VCV000659060	2	47233067	2	47005928	659060	630052		NC_000002.12:47005927:C:T
NM_020458.4(TTC7A):c.280A>T (p.Lys94Ter)	TTC7A	K60*, K94*	Multiple gastrointestinal atresias	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000640974	2	47177597	2	46950458	640974	630040		NC_000002.12:46950457:A:T
NM_020458.4(TTC7A):c.2515G>A (p.Ala839Thr)	TTC7A	A805T, A863T, A839T, A485T	Multiple gastrointestinal atresias	Pathogenic(Last reviewed: Jan 17, 2019)	no assertion criteria provided	VCV000440891	2	47301000	2	47073861	440891	434520	rs202044972	NC_000002.12:47073860:G:A
NM_020458.4(TTC7A):c.1616C>T (p.Ser539Leu)	TTC7A	S505L, S539L, S185L	Multiple gastrointestinal atresias	Pathogenic(Last reviewed: Jan 17, 2019)	no assertion criteria provided	VCV000440890	2	47251473	2	47024334	440890	434519	rs776906926	NC_000002.12:47024333:C:T
NM_020458.4(TTC7A):c.2494G>A (p.Ala832Thr)	TTC7A	A832T, A798T, A478T, A856T	Multiple gastrointestinal atresias	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000190394	2	47300979	2	47073840	190394	188222	rs876657393	NC_000002.12:47073839:G:A
NM_020458.4(TTC7A):c.1204-2A>G	TTC7A		Multiple gastrointestinal atresias	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000190392	2	47233778	2	47006639	190392	188220	rs876657392	NC_000002.12:47006638:A:G
NM_020458.4(TTC7A):c.764+1del	TTC7A		Multiple gastrointestinal atresias	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000190389	2	47206047	2	46978905	190389	188217	rs886037746	NC_000002.12:46978904:GGGG:GGG
NM_020458.4(TTC7A):c.1510+105T>A	TTC7A		Multiple gastrointestinal atresias	Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000140581	2	47249223	2	47022084	140581	150262	rs587777551	NC_000002.12:47022083:T:A
NM_020458.4(TTC7A):c.1673_1674insG (p.Leu559fs)	TTC7A		Multiple gastrointestinal atresias	Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000140580	2	47256394 - 47256395	2	47029255 - 47029256	140580	150261	rs587777550	NC_000002.12:47029255::G
NM_020458.4(TTC7A):c.1481del (p.Gly494fs)	TTC7A	G460fs, G494fs, G140fs	Multiple gastrointestinal atresias	Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000140579	2	47249087	2	47021948	140579	150260	rs587777549	NC_000002.12:47021947:GGG:GG
NM_020458.4(TTC7A):c.1008C>G (p.Tyr336Ter)	TTC7A	Y336*, Y302*	Multiple gastrointestinal atresias	Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000140578	2	47222281	2	46995142	140578	150259	rs587777548	NC_000002.12:46995141:C:G
NM_020458.4(TTC7A):c.829C>T (p.Gln277Ter)	TTC7A	Q277*, Q243*	Multiple gastrointestinal atresias	Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000140577	2	47220653	2	46993514	140577	150258	rs587777547	NC_000002.12:46993513:C:T
NM_020458.4(TTC7A):c.2470C>T (p.Gln824Ter)	TTC7A	Q790*, Q824*, Q470*, Q848*	Multiple gastrointestinal atresias	Pathogenic(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	VCV000369683	2	47300955	2	47073816	369683	353890	rs1057516047	NC_000002.12:47073815:C:T
NM_020458.4(TTC7A):c.1001+3_1001+6del	TTC7A		Multiple gastrointestinal atresias	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000050608	2	47221652 - 47221655	2	46994513 - 46994516	50608	59642	rs587776971	NC_000002.12:46994512:AAGTAAGT:AAGT
NM_020458.4(TTC7A):c.1250G>A (p.Trp417Ter)	TTC7A	W417*, W383*, W63*	Multiple gastrointestinal atresias|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000578081	2	47233826	2	47006687	578081	558478	rs1558568116	NC_000002.12:47006686:G:A
NM_020458.4(TTC7A):c.1576C>T (p.Gln526Ter)	TTC7A	Q526*, Q492*, Q172*	Multiple gastrointestinal atresias	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000190393	2	47251433	2	47024294	190393	188221	rs786205698	NC_000002.12:47024293:C:T
NM_020458.4(TTC7A):c.1183dup (p.Gln395fs)	TTC7A		not provided|Multiple gastrointestinal atresias	Pathogenic(Last reviewed: Oct 13, 2015)	criteria provided, multiple submitters, no conflicts	VCV000284148	2	47233177 - 47233178	2	47006038 - 47006039	284148	268385	rs886042806	NC_000002.12:47006038:C:CC
NM_020458.4(TTC7A):c.286G>T (p.Glu96Ter)	TTC7A	E62*, E96*	not provided|Multiple gastrointestinal atresias	Pathogenic(Last reviewed: Oct 13, 2015)	criteria provided, multiple submitters, no conflicts	VCV000284147	2	47177603	2	46950464	284147	268384	rs886042805	NC_000002.12:46950463:G:T
NM_020458.4(TTC7A):c.315_318del (p.Asn104_Tyr105insTer)	TTC7A		Multiple gastrointestinal atresias	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000190390	2	47177630 - 47177633	2	46950491 - 46950494	190390	188218	rs886037747	NC_000002.12:46950490:TATCTA:TA
NM_007375.3(TARDBP):c.892G>A (p.Gly298Ser)	TARDBP	G298S	not provided|Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000005232	1	11082358	1	11022301	5232	20271	rs4884357	NC_000001.11:11022300:G:A
NM_001006657.2(WDR35):c.3031G>T (p.Glu1011Ter)	WDR35	E1011*, E1000*	not provided	Pathogenic(Last reviewed: Feb 17, 2016)	criteria provided, single submitter	VCV000286127	2	20130280	2	19930519	286127	270364	rs886043316	NC_000002.12:19930518:C:A
NM_001006657.2(WDR35):c.143-18T>A	WDR35		Short rib polydactyly syndrome 5	Pathogenic(Last reviewed: Feb 6, 2018)	no assertion criteria provided	VCV000488656	2	20182313	2	19982552	488656	481531	rs1553324519	NC_000002.12:19982551:A:T
NM_020779.4(WDR35):c.2489A>T (p.Asp830Val)	WDR35	D841V, D830V	Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446645	2	20135290	2	19935529	446645	440062	rs1553316926	NC_000002.12:19935528:T:A
NM_020779.4(WDR35):c.1400+3A>G	WDR35		Jeune thoracic dystrophy	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446643	2	20153592	2	19953831	446643	440063	rs776631281	NC_000002.12:19953830:T:C
NM_020779.4(WDR35):c.504T>A (p.Ser168Arg)	WDR35	S168R	Cranioectodermal dysplasia 2	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000065624	2	20175357	2	19975596	65624	76532	rs397515536	NC_000002.12:19975595:A:T
NM_020779.4(WDR35):c.2879A>G (p.Tyr960Cys)	WDR35	Y971C, Y960C	Cranioectodermal dysplasia 2	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000065623	2	20131115	2	19931354	65623	76531	rs397515535	NC_000002.12:19931353:T:C
NM_020779.4(WDR35):c.25-2A>C	WDR35		Cranioectodermal dysplasia 2	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000065621	2	20189045	2	19989284	65621	76529	rs397515534	NC_000002.12:19989283:T:G
NM_001006657.2(WDR35):c.781T>C (p.Trp261Arg)	WDR35	W261R	Short rib polydactyly syndrome 5	Pathogenic(Last reviewed: Apr 8, 2011)	no assertion criteria provided	VCV000031045	2	20173425	2	19973664	31045	40002	rs431905505	NC_000002.12:19973663:A:G
NM_001006657.2(WDR35):c.1633C>T (p.Arg545Ter)	WDR35	R545*, R534*	Short rib polydactyly syndrome 5	Pathogenic(Last reviewed: Apr 8, 2011)	no assertion criteria provided	VCV000031044	2	20146256	2	19946495	31044	40001	rs387907085	NC_000002.12:19946494:G:A
NM_020779.4(WDR35):c.2976del (p.Leu993fs)	WDR35	L993fs, L1004fs	Short rib polydactyly syndrome 5|Cranioectodermal dysplasia 2	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000839633	2	20130302	2	19930541	839633	825542		NC_000002.12:19930540:GG:G
NM_020779.4(WDR35):c.994C>T (p.Arg332Ter)	WDR35	R332*	Short rib polydactyly syndrome 5|Cranioectodermal dysplasia 2	Pathogenic(Last reviewed: Aug 25, 2017)	criteria provided, single submitter	VCV000579675	2	20169255	2	19969494	579675	557810	rs199840434	NC_000002.12:19969493:G:A
NM_020779.4(WDR35):c.1381C>T (p.Arg461Ter)	WDR35	R472*, R461*	Cranioectodermal dysplasia 2|Short rib polydactyly syndrome 5	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000572077	2	20153614	2	19953853	572077	559522	rs767751856	NC_000002.12:19953852:G:A
NM_020779.4(WDR35):c.1195-1699dup	WDR35		Short rib polydactyly syndrome 5|Cranioectodermal dysplasia 2	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000570299	2	20162072 - 20162073	2	19962311 - 19962312	570299	559525	rs1327489348	NC_000002.12:19962311:CC:CCC
NM_020779.4(WDR35):c.3426G>T (p.Trp1142Cys)	WDR35	W1153C, W1142C	Cranioectodermal dysplasia 2	Pathogenic(Last reviewed: Feb 6, 2018)	no assertion criteria provided	VCV000488657	2	20113406	2	19913645	488657	481532	rs1553313859	NC_000002.12:19913644:C:A
NM_001006657.2(WDR35):c.307+214_436+1120del	WDR35		Short rib polydactyly syndrome 5	Pathogenic(Last reviewed: Apr 8, 2011)	no assertion criteria provided	VCV000031043	2	20177392 - 20180238	2	19977631 - 19980477	31043	40000		
NM_020779.4(WDR35):c.25-2A>G	WDR35		Cranioectodermal dysplasia 2	Pathogenic(Last reviewed: Sep 10, 2010)	no assertion criteria provided	VCV000000020	2	20189045	2	19989284	20	15059	rs397515534	NC_000002.12:19989283:T:C
NM_020779.4(WDR35):c.1559T>C (p.Leu520Pro)	WDR35	L531P, L520P	Cranioectodermal dysplasia 2	Pathogenic(Last reviewed: Feb 7, 2018)	no assertion criteria provided	VCV000065620	2	20146297	2	19946536	65620	76528	rs397515533	NC_000002.12:19946535:A:G
NM_020779.4(WDR35):c.2858del (p.Pro953fs)	WDR35	P953fs, P964fs	Cranioectodermal dysplasia 2	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000000022	2	20131136	2	19931375	22	15061	rs397515334	NC_000002.12:19931374:GG:G
NM_020779.4(WDR35):c.1844A>G (p.Glu615Gly)	WDR35	E626G, E615G	Cranioectodermal dysplasia 2	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000000021	2	20145548	2	19945787	21	15060	rs267607174	NC_000002.12:19945786:T:C
NM_020779.4(WDR35):c.1546C>T (p.Gln516Ter)	WDR35	Q527*, Q516*	Short rib polydactyly syndrome 5|Short Rib Polydactyly Syndrome	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000617914	2	20146310	2	19946549	617914	609305	rs1050086118	NC_000002.12:19946548:G:A
GRCh37/hg19 1q41(chr1:220408340-220490046)x1	RAB3GAP2		not provided	Pathogenic(Last reviewed: Aug 31, 2017)	no assertion criteria provided	VCV000687736	1	220408340 - 220490046			687736	675328		
NM_012414.4(RAB3GAP2):c.165_168del (p.Glu56fs)	RAB3GAP2	E56fs	not provided	Pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, single submitter	VCV000504367	1	220406153 - 220406156	1	220232811 - 220232814	504367	495072	rs767189501	NC_000001.11:220232810:TTCATT:TT
NM_012414.4(RAB3GAP2):c.2844dup (p.Gln949fs)	RAB3GAP2		not provided	Pathogenic(Last reviewed: Jan 25, 2017)	criteria provided, single submitter	VCV000423205	1	220340979 - 220340980	1	220167637 - 220167638	423205	405056	rs1553274382	NC_000001.11:220167637:TTT:TTTT
NM_012414.4(RAB3GAP2):c.2207dup (p.Leu737fs)	RAB3GAP2		Warburg micro syndrome 2	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000436479	1	220356064 - 220356065	1	220182722 - 220182723	436479	427709	rs1553275687	NC_000001.11:220182722:G:GG
NM_012414.4(RAB3GAP2):c.3085G>T (p.Glu1029Ter)	RAB3GAP2	E1029*	Warburg micro syndrome 2	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000100790	1	220340637	1	220167295	100790	106655	rs587777170	NC_000001.11:220167294:C:A
NM_012414.4(RAB3GAP2):c.3637C>T (p.Arg1213Ter)	RAB3GAP2	R1213*	Warburg micro syndrome 2	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000100789	1	220327318	1	220153976	100789	106654	rs587777169	NC_000001.11:220153975:G:A
NM_012414.4(RAB3GAP2):c.1434G>A (p.Trp478Ter)	RAB3GAP2	W478*	Warburg micro syndrome 2	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000100788	1	220364463	1	220191121	100788	106653	rs587777168	NC_000001.11:220191120:C:T
NM_014140.3(SMARCAL1):c.2291G>A (p.Arg764Gln)	SMARCAL1	R764Q	Schimke immuno-osseous dysplasia	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000004178	2	217340038	2	216475315	4178	19217	rs267607071	NC_000002.12:216475314:G:A
NM_012414.4(RAB3GAP2):c.499_507del (p.Phe167_Thr169del)	RAB3GAP2		Warburg micro syndrome 2	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000030782	1	220384146 - 220384154	1	220210804 - 220210812	30782	39739	rs1553278569	NC_000001.11:220210803:AGTGTAGAA:
NM_012414.4(RAB3GAP2):c.3154G>T (p.Gly1052Cys)	RAB3GAP2	G1051C, G1052C	Cataract-intellectual disability-hypogonadism syndrome	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000001820	1	220338075	1	220164733	1820	16859	rs121434310	NC_000001.11:220164732:C:A
NM_145277.5(HJV):c.624C>A (p.Cys208Ter)	HJV	C321*, C208*, C95*	Hemochromatosis type 1|Hemochromatosis type 2A	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000002371	1	145416618	1	146018395	2371	17410	rs121434374	NC_000001.11:146018394:G:T
NM_020458.4(TTC7A):c.844-1G>T	TTC7A		Multiple gastrointestinal atresias	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	VCV000190391	2	47221495	2	46994356	190391	188219	rs777469885	NC_000002.12:46994355:G:T
NM_006593.4(TBR1):c.1581_1587GGCTGCA[3] (p.Thr532fs)	TBR1		not provided|Autistic behavior|Intellectual disability|Severe global developmental delay|Autistic behavior|Moderate global developmental delay|Autistic behavior|Severe global developmental delay|Neurodevelopmental disorder|Autism 5	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000224144	2	162280263 - 162280264	2	161423752 - 161423753	224144	225802	rs869312704	NC_000002.12:161423752:GCTGCAGGCTGCAGGCTGCA:GCTGCAGGCTGCAGGCTGCAGGCTGCA
NM_001330311.2(DVL1):c.1547del (p.Thr516fs)	DVL1	T491fs, T516fs	Robinow syndrome, autosomal dominant 2	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000807594	1	1273524	1	1338144	807594	798456		NC_000001.11:1338143:G:
NM_014014.5(SNRNP200):c.2653C>G (p.Gln885Glu)	SNRNP200	Q885E	Retinitis pigmentosa 33	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000039747	2	96956153	2	96290415	39747	48346	rs397514575	NC_000002.12:96290414:G:C
NM_014014.5(SNRNP200):c.2047G>T (p.Val683Leu)	SNRNP200	V683L	Retinitis pigmentosa	Pathogenic	no assertion criteria provided	VCV000143145	2	96958823	2	96293085	143145	152863	rs527236114	NC_000002.12:96293084:C:A
NM_014014.5(SNRNP200):c.3269G>T (p.Arg1090Leu)	SNRNP200	R1090L	Retinitis pigmentosa 33	Pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	VCV000039746	2	96953697	2	96287959	39746	48345	rs397514574	NC_000002.12:96287958:C:A
NM_004700.4(KCNQ4):c.827G>C (p.Trp276Ser)	KCNQ4	W276S	Autosomal dominant nonsyndromic deafness 2A|Rare genetic deafness	Pathogenic(Last reviewed: Jun 24, 2014)	criteria provided, single submitter	VCV000006242	1	41285137	1	40819465	6242	21281	rs80358277	NC_000001.11:40819464:G:C
NM_007315.3(STAT1):c.820C>T (p.Arg274Trp)	STAT1	R274W	Immunodeficiency 31C|Mycobacterial and viral infections, susceptibility to, autosomal recessive|Immunodeficiency 31C|Immunodeficiency 31a	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030083	2	191859911	2	190995185	30083	39038	rs387906758	NC_000002.12:190995184:G:A
NM_003680.3(YARS1):c.586G>A (p.Glu196Lys)	YARS1	E196K	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, dominant intermediate C	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000006189	1	33263369	1	32797768	6189	21228	rs121908834	NC_000001.11:32797767:C:T
NM_001111.5(ADAR):c.2180del (p.Pro727fs)	ADAR	P708fs, P727fs, P736fs, P432fs	not provided	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000817053	1	154569371	1	154596895	817053	805174		NC_000001.11:154596894:GGG:GG
NM_001111.5(ADAR):c.2565_2568del (p.Asn857fs)	ADAR	N831fs, N857fs, N536fs, N866fs, N812fs, N562fs	not provided	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000817052	1	154562333 - 154562336	1	154589857 - 154589860	817052	805173		NC_000001.11:154589856:AGTCAG:AG
NM_001111.5(ADAR):c.638del (p.Pro213fs)	ADAR	P213fs, P222fs	Symmetrical dyschromatosis of extremities	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801553	1	154574480	1	154602004	801553	789851		NC_000001.11:154602003:GG:G
NM_001111.5(ADAR):c.1675C>T (p.Gln559Ter)	ADAR	Q559*, Q264*, Q568*	not provided	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000499262	1	154570988	1	154598512	499262	490686	rs1553212090	NC_000001.11:154598511:G:A
NM_001111.5(ADAR):c.1491_1492AG[1] (p.Glu498fs)	ADAR		not provided	Pathogenic(Last reviewed: Feb 23, 2017)	criteria provided, single submitter	VCV000420164	1	154573624 - 154573625	1	154601148 - 154601149	420164	404943	rs1064794324	NC_000001.11:154601147:CTCT:CT
NM_001111.5(ADAR):c.2669-1G>C	ADAR		not provided	Pathogenic(Last reviewed: Jul 27, 2015)	criteria provided, single submitter	VCV000419608	1	154561939	1	154589463	419608	404942	rs1064793987	NC_000001.11:154589462:C:G
NM_001111.5(ADAR):c.2130dup (p.Asn711fs)	ADAR		not provided	Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000289746	1	154569420 - 154569421	1	154596944 - 154596945	289746	273983	rs1553211449	NC_000001.11:154596944:GGG:GGGG
NM_015506.3(MMACHC):c.292C>T (p.Gln98Ter)	MMACHC	Q98*, Q41*	not provided	Pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000501284	1	45973899	1	45508227	501284	492708	rs759188647	NC_000001.11:45508226:C:T
NM_015506.3(MMACHC):c.158T>C (p.Leu53Pro)	MMACHC	L53P	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE, DIGENIC	Pathogenic(Last reviewed: Sep 27, 2018)	no assertion criteria provided	VCV000495216	1	45973104	1	45507432	495216	486715	rs756980496	NC_000001.11:45507431:T:C
NM_015506.3(MMACHC):c.81G>A (p.Gln27=)	MMACHC		METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE, DIGENIC	Pathogenic(Last reviewed: Sep 27, 2018)	no assertion criteria provided	VCV000495215	1	45966085	1	45500413	495215	486714	rs1553162317	NC_000001.11:45500412:G:A
NM_001111.5(ADAR):c.939_940CT[1] (p.Ser314fs)	ADAR		Symmetrical dyschromatosis of extremities	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000014822	1	154574176 - 154574177	1	154601700 - 154601701	14822	29861	rs387906541	NC_000001.11:154601699:AGAG:AG
NM_001111.5(ADAR):c.2077C>T (p.Gln693Ter)	ADAR	Q693*, Q398*, Q702*	Symmetrical dyschromatosis of extremities	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000014821	1	154569601	1	154597125	14821	29860	rs121912423	NC_000001.11:154597124:G:A
NM_001111.5(ADAR):c.3494T>C (p.Phe1165Ser)	ADAR	F1165S, F870S, F844S, F1139S, F1120S, F1174S	Symmetrical dyschromatosis of extremities	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000014820	1	154557469	1	154584993	14820	29859	rs28936681	NC_000001.11:154584992:A:G
NM_001111.5(ADAR):c.2854A>T (p.Lys952Ter)	ADAR	K952*, K657*, K907*, K926*, K631*, K961*	Symmetrical dyschromatosis of extremities	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000014819	1	154561058	1	154588582	14819	29858	rs121912422	NC_000001.11:154588581:T:A
NM_001111.5(ADAR):c.2768T>C (p.Leu923Pro)	ADAR	L923P, L628P, L932P, L602P, L878P, L897P	Symmetrical dyschromatosis of extremities	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000014818	1	154561144	1	154588668	14818	29857	rs28936680	NC_000001.11:154588667:A:G
NM_001111.5(ADAR):c.1420C>T (p.Arg474Ter)	ADAR	R474*, R179*, R483*	Symmetrical dyschromatosis of extremities	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000014817	1	154573698	1	154601222	14817	29856	rs121912421	NC_000001.11:154601221:G:A
NM_001330311.2(DVL1):c.1598del (p.Pro533fs)	DVL1	P508fs, P533fs	Robinow syndrome, autosomal dominant 2	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000219223	1	1273473	1	1338093	219223	217239	rs869025220	NC_000001.11:1338092:GG:G
NM_001330311.2(DVL1):c.1651_1658delinsG (p.Pro551fs)	DVL1		Robinow syndrome, autosomal dominant 2	Pathogenic(Last reviewed: Jul 30, 2015)	no assertion criteria provided	VCV000208050	1	1273413 - 1273420	1	1338033 - 1338040	208050	204307	rs797044840	NC_000001.11:1338032:TAGGCAGG:C
NM_001330311.2(DVL1):c.1637del (p.Pro546fs)	DVL1	P521fs, P546fs	Robinow syndrome, autosomal dominant 2	Pathogenic(Last reviewed: Jul 30, 2015)	no assertion criteria provided	VCV000208049	1	1273434	1	1338054	208049	204309	rs797044839	NC_000001.11:1338053:GGGGG:GGGG
NC_000001.11:g.(?_45500323)_(45509225_?)del	MMACHC		Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000833292	1	45965995 - 45974897			833292	818977		
NM_015506.3(MMACHC):c.626dup (p.Thr210fs)	MMACHC		Methylmalonic acidemia with homocystinuria	Pathogenic	criteria provided, single submitter	VCV000813353	1	45974663 - 45974664	1	45508991 - 45508992	813353	801599		NC_000001.11:45508991:T:TT
NM_015506.3(MMACHC):c.89G>A (p.Trp30Ter)	MMACHC	W30*	Methylmalonic acidemia with homocystinuria	Pathogenic	criteria provided, single submitter	VCV000813347	1	45973035	1	45507363	813347	801593		NC_000001.11:45507362:G:A
NM_015506.3(MMACHC):c.364dup (p.His122fs)	MMACHC		Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000633604	1	45973968 - 45973969	1	45508296 - 45508297	633604	622036	rs1557607997	NC_000001.11:45508296:CCC:CCCC
NM_015506.3(MMACHC):c.315C>G (p.Tyr105Ter)	MMACHC	Y105*, Y48*	Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000553788	1	45973922	1	45508250	553788	541103	rs528744719	NC_000001.11:45508249:C:G
NM_015506.3(MMACHC):c.464G>A (p.Gly155Glu)	MMACHC	G155E, G98E	Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000161119	1	45974502	1	45508830	161119	170963	rs606231425	NC_000001.11:45508829:G:A
NM_015506.3(MMACHC):c.276G>A (p.Glu92=)	MMACHC	E92E	Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000161118	1	45973222	1	45507550	161118	170962	rs556977618	NC_000001.11:45507549:G:A
NM_001111.5(ADAR):c.1630C>T (p.Arg544Ter)	ADAR	R544*, R249*, R553*	Aicardi-Goutieres syndrome 6	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000126560	1	154571033	1	154598557	126560	132070	rs768943773	NC_000001.11:154598556:G:A
NM_001111.5(ADAR):c.1076_1080del (p.Lys359fs)	ADAR	K359fs, K64fs, K368fs	Aicardi-Goutieres syndrome 6	Pathogenic(Last reviewed: Nov 1, 2012)	no assertion criteria provided	VCV000039462	1	154574038 - 154574042	1	154601562 - 154601566	39462	48061	rs398122898	NC_000001.11:154601561:TCGCTTC:TC
NM_001111.5(ADAR):c.2564dup (p.Thr856fs)	ADAR		Symmetrical dyschromatosis of extremities|Aicardi-Goutieres syndrome 6	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000649961	1	154562336 - 154562337	1	154589860 - 154589861	649961	626876		NC_000001.11:154589860:A:AA
NM_001111.5(ADAR):c.3346del (p.Arg1116fs)	ADAR	R1071fs, R821fs, R1090fs, R1116fs, R795fs, R1125fs	Symmetrical dyschromatosis of extremities|Aicardi-Goutieres syndrome 6	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000582556	1	154557790	1	154585314	582556	558134	rs1557863734	NC_000001.11:154585313:TTTT:TTT
NM_015506.3(MMACHC):c.497dup (p.Pro167fs)	MMACHC		Methylmalonic acidemia with homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000556532	1	45974534 - 45974535	1	45508862 - 45508863	556532	541170	rs1481893137	NC_000001.11:45508862:T:TT
NM_015506.3(MMACHC):c.500del (p.Pro167fs)	MMACHC	P167fs, P110fs	Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000553370	1	45974537	1	45508865	553370	541119	rs1553162918	NC_000001.11:45508864:CC:C
NM_001111.5(ADAR):c.2615T>C (p.Ile872Thr)	ADAR	I872T, I577T, I846T, I551T, I827T, I881T	Aicardi-Goutieres syndrome 6	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000039461	1	154562286	1	154589810	39461	48060	rs398122897	NC_000001.11:154589809:A:G
NM_001111.5(ADAR):c.2997G>T (p.Lys999Asn)	ADAR	K999N, K704N, K954N, K973N, K678N, K1008N	Aicardi-Goutieres syndrome 6	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000039460	1	154560623	1	154588147	39460	48059	rs398122896	NC_000001.11:154588146:C:A
NM_001111.5(ADAR):c.3335A>T (p.Tyr1112Phe)	ADAR	Y1112F, Y817F, Y791F, Y1067F, Y1086F, Y1121F	Aicardi-Goutieres syndrome 6	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000039459	1	154557801	1	154585325	39459	48058	rs398122895	NC_000001.11:154585324:T:A
NM_001111.5(ADAR):c.3337G>C (p.Asp1113His)	ADAR	D1113H, D818H, D1068H, D1087H, D792H, D1122H	Aicardi-Goutieres syndrome 6	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000039457	1	154557799	1	154585323	39457	48056	rs398122894	NC_000001.11:154585322:C:G
NM_001111.5(ADAR):c.2608G>A (p.Ala870Thr)	ADAR	A870T, A575T, A825T, A879T, A549T, A844T	Aicardi-Goutieres syndrome 6	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000039456	1	154562293	1	154589817	39456	48055	rs398122893	NC_000001.11:154589816:C:T
NM_001111.5(ADAR):c.2675G>A (p.Arg892His)	ADAR	R892H, R597H, R847H, R901H, R571H, R866H	Aicardi-Goutieres syndrome 6	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000039455	1	154561932	1	154589456	39455	48054	rs398122892	NC_000001.11:154589455:C:T
NM_015506.3(MMACHC):c.81+1G>A	MMACHC		Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000859433	1	45966086	1	45500414	859433	851313		NC_000001.11:45500413:G:A
NM_001111.5(ADAR):c.3363dup (p.Lys1122Ter)	ADAR		Symmetrical dyschromatosis of extremities|Aicardi-Goutieres syndrome 6	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000664624	1	154557772 - 154557773	1	154585296 - 154585297	664624	626874		NC_000001.11:154585296:A:AA
NM_015506.3(MMACHC):c.285dup (p.Glu96fs)	MMACHC		Methylmalonic acidemia with homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557871	1	45973891 - 45973892	1	45508219 - 45508220	557871	541228	rs1553162821	NC_000001.11:45508219:A:AA
NM_015506.3(MMACHC):c.90G>A (p.Trp30Ter)	MMACHC	W30*	Methylmalonic acidemia with homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000555758	1	45973036	1	45507364	555758	541225	rs771673343	NC_000001.11:45507363:G:A
NM_015506.3(MMACHC):c.3G>A (p.Met1Ile)	MMACHC	M1I	Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000203823	1	45966007	1	45500335	203823	199944	rs779893448	NC_000001.11:45500334:G:A
NM_015506.3(MMACHC):c.276G>T (p.Glu92Asp)	MMACHC	E92D, E35D	Methylmalonic acidemia with homocystinuria	Pathogenic	criteria provided, single submitter	VCV000161117	1	45973222	1	45507550	161117	170961	rs556977618	NC_000001.11:45507549:G:T
NM_001330311.2(DVL1):c.1604del (p.Gly535fs)	DVL1	G535fs, G510fs	Robinow syndrome, autosomal dominant 2	Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	VCV000208048	1	1273467	1	1338087	208048	204310	rs797044838	NC_000001.11:1338086:CCC:CC
NM_001330311.2(DVL1):c.1690del (p.Ser564fs)	DVL1	S539fs, S564fs	Robinow syndrome, autosomal dominant 2	Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	VCV000208047	1	1273381	1	1338001	208047	204306	rs797044837	NC_000001.11:1338000:T:
NM_001330311.2(DVL1):c.1580_1592del (p.His527fs)	DVL1	H502fs, H527fs	Robinow syndrome, autosomal dominant 2	Pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, single submitter	VCV000208044	1	1273479 - 1273491	1	1338099 - 1338111	208044	204312	rs797044834	NC_000001.11:1338098:GGGGCAGCCGGGTGGGGCAGC:GGGGCAGC
NM_014014.5(SNRNP200):c.2042G>A (p.Arg681His)	SNRNP200	R681H	Retinal dystrophy|Retinitis pigmentosa	Pathogenic(Last reviewed: Aug 16, 2019)	criteria provided, single submitter	VCV000143144	2	96958828	2	96293090	143144	152862	rs527236113	NC_000002.12:96293089:C:T
NM_015506.3(MMACHC):c.429+1G>C	MMACHC		Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000858710	1	45974037	1	45508365	858710	850777		NC_000001.11:45508364:G:C
NM_015506.3(MMACHC):c.578T>C (p.Leu193Pro)	MMACHC	L193P, L136P	Methylmalonic acidemia with homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000813352	1	45974616	1	45508944	813352	801598		NC_000001.11:45508943:T:C
NM_015506.3(MMACHC):c.398_399del (p.Gln133fs)	MMACHC	Q133fs, Q76fs	Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000553801	1	45974005 - 45974006	1	45508333 - 45508334	553801	541241	rs746135357	NC_000001.11:45508332:AA:
NM_001172509.2(SATB2):c.163del (p.Val55fs)	SATB2	V55fs	not provided	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000817354	2	200320598	2	199455875	817354	805282		NC_000002.12:199455874:C:
NM_001172509.2(SATB2):c.337C>T (p.Gln113Ter)	SATB2	Q113*	not provided	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000620517	2	200298070	2	199433347	620517	611559	rs1559052053	NC_000002.12:199433346:G:A
NM_001172509.2(SATB2):c.853C>T (p.Gln285Ter)	SATB2	Q285*	not provided	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000620393	2	200213744	2	199349021	620393	611558	rs1559175170	NC_000002.12:199349020:G:A
GRCh37/hg19 2q33.1(chr2:200154449-200255711)x1	SATB2		not provided	Pathogenic(Last reviewed: Dec 2, 2015)	no assertion criteria provided	VCV000604204	2	200154449 - 200255711			604204	595540		
NM_001172509.2(SATB2):c.1311_1314dup (p.Arg439fs)	SATB2		History of neurodevelopmental disorder	Pathogenic(Last reviewed: Dec 30, 2016)	criteria provided, single submitter	VCV000587771	2	200193492 - 200193493	2	199328769 - 199328770	587771	579002	rs1559164234	NC_000002.12:199328769:CTCCCTC:CTCCCTCCCTC
GRCh37/hg19 2q33.1(chr2:199994308-200599890)x1	SATB2		not provided	Pathogenic(Last reviewed: Apr 30, 2018)	no assertion criteria provided	VCV000562602	2	199994308 - 200599890			562602	553786		
NM_001172509.2(SATB2):c.369del (p.Arg122_Trp123insTer)	SATB2		not provided	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000504250	2	200246521	2	199381798	504250	495400	rs1553496413	NC_000002.12:199381797:CC:C
NM_001172509.2(SATB2):c.997C>T (p.Gln333Ter)	SATB2	Q333*	not provided	Pathogenic(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000504014	2	200213600	2	199348877	504014	495394	rs1424984467	NC_000002.12:199348876:G:A
NM_001172509.2(SATB2):c.1393dup (p.Thr465fs)	SATB2		not provided	Pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	VCV000504001	2	200188674 - 200188675	2	199323951 - 199323952	504001	495136	rs1553547055	NC_000002.12:199323951:TTTT:TTTTT
NM_001172509.2(SATB2):c.1515_1516insA (p.Ala506fs)	SATB2		not provided	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000452933	2	200188552 - 200188553	2	199323829 - 199323830	452933	443132	rs1553546975	NC_000002.12:199323829::T
NM_001172509.2(SATB2):c.895del (p.Ser299fs)	SATB2	S299fs	not provided	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000452556	2	200213702	2	199348979	452556	443133	rs1553551647	NC_000002.12:199348978:AAA:AA
NM_001172509.2(SATB2):c.568dup (p.Thr190fs)	SATB2		not provided	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000451437	2	200245115 - 200245116	2	199380392 - 199380393	451437	443136	rs1553496051	NC_000002.12:199380392:T:TT
NM_001172509.2(SATB2):c.124G>T (p.Gly42Ter)	SATB2	G42*	not provided	Pathogenic(Last reviewed: Aug 20, 2015)	criteria provided, single submitter	VCV000419551	2	200320637	2	199455914	419551	405540	rs1064793947	NC_000002.12:199455913:C:A
NM_001172509.2(SATB2):c.482del (p.Lys161fs)	SATB2	K161fs	not provided	Pathogenic(Last reviewed: Aug 7, 2015)	criteria provided, single submitter	VCV000419365	2	200245202	2	199380479	419365	405536	rs1064793820	NC_000002.12:199380478:TTT:TT
GRCh37/hg19 2q33.1(chr2:200165950-200205229)x1	SATB2		See cases	Pathogenic	no assertion criteria provided	VCV000395859	2	200165950 - 200205229			395859	382752		
NM_001172509.2(SATB2):c.1940_1941CT[1] (p.Leu648fs)	SATB2		not provided	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000373794	2	200137193 - 200137194	2	199272470 - 199272471	373794	359337	rs1057518614	NC_000002.12:199272469:AGAG:AG
NM_001172509.2(SATB2):c.83del (p.Pro28fs)	SATB2	P28fs	not provided	Pathogenic(Last reviewed: Apr 8, 2016)	criteria provided, single submitter	VCV000280492	2	200320678	2	199455955	280492	264084	rs886041685	NC_000002.12:199455954:GGGGG:GGGG
NM_001172509.2(SATB2):c.1515del (p.Phe505fs)	SATB2	F505fs	not provided	Pathogenic(Last reviewed: Aug 18, 2016)	criteria provided, single submitter	VCV000265695	2	200188553	2	199323830	265695	259716	rs886039740	NC_000002.12:199323829:AAA:AA
NM_001172509.2(SATB2):c.225T>A (p.Tyr75Ter)	SATB2	Y75*	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000807484	2	200298182	2	199433459	807484	798494		NC_000002.12:199433458:A:T
NM_001172509.2(SATB2):c.553_554insT (p.Glu185fs)	SATB2		Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000807483	2	200245130 - 200245131	2	199380407 - 199380408	807483	798493		NC_000002.12:199380407::A
NM_001172509.2(SATB2):c.1103_1106del (p.Val368fs)	SATB2	V368fs	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000807482	2	200213491 - 200213494	2	199348768 - 199348771	807482	798492		NC_000002.12:199348767:CTGACT:CT
NM_001172509.2(SATB2):c.474-2A>G	SATB2		Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801850	2	200245212	2	199380489	801850	790148		NC_000002.12:199380488:T:C
NM_001172509.2(SATB2):c.2018dup (p.His673fs)	SATB2		Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Jun 2, 2017)	no assertion criteria provided	VCV000584425	2	200137117 - 200137118	2	199272394 - 199272395	584425	575477	rs1559136015	NC_000002.12:199272394:T:TT
NM_001172509.2(SATB2):c.1945dup (p.Ser649fs)	SATB2		Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Jun 2, 2017)	no assertion criteria provided	VCV000584424	2	200137190 - 200137191	2	199272467 - 199272468	584424	575478	rs1559136052	NC_000002.12:199272467:AAA:AAAA
NM_001172509.2(SATB2):c.1186G>C (p.Glu396Gln)	SATB2	E396Q	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Jun 2, 2017)	no assertion criteria provided	VCV000584423	2	200193621	2	199328898	584423	575479	rs1559164403	NC_000002.12:199328897:C:G
NM_001172509.2(SATB2):c.1171C>T (p.Gln391Ter)	SATB2	Q391*	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Jun 2, 2017)	no assertion criteria provided	VCV000584422	2	200213426	2	199348703	584422	575480	rs1559174813	NC_000002.12:199348702:G:A
NM_001172509.2(SATB2):c.1142T>G (p.Val381Gly)	SATB2	V381G	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Jun 2, 2017)	no assertion criteria provided	VCV000584421	2	200213455	2	199348732	584421	575481	rs1559174854	NC_000002.12:199348731:A:C
NM_001172509.2(SATB2):c.748C>T (p.Gln250Ter)	SATB2	Q250*	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Jun 2, 2017)	no assertion criteria provided	VCV000584420	2	200213849	2	199349126	584420	575482	rs1558995207	NC_000002.12:199349125:G:A
NM_001172509.2(SATB2):c.346+2T>G	SATB2		Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Jun 2, 2017)	no assertion criteria provided	VCV000584419	2	200298059	2	199433336	584419	575483	rs1559052017	NC_000002.12:199433335:A:C
NM_001172509.2(SATB2):c.1495A>T (p.Lys499Ter)	SATB2	K499*	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Apr 14, 2016)	criteria provided, single submitter	VCV000235893	2	200188573	2	199323850	235893	237528	rs878853163	NC_000002.12:199323849:T:A
NM_001172509.2(SATB2):c.1127_1128GT[2] (p.Ser378fs)	SATB2		Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Jul 1, 2015)	criteria provided, single submitter	VCV000224131	2	200213465 - 200213466	2	199348742 - 199348743	224131	225861	rs875989830	NC_000002.12:199348741:ACACAC:ACAC
GRCh38/hg38 2q33.1(chr2:198496240-199425531)x1	SATB2		See cases	Pathogenic(Last reviewed: Sep 17, 2012)	no assertion criteria provided	VCV000149934	2	199360964 - 200290254	2	198496240 - 199425531	149934	159685		
GRCh38/hg38 1p34.1(chr1:44838131-44841480)x1	PTCH2		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000059967	1	45303803 - 45307152	1	44838131 - 44841480	59967	74562		
GRCh38/hg38 2q33.1(chr2:199309935-199403802)x3	SATB2		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000059162	2	200174658 - 200268525	2	199309935 - 199403802	59162	73757		
GRCh38/hg38 2q33.1(chr2:199278605-199372542)x3	SATB2		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000059161	2	200143328 - 200237265	2	199278605 - 199372542	59161	73756		
NM_003738.5(PTCH2):c.3357+5C>T	PTCH2		Basal cell carcinoma, somatic	Pathogenic(Last reviewed: Feb 1, 1999)	no assertion criteria provided	VCV000006146	1	45288736	1	44823064	6146	21185	rs587776628	NC_000001.11:44823063:G:A
NM_001172509.2(SATB2):c.1610del (p.Asn537fs)	SATB2	N537fs	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, single submitter	VCV000691258	2	200173613	2	199308890	691258	678936		NC_000002.12:199308889:TTTT:TTT
NM_001172509.2(SATB2):c.1826del (p.Asp609fs)	SATB2	D609fs	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000666260	2	200137310	2	199272587	666260	653808		NC_000002.12:199272586:T:
NM_001172509.2(SATB2):c.562C>T (p.Gln188Ter)	SATB2	Q188*	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000656899	2	200245122	2	199380399	656899	629272		NC_000002.12:199380398:G:A
GRCh37/hg19 2q33.1(chr2:200213361-200233633)	SATB2		Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625775	2	200213361 - 200233633			625775	614079		
NM_001172509.2(SATB2):c.2074G>T (p.Glu692Ter)	SATB2	E692*	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Jun 2, 2017)	no assertion criteria provided	VCV000584426	2	200137062	2	199272339	584426	575476	rs1559135904	NC_000002.12:199272338:C:A
NC_000002.11:g.(?_200213404)_(200298257_?)del	SATB2		Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000584397	2	200213404 - 200298257	2	199348681 - 199433534	584397	558074		
NM_001172509.2(SATB2):c.343C>T (p.Gln115Ter)	SATB2	Q115*	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000573402	2	200298064	2	199433341	573402	557859	rs1559052032	NC_000002.12:199433340:G:A
NM_001172509.2(SATB2):c.1652_1653AG[1] (p.Arg552fs)	SATB2		Dolichocephaly|Cleft palate|Macrocephalus|Abnormality of the dentition|Clinodactyly of the 5th finger|Global developmental delay	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523423	2	200173568 - 200173569	2	199308845 - 199308846	523423	513920	rs1553544133	NC_000002.12:199308844:CTCTC:CTC
NM_001172509.2(SATB2):c.1592dup (p.Asn531fs)	SATB2		Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000469544	2	200173630 - 200173631	2	199308907 - 199308908	469544	450196	rs1553544158	NC_000002.12:199308907:TTTT:TTTTT
NM_001172509.2(SATB2):c.19dup (p.Ser7fs)	SATB2		SATB2-Related Disorder|not provided	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000451780	2	200320741 - 200320742	2	199456018 - 199456019	451780	443137	rs1553507389	NC_000002.12:199456018:T:TT
NM_001172509.1(SATB2):c.170_346dup	SATB2		Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000218098	2	200298061 - 200298237	2	199391823 - 199446462	218098	214752		
NC_000002.12:g.(199364049_199364051)_(199399060_199399062)dup	SATB2		Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000217315	2	200228772 - 200263785	2	199364049 - 199399062	217315	213969		
NM_001172509.2(SATB2):c.1187A>G (p.Glu396Gly)	SATB2	E396G	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000848669	2	200193620	2	199328897	848669	825550		NC_000002.12:199328896:T:C
NM_001172509.2(SATB2):c.2002_2021del (p.Tyr668fs)	SATB2	Y668fs	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000840533	2	200137115 - 200137134	2	199272392 - 199272411	840533	825541		NC_000002.12:199272391:CCGTGGTGCTTCACGTGGTACCG:CCG
NM_001172509.2(SATB2):c.597+1G>A	SATB2		Chromosome 2q32-q33 deletion syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000620021	2	200245086	2	199380363	620021	611461	rs1559016679	NC_000002.12:199380362:C:T
NM_001172509.2(SATB2):c.1543G>A (p.Gly515Ser)	SATB2	G515S	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000545530	2	200173680	2	199308957	545530	536032	rs1553544187	NC_000002.12:199308956:C:T
NM_001172509.2(SATB2):c.1627del (p.Arg543fs)	SATB2	R543fs	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431132	2	200173596	2	199308873	431132	424642	rs1135401803	NC_000002.12:199308872:G:
NM_001172509.2(SATB2):c.1286G>A (p.Arg429Gln)	SATB2	R429Q	Chromosome 2q32-q33 deletion syndrome|not provided	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000280282	2	200193521	2	199328798	280282	264091	rs886041516	NC_000002.12:199328797:C:T
NM_001330311.2(DVL1):c.1645_1646delinsC (p.Phe549fs)	DVL1		Robinow syndrome, autosomal dominant 2	Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	VCV000208043	1	1273425 - 1273426	1	1338045 - 1338046	208043	204308	rs797044833	NC_000001.11:1338044:AA:G
NM_022168.4(IFIH1):c.1328A>G (p.Asp443Gly)	IFIH1	D443G	not provided	Pathogenic(Last reviewed: Jun 24, 2015)	criteria provided, single submitter	VCV000235556	2	163138034	2	162281524	235556	237237	rs878853066	NC_000002.12:162281523:T:C
NM_022168.4(IFIH1):c.2866A>G (p.Ile956Val)	IFIH1	I956V	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000812540	2	163124021	2	162267511	812540	800764		NC_000002.12:162267510:T:C
NM_022168.4(IFIH1):c.2561T>A (p.Met854Lys)	IFIH1	M854K	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000812539	2	163128791	2	162272281	812539	800765		NC_000002.12:162272280:A:T
NM_022168.4(IFIH1):c.2486C>G (p.Thr829Ser)	IFIH1	T829S	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000812537	2	163128866	2	162272356	812537	800767		NC_000002.12:162272355:G:C
NM_022168.4(IFIH1):c.2407A>T (p.Ile803Phe)	IFIH1	I803F	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000812535	2	163130352	2	162273842	812535	800769		NC_000002.12:162273841:T:A
NM_022168.4(IFIH1):c.2404A>G (p.Asn802Asp)	IFIH1	N802D	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000812534	2	163130355	2	162273845	812534	800770		NC_000002.12:162273844:T:C
NM_022168.4(IFIH1):c.2342G>A (p.Gly781Glu)	IFIH1	G781E	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000812533	2	163130417	2	162273907	812533	800771		NC_000002.12:162273906:C:T
NM_022168.4(IFIH1):c.2317G>C (p.Glu773Gln)	IFIH1	E773Q	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000812531	2	163130442	2	162273932	812531	800773		NC_000002.12:162273931:C:G
NM_022168.4(IFIH1):c.2156C>T (p.Ala719Val)	IFIH1	A719V	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000812530	2	163133345	2	162276835	812530	800774		NC_000002.12:162276834:G:A
NM_022168.4(IFIH1):c.1747A>G (p.Ile583Val)	IFIH1	I583V	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000812529	2	163134733	2	162278223	812529	800775		NC_000002.12:162278222:T:C
NM_022168.4(IFIH1):c.1347C>G (p.Asn449Lys)	IFIH1	N449K	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000812527	2	163138015	2	162281505	812527	800777		NC_000002.12:162281504:G:C
NM_022168.4(IFIH1):c.1331A>G (p.Glu444Gly)	IFIH1	E444G	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000812526	2	163138031	2	162281521	812526	800778		NC_000002.12:162281520:T:C
NM_022168.4(IFIH1):c.1178A>C (p.Asp393Ala)	IFIH1	D393A	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000812525	2	163139004	2	162282494	812525	800779		NC_000002.12:162282493:T:G
NM_022168.4(IFIH1):c.1165G>A (p.Gly389Arg)	IFIH1	G389R	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000812524	2	163139017	2	162282507	812524	800780		NC_000002.12:162282506:C:T
NM_022168.4(IFIH1):c.2439A>T (p.Glu813Asp)	IFIH1	E813D	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Apr 24, 2016)	no assertion criteria provided	VCV000623488	2	163130320	2	162273810	623488	612450	rs1559810905	NC_000002.12:162273809:T:A
NM_022168.4(IFIH1):c.1738C>T (p.Gln580Ter)	IFIH1	Q580*	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000587512	2	163134742	2	162278232	587512	578390	rs774888783	NC_000002.12:162278231:G:A
NM_022168.4(IFIH1):c.1114C>T (p.Leu372Phe)	IFIH1	L372F	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Jul 3, 2014)	no assertion criteria provided	VCV000140751	2	163139068	2	162282558	140751	150465	rs587777576	NC_000002.12:162282557:G:A
NM_022168.4(IFIH1):c.1354G>A (p.Ala452Thr)	IFIH1	A452T	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Jul 3, 2014)	no assertion criteria provided	VCV000140750	2	163138008	2	162281498	140750	150464	rs587777575	NC_000002.12:162281497:C:T
NM_001172509.2(SATB2):c.1285C>T (p.Arg429Ter)	SATB2	R429*	Chromosome 2q32-q33 deletion syndrome|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280687	2	200193522	2	199328799	280687	264070	rs886041847	NC_000002.12:199328798:G:A
NM_022168.4(IFIH1):c.2544T>G (p.Asp848Glu)	IFIH1	D848E	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000812538	2	163128808	2	162272298	812538	800766		NC_000002.12:162272297:A:C
NM_022168.4(IFIH1):c.2471G>A (p.Arg824Lys)	IFIH1	R824K	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000812536	2	163128881	2	162272371	812536	800768		NC_000002.12:162272370:C:T
NM_022168.4(IFIH1):c.1465G>A (p.Ala489Thr)	IFIH1	A489T	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000812528	2	163137897	2	162281387	812528	800776		NC_000002.12:162281386:C:T
NM_022168.4(IFIH1):c.992C>T (p.Thr331Ile)	IFIH1	T331I	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000812523	2	163144748	2	162288238	812523	800781		NC_000002.12:162288237:G:A
NM_022168.4(IFIH1):c.992C>G (p.Thr331Arg)	IFIH1	T331R	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000812522	2	163144748	2	162288238	812522	800782		NC_000002.12:162288237:G:C
NM_022168.4(IFIH1):c.1483G>A (p.Gly495Arg)	IFIH1	G495R	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000137625	2	163137879	2	162281369	137625	141328	rs672601336	NC_000002.12:162281368:C:T
NM_022168.4(IFIH1):c.1009A>G (p.Arg337Gly)	IFIH1	R337G	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000137623	2	163144731	2	162288221	137623	141326	rs587777447	NC_000002.12:162288220:T:C
NM_022168.4(IFIH1):c.2159G>A (p.Arg720Gln)	IFIH1	R720Q	Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000137621	2	163133342	2	162276832	137621	141324	rs587777445	NC_000002.12:162276831:C:T
NM_015506.3(MMACHC):c.617G>A (p.Arg206Gln)	MMACHC	R206Q, R149Q	Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000848845	1	45974655	1	45508983	848845	824202		NC_000001.11:45508982:G:A
NM_015506.3(MMACHC):c.420G>A (p.Trp140Ter)	MMACHC	W140*, W83*	Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000203827	1	45974027	1	45508355	203827	199950	rs796051996	NC_000001.11:45508354:G:A
NM_022168.4(IFIH1):c.2335C>T (p.Arg779Cys)	IFIH1	R779C	not provided|Aicardi-Goutieres syndrome 7	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000137624	2	163130424	2	162273914	137624	141327	rs587777448	NC_000002.12:162273913:G:A
NM_001172509.2(SATB2):c.1196G>A (p.Arg399His)	SATB2	R399H	Chromosome 2q32-q33 deletion syndrome|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000373069	2	200193611	2	199328888	373069	359408	rs1057518190	NC_000002.12:199328887:C:T
NM_003738.5(PTCH2):c.2156G>A (p.Arg719Gln)	PTCH2	R719Q	Gorlin syndrome	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000006147	1	45293289	1	44827617	6147	21186	rs121434397	NC_000001.11:44827616:C:T
NM_000329.3(RPE65):c.149_150del (p.Leu49_Phe50insTer)	RPE65		not provided	Pathogenic(Last reviewed: Oct 29, 2015)	criteria provided, single submitter	VCV000284150	1	68912488 - 68912489	1	68446805 - 68446806	284150	268387	rs886042807	NC_000001.11:68446804:AAA:A
NM_000329.3(RPE65):c.227A>C (p.His76Pro)	RPE65	H76P	Leber congenital amaurosis	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812408	1	68912411	1	68446728	812408	800448		NC_000001.11:68446727:T:G
NM_000329.3(RPE65):c.1101A>G (p.Arg367=)	RPE65		Leber congenital amaurosis	Pathogenic(Last reviewed: May 9, 2017)	no assertion criteria provided	VCV000427868	1	68903897	1	68438214	427868	418818	rs1553152989	NC_000001.11:68438213:T:C
NM_000329.3(RPE65):c.1084C>T (p.Gln362Ter)	RPE65	Q362*	Retinal dystrophy|Global developmental delay|Nystagmus|Rod-cone dystrophy|Autistic disorder of childhood onset	Pathogenic	no assertion criteria provided	VCV000812758	1	68903914	1	68438231	812758	800988		NC_000001.11:68438230:G:A
NM_000329.3(RPE65):c.825C>G (p.Tyr275Ter)	RPE65	Y275*	Adrenocorticotropic hormone deficiency	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000587393	1	68904907	1	68439224	587393	578341	rs988133284	NC_000001.11:68439223:G:C
NM_000329.3(RPE65):c.361dup (p.Ser121fs)	RPE65		Leber congenital amaurosis	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000559521	1	68910347 - 68910348	1	68444664 - 68444665	559521	550247	rs121918844	NC_000001.11:68444664:AAAAAAA:AAAAAAAA
NM_000329.3(RPE65):c.962dup (p.Asn321fs)	RPE65		Retinal dystrophy|not provided	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000098902	1	68904660 - 68904661	1	68438977 - 68438978	98902	104792	rs61752906	NC_000001.11:68438977:TT:TTT
NM_000329.3(RPE65):c.57_58del (p.Glu20fs)	RPE65	E20fs	Retinal dystrophy|not provided	Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000098877	1	68914343 - 68914344	1	68448660 - 68448661	98877	104767	rs62642582	NC_000001.11:68448659:CC:
NM_000329.3(RPE65):c.722A>T (p.His241Leu)	RPE65	H241L	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812407	1	68905247	1	68439564	812407	800447		NC_000001.11:68439563:T:A
NM_000329.3(RPE65):c.1583G>T (p.Gly528Val)	RPE65	G528V	Leber congenital amaurosis 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801494	1	68895478	1	68429795	801494	789992		NC_000001.11:68429794:C:A
NM_000329.3(RPE65):c.893del (p.Lys298fs)	RPE65	K298fs	Retinal dystrophy|not provided	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372493	1	68904730	1	68439047	372493	359276	rs61752902	NC_000001.11:68439046:TTTTT:TTTT
NM_000329.3(RPE65):c.1355T>G (p.Val452Gly)	RPE65	V452G	not provided|Retinitis pigmentosa 20	Pathogenic(Last reviewed: Mar 17, 1998)	no assertion criteria provided	VCV000013116	1	68896843	1	68431160	13116	28155	rs62637004	NC_000001.11:68431159:A:C
NM_001330311.2(DVL1):c.1583del (p.Pro528fs)	DVL1	P503fs, P528fs	Robinow syndrome, autosomal dominant 2	Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	VCV000208046	1	1273488	1	1338108	208046	204313	rs797044836	NC_000001.11:1338107:GGG:GG
NM_000748.3(CHRNB2):c.936C>G (p.Ile312Met)	CHRNB2	I312M	Epilepsy, nocturnal frontal lobe, type 3	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000041036	1	154544235	1	154571759	41036	49458	rs281865071	NC_000001.11:154571758:C:G
NM_000748.3(CHRNB2):c.901C>G (p.Leu301Val)	CHRNB2	L301V	Epilepsy, nocturnal frontal lobe, type 3	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000041034	1	154544200	1	154571724	41034	49456	rs281865069	NC_000001.11:154571723:C:G
NM_000748.3(CHRNB2):c.859G>T (p.Val287Leu)	CHRNB2	V287L	Epilepsy, nocturnal frontal lobe, type 3	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000041033	1	154544158	1	154571682	41033	49455	rs74315291	NC_000001.11:154571681:G:T
NM_000748.3(CHRNB2):c.1010T>G (p.Val337Gly)	CHRNB2	V337G	Epilepsy, nocturnal frontal lobe, type 3	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000041032	1	154544309	1	154571833	41032	49454	rs281865072	NC_000001.11:154571832:T:G
NM_001201543.2(FAM161A):c.1355_1356del (p.Thr452fs)	FAM161A	T452fs	Retinitis pigmentosa 28|Retinal dystrophy|Retinitis pigmentosa|not provided	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000037	2	62066783 - 62066784	2	61839648 - 61839649	37	15076	rs397704718	NC_000002.12:61839647:TGT:T
NM_000329.3(RPE65):c.147_148insCAAA (p.Phe50fs)	RPE65		Retinitis pigmentosa 20|Leber congenital amaurosis 2	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000848072	1	68912490 - 68912491	1	68446807 - 68446808	848072	824403		NC_000001.11:68446807::TTTG
NM_000329.3(RPE65):c.507C>A (p.Cys169Ter)	RPE65	C169*	Retinitis pigmentosa 20|Leber congenital amaurosis 2	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000838191	1	68906672	1	68440989	838191	824400		NC_000001.11:68440988:G:T
NM_000329.3(RPE65):c.10del (p.Gln4fs)	RPE65	Q4fs	Retinitis pigmentosa 20|Leber congenital amaurosis 2	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000569113	1	68915579	1	68449896	569113	558585	rs747393487	NC_000001.11:68449895:GG:G
NM_000329.3(RPE65):c.715T>G (p.Tyr239Asp)	RPE65	Y239D	not provided|Leber congenital amaurosis 2	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000098889	1	68905254	1	68439571	98889	104779	rs61752896	NC_000001.11:68439570:A:C
NM_015506.3(MMACHC):c.82-1G>A	MMACHC		Methylmalonic acidemia with homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556698	1	45973027	1	45507355	556698	541100	rs1255179780	NC_000001.11:45507354:G:A
NM_006343.3(MERTK):c.1744_1751delinsT (p.Val581_Ile582insTer)	MERTK		Retinal dystrophy	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000867009	2	112760722 - 112760729	2	112003145 - 112003152	867009	856137		NC_000002.12:112003144:ATTGACAG:T
NM_006343.3(MERTK):c.2179C>T (p.Arg727Ter)	MERTK	R727*	Retinal dystrophy	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000866075	2	112777089	2	112019512	866075	856142		NC_000002.12:112019511:C:T
GRCh37/hg19 2q13(chr2:112690808-112809020)x1	MERTK		not provided	Pathogenic(Last reviewed: Sep 12, 2018)	no assertion criteria provided	VCV000687501	2	112690808 - 112809020			687501	675093		
GRCh37/hg19 2q13(chr2:112690808-112809020)x1	MERTK		not provided	Pathogenic(Last reviewed: May 17, 2017)	no assertion criteria provided	VCV000687377	2	112690808 - 112809020			687377	674969		
GRCh37/hg19 1p21.3(chr1:97757431-97798061)x1	DPYD		not provided	Pathogenic(Last reviewed: Oct 18, 2017)	no assertion criteria provided	VCV000686684	1	97757431 - 97798061			686684	674276		
NM_006343.3(MERTK):c.2214del (p.Cys738fs)	MERTK	C738fs	not provided	Pathogenic(Last reviewed: Mar 12, 2016)	criteria provided, single submitter	VCV000265244	2	112779023	2	112021446	265244	259692	rs886039422	NC_000002.12:112021445:T:
NM_006343.3(MERTK):c.1868T>A (p.Leu623Ter)	MERTK	L623*	not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000849628	2	112765960	2	112008383	849628	824700		NC_000002.12:112008382:T:A
NM_006343.3(MERTK):c.2207_2210CTGT[1] (p.Cys738fs)	MERTK		not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000845892	2	112779016 - 112779019	2	112021439 - 112021442	845892	824706		NC_000002.12:112021438:CTGTCTGT:CTGT
NM_006343.3(MERTK):c.2228del (p.Gly743fs)	MERTK	G743fs	not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000841415	2	112779036	2	112021459	841415	824708		NC_000002.12:112021458:GG:G
NC_000002.12:g.(?_112021422)_(112021581_?)del	MERTK		not provided	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, single submitter	VCV000830608	2	112778999 - 112779158			830608	819042		
NM_006343.3(MERTK):c.2070_2074del (p.Gly691fs)	MERTK	G691fs	Retinitis pigmentosa 38	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000811356	2	112767631 - 112767635	2	112010054 - 112010058	811356	799236		NC_000002.12:112010053:GACAGGAC:GAC
NM_006343.3(MERTK):c.2530C>T (p.Arg844Cys)	MERTK	R844C	Retinitis pigmentosa 38	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801738	2	112785971	2	112028394	801738	790031		NC_000002.12:112028393:C:T
NM_006343.3(MERTK):c.1296+1G>C	MERTK		Retinitis pigmentosa 38	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801736	2	112740571	2	111982994	801736	790029		NC_000002.12:111982993:G:C
NM_006343.3(MERTK):c.2486+1G>A	MERTK		Retinitis pigmentosa 38	Pathogenic(Last reviewed: Sep 28, 2017)	no assertion criteria provided	VCV000522500	2	112779972	2	112022395	522500	513018	rs1309140887	NC_000002.12:112022394:G:A
DPYD, 1-BP DEL, 1897C	DPYD		Dihydropyrimidine dehydrogenase deficiency	Pathogenic(Last reviewed: Aug 1, 1997)	no assertion criteria provided	VCV000000436					436	15475		
NC_000002.12:g.(?_111944960)_(112028864_?)del	MERTK		not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000831456	2	112702537 - 112786441			831456	819041		
NM_000110.3(DPYD):c.763-2A>G	DPYD		Dihydropyrimidine dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000552475	1	98144740	1	97679184	552475	541354	rs1300669537	NC_000001.11:97679183:T:C
NM_001160301.1(DPYD):c.127_134del (p.Lys42_Arg43insTer)	DPYD		not provided|Dihydropyrimidine dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000502676	1	98348836 - 98348843	1	97883280 - 97883287	502676	494099	rs1207177925	NC_000001.11:97883279:GGATTTCT:
NM_006343.2:c.-8163_c.1145-1213del	MERTK		Retinitis pigmentosa 38	Pathogenic(Last reviewed: Jan 30, 2015)	no assertion criteria provided	VCV000224739					224739	226537		
NM_006343.3(MERTK):c.2323C>T (p.Arg775Ter)	MERTK	R775*	Retinitis pigmentosa 38	Pathogenic(Last reviewed: Jul 1, 2012)	no assertion criteria provided	VCV000037305	2	112779132	2	112021555	37305	45879	rs387907314	NC_000002.12:112021554:C:T
MERTK, 91-KB DEL	MERTK		Retinitis pigmentosa 38	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000037304					37304	45878		
NM_006343.3(MERTK):c.61+1G>A	MERTK		Retinitis pigmentosa 38	Pathogenic(Last reviewed: Mar 9, 2010)	no assertion criteria provided	VCV000037303	2	112656374	2	111898797	37303	45877		NC_000002.12:111898796:G:A
MERTK, 9-KB DEL	MERTK		Retinitis pigmentosa 38	Pathogenic(Last reviewed: Mar 9, 2010)	no assertion criteria provided	VCV000037302					37302	45876		
MERTK, 5-BP DEL, NT2070	MERTK		Retinitis pigmentosa 38	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000005400					5400	20439		
DPYD, 4-BP DEL, 296TCAT	DPYD		Dihydropyrimidine dehydrogenase deficiency	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000000434					434	15473		
NM_000110.3(DPYD):c.2921A>T (p.Asp974Val)	DPYD	D974V	Fluorouracil response	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000000433	1	97544689	1	97079133	433	15472	rs72547602	NC_000001.11:97079132:T:A
NM_000748.3(CHRNB2):c.859G>A (p.Val287Met)	CHRNB2	V287M	Epilepsy, nocturnal frontal lobe, type 3	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000017496	1	154544158	1	154571682	17496	32535	rs74315291	NC_000001.11:154571681:G:A
NM_000748.3(CHRNB2):c.859G>C (p.Val287Leu)	CHRNB2	V287L	Epilepsy, nocturnal frontal lobe, type 3	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000017495	1	154544158	1	154571682	17495	32534	rs74315291	NC_000001.11:154571681:G:C
NM_006642.5(SDCCAG8):c.1420del (p.Glu474fs)	SDCCAG8	E506fs, E173fs, E376fs, E474fs	Senior-Loken syndrome 7|Senior-Loken syndrome 7|Bardet-Biedl syndrome 16|Bardet-Biedl syndrome|not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000057	1	243507579	1	243344277	57	15096	rs397515335	NC_000001.11:243344276:GG:G
NM_000110.3(DPYD):c.661G>T (p.Glu221Ter)	DPYD	E221*	Dihydropyrimidine dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370661	1	98164926	1	97699370	370661	357178	rs146170505	NC_000001.11:97699369:C:A
NM_001160301.1(DPYD):c.208C>T (p.Arg70Ter)	DPYD	R70*	Dihydropyrimidine dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370660	1	98293695	1	97828139	370660	357184	rs141597515	NC_000001.11:97828138:G:A
NM_173076.3(ABCA12):c.4139A>G (p.Asn1380Ser)	ABCA12	N1380S, N1062S	Autosomal recessive congenital ichthyosis 4A|Autosomal recessive congenital ichthyosis 4B|Autosomal recessive congenital ichthyosis 4A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002855	2	215851290	2	214986566	2855	17894	rs28940269	NC_000002.12:214986565:T:C
NM_000329.3(RPE65):c.1067del (p.Asn356fs)	RPE65	N356fs	Leber congenital amaurosis 2|not provided	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000098821	1	68903931	1	68438248	98821	104711	rs281865520	NC_000001.11:68438247:TTTTTTTT:TTTTTTT
NM_000329.3(RPE65):c.700C>T (p.Arg234Ter)	RPE65	R234*	Leber congenital amaurosis 2|not provided	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000013114	1	68905269	1	68439586	13114	28153	rs61752895	NC_000001.11:68439585:G:A
NM_005850.5(SF3B4):c.1147del (p.His383fs)	SF3B4	H383fs	Inborn genetic diseases|Nager syndrome	Pathogenic(Last reviewed: May 1, 2017)	criteria provided, single submitter	VCV000031652	1	149895562	1	149923670	31652	40328	rs387907186	NC_000001.11:149923669:GGGGGGG:GGGGGG
NM_005850.5(SF3B4):c.1147dup (p.His383fs)	SF3B4		Nager syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 6, 2014)	criteria provided, single submitter	VCV000031651	1	149895561 - 149895562	1	149923669 - 149923670	31651	40327	rs387907186	NC_000001.11:149923669:GGGGGGG:GGGGGGGG
NM_012414.4(RAB3GAP2):c.1276C>T (p.Arg426Cys)	RAB3GAP2	R426C	Warburg micro syndrome 2|Cataract-intellectual disability-hypogonadism syndrome|Cataract-intellectual disability-hypogonadism syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000100787	1	220364621	1	220191279	100787	106652	rs587777167	NC_000001.11:220191278:G:A
NM_001330311.2(DVL1):c.1594del (p.Trp532fs)	DVL1	W507fs, W532fs	Robinow syndrome, autosomal dominant 2	Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	VCV000208045	1	1273477	1	1338097	208045	204311	rs797044835	NC_000001.11:1338096:A:
NM_015506.3(MMACHC):c.441_442TG[2] (p.Cys149fs)	MMACHC		not provided|Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Nov 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203834	1	45974478 - 45974479	1	45508806 - 45508807	203834	199953	rs796051999	NC_000001.11:45508805:GTGTGTG:GTGTG
NM_015506.3(MMACHC):c.382_384TAC[2] (p.Tyr130del)	MMACHC	Y130del	Methylmalonic acidemia with homocystinuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203833	1	45973989 - 45973991	1	45508317 - 45508319	203833	199949	rs796051998	NC_000001.11:45508316:TACTACTAC:TACTAC
NM_015506.3(MMACHC):c.217C>T (p.Arg73Ter)	MMACHC	R73*, R16*	not provided|Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Oct 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000203825	1	45973163	1	45507491	203825	199946	rs796051995	NC_000001.11:45507490:C:T
NM_000329.3(RPE65):c.907A>T (p.Lys303Ter)	RPE65	K303*	Leber congenital amaurosis 2|not provided	Pathogenic(Last reviewed: Jan 22, 2016)	criteria provided, single submitter	VCV000029872	1	68904716	1	68439033	29872	38827	rs61752904	NC_000001.11:68439032:T:A
NM_015311.3(OBSL1):c.2032C>T (p.Gln678Ter)	OBSL1	Q678*	not provided	Pathogenic(Last reviewed: Oct 28, 2015)	criteria provided, single submitter	VCV000429882	2	220431654	2	219566932	429882	421364	rs775865076	NC_000002.12:219566931:G:A
NM_015311.3(OBSL1):c.1997_2049del (p.Gly666fs)	OBSL1	G666fs	not provided	Pathogenic(Last reviewed: Aug 10, 2016)	criteria provided, single submitter	VCV000289410	2	220431637 - 220431689	2	219566915 - 219566967	289410	273647	rs1553537027	
NM_015311.3(OBSL1):c.1954del (p.Glu652fs)	OBSL1	E652fs	not provided	Pathogenic(Last reviewed: Feb 15, 2016)	criteria provided, single submitter	VCV000280285	2	220431732	2	219567010	280285	264090	rs886041519	NC_000002.12:219567009:CCCC:CCC
NM_015311.3(OBSL1):c.3955C>T (p.Gln1319Ter)	OBSL1	Q1319*	Three M syndrome 2	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000374350	2	220422176	2	219557454	374350	361173	rs1057518717	NC_000002.12:219557453:G:A
NM_015311.3(OBSL1):c.2474del (p.Val825fs)	OBSL1	V825fs	Three M syndrome 2	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000374349	2	220428283	2	219563561	374349	361174	rs1057518716	NC_000002.12:219563560:A:
NM_015311.3(OBSL1):c.457_458delinsT (p.Gly153fs)	OBSL1		Three M syndrome 2	Pathogenic(Last reviewed: Apr 8, 2019)	no assertion criteria provided	VCV000617511	2	220435497 - 220435498	2	219570775 - 219570776	617511	608874	rs1559160379	NC_000002.12:219570774:CC:A
NM_015311.3(OBSL1):c.1256_1265del (p.Arg419fs)	OBSL1	R419fs	Three M syndrome 2	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000001047	2	220432794 - 220432803	2	219568072 - 219568081	1047	16086	rs1335171880	NC_000002.12:219568071:GCCACGGTGCGC:GC
NM_015311.3(OBSL1):c.1149C>A (p.Cys383Ter)	OBSL1	C383*	Three M syndrome 2	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000001046	2	220432910	2	219568188	1046	16085	rs121918215	NC_000002.12:219568187:G:T
NM_015311.3(OBSL1):c.1465C>T (p.Arg489Ter)	OBSL1	R489*	Three M syndrome 2	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000001049	2	220432509	2	219567787	1049	16088	rs121918216	NC_000002.12:219567786:G:A
NM_006343.3(MERTK):c.1951C>T (p.Arg651Ter)	MERTK	R651*	not provided|Retinitis pigmentosa 38	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000005402	2	112766043	2	112008466	5402	20441	rs119489105	NC_000002.12:112008465:C:T
NM_007375.3(TARDBP):c.1009A>G (p.Met337Val)	TARDBP	M337V	Amyotrophic lateral sclerosis type 10|TARDBP-related frontotemporal dementia|Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000005228	1	11082475	1	11022418	5228	20267	rs80356730	NC_000001.11:11022417:A:G
NM_001918.4(DBT):c.433+1G>T	DBT		not provided	Pathogenic(Last reviewed: Aug 14, 2014)	criteria provided, single submitter	VCV000197203	1	100696288	1	100230732	197203	194364	rs794727635	NC_000001.11:100230731:C:A
NM_001918.4(DBT):c.434-15_434-4del	DBT		not provided	Pathogenic(Last reviewed: Feb 24, 2014)	criteria provided, single submitter	VCV000166983	1	100684307 - 100684318	1	100218751 - 100218762	166983	177668	rs727503895	NC_000001.11:100218750:GTAACAAGGTAA:
NM_001918.4(DBT):c.871C>T (p.Arg291Ter)	DBT	R291*	not provided	Pathogenic(Last reviewed: Oct 11, 2013)	criteria provided, single submitter	VCV000094015	1	100680441	1	100214885	94015	99917	rs398123675	NC_000001.11:100214884:G:A
NM_001918.4(DBT):c.773-2A>G	DBT		not provided	Pathogenic(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	VCV000094014	1	100680541	1	100214985	94014	99916	rs398123674	NC_000001.11:100214984:T:C
NM_001918.4(DBT):c.51+1G>T	DBT		not provided	Pathogenic(Last reviewed: Jun 22, 2015)	criteria provided, single submitter	VCV000094003	1	100715325	1	100249769	94003	99905	rs398123669	NC_000001.11:100249768:C:A
NM_001918.4(DBT):c.360del (p.Lys120fs)	DBT	K120fs	not provided	Pathogenic(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	VCV000094002	1	100696362	1	100230806	94002	99904	rs398123668	NC_000001.11:100230805:TTTTTT:TTTTT
NM_001918.4(DBT):c.339_345del (p.Tyr114fs)	DBT	Y114fs	not provided	Pathogenic(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	VCV000094001	1	100696377 - 100696383	1	100230821 - 100230827	94001	99903	rs398123667	NC_000001.11:100230820:ATCATAA:
NM_001918.4(DBT):c.272_275del (p.Thr91fs)	DBT	T91fs	not provided	Pathogenic(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	VCV000094000	1	100696447 - 100696450	1	100230891 - 100230894	94000	99902	rs398123666	NC_000001.11:100230890:ACTG:
NM_001918.4(DBT):c.251G>A (p.Trp84Ter)	DBT	W84*	not provided	Pathogenic(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	VCV000093999	1	100700992	1	100235436	93999	99901	rs398123665	NC_000001.11:100235435:C:T
NM_001918.4(DBT):c.581C>G (p.Ser194Ter)	DBT	S133*, S194*	Maple syrup urine disease type 2	Pathogenic(Last reviewed: Apr 23, 2004)	no assertion criteria provided	VCV000011953	1	100681730	1	100216174	11953	26992	rs121965003	NC_000001.11:100216173:G:C
NM_001918.4(DBT):c.1355A>G (p.His452Arg)	DBT	H391R, H452R	Maple syrup urine disease, thiamine-responsive, type II	Pathogenic(Last reviewed: Apr 23, 2004)	no assertion criteria provided	VCV000011952	1	100661905	1	100196349	11952	26991	rs121965002	NC_000001.11:100196348:T:C
NM_001918.3(DBT):c.1282-4142_*(434_435)del	DBT		Maple syrup urine disease type 2	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000011951	1	100661376 - 100666120	1	100195820 - 100200564	11951	26990		
NM_001918.4(DBT):c.294C>G (p.Ile98Met)	DBT	I37M, I98M	Intermediate maple syrup urine disease type 2	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000011948	1	100696428	1	100230872	11948	26987	rs121965001	NC_000001.11:100230871:G:C
NM_001918.4(DBT):c.1448G>T (p.Ter483Leu)	DBT	*483L	Intermediate maple syrup urine disease type 2	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000011947	1	100661812	1	100196256	11947	26986	rs121965000	NC_000001.11:100196255:C:A
NM_001918.4(DBT):c.1017+1del	DBT		Maple syrup urine disease type 2	Pathogenic(Last reviewed: Apr 1, 1991)	no assertion criteria provided	VCV000011945	1	100676249	1	100210693	11945	26984	rs796052134	NC_000001.11:100210692:CC:C
NM_001918.3(DBT):c.434_435insAATACCTTGTTACCAGA	DBT		Maple syrup urine disease, thiamine-responsive, type II	Pathogenic(Last reviewed: Feb 1, 1991)	no assertion criteria provided	VCV000011944					11944	26983		
NM_001918.3:c.48_171del	DBT		Maple syrup urine disease type 2	Pathogenic(Last reviewed: Feb 1, 1991)	no assertion criteria provided	VCV000011942					11942	26981		
NM_001918.4(DBT):c.1082dup (p.Asn361fs)	DBT		Maple syrup urine disease	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801528	1	100672127 - 100672128	1	100206571 - 100206572	801528	789811		NC_000001.11:100206571:TTTTT:TTTTTT
NM_001918.4(DBT):c.898del (p.Ala300fs)	DBT	A300fs	Maple syrup urine disease type 2	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635310	1	100680414	1	100214858	635310	623124		NC_000001.11:100214857:C:
NC_000001.11:g.(?_100214807)_(100230924_?)del	DBT		Maple syrup urine disease	Pathogenic(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000831148	1	100680363 - 100696480			831148	818826		
NM_001918.4(DBT):c.261del (p.Glu88fs)	DBT	E88fs	Maple syrup urine disease	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000657974	1	100696461	1	100230905	657974	626467		NC_000001.11:100230904:TTTT:TTT
NM_001918.4(DBT):c.663_670del (p.Lys222fs)	DBT	K222fs	Maple syrup urine disease	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623328	1	100681641 - 100681648	1	100216085 - 100216092	623328	612251	rs748851630	NC_000001.11:100216084:CAACTTTG:
NC_000001.10:g.(?_100661791)_(100661998_?)del	DBT		Maple syrup urine disease	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000457141	1	100661791 - 100661998	1	100196235 - 100196442	457141	446912		
NM_001918.4(DBT):c.902G>A (p.Arg301His)	DBT	R301H	Maple syrup urine disease	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000437447	1	100680410	1	100214854	437447	430989	rs770981889	NC_000001.11:100214853:C:T
NM_001918.4(DBT):c.1033G>A (p.Gly345Arg)	DBT	G345R	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	VCV000224073	1	100672177	1	100206621	224073	225800	rs869312132	NC_000001.11:100206620:C:T
NM_000329.3(RPE65):c.1205G>A (p.Trp402Ter)	RPE65	W402*	Leber congenital amaurosis 2|Retinitis pigmentosa 20|Retinal dystrophy	Pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000660359	1	68897192	1	68431509	660359	628253		NC_000001.11:68431508:C:T
NC_000001.11:g.(?_100240741)_(100240904_?)del	DBT		Maple syrup urine disease	Pathogenic(Last reviewed: Apr 10, 2019)	criteria provided, single submitter	VCV000831115	1	100706297 - 100706460			831115	818827		
NC_000001.11:g.(?_100240751)_(100240894_?)del	DBT		Maple syrup urine disease	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000830385	1	100706307 - 100706450			830385	818828		
NM_001918.4(DBT):c.126T>G (p.Tyr42Ter)	DBT	Y42*	not provided|Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: May 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000195157	1	100706366	1	100240810	195157	192318	rs794727262	NC_000001.11:100240809:A:C
NM_001918.4(DBT):c.1291C>T (p.Arg431Ter)	DBT	R431*	Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000093991	1	100661969	1	100196413	93991	99893	rs398123660	NC_000001.11:100196412:G:A
NC_000001.11:g.(?_45507336)_(45509235_?)del	MMACHC		Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000832298	1	45973008 - 45974907			832298	818978		
NM_015506.3(MMACHC):c.615C>A (p.Tyr205Ter)	MMACHC	Y205*, Y148*	Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000558292	1	45974653	1	45508981	558292	541138	rs747527726	NC_000001.11:45508980:C:A
NM_015506.3(MMACHC):c.457C>T (p.Arg153Ter)	MMACHC	R153*, R96*	Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550539	1	45974495	1	45508823	550539	541244	rs757325789	NC_000001.11:45508822:C:T
NM_015506.3(MMACHC):c.352del (p.Gln118fs)	MMACHC	Q118fs, Q61fs	not specified|not provided|Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000439905	1	45973957	1	45508285	439905	433698	rs749264632	NC_000001.11:45508284:CCC:CC
NM_015506.3(MMACHC):c.347T>C (p.Leu116Pro)	MMACHC	L116P, L59P	Methylmalonic acidemia with homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000001422	1	45973954	1	45508282	1422	16461	rs121918240	NC_000001.11:45508281:T:C
NC_000001.11:g.(?_100196245)_(100196432_?)del	DBT		Maple syrup urine disease	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000830477	1	100661801 - 100661988			830477	818825		
NM_025243.4(SLC19A3):c.895_925del (p.Val299fs)	SLC19A3	V295fs, V299fs	not provided	Pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000817638	2	228563506 - 228563536	2	227698790 - 227698820	817638	805292		NC_000002.12:227698789:ATGGCGCCTTGTAATCCCACAGGATTTGAACAT:AT
GRCh37/hg19 2q36.3(chr2:228568988-228610384)x1	SLC19A3		not provided	Pathogenic(Last reviewed: Aug 3, 2018)	no assertion criteria provided	VCV000687036	2	228568988 - 228610384			687036	674628		
GRCh37/hg19 2q36.3(chr2:228568988-228610384)x1	SLC19A3		not provided	Pathogenic(Last reviewed: Aug 31, 2017)	no assertion criteria provided	VCV000686051	2	228568988 - 228610384			686051	673643		
NM_025243.4(SLC19A3):c.189C>A (p.Tyr63Ter)	SLC19A3	Y63*	not provided	Pathogenic(Last reviewed: Aug 5, 2018)	criteria provided, single submitter	VCV000620288	2	228564242	2	227699526	620288	611566	rs1559250774	NC_000002.12:227699525:G:T
NM_025243.4(SLC19A3):c.464C>T (p.Ser155Leu)	SLC19A3	S155L	not provided	Pathogenic(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	VCV000429823	2	228563967	2	227699251	429823	421368	rs1131691615	NC_000002.12:227699250:G:A
NM_025243.4(SLC19A3):c.1314+1G>A	SLC19A3		not provided	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000265591	2	228552881	2	227688165	265591	259733	rs141957107	NC_000002.12:227688164:C:T
NM_025243.4(SLC19A3):c.1332C>G (p.Ser444Arg)	SLC19A3	S444R	not provided	Pathogenic(Last reviewed: Apr 16, 2014)	criteria provided, single submitter	VCV000215158	2	228552272	2	227687556	215158	210787	rs863224204	NC_000002.12:227687555:G:C
NM_025243.4(SLC19A3):c.541T>C (p.Ser181Pro)	SLC19A3	S181P	Biotin-thiamine-responsive basal ganglia disease	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000488596	2	228563890	2	227699174	488596	481464	rs773971505	NC_000002.12:227699173:A:G
NM_025243.4(SLC19A3):c.850T>C (p.Trp284Arg)	SLC19A3	W284R	Biotin-thiamine-responsive basal ganglia disease	Pathogenic(Last reviewed: Sep 14, 2017)	no assertion criteria provided	VCV000438729	2	228563581	2	227698865	438729	432354	rs1553571227	NC_000002.12:227698864:A:G
NM_025243.4(SLC19A3):c.962C>T (p.Ala321Val)	SLC19A3	A321V	Biotin-thiamine-responsive basal ganglia disease	Pathogenic(Last reviewed: Sep 14, 2017)	no assertion criteria provided	VCV000438728	2	228563469	2	227698753	438728	432353	rs1282844765	NC_000002.12:227698752:G:A
NM_025243.4(SLC19A3):c.197T>C (p.Leu66Pro)	SLC19A3	L66P	Biotin-thiamine-responsive basal ganglia disease	Pathogenic(Last reviewed: Sep 14, 2017)	no assertion criteria provided	VCV000438727	2	228564234	2	227699518	438727	432356	rs1553571813	NC_000002.12:227699517:A:G
NM_025243.4(SLC19A3):c.265A>C (p.Ser89Arg)	SLC19A3	S89R	Biotin-thiamine-responsive basal ganglia disease	Pathogenic(Last reviewed: Sep 14, 2017)	no assertion criteria provided	VCV000438726	2	228564166	2	227699450	438726	432355	rs759807393	NC_000002.12:227699449:T:G
NM_025243.4(SLC19A3):c.1274_1276TAG[1] (p.Val426del)	SLC19A3	V426del	Biotin-thiamine-responsive basal ganglia disease	Pathogenic(Last reviewed: Sep 14, 2017)	no assertion criteria provided	VCV000438725	2	228552917 - 228552919	2	227688201 - 227688203	438725	432352	rs1553568249	NC_000002.12:227688200:CTACTAC:CTAC
NM_025243.4(SLC19A3):c.854G>A (p.Trp285Ter)	SLC19A3	W285*, W281*	Biotin-thiamine-responsive basal ganglia disease	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000848983	2	228563577	2	227698861	848983	825820		NC_000002.12:227698860:C:T
NC_000002.12:g.(?_227687377)_(227702338_?)del	SLC19A3		Biotin-thiamine-responsive basal ganglia disease	Pathogenic(Last reviewed: Sep 20, 2019)	criteria provided, single submitter	VCV000830446	2	228552093 - 228567054			830446	819134		
NM_025243.4(SLC19A3):c.597dup (p.His200fs)	SLC19A3		Biotin-thiamine-responsive basal ganglia disease	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000533549	2	228563833 - 228563834	2	227699117 - 227699118	533549	517859	rs773140674	NC_000002.12:227699117:AAAAAA:AAAAAAA
NM_025243.3(SLC19A3):c.-4404_-3+408del	SLC19A3		Biotin-thiamine-responsive basal ganglia disease	Pathogenic(Last reviewed: Mar 20, 2017)	no assertion criteria provided	VCV000425554	2	228582251 - 228587060	2	227717535 - 227722344	425554	413895		
NM_025243.4(SLC19A3):c.1154T>G (p.Leu385Arg)	SLC19A3	L385R	Biotin-thiamine-responsive basal ganglia disease	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000215161	2	228560623	2	227695907	215161	210788	rs563607795	NC_000002.12:227695906:A:C
NM_025243.4(SLC19A3):c.20C>A (p.Ser7Ter)	SLC19A3	S7*	Biotin-thiamine-responsive basal ganglia disease	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000162137	2	228567015	2	227702299	162137	171852	rs713993048	NC_000002.12:227702298:G:T
SLC19A3, 1-BP DUP, 74T	SLC19A3		Biotin-thiamine-responsive basal ganglia disease	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000004567					4567	19606		
NM_025243.4(SLC19A3):c.958G>C (p.Glu320Gln)	SLC19A3	E320Q	Biotin-thiamine-responsive basal ganglia disease	Pathogenic(Last reviewed: Apr 23, 2009)	no assertion criteria provided	VCV000004566	2	228563473	2	227698757	4566	19605	rs137852958	NC_000002.12:227698756:C:G
NM_025243.4(SLC19A3):c.130A>G (p.Lys44Glu)	SLC19A3	K44E	Biotin-thiamine-responsive basal ganglia disease	Pathogenic(Last reviewed: Apr 23, 2009)	no assertion criteria provided	VCV000004565	2	228566905	2	227702189	4565	19604	rs137852957	NC_000002.12:227702188:T:C
SLC19A3, IVS3AS, A-G, -14	SLC19A3		Biotin-thiamine-responsive basal ganglia disease	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000004564					4564	19603		
NM_025243.4(SLC19A3):c.1079dup (p.Leu360fs)	SLC19A3		Biotin-thiamine-responsive basal ganglia disease	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000579605	2	228560697 - 228560698	2	227695981 - 227695982	579605	557894	rs1559247315	NC_000002.12:227695981:AAA:AAAA
NM_001172509.2(SATB2):c.715C>T (p.Arg239Ter)	SATB2	R239*	Chromosome 2q32-q33 deletion syndrome|not provided	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002519	2	200213882	2	199349159	2519	17558	rs137853127	NC_000002.12:199349158:G:A
NM_020779.4(WDR35):c.1255+1G>A	WDR35		not provided|Cranioectodermal dysplasia 2|Short rib polydactyly syndrome 5	Pathogenic/Likely pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000286673	2	20160314	2	19960553	286673	270910	rs371669862	NC_000002.12:19960552:C:T
NM_000329.3(RPE65):c.242G>T (p.Arg81Ile)	RPE65	R81I	Retinitis pigmentosa 20|Leber congenital amaurosis 2|Leber congenital amaurosis	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000559523	1	68912396	1	68446713	559523	550249	rs1429137932	NC_000001.11:68446712:C:A
NM_000329.3(RPE65):c.1087C>A (p.Pro363Thr)	RPE65	P363T	Leber congenital amaurosis 2|Retinitis pigmentosa 20|Retinitis pigmentosa 20	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000013117	1	68903911	1	68438228	13117	28156	rs121917744	NC_000001.11:68438227:G:T
NM_025243.4(SLC19A3):c.337T>C (p.Tyr113His)	SLC19A3	Y113H	Biotin-thiamine-responsive basal ganglia disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000369673	2	228564094	2	227699378	369673	353888	rs145999922	NC_000002.12:227699377:A:G
NM_001918.4(DBT):c.939G>C (p.Lys313Asn)	DBT	K313N	not provided|Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: May 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000094017	1	100680373	1	100214817	94017	99919	rs398123676	NC_000001.11:100214816:C:G
NM_005562.3(LAMC2):c.2T>C (p.Met1Thr)	LAMC2	M1T	not provided	Pathogenic(Last reviewed: Mar 28, 2016)	criteria provided, single submitter	VCV000488888	1	183155489	1	183186354	488888	481572	rs1553262199	NC_000001.11:183186353:T:C
NM_005562.3(LAMC2):c.2489dup (p.Leu830fs)	LAMC2		not provided	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000862349	1	183205625 - 183205626	1	183236490 - 183236491	862349	823045		NC_000001.11:183236490:TT:TTT
NM_005562.3(LAMC2):c.2244C>G (p.Tyr748Ter)	LAMC2	Y748*	not provided	Pathogenic(Last reviewed: Dec 7, 2019)	criteria provided, single submitter	VCV000846375	1	183203525	1	183234390	846375	823044		NC_000001.11:183234389:C:G
NM_005562.3(LAMC2):c.1711C>T (p.Arg571Ter)	LAMC2	R571*	not provided	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000841746	1	183197751	1	183228616	841746	823042		NC_000001.11:183228615:C:T
NM_005562.3(LAMC2):c.2143C>T (p.Arg715Ter)	LAMC2	R715*	not provided	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000838122	1	183201915	1	183232780	838122	823043		NC_000001.11:183232779:C:T
NC_000001.11:g.(?_183186343)_(183186441_?)del	LAMC2		not provided	Pathogenic(Last reviewed: Jun 23, 2019)	criteria provided, single submitter	VCV000831650	1	183155478 - 183155576			831650	818875		
NM_005562.3(LAMC2):c.1386_1396delinsAACCGC (p.Cys462_Asn466delinsTer)	LAMC2		not provided	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000665097	1	183196750 - 183196760	1	183227615 - 183227625	665097	627144		NC_000001.11:183227614:TCCCTGTCATA:AACCGC
NM_005562.3(LAMC2):c.2131C>T (p.Gln711Ter)	LAMC2	Q711*	not provided	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000645549	1	183201903	1	183232768	645549	627145		NC_000001.11:183232767:C:T
NM_005562.3(LAMC2):c.508C>T (p.Arg170Ter)	LAMC2	R170*	not provided	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000836408	1	183189964	1	183220829	836408	823041		NC_000001.11:183220828:C:T
NM_005562.3(LAMC2):c.2137_2143del (p.Gln713fs)	LAMC2	Q713fs	Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000014558	1	183201908 - 183201914	1	183232773 - 183232779	14558	29597	rs1558095794	NC_000001.11:183232772:CCAGAACC:C
NM_005562.3(LAMC2):c.1067-1G>A	LAMC2		Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic(Last reviewed: Mar 1, 1994)	no assertion criteria provided	VCV000014554	1	183195832	1	183226697	14554	29593	rs1558092501	NC_000001.11:183226696:G:A
NM_015311.3(OBSL1):c.1273dup (p.Thr425fs)	OBSL1		not provided|Three M syndrome 2	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000195306	2	220432785 - 220432786	2	219568063 - 219568064	195306	192467	rs762334954	NC_000002.12:219568063:T:TT
LAMC2, 1-BP INS, 3511A	LAMC2		Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000014561					14561	29600		
NM_005562.3(LAMC2):c.405-1G>A	LAMC2		Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000014560	1	183187524	1	183218389	14560	29599	rs1558088792	NC_000001.11:183218388:G:A
NM_005562.3(LAMC2):c.2348del (p.Glu783fs)	LAMC2	E783fs	Junctional epidermolysis bullosa gravis of Herlitz|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371486	1	183204757	1	183235622	371486	357021	rs776142807	NC_000001.11:183235621:A:
NM_005562.3(LAMC2):c.134_137del (p.Arg45fs)	LAMC2	R45fs	not provided|Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic/Likely pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370838	1	183177067 - 183177070	1	183207932 - 183207935	370838	357009	rs1057516806	NC_000001.11:183207931:ACAGACA:ACA
NM_005562.3(LAMC2):c.1659C>A (p.Cys553Ter)	LAMC2	C553*	not provided|Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000014557	1	183197699	1	183228564	14557	29596	rs118203900	NC_000001.11:183228563:C:A
NM_015506.3(MMACHC):c.507_519del (p.Glu170fs)	MMACHC	E113fs, E170fs	Methylmalonic acidemia with homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556017	1	45974542 - 45974554	1	45508870 - 45508882	556017	541122	rs1553162923	NC_000001.11:45508869:GATAGAGGTGCCAGAT:GAT
NM_015506.3(MMACHC):c.80A>G (p.Gln27Arg)	MMACHC	Q27R	Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000552467	1	45966084	1	45500412	552467	541098	rs546099787	NC_000001.11:45500411:A:G
NM_015506.3(MMACHC):c.1A>G (p.Met1Val)	MMACHC	M1V	not provided|Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000381577	1	45966005	1	45500333	381577	365372	rs758477536	NC_000001.11:45500332:A:G
NM_015506.3(MMACHC):c.615C>G (p.Tyr205Ter)	MMACHC	Y205*, Y148*	Methylmalonic acidemia with homocystinuria|not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000281007	1	45974653	1	45508981	281007	265244	rs747527726	NC_000001.11:45508980:C:G
NM_015506.3(MMACHC):c.545_546GT[1] (p.Val183fs)	MMACHC		Methylmalonic acidemia with homocystinuria|not provided	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000095704	1	45974582 - 45974583	1	45508910 - 45508911	95704	101601	rs1305170860	NC_000001.11:45508909:TGTGT:TGT
NM_001201543.2(FAM161A):c.1501del (p.Cys501fs)	FAM161A	C501fs	Retinitis pigmentosa 28|Retinal dystrophy|not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552429	2	62066638	2	61839503	552429	542144	rs767414973	NC_000002.12:61839502:A:
NM_025243.4(SLC19A3):c.74dup (p.Ser26fs)	SLC19A3		not provided|Biotin-thiamine-responsive basal ganglia disease	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000190224	2	228566960 - 228566961	2	227702244 - 227702245	190224	188047	rs786205213	NC_000002.12:227702244:AAAAAA:AAAAAAA
NM_020919.4(ALS2):c.2845_2854dup (p.His952fs)	ALS2		not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000504060	2	202592485 - 202592486	2	201727762 - 201727763	504060	495139	rs1553506317	NC_000002.12:201727762:GGTGCGTGGAG:GGTGCGTGGAGGTGCGTGGAG
NM_020919.4(ALS2):c.735_738del (p.Glu246fs)	ALS2	E246fs	not provided	Pathogenic(Last reviewed: May 4, 2015)	criteria provided, single submitter	VCV000419009	2	202625979 - 202625982	2	201761256 - 201761259	419009	405543	rs1064793583	NC_000002.12:201761255:TTCTTT:TT
NM_020919.4(ALS2):c.913del (p.Glu304_Leu305insTer)	ALS2		Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000807369	2	202625804	2	201761081	807369	798496		NC_000002.12:201761080:G:
NM_020919.4(ALS2):c.3583G>T (p.Gly1195Ter)	ALS2	G1195*	Juvenile primary lateral sclerosis	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000807368	2	202588094	2	201723371	807368	798495		NC_000002.12:201723370:C:A
NM_020919.4(ALS2):c.3520A>T (p.Lys1174Ter)	ALS2	K1174*	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000645923	2	202588157	2	201723434	645923	629297		NC_000002.12:201723433:T:A
NM_020919.4(ALS2):c.1921C>T (p.Gln641Ter)	ALS2	Q641*	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000533744	2	202611366	2	201746643	533744	517639	rs1553511680	NC_000002.12:201746642:G:A
NM_020919.4(ALS2):c.1425_1428del (p.Gly477fs)	ALS2	G477fs	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000241308	2	202622168 - 202622171	2	201757445 - 201757448	241308	238594	rs878855058	NC_000002.12:201757444:CTCT:
NM_020919.4(ALS2):c.1619G>A (p.Gly540Glu)	ALS2	G540E	Juvenile primary lateral sclerosis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000042137	2	202619247	2	201754524	42137	51303	rs386134178	NC_000002.12:201754523:C:T
NM_020919.4(ALS2):c.1999-2A>T	ALS2		Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000042060	2	202609154	2	201744431	42060	51226	rs386134182	NC_000002.12:201744430:T:A
NM_020919.4(ALS2):c.4573dup (p.Val1525fs)	ALS2		Amyotrophic lateral sclerosis type 2	Pathogenic(Last reviewed: Mar 25, 2014)	no assertion criteria provided	VCV000183240	2	202571575 - 202571576	2	201706852 - 201706853	183240	181373	rs730882256	NC_000002.12:201706852:CCCC:CCCCC
NM_020919.4(ALS2):c.2002G>T (p.Gly668Ter)	ALS2	G668*	Amyotrophic lateral sclerosis type 2	Pathogenic(Last reviewed: Mar 25, 2014)	no assertion criteria provided	VCV000183239	2	202609149	2	201744426	183239	181372	rs730882255	NC_000002.12:201744425:C:A
NM_020919.4(ALS2):c.2143C>T (p.Gln715Ter)	ALS2	Q715*	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004417	2	202609008	2	201744285	4417	19456	rs121908139	NC_000002.12:201744284:G:A
NM_020919.4(ALS2):c.2980-2A>G	ALS2		Juvenile primary lateral sclerosis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004416	2	202591591	2	201726868	4416	19455	rs386134184	NC_000002.12:201726867:T:C
NM_020919.4(ALS2):c.470G>A (p.Cys157Tyr)	ALS2	C156Y, C157Y	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004415	2	202626247	2	201761524	4415	19454	rs121908138	NC_000002.12:201761523:C:T
NM_020919.4(ALS2):c.2992C>T (p.Arg998Ter)	ALS2	R998*	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004413	2	202591577	2	201726854	4413	19452	rs121908137	NC_000002.12:201726853:G:A
NM_020919.4(ALS2):c.4721del (p.Val1574fs)	ALS2	V1574fs	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004412	2	202569294	2	201704571	4412	19451	rs386134188	NC_000002.12:201704570:A:
NM_020919.4(ALS2):c.2537_2538del (p.Asn846fs)	ALS2	N846fs	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004410	2	202598041 - 202598042	2	201733318 - 201733319	4410	19449	rs386134183	NC_000002.12:201733317:AT:
NM_020919.3(ALS2):c.1472_1481delTTTCCCCCAG	ALS2		Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004409	2	202619395	2	201754672	4409	19448	rs387906316	NC_000002.12:201754671:C:A
NM_020919.4(ALS2):c.3619del (p.Lys1206_Met1207insTer)	ALS2		Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004408	2	202588058	2	201723335	4408	19447	rs386134187	NC_000002.12:201723334:TTTT:TTT
NM_000182.5(HADHA):c.180_180+5delinsAT	HADHA		not provided	Pathogenic(Last reviewed: Sep 10, 2015)	criteria provided, single submitter	VCV000503510	2	26461797 - 26461802	2	26238929 - 26238934	503510	494929	rs1553316142	NC_000002.12:26238928:GATACC:AT
NC_000002.12:g.(?_26236845)_(26239153_?)del	HADHA		Mitochondrial trifunctional protein deficiency|Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000831608	2	26459713 - 26462021			831608	819149		
NC_000002.11:g.(?_26414109)_(26462021_?)del	HADHA		Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000661736	2	26414109 - 26462021			661736	650766		
NM_000182.5(HADHA):c.612dup (p.Arg205Ter)	HADHA		Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000638987	2	26453123 - 26453124	2	26230255 - 26230256	638987	629761		NC_000002.12:26230255:A:AA
NM_000182.5(HADHA):c.6_24dup (p.Ile9fs)	HADHA		Mitochondrial trifunctional protein deficiency|Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000579792	2	26467440 - 26467441	2	26244572 - 26244573	579792	561248	rs1456890163	NC_000002.12:26244572:GCCAATCGCCCGGCAGGCC:GCCAATCGCCCGGCAGGCCGCCAATCGCCCGGCAGGCC
NM_000182.5(HADHA):c.845T>A (p.Val282Asp)	HADHA	V246D, V282D	Mitochondrial trifunctional protein deficiency	Pathogenic(Last reviewed: Sep 15, 1998)	no assertion criteria provided	VCV000008735	2	26437385	2	26214516	8735	23774	rs137852773	NC_000002.12:26214515:A:T
NM_000182.5(HADHA):c.1025T>C (p.Leu342Pro)	HADHA	L342P	Mitochondrial trifunctional protein deficiency	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000008734	2	26432709	2	26209840	8734	23773	rs137852772	NC_000002.12:26209839:A:G
NM_000182.5(HADHA):c.676+2T>C	HADHA		Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000495728	2	26453058	2	26230190	495728	486934	rs772683361	NC_000002.12:26230189:A:G
NM_000182.5(HADHA):c.1195C>T (p.Arg399Ter)	HADHA	R399*	not provided|Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000449455	2	26426956	2	26204087	449455	443225	rs1243779049	NC_000002.12:26204086:G:A
NM_005562.3(LAMC2):c.3454C>T (p.Gln1152Ter)	LAMC2	Q1152*	Adult junctional epidermolysis bullosa|Junctional epidermolysis bullosa gravis of Herlitz|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620535	1	183212407	1	183243272	620535	611497	rs1217053724	NC_000001.11:183243271:C:T
NM_139343.3(BIN1):c.1371+1G>T	BIN1		not provided	Pathogenic(Last reviewed: Mar 4, 2016)	criteria provided, single submitter	VCV000286314	2	127809830	2	127052254	286314	270551	rs556129959	NC_000002.12:127052253:C:A
NM_139343.3(BIN1):c.380_381AC[3] (p.Tyr129fs)	BIN1		Autosomal recessive centronuclear myopathy	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000567114	2	127827598 - 127827599	2	127070022 - 127070023	567114	559198	rs761813363	NC_000002.12:127070022:GTGT:GTGTGT
NM_139343.3(BIN1):c.1713G>A (p.Trp571Ter)	BIN1	W571*, W363*, W387*, W402*, W491*, W540*, W496*, W528*, W417*, W432*, W448*, W460*, W484*, W544*, W453*, W475*	Autosomal recessive centronuclear myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158013	2	127806171	2	127048595	158013	167860	rs587783343	NC_000002.12:127048594:C:T
NM_139343.3(BIN1):c.451G>A (p.Asp151Asn)	BIN1	D151N, D127N, D124N	Autosomal recessive centronuclear myopathy	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000008298	2	127826568	2	127068992	8298	23337	rs121909274	NC_000002.12:127068991:C:T
NM_139343.3(BIN1):c.105G>T (p.Lys35Asn)	BIN1	K35N, K11N, K8N	Autosomal recessive centronuclear myopathy	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000008297	2	127834262	2	127076686	8297	23336	rs121909273	NC_000002.12:127076685:C:A
NM_000182.5(HADHA):c.157C>T (p.Arg53Ter)	HADHA	R53*	not provided|Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000092594	2	26461825	2	26238957	92594	98502	rs147103714	NC_000002.12:26238956:G:A
NM_020919.4(ALS2):c.2761C>T (p.Arg921Ter)	ALS2	R921*	not provided|Infantile-onset ascending hereditary spastic paralysis	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2014)	no assertion criteria provided	VCV000100653	2	202593315	2	201728592	100653	106525	rs587777132	NC_000002.12:201728591:G:A
NM_020919.4(ALS2):c.1007_1008del (p.Ile336fs)	ALS2	I336fs	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000004411	2	202625709 - 202625710	2	201760986 - 201760987	4411	19450	rs386134175	NC_000002.12:201760985:TAT:T
NM_020919.4(ALS2):c.1867_1868del (p.Leu623fs)	ALS2	L623fs	Juvenile primary lateral sclerosis|Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000004406	2	202611419 - 202611420	2	201746696 - 201746697	4406	19445	rs386134181	NC_000002.12:201746695:AG:
NM_000182.5(HADHA):c.919-2A>G	HADHA		Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000193564	2	26435497	2	26212628	193564	190727	rs200017313	NC_000002.12:26212627:T:C
NM_020919.4(ALS2):c.1233T>G (p.Tyr411Ter)	ALS2	Y411*	Infantile-onset ascending hereditary spastic paralysis|Juvenile primary lateral sclerosis|Amyotrophic lateral sclerosis type 2|Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000533743	2	202622363	2	201757640	533743	517535	rs369577952	NC_000002.12:201757639:A:C
NM_001135745.2(ALS2):c.553del (p.Thr185fs)	ALS2	T185fs	Amyotrophic lateral sclerosis type 2|Juvenile primary lateral sclerosis	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000004414	2	202626164	2	201761441	4414	19453	rs386134174	NC_000002.12:201761440:T:
NM_001232.3(CASQ2):c.939+1G>T	CASQ2		Cardiovascular phenotype	Pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	VCV000519365	1	116247812	1	115705191	519365	509075	rs905985075	NC_000001.11:115705190:C:A
NM_001232.3(CASQ2):c.234+2T>C	CASQ2		not provided	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000427018	1	116310927	1	115768306	427018	414723	rs757789935	NC_000001.11:115768305:A:G
NM_001232.3(CASQ2):c.213del (p.Gln71fs)	CASQ2	Q71fs	not provided	Pathogenic(Last reviewed: Apr 12, 2012)	criteria provided, single submitter	VCV000190759	1	116310950	1	115768329	190759	188315	rs786205799	NC_000001.11:115768328:TT:T
NM_001232.3(CASQ2):c.204del (p.Lys68fs)	CASQ2	K68fs	not provided	Pathogenic(Last reviewed: Mar 25, 2014)	criteria provided, single submitter	VCV000190754	1	116310959	1	115768338	190754	188316	rs786205795	NC_000001.11:115768337:TTTTT:TTTT
NM_001232.3(CASQ2):c.606+1G>C	CASQ2		not provided	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000190743	1	116275521	1	115732900	190743	188311	rs786205791	NC_000001.11:115732899:C:G
NM_006912.6(RIT1):c.104G>C (p.Ser35Thr)	RIT1	S35T, S52T	Noonan syndrome|Noonan syndrome 8|not provided	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183401	1	155880449	1	155910658	183401	181515	rs869025189	NC_000001.11:155910657:C:G
NM_001232.4(CASQ2):c.733C>T (p.Gln245Ter)	CASQ2	Q245*	Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000859128	1	116269617	1	115726996	859128	822585		NC_000001.11:115726995:G:A
NM_001232.3(CASQ2):c.475G>T (p.Glu159Ter)	CASQ2	E159*	Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000654552	1	116280902	1	115738281	654552	626677		NC_000001.11:115738280:C:A
NM_001232.3(CASQ2):c.856G>T (p.Glu286Ter)	CASQ2	E286*	Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000651334	1	116247896	1	115705275	651334	626676		NC_000001.11:115705274:C:A
NM_001232.3(CASQ2):c.62del (p.Glu21fs)	CASQ2	E21fs	Ventricular tachycardia, catecholaminergic polymorphic, 2	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000041042	1	116311101	1	115768480	41042	49464	rs397507555	NC_000001.11:115768479:T:
NM_001232.3(CASQ2):c.539A>G (p.Lys180Arg)	CASQ2	K180R	Ventricular tachycardia, catecholaminergic polymorphic, 2	Pathogenic(Last reviewed: Oct 13, 2016)	no assertion criteria provided	VCV000265850	1	116275589	1	115732968	265850	260553	rs886039816	NC_000001.11:115732967:T:C
NM_001232.3(CASQ2):c.500T>A (p.Leu167His)	CASQ2	L167H	Ventricular tachycardia, catecholaminergic polymorphic, 2	Pathogenic(Last reviewed: Sep 5, 2006)	no assertion criteria provided	VCV000017612	1	116280877	1	115738256	17612	32651	rs121434550	NC_000001.11:115738255:A:T
NM_020919.4(ALS2):c.1425_1426AG[1] (p.Glu476fs)	ALS2		Juvenile primary lateral sclerosis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004407	2	202622168 - 202622169	2	201757445 - 201757446	4407	19446	rs386134176	NC_000002.12:201757444:CTCT:CT
NM_000784.4(CYP27A1):c.256-2A>G	CYP27A1		not provided	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000598129	2	219674298	2	218809575	598129	589190	rs1559391390	NC_000002.12:218809574:A:G
NM_000784.4(CYP27A1):c.776del (p.Lys259fs)	CYP27A1	K259fs	not provided	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000594465	2	219677403	2	218812680	594465	585528	rs1343936087	NC_000002.12:218812679:AA:A
NM_000784.4(CYP27A1):c.446+1G>T	CYP27A1		not provided	Pathogenic(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	VCV000446259	2	219674491	2	218809768	446259	439638	rs587778797	NC_000002.12:218809767:G:T
NM_000784.4(CYP27A1):c.1477-2A>C	CYP27A1		not provided	Pathogenic(Last reviewed: Apr 24, 2015)	criteria provided, single submitter	VCV000379475	2	219679632	2	218814909	379475	367001	rs111570247	NC_000002.12:218814908:A:C
NM_000478.6(ALPL):c.1078_1081dup (p.Gln361fs)	ALPL		not provided	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000853207	1	21902304 - 21902305	1	21575811 - 21575812	853207	823360		NC_000001.11:21575811:CGGGC:CGGGCGGGC
NM_000478.6(ALPL):c.715del (p.Asp239fs)	ALPL	D162fs, D184fs, D239fs	not provided	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000852461	1	21894663	1	21568170	852461	823353		NC_000001.11:21568169:G:
NC_000001.11:g.(?_21560626)_(21564216_?)del	ALPL		not provided	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000833230	1	21887119 - 21890709			833230	818901		
NC_000001.11:g.(?_21554072)_(21554152_?)del	ALPL		not provided	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000832023	1	21880565 - 21880645			832023	818900		
NM_000478.6(ALPL):c.331G>A (p.Ala111Thr)	ALPL	A111T, A34T, A56T	Adult hypophosphatasia	Pathogenic(Last reviewed: Jun 25, 2019)	no assertion criteria provided	VCV000829876	1	21889636	1	21563143	829876	818168		NC_000001.11:21563142:G:A
NM_000478.6(ALPL):c.923C>G (p.Ser308Ter)	ALPL	S231*, S253*, S308*	not provided	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000661538	1	21900218	1	21573725	661538	627356		NC_000001.11:21573724:C:G
NM_000478.6(ALPL):c.1098_1100CTC[1] (p.Ser368del)	ALPL	S368del	Infantile hypophosphatasia	Pathogenic(Last reviewed: Feb 26, 2018)	no assertion criteria provided	VCV000545020	1	21902325 - 21902327	1	21575832 - 21575834	545020	535284	rs1558557341	NC_000001.11:21575831:CCTCCTC:CCTC
NM_000478.6(ALPL):c.18del (p.Val7fs)	ALPL	V7fs	Infantile hypophosphatasia	Pathogenic(Last reviewed: Feb 26, 2018)	no assertion criteria provided	VCV000518424	1	21880592	1	21554099	518424	508966	rs1558543066	NC_000001.11:21554098:A:
NM_000478.6(ALPL):c.323C>T (p.Pro108Leu)	ALPL	P91L, P108L, P31L, P53L	Odontohypophosphatasia	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000013680	1	21889628	1	21563135	13680	28719	rs121918015	NC_000001.11:21563134:C:T
NC_000002.12:g.(?_218809567)_(218809777_?)del	CYP27A1		Cholestanol storage disease	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000832296	2	219674290 - 219674500			832296	819125		
NM_000784.4(CYP27A1):c.1064del (p.Pro355fs)	CYP27A1	P355fs	Cholestanol storage disease	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000642850	2	219678788	2	218814065	642850	629467		NC_000002.12:218814064:CCC:CC
NM_000784.4(CYP27A1):c.1381C>T (p.Gln461Ter)	CYP27A1	Q461*	not provided	Pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, single submitter	VCV000597631	2	219679385	2	218814662	597631	588692	rs771819245	NC_000002.12:218814661:C:T
NM_000784.4(CYP27A1):c.506_507delinsA (p.Ala169fs)	CYP27A1		Cholestanol storage disease	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000575859	2	219677004 - 219677005	2	218812281 - 218812282	575859	557931	rs1559392331	NC_000002.12:218812280:CG:A
NM_000784.4(CYP27A1):c.399G>A (p.Trp133Ter)	CYP27A1	W133*	Cholestanol storage disease	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065999	2	219674443	2	218809720	65999	76907	rs1160640803	NC_000002.12:218809719:G:A
NM_000784.4(CYP27A1):c.863del (p.Glu288fs)	CYP27A1	E288fs	Cholestanol storage disease	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065910	2	219677665	2	218812942	65910	76818	rs587778815	NC_000002.12:218812941:A:
NM_000784.4(CYP27A1):c.779G>A (p.Trp260Ter)	CYP27A1	W260*	Cholestanol storage disease	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065899	2	219677407	2	218812684	65899	76807	rs587778810	NC_000002.12:218812683:G:A
NM_000784.4(CYP27A1):c.752C>A (p.Ser251Ter)	CYP27A1	S251*	Cholestanol storage disease	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065896	2	219677380	2	218812657	65896	76804	rs587778808	NC_000002.12:218812656:C:A
NM_000784.4(CYP27A1):c.73del (p.Ala25fs)	CYP27A1	A25fs	Cholestanol storage disease	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065894	2	219646975	2	218782252	65894	76802	rs587778807	NC_000002.12:218782251:GGGG:GGG
NM_000784.4(CYP27A1):c.647-1G>T	CYP27A1		Cholestanol storage disease	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065886	2	219677274	2	218812551	65886	76794	rs587778804	NC_000002.12:218812550:G:T
NM_000784.4(CYP27A1):c.5dup (p.Ala3fs)	CYP27A1		Cholestanol storage disease	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065882	2	219646909 - 219646910	2	218782186 - 218782187	65882	76790	rs587778802	NC_000002.12:218782186:C:CC
NM_000784.4(CYP27A1):c.583G>T (p.Glu195Ter)	CYP27A1	E195*	Cholestanol storage disease	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065878	2	219677081	2	218812358	65878	76786	rs587778800	NC_000002.12:218812357:G:T
NM_000784.4(CYP27A1):c.433G>A (p.Gly145Arg)	CYP27A1	G145R	Cholestanol storage disease	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065868	2	219674477	2	218809754	65868	76776	rs587778795	NC_000002.12:218809753:G:A
NM_000784.4(CYP27A1):c.373_379del (p.Pro125fs)	CYP27A1	P125fs	Cholestanol storage disease	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065864	2	219674412 - 219674418	2	218809689 - 218809695	65864	76772	rs587778794	NC_000002.12:218809688:AGTACCCAGTAC:AGTAC
NM_000784.4(CYP27A1):c.355del (p.Arg119fs)	CYP27A1	R119fs	Cholestanol storage disease	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065861	2	219674399	2	218809676	65861	76769	rs587778793	NC_000002.12:218809675:C:
NM_000784.4(CYP27A1):c.305del (p.Pro102fs)	CYP27A1	P102fs	Cholestanol storage disease	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065856	2	219674348	2	218809625	65856	76764	rs587778790	NC_000002.12:218809624:CC:C
NM_000784.4(CYP27A1):c.1415G>C (p.Gly472Ala)	CYP27A1	G472A	Cholestanol storage disease	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065851	2	219679419	2	218814696	65851	76759	rs200883871	NC_000002.12:218814695:G:C
NM_000784.4(CYP27A1):c.1402C>T (p.Pro468Ser)	CYP27A1	P468S	Cholestanol storage disease	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065850	2	219679406	2	218814683	65850	76758	rs587778787	NC_000002.12:218814682:C:T
NM_000784.4(CYP27A1):c.1264-1G>A	CYP27A1		Cholestanol storage disease	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065844	2	219679267	2	218814544	65844	76752	rs587778785	NC_000002.12:218814543:G:A
NM_000784.4(CYP27A1):c.1263+5G>T	CYP27A1		Cholestanol storage disease	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065841	2	219679186	2	218814463	65841	76749	rs587778784	NC_000002.12:218814462:G:T
NM_000784.4(CYP27A1):c.1238T>A (p.Val413Asp)	CYP27A1	V413D	Cholestanol storage disease	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065840	2	219679156	2	218814433	65840	76748	rs587778783	NC_000002.12:218814432:T:A
NM_000784.4(CYP27A1):c.1222G>T (p.Glu408Ter)	CYP27A1	E408*	Cholestanol storage disease	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065839	2	219679140	2	218814417	65839	76747	rs587778782	NC_000002.12:218814416:G:T
NM_000784.4(CYP27A1):c.1202C>G (p.Pro401Arg)	CYP27A1	P401R	Cholestanol storage disease	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065836	2	219679120	2	218814397	65836	76744	rs587778780	NC_000002.12:218814396:C:G
NM_000784.4(CYP27A1):c.1061A>G (p.Asp354Gly)	CYP27A1	D354G	Cholestanol storage disease	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065827	2	219678787	2	218814064	65827	76735	rs72551320	NC_000002.12:218814063:A:G
NM_000784.4(CYP27A1):c.1017G>C (p.Thr339=)	CYP27A1		Cholestanol storage disease	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000065825	2	219677819	2	218813096	65825	76733	rs200553205	NC_000002.12:218813095:G:C
NM_000478.6(ALPL):c.1366G>A (p.Gly456Arg)	ALPL	G439R, G456R, G379R, G401R	Infantile hypophosphatasia	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000013681	1	21903932	1	21577439	13681	28720	rs121918016	NC_000001.11:21577438:G:A
NM_000478.6(ALPL):c.892G>A (p.Glu298Lys)	ALPL	E281K, E298K, E221K, E243K	Infantile hypophosphatasia	Pathogenic(Last reviewed: Sep 1, 1994)	no assertion criteria provided	VCV000013669	1	21900187	1	21573694	13669	28708	rs121918017	NC_000001.11:21573693:G:A
NM_000478.6(ALPL):c.1306T>C (p.Tyr436His)	ALPL	Y419H, Y436H, Y359H, Y381H	Infantile hypophosphatasia	Pathogenic(Last reviewed: Oct 15, 1992)	no assertion criteria provided	VCV000013668	1	21903131	1	21576638	13668	28707	rs121918006	NC_000001.11:21576637:T:C
NM_000478.6(ALPL):c.212G>C (p.Arg71Pro)	ALPL	R54P, R71P, R16P	Infantile hypophosphatasia	Pathogenic(Last reviewed: Oct 15, 1992)	no assertion criteria provided	VCV000013665	1	21887620	1	21561127	13665	28704	rs121918003	NC_000001.11:21561126:G:C
NM_000478.6(ALPL):c.997+2T>G	ALPL		Infantile hypophosphatasia	Pathogenic(Last reviewed: Oct 26, 2016)	criteria provided, single submitter	VCV000371591	1	21900294	1	21573801	371591	357066	rs1057517391	NC_000001.11:21573800:T:G
NM_000784.4(CYP27A1):c.819del (p.Asp273fs)	CYP27A1	D273fs	Cholestanol storage disease	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000065903	2	219677447	2	218812724	65903	76811	rs587778812	NC_000002.12:218812723:T:
NM_000784.4(CYP27A1):c.434G>A (p.Gly145Glu)	CYP27A1	G112E, G145E	Cholestanol storage disease	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000004264	2	219674478	2	218809755	4264	19303	rs72551313	NC_000002.12:218809754:G:A
NM_001232.3(CASQ2):c.339_354del (p.Ser113fs)	CASQ2	S113fs	Ventricular tachycardia, catecholaminergic polymorphic, 2|not provided	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000017611	1	116283415 - 116283430	1	115740794 - 115740809	17611	32650	rs786205106	NC_000001.11:115740793:CTTAAGAATATACAGGCTT:CTT
NM_001232.3(CASQ2):c.919G>C (p.Asp307His)	CASQ2	D307H	Ventricular tachycardia, catecholaminergic polymorphic, 2	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000017610	1	116247833	1	115705212	17610	32649	rs121434549	NC_000001.11:115705211:C:G
NM_020451.3(SELENON):c.683_689dup (p.Met230fs)	SELENON		not provided	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, single submitter	VCV000419984	1	26135215 - 26135216	1	25808724 - 25808725	419984	405144	rs1553120055	NC_000001.11:25808724:TGAGCAT:TGAGCATTGAGCAT
NM_020247.5(COQ8A):c.1228C>T (p.Arg410Ter)	COQ8A	R410*	not provided	Pathogenic(Last reviewed: Jun 15, 2015)	criteria provided, single submitter	VCV000379797	1	227171527	1	226983826	379797	364923	rs753254213	NC_000001.11:226983825:C:T
NM_020247.5(COQ8A):c.1742dup (p.Ser582fs)	COQ8A		not provided	Pathogenic(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	VCV000286407	1	227174235 - 227174236	1	226986534 - 226986535	286407	270644	rs772127266	NC_000001.11:226986534:A:AA
NM_020247.5(COQ8A):c.638_645del (p.Arg213fs)	COQ8A	R213fs	not provided	Pathogenic(Last reviewed: Jul 10, 2015)	criteria provided, single submitter	VCV000281924	1	227153416 - 227153423	1	226965715 - 226965722	281924	266161	rs886042265	NC_000001.11:226965714:TGGCCGGCTGGCC:TGGCC
NM_020247.5(COQ8A):c.1702G>T (p.Glu568Ter)	COQ8A	E568*	not provided	Pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, single submitter	VCV000280452	1	227174196	1	226986495	280452	264007	rs376478331	NC_000001.11:226986494:G:T
NM_020451.3(SELENON):c.9_33del (p.Ala4fs)	SELENON	A4fs	not provided	Pathogenic(Last reviewed: Mar 9, 2016)	criteria provided, single submitter	VCV000280406	1	26126724 - 26126748	1	25800233 - 25800257	280406	264015	rs886041619	NC_000001.11:25800232:GGGCCGGGCCCGGCCGGGCCAACGCGGGCCG:GGGCCG
NM_020451.3(SELENON):c.1090C>T (p.Gln364Ter)	SELENON	Q364*, Q330*	not provided	Pathogenic(Last reviewed: Mar 30, 2016)	criteria provided, single submitter	VCV000280366	1	26138024	1	25811533	280366	264019	rs886041584	NC_000001.11:25811532:C:T
NM_020451.3(SELENON):c.1096G>T (p.Glu366Ter)	SELENON	E366*, E332*	not provided	Pathogenic(Last reviewed: Jan 20, 2015)	criteria provided, single submitter	VCV000199156	1	26138185	1	25811694	199156	196315	rs794727976	NC_000001.11:25811693:G:T
NM_020451.3(SELENON):c.872+2T>C	SELENON		not provided	Pathogenic(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	VCV000198238	1	26135643	1	25809152	198238	195399	rs794727808	NC_000001.11:25809151:T:C
NM_020451.3(SELENON):c.44_72dup (p.Arg25fs)	SELENON		not provided	Pathogenic(Last reviewed: Jan 15, 2015)	criteria provided, single submitter	VCV000193429	1	26126761 - 26126762	1	25800270 - 25800271	193429	190593	rs797044620	NC_000001.11:25800270:CCGGCCCCGCCGCGCAGCCTCCCGCGCCACCG:CCGGCCCCGCCGCGCAGCCTCCCGCGCCACCGGCCCCGCCGCGCAGCCTCCCGCGCCACCG
NM_020451.3(SELENON):c.301+1G>T	SELENON		not provided	Pathogenic(Last reviewed: Mar 1, 2013)	criteria provided, single submitter	VCV000095962	1	26127652	1	25801161	95962	101858	rs398124360	NC_000001.11:25801160:G:T
NM_020247.5(COQ8A):c.656-1G>T	COQ8A		Coenzyme Q10 deficiency, primary, 4	Pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	VCV000807530	1	227165149	1	226977448	807530	798463		NC_000001.11:226977447:G:T
NM_020247.5(COQ8A):c.175C>T (p.Gln59Ter)	COQ8A	Q59*	Coenzyme Q10 deficiency, primary, 4	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000807529	1	227149261	1	226961560	807529	798462		NC_000001.11:226961559:C:T
NM_020247.5(COQ8A):c.1358del (p.Leu453fs)	COQ8A	L453fs	Coenzyme Q10 deficiency, primary, 4	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801627	1	227171896	1	226984195	801627	789937		NC_000001.11:226984194:T:
NM_020247.5(COQ8A):c.1506+1G>A	COQ8A		Coenzyme Q10 deficiency, primary, 4	Pathogenic(Last reviewed: Aug 21, 2017)	no assertion criteria provided	VCV000446283	1	227172357	1	226984656	446283	439688	rs974677376	NC_000001.11:226984655:G:A
NM_020247.5(COQ8A):c.1523T>C (p.Phe508Ser)	COQ8A	F508S	Coenzyme Q10 deficiency, primary, 4	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000375331	1	227172593	1	226984892	375331	362098	rs1057519343	NC_000001.11:226984891:T:C
NM_020247.5(COQ8A):c.1844G>A (p.Gly615Asp)	COQ8A	G615D	Coenzyme Q10 deficiency, primary, 4	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000375330	1	227174338	1	226986637	375330	362099	rs752130338	NC_000001.11:226986636:G:A
NM_020247.5(COQ8A):c.1136T>A (p.Leu379Ter)	COQ8A	L379*	Coenzyme Q10 deficiency, primary, 4	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000375329	1	227171308	1	226983607	375329	362097	rs747150601	NC_000001.11:226983606:T:A
NM_020247.5(COQ8A):c.1081-1_1082dup	COQ8A		Coenzyme Q10 deficiency, primary, 4	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000375333	1	227171250 - 227171251	1	226983549 - 226983550	375333	362096	rs1057519344	NC_000001.11:226983549:AGTA:AGTAGTA
NM_020247.5(COQ8A):c.1332_1333CA[1] (p.Thr445fs)	COQ8A		Coenzyme Q10 deficiency, primary, 4	Pathogenic(Last reviewed: Aug 8, 2014)	criteria provided, single submitter	VCV000210096	1	227171870 - 227171871	1	226984169 - 226984170	210096	206765	rs797045217	NC_000001.11:226984168:CACA:CA
NM_000784.4(CYP27A1):c.562C>T (p.Arg188Ter)	CYP27A1	R188*	Cholestanol storage disease	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000801897	2	219677060	2	218812337	801897	790197		NC_000002.12:218812336:C:T
NM_000478.6(ALPL):c.1182dup (p.Ile395fs)	ALPL		Hypophosphatasia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000632629	1	21902409 - 21902410	1	21575916 - 21575917	632629	621069	rs754826836	NC_000001.11:21575916:T:TT
NM_000478.6(ALPL):c.1017dup (p.His340fs)	ALPL		Infantile hypophosphatasia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000554623	1	21902242 - 21902243	1	21575749 - 21575750	554623	540890	rs764908423	NC_000001.11:21575749:GGG:GGGG
NM_000784.4(CYP27A1):c.886C>T (p.Gln296Ter)	CYP27A1	Q296*	Cholestanol storage disease|not provided	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000502269	2	219677688	2	218812965	502269	493693	rs575064188	NC_000002.12:218812964:C:T
NM_000784.4(CYP27A1):c.850A>T (p.Lys284Ter)	CYP27A1	K284*	Cholestanol storage disease	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000065907	2	219677652	2	218812929	65907	76815	rs72551319	NC_000002.12:218812928:A:T
NM_000784.4(CYP27A1):c.1185-1G>T	CYP27A1		Cholestanol storage disease	Pathogenic(Last reviewed: Apr 7, 2014)	criteria provided, single submitter	VCV000065835	2	219679102	2	218814379	65835	76743	rs587778779	NC_000002.12:218814378:G:T
NM_020247.5(COQ8A):c.1645G>A (p.Gly549Ser)	COQ8A	G549S	Coenzyme Q10 deficiency, primary, 4	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000003646	1	227173027	1	226985326	3646	18685	rs119468009	NC_000001.11:226985325:G:A
NM_020247.5(COQ8A):c.1813dup (p.Glu605fs)	COQ8A		Coenzyme Q10 deficiency, primary, 4	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000003640	1	227174305 - 227174306	1	226986604 - 226986605	3640	18679	rs387906298	NC_000001.11:226986604:GG:GGG
NM_020247.5(COQ8A):c.815G>T (p.Gly272Val)	COQ8A	G272V	Coenzyme Q10 deficiency, primary, 4	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000003638	1	227169812	1	226982111	3638	18677	rs119468006	NC_000001.11:226982110:G:T
NM_020247.5(COQ8A):c.637C>T (p.Arg213Trp)	COQ8A	R213W	Coenzyme Q10 deficiency, primary, 4	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000003637	1	227153420	1	226965719	3637	18676	rs119468005	NC_000001.11:226965718:C:T
NM_014014.5(SNRNP200):c.3260C>T (p.Ser1087Leu)	SNRNP200	S1087L	Retinitis pigmentosa|Retinitis pigmentosa 33|Retinal dystrophy	Pathogenic(Last reviewed: Jul 25, 2019)	criteria provided, single submitter	VCV000007928	2	96953706	2	96287968	7928	22967	rs267607077	NC_000002.12:96287967:G:A
NM_020451.3(SELENON):c.481C>T (p.Arg161Ter)	SELENON	R127*, R161*	Eichsfeld type congenital muscular dystrophy	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000837936	1	26131710	1	25805219	837936	823853		NC_000001.11:25805218:C:T
NM_020451.3(SELENON):c.-64_36del	SELENON		Eichsfeld type congenital muscular dystrophy	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000665196	1	26126650 - 26126749	1	25800159 - 25800258	665196	650633		
NM_020451.3(SELENON):c.1180G>T (p.Glu394Ter)	SELENON	E394*, E360*	Eichsfeld type congenital muscular dystrophy	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000664698	1	26138269	1	25811778	664698	627736		NC_000001.11:25811777:G:T
NM_020451.3(SELENON):c.300del (p.Ser102fs)	SELENON	S102fs	Eichsfeld type congenital muscular dystrophy	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000662908	1	26127650	1	25801159	662908	627729		NC_000001.11:25801158:A:
NM_020451.3(SELENON):c.-55_183del	SELENON		Eichsfeld type congenital muscular dystrophy	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000659413	1	26126666 - 26126903	1	25800175 - 25800412	659413	650648		
NM_020451.3(SELENON):c.3_7GGGCC[3] (p.Arg5fs)	SELENON		Eichsfeld type congenital muscular dystrophy	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623320	1	26126723 - 26126724	1	25800232 - 25800233	623320	612256		NC_000001.11:25800232:GGGCCGGGCC:GGGCCGGGCCGGGCC
NM_020451.3(SELENON):c.1375C>T (p.Gln459Ter)	SELENON	Q459*, Q425*	Eichsfeld type congenital muscular dystrophy	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000575921	1	26139271	1	25812780	575921	557246	rs760063405	NC_000001.11:25812779:C:T
NM_020451.3(SELENON):c.166C>T (p.Gln56Ter)	SELENON	Q56*	Eichsfeld type congenital muscular dystrophy	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000574438	1	26126887	1	25800396	574438	557015	rs1557814050	NC_000001.11:25800395:C:T
NM_020451.3(SELENON):c.921G>A (p.Trp307Ter)	SELENON	W307*, W273*	Eichsfeld type congenital muscular dystrophy	Pathogenic(Last reviewed: Sep 4, 2017)	criteria provided, single submitter	VCV000530817	1	26136222	1	25809731	530817	515769	rs1553120202	NC_000001.11:25809730:G:A
NM_020451.3(SELENON):c.665G>A (p.Trp222Ter)	SELENON	W222*, W188*	Eichsfeld type congenital muscular dystrophy	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000461634	1	26135198	1	25808707	461634	447750	rs1553120047	NC_000001.11:25808706:G:A
NM_020451.3(SELENON):c.1384T>G	SELENON	U462G	Eichsfeld type congenital muscular dystrophy	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000004495	1	26139280	1	25812789	4495	19534	rs121908187	NC_000001.11:25812788:T:G
NM_020451.3(SELENON):c.1358G>C (p.Trp453Ser)	SELENON	W453S, W419S	Eichsfeld type congenital muscular dystrophy	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000004493	1	26139254	1	25812763	4493	19532	rs121908186	NC_000001.11:25812762:G:C
NM_020451.2(SEPN1):c.1385G>A (p.Sec462=)	SELENON	U462*	Eichsfeld type congenital muscular dystrophy	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000004490	1	26139281	1	25812790	4490	19529	rs587776597	NC_000001.11:25812789:G:A
NM_020451.3(SELENON):c.818G>A (p.Gly273Glu)	SELENON	G273E, G239E	Eichsfeld type congenital muscular dystrophy	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000004489	1	26135587	1	25809096	4489	19528	rs121908182	NC_000001.11:25809095:G:A
NM_020247.5(COQ8A):c.1398+2T>C	COQ8A		Coenzyme Q10 deficiency, primary, 4	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000003641	1	227171938	1	226984237	3641	18680	rs606231138	NC_000001.11:226984236:T:C
NM_020247.5(COQ8A):c.815G>A (p.Gly272Asp)	COQ8A	G272D	Coenzyme Q10 deficiency, primary, 4	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000003639	1	227169812	1	226982111	3639	18678	rs119468006	NC_000001.11:226982110:G:A
NM_015506.3(MMACHC):c.565C>A (p.Arg189Ser)	MMACHC	R189S, R132S	Methylmalonic acidemia with homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000558690	1	45974603	1	45508931	558690	541246	rs200895671	NC_000001.11:45508930:C:A
NM_015506.3(MMACHC):c.666C>A (p.Tyr222Ter)	MMACHC	Y222*, Y165*	Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000496436	1	45974704	1	45509032	496436	486903	rs201266016	NC_000001.11:45509031:C:A
NM_015506.3(MMACHC):c.270dup (p.Arg91Ter)	MMACHC		Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Jun 8, 2016)	no assertion criteria provided	VCV000417860	1	45973214 - 45973215	1	45507542 - 45507543	417860	404748	rs1553162786	NC_000001.11:45507542:TT:TTT
NM_015506.3(MMACHC):c.608G>A (p.Trp203Ter)	MMACHC	W203*, W146*	Methylmalonic acidemia with homocystinuria|not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095706	1	45974646	1	45508974	95706	101603	rs398124295	NC_000001.11:45508973:G:A
NM_000478.6(ALPL):c.997+1G>T	ALPL		not provided	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000853798	1	21900293	1	21573800	853798	850743		NC_000001.11:21573799:G:T
NM_000784.4(CYP27A1):c.256-1G>T	CYP27A1		Cholestanol storage disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000553433	2	219674299	2	218809576	553433	541767	rs886556800	NC_000002.12:218809575:G:T
NM_000784.4(CYP27A1):c.666_678del (p.Phe222fs)	CYP27A1	F222fs	not provided|Cholestanol storage disease	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000498394	2	219677292 - 219677304	2	218812569 - 218812581	498394	489818	rs755532803	NC_000002.12:218812568:TTCGAGAAACGCATT:TT
NM_000478.6(ALPL):c.360_361del (p.Val121fs)	ALPL	V121fs, V44fs, V66fs	not provided|Skeletal dysplasia	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000493003	1	21889663 - 21889664	1	21563170 - 21563171	493003	485947	rs751994699	NC_000001.11:21563169:GGGG:GG
NM_000478.6(ALPL):c.662dup (p.Gly222fs)	ALPL		not provided|Infantile hypophosphatasia	Pathogenic/Likely pathogenic(Last reviewed: May 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370379	1	21894604 - 21894605	1	21568111 - 21568112	370379	357062	rs769948289	NC_000001.11:21568111:GGGGGG:GGGGGGG
NM_000478.6(ALPL):c.88C>T (p.Arg30Ter)	ALPL	R30*	not provided|Infantile hypophosphatasia	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370232	1	21887145	1	21560652	370232	357055	rs1057516334	NC_000001.11:21560651:C:T
NM_000478.6(ALPL):c.46_49del (p.Asn16fs)	ALPL	N16fs	Infantile hypophosphatasia|Skeletal dysplasia	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000370095	1	21880617 - 21880620	1	21554124 - 21554127	370095	357053	rs1057516230	NC_000001.11:21554123:ACTAACT:ACT
NM_000784.4(CYP27A1):c.11_20dup (p.Arg8fs)	CYP27A1		Cholestanol storage disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280048	2	219646907 - 219646908	2	218782184 - 218782185	280048	264076	rs886041342	NC_000002.12:218782184:GGCTGCGCTGGGCTGCGC:GGCTGCGCTGGGCTGCGCTGGGCTGCGC
NM_000784.4(CYP27A1):c.691C>T (p.Arg231Ter)	CYP27A1	R231*	Cholestanol storage disease	Pathogenic(Last reviewed: Feb 2, 2019)	criteria provided, single submitter	VCV000065891	2	219677319	2	218812596	65891	76799	rs72551315	NC_000002.12:218812595:C:T
NM_000478.6(ALPL):c.620A>C (p.Gln207Pro)	ALPL	Q190P, Q207P, Q130P, Q152P	not provided|Infantile hypophosphatasia	Pathogenic(Last reviewed: May 6, 2016)	criteria provided, single submitter	VCV000013666	1	21890681	1	21564188	13666	28705	rs121918004	NC_000001.11:21564187:A:C
NM_020451.3(SELENON):c.1209dup (p.Lys404fs)	SELENON		Eichsfeld type congenital muscular dystrophy	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000835943	1	26138297 - 26138298	1	25811806 - 25811807	835943	823858		NC_000001.11:25811806:C:CC
NM_020451.3(SELENON):c.1406G>A (p.Arg469Gln)	SELENON	R469Q, R435Q	Eichsfeld type congenital muscular dystrophy	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000461629	1	26140390	1	25813899	461629	447970	rs779162837	NC_000001.11:25813898:G:A
NM_020247.5(COQ8A):c.1042C>T (p.Arg348Ter)	COQ8A	R348*	not provided|Coenzyme Q10 deficiency, primary, 4	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000242458	1	227170697	1	226982996	242458	214530	rs771578775	NC_000001.11:226982995:C:T
SEPN1, 92-BP DEL	SELENON		Eichsfeld type congenital muscular dystrophy	Pathogenic(Last reviewed: May 1, 2004)	no assertion criteria provided	VCV000004497					4497	19536		
NM_020247.5(COQ8A):c.1541A>G (p.Tyr514Cys)	COQ8A	Y514C	Coenzyme Q10 deficiency, primary, 4	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000003643	1	227172611	1	226984910	3643	18682	rs119468008	NC_000001.11:226984909:A:G
NM_020247.5(COQ8A):c.500_521delinsTTG (p.Gln167fs)	COQ8A		Coenzyme Q10 deficiency, primary, 4|not provided	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000003642	1	227153023 - 227153044	1	226965322 - 226965343	3642	18681	rs606231139	NC_000001.11:226965321:AATCCCCTGTTGGGGGCCTCAC:TTG
NM_020247.5(COQ8A):c.1651G>A (p.Glu551Lys)	COQ8A	E551K	Coenzyme Q10 deficiency, primary, 4	Pathogenic(Last reviewed: Oct 11, 2016)	criteria provided, single submitter	VCV000003636	1	227173033	1	226985332	3636	18675	rs119468004	NC_000001.11:226985331:G:A
NM_031844.3(HNRNPU):c.1681dup (p.Gln561fs)	HNRNPU		Epileptic encephalopathy, early infantile, 54	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801643	1	245020091 - 245020092	1	244856789 - 244856790	801643	789955		NC_000001.11:244856789:GGGGGG:GGGGGGG
NM_031844.3(HNRNPU):c.191_206del (p.Gly64fs)	HNRNPU	G64fs	not provided	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000524096	1	245027404 - 245027419	1	244864102 - 244864117	524096	514426	rs1553284007	NC_000001.11:244864101:CGCCCAGCGGAATCCCCGCCCAG:CGCCCAG
NM_031844.3(HNRNPU):c.1450C>T (p.Arg484Ter)	HNRNPU	R484*, R465*	not provided	Pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, single submitter	VCV000523871	1	245021357	1	244858055	523871	514425	rs1553282635	NC_000001.11:244858054:G:A
NM_031844.3(HNRNPU):c.1669C>T (p.Gln557Ter)	HNRNPU	Q557*, Q538*	not provided	Pathogenic(Last reviewed: Feb 28, 2018)	criteria provided, single submitter	VCV000523805	1	245020104	1	244856802	523805	514424	rs1553282390	NC_000001.11:244856801:G:A
NM_031844.3(HNRNPU):c.253dup (p.Glu85fs)	HNRNPU		not provided	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000503814	1	245027356 - 245027357	1	244864054 - 244864055	503814	495079	rs1553283982	NC_000001.11:244864054:C:CC
NM_031844.3(HNRNPU):c.743_749del (p.Arg248fs)	HNRNPU	R248fs, R229fs	not provided	Pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, single submitter	VCV000452072	1	245025975 - 245025981	1	244862673 - 244862679	452072	442793	rs1553283444	NC_000001.11:244862672:CGTGGTC:
NM_031844.3(HNRNPU):c.316_322del (p.Leu106fs)	HNRNPU	L106fs	not provided	Pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, single submitter	VCV000451994	1	245027288 - 245027294	1	244863986 - 244863992	451994	442794	rs1553283946	NC_000001.11:244863985:CTCCTAGCTCC:CTCC
NM_031844.3(HNRNPU):c.1681C>T (p.Gln561Ter)	HNRNPU	Q561*, Q542*	not provided	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000449036	1	245020092	1	244856790	449036	442792	rs1553282385	NC_000001.11:244856789:G:A
NM_031844.3(HNRNPU):c.1518del (p.Gly507fs)	HNRNPU	G488fs, G507fs	not provided	Pathogenic(Last reviewed: Mar 23, 2017)	criteria provided, single submitter	VCV000424511	1	245020996	1	244857694	424511	405136	rs1064797011	NC_000001.11:244857693:T:
NM_031844.3(HNRNPU):c.550_571dup (p.Thr191fs)	HNRNPU		not provided	Pathogenic(Last reviewed: Apr 13, 2016)	criteria provided, single submitter	VCV000420968	1	245027038 - 245027039	1	244863736 - 244863737	420968	405138	rs1064794823	NC_000001.11:244863736:TGGGGCCGCTGCTCTTCCCCGC:TGGGGCCGCTGCTCTTCCCCGCTGGGGCCGCTGCTCTTCCCCGC
NM_031844.3(HNRNPU):c.353C>A (p.Ser118Ter)	HNRNPU	S118*	not provided	Pathogenic(Last reviewed: Jan 23, 2017)	criteria provided, single submitter	VCV000392665	1	245027257	1	244863955	392665	365166	rs1057524584	NC_000001.11:244863954:G:T
NM_031844.3(HNRNPU):c.520C>T (p.Gln174Ter)	HNRNPU	Q174*	not provided	Pathogenic(Last reviewed: Sep 9, 2016)	criteria provided, single submitter	VCV000280850	1	245027090	1	244863788	280850	264013	rs886041983	NC_000001.11:244863787:G:A
NC_000001.10:g.(?_245017732)_(245020178_?)dup	HNRNPU		heterogeneous nuclear ribonucleoprotein G, human	Pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, single submitter	VCV000650710	1	245017732 - 245020178	1	244854430 - 244856876	650710	650590		
NC_000001.10:g.(?_245023617)_(245026052_?)del	HNRNPU		heterogeneous nuclear ribonucleoprotein G, human	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000649632	1	245023617 - 245026052	1	244860315 - 244862750	649632	650581		
NM_031844.3(HNRNPU):c.1171_1172TG[1] (p.Cys391_Glu392delinsTer)	HNRNPU		Epileptic encephalopathy, early infantile, 54	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000620055	1	245022087 - 245022088	1	244858785 - 244858786	620055	611375		NC_000001.11:244858784:CACA:CA
NM_031844.3(HNRNPU):c.2425-2A>G	HNRNPU		Epileptic encephalopathy, early infantile, 54	Pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	VCV000559858	1	245017807	1	244854505	559858	550580	rs1553281924	NC_000001.11:244854504:T:C
NM_031844.3(HNRNPU):c.484del (p.Gln162fs)	HNRNPU	Q162fs	heterogeneous nuclear ribonucleoprotein G, human	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000532560	1	245027126	1	244863824	532560	515794	rs1553283895	NC_000001.11:244863823:G:
NM_031844.3(HNRNPU):c.1137dup (p.Gly380fs)	HNRNPU		heterogeneous nuclear ribonucleoprotein G, human	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000532559	1	245022123 - 245022124	1	244858821 - 244858822	532559	515745	rs1553282754	NC_000001.11:244858821:A:AA
NM_031844.3(HNRNPU):c.307C>T (p.Gln103Ter)	HNRNPU	Q103*	heterogeneous nuclear ribonucleoprotein G, human	Pathogenic(Last reviewed: Apr 15, 2017)	criteria provided, single submitter	VCV000406728	1	245027303	1	244864001	406728	391184	rs1553283951	NC_000001.11:244864000:G:A
NM_031844.3(HNRNPU):c.1812dup (p.Val605fs)	HNRNPU		Epileptic encephalopathy, early infantile, 54	Pathogenic(Last reviewed: Mar 10, 2017)	no assertion criteria provided	VCV000393466	1	245019858 - 245019859	1	244856556 - 244856557	393466	380288	rs1057524916	NC_000001.11:244856556:AA:AAA
NM_031844.3(HNRNPU):c.511C>T (p.Gln171Ter)	HNRNPU	Q171*	Epileptic encephalopathy, early infantile, 54	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000393465	1	245027099	1	244863797	393465	380287	rs1057524915	NC_000001.11:244863796:G:A
NM_031844.3(HNRNPU):c.2471_2472delinsGA (p.Tyr824Ter)	HNRNPU	Y805*	Epileptic encephalopathy, early infantile, 54	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000393464	1	245017758 - 245017759	1	244854456 - 244854457	393464	380286	rs1057524914	NC_000001.11:244854455:AT:TC
NM_031844.3(HNRNPU):c.628dup (p.Ala210fs)	HNRNPU		not provided	Pathogenic(Last reviewed: Dec 12, 2016)	criteria provided, single submitter	VCV000376822	1	245026981 - 245026982	1	244863679 - 244863680	376822	363700	rs1057520065	NC_000001.11:244863679:CC:CCC
NM_031844.3(HNRNPU):c.651_660del (p.Gly218fs)	HNRNPU	G218fs	Epileptic encephalopathy	Pathogenic(Last reviewed: Oct 26, 2016)	criteria provided, single submitter	VCV000267738	1	245026950 - 245026959	1	244863648 - 244863657	267738	263011	rs779453109	NC_000001.11:244863647:TCCGCCGCCTTCCGCC:TCCGCC
NM_031844.3(HNRNPU):c.1089G>A (p.Trp363Ter)	HNRNPU	W363*, W344*	Epileptic encephalopathy	Pathogenic(Last reviewed: Oct 26, 2016)	criteria provided, single submitter	VCV000267736	1	245022605	1	244859303	267736	263010	rs1135401732	NC_000001.11:244859302:C:T
NM_031844.3(HNRNPU):c.16delinsATT (p.Val6fs)	HNRNPU		Epileptic encephalopathy, early infantile, 54	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431120	1	245027594	1	244864292	431120	424638	rs1135401794	NC_000001.11:244864291:C:AAT
NM_025243.4(SLC19A3):c.980-14A>G	SLC19A3		Biotin-thiamine-responsive basal ganglia disease|not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000446038	2	228560811	2	227696095	446038	439310	rs200542114	NC_000002.12:227696094:T:C
NC_000001.10:g.(?_245017732)_(245027629_?)del	HNRNPU		heterogeneous nuclear ribonucleoprotein G, human	Pathogenic(Last reviewed: Nov 23, 2019)	criteria provided, single submitter	VCV000584092	1	245017732 - 245027629	1	244854430 - 244864327	584092	556502		
NM_031844.3(HNRNPU):c.481C>T (p.Gln161Ter)	HNRNPU	Q161*	Epileptic encephalopathy, early infantile, 54|heterogeneous nuclear ribonucleoprotein G, human	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000446393	1	245027129	1	244863827	446393	439855	rs1553283899	NC_000001.11:244863826:G:A
NM_031844.3(HNRNPU):c.2270_2271del (p.Pro757fs)	HNRNPU	P738fs, P757fs	not provided|Epileptic encephalopathy	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000267739	1	245018807 - 245018808	1	244855505 - 244855506	267739	263008	rs1135401734	NC_000001.11:244855504:AG:
NM_000784.4(CYP27A1):c.1072C>T (p.Gln358Ter)	CYP27A1	Q358*	Cholestanol storage disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000554665	2	219678798	2	218814075	554665	541940	rs533885672	NC_000002.12:218814074:C:T
NM_000478.6(ALPL):c.522del (p.Ser175fs)	ALPL	S120fs, S175fs, S98fs	Infantile hypophosphatasia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371067	1	21890579	1	21564086	371067	357060	rs750174638	NC_000001.11:21564085:CCCCC:CCCC
NM_000478.6(ALPL):c.648+1G>A	ALPL		Infantile hypophosphatasia|Hypophosphatasia, perinatal lethal	Pathogenic(Last reviewed: Jan 2, 2017)	criteria provided, single submitter	VCV000013678	1	21890710	1	21564217	13678	28717	rs749544042	NC_000001.11:21564216:G:A
NM_000784.4(CYP27A1):c.944_948del (p.Leu315fs)	CYP27A1	L315fs	Cholestanol storage disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004265	2	219677745 - 219677749	2	218813022 - 218813026	4265	19304	rs397515356	NC_000002.12:218813021:CTGGCC:C
NM_020919.4(ALS2):c.601C>T (p.Arg201Ter)	ALS2	R201*	Amyotrophic lateral sclerosis type 2|Infantile-onset ascending hereditary spastic paralysis|Amyotrophic lateral sclerosis type 2|Juvenile primary lateral sclerosis|Infantile-onset ascending hereditary spastic paralysis	Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000804392	2	202626116	2	201761393	804392	792726		NC_000002.12:201761392:G:A
NM_020919.4(ALS2):c.138del (p.Ala47fs)	ALS2	A47fs	Amyotrophic lateral sclerosis type 2	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004405	2	202631989	2	201767266	4405	19444	rs386134173	NC_000002.12:201767265:T:
NM_020451.3(SELENON):c.1010+1G>A	SELENON		Eichsfeld type congenital muscular dystrophy	Pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000837938	1	26136312	1	25809821	837938	851295		NC_000001.11:25809820:G:A
NM_020451.3(SELENON):c.249_250dup (p.Asp84fs)	SELENON		not provided|Eichsfeld type congenital muscular dystrophy	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523931	1	26127596 - 26127597	1	25801105 - 25801106	523931	514427	rs1553198611	NC_000001.11:25801105:GGGG:GGGGGG
NM_020451.3(SELENON):c.1469G>A (p.Trp490Ter)	SELENON	W490*, W456*	Eichsfeld type congenital muscular dystrophy|not provided	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000461630	1	26140453	1	25813962	461630	448072	rs960468382	NC_000001.11:25813961:G:A
NM_031844.3(HNRNPU):c.2302_2303AG[1] (p.Gly769fs)	HNRNPU		Intellectual disability and seizures	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000203383	1	245018773 - 245018774	1	244855471 - 244855472	203383	199781	rs794729648	NC_000001.11:244855470:CTCT:CT
NM_003126.4(SPTA1):c.1833+1G>A	SPTA1		Hereditary pyropoikilocytosis	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801565	1	158639197	1	158669407	801565	789863		NC_000001.11:158669406:C:T
NM_003126.4(SPTA1):c.5950A>T (p.Arg1984Ter)	SPTA1	R1984*	not provided	Pathogenic(Last reviewed: Apr 22, 2016)	criteria provided, single submitter	VCV000279900	1	158592943	1	158623153	279900	263960	rs886041244	NC_000001.11:158623152:T:A
NM_003126.4:c.47854delG	SPTA1		Prenatal anemia	Pathogenic(Last reviewed: Apr 9, 2019)	no assertion criteria provided	VCV000635928					635928	623741		
NM_003126.4(SPTA1):c.4975C>T (p.Arg1659Ter)	SPTA1	R1659*	Hereditary pyropoikilocytosis	Pathogenic(Last reviewed: Sep 9, 2018)	no assertion criteria provided	VCV000561993	1	158609377	1	158639587	561993	553135	rs1394141324	NC_000001.11:158639586:G:A
NM_003126.4(SPTA1):c.3291G>A (p.Trp1097Ter)	SPTA1	W1097*	Congenital hemolytic anemia	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000544823	1	158622341	1	158652551	544823	535242	rs1553231217	NC_000001.11:158652550:C:T
NM_003126.4(SPTA1):c.1850dup (p.Ser618fs)	SPTA1		Spherocytosis type 3	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000496724	1	158637835 - 158637836	1	158668045 - 158668046	496724	488176	rs1553234309	NC_000001.11:158668045:TT:TTT
NM_003126.4(SPTA1):c.3188+5G>A	SPTA1		Hereditary pyropoikilocytosis	Pathogenic(Last reviewed: Dec 15, 2005)	no assertion criteria provided	VCV000012865	1	158623059	1	158653269	12865	27904	rs1557961718	NC_000001.11:158653268:C:T
SPTA1, IVS30, C-T, -99	SPTA1		Spherocytosis type 3	Pathogenic(Last reviewed: Nov 15, 1996)	no assertion criteria provided	VCV000012864					12864	27903		
NM_003126.2(SPTA1):c.5190_5310del	SPTA1		Spherocytosis type 3	Pathogenic(Last reviewed: Nov 15, 1996)	no assertion criteria provided	VCV000012863	1	158606553	1	158636763	12863	27902	rs754614154	NC_000001.11:158636762:T:C
NM_003126.4(SPTA1):c.121C>T (p.Arg41Trp)	SPTA1	R41W	Elliptocytosis 2	Pathogenic(Last reviewed: Aug 1, 1989)	no assertion criteria provided	VCV000012852	1	158655041	1	158685251	12852	27891	rs121918640	NC_000001.11:158685250:G:A
NM_003126.4(SPTA1):c.2465-1G>A	SPTA1		Elliptocytosis 2	Pathogenic(Last reviewed: May 15, 1993)	no assertion criteria provided	VCV000012860	1	158631200	1	158661410	12860	27899	rs863223305	NC_000001.11:158661409:C:T
NM_003126.4(SPTA1):c.781T>C (p.Ser261Pro)	SPTA1	S261P	Elliptocytosis 2	Pathogenic(Last reviewed: Oct 1, 1989)	no assertion criteria provided	VCV000012848	1	158648222	1	158678432	12848	27887	rs121918636	NC_000001.11:158678431:A:G
NM_003126.4(SPTA1):c.1412A>C (p.Gln471Pro)	SPTA1	Q471P	Elliptocytosis 2	Pathogenic(Last reviewed: Oct 1, 1989)	no assertion criteria provided	VCV000012845	1	158641925	1	158672135	12845	27884	rs121918635	NC_000001.11:158672134:T:G
NM_000182.5(HADHA):c.1086-3_1092del	HADHA		Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency|Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370400	2	26427059 - 26427068	2	26204190 - 26204199	370400	357259	rs1057516460	NC_000002.12:26204189:CAGATGCCTGCA:CA
NM_003126.4(SPTA1):c.83G>T (p.Arg28Leu)	SPTA1	R28L	not specified|Elliptocytosis 2	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000012853	1	158655079	1	158685289	12853	27892	rs121918641	NC_000001.11:158685288:C:A
NM_003126.4(SPTA1):c.135G>T (p.Arg45Ser)	SPTA1	R45S	Hereditary pyropoikilocytosis|Elliptocytosis 2	Pathogenic(Last reviewed: Apr 1, 1990)	no assertion criteria provided	VCV000012849	1	158655027	1	158685237	12849	27888	rs121918637	NC_000001.11:158685236:C:A
NM_003238.6(TGFB2):c.798_805delinsA (p.Ile267fs)	TGFB2		not provided	Pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000818078	1	218609355 - 218609362	1	218436013 - 218436020	818078	805205		NC_000001.11:218436012:TATAAAGT:A
NM_001135599.3(TGFB2):c.1107C>A (p.Tyr369Ter)	TGFB2	Y341*, Y369*	Cardiovascular phenotype	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000520197	1	218610775	1	218437433	520197	509134	rs1553303357	NC_000001.11:218437432:C:A
NM_001135599.3(TGFB2):c.280del (p.Ser94fs)	TGFB2	S94fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000520193	1	218520323	1	218346981	520193	509129	rs1553292123	NC_000001.11:218346980:A:
NM_001135599.3(TGFB2):c.1016+1G>A	TGFB2		not provided	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000449107	1	218609490	1	218436148	449107	442720	rs1553303221	NC_000001.11:218436147:G:A
NM_001135599.3(TGFB2):c.213C>A (p.Tyr71Ter)	TGFB2	Y71*	not provided	Pathogenic(Last reviewed: Apr 30, 2015)	criteria provided, single submitter	VCV000379573	1	218520256	1	218346914	379573	364752	rs766024374	NC_000001.11:218346913:C:A
NM_001135599.3(TGFB2):c.440del (p.Pro147fs)	TGFB2	P119fs, P147fs	not provided	Pathogenic(Last reviewed: May 11, 2015)	criteria provided, single submitter	VCV000213852	1	218578518	1	218405176	213852	209433	rs863223797	NC_000001.11:218405175:CCC:CC
NM_001135599.3(TGFB2):c.238_239delinsAAG (p.Glu80fs)	TGFB2		Holt-Oram syndrome	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000662995	1	218520281 - 218520282	1	218346939 - 218346940	662995	627371		NC_000001.11:218346938:GA:AAG
NM_001135599.2:c.595_1245del	TGFB2		Loeys-Dietz syndrome 4	Pathogenic(Last reviewed: Oct 12, 2016)	criteria provided, single submitter	VCV000620591					620591	611984		
NM_001135599.3(TGFB2):c.976_985del (p.Arg326fs)	TGFB2	R298fs, R326fs	Holt-Oram syndrome	Pathogenic(Last reviewed: Apr 21, 2017)	criteria provided, single submitter	VCV000459270	1	218609449 - 218609458	1	218436107 - 218436116	459270	447499	rs1553303203	NC_000001.11:218436106:CGGCGGAAGA:
NM_001135599.3(TGFB2):c.660_661del (p.Arg221fs)	TGFB2	R193fs, R221fs	Cardiovascular phenotype|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000423134	1	218607489 - 218607490	1	218434147 - 218434148	423134	405048	rs1064796256	NC_000001.11:218434146:AA:
NM_001135599.3(TGFB2):c.252dup (p.Arg85fs)	TGFB2		Holt-Oram syndrome	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000408427	1	218520293 - 218520294	1	218346951 - 218346952	408427	391044	rs1553292112	NC_000001.11:218346951:GG:GGG
NM_001135599.3(TGFB2):c.297C>A (p.Tyr99Ter)	TGFB2	Y99*	Loeys-Dietz syndrome 4	Pathogenic	criteria provided, single submitter	VCV000224874	1	218520340	1	218346998	224874	226713	rs760759052	NC_000001.11:218346997:C:A
NM_001135599.3(TGFB2):c.771C>A (p.Cys257Ter)	TGFB2	C229*, C257*	Loeys-Dietz syndrome 4	Pathogenic(Last reviewed: Jul 8, 2012)	no assertion criteria provided	VCV000037088	1	218607723	1	218434381	37088	45763	rs398122885	NC_000001.11:218434380:C:A
NM_003126.4(SPTA1):c.82C>T (p.Arg28Cys)	SPTA1	R28C	Hereditary pyropoikilocytosis|Elliptocytosis 2	Pathogenic(Last reviewed: Jan 1, 1993)	no assertion criteria provided	VCV000012855	1	158655080	1	158685290	12855	27894	rs121918642	NC_000001.11:158685289:G:A
NM_003126.4(SPTA1):c.82C>A (p.Arg28Ser)	SPTA1	R28S	Hereditary pyropoikilocytosis|Elliptocytosis 2	Pathogenic(Last reviewed: Jan 1, 1991)	no assertion criteria provided	VCV000012854	1	158655080	1	158685290	12854	27893	rs121918642	NC_000001.11:158685289:G:T
NM_003238.6(TGFB2):c.297C>G (p.Tyr99Ter)	TGFB2	Y99*	Holt-Oram syndrome	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000837843	1	218520340	1	218346998	837843	823472		NC_000001.11:218346997:C:G
NM_003238.6(TGFB2):c.990dup (p.Gly331fs)	TGFB2		Holt-Oram syndrome	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000643407	1	218610741 - 218610742	1	218437399 - 218437400	643407	627375		NC_000001.11:218437399:A:AA
NM_001135599.3(TGFB2):c.1097C>A (p.Pro366His)	TGFB2	P366H, P338H	Loeys-Dietz syndrome 4	Pathogenic	criteria provided, single submitter	VCV000037085	1	218610765	1	218437423	37085	45760	rs387907278	NC_000001.11:218437422:C:A
NC_000001.10:g.(?_218520024)_(218614724_?)del	TGFB2		Holt-Oram syndrome	Pathogenic(Last reviewed: Feb 22, 2018)	criteria provided, single submitter	VCV000528890	1	218520024 - 218614724	1	218346682 - 218441382	528890	514885		
NM_001135599.3(TGFB2):c.980G>A (p.Arg327Gln)	TGFB2	R299Q, R327Q	Loeys-Dietz syndrome 4|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000381708	1	218609453	1	218436111	381708	364644	rs1057521150	NC_000001.11:218436110:G:A
NM_001135599.3(TGFB2):c.1106_1110del (p.Tyr369fs)	TGFB2	Y341fs, Y369fs	Loeys-Dietz syndrome 4	Pathogenic	criteria provided, single submitter	VCV000224873	1	218610773 - 218610777	1	218437431 - 218437435	224873	226715	rs398122884	NC_000001.11:218437430:TACAAT:T
NM_001135599.3(TGFB2):c.667G>T (p.Glu223Ter)	TGFB2	E195*, E223*	not provided|Holt-Oram syndrome	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000213841	1	218607496	1	218434154	213841	209436	rs863223790	NC_000001.11:218434153:G:T
NM_000329.3(RPE65):c.1338+1G>A	RPE65		Congenital blindness|Retinal degeneration|Abnormal electroretinogram|Abnormality of vision|Leber congenital amaurosis 2|Retinitis pigmentosa 20	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000374139	1	68896964	1	68431281	374139	360814	rs1057518922	NC_000001.11:68431280:C:T
NM_000396.4(CTSK):c.436G>C (p.Gly146Arg)	CTSK	G146R	Pyknodysostosis|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 23, 2017)	criteria provided, single submitter	VCV000008421	1	150776679	1	150804203	8421	23460	rs74315302	NC_000001.11:150804202:C:G
NM_031844.3(HNRNPU):c.1714C>T (p.Arg572Ter)	HNRNPU	R572*, R553*	Epileptic encephalopathy|Intellectual disability|Seizures	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000267737	1	245020059	1	244856757	267737	263009	rs1135401733	NC_000001.11:244856756:G:A
NM_003126.4(SPTA1):c.2806-13T>G	SPTA1		Hereditary pyropoikilocytosis	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000012862	1	158626459	1	158656669	12862	27901	rs757147440	NC_000001.11:158656668:A:C
SPTA1, EX5DEL, SVA RETROTRANSPOSON INS	SPTA1		Elliptocytosis 2|Pyropoikilocytosis	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000012861					12861	27900		
NC_000002.11:g.166679228_166818452inv	TTC21B		Epilepsy	Pathogenic(Last reviewed: Apr 9, 2019)	no assertion criteria provided	VCV000635921	2	166679228 - 166818452			635921	623734		
NM_024753.5(TTC21B):c.1999C>T (p.Gln667Ter)	TTC21B	Q667*	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562402	2	166771850	2	165915340	562402	553586	rs1559056633	NC_000002.12:165915339:G:A
NM_024753.5(TTC21B):c.152-2A>G	TTC21B		Asphyxiating thoracic dystrophy 4	Pathogenic(Last reviewed: Jun 18, 2018)	no assertion criteria provided	VCV000545537	2	166806016	2	165949506	545537	536039	rs760214276	NC_000002.12:165949505:T:C
NM_024753.5(TTC21B):c.2500C>T (p.Gln834Ter)	TTC21B	Q834*	Short rib-polydactyly syndrome, Majewski type	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446649	2	166764256	2	165907746	446649	440056	rs79746977	NC_000002.12:165907745:G:A
NM_024753.5(TTC21B):c.131C>A (p.Ala44Asp)	TTC21B	A44D	Short rib-polydactyly syndrome, Majewski type	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000446648	2	166806125	2	165949615	446648	440060	rs1553516687	NC_000002.12:165949614:G:T
NM_024753.5(TTC21B):c.2384T>C (p.Leu795Pro)	TTC21B	L795P	Asphyxiating thoracic dystrophy 4	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030939	2	166767914	2	165911404	30939	39896	rs387907060	NC_000002.12:165911403:A:G
NM_024753.5(TTC21B):c.3383_3384del (p.Tyr1128fs)	TTC21B	Y1128fs	Nephronophthisis|Jeune thoracic dystrophy	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000528906	2	166744864 - 166744865	2	165888354 - 165888355	528906	516520	rs1553506530	NC_000002.12:165888353:ATA:A
NM_000784.4(CYP27A1):c.646G>C (p.Ala216Pro)	CYP27A1	A216P	Cholestanol storage disease	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000065885	2	219677144	2	218812421	65885	76793	rs201346271	NC_000002.12:218812420:G:C
NM_000784.4(CYP27A1):c.475C>T (p.Gln159Ter)	CYP27A1	Q159*	not provided|Cholestanol storage disease	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000065873	2	219676973	2	218812250	65873	76781	rs72551314	NC_000002.12:218812249:C:T
NM_000784.4(CYP27A1):c.446+1G>A	CYP27A1		not provided|Cholestanol storage disease	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000065871	2	219674491	2	218809768	65871	76779	rs587778797	NC_000002.12:218809767:G:A
NM_024753.5(TTC21B):c.1231C>T (p.Arg411Ter)	TTC21B	R411*	Asphyxiating thoracic dystrophy 4|not provided	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000030938	2	166785800	2	165929290	30938	39895	rs185089786	NC_000002.12:165929289:G:A
NM_024753.5(TTC21B):c.1656T>A (p.Cys552Ter)	TTC21B	C552*	Nephronophthisis 12	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030936	2	166775804	2	165919294	30936	39893	rs387907059	NC_000002.12:165919293:A:T
NM_005562.3(LAMC2):c.283C>T (p.Arg95Ter)	LAMC2	R95*	Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014555	1	183184602	1	183215467	14555	29594	rs80356683	NC_000001.11:183215466:C:T
NM_007315.3(STAT1):c.821G>A (p.Arg274Gln)	STAT1	R274Q	Immunodeficiency 31C|Eczema|Recurrent Staphylococcus aureus infections|Blepharitis|Chronic oral candidiasis|Recurrent candida infections|Recurrent fungal infections|Recurrent skin infections|Chronic mucocutaneous candidiasis|Recurrent bacterial skin infections|Onychomycosis|Recurrent infections|Mycobacterial and viral infections, susceptibility to, autosomal recessive|Immunodeficiency 31C|Immunodeficiency 31a	Pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030085	2	191859910	2	190995184	30085	39040	rs387906760	NC_000002.12:190995183:C:T
NC_000001.11:g.(?_218344334)_(218445619_?)del	TGFB2		Holt-Oram syndrome	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000832707	1	218517676 - 218618961			832707	818926		
NM_001029883.3(PCARE):c.1525del (p.Thr509fs)	PCARE	T509fs	Retinal dystrophy	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000866909	2	29295603	2	29072737	866909	856176		NC_000002.12:29072736:TTTTTT:TTTTT
NM_001029883.3(PCARE):c.1709_1728del (p.Gly570fs)	PCARE	G570fs	Retinal dystrophy	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000866727	2	29295400 - 29295419	2	29072534 - 29072553	866727	856175		NC_000002.12:29072533:TGGGGGGACCACTGTCCTCC:
NM_001029883.3(PCARE):c.802C>T (p.Gln268Ter)	PCARE	Q268*	Retinal dystrophy	Pathogenic(Last reviewed: May 27, 2019)	criteria provided, single submitter	VCV000866617	2	29296326	2	29073460	866617	856179		NC_000002.12:29073459:G:A
NM_001029883.3(PCARE):c.478_479insA (p.Cys160Ter)	PCARE		Cone-rod degeneration	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812241	2	29296649 - 29296650	2	29073783 - 29073784	812241	800471		NC_000002.12:29073783::T
NM_001029883.3(PCARE):c.2920_2921insC (p.Glu974fs)	PCARE		not provided	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000499277	2	29294207 - 29294208	2	29071341 - 29071342	499277	490701	rs1553354488	NC_000002.12:29071341::G
NM_001029883.3(PCARE):c.2506G>T (p.Glu836Ter)	PCARE	E836*	not provided	Pathogenic(Last reviewed: Jul 5, 2016)	criteria provided, single submitter	VCV000289252	2	29294622	2	29071756	289252	273489	rs886044135	NC_000002.12:29071755:C:A
NM_001029883.3(PCARE):c.1828C>T (p.Gln610Ter)	PCARE	Q610*	not provided	Pathogenic(Last reviewed: Jul 12, 2016)	criteria provided, single submitter	VCV000288775	2	29295300	2	29072434	288775	273012	rs886044003	NC_000002.12:29072433:G:A
NM_001029883.3(PCARE):c.2225_2226AG[1] (p.Leu744fs)	PCARE		not provided	Pathogenic(Last reviewed: Jul 12, 2016)	criteria provided, single submitter	VCV000288774	2	29294900 - 29294901	2	29072034 - 29072035	288774	273011	rs886044002	NC_000002.12:29072033:CTCTC:CTC
NM_001029883.3(PCARE):c.2421del (p.Leu808fs)	PCARE	L808fs	not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000844048	2	29294707	2	29071841	844048	826249		NC_000002.12:29071840:A:
NM_001029883.3(PCARE):c.3488G>A (p.Trp1163Ter)	PCARE	W1163*	not provided	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000841160	2	29293640	2	29070774	841160	826236		NC_000002.12:29070773:C:T
NM_001029883.3(PCARE):c.3049A>T (p.Arg1017Ter)	PCARE	R1017*	not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000836420	2	29294079	2	29071213	836420	826244		NC_000002.12:29071212:T:A
NM_001029883.3(PCARE):c.1191G>A (p.Trp397Ter)	PCARE	W397*	Retinitis pigmentosa 54	Pathogenic(Last reviewed: Dec 6, 2018)	no assertion criteria provided	VCV000599266	2	29295937	2	29073071	599266	590511	rs777103184	NC_000002.12:29073070:C:T
NM_001029883.3(PCARE):c.1545dup (p.Ser516fs)	PCARE		Retinitis pigmentosa 54	Pathogenic(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000522284	2	29295582 - 29295583	2	29072716 - 29072717	522284	512895	rs1553354826	NC_000002.12:29072716:TT:TTT
NM_001029883.3(PCARE):c.1837C>T (p.Arg613Ter)	PCARE	R613*	not provided	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000841159	2	29295291	2	29072425	841159	826253		NC_000002.12:29072424:G:A
NM_001029883.3(PCARE):c.601A>T (p.Ile201Phe)	PCARE	I201F	Retinitis pigmentosa 54	Pathogenic(Last reviewed: May 14, 2010)	no assertion criteria provided	VCV000000102	2	29296527	2	29073661	102	15141	rs267606690	NC_000002.12:29073660:T:A
PCARE, TRP253TER	PCARE	W253*	Retinitis pigmentosa 54	Pathogenic(Last reviewed: May 14, 2010)	no assertion criteria provided	VCV000000101					101	15140		
NM_020451.3(SELENON):c.2T>C (p.Met1Thr)	SELENON	M1T	Eichsfeld type congenital muscular dystrophy	Pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000530813	1	26126723	1	25800232	530813	515885	rs1174570887	NC_000001.11:25800231:T:C
NM_020451.3(SELENON):c.2T>G (p.Met1Arg)	SELENON	M1R	Eichsfeld type congenital muscular dystrophy	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000461632	1	26126723	1	25800232	461632	448054	rs1174570887	NC_000001.11:25800231:T:G
NM_020451.3(SELENON):c.997_1000del (p.Val333fs)	SELENON	V299fs, V333fs	Eichsfeld type congenital muscular dystrophy|not provided	Pathogenic(Last reviewed: May 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280493	1	26136297 - 26136300	1	25809806 - 25809809	280493	263988	rs886041686	NC_000001.11:25809805:CGTGC:C
NM_020247.5(COQ8A):c.1747_1749ACC[1] (p.Thr584del)	COQ8A	T584del	Coenzyme Q10 deficiency, primary, 4|not provided	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, multiple submitters, no conflicts	VCV000003644	1	227174240 - 227174242	1	226986539 - 226986541	3644	18683	rs387906299	NC_000001.11:226986538:CACCACC:CACC
NM_024753.5(TTC21B):c.3605T>C (p.Leu1202Pro)	TTC21B	L1202P	Asphyxiating thoracic dystrophy 4|Type IV short rib polydactyly syndrome	Pathogenic(Last reviewed: Jun 18, 2018)	no assertion criteria provided	VCV000446651	2	166740383	2	165883873	446651	440054	rs759086770	NC_000002.12:165883872:A:G
NM_001918.4(DBT):c.670G>T (p.Glu224Ter)	DBT	E224*	not provided|Maple syrup urine disease	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000094009	1	100681641	1	100216085	94009	99911	rs74103423	NC_000001.11:100216084:C:A
NM_001029883.3(PCARE):c.772_773AG[2] (p.Glu259fs)	PCARE		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812239	2	29296351 - 29296352	2	29073485 - 29073486	812239	800469		NC_000002.12:29073484:CTCTCT:CTCT
NM_001029883.3(PCARE):c.2950C>T (p.Arg984Ter)	PCARE	R984*	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812238	2	29294178	2	29071312	812238	800468		NC_000002.12:29071311:G:A
NM_001029883.3(PCARE):c.3289C>T (p.Gln1097Ter)	PCARE	Q1097*	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812237	2	29293839	2	29070973	812237	800467		NC_000002.12:29070972:G:A
NM_001029883.3(PCARE):c.758G>A (p.Trp253Ter)	PCARE	W253*	Retinal dystrophy	Pathogenic(Last reviewed: Nov 23, 2017)	criteria provided, single submitter	VCV000438049	2	29296370	2	29073504	438049	431652	rs750987123	NC_000002.12:29073503:C:T
NM_001029883.3(PCARE):c.3604C>T (p.Arg1202Ter)	PCARE	R1202*	Retinal dystrophy|not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000839525	2	29293524	2	29070658	839525	826233		NC_000002.12:29070657:G:A
NM_001029883.3(PCARE):c.712A>T (p.Lys238Ter)	PCARE	K238*	Retinitis pigmentosa	Pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000191360	2	29296416	2	29073550	191360	189158	rs863223344	NC_000002.12:29073549:T:A
NM_003126.4(SPTA1):c.620T>C (p.Leu207Pro)	SPTA1	L207P	Hereditary pyropoikilocytosis|Elliptocytosis 2	Pathogenic(Last reviewed: Dec 15, 2005)	no assertion criteria provided	VCV000012857	1	158650431	1	158680641	12857	27896	rs121918643	NC_000001.11:158680640:A:G
NM_020435.4(GJC2):c.80G>A (p.Trp27Ter)	GJC2	W27*	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 19, 2015)	criteria provided, single submitter	VCV000520879	1	228345539	1	228157838	520879	511236	rs1553262429	NC_000001.11:228157837:G:A
NM_012233.3(RAB3GAP1):c.1471C>T (p.Arg491Ter)	RAB3GAP1	R491*	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, single submitter	VCV000521948	2	135891575	2	135134005	521948	511319	rs752667359	NC_000002.12:135134004:C:T
NM_012233.3(RAB3GAP1):c.1386_1387GT[1] (p.Cys463fs)	RAB3GAP1		Inborn genetic diseases	Pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, single submitter	VCV000521947	2	135891489 - 135891490	2	135133919 - 135133920	521947	511318	rs1282248700	NC_000002.12:135133918:TGTGT:TGT
NM_015488.5(PNKD):c.20C>T (p.Ala7Val)	PNKD	A7V	Paroxysmal non-kinesigenic dyskinesia|Paroxysmal nonkinesigenic dyskinesia 1	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000001893	2	219135278	2	218270555	1893	16932	rs121434512	NC_000002.12:218270554:C:T
NM_001146289.1(P3H1):c.1080+1G>T	P3H1		not provided|Osteogenesis imperfecta type 8	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001253	1	43223453	1	42757782	1253	16292	rs72659351	NC_000001.11:42757781:C:A
NM_025243.4(SLC19A3):c.81_82dup (p.Met28fs)	SLC19A3		not provided|Biotin-thiamine-responsive basal ganglia disease	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000369672	2	228566952 - 228566953	2	227702236 - 227702237	369672	353889	rs775835429	NC_000002.12:227702236:TC:TCTC
NM_025243.4(SLC19A3):c.1264A>G (p.Thr422Ala)	SLC19A3	T422A	not provided|Biotin-thiamine-responsive basal ganglia disease	Pathogenic(Last reviewed: Dec 9, 2016)	criteria provided, multiple submitters, no conflicts	VCV000004563	2	228552932	2	227688216	4563	19602	rs121917884	NC_000002.12:227688215:T:C
NM_024753.5(TTC21B):c.2758-2A>G	TTC21B		Infantile nephronophthisis|Nephronophthisis 12	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000030937	2	166756392	2	165899882	30937	39894	rs766132877	NC_000002.12:165899881:T:C
NM_000310.3(PPT1):c.362+5G>A	PPT1		not provided	Pathogenic(Last reviewed: Jul 19, 2013)	criteria provided, single submitter	VCV000206643	1	40557712	1	40092040	206643	201115	rs796052924	NC_000001.11:40092039:C:T
NM_000310.3(PPT1):c.234+1G>A	PPT1		not provided	Pathogenic(Last reviewed: Aug 6, 2013)	criteria provided, single submitter	VCV000206642	1	40558069	1	40092397	206642	201117	rs796052923	NC_000001.11:40092396:C:T
NM_000310.3(PPT1):c.810del (p.Gly270_Leu271insTer)	PPT1		not provided	Pathogenic(Last reviewed: Feb 26, 2015)	criteria provided, single submitter	VCV000199010	1	40539844	1	40074172	199010	196170	rs794727955	NC_000001.11:40074171:CCCC:CCC
NM_000310.4(PPT1):c.289_290del (p.Gln97fs)	PPT1	Q97fs		Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000856480	1	40557789 - 40557790	1	40092117 - 40092118	856480	823954		NC_000001.11:40092116:TG:
NM_000310.4(PPT1):c.102del (p.Leu35fs)	PPT1	L35fs		Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000835915	1	40562809	1	40097137	835915	823956		NC_000001.11:40097136:C:
NC_000001.11:g.(?_40089400)_(40097248_?)del	PPT1			Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000831860	1	40555072 - 40562920			831860	818966		
NC_000001.10:g.40558255_40562842del	PPT1			Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000666429	1	40558255 - 40562842			666429	653988		
NM_000310.4(PPT1):c.6del (p.Ser3fs)	PPT1	S3fs		Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000664850	1	40562905	1	40097233	664850	627831		NC_000001.11:40097232:C:
NM_000310.3(PPT1):c.629_630dup (p.Ile211fs)	PPT1			Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000662960	1	40544327 - 40544328	1	40078655 - 40078656	662960	627827		NC_000001.11:40078655:AC:ACAC
NM_001142604.2(PPT1):c.125-2560_125-2559del	PPT1	M112fs		Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000649994	1	40557743 - 40557744	1	40092071 - 40092072	649994	627829		NC_000001.11:40092070:CA:
NM_001142604.2(PPT1):c.125-2986G>A	PPT1	C45Y		Pathogenic(Last reviewed: Jan 30, 2007)	no assertion criteria provided	VCV000008908	1	40558170	1	40092498	8908	23947	rs137852702	NC_000001.11:40092497:C:T
NM_001142604.2(PPT1):c.125-2573G>C	PPT1	G108R		Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000008907	1	40557757	1	40092085	8907	23946	rs137852701	NC_000001.11:40092084:C:G
PPT1, 451C-T	PPT1			Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	VCV000008906					8906	23945		
PPT1, 1-BP INS, 169A	PPT1			Pathogenic(Last reviewed: Apr 17, 1998)	no assertion criteria provided	VCV000008905					8905	23944		
NM_000310.3(PPT1):c.656T>A (p.Leu219Gln)	PPT1	L219Q, L116Q		Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000008902	1	40544302	1	40078630	8902	23941	rs137852698	NC_000001.11:40078629:A:T
NM_001142604.2(PPT1):c.125-2659A>G	PPT1	D79G		Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000008901	1	40557843	1	40092171	8901	23940	rs137852697	NC_000001.11:40092170:T:C
NM_001079878.2(CNGA3):c.1225C>T (p.Arg409Cys)	CNGA3	R427C, R409C	Achromatopsia|not provided|Retinal dystrophy|Macular dystrophy	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000497256	2	99012912	2	98396449	497256	488680	rs141386891	NC_000002.12:98396448:C:T
NM_000310.3(PPT1):c.455del (p.Cys152fs)	PPT1	C152fs, C49fs	|not provided	Pathogenic(Last reviewed: Mar 4, 2016)	criteria provided, single submitter	VCV000280344	1	40555163	1	40089491	280344	264002	rs886041568	NC_000001.11:40089490:C:
NM_000310.3(PPT1):c.2T>C (p.Met1Thr)	PPT1	M1T	not provided|	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000206651	1	40562909	1	40097237	206651	201123	rs796052927	NC_000001.11:40097236:A:G
NM_000310.3(PPT1):c.424C>T (p.Gln142Ter)	PPT1	Q142*	not provided|	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000206645	1	40557010	1	40091338	206645	201113	rs796052925	NC_000001.11:40091337:G:A
NM_000478.6(ALPL):c.978_980CTT[2] (p.Phe328del)	ALPL		not specified|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000654922	1	21900273 - 21900275	1	21573780 - 21573782	654922	627357		NC_000001.11:21573779:CTTCTTCTT:CTTCTT
NM_000784.4(CYP27A1):c.1185-1G>A	CYP27A1		not provided|Cholestanol storage disease	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000500370	2	219679102	2	218814379	500370	491794	rs587778779	NC_000002.12:218814378:G:A
NM_000784.4(CYP27A1):c.845-1G>A	CYP27A1		Cholestanol storage disease|not provided	Pathogenic(Last reviewed: Mar 8, 2016)	criteria provided, single submitter	VCV000004256	2	219677646	2	218812923	4256	19295	rs397515353	NC_000002.12:218812922:G:A
NM_001029883.3(PCARE):c.2756_2768del (p.Lys919fs)	PCARE	K919fs	Retinitis pigmentosa 54|Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000000105	2	29294360 - 29294372	2	29071494 - 29071506	105	15144	rs794728002	NC_000002.12:29071493:TCCAGGGCTGGCTTCC:TCC
NM_001029883.3(PCARE):c.556C>T (p.Gln186Ter)	PCARE	Q186*	Retinitis pigmentosa 54|Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000000104	2	29296572	2	29073706	104	15143	rs267606691	NC_000002.12:29073705:G:A
NM_001029883.3(PCARE):c.947del (p.Asn316fs)	PCARE	N316fs	Retinitis pigmentosa 54|not provided	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000000103	2	29296181	2	29073315	103	15142	rs779886453	NC_000002.12:29073314:TT:T
NM_000310.4(PPT1):c.124+1215_235-103del	PPT1			Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000846185	1	40557947 - 40561572	1	40092275 - 40095900	846185	850711		
NM_020451.3(SELENON):c.1315C>T (p.Arg439Ter)	SELENON	R439*, R405*	not provided|Eichsfeld type congenital muscular dystrophy	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000095958	1	26139211	1	25812720	95958	101854	rs377215510	NC_000001.11:25812719:C:T
NM_001135599.3(TGFB2):c.905dup (p.Asn302fs)	TGFB2		not provided|Holt-Oram syndrome|not specified	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000213849	1	218609370 - 218609371	1	218436028 - 218436029	213849	209439	rs863223796	NC_000001.11:218436028:AAAAAAAA:AAAAAAAAA
NM_000191.3(HMGCL):c.31C>T (p.Arg11Ter)	HMGCL	R11*	Deficiency of hydroxymethylglutaryl-CoA lyase|Inborn genetic diseases	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000521752	1	24151875	1	23825385	521752	511254	rs1212444447	NC_000001.11:23825384:G:A
NM_000310.3(PPT1):c.536+1G>A	PPT1		Neuronal ceroid lipofuscinosis|	Pathogenic/Likely pathogenic(Last reviewed: Jul 23, 2009)	no assertion criteria provided	VCV000056199	1	40555081	1	40089409	56199	70838	rs386833651	NC_000001.11:40089408:C:T
NM_001142604.2(PPT1):c.125-2945del	PPT1	E59fs		Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000056183	1	40558129	1	40092457	56183	70822	rs386833635	NC_000001.11:40092456:CC:C
NM_015506.3(MMACHC):c.328_331del (p.Asn110fs)	MMACHC	N53fs, N110fs	not provided|Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Sep 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203835	1	45973933 - 45973936	1	45508261 - 45508264	203835	199948	rs796052000	NC_000001.11:45508260:CCAACC:CC
NM_002617.3(PEX10):c.295del (p.His99fs)	PEX10	H99fs	not provided	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000597855	1	2340196	1	2408757	597855	588916	rs1557910651	NC_000001.11:2408756:G:
NM_002617.3(PEX10):c.835G>T (p.Glu279Ter)	PEX10	E299*, E279*	not provided	Pathogenic(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	VCV000282334	1	2338000	1	2406561	282334	266571	rs62641225	NC_000001.11:2406560:C:A
NM_002617.3(PEX10):c.867_868insG (p.His290fs)	PEX10		not provided	Pathogenic(Last reviewed: Feb 4, 2015)	criteria provided, single submitter	VCV000197886	1	2337967 - 2337968	1	2406528 - 2406529	197886	195047	rs797044762	NC_000001.11:2406528::C
NM_000310.3(PPT1):c.727-2A>T	PPT1		|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000056213	1	40542587	1	40076915	56213	70852	rs386833664	NC_000001.11:40076914:T:A
NC_000001.11:g.(?_2405746)_(2412522_?)del	PEX10		Peroxisome biogenesis disorder, complementation group 7	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000832324	1	2337185 - 2343961			832324	818947		
NC_000001.11:g.(?_2405756)_(2412512_?)del	PEX10		Peroxisome biogenesis disorder, complementation group 7	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000830835	1	2337195 - 2343951			830835	818948		
PEX10, DEL/INS/FS, NT13	PEX10		Peroxisome biogenesis disorder 6A	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000006775					6775	21814		
NM_002617.3(PEX10):c.870C>G (p.His290Gln)	PEX10	H290Q, H310Q	Peroxisome biogenesis disorder 6B	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000006771	1	2337965	1	2406526	6771	21810	rs61752095	NC_000001.11:2406525:G:C
NM_002617.3(PEX10):c.337del (p.Leu113fs)	PEX10	L113fs	Peroxisome biogenesis disorder 6B	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000162431	1	2340154	1	2408715	162431	172122	rs724159999	NC_000001.11:2408714:GGGGG:GGGG
PEX10, 2-BP DEL, 814CT	PEX10		Peroxisome biogenesis disorder 6A	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000006773					6773	21812		
NM_153818.1(PEX10):c.752_763del (p.Ser251_Gln255delinsTer)	PEX10		Peroxisome biogenesis disorder, complementation group 7|Peroxisome biogenesis disorder 6B|Peroxisome biogenesis disorder 6A	Pathogenic/Likely pathogenic(Last reviewed: May 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557464	1	2338232 - 2338243	1	2406793 - 2406804	557464	541021	rs768893724	NC_000001.11:2406792:GCAGCCCCATGG:
NM_153818.1(PEX10):c.623_624del (p.Leu208fs)	PEX10	L208fs	Peroxisome biogenesis disorder 6A|Peroxisome biogenesis disorder 6B|Peroxisome biogenesis disorder, complementation group 7	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556606	1	2338371 - 2338372	1	2406932 - 2406933	556606	541160	rs1553231896	NC_000001.11:2406931:GAG:G
NM_002617.3(PEX10):c.761del (p.Gly254fs)	PEX10	G274fs, G254fs	not provided|Peroxisome biogenesis disorder 6A|Peroxisome biogenesis disorder 6B	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000554630	1	2338174	1	2406735	554630	541126	rs1553231820	NC_000001.11:2406734:CC:C
NM_005562.3(LAMC2):c.733C>T (p.Arg245Ter)	LAMC2	R245*	not provided|Adult junctional epidermolysis bullosa|	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014559	1	183191316	1	183222181	14559	29598	rs118203901	NC_000001.11:183222180:C:T
NM_002617.3(PEX10):c.338del (p.Leu113fs)	PEX10	L113fs	Peroxisome biogenesis disorder, complementation group 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000235465	1	2340153	1	2408714	235465	237148	rs878853044	NC_000001.11:2408713:A:
NM_001232.3(CASQ2):c.923C>T (p.Pro308Leu)	CASQ2	P308L	not provided|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia	Pathogenic/Likely pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000190755	1	116247829	1	115705208	190755	188307	rs139228801	NC_000001.11:115705207:G:A
NM_001232.3(CASQ2):c.97C>T (p.Arg33Ter)	CASQ2	R33*	Ventricular tachycardia, catecholaminergic polymorphic, 2|Catecholaminergic polymorphic ventricular tachycardia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000041043	1	116311066	1	115768445	41043	49465	rs397507556	NC_000001.11:115768444:G:A
NM_022168.4(IFIH1):c.2336G>A (p.Arg779His)	IFIH1	R779H	Neonatal hypotonia|Developmental regression|Abnormality of the cerebral white matter|Clonus|Abnormality of the basal ganglia|Abnormal upper motor neuron morphology|Hyperreflexia|not provided|Aicardi-Goutieres syndrome 7|Singleton-Merten syndrome 1|Aicardi-Goutieres syndrome 7	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000137622	2	163130423	2	162273913	137622	141325	rs587777446	NC_000002.12:162273912:C:T
NM_001135599.3(TGFB2):c.475C>T (p.Arg159Ter)	TGFB2	R131*, R159*	Holt-Oram syndrome|Loeys-Dietz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000222832	1	218578555	1	218405213	222832	224188	rs869025531	NC_000001.11:218405212:C:T
NM_000784.4(CYP27A1):c.808C>T (p.Arg270Ter)	CYP27A1	R270*	not provided|Cholestanol storage disease	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000065902	2	219677436	2	218812713	65902	76810	rs72551318	NC_000002.12:218812712:C:T
NM_000478.6(ALPL):c.98C>T (p.Ala33Val)	ALPL	A16V, A33V	not provided|Infantile hypophosphatasia	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000013667	1	21887155	1	21560662	13667	28706	rs121918005	NC_000001.11:21560661:C:T
NM_002354.2(EPCAM):c.373_374insC (p.Arg125fs)	EPCAM		Diarrhea 5, with tufting enteropathy, congenital	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000488505	2	47601135 - 47601136	2	47373996 - 47373997	488505	481373	rs1553342984	NC_000002.12:47373996::C
NM_002354.3(EPCAM):c.265C>T (p.Gln89Ter)	EPCAM	Q89*	Diarrhea 5, with tufting enteropathy, congenital	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000800510	2	47601027	2	47373888	800510	789114		NC_000002.12:47373887:C:T
NC_000002.11:g.(?_47600602)_(47604216_?)del	EPCAM		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	VCV000583448	2	47600602 - 47604216	2	47373463 - 47377077	583448	559137		
NM_002354.2(EPCAM):c.712del (p.Glu238fs)	EPCAM	E238fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	VCV000579230	2	47606959	2	47379820	579230	558119	rs1558438591	NC_000002.12:47379819:GGGG:GGG
NM_002354.2(EPCAM):c.429G>A (p.Trp143Ter)	EPCAM	W143*	Diarrhea 5, with tufting enteropathy, congenital	Pathogenic(Last reviewed: Sep 3, 2015)	criteria provided, single submitter	VCV000239127	2	47602376	2	47375237	239127	238788	rs878854488	NC_000002.12:47375236:G:A
NM_002354.2(EPCAM):c.412C>T (p.Arg138Ter)	EPCAM	R138*	Diarrhea 5, with tufting enteropathy, congenital	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000040256	2	47601174	2	47374035	40256	48740	rs397514661	NC_000002.12:47374034:C:T
NM_002354.2(EPCAM):c.859-1462_*1999del	EPCAM		Hereditary nonpolyposis colorectal cancer type 8	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000012775	2	47610843 - 47615751	2	47383704 - 47388612	12775	27814		
NM_002354.2(EPCAM):c.197G>A (p.Cys66Tyr)	EPCAM	C66Y	Diarrhea 5, with tufting enteropathy, congenital	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000012773	2	47600959	2	47373820	12773	27812	rs267606785	NC_000002.12:47373819:G:A
NM_002354.2(EPCAM):c.491+1G>A	EPCAM		Diarrhea 5, with tufting enteropathy, congenital	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000012771	2	47602439	2	47375300	12771	27810	rs606231203	NC_000002.12:47375299:G:A
NR_030286.1(MIR559):n.278_23134del	EPCAM		Hereditary nonpolyposis colorectal cancer type 8	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000012776			2	47377952 - 47400851	12776	27815		
NM_144573.3(NEXN):c.1445_1446del (p.Lys482fs)	NEXN	K418fs, K482fs	not provided	Pathogenic(Last reviewed: Jun 6, 2014)	criteria provided, single submitter	VCV000201941	1	78401700 - 78401701	1	77936015 - 77936016	201941	198093	rs794729092	NC_000001.11:77936014:AAA:A
NM_144573.3(NEXN):c.461_464del (p.Asn154fs)	NEXN	N154fs, N90fs	not provided	Pathogenic(Last reviewed: Apr 8, 2013)	criteria provided, single submitter	VCV000201937	1	78390884 - 78390887	1	77925199 - 77925202	201937	198077	rs794729088	NC_000001.11:77925198:AAACAA:AA
NM_144573.3(NEXN):c.391C>G (p.Gln131Glu)	NEXN	Q131E, Q67E	Familial hypertrophic cardiomyopathy 20	Pathogenic(Last reviewed: Nov 12, 2010)	no assertion criteria provided	VCV000030993	1	78383902	1	77918217	30993	39950	rs387907079	NC_000001.11:77918216:C:G
NM_144573.3(NEXN):c.1831C>A (p.Pro611Thr)	NEXN	P611T, P547T	Dilated cardiomyopathy 1CC	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000000327	1	78408317	1	77942632	327	15366	rs137853198	NC_000001.11:77942631:C:A
NEXN, 3-BP DEL, 1948GGA	NEXN		Dilated cardiomyopathy 1CC	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000000325					325	15364		
NM_000329.3(RPE65):c.1067dup (p.Asn356fs)	RPE65		Retinitis pigmentosa 20|Leber congenital amaurosis 2|Retinal dystrophy|not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000596673	1	68903930 - 68903931	1	68438247 - 68438248	596673	587734	rs281865520	NC_000001.11:68438247:TTTTTTTT:TTTTTTTTT
NM_000329.3(RPE65):c.370C>T (p.Arg124Ter)	RPE65	R124*	Retinitis pigmentosa 20|Leber congenital amaurosis 2|not provided|Leber congenital amaurosis 2	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000098866	1	68910339	1	68444656	98866	104756	rs61752877	NC_000001.11:68444655:G:A
NM_000329.3(RPE65):c.1292A>G (p.Tyr431Cys)	RPE65	Y431C	Leber congenital amaurosis 2|Leber congenital amaurosis 2|Retinitis pigmentosa 20|not provided	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000029873	1	68897011	1	68431328	29873	38828	rs62636300	NC_000001.11:68431327:T:C
NC_000002.12:g.(?_47369506)_(47369591_?)del	EPCAM		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000833438	2	47596645 - 47596730			833438	819178		
NC_000002.11:g.(?_47596635)_(47596730_?)del	EPCAM		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV000584382	2	47596635 - 47596730	2	47369496 - 47369591	584382	558645		
NC_000002.11:g.(?_47596639)_(47596726_?)del	EPCAM		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 9, 2018)	criteria provided, single submitter	VCV000455031	2	47596639 - 47596726	2	47369500 - 47369587	455031	448553		
NM_002354.2(EPCAM):c.491+1G>T	EPCAM		Diarrhea 5, with tufting enteropathy, congenital	Pathogenic(Last reviewed: Sep 3, 2015)	criteria provided, single submitter	VCV000220128	2	47602439	2	47375300	220128	221191	rs606231203	NC_000002.12:47375299:G:T
NM_002354.2(EPCAM):c.492-2A>G	EPCAM		not provided|Diarrhea 5, with tufting enteropathy, congenital	Pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	VCV000157604	2	47604151	2	47377012	157604	167464	rs606231281	NC_000002.12:47377011:A:G
NC_000002.12:g.(?_47378939)_(47386613_?)del	EPCAM		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000832005	2	47606078 - 47613752			832005	819192		
NM_022089.4(ATP13A2):c.2455C>T (p.Arg819Ter)	ATP13A2	R819*, R814*	not provided	Pathogenic(Last reviewed: May 26, 2017)	criteria provided, single submitter	VCV000502116	1	17316456	1	16989961	502116	493540	rs866035312	NC_000001.11:16989960:G:A
NM_022089.4(ATP13A2):c.212G>A (p.Trp71Ter)	ATP13A2	W71*	not provided	Pathogenic(Last reviewed: Jun 6, 2017)	criteria provided, single submitter	VCV000432661	1	17331945	1	17005450	432661	425322	rs373607247	NC_000001.11:17005449:C:T
NM_022089.4(ATP13A2):c.1345C>T (p.Arg449Ter)	ATP13A2	R444*, R449*	Spastic paraplegia 78, autosomal recessive	Pathogenic(Last reviewed: Feb 1, 2017)	no assertion criteria provided	VCV000374890	1	17322757	1	16996262	374890	361795	rs1057519293	NC_000001.11:16996261:G:A
NM_022089.4(ATP13A2):c.364C>T (p.Gln122Ter)	ATP13A2	Q122*	Spastic paraplegia 78, autosomal recessive	Pathogenic(Last reviewed: Feb 1, 2017)	no assertion criteria provided	VCV000374889	1	17331300	1	17004805	374889	361794	rs1057519292	NC_000001.11:17004804:G:A
NM_022089.4(ATP13A2):c.3149_3151TCT[1] (p.Phe1051del)	ATP13A2	F1007del, F1051del	Spastic paraplegia 78, autosomal recessive	Pathogenic(Last reviewed: Jan 11, 2017)	no assertion criteria provided	VCV000374887	1	17313381 - 17313383	1	16986886 - 16986888	374887	361792	rs1057519290	NC_000001.11:16986885:AGAAGA:AGA
NM_022089.4(ATP13A2):c.3418C>T (p.Gln1140Ter)	ATP13A2	Q1135*, P1039L, Q1140*	Spastic paraplegia 78, autosomal recessive	Pathogenic(Last reviewed: Feb 1, 2017)	no assertion criteria provided	VCV000374886	1	17312841	1	16986346	374886	361791	rs1057519289	NC_000001.11:16986345:G:A
NM_022089.4(ATP13A2):c.1550C>T (p.Thr517Ile)	ATP13A2	T512I, T517I	Spastic paraplegia 78, autosomal recessive	Pathogenic(Last reviewed: Feb 1, 2017)	no assertion criteria provided	VCV000374888	1	17320323	1	16993828	374888	361793	rs1057519291	NC_000001.11:16993827:G:A
NM_022089.4(ATP13A2):c.490C>T (p.Arg164Trp)	ATP13A2	R164W, R159W		Pathogenic	no assertion criteria provided	VCV000143196	1	17330894	1	17004399	143196	152914	rs199624796	NC_000001.11:17004398:G:A
NM_006343.3(MERTK):c.2164C>T (p.Arg722Ter)	MERTK	R722*	Retinitis pigmentosa|Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000437995	2	112777074	2	112019497	437995	431641	rs541717028	NC_000002.12:112019496:C:T
NM_022089.4(ATP13A2):c.409del (p.Val137fs)	ATP13A2	V137fs	|Spastic paraplegia 78, autosomal recessive	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000859962	1	17331255	1	17004760	859962	822988		NC_000001.11:17004759:CC:C
NM_022089.4(ATP13A2):c.3153_3154CT[2] (p.Leu1053fs)	ATP13A2		|Spastic paraplegia 78, autosomal recessive	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000660925	1	17313377 - 17313378	1	16986882 - 16986883	660925	627060		NC_000001.11:16986881:AGAGAGA:AGAGA
NM_022089.4(ATP13A2):c.2629G>A (p.Gly877Arg)	ATP13A2	G877R, G833R, G872R		Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000066099	1	17314950	1	16988455	66099	77001	rs144701072	NC_000001.11:16988454:C:T
NM_022089.4(ATP13A2):c.2552_2553del (p.Phe851fs)	ATP13A2	F807fs, F846fs, F851fs		Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000030834	1	17316242 - 17316243	1	16989747 - 16989748	30834	39791	rs587776890	NC_000001.11:16989746:AAA:A
NM_022089.4(ATP13A2):c.1099_1100GA[3] (p.Thr368fs)	ATP13A2			Pathogenic(Last reviewed: Jun 15, 2010)	no assertion criteria provided	VCV000030833	1	17323607 - 17323608	1	16997112 - 16997113	30833	39790	rs762033589	NC_000001.11:16997112:TCTCT:TCTCTCT
NM_022089.4(ATP13A2):c.1510G>C (p.Gly504Arg)	ATP13A2	G504R, G499R		Pathogenic(Last reviewed: May 8, 2007)	no assertion criteria provided	VCV000001221	1	17322503	1	16996008	1221	16260	rs121918227	NC_000001.11:16996007:C:G
NC_000002.12:g.(?_47369496)_(47379979_?)del	EPCAM		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, single submitter	VCV000831211	2	47596635 - 47607118			831211	819175		
NC_000002.12:g.(?_47369506)_(47386613_?)del	EPCAM		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000831084	2	47596645 - 47613752			831084	819180		
NC_000002.12:g.(?_47375224)_(47377087_?)del	EPCAM		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: May 23, 2019)	criteria provided, single submitter	VCV000831081	2	47602363 - 47604226			831081	819189		
NC_000002.11:g.(?_47604143)_(47604226_?)del	EPCAM		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000639884	2	47604143 - 47604226	2	47377004 - 47377087	639884	650784		
NM_153818.1(PEX10):c.790C>T (p.Arg264Ter)	PEX10	R264*, R244*	Peroxisome biogenesis disorder 6A|Peroxisome biogenesis disorder 6B|Peroxisome biogenesis disorder 6A|Peroxisome biogenesis disorder 6B	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, single submitter	VCV000162435	1	2338205	1	2406766	162435	172126	rs61752092	NC_000001.11:2406765:G:A
NM_153818.1(PEX10):c.373C>T (p.Arg125Ter)	PEX10	R125*	Peroxisome biogenesis disorder 6A|Peroxisome biogenesis disorder 6B|Peroxisome biogenesis disorder, complementation group 7|Peroxisome biogenesis disorder 6B	Pathogenic/Likely pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006772	1	2340118	1	2408679	6772	21811	rs61750434	NC_000001.11:2408678:G:A
NM_022089.4(ATP13A2):c.2561T>G (p.Met854Arg)	ATP13A2	M810R, M854R, M849R		Pathogenic(Last reviewed: Jun 15, 2012)	no assertion criteria provided	VCV000066098	1	17316234	1	16989739	66098	77000	rs587777053	NC_000001.11:16989738:A:C
ATP13A2, 22-BP DUP	ATP13A2			Pathogenic(Last reviewed: Aug 26, 2011)	no assertion criteria provided	VCV000001220					1220	16259		
NM_022089.4(ATP13A2):c.1306+5G>A	ATP13A2			Pathogenic(Last reviewed: Aug 26, 2011)	no assertion criteria provided	VCV000001219	1	17322876	1	16996381	1219	16258	rs786205056	NC_000001.11:16996380:C:T
ATP13A2, 1-BP DEL, 3057C	ATP13A2			Pathogenic(Last reviewed: Aug 26, 2011)	no assertion criteria provided	VCV000001218					1218	16257		
NM_001142604.2(PPT1):c.181C>T (p.Arg61Ter)	PPT1	R164*, R61*		Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000056197	1	40555128	1	40089456	56197	70836	rs386833649	NC_000001.11:40089455:G:A
NM_001135599.3(TGFB2):c.628C>T (p.Gln210Ter)	TGFB2	Q182*, Q210*	not provided|Holt-Oram syndrome|Loeys-Dietz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000180536	1	218607457	1	218434115	180536	178439	rs730880221	NC_000001.11:218434114:C:T
NC_000001.10:g.(?_17318209)_(17319096_?)del	ATP13A2		|Spastic paraplegia 78, autosomal recessive	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000660676	1	17318209 - 17319096	1	16991714 - 16992601	660676	650536		
NM_022089.4(ATP13A2):c.1903C>T (p.Gln635Ter)	ATP13A2	Q635*, Q630*	Spastic paraplegia 78, autosomal recessive|	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000465252	1	17318840	1	16992345	465252	447471	rs773246271	NC_000001.11:16992344:G:A
NM_005267.5(GJA8):c.139G>C (p.Asp47His)	GJA8	D47H	not provided	Pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000280147	1	147380221	1	147908094	280147	263944	rs121434643	NC_000001.11:147908093:G:C
NM_005267.5(GJA8):c.484G>A (p.Glu162Lys)	GJA8	E162K	Congenital cataract	Pathogenic(Last reviewed: Jul 29, 2016)	no assertion criteria provided	VCV000252947	1	147380566	1	147908439	252947	247346	rs1114167310	NC_000001.11:147908438:G:A
NM_005267.5(GJA8):c.73T>C (p.Trp25Arg)	GJA8	W25R	Congenital cataract	Pathogenic(Last reviewed: Jul 29, 2016)	no assertion criteria provided	VCV000252946	1	147380155	1	147908028	252946	247345	rs1114167309	NC_000001.11:147908027:T:C
NM_002354.2(EPCAM):c.499dup (p.Gln167fs)	EPCAM		not provided|Diarrhea 5, with tufting enteropathy, congenital	Pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	VCV000012774	2	47604159 - 47604160	2	47377020 - 47377021	12774	27813	rs606231204	NC_000002.12:47377020:C:CC
NC_000001.10:g.(?_147380063)_(147381404_?)del	GJA8		Cataract 1	Pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, single submitter	VCV000833373	1	147380063 - 147381404			833373	818813		
NM_005267.5(GJA8):c.827C>T (p.Ser276Phe)	GJA8	S276F	Cataract 1	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000427758	1	147380909	1	147908782	427758	417647	rs45619342	NC_000001.11:147908781:C:T
NM_005267.5(GJA8):c.89dup (p.Ile31fs)	GJA8		Congenital cataract	Pathogenic(Last reviewed: Jan 9, 2015)	no assertion criteria provided	VCV000217331	1	147380167 - 147380168	1	147908040 - 147908041	217331	213975	rs864309684	NC_000001.11:147908040:TTTT:TTTTT
NM_005267.5(GJA8):c.566C>T (p.Pro189Leu)	GJA8	P189L	Cataract 1	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000068465	1	147380648	1	147908521	68465	79357	rs397515627	NC_000001.11:147908520:C:T
NM_005267.5(GJA8):c.131T>A (p.Val44Glu)	GJA8	V44E	Cataract 1	Pathogenic(Last reviewed: Mar 23, 2006)	no assertion criteria provided	VCV000008725	1	147380213	1	147908086	8725	23764	rs80358204	NC_000001.11:147908085:T:A
NM_005267.5(GJA8):c.68G>C (p.Arg23Thr)	GJA8	R23T	Cataract 1	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000008724	1	147380150	1	147908023	8724	23763	rs80358203	NC_000001.11:147908022:G:C
NM_005267.5(GJA8):c.142G>A (p.Glu48Lys)	GJA8	E48K	Cataract 1	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000008722	1	147380224	1	147908097	8722	23761	rs80358201	NC_000001.11:147908096:G:A
NM_005267.5(GJA8):c.602A>G (p.Glu201Gly)	GJA8	E201G	Cataract 1	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000861618	1	147380684	1	147908557	861618	822679		NC_000001.11:147908556:A:G
NM_005267.5(GJA8):c.139G>A (p.Asp47Asn)	GJA8	D47N	Cataract 1	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000008727	1	147380221	1	147908094	8727	23766	rs121434643	NC_000001.11:147908093:G:A
NM_005267.5(GJA8):c.153C>G (p.Asp51Glu)	GJA8	D51E	Cataract 1	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000574353	1	147380235	1	147908108	574353	558106	rs1307969607	NC_000001.11:147908107:C:G
NM_005267.5(GJA8):c.593G>A (p.Arg198Gln)	GJA8	R198Q	Cataract 1	Pathogenic(Last reviewed: Mar 30, 2012)	no assertion criteria provided	VCV000008726	1	147380675	1	147908548	8726	23765	rs80358205	NC_000001.11:147908547:G:A
NM_000784.4(CYP27A1):c.1213C>T (p.Arg405Trp)	CYP27A1	R405W	Cholestanol storage disease|not provided	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000065838	2	219679131	2	218814408	65838	76746	rs573951598	NC_000002.12:218814407:C:T
NM_005270.4(GLI2):c.2799_2845del (p.Leu935Argfs)	GLI2	L935fs	not provided	Pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	VCV000597515	2	121746284 - 121746330	2	120988708 - 120988754	597515	588576	rs1558941490	NC_000002.12:120988707:CCACGCCCACTGGGGCCGCGGCGTGGCAGCGACGGGCCGACCTATGGCCACG:CCACG
GRCh37/hg19 2q14.2(chr2:121612201-121734527)x1	GLI2		not provided	Pathogenic(Last reviewed: Dec 14, 2017)	no assertion criteria provided	VCV000562519	2	121612201 - 121734527			562519	553703		
NM_005270.4(GLI2):c.2314delA (p.Ser772Valfs)	GLI2	S772fs	Culler-Jones syndrome	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522404	2	121745804	2	120988228	522404	513019	rs1553478423	NC_000002.12:120988227:A:
NM_005270.4(GLI2):c.1421G>A (p.Trp474Ter)	GLI2	W474*	not provided	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000498545	2	121736062	2	120978486	498545	489969	rs1553476382	NC_000002.12:120978485:G:A
NM_005270.4(GLI2):c.845+1G>C	GLI2		not provided	Pathogenic(Last reviewed: Jul 23, 2015)	criteria provided, single submitter	VCV000419412	2	121726492	2	120968916	419412	405287	rs1064793857	NC_000002.12:120968915:G:C
NC_000002.12:g.120989352G>A	GLI2		White-sutton syndrome	Pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, single submitter	VCV000816868					816868	805076		
NM_005270.4(GLI2):c.891delG (p.Gln297Hisfs)	GLI2	Q297fs	Holoprosencephaly 9	Pathogenic(Last reviewed: Jun 19, 2014)	no assertion criteria provided	VCV000374323	2	121728014	2	120970438	374323	361163	rs1057518696	NC_000002.12:120970437:G:
NM_005270.4(GLI2):c.3261dupC (p.Thr1088Hisfs)	GLI2		Holoprosencephaly 9	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000374313	2	121746748 - 121746749	2	120989172 - 120989173	374313	361164	rs1057518689	NC_000002.12:120989172:CCC:CCCC
NM_005270.4(GLI2):c.1138G>T (p.Glu380Ter)	GLI2	E380*	Culler-Jones syndrome	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000139431	2	121729595	2	120972019	139431	143123	rs374155310	NC_000002.12:120972018:G:T
NM_005270.4(GLI2):c.2081_2084del (p.Leu694Argfs)	GLI2	L694fs	Culler-Jones syndrome	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000139430	2	121743977 - 121743980	2	120986401 - 120986404	139430	143122	rs587777456	NC_000002.12:120986400:CTGAC:C
NM_005270.4(GLI2):c.2362_2368del (p.Leu788Serfs)	GLI2	L788fs	Culler-Jones syndrome	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000139429	2	121745849 - 121745855	2	120988273 - 120988279	139429	143121	rs587777455	NC_000002.12:120988272:CGGCTGTCGG:CGG
NM_005270.4(GLI2):c.192dup (p.Asp65Terfs)	GLI2		Culler-Jones syndrome|Holoprosencephaly 9	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000573009	2	121684978 - 121684979	2	120927402 - 120927403	573009	558707	rs1388607733	NC_000002.12:120927402:TT:TTT
GLI2, 1256TER	GLI2		Culler-Jones syndrome	Pathogenic(Last reviewed: Aug 1, 2005)	no assertion criteria provided	VCV000139428					139428	143120		
NM_005270.4(GLI2):c.1885G>A (p.Glu629Lys)	GLI2	E629K	Holoprosencephaly 9	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000037083	2	121742248	2	120984672	37083	45758	rs387907277	NC_000002.12:120984671:G:A
NM_005270.4(GLI2):c.864_865del (p.His289Profs)	GLI2	H289fs	Holoprosencephaly 9	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000037082	2	121727984 - 121727985	2	120970408 - 120970409	37082	45757	rs398122882	NC_000002.12:120970407:CCCCC:CCC
NM_005270.4(GLI2):c.1435C>G (p.Arg479Gly)	GLI2	R151G, R479G	Holoprosencephaly 9	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000013836	2	121736076	2	120978500	13836	28875	rs121917708	NC_000002.12:120978499:C:G
NM_020451.3(SELENON):c.13_22dup (p.Gln8fs)	SELENON		Eichsfeld type congenital muscular dystrophy|not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000193432	1	26126724 - 26126725	1	25800233 - 25800234	193432	190596	rs797044621	NC_000001.11:25800233:GGCCGGGCCCGGCCGGGCC:GGCCGGGCCCGGCCGGGCCCGGCCGGGCC
NM_020451.3(SELENON):c.1A>G (p.Met1Val)	SELENON	M1V	Eichsfeld type congenital muscular dystrophy|not provided	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004491	1	26126722	1	25800231	4491	19530	rs121908184	NC_000001.11:25800230:A:G
NM_005270.5(GLI2):c.3618del (p.Gln1206fs)	GLI2	Q1064fs, Q1189fs, Q1206fs	Holoprosencephaly 9|Culler-Jones syndrome	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000863253	2	121747108	2	120989532	863253	824724		NC_000002.12:120989531:G:
NM_005270.4(GLI2):c.1323G>A (p.Trp441Ter)	GLI2	W441*	Holoprosencephaly 9	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000013835	2	121732640	2	120975064	13835	28874	rs121917707	NC_000002.12:120975063:G:A
GLI2, 1-BP DEL, NT2274	GLI2		Holoprosencephaly 9	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000013834					13834	28873		
NM_015506.3(MMACHC):c.567dup (p.Ile190fs)	MMACHC		Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000556708	1	45974604 - 45974605	1	45508932 - 45508933	556708	541135	rs1463495909	NC_000001.11:45508932:T:TT
NM_000310.3(PPT1):c.325T>G (p.Tyr109Asp)	PPT1	Y109D	|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056190	1	40557754	1	40092082	56190	70829	rs386833642	NC_000001.11:40092081:A:C
NC_000002.12:g.(?_47385156)_(47386613_?)del	EPCAM		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000832828	2	47612295 - 47613752			832828	819196		
NC_000002.12:g.(?_47385055)_(47391097_?)del	EPCAM		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000832062	2	47612194 - 47618236			832062	819195		
NC_000002.11:g.(?_47612295)_(47613762_?)del	EPCAM		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000644275	2	47612295 - 47613762	2	47385156 - 47386623	644275	650786		
NM_001079878.2(CNGA3):c.1174C>T (p.Arg392Trp)	CNGA3	R411W, R392W, R410W	Retinal dystrophy|not provided|Achromatopsia 2	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009479	2	99012861	2	98396398	9479	24518	rs137852608	NC_000002.12:98396397:C:T
NM_022168.4(IFIH1):c.2465G>A (p.Arg822Gln)	IFIH1	R822Q	Aicardi-Goutieres syndrome 7|not provided|Singleton-Merten syndrome 1|Aicardi-Goutieres syndrome 7|Singleton-Merten syndrome 1	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189338	2	163128887	2	162272377	189338	187227	rs376048533	NC_000002.12:162272376:C:T
GRCh37/hg19 1q21.2(chr1:147245049-147246661)	GJA5		Atrial fibrillation, familial, 11	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625769	1	147245049 - 147246661			625769	614073		
NM_181703.4(GJA5):c.223A>T (p.Ile75Phe)	GJA5	I75F	Atrial fibrillation, familial, 11	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000126903	1	147231124	1	147759016	126903	132416	rs587777304	NC_000001.11:147759015:T:A
NM_181703.4(GJA5):c.661C>A (p.Leu221Ile)	GJA5	L221I	Atrial fibrillation, familial, 11	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000029665	1	147230686	1	147758578	29665	38620	rs387906614	NC_000001.11:147758577:G:T
NM_181703.4(GJA5):c.253G>A (p.Val85Ile)	GJA5	V85I	Atrial fibrillation, familial, 11	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000029664	1	147231094	1	147758986	29664	38619	rs387906613	NC_000001.11:147758985:C:T
NM_181703.4(GJA5):c.145C>T (p.Gln49Ter)	GJA5	Q49*	Atrial fibrillation, familial, 11	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000029663	1	147231202	1	147759094	29663	38618	rs387906612	NC_000001.11:147759093:G:A
NM_181703.4(GJA5):c.262C>T (p.Pro88Ser)	GJA5	P88S	Atrial fibrillation, somatic	Pathogenic(Last reviewed: Jun 22, 2006)	no assertion criteria provided	VCV000016999	1	147231085	1	147758977	16999	32038	rs121434558	NC_000001.11:147758976:G:A
NM_001079866.2(BCS1L):c.781_782CT[2] (p.Leu261_Ser262insTer)	BCS1L		Inborn genetic diseases	Pathogenic(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	VCV000520622	2	219527294 - 219527295	2	218662571 - 218662572	520622	511395	rs1553597538	NC_000002.12:218662570:CTCTCT:CTCT
NM_001135599.3(TGFB2):c.988C>T (p.Arg330Cys)	TGFB2	R302C, R330C	Holt-Oram syndrome|not provided|Loeys-Dietz syndrome 4	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000224872	1	218609461	1	218436119	224872	226714	rs869312903	NC_000001.11:218436118:C:T
NM_181703.4(GJA5):c.685C>A (p.Leu229Met)	GJA5	L229M	Atrial fibrillation, familial, 11	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000029666	1	147230662	1	147758554	29666	38621	rs387906615	NC_000001.11:147758553:G:T
NM_002437.5(MPV17):c.293C>T (p.Pro98Leu)	MPV17	P98L	Navajo neurohepatopathy|CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE|MPV17-Related Disorders|not provided	Pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000038355	2	27535443	2	27312576	38355	46918	rs267607258	NC_000002.12:27312575:G:A
NM_000228.3(LAMB3):c.2533C>T (p.Gln845Ter)	LAMB3	Q845*	not provided	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000816952	1	209796350	1	209623005	816952	805196		NC_000001.11:209623004:G:A
NM_000228.3(LAMB3):c.2275G>T (p.Gly759Ter)	LAMB3	G759*	not provided	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000620454	1	209796933	1	209623588	620454	611504	rs780424034	NC_000001.11:209623587:C:A
NM_000228.3(LAMB3):c.285G>A (p.Trp95Ter)	LAMB3	W95*	not provided	Pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	VCV000620137	1	209811892	1	209638547	620137	611505	rs1558163550	NC_000001.11:209638546:C:T
NM_000228.3(LAMB3):c.2766_2767CA[1] (p.Thr923fs)	LAMB3		not provided	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000595836	1	209791937 - 209791938	1	209618592 - 209618593	595836	586898	rs1558148080	NC_000001.11:209618591:TGTG:TG
NM_000228.3(LAMB3):c.241C>T (p.Arg81Ter)	LAMB3	R81*	not provided	Pathogenic(Last reviewed: Aug 7, 2015)	criteria provided, single submitter	VCV000419475	1	209811936	1	209638591	419475	405022	rs1064793896	NC_000001.11:209638590:G:A
NM_000228.3(LAMB3):c.436dup (p.Tyr146fs)	LAMB3		not provided	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000864602	1	209807919 - 209807920	1	209634574 - 209634575	864602	823302		NC_000001.11:209634574:A:AA
NM_000228.3(LAMB3):c.217C>T (p.Gln73Ter)	LAMB3	Q73*	not provided	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000841750	1	209811960	1	209638615	841750	823303		NC_000001.11:209638614:G:A
NM_000228.3(LAMB3):c.2551C>T (p.Gln851Ter)	LAMB3	Q851*	not provided	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000664083	1	209796332	1	209622987	664083	627346		NC_000001.11:209622986:G:A
NM_000228.3(LAMB3):c.55C>T (p.Gln19Ter)	LAMB3	Q19*	not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000642411	1	209823437	1	209650092	642411	627347		NC_000001.11:209650091:G:A
NM_000228.3(LAMB3):c.3340G>T (p.Glu1114Ter)	LAMB3	E1114*	Amelogenesis imperfecta, type IA	Pathogenic(Last reviewed: Mar 1, 2017)	no assertion criteria provided	VCV000393554	1	209789858	1	209616513	393554	380445	rs1553275195	NC_000001.11:209616512:C:A
NM_000228.3(LAMB3):c.3383-1G>A	LAMB3		Amelogenesis imperfecta, type IA	Pathogenic(Last reviewed: Mar 1, 2017)	no assertion criteria provided	VCV000393553	1	209788753	1	209615408	393553	380444	rs1553275070	NC_000001.11:209615407:C:T
NM_000228.3(LAMB3):c.3394dup (p.Glu1132fs)	LAMB3		Amelogenesis imperfecta, type IA	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000180677	1	209788740 - 209788741	1	209615395 - 209615396	180677	178846	rs786201004	NC_000001.11:209615395:CC:CCC
NM_000228.3(LAMB3):c.3431C>A (p.Ser1144Ter)	LAMB3	S1144*	Amelogenesis imperfecta, type IA	Pathogenic(Last reviewed: May 1, 2006)	no assertion criteria provided	VCV000180676	1	209788704	1	209615359	180676	178845	rs869320671	NC_000001.11:209615358:G:T
NM_000228.2(LAMB3):c.957_958ins77 (p.?)	LAMB3		Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic(Last reviewed: Feb 22, 2008)	no assertion criteria provided	VCV000021132	1	209803256 - 209803257	1	209629911 - 209629912	21132	33984		
NM_000228.3(LAMB3):c.1500C>A (p.Cys500Ter)	LAMB3	C500*	not provided	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000845563	1	209800309	1	209626964	845563	823301		NC_000001.11:209626963:G:T
NM_000228.3(LAMB3):c.1344_1345del (p.Ser448fs)	LAMB3	S448fs	Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000523029	1	209800868 - 209800869	1	209627523 - 209627524	523029	513503	rs1553277267	NC_000001.11:209627522:CAC:C
NM_000228.3(LAMB3):c.3446_3453del (p.Gly1149fs)	LAMB3	G1149fs	Amelogenesis imperfecta, type IA	Pathogenic(Last reviewed: Oct 1, 2013)	no assertion criteria provided	VCV000180675	1	209788682 - 209788689	1	209615337 - 209615344	180675	178844	rs1553275034	NC_000001.11:209615336:CTCCAGTCCT:CT
NM_000228.3(LAMB3):c.496C>T (p.Gln166Ter)	LAMB3	Q166*	Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000014544	1	209807860	1	209634515	14544	29583	rs121912483	NC_000001.11:209634514:G:A
NM_005267.5(GJA8):c.134G>T (p.Trp45Leu)	GJA8	W45L	Cataract 1	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000845873	1	147380216	1	147908089	845873	822676		NC_000001.11:147908088:G:T
NM_005267.5(GJA8):c.262C>G (p.Pro88Ala)	GJA8	P88A	Cataract 1	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000650108	1	147380344	1	147908217	650108	626787		NC_000001.11:147908216:C:G
NM_005267.5(GJA8):c.262C>T (p.Pro88Ser)	GJA8	P88S	Cataract 1	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000008721	1	147380344	1	147908217	8721	23760	rs80358200	NC_000001.11:147908216:C:T
NM_000228.3(LAMB3):c.1486-1G>A	LAMB3		Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic/Likely pathogenic(Last reviewed: May 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000558343	1	209800324	1	209626979	558343	540755	rs1418276828	NC_000001.11:209626978:C:T
NM_000228.3(LAMB3):c.76dup (p.Cys26fs)	LAMB3		Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000495060	1	209823415 - 209823416	1	209650070 - 209650071	495060	486607	rs1553281335	NC_000001.11:209650070:A:AA
NM_000228.3(LAMB3):c.2346del (p.Thr783fs)	LAMB3	T783fs	not provided|Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic/Likely pathogenic(Last reviewed: Feb 9, 2016)	criteria provided, multiple submitters, no conflicts	VCV000370435	1	209796862	1	209623517	370435	357033	rs1057516486	NC_000001.11:209623516:GGG:GG
NM_000228.3(LAMB3):c.497_498AG[1] (p.Ser167fs)	LAMB3		Junctional epidermolysis bullosa gravis of Herlitz|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2016)	criteria provided, multiple submitters, no conflicts	VCV000370111	1	209807856 - 209807857	1	209634511 - 209634512	370111	357048	rs1057516241	NC_000001.11:209634510:CTCT:CT
NM_000228.3(LAMB3):c.2288del (p.Gly763fs)	LAMB3	G763fs	Junctional epidermolysis bullosa gravis of Herlitz|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280743	1	209796920	1	209623575	280743	263970	rs886041893	NC_000001.11:209623574:CC:C
NM_000228.3(LAMB3):c.629-1G>A	LAMB3		Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000014553	1	209806122	1	209632777	14553	29592	rs587776814	NC_000001.11:209632776:C:T
NM_000228.3(LAMB3):c.619A>C (p.Lys207Gln)	LAMB3	K207Q	Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000014552	1	209806424	1	209633079	14552	29591	rs121912487	NC_000001.11:209633078:T:G
NM_000228.3(LAMB3):c.565-3T>C	LAMB3		Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000014551	1	209806481	1	209633136	14551	29590	rs587776813	NC_000001.11:209633135:A:G
NM_000329.3(RPE65):c.130C>T (p.Arg44Ter)	RPE65	R44*	Retinitis pigmentosa|Leber congenital amaurosis 2|Retinitis pigmentosa 20|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000374497	1	68912508	1	68446825	374497	361383	rs368088025	NC_000001.11:68446824:G:A
NM_000329.3(RPE65):c.304G>T (p.Glu102Ter)	RPE65	E102*	not provided|Retinitis pigmentosa 20|Leber congenital amaurosis 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000098863	1	68910508	1	68444825	98863	104753	rs62642584	NC_000001.11:68444824:C:A
NM_000329.3(RPE65):c.131G>A (p.Arg44Gln)	RPE65	R44Q	Retinitis pigmentosa 20|Leber congenital amaurosis 2|not provided	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000098840	1	68912507	1	68446824	98840	104730	rs61751282	NC_000001.11:68446823:C:T
NM_025243.4(SLC19A3):c.68G>T (p.Gly23Val)	SLC19A3	G23V	Biotin-thiamine-responsive basal ganglia disease	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004562	2	228566967	2	227702251	4562	19601	rs121917882	NC_000002.12:227702250:C:A
NM_000228.3(LAMB3):c.430C>T (p.Arg144Ter)	LAMB3	R144*	not provided|Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000488703	1	209807926	1	209634581	488703	481579	rs759518184	NC_000001.11:209634580:G:A
NM_000228.3(LAMB3):c.2914C>T (p.Arg972Ter)	LAMB3	R972*	not provided	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449050	1	209791389	1	209618044	449050	442704	rs747916314	NC_000001.11:209618043:G:A
NM_000228.3(LAMB3):c.1823dup (p.Ser608fs)	LAMB3		Junctional epidermolysis bullosa gravis of Herlitz|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370083	1	209799145 - 209799146	1	209625800 - 209625801	370083	357036	rs1057516219	NC_000001.11:209625800:C:CC
NM_000228.3(LAMB3):c.1587_1588del (p.Gly530fs)	LAMB3	G530fs	Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	VCV000014548	1	209800221 - 209800222	1	209626876 - 209626877	14548	29587	rs769151482	NC_000001.11:209626875:CT:
NM_000228.3(LAMB3):c.1439_1443del (p.Pro480fs)	LAMB3	P480fs	Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000014547	1	209800770 - 209800774	1	209627425 - 209627429	14547	29586	rs786205095	NC_000001.11:209627424:ACACG:
NM_000228.3(LAMB3):c.904del (p.Trp302fs)	LAMB3	W302fs	Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000014542	1	209803999	1	209630654	14542	29581	rs786205094	NC_000001.11:209630653:A:
NM_000228.3(LAMB3):c.3228+1G>A	LAMB3		not provided	Pathogenic(Last reviewed: Jul 3, 2019)	criteria provided, single submitter	VCV000839926	1	209790754	1	209617409	839926	851271		NC_000001.11:209617408:C:T
NM_000228.3(LAMB3):c.1017T>G (p.Tyr339Ter)	LAMB3	Y339*	not provided|Junctional epidermolysis bullosa gravis of Herlitz|Amelogenesis imperfecta, type IA|Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372402	1	209803197	1	209629852	372402	359226	rs774174881	NC_000001.11:209629851:A:C
NM_000228.3(LAMB3):c.628+1G>A	LAMB3		not provided|Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000370503	1	209806414	1	209633069	370503	357043	rs1057516539	NC_000001.11:209633068:C:T
NM_000228.3(LAMB3):c.1132+5G>A	LAMB3		not provided|	Pathogenic/Likely pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000265229	1	209803077	1	209629732	265229	259645	rs770302956	NC_000001.11:209629731:C:T
NM_000228.3(LAMB3):c.2806C>T (p.Gln936Ter)	LAMB3	Q936*	Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000014546	1	209791900	1	209618555	14546	29585	rs121912485	NC_000001.11:209618554:G:A
NM_006343.3(MERTK):c.1605-2A>G	MERTK		Retinal dystrophy|not provided|Retinitis pigmentosa 38	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005401	2	112758776	2	112001199	5401	20440	rs730880273	NC_000002.12:112001198:A:G
NM_000784.4(CYP27A1):c.1421G>A (p.Arg474Gln)	CYP27A1	R441Q, R474Q	Cholestanol storage disease	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000004258	2	219679425	2	218814702	4258	19297	rs121908097	NC_000002.12:218814701:G:A
NM_000784.4(CYP27A1):c.1435C>T (p.Arg479Cys)	CYP27A1	R446C, R479C	Cholestanol storage disease|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004254	2	219679439	2	218814716	4254	19293	rs72551322	NC_000002.12:218814715:C:T
NM_000228.3(LAMB3):c.1117C>T (p.Gln373Ter)	LAMB3	Q373*	|Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371216	1	209803097	1	209629752	371216	357037	rs1057517096	NC_000001.11:209629751:G:A
NM_000228.3(LAMB3):c.1830G>A (p.Trp610Ter)	LAMB3	W610*	Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000014545	1	209799139	1	209625794	14545	29584	rs121912484	NC_000001.11:209625793:C:T
NM_000228.3(LAMB3):c.628G>A (p.Glu210Lys)	LAMB3	E210K	Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000014543	1	209806415	1	209633070	14543	29582	rs121912482	NC_000001.11:209633069:C:T
NM_020451.3(SELENON):c.872G>A (p.Arg291Gln)	SELENON	R291Q, R257Q	Eichsfeld type congenital muscular dystrophy|Eichsfeld type congenital muscular dystrophy|Congenital myopathy with fiber type disproportion|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280026	1	26135641	1	25809150	280026	264017	rs199564797	NC_000001.11:25809149:G:A
NM_005267.5(GJA8):c.134G>C (p.Trp45Ser)	GJA8	W45S	Congenital cataract|Cataract 1	Pathogenic(Last reviewed: Sep 10, 2019)	criteria provided, single submitter	VCV000217335	1	147380216	1	147908089	217335	213977	rs864309688	NC_000001.11:147908088:G:C
NM_000310.3(PPT1):c.223A>C (p.Thr75Pro)	PPT1	T75P	|not provided	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008900	1	40558081	1	40092409	8900	23939	rs137852696	NC_000001.11:40092408:T:G
NM_002074.5(GNB1):c.353A>G (p.Asp118Gly)	GNB1	D118G, D18G	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 29, 2016)	criteria provided, single submitter	VCV000521213	1	1735935	1	1804496	521213	511195	rs1553194162	NC_000001.11:1804495:T:C
NM_002074.5(GNB1):c.1011_1013del (p.Lys337_Ile338delinsAsn)	GNB1		Inborn genetic diseases	Pathogenic(Last reviewed: Apr 25, 2016)	criteria provided, single submitter	VCV000521025	1	1718780 - 1718782	1	1787341 - 1787343	521025	511192	rs1553191393	NC_000001.11:1787340:ATC:
NM_000191.3(HMGCL):c.503_504TC[1] (p.Ser169fs)	HMGCL		Deficiency of hydroxymethylglutaryl-CoA lyase|Inborn genetic diseases	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521753	1	24137281 - 24137282	1	23810791 - 23810792	521753	511253	rs764264834	NC_000001.11:23810790:GAGA:GA
NM_000228.3(LAMB3):c.823-1G>T	LAMB3		not provided|Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553742	1	209804081	1	209630736	553742	540803	rs778372285	NC_000001.11:209630735:C:A
NM_000228.3(LAMB3):c.958_1034dup (p.Asn345fs)	LAMB3		not provided|Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic(Last reviewed: Jul 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279829	1	209803179 - 209803180	1	209629834 - 209629835	279829	263971	rs1553277702	
NM_020919.4(ALS2):c.4897C>T (p.Gln1633Ter)	ALS2	Q1633*	Inborn genetic diseases	Pathogenic(Last reviewed: May 28, 2013)	criteria provided, single submitter	VCV000208757	2	202568883	2	201704160	208757	205229	rs797044934	NC_000002.12:201704159:G:A
NM_000182.5(HADHA):c.871C>T (p.Arg291Ter)	HADHA	R255*, R291*	Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency|Mitochondrial trifunctional protein deficiency|Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008737	2	26437359	2	26214490	8737	23776	rs137852775	NC_000002.12:26214489:G:A
NM_001135599.3(TGFB2):c.979C>T (p.Arg327Trp)	TGFB2	R299W, R327W	Holt-Oram syndrome|not provided|Loeys-Dietz syndrome 4	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000213845	1	218609452	1	218436110	213845	209442	rs863223792	NC_000001.11:218436109:C:T
NM_014014.5(SNRNP200):c.2041C>T (p.Arg681Cys)	SNRNP200	R681C	not provided|Retinitis pigmentosa 33|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000636112	2	96958829	2	96293091	636112	623829		NC_000002.12:96293090:G:A
SCN3A, LEU247PRO	SCN3A	L247P	Epilepsy, familial focal, with variable foci 4	Pathogenic(Last reviewed: Oct 14, 2019)	no assertion criteria provided	VCV000522566					522566	513178		
NM_006922.4(SCN3A):c.4114A>G (p.Met1372Val)	SCN3A	M1323V, M1372V	Epilepsy, familial focal, with variable foci 4	Pathogenic(Last reviewed: Oct 14, 2019)	no assertion criteria provided	VCV000522565	2	165953887	2	165097377	522565	513177	rs758906955	NC_000002.12:165097376:T:C
NM_006922.4(SCN3A):c.2443G>A (p.Asp815Asn)	SCN3A	D766N, D815N	Epilepsy, familial focal, with variable foci 4	Pathogenic(Last reviewed: Oct 14, 2019)	no assertion criteria provided	VCV000522564	2	165987876	2	165131366	522564	513176	rs755440336	NC_000002.12:165131365:C:T
NM_006922.4(SCN3A):c.3998C>T (p.Pro1333Leu)	SCN3A	P1333L, P1284L	Early infantile epileptic encephalopathy 62|not provided	Pathogenic(Last reviewed: May 19, 2015)	criteria provided, single submitter	VCV000379838	2	165954003	2	165097493	379838	366028	rs1057520753	NC_000002.12:165097492:G:A
NM_001029883.3(PCARE):c.3002G>A (p.Trp1001Ter)	PCARE	W1001*	Retinal dystrophy|Retinitis pigmentosa|not provided	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000438048	2	29294126	2	29071260	438048	431651	rs367658438	NC_000002.12:29071259:C:T
NM_015506.3(MMACHC):c.440G>A (p.Gly147Asp)	MMACHC	G147D, G90D	Methylmalonic acidemia with homocystinuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203829	1	45974478	1	45508806	203829	199951	rs140522266	NC_000001.11:45508805:G:A
NM_015506.3(MMACHC):c.481C>T (p.Arg161Ter)	MMACHC	R161*, R104*	not provided|Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000095703	1	45974519	1	45508847	95703	101600	rs370596113	NC_000001.11:45508846:C:T
NM_000228.3(LAMB3):c.1365_1366del (p.Asn456fs)	LAMB3	N456fs	Adult junctional epidermolysis bullosa|Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2016)	criteria provided, multiple submitters, no conflicts	VCV000189004	1	209800847 - 209800848	1	209627502 - 209627503	189004	186611	rs769967565	NC_000001.11:209627501:TG:
NM_000228.3(LAMB3):c.463dup (p.Ser155fs)	LAMB3		not provided|Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic/Likely pathogenic(Last reviewed: Sep 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188937	1	209807892 - 209807893	1	209634547 - 209634548	188937	186613	rs776537364	NC_000001.11:209634547:A:AA
NM_007315.3(STAT1):c.800C>T (p.Ala267Val)	STAT1	A267V	Chronic mucocutaneous candidiasis|Immunodeficiency 31C|Mycobacterial and viral infections, susceptibility to, autosomal recessive|Immunodeficiency 31C|Immunodeficiency 31a	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030084	2	191859931	2	190995205	30084	39039	rs387906759	NC_000002.12:190995204:G:A
NM_000310.3(PPT1):c.628-1G>T	PPT1		|Neuronal ceroid lipofuscinosis	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000056208	1	40544331	1	40078659	56208	70847	rs386833659	NC_000001.11:40078658:C:A
NM_000310.3(PPT1):c.529C>G (p.Gln177Glu)	PPT1	Q177E, Q74E	|not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056198	1	40555089	1	40089417	56198	70837	rs386833650	NC_000001.11:40089416:G:C
NM_000478.6(ALPL):c.1471G>A (p.Gly491Arg)	ALPL	G491R, G414R, G436R	Childhood hypophosphatasia|Adult hypophosphatasia|Infantile hypophosphatasia|Infantile hypophosphatasia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551446	1	21904037	1	21577544	551446	540900	rs1413274209	NC_000001.11:21577543:G:A
NM_000478.6(ALPL):c.1363G>A (p.Gly455Ser)	ALPL	G455S, G400S, G378S	not provided|Infantile hypophosphatasia|Hypophosphatasia	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371400	1	21903929	1	21577436	371400	357070	rs149889416	NC_000001.11:21577435:G:A
NM_000478.6(ALPL):c.814C>T (p.Arg272Cys)	ALPL	R272C, R195C, R217C	not provided|Infantile hypophosphatasia|Childhood hypophosphatasia	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000013684	1	21896819	1	21570326	13684	28723	rs121918020	NC_000001.11:21570325:C:T
NM_020451.3(SELENON):c.-11_81del (p.Met1fs)	SELENON	M1fs	Eichsfeld type congenital muscular dystrophy|Congenital myopathy with fiber type disproportion|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000373075	1	26126703 - 26126794	1	25800212 - 25800303	373075	359257	rs1553198464	
NM_000329.2(RPE65):c.292_311del (p.Ile98Hisfs)	RPE65	I98fs	Leber congenital amaurosis|Leber congenital amaurosis 2|not provided|Retinitis pigmentosa 20|Leber congenital amaurosis 2	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000098860	1	68910501 - 68910520	1	68444818 - 68444837	98860	104750	rs62642583	NC_000001.11:68444817:CCAAATTCTGTTATGACGATCC:CC
NM_000228.3(LAMB3):c.1705C>T (p.Arg569Ter)	LAMB3	R569*	not provided|Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic/Likely pathogenic(Last reviewed: May 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188764	1	209799264	1	209625919	188764	186610	rs201551805	NC_000001.11:209625918:G:A
NM_000272.4(NPHP1):c.1719del (p.Ile573fs)	NPHP1	I454fs, I517fs, I572fs, I573fs	not provided	Pathogenic(Last reviewed: Dec 26, 2017)	criteria provided, single submitter	VCV000595558	2	110889347	2	110131770	595558	586620	rs1017750255	NC_000002.12:110131769:AA:A
NM_000272.4(NPHP1):c.415G>T (p.Glu139Ter)	NPHP1	E139*, E77*	not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000595311	2	110927490	2	110169913	595311	586373	rs1349732291	NC_000002.12:110169912:C:A
NM_000272.4(NPHP1):c.329+1G>A	NPHP1		not provided	Pathogenic(Last reviewed: Mar 16, 2016)	criteria provided, single submitter	VCV000286936	2	110935999	2	110178422	286936	271173	rs376974221	NC_000002.12:110178421:C:T
GRCh37/hg19 2q13(chr2:110881237-110963848)x1	NPHP1		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253441	2	110881237 - 110963848			253441	247889		
NM_000272.4(NPHP1):c.1184dup (p.Leu396fs)	NPHP1		not provided	Pathogenic(Last reviewed: Jan 21, 2013)	criteria provided, single submitter	VCV000092716	2	110917770 - 110917771	2	110160193 - 110160194	92716	98623	rs398123285	NC_000002.12:110160193:GG:GGG
NM_001128178.3(NPHP1):c.771+77_771+78del	NPHP1		Nephronophthisis	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000861607	2	110922187 - 110922188	2	110164610 - 110164611	861607	824684		NC_000002.12:110164609:CACA:CA
NM_001128178.3(NPHP1):c.643G>T (p.Glu215Ter)	NPHP1	E153*, E215*	Nephronophthisis	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000838041	2	110922714	2	110165137	838041	824686		NC_000002.12:110165136:C:A
NC_000002.12:g.(?_110144493)_(110150256_?)del	NPHP1		Nephronophthisis	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000833115	2	110902070 - 110907833			833115	819034		
NM_000272.4(NPHP1):c.1529_1530del (p.Glu510fs)	NPHP1	E454fs, E509fs, E391fs, E510fs	Nephronophthisis 1	Pathogenic(Last reviewed: Jun 30, 2016)	criteria provided, single submitter	VCV000436026	2	110902137 - 110902138	2	110144560 - 110144561	436026	427871	rs1553484094	NC_000002.12:110144559:CTC:C
GRCh37/hg19 2q13(chr2:110875689-110967529)	NPHP1		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000431747	2	110875689 - 110967529			431747	425253		
NM_000272.3(NPHP1):c.-94_*455del	NPHP1		Nephronophthisis	Pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000237627	2	110880913 - 110962639	2	110123336 - 110205062	237627	238354		
NM_000272.3(NPHP1):c.(?_-1)_(*1_?)del	NPHP1		Nephronophthisis	Pathogenic(Last reviewed: Jul 16, 2015)	criteria provided, single submitter	VCV000224960					224960	226829		
NM_000272.4(NPHP1):c.1884+1G>T	NPHP1		Nephronophthisis 1	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000003507	2	110886762	2	110129185	3507	18546	rs1233478832	NC_000002.12:110129184:C:A
NM_001128178.3(NPHP1):c.1977del (p.Phe659fs)	NPHP1	F658fs, F659fs, F714fs, F596fs, F715fs	Nephronophthisis	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000854284	2	110881425	2	110123848	854284	824678		NC_000002.12:110123847:AAAA:AAA
NC_000002.12:g.(?_110123791)_(110201494_?)del	NPHP1		Nephronophthisis	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000833368	2	110881368 - 110959071			833368	819032		
NM_001128178.3(NPHP1):c.555del (p.Lys185fs)	NPHP1	K185fs, K123fs	Nephronophthisis	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000638899	2	110926098	2	110168521	638899	628412		NC_000002.12:110168520:TTTTTTTT:TTTTTTT
NM_000272.4(NPHP1):c.1039C>T (p.Arg347Ter)	NPHP1	R347*, R228*, R346*, R291*	Nephronophthisis	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000579607	2	110919263	2	110161686	579607	558701	rs765263671	NC_000002.12:110161685:G:A
NM_001286044.1(ACADM):c.-29_-28GA[1]	ACADM		not provided	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000496786	1	76205735 - 76205736	1	75740050 - 75740051	496786	488211	rs1553123871	NC_000001.11:75740049:GAGA:GA
NM_000016.5(ACADM):c.287-1G>C	ACADM		not provided	Pathogenic(Last reviewed: Dec 3, 2014)	criteria provided, single submitter	VCV000197616	1	76199212	1	75733527	197616	194777	rs794727694	NC_000001.11:75733526:G:C
NM_000016.5(ACADM):c.216+2T>G	ACADM		not provided	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000092260	1	76198428	1	75732743	92260	98171	rs398123073	NC_000001.11:75732742:T:G
NM_000016.6(ACADM):c.216+2T>C	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000811864	1	76198428	1	75732743	811864	799225		NC_000001.11:75732742:T:C
NM_000016.5(ACADM):c.849+1G>A	ACADM		not provided	Pathogenic(Last reviewed: Feb 23, 2016)	criteria provided, single submitter	VCV000235753	1	76215245	1	75749560	235753	237433	rs878853106	NC_000001.11:75749559:G:A
NM_000016.6(ACADM):c.686del (p.Pro229fs)	ACADM	P233fs, P40fs, P193fs, P262fs, P229fs	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000862822	1	76211574	1	75745889	862822	824415		NC_000001.11:75745888:CCCC:CCC
NM_000016.6(ACADM):c.333_345del (p.Glu111fs)	ACADM	E75fs, E111fs, E115fs, E144fs	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000849706	1	76199257 - 76199269	1	75733572 - 75733584	849706	824406		NC_000001.11:75733571:GAATTGGCTTATGGA:GA
NM_000016.6(ACADM):c.973dup (p.Glu325fs)	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000834525	1	76226833 - 76226834	1	75761148 - 75761149	834525	824416		NC_000001.11:75761148:G:GG
NC_000001.11:g.(?_75724778)_(75750556_?)del	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000833092	1	76190463 - 76216241			833092	818996		
NC_000001.11:g.(?_75724778)_(75724827_?)del	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV000832116	1	76190463 - 76190512			832116	818995		
NC_000001.11:g.(?_75724778)_(75762773_?)del	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000831248	1	76190463 - 76228458			831248	818997		
NC_000001.11:g.(?_75724768)_(75724837_?)del	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000831210	1	76190453 - 76190522			831210	818993		
NC_000001.11:g.(?_75724768)_(75762783_?)del	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Jul 2, 2019)	criteria provided, single submitter	VCV000830699	1	76190453 - 76228468			830699	818994		
NM_000016.6(ACADM):c.201T>A (p.Tyr67Ter)	ACADM	Y31*, Y67*, Y71*	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000801498	1	76198411	1	75732726	801498	789996		NC_000001.11:75732725:T:A
NM_000016.5(ACADM):c.67C>T (p.Gln23Ter)	ACADM	Q27*, Q23*	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000665907	1	76194122	1	75728437	665907	628255		NC_000001.11:75728436:C:T
NM_001286044.1(ACADM):c.-100+1877TAT[2]	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Oct 20, 2018)	criteria provided, single submitter	VCV000650461	1	76200484 - 76200486	1	75734799 - 75734801	650461	628257		NC_000001.11:75734798:TATTATTATT:TATTATT
NM_001286044.1(ACADM):c.-221del	ACADM	F55fs, F19fs, F59fs	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, single submitter	VCV000576994	1	76198373	1	75732688	576994	558587	rs1319192670	NC_000001.11:75732687:TTT:TT
NM_001286042.1(ACADM):c.10+3600del	ACADM	S20fs, S16fs	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000528454	1	76194102	1	75728417	528454	516107	rs1325949559	NC_000001.11:75728416:C:
NM_001286044.1(ACADM):c.-100+1906del	ACADM	K106fs, K142fs, K175fs, K146fs	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000458787	1	76200510	1	75734825	458787	448357	rs886042087	NC_000001.11:75734824:AAAA:AAA
NM_000016.5(ACADM):c.1055A>G (p.Tyr352Cys)	ACADM	Y352C, Y163C, Y385C, Y316C, Y356C	not provided	Pathogenic(Last reviewed: Mar 28, 2017)	criteria provided, single submitter	VCV000438861	1	76226916	1	75761231	438861	432498	rs1227800781	NC_000001.11:75761230:A:G
NM_000016.5(ACADM):c.464T>C (p.Met155Thr)	ACADM	M155T, M159T, M188T, M119T	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	VCV000226106	1	76200552	1	75734867	226106	227878	rs875989876	NC_000001.11:75734866:T:C
NM_000016.5(ACADM):c.1012_1013insTAGAATGAGTTAC (p.Gln338delinsLeuGluTer)	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	VCV000226103	1	76226872 - 76226873	1	75761187 - 75761188	226103	227905	rs875989874	NC_000001.11:75761187:C:CTAGAATGAGTTAC
NM_000016.5(ACADM):c.469-1G>A	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	VCV000226091	1	76205664	1	75739979	226091	227882	rs875989869	NC_000001.11:75739978:G:A
NM_000016.5(ACADM):c.742A>G (p.Arg248Gly)	ACADM	R248G, R252G, R212G, R281G, R59G	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	VCV000226089	1	76215137	1	75749452	226089	227895	rs875989867	NC_000001.11:75749451:A:G
NM_000016.5(ACADM):c.1012C>T (p.Gln338Ter)	ACADM	Q338*, Q342*, Q149*, Q302*, Q371*	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	VCV000226087	1	76226873	1	75761188	226087	227904	rs796051896	NC_000001.11:75761187:C:T
NM_000016.5(ACADM):c.-6_6delinsACCCCGAAGG (p.Met1fs)	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	VCV000226085	1	76190467 - 76190478	1	75724782 - 75724793	226085	227856	rs875989865	NC_000001.11:75724781:GCCAACATGGCA:ACCCCGAAGG
NM_000016.5(ACADM):c.609A>C (p.Leu203Phe)	ACADM	L203F, L207F, L14F, L236F, L167F	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	VCV000226065	1	76211500	1	75745815	226065	227891	rs751829413	NC_000001.11:75745814:A:C
NM_000016.5(ACADM):c.985A>C (p.Lys329Gln)	ACADM	K329Q, K333Q, K140Q, K293Q, K362Q	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	VCV000226057	1	76226846	1	75761161	226057	227903	rs77931234	NC_000001.11:75761160:A:C
NM_000016.5(ACADM):c.842G>C (p.Arg281Thr)	ACADM	R256T, R281T, R285T, R92T, R245T, R314T	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000003596	1	76215237	1	75749552	3596	18635	rs121434282	NC_000001.11:75749551:G:C
NM_001286044.1(ACADM):c.-100+662_-100+667del	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: May 1, 1995)	no assertion criteria provided	VCV000003593	1	76199268 - 76199273	1	75733583 - 75733588	3593	18632	rs864621963	NC_000001.11:75733582:TGGATGT:T
NM_000016.5(ACADM):c.730T>C (p.Cys244Arg)	ACADM	C244R, C248R, C55R, C208R, C277R	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 1, 1991)	no assertion criteria provided	VCV000003590	1	76215125	1	75749440	3590	18629	rs121434276	NC_000001.11:75749439:T:C
NM_000016.5(ACADM):c.1124T>C (p.Ile375Thr)	ACADM	I375T, I379T, I186T, I339T, I408T	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 1, 1991)	no assertion criteria provided	VCV000003589	1	76226985	1	75761300	3589	18628	rs121434275	NC_000001.11:75761299:T:C
NM_000016.6(ACADM):c.608T>A (p.Leu203Ter)	ACADM	L203*, L14*, L207*, L236*, L167*	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000842222	1	76211499	1	75745814	842222	824413		NC_000001.11:75745813:T:A
NM_000016.5(ACADM):c.946-6T>G	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000558685	1	76226801	1	75761116	558685	541284	rs765793260	NC_000001.11:75761115:T:G
NM_000016.5(ACADM):c.1114dup (p.Ala372fs)	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: May 19, 2016)	criteria provided, single submitter	VCV000370160	1	76226974 - 76226975	1	75761289 - 75761290	370160	357145	rs1057516278	NC_000001.11:75761289:G:GG
NM_001286042.1(ACADM):c.10+3660_10+3666dup	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000226104	1	76194157 - 76194158	1	75728472 - 75728473	226104	227860	rs875989875	NC_000001.11:75728472:TTAGGATTTAG:TTAGGATTTAGGATTTAG
NM_000016.5(ACADM):c.817_829del (p.Ala273fs)	ACADM	A237fs, A273fs, A306fs, A277fs, A84fs	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, multiple submitters, no conflicts	VCV000226099	1	76215210 - 76215222	1	75749525 - 75749537	226099	227898	rs875989872	NC_000001.11:75749524:TTGCAATGGGAGCTT:TT
NM_000016.5(ACADM):c.926dup (p.Gly310fs)	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Feb 24, 2016)	criteria provided, multiple submitters, no conflicts	VCV000226077	1	76216209 - 76216210	1	75750524 - 75750525	226077	227901	rs875989864	NC_000001.11:75750524:TTT:TTTT
2q13 deletion (290 kb)	NPHP1		Nephronophthisis	Pathogenic(Last reviewed: Feb 10, 2016)	no assertion criteria provided	VCV000242361					242361	243912		
NM_000272.4(NPHP1):c.80T>A (p.Leu27Ter)	NPHP1	L27*	Nephronophthisis|Nephronophthisis 1	Pathogenic(Last reviewed: Feb 10, 2016)	no assertion criteria provided	VCV000003509	2	110959061	2	110201484	3509	18548	rs121907898	NC_000002.12:110201483:A:T
NM_153818.1(PEX10):c.600+1G>A	PEX10		not provided|Peroxisome biogenesis disorder, complementation group 7|Peroxisome biogenesis disorder 6A|Peroxisome biogenesis disorder 6B	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006770	1	2339890	1	2408451	6770	21809	rs267608183	NC_000001.11:2408450:C:T
NM_000016.6(ACADM):c.982A>G (p.Met328Val)	ACADM	M139V, M332V, M292V, M361V, M328V	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000859269	1	76226843	1	75761158	859269	824417		NC_000001.11:75761157:A:G
NM_000016.5(ACADM):c.217-1G>A	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000643196	1	76198537	1	75732852	643196	650775		NC_000001.11:75732851:G:A
NM_000016.5(ACADM):c.927del (p.Phe309fs)	ACADM	F309fs, F313fs, F342fs, F273fs, F120fs	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000593740	1	76216213	1	75750528	593740	584803	rs1557458562	NC_000001.11:75750527:C:
NM_000016.5(ACADM):c.1194+1G>A	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000555602	1	76227056	1	75761371	555602	541330	rs769331400	NC_000001.11:75761370:G:A
NM_000016.5(ACADM):c.989_1010del (p.Val330fs)	ACADM	V294fs, V334fs, V363fs, V141fs, V330fs	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000458791	1	76226850 - 76226871	1	75761165 - 75761186	458791	448232	rs1553127172	NC_000001.11:75761164:TTGAACTAGCTAGAATGAGTTA:
NM_000016.5(ACADM):c.1150G>T (p.Glu384Ter)	ACADM	E384*, E348*, E388*, E417*, E195*	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371122	1	76227011	1	75761326	371122	357146	rs748110745	NC_000001.11:75761325:G:T
NM_000016.5(ACADM):c.1189dup (p.Tyr397fs)	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000226109	1	76227049 - 76227050	1	75761364 - 75761365	226109	227911	rs875989877	NC_000001.11:75761364:T:TT
NM_000016.5(ACADM):c.1221_1222del (p.Arg408fs)	ACADM	R219fs, R441fs, R408fs, R412fs, R372fs	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000226069	1	76228402 - 76228403	1	75762717 - 75762718	226069	227912	rs875989860	NC_000001.11:75762716:AAA:A
NM_000016.5(ACADM):c.880_881AG[1] (p.Arg294fs)	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000203549	1	76216166 - 76216167	1	75750481 - 75750482	203549	199978	rs796051901	NC_000001.11:75750480:AGAG:AG
NM_001286044.1(ACADM):c.-100+1907del	ACADM	K143fs, K176fs, K107fs, K147fs	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Feb 20, 2015)	criteria provided, multiple submitters, no conflicts	VCV000203548	1	76200514	1	75734829	203548	199974	rs777998984	NC_000001.11:75734828:G:
NM_001286044.1(ACADM):c.-100+1928G>A	ACADM	M149I, M153I, M113I, M182I	not provided|Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Jun 13, 2014)	criteria provided, single submitter	VCV000003591	1	76200535	1	75734850	3591	18630	rs121434277	NC_000001.11:75734849:G:A
NM_006912.6(RIT1):c.246T>G (p.Phe82Leu)	RIT1	F82L, F99L, F46L	Noonan syndrome|Noonan syndrome 8|not provided	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000181522	1	155874285	1	155904494	181522	178911	rs730881014	NC_000001.11:155904493:A:C
NM_000272.4(NPHP1):c.1520+1del	NPHP1		Nephronophthisis 1|Nephronophthisis	Pathogenic(Last reviewed: Jun 5, 2017)	criteria provided, single submitter	VCV000462705	2	110904329	2	110146752	462705	448755	rs747861275	NC_000002.12:110146751:C:
NM_001079878.2(CNGA3):c.1587C>A (p.Phe529Leu)	CNGA3	F547L, F529L	Retinal dystrophy|Achromatopsia|not provided|Achromatopsia 2|Monochromacy	Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009478	2	99013274	2	98396811	9478	24517	rs104893617	NC_000002.12:98396810:C:A
NM_001615.4(ACTG2):c.533G>A (p.Arg178His)	ACTG2	R178H, R135H	Inborn genetic diseases|Visceral myopathy	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000132801	2	74140693	2	73913566	132801	136550	rs587777384	NC_000002.12:73913565:G:A
NM_001615.4(ACTG2):c.533G>T (p.Arg178Leu)	ACTG2	R178L, R135L	Inborn genetic diseases|Visceral myopathy	Pathogenic(Last reviewed: May 18, 2016)	criteria provided, single submitter	VCV000132798	2	74140693	2	73913566	132798	136547	rs587777384	NC_000002.12:73913565:G:T
NM_000016.6(ACADM):c.1085G>A (p.Gly362Glu)	ACADM	G326E, G366E, G395E, G173E, G362E	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000843524	1	76226946	1	75761261	843524	824418		NC_000001.11:75761260:G:A
NM_001127328.2(ACADM):c.806_815delinsTTTAA (p.Gly269_Ala272delinsValTer)	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000569821	1	76215189 - 76215198	1	75749504 - 75749513	569821	558591	rs1557457623	NC_000001.11:75749503:GTGACGGAGC:TTTAA
NM_000016.5(ACADM):c.1190A>C (p.Tyr397Ser)	ACADM	Y397S, Y208S, Y361S, Y401S, Y430S	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, single submitter	VCV000528453	1	76227051	1	75761366	528453	516071	rs1553127216	NC_000001.11:75761365:A:C
NM_001286044.1(ACADM):c.-100+674dup	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000422601	1	76199277 - 76199278	1	75733592 - 75733593	422601	405233	rs1553123071	NC_000001.11:75733592:GGGG:GGGGG
NM_000016.5(ACADM):c.599+2T>C	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000370479	1	76205797	1	75740112	370479	357138	rs148260275	NC_000001.11:75740111:T:C
NM_000016.5(ACADM):c.984del (p.Met328fs)	ACADM	M328fs, M332fs, M292fs, M139fs, M361fs	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000226096	1	76226845	1	75761160	226096	227902	rs747610156	NC_000001.11:75761159:G:
NM_000016.5(ACADM):c.881G>C (p.Arg294Thr)	ACADM	R294T, R298T, R105T, R258T, R327T	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000226075	1	76216167	1	75750482	226075	227899	rs779759347	NC_000001.11:75750481:G:C
NM_000016.5(ACADM):c.233T>C (p.Ile78Thr)	ACADM	I78T, I82T, I42T	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092261	1	76198554	1	75732869	92261	98172	rs398123074	NC_000001.11:75732868:T:C
NM_001367561.1(DOCK7):c.4237C>T (p.Arg1413Ter)	DOCK7	R1413*, R1382*	Epileptic encephalopathy, early infantile, 23	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000855852	1	62979160	1	62513489	855852	824304		NC_000001.11:62513488:G:A
NM_001367561.1(DOCK7):c.3976C>T (p.Arg1326Ter)	DOCK7	R1295*, R1326*	Epileptic encephalopathy, early infantile, 23	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000837527	1	62979530	1	62513859	837527	824306		NC_000001.11:62513858:G:A
NM_001367561.1(DOCK7):c.783del (p.Phe261fs)	DOCK7	F261fs	Epileptic encephalopathy, early infantile, 23	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000581758	1	63113397	1	62647726	581758	558018	rs1557855477	NC_000001.11:62647725:AAAA:AAA
NM_001271999.1(DOCK7):c.3937-686_4570del	DOCK7		Epileptic encephalopathy, early infantile, 23	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000580298	1	62971367 - 62980255	1	62505696 - 62514584	580298	558565		
NM_001367561.1(DOCK7):c.191_195delinsA (p.Leu64fs)	DOCK7		Epileptic encephalopathy, early infantile, 23	Pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, single submitter	VCV000567195	1	63119780 - 63119784	1	62654109 - 62654113	567195	557399	rs1557864817	NC_000001.11:62654108:AATGA:T
NM_001367561.1(DOCK7):c.4783del (p.Met1595fs)	DOCK7	M1564fs, M1586fs, M1595fs, M1555fs	Epileptic encephalopathy, early infantile, 23	Pathogenic(Last reviewed: Jun 30, 2018)	criteria provided, single submitter	VCV000475155	1	62962150	1	62496479	475155	448138	rs1553156203	NC_000001.11:62496478:TTTT:TTT
NM_001367561.1(DOCK7):c.6265G>T (p.Glu2089Ter)	DOCK7	E2078*, E2058*, E2047*, E2089*, E2049*, E2080*	Epileptic encephalopathy, early infantile, 23	Pathogenic(Last reviewed: Jun 5, 2014)	no assertion criteria provided	VCV000139539	1	62923324	1	62457653	139539	143183	rs587777485	NC_000001.11:62457652:C:A
NM_001367561.1(DOCK7):c.983C>G (p.Ser328Ter)	DOCK7	S328*	Epileptic encephalopathy, early infantile, 23	Pathogenic(Last reviewed: Jun 5, 2014)	no assertion criteria provided	VCV000139538	1	63100496	1	62634825	139538	143182	rs886037666	NC_000001.11:62634824:G:C
NM_001367561.1(DOCK7):c.3709C>T (p.Arg1237Ter)	DOCK7	R1237*, R1206*	Epileptic encephalopathy, early infantile, 23	Pathogenic(Last reviewed: Jun 5, 2014)	no assertion criteria provided	VCV000139537	1	62995020	1	62529349	139537	143181	rs587777484	NC_000001.11:62529348:G:A
NM_001367561.1(DOCK7):c.2510del (p.Asp837fs)	DOCK7	D837fs	Epileptic encephalopathy, early infantile, 23	Pathogenic(Last reviewed: Jun 5, 2014)	no assertion criteria provided	VCV000139536	1	63021582	1	62555911	139536	143180	rs886037665	NC_000001.11:62555910:T:
NM_002354.2(EPCAM):c.556-14A>G	EPCAM		Diarrhea 5, with tufting enteropathy, congenital|Hereditary nonpolyposis colorectal cancer type 8|Diarrhea 5, with tufting enteropathy, congenital|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000157603	2	47606078	2	47378939	157603	167463	rs376155665	NC_000002.12:47378938:A:G
NM_001367561.1(DOCK7):c.1285C>T (p.Arg429Ter)	DOCK7	R429*	Epileptic encephalopathy, early infantile, 23|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000376968	1	63091070	1	62625399	376968	363846	rs1057520100	NC_000001.11:62625398:G:A
NM_000016.5(ACADM):c.387+1G>A	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371544	1	76199314	1	75733629	371544	357134	rs1057516983	NC_000001.11:75733628:G:A
NM_000016.5(ACADM):c.322_325del (p.Ile108fs)	ACADM	I108fs, I141fs, I72fs, I112fs	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Apr 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000226102	1	76199245 - 76199248	1	75733560 - 75733563	226102	227871	rs875989873	NC_000001.11:75733559:TTAATTA:TTA
NM_000016.5(ACADM):c.1045C>T (p.Arg349Ter)	ACADM	R349*, R353*, R160*, R313*, R382*	not provided|Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jul 20, 2016)	criteria provided, multiple submitters, no conflicts	VCV000189016	1	76226906	1	75761221	189016	186634	rs148207467	NC_000001.11:75761220:C:T
NM_006922.4(SCN3A):c.2624T>C (p.Ile875Thr)	SCN3A	I875T, I826T	not provided|Early infantile epileptic encephalopathy 62|Developmental delay|Polymicrogyria	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000373960	2	165986748	2	165130238	373960	360822	rs1057518801	NC_000002.12:165130237:A:G
NM_022089.4(ATP13A2):c.3057del (p.Tyr1020fs)	ATP13A2	Y1020fs, Y976fs, Y1015fs	|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000465253	1	17313567	1	16987072	465253	447466	rs765632065	NC_000001.11:16987071:G:
NM_003001.3(SDHC):c.17_18dup (p.Arg7Ter)	SDHC		not provided	Pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000546054	1	161284211 - 161284212	1	161314421 - 161314422	546054	536222	rs1553260596	NC_000001.11:161314421:TG:TGTG
NM_003001.5(SDHC):c.250_253del (p.Phe85fs)	SDHC	F32fs, F51fs, F85fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000821378	1	161326474 - 161326477	1	161356684 - 161356687	821378	806465		NC_000001.11:161356683:TCTTT:T
NM_003001.5(SDHC):c.233dup (p.Leu78fs)	SDHC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000821121	1	161310434 - 161310435	1	161340644 - 161340645	821121	806463		NC_000001.11:161340644:TTT:TTTT
NM_001035511.2(SDHC):c.242-5518_242-5503del	SDHC	Y126fs, Y92fs, Y73fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	VCV000480810	1	161326598 - 161326613	1	161356808 - 161356823	480810	472312	rs1553265817	NC_000001.11:161356807:ATGTATCATACCTGGAATG:ATG
NM_001035511.2(SDHC):c.242-5518dup	SDHC		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 9, 2015)	criteria provided, single submitter	VCV000229958	1	161326600 - 161326601	1	161356810 - 161356811	229958	232170	rs876658301	NC_000001.11:161356810:T:TT
NM_003001.3(SDHC):c.6del (p.Ala3fs)	SDHC	A3fs	Carney triad|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 8, 2013)	criteria provided, single submitter	VCV000189840	1	161284201	1	161314411	189840	187697	rs786205146	NC_000001.11:161314410:T:
NC_000002.11:g.(?_110881368)_(110962545_?)del	NPHP1		Nephronophthisis	Pathogenic(Last reviewed: Dec 28, 2019)	criteria provided, single submitter	VCV000583935	2	110881368 - 110962545	2	110123791 - 110204968	583935	558068		
NC_000002.11:g.(?_110920625)_(110962545_?)del	NPHP1		Nephronophthisis	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000583618	2	110920625 - 110962545	2	110163048 - 110204968	583618	557469		
NC_000002.11:g.(?_110881348)_(110962565_?)del	NPHP1		Nephronophthisis	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000462702			2	110123771 - 110204988	462702	448470		
NM_003001.3(SDHC):c.407_*1del (p.Met136_Ter170delinsXaa)	SDHC		Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic	no assertion criteria provided	VCV000438443	1	161332119 - 161332223	1	161362329 - 161362433	438443	432023	rs1553266474	
NM_003001.3(SDHC):c.387G>A (p.Trp129Ter)	SDHC	W129*, W95*, W76*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428935	1	161326612	1	161356822	428935	420735	rs981049067	NC_000001.11:161356821:G:A
NM_013339.4(ALG6):c.998C>T (p.Ala333Val)	ALG6	A333V	Congenital disorder of glycosylation type 1C	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005497	1	63885051	1	63419380	5497	20536	rs121908443	NC_000001.11:63419379:C:T
NM_000016.5(ACADM):c.843A>T (p.Arg281Ser)	ACADM	R281S, R314S, R245S, R92S, R285S	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000550313	1	76215238	1	75749553	550313	541324	rs780504551	NC_000001.11:75749552:A:T
NM_000016.5(ACADM):c.1189T>A (p.Tyr397Asn)	ACADM	Y397N, Y401N, Y361N, Y430N, Y208N	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000226095	1	76227050	1	75761365	226095	227910	rs759158371	NC_000001.11:75761364:T:A
NM_000228.3(LAMB3):c.31dup (p.Leu11fs)	LAMB3		not provided|Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633285	1	209823460 - 209823461	1	209650115 - 209650116	633285	621067	rs777672897	NC_000001.11:209650115:GGG:GGGG
NM_000228.3(LAMB3):c.565-2A>G	LAMB3		not provided|Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188846	1	209806480	1	209633135	188846	186612	rs370148688	NC_000001.11:209633134:T:C
NM_000310.3(PPT1):c.353G>A (p.Gly118Asp)	PPT1	G118D	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 7, 2015)	criteria provided, single submitter	VCV000520610	1	40557726	1	40092054	520610	511272	rs143657539	NC_000001.11:40092053:C:T
NM_000310.3(PPT1):c.550G>A (p.Glu184Lys)	PPT1	E184K, E81K	|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056204	1	40546146	1	40080474	56204	70843	rs386833655	NC_000001.11:40080473:C:T
NM_000310.3(PPT1):c.169dup (p.Met57fs)	PPT1		|Neuronal ceroid lipofuscinosis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056182	1	40558134 - 40558135	1	40092462 - 40092463	56182	70821	rs386833634	NC_000001.11:40092462:TTTTTTT:TTTTTTTT
NM_001918.4(DBT):c.827T>G (p.Phe276Cys)	DBT	F215C, F276C	Maple syrup urine disease|Maple syrup urine disease, thiamine-responsive, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011943	1	100680485	1	100214929	11943	26982	rs121964999	NC_000001.11:100214928:A:C
NM_001330311.2(DVL1):c.1579del (p.His527fs)	DVL1	H527fs, H502fs	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 6, 2016)	criteria provided, single submitter	VCV000520999	1	1273492	1	1338112	520999	511161	rs1553173425	NC_000001.11:1338111:GGGG:GGG
NM_005378.6(MYCN):c.442del (p.Gln148fs)	MYCN	Q148fs	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, multiple submitters, no conflicts	VCV000280632	2	16082626	2	15942504	280632	264040	rs886041801	NC_000002.12:15942503:CCC:CC
NM_024408.4(NOTCH2):c.4005+1G>A	NOTCH2		not provided	Pathogenic(Last reviewed: Jan 9, 2018)	criteria provided, single submitter	VCV000595673	1	120469121	1	119926498	595673	586735	rs1557807153	NC_000001.11:119926497:C:T
NM_024408.4(NOTCH2):c.3415dup (p.Leu1139fs)	NOTCH2		not provided	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000595217	1	120480011 - 120480012	1	119937388 - 119937389	595217	586279	rs1557812162	NC_000001.11:119937388:GGGGG:GGGGGG
NM_024408.4(NOTCH2):c.5843del (p.Leu1948fs)	NOTCH2	L1948fs	not provided	Pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000593902	1	120461115	1	119918492	593902	584965	rs1557803353	NC_000001.11:119918491:A:
NM_024408.4(NOTCH2):c.5664dup (p.Arg1889fs)	NOTCH2		not provided	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000593268	1	120462051 - 120462052	1	119919428 - 119919429	593268	584332	rs927740391	NC_000001.11:119919428:T:TT
NM_024408.4(NOTCH2):c.7198C>T (p.Arg2400Ter)	NOTCH2	R2400*	Hajdu-Cheney syndrome	Pathogenic(Last reviewed: Oct 1, 2017)	no assertion criteria provided	VCV000518450	1	120458147	1	119915524	518450	509040	rs1325403451	NC_000001.11:119915523:G:A
NM_024408.4(NOTCH2):c.7078C>T (p.Gln2360Ter)	NOTCH2	Q2360*	Hajdu-Cheney syndrome	Pathogenic(Last reviewed: Oct 1, 2017)	no assertion criteria provided	VCV000518449	1	120458267	1	119915644	518449	509039	rs1553193485	NC_000001.11:119915643:G:A
NM_024408.4(NOTCH2):c.1835dup (p.Tyr612Ter)	NOTCH2		not provided	Pathogenic(Last reviewed: Apr 10, 2017)	criteria provided, single submitter	VCV000501351	1	120506276 - 120506277	1	119963653 - 119963654	501351	492775	rs1553199298	NC_000001.11:119963653:T:TT
NM_024408.4(NOTCH2):c.5274G>A (p.Trp1758Ter)	NOTCH2	W1758*	not provided	Pathogenic(Last reviewed: Mar 8, 2017)	criteria provided, single submitter	VCV000500759	1	120464372	1	119921749	500759	492183	rs1553194093	NC_000001.11:119921748:C:T
NM_024408.4(NOTCH2):c.1021dup (p.Asp341fs)	NOTCH2		not provided	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000498834	1	120512220 - 120512221	1	119969597 - 119969598	498834	490258	rs1553200134	NC_000001.11:119969597:C:CC
NM_024408.4(NOTCH2):c.3246dup (p.Ala1083fs)	NOTCH2		not provided	Pathogenic(Last reviewed: Nov 18, 2016)	criteria provided, single submitter	VCV000498741	1	120480570 - 120480571	1	119937947 - 119937948	498741	490165	rs1553195973	NC_000001.11:119937947:TTTTTT:TTTTTTT
NM_024408.4(NOTCH2):c.6758G>A (p.Trp2253Ter)	NOTCH2	W2253*	not provided	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	VCV000451587	1	120458587	1	119915964	451587	442605	rs1553193524	NC_000001.11:119915963:C:T
NM_024408.4(NOTCH2):c.4457del (p.Thr1486fs)	NOTCH2	T1486fs	not provided	Pathogenic(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	VCV000419122	1	120467982	1	119925359	419122	404893	rs1064793660	NC_000001.11:119925358:G:
NM_024408.4(NOTCH2):c.6424_6427del (p.Ser2142fs)	NOTCH2	S2142fs	not provided	Pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	VCV000418907	1	120458918 - 120458921	1	119916295 - 119916298	418907	404891	rs1064793515	NC_000001.11:119916294:CAGACAG:CAG
NM_024408.4(NOTCH2):c.6659C>G (p.Ser2220Ter)	NOTCH2	S2220*	not provided	Pathogenic(Last reviewed: Sep 14, 2016)	criteria provided, single submitter	VCV000280845	1	120458686	1	119916063	280845	263936	rs886041979	NC_000001.11:119916062:G:C
NM_024408.4(NOTCH2):c.6787C>T (p.Gln2263Ter)	NOTCH2	Q2263*	not provided	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000280705	1	120458558	1	119915935	280705	263945	rs886041862	NC_000001.11:119915934:G:A
NM_024408.4(NOTCH2):c.6007C>T (p.Arg2003Ter)	NOTCH2	R2003*	not provided	Pathogenic(Last reviewed: Mar 23, 2017)	criteria provided, single submitter	VCV000041266	1	120460308	1	119917685	41266	49690	rs312262801	NC_000001.11:119917684:G:A
NM_024408.4(NOTCH2):c.4174C>T (p.Gln1392Ter)	NOTCH2	Q1392*	Hajdu-Cheney syndrome	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000845754	1	120468265	1	119925642	845754	822625		NC_000001.11:119925641:G:A
NM_024408.4(NOTCH2):c.6909del (p.Ile2304fs)	NOTCH2	I2304fs	Hajdu-Cheney syndrome	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000623649	1	120458436	1	119915813	623649	612470	rs771237928	NC_000001.11:119915812:GGGGGG:GGGGG
NM_024408.4(NOTCH2):c.6449_6450del (p.Pro2150fs)	NOTCH2	P2150fs	Hajdu-Cheney syndrome	Pathogenic(Last reviewed: May 29, 2017)	criteria provided, single submitter	VCV000463176	1	120458895 - 120458896	1	119916272 - 119916273	463176	447244	rs1553193574	NC_000001.11:119916271:AG:
NM_024408.4(NOTCH2):c.5345del (p.Asp1782fs)	NOTCH2	D1782fs	Hajdu-Cheney syndrome	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000463175	1	120462986	1	119920363	463175	447170	rs1553193977	NC_000001.11:119920362:T:
NM_024408.4(NOTCH2):c.6949C>T (p.Gln2317Ter)	NOTCH2	Q2317*	Hajdu-Cheney syndrome	Pathogenic(Last reviewed: Mar 6, 2011)	no assertion criteria provided	VCV000030059	1	120458396	1	119915773	30059	39014	rs387906747	NC_000001.11:119915772:G:A
NM_024408.4(NOTCH2):c.7119T>G (p.Tyr2373Ter)	NOTCH2	Y2373*	Hajdu-Cheney syndrome	Pathogenic(Last reviewed: Mar 6, 2011)	no assertion criteria provided	VCV000030058	1	120458226	1	119915603	30058	39013	rs1557801639	NC_000001.11:119915602:A:C
NM_024408.4(NOTCH2):c.6622C>T (p.Gln2208Ter)	NOTCH2	Q2208*	Hajdu-Cheney syndrome	Pathogenic(Last reviewed: Mar 6, 2011)	no assertion criteria provided	VCV000030057	1	120458723	1	119916100	30057	39012	rs387906746	NC_000001.11:119916099:G:A
NOTCH2, 1-BP DEL, 6460T	NOTCH2		Hajdu-Cheney syndrome	Pathogenic(Last reviewed: Mar 6, 2011)	no assertion criteria provided	VCV000030056					30056	39011		
NM_024408.4(NOTCH2):c.6272del (p.Phe2091fs)	NOTCH2	F2091fs	Hajdu-Cheney syndrome	Pathogenic(Last reviewed: Mar 6, 2011)	no assertion criteria provided	VCV000030055	1	120459073	1	119916450	30055	39010	rs1557802353	NC_000001.11:119916449:AAA:AA
NM_024408.4(NOTCH2):c.5644C>T (p.His1882Tyr)	NOTCH2	H1882Y	Alagille syndrome 2	Pathogenic(Last reviewed: Jul 10, 2014)	no assertion criteria provided	VCV000684619	1	120462072	1	119919449	684619	672207		NC_000001.11:119919448:G:A
NM_024408.4(NOTCH2):c.5222C>T (p.Ser1741Leu)	NOTCH2	S1741L	Alagille syndrome 2	Pathogenic(Last reviewed: Jul 10, 2014)	no assertion criteria provided	VCV000684618	1	120464424	1	119921801	684618	672208		NC_000001.11:119921800:G:A
NM_024408.4(NOTCH2):c.6503del (p.Pro2168fs)	NOTCH2	P2168fs	Hajdu-Cheney syndrome	Pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, single submitter	VCV000571329	1	120458842	1	119916219	571329	556572	rs1557802165	NC_000001.11:119916218:GG:G
NM_024408.4(NOTCH2):c.7165C>T (p.Gln2389Ter)	NOTCH2	Q2389*	Hajdu-Cheney syndrome	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000030061	1	120458180	1	119915557	30061	39016	rs387906749	NC_000001.11:119915556:G:A
NM_024408.4(NOTCH2):c.6895G>T (p.Glu2299Ter)	NOTCH2	E2299*	Hajdu-Cheney syndrome	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000030060	1	120458450	1	119915827	30060	39015	rs387906748	NC_000001.11:119915826:C:A
NM_024408.4(NOTCH2):c.1331G>A (p.Cys444Tyr)	NOTCH2	C444Y	Alagille syndrome 2	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000009230	1	120510178	1	119967555	9230	24269	rs111033632	NC_000001.11:119967554:C:T
NM_024408.4(NOTCH2):c.5930-1G>A	NOTCH2		Alagille syndrome 2	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000009229	1	120460386	1	119917763	9229	24268		NC_000001.11:119917762:C:T
NM_000478.6(ALPL):c.668G>A (p.Arg223Gln)	ALPL	R223Q, R168Q, R146Q	Infantile hypophosphatasia|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000381586	1	21894616	1	21568123	381586	364747	rs199665722	NC_000001.11:21568122:G:A
NM_000784.4(CYP27A1):c.380G>A (p.Arg127Gln)	CYP27A1	R127Q	Cholestanol storage disease	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000065866	2	219674424	2	218809701	65866	76774	rs376230356	NC_000002.12:218809700:G:A
NM_000784.4(CYP27A1):c.379C>T (p.Arg127Trp)	CYP27A1	R127W	Cholestanol storage disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000065865	2	219674423	2	218809700	65865	76773	rs201114717	NC_000002.12:218809699:C:T
NM_000784.4(CYP27A1):c.844+1G>A	CYP27A1		Cholestanol storage disease	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004257	2	219677473	2	218812750	4257	19296	rs397515354	NC_000002.12:218812749:G:A
NM_024408.4(NOTCH2):c.6853C>T (p.Gln2285Ter)	NOTCH2	Q2285*	Hajdu-Cheney syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000545566	1	120458492	1	119915869	545566	536068	rs1553193507	NC_000001.11:119915868:G:A
NM_000016.5(ACADM):c.946-2A>C	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265452	1	76226805	1	75761120	265452	259676	rs758753966	NC_000001.11:75761119:A:C
NM_153818.1(PEX10):c.836+1G>C	PEX10		Inborn genetic diseases	Pathogenic(Last reviewed: Aug 30, 2012)	criteria provided, single submitter	VCV000225040	1	2338158	1	2406719	225040	226879	rs869312935	NC_000001.11:2406718:C:G
NM_000228.3(LAMB3):c.1978C>T (p.Arg660Ter)	LAMB3	R660*	Junctional epidermolysis bullosa gravis of Herlitz|not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189034	1	209797344	1	209623999	189034	186609	rs146794392	NC_000001.11:209623998:G:A
NM_000016.5(ACADM):c.347G>A (p.Cys116Tyr)	ACADM	C116Y, C120Y, C80Y, C149Y	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000226068	1	76199273	1	75733588	226068	227873	rs875989859	NC_000001.11:75733587:G:A
NM_000182.5(HADHA):c.274_278del (p.Ser92fs)	HADHA	S92fs	Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency|HADHA-Related Disorders|Mitochondrial trifunctional protein deficiency|Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189105	2	26459759 - 26459763	2	26236891 - 26236895	189105	186668	rs781205883	NC_000002.12:26236890:GATGAGAT:GAT
NM_000182.5(HADHA):c.180+3A>G	HADHA		Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency|Mitochondrial trifunctional protein deficiency|Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008731	2	26461799	2	26238931	8731	23770	rs781222705	NC_000002.12:26238930:T:C
NM_000530.8(MPZ):c.558del (p.Arg186fs)	MPZ	R186fs	Dejerine-Sottas disease	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000488548	1	161276145	1	161306355	488548	481416	rs1553259568	NC_000001.11:161306354:CC:C
NM_000530.8(MPZ):c.585-2A>T	MPZ		not provided	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000432541	1	161275960	1	161306170	432541	425319	rs1553259536	NC_000001.11:161306169:T:A
NM_000530.8(MPZ):c.-23_8dup (p.Ala5fs)	MPZ		not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000426657	1	161279687 - 161279688	1	161309897 - 161309898	426657	414742	rs1553260017	NC_000001.11:161309897:GGAGCCATAGCTGGGGCAGGGGCAGGGGCCCGGAGC:GGAGCCATAGCTGGGGCAGGGGCAGGGGCCCGGAGCCATAGCTGGGGCAGGGGCAGGGGCCCGGAGC
NM_000530.8(MPZ):c.68-1G>C	MPZ		not provided	Pathogenic(Last reviewed: Dec 30, 2015)	criteria provided, single submitter	VCV000372846	1	161277215	1	161307425	372846	359240	rs1057518021	NC_000001.11:161307424:C:G
NM_000530.8(MPZ):c.149G>T (p.Cys50Phe)	MPZ	C50F	not provided	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000234908	1	161277133	1	161307343	234908	231446	rs876661287	NC_000001.11:161307342:C:A
NM_000530.8(MPZ):c.67+1G>A	MPZ		not provided	Pathogenic(Last reviewed: Dec 28, 2016)	criteria provided, single submitter	VCV000447733	1	161279628	1	161309838	447733	440410	rs1553260014	NC_000001.11:161309837:C:T
GRCh37/hg19 1q23.3(chr1:161255241-161276497)	MPZ		Congenital hypomyelinating neuropathy 1, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000374304	1	161255241 - 161276497			374304	361263		
NM_000530.8(MPZ):c.371C>A (p.Thr124Lys)	MPZ	T124K	Congenital hypomyelinating neuropathy 2	Pathogenic(Last reviewed: Jun 8, 2004)	no assertion criteria provided	VCV000014196	1	161276575	1	161306785	14196	29235	rs121913595	NC_000001.11:161306784:G:T
MPZ, 3-BP DEL/1-BP INS, NT550	MPZ		Congenital hypomyelinating neuropathy 2	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000014192					14192	29231		
NM_000530.8(MPZ):c.560del (p.Gln187fs)	MPZ	Q187fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637770	1	161276143	1	161306353	637770	625009		NC_000001.11:161306352:T:
NM_000530.8(MPZ):c.68-5_71del	MPZ		Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637769	1	161277211 - 161277219	1	161307421 - 161307429	637769	625738		NC_000001.11:161307420:AGCACTGCAAGCAC:AGCAC
NM_000530.8(MPZ):c.204C>A (p.Tyr68Ter)	MPZ	Y68*	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637508	1	161277078	1	161307288	637508	625066		NC_000001.11:161307287:G:T
NM_000530.8(MPZ):c.197G>A (p.Trp66Ter)	MPZ	W66*	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637507	1	161277085	1	161307295	637507	625070		NC_000001.11:161307294:C:T
NM_000530.8(MPZ):c.1A>G (p.Met1Val)	MPZ	M1V	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637506	1	161279695	1	161309905	637506	625095		NC_000001.11:161309904:T:C
NM_000530.8(MPZ):c.572_573AG[1] (p.Arg192fs)	MPZ		Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637320	1	161276128 - 161276129	1	161306338 - 161306339	637320	625006		NC_000001.11:161306337:CTCT:CT
NP_000521.1(MPZ):p.Asn116Ser	MPZ		Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Dec 18, 2014)	no assertion criteria provided	VCV000208244					208244	204479		
NM_000530.8(MPZ):c.588dup (p.Met197fs)	MPZ		Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Mar 26, 2015)	no assertion criteria provided	VCV000041023	1	161275954 - 161275955	1	161306164 - 161306165	41023	49445	rs281865129	NC_000001.11:161306164:A:AA
NM_000530.8(MPZ):c.266T>C (p.Ile89Thr)	MPZ	I89T	Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Oct 18, 2012)	no assertion criteria provided	VCV000041018	1	161276680	1	161306890	41018	49440	rs267607244	NC_000001.11:161306889:A:G
NM_000530.8(MPZ):c.175T>A (p.Ser59Thr)	MPZ	S59T	Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Mar 26, 2015)	no assertion criteria provided	VCV000041015	1	161277107	1	161307317	41015	49437	rs281865122	NC_000001.11:161307316:A:T
NM_000530.8(MPZ):c.290A>T (p.Glu97Val)	MPZ	E97V	Charcot-Marie-Tooth disease type 2J	Pathogenic(Last reviewed: Aug 24, 2004)	no assertion criteria provided	VCV000014195	1	161276656	1	161306866	14195	29234	rs121913606	NC_000001.11:161306865:T:A
MPZ, 1-BP DEL	MPZ		Autosomal recessive Dejerine-Sottas syndrome	Pathogenic(Last reviewed: Sep 1, 1996)	no assertion criteria provided	VCV000014190					14190	29229		
NM_000530.8(MPZ):c.184A>T (p.Ile62Phe)	MPZ	I62F	Charcot-Marie-Tooth disease, type 1b, with focally folded myelin sheaths	Pathogenic(Last reviewed: Apr 12, 1999)	no assertion criteria provided	VCV000014189	1	161277098	1	161307308	14189	29228	rs121913602	NC_000001.11:161307307:T:A
NM_000530.8(MPZ):c.643C>T (p.Gln215Ter)	MPZ	Q186*, Q215*	Neuropathy, congenital hypomyelinating, autosomal dominant	Pathogenic(Last reviewed: Sep 1, 1996)	no assertion criteria provided	VCV000014178	1	161275900	1	161306110	14178	29217	rs121913593	NC_000001.11:161306109:G:A
NM_000530.8(MPZ):c.333_336del (p.Ile112fs)	MPZ	I112fs	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000835791	1	161276610 - 161276613	1	161306820 - 161306823	835791	822937		NC_000001.11:161306819:AATG:
NM_000530.8(MPZ):c.159G>A (p.Trp53Ter)	MPZ	W53*	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000640717	1	161277123	1	161307333	640717	627028		NC_000001.11:161307332:C:T
NM_000530.8(MPZ):c.380_383dup (p.Asp128delinsGluTer)	MPZ		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Nov 6, 2016)	criteria provided, single submitter	VCV000411659	1	161276562 - 161276563	1	161306772 - 161306773	411659	390859	rs1553259651	NC_000001.11:161306772:TCAC:TCACTCAC
MPZ, ASP195TYR	MPZ	D195Y	Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000014201					14201	29240		
NM_000530.8(MPZ):c.178G>C (p.Asp60His)	MPZ	D60H	Charcot-Marie-Tooth disease type 2I	Pathogenic(Last reviewed: Jul 13, 2004)	no assertion criteria provided	VCV000014193	1	161277104	1	161307314	14193	29232	rs121913604	NC_000001.11:161307313:C:G
NM_000530.8(MPZ):c.188C>T (p.Ser63Phe)	MPZ	S63F	Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Dec 1, 1995)	no assertion criteria provided	VCV000014177	1	161277094	1	161307304	14177	29216	rs121913585	NC_000001.11:161307303:G:A
MPZ, THR216GLU-ARG	MPZ	T216E	Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Nov 15, 1993)	no assertion criteria provided	VCV000014171					14171	29210		
NM_001134673.4(NFIA):c.1145_1148del (p.Tyr382fs)	NFIA	Y382fs, Y427fs, Y374fs	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 26, 2016)	criteria provided, single submitter	VCV000521252	1	61869842 - 61869845	1	61404170 - 61404173	521252	511290	rs1553182964	NC_000001.11:61404169:CTTACTT:CTT
NM_001134673.4(NFIA):c.307dup (p.Cys103fs)	NFIA		Inborn genetic diseases	Pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, single submitter	VCV000520892	1	61554098 - 61554099	1	61088426 - 61088427	520892	511288	rs1553149206	NC_000001.11:61088426:TT:TTT
NM_001134673.4(NFIA):c.1076-1G>A	NFIA		Inborn genetic diseases	Pathogenic(Last reviewed: Nov 25, 2014)	criteria provided, single submitter	VCV000520601	1	61869775	1	61404103	520601	511289	rs1553182933	NC_000001.11:61404102:G:A
NM_000530.8(MPZ):c.129_136del (p.Ser44fs)	MPZ	S44fs	Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Jan 9, 2017)	criteria provided, single submitter	VCV000246122	1	161277146 - 161277153	1	161307356 - 161307363	246122	244256	rs760730366	NC_000001.11:161307355:CCCGGGAGCCC:CCC
NM_000530.8(MPZ):c.314C>T (p.Pro105Leu)	MPZ	P105L	Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000188325	1	161276632	1	161306842	188325	185951	rs786204215	NC_000001.11:161306841:G:A
NC_000001.11:g.(?_161305674)_(161309915_?)dup	MPZ		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, single submitter	VCV000830394	1	161275464 - 161279705			830394	818850		
NM_000530.8(MPZ):c.556_559AGGC[3] (p.Ala189fs)	MPZ		Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000531694	1	161276139 - 161276140	1	161306349 - 161306350	531694	515225	rs1553259566	NC_000001.11:161306349:GCCTGCCTGC:GCCTGCCTGCCTGC
NM_000530.8(MPZ):c.266_270dup (p.Glu91fs)	MPZ		not provided|Charcot-Marie-Tooth disease, type I	Pathogenic/Likely pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000444185	1	161276675 - 161276676	1	161306885 - 161306886	444185	437825	rs1553259697	NC_000001.11:161306885:GTCAA:GTCAAGTCAA
NM_000530.8(MPZ):c.410G>A (p.Gly137Asp)	MPZ	G137D	Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Sep 3, 2015)	criteria provided, single submitter	VCV000217233	1	161276536	1	161306746	217233	213793	rs863225025	NC_000001.11:161306745:C:T
NM_000530.8(MPZ):c.404T>C (p.Ile135Thr)	MPZ	I135T	Charcot-Marie-Tooth disease, demyelinating, type 1b|not provided	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000014172	1	161276542	1	161306752	14172	29211	rs121913587	NC_000001.11:161306751:A:G
NM_001079878.2(CNGA3):c.794G>A (p.Arg265Gln)	CNGA3	R283Q, R265Q	Retinal dystrophy|not provided|Achromatopsia|Achromatopsia 2	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009475	2	99012481	2	98396018	9475	24514	rs104893614	NC_000002.12:98396017:G:A
NM_000302.4(PLOD1):c.916_928dup (p.Arg310fs)	PLOD1		not provided	Pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, single submitter	VCV000817784	1	12018643 - 12018644	1	11958586 - 11958587	817784	805149		NC_000001.11:11958586:CCAGCGGCTCCTGC:CCAGCGGCTCCTGCCAGCGGCTCCTGC
NM_000302.4(PLOD1):c.166C>T (p.Gln56Ter)	PLOD1	Q56*, Q103*	Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 5, 2016)	criteria provided, single submitter	VCV000520105	1	12008122	1	11948065	520105	509080	rs1433428588	NC_000001.11:11948064:C:T
NM_000302.4(PLOD1):c.1097+1G>A	PLOD1		not provided	Pathogenic(Last reviewed: Jul 6, 2017)	criteria provided, single submitter	VCV000450404	1	12020825	1	11960768	450404	442594	rs1389548210	NC_000001.11:11960767:G:A
NM_000302.4(PLOD1):c.583C>T (p.Gln195Ter)	PLOD1	Q195*, Q242*	not provided	Pathogenic(Last reviewed: Jul 6, 2017)	criteria provided, single submitter	VCV000450403	1	12014890	1	11954833	450403	442593	rs1553134578	NC_000001.11:11954832:C:T
NM_000302.4(PLOD1):c.402del (p.Asp135fs)	PLOD1	D135fs, D182fs	not provided	Pathogenic(Last reviewed: Jun 7, 2016)	criteria provided, single submitter	VCV000288527	1	12010513	1	11950456	288527	272764	rs886043926	NC_000001.11:11950455:A:
NM_000302.4(PLOD1):c.1479dup (p.Met494fs)	PLOD1		Ehlers-Danlos syndrome, hydroxylysine-deficient	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801439	1	12025544 - 12025545	1	11965487 - 11965488	801439	789827		NC_000001.11:11965487:C:CC
GRCh37/hg19 1p36.22(chr1:12019879-12028775)	PLOD1		Bilateral cryptorchidism|Thromboembolism|High palate|Mitral valve prolapse|Dilatation|Tall stature|Deep venous thrombosis|Kyphoscoliosis|Joint hypermobility	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523241	1	12019879 - 12028775			523241	514157		
GRCh37/hg19 1p36.22(chr1:12019879-12028775)	PLOD1		Bilateral cryptorchidism|Feeding difficulties|Generalized neonatal hypotonia|Short chin|Scrotal hypoplasia|Joint hypermobility	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523240	1	12019879 - 12028775			523240	514156		
GRCh37/hg19 1p36.22(chr1:12019879-12028775)	PLOD1		Neonatal hypotonia|Macrocephaly at birth|Dolichocephaly|Hydrocephalus|Severe global developmental delay|Narrow chest|Umbilical hernia|Acquired porencephaly	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523237	1	12019879 - 12028775			523237	514153		
NM_000302.4(PLOD1):c.2008C>T (p.Arg670Ter)	PLOD1	R670*, R717*	Ehlers-Danlos syndrome, hydroxylysine-deficient	Pathogenic(Last reviewed: Dec 21, 2017)	no assertion criteria provided	VCV000014373	1	12033034	1	11972977	14373	29412	rs121913554	NC_000001.11:11972976:C:T
NM_000272.4(NPHP1):c.555dup (p.Pro186fs)	NPHP1		not provided|Nephronophthisis|Nephronophthisis 1	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000283524	2	110926097 - 110926098	2	110168520 - 110168521	283524	267761	rs766524637	NC_000002.12:110168520:TTTTTTTT:TTTTTTTTT
NM_000302.4(PLOD1):c.1772del (p.Gly591fs)	PLOD1	G638fs, G591fs	Ehlers-Danlos syndrome, hydroxylysine-deficient	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000843360	1	12030741	1	11970684	843360	822610		NC_000001.11:11970683:GGG:GG
NM_000302.4(PLOD1):c.1906C>T (p.Gln636Ter)	PLOD1	Q636*, Q683*	Ehlers-Danlos syndrome, hydroxylysine-deficient	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000659390	1	12032932	1	11972875	659390	626717		NC_000001.11:11972874:C:T
NM_000302.4(PLOD1):c.1015C>T (p.Gln339Ter)	PLOD1	Q386*, Q339*	Ehlers-Danlos syndrome, hydroxylysine-deficient	Pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000648887	1	12020742	1	11960685	648887	626706		NC_000001.11:11960684:C:T
NC_000001.10:g.(?_12009820)_(12012802_?)del	PLOD1		Ehlers-Danlos syndrome, hydroxylysine-deficient	Pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000645355	1	12009820 - 12012802	1	11949763 - 11952745	645355	650524		
NC_000001.10:g.(?_12020703)_(12020824_?)del	PLOD1		Ehlers-Danlos syndrome, hydroxylysine-deficient	Pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, single submitter	VCV000584255	1	12020703 - 12020824	1	11960646 - 11960767	584255	556514		
NM_000302.4(PLOD1):c.1651-2A>C	PLOD1		Ehlers-Danlos syndrome, hydroxylysine-deficient	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000548602	1	12027042	1	11966985	548602	538941	rs565513365	NC_000001.11:11966984:A:C
NM_000302.4(PLOD1):c.404_423del (p.Asp135fs)	PLOD1	D135fs, D182fs	not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000264119	1	12010513 - 12010532	1	11950456 - 11950475	264119	257918	rs745409628	NC_000001.11:11950455:AGACCGCAGGCTGGAGACCAAG:AG
NM_000302.4(PLOD1):c.1836G>C (p.Trp612Cys)	PLOD1	W612C, W659C	Ehlers-Danlos syndrome, hydroxylysine-deficient	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000014372	1	12030807	1	11970750	14372	29411	rs121913553	NC_000001.11:11970749:G:C
NM_000302.4(PLOD1):c.579+1G>A	PLOD1		Ehlers-Danlos syndrome, hydroxylysine-deficient	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000014371	1	12012793	1	11952736	14371	29410	rs797044448	NC_000001.11:11952735:G:A
NM_000302.4(PLOD1):c.1651-2del	PLOD1		Ehlers-Danlos syndrome, hydroxylysine-deficient	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000014368	1	12027042	1	11966985	14368	29407	rs797044447	NC_000001.11:11966984:A:
NM_000302.4(PLOD1):c.1594_1596del (p.Glu532del)	PLOD1	E579del	Ehlers-Danlos syndrome, hydroxylysine-deficient	Pathogenic(Last reviewed: Apr 1, 1994)	no assertion criteria provided	VCV000014367	1	12026315 - 12026317	1	11966258 - 11966260	14367	29406	rs797044446	NC_000001.11:11966257:AGGAG:AG
NM_000302.4(PLOD1):c.1795del (p.Ile599fs)	PLOD1	I599fs, I646fs	Ehlers-Danlos syndrome, hydroxylysine-deficient	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561086	1	12030766	1	11970709	561086	552031	rs1557500194	NC_000001.11:11970708:A:
NM_000302.4(PLOD1):c.1651-2A>G	PLOD1		not provided|Ehlers-Danlos syndrome, hydroxylysine-deficient	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265507	1	12027042	1	11966985	265507	259623	rs565513365	NC_000001.11:11966984:A:G
NM_000530.8(MPZ):c.130_137del (p.Ser44fs)	MPZ	S44fs	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000637764	1	161277145 - 161277152	1	161307355 - 161307362	637764	625084		NC_000001.11:161307354:ACCCGGGA:
NM_000530.8(MPZ):c.411C>T (p.Gly137=)	MPZ		Charcot-Marie-Tooth disease, type I|Dejerine-Sottas disease	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000577671	1	161276535	1	161306745	577671	557010	rs1558153994	NC_000001.11:161306744:G:A
NM_000530.8(MPZ):c.77del (p.Pro26fs)	MPZ	P26fs	Charcot-Marie-Tooth disease, type I|not provided	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000574580	1	161277205	1	161307415	574580	557014	rs1558154754	NC_000001.11:161307414:GGGG:GGG
NM_000530.8(MPZ):c.302G>A (p.Trp101Ter)	MPZ	W101*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000570159	1	161276644	1	161306854	570159	556664	rs1017715903	NC_000001.11:161306853:C:T
NM_000530.8(MPZ):c.298C>T (p.Gln100Ter)	MPZ	Q100*	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000531678	1	161276648	1	161306858	531678	515242	rs1553259683	NC_000001.11:161306857:G:A
NM_000530.8(MPZ):c.434_437del (p.Tyr145fs)	MPZ	Y145fs	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000531677	1	161276509 - 161276512	1	161306719 - 161306722	531677	515228	rs1553259643	NC_000001.11:161306718:ACATACA:ACA
NM_000530.8(MPZ):c.256C>T (p.Gln86Ter)	MPZ	Q86*	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000462792	1	161276690	1	161306900	462792	447368	rs1553259703	NC_000001.11:161306899:G:A
NM_000530.8(MPZ):c.646-10_650del	MPZ		Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Aug 7, 2015)	criteria provided, single submitter	VCV000217234	1	161275763 - 161275777	1	161305973 - 161305987	217234	213792	rs863225026	NC_000001.11:161305972:GGCGTCTGGGGGAGGGGCG:GGCG
NM_000530.8(MPZ):c.103G>T (p.Asp35Tyr)	MPZ	D6Y, D35Y	|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000014183	1	161277179	1	161307389	14183	29222	rs121913596	NC_000001.11:161307388:C:A
NM_201253.3(CRB1):c.1772_1775del (p.Cys591fs)	CRB1	C522fs, C591fs, C479fs	Retinal dystrophy	Pathogenic(Last reviewed: May 9, 2019)	criteria provided, single submitter	VCV000867150	1	197390728 - 197390731	1	197421598 - 197421601	867150	855876		NC_000001.11:197421597:ATGCAT:AT
NM_201253.3(CRB1):c.1436T>C (p.Leu479Pro)	CRB1	L367P, L410P, L479P	Retinal dystrophy	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000866833	1	197390394	1	197421264	866833	855874		NC_000001.11:197421263:T:C
NM_201253.3(CRB1):c.1429G>A (p.Gly477Arg)	CRB1	G477R, G365R, G408R	Retinal dystrophy	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000866829	1	197390387	1	197421257	866829	855873		NC_000001.11:197421256:G:A
NM_201253.3(CRB1):c.1125C>G (p.Tyr375Ter)	CRB1	Y375*, Y306*, Y263*	Retinal dystrophy	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, single submitter	VCV000866778	1	197326097	1	197356967	866778	855870		NC_000001.11:197356966:C:G
NM_201253.3(CRB1):c.2416G>T (p.Glu806Ter)	CRB1	E694*, E737*, E806*	Retinal dystrophy	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000866373	1	197396871	1	197427741	866373	855882		NC_000001.11:197427740:G:T
NM_201253.3(CRB1):c.3991C>T (p.Arg1331Cys)	CRB1	R1219C, R1307C, R1331C, R795C	Retinal dystrophy	Pathogenic(Last reviewed: May 11, 2019)	criteria provided, single submitter	VCV000865928	1	197411408	1	197442278	865928	855900		NC_000001.11:197442277:C:T
NM_201253.3(CRB1):c.2673C>A (p.Cys891Ter)	CRB1	C891*, C779*, C822*	Early-onset retinal dystrophy	Pathogenic(Last reviewed: Dec 13, 2017)	no assertion criteria provided	VCV000635156	1	197397128	1	197427998	635156	622990	rs759662695	NC_000001.11:197427997:C:A
NM_201253.3(CRB1):c.1084C>T (p.Gln362Ter)	CRB1	Q362*, Q250*, Q293*	not provided	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000620109	1	197326056	1	197356926	620109	611502	rs778627080	NC_000001.11:197356925:C:T
NM_201253.3(CRB1):c.799_800delinsA (p.Ala267fs)	CRB1		not provided	Pathogenic(Last reviewed: Apr 27, 2016)	criteria provided, single submitter	VCV000287179	1	197313557 - 197313558	1	197344427 - 197344428	287179	271416	rs886043587	NC_000001.11:197344426:GC:A
NM_201253.3(CRB1):c.3383del (p.Ile1128fs)	CRB1	I1016fs, I1104fs, I1128fs	not provided	Pathogenic(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	VCV000199200	1	197404376	1	197435246	199200	196359	rs794727980	NC_000001.11:197435245:T:
NM_201253.3(CRB1):c.4005+1G>A	CRB1		Leber congenital amaurosis	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812303	1	197411423	1	197442293	812303	800684		NC_000001.11:197442292:G:A
NM_201253.3(CRB1):c.2680_2684del (p.Asn894fs)	CRB1	N782fs, N870fs, N894fs	Leber congenital amaurosis	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812301	1	197398580 - 197398584	1	197429450 - 197429454	812301	800424		NC_000001.11:197429449:CCAACCC:CC
NM_201253.3(CRB1):c.4141C>A (p.Pro1381Thr)	CRB1	P1381T, P1357T, P1269T, P845T	Macular dystrophy	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000446252	1	197446929	1	197477799	446252	439632	rs1201356843	NC_000001.11:197477798:C:A
NM_201253.3(CRB1):c.253_254TG[4] (p.Asn87Ter)	CRB1		not provided	Pathogenic(Last reviewed: May 21, 2015)	criteria provided, single submitter	VCV000419132	1	197297733 - 197297734	1	197328603 - 197328604	419132	405001	rs62636260	NC_000001.11:197328603:TGTGTG:TGTGTGTG
NM_201253.3(CRB1):c.3460_3461TG[1] (p.Cys1154_Glu1155delinsTer)	CRB1		Leber congenital amaurosis 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801600	1	197404453 - 197404454	1	197435323 - 197435324	801600	789908		NC_000001.11:197435322:TGTG:TG
NM_201253.3(CRB1):c.1455_1458dup (p.Ser487fs)	CRB1		Leber congenital amaurosis 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801596	1	197390412 - 197390413	1	197421282 - 197421283	801596	789904		NC_000001.11:197421282:ACTT:ACTTACTT
NM_201253.3(CRB1):c.984G>A (p.Trp328Ter)	CRB1	W259*, W328*	Leber congenital amaurosis 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801594	1	197316605	1	197347475	801594	789902		NC_000001.11:197347474:G:A
NM_201253.3(CRB1):c.281_282del (p.Phe94fs)	CRB1	F25fs, F94fs	Leber congenital amaurosis 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801590	1	197297761 - 197297762	1	197328631 - 197328632	801590	789898		NC_000001.11:197328630:TTT:T
NM_201253.3(CRB1):c.3542dup (p.Cys1181fs)	CRB1		Retinal dystrophy	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000438079	1	197404534 - 197404535	1	197435404 - 197435405	438079	431569	rs1553263218	NC_000001.11:197435404:G:GG
NM_201253.3(CRB1):c.998G>A (p.Gly333Asp)	CRB1	G333D, G221D, G264D	Leber congenital amaurosis 8	Pathogenic(Last reviewed: Sep 18, 2014)	no assertion criteria provided	VCV000156384	1	197325970	1	197356840	156384	166165	rs587783015	NC_000001.11:197356839:G:A
NM_201253.3(CRB1):c.2498G>A (p.Gly833Asp)	CRB1	G764D, G721D, G833D	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812300	1	197396953	1	197427823	812300	800423		NC_000001.11:197427822:G:A
NM_201253.3(CRB1):c.455G>A (p.Cys152Tyr)	CRB1	C83Y, C152Y	Retinal dystrophy|Leber congenital amaurosis	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000812296	1	197297936	1	197328806	812296	800419		NC_000001.11:197328805:G:A
NM_201253.3(CRB1):c.424G>T (p.Gly142Ter)	CRB1	G73*, G142*	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812295	1	197297905	1	197328775	812295	800418		NC_000001.11:197328774:G:T
NM_201253.3(CRB1):c.1148G>A (p.Cys383Tyr)	CRB1	C383Y, C271Y, C314Y	Leber congenital amaurosis|not provided	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000099866	1	197326120	1	197356990	99866	105755	rs62645754	NC_000001.11:197356989:G:A
NM_201253.3(CRB1):c.3997G>T (p.Glu1333Ter)	CRB1	E1333*, E1221*, E1309*, E797*	Leber congenital amaurosis 8	Pathogenic(Last reviewed: Jul 1, 2001)	no assertion criteria provided	VCV000005735	1	197411414	1	197442284	5735	20774	rs137853136	NC_000001.11:197442283:G:T
CRB1, ALU INS, NT2320	CRB1		Retinitis pigmentosa 12	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000005729					5729	20768		
NM_000302.4(PLOD1):c.979C>T (p.Gln327Ter)	PLOD1	Q327*, Q374*	Ehlers-Danlos syndrome, hydroxylysine-deficient	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561087	1	12020706	1	11960649	561087	552030	rs1224538282	NC_000001.11:11960648:C:T
NM_000302.4(PLOD1):c.327del (p.Arg111fs)	PLOD1	R158fs, R111fs	not provided|Ehlers-Danlos syndrome, hydroxylysine-deficient	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000284903	1	12010435	1	11950378	284903	269140	rs886042976	NC_000001.11:11950377:GGGG:GGG
NM_000302.3(PLOD1):c.1756_1902del	PLOD1		Ehlers-Danlos syndrome, hydroxylysine-deficient	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000014369	1	12028292 - 12031717	1	11968235 - 11971660	14369	29408		
NM_201253.3(CRB1):c.481del (p.Ala161fs)	CRB1	A161fs, A92fs	Leber congenital amaurosis 8|Retinitis pigmentosa 12	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000856894	1	197297959	1	197328829	856894	823110		NC_000001.11:197328828:GGGG:GGG
NM_201253.3(CRB1):c.490C>T (p.Gln164Ter)	CRB1	Q164*, Q95*	Retinitis pigmentosa 12|Leber congenital amaurosis 8	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000851408	1	197297971	1	197328841	851408	823111		NC_000001.11:197328840:C:T
NM_201253.3(CRB1):c.1136C>G (p.Ser379Ter)	CRB1	S267*, S379*, S310*	Retinitis pigmentosa 12|Leber congenital amaurosis 8	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000848307	1	197326108	1	197356978	848307	823120		NC_000001.11:197356977:C:G
NM_201253.3(CRB1):c.1697del (p.Glu566fs)	CRB1	E566fs, E454fs, E497fs	Leber congenital amaurosis 8|Retinitis pigmentosa 12	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000844579	1	197390655	1	197421525	844579	823123		NC_000001.11:197421524:A:
NM_201253.3(CRB1):c.993_994CA[1] (p.Thr332fs)	CRB1		Leber congenital amaurosis 8|Retinitis pigmentosa 12	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000840786	1	197325964 - 197325965	1	197356834 - 197356835	840786	823118		NC_000001.11:197356833:ACACA:ACA
NC_000001.11:g.(?_197268413)_(197357013_?)del	CRB1		Leber congenital amaurosis 8|Retinitis pigmentosa 12	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000830603	1	197237543 - 197326143			830603	818892		
NM_201253.3(CRB1):c.437_440AGAT[1] (p.Asp148fs)	CRB1		Leber congenital amaurosis 8|Retinitis pigmentosa 12	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000662920	1	197297918 - 197297921	1	197328788 - 197328791	662920	627197		NC_000001.11:197328787:AGATAGAT:AGAT
NM_201253.3(CRB1):c.2425C>T (p.Gln809Ter)	CRB1	Q809*, Q697*, Q740*	Leber congenital amaurosis 8|Retinitis pigmentosa 12	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000647091	1	197396880	1	197427750	647091	627199		NC_000001.11:197427749:C:T
NC_000001.10:g.(?_197237324)_(197237622_?)del	CRB1		Leber congenital amaurosis 8|Retinitis pigmentosa 12	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000646396	1	197237324 - 197237622	1	197268194 - 197268492	646396	650540		
NM_201253.3(CRB1):c.2072G>A (p.Trp691Ter)	CRB1	W691*, W579*, W622*	Leber congenital amaurosis 8	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000587388	1	197391030	1	197421900	587388	578338	rs1558127317	NC_000001.11:197421899:G:A
NM_201253.3(CRB1):c.70+1G>A	CRB1		Leber congenital amaurosis 8	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000587387	1	197237613	1	197268483	587387	578336	rs1237424465	NC_000001.11:197268482:G:A
NM_201253.3(CRB1):c.410del (p.Pro137fs)	CRB1	P68fs, P137fs	Leber congenital amaurosis 8	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000587386	1	197297889	1	197328759	587386	578337	rs1558057153	NC_000001.11:197328758:CCC:CC
NM_201253.3(CRB1):c.4039del (p.Thr1347fs)	CRB1	T1235fs, T1323fs, T1347fs, T811fs	Leber congenital amaurosis 8	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000587385	1	197446827	1	197477697	587385	578340	rs745422941	NC_000001.11:197477696:A:
NM_201253.3(CRB1):c.2842T>C (p.Cys948Arg)	CRB1	C948R, C924R, C836R	Leber congenital amaurosis|Leber congenital amaurosis 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000427863	1	197398744	1	197429614	427863	418814	rs62645747	NC_000001.11:197429613:T:C
NM_201253.3(CRB1):c.1459dup (p.Ser487fs)	CRB1		Retinitis pigmentosa	Pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000191358	1	197390414 - 197390415	1	197421284 - 197421285	191358	189155	rs863223342	NC_000001.11:197421284:TTT:TTTT
NM_201253.3(CRB1):c.2783G>A (p.Cys928Tyr)	CRB1	C904Y, C928Y, C816Y	Retinitis pigmentosa	Pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000191357	1	197398685	1	197429555	191357	189156	rs863223341	NC_000001.11:197429554:G:A
NM_201253.3(CRB1):c.3541T>C (p.Cys1181Arg)	CRB1	C1181R, C1069R, C1157R	Retinitis pigmentosa 12|not provided	Pathogenic(Last reviewed: Jul 1, 2001)	no assertion criteria provided	VCV000005737	1	197404534	1	197435404	5737	20776	rs62636291	NC_000001.11:197435403:T:C
NM_201253.3(CRB1):c.2983G>T (p.Glu995Ter)	CRB1	E995*, E971*, E883*	Retinitis pigmentosa 12|not provided	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000005731	1	197403976	1	197434846	5731	20770	rs62635655	NC_000001.11:197434845:G:T
NM_000478.6(ALPL):c.1559del (p.Leu520fs)	ALPL	L443fs, L520fs, L465fs	Hypophosphatasia|not provided|Infantile hypophosphatasia	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013674	1	21904125	1	21577632	13674	28713	rs387906525	NC_000001.11:21577631:T:
NM_020779.4(WDR35):c.1889T>G (p.Leu630Ter)	WDR35	L641*, L630*	Jeune thoracic dystrophy|Cranioectodermal dysplasia 2|WDR35-Related Disorders|Cranioectodermal dysplasia|Cranioectodermal dysplasia 2|Short rib polydactyly syndrome 5	Pathogenic/Likely pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000065619	2	20141557	2	19941796	65619	76527	rs199952377	NC_000002.12:19941795:A:C
NM_000302.4(PLOD1):c.1562G>A (p.Trp521Ter)	PLOD1	W521*, W568*	Severe global developmental delay|Neonatal hypotonia|Macrocephaly at birth|Hydrocephalus|Dolichocephaly|Acquired porencephaly|Narrow chest|Umbilical hernia|Scrotal hypoplasia|Short chin|Feeding difficulties|Generalized neonatal hypotonia|Bilateral cryptorchidism|Joint hypermobility|Depressed nasal bridge|Congenital omphalocele|Thoracolumbar scoliosis|Generalized hypotonia|High palate|Joint hypermobility	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000374077	1	12025628	1	11965571	374077	360800	rs1057518879	NC_000001.11:11965570:G:A
NM_201253.3(CRB1):c.1334_1740del (p.Cys445fs)	CRB1	C333fs, C376fs, C445fs	Leber congenital amaurosis 8|Retinitis pigmentosa 12	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000861706	1	197390291 - 197390697	1	197421161 - 197421567	861706	823122		
NM_201253.3(CRB1):c.522T>A (p.Cys174Ter)	CRB1	C174*, C105*	Leber congenital amaurosis 8|Retinitis pigmentosa 12	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000844891	1	197298003	1	197328873	844891	823112		NC_000001.11:197328872:T:A
NM_201253.3(CRB1):c.661_662TG[1] (p.Cys221_Glu222delinsTer)	CRB1		Leber congenital amaurosis 8|Retinitis pigmentosa 12	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000844387	1	197313419 - 197313420	1	197344289 - 197344290	844387	823113		NC_000001.11:197344288:TGTG:TG
NM_201253.3(CRB1):c.3037C>T (p.Gln1013Ter)	CRB1	Q1013*, Q901*, Q989*	Leber congenital amaurosis 8|Retinitis pigmentosa 12	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000660235	1	197404030	1	197434900	660235	627200		NC_000001.11:197434899:C:T
NM_201253.3(CRB1):c.2230C>T (p.Arg744Ter)	CRB1	R744*, R675*, R632*	Early-onset retinal dystrophy|Leber congenital amaurosis|Retinal dystrophy	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000635155	1	197396685	1	197427555	635155	622989	rs150412614	NC_000001.11:197427554:C:T
NM_201253.3(CRB1):c.3299T>G (p.Ile1100Arg)	CRB1	I1100R, I988R, I1076R	Leber congenital amaurosis 8|not provided	Pathogenic(Last reviewed: Jul 1, 2001)	no assertion criteria provided	VCV000005734	1	197404292	1	197435162	5734	20773	rs62635659	NC_000001.11:197435161:T:G
NM_133259.4(LRPPRC):c.1649_1649+1delinsTTT	LRPPRC		not provided	Pathogenic(Last reviewed: Mar 25, 2014)	criteria provided, single submitter	VCV000214618	2	44184523 - 44184524	2	43957384 - 43957385	214618	210845	rs863224059	NC_000002.12:43957383:CC:AAA
NM_133259.4(LRPPRC):c.1920+1G>T	LRPPRC		not provided	Pathogenic(Last reviewed: Mar 3, 2014)	criteria provided, single submitter	VCV000214607	2	44175260	2	43948121	214607	210842	rs863224055	NC_000002.12:43948120:C:A
NM_133259.4(LRPPRC):c.864+2T>C	LRPPRC		not provided	Pathogenic(Last reviewed: Jan 29, 2013)	criteria provided, single submitter	VCV000214601	2	44202228	2	43975089	214601	210855	rs863224053	NC_000002.12:43975088:A:G
NM_133259.4(LRPPRC):c.3963C>A (p.Tyr1321Ter)	LRPPRC	Y1321*	not provided	Pathogenic(Last reviewed: Dec 27, 2013)	criteria provided, single submitter	VCV000214597	2	44121706	2	43894567	214597	210825	rs863224052	NC_000002.12:43894566:G:T
NM_133259.4(LRPPRC):c.283C>T (p.Arg95Ter)	LRPPRC	R95*	not provided	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000843177	2	44209440	2	43982301	843177	826487		NC_000002.12:43982300:G:A
NM_133259.4(LRPPRC):c.3524C>G (p.Ser1175Ter)	LRPPRC	S1175*	not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000836039	2	44128504	2	43901365	836039	826485		NC_000002.12:43901364:G:C
NM_133259.4(LRPPRC):c.3397C>T (p.Gln1133Ter)	LRPPRC	Q1133*	not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000834120	2	44128631	2	43901492	834120	826486		NC_000002.12:43901491:G:A
NM_133259.4(LRPPRC):c.3799del (p.Val1267fs)	LRPPRC	V1267fs	not provided	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000645281	2	44126384	2	43899245	645281	630006		NC_000002.12:43899244:CC:C
NM_133259.4(LRPPRC):c.3147dup (p.Gly1050fs)	LRPPRC		Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type	Pathogenic(Last reviewed: Dec 1, 2015)	no assertion criteria provided	VCV000218169	2	44145164 - 44145165	2	43918025 - 43918026	218169	214821	rs769022521	NC_000002.12:43918025:TTTTTTTT:TTTTTTTTT
NM_133259.4(LRPPRC):c.2595_2597del (p.Val866del)	LRPPRC	V866del	Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type	Pathogenic(Last reviewed: Dec 1, 2015)	no assertion criteria provided	VCV000218166	2	44161925 - 44161927	2	43934786 - 43934788	218166	214818	rs863225444	NC_000002.12:43934785:ACCA:A
NM_133259.4(LRPPRC):c.3900+1G>C	LRPPRC		Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type	Pathogenic(Last reviewed: Dec 1, 2015)	no assertion criteria provided	VCV000218165	2	44123772	2	43896633	218165	214817	rs863225443	NC_000002.12:43896632:C:G
LRPPRC, 8-BP DEL, EXON 35	LRPPRC		Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type	Pathogenic(Last reviewed: Jan 21, 2003)	no assertion criteria provided	VCV000003111					3111	18150		
NM_133259.4(LRPPRC):c.2723_2725AGA[1] (p.Lys909del)	LRPPRC	K909del	Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000218167	2	44161337 - 44161339	2	43934198 - 43934200	218167	214819	rs863225445	NC_000002.12:43934197:TCTTCTT:TCTT
NM_133259.4(LRPPRC):c.1722_1723del (p.Gly576fs)	LRPPRC	G576fs	Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555555	2	44176753 - 44176754	2	43949614 - 43949615	555555	542118	rs750343121	NC_000002.12:43949613:GAG:G
NM_000530.8(MPZ):c.316C>T (p.Arg106Cys)	MPZ	R106C	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000637797	1	161276630	1	161306840	637797	625050		NC_000001.11:161306839:G:A
NM_000530.8(MPZ):c.584+2T>G	MPZ		not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Nov 19, 2015)	criteria provided, single submitter	VCV000246029	1	161276117	1	161306327	246029	244251	rs879254054	NC_000001.11:161306326:A:C
NM_003742.4(ABCB11):c.3669G>C (p.Glu1223Asp)	ABCB11	E1223D	Cholestasis, intrahepatic, of pregnancy 3	Pathogenic	no assertion criteria provided	VCV000812747	2	169781263	2	168924753	812747	800993		NC_000002.12:168924752:C:G
NM_003742.4(ABCB11):c.2950del (p.Cys984fs)	ABCB11	C984fs	not provided	Pathogenic(Last reviewed: Jul 27, 2018)	criteria provided, single submitter	VCV000598180	2	169791800	2	168935290	598180	589241	rs1559183490	NC_000002.12:168935289:A:
NM_003742.4(ABCB11):c.1948del (p.Tyr650fs)	ABCB11	Y650fs	not provided	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, single submitter	VCV000597001	2	169825923	2	168969413	597001	588062	rs1558894166	NC_000002.12:168969412:AAA:AA
NM_003742.4(ABCB11):c.2178+1G>A	ABCB11		not provided	Pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000596620	2	169820715	2	168964205	596620	587681	rs1459273753	NC_000002.12:168964204:C:T
NM_003742.4(ABCB11):c.2944G>A (p.Gly982Arg)	ABCB11	G982R	not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000595313	2	169791806	2	168935296	595313	586375	rs72549399	NC_000002.12:168935295:C:T
NM_003742.4(ABCB11):c.847G>T (p.Glu283Ter)	ABCB11	E283*	not provided	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000594456	2	169847372	2	168990862	594456	585519	rs1558912774	NC_000002.12:168990861:C:A
NM_003742.4(ABCB11):c.390-1G>T	ABCB11		not provided	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000594334	2	169853233	2	168996723	594334	585397	rs1558917090	NC_000002.12:168996722:C:A
NM_003742.4(ABCB11):c.409G>T (p.Glu137Ter)	ABCB11	E137*	not provided	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000593441	2	169853213	2	168996703	593441	584505	rs1026511416	NC_000002.12:168996702:C:A
NM_003742.4(ABCB11):c.167C>G (p.Ser56Ter)	ABCB11	S56*	not provided	Pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, single submitter	VCV000593338	2	169870004	2	169013494	593338	584402	rs11568361	NC_000002.12:169013493:G:C
NM_003742.4(ABCB11):c.3268C>T (p.Arg1090Ter)	ABCB11	R1090*	not provided	Pathogenic(Last reviewed: Apr 20, 2017)	criteria provided, single submitter	VCV000501601	2	169787318	2	168930808	501601	493025	rs72549396	NC_000002.12:168930807:G:A
NM_003742.4(ABCB11):c.1631del (p.Leu544fs)	ABCB11	L544fs	not provided	Pathogenic(Last reviewed: Apr 17, 2017)	criteria provided, single submitter	VCV000501511	2	169828364	2	168971854	501511	492935	rs1553466489	NC_000002.12:168971853:A:
NM_003742.4(ABCB11):c.1810-1G>A	ABCB11		not provided	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000500951	2	169826062	2	168969552	500951	492375	rs1553466082	NC_000002.12:168969551:C:T
NM_003742.4(ABCB11):c.1408C>T (p.Arg470Ter)	ABCB11	R470*	not provided	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000499068	2	169830251	2	168973741	499068	490492	rs774824767	NC_000002.12:168973740:G:A
NM_003742.4(ABCB11):c.1354_1427del (p.Ala452fs)	ABCB11	A452fs	not provided	Pathogenic(Last reviewed: Jul 6, 2016)	criteria provided, single submitter	VCV000289254	2	169830232 - 169830305	2	168973722 - 168973795	289254	273491	rs1553466863	
NM_003742.4(ABCB11):c.22C>T (p.Arg8Ter)	ABCB11	R8*	not provided	Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, single submitter	VCV000288711	2	169874614	2	169018104	288711	272948	rs886043986	NC_000002.12:169018103:G:A
NM_003742.4(ABCB11):c.1069G>T (p.Gly357Ter)	ABCB11	G357*	not provided	Pathogenic(Last reviewed: Jun 23, 2016)	criteria provided, single submitter	VCV000288554	2	169842634	2	168986124	288554	272791	rs886043935	NC_000002.12:168986123:C:A
NM_003742.4(ABCB11):c.150+1G>A	ABCB11		not provided	Pathogenic(Last reviewed: Jun 19, 2016)	criteria provided, single submitter	VCV000288366	2	169870812	2	169014302	288366	272603	rs886043875	NC_000002.12:169014301:C:T
NM_003742.4(ABCB11):c.1271del (p.Asn424fs)	ABCB11	N424fs	not provided	Pathogenic(Last reviewed: Apr 18, 2016)	criteria provided, single submitter	VCV000287708	2	169833124	2	168976614	287708	271945	rs886043703	NC_000002.12:168976613:TT:T
NM_003742.4(ABCB11):c.908+1G>A	ABCB11		not provided	Pathogenic(Last reviewed: Jan 15, 2016)	criteria provided, single submitter	VCV000285414	2	169847310	2	168990800	285414	269651	rs147649016	NC_000002.12:168990799:C:T
NM_003742.4(ABCB11):c.1654del (p.Val552fs)	ABCB11	V552fs	not provided	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000841658	2	169826710	2	168970200	841658	825194		NC_000002.12:168970199:C:
NC_000002.12:g.(?_168935174)_(168935435_?)del	ABCB11		not provided	Pathogenic(Last reviewed: Jul 22, 2019)	criteria provided, single submitter	VCV000832388	2	169791684 - 169791945			832388	819079		
NM_003742.4(ABCB11):c.2541del (p.Phe847fs)	ABCB11	F847fs	not provided	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000657852	2	169801184	2	168944674	657852	628978		NC_000002.12:168944673:AAA:AA
NM_003742.4(ABCB11):c.2495del (p.Arg832fs)	ABCB11	R832fs	not provided	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000642518	2	169801230	2	168944720	642518	628979		NC_000002.12:168944719:C:
NM_003742.4(ABCB11):c.1417_1418insTGATTCCTTC (p.Asp473fs)	ABCB11		not provided	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000639069	2	169830241 - 169830242	2	168973731 - 168973732	639069	628980		NC_000002.12:168973731::GAAGGAATCA
NM_003742.4(ABCB11):c.1966_1967del (p.Leu656fs)	ABCB11	L656fs	not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000425233	2	169825904 - 169825905	2	168969394 - 168969395	425233	413567	rs1064797270	NC_000002.12:168969393:AAA:A
NM_003742.4(ABCB11):c.3148C>T (p.Arg1050Cys)	ABCB11	R1050C	Intrahepatic Cholestasis|Pruritus|Abnormal liver function tests during pregnancy	Pathogenic(Last reviewed: Jun 18, 2015)	criteria provided, single submitter	VCV000374098	2	169788952	2	168932442	374098	360825	rs72549398	NC_000002.12:168932441:G:A
GRCh37/hg19 2q31.1(chr2:169824976-169830328)	ABCB11		Progressive familial intrahepatic cholestasis 2	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625825	2	169824976 - 169830328			625825	614129		
NM_003742.4(ABCB11):c.1416T>A (p.Tyr472Ter)	ABCB11	Y472*	Progressive familial intrahepatic cholestasis 2	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623288	2	169830243	2	168973733	623288	612260	rs1558898789	NC_000002.12:168973732:A:T
NM_003742.4(ABCB11):c.1763C>T (p.Ala588Val)	ABCB11	A588V	not provided	Pathogenic(Last reviewed: Jul 31, 2018)	criteria provided, single submitter	VCV000594531	2	169826601	2	168970091	594531	585594	rs917981474	NC_000002.12:168970090:G:A
NM_003742.4(ABCB11):c.1295G>C (p.Arg432Thr)	ABCB11	R432T		Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000006595	2	169833100	2	168976590	6595	21634	rs121908935	NC_000002.12:168976589:C:G
NM_003742.4(ABCB11):c.150+3A>C	ABCB11		Progressive familial intrahepatic cholestasis 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000006593	2	169870810	2	169014300	6593	21632	rs387906354	NC_000002.12:169014299:T:G
NM_003742.4(ABCB11):c.3767dup (p.Val1257fs)	ABCB11		Progressive familial intrahepatic cholestasis 2	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000006592	2	169780330 - 169780331	2	168923820 - 168923821	6592	21631	rs387907317	NC_000002.12:168923820:G:GG
NM_003742.4(ABCB11):c.908+1del	ABCB11		Progressive familial intrahepatic cholestasis 2	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000006591	2	169847310	2	168990800	6591	21630	rs1553469602	NC_000002.12:168990799:CC:C
NM_003742.4(ABCB11):c.1723C>T (p.Arg575Ter)	ABCB11	R575*	Progressive familial intrahepatic cholestasis 2	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000006589	2	169826641	2	168970131	6589	21628	rs72549401	NC_000002.12:168970130:G:A
NM_000228.3(LAMB3):c.2842del (p.Val948fs)	LAMB3	V948fs	not provided|Junctional epidermolysis bullosa gravis of Herlitz|Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372403	1	209791864	1	209618519	372403	359293	rs772421306	NC_000001.11:209618518:CC:C
NM_003742.4(ABCB11):c.2380C>T (p.Gln794Ter)	ABCB11	Q794*	not provided|Progressive familial intrahepatic cholestasis 2|	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000417884	2	169801435	2	168944925	417884	404753	rs1060499579	NC_000002.12:168944924:G:A
NM_003742.4(ABCB11):c.2296G>A (p.Gly766Arg)	ABCB11	G766R	not provided	Pathogenic(Last reviewed: Apr 14, 2017)	criteria provided, single submitter	VCV000290133	2	169814521	2	168958011	290133	274370	rs763782349	NC_000002.12:168958010:C:T
NC_000001.10:g.(?_12020693)_(12027158_?)dup	PLOD1		Ehlers-Danlos syndrome, hydroxylysine-deficient	Pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000646377	1	12020693 - 12027158	1	11960636 - 11967101	646377	650525		
NM_000302.4(PLOD1):c.1470+2T>C	PLOD1		not provided|Ehlers-Danlos syndrome, hydroxylysine-deficient	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000288528	1	12024844	1	11964787	288528	272765	rs886043927	NC_000001.11:11964786:T:C
NC_000001.11:g.(11959822_11959973)_(11968469_11968718)dup	PLOD1		Ehlers-Danlos syndrome, hydroxylysine-deficient	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000014365	1	12019879 - 12028775	1	11959822 - 11968718	14365	29404		
NM_000364.4(TNNT2):c.838A>G (p.Lys280Glu)	TNNT2	K273E, K280E, K283E, K240E, K267E, K270E	not provided	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000431937	1	201328755	1	201359627	431937	425329	rs1553279294	NC_000001.11:201359626:T:C
NM_000364.4(TNNT2):c.305G>T (p.Arg102Leu)	TNNT2	R102L, R92L, R87L	not provided	Pathogenic(Last reviewed: Jan 18, 2012)	no assertion criteria provided	VCV000235063	1	201334425	1	201365297	235063	236740	rs121964856	NC_000001.11:201365296:C:A
NM_000364.4(TNNT2):c.269C>T (p.Pro90Leu)	TNNT2	P80L, P90L, P75L, P89L	not provided	Pathogenic(Last reviewed: Oct 14, 2014)	criteria provided, single submitter	VCV000181641	1	201334763	1	201365635	181641	178951	rs730881121	NC_000001.11:201365634:G:A
NM_000364.4(TNNT2):c.843-1G>T	TNNT2		not provided	Pathogenic(Last reviewed: Apr 2, 2013)	criteria provided, single submitter	VCV000181634	1	201328384	1	201359256	181634	178914	rs730881114	NC_000001.11:201359255:C:A
NM_000364.4(TNNT2):c.349G>T (p.Glu117Ter)	TNNT2	E107*, E117*, E102*	not provided	Pathogenic(Last reviewed: Mar 8, 2012)	criteria provided, single submitter	VCV000181615	1	201334381	1	201365253	181615	178946	rs730881099	NC_000001.11:201365252:C:A
NM_001276345.2(TNNT2):c.844dup (p.Gln282fs)	TNNT2		Cardiomyopathy	Pathogenic(Last reviewed: Sep 11, 2013)	criteria provided, single submitter	VCV000181639	1	201328757 - 201328758	1	201359629 - 201359630	181639	178916	rs730881119	NC_000001.11:201359629:GG:GGG
TNNT2, 3-BP DEL, 285GGA	TNNT2		Familial restrictive cardiomyopathy 3	Pathogenic(Last reviewed: Jan 25, 2008)	no assertion criteria provided	VCV000012418					12418	27457		
NM_003742.4(ABCB11):c.1822_1823CA[4] (p.Ile610fs)	ABCB11		not provided	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000847009	2	169826043 - 169826044	2	168969533 - 168969534	847009	825193		NC_000002.12:168969533:TGTGTG:TGTGTGTG
NM_003742.4(ABCB11):c.3382C>T (p.Arg1128Cys)	ABCB11	R1128C	not provided	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000639640	2	169787204	2	168930694	639640	628977		NC_000002.12:168930693:G:A
NM_003742.4(ABCB11):c.2842C>T (p.Arg948Cys)	ABCB11	R948C	not provided	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000598092	2	169791908	2	168935398	598092	589153	rs1559183717	NC_000002.12:168935397:G:A
NM_003742.4(ABCB11):c.379del (p.Thr127fs)	ABCB11	T127fs	not provided|Progressive familial intrahepatic cholestasis 2	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000594630	2	169869792	2	169013282	594630	585693	rs1558927163	NC_000002.12:169013281:TT:T
NM_003742.4(ABCB11):c.2782C>T (p.Arg928Ter)	ABCB11	R928*	not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000500467	2	169792772	2	168936262	500467	491891	rs756529333	NC_000002.12:168936261:G:A
NM_003742.4(ABCB11):c.3692G>A (p.Arg1231Gln)	ABCB11	R1231Q	not provided	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000287364	2	169781240	2	168924730	287364	271601	rs758069019	NC_000002.12:168924729:C:T
NC_000001.11:g.(?_197328412)_(197442544_?)del	CRB1		Retinitis pigmentosa 12|Leber congenital amaurosis 8	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000832442	1	197297542 - 197411674			832442	818893		
NM_201253.3(CRB1):c.2533_2539del (p.Gly845fs)	CRB1	G733fs, G776fs, G845fs	Leber congenital amaurosis 8|Retinitis pigmentosa 12|Leber congenital amaurosis 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000801599	1	197396986 - 197396992	1	197427856 - 197427862	801599	789907		NC_000001.11:197427855:ATGGTGGAT:AT
NM_201253.3(CRB1):c.1182C>A (p.Cys394Ter)	CRB1	C394*, C282*, C325*	not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000285386	1	197390140	1	197421010	285386	269623	rs115352681	NC_000001.11:197421009:C:A
NM_002529.3(NTRK1):c.1444A>T (p.Lys482Ter)	NTRK1	K446*, K476*, K482*	not provided	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000245653	1	156845401	1	156875609	245653	244248	rs879253890	NC_000001.11:156875608:A:T
NM_002529.3(NTRK1):c.226_229dup (p.Gln77fs)	NTRK1		Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000862988	1	156834157 - 156834158	1	156864365 - 156864366	862988	822834		NC_000001.11:156864365:CCAGC:CCAGCCAGC
NM_002529.3(NTRK1):c.478C>T (p.Gln160Ter)	NTRK1	Q160*, Q130*	Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000854137	1	156837945	1	156868153	854137	822837		NC_000001.11:156868152:C:T
NM_002529.3(NTRK1):c.2055_2058dup (p.Thr687fs)	NTRK1		Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000835302	1	156849798 - 156849799	1	156880006 - 156880007	835302	822857		NC_000001.11:156880006:CCGC:CCGCCCGC
NM_002529.3(NTRK1):c.538C>T (p.Gln180Ter)	NTRK1	Q180*, Q150*	Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000659393	1	156838005	1	156868213	659393	626939		NC_000001.11:156868212:C:T
NM_002529.3(NTRK1):c.396G>A (p.Trp132Ter)	NTRK1	W102*, W132*	Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000657340	1	156836738	1	156866946	657340	626938		NC_000001.11:156866945:G:A
NM_002529.3(NTRK1):c.1031_1043del (p.Gly344fs)	NTRK1	G344fs, G314fs	Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000649492	1	156843605 - 156843617	1	156873813 - 156873825	649492	626951		NC_000001.11:156873812:GGTGTCTGCGCCT:
NM_001012331.1(NTRK1):c.575delG	NTRK1		Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000648715	1	156838296	1	156868504	648715	650638		NC_000001.11:156868503:GG:G
NM_002529.3(NTRK1):c.1659del (p.Arg554fs)	NTRK1	R518fs, R554fs, R548fs	Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000579700	1	156846218	1	156876426	579700	556636	rs1363364803	NC_000001.11:156876425:T:
NM_002529.3(NTRK1):c.1310_1313dup (p.Leu439fs)	NTRK1		Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000578173	1	156844755 - 156844756	1	156874963 - 156874964	578173	558158	rs1558105252	NC_000001.11:156874963:TTGT:TTGTTTGT
NM_002529.3(NTRK1):c.424G>T (p.Glu142Ter)	NTRK1	E142*, E112*	Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000570317	1	156836766	1	156866974	570317	556626	rs370483210	NC_000001.11:156866973:G:T
NM_002529.3(NTRK1):c.1550G>A (p.Gly517Glu)	NTRK1	G517E, G481E, G511E	Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Oct 31, 2014)	no assertion criteria provided	VCV000161443	1	156845920	1	156876128	161443	171279	rs606231467	NC_000001.11:156876127:G:A
NM_002529.3(NTRK1):c.717+4A>T	NTRK1		Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Oct 31, 2014)	no assertion criteria provided	VCV000161442	1	156838443	1	156868651	161442	171278	rs606231466	NC_000001.11:156868650:A:T
NM_002529.3(NTRK1):c.1354+13_1634del	NTRK1		Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Aug 5, 2008)	no assertion criteria provided	VCV000065491	1	156844810 - 156846190	1	156875018 - 156876398	65491	76399		
NM_002529.3(NTRK1):c.25C>T (p.Gln9Ter)	NTRK1	Q9*	Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Aug 5, 2008)	no assertion criteria provided	VCV000038360	1	156830751	1	156860959	38360	27343	rs80356673	NC_000001.11:156860958:C:T
NM_002529.3(NTRK1):c.207_208del (p.Glu70fs)	NTRK1	E70fs	Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000029920	1	156830933 - 156830934	1	156861141 - 156861142	29920	38875	rs398122810	NC_000001.11:156861140:TG:
NM_002529.3(NTRK1):c.2020G>T (p.Asp674Tyr)	NTRK1	D638Y, D668Y, D674Y	Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Aug 5, 2008)	no assertion criteria provided	VCV000021307	1	156849128	1	156879336	21307	34159	rs80356677	NC_000001.11:156879335:G:T
NTRK1, 1-BP INS, 1926T	NTRK1		Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Jun 19, 2000)	no assertion criteria provided	VCV000012309					12309	27348		
NTRK1, IVS7AS, T-A, -33	NTRK1		Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000012306					12306	27345		
NM_002529.3(NTRK1):c.2339G>C (p.Arg780Pro)	NTRK1	R774P, R744P, R780P	Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Apr 1, 1999)	no assertion criteria provided	VCV000012303	1	156851382	1	156881590	12303	27342	rs35669708	NC_000001.11:156881589:G:C
NM_002529.3(NTRK1):c.1729G>C (p.Gly577Arg)	NTRK1	G571R, G541R, G577R	Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000012302	1	156846288	1	156876496	12302	27341	rs121964866	NC_000001.11:156876495:G:C
NM_015506.3(MMACHC):c.658_660del (p.Lys220del)	MMACHC	K220del, K163del	Methylmalonic acidemia with homocystinuria|not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000095707	1	45974694 - 45974696	1	45509022 - 45509024	95707	101604	rs398124296	NC_000001.11:45509021:AGAAG:AG
NM_002529.3(NTRK1):c.1804C>T (p.Arg602Ter)	NTRK1	R566*, R596*, R602*	Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	VCV000620139	1	156846363	1	156876571	620139	611494	rs763758904	NC_000001.11:156876570:C:T
NM_002529.3(NTRK1):c.526C>T (p.Gln176Ter)	NTRK1	Q146*, Q176*	Hereditary insensitivity to pain with anhidrosis|not provided	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000245651	1	156837993	1	156868201	245651	244244	rs879253889	NC_000001.11:156868200:C:T
NM_002529.3(NTRK1):c.360-2A>C	NTRK1		Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Jun 10, 2014)	criteria provided, single submitter	VCV000209177	1	156836700	1	156866908	209177	205720	rs797045059	NC_000001.11:156866907:A:C
NTRK1, IVS4, G-C, -1 AND ARG85SER	NTRK1	R85S	Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	VCV000012305					12305	27344		
NM_001243766.1(POMGNT1):c.10del (p.Trp4fs)	POMGNT1	W4fs	Limb-girdle muscular dystrophy-dystroglycanopathy, type C3|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000642652	1	46663484	1	46197812	642652	628134		NC_000001.11:46197811:A:
NM_017739.3(POMGNT1):c.92dup (p.Asn31fs)	POMGNT1		not provided	Pathogenic(Last reviewed: Jun 11, 2013)	no assertion criteria provided	VCV000095762	1	46663401 - 46663402	1	46197729 - 46197730	95762	101659	rs398124310	NC_000001.11:46197729:TTT:TTTT
POMGNT1, 9-BP DUP, -83	POMGNT1		Limb-girdle muscular dystrophy-dystroglycanopathy, type C3	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000039719					39719	48318		
NC_000002.12:g.(?_168923612)_(168924813_?)del	ABCB11		not provided	Pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, single submitter	VCV000832436	2	169780122 - 169781323			832436	819078		
NM_017739.4(POMGNT1):c.36del (p.Phe13fs)	POMGNT1	F13fs	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3|Limb-girdle muscular dystrophy-dystroglycanopathy, type C3	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000845990	1	46663458	1	46197786	845990	824217		NC_000001.11:46197785:GGG:GG
NM_001276345.2(TNNT2):c.548G>T (p.Arg183Leu)	TNNT2	R143L, R168L, R173L, R183L	Left ventricular noncompaction 6	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000691967	1	201332476	1	201363348	691967	679713		NC_000001.11:201363347:C:A
NM_001276345.2(TNNT2):c.328_333del (p.Asn110_Glu111del)	TNNT2		Primary familial hypertrophic cardiomyopathy	Pathogenic	criteria provided, single submitter	VCV000684850	1	201334397 - 201334402	1	201365269 - 201365274	684850	672375		NC_000001.11:201365268:CTCATTC:C
NM_001276345.2(TNNT2):c.316G>A (p.Glu106Lys)	TNNT2	E96K, E106K, E91K	Left ventricular noncompaction 6	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000224775	1	201334414	1	201365286	224775	226594	rs869312881	NC_000001.11:201365285:C:T
NM_000364.4(TNNT2):c.274G>A (p.Gly92Arg)	TNNT2	G82R, G92R, G77R, G91R	not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2016)	criteria provided, multiple submitters, no conflicts	VCV000177644	1	201334758	1	201365630	177644	172365	rs727504255	NC_000001.11:201365629:C:T
NM_001276345.2(TNNT2):c.838G>A (p.Asp280Asn)	TNNT2	D270N, D277N, D267N, D280N, D237N, D264N	Left ventricular noncompaction 6	Pathogenic(Last reviewed: Nov 16, 2004)	no assertion criteria provided	VCV000012417	1	201328764	1	201359636	12417	27456	rs121964861	NC_000001.11:201359635:C:T
NM_001276345.2(TNNT2):c.644G>T (p.Arg215Leu)	TNNT2	R205L, R212L, R202L, R172L, R199L, R215L	Left ventricular noncompaction 6	Pathogenic(Last reviewed: Nov 16, 2004)	no assertion criteria provided	VCV000012416	1	201331116	1	201361988	12416	27455	rs121964860	NC_000001.11:201361987:C:A
TNNT2, IVS15, G-A, +1	TNNT2		Familial hypertrophic cardiomyopathy 2	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000012410					12410	27449		
NC_000001.10:g.(?_161326467)_(161326630_?)del	SDHC		Paragangliomas 3	Pathogenic(Last reviewed: Jun 26, 2016)	criteria provided, single submitter	VCV000417389	1	161326467 - 161326630	1	161356677 - 161356840	417389	390719		
SDHC, 8,372-BP DEL	SDHC		Paragangliomas 3	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000007243					7243	22282		
NM_003126.4(SPTA1):c.83G>A (p.Arg28His)	SPTA1	R28H	Hereditary pyropoikilocytosis|Prenatal anemia|not specified|not provided|Elliptocytosis 2	Pathogenic(Last reviewed: May 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000012856	1	158655079	1	158685289	12856	27895	rs121918641	NC_000001.11:158685288:C:T
NM_002529.3(NTRK1):c.287+2dup	NTRK1		Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000859211	1	156834221 - 156834222	1	156864429 - 156864430	859211	850731		NC_000001.11:156864429:T:TT
NM_003742.4(ABCB11):c.3457C>T (p.Arg1153Cys)	ABCB11	R1153C	Progressive familial intrahepatic cholestasis 2|not provided	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000288726	2	169783827	2	168927317	288726	272963	rs72549395	NC_000002.12:168927316:G:A
NM_003742.4(ABCB11):c.2783_2787dup (p.Lys930fs)	ABCB11		not provided|Progressive familial intrahepatic cholestasis 2	Pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, single submitter	VCV000006594	2	169792766 - 169792767	2	168936256 - 168936257	6594	21633	rs752919965	NC_000002.12:168936256:ATCTC:ATCTCATCTC
NM_001172509.2(SATB2):c.1375C>T (p.Arg459Ter)	SATB2	R459*	Cleft palate, isolated|Dystonia|Intellectual disability|History of neurodevelopmental disorder|Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000522269	2	200193432	2	199328709	522269	512805	rs1553547838	NC_000002.12:199328708:G:A
NM_201253.3(CRB1):c.3488G>T (p.Cys1163Phe)	CRB1	C1051F, C1139F, C1163F	Leber congenital amaurosis 8|Retinitis pigmentosa 12	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000845976	1	197404481	1	197435351	845976	823134		NC_000001.11:197435350:G:T
NC_000001.11:g.(?_197438537)_(197442544_?)del	CRB1		Leber congenital amaurosis 8|Retinitis pigmentosa 12	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000831883	1	197407667 - 197411674			831883	818894		
NM_201253.3(CRB1):c.4168C>T (p.Arg1390Ter)	CRB1	R1278*, R1390*, R1366*, R854*	Leber congenital amaurosis 8|Retinitis pigmentosa 12	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000659686	1	197446956	1	197477826	659686	627201		NC_000001.11:197477825:C:T
NM_201253.3(CRB1):c.2548G>A (p.Gly850Ser)	CRB1	G850S, G738S, G781S	Leber congenital amaurosis 8|Retinitis pigmentosa 12	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000565382	1	197397003	1	197427873	565382	557082	rs776591659	NC_000001.11:197427872:G:A
NM_201253.3(CRB1):c.1431del (p.Ser478fs)	CRB1	S409fs, S478fs, S366fs	Macular dystrophy|Leber congenital amaurosis 8|Retinitis pigmentosa 12	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000446253	1	197390387	1	197421257	446253	439631	rs1553260321	NC_000001.11:197421256:GGG:GG
NM_001243766.1(POMGNT1):c.187C>T (p.Arg63Ter)	POMGNT1	R63*, R41*	Retinitis pigmentosa 76|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A3	Pathogenic(Last reviewed: Sep 20, 2016)	no assertion criteria provided	VCV000003994	1	46662690	1	46197018	3994	19033	rs193919337	NC_000001.11:46197017:G:A
NM_002529.3(NTRK1):c.1860_1861insT (p.Pro621fs)	NTRK1		not provided|Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000021306	1	156848968 - 156848969	1	156879176 - 156879177	21306	34158	rs80356676	NC_000001.11:156879176::T
NM_002529.3(NTRK1):c.1660del (p.Arg554fs)	NTRK1	R548fs, R518fs, R554fs	Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Aug 5, 2008)	no assertion criteria provided	VCV000021305	1	156846219	1	156876427	21305	34157	rs80356675	NC_000001.11:156876426:C:
NM_000329.3(RPE65):c.1022T>C (p.Leu341Ser)	RPE65	L341S	not provided|Leber congenital amaurosis 2|Retinitis pigmentosa 20|Retinitis pigmentosa 20|Leber congenital amaurosis 2	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013118	1	68903976	1	68438293	13118	28157	rs61752909	NC_000001.11:68438292:A:G
NC_000001.11:g.(?_75761112)_(75762773_?)del	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000832399	1	76226797 - 76228458			832399	818998		
NC_000001.10:g.(?_76226787)_(76228468_?)del	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000583848	1	76226787 - 76228468	1	75761102 - 75762783	583848	556884		
NM_000016.5(ACADM):c.449_452del (p.Thr150fs)	ACADM	T150fs, T154fs, T183fs, T114fs	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189036	1	76200534 - 76200537	1	75734849 - 75734852	189036	186630	rs786204642	NC_000001.11:75734848:TGACTGA:TGA
NM_000016.5(ACADM):c.1102_1105del (p.Ala369fs)	ACADM	A180fs, A402fs, A333fs, A369fs, A373fs	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003592	1	76226961 - 76226964	1	75761276 - 75761279	3592	18631	rs387906297	NC_000001.11:75761275:AGTTAG:AG
NM_000016.5(ACADM):c.999_1011dup (p.Gln338Ter)	ACADM		not provided|Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003587	1	76226858 - 76226859	1	75761173 - 75761174	3587	18626	rs1225471006	NC_000001.11:75761173:CTAGAATGAGTTAC:CTAGAATGAGTTACTAGAATGAGTTAC
NM_003742.4(ABCB11):c.1708G>A (p.Ala570Thr)	ABCB11	A570T	not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000288100	2	169826656	2	168970146	288100	272337	rs886043807	NC_000002.12:168970145:C:T
NM_000348.4(SRD5A2):c.680G>A (p.Arg227Gln)	SRD5A2	R227Q	not provided|Micropenis|3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003351	2	31754395	2	31529325	3351	18390	rs9332964	NC_000002.12:31529324:C:T
NM_024408.4(NOTCH2):c.6909dup (p.Ile2304fs)	NOTCH2		Hajdu-Cheney syndrome|Monoclonal B-Cell Lymphocytosis	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000223003	1	120458435 - 120458436	1	119915812 - 119915813	223003	224678	rs771237928	NC_000001.11:119915812:GGGGGG:GGGGGGG
NM_000302.4(PLOD1):c.955C>T (p.Arg319Ter)	PLOD1	R319*, R366*	not provided|Ehlers-Danlos syndrome, hydroxylysine-deficient	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000014364	1	12018684	1	11958627	14364	29403	rs121913550	NC_000001.11:11958626:C:T
NM_002529.3(NTRK1):c.543del (p.Leu183fs)	NTRK1	L153fs, L183fs	Charcot-Marie-Tooth disease|Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000637814	1	156838008	1	156868216	637814	624974		NC_000001.11:156868215:GGG:GG
NM_002529.3(NTRK1):c.2303C>T (p.Pro768Leu)	NTRK1	P768L, P732L, P762L	Charcot-Marie-Tooth disease|Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000637485	1	156851346	1	156881554	637485	624990		NC_000001.11:156881553:C:T
NM_002529.3(NTRK1):c.1759A>G (p.Met587Val)	NTRK1	M581V, M551V, M587V	Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: May 18, 2019)	criteria provided, single submitter	VCV000012312	1	156846318	1	156876526	12312	27351	rs121964870	NC_000001.11:156876525:A:G
NM_201253.3(CRB1):c.3014A>T (p.Asp1005Val)	CRB1	D981V, D1005V, D893V	Retinitis pigmentosa 12|Leber congenital amaurosis 8|Retinal dystrophy	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000846589	1	197404007	1	197434877	846589	823132		NC_000001.11:197434876:A:T
NM_201253.3(CRB1):c.3996C>A (p.Cys1332Ter)	CRB1	C1308*, C796*, C1220*, C1332*	Leber congenital amaurosis 8|Retinitis pigmentosa 12	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000841844	1	197411413	1	197442283	841844	823137		NC_000001.11:197442282:C:A
NM_201253.3(CRB1):c.2555T>C (p.Ile852Thr)	CRB1	I852T, I783T, I740T	Leber congenital amaurosis 8|Retinitis pigmentosa 12|Leber congenital amaurosis|not provided	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000099883	1	197397010	1	197427880	99883	105772	rs62636271	NC_000001.11:197427879:T:C
NM_014625.3(NPHS2):c.503G>A (p.Arg168His)	NPHS2	R168H	not provided|Nephrotic syndrome, idiopathic, steroid-resistant	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000188730	1	179528845	1	179559710	188730	186605	rs530318579	NC_000001.11:179559709:C:T
NM_014625.3(NPHS2):c.412C>T (p.Arg138Ter)	NPHS2	R138*	Nephrotic syndrome, idiopathic, steroid-resistant|not provided	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005361	1	179530463	1	179561328	5361	20400	rs74315343	NC_000001.11:179561327:G:A
NM_000310.3(PPT1):c.3G>A (p.Met1Ile)	PPT1	M1I	Neuronal ceroid lipofuscinosis|	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056193	1	40562908	1	40097236	56193	70832	rs386833645	NC_000001.11:40097235:C:T
NM_172362.3(KCNH1):c.1070G>A (p.Arg357Gln)	KCNH1	R357Q, R330Q	Seizures|Abnormal facial shape|Intellectual disability, severe|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000279981	1	211093374	1	210920032	279981	263996	rs886041300	NC_000001.11:210920031:C:T
NM_000530.8(MPZ):c.152C>T (p.Ser51Phe)	MPZ	S51F	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000531693	1	161277130	1	161307340	531693	515335	rs1553259790	NC_000001.11:161307339:G:A
NM_000530.8(MPZ):c.646dup (p.Thr216fs)	MPZ		Charcot-Marie-Tooth disease, type I|not provided	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000462798	1	161275766 - 161275767	1	161305976 - 161305977	462798	447420	rs1553259511	NC_000001.11:161305976:T:TT
NM_000530.8(MPZ):c.103G>A (p.Asp35Asn)	MPZ	D35N	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000462790	1	161277179	1	161307389	462790	447442	rs121913596	NC_000001.11:161307388:C:T
NM_000530.8(MPZ):c.233C>G (p.Ser78Trp)	MPZ	S78W	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000411669	1	161277049	1	161307259	411669	390849	rs121913601	NC_000001.11:161307258:G:C
NM_000530.8(MPZ):c.403A>C (p.Ile135Leu)	MPZ	I135L	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	VCV000243089	1	161276543	1	161306753	243089	244171	rs879253858	NC_000001.11:161306752:T:G
NM_000530.8(MPZ):c.182A>G (p.Asp61Gly)	MPZ	D61G	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic/Likely pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188168	1	161277100	1	161307310	188168	185952	rs786204119	NC_000001.11:161307309:T:C
NM_133259.4(LRPPRC):c.1061C>T (p.Ala354Val)	LRPPRC	A354V	not provided|Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003110	2	44201383	2	43974244	3110	18149	rs119466000	NC_000002.12:43974243:G:A
NM_006922.4(SCN3A):c.1318C>T (p.Gln440Ter)	SCN3A	Q440*	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 5, 2014)	criteria provided, single submitter	VCV000208754	2	166011024	2	165154514	208754	205223	rs797044933	NC_000002.12:165154513:G:A
NM_004895.4(NLRP3):c.1071A>C (p.Lys357Asn)	NLRP3	K357N, K355N	not provided	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, single submitter	VCV000429285	1	247587816	1	247424514	429285	421236	rs1131691298	NC_000001.11:247424513:A:C
NM_004895.4(NLRP3):c.1711G>A (p.Gly571Arg)	NLRP3	G571R, G569R	not provided	Pathogenic(Last reviewed: Jul 9, 2013)	criteria provided, single submitter	VCV000234301	1	247588456	1	247425154	234301	231479	rs121908151	NC_000001.11:247425153:G:A
NM_004895.5(NLRP3):c.911T>G (p.Phe304Cys)	NLRP3	F304C, F302C	Cryopyrin associated periodic syndrome	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, single submitter	VCV000837881	1	247587656	1	247424354	837881	823840		NC_000001.11:247424353:T:G
NM_003742.4(ABCB11):c.3169C>T (p.Arg1057Ter)	ABCB11	R1057*	not provided|Progressive familial intrahepatic cholestasis 2	Pathogenic(Last reviewed: Aug 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006596	2	169788931	2	168932421	6596	21635	rs72549397	NC_000002.12:168932420:G:A
NM_004895.4(NLRP3):c.916G>A (p.Glu306Lys)	NLRP3	E306K, E304K	Familial cold urticaria|not provided	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000097981	1	247587661	1	247424359	97981	103873	rs180177484	NC_000001.11:247424358:G:A
NM_004895.4(NLRP3):c.2582A>G (p.Tyr861Cys)	NLRP3	Y861C, Y859C, Y804C	not provided|Familial cold urticaria	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000097960	1	247599355	1	247436053	97960	103852	rs180177452	NC_000001.11:247436052:A:G
NM_001243133.1(NLRP3):c.926T>C (p.Phe309Ser)	NLRP3	F309S, F311S	Chronic infantile neurological, cutaneous and articular syndrome|Familial cold urticaria	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000004378	1	247587677	1	247424375	4378	19417	rs121908154	NC_000001.11:247424374:T:C
NM_001243133.1(NLRP3):c.1718T>C (p.Phe573Ser)	NLRP3	F573S, F575S	Chronic infantile neurological, cutaneous and articular syndrome|Familial cold urticaria	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000004376	1	247588469	1	247425167	4376	19415	rs121908152	NC_000001.11:247425166:T:C
NM_001243133.1(NLRP3):c.1705G>C (p.Gly569Arg)	NLRP3	G569R, G571R	Familial amyloid nephropathy with urticaria AND deafness|Familial cold urticaria	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000004375	1	247588456	1	247425154	4375	19414	rs121908151	NC_000001.11:247425153:G:C
NM_001243133.1(NLRP3):c.1055C>T (p.Ala352Val)	NLRP3	A352V, A354V	Familial amyloid nephropathy with urticaria AND deafness|Familial cold urticaria	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000004373	1	247587806	1	247424504	4373	19412	rs121908149	NC_000001.11:247424503:C:T
NM_001243133.1(NLRP3):c.1880A>G (p.Glu627Gly)	NLRP3	E627G, E629G	Familial cold urticaria	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000004372	1	247588631	1	247425329	4372	19411	rs121908148	NC_000001.11:247425328:A:G
NM_000228.3(LAMB3):c.727C>T (p.Gln243Ter)	LAMB3	Q243*	not provided|Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000035480	1	209806023	1	209632678	35480	33855	rs80356681	NC_000001.11:209632677:G:A
NM_004895.4(NLRP3):c.983G>A (p.Gly328Glu)	NLRP3	G328E, G326E	Cryopyrin associated periodic syndrome|Familial cold urticaria	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000097992	1	247587728	1	247424426	97992	103884	rs180177456	NC_000001.11:247424425:G:A
NM_000478.6(ALPL):c.1171C>T (p.Arg391Cys)	ALPL	R391C, R314C, R336C	Childhood hypophosphatasia|Adult hypophosphatasia|Infantile hypophosphatasia|not provided|Infantile hypophosphatasia	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000550442	1	21902399	1	21575906	550442	540957	rs371243939	NC_000001.11:21575905:C:T
NM_001918.4(DBT):c.901C>T (p.Arg301Cys)	DBT	R301C	not provided|Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094016	1	100680411	1	100214855	94016	99918	rs185492864	NC_000001.11:100214854:G:A
NM_001918.4(DBT):c.75_76del (p.Cys26fs)	DBT	C26fs	Maple syrup urine disease type 2|Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011950	1	100706416 - 100706417	1	100240860 - 100240861	11950	26989	rs768832921	NC_000001.11:100240859:AT:
NPHP1, DEL	NPHP1		Nephronophthisis 1|Senior-Loken syndrome 1|Joubert syndrome 4	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000003511					3511	18550		
NM_000530.8(MPZ):c.296T>C (p.Ile99Thr)	MPZ	I99T	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000637349	1	161276650	1	161306860	637349	625053		NC_000001.11:161306859:A:G
NM_000530.8(MPZ):c.397C>A (p.Pro133Thr)	MPZ	P133T	Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, demyelinating, type 1b|Roussy-Lévy syndrome|Charcot-Marie-Tooth disease type 2I||Charcot-Marie-Tooth disease type 2J|Congenital hypomyelinating neuropathy 1, autosomal recessive|Dejerine-Sottas disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000462797	1	161276549	1	161306759	462797	447245	rs1553259648	NC_000001.11:161306758:G:T
NM_000530.8(MPZ):c.286A>G (p.Lys96Glu)	MPZ	K96E	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000014166	1	161276660	1	161306870	14166	29205	rs121913583	NC_000001.11:161306869:T:C
NM_000016.5(ACADM):c.431_434del (p.Lys144fs)	ACADM	K144fs, K148fs, K177fs, K108fs	not provided|Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371546	1	76200518 - 76200521	1	75734833 - 75734836	371546	357136	rs1057517356	NC_000001.11:75734832:AAGTA:A
NM_000016.5(ACADM):c.617G>A (p.Arg206His)	ACADM	R206H, R210H, R170H, R17H, R239H	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092268	1	76211508	1	75745823	92268	98179	rs200724875	NC_000001.11:75745822:G:A
NM_002529.3(NTRK1):c.1945C>T (p.Arg649Trp)	NTRK1	R643W, R649W, R613W	Hereditary insensitivity to pain with anhidrosis	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000834440	1	156849053	1	156879261	834440	822856		NC_000001.11:156879260:C:T
NM_024529.4(CDC73):c.375_376delinsT (p.Lys125fs)	CDC73		not provided	Pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, single submitter	VCV000545876	1	193104671 - 193104672	1	193135541 - 193135542	545876	536225	rs1553278841	NC_000001.11:193135540:AC:T
NM_024529.4(CDC73):c.3G>T (p.Met1Ile)	CDC73	M1I	not provided	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000489059	1	193091333	1	193122203	489059	481573	rs28942098	NC_000001.11:193122202:G:T
NM_024529.4(CDC73):c.423+1G>A	CDC73		not provided	Pathogenic(Last reviewed: Sep 25, 2015)	criteria provided, single submitter	VCV000430013	1	193104720	1	193135590	430013	421192	rs1131691732	NC_000001.11:193135589:G:A
NM_024529.4(CDC73):c.238-2A>T	CDC73		not provided	Pathogenic(Last reviewed: Jul 16, 2015)	criteria provided, single submitter	VCV000419476	1	193099302	1	193130172	419476	404994	rs1064793897	NC_000001.11:193130171:A:T
NM_024529.4(CDC73):c.723_725delinsC (p.Gly242fs)	CDC73		not provided	Pathogenic(Last reviewed: Apr 29, 2016)	criteria provided, single submitter	VCV000280360	1	193111190 - 193111192	1	193142060 - 193142062	280360	263962	rs886041580	NC_000001.11:193142059:AGG:C
NM_024529.4(CDC73):c.355C>T (p.Gln119Ter)	CDC73	Q119*	not provided	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000279950	1	193104568	1	193135438	279950	263995	rs886041278	NC_000001.11:193135437:C:T
NM_024529.4(CDC73):c.226C>T (p.Arg76Ter)	CDC73	R76*	not provided	Pathogenic(Last reviewed: Oct 20, 2016)	criteria provided, single submitter	VCV000279741	1	193094336	1	193125206	279741	263993	rs886041158	NC_000001.11:193125205:C:T
NM_024529.4(CDC73):c.109A>T (p.Lys37Ter)	CDC73	K37*	not provided	Pathogenic(Last reviewed: Aug 17, 2016)	criteria provided, single submitter	VCV000265669	1	193091439	1	193122309	265669	259638	rs886039716	NC_000001.11:193122308:A:T
NM_024529.5(CDC73):c.220dup (p.Tyr74fs)	CDC73		Parathyroid carcinoma	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801586	1	193094327 - 193094328	1	193125197 - 193125198	801586	789894		NC_000001.11:193125197:TTT:TTTT
NM_024529.4(CDC73):c.8_10delinsCT (p.Asp3fs)	CDC73		Ossifying fibroma of the jaw	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000252999	1	193091338 - 193091340	1	193122208 - 193122210	252999	247400	rs1057519385	NC_000001.11:193122207:ACG:CT
NM_024529.4(CDC73):c.13_16del (p.Leu5fs)	CDC73	L5fs	Ossifying fibroma of the jaw	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000252998	1	193091343 - 193091346	1	193122213 - 193122216	252998	247401	rs1057519384	NC_000001.11:193122212:CTTA:
NM_024529.4(CDC73):c.54del (p.Ile18fs)	CDC73	I18fs	Cystic parathyroid adenoma	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000003273	1	193091383	1	193122253	3273	18312	rs587776557	NC_000001.11:193122252:TT:T
NM_024529.5(CDC73):c.1001_1004del (p.Thr334fs)	CDC73	T334fs	Parathyroid carcinoma	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000844763	1	193172953 - 193172956	1	193203823 - 193203826	844763	823096		NC_000001.11:193203822:CTCC:
NC_000001.11:g.(?_193122191)_(193125227_?)del	CDC73		Parathyroid carcinoma	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000831275	1	193091321 - 193094357			831275	818877		
NC_000001.11:g.(?_193122201)_(193125227_?)del	CDC73		Parathyroid carcinoma	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV000830741	1	193091331 - 193094357			830741	818881		
NC_000001.11:g.(?_193122191)_(193150392_?)del	CDC73		Parathyroid carcinoma	Pathogenic(Last reviewed: Jul 20, 2019)	criteria provided, single submitter	VCV000830553	1	193091321 - 193119522			830553	818878		
NM_024529.5(CDC73):c.718del (p.Ser240fs)	CDC73	S240fs	Parathyroid carcinoma	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000660497	1	193111183	1	193142053	660497	627180		NC_000001.11:193142052:AAA:AA
NM_024529.4(CDC73):c.358C>T (p.Arg120Ter)	CDC73	R120*	Parathyroid carcinoma	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000642112	1	193104571	1	193135441	642112	627174		NC_000001.11:193135440:C:T
NC_000001.10:g.(?_193205376)_(193205496_?)del	CDC73		Parathyroid carcinoma	Pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000583777	1	193205376 - 193205496	1	193236246 - 193236366	583777	556496		
NC_000001.10:g.(?_193091321)_(193091471_?)del	CDC73		Parathyroid carcinoma	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000583491	1	193091321 - 193091471	1	193122191 - 193122341	583491	556495		
NM_024529.4(CDC73):c.53_54del (p.Ile18fs)	CDC73	I18fs	Parathyroid carcinoma	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000567635	1	193091383 - 193091384	1	193122253 - 193122254	567635	557072	rs1558276157	NC_000001.11:193122252:TT:
NM_024529.4(CDC73):c.483dup (p.Glu162fs)	CDC73		Parathyroid carcinoma	Pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	VCV000531648	1	193107271 - 193107272	1	193138141 - 193138142	531648	515395	rs1553279085	NC_000001.11:193138141:AAA:AAAA
NM_024529.4(CDC73):c.505C>T (p.Gln169Ter)	CDC73	Q169*	Parathyroid carcinoma	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000462764	1	193107296	1	193138166	462764	447332	rs1553279088	NC_000001.11:193138165:C:T
NM_024529.4(CDC73):c.1052del (p.Pro351fs)	CDC73	P351fs	Parathyroid carcinoma	Pathogenic(Last reviewed: Oct 11, 2017)	criteria provided, single submitter	VCV000462737	1	193181212	1	193212082	462737	447342	rs1553288362	NC_000001.11:193212081:CCCCC:CCCC
NC_000001.10:g.(?_193099304)_(193099373_?)del	CDC73		Parathyroid carcinoma	Pathogenic(Last reviewed: Apr 21, 2016)	criteria provided, single submitter	VCV000417319	1	193099304 - 193099373	1	193130174 - 193130243	417319	390715		
NM_024529.4(CDC73):c.4del (p.Ala2fs)	CDC73	A2fs	Parathyroid carcinoma	Pathogenic(Last reviewed: Apr 16, 2016)	criteria provided, single submitter	VCV000403893	1	193091333	1	193122203	403893	390953	rs1060500020	NC_000001.11:193122202:GG:G
NM_024529.4(CDC73):c.451_452GA[2] (p.Arg152fs)	CDC73		Parathyroid carcinoma	Pathogenic(Last reviewed: Dec 26, 2016)	criteria provided, single submitter	VCV000403892	1	193107241 - 193107242	1	193138111 - 193138112	403892	390955	rs1060500019	NC_000001.11:193138110:AGAGAGA:AGAGA
NM_024529.4(CDC73):c.245del (p.Asn82fs)	CDC73	N82fs	Parathyroid carcinoma	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000403878	1	193099308	1	193130178	403878	390933	rs1060500009	NC_000001.11:193130177:AAAA:AAA
NM_024529.4(CDC73):c.237+1G>T	CDC73		not provided	Pathogenic(Last reviewed: Jan 27, 2015)	criteria provided, single submitter	VCV000195377	1	193094348	1	193125218	195377	192538	rs794727303	NC_000001.11:193125217:G:T
NM_024529.4(CDC73):c.766_767del (p.Val256fs)	CDC73	V256fs	Parathyroid carcinoma	Pathogenic(Last reviewed: May 24, 2012)	no assertion criteria provided	VCV000021687	1	193117032 - 193117033	1	193147902 - 193147903	21687	34539	rs80356650	NC_000001.11:193147901:TGT:T
NM_024529.4(CDC73):c.13_30del (p.Leu5_Gln10del)	CDC73		Parathyroid carcinoma	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000003281	1	193091342 - 193091359	1	193122212 - 193122229	3281	18320	rs587776561	NC_000001.11:193122211:GCTTAGCGTCCTGCGACAG:G
NM_024529.4(CDC73):c.85del (p.Glu29fs)	CDC73	E29fs	Parathyroid carcinoma	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000003280	1	193091412	1	193122282	3280	18319	rs587776560	NC_000001.11:193122281:GGGG:GGG
NM_024529.4(CDC73):c.375dup (p.Arg126fs)	CDC73		Parathyroid carcinoma	Pathogenic(Last reviewed: Oct 30, 2003)	no assertion criteria provided	VCV000003275	1	193104668 - 193104669	1	193135538 - 193135539	3275	18314		NC_000001.11:193135538:AAA:AAAA
NM_024529.4(CDC73):c.191T>C (p.Leu64Pro)	CDC73	L64P	Hyperparathyroidism 1	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000003272	1	193094301	1	193125171	3272	18311	rs121434264	NC_000001.11:193125170:T:C
NM_024529.4(CDC73):c.128G>A (p.Trp43Ter)	CDC73	W43*	Parathyroid carcinoma	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000003271	1	193091458	1	193122328	3271	18310	rs121434263	NC_000001.11:193122327:G:A
NC_000001.11:g.(?_193125102)_(193130253_?)del	CDC73		Parathyroid carcinoma	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000831107	1	193094232 - 193099383			831107	818886		
NM_024529.5(CDC73):c.237+1G>A	CDC73		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000821167	1	193094348	1	193125218	821167	815216		NC_000001.11:193125217:G:A
NM_024529.5(CDC73):c.1247del (p.Gly416fs)	CDC73	G416fs	Parathyroid carcinoma	Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000658249	1	193202211	1	193233081	658249	627187		NC_000001.11:193233080:GGGGG:GGGG
NM_024529.4(CDC73):c.12_31dup (p.Tyr11fs)	CDC73		Parathyroid carcinoma	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000579524	1	193091339 - 193091340	1	193122209 - 193122210	579524	556716	rs1558276082	NC_000001.11:193122209:GTGCTTAGCGTCCTGCGACAGT:GTGCTTAGCGTCCTGCGACAGTGCTTAGCGTCCTGCGACAGT
NM_024529.4(CDC73):c.376C>T (p.Arg126Ter)	CDC73	R126*	Parathyroid carcinoma	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000462760	1	193104672	1	193135542	462760	447543	rs1553278844	NC_000001.11:193135541:C:T
NM_024529.4(CDC73):c.238-1G>A	CDC73		Hyperparathyroidism 2	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000003279	1	193099303	1	193130173	3279	18318	rs587776559	NC_000001.11:193130172:G:A
CDC73, 2-BP DEL	CDC73		Hyperparathyroidism 2	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000003277					3277	18316		
CDC73, 41-BP DUP/INS	CDC73		Hyperparathyroidism 2	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000003269					3269	18308		
NM_024529.4(CDC73):c.25C>T (p.Arg9Ter)	CDC73	R9*	Hyperparathyroidism 2	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000003268	1	193091355	1	193122225	3268	18307	rs121434262	NC_000001.11:193122224:C:T
NM_024529.4(CDC73):c.3G>A (p.Met1Ile)	CDC73	M1I	Hyperparathyroidism 2	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000003267	1	193091333	1	193122203	3267	18306	rs28942098	NC_000001.11:193122202:G:A
NC_000001.11:g.(?_193135381)_(193138183_?)del	CDC73		Parathyroid carcinoma	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000833443	1	193104511 - 193107313			833443	818887		
NC_000001.11:g.(?_193122191)_(193152454_?)del	CDC73		Parathyroid carcinoma	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000832317	1	193091321 - 193121584			832317	818879		
NM_024529.4(CDC73):c.679_680AG[3] (p.Arg229fs)	CDC73		Parathyroid adenoma|Parathyroid carcinoma	Pathogenic(Last reviewed: Aug 1, 2006)	no assertion criteria provided	VCV000003278	1	193111146 - 193111149	1	193142016 - 193142019	3278	18317		NC_000001.11:193142015:AGAGAGAGAG:AGAGAG
NM_024529.4(CDC73):c.162C>G (p.Tyr54Ter)	CDC73	Y54*	Parathyroid carcinoma	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000003274	1	193094272	1	193125142	3274	18313	rs121434265	NC_000001.11:193125141:C:G
NM_004958.4(MTOR):c.4366T>G (p.Trp1456Gly)	MTOR	W1456G	Focal cortical dysplasia type II	Pathogenic(Last reviewed: Apr 11, 2017)	no assertion criteria provided	VCV000417727	1	11217312	1	11157255	417727	404628	rs1085307114	NC_000001.11:11157254:A:C
NM_004958.4(MTOR):c.7280T>A (p.Leu2427Gln)	MTOR	L2427Q	Focal cortical dysplasia type II	Pathogenic(Last reviewed: Apr 11, 2017)	no assertion criteria provided	VCV000417724	1	11174395	1	11114338	417724	404625	rs1085307113	NC_000001.11:11114337:A:T
NM_004958.4(MTOR):c.7280T>C (p.Leu2427Pro)	MTOR	L2427P	Focal cortical dysplasia type II	Pathogenic(Last reviewed: Apr 11, 2017)	no assertion criteria provided	VCV000417723	1	11174395	1	11114338	417723	404624	rs1085307113	NC_000001.11:11114337:A:G
NM_004958.4(MTOR):c.3026G>A (p.Arg1009Gln)	MTOR	R1009Q	Renal cell carcinoma, papillary, 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801436	1	11288729	1	11228672	801436	789820		NC_000001.11:11228671:C:T
NM_004958.4(MTOR):c.6981G>A (p.Met2327Ile)	MTOR	M2327I	Smith-Kingsmore syndrome	Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, single submitter	VCV000242349	1	11177096	1	11117039	242349	243900	rs878855328	NC_000001.11:11117038:C:T
NM_024529.5(CDC73):c.271C>T (p.Arg91Ter)	CDC73	R91*	Parathyroid carcinoma	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000846304	1	193099337	1	193130207	846304	823082		NC_000001.11:193130206:C:T
NM_024529.4(CDC73):c.237+1G>C	CDC73		Parathyroid carcinoma	Pathogenic(Last reviewed: May 23, 2019)	criteria provided, single submitter	VCV000403882	1	193094348	1	193125218	403882	390974	rs794727303	NC_000001.11:193125217:G:C
NM_201253.3(CRB1):c.1438T>C (p.Cys480Arg)	CRB1	C480R, C368R, C411R	Leber congenital amaurosis 8|Retinitis pigmentosa 12|not provided	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000099870	1	197390396	1	197421266	99870	105759	rs62636264	NC_000001.11:197421265:T:C
NM_015506.3(MMACHC):c.331C>T (p.Arg111Ter)	MMACHC	R111*, R54*	not provided|Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001424	1	45973938	1	45508266	1424	16463	rs121918242	NC_000001.11:45508265:C:T
NM_004958.4(MTOR):c.5930C>T (p.Thr1977Ile)	MTOR	T1977I	Focal cortical dysplasia type II|MTOR-related megalencephaly and pigmentary mosaicism in skin	Pathogenic(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000584432	1	11188164	1	11128107	584432	575484	rs587777893	NC_000001.11:11128106:G:A
NM_004958.4(MTOR):c.4379T>C (p.Leu1460Pro)	MTOR	L1460P	Kidney Carcinoma|Focal cortical dysplasia type II	Pathogenic/Likely pathogenic(Last reviewed: Apr 11, 2017)	no assertion criteria provided	VCV000376130	1	11217299	1	11157242	376130	363009	rs1057519779	NC_000001.11:11157241:A:G
NM_004958.4(MTOR):c.5663T>G (p.Phe1888Cys)	MTOR	F1888C	not provided|Smith-Kingsmore syndrome	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000224083	1	11189846	1	11129789	224083	225813	rs869312666	NC_000001.11:11129788:A:C
NM_000702.4(ATP1A2):c.1882G>A (p.Val628Met)	ATP1A2	V628M	not provided	Pathogenic(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	VCV000449380	1	160104328	1	160134538	449380	442651	rs1553245659	NC_000001.11:160134537:G:A
NM_000702.4(ATP1A2):c.1816G>A (p.Ala606Thr)	ATP1A2	A606T	not provided	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000449379	1	160100376	1	160130586	449379	442650	rs1414742926	NC_000001.11:160130585:G:A
NM_000702.4(ATP1A2):c.2500C>T (p.Arg834Ter)	ATP1A2	R834*	not provided	Pathogenic(Last reviewed: Aug 11, 2016)	criteria provided, single submitter	VCV000265408	1	160106097	1	160136307	265408	259634	rs755310507	NC_000001.11:160136306:C:T
NM_000702.4(ATP1A2):c.1127C>G (p.Thr376Arg)	ATP1A2	T376R	not provided	Pathogenic(Last reviewed: Sep 4, 2013)	criteria provided, single submitter	VCV000204885	1	160098551	1	160128761	204885	201079	rs121918620	NC_000001.11:160128760:C:G
NM_000702.4(ATP1A2):c.293_294TC[3] (p.Ile100fs)	ATP1A2		Polymicrogyria	Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, single submitter	VCV000549760	1	160093117 - 160093118	1	160123327 - 160123328	549760	540526	rs1558003446	NC_000001.11:160123327:TCTC:TCTCTC
NM_000702.4(ATP1A2):c.2869G>T (p.Glu957Ter)	ATP1A2	E957*	Polymicrogyria	Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, single submitter	VCV000549759	1	160109458	1	160139668	549759	540525	rs1558010146	NC_000001.11:160139667:G:T
NM_000702.4(ATP1A2):c.1743C>A (p.Cys581Ter)	ATP1A2	C581*	Familial hemiplegic migraine	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000644202	1	160100303	1	160130513	644202	627001		NC_000001.11:160130512:C:A
NM_000702.4(ATP1A2):c.571G>A (p.Val191Met)	ATP1A2	V191M	Familial hemiplegic migraine type 2	Pathogenic(Last reviewed: Feb 18, 2016)	no assertion criteria provided	VCV000222078	1	160094161	1	160124371	222078	223777	rs869025341	NC_000001.11:160124370:G:A
NM_000702.4(ATP1A2):c.857T>C (p.Ile286Thr)	ATP1A2	I286T	Familial hemiplegic migraine type 2	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000012927	1	160097450	1	160127660	12927	27966	rs121918617	NC_000001.11:160127659:T:C
NM_000702.4(ATP1A2):c.2152G>A (p.Asp718Asn)	ATP1A2	D718N	Familial hemiplegic migraine type 2	Pathogenic(Last reviewed: May 25, 2004)	no assertion criteria provided	VCV000012924	1	160105260	1	160135470	12924	27963	rs121918614	NC_000001.11:160135469:G:A
NM_000702.4(ATP1A2):c.901G>A (p.Gly301Arg)	ATP1A2	G301R	Familial hemiplegic migraine type 2	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000012922	1	160097494	1	160127704	12922	27961	rs121918612	NC_000001.11:160127703:G:A
NM_000702.4(ATP1A2):c.2659T>C (p.Trp887Arg)	ATP1A2	W887R	Familial hemiplegic migraine type 2	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000012918	1	160106455	1	160136665	12918	27957	rs28933399	NC_000001.11:160136664:T:C
NM_000702.4(ATP1A2):c.2291T>C (p.Leu764Pro)	ATP1A2	L764P	Familial hemiplegic migraine type 2	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000012917	1	160105635	1	160135845	12917	27956	rs28933398	NC_000001.11:160135844:T:C
NM_003001.5(SDHC):c.86del (p.Pro29fs)	SDHC	P29fs	Paragangliomas 3|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000858738	1	161298193	1	161328403	858738	822948		NC_000001.11:161328402:CC:C
NM_003001.5(SDHC):c.247dup (p.Ser83fs)	SDHC		Gastrointestinal stromal tumor|Paragangliomas 3	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000853482	1	161326471 - 161326472	1	161356681 - 161356682	853482	822953		NC_000001.11:161356681:T:TT
NM_003001.5(SDHC):c.183del (p.Trp61fs)	SDHC	W61fs, W8fs, W27fs	Paragangliomas 3|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000851539	1	161310386	1	161340596	851539	822951		NC_000001.11:161340595:GG:G
NM_003001.3(SDHC):c.215del (p.Arg72fs)	SDHC	R38fs, R72fs, R19fs	Paragangliomas 3|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	VCV000534368	1	161310419	1	161340629	534368	515277	rs1553264218	NC_000001.11:161340628:G:
NM_003001.3(SDHC):c.406-?_*2318+?del	SDHC		Paragangliomas 3|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Feb 9, 2016)	criteria provided, single submitter	VCV000239456					239456	238107		
NM_024529.4(CDC73):c.85G>T (p.Glu29Ter)	CDC73	E29*	not provided|Parathyroid carcinoma	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429954	1	193091415	1	193122285	429954	421191	rs1131691698	NC_000001.11:193122284:G:T
NM_000702.4(ATP1A2):c.1643G>A (p.Arg548His)	ATP1A2	R548H	not provided|Migraine, familial basilar	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000012926	1	160100073	1	160130283	12926	27965	rs121918616	NC_000001.11:160130282:G:A
NM_000702.4(ATP1A2):c.1133C>A (p.Thr378Asn)	ATP1A2	T378N	Alternating hemiplegia of childhood 1	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000012921	1	160098557	1	160128767	12921	27960	rs28934002	NC_000001.11:160128766:C:A
NM_000702.4(ATP1A2):c.788C>T (p.Thr263Met)	ATP1A2	T263M	not provided	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000585463	1	160097381	1	160127591	585463	576418	rs777400961	NC_000001.11:160127590:C:T
NM_000702.4(ATP1A2):c.1261C>T (p.Arg421Ter)	ATP1A2	R421*	not provided|Familial hemiplegic migraine	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000444184	1	160098814	1	160129024	444184	437824	rs1165052640	NC_000001.11:160129023:C:T
NM_000702.4(ATP1A2):c.1033A>G (p.Thr345Ala)	ATP1A2	T345A	Familial hemiplegic migraine type 2	Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000012923	1	160098457	1	160128667	12923	27962	rs121918613	NC_000001.11:160128666:A:G
NM_000364.4(TNNT2):c.842+1G>A	TNNT2		Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 22, 2014)	criteria provided, single submitter	VCV000043673	1	201328750	1	201359622	43673	52842	rs111377893	NC_000001.11:201359621:C:T
NM_000702.4(ATP1A2):c.2192T>C (p.Met731Thr)	ATP1A2	M731T	Familial hemiplegic migraine type 2	Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000012919	1	160105300	1	160135510	12919	27958	rs28933400	NC_000001.11:160135509:T:C
NM_000310.3(PPT1):c.541G>T (p.Val181Leu)	PPT1	V181L, V78L	|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056202	1	40546155	1	40080483	56202	70841	rs148412181	NC_000001.11:40080482:C:A
NM_018122.5(DARS2):c.492+2T>C	DARS2		Clubfoot|Abnormality of the foot|EMG: axonal abnormality|Hypertensive disorder|Gout|Sensorimotor neuropathy|CNS demyelination|Impaired vibration sensation in the lower limbs|Cerebral cortical atrophy|Difficulty walking|Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation|not provided|Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|Gait ataxia|Gait imbalance|Dysmetria	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001062	1	173800770	1	173831632	1062	16101	rs142433332	NC_000001.11:173831631:T:C
NM_013339.4(ALG6):c.257+5G>A	ALG6		not provided|Congenital disorder of glycosylation type 1C	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095529	1	63868019	1	63402348	95529	101428	rs199682486	NC_000001.11:63402347:G:A
NM_024529.4(CDC73):c.679_680AG[6] (p.Val230fs)	CDC73		Parathyroid carcinoma|not provided	Pathogenic(Last reviewed: Jan 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000241496	1	193111145 - 193111146	1	193142015 - 193142016	241496	238201	rs760591174	NC_000001.11:193142015:AGAGAGAGAG:AGAGAGAGAGAG
NM_000702.4(ATP1A2):c.2143G>A (p.Gly715Arg)	ATP1A2	G715R	Familial hemiplegic migraine|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000446869	1	160105251	1	160135461	446869	440365	rs1553245771	NC_000001.11:160135460:G:A
NM_000530.8(MPZ):c.487G>A (p.Gly163Arg)	MPZ	G163R	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000208148	1	161276216	1	161306426	208148	204408	rs281865128	NC_000001.11:161306425:C:T
NM_004525.3(LRP2):c.6978dup (p.Thr2327fs)	LRP2		not provided	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000817484	2	170063251 - 170063252	2	169206741 - 169206742	817484	805254		NC_000002.12:169206741:C:CC
NM_004525.3(LRP2):c.2474del (p.Tyr824_Leu825insTer)	LRP2		not provided	Pathogenic(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000452405	2	170115574	2	169259064	452405	443052	rs1553504456	NC_000002.12:169259063:AAA:AA
NM_004525.3(LRP2):c.2474T>G (p.Leu825Ter)	LRP2	L825*		Pathogenic	no assertion criteria provided	VCV000625858	2	170115574	2	169259064	625858	614162	rs1559043276	NC_000002.12:169259063:A:C
NM_004525.3(LRP2):c.832C>T (p.Arg278Ter)	LRP2	R278*		Pathogenic	no assertion criteria provided	VCV000625857	2	170147445	2	169290935	625857	614161	rs1358532875	NC_000002.12:169290934:G:A
NM_003036.4(SKI):c.91T>C (p.Ser31Pro)	SKI	S31P	Shprintzen-Goldberg syndrome	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000692060	1	2160296	1	2228857	692060	679733		NC_000001.11:2228856:T:C
NM_004525.3(LRP2):c.2639+1G>A	LRP2			Pathogenic(Last reviewed: Apr 12, 2018)	no assertion criteria provided	VCV000559644	2	170113633	2	169257123	559644	550350	rs746752313	NC_000002.12:169257122:C:T
NM_003036.4(SKI):c.62T>G (p.Leu21Arg)	SKI	L21R	Shprintzen-Goldberg syndrome	Pathogenic	criteria provided, single submitter	VCV000224869	1	2160267	1	2228828	224869	226716	rs869312902	NC_000001.11:2228827:T:G
NM_004525.3(LRP2):c.6160G>A (p.Asp2054Asn)	LRP2	D2054N		Pathogenic(Last reviewed: Nov 15, 2012)	no assertion criteria provided	VCV000039974	2	170068598	2	169212088	39974	48494	rs138269726	NC_000002.12:169212087:C:T
NM_004525.3(LRP2):c.12437del (p.Gly4146fs)	LRP2	G4146fs		Pathogenic(Last reviewed: Nov 15, 2012)	no assertion criteria provided	VCV000039973	2	170009333	2	169152823	39973	48493	rs786205122	NC_000002.12:169152822:CC:C
NM_003036.4(SKI):c.280_291del (p.Ser94_Ser97del)	SKI		Shprintzen-Goldberg syndrome	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039784	1	2160485 - 2160496	1	2229046 - 2229057	39784	48383	rs398122914	NC_000001.11:2229045:TCCGACCGCTCC:
NM_004525.3(LRP2):c.9358_9359del (p.Ser3120fs)	LRP2	S3120fs		Pathogenic(Last reviewed: Jun 28, 2011)	no assertion criteria provided	VCV000021421	2	170042499 - 170042500	2	169185989 - 169185990	21421	34273	rs80338750	NC_000002.12:169185988:CT:
NM_004525.3(LRP2):c.770-2A>G	LRP2			Pathogenic(Last reviewed: Jun 28, 2011)	no assertion criteria provided	VCV000021420	2	170147509	2	169290999	21420	34272	rs80338743	NC_000002.12:169290998:T:C
NM_004525.3(LRP2):c.13139dup (p.Cys4381fs)	LRP2			Pathogenic(Last reviewed: Jun 28, 2011)	no assertion criteria provided	VCV000021419	2	169997024 - 169997025	2	169140514 - 169140515	21419	34271	rs80338754	NC_000002.12:169140514:GGGGGGGG:GGGGGGGGG
NM_004525.3(LRP2):c.11469_11472del (p.Cys3823fs)	LRP2	C3823fs		Pathogenic(Last reviewed: Jun 28, 2011)	no assertion criteria provided	VCV000021418	2	170026237 - 170026240	2	169169727 - 169169730	21418	34270	rs80338753	NC_000002.12:169169726:CAAACA:CA
NM_003036.4(SKI):c.101G>T (p.Gly34Val)	SKI	G34V	Shprintzen-Goldberg syndrome	Pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000039783	1	2160306	1	2228867	39783	48382	rs387907305	NC_000001.11:2228866:G:T
NM_003036.4(SKI):c.283_291del (p.Asp95_Ser97del)	SKI		Shprintzen-Goldberg syndrome	Pathogenic	criteria provided, single submitter	VCV000037263	1	2160485 - 2160493	1	2229046 - 2229054	37263	45853	rs398122889	NC_000001.11:2229045:TCCGACCGCTCC:TCC
NM_003036.4(SKI):c.347G>A (p.Gly116Glu)	SKI	G116E	Shprintzen-Goldberg syndrome	Pathogenic	criteria provided, single submitter	VCV000037258	1	2160552	1	2229113	37258	45848	rs387907303	NC_000001.11:2229112:G:A
NM_153759.3(DNMT3A):c.2077C>T (p.Arg693Cys)	DNMT3A	R693C, R882C, R822C, R730C	Acute myeloid leukemia|Tatton-Brown-rahman syndrome|Lung adenocarcinoma|Myelodysplastic syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 8, 2018)	no assertion criteria provided	VCV000375882	2	25457243	2	25234374	375882	362761	rs377577594	NC_000002.12:25234373:G:A
NM_003036.4(SKI):c.638_895del (p.Leu213_Ala298del)	SKI		Shprintzen-Goldberg syndrome	Pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	VCV000463409	1	2160841 - 2161098	1	2229402 - 2229659	463409	447810	rs1553189986	
NM_003036.4(SKI):c.349G>C (p.Gly117Arg)	SKI	G117R	not provided|Shprintzen-Goldberg syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000224868	1	2160554	1	2229115	224868	226717	rs869312901	NC_000001.11:2229114:G:C
NM_003036.4(SKI):c.101G>A (p.Gly34Asp)	SKI	G34D	Shprintzen-Goldberg syndrome	Pathogenic	criteria provided, single submitter	VCV000037260	1	2160306	1	2228867	37260	45850	rs387907305	NC_000001.11:2228866:G:A
NM_004525.3(LRP2):c.1093C>T (p.Arg365Ter)	LRP2	R365*		Pathogenic(Last reviewed: Jun 28, 2011)	no assertion criteria provided	VCV000009457	2	170139461	2	169282951	9457	24496	rs80338744	NC_000002.12:169282950:G:A
NM_004525.3(LRP2):c.1341+2T>G	LRP2			Pathogenic(Last reviewed: Jun 28, 2011)	no assertion criteria provided	VCV000009456	2	170136858	2	169280348	9456	24495	rs80338745	NC_000002.12:169280347:A:C
NM_004525.3(LRP2):c.10195C>T (p.Arg3399Ter)	LRP2	R3399*		Pathogenic(Last reviewed: Jun 28, 2011)	no assertion criteria provided	VCV000009455	2	170034511	2	169178001	9455	24494	rs80338752	NC_000002.12:169178000:G:A
NM_004525.3(LRP2):c.8452+1G>A	LRP2			Pathogenic(Last reviewed: Jun 28, 2011)	no assertion criteria provided	VCV000009454	2	170058137	2	169201627	9454	24493	rs80338748	NC_000002.12:169201626:C:T
NM_004525.3(LRP2):c.8519_8522del (p.Tyr2840fs)	LRP2	Y2840fs		Pathogenic(Last reviewed: Jun 28, 2011)	no assertion criteria provided	VCV000009453	2	170055352 - 170055355	2	169198842 - 169198845	9453	24492	rs80338749	NC_000002.12:169198841:AAATAAA:AAA
NM_004525.3(LRP2):c.2640-1G>A	LRP2			Pathogenic(Last reviewed: Jun 28, 2011)	no assertion criteria provided	VCV000009452	2	170112747	2	169256237	9452	24491	rs587776717	NC_000002.12:169256236:C:T
NM_004525.3(LRP2):c.9484_9485del (p.Val3162fs)	LRP2	V3162fs		Pathogenic(Last reviewed: Jun 28, 2011)	no assertion criteria provided	VCV000009451	2	170042373 - 170042374	2	169185863 - 169185864	9451	24490	rs80338751	NC_000002.12:169185862:ACA:A
NM_000702.4(ATP1A2):c.2563G>A (p.Gly855Arg)	ATP1A2	G855R	Familial hemiplegic migraine|not provided	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000446871	1	160106160	1	160136370	446871	440367	rs1553245857	NC_000001.11:160136369:G:A
NM_000702.4(ATP1A2):c.1127C>T (p.Thr376Met)	ATP1A2	T376M	Familial hemiplegic migraine type 2|Familial hemiplegic migraine	Pathogenic(Last reviewed: May 17, 2019)	criteria provided, single submitter	VCV000012930	1	160098551	1	160128761	12930	27969	rs121918620	NC_000001.11:160128760:C:T
NM_024529.4(CDC73):c.664C>T (p.Arg222Ter)	CDC73	R222*	Parathyroid carcinoma	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000658835	1	193111131	1	193142001	658835	627176		NC_000001.11:193142000:C:T
NM_201253.3(CRB1):c.2308G>A (p.Gly770Ser)	CRB1	G770S, G658S, G701S	Retinal dystrophy|Leber congenital amaurosis 8|Retinitis pigmentosa 12	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000236478	1	197396763	1	197427633	236478	237970	rs767648174	NC_000001.11:197427632:G:A
NM_201253.3(CRB1):c.4121_4130del (p.Ala1374fs)	CRB1	A1262fs, A1374fs, A838fs, A1350fs	Retinitis pigmentosa 12|Leber congenital amaurosis 8|Leber congenital amaurosis|not provided	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000005740	1	197446905 - 197446914	1	197477775 - 197477784	5740	20779	rs281865175	NC_000001.11:197477774:AGGGCAACTCAGGG:AGGG
NM_000016.5(ACADM):c.250C>T (p.Leu84Phe)	ACADM	L84F, L88F, L48F	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000226097	1	76198571	1	75732886	226097	227867	rs762114560	NC_000001.11:75732885:C:T
NM_001253852.3(AP4B1):c.405_409del (p.Tyr135_Arg137delinsTer)	AP4B1		Inborn genetic diseases	Pathogenic(Last reviewed: Mar 2, 2015)	criteria provided, single submitter	VCV000520648	1	114444437 - 114444441	1	113901815 - 113901819	520648	511156	rs1553259463	NC_000001.11:113901814:TGACAT:T
NM_000478.6(ALPL):c.526G>A (p.Ala176Thr)	ALPL	A176T, A121T, A99T	Infantile hypophosphatasia|not provided|Childhood hypophosphatasia|Adult hypophosphatasia|Infantile hypophosphatasia|Childhood hypophosphatasia	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013683	1	21890587	1	21564094	13683	28722	rs121918019	NC_000001.11:21564093:G:A
NM_000784.4(CYP27A1):c.1420C>T (p.Arg474Trp)	CYP27A1	R441W, R474W	Cholestanol storage disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004259	2	219679424	2	218814701	4259	19298	rs121908098	NC_000002.12:218814700:C:T
NM_020451.3(SELENON):c.713dup (p.Asn238fs)	SELENON		Eichsfeld type congenital muscular dystrophy|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004494	1	26135244 - 26135245	1	25808753 - 25808754	4494	19533	rs368104077	NC_000001.11:25808753:AA:AAA
NM_002529.3(NTRK1):c.638T>C (p.Leu213Pro)	NTRK1	L183P, L213P	Hereditary insensitivity to pain with anhidrosis|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000526734	1	156838360	1	156868568	526734	515140	rs747711259	NC_000001.11:156868567:T:C
NM_003036.4(SKI):c.94C>G (p.Leu32Val)	SKI	L32V	Shprintzen-Goldberg syndrome	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000037259	1	2160299	1	2228860	37259	45849	rs387907304	NC_000001.11:2228859:C:G
NC_000001.11:g.(?_161340584)_(161356850_?)del	SDHC		Paragangliomas 3|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000833142	1	161310374 - 161326640			833142	818858		
NC_000001.11:g.(?_161314368)_(161362518_?)del	SDHC		Gastrointestinal stromal tumor|Paragangliomas 3	Pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000831911	1	161284158 - 161332308			831911	818852		
NC_000001.10:g.(?_161326457)_(161326640_?)del	SDHC		Paragangliomas 3|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000644840	1	161326457 - 161326640	1	161356667 - 161356850	644840	650563		
NC_000001.10:g.(?_161284190)_(161332229_?)del	SDHC		Paragangliomas 3|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000534384	1	161284190 - 161332229	1	161314400 - 161362439	534384	514871		
NM_014946.4(SPAST):c.1454_1463del (p.Ala485fs)	SPAST	A484fs, A453fs, A485fs, A452fs	not provided	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000817403	2	32362217 - 32362226	2	32137148 - 32137157	817403	805308		NC_000002.12:32137147:GCAACTAATAG:G
NC_000002.12:g.32089530_32089531TG[1]	SPAST		Spastic paraplegia	Pathogenic	no assertion criteria provided	VCV000812986	2	32314598 - 32314599	2	32089529 - 32089530	812986	801066		NC_000002.12:32089528:GTGTG:GTG
NM_014946.3(SPAST):c.1056del (p.Ala353fs)	SPAST	A320fs, A353fs, A321fs, A352fs	not provided	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000503807	2	32341238	2	32116169	503807	495414	rs1553315336	NC_000002.12:32116168:AA:A
NM_014946.3(SPAST):c.841G>T (p.Gly281Ter)	SPAST	G281*, G249*, G248*, G280*	not provided	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000489004	2	32339865	2	32114796	489004	481651	rs1553314951	NC_000002.12:32114795:G:T
NM_014946.3(SPAST):c.871-1G>C	SPAST		not provided	Pathogenic(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	VCV000392516	2	32340770	2	32115701	392516	366618	rs1057524526	NC_000002.12:32115700:G:C
NM_014946.3(SPAST):c.415+1G>T	SPAST		not provided	Pathogenic(Last reviewed: Apr 25, 2016)	criteria provided, single submitter	VCV000381666	2	32289316	2	32064247	381666	366614	rs1057521135	NC_000002.12:32064246:G:T
NM_014946.3(SPAST):c.571del (p.Arg191fs)	SPAST	R190fs, R191fs	not provided	Pathogenic(Last reviewed: Oct 18, 2016)	criteria provided, single submitter	VCV000372769	2	32314658	2	32089589	372769	359382	rs1057517974	NC_000002.12:32089588:CC:C
NM_014946.3(SPAST):c.1331A>G (p.Asp444Gly)	SPAST	D444G, D412G, D411G, D443G	not provided	Pathogenic(Last reviewed: Jul 7, 2016)	criteria provided, single submitter	VCV000280383	2	32361955	2	32136886	280383	264096	rs886041597	NC_000002.12:32136885:A:G
NM_014946.3(SPAST):c.364C>T (p.Gln122Ter)	SPAST	Q122*	not provided	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000805513	2	32289264	2	32064195	805513	792975		NC_000002.12:32064194:C:T
NM_014946.3(SPAST):c.1841C>T (p.Thr614Ile)	SPAST	T581I, T613I, T582I, T614I	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801666	2	32379555	2	32154486	801666	790235		NC_000002.12:32154485:C:T
NM_014946.3(SPAST):c.1469_1470del (p.Gln490fs)	SPAST	Q458fs, Q457fs, Q489fs, Q490fs	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801663	2	32362233 - 32362234	2	32137164 - 32137165	801663	790232		NC_000002.12:32137163:AA:
NM_014946.3(SPAST):c.1174-2A>T	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801662	2	32353475	2	32128406	801662	790231		NC_000002.12:32128405:A:T
NM_014946.3(SPAST):c.1091_1092del (p.Arg364fs)	SPAST	R332fs, R364fs, R331fs, R363fs	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801661	2	32341274 - 32341275	2	32116205 - 32116206	801661	790230		NC_000002.12:32116204:GG:
NM_014946.3(SPAST):c.1253_1255del (p.Glu418del)	SPAST	E418del, E417del, E385del, E386del	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Feb 11, 2019)	no assertion criteria provided	VCV000617765	2	32361637 - 32361639	2	32136568 - 32136570	617765	609162	rs1558336544	NC_000002.12:32136567:AGAAG:AG
NM_014946.3(SPAST):c.1307C>T (p.Ser436Phe)	SPAST	S436F, S435F, S404F, S403F	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Feb 8, 2019)	no assertion criteria provided	VCV000617749	2	32361693	2	32136624	617749	609147	rs1553318184	NC_000002.12:32136623:C:T
NM_014946.3(SPAST):c.839dup (p.Ser282fs)	SPAST		not provided	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000586666	2	32339862 - 32339863	2	32114793 - 32114794	586666	576682	rs1558323598	NC_000002.12:32114793:A:AA
NM_014946.3(SPAST):c.1586T>A (p.Leu529Ter)	SPAST	L529*, L528*, L496*, L497*	not provided	Pathogenic(Last reviewed: Feb 19, 2018)	criteria provided, single submitter	VCV000586663	2	32368454	2	32143385	586663	576693	rs1558340832	NC_000002.12:32143384:T:A
NM_014946.3(SPAST):c.156T>A (p.Tyr52Ter)	SPAST	Y52*	not provided	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000586662	2	32289056	2	32063987	586662	576679	rs1553394497	NC_000002.12:32063986:T:A
NM_014946.3(SPAST):c.1224dup (p.Ala409fs)	SPAST		not provided	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000586657	2	32353526 - 32353527	2	32128457 - 32128458	586657	576688	rs1558331940	NC_000002.12:32128457:T:TT
NM_014946.3(SPAST):c.1039C>T (p.Gln347Ter)	SPAST	Q347*, Q314*, Q346*, Q315*	Fatigue|Abnormal myelination|Seizures	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523507	2	32341222	2	32116153	523507	513926	rs1553315329	NC_000002.12:32116152:C:T
NM_014946.3(SPAST):c.1484C>T (p.Ala495Val)	SPAST	A495V, A494V, A462V, A463V	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000488606	2	32362248	2	32137179	488606	481474	rs1553318347	NC_000002.12:32137178:C:T
NM_014946.3(SPAST):c.1169T>A (p.Met390Lys)	SPAST	M390K, M358K, M357K, M389K	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000488605	2	32352087	2	32127018	488605	481473	rs1131691977	NC_000002.12:32127017:T:A
NM_014946.3(SPAST):c.871-2A>T	SPAST		not provided	Pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, single submitter	VCV000448457	2	32340769	2	32115700	448457	440702	rs1553315169	NC_000002.12:32115699:A:T
NM_014946.3(SPAST):c.1601del (p.Leu534fs)	SPAST	L501fs, L502fs, L533fs, L534fs	not provided	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000448448	2	32368469	2	32143400	448448	440715	rs1553319318	NC_000002.12:32143399:T:
NM_014946.3(SPAST):c.1322-30_1322-2del	SPAST		not provided	Pathogenic(Last reviewed: Jun 29, 2016)	criteria provided, single submitter	VCV000448446	2	32361914 - 32361942	2	32136845 - 32136873	448446	440713	rs1553318205	NC_000002.12:32136844:TAATTAAAGTCTTATACTTGTATTTCCTCTA:TA
NM_199436.1(SPAST):c.1188_1189TG[3] (p.Ala398fs)	SPAST		not provided	Pathogenic(Last reviewed: May 12, 2017)	criteria provided, single submitter	VCV000448445	2	32361669 - 32361670	2	32136600 - 32136601	448445	440712	rs1553318177	NC_000002.12:32136600:TGTG:TGTGTG
NM_014946.3(SPAST):c.1027_1031dup (p.Ile344fs)	SPAST		not provided	Pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, single submitter	VCV000448438	2	32341207 - 32341208	2	32116138 - 32116139	448438	440705	rs1553315323	NC_000002.12:32116138:ATGATAT:ATGATATGATAT
NM_014946.3(SPAST):c.1117del (p.Ala373fs)	SPAST	A340fs, A341fs, A372fs, A373fs	Spastic paraplegia	Pathogenic(Last reviewed: May 5, 2015)	criteria provided, single submitter	VCV000374078	2	32352035	2	32126966	374078	360841	rs1057518880	NC_000002.12:32126965:G:
NM_014946.4(SPAST):c.923_927del (p.Thr308fs)	SPAST	T275fs, T276fs, T307fs, T308fs	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jan 14, 2020)	criteria provided, single submitter	VCV000860362	2	32340823 - 32340827	2	32115754 - 32115758	860362	826424		NC_000002.12:32115753:CTCGT:
NM_014946.4(SPAST):c.1390G>T (p.Glu464Ter)	SPAST	E463*, E431*, E432*, E464*	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000848809	2	32362014	2	32136945	848809	826432		NC_000002.12:32136944:G:T
NM_014946.4(SPAST):c.521del (p.Ala174fs)	SPAST	A173fs, A174fs	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV000847697	2	32314609	2	32089540	847697	826422		NC_000002.12:32089539:C:
NM_014946.4(SPAST):c.1740del (p.Arg581fs)	SPAST	R548fs, R580fs, R581fs, R549fs	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000836858	2	32379453	2	32154384	836858	826437		NC_000002.12:32154383:TT:T
NM_014946.3(SPAST):c.1413+1G>A	SPAST		not provided	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000805511	2	32362038	2	32136969	805511	794010		NC_000002.12:32136968:G:A
NM_014946.3(SPAST):c.1359_1360dup (p.Glu454fs)	SPAST		not provided	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000805507	2	32361980 - 32361981	2	32136911 - 32136912	805507	792977		NC_000002.12:32136911:GGGG:GGGGGG
NM_014946.3(SPAST):c.1174-1G>C	SPAST		not provided	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000805506	2	32353476	2	32128407	805506	794008		NC_000002.12:32128406:G:C
NM_014946.3(SPAST):c.1583del (p.Pro528fs)	SPAST	P527fs, P528fs, P495fs, P496fs	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000662756	2	32368450	2	32143381	662756	629965		NC_000002.12:32143380:CC:C
NM_014946.3(SPAST):c.1361dup (p.His455fs)	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000662160	2	32361984 - 32361985	2	32136915 - 32136916	662160	629963		NC_000002.12:32136915:A:AA
NM_014946.3(SPAST):c.698del (p.Pro233fs)	SPAST	P200fs, P201fs, P232fs, P233fs	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000650603	2	32339721	2	32114652	650603	629957		NC_000002.12:32114651:CC:C
NM_014946.3(SPAST):c.1368dup (p.Ala457fs)	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000639149	2	32361991 - 32361992	2	32136922 - 32136923	639149	629964		NC_000002.12:32136922:T:TT
NM_014946.3(SPAST):c.1458_1459dup (p.Asn487fs)	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000582977	2	32362221 - 32362222	2	32137152 - 32137153	582977	561505	rs1558337136	NC_000002.12:32137152:TA:TATA
NM_199436.1(SPAST):c.622_623AC[3] (p.His209_Thr210insTer)	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000577409	2	32339742 - 32339743	2	32114673 - 32114674	577409	558432	rs1558323426	NC_000002.12:32114672:ACACACAC:ACACAC
NM_014946.3(SPAST):c.1392del (p.Glu464fs)	SPAST	E432fs, E431fs, E464fs, E463fs	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000570164	2	32362015	2	32136946	570164	561500	rs1558336906	NC_000002.12:32136945:AA:A
NM_014946.3(SPAST):c.344_353dup (p.Phe119fs)	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000565925	2	32289243 - 32289244	2	32064174 - 32064175	565925	561494	rs1558606204	NC_000002.12:32064174:GCGTCCGAGT:GCGTCCGAGTGCGTCCGAGT
NM_014946.3(SPAST):c.1375A>G (p.Arg459Gly)	SPAST	R459G, R426G, R427G, R458G	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Sep 29, 2017)	no assertion criteria provided	VCV000559624	2	32361999	2	32136930	559624	550352	rs1553318238	NC_000002.12:32136929:A:G
NM_014946.3(SPAST):c.166_175del (p.Tyr55_Pro56insTer)	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000536450	2	32289066 - 32289075	2	32063997 - 32064006	536450	518186	rs1553394509	NC_000002.12:32063996:CCGCTGTTTG:
NM_014946.3(SPAST):c.1252G>T (p.Glu418Ter)	SPAST	E418*, E385*, E386*, E417*	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Sep 30, 2017)	criteria provided, single submitter	VCV000536439	2	32361638	2	32136569	536439	518191	rs1553318164	NC_000002.12:32136568:G:T
NM_014946.3(SPAST):c.156T>G (p.Tyr52Ter)	SPAST	Y52*	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	VCV000536435	2	32289056	2	32063987	536435	518183	rs1553394497	NC_000002.12:32063986:T:G
NM_014946.3(SPAST):c.883dup (p.Thr295fs)	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	VCV000468576	2	32340779 - 32340780	2	32115710 - 32115711	468576	450994	rs1553315181	NC_000002.12:32115710:AAAA:AAAAA
NM_014946.3(SPAST):c.6_7del (p.Pro4fs)	SPAST	P4fs	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	VCV000468574	2	32288906 - 32288907	2	32063837 - 32063838	468574	451182	rs1553394366	NC_000002.12:32063836:TT:
NM_014946.3(SPAST):c.1412G>A (p.Gly471Asp)	SPAST	G471D, G438D, G439D, G470D	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000468565	2	32362036	2	32136967	468565	451192	rs1553318274	NC_000002.12:32136966:G:A
NM_014946.3(SPAST):c.1442_1443insA (p.Val482fs)	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000468564	2	32362206 - 32362207	2	32137137 - 32137138	468564	451204	rs1553318313	NC_000002.12:32137137::A
NM_014946.3(SPAST):c.1018_1022del (p.Val339_Lys340insTer)	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000468560	2	32341199 - 32341203	2	32116130 - 32116134	468560	450998	rs1553315321	NC_000002.12:32116129:TTAAATT:TT
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, single submitter	VCV000468559			2	32136543 - 32137208	468559	448547		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000468558			2	32126928 - 32128499	468558	448395		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000468557			2	32063812 - 32154516	468557	448543		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000468556			2	32063812 - 32116232	468556	448596		
NM_014946.3(SPAST):c.782C>A (p.Ser261Ter)	SPAST	S261*, S229*, S260*, S228*	not provided	Pathogenic(Last reviewed: Feb 22, 2017)	criteria provided, single submitter	VCV000448454	2	32339806	2	32114737	448454	440699	rs768241184	NC_000002.12:32114736:C:A
NM_014946.3(SPAST):c.1167_1168del (p.Met390fs)	SPAST	M389fs, M390fs, M357fs, M358fs	not provided	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000448441	2	32352085 - 32352086	2	32127016 - 32127017	448441	440708	rs1553316843	NC_000002.12:32127015:AA:
NM_199436.1(SPAST):c.1113_1116del (p.Phe371fs)	SPAST	F371fs, F370fs, F402fs, F403fs	not provided	Pathogenic/Likely pathogenic(Last reviewed: May 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000444492	2	32353510 - 32353513	2	32128441 - 32128444	444492	438132	rs1553317029	NC_000002.12:32128440:TTCTTT:TT
NM_014946.3(SPAST):c.1133T>A (p.Leu378Gln)	SPAST	L378Q, L377Q, L345Q, L346Q	Hereditary spastic paraplegia	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000424653	2	32352051	2	32126982	424653	411555	rs1553316816	NC_000002.12:32126981:T:A
NC_000002.11:g.(?_32339707)_(32382706_?)del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: May 4, 2016)	criteria provided, single submitter	VCV000417455	2	32339707 - 32382706	2	32114638 - 32157637	417455	391351		
NC_000002.11:g.(?_32288680)_(32289315_?)del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jul 26, 2016)	criteria provided, single submitter	VCV000417454	2	32288680 - 32289315	2	32063611 - 32064246	417454	391550		
NM_199436.1(SPAST):c.390_391delinsGGT (p.Leu131fs)	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	VCV000409034	2	32289290 - 32289291	2	32064221 - 32064222	409034	392683	rs1060502230	NC_000002.12:32064220:CC:GGT
NM_014946.3(SPAST):c.410del (p.Glu137fs)	SPAST	E137fs	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000409033	2	32289310	2	32064241	409033	392653	rs1060502229	NC_000002.12:32064240:A:
NM_014946.3(SPAST):c.127G>T (p.Glu43Ter)	SPAST	E43*	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Oct 1, 2016)	criteria provided, single submitter	VCV000409028	2	32289027	2	32063958	409028	393012	rs573642949	NC_000002.12:32063957:G:T
NC_000002.11:g.(?_32288895)_(32312653_?)del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	VCV000267324	2	32288895 - 32312653	2	32063826 - 32087584	267324	262398		
NM_014946.3(SPAST):c.1494-?_1728+?del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jan 17, 2016)	criteria provided, single submitter	VCV000254054					254054	248484		
NM_199436.1(SPAST):c.1339_1340AG[1] (p.Arg447fs)	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000219826	2	32362199 - 32362200	2	32137130 - 32137131	219826	221178	rs864622268	NC_000002.12:32137129:AGAG:AG
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219094	2	32358735 - 32362780			219094	216784		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219092	2	32351059 - 32359958	2	32125992 - 32134891	219092	216782		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219091	2	32339714 - 32347794	2	32114645 - 32122725	219091	216781		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219090	2	32338733 - 32350391	2	32113664 - 32125322	219090	216780		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219089	2	32308541 - 32367923	2	32083472 - 32142854	219089	216779		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219088	2	32350954 - 32360289	2	32125886 - 32135221	219088	216778		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219086	2	32288708 - 32305196	2	32063639 - 32080127	219086	216776		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219084	2	32365295 - 32374446	2	32140226 - 32149377	219084	216774		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219083	2	32372832 - 32390406	2	32147763 - 32165337	219083	216773		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219082	2	32360319 - 32381228	2	32135250 - 32156159	219082	216772		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219081	2	32352108 - 32379647	2	32127040 - 32154579	219081	216771		
NM_014946.3(SPAST):c.683-1277_870+399del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219080	2	32338430 - 32340293	2	32113361 - 32115224	219080	216770		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219079	2	32291802 - 32364656	2	32066734 - 32139588	219079	216769		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219076	2	32274911 - 32291246	2	32049842 - 32066177	219076	216766		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219075	2	32308157 - 32341651	2	32083106 - 32116600	219075	216765		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219074	2	32288217 - 32292251	2	32063148 - 32067182	219074	216764		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219073	2	32376112 - 32381206	2	32151043 - 32156137	219073	216763		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219072	2	32332674 - 32340934	2	32107605 - 32115865	219072	216762		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219071	2	32282760 - 32303254	2	32057691 - 32078185	219071	216761		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219070	2	32291779 - 32357195	2	32066710 - 32132126	219070	216760		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219069	2	32353207 - 32359908			219069	216759		
NM_014946.3(SPAST):c.1688-378_1728+1541del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219068	2	32371908 - 32373867	2	32146839 - 32148798	219068	216758		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219067	2	32340402 - 32345422	2	32115334 - 32120354	219067	216757		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219066	2	32302137 - 32351058	2	32077068 - 32125989	219066	216756		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219065	2	32356943 - 32372914	2	32131874 - 32147845	219065	216755		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219063	2	32282852 - 32295403	2	32057783 - 32070334	219063	216753		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219059	2	32329723 - 32373142	2	32104654 - 32148073	219059	216749		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219056	2	32365580 - 32371821			219056	216746		
NM_014946.3(SPAST):c.1729-884_*1715del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219053	2	32378559 - 32381280	2	32153490 - 32156211	219053	216743		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219051	2	32374427 - 32388831	2	32149358 - 32163762	219051	216741		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219050	2	32378898 - 32384398	2	32153843 - 32159343	219050	216740		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219049	2	32372792 - 32389594	2	32147726 - 32164528	219049	216739		
Single allele	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000219048	2	32373679 - 32384445	2	32148610 - 32159376	219048	216738		
NM_014946.3(SPAST):c.925del (p.Arg309fs)	SPAST	R277fs, R308fs, R309fs, R276fs	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000216113	2	32340825	2	32115756	216113	212145	rs863224515	NC_000002.12:32115755:C:
NM_014946.3(SPAST):c.1417C>T (p.Gln473Ter)	SPAST	Q473*, Q441*, Q472*, Q440*	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: May 18, 2015)	criteria provided, single submitter	VCV000216111	2	32362181	2	32137112	216111	212148	rs757130394	NC_000002.12:32137111:C:T
NM_014946.3(SPAST):c.1414-1G>C	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Nov 11, 2014)	criteria provided, single submitter	VCV000188227	2	32362177	2	32137108	188227	185967	rs786204163	NC_000002.12:32137107:G:C
NM_014946.3(SPAST):c.1165A>G (p.Thr389Ala)	SPAST	T389A, T356A, T357A, T388A	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Oct 29, 2014)	criteria provided, single submitter	VCV000188190	2	32352083	2	32127014	188190	185965	rs786204132	NC_000002.12:32127013:A:G
NM_014946.3(SPAST):c.1335C>A (p.Ser445Arg)	SPAST	S445R, S413R, S412R, S444R	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jul 11, 2006)	no assertion criteria provided	VCV000005676	2	32361959	2	32136890	5676	20715	rs121908519	NC_000002.12:32136889:C:A
NM_014946.3(SPAST):c.1409A>T (p.Asp470Val)	SPAST	D470V, D437V, D438V, D469V	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000005670	2	32362033	2	32136964	5670	20709	rs121908516	NC_000002.12:32136963:A:T
NM_014946.3(SPAST):c.1031T>A (p.Ile344Lys)	SPAST	I344K, I343K, I311K, I312K	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000005668	2	32341214	2	32116145	5668	20707	rs121908513	NC_000002.12:32116144:T:A
NM_199436.1(SPAST):c.1317+2dup	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000005667	2	32362038 - 32362039	2	32136969 - 32136970	5667	20706	rs587777756	NC_000002.12:32136969:T:TT
NM_014946.3(SPAST):c.1728+1G>C	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Sep 12, 2000)	no assertion criteria provided	VCV000005665	2	32372328	2	32147259	5665	20704	rs587777754	NC_000002.12:32147258:G:C
NM_014946.3(SPAST):c.453dup (p.Gly152fs)	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	VCV000005663	2	32312595 - 32312596	2	32087526 - 32087527	5663	20702	rs587777753	NC_000002.12:32087526:AAA:AAAA
SPAST, LYS229TER	SPAST	K229*	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	VCV000005662					5662	20701		
NM_014946.3(SPAST):c.1395del (p.Phe465_Leu466insTer)	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000005659	2	32362017	2	32136948	5659	20698	rs587777751	NC_000002.12:32136947:TTT:TT
NM_014946.3(SPAST):c.1085C>G (p.Ser362Cys)	SPAST	S362C, S330C, S329C, S361C	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000005657	2	32341268	2	32116199	5657	20696	rs121908509	NC_000002.12:32116198:C:G
NM_014946.4(SPAST):c.1180del (p.Ala394fs)	SPAST	A394fs, A362fs, A393fs, A361fs	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000847036	2	32353483	2	32128414	847036	826431		NC_000002.12:32128413:G:
NM_014946.4(SPAST):c.977dup (p.Asn326fs)	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000834811	2	32340875 - 32340876	2	32115806 - 32115807	834811	826426		NC_000002.12:32115806:AA:AAA
NC_000002.12:g.(?_32098786)_(32116222_?)del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000832540	2	32323855 - 32341291			832540	819162		
NC_000002.12:g.(?_32087482)_(32116222_?)del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 25, 2019)	criteria provided, single submitter	VCV000831297	2	32312551 - 32341291			831297	819161		
NC_000002.12:g.(?_32063822)_(32089615_?)del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000830857	2	32288891 - 32314684			830857	819158		
NM_014946.3(SPAST):c.1151C>T (p.Pro384Leu)	SPAST	P351L, P383L, P384L, P352L	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000660105	2	32352069	2	32127000	660105	629958		NC_000002.12:32126999:C:T
NM_014946.3(SPAST):c.1005-1G>A	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000650879	2	32341187	2	32116118	650879	650955		NC_000002.12:32116117:G:A
NM_014946.3(SPAST):c.1688-1G>A	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000649713	2	32372286	2	32147217	649713	650958		NC_000002.12:32147216:G:A
NM_014946.3(SPAST):c.1238C>T (p.Ser413Leu)	SPAST	S412L, S381L, S380L, S413L	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000645183	2	32353541	2	32128472	645183	629960		NC_000002.12:32128471:C:T
NM_014946.3(SPAST):c.443G>A (p.Trp148Ter)	SPAST	W148*, W147*	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000642650	2	32312588	2	32087519	642650	629956		NC_000002.12:32087518:G:A
NM_014946.3(SPAST):c.867_868del (p.His289fs)	SPAST	H288fs, H256fs, H257fs, H289fs	not provided	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000586667	2	32339890 - 32339891	2	32114821 - 32114822	586667	576683	rs1558323659	NC_000002.12:32114820:ATA:A
NM_014946.3(SPAST):c.746C>G (p.Ser249Ter)	SPAST	S249*, S216*, S217*, S248*	not provided	Pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000586665	2	32339770	2	32114701	586665	576681	rs1553314902	NC_000002.12:32114700:C:G
NM_014946.3(SPAST):c.1573C>T (p.Gln525Ter)	SPAST	Q525*, Q493*, Q524*, Q492*	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000536451	2	32368441	2	32143372	536451	518321	rs1553319296	NC_000002.12:32143371:C:T
NM_014946.3(SPAST):c.328_340del (p.Gly110fs)	SPAST	G110fs	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000536443	2	32289224 - 32289236	2	32064155 - 32064167	536443	518301	rs1410418105	NC_000002.12:32064154:GCCGGGCGGCGAGGCCG:GCCG
NM_014946.3(SPAST):c.1577_1580del (p.Gly526fs)	SPAST	G493fs, G525fs, G494fs, G526fs	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000536440	2	32368442 - 32368445	2	32143373 - 32143376	536440	518197	rs1553319298	NC_000002.12:32143372:AAGGAAG:AAG
NM_014946.3(SPAST):c.562del (p.Ala188fs)	SPAST	A187fs, A188fs	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000468573	2	32314649	2	32089580	468573	450867	rs1553400002	NC_000002.12:32089579:GG:G
NM_014946.3(SPAST):c.422_425del (p.Gln141fs)	SPAST	Q140fs, Q141fs	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000468572	2	32312567 - 32312570	2	32087498 - 32087501	468572	451180	rs1553399472	NC_000002.12:32087497:AGAA:
NM_014946.3(SPAST):c.421C>T (p.Gln141Ter)	SPAST	Q141*, Q140*	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000468571	2	32312566	2	32087497	468571	450992	rs1485703744	NC_000002.12:32087496:C:T
NG_008730.1:g.75057_79101dup	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000005677	2	32358736 - 32362780	2	32133667 - 32137711	5677	20716		
NM_014946.3(SPAST):c.1322A>G (p.Asp441Gly)	SPAST	D441G, D440G, D408G, D409G	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Oct 1, 2000)	no assertion criteria provided	VCV000005664	2	32361946	2	32136877	5664	20703	rs121908512	NC_000002.12:32136876:A:G
NM_014946.3(SPAST):c.1343G>A (p.Cys448Tyr)	SPAST	C448Y, C415Y, C416Y, C447Y	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000005658	2	32361967	2	32136898	5658	20697	rs121908510	NC_000002.12:32136897:G:A
NM_000530.8(MPZ):c.380G>C (p.Cys127Ser)	MPZ	C127S	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 27, 2013)	criteria provided, single submitter	VCV000208765	1	161276566	1	161306776	208765	205215	rs797044941	NC_000001.11:161306775:C:G
NM_000530.8(MPZ):c.499G>A (p.Gly167Arg)	MPZ	G167R	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000208149	1	161276204	1	161306414	208149	204407	rs121913586	NC_000001.11:161306413:C:T
NM_000530.8(MPZ):c.670G>T (p.Asp224Tyr)	MPZ	D224Y	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000041024	1	161275743	1	161305953	41024	49446	rs267607247	NC_000001.11:161305952:C:A
NM_000530.8(MPZ):c.244T>C (p.Tyr82His)	MPZ	Y82H	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000041017	1	161276702	1	161306912	41017	49439	rs281865124	NC_000001.11:161306911:A:G
NM_000530.8(MPZ):c.499G>C (p.Gly167Arg)	MPZ	G167R	Dejerine-Sottas syndrome, autosomal dominant|Congenital hypomyelinating neuropathy 1, autosomal recessive||Dejerine-Sottas disease|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease, demyelinating, type 1b|Roussy-Lévy syndrome|Dejerine-Sottas disease	Pathogenic(Last reviewed: Mar 11, 2014)	criteria provided, single submitter	VCV000014170	1	161276204	1	161306414	14170	29209	rs121913586	NC_000001.11:161306413:C:G
NM_000530.8(MPZ):c.270C>A (p.Asp90Glu)	MPZ	D90E	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000014167	1	161276676	1	161306886	14167	29206	rs121913584	NC_000001.11:161306885:G:T
NC_000002.12:g.(?_32063822)_(32154506_?)del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000833363	2	32288891 - 32379575			833363	819159		
NC_000002.12:g.(?_32114628)_(32114835_?)del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000832723	2	32339697 - 32339904			832723	819163		
NC_000002.12:g.(?_32147208)_(32147268_?)dup	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000831588	2	32372277 - 32372337			831588	819167		
NM_014946.3(SPAST):c.1617-2A>G	SPAST		not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000805512	2	32370004	2	32144935	805512	794011		NC_000002.12:32144934:A:G
NM_014946.3(SPAST):c.1174-1del	SPAST		not provided	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000805505	2	32353476	2	32128407	805505	794009		NC_000002.12:32128406:GG:G
NM_014946.3(SPAST):c.286del (p.Ala96fs)	SPAST	A96fs	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000665989	2	32289186	2	32064117	665989	629954		NC_000002.12:32064116:G:
NC_000002.11:g.(?_32352007)_(32353558_?)del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Feb 10, 2019)	criteria provided, single submitter	VCV000655754	2	32352007 - 32353558	2	32126938 - 32128489	655754	650832		
NC_000002.11:g.(?_32361622)_(32362267_?)del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000649635	2	32361622 - 32362267	2	32136553 - 32137198	649635	650802		
NC_000002.11:g.(?_32361622)_(32361717_?)del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000645369	2	32361622 - 32361717	2	32136553 - 32136648	645369	650758		
NM_014946.3(SPAST):c.1413+5G>A	SPAST		not provided	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000586660	2	32362042	2	32136973	586660	576691	rs1553318282	NC_000002.12:32136972:G:A
NM_014946.3(SPAST):c.1728+1G>A	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000566838	2	32372328	2	32147259	566838	558450	rs587777754	NC_000002.12:32147258:G:A
NC_000002.11:g.(?_32339687)_(32353568_?)del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Oct 14, 2017)	criteria provided, single submitter	VCV000536453	2	32339687 - 32353568	2	32114618 - 32128499	536453	516228		
NM_014946.3(SPAST):c.444G>A (p.Trp148Ter)	SPAST	W148*, W147*	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000536448	2	32312589	2	32087520	536448	518240	rs1553399493	NC_000002.12:32087519:G:A
NM_014946.3(SPAST):c.1494G>C (p.Arg498Ser)	SPAST	R498S, R466S, R497S, R465S	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Nov 22, 2018)	criteria provided, single submitter	VCV000536434	2	32366973	2	32141904	536434	518317	rs1553319075	NC_000002.12:32141903:G:C
NM_014946.3(SPAST):c.870G>A (p.Lys290=)	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000468575	2	32339894	2	32114825	468575	451183	rs1421791559	NC_000002.12:32114824:G:A
NM_014946.3(SPAST):c.1215_1219del (p.Asn405fs)	SPAST	N372fs, N404fs, N405fs, N373fs	Spastic paraplegia 4, autosomal dominant|not provided	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000468562	2	32353515 - 32353519	2	32128446 - 32128450	468562	451190	rs1553317032	NC_000002.12:32128445:TAATATAA:TAA
NM_014946.3(SPAST):c.1413+1G>T	SPAST		not provided	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000431996	2	32362038	2	32136969	431996	425492	rs1553318276	NC_000002.12:32136968:G:T
NM_014946.3(SPAST):c.508C>T (p.Gln170Ter)	SPAST	Q170*, Q169*	Spastic paraplegia 4, autosomal dominant|not provided	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265647	2	32314596	2	32089527	265647	259736	rs886039695	NC_000002.12:32089526:C:T
NM_014946.3(SPAST):c.-112_415+1779del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000005674	2	32288788 - 32291093	2	32063720 - 32066025	5674	20713		
NM_014946.3(SPAST):c.1245+4A>G	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000005666	2	32353552	2	32128483	5666	20705	rs587777755	NC_000002.12:32128482:A:G
NC_000002.12:g.(?_32063826)_(32098897_?)del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000832003	2	32288895 - 32323966			832003	819160		
NM_014946.3(SPAST):c.1360G>A (p.Glu454Lys)	SPAST	E422K, E421K, E453K, E454K	Spastic paraplegia 4, autosomal dominant	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000665112	2	32361984	2	32136915	665112	629962		NC_000002.12:32136914:G:A
NC_000002.11:g.(?_32379433)_(32379575_?)del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000665031	2	32379433 - 32379575	2	32154364 - 32154506	665031	650811		
NC_000002.11:g.(?_32352007)_(32379575_?)del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000656839	2	32352007 - 32379575	2	32126938 - 32154506	656839	650800		
NM_014946.3(SPAST):c.1617-1G>A	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	VCV000574791	2	32370005	2	32144936	574791	560627	rs1553319526	NC_000002.12:32144935:G:A
NM_014946.3(SPAST):c.1494-2A>G	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000569227	2	32366971	2	32141902	569227	558442	rs1218081251	NC_000002.12:32141901:A:G
NM_014946.3(SPAST):c.1103T>C (p.Phe368Ser)	SPAST	F368S, F367S, F335S, F336S	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000536436	2	32352021	2	32126952	536436	518192	rs1553316799	NC_000002.12:32126951:T:C
NM_014946.3(SPAST):c.(?_1729)_(1851_?)del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000437841	2	32379443 - 32379565	2	32154374 - 32154496	437841	420990		
NM_014946.3(SPAST):c.1688-2A>G	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000005661	2	32372285	2	32147216	5661	20700	rs587777752	NC_000002.12:32147215:A:G
NM_001265593.1(PLEKHG5):c.265del (p.Arg89fs)	PLEKHG5	R20fs, R89fs, R99fs, R97fs, R76fs	Spinal muscular atrophy, facioscapulohumeral type	Pathogenic(Last reviewed: Apr 25, 2018)	no assertion criteria provided	VCV000549691	1	6536082	1	6476022	549691	540441	rs1553175760	NC_000001.11:6476021:GGG:GG
NM_020631.6(PLEKHG5):c.1788del (p.Lys597fs)	PLEKHG5	K676fs, K597fs, K653fs, K666fs, K674fs	Distal spinal muscular atrophy, autosomal recessive 4|Charcot-Marie-Tooth disease, recessive intermediate c	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000859523	1	6530308	1	6470248	859523	824366		NC_000001.11:6470247:CCCC:CCC
NM_020631.6(PLEKHG5):c.1452_1453del (p.His485fs)	PLEKHG5	H554fs, H562fs, H485fs, H541fs, H564fs	Charcot-Marie-Tooth disease, recessive intermediate c|Distal spinal muscular atrophy, autosomal recessive 4	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, single submitter	VCV000855821	1	6530884 - 6530885	1	6470824 - 6470825	855821	824370		NC_000001.11:6470823:GGGG:GG
NM_020631.6(PLEKHG5):c.779_780del (p.Thr260fs)	PLEKHG5	T337fs, T339fs, T260fs, T316fs, T329fs	Distal spinal muscular atrophy, autosomal recessive 4|Charcot-Marie-Tooth disease, recessive intermediate c	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000845778	1	6533326 - 6533327	1	6473266 - 6473267	845778	824375		NC_000001.11:6473265:GG:
NM_020631.6(PLEKHG5):c.1002del (p.Gln334fs)	PLEKHG5	Q411fs, Q334fs, Q390fs, Q403fs, Q413fs	Distal spinal muscular atrophy, autosomal recessive 4|Charcot-Marie-Tooth disease, recessive intermediate c	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000835966	1	6532665	1	6472605	835966	824373		NC_000001.11:6472604:C:
NC_000001.11:g.(?_6474003)_(6477668_?)del	PLEKHG5		Distal spinal muscular atrophy, autosomal recessive 4|Charcot-Marie-Tooth disease, recessive intermediate c	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000832925	1	6534063 - 6537728			832925	818990		
NC_000001.11:g.(?_6467553)_(6477668_?)del	PLEKHG5		Distal spinal muscular atrophy, autosomal recessive 4|Charcot-Marie-Tooth disease, recessive intermediate c	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000832446	1	6527613 - 6537728			832446	818989		
NM_020631.5(PLEKHG5):c.453_543del (p.Gly152fs)	PLEKHG5	G229fs, G208fs, G152fs, G221fs, G231fs	Charcot-Marie-Tooth disease, recessive intermediate c|Distal spinal muscular atrophy, autosomal recessive 4	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000663141	1	6534121 - 6534211	1	6474061 - 6474151	663141	628239		
NM_020631.5(PLEKHG5):c.2542C>T (p.Arg848Ter)	PLEKHG5	R848*, R925*, R904*, R917*, R927*	Charcot-Marie-Tooth disease, recessive intermediate c|Distal spinal muscular atrophy, autosomal recessive 4	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000566096	1	6528354	1	6468294	566096	557360	rs770593694	NC_000001.11:6468293:G:A
NM_020631.5(PLEKHG5):c.2362_2363TC[2] (p.Leu789fs)	PLEKHG5		Charcot-Marie-Tooth disease, recessive intermediate c|Distal spinal muscular atrophy, autosomal recessive 4	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000468906	1	6528529 - 6528530	1	6468469 - 6468470	468906	448208	rs759212541	NC_000001.11:6468468:GAGAGAG:GAGAG
NM_020631.5(PLEKHG5):c.2458G>C (p.Gly820Arg)	PLEKHG5	G820R, G889R, G897R, G876R, G899R	Charcot-Marie-Tooth disease, recessive intermediate c	Pathogenic(Last reviewed: Jul 12, 2013)	no assertion criteria provided	VCV000060779	1	6528438	1	6468378	60779	75318	rs202191898	NC_000001.11:6468377:C:G
NM_020631.5(PLEKHG5):c.912_918dup (p.Glu307Ter)	PLEKHG5		Charcot-Marie-Tooth disease, recessive intermediate c	Pathogenic(Last reviewed: Oct 15, 2013)	no assertion criteria provided	VCV000060778	1	6533111 - 6533112	1	6473051 - 6473052	60778	75317	rs397515455	NC_000001.11:6473051:GTCTTCA:GTCTTCAGTCTTCA
NM_020631.5(PLEKHG5):c.38del (p.Pro13fs)	PLEKHG5	P69fs, P13fs, P92fs, P82fs, P90fs	Charcot-Marie-Tooth disease, recessive intermediate c	Pathogenic(Last reviewed: Oct 15, 2013)	no assertion criteria provided	VCV000060777	1	6537594	1	6477534	60777	75316	rs397515454	NC_000001.11:6477533:GGGGG:GGGG
NM_020631.5(PLEKHG5):c.2053C>T (p.Gln685Ter)	PLEKHG5	Q685*, Q754*, Q762*, Q764*, Q741*	Charcot-Marie-Tooth disease, recessive intermediate c|Distal spinal muscular atrophy, autosomal recessive 4|not provided	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000489025	1	6529298	1	6469238	489025	481599	rs772217003	NC_000001.11:6469237:G:A
NC_000002.12:g.(?_32144927)_(32154506_?)del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000831019	2	32369996 - 32379575			831019	819166		
NC_000002.11:g.(?_32339687)_(32372347_?)del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000584023	2	32339687 - 32372347	2	32114618 - 32147278	584023	557493		
NM_014946.3(SPAST):c.1494-2A>C	SPAST		Spastic paraplegia 4, autosomal dominant|not provided	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000468568	2	32366971	2	32141902	468568	450871	rs1218081251	NC_000002.12:32141901:A:C
NM_014946.3(SPAST):c.1164G>T (p.Lys388Asn)	SPAST	K388N, K387N, K355N, K356N	Spastic paraplegia 4, autosomal dominant|not provided	Pathogenic(Last reviewed: Oct 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000450255	2	32352082	2	32127013	450255	443240	rs1553316838	NC_000002.12:32127012:G:T
NM_199436.1(SPAST):c.465del (p.Glu155fs)	SPAST	E154fs, E155fs	not provided|Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jul 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000216112	2	32312609	2	32087540	216112	212144	rs863224514	NC_000002.12:32087539:AA:A
NM_199436.1(SPAST):c.1149del (p.Lys382_Tyr383insTer)	SPAST		not provided|Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000216109	2	32353548	2	32128479	216109	212146	rs863224513	NC_000002.12:32128478:C:
NM_014946.3(SPAST):c.1637G>A (p.Gly546Glu)	SPAST	G546E, G545E, G513E, G514E	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000188083	2	32370026	2	32144957	188083	185968	rs786204057	NC_000002.12:32144956:G:A
NM_012414.4(RAB3GAP2):c.2213-1G>A	RAB3GAP2		Inborn genetic diseases	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000521623	1	220355697	1	220182355	521623	511228	rs1553275644	NC_000001.11:220182354:C:T
NM_201253.3(CRB1):c.3676G>T (p.Gly1226Ter)	CRB1	G1226*, G1114*, G1202*	Retinitis pigmentosa|Leber congenital amaurosis 8|Retinitis pigmentosa 12	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000438080	1	197404669	1	197435539	438080	431570	rs757740068	NC_000001.11:197435538:G:T
NM_201253.3(CRB1):c.2129A>T (p.Glu710Val)	CRB1	E710V, E598V, E641V	Leber congenital amaurosis 8|Retinitis pigmentosa 12|Retinal dystrophy	Pathogenic(Last reviewed: Aug 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000438073	1	197396584	1	197427454	438073	431564	rs145282040	NC_000001.11:197427453:A:T
NM_001111.5(ADAR):c.3019G>A (p.Gly1007Arg)	ADAR	G1007R, G712R, G981R, G1016R, G962R, G686R	Aicardi-Goutieres syndrome 6|Aicardi-Goutieres syndrome 6|Symmetrical dyschromatosis of extremities|Symmetrical dyschromatosis of extremities	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039458	1	154560601	1	154588125	39458	48057	rs398122822	NC_000001.11:154588124:C:T
NM_024529.4(CDC73):c.679_680insAG (p.Arg227fs)	CDC73		Hyperparathyroidism 1|Parathyroid carcinoma|Hyperparathyroidism 2	Pathogenic(Last reviewed: May 24, 2012)	no assertion criteria provided	VCV000003270	1	193111146 - 193111147	1	193142016 - 193142017	3270	18309	rs80356649	NC_000001.11:193142016::AG
NC_000002.12:g.(?_32063822)_(32064256_?)del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000831670	2	32288891 - 32289325			831670	819157		
NC_000002.11:g.(?_32288881)_(32289335_?)del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000583912	2	32288881 - 32289335	2	32063812 - 32064266	583912	557491		
NM_014946.3(SPAST):c.1493+2_1493+5del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000568108	2	32362256 - 32362259	2	32137187 - 32137190	568108	558440	rs1558337180	NC_000002.12:32137186:AGGTAGG:AGG
NM_014946.3(SPAST):c.838C>T (p.Gln280Ter)	SPAST	Q280*, Q247*, Q279*, Q248*	Spastic paraplegia 4, autosomal dominant|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000448456	2	32339862	2	32114793	448456	440701	rs1553314948	NC_000002.12:32114792:C:T
NM_014946.3(SPAST):c.1729-1G>A	SPAST		Spastic paraplegia 4, autosomal dominant|not provided	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419590	2	32379442	2	32154373	419590	405721	rs1064793976	NC_000002.12:32154372:G:A
NM_014946.3(SPAST):c.1173+1G>A	SPAST		Spastic paraplegia 4, autosomal dominant|not provided	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000409030	2	32352092	2	32127023	409030	392807	rs1060502226	NC_000002.12:32127022:G:A
NM_001276345.2(TNNT2):c.360T>G (p.Phe120Leu)	TNNT2	F110L, F120L, F105L	not provided|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000177807	1	201334370	1	201365242	177807	172501	rs727504331	NC_000001.11:201365241:A:C
NM_000016.5(ACADM):c.698T>C (p.Ile233Thr)	ACADM	I233T, I237T, I197T, I266T, I44T	Hydrocephalus, congenital, 2, with or without brain or eye anomalies|Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203539	1	76211589	1	75745904	203539	199976	rs770273135	NC_000001.11:75745903:T:C
NM_000016.5(ACADM):c.734C>T (p.Ser245Leu)	ACADM	S220L, S245L, S249L, S209L, S278L, S56L	not provided|Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003598	1	76215129	1	75749444	3598	18637	rs121434281	NC_000001.11:75749443:C:T
NC_000002.12:g.(?_227272939)_(227280600_?)del	COL4A3		not provided	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000832672	2	228137655 - 228145316			832672	819132		
GRCh37/hg19 2q36.3(chr2:228167754-228169799)	COL4A3		Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	VCV000813304	2	228167754 - 228169799			813304	801556		
NM_000091.5(COL4A3):c.28C>T (p.Gln10Ter)	COL4A3	Q10*	Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807562	2	228029470	2	227164754	807562	798499		NC_000002.12:227164753:C:T
COL4A3, IVS21DS, G-A, -1	COL4A3		Alport syndrome 3, autosomal dominant	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000017491					17491	32530		
COL4A3, ALU INS, EX6	COL4A3		Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000017488					17488	32527		
COL4A3, 5-BP DEL, NT4414	COL4A3		Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000017483					17483	32522		
NM_014946.3(SPAST):c.1174-1G>A	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000635759	2	32353476	2	32128407	635759	623591		NC_000002.12:32128406:G:A
NM_014946.3(SPAST):c.870+1G>A	SPAST		Spastic paraplegia|Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000523508	2	32339895	2	32114826	523508	513925	rs1553314978	NC_000002.12:32114825:G:A
NM_014946.3(SPAST):c.1157A>G (p.Asn386Ser)	SPAST	N386S, N354S, N385S, N353S	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000005669	2	32352075	2	32127006	5669	20708	rs121908514	NC_000002.12:32127005:A:G
NM_001367561.1(DOCK7):c.4138C>T (p.Arg1380Ter)	DOCK7	R1349*, R1380*	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000521571	1	62979259	1	62513588	521571	511291	rs1479675678	NC_000001.11:62513587:G:A
NC_000002.11:g.(?_47604153)_(47604216_?)del	EPCAM		Lynch syndrome	Pathogenic(Last reviewed: Sep 4, 2016)	criteria provided, single submitter	VCV000417534	2	47604153 - 47604216	2	47377014 - 47377077	417534	391360		
NC_000002.11:g.(?_47606092)_(47614167_?)del	EPCAM		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000417532	2	47606092 - 47614167	2	47378953 - 47387028	417532	391386		
NM_002354.2(EPCAM):c.523C>T (p.Gln175Ter)	EPCAM	Q175*	Lynch syndrome	Pathogenic(Last reviewed: Jan 23, 2016)	criteria provided, single submitter	VCV000239132	2	47604184	2	47377045	239132	238792	rs878854491	NC_000002.12:47377044:C:T
NM_002354.2(EPCAM):c.133C>T (p.Gln45Ter)	EPCAM	Q45*	Lynch syndrome	Pathogenic(Last reviewed: Feb 1, 2016)	criteria provided, single submitter	VCV000239120	2	47600658	2	47373519	239120	238783	rs878854485	NC_000002.12:47373518:C:T
NM_002354.2(EPCAM):c.859-?_*415del	EPCAM		Lynch syndrome	Pathogenic(Last reviewed: Jan 19, 2017)	criteria provided, single submitter	VCV000188070	2	47612305 - 47614167	2	47385166 - 47387028	188070	185960		
NM_000530.8(MPZ):c.393C>A (p.Asn131Lys)	MPZ	N131K	Charcot-Marie-Tooth disease, demyelinating, type 1b|Roussy-Lévy syndrome|not provided|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014186	1	161276553	1	161306763	14186	29225	rs121913599	NC_000001.11:161306762:G:T
NM_000530.8(MPZ):c.224A>T (p.Asp75Val)	MPZ	D75V, D85V	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000014184	1	161277058	1	161307268	14184	29223	rs121913597	NC_000001.11:161307267:T:A
NM_000530.8(MPZ):c.242A>G (p.His81Arg)	MPZ	H81R	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: May 28, 2015)	criteria provided, single submitter	VCV000014179	1	161276704	1	161306914	14179	29218	rs121913594	NC_000001.11:161306913:T:C
NM_194248.3(OTOF):c.5581del (p.Ala1861fs)	OTOF	A1171fs, A1094fs, A1861fs	not provided	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000817737	2	26683851	2	26460983	817737	805304		NC_000002.12:26460982:C:
NM_194248.3(OTOF):c.1051C>T (p.Gln351Ter)	OTOF	Q351*	not provided	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000620323	2	26707496	2	26484628	620323	611569	rs1558492758	NC_000002.12:26484627:G:A
NM_194248.3(OTOF):c.1550T>C (p.Leu517Pro)	OTOF	L517P	Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560901	2	26705303	2	26482435	560901	551999	rs1558490542	NC_000002.12:26482434:A:G
NM_194248.3(OTOF):c.3376dup (p.Ile1126fs)	OTOF		Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560900	2	26696890 - 26696891	2	26474022 - 26474023	560900	551998	rs1558480402	NC_000002.12:26474022:T:TT
NM_194248.3(OTOF):c.3864+1G>A	OTOF		Rare genetic deafness	Pathogenic(Last reviewed: Feb 24, 2018)	criteria provided, single submitter	VCV000667426	2	26695386	2	26472518	667426	654272		NC_000002.12:26472517:C:T
NM_194248.3(OTOF):c.2818C>T (p.Gln940Ter)	OTOF	Q940*, Q193*, Q250*	Rare genetic deafness	Pathogenic(Last reviewed: Jan 30, 2014)	criteria provided, single submitter	VCV000179539	2	26699044	2	26476176	179539	173511	rs727504936	NC_000002.12:26476175:G:A
NM_194248.3(OTOF):c.3178del (p.Ala1060fs)	OTOF	A313fs, A370fs, A1060fs	Rare genetic deafness	Pathogenic(Last reviewed: Aug 1, 2013)	criteria provided, single submitter	VCV000179115	2	26697491	2	26474623	179115	173509	rs727504639	NC_000002.12:26474622:CC:C
NM_194248.3(OTOF):c.2991+2T>G	OTOF		Rare genetic deafness	Pathogenic(Last reviewed: Jun 3, 2014)	criteria provided, single submitter	VCV000178509	2	26698780	2	26475912	178509	173510	rs370132645	NC_000002.12:26475911:A:C
NM_194248.3(OTOF):c.4799+1G>A	OTOF		Rare genetic deafness	Pathogenic(Last reviewed: Jan 30, 2014)	criteria provided, single submitter	VCV000164841	2	26688539	2	26465671	164841	173640	rs200147906	NC_000002.12:26465670:C:T
NM_194248.3(OTOF):c.5203del (p.Arg1735fs)	OTOF	R968fs, R1735fs, R1045fs	Rare genetic deafness	Pathogenic(Last reviewed: Jun 10, 2014)	criteria provided, single submitter	VCV000164835	2	26685039	2	26462171	164835	173637	rs727503352	NC_000002.12:26462170:G:
NM_194248.3(OTOF):c.2153G>A (p.Trp718Ter)	OTOF	W718*	Rare genetic deafness	Pathogenic(Last reviewed: Oct 17, 2012)	criteria provided, single submitter	VCV000048187	2	26702193	2	26479325	48187	57351	rs111033383	NC_000002.12:26479324:C:T
NM_194248.3(OTOF):c.*164C>G	OTOF	P50R, P1220R, P1987R	Auditory neuropathy, autosomal recessive, 1	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000006141	2	26680942	2	26458074	6141	21180	rs121908598	NC_000002.12:26458073:G:C
OTOF, 1-BP DEL, 1778G	OTOF		Auditory neuropathy, autosomal recessive, 1	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000006139					6139	21178		
NM_194248.3(OTOF):c.1801G>T (p.Glu601Ter)	OTOF	E601*	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627469	2	26703656	2	26480788	627469	615787	rs1558489384	NC_000002.12:26480787:C:A
NM_194248.3(OTOF):c.2989G>T (p.Glu997Ter)	OTOF	E997*, E250*, E307*	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627468	2	26698784	2	26475916	627468	615786	rs1558482554	NC_000002.12:26475915:C:A
NM_194248.3(OTOF):c.5714G>T (p.Gly1905Val)	OTOF	G1905V, G1215V, G1138V	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562085	2	26683614	2	26460746	562085	553252	rs1558464965	NC_000002.12:26460745:C:A
NM_194248.3(OTOF):c.1904T>A (p.Val635Asp)	OTOF	V635D	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562082	2	26703079	2	26480211	562082	553253	rs1558488902	NC_000002.12:26480210:A:T
NM_194248.3(OTOF):c.*19C>T	OTOF	R1172W, R1939W	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562079	2	26681087	2	26458219	562079	553251	rs530821443	NC_000002.12:26458218:G:A
NM_194248.3(OTOF):c.4030C>T (p.Arg1344Ter)	OTOF	R1344*, R577*, R654*	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402271	2	26691336	2	26468468	402271	389220	rs1060499805	NC_000002.12:26468467:G:A
NM_194248.3(OTOF):c.4747C>T (p.Arg1583Cys)	OTOF	R1583C, R816C, R893C	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402270	2	26688592	2	26465724	402270	389219	rs781688103	NC_000002.12:26465723:G:A
NM_194248.3(OTOF):c.1111G>C (p.Gly371Arg)	OTOF	G371R	Deafness, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000252378	2	26707436	2	26484568	252378	246783	rs879255246	NC_000002.12:26484567:C:G
NM_194248.3(OTOF):c.4157C>T (p.Thr1386Ile)	OTOF	T1386I, T619I, T696I	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065801	2	26690303	2	26467435	65801	76709	rs397515600	NC_000002.12:26467434:G:A
NM_000488.3(SERPINC1):c.218C>T (p.Pro73Leu)	SERPINC1	P41L, P73L, P25L	Antithrombin III deficiency|Antithrombin deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000018011	1	173883881	1	173914743	18011	33050	rs121909551	NC_000001.11:173914742:G:A
NM_194248.3(OTOF):c.4362+1G>C	OTOF		Deafness, autosomal recessive 9	Pathogenic	criteria provided, single submitter	VCV000634822	2	26689966	2	26467098	634822	622685	rs1274464930	NC_000002.12:26467097:C:G
NM_194248.3(OTOF):c.2443del (p.Gln815fs)	OTOF	Q68fs, Q815fs, Q125fs	Deafness, autosomal recessive 9	Pathogenic	criteria provided, single submitter	VCV000634820	2	26700120	2	26477252	634820	622687	rs1558485249	NC_000002.12:26477251:GGG:GG
NM_194248.3(OTOF):c.*20G>A	OTOF	R1939Q, R1172Q	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000548986	2	26681086	2	26458218	548986	539468	rs201326023	NC_000002.12:26458217:C:T
NM_194248.3(OTOF):c.897+5G>A	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446442	2	26717805	2	26494937	446442	439898	rs1553356452	NC_000002.12:26494936:C:T
NM_194248.3(OTOF):c.5992T>C (p.Ter1998Arg)	OTOF	*1998R, *1308R, *1231R	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446441	2	26682895	2	26460027	446441	439894	rs1207102900	NC_000002.12:26460026:A:G
NM_194248.3(OTOF):c.5466C>G (p.Tyr1822Ter)	OTOF	Y1822*, Y1055*, Y1132*	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446440	2	26684631	2	26461763	446440	439895	rs753580324	NC_000002.12:26461762:G:C
NM_194248.3(OTOF):c.1946_1965del (p.Arg649fs)	OTOF	R649fs	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446439	2	26702469 - 26702488	2	26479601 - 26479620	446439	439896	rs1553353527	NC_000002.12:26479600:GGGCCGAGGCCGCTGGGGCCGGG:GGG
NM_194248.3(OTOF):c.1422T>A (p.Tyr474Ter)	OTOF	Y474*	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000446438	2	26705431	2	26482563	446438	439897	rs1403112959	NC_000002.12:26482562:A:T
NM_194248.1:c.766-2T>A	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065816					65816	76724		
NM_194248.3(OTOF):c.765G>C (p.Gln255His)	OTOF	Q255H	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065815	2	26724622	2	26501754	65815	76723	rs397515611	NC_000002.12:26501753:C:G
NM_194248.3(OTOF):c.709C>T (p.Arg237Ter)	OTOF	R237*	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065814	2	26725169	2	26502301	65814	76722	rs397515610	NC_000002.12:26502300:G:A
NM_194248.3(OTOF):c.5567G>A (p.Arg1856Gln)	OTOF	R1856Q, R1089Q, R1166Q	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065811	2	26683865	2	26460997	65811	76719	rs397515608	NC_000002.12:26460996:C:T
NM_194248.3(OTOF):c.5197G>A (p.Glu1733Lys)	OTOF	E1733K, E1043K, E966K	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065808	2	26685045	2	26462177	65808	76716	rs397515605	NC_000002.12:26462176:C:T
NM_194248.3(OTOF):c.5011dup (p.Trp1671fs)	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065807	2	26686923 - 26686924	2	26464055 - 26464056	65807	76715	rs397515604	NC_000002.12:26464055:A:AA
NM_194248.3(OTOF):c.4809C>A (p.Tyr1603Ter)	OTOF	Y1603*, Y913*, Y836*	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065805	2	26687888	2	26465020	65805	76713	rs143939430	NC_000002.12:26465019:G:T
NM_194248.3(OTOF):c.4351G>T (p.Gly1451Ter)	OTOF	G1451*, G761*, G684*	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065803	2	26689978	2	26467110	65803	76711	rs397515602	NC_000002.12:26467109:C:A
NM_194248.1:c.3704-3720delACCGCTCGGCCCCCAG	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065800					65800	76708		
NM_194248.3(OTOF):c.3413T>C (p.Leu1138Pro)	OTOF	L1138P, L448P, L391P	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065799	2	26696431	2	26473563	65799	76707	rs397515599	NC_000002.12:26473562:A:G
NM_194248.3(OTOF):c.3400C>T (p.Arg1134Ter)	OTOF	R1134*, R387*, R444*	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065798	2	26696867	2	26473999	65798	76706	rs199848801	NC_000002.12:26473998:G:A
NM_194248.3(OTOF):c.3269C>A (p.Ala1090Glu)	OTOF	A1090E, A343E, A400E	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065797	2	26697400	2	26474532	65797	76705	rs370609551	NC_000002.12:26474531:G:T
NM_194248.3(OTOF):c.3239G>C (p.Arg1080Pro)	OTOF	R1080P, R390P, R333P	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065796	2	26697430	2	26474562	65796	76704	rs397515598	NC_000002.12:26474561:C:G
NM_194248.3(OTOF):c.2905_2923delinsCTCCGAGCGCA (p.Ala969fs)	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065794	2	26698850 - 26698868	2	26475982 - 26476000	65794	76702	rs397515596	NC_000002.12:26475981:CGGCAAAGAGGCTGCGGGC:TGCGCTCGGAG
NM_194248.3(OTOF):c.2684_2685del (p.Gly895fs)	OTOF	G148fs, G205fs, G895fs	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065791	2	26699177 - 26699178	2	26476309 - 26476310	65791	76699	rs397515594	NC_000002.12:26476308:CCC:C
NM_194248.3(OTOF):c.2649C>A (p.Cys883Ter)	OTOF	C883*, C193*, C136*	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065790	2	26699786	2	26476918	65790	76698	rs397515593	NC_000002.12:26476917:G:T
NM_194248.3(OTOF):c.2316C>A (p.Cys772Ter)	OTOF	C772*, C25*, C82*	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065789	2	26700374	2	26477506	65789	76697	rs397515592	NC_000002.12:26477505:G:T
NM_194248.1:c.2295_2297delG	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065788					65788	76696		
NM_194248.3(OTOF):c.1966del (p.Arg656fs)	OTOF	R656fs	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065786	2	26702468	2	26479600	65786	76694	rs397515590	NC_000002.12:26479599:GGGG:GGG
NM_194248.1:c.1912-2C>T	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065785					65785	76693		
NM_194248.3(OTOF):c.1841G>A (p.Gly614Glu)	OTOF	G614E	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065784	2	26703142	2	26480274	65784	76692	rs397515589	NC_000002.12:26480273:C:T
NM_194248.3(OTOF):c.1780G>A (p.Glu594Lys)	OTOF	E594K	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065783	2	26703677	2	26480809	65783	76691	rs397515588	NC_000002.12:26480808:C:T
NM_194248.3(OTOF):c.1740del (p.Ser581fs)	OTOF	S581fs	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065782	2	26703717	2	26480849	65782	76690	rs397515587	NC_000002.12:26480848:GG:G
NM_194248.3(OTOF):c.1718T>G (p.Leu573Arg)	OTOF	L573R	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065781	2	26703739	2	26480871	65781	76689	rs397515586	NC_000002.12:26480870:A:C
NM_194248.3(OTOF):c.1609del (p.Trp536_Val537insTer)	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065780	2	26703848	2	26480980	65780	76688	rs397515585	NC_000002.12:26480979:CCC:CC
NM_194248.3(OTOF):c.1607G>A (p.Trp536Ter)	OTOF	W536*	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065779	2	26703850	2	26480982	65779	76687	rs397515584	NC_000002.12:26480981:C:T
NM_194248.3(OTOF):c.1601del (p.Pro534fs)	OTOF	P534fs	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065778	2	26703856	2	26480988	65778	76686	rs397515583	NC_000002.12:26480987:GGG:GG
NM_194248.3(OTOF):c.1552_1567del (p.Arg518fs)	OTOF	R518fs	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065777	2	26705286 - 26705301	2	26482418 - 26482433	65777	76685	rs1443739332	NC_000002.12:26482417:CATTAGAAATCTTGCGCA:CA
NM_194248.3(OTOF):c.1273C>T (p.Arg425Ter)	OTOF	R425*	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065776	2	26706449	2	26483581	65776	76684	rs397515582	NC_000002.12:26483580:G:A
NM_194248.3(OTOF):c.1180dup (p.Glu394fs)	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065774	2	26707366 - 26707367	2	26484498 - 26484499	65774	76682	rs397515580	NC_000002.12:26484498:C:CC
NM_194248.3(OTOF):c.1103_1104delinsC (p.Gly368fs)	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065773	2	26707443 - 26707444	2	26484575 - 26484576	65773	76681	rs397515579	NC_000002.12:26484574:CC:G
NM_194248.3(OTOF):c.5960C>G (p.Pro1987Arg)	OTOF	P1987R, P1220R, P1297R	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000021863	2	26682927	2	26460059	21863	34715	rs80356606	NC_000002.12:26460058:G:C
NM_194248.1:c.5860_5862delATC	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000021862					21862	34714		
NM_194248.3(OTOF):c.5712+1G>A	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000021860	2	26683719	2	26460851	21860	34712	rs80356604	NC_000002.12:26460850:C:T
NM_194248.3(OTOF):c.4500+2T>G	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000021851	2	26689580	2	26466712	21851	34703	rs80356599	NC_000002.12:26466711:A:C
NM_194248.3(OTOF):c.4275G>A (p.Trp1425Ter)	OTOF	W1425*, W735*, W658*	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000021849	2	26690054	2	26467186	21849	34701	rs80356598	NC_000002.12:26467185:C:T
NM_194248.3(OTOF):c.3571-2A>C	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000021846	2	26696164	2	26473296	21846	34698	rs80356597	NC_000002.12:26473295:T:G
NM_194248.3(OTOF):c.2991+1G>A	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000021841	2	26698781	2	26475913	21841	34693	rs80356594	NC_000002.12:26475912:C:T
NM_194248.3(OTOF):c.2214+1G>T	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000021832	2	26702131	2	26479263	21832	34684	rs80356589	NC_000002.12:26479262:C:A
NM_194248.3(OTOF):c.1886dup (p.Pro630fs)	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000021827	2	26703096 - 26703097	2	26480228 - 26480229	21827	34679	rs80356588	NC_000002.12:26480228:TT:TTT
NM_194248.3(OTOF):c.1651del (p.Glu551fs)	OTOF	E551fs	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000021825	2	26703806	2	26480938	21825	34677	rs80356587	NC_000002.12:26480937:C:
NM_194248.3(OTOF):c.1469C>A (p.Pro490Gln)	OTOF	P490Q	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000021823	2	26705384	2	26482516	21823	34675	rs80356585	NC_000002.12:26482515:G:T
OTOF, IVS5, G-A, +1	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000006135					6135	21174		
NM_024529.4(CDC73):c.131+1G>A	CDC73		not provided|Parathyroid adenoma, somatic|Parathyroid carcinoma|Hyperparathyroidism 1	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003276	1	193091462	1	193122332	3276	18315	rs587776558	NC_000001.11:193122331:G:A
NM_194248.2(OTOF):c.4227+1G>T	OTOF		Deafness, autosomal recessive 9	Pathogenic/Likely pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000065802	2	26690232	2	26467364	65802	76710	rs397515601	NC_000002.12:26467363:C:A
NM_194248.3(OTOF):c.2891C>A (p.Ala964Glu)	OTOF	A964E, A217E, A274E	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065793	2	26698882	2	26476014	65793	76701	rs201329629	NC_000002.12:26476013:G:T
NM_194248.3(OTOF):c.2732_2735dup (p.Tyr913fs)	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065792	2	26699126 - 26699127	2	26476258 - 26476259	65792	76700	rs397515595	NC_000002.12:26476258:AGCT:AGCTAGCT
NM_194248.3(OTOF):c.1236del (p.Glu413fs)	OTOF	E413fs	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000065775	2	26706486	2	26483618	65775	76683	rs397515581	NC_000002.12:26483617:GGGGGG:GGGGG
NM_194248.3(OTOF):c.1621G>A (p.Gly541Ser)	OTOF	G541S	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000040177	2	26703836	2	26480968	40177	48674	rs397515435	NC_000002.12:26480967:C:T
NM_194248.3(OTOF):c.5473C>G (p.Pro1825Ala)	OTOF	P1825A, P1135A, P1058A	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000006138	2	26684624	2	26461756	6138	21177	rs28937591	NC_000002.12:26461755:G:C
NM_194248.3(OTOF):c.766-2A>G	OTOF		Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000006134	2	26717943	2	26495075	6134	21173	rs80356584	NC_000002.12:26495074:T:C
NM_000478.6(ALPL):c.400_401delinsCA (p.Thr134His)	ALPL		not provided|Hypophosphatemia|Adult hypophosphatasia|Infantile hypophosphatasia|Childhood hypophosphatasia|Infantile hypophosphatasia	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000188877	1	21889705 - 21889706	1	21563212 - 21563213	188877	186616	rs786204530	NC_000001.11:21563211:AC:CA
NC_000002.12:g.(?_32143325)_(32147268_?)del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000830778	2	32368394 - 32372337			830778	819165		
NM_014946.3(SPAST):c.1684C>G (p.Arg562Gly)	SPAST	R562G, R529G, R561G, R530G	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000005673	2	32370073	2	32145004	5673	20712	rs121908518	NC_000002.12:32145003:C:G
NM_194248.3(OTOF):c.5384T>G (p.Phe1795Cys)	OTOF	F1795C, F1028C, F1105C	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000065809	2	26684713	2	26461845	65809	76717	rs397515606	NC_000002.12:26461844:A:C
NM_194248.3(OTOF):c.2887C>T (p.Arg963Ter)	OTOF	R963*, R216*, R273*	not provided|Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000021840	2	26698886	2	26476018	21840	34692	rs80356595	NC_000002.12:26476017:G:A
NM_194248.3(OTOF):c.4960+1G>C	OTOF		Auditory neuropathy, autosomal recessive, 1|Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000006140	2	26687736	2	26464868	6140	21179	rs80356602	NC_000002.12:26464867:C:G
NM_201253.3(CRB1):c.3988del (p.Glu1330fs)	CRB1	E1306fs, E1330fs, E1218fs, E794fs	not provided|Leber congenital amaurosis 8|Retinitis pigmentosa 12|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000377183	1	197411405	1	197442275	377183	364061	rs1057520152	NC_000001.11:197442274:G:
NM_007315.3(STAT1):c.1154C>T (p.Thr385Met)	STAT1	T385M	Short stature|Liver abscess|Severe T-cell immunodeficiency|Primary hypothyroidism|Delayed speech and language development|Hypothyroidism|Chronic oral candidiasis|Inherited Immunodeficiency Diseases|Bronchiectasis|Congenital combined immunodeficiency|Cognitive impairment|Chronic diarrhea|Failure to thrive|Hypothyroidism|Immunodeficiency 31C|Immunodeficiency 31a|Mycobacterial and viral infections, susceptibility to, autosomal recessive|Immunodeficiency 31C	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000144006	2	191851647	2	190986921	144006	153737	rs587777630	NC_000002.12:190986920:G:A
NM_004895.4(NLRP3):c.784C>T (p.Arg262Trp)	NLRP3	R260W, R262W	Cryopyrin associated periodic syndrome|Familial amyloid nephropathy with urticaria AND deafness|not provided|Familial cold urticaria	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004374	1	247587529	1	247424227	4374	19413	rs121908150	NC_000001.11:247424226:C:T
NM_194248.3(OTOF):c.2975_2976AG[1] (p.Gln994fs)	OTOF		Rare genetic deafness|Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Jun 10, 2014)	criteria provided, single submitter	VCV000179828	2	26698795 - 26698796	2	26475927 - 26475928	179828	173648	rs397515597	NC_000002.12:26475926:CTCT:CT
NM_194248.3(OTOF):c.3032T>C (p.Leu1011Pro)	OTOF	L1011P, L264P, L321P	Auditory neuropathy, autosomal recessive, 1|Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Apr 26, 2011)	no assertion criteria provided	VCV000006142	2	26698321	2	26475453	6142	21181	rs80356596	NC_000002.12:26475452:A:G
NM_001276345.2(TNNT2):c.358T>A (p.Phe120Ile)	TNNT2	F110I, F120I, F105I	not provided|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000012412	1	201334372	1	201365244	12412	27451	rs121964858	NC_000001.11:201365243:A:T
NM_194248.3(OTOF):c.2348del (p.Gly783fs)	OTOF	G783fs, G93fs, G36fs	Deafness, autosomal recessive 9|Rare genetic deafness	Pathogenic(Last reviewed: Feb 26, 2015)	criteria provided, single submitter	VCV000021834	2	26700342	2	26477474	21834	34686	rs80356591	NC_000002.12:26477473:CCC:CC
NM_014362.4(HIBCH):c.365A>G (p.Tyr122Cys)	HIBCH	Y122C	Inborn genetic diseases|not provided|Beta-hydroxyisobutyryl-CoA deacylase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001145	2	191155151	2	190290425	1145	16184	rs121918329	NC_000002.12:190290424:T:C
NM_015215.4(CAMTA1):c.420del (p.Lys141fs)	CAMTA1	K111fs, K141fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	VCV000521550	1	7309668	1	7249608	521550	511294	rs1553288266	NC_000001.11:7249607:C:
NM_000092.5(COL4A4):c.2219dup (p.Val741fs)	COL4A4		not provided	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000817981	2	227924284 - 227924285	2	227059568 - 227059569	817981	805291		NC_000002.12:227059568:GGGG:GGGGG
NM_000092.4(COL4A4):c.2734G>A (p.Gly912Ser)	COL4A4	G912S	not provided	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000546271	2	227919436	2	227054720	546271	536625	rs1553640846	NC_000002.12:227054719:C:T
NM_000092.5(COL4A4):c.748C>T (p.Gln250Ter)	COL4A4	Q250*	not provided	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000852969	2	227968756	2	227104040	852969	825796		NC_000002.12:227104039:G:A
NM_000092.5(COL4A4):c.2232dup (p.Gly745fs)	COL4A4		not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000844538	2	227924271 - 227924272	2	227059555 - 227059556	844538	825793		NC_000002.12:227059555:T:TT
NC_000002.12:g.(?_227147403)_(227147493_?)del	COL4A4		not provided	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000832055	2	228012119 - 228012209			832055	819131		
NM_000092.5(COL4A4):c.1161dup (p.Gly388fs)	COL4A4		not provided	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000659123	2	227963452 - 227963453	2	227098736 - 227098737	659123	629504		NC_000002.12:227098736:A:AA
NM_000092.5(COL4A4):c.71+1G>A	COL4A4		Benign familial hematuria	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000627584	2	228012128	2	227147412	627584	615935	rs1559742015	NC_000002.12:227147411:C:T
GRCh37/hg19 2q36.3(chr2:227939002-227943108)	COL4A4		Specific language impairment 5	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625777	2	227939002 - 227943108			625777	614081		
NM_000092.4(COL4A4):c.4334G>A (p.Gly1445Glu)	COL4A4	G1445E	not provided	Pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, single submitter	VCV000585532	2	227875217	2	227010501	585532	576649	rs1559402680	NC_000002.12:227010500:C:T
NM_000092.4(COL4A4):c.1623+1G>A	COL4A4		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562446	2	227953368	2	227088652	562446	553630	rs1559590037	NC_000002.12:227088651:C:T
NM_000092.4(COL4A4):c.1889del (p.Pro630fs)	COL4A4	P630fs	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562435	2	227942708	2	227077992	562435	553619	rs757688183	NC_000002.12:227077991:GGGGG:GGGG
NM_000092.4(COL4A4):c.2826_2827insAC (p.Leu943fs)	COL4A4		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562424	2	227919343 - 227919344	2	227054627 - 227054628	562424	553608	rs1559508134	NC_000002.12:227054627:G:GTG
NM_000092.4(COL4A4):c.3109_3110del (p.Leu1037fs)	COL4A4	L1037fs	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562421	2	227915733 - 227915734	2	227051017 - 227051018	562421	553605	rs1559500363	NC_000002.12:227051016:AGA:A
NM_000092.4(COL4A4):c.3861_3862insTC (p.Arg1288fs)	COL4A4		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562396	2	227895270 - 227895271	2	227030554 - 227030555	562396	553580	rs1559450594	NC_000002.12:227030554::GA
NM_000092.4(COL4A4):c.4768C>T (p.Gln1590Ter)	COL4A4	Q1590*	not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562368	2	227872775	2	227008059	562368	553552	rs1559395617	NC_000002.12:227008058:G:A
NM_000092.4(COL4A4):c.4082-1G>T	COL4A4		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562353	2	227890527	2	227025811	562353	553537	rs1559438651	NC_000002.12:227025810:C:A
NM_000092.4(COL4A4):c.4621_4624dup (p.Trp1542fs)	COL4A4		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562352	2	227872918 - 227872919	2	227008202 - 227008203	562352	553536	rs1559396675	NC_000002.12:227008202:AGTA:AGTAAGTA
NM_000092.4(COL4A4):c.2110G>A (p.Gly704Arg)	COL4A4	G704R	not provided	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, single submitter	VCV000447185	2	227924906	2	227060190	447185	440661	rs1379525680	NC_000002.12:227060189:C:T
NM_000092.4(COL4A4):c.1603G>T (p.Glu535Ter)	COL4A4	E535*	not provided	Pathogenic(Last reviewed: Dec 27, 2016)	criteria provided, single submitter	VCV000447181	2	227953389	2	227088673	447181	440664	rs1553669674	NC_000002.12:227088672:C:A
NM_000092.4(COL4A4):c.1100-2A>C	COL4A4		Benign familial hematuria	Pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, single submitter	VCV000222056	2	227963516	2	227098800	222056	223749	rs869025329	NC_000002.12:227098799:T:G
NM_000092.4(COL4A4):c.2986G>A (p.Gly996Arg)	COL4A4	G996R	Benign familial hematuria	Pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, single submitter	VCV000222055	2	227915857	2	227051141	222055	223746	rs370474706	NC_000002.12:227051140:C:T
NM_000092.4(COL4A4):c.2878G>C (p.Gly960Arg)	COL4A4	G960R	Benign familial hematuria	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000017411	2	227917111	2	227052395	17411	32450	rs769783985	NC_000002.12:227052394:C:G
NM_000092.4(COL4A4):c.3222dup (p.Gly1075fs)	COL4A4		Benign familial hematuria	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000017410	2	227912257 - 227912258	2	227047541 - 227047542	17410	32449	rs1559493506	NC_000002.12:227047541:TTT:TTTT
NM_000092.5(COL4A4):c.678_682dup (p.Pro228fs)	COL4A4		Alport syndrome 3, autosomal dominant	Pathogenic(Last reviewed: Oct 8, 2019)	no assertion criteria provided	VCV000830016	2	227973559 - 227973560	2	227108843 - 227108844	830016	818193		NC_000002.12:227108843:GACGC:GACGCGACGC
NM_000092.5(COL4A4):c.4624_4627TGGC[1] (p.Leu1543fs)	COL4A4		Alport syndrome 3, autosomal dominant	Pathogenic(Last reviewed: Mar 19, 2019)	no assertion criteria provided	VCV000829937	2	227872912 - 227872915	2	227008196 - 227008199	829937	818183		NC_000002.12:227008195:GCCAGCCAG:GCCAG
NM_000092.5(COL4A4):c.4522G>A (p.Gly1508Ser)	COL4A4	G1508S	Alport syndrome 3, autosomal dominant	Pathogenic(Last reviewed: Nov 19, 2019)	no assertion criteria provided	VCV000829920	2	227875029	2	227010313	829920	818185		NC_000002.12:227010312:C:T
NM_000092.5(COL4A4):c.192+1_192+2delinsTGATGTA	COL4A4		Alport syndrome 3, autosomal dominant	Pathogenic(Last reviewed: Jun 3, 2019)	no assertion criteria provided	VCV000829857	2	228004875 - 228004876	2	227140159 - 227140160	829857	818194		NC_000002.12:227140158:AC:TACATCA
GRCh37/hg19 2q36.3(chr2:227942610-227945265)	COL4A4		Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000813305	2	227942610 - 227945265			813305	801557		
NM_000092.5(COL4A4):c.2171del (p.Arg724fs)	COL4A4	R724fs	Alport syndrome 3, autosomal dominant	Pathogenic(Last reviewed: Feb 27, 2019)	no assertion criteria provided	VCV000635547	2	227924333	2	227059617	635547	623257		NC_000002.12:227059616:C:
NM_000092.4(COL4A4):c.4460_4463dup (p.Trp1488fs)	COL4A4		Alport syndrome 3, autosomal dominant	Pathogenic(Last reviewed: Nov 20, 2018)	no assertion criteria provided	VCV000635509	2	227875087 - 227875088	2	227010371 - 227010372	635509	623255		NC_000002.12:227010371:CAGA:CAGACAGA
NM_000092.5(COL4A4):c.1389del (p.Asn464fs)	COL4A4	N464fs	Alport syndrome 3, autosomal dominant	Pathogenic(Last reviewed: Oct 9, 2018)	no assertion criteria provided	VCV000635494	2	227954654	2	227089938	635494	623258		NC_000002.12:227089937:CCC:CC
NM_000092.4(COL4A4):c.1221_1237del (p.Gly408fs)	COL4A4	G408fs	Alport syndrome 3, autosomal dominant	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000599148	2	227958973 - 227958989	2	227094257 - 227094273	599148	590254	rs1559606445	NC_000002.12:227094256:GAAATCCTTGTGGCCCAG:G
NM_000092.4(COL4A4):c.4820del (p.Ala1607fs)	COL4A4	A1607fs	Alport syndrome 3, autosomal dominant	Pathogenic(Last reviewed: Mar 5, 2018)	no assertion criteria provided	VCV000599086	2	227872294	2	227007578	599086	590242	rs1559394354	NC_000002.12:227007577:G:
NM_000092.4(COL4A4):c.1441G>A (p.Gly481Ser)	COL4A4	G481S	not provided	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000585525	2	227954602	2	227089886	585525	576656	rs181528936	NC_000002.12:227089885:C:T
NM_000092.5(COL4A4):c.2969-1G>C	COL4A4		Alport syndrome 3, autosomal dominant	Pathogenic(Last reviewed: Nov 28, 2017)	no assertion criteria provided	VCV000522543	2	227915875	2	227051159	522543	513035	rs1553639043	NC_000002.12:227051158:C:G
NM_000092.4(COL4A4):c.3834dup (p.Gly1279fs)	COL4A4		Alport syndrome 3, autosomal dominant	Pathogenic(Last reviewed: Nov 27, 2017)	no assertion criteria provided	VCV000522537	2	227895297 - 227895298	2	227030581 - 227030582	522537	513032	rs1553625684	NC_000002.12:227030581:T:TT
NM_000092.4(COL4A4):c.4694_4713del (p.Arg1565fs)	COL4A4	R1565fs	Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522488	2	227872830 - 227872849	2	227008114 - 227008133	522488	513026	rs1553612433	NC_000002.12:227008113:GGCCTCGCATACCGCACAGCGGC:GGC
NM_000092.4(COL4A4):c.914_930+29del	COL4A4		not provided	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000447196	2	227967476 - 227967521	2	227102760 - 227102805	447196	440668	rs1553683757	NC_000002.12:227102759:CACTGATGTTAACAGCAAATGATGCTTACCCGAGGCCCTGGAAATCCA:CA
NM_000092.4(COL4A4):c.2638_2639del (p.Ala880fs)	COL4A4	A880fs	Alport syndrome, autosomal recessive	Pathogenic	no assertion criteria provided	VCV000441259	2	227920738 - 227920739	2	227056022 - 227056023	441259	434902	rs1553641611	NC_000002.12:227056021:GC:
NM_000092.4(COL4A4):c.2420del (p.Gly807fs)	COL4A4	G807fs	not provided	Pathogenic(Last reviewed: Jan 23, 2017)	criteria provided, single submitter	VCV000191313	2	227922280	2	227057564	191313	189116	rs786205640	NC_000002.12:227057563:CC:C
NM_000092.4(COL4A4):c.1598G>A (p.Gly533Asp)	COL4A4	G533D	Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000556434	2	227953394	2	227088678	556434	541864	rs1553669704	NC_000002.12:227088677:C:T
NM_000092.4(COL4A4):c.2638del (p.Ala880fs)	COL4A4	A880fs	Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Jan 27, 2017)	criteria provided, single submitter	VCV000550471	2	227920739	2	227056023	550471	541837	rs778043831	NC_000002.12:227056022:CCCC:CCC
NM_000092.4(COL4A4):c.1045C>T (p.Arg349Ter)	COL4A4	R349*	not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000447178	2	227964390	2	227099674	447178	440667	rs534522842	NC_000002.12:227099673:G:A
NM_000092.4(COL4A4):c.4923C>A (p.Cys1641Ter)	COL4A4	C1641*	Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000017408	2	227872191	2	227007475	17408	32447	rs121912862	NC_000002.12:227007474:G:T
NM_000016.5(ACADM):c.443G>A (p.Arg148Lys)	ACADM	R152K, R148K, R112K, R181K	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000198025	1	76200531	1	75734846	198025	195186	rs778906552	NC_000001.11:75734845:G:A
NM_000016.5(ACADM):c.244dup (p.Trp82fs)	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188934	1	76198564 - 76198565	1	75732879 - 75732880	188934	186628	rs786204566	NC_000001.11:75732879:T:TT
NM_000092.4(COL4A4):c.3713C>A (p.Ser1238Ter)	COL4A4	S1238*	Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000017405	2	227896765	2	227032049	17405	32444	rs121912859	NC_000002.12:227032048:G:T
NM_000092.4(COL4A4):c.3601G>A (p.Gly1201Ser)	COL4A4	G1201S	Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000017404	2	227896969	2	227032253	17404	32443	rs121912858	NC_000002.12:227032252:C:T
NM_000092.5(COL4A4):c.595G>T (p.Gly199Ter)	COL4A4	G199*	not provided|Alport syndrome 3, autosomal dominant	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000812583	2	227974002	2	227109286	812583	800832		NC_000002.12:227109285:C:A
NM_000092.5(COL4A4):c.1221del (p.Pro409fs)	COL4A4	P409fs	not provided|Alport syndrome 3, autosomal dominant	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000635526	2	227958989	2	227094273	635526	623259		NC_000002.12:227094272:A:
NM_000092.4(COL4A4):c.1320_1369+2del	COL4A4		Alport syndrome, autosomal recessive|Alport syndrome 3, autosomal dominant	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000242441	2	227958838 - 227958889	2	227094122 - 227094173	242441	223748	rs1553676221	
NM_172362.3(KCNH1):c.1486G>A (p.Gly496Arg)	KCNH1	G469R, G496R	Inborn genetic diseases|not provided|Zimmermann-Laband syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183418	1	210977485	1	210804143	183418	181517	rs730882175	NC_000001.11:210804142:C:T
NM_015506.3(MMACHC):c.609G>A (p.Trp203Ter)	MMACHC	W203*, W146*	Methylmalonic acidemia with homocystinuria|not provided	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030800	1	45974647	1	45508975	30800	39757	rs587776889	NC_000001.11:45508974:G:A
NM_000092.4(COL4A4):c.1118G>A (p.Gly373Glu)	COL4A4	G373E	Alport syndrome, autosomal recessive|not provided	Pathogenic(Last reviewed: Sep 28, 2015)	criteria provided, single submitter	VCV000447179	2	227963496	2	227098780	447179	440666	rs755649235	NC_000002.12:227098779:C:T
NM_000530.8(MPZ):c.486del (p.Ile162fs)	MPZ	I162fs	Charcot-Marie-Tooth disease|Intellectual disability|Charcot-Marie-Tooth disease, type I	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000625199	1	161276217	1	161306427	625199	613532		NC_000001.11:161306426:G:
NM_000530.8(MPZ):c.188_190del (p.Ser63del)	MPZ	S63del, S34del	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000246121	1	161277092 - 161277094	1	161307302 - 161307304	246121	244254	rs879254109	NC_000001.11:161307301:AGGAG:AG
NM_000530.8(MPZ):c.106A>T (p.Arg36Trp)	MPZ	R36W	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000221065	1	161277176	1	161307386	221065	221083	rs864622732	NC_000001.11:161307385:T:A
NM_000530.8(MPZ):c.434A>C (p.Tyr145Ser)	MPZ	Y145S	Congenital hypomyelinating neuropathy 1, autosomal recessive||Dejerine-Sottas disease|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease, demyelinating, type 1b|Roussy-Lévy syndrome|Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|not provided	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014191	1	161276512	1	161306722	14191	29230	rs121913603	NC_000001.11:161306721:T:G
NM_153818.1(PEX10):c.874_875del (p.Leu292fs)	PEX10	L272fs, L292fs	not provided|Peroxisome biogenesis disorder 6A|Peroxisome biogenesis disorder 6B|Peroxisome biogenesis disorder, complementation group 7|Peroxisome biogenesis disorders, Zellweger syndrome spectrum	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000296273	1	2338020 - 2338021	1	2406581 - 2406582	296273	281791	rs61752093	NC_000001.11:2406580:AG:
NC_000001.10:g.(?_161326457)_(161332233_?)del	SDHC		Gastrointestinal stromal tumor|Paragangliomas 3	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000650709	1	161326457 - 161332233	1	161356667 - 161362443	650709	650557		
GRCh37/hg19 1p36.31(chr1:5979667-6007969)x1	NPHP4		not provided	Pathogenic(Last reviewed: Nov 28, 2017)	no assertion criteria provided	VCV000688495	1	5979667 - 6007969			688495	676087		
NM_015102.5(NPHP4):c.3409_3412del (p.Tyr1137fs)	NPHP4	Y624fs, Y625fs, Y1137fs	not provided	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000598365	1	5927860 - 5927863	1	5867800 - 5867803	598365	589426	rs762371581	NC_000001.11:5867799:GATAGA:GA
NM_015102.5(NPHP4):c.3618del (p.Asp1208fs)	NPHP4	D695fs, D1208fs, D696fs	not provided	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000595319	1	5926459	1	5866399	595319	586381	rs1557588167	NC_000001.11:5866398:G:
NM_015102.5(NPHP4):c.2611+1G>A	NPHP4		not provided	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000595124	1	5940173	1	5880113	595124	586186	rs374141736	NC_000001.11:5880112:C:T
NM_015102.5(NPHP4):c.189_192del (p.Phe63fs)	NPHP4	F63fs	not provided	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000501697	1	6038417 - 6038420	1	5978357 - 5978360	501697	493121	rs1553200990	NC_000001.11:5978356:ATCAA:A
NM_015102.5(NPHP4):c.2011C>T (p.Gln671Ter)	NPHP4	Q671*, Q159*, Q158*	not provided	Pathogenic(Last reviewed: Nov 9, 2016)	criteria provided, single submitter	VCV000498434	1	5964809	1	5904749	498434	489858	rs1025515771	NC_000001.11:5904748:G:A
NM_015102.5(NPHP4):c.750dup (p.Ser251fs)	NPHP4		Nephronophthisis 4	Pathogenic(Last reviewed: May 28, 2019)	no assertion criteria provided	VCV000829848	1	6012819 - 6012820	1	5952759 - 5952760	829848	818173		NC_000001.11:5952759:GGGG:GGGGG
NM_015102.5(NPHP4):c.2930C>T (p.Thr977Met)	NPHP4	T464M, T465M, T977M	Senior-Loken syndrome 4	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812121	1	5935048	1	5874988	812121	800349		NC_000001.11:5874987:G:A
NM_015102.5(NPHP4):c.3325C>T (p.Arg1109Ter)	NPHP4	R1109*, R596*, R597*	Nephronophthisis	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000639470	1	5927947	1	5867887	639470	628170		NC_000001.11:5867886:G:A
NM_015102.5(NPHP4):c.133C>T (p.Gln45Ter)	NPHP4	Q45*	not provided	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000562355	1	6046217	1	5986157	562355	553539	rs370210428	NC_000001.11:5986156:G:A
NM_015102.5(NPHP4):c.3272del (p.Val1091fs)	NPHP4	V1091fs, V579fs, V578fs	Nephronophthisis 4	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000003403	1	5933355	1	5873295	3403	18442	rs1278089386	NC_000001.11:5873294:A:
NM_015102.5(NPHP4):c.2972T>C (p.Phe991Ser)	NPHP4	F991S, F478S, F479S	Nephronophthisis 4	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000003402	1	5935006	1	5874946	3402	18441	rs28940891	NC_000001.11:5874945:A:G
NM_015102.5(NPHP4):c.2368G>T (p.Glu790Ter)	NPHP4	E790*, E278*, E277*	Nephronophthisis 4	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000003399	1	5947463	1	5887403	3399	18438	rs137852918	NC_000001.11:5887402:C:A
NM_000092.4(COL4A4):c.1396G>A (p.Gly466Arg)	COL4A4	G466R	not provided|Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, single submitter	VCV000447180	2	227954647	2	227089931	447180	440665	rs201859109	NC_000002.12:227089930:C:T
NM_004895.4(NLRP3):c.1064T>C (p.Leu355Pro)	NLRP3	L353P, L355P	Cryopyrin associated periodic syndrome|Familial amyloid nephropathy with urticaria AND deafness|Keratitis fugax hereditaria|Familial cold urticaria|DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION|Chronic infantile neurological, cutaneous and articular syndrome|not specified|not provided|Familial cold urticaria	Pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004379	1	247587809	1	247424507	4379	19418	rs28937896	NC_000001.11:247424506:T:C
NM_194248.3(OTOF):c.4483C>T (p.Arg1495Ter)	OTOF	R1495*, R728*, R805*	Deafness, autosomal recessive 9|Hearing impairment|not specified	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000065804	2	26689599	2	26466731	65804	76712	rs147321712	NC_000002.12:26466730:G:A
NM_194248.3(OTOF):c.2122C>T (p.Arg708Ter)	OTOF	R708*	Deafness, autosomal recessive 9|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000021831	2	26702224	2	26479356	21831	34683	rs80356590	NC_000002.12:26479355:G:A
NM_194248.3(OTOF):c.4491T>A (p.Tyr1497Ter)	OTOF	Y730*, Y1497*, Y807*	Rare genetic deafness|Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Feb 26, 2015)	criteria provided, single submitter	VCV000006133	2	26689591	2	26466723	6133	21172	rs80356600	NC_000002.12:26466722:A:T
NM_015102.5(NPHP4):c.1357G>T (p.Glu453Ter)	NPHP4	E453*	not provided|Nephronophthisis	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000596144	1	5987793	1	5927733	596144	587205	rs1210874691	NC_000001.11:5927732:C:A
NM_015102.5(NPHP4):c.2940_2944dup (p.His982fs)	NPHP4		Nephronophthisis|not provided	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000496917	1	5935033 - 5935034	1	5874973 - 5874974	496917	488341	rs398124289	NC_000001.11:5874973:GGAGCG:GGAGCGGAGCG
NM_000302.4(PLOD1):c.1533C>G (p.Tyr511Ter)	PLOD1	Y511*, Y558*	Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome, hydroxylysine-deficient	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000014370	1	12025599	1	11965542	14370	29409	rs121913552	NC_000001.11:11965541:C:G
NM_201253.3(CRB1):c.584G>T (p.Cys195Phe)	CRB1	C195F, C126F	Retinal dystrophy|not provided|Retinitis pigmentosa 12|Leber congenital amaurosis 8|Macular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265083	1	197298065	1	197328935	265083	259643	rs764256655	NC_000001.11:197328934:G:T
NM_015102.5(NPHP4):c.2044C>T (p.Arg682Ter)	NPHP4	R682*, R169*, R170*	Nephronophthisis 4|Cerebello-oculo-renal syndrome (nephronophthisis, oculomotor apraxia and cerebellar abnormalities)|Infertility	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000003401	1	5964776	1	5904716	3401	18440	rs137852920	NC_000001.11:5904715:G:A
NM_000091.4(COL4A3):c.40_63del (p.Leu14_Leu21del)	COL4A3		Alport syndrome, autosomal recessive|not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000192299	2	228029472 - 228029495	2	227164756 - 227164779	192299	190092	rs876657397	NC_000002.12:227164755:GGTGCTCCTGCTGCCGCTCCTGCTGGTGCTCCTG:GGTGCTCCTG
NM_014946.3(SPAST):c.734C>G (p.Ser245Ter)	SPAST	S245*, S212*, S244*, S213*	Spastic paraplegia 4, autosomal dominant|not provided	Pathogenic(Last reviewed: May 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000448453	2	32339758	2	32114689	448453	440698	rs1553314896	NC_000002.12:32114688:C:G
NM_014946.3(SPAST):c.1276C>G (p.Leu426Val)	SPAST	L426V, L393V, L425V, L394V	Spastic paraplegia 4, autosomal dominant|not provided	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000409031	2	32361662	2	32136593	409031	392811	rs1060502227	NC_000002.12:32136592:C:G
NM_014946.3(SPAST):c.1507C>T (p.Arg503Trp)	SPAST	R503W, R470W, R471W, R502W	not provided|Spastic paraplegia 4, autosomal dominant	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000219575	2	32366986	2	32141917	219575	221179	rs864622162	NC_000002.12:32141916:C:T
NM_014946.3(SPAST):c.1685G>A (p.Arg562Gln)	SPAST	R562Q, R530Q, R561Q, R529Q	Spastic paraplegia 4, autosomal dominant	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217004	2	32370074	2	32145005	217004	213539	rs863224923	NC_000002.12:32145004:G:A
NM_015102.5(NPHP4):c.2335C>T (p.Gln779Ter)	NPHP4	Q779*, Q266*, Q267*	Nephronophthisis|Senior-Loken syndrome 4	Pathogenic(Last reviewed: Feb 10, 2016)	no assertion criteria provided	VCV000003404	1	5947496	1	5887436	3404	18443	rs137852922	NC_000001.11:5887435:G:A
NM_015102.5(NPHP4):c.2377C>T (p.Gln793Ter)	NPHP4	Q793*, Q280*, Q281*	Nephronophthisis|Nephronophthisis 4	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000003400	1	5947454	1	5887394	3400	18439	rs137852919	NC_000001.11:5887393:G:A
NM_000092.4(COL4A4):c.3861delinsCTC (p.Arg1288fs)	COL4A4		not provided|Alport syndrome, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000634651	2	227895271	2	227030555	634651	622522		NC_000002.12:227030554:C:GAG
NM_014874.3(MFN2):c.628G>T (p.Asp210Tyr)	MFN2	D210Y	not provided	Pathogenic(Last reviewed: Feb 22, 2017)	criteria provided, single submitter	VCV000420142	1	12058855	1	11998798	420142	404894	rs1064794315	NC_000001.11:11998797:G:T
NM_014874.3(MFN2):c.827A>G (p.Gln276Arg)	MFN2	Q276R	Hereditary motor and sensory neuropathy with optic atrophy	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000002277	1	12061468	1	12001411	2277	17316	rs119103264	NC_000001.11:12001410:A:G
NM_014874.3(MFN2):c.2037C>G (p.Tyr679Ter)	MFN2	Y679*	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637064	1	12067274	1	12007217	637064	624958		NC_000001.11:12007216:C:G
NM_014874.3(MFN2):c.1392+1G>A	MFN2		Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637063	1	12064671	1	12004614	637063	625726		NC_000001.11:12004613:G:A
MFN2, EX7-8DEL	MFN2		Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B	Pathogenic(Last reviewed: Jul 12, 2011)	no assertion criteria provided	VCV000030737					30737	39694		
NM_014874.4(MFN2):c.1612del (p.Gln538fs)	MFN2	Q538fs	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000656157	1	12065883	1	12005826	656157	626760		NC_000001.11:12005825:CC:C
NM_014874.4(MFN2):c.2092del (p.His698fs)	MFN2	H698fs	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000642494	1	12069671	1	12009614	642494	626764		NC_000001.11:12009613:C:
NM_014874.3(MFN2):c.1292C>A (p.Ser431Ter)	MFN2	S431*	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000639842	1	12064570	1	12004513	639842	626756		NC_000001.11:12004512:C:A
NM_014874.3(MFN2):c.718T>G (p.Phe240Val)	MFN2	F240V	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Aug 26, 2018)	criteria provided, single submitter	VCV000567033	1	12059054	1	11998997	567033	558084	rs1557525005	NC_000001.11:11998996:T:G
NM_014874.3(MFN2):c.1082A>C (p.His361Pro)	MFN2	H361P	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000543232	1	12062082	1	12002025	543232	515086	rs1064793170	NC_000001.11:12002024:A:C
NM_014874.3(MFN2):c.703C>T (p.Gln235Ter)	MFN2	Q235*	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jul 27, 2018)	criteria provided, single submitter	VCV000408318	1	12058930	1	11998873	408318	390794	rs879254210	NC_000001.11:11998872:C:T
NM_014874.3(MFN2):c.2256C>G (p.Tyr752Ter)	MFN2	Y752*	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jan 16, 2016)	criteria provided, single submitter	VCV000240946	1	12071604	1	12011547	240946	238138	rs863224968	NC_000001.11:12011546:C:G
NM_014874.3(MFN2):c.600-?_816+?del	MFN2		Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Oct 10, 2016)	criteria provided, single submitter	VCV000216110	1	12058827 - 12059152	1	11998770 - 11999095	216110	212060		
NM_014874.3(MFN2):c.1148C>T (p.Ala383Val)	MFN2	A383V	not provided	Pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000193898	1	12062148	1	12002091	193898	191061	rs794727035	NC_000001.11:12002090:C:T
NM_000478.6(ALPL):c.881A>C (p.Asp294Ala)	ALPL	D277A, D294A, D217A, D239A	Adult hypophosphatasia|Infantile hypophosphatasia|Hypophosphatasia|Childhood hypophosphatasia|not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013664	1	21900176	1	21573683	13664	28703	rs121918002	NC_000001.11:21573682:A:C
NM_000784.4(CYP27A1):c.1263+1G>A	CYP27A1		Cholestanol storage disease|not provided	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004262	2	219679182	2	218814459	4262	19301	rs397515355	NC_000002.12:218814458:G:A
NM_014874.4(MFN2):c.880C>T (p.Arg294Ter)	MFN2	R294*	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000857318	1	12061521	1	12001464	857318	822639		NC_000001.11:12001463:C:T
NM_014874.3(MFN2):c.1198C>T (p.Arg400Ter)	MFN2	R400*	Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, single submitter	VCV000245768	1	12064086	1	12004029	245768	244198	rs879253939	NC_000001.11:12004028:C:T
NM_015102.5(NPHP4):c.1972C>T (p.Arg658Ter)	NPHP4	R658*, R145*, R146*	Nephronophthisis|Senior-Loken syndrome 4|Nephronophthisis 4	Pathogenic(Last reviewed: Aug 16, 2018)	no assertion criteria provided	VCV000003405	1	5964848	1	5904788	3405	18444	rs137852923	NC_000001.11:5904787:G:A
NM_014874.3(MFN2):c.406dup (p.Val136fs)	MFN2		not provided|Charcot-Marie-Tooth disease, type 2	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000451440	1	12056304 - 12056305	1	11996247 - 11996248	451440	442607	rs759844257	NC_000001.11:11996247:GGG:GGGG
NM_014874.3(MFN2):c.2221T>G (p.Leu741Val)	MFN2	L741V	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, single submitter	VCV000408322	1	12071569	1	12011512	408322	390801	rs1060501917	NC_000001.11:12011511:T:G
NM_001127660.1(MFN2):c.730G>T (p.Val244Leu)	MFN2	V244L	Charcot-Marie-Tooth disease, type 2A2A	Pathogenic(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	VCV000243057	1	12059066	1	11999009	243057	244137	rs879253777	NC_000001.11:11999008:G:T
NM_014874.4(MFN2):c.2256C>A (p.Tyr752Ter)	MFN2	Y752*	Charcot-Marie-Tooth disease, type 2A2A	Pathogenic(Last reviewed: Aug 20, 2015)	criteria provided, single submitter	VCV000217162	1	12071604	1	12011547	217162	213791	rs863224968	NC_000001.11:12011546:C:A
NM_014874.3(MFN2):c.205G>T (p.Val69Phe)	MFN2	V69F	Charcot-Marie-Tooth disease, type 2A2A	Pathogenic(Last reviewed: May 11, 2004)	no assertion criteria provided	VCV000002273	1	12052641	1	11992584	2273	17312	rs28940296	NC_000001.11:11992583:G:T
NM_014874.3(MFN2):c.776G>T (p.Arg259Leu)	MFN2	R259L	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Dec 29, 2018)	criteria provided, single submitter	VCV000637279	1	12059112	1	11999055	637279	624925		NC_000001.11:11999054:G:T
NM_014874.3(MFN2):c.2251C>T (p.Gln751Ter)	MFN2	Q751*	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000572169	1	12071599	1	12011542	572169	556909	rs1557539119	NC_000001.11:12011541:C:T
NM_005270.4(GLI2):c.1648dup (p.Arg550Profs)	GLI2		Inborn genetic diseases	Pathogenic(Last reviewed: Feb 23, 2016)	criteria provided, single submitter	VCV000520933	2	121740419 - 121740420	2	120982843 - 120982844	520933	511315	rs1553477189	NC_000002.12:120982843:CC:CCC
NM_005270.4(GLI2):c.562delG (p.Ala188Argfs)	GLI2	A188fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 15, 2014)	criteria provided, single submitter	VCV000225098	2	121712925	2	120955349	225098	226888	rs869312965	NC_000002.12:120955348:G:
NM_003000.2(SDHB):c.537dup (p.Leu180fs)	SDHB		not provided	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000545881	1	17354246 - 17354247	1	17027751 - 17027752	545881	536223	rs1553177669	NC_000001.11:17027751:TTT:TTTT
NM_003000.2(SDHB):c.379dup (p.Ile127fs)	SDHB		not provided	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000545743	1	17355138 - 17355139	1	17028643 - 17028644	545743	536224	rs1553177741	NC_000001.11:17028643:TTTTT:TTTTTT
NM_003000.2(SDHB):c.642+2T>G	SDHB		not provided	Pathogenic(Last reviewed: Aug 4, 2015)	criteria provided, single submitter	VCV000449099	1	17350466	1	17023971	449099	442663	rs1553177424	NC_000001.11:17023970:A:C
NM_003000.2(SDHB):c.330_333dup (p.Ala112fs)	SDHB		not provided	Pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	VCV000201605	1	17355184 - 17355185	1	17028689 - 17028690	201605	196492	rs794728948	NC_000001.11:17028689:TAGA:TAGATAGA
NM_003000.3(SDHB):c.541-1G>T	SDHB		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000825712	1	17350570	1	17024075	825712	815215		NC_000001.11:17024074:C:A
NM_003000.2(SDHB):c.595_604delinsGG (p.Tyr199fs)	SDHB		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 20, 2015)	criteria provided, single submitter	VCV000428930	1	17350506 - 17350515	1	17024011 - 17024020	428930	420744	rs1131691059	NC_000001.11:17024010:TCCACCAGTA:CC
NM_003000.2(SDHB):c.17_42dup (p.Ala15delinsProSerProTer)	SDHB		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 10, 2014)	criteria provided, single submitter	VCV000428926	1	17380472 - 17380473	1	17053977 - 17053978	428926	420753	rs1553179337	NC_000001.11:17053977:CGGCAACCGGCGCCTCAAGGAGAGGGCG:CGGCAACCGGCGCCTCAAGGAGAGGGCGGCAACCGGCGCCTCAAGGAGAGGGCG
NM_003000.2(SDHB):c.605_609dup (p.Asp204fs)	SDHB		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, single submitter	VCV000428919	1	17350500 - 17350501	1	17024005 - 17024006	428919	420742	rs1131691050	NC_000001.11:17024005:TCCGTTCC:TCCGTTCCGTTCC
NM_003000.2(SDHB):c.639del (p.Met213fs)	SDHB	M213fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 11, 2011)	criteria provided, single submitter	VCV000428915	1	17350471	1	17023976	428915	420741	rs1131691047	NC_000001.11:17023975:C:
NM_003000.2(SDHB):c.642_642+6del	SDHB		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 11, 2015)	criteria provided, single submitter	VCV000233382	1	17350462 - 17350468	1	17023967 - 17023973	233382	232174	rs876660368	NC_000001.11:17023966:CCTCACC:
NM_003000.2(SDHB):c.442del (p.Ala148fs)	SDHB	A148fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 29, 2015)	criteria provided, single submitter	VCV000232009	1	17354342	1	17027847	232009	232180	rs876659491	NC_000001.11:17027846:C:
NM_003000.3(SDHB):c.688dup (p.Arg230fs)	SDHB		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000826681	1	17349179 - 17349180	1	17022684 - 17022685	826681	806480		NC_000001.11:17022684:G:GG
NM_003000.2(SDHB):c.21del (p.Ser8fs)	SDHB	S8fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000480807	1	17380494	1	17053999	480807	472282	rs1553179359	NC_000001.11:17053998:G:
NM_003000.2(SDHB):c.424-1G>A	SDHB		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 21, 2015)	criteria provided, single submitter	VCV000428931	1	17354361	1	17027866	428931	420745	rs1131691060	NC_000001.11:17027865:C:T
NM_014874.3(MFN2):c.638T>C (p.Ile213Thr)	MFN2	I213T	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000575481	1	12058865	1	11998808	575481	556615	rs1557524703	NC_000001.11:11998807:T:C
NM_014874.3(MFN2):c.497C>T (p.Ala166Val)	MFN2	A166V	Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, type 2	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000575387	1	12057376	1	11997319	575387	556900	rs1557522849	NC_000001.11:11997318:C:T
NM_003000.2(SDHB):c.654G>A (p.Trp218Ter)	SDHB	W218*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: May 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428923	1	17349214	1	17022719	428923	420739	rs916516745	NC_000001.11:17022718:C:T
NM_003000.2(SDHB):c.287-2A>G	SDHB		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000420072	1	17355233	1	17028738	420072	404981	rs1064794270	NC_000001.11:17028737:T:C
NM_003000.2(SDHB):c.423+1G>C	SDHB		Carney-Stratakis syndrome	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000012790	1	17355094	1	17028599	12790	27829	rs398122805	NC_000001.11:17028598:C:G
NM_003000.2(SDHB):c.287_540del	SDHB		Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic	no assertion criteria provided	VCV000438432					438432	432055		
NM_003000.2:c.73_846del	SDHB		Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic	no assertion criteria provided	VCV000438431					438431	432054		
NM_003000.2(SDHB):c.1_843del	SDHB		Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic	no assertion criteria provided	VCV000438430					438430	432053		
NM_003000.2(SDHB):c.761dup (p.Pro254_Lys255insTer)	SDHB		Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic	no assertion criteria provided	VCV000438429	1	17349106 - 17349107	1	17022611 - 17022612	438429	432024	rs34309090	NC_000001.11:17022611:GG:GGG
NM_003000.2(SDHB):c.736A>T (p.Ile246Phe)	SDHB	I246F	Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic	no assertion criteria provided	VCV000438427	1	17349132	1	17022637	438427	432025	rs146800605	NC_000001.11:17022636:T:A
NM_003000.2(SDHB):c.642+1G>A	SDHB		Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic	no assertion criteria provided	VCV000438425	1	17350467	1	17023972	438425	432027	rs1131691052	NC_000001.11:17023971:C:T
NM_003000.2(SDHB):c.553G>T (p.Glu185Ter)	SDHB	E185*	Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic	no assertion criteria provided	VCV000438424	1	17350557	1	17024062	438424	432029	rs1045881797	NC_000001.11:17024061:C:A
NM_003000.2(SDHB):c.490C>T (p.Gln164Ter)	SDHB	Q164*	Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic	no assertion criteria provided	VCV000438423	1	17354294	1	17027799	438423	432032	rs1553177679	NC_000001.11:17027798:G:A
NM_003000.2(SDHB):c.445_447delinsGGTATCT (p.Gln149fs)	SDHB		Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic	no assertion criteria provided	VCV000438422	1	17354337 - 17354339	1	17027842 - 17027844	438422	432033	rs1553177687	NC_000001.11:17027841:CTG:AGATACC
NM_003000.2(SDHB):c.523_527delinsAAGG (p.Glu175fs)	SDHB		Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic	no assertion criteria provided	VCV000438421	1	17354257 - 17354261	1	17027762 - 17027766	438421	432031	rs1553177672	NC_000001.11:17027761:TCTTC:CCTT
NM_003000.2(SDHB):c.392del (p.Pro131fs)	SDHB	P131fs	Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic	no assertion criteria provided	VCV000438416	1	17355126	1	17028631	438416	432034	rs1553177739	NC_000001.11:17028630:GG:G
NM_003000.2(SDHB):c.369_370insA (p.Val124fs)	SDHB		Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic	no assertion criteria provided	VCV000438415	1	17355148 - 17355149	1	17028653 - 17028654	438415	432035	rs1553177742	NC_000001.11:17028653::T
NM_003000.2(SDHB):c.274T>C (p.Ser92Pro)	SDHB	S92P	Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic	no assertion criteria provided	VCV000438414	1	17359567	1	17033072	438414	432040	rs1553178041	NC_000001.11:17033071:A:G
NM_003000.2(SDHB):c.275C>A (p.Ser92Ter)	SDHB	S92*	Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic	no assertion criteria provided	VCV000438413	1	17359566	1	17033071	438413	432039	rs1553178040	NC_000001.11:17033070:G:T
NM_003000.2(SDHB):c.183T>G (p.Tyr61Ter)	SDHB	Y61*	Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic	no assertion criteria provided	VCV000438412	1	17371273	1	17044778	438412	432041	rs760169139	NC_000001.11:17044777:A:C
NM_003000.2(SDHB):c.73-9A>G	SDHB		Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic	no assertion criteria provided	VCV000438411	1	17371392	1	17044897	438411	432042	rs1553178757	NC_000001.11:17044896:T:C
NM_003000.2(SDHB):c.1_72del (p.Met1_Gln24del)	SDHB		Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic	no assertion criteria provided	VCV000438410	1	17380443 - 17380514	1	17053948 - 17054019	438410	432043	rs1553179313	
NM_003000.2(SDHB):c.72+1G>A	SDHB		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000428927	1	17380442	1	17053947	428927	420751	rs587782703	NC_000001.11:17053946:C:T
NM_003000.2(SDHB):c.481del (p.Asp161fs)	SDHB	D161fs	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000201606	1	17354303	1	17027808	201606	196491	rs794728949	NC_000001.11:17027807:CC:C
NM_003000.2(SDHB):c.111_112dup (p.Arg38fs)	SDHB		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000094093	1	17371343 - 17371344	1	17044848 - 17044849	94093	99993	rs398123690	NC_000001.11:17044848:GGGG:GGGGGG
NC_000002.11:g.(?_32361612)_(32372347_?)del	SPAST		Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000584125	2	32361612 - 32372347	2	32136543 - 32147278	584125	557440		
NM_014946.3(SPAST):c.1684C>T (p.Arg562Ter)	SPAST	R562*, R530*, R529*, R561*	Spastic paraplegia 4, autosomal dominant|not provided	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000448449	2	32370073	2	32145004	448449	440716	rs121908518	NC_000002.12:32145003:C:T
NM_003000.2(SDHB):c.71dup (p.Ala25fs)	SDHB		SDHB-Related Disorders|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000428928	1	17380443 - 17380444	1	17053948 - 17053949	428928	420752	rs1131691057	NC_000001.11:17053948:T:TT
NM_003000.2(SDHB):c.299C>T (p.Ser100Phe)	SDHB	S100F	Pheochromocytoma	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000012788	1	17355219	1	17028724	12788	27827	rs121917755	NC_000001.11:17028723:G:A
NM_003000.2(SDHB):c.302G>A (p.Cys101Tyr)	SDHB	C101Y	Pheochromocytoma	Pathogenic(Last reviewed: May 9, 2002)	no assertion criteria provided	VCV000012786	1	17355216	1	17028721	12786	27825	rs74315371	NC_000001.11:17028720:C:T
NM_000530.8(MPZ):c.245A>G (p.Tyr82Cys)	MPZ	Y82C	Charcot-Marie-Tooth disease||Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000549681	1	161276701	1	161306911	549681	540438	rs1553259707	NC_000001.11:161306910:T:C
NM_000530.8(MPZ):c.418T>A (p.Ser140Thr)	MPZ	S140T	not specified|Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease, type I	Pathogenic/Likely pathogenic(Last reviewed: May 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000447730	1	161276528	1	161306738	447730	440403	rs572010627	NC_000001.11:161306737:A:T
NM_000530.8(MPZ):c.90C>G (p.Ile30Met)	MPZ	I30M	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217235	1	161277192	1	161307402	217235	213795	rs770546306	NC_000001.11:161307401:G:C
NM_000530.8(MPZ):c.181G>A (p.Asp61Asn)	MPZ	D61N	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208146	1	161277101	1	161307311	208146	204409	rs797044845	NC_000001.11:161307310:C:T
NM_004895.4(NLRP3):c.1313C>T (p.Thr438Ile)	NLRP3	T438I, T436I	Familial cold urticaria|Cryopyrin associated periodic syndrome	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000097924	1	247588058	1	247424756	97924	103816	rs180177433	NC_000001.11:247424755:C:T
NM_014795.4(ZEB2):c.1053_1058delinsAAGAA (p.Ser352fs)	ZEB2		not provided	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000818054	2	145157696 - 145157701	2	144400129 - 144400134	818054	805238		NC_000002.12:144400128:GAAGAA:TTCTT
NM_014795.4(ZEB2):c.2576_2577CT[3] (p.Leu860_Asn861insTer)	ZEB2		not provided	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000817570	2	145156174 - 145156175	2	144398607 - 144398608	817570	805236		NC_000002.12:144398607:AGAG:AGAGAG
NM_014795.4(ZEB2):c.891_892delinsAT (p.Lys298Ter)	ZEB2		not provided	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, single submitter	VCV000817562	2	145158790 - 145158791	2	144401223 - 144401224	817562	805239		NC_000002.12:144401222:TC:AT
NM_014795.4(ZEB2):c.1640C>G (p.Ser547Ter)	ZEB2	S547*, S523*	not provided	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000817511	2	145157114	2	144399547	817511	805237		NC_000002.12:144399546:G:C
NM_014795.4(ZEB2):c.232del (p.Leu78fs)	ZEB2	L78fs	not provided	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000817474	2	145187435	2	144429868	817474	805240		NC_000002.12:144429867:G:
NM_014795.3:c.1600_1601insAlu	ZEB2		not provided	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000801011					801011	789396		
NM_014795.4(ZEB2):c.3243C>A (p.Cys1081Ter)	ZEB2	C1081*, C1057*	not provided	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000620299	2	145147420	2	144389853	620299	611529	rs1560602156	NC_000002.12:144389852:G:T
GRCh37/hg19 2q22.3(chr2:145110888-145255210)x1	ZEB2		not provided	Pathogenic(Last reviewed: Jan 11, 2018)	no assertion criteria provided	VCV000562525	2	145110888 - 145255210			562525	553709		
NM_014795.4(ZEB2):c.1172_1176del (p.Lys391fs)	ZEB2	K391fs, K367fs	not provided	Pathogenic(Last reviewed: Jul 11, 2018)	criteria provided, single submitter	VCV000546530	2	145157578 - 145157582	2	144400011 - 144400015	546530	536604	rs1553961746	NC_000002.12:144400010:TGTTTT:T
NM_014795.4(ZEB2):c.3213dup (p.Gln1072fs)	ZEB2		not provided	Pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, single submitter	VCV000504383	2	145147449 - 145147450	2	144389882 - 144389883	504383	495114	rs1553960776	NC_000002.12:144389882:C:CC
NM_014795.4(ZEB2):c.1135_1138dup (p.Ser380delinsThrTer)	ZEB2		not provided	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000504152	2	145157615 - 145157616	2	144400048 - 144400049	504152	495091	rs1553961749	NC_000002.12:144400048:TAAGT:TAAGTAAGT
NM_014795.4(ZEB2):c.2982_2983AG[2] (p.Ser996fs)	ZEB2		not provided	Pathogenic(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	VCV000500047	2	145154059 - 145154060	2	144396492 - 144396493	500047	491471	rs1553961343	NC_000002.12:144396491:CTCTCT:CTCT
NM_014795.4(ZEB2):c.785_786CA[2] (p.His263fs)	ZEB2		not provided	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000498049	2	145161500 - 145161501	2	144403933 - 144403934	498049	489473	rs1553962048	NC_000002.12:144403932:TGTGTGT:TGTGT
NM_014795.4(ZEB2):c.1806C>G (p.Tyr602Ter)	ZEB2	Y602*, Y578*	not provided	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000496893	2	145156948	2	144399381	496893	488317	rs1553961660	NC_000002.12:144399380:G:C
NM_014795.4(ZEB2):c.3206C>A (p.Ser1069Ter)	ZEB2	S1069*, S1045*	not provided	Pathogenic(Last reviewed: Nov 24, 2017)	criteria provided, single submitter	VCV000489157	2	145147457	2	144389890	489157	481605	rs1553960778	NC_000002.12:144389889:G:T
NM_014795.4(ZEB2):c.1825G>T (p.Glu609Ter)	ZEB2	E609*, E585*	not provided	Pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	VCV000488801	2	145156929	2	144399362	488801	481606	rs1553961655	NC_000002.12:144399361:C:A
NM_014795.4(ZEB2):c.760_761del (p.Thr254fs)	ZEB2	T254fs, T230fs	not provided	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000451579	2	145161529 - 145161530	2	144403962 - 144403963	451579	442927	rs587776605	NC_000002.12:144403961:GTG:G
NM_014795.4(ZEB2):c.1467T>A (p.Tyr489Ter)	ZEB2	Y489*, Y465*	not provided	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000451445	2	145157287	2	144399720	451445	442924	rs1553961705	NC_000002.12:144399719:A:T
NM_014795.4(ZEB2):c.997A>T (p.Lys333Ter)	ZEB2	K333*, K309*	not provided	Pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, single submitter	VCV000451129	2	145157757	2	144400190	451129	442926	rs1553961777	NC_000002.12:144400189:T:A
NM_014795.4(ZEB2):c.855dup (p.Glu286fs)	ZEB2		not provided	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000430336	2	145158826 - 145158827	2	144401259 - 144401260	430336	421272	rs1131691912	NC_000002.12:144401259:T:TT
NM_014795.4(ZEB2):c.64del (p.Arg22fs)	ZEB2	R22fs	not provided	Pathogenic(Last reviewed: Oct 29, 2015)	criteria provided, single submitter	VCV000430051	2	145274854	2	144517287	430051	421274	rs1131691756	NC_000002.12:144517286:T:
NM_014795.4(ZEB2):c.3067+1G>A	ZEB2		not provided	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000429990	2	145153978	2	144396411	429990	421271	rs1131691714	NC_000002.12:144396410:C:T
NM_014795.4(ZEB2):c.351dup (p.Asp118Ter)	ZEB2		not provided	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, single submitter	VCV000429304	2	145182414 - 145182415	2	144424847 - 144424848	429304	421273	rs1131691309	NC_000002.12:144424847:A:AA
NM_014795.4(ZEB2):c.1817_1820TGAA[1] (p.Asn607fs)	ZEB2		not provided	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000373072	2	145156930 - 145156933	2	144399363 - 144399366	373072	359271	rs1057518193	NC_000002.12:144399362:TTCATTCAT:TTCAT
NM_014795.4(ZEB2):c.2908C>T (p.Gln970Ter)	ZEB2	Q970*, Q946*	not provided	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000373064	2	145154138	2	144396571	373064	359375	rs1057518185	NC_000002.12:144396570:G:A
NM_014795.4(ZEB2):c.2100C>G (p.Tyr700Ter)	ZEB2	Y700*, Y676*	not provided	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000373033	2	145156654	2	144399087	373033	359269	rs1057518156	NC_000002.12:144399086:G:C
NM_014795.4(ZEB2):c.1451C>A (p.Ser484Ter)	ZEB2	S484*, S460*	not provided	Pathogenic(Last reviewed: Apr 15, 2016)	criteria provided, single submitter	VCV000280506	2	145157303	2	144399736	280506	264037	rs886041698	NC_000002.12:144399735:G:T
NM_014795.4(ZEB2):c.1091_1092dup (p.Ala365fs)	ZEB2		not provided	Pathogenic(Last reviewed: Mar 5, 2016)	criteria provided, single submitter	VCV000280387	2	145157661 - 145157662	2	144400094 - 144400095	280387	264044	rs886041601	NC_000002.12:144400094:TG:TGTG
NM_014795.4(ZEB2):c.379del (p.Gln127fs)	ZEB2	Q127fs	not provided	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000280252	2	145182387	2	144424820	280252	264031	rs886041489	NC_000002.12:144424819:GG:G
NM_014795.4(ZEB2):c.1038del (p.Asn346fs)	ZEB2	N322fs, N346fs	not provided	Pathogenic(Last reviewed: Jun 8, 2016)	criteria provided, single submitter	VCV000265598	2	145157716	2	144400149	265598	259694	rs886039655	NC_000002.12:144400148:G:
NM_014795.4(ZEB2):c.980C>A (p.Ser327Ter)	ZEB2	S327*, S303*	not provided	Pathogenic(Last reviewed: May 26, 2015)	criteria provided, single submitter	VCV000198864	2	145157774	2	144400207	198864	196024	rs756686919	NC_000002.12:144400206:G:T
NM_014795.4(ZEB2):c.808-1G>T	ZEB2		not provided	Pathogenic(Last reviewed: Jan 30, 2015)	no assertion criteria provided	VCV000187815	2	145158875	2	144401308	187815	185721	rs786203993	NC_000002.12:144401307:C:A
NM_014795.4(ZEB2):c.2365del (p.Ser789fs)	ZEB2	S765fs, S789fs	not provided	Pathogenic(Last reviewed: Jan 30, 2015)	no assertion criteria provided	VCV000187814	2	145156389	2	144398822	187814	185719	rs786203992	NC_000002.12:144398821:AAA:AA
NM_014795.4(ZEB2):c.3544del (p.Glu1182fs)	ZEB2	E1182fs, E1158fs	not provided	Pathogenic(Last reviewed: Jan 30, 2015)	no assertion criteria provided	VCV000187813	2	145147119	2	144389552	187813	185717	rs786203991	NC_000002.12:144389551:C:
NM_014795.4(ZEB2):c.2398dup (p.Ser800fs)	ZEB2		not provided	Pathogenic(Last reviewed: Jan 30, 2015)	no assertion criteria provided	VCV000187812	2	145156355 - 145156356	2	144398788 - 144398789	187812	185718	rs786203990	NC_000002.12:144398788:AA:AAA
NM_014795.4(ZEB2):c.1921del (p.Ser641fs)	ZEB2	S617fs, S641fs	not provided	Pathogenic(Last reviewed: Jun 18, 2013)	criteria provided, single submitter	VCV000181753	2	145156833	2	144399266	181753	178984	rs730881209	NC_000002.12:144399265:AAA:AA
NM_014795.4(ZEB2):c.280G>T (p.Glu94Ter)	ZEB2	E94*	not provided	Pathogenic(Last reviewed: Apr 29, 2014)	criteria provided, single submitter	VCV000167860	2	145187387	2	144429820	167860	177197	rs727504228	NC_000002.12:144429819:C:A
NM_014795.4(ZEB2):c.304dup (p.Ile102fs)	ZEB2		not provided	Pathogenic(Last reviewed: Dec 20, 2013)	no assertion criteria provided	VCV000167859	2	145187362 - 145187363	2	144429795 - 144429796	167859	178163	rs786200997	NC_000002.12:144429795:T:TT
NM_014795.4(ZEB2):c.930C>A (p.Tyr310Ter)	ZEB2	Y310*, Y286*	not provided	Pathogenic(Last reviewed: Feb 25, 2014)	criteria provided, single submitter	VCV000167857	2	145157824	2	144400257	167857	178162	rs6711223	NC_000002.12:144400256:G:T
NM_014795.4(ZEB2):c.3533del (p.Thr1178fs)	ZEB2	T1154fs, T1178fs	not provided	Pathogenic(Last reviewed: May 16, 2013)	criteria provided, single submitter	VCV000167852	2	145147130	2	144389563	167852	178159	rs727504223	NC_000002.12:144389562:G:
NM_014795.4(ZEB2):c.805C>T (p.Gln269Ter)	ZEB2	Q269*, Q245*	not provided	Pathogenic(Last reviewed: Apr 22, 2013)	criteria provided, single submitter	VCV000095641	2	145161485	2	144403918	95641	101539	rs398124284	NC_000002.12:144403917:G:A
NM_014795.4(ZEB2):c.782_783del (p.Val261fs)	ZEB2	V237fs, V261fs	not provided	Pathogenic(Last reviewed: Jan 22, 2013)	criteria provided, single submitter	VCV000095640	2	145161507 - 145161508	2	144403940 - 144403941	95640	101538	rs398124283	NC_000002.12:144403939:CAC:C
NM_014795.4(ZEB2):c.2032del (p.Ser678fs)	ZEB2	S654fs, S678fs	not provided	Pathogenic(Last reviewed: Aug 27, 2013)	criteria provided, single submitter	VCV000095626	2	145156722	2	144399155	95626	101524	rs398124277	NC_000002.12:144399154:AAA:AA
NM_014795.4(ZEB2):c.1586del (p.Thr529fs)	ZEB2	T505fs, T529fs	not provided	Pathogenic(Last reviewed: Apr 23, 2013)	criteria provided, single submitter	VCV000095624	2	145157168	2	144399601	95624	101522	rs398124276	NC_000002.12:144399600:G:
NM_014795.4(ZEB2):c.1381C>T (p.Gln461Ter)	ZEB2	Q461*, Q437*	not provided	Pathogenic(Last reviewed: Aug 10, 2012)	criteria provided, single submitter	VCV000095620	2	145157373	2	144399806	95620	101518	rs398124274	NC_000002.12:144399805:G:A
NM_014795.4(ZEB2):c.3046C>T (p.Arg1016Ter)	ZEB2	R1016*, R992*	not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280856	2	145154000	2	144396433	280856	264012	rs886041989	NC_000002.12:144396432:G:A
NM_014795.4(ZEB2):c.1102C>T (p.Gln368Ter)	ZEB2	Q368*, Q344*	not provided	Pathogenic(Last reviewed: Jun 20, 2016)	criteria provided, multiple submitters, no conflicts	VCV000280042	2	145157652	2	144400085	280042	264038	rs886041338	NC_000002.12:144400084:G:A
NM_014795.4(ZEB2):c.3146A>C (p.His1049Pro)	ZEB2	H1049P, H1025P	Smith-Magenis Syndrome-like	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000254205	2	145147517	2	144389950	254205	248720	rs1114167349	NC_000002.12:144389949:T:G
NM_014795.4(ZEB2):c.1115del (p.Lys372fs)	ZEB2	K372fs, K348fs	not provided	Pathogenic(Last reviewed: Jul 28, 2015)	criteria provided, single submitter	VCV000235349	2	145157639	2	144400072	235349	237036	rs878853016	NC_000002.12:144400071:TT:T
NM_014795.4(ZEB2):c.2701C>T (p.Gln901Ter)	ZEB2	Q901*, Q877*	not provided	Pathogenic(Last reviewed: Jun 4, 2014)	criteria provided, single submitter	VCV000198867	2	145156053	2	144398486	198867	196027	rs794727924	NC_000002.12:144398485:G:A
NM_014795.4(ZEB2):c.2174_2177dup (p.Leu728fs)	ZEB2		not provided	Pathogenic(Last reviewed: Nov 5, 2013)	no assertion criteria provided	VCV000095628	2	145156576 - 145156577	2	144399009 - 144399010	95628	101526	rs398124278	NC_000002.12:144399009:GAGT:GAGTGAGT
NM_014795.4(ZEB2):c.1541dup (p.Val515fs)	ZEB2		not provided	Pathogenic(Last reviewed: Jul 27, 2012)	no assertion criteria provided	VCV000095623	2	145157212 - 145157213	2	144399645 - 144399646	95623	101521	rs398124275	NC_000002.12:144399645:GG:GGG
NM_014795.4(ZEB2):c.425_429del (p.Ser142fs)	ZEB2	S142fs, S118fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000807525	2	145162566 - 145162570	2	144404999 - 144405003	807525	798483		NC_000002.12:144404998:ATCTGAT:AT
NM_014795.4(ZEB2):c.770_771del (p.Glu257fs)	ZEB2	E233fs, E257fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000807524	2	145161519 - 145161520	2	144403952 - 144403953	807524	798482		NC_000002.12:144403951:CTC:C
NM_014795.4(ZEB2):c.192_193TG[1] (p.Val65fs)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801757	2	145187472 - 145187473	2	144429905 - 144429906	801757	790050		NC_000002.12:144429904:CACAC:CAC
NM_014795.4(ZEB2):c.2095C>T (p.Gln699Ter)	ZEB2	Q675*, Q699*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801755	2	145156659	2	144399092	801755	790048		NC_000002.12:144399091:G:A
NM_014795.4(ZEB2):c.2996_3003del (p.Met998_Tyr999insTer)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801754	2	145154043 - 145154050	2	144396476 - 144396483	801754	790047		NC_000002.12:144396475:ACATGCATACATGC:ACATGC
NM_014795.4(ZEB2):c.703G>T (p.Glu235Ter)	ZEB2	E235*, E211*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000619079	2	145161587	2	144404020	619079	610477		NC_000002.12:144404019:C:A
NM_014795.4(ZEB2):c.2672_2678del (p.Ala891fs)	ZEB2	A867fs, A891fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, single submitter	VCV000242351	2	145156076 - 145156082	2	144398509 - 144398515	242351	243902	rs878855329	NC_000002.12:144398508:GGTTTGG:
NM_014795.4(ZEB2):c.1687del (p.Leu562_Ile563insTer)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189286	2	145157067	2	144399500	189286	187159	rs786204819	NC_000002.12:144399499:TT:T
NM_014795.4(ZEB2):c.1966_1967del (p.Met656fs)	ZEB2	M632fs, M656fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189285	2	145156787 - 145156788	2	144399220 - 144399221	189285	187154	rs786204818	NC_000002.12:144399219:AT:
NM_014795.3(ZEB2):c.3068-?_(*5076_?)del	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189284					189284	187148		
NM_014795.4(ZEB2):c.460del (p.Glu154fs)	ZEB2	E154fs, E130fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189283	2	145162535	2	144404968	189283	187169	rs786204817	NC_000002.12:144404967:CC:C
NM_014795.4(ZEB2):c.3391_3400del (p.Pro1131fs)	ZEB2	P1131fs, P1107fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189282	2	145147263 - 145147272	2	144389696 - 144389705	189282	187150	rs786204816	NC_000002.12:144389695:CATCCCTCGGCAT:CAT
NM_014795.4(ZEB2):c.1416_1420del (p.Arg473fs)	ZEB2	R473fs, R449fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189280	2	145157334 - 145157338	2	144399767 - 144399771	189280	187162	rs786204814	NC_000002.12:144399766:GCCTGG:G
NM_014795.4(ZEB2):c.227_233del (p.Gln76fs)	ZEB2	Q76fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189278	2	145187434 - 145187440	2	144429867 - 144429873	189278	187170	rs786204812	NC_000002.12:144429866:AGAGCTT:
NM_014795.4(ZEB2):c.1884del (p.Phe628fs)	ZEB2	F604fs, F628fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189277	2	145156870	2	144399303	189277	187156	rs786204811	NC_000002.12:144399302:AAAAA:AAAA
NM_014795.4(ZEB2):c.2179_2180del (p.Leu727fs)	ZEB2	L727fs, L703fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189276	2	145156574 - 145156575	2	144399007 - 144399008	189276	187152	rs786204810	NC_000002.12:144399006:AAA:A
NM_014795.4(ZEB2):c.1754del (p.Phe585fs)	ZEB2	F585fs, F561fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189275	2	145157000	2	144399433	189275	187157	rs786204809	NC_000002.12:144399432:AA:A
NM_014795.4(ZEB2):c.1749C>A (p.Cys583Ter)	ZEB2	C583*, C559*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189274	2	145157005	2	144399438	189274	187158	rs786204808	NC_000002.12:144399437:G:T
NM_014795.4(ZEB2):c.1277T>G (p.Leu426Ter)	ZEB2	L426*, L402*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189273	2	145157477	2	144399910	189273	187163	rs786204807	NC_000002.12:144399909:A:C
NM_014795.4(ZEB2):c.703del (p.Glu235fs)	ZEB2	E211fs, E235fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189272	2	145161587	2	144404020	189272	187167	rs786204806	NC_000002.12:144404019:C:
NM_014795.4(ZEB2):c.1541_1542insA (p.Val515fs)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189271	2	145157212 - 145157213	2	144399645 - 144399646	189271	187161	rs1553961695	NC_000002.12:144399645::T
NM_014795.3(ZEB2):c.(?_-522)_(*5076_?)del	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189270					189270	187173		
NM_014795.4(ZEB2):c.660C>G (p.Tyr220Ter)	ZEB2	Y220*, Y196*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189269	2	145161630	2	144404063	189269	187168	rs111724246	NC_000002.12:144404062:G:C
NM_014795.3(ZEB2):c.404-?_(*5076_?)del	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189268					189268	187149		
NM_014795.4(ZEB2):c.1172_1182delinsTGACTTAAAATTAATG (p.Lys391_Pro394delinsMetThrTer)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189267	2	145157572 - 145157582	2	144400005 - 144400015	189267	187165	rs786204805	NC_000002.12:144400004:TGGTTCTGTTT:CATTAATTTTAAGTCA
NM_014795.4(ZEB2):c.2685_2686CA[3] (p.Ala897fs)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189266	2	145156065 - 145156066	2	144398498 - 144398499	189266	187151	rs786204804	NC_000002.12:144398498:TGTGT:TGTGTGT
NM_014795.4(ZEB2):c.1944del (p.Ile649fs)	ZEB2	I625fs, I649fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189265	2	145156810	2	144399243	189265	187155	rs786204803	NC_000002.12:144399242:GGGG:GGG
NM_014795.4(ZEB2):c.20_21insT (p.Asp8fs)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189264	2	145274897 - 145274898	2	144517330 - 144517331	189264	187172	rs786204802	NC_000002.12:144517330::A
NM_014795.4(ZEB2):c.1257del (p.Gly421fs)	ZEB2	G421fs, G397fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189263	2	145157497	2	144399930	189263	187164	rs786204801	NC_000002.12:144399929:CCC:CC
NM_014795.4(ZEB2):c.3499del (p.Ser1167fs)	ZEB2	S1143fs, S1167fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 18, 2014)	criteria provided, single submitter	VCV000181763	2	145147164	2	144389597	181763	178960	rs730881218	NC_000002.12:144389596:TTT:TT
NM_014795.4(ZEB2):c.3073del (p.Arg1025fs)	ZEB2	R1001fs, R1025fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 18, 2014)	criteria provided, single submitter	VCV000181762	2	145147590	2	144390023	181762	178968	rs730881217	NC_000002.12:144390022:TTTTT:TTTT
NM_014795.4(ZEB2):c.178_190delinsGTT (p.Thr60fs)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 11, 2014)	criteria provided, single submitter	VCV000181758	2	145187477 - 145187489	2	144429910 - 144429922	181758	179008	rs730881215	NC_000002.12:144429909:TAGCTGGACTCGT:AAC
NM_014795.4(ZEB2):c.3195dup (p.His1066fs)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 11, 2013)	criteria provided, single submitter	VCV000181756	2	145147467 - 145147468	2	144389900 - 144389901	181756	178965	rs730881213	NC_000002.12:144389900:T:TT
NM_014795.4(ZEB2):c.3002del (p.Cys1001fs)	ZEB2	C1001fs, C977fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 4, 2013)	criteria provided, single submitter	VCV000181755	2	145154044	2	144396477	181755	178969	rs730881212	NC_000002.12:144396476:C:
NM_014795.4(ZEB2):c.2228_2229del (p.Ser743fs)	ZEB2	S719fs, S743fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 3, 2014)	criteria provided, single submitter	VCV000181754	2	145156525 - 145156526	2	144398958 - 144398959	181754	178980	rs730881211	NC_000002.12:144398957:AGA:A
NM_014795.4(ZEB2):c.999del (p.Lys333fs)	ZEB2	K309fs, K333fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 31, 2014)	criteria provided, single submitter	VCV000181751	2	145157755	2	144400188	181751	178996	rs730881208	NC_000002.12:144400187:TTT:TT
NM_014795.4(ZEB2):c.1434C>A (p.Cys478Ter)	ZEB2	C478*, C454*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000846691	2	145157320	2	144399753	846691	824769		NC_000002.12:144399752:G:T
NM_014795.4(ZEB2):c.1277T>A (p.Leu426Ter)	ZEB2	L426*, L402*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Apr 20, 2019)	criteria provided, single submitter	VCV000844347	2	145157477	2	144399910	844347	824770		NC_000002.12:144399909:A:T
NM_014795.4(ZEB2):c.493G>T (p.Glu165Ter)	ZEB2	E141*, E165*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000843162	2	145162502	2	144404935	843162	824775		NC_000002.12:144404934:C:A
NM_014795.4(ZEB2):c.1387del (p.Val463fs)	ZEB2	V439fs, V463fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000692022	2	145157367	2	144399800	692022	679737		NC_000002.12:144399799:CC:C
NM_014795.4(ZEB2):c.656del (p.Gly219fs)	ZEB2	G195fs, G219fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000691991	2	145161634	2	144404067	691991	679738		NC_000002.12:144404066:CCCC:CCC
NM_014795.4(ZEB2):c.1017del (p.Ser339_Val340insTer)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 9, 2018)	criteria provided, single submitter	VCV000650576	2	145157737	2	144400170	650576	628455		NC_000002.12:144400169:A:
NM_014795.4(ZEB2):c.432dup (p.Glu145Ter)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000572710	2	145162562 - 145162563	2	144404995 - 144404996	572710	557524	rs1560609810	NC_000002.12:144404995:AAAA:AAAAA
NM_014795.4(ZEB2):c.3025C>T (p.Gln1009Ter)	ZEB2	Q1009*, Q985*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, single submitter	VCV000572098	2	145154021	2	144396454	572098	559208	rs1560604977	NC_000002.12:144396453:G:A
NM_014795.4(ZEB2):c.1570dup (p.Ser524fs)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Feb 10, 2018)	criteria provided, single submitter	VCV000571056	2	145157183 - 145157184	2	144399616 - 144399617	571056	558725	rs1560606974	NC_000002.12:144399616:TTTT:TTTTT
NM_014795.4(ZEB2):c.236_239del (p.Leu78_Leu79insTer)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000569754	2	145187428 - 145187431	2	144429861 - 144429864	569754	557567	rs1560620837	NC_000002.12:144429860:GGCA:
NM_014795.4(ZEB2):c.2337del (p.Ser780fs)	ZEB2	S756fs, S780fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000569753	2	145156417	2	144398850	569753	559212	rs1560606294	NC_000002.12:144398849:CC:C
NM_014795.4(ZEB2):c.71dup (p.Asn24fs)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 22, 2018)	no assertion criteria provided	VCV000559637	2	145274846 - 145274847	2	144517279 - 144517280	559637	550349	rs1553971826	NC_000002.12:144517279:TTTTT:TTTTTT
NM_014795.4(ZEB2):c.2227del (p.Ser743fs)	ZEB2	S719fs, S743fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547835	2	145156527	2	144398960	547835	537692	rs1553961580	NC_000002.12:144398959:A:
NM_014795.4(ZEB2):c.2806del (p.Ala936fs)	ZEB2	A936fs, A912fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000534632	2	145155948	2	144398381	534632	516342	rs1553961487	NC_000002.12:144398380:CC:C
NM_014795.4(ZEB2):c.234_235del (p.Leu79fs)	ZEB2	L79fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000534631	2	145187432 - 145187433	2	144429865 - 144429866	534631	516345	rs1553964147	NC_000002.12:144429864:ACA:A
NM_014795.4(ZEB2):c.481del (p.Val161fs)	ZEB2	V161fs, V137fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000466289	2	145162514	2	144404947	466289	448735	rs1553962198	NC_000002.12:144404946:C:
NM_014795.4(ZEB2):c.2688dup (p.Ala897fs)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000466281	2	145156065 - 145156066	2	144398498 - 144398499	466281	448708	rs1553961510	NC_000002.12:144398498:T:TT
NM_014795.4(ZEB2):c.2038_2152dup (p.Asn718delinsSerCysGlyProSerSerGlyIleCysGluGlyMetValTer)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000466279	2	145156601 - 145156602	2	144399034 - 144399035	466279	448705	rs1553961598	
Single allele	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, single submitter	VCV000466272			2	144517258 - 144517420	466272	448525		
NM_014795.4(ZEB2):c.2211_2214dup (p.Ile739fs)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	VCV000448970	2	145156539 - 145156540	2	144398972 - 144398973	448970	442547	rs1553961585	NC_000002.12:144398972:GGAG:GGAGGGAG
NM_014795.4(ZEB2):c.1489C>T (p.Gln497Ter)	ZEB2	Q497*, Q473*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000437333	2	145157265	2	144399698	437333	427889	rs1553961702	NC_000002.12:144399697:G:A
NM_014795.4(ZEB2):c.2072G>A (p.Trp691Ter)	ZEB2	W691*, W667*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Oct 2, 2015)	criteria provided, single submitter	VCV000437332	2	145156682	2	144399115	437332	427887	rs1553961610	NC_000002.12:144399114:C:T
NM_014795.4(ZEB2):c.3109A>T (p.Lys1037Ter)	ZEB2	K1037*, K1013*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Dec 21, 2015)	criteria provided, single submitter	VCV000437324	2	145147554	2	144389987	437324	427883	rs1553960793	NC_000002.12:144389986:T:A
NC_000002.11:g.(?_145274845)_(145274986_?)del	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 3, 2016)	criteria provided, single submitter	VCV000417344	2	145274845 - 145274986	2	144517278 - 144517419	417344	391349		
NM_014795.4(ZEB2):c.3095del (p.Cys1032fs)	ZEB2	C1032fs, C1008fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000405331	2	145147568	2	144390001	405331	391416	rs1060500653	NC_000002.12:144390000:C:
NM_014795.4(ZEB2):c.3137C>A (p.Ser1046Ter)	ZEB2	S1046*, S1022*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Feb 3, 2015)	criteria provided, single submitter	VCV000212636	2	145147526	2	144389959	212636	206846	rs797046121	NC_000002.12:144389958:G:T
NM_014795.4(ZEB2):c.2894T>A (p.Leu965Ter)	ZEB2	L965*, L941*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Aug 19, 2014)	criteria provided, single submitter	VCV000212635	2	145154152	2	144396585	212635	206847	rs797046120	NC_000002.12:144396584:A:T
NM_014795.4(ZEB2):c.2404_2407del (p.Thr802fs)	ZEB2	T778fs, T802fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Feb 9, 2015)	criteria provided, single submitter	VCV000212634	2	145156347 - 145156350	2	144398780 - 144398783	212634	206848	rs797046119	NC_000002.12:144398779:GAGTG:G
NM_014795.4(ZEB2):c.2061del (p.Phe687fs)	ZEB2	F663fs, F687fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 31, 2014)	criteria provided, single submitter	VCV000212633	2	145156693	2	144399126	212633	206849	rs797046118	NC_000002.12:144399125:AAA:AA
NM_014795.4(ZEB2):c.1106T>A (p.Leu369Ter)	ZEB2	L369*, L345*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 24, 2014)	criteria provided, single submitter	VCV000212632	2	145157648	2	144400081	212632	206850	rs797046117	NC_000002.12:144400080:A:T
NM_014795.4(ZEB2):c.3134A>G (p.His1045Arg)	ZEB2	H1045R, H1021R	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000056827	2	145147529	2	144389962	56827	71450	rs397515449	NC_000002.12:144389961:T:C
NM_014795.4(ZEB2):c.3211T>C (p.Ser1071Pro)	ZEB2	S1071P, S1047P	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000056826	2	145147452	2	144389885	56826	71449	rs397515448	NC_000002.12:144389884:A:G
NM_014795.4(ZEB2):c.3356A>G (p.Gln1119Arg)	ZEB2	Q1119R, Q1095R	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000004768	2	145147307	2	144389740	4768	19807	rs137852983	NC_000002.12:144389739:T:C
NM_014795.4(ZEB2):c.1862del (p.Val621fs)	ZEB2	V621fs, V597fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000004766	2	145156892	2	144399325	4766	19805	rs587776611	NC_000002.12:144399324:A:
NM_014795.4(ZEB2):c.3566_3567dup (p.Met1190fs)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 15, 2002)	no assertion criteria provided	VCV000004763	2	145147095 - 145147096	2	144389528 - 144389529	4763	19802	rs587776609	NC_000002.12:144389528:GG:GGGG
NM_014795.4(ZEB2):c.2555C>G (p.Ser852Ter)	ZEB2	S852*, S828*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 15, 2002)	no assertion criteria provided	VCV000004762	2	145156199	2	144398632	4762	19801	rs137852982	NC_000002.12:144398631:G:C
NM_014795.4(ZEB2):c.1892del (p.Asn631fs)	ZEB2	N607fs, N631fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 15, 2002)	no assertion criteria provided	VCV000004760	2	145156862	2	144399295	4760	19799	rs587776607	NC_000002.12:144399294:TT:T
NM_014795.4(ZEB2):c.2453dup (p.Leu818fs)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000004759	2	145156300 - 145156301	2	144398733 - 144398734	4759	19798	rs587776606	NC_000002.12:144398733:AA:AAA
NM_014795.4(ZEB2):c.760_761dup (p.Gln255fs)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000004758	2	145161528 - 145161529	2	144403961 - 144403962	4758	19797	rs587776605	NC_000002.12:144403961:GTG:GTGTG
NM_014795.4(ZEB2):c.1173_1176del (p.Thr392fs)	ZEB2	T392fs, T368fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000004756	2	145157578 - 145157581	2	144400011 - 144400014	4756	19795	rs587776603	NC_000002.12:144400010:TGTTT:T
NM_014795.4(ZEB2):c.1645A>T (p.Arg549Ter)	ZEB2	R549*, R525*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000004754	2	145157109	2	144399542	4754	19793	rs137852980	NC_000002.12:144399541:T:A
NM_014874.3(MFN2):c.275T>C (p.Leu92Pro)	MFN2	L92P	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000637730	1	12052711	1	11992654	637730	624892		NC_000001.11:11992653:T:C
NM_014874.4(MFN2):c.746C>T (p.Ser249Phe)	MFN2	S249F	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2A2A	Pathogenic(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	VCV000202171	1	12059082	1	11999025	202171	198602	rs794729198	NC_000001.11:11999024:C:T
NM_018328.5(MBD5):c.3125del (p.Pro1042fs)	MBD5	P1042fs, P1275fs	not provided	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000817859	2	149247024	2	148489455	817859	805242		NC_000002.12:148489454:CC:C
GRCh37/hg19 2q23.1(chr2:148883626-149209179)x1	MBD5		not provided	Pathogenic(Last reviewed: Dec 18, 2018)	no assertion criteria provided	VCV000814321	2	148883626 - 149209179			814321	802534		
NM_018328.4(MBD5):c.1039C>T (p.Gln347Ter)	MBD5	Q347*	not provided	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000620414	2	149226551	2	148468982	620414	611532	rs1559086213	NC_000002.12:148468981:C:T
NM_018328.4(MBD5):c.601C>T (p.Gln201Ter)	MBD5	Q201*	not provided	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000620346	2	149226113	2	148468544	620346	611531	rs200287454	NC_000002.12:148468543:C:T
NM_018328.4(MBD5):c.546T>G (p.Tyr182Ter)	MBD5	Y182*	not provided	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000620331	2	149226058	2	148468489	620331	611530	rs1559085550	NC_000002.12:148468488:T:G
NM_018328.4(MBD5):c.1759C>T (p.Gln587Ter)	MBD5	Q587*	not provided	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000620270	2	149227271	2	148469702	620270	611533	rs1559087186	NC_000002.12:148469701:C:T
GRCh37/hg19 2q23.1(chr2:149094014-149166807)x1	MBD5		not provided	Pathogenic(Last reviewed: Jan 2, 2018)	no assertion criteria provided	VCV000562499	2	149094014 - 149166807			562499	553683		
GRCh37/hg19 2q23.1(chr2:148984799-149022674)x1	MBD5		not provided	Pathogenic(Last reviewed: Jan 30, 2018)	no assertion criteria provided	VCV000562479	2	148984799 - 149022674			562479	553663		
NM_018328.4(MBD5):c.1549C>T (p.Gln517Ter)	MBD5	Q517*	not provided	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000523903	2	149227061	2	148469492	523903	514435	rs1553518593	NC_000002.12:148469491:C:T
NM_018328.4(MBD5):c.3699dup (p.Val1234fs)	MBD5		not provided	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	VCV000504260	2	149247598 - 149247599	2	148490029 - 148490030	504260	495093	rs1553520585	NC_000002.12:148490029:T:TT
NM_018328.4(MBD5):c.361_362del (p.Pro121fs)	MBD5	P121fs	not provided	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000503821	2	149221452 - 149221453	2	148463883 - 148463884	503821	495345	rs1553517973	NC_000002.12:148463882:CC:
NM_018328.4(MBD5):c.1114_1115dup (p.Asn372fs)	MBD5		not provided	Pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	VCV000450966	2	149226625 - 149226626	2	148469056 - 148469057	450966	442930	rs1553518527	NC_000002.12:148469056:AA:AAAA
NM_018328.4(MBD5):c.2025_2028del (p.Met675fs)	MBD5	M675fs	not provided	Pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, single submitter	VCV000429989	2	149227535 - 149227538	2	148469966 - 148469969	429989	421276	rs1131691713	NC_000002.12:148469965:ATGGAT:AT
NM_018328.4(MBD5):c.688C>T (p.Gln230Ter)	MBD5	Q230*	not provided	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	VCV000426936	2	149226200	2	148468631	426936	414820	rs1085307859	NC_000002.12:148468630:C:T
GRCh37/hg19 2q23.1(chr2:148893782-149041073)x1	MBD5		See cases	Pathogenic	no assertion criteria provided	VCV000397242	2	148893782 - 149041073			397242	384135		
GRCh37/hg19 2q23.1(chr2:148897424-148979973)x1	MBD5		See cases	Pathogenic	no assertion criteria provided	VCV000397049	2	148897424 - 148979973			397049	383942		
GRCh37/hg19 2q23.1(chr2:148894900-148979973)x1	MBD5		See cases	Pathogenic	no assertion criteria provided	VCV000397013	2	148894900 - 148979973			397013	383906		
GRCh37/hg19 2q23.1(chr2:149201266-149239392)x3	MBD5		See cases	Pathogenic	no assertion criteria provided	VCV000396638	2	149201266 - 149239392			396638	383531		
GRCh37/hg19 2q23.1(chr2:148957572-149100105)x1	MBD5		See cases	Pathogenic	no assertion criteria provided	VCV000394494	2	148957572 - 149100105			394494	381387		
NM_000310.3(PPT1):c.541G>A (p.Val181Met)	PPT1	V181M, V78M		Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188857	1	40546155	1	40080483	188857	186623	rs148412181	NC_000001.11:40080482:C:T
NM_018328.5(MBD5):c.698del (p.Gly233fs)	MBD5	G233fs	Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000841779	2	149226209	2	148468640	841779	824786		NC_000002.12:148468639:GG:G
NC_000002.12:g.(?_148458739)_(148463939_?)del	MBD5		Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Nov 2, 2019)	criteria provided, single submitter	VCV000831961	2	149216308 - 149221508			831961	819048		
NM_018328.4(MBD5):c.1000del (p.Gln334fs)	MBD5	Q334fs	Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000665197	2	149226509	2	148468940	665197	628469		NC_000002.12:148468939:CCCC:CCC
NM_018328.4(MBD5):c.2586_2667del (p.Ser863fs)	MBD5	S863fs	Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000576080	2	149240746 - 149240827	2	148483177 - 148483258	576080	557530	rs1559094754	
NM_018328.4(MBD5):c.2321del (p.Pro774fs)	MBD5	P774fs	Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000536673	2	149227832	2	148470263	536673	516474	rs1553518752	NC_000002.12:148470262:CC:C
NM_018328.4(MBD5):c.379del (p.Ser127fs)	MBD5	S127fs	Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	VCV000536672	2	149221470	2	148463901	536672	516463	rs1553517984	NC_000002.12:148463900:A:
NM_018328.4(MBD5):c.1025dup (p.Ser343fs)	MBD5		Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000536668	2	149226535 - 149226536	2	148468966 - 148468967	536668	516455	rs1553518511	NC_000002.12:148468966:CC:CCC
NM_018328.4(MBD5):c.2633del (p.Pro878fs)	MBD5	P878fs	Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000468775	2	149240791	2	148483222	468775	448753	rs1553519853	NC_000002.12:148483221:CCC:CC
NM_018328.4(MBD5):c.2299_2302del (p.Asn767fs)	MBD5	N767fs	Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000406455	2	149227808 - 149227811	2	148470239 - 148470242	406455	391514	rs1060501153	NC_000002.12:148470238:ACTAACT:ACT
NM_018328.4(MBD5):c.4455del (p.Lys1486fs)	MBD5	K1486fs	Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000406452	2	149270475	2	148512906	406452	391608	rs1060501151	NC_000002.12:148512905:CCCCCC:CCCCC
MBD5, THR157GLNFSTER4	MBD5		Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000060718					60718	75280		
nsv513766	MBD5		Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000000921					921	15960		
NM_014795.4(ZEB2):c.808-2A>G	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, single submitter	VCV000569478	2	145158876	2	144401309	569478	557565	rs1560607925	NC_000002.12:144401308:T:C
NM_014795.4(ZEB2):c.351T>A (p.Tyr117Ter)	ZEB2	Y117*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000567647	2	145182415	2	144424848	567647	557526	rs1560618505	NC_000002.12:144424847:A:T
NM_014795.4(ZEB2):c.2757del (p.Leu920fs)	ZEB2	L896fs, L920fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561145	2	145155997	2	144398430	561145	552050	rs1560605892	NC_000002.12:144398429:CCC:CC
NM_014795.4(ZEB2):c.3170G>A (p.Cys1057Tyr)	ZEB2	C1057Y, C1033Y	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431116	2	145147493	2	144389926	431116	424640	rs1135401790	NC_000002.12:144389925:C:T
NM_014795.4(ZEB2):c.2177_2180del (p.Ser726fs)	ZEB2	S726fs, S702fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189288	2	145156574 - 145156577	2	144399007 - 144399010	189288	187153	rs786204821	NC_000002.12:144399006:AAAGA:A
NM_014795.4(ZEB2):c.1218del (p.His407fs)	ZEB2	H383fs, H407fs	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Jan 22, 2014)	criteria provided, single submitter	VCV000167856	2	145157536	2	144399969	167856	178161	rs727504226	NC_000002.12:144399968:T:
NM_014795.4(ZEB2):c.3359_3364delinsTAATG (p.Gly1120fs)	ZEB2		Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Feb 25, 2013)	criteria provided, single submitter	VCV000095635	2	145147299 - 145147304	2	144389732 - 144389737	95635	101533	rs398124280	NC_000002.12:144389731:AGTACC:CATTA
NM_014795.4(ZEB2):c.-69-1G>A	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Apr 15, 2008)	no assertion criteria provided	VCV000004767	2	145274987	2	144517420	4767	19806	rs587776612	NC_000002.12:144517419:C:T
NM_018328.5:c.728del	MBD5	P243fs	Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000812175	2	149226238	2	148468669	812175	800682		NC_000002.12:148468668:CCC:CC
NM_018328.4(MBD5):c.4235C>A (p.Ser1412Ter)	MBD5	S1412*	Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561057	2	149248135	2	148490566	561057	552052	rs1559099927	NC_000002.12:148490565:C:A
Single allele	MBD5		Schizophrenia	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000545250			2	148211972 - 148423169	545250	535514		
Single allele	MBD5		Schizophrenia	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000545249			2	148158424 - 148226279	545249	535513		
Single allele	MBD5		Schizophrenia	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000545247			2	148139385 - 148242336	545247	535511		
NM_018328.4(MBD5):c.440C>G (p.Ser147Ter)	MBD5	S147*	Mental retardation, autosomal dominant 1|not provided	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000267726	2	149225952	2	148468383	267726	262998	rs886041003	NC_000002.12:148468382:C:G
NM_018328.4(MBD5):c.888_889TA[1] (p.Ile297fs)	MBD5		not provided|Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Apr 16, 2014)	criteria provided, single submitter	VCV000206110	2	149226399 - 149226400	2	148468830 - 148468831	206110	201190	rs796052719	NC_000002.12:148468829:ATATA:ATA
NM_018328.4(MBD5):c.340_347del (p.Lys114fs)	MBD5	K114fs	not provided|Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Jun 13, 2014)	criteria provided, single submitter	VCV000198890	2	149221428 - 149221435	2	148463859 - 148463866	198890	196050	rs794727928	NC_000002.12:148463858:CATAAAAGCAT:CAT
NM_018328.4(MBD5):c.150del (p.Thr52fs)	MBD5	T52fs	Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Jul 21, 2016)	no assertion criteria provided	VCV000088896	2	149220186	2	148462617	88896	94455	rs398122412	NC_000002.12:148462616:TT:T
Single allele	MBD5		Autistic disorder of childhood onset|Schizophrenia	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000545248			2	148157591 - 148226058	545248	535512		
NM_018328.4(MBD5):c.397+1G>A	MBD5		Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000536667	2	149221489	2	148463920	536667	516447	rs1553517991	NC_000002.12:148463919:G:A
NM_194248.3(OTOF):c.2239G>T (p.Glu747Ter)	OTOF	E747*, E57*	Deafness, autosomal recessive 9|not provided|Rare genetic deafness	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000065787	2	26700593	2	26477725	65787	76695	rs397515591	NC_000002.12:26477724:C:A
NM_022114.4(PRDM16):c.1573dup (p.Arg525fs)	PRDM16		not provided	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, single submitter	VCV000280120	1	3328329 - 3328330	1	3411765 - 3411766	280120	264033	rs886041395	NC_000001.11:3411765:CCCCC:CCCCCC
NM_000092.4(COL4A4):c.2878G>A (p.Gly960Arg)	COL4A4	G960R	Alport syndrome 3, autosomal dominant|Alport syndrome, autosomal recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550472	2	227917111	2	227052395	550472	542043	rs769783985	NC_000002.12:227052394:C:T
NM_000092.4(COL4A4):c.2906C>G (p.Ser969Ter)	COL4A4	S969*	not provided|Alport syndrome, autosomal recessive	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449549	2	227917083	2	227052367	449549	443176	rs35138315	NC_000002.12:227052366:G:C
NM_000092.4(COL4A4):c.4129C>T (p.Arg1377Ter)	COL4A4	R1377*	Alport syndrome, autosomal recessive|not provided|Alport syndrome 3, autosomal dominant	Pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000017407	2	227886851	2	227022135	17407	32446	rs121912861	NC_000002.12:227022134:G:A
NM_022114.4(PRDM16):c.827del (p.Gly276fs)	PRDM16	G276fs	not provided	Pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, single submitter	VCV000377306	1	3319504	1	3402940	377306	364184	rs1057520188	NC_000001.11:3402939:GG:G
NM_022114.4(PRDM16):c.2660T>C (p.Leu887Pro)	PRDM16	L887P	Dilated cardiomyopathy 1LL	Pathogenic(Last reviewed: Jul 11, 2013)	no assertion criteria provided	VCV000060729	1	3331180	1	3414616	60729	75289	rs202115331	NC_000001.11:3414615:T:C
NM_022114.4(PRDM16):c.872C>T (p.Pro291Leu)	PRDM16	P291L	Dilated cardiomyopathy 1LL	Pathogenic(Last reviewed: Jul 11, 2013)	no assertion criteria provided	VCV000060728	1	3319550	1	3402986	60728	75288	rs397514744	NC_000001.11:3402985:C:T
PRDM16, 1-BP DUP, 1573C	PRDM16		Left ventricular noncompaction 8	Pathogenic(Last reviewed: Jul 11, 2013)	no assertion criteria provided	VCV000060725					60725	75285		
NM_022114.4(PRDM16):c.2104A>T (p.Lys702Ter)	PRDM16	K702*	Left ventricular noncompaction 8	Pathogenic(Last reviewed: Jul 11, 2013)	no assertion criteria provided	VCV000060724	1	3328865	1	3412301	60724	75284	rs397514742	NC_000001.11:3412300:A:T
NM_014795.4(ZEB2):c.674C>A (p.Ser225Ter)	ZEB2	S225*, S201*	not provided|Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000212637	2	145161616	2	144404049	212637	206852	rs797046122	NC_000002.12:144404048:G:T
NM_014795.4(ZEB2):c.1653del (p.Ser552fs)	ZEB2	S552fs, S528fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000189287	2	145157101	2	144399534	189287	187160	rs786204820	NC_000002.12:144399533:G:
NM_014795.4(ZEB2):c.73+1del	ZEB2		Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	VCV000189279	2	145274844	2	144517277	189279	187171	rs786204813	NC_000002.12:144517276:CC:C
NM_014795.4(ZEB2):c.1876G>T (p.Gly626Ter)	ZEB2	G626*, G602*	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	VCV000167854	2	145156878	2	144399311	167854	177329	rs727504224	NC_000002.12:144399310:C:A
NM_014795.4(ZEB2):c.2501del (p.Lys834fs)	ZEB2	K810fs, K834fs	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000160322	2	145156253	2	144398686	160322	168024	rs587784565	NC_000002.12:144398685:TTT:TT
NM_014795.4(ZEB2):c.643_659del (p.Tyr215fs)	ZEB2	Y215fs, Y191fs	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000095638	2	145161631 - 145161647	2	144404064 - 144404080	95638	101536	rs398124281	NC_000002.12:144404063:TAGCCCCGGTCGCAGTA:
NC_000002.12:g.(?_148458739)_(148512961_?)del	MBD5		Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000832942	2	149216308 - 149270530			832942	819049		
NC_000002.12:g.(?_148458759)_(148512941_?)del	MBD5		Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000830448	2	149216328 - 149270510			830448	819050		
NM_003000.2(SDHB):c.713del (p.Phe238fs)	SDHB	F238fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000233795	1	17349155	1	17022660	233795	232173	rs876660642	NC_000001.11:17022659:AA:A
NM_003000.2(SDHB):c.718_721del (p.Leu240fs)	SDHB	L240fs	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Apr 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000201607	1	17349147 - 17349150	1	17022652 - 17022655	201607	196489	rs794728950	NC_000001.11:17022651:ATAGA:A
NM_003000.2(SDHB):c.526G>T (p.Glu176Ter)	SDHB	E176*	Hereditary Paraganglioma-Pheochromocytoma Syndromes|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 3, 2014)	criteria provided, single submitter	VCV000201603	1	17354258	1	17027763	201603	196490	rs794728946	NC_000001.11:17027762:C:A
NM_003000.2(SDHB):c.26T>A (p.Leu9Ter)	SDHB	L9*	Hereditary cancer-predisposing syndrome|Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic(Last reviewed: Feb 29, 2016)	criteria provided, single submitter	VCV000187527	1	17380489	1	17053994	187527	181626	rs786203800	NC_000001.11:17053993:A:T
NM_001103.3(ACTN2):c.2527-1G>A	ACTN2		not provided	Pathogenic(Last reviewed: Sep 4, 2012)	criteria provided, single submitter	VCV000201635	1	236925760	1	236762460	201635	198066	rs794728966	NC_000001.11:236762459:G:A
NM_001103.3(ACTN2):c.1459T>C (p.Cys487Arg)	ACTN2	C487R, C279R	MYOPATHY, DISTAL, 6, ADULT-ONSET, AUTOSOMAL DOMINANT	Pathogenic(Last reviewed: Nov 11, 2019)	no assertion criteria provided	VCV000694348	1	236911019	1	236747719	694348	682242		NC_000001.11:236747718:T:C
NM_001103.3(ACTN2):c.392T>C (p.Leu131Pro)	ACTN2	L131P	MYOPATHY, DISTAL, 6, ADULT-ONSET, AUTOSOMAL DOMINANT	Pathogenic(Last reviewed: Nov 8, 2019)	no assertion criteria provided	VCV000694347	1	236883435	1	236720135	694347	682241		NC_000001.11:236720134:T:C
NM_001103.3(ACTN2):c.2194_2226del (p.Ala732_Ile742del)	ACTN2		MYOPATHY, CONGENITAL, WITH STRUCTURED CORES AND Z-LINE ABNORMALITIES	Pathogenic(Last reviewed: Nov 8, 2019)	no assertion criteria provided	VCV000694346	1	236920822 - 236920854	1	236757522 - 236757554	694346	682240		NC_000001.11:236757521:ATCGCCAGAACCATCAATGAGGTGGAGACTCAGATC:ATC
NM_001103.3(ACTN2):c.2180T>G (p.Leu727Arg)	ACTN2	L727R, L519R	MYOPATHY, CONGENITAL, WITH STRUCTURED CORES AND Z-LINE ABNORMALITIES	Pathogenic(Last reviewed: Nov 8, 2019)	no assertion criteria provided	VCV000694345	1	236920811	1	236757511	694345	682239		NC_000001.11:236757510:T:G
NM_001103.3(ACTN2):c.1883A>G (p.Glu628Gly)	ACTN2	E628G, E420G	Familial hypertrophic cardiomyopathy 23	Pathogenic(Last reviewed: Mar 16, 2010)	no assertion criteria provided	VCV000189517	1	236917290	1	236753990	189517	187394	rs786204951	NC_000001.11:236753989:A:G
NM_001103.3(ACTN2):c.2276G>C (p.Arg759Thr)	ACTN2	R759T, R551T	Familial hypertrophic cardiomyopathy 23	Pathogenic(Last reviewed: Dec 29, 2006)	no assertion criteria provided	VCV000189516	1	236920907	1	236757607	189516	187393	rs786204950	NC_000001.11:236757606:G:C
NM_001103.3(ACTN2):c.332G>T (p.Gly111Val)	ACTN2	G111V	Familial hypertrophic cardiomyopathy 23	Pathogenic(Last reviewed: Dec 29, 2006)	no assertion criteria provided	VCV000189514	1	236882284	1	236718984	189514	187391	rs786204949	NC_000001.11:236718983:G:T
NM_001103.3(ACTN2):c.2578C>T (p.Gln860Ter)	ACTN2	Q860*, Q652*	not specified|not provided	Pathogenic(Last reviewed: Jan 28, 2013)	criteria provided, single submitter	VCV000201650	1	236925812	1	236762512	201650	198068	rs763078071	NC_000001.11:236762511:C:T
NM_001127207.2(SMARCAL1):c.2542G>T (p.Glu848Ter)	SMARCAL1	E848*	Schimke immuno-osseous dysplasia|Focal segmental glomerulosclerosis|Steroid-resistant nephrotic syndrome|Disproportionate short-trunk short stature|Atrioventricular septal defect|Small for gestational age|Decreased body weight|Congenital microcephaly|Short stature|Microcephaly	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004171	2	217342939	2	216478216	4171	19210	rs119473033	NC_000002.12:216478215:G:T
NM_014795.4(ZEB2):c.855_856AG[1] (p.Glu286fs)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000641571	2	145158824 - 145158825	2	144401257 - 144401258	641571	628457		NC_000002.12:144401256:CTCT:CT
NM_014795.4(ZEB2):c.73+2T>C	ZEB2		Mowat-Wilson syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000095639	2	145274843	2	144517276	95639	101537	rs398124282	NC_000002.12:144517275:A:G
NM_003742.4(ABCB11):c.1445A>G (p.Asp482Gly)	ABCB11	D482G	Progressive familial intrahepatic cholestasis 2|not provided	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000288555	2	169828550	2	168972040	288555	272792	rs72549402	NC_000002.12:168972039:T:C
NM_003742.4(ABCB11):c.2012-8T>G	ABCB11		Cholestasis, intrahepatic, of pregnancy 3|not provided|Progressive familial intrahepatic cholestasis 2|Progressive familial intrahepatic cholestasis 2|	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000284637	2	169825008	2	168968498	284637	268874	rs769910565	NC_000002.12:168968497:A:C
NM_014795.4(ZEB2):c.1956C>A (p.Tyr652Ter)	ZEB2	Y652*, Y628*	History of neurodevelopmental disorder|Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 8, 2016)	criteria provided, multiple submitters, no conflicts	VCV000589324	2	145156798	2	144399231	589324	578959	rs587784563	NC_000002.12:144399230:G:T
NM_014795.4(ZEB2):c.904C>T (p.Arg302Ter)	ZEB2	R302*, R278*	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000160329	2	145158778	2	144401211	160329	168031	rs587784571	NC_000002.12:144401210:G:A
NM_003000.2(SDHB):c.575G>A (p.Cys192Tyr)	SDHB	C192Y	Hereditary cancer-predisposing syndrome|Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic(Last reviewed: Dec 5, 2015)	criteria provided, single submitter	VCV000142047	1	17350535	1	17024040	142047	151761	rs397516835	NC_000001.11:17024039:C:T
NM_001298.3(CNGA3):c.1306C>T (p.Arg436Trp)	CNGA3	R436W, R418W	Retinal dystrophy|not provided|Achromatopsia|Achromatopsia 2	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009482	2	99012939	2	98396476	9482	24521	rs104893621	NC_000002.12:98396475:C:T
NM_000329.3(RPE65):c.118G>A (p.Gly40Ser)	RPE65	G40S	Retinal dystrophy|not provided|Retinitis pigmentosa|Retinitis pigmentosa 20|Leber congenital amaurosis 2	Pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000098830	1	68912520	1	68446837	98830	104720	rs61751281	NC_000001.11:68446836:C:T
NM_014946.3(SPAST):c.1196C>T (p.Ser399Leu)	SPAST	S399L, S398L, S366L, S367L	Spastic paraplegia 4, autosomal dominant|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000448442	2	32353499	2	32128430	448442	440709	rs1553317025	NC_000002.12:32128429:C:T
NM_014795.4(ZEB2):c.289del (p.Trp97fs)	ZEB2	W97fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000180207	2	145187378	2	144429811	180207	178387	rs727503784	NC_000002.12:144429810:A:
NM_001105.5(ACVR1):c.983G>A (p.Gly328Glu)	ACVR1	G328E	Brainstem glioma|Progressive myositis ossificans|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000029595	2	158622516	2	157766004	29595	38549	rs387906589	NC_000002.12:157766003:C:T
NM_001301365.1(LYST):c.10345C>T (p.Arg3449Ter)	LYST	R3449*	not provided	Pathogenic(Last reviewed: Jun 29, 2016)	criteria provided, single submitter	VCV000280681	1	235866076	1	235702776	280681	264000	rs754616030	NC_000001.11:235702775:G:A
NM_001301365.1(LYST):c.11102G>T (p.Cys3701Phe)	LYST	C3701F	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Jan 15, 2015)	no assertion criteria provided	VCV000180630	1	235827858	1	235664558	180630	178797		NC_000001.11:235664557:C:A
NM_001301365.1(LYST):c.9827_9832del (p.Asn3276_Thr3277del)	LYST		Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Jan 15, 2015)	no assertion criteria provided	VCV000180629	1	235875450 - 235875455	1	235712150 - 235712155	180629	178788		NC_000001.11:235712149:TTGTATTTGTA:TTGTA
NM_001301365.1(LYST):c.8281A>T (p.Arg2761Ter)	LYST	R2761*	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Jan 15, 2015)	no assertion criteria provided	VCV000180628	1	235904799	1	235741499	180628	178789		NC_000001.11:235741498:T:A
NM_001301365.1(LYST):c.7982C>G (p.Ser2661Ter)	LYST	S2661*	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Jan 15, 2015)	no assertion criteria provided	VCV000180627	1	235907448	1	235744148	180627	178790		NC_000001.11:235744147:G:C
NM_001301365.1(LYST):c.5541_5542del (p.Arg1848fs)	LYST	R1848fs	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Jan 15, 2015)	no assertion criteria provided	VCV000180626	1	235938305 - 235938306	1	235775005 - 235775006	180626	178791		NC_000001.11:235775004:TTT:T
NM_001301365.1(LYST):c.5506C>T (p.Arg1836Ter)	LYST	R1836*	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Jan 15, 2015)	no assertion criteria provided	VCV000180625	1	235938341	1	235775041	180625	178792		NC_000001.11:235775040:G:A
NM_001301365.1(LYST):c.3944dup (p.Val1316fs)	LYST		Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Jan 15, 2015)	no assertion criteria provided	VCV000180624	1	235963681 - 235963682	1	235800381 - 235800382	180624	178793		NC_000001.11:235800381:G:GG
NM_001301365.1(LYST):c.3622C>T (p.Gln1208Ter)	LYST	Q1208*	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Jan 15, 2015)	no assertion criteria provided	VCV000180623	1	235966298	1	235802998	180623	178794		NC_000001.11:235802997:G:A
NM_001301365.1(LYST):c.9893del (p.Phe3298fs)	LYST	F3298fs	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000065552	1	235875389	1	235712089	65552	76460		NC_000001.11:235712088:AAAAA:AAAA
NM_001301365.1(LYST):c.9228_9229insTTCTTTCAGT (p.Lys3077delinsPhePheGlnTer)	LYST		Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000065550	1	235887414 - 235887415	1	235724114 - 235724115	65550	76458		NC_000001.11:235724114::ACTGAAAGAA
NM_001301365.1(LYST):c.8583G>A (p.Trp2861Ter)	LYST	W2861*	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000065549	1	235897159	1	235733859	65549	76457		NC_000001.11:235733858:C:T
NM_001301365.1(LYST):c.8428G>A (p.Glu2810Lys)	LYST	E2810K	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000065548	1	235897890	1	235734590	65548	76456		NC_000001.11:235734589:C:T
NM_001301365.1(LYST):c.7555del (p.Tyr2519fs)	LYST	Y2519fs	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000065547	1	235915377	1	235752077	65547	76455		NC_000001.11:235752076:A:
NM_000081.3(LYST):c.7060_7066del (p.Leu2354Metfs)	LYST		Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000065546	1	235918941 - 235918947	1	235755641 - 235755647	65546	76454		NC_000001.11:235755640:CTAATAGCTAA:CTAA
NM_001301365.1(LYST):c.6078C>A (p.Tyr2026Ter)	LYST	Y2026*	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000065545	1	235929422	1	235766122	65545	76453		NC_000001.11:235766121:G:T
NM_001301365.1(LYST):c.5317del (p.Arg1773fs)	LYST	R1773fs	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000065544	1	235940506	1	235777206	65544	76452		NC_000001.11:235777205:TTT:TT
NM_001301365.1(LYST):c.5061T>A (p.Tyr1687Ter)	LYST	Y1687*	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000065543	1	235944318	1	235781018	65543	76451		NC_000001.11:235781017:A:T
NM_001301365.1(LYST):c.4361C>A (p.Ala1454Asp)	LYST	A1454D	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000065542	1	235955181	1	235791881	65542	76450		NC_000001.11:235791880:G:T
NM_001301365.1(LYST):c.4274del (p.Leu1425fs)	LYST	L1425fs	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000065541	1	235955268	1	235791968	65541	76449		NC_000001.11:235791967:AAA:AA
NM_001301365.1(LYST):c.4052C>G (p.Ser1351Ter)	LYST	S1351*	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000065540	1	235956867	1	235793567	65540	76448		NC_000001.11:235793566:G:C
NM_001301365.1(LYST):c.3434dup (p.His1145fs)	LYST		Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000065539	1	235967924 - 235967925	1	235804624 - 235804625	65539	76447		NC_000001.11:235804624:T:TT
NM_001301365.1(LYST):c.3073_3074del (p.Asn1025fs)	LYST	N1025fs	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000065538	1	235969362 - 235969363	1	235806062 - 235806063	65538	76446		NC_000001.11:235806061:TTT:T
NM_001301365.1(LYST):c.2454del (p.Ala819fs)	LYST	A819fs	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000065536	1	235969982	1	235806682	65536	76444		NC_000001.11:235806681:TTTT:TTT
NM_001301365.1(LYST):c.1540C>T (p.Arg514Ter)	LYST	R514*	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000065533	1	235972578	1	235809278	65533	76441		NC_000001.11:235809277:G:A
NM_001301365.1(LYST):c.10395del (p.Gly3466fs)	LYST	G3466fs	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000065530	1	235860552	1	235697252	65530	76438		NC_000001.11:235697251:TTTT:TTT
NM_000081.3(LYST):c.9107_9162del (p.Gly3036Glufs)	LYST		Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000040979	1	235891376 - 235891431	1	235728074 - 235728129	40979	49401		
NM_000081.4(LYST):c.9874G>T (p.Glu3292Ter)	LYST	E3292*	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000838337	1	235875408	1	235712108	838337	823553		NC_000001.11:235712107:C:A
NM_000081.4(LYST):c.3601del (p.Ser1201fs)	LYST	S1201fs	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Aug 26, 2018)	criteria provided, single submitter	VCV000662959	1	235966319	1	235803019	662959	627487		NC_000001.11:235803018:AAAAA:AAAA
NM_001301365.1(LYST):c.2413G>T (p.Glu805Ter)	LYST	E805*	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000571664	1	235970023	1	235806723	571664	557197		NC_000001.11:235806722:C:A
NM_001301365.1(LYST):c.5956C>T (p.Arg1986Ter)	LYST	R1986*	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000525149	1	235929544	1	235766244	525149	515536		NC_000001.11:235766243:G:A
NM_001301365.1(LYST):c.8802-2A>G	LYST		Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Nov 23, 2016)	criteria provided, single submitter	VCV000435793	1	235894479	1	235731179	435793	427726		NC_000001.11:235731178:T:C
NM_001301365.1(LYST):c.11173G>A (p.Gly3725Arg)	LYST	G3725R	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Jan 15, 2015)	no assertion criteria provided	VCV000180631	1	235827787	1	235664487	180631	178787		NC_000001.11:235664486:C:T
NM_001301365.1(LYST):c.772T>C (p.Cys258Arg)	LYST	C258R	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Jan 15, 2015)	no assertion criteria provided	VCV000180622	1	235973346	1	235810046	180622	178796		NC_000001.11:235810045:A:G
NM_001301365.1(LYST):c.2413del (p.Glu805fs)	LYST	E805fs	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000065535	1	235970023	1	235806723	65535	76443		NC_000001.11:235806722:C:
NM_001301365.1(LYST):c.5996T>A (p.Val1999Asp)	LYST	V1999D	Chediak-Higashi syndrome, adult type|Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000003817	1	235929504	1	235766204	3817	18856	rs28942077	NC_000001.11:235766203:A:T
NM_001301365.1(LYST):c.4688G>A (p.Arg1563His)	LYST	R1563H	Chediak-Higashi syndrome, adult type|Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000003816	1	235952001	1	235788701	3816	18855	rs80338657	NC_000001.11:235788700:C:T
NM_001301365.1(LYST):c.2623del (p.Tyr875fs)	LYST	Y875fs	Chediak-Higashi syndrome, childhood type|Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000003815	1	235969813	1	235806513	3815	18854	rs80338649	NC_000001.11:235806512:AAAA:AAA
NM_001301365.1(LYST):c.148C>T (p.Arg50Ter)	LYST	R50*	Chediak-Higashi syndrome, childhood type|Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000003813	1	235993570	1	235830270	3813	18852	rs80338643	NC_000001.11:235830269:G:A
NM_001301365.1(LYST):c.9590del (p.Tyr3197fs)	LYST	Y3197fs	Chediak-Higashi syndrome, childhood type|Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000003812	1	235880049	1	235716749	3812	18851	rs80338667	NC_000001.11:235716748:T:
NM_001301365.1(LYST):c.1467del (p.Glu489fs)	LYST	E489fs	Chediak-Higashi syndrome, childhood type|Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000003808	1	235972651	1	235809351	3808	18847	rs80338644	NC_000001.11:235809350:C:
NM_000784.4(CYP27A1):c.1184+1G>A	CYP27A1		Cholestanol storage disease|not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000065833	2	219678911	2	218814188	65833	76741	rs587778777	NC_000002.12:218814187:G:A
NM_003000.2(SDHB):c.445C>T (p.Gln149Ter)	SDHB	Q149*	Hereditary cancer-predisposing syndrome|Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000230224	1	17354339	1	17027844	230224	232179	rs876658451	NC_000001.11:17027843:G:A
NM_001301365.1(LYST):c.925C>T (p.Arg309Ter)	LYST	R309*	Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Aug 26, 2018)	criteria provided, single submitter	VCV000180621	1	235973193	1	235809893	180621	178795		NC_000001.11:235809892:G:A
NM_001301365.1(LYST):c.1902dup (p.Ala635fs)	LYST		Chediak-Higashi syndrome, childhood type|Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000003811	1	235972215 - 235972216	1	235808915 - 235808916	3811	18850	rs80338646	NC_000001.11:235808915:TTTTTT:TTTTTTT
NM_001301365.1(LYST):c.118dup (p.Ala40fs)	LYST		Chediak-Higashi syndrome, childhood type|Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000003810	1	235993599 - 235993600	1	235830299 - 235830300	3810	18849	rs80338642	NC_000001.11:235830299:CC:CCC
NM_001692.4(ATP6V1B1):c.340C>T (p.Arg114Ter)	ATP6V1B1	R114*	Renal tubular acidosis with progressive nerve deafness|Inborn genetic diseases	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521461	2	71185529	2	70958399	521461	511434	rs782138777	NC_000002.12:70958398:C:T
NM_001692.4(ATP6V1B1):c.232G>A (p.Gly78Arg)	ATP6V1B1	G78R	Renal tubular acidosis, distal, with progressive deafness|Inborn genetic diseases	Pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	VCV000012229	2	71185233	2	70958103	12229	27268	rs121964881	NC_000002.12:70958102:G:A
NM_007375.3(TARDBP):c.1042G>T (p.Gly348Cys)	TARDBP	G348C	Amyotrophic lateral sclerosis type 10|not provided	Pathogenic(Last reviewed: May 19, 2016)	criteria provided, single submitter	VCV000005234	1	11082508	1	11022451	5234	20273	rs80356733	NC_000001.11:11022450:G:T
NM_001301365.1(LYST):c.3085C>T (p.Gln1029Ter)	LYST	Q1029*	Chediak-Higashi syndrome, childhood type|Chédiak-Higashi syndrome	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000003814	1	235969351	1	235806051	3814	18853	rs80338651	NC_000001.11:235806050:G:A
NM_000272.4(NPHP1):c.1027G>A (p.Gly343Arg)	NPHP1	G343R, G342R, G224R, G287R	not provided|NPHP1-Related Disorders|Nephronophthisis|Nephronophthisis 1	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003510	2	110920625	2	110163048	3510	18549	rs121907899	NC_000002.12:110163047:C:T
NM_004895.4(NLRP3):c.913G>A (p.Asp305Asn)	NLRP3	D303N, D305N	Cryopyrin associated periodic syndrome|Chronic infantile neurological, cutaneous and articular syndrome|Familial amyloid nephropathy with urticaria AND deafness|not provided|Familial cold urticaria	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004377	1	247587658	1	247424356	4377	19416	rs121908153	NC_000001.11:247424355:G:A
NM_004895.4(NLRP3):c.1322C>T (p.Ala441Val)	NLRP3	A439V, A441V	Cryopyrin associated periodic syndrome|not specified|not provided|Familial cold urticaria	Pathogenic(Last reviewed: Jan 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004370	1	247588067	1	247424765	4370	19409	rs121908146	NC_000001.11:247424764:C:T
NM_000016.5(ACADM):c.616C>T (p.Arg206Cys)	ACADM	R206C, R210C, R17C, R170C, R239C	not provided|Medium-chain acyl-coenzyme A dehydrogenase deficiency|not specified	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092267	1	76211507	1	75745822	92267	98178	rs373715782	NC_000001.11:75745821:C:T
NM_000016.5(ACADM):c.157C>T (p.Arg53Cys)	ACADM	R53C, R57C, R17C	not provided|Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092258	1	76198367	1	75732682	92258	98169	rs398123072	NC_000001.11:75732681:C:T
NM_000530.8(MPZ):c.131C>T (p.Ser44Phe)	MPZ	S44F	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000014185	1	161277151	1	161307361	14185	29224	rs121913598	NC_000001.11:161307360:G:A
NM_000530.8(MPZ):c.293G>C (p.Arg98Pro)	MPZ	R98P	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|not specified	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014174	1	161276653	1	161306863	14174	29213	rs121913589	NC_000001.11:161306862:C:G
NM_014795.4(ZEB2):c.1426dup (p.Met476fs)	ZEB2		not provided|Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004757	2	145157327 - 145157328	2	144399760 - 144399761	4757	19796	rs587776604	NC_000002.12:144399760:TTTTTT:TTTTTTT
NM_001135599.3(TGFB2):c.229_245del (p.Leu77fs)	TGFB2	L77fs	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, single submitter	VCV000521316	1	218520271 - 218520287	1	218346929 - 218346945	521316	511227	rs1553292105	NC_000001.11:218346928:CTTGCTCCAGGAGAAGGC:C
NM_000228.3(LAMB3):c.124C>T (p.Arg42Ter)	LAMB3	R42*	not provided|Junctional epidermolysis bullosa gravis of Herlitz|Amelogenesis imperfecta, type IA|Junctional epidermolysis bullosa gravis of Herlitz|Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014541	1	209823368	1	209650023	14541	29580	rs80356680	NC_000001.11:209650022:G:A
NM_003000.2(SDHB):c.502C>T (p.Gln168Ter)	SDHB	Q168*	Paragangliomas 4	Pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000468234	1	17354282	1	17027787	468234	447473	rs1553177677	NC_000001.11:17027786:G:A
NM_003000.2(SDHB):c.190del (p.Asp64fs)	SDHB	D64fs	Paragangliomas 4	Pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000468233	1	17371266	1	17044771	468233	447510	rs1553178729	NC_000001.11:17044770:C:
NC_000001.10:g.(?_17345370)_(17371389_?)del	SDHB		Paragangliomas 4	Pathogenic(Last reviewed: Apr 20, 2017)	criteria provided, single submitter	VCV000468230	1	17345370 - 17371389	1	17018875 - 17044894	468230	446920		
NM_003000.2(SDHB):c.22_23delTC	SDHB		Paragangliomas 4	Pathogenic(Last reviewed: Feb 14, 2017)	criteria provided, single submitter	VCV000412488	1	17380492 - 17380493	1	17053997 - 17053998	412488	390942	rs1060503767	NC_000001.11:17053996:GAGAG:GAG
NM_003000.2(SDHB):c.(?_-151)_(72+1_73-1)del	SDHB		Paragangliomas 4	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000012784					12784	27823		
NM_201253.3(CRB1):c.1576C>T (p.Arg526Ter)	CRB1	R526*, R457*, R414*	Retinal dystrophy|Leber congenital amaurosis|Leber congenital amaurosis 8|Leber congenital amaurosis 8|Retinitis pigmentosa 12|not provided	Pathogenic(Last reviewed: Jul 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143167	1	197390534	1	197421404	143167	152885	rs114342808	NC_000001.11:197421403:C:T
NC_000001.11:g.(?_161323604)_(161328507_?)del	SDHC		Gastrointestinal stromal tumor|Paragangliomas 3	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000831126	1	161293394 - 161298297			831126	818855		
NM_003001.3(SDHC):c.405+1G>A	SDHC		Gastrointestinal stromal tumor|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Carney triad|Carney-Stratakis syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 4, 2011)	no assertion criteria provided	VCV000007244	1	161326631	1	161356841	7244	22283	rs587776653	NC_000001.11:161356840:G:A
NM_003001.3(SDHC):c.3G>A (p.Met1Ile)	SDHC	M1I	Paragangliomas 3|Paragangliomas 3|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000007241	1	161284198	1	161314408	7241	22280	rs587776652	NC_000001.11:161314407:G:A
NM_001204.7(BMPR2):c.26_41del (p.Trp9fs)	BMPR2	W9fs	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000813012	2	203242221 - 203242236	2	202377498 - 202377513	813012	801001		NC_000002.12:202377497:CTGGCGGGTGCCCTGGCT:CT
NM_001204.7(BMPR2):c.19del (p.Arg7fs)	BMPR2	R7fs	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000813011	2	203242216	2	202377493	813011	801000		NC_000002.12:202377492:C:
NC_000002.12:g.202461237_202467808del	BMPR2		Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812939	2	203325958 - 203332529			812939	801002		
NC_000002.12:g.202373247_202381017del	BMPR2		Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812937	2	203237969 - 203245739			812937	800998		
Single allele	BMPR2		Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812936	2	203234119 - 203242446			812936	801258		
NM_001204.7(BMPR2):c.2608_2612del (p.Leu870fs)	BMPR2	L870fs	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812849	2	203420994 - 203420998	2	202556271 - 202556275	812849	801061		NC_000002.12:202556270:CTTTACT:CT
NM_001204.7(BMPR2):c.2558_2559insA (p.Gly853_Glu854insTer)	BMPR2		Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812848	2	203420946 - 203420947	2	202556223 - 202556224	812848	801060		NC_000002.12:202556223::A
NM_001204.7(BMPR2):c.2548C>T (p.Gln850Ter)	BMPR2	Q850*	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812847	2	203420936	2	202556213	812847	801059		NC_000002.12:202556212:C:T
NM_001204.7(BMPR2):c.2533del (p.Glu845fs)	BMPR2	E845fs	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812845	2	203420921	2	202556198	812845	801057		NC_000002.12:202556197:G:
NM_001204.7(BMPR2):c.2500C>T (p.Gln834Ter)	BMPR2	Q834*	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812844	2	203420888	2	202556165	812844	801056		NC_000002.12:202556164:C:T
NM_001204.7(BMPR2):c.2426dup (p.Ala810fs)	BMPR2		Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812843	2	203420813 - 203420814	2	202556090 - 202556091	812843	801055		NC_000002.12:202556090:T:TT
NM_001204.7(BMPR2):c.2372_2373del (p.Met791fs)	BMPR2	M791fs	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812842	2	203420760 - 203420761	2	202556037 - 202556038	812842	801054		NC_000002.12:202556036:TG:
NM_001204.7(BMPR2):c.2245dup (p.Gln749fs)	BMPR2		Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812841	2	203420632 - 203420633	2	202555909 - 202555910	812841	801053		NC_000002.12:202555909:C:CC
NM_001204.7(BMPR2):c.2158C>T (p.Gln720Ter)	BMPR2	Q720*	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812840	2	203420546	2	202555823	812840	801052		NC_000002.12:202555822:C:T
NM_001204.7(BMPR2):c.2027_2030dup (p.Lys678fs)	BMPR2		Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812839	2	203420414 - 203420415	2	202555691 - 202555692	812839	801051		NC_000002.12:202555691:ACCT:ACCTACCT
NM_001204.7(BMPR2):c.2014G>T (p.Glu672Ter)	BMPR2	E672*	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812838	2	203420402	2	202555679	812838	801050		NC_000002.12:202555678:G:T
NM_001204.7(BMPR2):c.1962_1963insGA (p.Cys655fs)	BMPR2		Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812836	2	203420350 - 203420351	2	202555627 - 202555628	812836	801048		NC_000002.12:202555627::GA
NM_001204.7(BMPR2):c.1958_1959del (p.Pro653fs)	BMPR2	P653fs	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812835	2	203420346 - 203420347	2	202555623 - 202555624	812835	801047		NC_000002.12:202555622:CT:
NM_001204.7(BMPR2):c.1432G>T (p.Glu478Ter)	BMPR2	E478*	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812832	2	203417457	2	202552734	812832	801044		NC_000002.12:202552733:G:T
NM_001204.7(BMPR2):c.1353_1354TC[3] (p.Val453fs)	BMPR2		Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812831	2	203407109 - 203407110	2	202542386 - 202542387	812831	801042		NC_000002.12:202542386:TCTC:TCTCTC
NM_001204.7(BMPR2):c.1242G>A (p.Trp414Ter)	BMPR2	W414*	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812828	2	203397421	2	202532698	812828	801037		NC_000002.12:202532697:G:A
NM_001204.7(BMPR2):c.1228G>C (p.Gly410Arg)	BMPR2	G410R	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812827	2	203397407	2	202532684	812827	801036		NC_000002.12:202532683:G:C
NM_001204.7(BMPR2):c.1128+2T>G	BMPR2		Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812823	2	203395679	2	202530956	812823	801242		NC_000002.12:202530955:T:G
NM_001204.7(BMPR2):c.852_852+1insA	BMPR2		Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812821	2	203383775 - 203383776	2	202519052 - 202519053	812821	801241		NC_000002.12:202519052::A
NM_001204.7(BMPR2):c.846T>A (p.Tyr282Ter)	BMPR2	Y282*	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812820	2	203383769	2	202519046	812820	801029		NC_000002.12:202519045:T:A
NM_001204.7(BMPR2):c.843C>G (p.Tyr281Ter)	BMPR2	Y281*	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812819	2	203383766	2	202519043	812819	801028		NC_000002.12:202519042:C:G
NM_001204.7(BMPR2):c.823dup (p.Tyr275fs)	BMPR2		Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812818	2	203383745 - 203383746	2	202519022 - 202519023	812818	801027		NC_000002.12:202519022:T:TT
NM_001204.7(BMPR2):c.793G>T (p.Glu265Ter)	BMPR2	E265*	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812817	2	203383716	2	202518993	812817	801026		NC_000002.12:202518992:G:T
NM_001204.7(BMPR2):c.761_762del (p.His254fs)	BMPR2	H254fs	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812816	2	203383684 - 203383685	2	202518961 - 202518962	812816	801025		NC_000002.12:202518960:AT:
NM_001204.7(BMPR2):c.691del (p.Val231fs)	BMPR2	V231fs	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812815	2	203383614	2	202518891	812815	801024		NC_000002.12:202518890:G:
NM_001204.7(BMPR2):c.687_693del (p.Lys230fs)	BMPR2	K230fs	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812814	2	203383610 - 203383616	2	202518887 - 202518893	812814	801023		NC_000002.12:202518886:AAAAGTG:
NM_001204.7(BMPR2):c.683del (p.Ala228fs)	BMPR2	A228fs	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812813	2	203383606	2	202518883	812813	801022		NC_000002.12:202518882:C:
NM_001204.7(BMPR2):c.657del (p.Gly220fs)	BMPR2	G220fs	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812812	2	203383578	2	202518855	812812	801021		NC_000002.12:202518854:AAA:AA
NM_001204.7(BMPR2):c.621+1G>A	BMPR2		Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812809	2	203379703	2	202514980	812809	801238		NC_000002.12:202514979:G:A
NM_001204.7(BMPR2):c.619dup (p.Glu207fs)	BMPR2		Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812808	2	203379698 - 203379699	2	202514975 - 202514976	812808	801019		NC_000002.12:202514975:GG:GGG
NM_001204.7(BMPR2):c.533_536dup (p.Lys180fs)	BMPR2		Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812807	2	203379612 - 203379613	2	202514889 - 202514890	812807	801018		NC_000002.12:202514889:GACCG:GACCGACCG
NM_001204.7(BMPR2):c.470C>G (p.Ser157Ter)	BMPR2	S157*	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812805	2	203378493	2	202513770	812805	801017		NC_000002.12:202513769:C:G
NM_001204.7(BMPR2):c.349T>G (p.Cys117Gly)	BMPR2	C117G	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812802	2	203332343	2	202467620	812802	801013		NC_000002.12:202467619:T:G
NM_001204.7(BMPR2):c.346T>C (p.Cys116Arg)	BMPR2	C116R	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812801	2	203332340	2	202467617	812801	801012		NC_000002.12:202467616:T:C
NM_001204.7(BMPR2):c.344dup (p.Cys116fs)	BMPR2		Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812800	2	203332335 - 203332336	2	202467612 - 202467613	812800	801011		NC_000002.12:202467612:TTT:TTTT
NM_001204.7(BMPR2):c.314del (p.Pro105fs)	BMPR2	P105fs	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812799	2	203332307	2	202467584	812799	801010		NC_000002.12:202467583:CC:C
NM_001204.7(BMPR2):c.288T>G (p.Tyr96Ter)	BMPR2	Y96*	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812798	2	203332282	2	202467559	812798	801009		NC_000002.12:202467558:T:G
NM_001204.7(BMPR2):c.274del (p.Gln92fs)	BMPR2	Q92fs	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812797	2	203332265	2	202467542	812797	801008		NC_000002.12:202467541:CCCC:CCC
NM_001204.7(BMPR2):c.251G>A (p.Cys84Tyr)	BMPR2	C84Y	Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812796	2	203332245	2	202467522	812796	801007		NC_000002.12:202467521:G:A
NM_001204.7(BMPR2):c.93_94insT (p.Arg32fs)	BMPR2		Pulmonary arterial hypertension	Pathogenic	no assertion criteria provided	VCV000812795	2	203329548 - 203329549	2	202464825 - 202464826	812795	801004		NC_000002.12:202464825::T
NM_001204.7(BMPR2):c.1077_1078del (p.Gly360fs)	BMPR2	G360fs	not specified	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000811205	2	203395626 - 203395627	2	202530903 - 202530904	811205	799277		NC_000002.12:202530902:TG:
NM_001204.7(BMPR2):c.712C>T (p.Gln238Ter)	BMPR2	Q238*	not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000618545	2	203383635	2	202518912	618545	609469	rs1559062859	NC_000002.12:202518911:C:T
NM_001204.7(BMPR2):c.1342del (p.Asp448fs)	BMPR2	D448fs	not provided	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000617994	2	203407098	2	202542375	617994	609470	rs1559070248	NC_000002.12:202542374:GG:G
NM_001204.7(BMPR2):c.1506del (p.Glu503fs)	BMPR2	E503fs	not specified	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000439439	2	203417531	2	202552808	439439	433383	rs1553512523	NC_000002.12:202552807:T:
GRCh37/hg19 2q33.2(chr2:203412125-203441031)x1	BMPR2		See cases	Pathogenic	no assertion criteria provided	VCV000396740	2	203412125 - 203441031			396740	383633		
NM_001204.7(BMPR2):c.186dup (p.Gly63fs)	BMPR2		not provided	Pathogenic(Last reviewed: Apr 24, 2015)	criteria provided, single submitter	VCV000212814	2	203329638 - 203329639	2	202464915 - 202464916	212814	209583	rs863223423	NC_000002.12:202464915:AAA:AAAA
NM_001204.7(BMPR2):c.846T>G (p.Tyr282Ter)	BMPR2	Y282*	not provided	Pathogenic(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	VCV000212809	2	203383769	2	202519046	212809	209587	rs863223419	NC_000002.12:202519045:T:G
NM_001204.7(BMPR2):c.172_173AT[3] (p.Leu59fs)	BMPR2		Primary pulmonary hypertension	Pathogenic(Last reviewed: Jul 11, 2016)	no assertion criteria provided	VCV000264655	2	203329626 - 203329627	2	202464903 - 202464904	264655	259245	rs886039223	NC_000002.12:202464903:ATAT:ATATAT
NM_001204.7(BMPR2):c.1443_1445del (p.Glu481del)	BMPR2	E481del	Primary pulmonary hypertension	Pathogenic(Last reviewed: Jul 11, 2016)	no assertion criteria provided	VCV000264652	2	203417466 - 203417468	2	202552743 - 202552745	264652	259247	rs886039221	NC_000002.12:202552742:GAAGA:GA
NM_001204.7(BMPR2):c.1277-10_1277-9insGGG	BMPR2		Primary pulmonary hypertension	Pathogenic(Last reviewed: Jul 11, 2016)	no assertion criteria provided	VCV000264651	2	203407024 - 203407025	2	202542301 - 202542302	264651	259246	rs886039220	NC_000002.12:202542301::GGG
GRCh38/hg38 2q33.1-33.2(chr2:202445130-202631487)x1	BMPR2		See cases	Pathogenic(Last reviewed: Dec 13, 2010)	no assertion criteria provided	VCV000145553	2	203309853 - 203496210	2	202445130 - 202631487	145553	155304		
NM_001204.7(BMPR2):c.583G>T (p.Glu195Ter)	BMPR2	E195*	Pulmonary venoocclusive disease 1	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000039423	2	203379664	2	202514941	39423	48022	rs397514497	NC_000002.12:202514940:G:T
NM_001204.7(BMPR2):c.604A>T (p.Asn202Tyr)	BMPR2	N202Y	Pulmonary venoocclusive disease 1	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000039422	2	203379685	2	202514962	39422	48021	rs397514496	NC_000002.12:202514961:A:T
NM_001204.7(BMPR2):c.120T>G (p.Tyr40Ter)	BMPR2	Y40*	Pulmonary venoocclusive disease 1	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000008815	2	203329575	2	202464852	8815	23854	rs137852755	NC_000002.12:202464851:T:G
NM_001204.7(BMPR2):c.2202del (p.Pro735fs)	BMPR2	P735fs	Primary pulmonary hypertension	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000845712	2	203420589	2	202555866	845712	825604		NC_000002.12:202555865:TT:T
NM_001204.7(BMPR2):c.142dup (p.Glu48fs)	BMPR2		Primary pulmonary hypertension	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000838701	2	203329596 - 203329597	2	202464873 - 202464874	838701	825601		NC_000002.12:202464873:G:GG
NM_001204.7(BMPR2):c.443del (p.Asp148fs)	BMPR2	D148fs	Primary pulmonary hypertension	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000836469	2	203378466	2	202513743	836469	825603		NC_000002.12:202513742:A:
NC_000002.12:g.(?_202530784)_(202542457_?)del	BMPR2		Primary pulmonary hypertension	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000832606	2	203395507 - 203407180			832606	819103		
NM_001204.7(BMPR2):c.1536del (p.Lys512fs)	BMPR2	K512fs	Primary pulmonary hypertension	Pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, single submitter	VCV000660183	2	203417559	2	202552836	660183	629306		NC_000002.12:202552835:AAA:AA
NC_000002.11:g.(?_203378432)_(203384934_?)del	BMPR2		Primary pulmonary hypertension	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000660143	2	203378432 - 203384934	2	202513709 - 202520211	660143	650726		
NC_000002.11:g.(?_203378422)_(203395697_?)del	BMPR2		Primary pulmonary hypertension	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000658435	2	203378422 - 203395697	2	202513699 - 202530974	658435	650783		
NM_001204.7(BMPR2):c.1662_1663CT[1] (p.Ser555fs)	BMPR2		Primary pulmonary hypertension	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000648237	2	203420050 - 203420051	2	202555327 - 202555328	648237	629307		NC_000002.12:202555326:CTCT:CT
NC_000002.11:g.(?_203378422)_(203407190_?)del	BMPR2		Primary pulmonary hypertension	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000583625	2	203378422 - 203407190	2	202513699 - 202542467	583625	558078		
NM_001204.7(BMPR2):c.1513dup (p.Met505fs)	BMPR2		Primary pulmonary hypertension	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000568737	2	203417537 - 203417538	2	202552814 - 202552815	568737	557816	rs1559073178	NC_000002.12:202552814:A:AA
NM_001204.7(BMPR2):c.1142_1143dup (p.Tyr382fs)	BMPR2		Primary pulmonary hypertension	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000528331	2	203397319 - 203397320	2	202532596 - 202532597	528331	517786	rs1553509983	NC_000002.12:202532596:AGA:AGAGA
NM_001204.7(BMPR2):c.1148del (p.Met383fs)	BMPR2	M383fs	Primary pulmonary hypertension	Pathogenic(Last reviewed: Feb 4, 2017)	criteria provided, single submitter	VCV000458623	2	203397327	2	202532604	458623	450259	rs1553509984	NC_000002.12:202532603:T:
NC_000002.11:g.(?_203332222)_(203379722_?)del	BMPR2		Primary pulmonary hypertension	Pathogenic(Last reviewed: Feb 20, 2017)	criteria provided, single submitter	VCV000458622	2	203332222 - 203379722	2	202467499 - 202514999	458622	448566		
NM_001204.7(BMPR2):c.2737C>T (p.Gln913Ter)	BMPR2	Q913*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000426005	2	203421125	2	202556402	426005	414368	rs769603144	NC_000002.12:202556401:C:T
NM_001204.7(BMPR2):c.2730T>A (p.Cys910Ter)	BMPR2	C910*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000426004	2	203421118	2	202556395	426004	414367	rs1085307400	NC_000002.12:202556394:T:A
NM_001204.7(BMPR2):c.2533G>T (p.Glu845Ter)	BMPR2	E845*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425995	2	203420921	2	202556198	425995	414358	rs1085307394	NC_000002.12:202556197:G:T
NM_001204.7(BMPR2):c.2484del (p.Thr829fs)	BMPR2	T829fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425988	2	203420870	2	202556147	425988	414351	rs1085307387	NC_000002.12:202556146:GGG:GG
NM_001204.7(BMPR2):c.2303_2309del (p.Glu768fs)	BMPR2	E768fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425980	2	203420690 - 203420696	2	202555967 - 202555973	425980	414343	rs1085307379	NC_000002.12:202555966:GAGCCCCG:G
NM_001204.7(BMPR2):c.1981G>T (p.Glu661Ter)	BMPR2	E661*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425972	2	203420369	2	202555646	425972	414335	rs759293027	NC_000002.12:202555645:G:T
NM_001204.7(BMPR2):c.1969C>T (p.Gln657Ter)	BMPR2	Q657*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425970	2	203420357	2	202555634	425970	414333	rs1085307371	NC_000002.12:202555633:C:T
NM_001204.7(BMPR2):c.1629T>G (p.Tyr543Ter)	BMPR2	Y543*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425963	2	203420017	2	202555294	425963	414326	rs759990771	NC_000002.12:202555293:T:G
NM_001204.7(BMPR2):c.1587-7_1587-4del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425961	2	203419961 - 203419964	2	202555238 - 202555241	425961	414324	rs769408722	NC_000002.12:202555237:TTTCTTTCTTT:TTTCTTT
NM_001204.7(BMPR2):c.1486T>C (p.Cys496Arg)	BMPR2	C496R	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425953	2	203417511	2	202552788	425953	414316	rs1085307361	NC_000002.12:202552787:T:C
NM_001204.7(BMPR2):c.1477dup (p.Thr493fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425951	2	203417501 - 203417502	2	202552778 - 202552779	425951	414314	rs1085307359	NC_000002.12:202552778:A:AA
NM_001204.7(BMPR2):c.1456C>T (p.Gln486Ter)	BMPR2	Q486*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425949	2	203417481	2	202552758	425949	414312	rs1085307357	NC_000002.12:202552757:C:T
NM_001204.7(BMPR2):c.1453G>A (p.Asp485Asn)	BMPR2	D485N	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425948	2	203417478	2	202552755	425948	414311	rs1085307356	NC_000002.12:202552754:G:A
NM_001204.7(BMPR2):c.1451G>A (p.Trp484Ter)	BMPR2	W484*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425947	2	203417476	2	202552753	425947	414310	rs1085307355	NC_000002.12:202552752:G:A
NM_001204.7(BMPR2):c.1447T>C (p.Cys483Arg)	BMPR2	C483R	Pulmonary hypertension, primary, dexfenfluramine-associated	Pathogenic	no assertion criteria provided	VCV000425946	2	203417472	2	202552749	425946	414309	rs1085307354	NC_000002.12:202552748:T:C
NM_001204.7(BMPR2):c.1441G>T (p.Glu481Ter)	BMPR2	E481*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425945	2	203417466	2	202552743	425945	414308	rs937502048	NC_000002.12:202552742:G:T
NM_001204.7(BMPR2):c.1402G>T (p.Glu468Ter)	BMPR2	E468*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425937	2	203407159	2	202542436	425937	414302	rs1085307348	NC_000002.12:202542435:G:T
NM_001204.7(BMPR2):c.1371del (p.Lys457fs)	BMPR2	K457fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425929	2	203407124	2	202542401	425929	414294	rs1085307340	NC_000002.12:202542400:AAAAA:AAAA
NM_001204.7(BMPR2):c.1285_1292GTACCAGA[1] (p.Glu431fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425923	2	203407042 - 203407049	2	202542319 - 202542326	425923	414288	rs1085307335	NC_000002.12:202542318:GTACCAGAGTACCAGA:GTACCAGA
NM_001204.7(BMPR2):c.1285_1286insGGATT (p.Val429fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425922	2	203407042 - 203407043	2	202542319 - 202542320	425922	414287	rs1085307334	NC_000002.12:202542319::GGATT
NM_001204.6(BMPR2):c.1279delG (p.E427Nfs*47)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425921	2	203407033	2	202542310	425921	414286	rs1085307333	NC_000002.12:202542309:GGGG:GGG
NM_001204.7(BMPR2):c.1277-8A>G	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425918	2	203407026	2	202542303	425918	414285	rs1085307332	NC_000002.12:202542302:A:G
NM_001204.7(BMPR2):c.1277-9A>C	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425916	2	203407025	2	202542302	425916	414283	rs1085307331	NC_000002.12:202542301:A:C
NM_001204.7(BMPR2):c.1268dup (p.Phe424fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425908	2	203397446 - 203397447	2	202532723 - 202532724	425908	414275	rs1085307326	NC_000002.12:202532723:T:TT
NM_001204.7(BMPR2):c.1220A>C (p.Tyr407Ser)	BMPR2	Y407S	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425895	2	203397399	2	202532676	425895	414262	rs1085307314	NC_000002.12:202532675:A:C
NM_001204.7(BMPR2):c.1156G>C (p.Glu386Gln)	BMPR2	E386Q	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425884	2	203397335	2	202532612	425884	414252	rs1085307306	NC_000002.12:202532611:G:C
NM_001204.7(BMPR2):c.1129-1_1129dup	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425879	2	203397306 - 203397307	2	202532583 - 202532584	425879	414431	rs1085307302	NC_000002.12:202532583:GG:GGGG
NM_001204.7(BMPR2):c.1126G>T (p.Glu376Ter)	BMPR2	E376*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425876	2	203395675	2	202530952	425876	414245	rs1085307301	NC_000002.12:202530951:G:T
NM_001204.7(BMPR2):c.1120del (p.Ala373_Ile374insTer)	BMPR2		Pulmonary venoocclusive disease 1, autosomal dominant	Pathogenic	no assertion criteria provided	VCV000425875	2	203395669	2	202530946	425875	414244	rs1085307300	NC_000002.12:202530945:A:
NM_001204.7(BMPR2):c.1060del (p.Leu354fs)	BMPR2	L354fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425867	2	203395609	2	202530886	425867	414236	rs1085307292	NC_000002.12:202530885:C:
NM_001204.7(BMPR2):c.1011_1015del (p.Arg337fs)	BMPR2	R337fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425862	2	203395559 - 203395563	2	202530836 - 202530840	425862	414231	rs1085307287	NC_000002.12:202530835:GAAATG:G
NM_001204.7(BMPR2):c.968-3C>G	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425852	2	203395514	2	202530791	425852	414224	rs1085307280	NC_000002.12:202530790:C:G
NM_001204.7(BMPR2):c.967+2T>C	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425848	2	203384926	2	202520203	425848	414220	rs1085307277	NC_000002.12:202520202:T:C
NM_001204.7(BMPR2):c.961del (p.Arg321fs)	BMPR2	R321fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425847	2	203384918	2	202520195	425847	414219	rs1085307276	NC_000002.12:202520194:C:
NM_001204.7(BMPR2):c.894_895dup (p.Val299fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425841	2	203384849 - 203384850	2	202520126 - 202520127	425841	414213	rs1085307272	NC_000002.12:202520126:GGG:GGGGG
NM_001204.7(BMPR2):c.893G>A (p.Trp298Ter)	BMPR2	W298*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425840	2	203384850	2	202520127	425840	414212	rs1085307271	NC_000002.12:202520126:G:A
NM_001204.7(BMPR2):c.872T>G (p.Leu291Ter)	BMPR2	L291*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425838	2	203384829	2	202520106	425838	414210	rs1085307269	NC_000002.12:202520105:T:G
NM_001204.7(BMPR2):c.795_796delinsTT (p.Glu265_Arg266delinsAspTer)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425825	2	203383718 - 203383719	2	202518995 - 202518996	425825	414198	rs1085307260	NC_000002.12:202518994:GA:TT
NM_001204.7(BMPR2):c.673_679del (p.Arg225fs)	BMPR2	R225fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425813	2	203383594 - 203383600	2	202518871 - 202518877	425813	414186	rs1085307250	NC_000002.12:202518870:AGCGTCCAG:AG
NM_001204.7(BMPR2):c.642T>G (p.Tyr214Ter)	BMPR2	Y214*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425810	2	203383565	2	202518842	425810	414183	rs1085307247	NC_000002.12:202518841:T:G
NM_001204.7(BMPR2):c.556A>G (p.Met186Val)	BMPR2	M186V	Pulmonary arterial hypertension associated with congenital heart disease	Pathogenic	no assertion criteria provided	VCV000425805	2	203379637	2	202514914	425805	414180	rs1085307244	NC_000002.12:202514913:A:G
NM_001204.6(BMPR2):c.530-?_621+?del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425801					425801	414058		
NM_001204.7(BMPR2):c.482T>A (p.Leu161Ter)	BMPR2	L161*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425794	2	203378505	2	202513782	425794	414172	rs1085307235	NC_000002.12:202513781:T:A
NM_001204.7(BMPR2):c.435del (p.Phe145fs)	BMPR2	F145fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425791	2	203378456	2	202513733	425791	414169	rs1085307233	NC_000002.12:202513732:TTT:TT
NM_001204.6(BMPR2):c.419-?_1413+?del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425788					425788	414057		
NM_001204.6(BMPR2):c.419-?_967+?del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425786					425786	414055		
NM_001204.6(BMPR2):c.419-?_529+?del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425784					425784	414053		
NM_001204.7(BMPR2):c.353del (p.Cys118fs)	BMPR2	C118fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425769	2	203332347	2	202467624	425769	414154	rs1085307217	NC_000002.12:202467623:G:
NM_001204.7(BMPR2):c.345_346del (p.Phe115fs)	BMPR2	F115fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425764	2	203332338 - 203332339	2	202467615 - 202467616	425764	414149	rs1085307213	NC_000002.12:202467614:TCT:T
NM_001204.7(BMPR2):c.339_340insAA (p.Arg114fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425763	2	203332333 - 203332334	2	202467610 - 202467611	425763	414148	rs1085307212	NC_000002.12:202467610::AA
NM_001204.7(BMPR2):c.319T>C (p.Ser107Pro)	BMPR2	S107P	Pulmonary arterial hypertension associated with congenital heart disease	Pathogenic	no assertion criteria provided	VCV000425757	2	203332313	2	202467590	425757	414142	rs1085307207	NC_000002.12:202467589:T:C
NM_001204.7(BMPR2):c.304A>G (p.Thr102Ala)	BMPR2	T102A	Pulmonary arterial hypertension associated with congenital heart disease	Pathogenic	no assertion criteria provided	VCV000425756	2	203332298	2	202467575	425756	414141	rs1085307206	NC_000002.12:202467574:A:G
NM_001204.6(BMPR2):c.248-?_418+?dup	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425740					425740	414052		
NM_001204.7(BMPR2):c.246dup (p.Gly83fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425728	2	203329699 - 203329700	2	202464976 - 202464977	425728	414115	rs1085307186	NC_000002.12:202464976:AA:AAA
NM_001204.7(BMPR2):c.246A>C (p.Gln82His)	BMPR2	Q82H	Pulmonary hypertension, primary, dexfenfluramine-associated	Pathogenic	no assertion criteria provided	VCV000425727	2	203329701	2	202464978	425727	414114	rs1085307185	NC_000002.12:202464977:A:C
NM_001204.7(BMPR2):c.236_238delinsAAAAGGGGACA (p.Leu79fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425723	2	203329691 - 203329693	2	202464968 - 202464970	425723	414111	rs1085307181	NC_000002.12:202464967:TTG:AAAAGGGGACA
NM_001204.7(BMPR2):c.196T>G (p.Cys66Gly)	BMPR2	C66G	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425717	2	203329651	2	202464928	425717	414105	rs1085307175	NC_000002.12:202464927:T:G
NM_001204.7(BMPR2):c.178T>C (p.Cys60Arg)	BMPR2	C60R	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425710	2	203329633	2	202464910	425710	414098	rs1085307171	NC_000002.12:202464909:T:C
NM_001204.7(BMPR2):c.140G>A (p.Gly47Asp)	BMPR2	G47D	Pulmonary arterial hypertension associated with congenital heart disease	Pathogenic	no assertion criteria provided	VCV000425707	2	203329595	2	202464872	425707	414095	rs1085307168	NC_000002.12:202464871:G:A
NM_001204.7(BMPR2):c.125A>G (p.Gln42Arg)	BMPR2	Q42R	Pulmonary arterial hypertension associated with congenital heart disease	Pathogenic	no assertion criteria provided	VCV000425706	2	203329580	2	202464857	425706	414094	rs1085307167	NC_000002.12:202464856:A:G
NM_001204.7(BMPR2):c.82C>T (p.Gln28Ter)	BMPR2	Q28*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425699	2	203329537	2	202464814	425699	414087	rs1085307160	NC_000002.12:202464813:C:T
NM_001204.6(BMPR2):c.77-?_1276+?del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425697					425697	414050		
NM_001204.6(BMPR2):c.77-?_621+?del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425695					425695	414048		
NM_001204.7(BMPR2):c.77-1G>A	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425692	2	203329531	2	202464808	425692	414086	rs1085307159	NC_000002.12:202464807:G:A
NM_001204.7(BMPR2):c.76+2T>C	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425689	2	203242275	2	202377552	425689	414083	rs1085307156	NC_000002.12:202377551:T:C
NM_001204.7(BMPR2):c.76+1G>T	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425688	2	203242274	2	202377551	425688	414082	rs1085307155	NC_000002.12:202377550:G:T
NM_001204.7(BMPR2):c.9dup (p.Ser4fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425676	2	203242204 - 203242205	2	202377481 - 202377482	425676	414071	rs1085307145	NC_000002.12:202377481:CC:CCC
NM_001204.6(BMPR2):c.(?_-540)_(*1_?)del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425670	2	203241658 - 203424670	2	202376935 - 202559947	425670	414040		
NM_001204.7(BMPR2):c.1125_1128+16del	BMPR2		Primary pulmonary hypertension	Pathogenic(Last reviewed: Nov 19, 2015)	criteria provided, single submitter	VCV000238628	2	203395674 - 203395693	2	202530951 - 202530970	238628	238597	rs878854272	NC_000002.12:202530950:CGAGGTGAGTGTATACAAAA:
NM_001204.7(BMPR2):c.1426_1450del (p.Leu476fs)	BMPR2	L476fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000212813	2	203417451 - 203417475	2	202552728 - 202552752	212813	209590	rs863223422	NC_000002.12:202552727:CTCAAGGAGACAATCGAAGACTGTT:
BMPR2, EX1-13DEL	BMPR2		Primary pulmonary hypertension	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000008818					8818	23857		
BMPR2, EX10DEL	BMPR2		Primary pulmonary hypertension	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000008817					8817	23856		
NM_001204.7(BMPR2):c.367T>A (p.Cys123Ser)	BMPR2	C123S	Primary pulmonary hypertension	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000008809	2	203332361	2	202467638	8809	23848	rs137852750	NC_000002.12:202467637:T:A
BMPR2, 2-BP DEL, 1-BP INS, NT690	BMPR2		Primary pulmonary hypertension	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000008807					8807	23846		
BMPR2, 5-BP DEL, NT1099	BMPR2		Primary pulmonary hypertension	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000008803					8803	23842		
NM_000092.4(COL4A4):c.2690G>A (p.Gly897Glu)	COL4A4	G897E	not provided|Benign familial hematuria|Alport syndrome, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017406	2	227920687	2	227055971	17406	32445	rs121912860	NC_000002.12:227055970:C:T
NC_000002.12:g.(?_202514864)_(202514989_?)del	BMPR2		Primary pulmonary hypertension	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000833519	2	203379587 - 203379712			833519	819101		
NM_001204.7(BMPR2):c.2945A>G (p.Lys982Arg)	BMPR2	K982R	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000426008	2	203424497	2	202559774	426008	414371	rs1085307403	NC_000002.12:202559773:A:G
NM_001204.7(BMPR2):c.2752C>T (p.Gln918Ter)	BMPR2	Q918*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000426006	2	203421140	2	202556417	426006	414369	rs1085307401	NC_000002.12:202556416:C:T
NM_001204.7(BMPR2):c.2668del (p.Arg890fs)	BMPR2	R890fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000426002	2	203421056	2	202556333	426002	414365	rs1085307399	NC_000002.12:202556332:A:
NM_001204.7(BMPR2):c.2620G>T (p.Glu874Ter)	BMPR2	E874*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000426000	2	203421008	2	202556285	426000	414363	rs1085307397	NC_000002.12:202556284:G:T
NM_001204.7(BMPR2):c.2609del (p.Leu870fs)	BMPR2	L870fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425998	2	203420995	2	202556272	425998	414361	rs1085307396	NC_000002.12:202556271:TTT:TT
NM_001204.7(BMPR2):c.2588G>A (p.Ser863Asn)	BMPR2	S863N	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425997	2	203420976	2	202556253	425997	414360	rs1006246556	NC_000002.12:202556252:G:A
NM_001204.7(BMPR2):c.2519_2520CA[3] (p.Arg842fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425993	2	203420905 - 203420906	2	202556182 - 202556183	425993	414356	rs1085307392	NC_000002.12:202556182:ACACA:ACACACA
NM_001204.7(BMPR2):c.2506_2522del (p.Thr835_Thr836insTer)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425992	2	203420891 - 203420907	2	202556168 - 202556184	425992	414355	rs1085307391	NC_000002.12:202556167:ACAACCAACATAGTGACACA:ACA
NM_001204.7(BMPR2):c.2504del (p.Thr835fs)	BMPR2	T835fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425991	2	203420892	2	202556169	425991	414354	rs1085307390	NC_000002.12:202556168:C:
NM_001204.7(BMPR2):c.2444_2445GT[3] (p.Asn817fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425987	2	203420831 - 203420832	2	202556108 - 202556109	425987	414350	rs1085307386	NC_000002.12:202556108:GTGT:GTGTGT
NM_001204.7(BMPR2):c.2440_2441CA[1] (p.His814fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425986	2	203420828 - 203420829	2	202556105 - 202556106	425986	414349	rs1085307385	NC_000002.12:202556104:CACA:CA
NM_001204.7(BMPR2):c.2413dup (p.Thr805fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425985	2	203420800 - 203420801	2	202556077 - 202556078	425985	414348	rs1085307384	NC_000002.12:202556077:A:AA
NM_001204.7(BMPR2):c.2410_2413del (p.Val804fs)	BMPR2	V804fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425984	2	203420796 - 203420799	2	202556073 - 202556076	425984	414347	rs1085307383	NC_000002.12:202556072:CAGTCA:CA
NM_001204.7(BMPR2):c.2407_2408insTG (p.Thr803fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425983	2	203420795 - 203420796	2	202556072 - 202556073	425983	414346	rs1085307382	NC_000002.12:202556072::TG
NM_001204.7(BMPR2):c.2386del (p.Ala796fs)	BMPR2	A796fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425982	2	203420774	2	202556051	425982	414345	rs1085307381	NC_000002.12:202556050:G:
NM_001204.7(BMPR2):c.2297del (p.Thr766fs)	BMPR2	T766fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425979	2	203420685	2	202555962	425979	414342	rs1085307378	NC_000002.12:202555961:C:
NM_001204.7(BMPR2):c.2291dup (p.Asn764fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425977	2	203420674 - 203420675	2	202555951 - 202555952	425977	414340	rs1085307377	NC_000002.12:202555951:AAAAA:AAAAAA
NM_001204.7(BMPR2):c.2286del (p.Asn764fs)	BMPR2	N764fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425976	2	203420673	2	202555950	425976	414339	rs1085307376	NC_000002.12:202555949:CC:C
NM_001204.7(BMPR2):c.2124C>G (p.Tyr708Ter)	BMPR2	Y708*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425974	2	203420512	2	202555789	425974	414337	rs1085307374	NC_000002.12:202555788:C:G
NM_001204.7(BMPR2):c.2009del (p.Pro670fs)	BMPR2	P670fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425973	2	203420395	2	202555672	425973	414336	rs1085307373	NC_000002.12:202555671:CCC:CC
NM_001204.7(BMPR2):c.1978G>T (p.Glu660Ter)	BMPR2	E660*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425971	2	203420366	2	202555643	425971	414334	rs1085307372	NC_000002.12:202555642:G:T
NM_001204.7(BMPR2):c.1771C>T (p.Arg591Ter)	BMPR2	R591*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425967	2	203420159	2	202555436	425967	414330	rs777458559	NC_000002.12:202555435:C:T
NM_001204.7(BMPR2):c.1687G>A (p.Val563Met)	BMPR2	V563M	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425964	2	203420075	2	202555352	425964	414327	rs557172581	NC_000002.12:202555351:G:A
NM_001204.7(BMPR2):c.1585del (p.Arg529fs)	BMPR2	R529fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425960	2	203417610	2	202552887	425960	414323	rs1085307366	NC_000002.12:202552886:C:
NM_001204.7(BMPR2):c.1557T>A (p.Asn519Lys)	BMPR2	N519K	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425959	2	203417582	2	202552859	425959	414322	rs1085307365	NC_000002.12:202552858:T:A
NM_001204.7(BMPR2):c.1535A>C (p.Lys512Thr)	BMPR2	K512T	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425958	2	203417560	2	202552837	425958	414321	rs1085307364	NC_000002.12:202552836:A:C
NM_001204.7(BMPR2):c.1525G>T (p.Glu509Ter)	BMPR2	E509*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425957	2	203417550	2	202552827	425957	414320	rs1085307363	NC_000002.12:202552826:G:T
NM_001204.7(BMPR2):c.1523G>A (p.Trp508Ter)	BMPR2	W508*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425956	2	203417548	2	202552825	425956	414319	rs780722371	NC_000002.12:202552824:G:A
NM_001204.7(BMPR2):c.1427del (p.Leu476fs)	BMPR2	L476fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425944	2	203417452	2	202552729	425944	414307	rs1085307353	NC_000002.12:202552728:T:
NM_001204.7(BMPR2):c.1414-2A>T	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425940	2	203417437	2	202552714	425940	414305	rs1085307351	NC_000002.12:202552713:A:T
NM_001204.7(BMPR2):c.1389dup (p.Glu464fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425933	2	203407145 - 203407146	2	202542422 - 202542423	425933	414298	rs1085307344	NC_000002.12:202542422:A:AA
NM_001204.7(BMPR2):c.1387_1388insA (p.Pro463fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425932	2	203407144 - 203407145	2	202542421 - 202542422	425932	414297	rs1085307343	NC_000002.12:202542421::A
NM_001204.7(BMPR2):c.1366delinsCA (p.Glu456fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425928	2	203407123	2	202542400	425928	414293	rs1085307339	NC_000002.12:202542399:G:CA
NM_001204.7(BMPR2):c.1346T>G (p.Met449Arg)	BMPR2	M449R	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425926	2	203407103	2	202542380	425926	414291	rs1085307338	NC_000002.12:202542379:T:G
NM_001204.7(BMPR2):c.1296C>G (p.Tyr432Ter)	BMPR2	Y432*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425924	2	203407053	2	202542330	425924	414289	rs1085307336	NC_000002.12:202542329:C:G
NM_001204.6(BMPR2):c.1277-289_1413+4737del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425915	2	203406745 - 203411907	2	202542022 - 202547184	425915	414282		
NM_001204.7(BMPR2):c.1276+4A>G	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425914	2	203397459	2	202532736	425914	414281	rs1085307330	NC_000002.12:202532735:A:G
NM_001204.7(BMPR2):c.1276+3A>T	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425913	2	203397458	2	202532735	425913	414280	rs1085307329	NC_000002.12:202532734:A:T
NM_001204.7(BMPR2):c.1276+3A>G	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425912	2	203397458	2	202532735	425912	414279	rs1085307329	NC_000002.12:202532734:A:G
NM_001204.7(BMPR2):c.1274dup (p.Gly426fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425910	2	203397450 - 203397451	2	202532727 - 202532728	425910	414277	rs1085307328	NC_000002.12:202532727:CCC:CCCC
NM_001204.7(BMPR2):c.1271_1276delinsCGGAGA (p.Phe424_Gly426delinsSerGluArg)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425909	2	203397450 - 203397455	2	202532727 - 202532732	425909	414276	rs1085307327	NC_000002.12:202532726:TCCCAG:CGGAGA
NM_001204.7(BMPR2):c.1257A>T (p.Arg419Ser)	BMPR2	R419S	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425905	2	203397436	2	202532713	425905	414272	rs1085307323	NC_000002.12:202532712:A:T
NM_001204.7(BMPR2):c.1250_1253del (p.Ile416_Phe417insTer)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425904	2	203397426 - 203397429	2	202532703 - 202532706	425904	414271	rs1085307322	NC_000002.12:202532702:TATTTAT:TAT
NM_001204.7(BMPR2):c.1247_1250delinsGA (p.Ile416fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425902	2	203397426 - 203397429	2	202532703 - 202532706	425902	414269	rs1085307320	NC_000002.12:202532702:TATT:GA
NM_001204.7(BMPR2):c.1246_1247insG (p.Ile416fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425901	2	203397425 - 203397426	2	202532702 - 202532703	425901	414268	rs1085307319	NC_000002.12:202532702::G
NM_001204.7(BMPR2):c.1243G>T (p.Glu415Ter)	BMPR2	E415*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425899	2	203397422	2	202532699	425899	414266	rs1085307318	NC_000002.12:202532698:G:T
NM_001204.7(BMPR2):c.1241G>A (p.Trp414Ter)	BMPR2	W414*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425898	2	203397420	2	202532697	425898	414265	rs1085307317	NC_000002.12:202532696:G:A
NM_001204.7(BMPR2):c.1228G>A (p.Gly410Arg)	BMPR2	G410R	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425897	2	203397407	2	202532684	425897	414264	rs1085307316	NC_000002.12:202532683:G:A
NM_001204.7(BMPR2):c.1214del (p.Asp405fs)	BMPR2	D405fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425894	2	203397393	2	202532670	425894	414261	rs1085307313	NC_000002.12:202532669:A:
NM_001204.7(BMPR2):c.1196C>G (p.Ser399Ter)	BMPR2	S399*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425891	2	203397375	2	202532652	425891	414258	rs1085307311	NC_000002.12:202532651:C:G
NM_001204.7(BMPR2):c.1171G>A (p.Ala391Thr)	BMPR2	A391T	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425888	2	203397350	2	202532627	425888	414256	rs1085307308	NC_000002.12:202532626:G:A
NM_001204.7(BMPR2):c.1157A>T (p.Glu386Val)	BMPR2	E386V	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425887	2	203397336	2	202532613	425887	414255	rs1085307307	NC_000002.12:202532612:A:T
NM_001204.7(BMPR2):c.1157A>G (p.Glu386Gly)	BMPR2	E386G	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425886	2	203397336	2	202532613	425886	414254	rs1085307307	NC_000002.12:202532612:A:G
NM_001204.7(BMPR2):c.1157A>C (p.Glu386Ala)	BMPR2	E386A	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425885	2	203397336	2	202532613	425885	414253	rs1085307307	NC_000002.12:202532612:A:C
NM_001204.7(BMPR2):c.1156G>A (p.Glu386Lys)	BMPR2	E386K	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425883	2	203397335	2	202532612	425883	414251	rs1085307306	NC_000002.12:202532611:G:A
NM_001204.7(BMPR2):c.1151C>T (p.Ala384Val)	BMPR2	A384V	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425882	2	203397330	2	202532607	425882	414250	rs1085307305	NC_000002.12:202532606:C:T
NM_001204.7(BMPR2):c.1146T>G (p.Tyr382Ter)	BMPR2	Y382*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425881	2	203397325	2	202532602	425881	414249	rs1085307304	NC_000002.12:202532601:T:G
NM_001204.7(BMPR2):c.1141dup (p.Arg381fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425880	2	203397319 - 203397320	2	202532596 - 202532597	425880	414248	rs1085307303	NC_000002.12:202532596:A:AA
NM_001204.7(BMPR2):c.1093_1098delinsG (p.Arg365fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425870	2	203395642 - 203395647	2	202530919 - 202530924	425870	414239	rs1085307295	NC_000002.12:202530918:CGCCCA:G
NM_001204.7(BMPR2):c.1076del (p.Thr359fs)	BMPR2	T359fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425869	2	203395625	2	202530902	425869	414238	rs1085307294	NC_000002.12:202530901:C:
NM_001204.7(BMPR2):c.1044del (p.Ile349fs)	BMPR2	I349fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425866	2	203395592	2	202530869	425866	414235	rs1085307291	NC_000002.12:202530868:TT:T
NM_001204.7(BMPR2):c.1001T>G (p.Leu334Ter)	BMPR2	L334*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425861	2	203395550	2	202530827	425861	414230	rs1085307286	NC_000002.12:202530826:T:G
NM_001204.7(BMPR2):c.980del (p.Pro327fs)	BMPR2	P327fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425859	2	203395528	2	202530805	425859	414228	rs1085307284	NC_000002.12:202530804:CC:C
NM_001204.6(BMPR2):c.968-?_1413+?dup	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425857					425857	414065		
NM_001204.6(BMPR2):c.968-?_1276+?del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425856					425856	414064		
NM_001204.7(BMPR2):c.968-2A>C	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425853	2	203395515	2	202530792	425853	414225	rs1085307281	NC_000002.12:202530791:A:C
NM_001204.7(BMPR2):c.967+5G>T	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425851	2	203384929	2	202520206	425851	414223	rs1085307279	NC_000002.12:202520205:G:T
NM_001204.7(BMPR2):c.967+5G>C	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425850	2	203384929	2	202520206	425850	414222	rs1085307279	NC_000002.12:202520205:G:C
NM_001204.7(BMPR2):c.937G>C (p.Ala313Pro)	BMPR2	A313P	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425845	2	203384894	2	202520171	425845	414217	rs1085307275	NC_000002.12:202520170:G:C
NM_001204.7(BMPR2):c.932G>A (p.Gly311Glu)	BMPR2	G311E	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425844	2	203384889	2	202520166	425844	414216	rs1085307274	NC_000002.12:202520165:G:A
NM_001204.7(BMPR2):c.928A>T (p.Arg310Ter)	BMPR2	R310*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425843	2	203384885	2	202520162	425843	414215	rs1085307273	NC_000002.12:202520161:A:T
NM_001204.7(BMPR2):c.908G>A (p.Arg303His)	BMPR2	R303H	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425842	2	203384865	2	202520142	425842	414214	rs200948870	NC_000002.12:202520141:G:A
NM_001204.7(BMPR2):c.872del (p.Tyr290_Leu291insTer)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425839	2	203384827	2	202520104	425839	414211	rs1085307270	NC_000002.12:202520103:TTT:TT
NM_001204.7(BMPR2):c.855del (p.Ser286fs)	BMPR2	S286fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425836	2	203384812	2	202520089	425836	414208	rs1085307268	NC_000002.12:202520088:A:
NM_001204.6(BMPR2):c.853-?_967+?dup	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425835					425835	414062		
NM_001204.7(BMPR2):c.853-1G>C	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425834	2	203384809	2	202520086	425834	414207	rs1085307267	NC_000002.12:202520085:G:C
NM_001204.7(BMPR2):c.852+1G>C	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425832	2	203383776	2	202519053	425832	414205	rs1085307266	NC_000002.12:202519052:G:C
NM_001204.7(BMPR2):c.852+1G>A	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425831	2	203383776	2	202519053	425831	414204	rs1085307266	NC_000002.12:202519052:G:A
NM_001204.7(BMPR2):c.804del (p.Ala269fs)	BMPR2	A269fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425828	2	203383727	2	202519004	425828	414201	rs1085307263	NC_000002.12:202519003:T:
NM_001204.7(BMPR2):c.802dup (p.Thr268fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425827	2	203383724 - 203383725	2	202519001 - 202519002	425827	414200	rs1085307262	NC_000002.12:202519001:A:AA
NM_001204.7(BMPR2):c.794A>G (p.Glu265Gly)	BMPR2	E265G	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425824	2	203383717	2	202518994	425824	414197	rs1085307259	NC_000002.12:202518993:A:G
NM_001204.7(BMPR2):c.790del (p.Asp264fs)	BMPR2	D264fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425823	2	203383713	2	202518990	425823	414196	rs1085307258	NC_000002.12:202518989:G:
NM_001204.7(BMPR2):c.786dup (p.Gly263fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425822	2	203383707 - 203383708	2	202518984 - 202518985	425822	414195	rs1085307257	NC_000002.12:202518984:TT:TTT
NM_001204.7(BMPR2):c.780_781TA[1] (p.Ile261fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425821	2	203383703 - 203383704	2	202518980 - 202518981	425821	414194	rs1085307256	NC_000002.12:202518979:TATA:TA
NM_001204.7(BMPR2):c.775del (p.Arg259fs)	BMPR2	R259fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425820	2	203383696	2	202518973	425820	414193	rs1085307255	NC_000002.12:202518972:CCC:CC
NM_001204.7(BMPR2):c.727G>C (p.Glu243Gln)	BMPR2	E243Q	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425818	2	203383650	2	202518927	425818	414191	rs1085307254	NC_000002.12:202518926:G:C
NM_001204.7(BMPR2):c.727G>A (p.Glu243Lys)	BMPR2	E243K	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425817	2	203383650	2	202518927	425817	414190	rs1085307254	NC_000002.12:202518926:G:A
NM_001204.7(BMPR2):c.690A>T (p.Lys230Asn)	BMPR2	K230N	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425815	2	203383613	2	202518890	425815	414188	rs1085307252	NC_000002.12:202518889:A:T
NM_001204.7(BMPR2):c.689_690del (p.Lys230fs)	BMPR2	K230fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425814	2	203383610 - 203383611	2	202518887 - 202518888	425814	414187	rs1085307251	NC_000002.12:202518886:AAAA:AA
NM_001204.7(BMPR2):c.664_665delinsAAGG (p.Leu222fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425812	2	203383587 - 203383588	2	202518864 - 202518865	425812	414185	rs1085307249	NC_000002.12:202518863:TT:AAGG
NM_001204.6(BMPR2):c.622-?_967+?del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425809					425809	414061		
NM_001204.6(BMPR2):c.622-?_852+?del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425808					425808	414060		
NM_001204.7(BMPR2):c.608_609del (p.Leu203fs)	BMPR2	L203fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425806	2	203379689 - 203379690	2	202514966 - 202514967	425806	414181	rs1085307245	NC_000002.12:202514965:TG:
NM_001204.7(BMPR2):c.551_573del (p.His184fs)	BMPR2	H184fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425804	2	203379632 - 203379654	2	202514909 - 202514931	425804	414179	rs1085307243	NC_000002.12:202514908:ACAGTATGAACATGATGGAGGCA:
NM_001204.6(BMPR2):c.530-?_967+?del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425802					425802	414059		
NM_001204.7(BMPR2):c.529+2T>C	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425800	2	203378554	2	202513831	425800	414177	rs1085307241	NC_000002.12:202513830:T:C
NM_001204.7(BMPR2):c.528del (p.Gly177fs)	BMPR2	G177fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425799	2	203378551	2	202513828	425799	414176	rs1085307240	NC_000002.12:202513827:A:
NM_001204.7(BMPR2):c.516C>G (p.Tyr172Ter)	BMPR2	Y172*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425798	2	203378539	2	202513816	425798	414175	rs1085307239	NC_000002.12:202513815:C:G
NM_001204.7(BMPR2):c.507_510delinsAAA (p.Cys169_Phe170delinsTer)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425797	2	203378530 - 203378533	2	202513807 - 202513810	425797	414430	rs1085307238	NC_000002.12:202513806:CTTT:AAA
NM_001204.7(BMPR2):c.503dup (p.Leu168fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425796	2	203378524 - 203378525	2	202513801 - 202513802	425796	414174	rs1085307237	NC_000002.12:202513801:TT:TTT
NM_001204.7(BMPR2):c.420_421insG (p.Pro141fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425790	2	203378443 - 203378444	2	202513720 - 202513721	425790	414168	rs1085307232	NC_000002.12:202513720::G
NM_001204.6(BMPR2):c.(418+1_419-1)_(*1_?)del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425789	2	203332413 - 203424670	2	202467690 - 202559947	425789	414037		
NM_001204.6(BMPR2):c.419-?_1128+?dup	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425787					425787	414056		
NM_001204.7(BMPR2):c.419-10T>C	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425783	2	203378432	2	202513709	425783	414167	rs1085307231	NC_000002.12:202513708:T:C
NM_001204.7(BMPR2):c.418+5_418+8del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425782	2	203332412 - 203332415	2	202467689 - 202467692	425782	414166	rs1085307230	NC_000002.12:202467688:AGTAAGTAA:AGTAA
NM_001204.7(BMPR2):c.418+2_418+4delinsGAG	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425779	2	203332414 - 203332416	2	202467691 - 202467693	425779	414163	rs1085307227	NC_000002.12:202467690:TAA:GAG
NM_001204.7(BMPR2):c.418+1G>C	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425778	2	203332413	2	202467690	425778	414162	rs1085307226	NC_000002.12:202467689:G:C
NM_001204.7(BMPR2):c.405_406CA[1] (p.Thr136fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425776	2	203332398 - 203332399	2	202467675 - 202467676	425776	414160	rs1085307224	NC_000002.12:202467674:ACACA:ACA
NM_001204.7(BMPR2):c.370A>G (p.Asn124Asp)	BMPR2	N124D	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425773	2	203332364	2	202467641	425773	414157	rs1085307221	NC_000002.12:202467640:A:G
NM_001204.7(BMPR2):c.357_358CA[1] (p.Thr120fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425772	2	203332351 - 203332352	2	202467628 - 202467629	425772	414156	rs1085307220	NC_000002.12:202467627:CACA:CA
NM_001204.7(BMPR2):c.354_355delinsAG (p.Cys118_Ser119delinsTer)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425770	2	203332348 - 203332349	2	202467625 - 202467626	425770	414429	rs1085307218	NC_000002.12:202467624:TA:AG
NM_001204.7(BMPR2):c.350G>C (p.Cys117Ser)	BMPR2	C117S	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425767	2	203332344	2	202467621	425767	414152	rs1085307215	NC_000002.12:202467620:G:C
NM_001204.7(BMPR2):c.349T>C (p.Cys117Arg)	BMPR2	C117R	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425765	2	203332343	2	202467620	425765	414150	rs1085307214	NC_000002.12:202467619:T:C
NM_001204.7(BMPR2):c.339C>G (p.Tyr113Ter)	BMPR2	Y113*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425762	2	203332333	2	202467610	425762	414147	rs1085307211	NC_000002.12:202467609:C:G
NM_001204.7(BMPR2):c.338A>G (p.Tyr113Cys)	BMPR2	Y113C	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425759	2	203332332	2	202467609	425759	414144	rs1085307209	NC_000002.12:202467608:A:G
NM_001204.7(BMPR2):c.320C>G (p.Ser107Ter)	BMPR2	S107*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425758	2	203332314	2	202467591	425758	414143	rs1085307208	NC_000002.12:202467590:C:G
NM_001204.7(BMPR2):c.296G>T (p.Cys99Phe)	BMPR2	C99F	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425755	2	203332290	2	202467567	425755	414140	rs1085307205	NC_000002.12:202467566:G:T
NM_001204.7(BMPR2):c.296G>A (p.Cys99Tyr)	BMPR2	C99Y	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425754	2	203332290	2	202467567	425754	414139	rs1085307205	NC_000002.12:202467566:G:A
NM_001204.7(BMPR2):c.292G>T (p.Glu98Ter)	BMPR2	E98*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425753	2	203332286	2	202467563	425753	414138	rs1085307204	NC_000002.12:202467562:G:T
NM_001204.7(BMPR2):c.277dup (p.Glu93fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425749	2	203332270 - 203332271	2	202467547 - 202467548	425749	414134	rs1085307202	NC_000002.12:202467547:G:GG
NM_001204.7(BMPR2):c.260dup (p.His87fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425746	2	203332253 - 203332254	2	202467530 - 202467531	425746	414131	rs1085307199	NC_000002.12:202467530:A:AA
NM_001204.7(BMPR2):c.251G>T (p.Cys84Phe)	BMPR2	C84F	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425744	2	203332245	2	202467522	425744	414129	rs1085307197	NC_000002.12:202467521:G:T
NM_001204.7(BMPR2):c.250T>G (p.Cys84Gly)	BMPR2	C84G	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425743	2	203332244	2	202467521	425743	414128	rs1085307196	NC_000002.12:202467520:T:G
NM_001204.7(BMPR2):c.250T>C (p.Cys84Arg)	BMPR2	C84R	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425742	2	203332244	2	202467521	425742	414127	rs1085307196	NC_000002.12:202467520:T:C
NM_001204.7(BMPR2):c.248G>A (p.Gly83Glu)	BMPR2	G83E	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425741	2	203332242	2	202467519	425741	414126	rs1085307195	NC_000002.12:202467518:G:A
NM_001204.7(BMPR2):c.248-1G>A	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425738	2	203332241	2	202467518	425738	414125	rs1085307194	NC_000002.12:202467517:G:A
NM_001204.7(BMPR2):c.248-3T>G	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425736	2	203332239	2	202467516	425736	414123	rs368090069	NC_000002.12:202467515:T:G
NM_001204.7(BMPR2):c.248-5_248delinsAC	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425735	2	203332237 - 203332242	2	202467514 - 202467519	425735	414122	rs1085307192	NC_000002.12:202467513:TATAGG:AC
NM_001204.7(BMPR2):c.248-592_413delinsGTAAAGTA	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425734	2	203331650 - 203332407	2	202466927 - 202467684	425734	414121	rs1553503473	
NM_001204.7(BMPR2):c.247+6T>G	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425733	2	203329708	2	202464985	425733	414120	rs1085307191	NC_000002.12:202464984:T:G
NM_001204.7(BMPR2):c.247+2del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425732	2	203329704	2	202464981	425732	414119	rs1085307190	NC_000002.12:202464980:C:
NM_001204.7(BMPR2):c.247+1_247+7del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425731	2	203329702 - 203329708	2	202464979 - 202464985	425731	414118	rs1085307189	NC_000002.12:202464978:GGCAAGTG:G
NM_001204.7(BMPR2):c.247G>A (p.Gly83Arg)	BMPR2	G83R	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425729	2	203329702	2	202464979	425729	414116	rs1085307187	NC_000002.12:202464978:G:A
NM_001204.7(BMPR2):c.240_241insT (p.Lys81Ter)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425725	2	203329695 - 203329696	2	202464972 - 202464973	425725	414428	rs1085307183	NC_000002.12:202464972::T
NM_001204.7(BMPR2):c.237del (p.Leu79_Val80insTer)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425724	2	203329691	2	202464968	425724	414112	rs1085307182	NC_000002.12:202464967:TT:T
NM_001204.7(BMPR2):c.200dup (p.Tyr67Ter)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425720	2	203329654 - 203329655	2	202464931 - 202464932	425720	414108	rs1085307178	NC_000002.12:202464931:A:AA
NM_001204.7(BMPR2):c.189_207delinsGGAGCATAATCAAA (p.Ser64fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425714	2	203329644 - 203329662	2	202464921 - 202464939	425714	414102	rs1085307173	NC_000002.12:202464920:TAGCACCTGCTATGGCCTT:GGAGCATAATCAAA
NM_001204.7(BMPR2):c.186_187insTACC (p.Gly63fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425713	2	203329641 - 203329642	2	202464918 - 202464919	425713	414101	rs1553503200	NC_000002.12:202464918::TACC
NM_001204.7(BMPR2):c.179G>A (p.Cys60Tyr)	BMPR2	C60Y	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425712	2	203329634	2	202464911	425712	414100	rs1085307172	NC_000002.12:202464910:G:A
NM_001204.7(BMPR2):c.178T>G (p.Cys60Gly)	BMPR2	C60G	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425711	2	203329633	2	202464910	425711	414099	rs1085307171	NC_000002.12:202464909:T:G
NM_001204.7(BMPR2):c.168del (p.Thr57fs)	BMPR2	T57fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425709	2	203329621	2	202464898	425709	414097	rs1085307170	NC_000002.12:202464897:GGG:GG
NM_001204.7(BMPR2):c.124C>T (p.Gln42Ter)	BMPR2	Q42*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425705	2	203329579	2	202464856	425705	414093	rs1085307166	NC_000002.12:202464855:C:T
NM_001204.7(BMPR2):c.116del (p.Pro39fs)	BMPR2	P39fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425704	2	203329570	2	202464847	425704	414092	rs1085307165	NC_000002.12:202464846:CC:C
NM_001204.7(BMPR2):c.103del (p.Ala35fs)	BMPR2	A35fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425703	2	203329558	2	202464835	425703	414091	rs1085307164	NC_000002.12:202464834:G:
NM_001204.7(BMPR2):c.88C>T (p.Gln30Ter)	BMPR2	Q30*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425700	2	203329543	2	202464820	425700	414088	rs1085307161	NC_000002.12:202464819:C:T
NM_001204.6(BMPR2):c.(76+1_77-1)_(*1_?)del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425698	2	203242274 - 203424670	2	202377551 - 202559947	425698	414036		
NM_001204.6(BMPR2):c.77-?_967+?dup	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425696					425696	414049		
NM_001204.6(BMPR2):c.77-?_418+?dup	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425694					425694	414047		
NM_001204.6(BMPR2):c.77-?_247+?dup	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425693					425693	414046		
NM_001204.7(BMPR2):c.77-35_86del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425691	2	203329496 - 203329540	2	202464773 - 202464817	425691	414085	rs1085307158	NC_000002.12:202464772:AAATAATTTGTCATTCCTTTATTTCCTTTATTTTAGCTTCGCAGAA:A
NM_001204.7(BMPR2):c.71C>A (p.Ala24Glu)	BMPR2	A24E	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425687	2	203242268	2	202377545	425687	414081	rs370120266	NC_000002.12:202377544:C:A
NM_001204.6(BMPR2):c.51_814del (p.I18Hfs*25)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425686	2	203242248 - 203383737	2	202377525 - 202519014	425686	414372		
NM_001204.7(BMPR2):c.39G>A (p.Trp13Ter)	BMPR2	W13*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425683	2	203242236	2	202377513	425683	414078	rs1085307152	NC_000002.12:202377512:G:A
NM_001204.7(BMPR2):c.38G>A (p.Trp13Ter)	BMPR2	W13*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425682	2	203242235	2	202377512	425682	414077	rs1085307151	NC_000002.12:202377511:G:A
NM_001204.7(BMPR2):c.28C>T (p.Arg10Trp)	BMPR2	R10W	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425681	2	203242225	2	202377502	425681	414076	rs1085307150	NC_000002.12:202377501:C:T
NM_001204.7(BMPR2):c.21_29delinsA (p.Pro8fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425679	2	203242218 - 203242226	2	202377495 - 202377503	425679	414073	rs1085307148	NC_000002.12:202377494:GCCCTGGCG:A
NM_001204.7(BMPR2):c.21del (p.Trp9fs)	BMPR2	W9fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425678	2	203242217	2	202377494	425678	414074	rs1085307147	NC_000002.12:202377493:GG:G
NM_001204.7(BMPR2):c.16_20del (p.Gln6fs)	BMPR2	Q6fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425677	2	203242212 - 203242216	2	202377489 - 202377493	425677	414072	rs1085307146	NC_000002.12:202377488:GCAGCG:G
NM_001204.6(BMPR2):c.(?_-1)_(1128+1_1129-1)del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425674	2	203242197 - 203397307	2	202377474 - 202532584	425674	414044		
NM_001204.6(BMPR2):c.(?_-1)_(529+1_530-1)del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425673	2	203242197 - 203379610	2	202377474 - 202514887	425673	414043		
NM_001204.7(BMPR2):c.-947_-946delinsAT	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425668	2	203241251 - 203241252	2	202376528 - 202376529	425668	414070	rs1085307144	NC_000002.12:202376527:GC:AT
NM_001204.7(BMPR2):c.2216del (p.Pro739fs)	BMPR2	P739fs	not specified|Primary pulmonary hypertension	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000650617	2	203420603	2	202555880	650617	629308		NC_000002.12:202555879:CC:C
NM_001204.7(BMPR2):c.2789C>G (p.Ser930Ter)	BMPR2	S930*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000426007	2	203421177	2	202556454	426007	414370	rs1085307402	NC_000002.12:202556453:C:G
NM_001204.7(BMPR2):c.2626C>T (p.Gln876Ter)	BMPR2	Q876*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000426001	2	203421014	2	202556291	426001	414364	rs1085307398	NC_000002.12:202556290:C:T
NM_001204.7(BMPR2):c.2527del (p.Ala843fs)	BMPR2	A843fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425994	2	203420913	2	202556190	425994	414357	rs1085307393	NC_000002.12:202556189:GGG:GG
NM_001204.7(BMPR2):c.2503_2506del (p.Thr835fs)	BMPR2	T835fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425990	2	203420888 - 203420891	2	202556165 - 202556168	425990	414352	rs1085307389	NC_000002.12:202556164:CAAACAA:CAA
NM_001204.7(BMPR2):c.2503dup (p.Thr835fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425989	2	203420888 - 203420889	2	202556165 - 202556166	425989	414353	rs1085307388	NC_000002.12:202556165:AAA:AAAA
NM_001204.7(BMPR2):c.2308del (p.Arg770fs)	BMPR2	R770fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425981	2	203420693	2	202555970	425981	414344	rs1085307380	NC_000002.12:202555969:CCCC:CCC
NM_001204.7(BMPR2):c.2128del (p.Leu710fs)	BMPR2	L710fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425975	2	203420516	2	202555793	425975	414338	rs1085307375	NC_000002.12:202555792:C:
NM_001204.7(BMPR2):c.1968dup (p.Gln657fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425969	2	203420355 - 203420356	2	202555632 - 202555633	425969	414332	rs1085307370	NC_000002.12:202555632:A:AA
NM_001204.7(BMPR2):c.1954_1955dup (p.Val654fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425968	2	203420341 - 203420342	2	202555618 - 202555619	425968	414331	rs1085307369	NC_000002.12:202555618:AC:ACAC
NM_001204.7(BMPR2):c.1483C>T (p.Gln495Ter)	BMPR2	Q495*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425952	2	203417508	2	202552785	425952	414315	rs1085307360	NC_000002.12:202552784:C:T
NM_001204.7(BMPR2):c.1460A>T (p.Asp487Val)	BMPR2	D487V	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425950	2	203417485	2	202552762	425950	414313	rs1085307358	NC_000002.12:202552761:A:T
NM_001204.7(BMPR2):c.1413+3A>T	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425939	2	203407173	2	202542450	425939	414304	rs1085307350	NC_000002.12:202542449:A:T
NM_001204.7(BMPR2):c.1401del (p.Glu468fs)	BMPR2	E468fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425936	2	203407156	2	202542433	425936	414301	rs1085307347	NC_000002.12:202542432:AAA:AA
NM_001204.7(BMPR2):c.1392del (p.Ala465fs)	BMPR2	A465fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425934	2	203407148	2	202542425	425934	414299	rs1085307345	NC_000002.12:202542424:AA:A
NM_001204.7(BMPR2):c.1309_1312CAGA[1] (p.Thr438fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425925	2	203407066 - 203407069	2	202542343 - 202542346	425925	414290	rs1085307337	NC_000002.12:202542342:CAGACAGA:CAGA
NM_001204.6(BMPR2):c.1277-?_1413+?dup	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425920					425920	414067		
NM_001204.7(BMPR2):c.1277-9A>G	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425917	2	203407025	2	202542302	425917	414284	rs1085307331	NC_000002.12:202542301:A:G
NM_001204.7(BMPR2):c.1258T>C (p.Cys420Arg)	BMPR2	C420R	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425906	2	203397437	2	202532714	425906	414273	rs1085307324	NC_000002.12:202532713:T:C
NM_001204.7(BMPR2):c.1221T>G (p.Tyr407Ter)	BMPR2	Y407*	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425896	2	203397400	2	202532677	425896	414263	rs1085307315	NC_000002.12:202532676:T:G
NM_001204.7(BMPR2):c.1189_1190TG[1] (p.Cys397_Glu398delinsTer)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425890	2	203397368 - 203397369	2	202532645 - 202532646	425890	414432	rs1085307310	NC_000002.12:202532644:TGTG:TG
NM_001204.7(BMPR2):c.1175T>C (p.Val392Ala)	BMPR2	V392A	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425889	2	203397354	2	202532631	425889	414257	rs1085307309	NC_000002.12:202532630:T:C
NM_001204.7(BMPR2):c.1113dup (p.Ala372fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425873	2	203395661 - 203395662	2	202530938 - 202530939	425873	414242	rs1085307298	NC_000002.12:202530938:T:TT
NM_001204.7(BMPR2):c.1016T>A (p.Val339Asp)	BMPR2	V339D	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425863	2	203395565	2	202530842	425863	414232	rs1085307288	NC_000002.12:202530841:T:A
NM_001204.7(BMPR2):c.969dup (p.His324fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425858	2	203395517 - 203395518	2	202530794 - 202530795	425858	414227	rs1085307283	NC_000002.12:202530794:T:TT
NM_001204.6(BMPR2):c.968-?_1128+?del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425855					425855	414063		
NM_001204.7(BMPR2):c.968-1G>T	BMPR2		Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425854	2	203395516	2	202530793	425854	414226	rs1085307282	NC_000002.12:202530792:G:T
NM_001204.7(BMPR2):c.853-1G>A	BMPR2		Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic/Likely pathogenic	no assertion criteria provided	VCV000425833	2	203384809	2	202520086	425833	414206	rs1085307267	NC_000002.12:202520085:G:A
NM_001204.7(BMPR2):c.830T>C (p.Leu277Pro)	BMPR2	L277P	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425830	2	203383753	2	202519030	425830	414203	rs1085307265	NC_000002.12:202519029:T:C
NM_001204.7(BMPR2):c.541C>T (p.Gln181Ter)	BMPR2	Q181*	not provided|Primary pulmonary hypertension	Pathogenic(Last reviewed: Aug 31, 2015)	criteria provided, single submitter	VCV000425803	2	203379622	2	202514899	425803	414178	rs1085307242	NC_000002.12:202514898:C:T
NM_001204.7(BMPR2):c.498del (p.Ala167fs)	BMPR2	A167fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425795	2	203378520	2	202513797	425795	414173	rs1085307236	NC_000002.12:202513796:TT:T
NM_001204.7(BMPR2):c.418+3A>T	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425780	2	203332415	2	202467692	425780	414164	rs1085307228	NC_000002.12:202467691:A:T
NM_001204.7(BMPR2):c.355del (p.Ser119fs)	BMPR2	S119fs	Primary pulmonary hypertension	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000425771	2	203332349	2	202467626	425771	414155	rs1085307219	NC_000002.12:202467625:A:
NM_001204.7(BMPR2):c.339C>A (p.Tyr113Ter)	BMPR2	Y113*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425761	2	203332333	2	202467610	425761	414146	rs1085307211	NC_000002.12:202467609:C:A
NM_001204.7(BMPR2):c.338dup (p.Tyr113Ter)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425760	2	203332331 - 203332332	2	202467608 - 202467609	425760	414145	rs1085307210	NC_000002.12:202467608:A:AA
NM_001204.7(BMPR2):c.280T>G (p.Cys94Gly)	BMPR2	C94G	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425751	2	203332274	2	202467551	425751	414136	rs1085307203	NC_000002.12:202467550:T:G
NM_001204.7(BMPR2):c.274C>T (p.Gln92Ter)	BMPR2	Q92*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425748	2	203332268	2	202467545	425748	414133	rs1085307201	NC_000002.12:202467544:C:T
NM_001204.7(BMPR2):c.255G>A (p.Trp85Ter)	BMPR2	W85*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425745	2	203332249	2	202467526	425745	414130	rs1085307198	NC_000002.12:202467525:G:A
NM_001204.7(BMPR2):c.247+1G>A	BMPR2		Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425730	2	203329703	2	202464980	425730	414117	rs1085307188	NC_000002.12:202464979:G:A
NM_001204.7(BMPR2):c.197G>A (p.Cys66Tyr)	BMPR2	C66Y	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425718	2	203329652	2	202464929	425718	414106	rs1085307176	NC_000002.12:202464928:G:A
NM_001204.7(BMPR2):c.196T>C (p.Cys66Arg)	BMPR2	C66R	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425716	2	203329651	2	202464928	425716	414104	rs1085307175	NC_000002.12:202464927:T:C
NM_001204.7(BMPR2):c.91G>T (p.Glu31Ter)	BMPR2	E31*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425701	2	203329546	2	202464823	425701	414089	rs1085307162	NC_000002.12:202464822:G:T
NM_001204.7(BMPR2):c.47G>A (p.Trp16Ter)	BMPR2	W16*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425684	2	203242244	2	202377521	425684	414079	rs1085307153	NC_000002.12:202377520:G:A
NM_001204.6(BMPR2):c.(?_-1)_(*1_?)del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425675	2	203242197 - 203424670	2	202377474 - 202559947	425675	414045		
NM_001204.6(BMPR2):c.(?_-1)_(418+1_419-1)del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425672	2	203242197 - 203378441	2	202377474 - 202513718	425672	414042		
NM_001204.6(BMPR2):c.(?_-540)_(76+1_77-1)del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425669	2	203241658 - 203329531	2	202376935 - 202464808	425669	414039		
NM_001204.7(BMPR2):c.1789C>T (p.Arg597Ter)	BMPR2	R597*	not provided|Primary pulmonary hypertension	Pathogenic(Last reviewed: Jun 15, 2016)	criteria provided, single submitter	VCV000265619	2	203420177	2	202555454	265619	259717	rs886039673	NC_000002.12:202555453:C:T
NM_001204.7(BMPR2):c.16C>T (p.Gln6Ter)	BMPR2	Q6*	Primary pulmonary hypertension	Pathogenic(Last reviewed: Jul 11, 2016)	no assertion criteria provided	VCV000264650	2	203242213	2	202377490	264650	259244	rs886039219	NC_000002.12:202377489:C:T
NM_001204.7(BMPR2):c.1454A>G (p.Asp485Gly)	BMPR2	D485G	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000008801	2	203417479	2	202552756	8801	23840	rs137852745	NC_000002.12:202552755:A:G
NM_001204.7(BMPR2):c.354T>G (p.Cys118Trp)	BMPR2	C118W	Primary pulmonary hypertension	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000008799	2	203332348	2	202467625	8799	23838	rs137852743	NC_000002.12:202467624:T:G
NM_001204.7(BMPR2):c.218C>G (p.Ser73Ter)	BMPR2	S73*	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000008797	2	203329673	2	202464950	8797	23836	rs137852742	NC_000002.12:202464949:C:G
NM_001204.7(BMPR2):c.2708A>G (p.Asn903Ser)	BMPR2	N903S	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic/Likely pathogenic	no assertion criteria provided	VCV000426003	2	203421096	2	202556373	426003	414366	rs373725296	NC_000002.12:202556372:A:G
NM_001204.7(BMPR2):c.1487G>A (p.Cys496Tyr)	BMPR2	C496Y	not specified|Primary pulmonary hypertension	Pathogenic(Last reviewed: Aug 12, 2016)	criteria provided, single submitter	VCV000425954	2	203417512	2	202552789	425954	414317	rs1085307362	NC_000002.12:202552788:G:A
NM_001204.6(BMPR2):c.(1413+1_1414-1)_(*1_?)del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425942	2	203407171 - 203424670	2	202542448 - 202559947	425942	414038		
NM_001204.7(BMPR2):c.1371dup (p.Gln458fs)	BMPR2		Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425930	2	203407123 - 203407124	2	202542400 - 202542401	425930	414295	rs1085307340	NC_000002.12:202542400:AAAAA:AAAAAA
NM_001204.7(BMPR2):c.1348C>T (p.Gln450Ter)	BMPR2	Q450*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425927	2	203407105	2	202542382	425927	414292	rs868369541	NC_000002.12:202542381:C:T
NM_001204.7(BMPR2):c.1248del (p.Phe417fs)	BMPR2	F417fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425903	2	203397427	2	202532704	425903	414270	rs1085307321	NC_000002.12:202532703:A:
NM_001204.7(BMPR2):c.1243_1244GA[3] (p.Ile416fs)	BMPR2		Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425900	2	203397421 - 203397422	2	202532698 - 202532699	425900	414267	rs1553509997	NC_000002.12:202532698:GAGA:GAGAGA
NM_001204.7(BMPR2):c.1202T>C (p.Leu401Ser)	BMPR2	L401S	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic/Likely pathogenic	no assertion criteria provided	VCV000425892	2	203397381	2	202532658	425892	414259	rs1085307312	NC_000002.12:202532657:T:C
NM_001204.7(BMPR2):c.1128+1G>T	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425877	2	203395678	2	202530955	425877	414246	rs863223420	NC_000002.12:202530954:G:T
NM_001204.7(BMPR2):c.1101_1105del (p.Glu368fs)	BMPR2	E368fs	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425872	2	203395647 - 203395651	2	202530924 - 202530928	425872	414241	rs1085307297	NC_000002.12:202530923:AGGGGAGG:AGG
NM_001204.7(BMPR2):c.1097del (p.Pro366fs)	BMPR2	P366fs	not provided|Primary pulmonary hypertension	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000425871	2	203395644	2	202530921	425871	414240	rs1085307296	NC_000002.12:202530920:CCC:CC
NM_001204.7(BMPR2):c.1039T>C (p.Cys347Arg)	BMPR2	C347R	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425865	2	203395588	2	202530865	425865	414234	rs1085307290	NC_000002.12:202530864:T:C
NM_001204.7(BMPR2):c.1019T>C (p.Leu340Pro)	BMPR2	L340P	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425864	2	203395568	2	202530845	425864	414233	rs1085307289	NC_000002.12:202530844:T:C
NM_001204.7(BMPR2):c.992A>G (p.His331Arg)	BMPR2	H331R	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425860	2	203395541	2	202530818	425860	414229	rs1085307285	NC_000002.12:202530817:A:G
NM_001204.7(BMPR2):c.967+4del	BMPR2		Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425849	2	203384927	2	202520204	425849	414221	rs1085307278	NC_000002.12:202520203:AA:A
NM_001204.7(BMPR2):c.860T>A (p.Leu287Ter)	BMPR2	L287*	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425837	2	203384817	2	202520094	425837	414209	rs576091247	NC_000002.12:202520093:T:A
NM_001204.7(BMPR2):c.794_795AG[1] (p.Arg266fs)	BMPR2		Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425826	2	203383716 - 203383719	2	202518993 - 202518996	425826	414199	rs1085307261	NC_000002.12:202518992:GAGAGAG:GAG
NM_001204.7(BMPR2):c.727G>T (p.Glu243Ter)	BMPR2	E243*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425819	2	203383650	2	202518927	425819	414192	rs1085307254	NC_000002.12:202518926:G:T
NM_001204.7(BMPR2):c.690_691delinsT (p.Lys230fs)	BMPR2		Primary pulmonary hypertension	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000425816	2	203383613 - 203383614	2	202518890 - 202518891	425816	414189	rs1085307253	NC_000002.12:202518889:AG:T
NM_001204.7(BMPR2):c.659dup (p.Ser221fs)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425811	2	203383580 - 203383581	2	202518857 - 202518858	425811	414184	rs1085307248	NC_000002.12:202518857:GG:GGG
NM_001204.7(BMPR2):c.612del (p.Lys204fs)	BMPR2	K204fs	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425807	2	203379691	2	202514968	425807	414182	rs1085307246	NC_000002.12:202514967:AAA:AA
NM_001204.7(BMPR2):c.449dup (p.Ile151fs)	BMPR2		Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425792	2	203378471 - 203378472	2	202513748 - 202513749	425792	414170	rs1085307234	NC_000002.12:202513748:C:CC
NM_001204.6(BMPR2):c.419-?_621+?del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425785					425785	414054		
NM_001204.7(BMPR2):c.408_412del (p.Pro138fs)	BMPR2	P138fs	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425777	2	203332398 - 203332402	2	202467675 - 202467679	425777	414161	rs1085307225	NC_000002.12:202467674:ACACAACAC:ACAC
NM_001204.7(BMPR2):c.399del (p.Pro134fs)	BMPR2	P134fs	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425775	2	203332393	2	202467670	425775	414159	rs1085307223	NC_000002.12:202467669:T:
NM_001204.7(BMPR2):c.371dup (p.Asn124fs)	BMPR2		Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425774	2	203332363 - 203332364	2	202467640 - 202467641	425774	414158	rs1085307222	NC_000002.12:202467640:AA:AAA
NM_001204.7(BMPR2):c.280T>C (p.Cys94Arg)	BMPR2	C94R	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425750	2	203332274	2	202467551	425750	414135	rs1085307203	NC_000002.12:202467550:T:C
NM_001204.6(BMPR2):c.248-?_418+?del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425739					425739	414051		
NM_001204.7(BMPR2):c.189_209del (p.Ser64_Trp70del)	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425715	2	203329643 - 203329663	2	202464920 - 202464940	425715	414103	rs1085307174	NC_000002.12:202464919:GTAGCACCTGCTATGGCCTTTG:G
NM_001204.7(BMPR2):c.152_153TC[2] (p.Ser52_His53insTer)	BMPR2		Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425708	2	203329607 - 203329608	2	202464884 - 202464885	425708	414096	rs1085307169	NC_000002.12:202464883:TCTCTC:TCTC
NM_001204.7(BMPR2):c.100T>C (p.Cys34Arg)	BMPR2	C34R	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425702	2	203329555	2	202464832	425702	414090	rs1085307163	NC_000002.12:202464831:T:C
NM_001204.7(BMPR2):c.76+5G>A	BMPR2		Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic/Likely pathogenic	no assertion criteria provided	VCV000425690	2	203242278	2	202377555	425690	414084	rs1085307157	NC_000002.12:202377554:G:A
NM_001204.6(BMPR2):c.(?_-1)_(76+1_77-1)del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425671	2	203242197 - 203329531	2	202377474 - 202464808	425671	414041		
NM_001204.7(BMPR2):c.1469C>T (p.Ala490Val)	BMPR2	A490V	Primary pulmonary hypertension	Pathogenic(Last reviewed: Jul 11, 2016)	no assertion criteria provided	VCV000264653	2	203417494	2	202552771	264653	259248	rs886039222	NC_000002.12:202552770:C:T
NM_001204.7(BMPR2):c.2696G>C (p.Arg899Pro)	BMPR2	R899P	Primary pulmonary hypertension	Pathogenic(Last reviewed: Aug 1, 2005)	no assertion criteria provided	VCV000008811	2	203421084	2	202556361	8811	23850	rs137852752	NC_000002.12:202556360:G:C
NM_001204.7(BMPR2):c.1040G>A (p.Cys347Tyr)	BMPR2	C347Y	Primary pulmonary hypertension	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000008800	2	203395589	2	202530866	8800	23839	rs137852744	NC_000002.12:202530865:G:A
NM_006912.6(RIT1):c.284G>C (p.Gly95Ala)	RIT1	G95A, G112A, G59A	Noonan syndrome|Noonan syndrome 8|not provided	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000060509	1	155874247	1	155904456	60509	75096	rs672601335	NC_000001.11:155904455:C:G
NM_006912.6(RIT1):c.170C>G (p.Ala57Gly)	RIT1	A57G, A74G, A21G	Noonan syndrome|Noonan syndrome 1|Noonan syndrome 8|not provided	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000060506	1	155874589	1	155904798	60506	75093	rs672601334	NC_000001.11:155904797:G:C
NM_001204.7(BMPR2):c.1424C>A (p.Ser475Ter)	BMPR2	S475*	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425943	2	203417449	2	202552726	425943	414306	rs1085307352	NC_000002.12:202552725:C:A
NM_001204.6(BMPR2):c.1414-?_2866+?del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425941					425941	414068		
NM_001204.7(BMPR2):c.1413+1G>A	BMPR2		Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425938	2	203407171	2	202542448	425938	414303	rs1085307349	NC_000002.12:202542447:G:A
NM_001204.7(BMPR2):c.1397G>A (p.Trp466Ter)	BMPR2	W466*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425935	2	203407154	2	202542431	425935	414300	rs1085307346	NC_000002.12:202542430:G:A
NM_001204.7(BMPR2):c.1374_1375GA[1] (p.Arg459fs)	BMPR2		not specified|Primary pulmonary hypertension	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000425931	2	203407130 - 203407131	2	202542407 - 202542408	425931	414296	rs1085307342	NC_000002.12:202542406:AGAGA:AGA
NM_001204.7(BMPR2):c.1207C>T (p.Gln403Ter)	BMPR2	Q403*	Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425893	2	203397386	2	202532663	425893	414260	rs946132834	NC_000002.12:202532662:C:T
NM_001204.7(BMPR2):c.418+5G>A	BMPR2		Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic/Likely pathogenic	no assertion criteria provided	VCV000425781	2	203332417	2	202467694	425781	414165	rs1085307229	NC_000002.12:202467693:G:A
NM_001204.7(BMPR2):c.350G>A (p.Cys117Tyr)	BMPR2	C117Y	not specified|Primary pulmonary hypertension	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000425766	2	203332344	2	202467621	425766	414151	rs1085307215	NC_000002.12:202467620:G:A
NM_001204.7(BMPR2):c.203G>A (p.Gly68Asp)	BMPR2	G68D	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425722	2	203329658	2	202464935	425722	414110	rs1085307180	NC_000002.12:202464934:G:A
NM_001204.7(BMPR2):c.201T>G (p.Tyr67Ter)	BMPR2	Y67*	Primary pulmonary hypertension	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000425721	2	203329656	2	202464933	425721	414109	rs1085307179	NC_000002.12:202464932:T:G
NM_001204.7(BMPR2):c.27G>A (p.Trp9Ter)	BMPR2	W9*	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425680	2	203242224	2	202377501	425680	414075	rs1085307149	NC_000002.12:202377500:G:A
NM_001204.6(BMPR2):c.77-?_418+?del	BMPR2		Primary pulmonary hypertension	Pathogenic(Last reviewed: Jul 26, 2016)	criteria provided, single submitter	VCV000417478	2	203329532 - 203332412	2	202464809 - 202467689	417478	391465		
NM_001204.7(BMPR2):c.44del (p.Pro15fs)	BMPR2	P15fs	Pulmonary venoocclusive disease 1|Primary pulmonary hypertension	Pathogenic(Last reviewed: Mar 15, 2003)	no assertion criteria provided	VCV000008814	2	203242240	2	202377517	8814	23853	rs483352902	NC_000002.12:202377516:CC:C
NM_001204.7(BMPR2):c.507C>A (p.Cys169Ter)	BMPR2	C169*	Primary pulmonary hypertension	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000008804	2	203378530	2	202513807	8804	23843	rs137852747	NC_000002.12:202513806:C:A
NM_194248.3(OTOF):c.2485C>T (p.Gln829Ter)	OTOF	Q829*, Q139*, Q82*	Deafness, autosomal recessive 9|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Jun 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000006137	2	26700078	2	26477210	6137	21176	rs80356593	NC_000002.12:26477209:G:A
GRCh37/hg19 1p21.2(chr1:100302513-100319101)x1	AGL		not provided	Pathogenic(Last reviewed: Aug 31, 2017)	no assertion criteria provided	VCV000685074	1	100302513 - 100319101			685074	672666		
NM_000642.3(AGL):c.2158-1G>A	AGL		not provided	Pathogenic(Last reviewed: Jun 10, 2016)	criteria provided, single submitter	VCV000288730	1	100347096	1	99881540	288730	272967	rs886043990	NC_000001.11:99881539:G:A
NM_000642.3(AGL):c.1996_1999delinsT (p.His666_Gln667delinsTer)	AGL		not provided	Pathogenic(Last reviewed: Sep 14, 2016)	criteria provided, single submitter	VCV000280882	1	100346728 - 100346731	1	99881172 - 99881175	280882	264030	rs886042008	NC_000001.11:99881171:CATC:T
NM_000642.3(AGL):c.1485del (p.Arg494_Tyr495insTer)	AGL		not provided	Pathogenic(Last reviewed: Jun 13, 2014)	criteria provided, single submitter	VCV000194005	1	100343258	1	99877702	194005	191168	rs794727051	NC_000001.11:99877701:T:
NM_000028.2(AGL):c.1999del (p.Gln667fs)	AGL	Q651fs, Q667fs	Glycogen storage disease IIIb	Pathogenic(Last reviewed: Jul 31, 2000)	no assertion criteria provided	VCV000001104	1	100346731	1	99881175	1104	16143	rs387906246	NC_000001.11:99881174:C:
AGL, EcoRI FRAGMENT INS	AGL		Glycogen storage disease IIIa	Pathogenic(Last reviewed: Jul 16, 1996)	no assertion criteria provided	VCV000001101					1101	16140		
NM_000642.3(AGL):c.3637C>T (p.Gln1213Ter)	AGL	Q1197*, Q1213*	Glycogen storage disease type III	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801527	1	100368287	1	99902731	801527	790027		NC_000001.11:99902730:C:T
NM_000642.3(AGL):c.3492C>G (p.Tyr1164Ter)	AGL	Y1148*, Y1164*	Glycogen storage disease type III	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801525	1	100366321	1	99900765	801525	790025		NC_000001.11:99900764:C:G
NM_000642.3(AGL):c.2083C>T (p.Gln695Ter)	AGL	Q679*, Q695*	Glycogen storage disease type III	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801524	1	100346929	1	99881373	801524	790024		NC_000001.11:99881372:C:T
NM_000642.3(AGL):c.576T>G (p.Tyr192Ter)	AGL	Y176*, Y192*	Glycogen storage disease type III	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801521	1	100330057	1	99864501	801521	790021		NC_000001.11:99864500:T:G
NM_000642.3(AGL):c.1083-2A>G	AGL		Glycogen storage disease IIIa	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000635292	1	100340708	1	99875152	635292	623173		NC_000001.11:99875151:A:G
NM_000642.3(AGL):c.3837-1G>A	AGL		Glycogen storage disease IIIa	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635291	1	100377960	1	99912404	635291	623175		NC_000001.11:99912403:G:A
NM_000642.3(AGL):c.2950-2A>G	AGL		Glycogen storage disease IIIa	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635290	1	100357160	1	99891604	635290	623174		NC_000001.11:99891603:A:G
NM_000642.3(AGL):c.378T>A (p.Cys126Ter)	AGL	C126*, C110*	Glycogen storage disease type III	Pathogenic(Last reviewed: Dec 7, 2017)	no assertion criteria provided	VCV000522549	1	100327897	1	99862341	522549	513017	rs1553183359	NC_000001.11:99862340:T:A
NM_000642.3(AGL):c.3836+1G>A	AGL		Glycogen storage disease type III	Pathogenic(Last reviewed: Jun 2, 2015)	no assertion criteria provided	VCV000374346	1	100376404	1	99910848	374346	361161	rs780883601	NC_000001.11:99910847:G:A
NM_000642.3(AGL):c.3439A>G (p.Arg1147Gly)	AGL	R1147G, R1131G	Glycogen storage disease IIIc	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000001107	1	100366268	1	99900712	1107	16146	rs267606639	NC_000001.11:99900711:A:G
NM_000642.3(AGL):c.4342G>C (p.Gly1448Arg)	AGL	G1448R, G1432R	Glycogen storage disease IIIa	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000001102	1	100382048	1	99916492	1102	16141	rs118203964	NC_000001.11:99916491:G:C
NM_000642.3(AGL):c.4087A>T (p.Lys1363Ter)	AGL	K1347*, K1363*	Glycogen storage disease type III	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000855438	1	100379220	1	99913664	855438	824604		NC_000001.11:99913663:A:T
NM_000642.3(AGL):c.158del (p.Pro53fs)	AGL	P37fs, P53fs	Glycogen storage disease type III	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000854913	1	100327133	1	99861577	854913	824570		NC_000001.11:99861576:CC:C
NM_000642.3(AGL):c.2905dup (p.Tyr969fs)	AGL		Glycogen storage disease type III	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000835381	1	100356867 - 100356868	1	99891311 - 99891312	835381	824593		NC_000001.11:99891311:T:TT
NC_000001.11:g.(?_99910692)_(99910867_?)del	AGL		Glycogen storage disease type III	Pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, single submitter	VCV000832911	1	100376248 - 100376423			832911	819011		
NC_000001.11:g.(?_99892422)_(99892617_?)del	AGL		Glycogen storage disease type III	Pathogenic(Last reviewed: Sep 14, 2019)	criteria provided, single submitter	VCV000832558	1	100357978 - 100358173			832558	819010		
NC_000001.11:g.(?_99862247)_(99862433_?)del	AGL		Glycogen storage disease type III	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000830644	1	100327803 - 100327989			830644	819009		
NM_000642.3(AGL):c.3481_3589-405del	AGL		Glycogen storage disease type III	Pathogenic	criteria provided, single submitter	VCV000813333	1	100366308 - 100367832	1	99900752 - 99902276	813333	801601		
NM_000642.3(AGL):c.1565del (p.Gly522fs)	AGL	G506fs, G522fs	Glycogen storage disease type III	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000662810	1	100343336	1	99877780	662810	628316		NC_000001.11:99877779:GGG:GG
NC_000001.10:g.(?_100376248)_(100379314_?)del	AGL		Glycogen storage disease type III	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000662279	1	100376248 - 100379314	1	99910692 - 99913758	662279	650598		
NM_000642.3(AGL):c.2727C>G (p.Tyr909Ter)	AGL	Y893*, Y909*	Glycogen storage disease type III	Pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000661921	1	100353579	1	99888023	661921	628337		NC_000001.11:99888022:C:G
NM_000642.3(AGL):c.3179C>G (p.Ser1060Ter)	AGL	S1060*, S1044*	Glycogen storage disease type III	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000661058	1	100358083	1	99892527	661058	628341		NC_000001.11:99892526:C:G
NM_000642.3(AGL):c.1180G>T (p.Glu394Ter)	AGL	E378*, E394*	Glycogen storage disease type III	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000660008	1	100340807	1	99875251	660008	628313		NC_000001.11:99875250:G:T
NC_000001.10:g.(?_100368219)_(100368370_?)del	AGL		Glycogen storage disease type III	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000653523	1	100368219 - 100368370	1	99902663 - 99902814	653523	650549		
NM_000642.3(AGL):c.2384C>A (p.Ser795Ter)	AGL	S779*, S795*	Glycogen storage disease type III	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000648558	1	100349751	1	99884195	648558	628333		NC_000001.11:99884194:C:A
NM_000642.3(AGL):c.609del (p.Lys203fs)	AGL	K187fs, K203fs	Glycogen storage disease type III	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000646363	1	100330086	1	99864530	646363	628308		NC_000001.11:99864529:AAAAA:AAAA
NM_000642.3(AGL):c.861_864del (p.Ile288fs)	AGL	I272fs, I288fs	Glycogen storage disease type III	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000641579	1	100336327 - 100336330	1	99870771 - 99870774	641579	628310		NC_000001.11:99870770:TAATT:T
NM_000642.3(AGL):c.525del (p.Ala176fs)	AGL	A176fs, A160fs	Glycogen storage disease type III	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000640973	1	100330005	1	99864449	640973	628306		NC_000001.11:99864448:TT:T
NM_000642.3(AGL):c.251dup (p.Asn84fs)	AGL		Glycogen storage disease type III	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000574527	1	100327225 - 100327226	1	99861669 - 99861670	574527	558609	rs756175624	NC_000001.11:99861669:AA:AAA
NM_000642.3(AGL):c.4385_4389dup (p.Tyr1464fs)	AGL		Glycogen storage disease type III	Pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, single submitter	VCV000565317	1	100382189 - 100382190	1	99916633 - 99916634	565317	557412	rs1557794150	NC_000001.11:99916633:AAATTA:AAATTAAATTA
NM_000642.3(AGL):c.2457_2460del (p.Gln820fs)	AGL	Q820fs, Q804fs	Glycogen storage disease type III	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551333	1	100349916 - 100349919	1	99884360 - 99884363	551333	541441	rs1553187237	NC_000001.11:99884359:AAACAA:AA
NM_000642.3(AGL):c.1614C>G (p.Tyr538Ter)	AGL	Y538*, Y522*	Glycogen storage disease type III	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000526587	1	100345481	1	99879925	526587	516261	rs1188310172	NC_000001.11:99879924:C:G
NM_000642.3(AGL):c.1226_1229TGGC[1] (p.Gly411fs)	AGL		Glycogen storage disease type III	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000526580	1	100340953 - 100340956	1	99875397 - 99875400	526580	516134	rs1553185474	NC_000001.11:99875396:CTGGCTGGC:CTGGC
NM_000642.3(AGL):c.967C>T (p.Arg323Ter)	AGL	R323*, R307*	Glycogen storage disease type III	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000526570	1	100340251	1	99874695	526570	516161	rs757987101	NC_000001.11:99874694:C:T
NM_000642.3(AGL):c.939del (p.Phe313fs)	AGL	F313fs, F297fs	Glycogen storage disease type III	Pathogenic(Last reviewed: Jan 10, 2020)	criteria provided, single submitter	VCV000526569	1	100336404	1	99870848	526569	516110	rs760589837	NC_000001.11:99870847:TTT:TT
NM_000642.3(AGL):c.1437C>A (p.Tyr479Ter)	AGL	Y479*, Y463*	Glycogen storage disease type III	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, single submitter	VCV000526564	1	100343210	1	99877654	526564	516164	rs140095668	NC_000001.11:99877653:C:A
NM_000642.3(AGL):c.3202_3203TA[1] (p.Tyr1068_Arg1069delinsTer)	AGL		Glycogen storage disease type III	Pathogenic(Last reviewed: May 10, 2017)	criteria provided, single submitter	VCV000456486	1	100358106 - 100358107	1	99892550 - 99892551	456486	448441	rs1553188832	NC_000001.11:99892549:TATA:TA
NC_000001.10:g.(?_100366308)_(100367832_?)del	AGL		Glycogen storage disease type III	Pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, single submitter	VCV000456446	1	100366308 - 100367832			456446	446966		
NM_000642.3(AGL):c.4353G>T (p.Trp1451Cys)	AGL	W1451C, W1435C	Glycogen storage disease type III	Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000374339	1	100382159	1	99916603	374339	361162	rs775685508	NC_000001.11:99916602:G:T
NM_000642.3(AGL):c.2681+1G>T	AGL		Glycogen storage disease type III	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, single submitter	VCV000371344	1	100350260	1	99884704	371344	357212	rs201201443	NC_000001.11:99884703:G:T
NM_000642.3(AGL):c.595C>T (p.Gln199Ter)	AGL	Q183*, Q199*	Glycogen storage disease type III	Pathogenic(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000862529	1	100330076	1	99864520	862529	824573		NC_000001.11:99864519:C:T
NM_000642.3(AGL):c.2155C>T (p.Gln719Ter)	AGL	Q703*, Q719*	Glycogen storage disease type III	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000856946	1	100347001	1	99881445	856946	824586		NC_000001.11:99881444:C:T
NM_000642.3(AGL):c.3481_3589-407del	AGL		Glycogen storage disease type III	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804334	1	100366310 - 100367832	1	99900754 - 99902276	804334	792678		
NM_000642.3(AGL):c.2717_2721del (p.Gln906fs)	AGL	Q906fs, Q890fs	Glycogen storage disease type III	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000558529	1	100353566 - 100353570	1	99888010 - 99888014	558529	541452	rs1553187957	NC_000001.11:99888009:ATCAGATC:ATC
NM_000642.3(AGL):c.22del (p.Arg8fs)	AGL	R8fs	Glycogen storage disease type III	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557911	1	100316620	1	99851064	557911	541386	rs1215043175	NC_000001.11:99851063:C:
NM_000642.3(AGL):c.2728C>T (p.Arg910Ter)	AGL	R910*, R894*	Glycogen storage disease type III	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000555290	1	100353580	1	99888024	555290	541457	rs773095419	NC_000001.11:99888023:C:T
NM_000642.3(AGL):c.1589C>G (p.Ser530Ter)	AGL	S530*, S514*	Glycogen storage disease type III	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000554746	1	100343362	1	99877806	554746	541442	rs1553185905	NC_000001.11:99877805:C:G
NM_000642.3(AGL):c.958+1G>A	AGL		Glycogen storage disease type III	Pathogenic(Last reviewed: Jan 3, 2017)	criteria provided, single submitter	VCV000550103	1	100336426	1	99870870	550103	541439	rs1553184657	NC_000001.11:99870869:G:A
NM_000642.3(AGL):c.2001+5G>A	AGL		Glycogen storage disease type III	Pathogenic(Last reviewed: Jan 10, 2020)	criteria provided, single submitter	VCV000526568	1	100346738	1	99881182	526568	516148	rs1553186489	NC_000001.11:99881181:G:A
NM_000642.3(AGL):c.1533dup (p.Tyr512fs)	AGL		Glycogen storage disease type III	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000526563	1	100343300 - 100343301	1	99877744 - 99877745	526563	516121	rs776733170	NC_000001.11:99877744:AAAAAA:AAAAAAA
NM_000642.3(AGL):c.289C>T (p.Gln97Ter)	AGL	Q97*, Q81*	not provided|Glycogen storage disease type III	Pathogenic(Last reviewed: Sep 28, 2016)	criteria provided, single submitter	VCV000497124	1	100327265	1	99861709	497124	488548	rs1553183220	NC_000001.11:99861708:C:T
NM_000642.3(AGL):c.276del (p.Gln92fs)	AGL	Q92fs, Q76fs	Glycogen storage disease type III	Pathogenic(Last reviewed: Sep 13, 2016)	criteria provided, single submitter	VCV000371401	1	100327252	1	99861696	371401	357191	rs1057517243	NC_000001.11:99861695:G:
NM_000642.3(AGL):c.3011del (p.Pro1004fs)	AGL	P988fs, P1004fs	Glycogen storage disease type III	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370197	1	100357221	1	99891665	370197	357215	rs1057516306	NC_000001.11:99891664:CCC:CC
NM_000642.3(AGL):c.535_538del (p.Leu179fs)	AGL	L163fs, L179fs	not provided|Glycogen storage disease type III	Pathogenic(Last reviewed: Mar 12, 2015)	criteria provided, single submitter	VCV000197686	1	100330014 - 100330017	1	99864458 - 99864461	197686	194847	rs794727706	NC_000001.11:99864457:AGTTAG:AG
NM_000642.3(AGL):c.3444C>A (p.Tyr1148Ter)	AGL	Y1148*, Y1132*	Glycogen storage disease type III	Pathogenic(Last reviewed: Oct 22, 2019)	criteria provided, single submitter	VCV000655389	1	100366273	1	99900717	655389	628345		NC_000001.11:99900716:C:A
NM_000642.3(AGL):c.1783C>T (p.Arg595Ter)	AGL	R579*, R595*	Glycogen storage disease type III	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000650313	1	100346235	1	99880679	650313	628321		NC_000001.11:99880678:C:T
NM_000642.3(AGL):c.4221del (p.Lys1407fs)	AGL	K1391fs, K1407fs	Glycogen storage disease type III	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633033	1	100380997	1	99915441	633033	621093	rs786204655	NC_000001.11:99915440:AAAAAAAA:AAAAAAA
NM_000642.3(AGL):c.2670del (p.Pro891fs)	AGL	P875fs, P891fs	Glycogen storage disease type III|not provided	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000546284	1	100350247	1	99884691	546284	536600	rs764591009	NC_000001.11:99884690:TT:T
NM_000642.3(AGL):c.4347+1G>A	AGL		Glycogen storage disease type III	Pathogenic(Last reviewed: Jul 7, 2017)	criteria provided, single submitter	VCV000456505	1	100382054	1	99916498	456505	448520	rs1553193463	NC_000001.11:99916497:G:A
NM_000642.3(AGL):c.1102del (p.Glu368fs)	AGL	E352fs, E368fs	not provided|Glycogen storage disease type III	Pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	VCV000456447	1	100340729	1	99875173	456447	448491	rs1553185403	NC_000001.11:99875172:G:
NM_000642.3(AGL):c.4322_4323dup (p.Gly1442fs)	AGL		not provided|Glycogen storage disease type III	Pathogenic/Likely pathogenic(Last reviewed: Nov 23, 2016)	criteria provided, multiple submitters, no conflicts	VCV000371085	1	100382026 - 100382027	1	99916470 - 99916471	371085	357224	rs1057516994	NC_000001.11:99916470:AAA:AAAAA
NM_000642.3(AGL):c.3554del (p.Thr1185fs)	AGL	T1185fs, T1169fs	Glycogen storage disease type III	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370894	1	100366383	1	99900827	370894	357219	rs764318570	NC_000001.11:99900826:C:
NM_000642.3(AGL):c.4221dup (p.Leu1408fs)	AGL		Glycogen storage disease type III	Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189052	1	100380996 - 100380997	1	99915440 - 99915441	189052	186647	rs786204655	NC_000001.11:99915440:AAAAAAAA:AAAAAAAAA
NC_000002.12:g.(?_202467509)_(202467699_?)del	BMPR2		Primary pulmonary hypertension	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000830694	2	203332232 - 203332422			830694	819099		
NM_001204.7(BMPR2):c.1750C>T (p.Arg584Ter)	BMPR2	R584*	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425965	2	203420138	2	202555415	425965	414328	rs765887545	NC_000002.12:202555414:C:T
NM_001204.6(BMPR2):c.1277-?_1413+?del	BMPR2		Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425919					425919	414066		
NM_001204.7(BMPR2):c.244C>T (p.Gln82Ter)	BMPR2	Q82*	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425726	2	203329699	2	202464976	425726	414113	rs1085307184	NC_000002.12:202464975:C:T
NM_001204.7(BMPR2):c.1128+1G>C	BMPR2		not provided|Primary pulmonary hypertension	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280837	2	203395678	2	202530955	280837	264060	rs863223420	NC_000002.12:202530954:G:C
NM_001204.7(BMPR2):c.295T>C (p.Cys99Arg)	BMPR2	C99R	Primary pulmonary hypertension|not provided	Pathogenic(Last reviewed: Oct 9, 2014)	criteria provided, single submitter	VCV000212816	2	203332289	2	202467566	212816	209584	rs863223425	NC_000002.12:202467565:T:C
NM_001204.7(BMPR2):c.1297C>T (p.Gln433Ter)	BMPR2	Q433*	Primary pulmonary hypertension|Pulmonary hypertension, primary, 1, with hereditary hemorrhagic telangiectasia	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000008819	2	203407054	2	202542331	8819	23858	rs137852756	NC_000002.12:202542330:C:T
NM_018136.5(ASPM):c.1409_1411delinsTT (p.Pro470fs)	ASPM		not provided	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000818033	1	197111971 - 197111973	1	197142841 - 197142843	818033	805194		NC_000001.11:197142840:TAG:AA
NM_018136.5(ASPM):c.1235_1239del (p.Lys412fs)	ASPM	K412fs	not provided	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000817084	1	197112143 - 197112147	1	197143013 - 197143017	817084	805195		NC_000001.11:197143012:TACTTTAC:TAC
NM_018136.5(ASPM):c.6545_6548del (p.Val2182fs)	ASPM	V2182fs	not provided	Pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, single submitter	VCV000817073	1	197071833 - 197071836	1	197102703 - 197102706	817073	805191		NC_000001.11:197102702:CTAACT:CT
NM_018136.5(ASPM):c.1892_1893GA[2] (p.Lys633fs)	ASPM		not provided	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000817060	1	197111485 - 197111486	1	197142355 - 197142356	817060	805193		NC_000001.11:197142354:TCTCTCT:TCTCT
NM_018136.5(ASPM):c.3229A>T (p.Lys1077Ter)	ASPM	K1077*	not provided	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000620375	1	197093401	1	197124271	620375	611501	rs139317695	NC_000001.11:197124270:T:A
NM_018136.5(ASPM):c.6624C>A (p.Tyr2208Ter)	ASPM	Y2208*	not provided	Pathogenic(Last reviewed: Jul 11, 2018)	criteria provided, single submitter	VCV000620265	1	197071757	1	197102627	620265	611500	rs1226333994	NC_000001.11:197102626:G:T
NM_018136.5(ASPM):c.6082C>T (p.Gln2028Ter)	ASPM	Q2028*	not provided	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000523814	1	197072299	1	197103169	523814	514419	rs1553223496	NC_000001.11:197103168:G:A
NM_018136.5(ASPM):c.523_524dup (p.Asn176fs)	ASPM		not provided	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000504325	1	197112857 - 197112858	1	197143727 - 197143728	504325	495065	rs1553228009	NC_000001.11:197143727:ACA:ACACA
NM_018136.5(ASPM):c.9961C>T (p.Gln3321Ter)	ASPM	Q3321*, Q1736*	not provided	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000489306	1	197059083	1	197089953	489306	481574	rs1482100822	NC_000001.11:197089952:G:A
NM_018136.5(ASPM):c.8987+1G>A	ASPM		not provided	Pathogenic(Last reviewed: Aug 11, 2016)	criteria provided, single submitter	VCV000448986	1	197065127	1	197095997	448986	442685	rs1553326840	NC_000001.11:197095996:C:T
NM_018136.5(ASPM):c.1697C>A (p.Ser566Ter)	ASPM	S566*	not provided	Pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000432552	1	197111685	1	197142555	432552	425327	rs555866170	NC_000001.11:197142554:G:T
NM_018136.5(ASPM):c.7783_7786del (p.Lys2595fs)	ASPM	K2595fs	not provided	Pathogenic(Last reviewed: Apr 17, 2017)	criteria provided, single submitter	VCV000426428	1	197070595 - 197070598	1	197101465 - 197101468	426428	414749	rs763800571	NC_000001.11:197101464:CTTTCT:CT
NM_018136.5(ASPM):c.5101_5102insG (p.Leu1701fs)	ASPM		not provided	Pathogenic(Last reviewed: Feb 24, 2016)	criteria provided, single submitter	VCV000419191	1	197073279 - 197073280	1	197104149 - 197104150	419191	404997	rs1064793707	NC_000001.11:197104149::C
NM_018136.5(ASPM):c.2409G>A (p.Trp803Ter)	ASPM	W803*	not provided	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000373176	1	197102490	1	197133360	373176	359283	rs1057518269	NC_000001.11:197133359:C:T
NM_018136.5(ASPM):c.1726_1727del (p.Lys576fs)	ASPM	K576fs	not provided	Pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, single submitter	VCV000373175	1	197111655 - 197111656	1	197142525 - 197142526	373175	359212	rs1057518268	NC_000001.11:197142524:TTT:T
NM_018136.5(ASPM):c.8829G>A (p.Trp2943Ter)	ASPM	W2943*, W1358*	not provided	Pathogenic(Last reviewed: Jan 28, 2016)	criteria provided, single submitter	VCV000285908	1	197065286	1	197096156	285908	270145	rs886043249	NC_000001.11:197096155:C:T
NM_018136.5(ASPM):c.3428dup (p.Leu1144fs)	ASPM		not provided	Pathogenic(Last reviewed: Apr 25, 2016)	criteria provided, single submitter	VCV000280533	1	197091687 - 197091688	1	197122557 - 197122558	280533	263964	rs886041721	NC_000001.11:197122557:A:AA
NM_018136.5(ASPM):c.2922T>A (p.Cys974Ter)	ASPM	C974*	not provided	Pathogenic(Last reviewed: Apr 25, 2016)	criteria provided, single submitter	VCV000280532	1	197097634	1	197128504	280532	263986	rs886041720	NC_000001.11:197128503:A:T
NM_018136.5(ASPM):c.5681_5685del (p.Ile1894fs)	ASPM	I1894fs	not provided	Pathogenic(Last reviewed: Feb 24, 2016)	criteria provided, single submitter	VCV000279957	1	197072696 - 197072700	1	197103566 - 197103570	279957	263999	rs886041282	NC_000001.11:197103565:TCTAATCT:TCT
NM_018136.5(ASPM):c.1353dup (p.Glu452Ter)	ASPM		not provided	Pathogenic(Last reviewed: Apr 26, 2016)	criteria provided, single submitter	VCV000279693	1	197112028 - 197112029	1	197142898 - 197142899	279693	263968	rs774814318	NC_000001.11:197142898:AAAAA:AAAAAA
NM_018136.5(ASPM):c.2770G>T (p.Glu924Ter)	ASPM	E924*	not provided	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000234778	1	197097786	1	197128656	234778	231466	rs749462358	NC_000001.11:197128655:C:A
NM_018136.5(ASPM):c.4732C>T (p.Arg1578Ter)	ASPM	R1578*	not provided	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000234718	1	197073649	1	197104519	234718	231455	rs753406334	NC_000001.11:197104518:G:A
NM_018136.5(ASPM):c.8599del (p.Gln2867fs)	ASPM	Q2867fs	not provided	Pathogenic(Last reviewed: Dec 15, 2015)	criteria provided, single submitter	VCV000234674	1	197069782	1	197100652	234674	231449	rs876661154	NC_000001.11:197100651:G:
NM_018136.5(ASPM):c.4422G>A (p.Trp1474Ter)	ASPM	W1474*	not provided	Pathogenic(Last reviewed: Dec 15, 2015)	criteria provided, single submitter	VCV000234655	1	197073959	1	197104829	234655	231465	rs147622433	NC_000001.11:197104828:C:T
NM_018136.5(ASPM):c.8124T>G (p.Tyr2708Ter)	ASPM	Y2708*	not provided	Pathogenic(Last reviewed: Apr 24, 2015)	criteria provided, single submitter	VCV000234471	1	197070257	1	197101127	234471	231456	rs876661036	NC_000001.11:197101126:A:C
NM_018136.5(ASPM):c.6183_6184del (p.Lys2062fs)	ASPM	K2062fs	not provided	Pathogenic(Last reviewed: Apr 13, 2015)	criteria provided, single submitter	VCV000234435	1	197072197 - 197072198	1	197103067 - 197103068	234435	231461	rs750664956	NC_000001.11:197103066:TCT:T
NM_018136.5(ASPM):c.9337del (p.Ala3113fs)	ASPM	A1528fs, A3113fs	not provided	Pathogenic(Last reviewed: May 24, 2016)	criteria provided, single submitter	VCV000234261	1	197061144	1	197092014	234261	231452	rs876660961	NC_000001.11:197092013:C:
NM_018136.5(ASPM):c.8043dup (p.Arg2682fs)	ASPM		not provided	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000234259	1	197070337 - 197070338	1	197101207 - 197101208	234259	231457	rs876660960	NC_000001.11:197101207:T:TT
NM_018136.5(ASPM):c.7296dup (p.Ala2433fs)	ASPM		not provided	Pathogenic(Last reviewed: May 9, 2014)	criteria provided, single submitter	VCV000234257	1	197071084 - 197071085	1	197101954 - 197101955	234257	231454	rs876660959	NC_000001.11:197101954:TTTTTT:TTTTTTT
NM_018136.5(ASPM):c.9324del (p.Leu3109fs)	ASPM	L1524fs, L3109fs	not provided	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000643176	1	197061157	1	197092027	643176	627196		NC_000001.11:197092026:AA:A
NM_018136.5(ASPM):c.8200_8201del (p.Asn2734fs)	ASPM	N2734fs	Primary autosomal recessive microcephaly 1	Pathogenic	criteria provided, single submitter	VCV000694722	1	197070180 - 197070181	1	197101050 - 197101051	694722	682798		NC_000001.11:197101049:TTTTTT:TTTT
NM_018136.5(ASPM):c.5863dup (p.Gln1955fs)	ASPM		Primary autosomal recessive microcephaly 1	Pathogenic	criteria provided, single submitter	VCV000694714	1	197072517 - 197072518	1	197103387 - 197103388	694714	682799		NC_000001.11:197103387:G:GG
NM_018136.5(ASPM):c.2863C>T (p.Gln955Ter)	ASPM	Q955*	Fetal akinesia sequence|Arthrogryposis multiplex congenita	Pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000692298	1	197097693	1	197128563	692298	680087		NC_000001.11:197128562:G:A
NM_018136.5(ASPM):c.7324C>T (p.Arg2442Ter)	ASPM	R2442*	not provided	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000585449	1	197071057	1	197101927	585449	576447	rs769364943	NC_000001.11:197101926:G:A
NM_018136.5(ASPM):c.3974dup (p.Tyr1325Ter)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic	no assertion criteria provided	VCV000524205	1	197087009 - 197087010	1	197117879 - 197117880	524205	514852	rs1553225179	NC_000001.11:197117879:T:TT
NM_018136.5(ASPM):c.2085G>A (p.Trp695Ter)	ASPM	W695*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Mar 29, 2017)	no assertion criteria provided	VCV000430727	1	197104314	1	197135184	430727	424265	rs1553227021	NC_000001.11:197135183:C:T
NM_018136.5(ASPM):c.5467C>T (p.Gln1823Ter)	ASPM	Q1823*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Apr 28, 2016)	criteria provided, single submitter	VCV000375459	1	197072914	1	197103784	375459	362224	rs754909135	NC_000001.11:197103783:G:A
nsv930453	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000038806	1	197091967 - 197113811	1	197122837 - 197144681	38806	47412		
NM_018136.5(ASPM):c.9984+1G>T	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021641	1	197059059	1	197089929	21641	34493	rs199422200	NC_000001.11:197089928:C:A
NM_018136.5(ASPM):c.9841A>T (p.Arg3281Ter)	ASPM	R3281*, R1696*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021640	1	197059203	1	197090073	21640	34492	rs199422199	NC_000001.11:197090072:T:A
NM_018136.5(ASPM):c.9789T>A (p.Tyr3263Ter)	ASPM	Y3263*, Y1678*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021639	1	197059366	1	197090236	21639	34491	rs199422198	NC_000001.11:197090235:A:T
NM_018136.5(ASPM):c.9754del (p.Arg3252fs)	ASPM	R3252fs, R1667fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021637	1	197059401	1	197090271	21637	34489	rs199422197	NC_000001.11:197090270:TTTT:TTT
NM_018136.5(ASPM):c.9745_9746CT[1] (p.Tyr3250fs)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021636	1	197059407 - 197059408	1	197090277 - 197090278	21636	34488	rs199422196	NC_000001.11:197090276:AGAG:AG
NM_018136.5(ASPM):c.9686_9690del (p.Ile3229fs)	ASPM	I1644fs, I3229fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021633	1	197059465 - 197059469	1	197090335 - 197090339	21633	34485	rs199422193	NC_000001.11:197090334:TTTAATTT:TTT
NM_018136.5(ASPM):c.9685del (p.Ile3229fs)	ASPM	I1644fs, I3229fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021632	1	197059470	1	197090340	21632	34484	rs199422192	NC_000001.11:197090339:TTTTT:TTTT
NM_018136.5(ASPM):c.9677dup (p.Cys3226fs)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021631	1	197059477 - 197059478	1	197090347 - 197090348	21631	34483	rs199422191	NC_000001.11:197090347:C:CC
NM_018136.5(ASPM):c.9595A>T (p.Lys3199Ter)	ASPM	K3199*, K1614*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021630	1	197060021	1	197090891	21630	34482	rs199422190	NC_000001.11:197090890:T:A
NM_018136.5(ASPM):c.9507del (p.Ile3170fs)	ASPM	I3170fs, I1585fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021627	1	197060109	1	197090979	21627	34479	rs199422188	NC_000001.11:197090978:C:
NM_018136.5(ASPM):c.9492T>G (p.Tyr3164Ter)	ASPM	Y3164*, Y1579*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021626	1	197060124	1	197090994	21626	34478	rs143931757	NC_000001.11:197090993:A:C
NM_018136.5(ASPM):c.9319C>T (p.Arg3107Ter)	ASPM	R3107*, R1522*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021623	1	197061162	1	197092032	21623	34475	rs199422187	NC_000001.11:197092031:G:A
NM_018136.5(ASPM):c.9238A>T (p.Lys3080Ter)	ASPM	K3080*, K1495*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021622	1	197062238	1	197093108	21622	34474	rs199422186	NC_000001.11:197093107:T:A
NM_018136.5(ASPM):c.9115_9118dup (p.Tyr3040fs)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021620	1	197062357 - 197062358	1	197093227 - 197093228	21620	34472	rs199422183	NC_000001.11:197093227:AATG:AATGAATG
NM_018136.5(ASPM):c.8844del (p.Lys2949fs)	ASPM	K1364fs, K2949fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021619	1	197065271	1	197096141	21619	34471	rs199422182	NC_000001.11:197096140:GG:G
NM_018136.5(ASPM):c.8668C>T (p.Gln2890Ter)	ASPM	Q2890*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021618	1	197069713	1	197100583	21618	34470	rs199422181	NC_000001.11:197100582:G:A
NM_018136.5(ASPM):c.8508_8509del (p.Lys2837fs)	ASPM	K2837fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021617	1	197069872 - 197069873	1	197100742 - 197100743	21617	34469	rs199422180	NC_000001.11:197100741:TCT:T
NM_018136.5(ASPM):c.8378del (p.Met2793fs)	ASPM	M2793fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021615	1	197070003	1	197100873	21615	34467	rs199422179	NC_000001.11:197100872:A:
NM_018136.5(ASPM):c.8273T>A (p.Leu2758Ter)	ASPM	L2758*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021614	1	197070108	1	197100978	21614	34466	rs199422178	NC_000001.11:197100977:A:T
NM_018136.5(ASPM):c.8191_8192del (p.Glu2731fs)	ASPM	E2731fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021613	1	197070189 - 197070190	1	197101059 - 197101060	21613	34465	rs199422177	NC_000001.11:197101058:TCT:T
NM_018136.5(ASPM):c.8131_8132del (p.Lys2711fs)	ASPM	K2711fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021612	1	197070249 - 197070250	1	197101119 - 197101120	21612	34464	rs199422176	NC_000001.11:197101118:TTT:T
NM_018136.5(ASPM):c.7894C>T (p.Gln2632Ter)	ASPM	Q2632*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021610	1	197070487	1	197101357	21610	34462	rs199422175	NC_000001.11:197101356:G:A
NM_018136.5(ASPM):c.7860_7861del (p.Gln2620fs)	ASPM	Q2620fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021608	1	197070520 - 197070521	1	197101390 - 197101391	21608	34460	rs199422174	NC_000001.11:197101389:TCT:T
NM_018136.5(ASPM):c.77del (p.Gly26fs)	ASPM	G26fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021607	1	197115491	1	197146361	21607	34459	rs199422131	NC_000001.11:197146360:CCCC:CCC
NM_018136.5(ASPM):c.7491_7495del (p.Thr2499fs)	ASPM	T2499fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021600	1	197070886 - 197070890	1	197101756 - 197101760	21600	34452	rs199422172	NC_000001.11:197101755:TAATATA:TA
NM_018136.5(ASPM):c.6732del (p.Tyr2245fs)	ASPM	Y2245fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021597	1	197071649	1	197102519	21597	34449	rs199422171	NC_000001.11:197102518:T:
NM_018136.5(ASPM):c.6651_6654del (p.Thr2218fs)	ASPM	T2218fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021596	1	197071727 - 197071730	1	197102597 - 197102600	21596	34448	rs199422170	NC_000001.11:197102596:TGTTT:T
NM_018136.5(ASPM):c.6232C>T (p.Arg2078Ter)	ASPM	R2078*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021594	1	197072149	1	197103019	21594	34446	rs199422168	NC_000001.11:197103018:G:A
NM_018136.5(ASPM):c.5149del (p.Lys1716_Ile1717insTer)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021591	1	197073232	1	197104102	21591	34443	rs199422167	NC_000001.11:197104101:TTTTTTT:TTTTTT
NM_018136.5(ASPM):c.5136C>A (p.Tyr1712Ter)	ASPM	Y1712*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021590	1	197073245	1	197104115	21590	34442	rs148294838	NC_000001.11:197104114:G:T
NM_018136.5(ASPM):c.4856_4857AT[1] (p.Ile1620fs)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021589	1	197073522 - 197073523	1	197104392 - 197104393	21589	34441	rs199422166	NC_000001.11:197104391:ATATA:ATA
NM_018136.5(ASPM):c.4583del (p.Lys1528fs)	ASPM	K1528fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021587	1	197073798	1	197104668	21587	34439	rs199422164	NC_000001.11:197104667:TTT:TT
NM_018136.5(ASPM):c.440del (p.Lys147fs)	ASPM	K147fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021585	1	197113088	1	197143958	21585	34437	rs199422133	NC_000001.11:197143957:TTTTT:TTTT
NM_018136.5(ASPM):c.4074G>A (p.Trp1358Ter)	ASPM	W1358*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021584	1	197074307	1	197105177	21584	34436	rs199422162	NC_000001.11:197105176:C:T
NM_018136.5(ASPM):c.3741+1G>A	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021581	1	197091288	1	197122158	21581	34433	rs199422160	NC_000001.11:197122157:C:T
NM_018136.5(ASPM):c.3663del (p.Arg1221fs)	ASPM	R1221fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021579	1	197091367	1	197122237	21579	34431	rs199422158	NC_000001.11:197122236:CC:C
NM_018136.5(ASPM):c.3527C>G (p.Ser1176Ter)	ASPM	S1176*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021577	1	197091589	1	197122459	21577	34429	rs199422157	NC_000001.11:197122458:G:C
NM_018136.5(ASPM):c.3477_3481del (p.Ala1160fs)	ASPM	A1160fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021576	1	197091635 - 197091639	1	197122505 - 197122509	21576	34428	rs199422156	NC_000001.11:197122504:TAGCGT:T
NM_018136.5(ASPM):c.3188T>G (p.Leu1063Ter)	ASPM	L1063*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021574	1	197093442	1	197124312	21574	34426	rs199422155	NC_000001.11:197124311:A:C
NM_018136.5(ASPM):c.3082G>A (p.Gly1028Arg)	ASPM	G1028R	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021572	1	197094176	1	197125046	21572	34424	rs199422154	NC_000001.11:197125045:C:T
NM_018136.5(ASPM):c.3055C>T (p.Arg1019Ter)	ASPM	R1019*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021571	1	197094203	1	197125073	21571	34423	rs199422153	NC_000001.11:197125072:G:A
NM_018136.5(ASPM):c.2936+5G>T	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021568	1	197097615	1	197128485	21568	34420	rs199422150	NC_000001.11:197128484:C:A
NM_018136.5(ASPM):c.2761-25A>G	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021565	1	197097820	1	197128690	21565	34417	rs199422149	NC_000001.11:197128689:T:C
NM_018136.5(ASPM):c.1990C>T (p.Gln664Ter)	ASPM	Q664*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021562	1	197108933	1	197139803	21562	34414	rs199422148	NC_000001.11:197139802:G:A
NM_018136.5(ASPM):c.1590del (p.Lys530_Val531insTer)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021556	1	197111792	1	197142662	21556	34408	rs199422143	NC_000001.11:197142661:TTTTT:TTTT
NM_018136.5(ASPM):c.1406_1413del (p.Asn469fs)	ASPM	N469fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021555	1	197111969 - 197111976	1	197142839 - 197142846	21555	34407	rs199422142	NC_000001.11:197142838:TTTAGGATT:T
NM_018136.5(ASPM):c.10059C>A (p.Tyr3353Ter)	ASPM	Y3353*, Y1768*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021549	1	197057488	1	197088358	21549	34401	rs199422201	NC_000001.11:197088357:G:T
NM_018136.5(ASPM):c.1002del (p.Leu334_Val335insTer)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021548	1	197112380	1	197143250	21548	34400	rs199422136	NC_000001.11:197143249:T:
NM_018136.5(ASPM):c.8596_8597del (p.Leu2866fs)	ASPM	L2866fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000800509	1	197069784 - 197069785	1	197100654 - 197100655	800509	789105		NC_000001.11:197100653:AAA:A
NM_018136.5(ASPM):c.8266C>T (p.Gln2756Ter)	ASPM	Q2756*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000522990	1	197070115	1	197100985	522990	513501	rs763909256	NC_000001.11:197100984:G:A
NM_018136.5(ASPM):c.6997G>T (p.Glu2333Ter)	ASPM	E2333*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Apr 19, 2017)	criteria provided, single submitter	VCV000434421	1	197071384	1	197102254	434421	427671	rs1334947797	NC_000001.11:197102253:C:A
NM_018136.5(ASPM):c.297+1G>C	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Dec 18, 2015)	criteria provided, single submitter	VCV000434420	1	197115270	1	197146140	434420	427683	rs1553228275	NC_000001.11:197146139:C:G
NM_018136.5(ASPM):c.1530_1531del (p.Glu511fs)	ASPM	E511fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 10, 2016)	criteria provided, single submitter	VCV000434419	1	197111851 - 197111852	1	197142721 - 197142722	434419	427682	rs1404276011	NC_000001.11:197142720:CA:
NM_018136.5(ASPM):c.1798_1801del (p.Lys600fs)	ASPM	K600fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Jul 27, 2016)	criteria provided, single submitter	VCV000434418	1	197111581 - 197111584	1	197142451 - 197142454	434418	427680	rs1553227645	NC_000001.11:197142450:TTTT:
NM_018136.5(ASPM):c.2488-1G>C	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	VCV000434416	1	197099187	1	197130057	434416	427677	rs1321892596	NC_000001.11:197130056:C:G
NM_018136.5(ASPM):c.3504_3505TG[1] (p.Val1169fs)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Dec 11, 2015)	criteria provided, single submitter	VCV000434415	1	197091609 - 197091610	1	197122479 - 197122480	434415	427675	rs769818500	NC_000001.11:197122478:CACA:CA
NM_018136.5(ASPM):c.7857dup (p.Gln2620fs)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210360	1	197070523 - 197070524	1	197101393 - 197101394	210360	206738	rs797045316	NC_000001.11:197101393:TTTTTTT:TTTTTTTT
NM_018136.5(ASPM):c.7308dup (p.Val2437fs)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210359	1	197071072 - 197071073	1	197101942 - 197101943	210359	206739	rs797045315	NC_000001.11:197101942:AAAAA:AAAAAA
NM_018136.5(ASPM):c.3960_3961insA (p.Val1321fs)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210355	1	197087023 - 197087024	1	197117893 - 197117894	210355	206743	rs759632528	NC_000001.11:197117893::T
NM_018136.5(ASPM):c.3390+3_3390+6del	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210353	1	197093234 - 197093237	1	197124104 - 197124107	210353	206745	rs797045313	NC_000001.11:197124103:ACTTAC:AC
NM_018136.5(ASPM):c.2936dup (p.Arg980fs)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210350	1	197097619 - 197097620	1	197128489 - 197128490	210350	206748	rs797045311	NC_000001.11:197128489:A:AA
NM_018136.5(ASPM):c.10060C>T (p.Arg3354Ter)	ASPM	R3354*, R1769*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Jul 23, 2015)	criteria provided, single submitter	VCV000210343	1	197057487	1	197088357	210343	206735	rs748529285	NC_000001.11:197088356:G:A
NM_018136.5(ASPM):c.9305_9306AG[2] (p.Arg3103fs)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157908	1	197061171 - 197061172	1	197092041 - 197092042	157908	167755	rs587783289	NC_000001.11:197092040:CTCTCT:CTCT
NM_018136.5(ASPM):c.9104T>A (p.Leu3035Ter)	ASPM	L3035*, L1450*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157905	1	197062372	1	197093242	157905	167752	rs587783288	NC_000001.11:197093241:A:T
NM_018136.5(ASPM):c.9091C>T (p.Arg3031Ter)	ASPM	R3031*, R1446*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157904	1	197062385	1	197093255	157904	167751	rs587783287	NC_000001.11:197093254:G:A
NM_018136.5(ASPM):c.8903G>A (p.Trp2968Ter)	ASPM	W2968*, W1383*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157901	1	197065212	1	197096082	157901	167748	rs587783285	NC_000001.11:197096081:C:T
NM_018136.5(ASPM):c.8704C>T (p.Gln2902Ter)	ASPM	Q2902*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Dec 11, 2013)	criteria provided, single submitter	VCV000157897	1	197069677	1	197100547	157897	167744	rs587783282	NC_000001.11:197100546:G:A
NM_018136.5(ASPM):c.8133_8136del (p.Lys2712fs)	ASPM	K2712fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157888	1	197070245 - 197070248	1	197101115 - 197101118	157888	167735	rs587783278	NC_000001.11:197101114:TTTCTTT:TTT
NM_018136.5(ASPM):c.803_804del (p.Lys268fs)	ASPM	K268fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157887	1	197112578 - 197112579	1	197143448 - 197143449	157887	167734	rs587783277	NC_000001.11:197143447:TTTT:TT
NM_018136.5(ASPM):c.7825C>T (p.Gln2609Ter)	ASPM	Q2609*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157880	1	197070556	1	197101426	157880	167727	rs587783272	NC_000001.11:197101425:G:A
NM_018136.5(ASPM):c.7665del (p.Ala2556fs)	ASPM	A2556fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157874	1	197070716	1	197101586	157874	167721	rs587783269	NC_000001.11:197101585:TTT:TT
NM_018136.5(ASPM):c.7612C>T (p.Gln2538Ter)	ASPM	Q2538*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157873	1	197070769	1	197101639	157873	167720	rs587783268	NC_000001.11:197101638:G:A
NM_018136.5(ASPM):c.7158_7159CT[1] (p.Ser2387fs)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Dec 13, 2013)	criteria provided, single submitter	VCV000157867	1	197071220 - 197071221	1	197102090 - 197102091	157867	167714	rs587783265	NC_000001.11:197102089:AGAG:AG
NM_018136.5(ASPM):c.6848_6849TC[2] (p.Leu2285fs)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Dec 17, 2013)	criteria provided, single submitter	VCV000157859	1	197071526 - 197071529	1	197102396 - 197102399	157859	167706	rs587783259	NC_000001.11:197102395:GAGAGAGAG:GAGAG
NM_018136.5(ASPM):c.5233C>T (p.Arg1745Ter)	ASPM	R1745*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Dec 7, 2012)	criteria provided, single submitter	VCV000157831	1	197073148	1	197104018	157831	167678	rs587783248	NC_000001.11:197104017:G:A
NM_018136.5(ASPM):c.5196T>A (p.Cys1732Ter)	ASPM	C1732*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157829	1	197073185	1	197104055	157829	167676	rs587783247	NC_000001.11:197104054:A:T
NM_018136.5(ASPM):c.3853_3854del (p.Asp1285fs)	ASPM	D1285fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157813	1	197091061 - 197091062	1	197121931 - 197121932	157813	167660	rs587783239	NC_000001.11:197121930:TCT:T
NM_018136.5(ASPM):c.3830G>A (p.Trp1277Ter)	ASPM	W1277*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Jan 24, 2014)	criteria provided, single submitter	VCV000157812	1	197091085	1	197121955	157812	167659	rs587783238	NC_000001.11:197121954:C:T
NM_018136.5(ASPM):c.3327T>G (p.Tyr1109Ter)	ASPM	Y1109*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157803	1	197093303	1	197124173	157803	167650	rs587783230	NC_000001.11:197124172:A:C
NM_018136.5(ASPM):c.2968del (p.Asp990fs)	ASPM	D990fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157799	1	197094290	1	197125160	157799	167646	rs587783228	NC_000001.11:197125159:CCC:CC
NM_018136.5(ASPM):c.1722_1725AAGA[1] (p.Lys576fs)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157785	1	197111653 - 197111656	1	197142523 - 197142526	157785	167632	rs587783221	NC_000001.11:197142522:TCTTTCTTT:TCTTT
NM_018136.5(ASPM):c.1671_1672del (p.Ser557fs)	ASPM	S557fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Nov 12, 2013)	criteria provided, single submitter	VCV000157783	1	197111710 - 197111711	1	197142580 - 197142581	157783	167630	rs587783220	NC_000001.11:197142579:AA:
NM_018136.5(ASPM):c.117_118del (p.Leu41fs)	ASPM	L41fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157778	1	197115450 - 197115451	1	197146320 - 197146321	157778	167625	rs587783216	NC_000001.11:197146319:ACA:A
ASPM, 2-BP DEL, 7781AG	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000004966					4966	20005		
NM_000104.3(CYP1B1):c.171G>A (p.Trp57Ter)	CYP1B1	W57*	Glaucoma, congenital|Glaucoma 3, primary infantile, b|Glaucoma 3, primary congenital, A|Anterior segment dysgenesis 6|Anterior segment dysgenesis 6|CYP1B1-Related Disorders|Irido-corneo-trabecular dysgenesis|Glaucoma 3, primary congenital, A|not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000007737	2	38302361	2	38075218	7737	22776	rs72549387	NC_000002.12:38075217:C:T
NM_018136.5(ASPM):c.6678_6681GAAA[2] (p.Arg2229fs)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic	criteria provided, single submitter	VCV000694011	1	197071692 - 197071695	1	197102562 - 197102565	694011	681820		NC_000001.11:197102561:TTTCTTTCTTTC:TTTCTTTC
NM_018136.5(ASPM):c.5588_5589CT[1] (p.Leu1864fs)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic	criteria provided, single submitter	VCV000694010	1	197072790 - 197072791	1	197103660 - 197103661	694010	681822		NC_000001.11:197103659:AGAG:AG
NM_018136.5(ASPM):c.4248_4249AT[1] (p.Arg1416_Tyr1417insTer)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic	criteria provided, single submitter	VCV000694009	1	197074130 - 197074131	1	197105000 - 197105001	694009	681823		NC_000001.11:197104999:ATAT:AT
NM_018136.5(ASPM):c.6513dup (p.Val2172fs)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic	criteria provided, single submitter	VCV000694007	1	197071867 - 197071868	1	197102737 - 197102738	694007	681821		NC_000001.11:197102737:TTT:TTTT
NM_018136.5(ASPM):c.3082+1G>C	ASPM		Arthrogryposis multiplex congenita|Fetal akinesia sequence|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280518	1	197094175	1	197125045	280518	263959	rs886041709	NC_000001.11:197125044:C:G
NM_018136.5(ASPM):c.6335_6336AT[1] (p.Ile2113fs)	ASPM		Primary autosomal recessive microcephaly 5|not provided	Pathogenic(Last reviewed: Apr 21, 2016)	criteria provided, single submitter	VCV000265381	1	197072043 - 197072044	1	197102913 - 197102914	265381	259640	rs199422169	NC_000001.11:197102912:ATAT:AT
NM_018136.5(ASPM):c.8017C>T (p.Gln2673Ter)	ASPM	Q2673*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157885	1	197070364	1	197101234	157885	167732	rs587783275	NC_000001.11:197101233:G:A
NM_018136.5(ASPM):c.9557C>G (p.Ser3186Ter)	ASPM	S3186*, S1601*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000021629	1	197060059	1	197090929	21629	34481	rs199422189	NC_000001.11:197090928:G:C
NM_018136.5(ASPM):c.9190C>T (p.Arg3064Ter)	ASPM	R3064*, R1479*	Primary autosomal recessive microcephaly 5|not provided	Pathogenic(Last reviewed: Apr 14, 2017)	criteria provided, single submitter	VCV000021621	1	197062286	1	197093156	21621	34473	rs199422185	NC_000001.11:197093155:G:A
NM_018136.5(ASPM):c.3811C>T (p.Arg1271Ter)	ASPM	R1271*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000021583	1	197091104	1	197121974	21583	34435	rs140602858	NC_000001.11:197121973:G:A
NM_018136.5(ASPM):c.3796G>T (p.Glu1266Ter)	ASPM	E1266*	Primary autosomal recessive microcephaly 5|not provided	Pathogenic(Last reviewed: Jul 13, 2015)	criteria provided, single submitter	VCV000021582	1	197091119	1	197121989	21582	34434	rs199422161	NC_000001.11:197121988:C:A
NM_018136.5(ASPM):c.3710C>G (p.Ser1237Ter)	ASPM	S1237*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000021580	1	197091320	1	197122190	21580	34432	rs199422159	NC_000001.11:197122189:G:C
NM_018136.5(ASPM):c.1631_1635del (p.Tyr544fs)	ASPM	Y544fs	not provided|Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Aug 11, 2016)	criteria provided, single submitter	VCV000021558	1	197111747 - 197111751	1	197142617 - 197142621	21558	34410	rs199422144	NC_000001.11:197142616:AAGATAAGA:AAGA
NM_018136.5(ASPM):c.1260_1266del (p.Gln421fs)	ASPM	Q421fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021552	1	197112116 - 197112122	1	197142986 - 197142992	21552	34404	rs199422139	NC_000001.11:197142985:GACTTGAGA:GA
NM_018136.5(ASPM):c.1179del (p.Asn394fs)	ASPM	N394fs	not provided|Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000021551	1	197112203	1	197143073	21551	34403	rs199422138	NC_000001.11:197143072:A:
NM_018136.5(ASPM):c.349C>T (p.Arg117Ter)	ASPM	R117*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000004962	1	197113179	1	197144049	4962	20001	rs137852996	NC_000001.11:197144048:G:A
NM_018136.5(ASPM):c.3978G>A (p.Trp1326Ter)	ASPM	W1326*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000004961	1	197087006	1	197117876	4961	20000	rs137852995	NC_000001.11:197117875:C:T
NM_018136.5(ASPM):c.9159del (p.Lys3053fs)	ASPM	K3053fs, K1468fs	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000004959	1	197062317	1	197093187	4959	19998	rs199422184	NC_000001.11:197093186:TTT:TT
NM_018136.5(ASPM):c.7761T>G (p.Tyr2587Ter)	ASPM	Y2587*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000004958	1	197070620	1	197101490	4958	19997	rs189678019	NC_000001.11:197101489:A:C
NM_018136.5(ASPM):c.715_716CT[2] (p.Ser240fs)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000004956	1	197112662 - 197112663	1	197143532 - 197143533	4956	19995	rs199422135	NC_000001.11:197143531:AGAGAG:AGAG
NM_005529.7(HSPG2):c.3603_3604delinsT (p.Thr1202fs)	HSPG2		not provided	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000817179	1	22200951 - 22200952	1	21874458 - 21874459	817179	805206		NC_000001.11:21874457:TC:A
NM_005529.7(HSPG2):c.4145_4163del (p.Leu1382fs)	HSPG2	L1383fs, L1382fs		Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801456	1	22198737 - 22198755	1	21872244 - 21872262	801456	789932		NC_000001.11:21872243:GCAAAGTTGCCAAAAGAGAGC:GC
NM_005529.7(HSPG2):c.10894C>T (p.Arg3632Ter)	HSPG2	R3632*, R3633*	not provided	Pathogenic(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	VCV000284213	1	22160044	1	21833551	284213	268450	rs762281715	NC_000001.11:21833550:G:A
NM_005529.7(HSPG2):c.2035_2036CG[2] (p.Ala680fs)	HSPG2		not provided	Pathogenic(Last reviewed: Mar 28, 2016)	criteria provided, single submitter	VCV000280466	1	22207011 - 22207012	1	21880518 - 21880519	280466	263979	rs886041667	NC_000001.11:21880517:CGCGCGC:CGCGC
NM_005529.7(HSPG2):c.7006+1G>A	HSPG2		not provided	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000265454	1	22178283	1	21851790	265454	259654	rs778653296	NC_000001.11:21851789:C:T
NM_005529.7(HSPG2):c.8316+1G>A	HSPG2			Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000800538	1	22172940	1	21846447	800538	789106		NC_000001.11:21846446:C:T
HSPG2, 9-BP DEL	HSPG2			Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000014925					14925	29964		
HSPG2, 8544G-A	HSPG2			Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000014924					14924	29963		
HSPG2, EX60/61 FUSION	HSPG2			Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000014923					14923	29962		
NM_005529.7(HSPG2):c.7294+4A>G	HSPG2			Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000014922	1	22176852	1	21850359	14922	29961		NC_000001.11:21850358:T:C
HSPG2, 10328C-T	HSPG2		Lethal Kniest-like syndrome	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000014921					14921	29960		
HSPG2, 7086G-A, +5	HSPG2		Lethal Kniest-like syndrome	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000014920					14920	29959		
HSPG2, 89-BP DUP, EX34	HSPG2		Lethal Kniest-like syndrome	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000014919					14919	29958		
NM_005529.7(HSPG2):c.8464+4A>G	HSPG2			Pathogenic(Last reviewed: Dec 1, 2000)	no assertion criteria provided	VCV000014917	1	22172597	1	21846104	14917	29956		NC_000001.11:21846103:T:C
NG_012340.1:g.21597_29501del	SDHB		Paragangliomas 4	Pathogenic(Last reviewed: Jan 11, 2006)	no assertion criteria provided	VCV000523118					523118	513743		
HSPG2, 7,108-BP DEL	HSPG2			Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000014926					14926	29965		
NM_005529.7(HSPG2):c.4595G>A (p.Cys1532Tyr)	HSPG2	C1532Y, C1533Y		Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000014918	1	22191367	1	21864874	14918	29957	rs137853248	NC_000001.11:21864873:C:T
NM_000642.3(AGL):c.958+1G>T	AGL		Glycogen storage disease type III	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000844910	1	100336426	1	99870870	844910	851075		NC_000001.11:99870869:G:T
NM_000642.3(AGL):c.1423+1G>C	AGL		Glycogen storage disease type III	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV000841722	1	100342154	1	99876598	841722	851329		NC_000001.11:99876597:G:C
NM_000642.3(AGL):c.1384del (p.Trp461_Val462insTer)	AGL		Glycogen storage disease type III	Pathogenic/Likely pathogenic(Last reviewed: Oct 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189080	1	100342112	1	99876556	189080	186641	rs786204678	NC_000001.11:99876555:GGG:GG
NM_000642.3(AGL):c.4197del (p.Ala1400fs)	AGL	A1400fs, A1384fs	Glycogen storage disease type III	Pathogenic/Likely pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188970	1	100380978	1	99915422	188970	186646	rs786204595	NC_000001.11:99915421:AAA:AA
NM_000642.3(AGL):c.2309-1G>A	AGL		Glycogen storage disease IIIa|Glycogen storage disease type III	Pathogenic/Likely pathogenic(Last reviewed: Aug 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000188804	1	100349675	1	99884119	188804	186643	rs786204481	NC_000001.11:99884118:G:A
NM_018136.5(ASPM):c.6568C>T (p.Gln2190Ter)	ASPM	Q2190*	Primary autosomal recessive microcephaly 5|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523815	1	197071813	1	197102683	523815	514418	rs199910503	NC_000001.11:197102682:G:A
NM_018136.5(ASPM):c.9910C>T (p.Arg3304Ter)	ASPM	R3304*, R1719*	Primary autosomal recessive microcephaly 5|not provided	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000157918	1	197059134	1	197090004	157918	167765	rs587783295	NC_000001.11:197090003:G:A
NM_018136.5(ASPM):c.9454C>T (p.Arg3152Ter)	ASPM	R3152*, R1567*	Primary autosomal recessive microcephaly 5|not provided	Pathogenic(Last reviewed: Jun 26, 2014)	criteria provided, multiple submitters, no conflicts	VCV000157913	1	197060162	1	197091032	157913	167760	rs587783292	NC_000001.11:197091031:G:A
NM_018136.5(ASPM):c.8711_8712del (p.Gln2904fs)	ASPM	Q2904fs	Primary autosomal recessive microcephaly 5|not provided	Pathogenic(Last reviewed: Apr 16, 2015)	criteria provided, multiple submitters, no conflicts	VCV000157898	1	197069669 - 197069670	1	197100539 - 197100540	157898	167745	rs587783283	NC_000001.11:197100538:TT:
NM_018136.5(ASPM):c.8504_8505CA[1] (p.Gln2836fs)	ASPM		Primary autosomal recessive microcephaly 5|not provided	Pathogenic(Last reviewed: Sep 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000157894	1	197069874 - 197069875	1	197100744 - 197100745	157894	167741	rs587783280	NC_000001.11:197100743:TGTGT:TGT
NM_018136.5(ASPM):c.7125_7128dup (p.Gln2377fs)	ASPM		Primary autosomal recessive microcephaly 5|not provided	Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, multiple submitters, no conflicts	VCV000157864	1	197071252 - 197071253	1	197102122 - 197102123	157864	167711	rs587783263	NC_000001.11:197102122:CAGT:CAGTCAGT
NM_018136.5(ASPM):c.637del (p.Ile213fs)	ASPM	I213fs	Primary autosomal recessive microcephaly 5|not provided	Pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, multiple submitters, no conflicts	VCV000157854	1	197112745	1	197143615	157854	167701	rs587783258	NC_000001.11:197143614:TT:T
NM_018136.5(ASPM):c.4726_4727AG[1] (p.Arg1576fs)	ASPM		not provided|Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000157824	1	197073652 - 197073653	1	197104522 - 197104523	157824	167671	rs587783245	NC_000001.11:197104521:CTCT:CT
NM_018136.5(ASPM):c.3943_3944AG[1] (p.Arg1315fs)	ASPM		not provided|Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000157815	1	197087038 - 197087039	1	197117908 - 197117909	157815	167662	rs587783240	NC_000001.11:197117907:CTCT:CT
NM_018136.5(ASPM):c.2791C>T (p.Arg931Ter)	ASPM	R931*	not provided|Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000157797	1	197097765	1	197128635	157797	167644	rs587783227	NC_000001.11:197128634:G:A
NM_018136.5(ASPM):c.2419+2T>C	ASPM		not provided|Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Jan 19, 2016)	criteria provided, multiple submitters, no conflicts	VCV000157795	1	197102478	1	197133348	157795	167642	rs587783225	NC_000001.11:197133347:A:G
NM_018136.5(ASPM):c.2967G>A (p.Trp989Ter)	ASPM	W989*	Primary autosomal recessive microcephaly 1|Primary autosomal recessive microcephaly 5	Pathogenic	criteria provided, single submitter	VCV000021570	1	197094291	1	197125161	21570	34422	rs199422152	NC_000001.11:197125160:C:T
NM_018136.5(ASPM):c.2938C>T (p.Arg980Ter)	ASPM	R980*	Primary autosomal recessive microcephaly 1|Primary autosomal recessive microcephaly 5	Pathogenic	criteria provided, single submitter	VCV000021569	1	197094320	1	197125190	21569	34421	rs199422151	NC_000001.11:197125189:G:A
NM_018136.5(ASPM):c.4363G>T (p.Glu1455Ter)	ASPM	E1455*	not provided|Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, multiple submitters, no conflicts	VCV000380612	1	197074018	1	197104888	380612	364730	rs1057520873	NC_000001.11:197104887:C:A
NM_018136.5(ASPM):c.1152_1153AG[1] (p.Glu385fs)	ASPM		not provided|Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Apr 16, 2015)	criteria provided, multiple submitters, no conflicts	VCV000234465	1	197112227 - 197112228	1	197143097 - 197143098	234465	231475	rs199422137	NC_000001.11:197143096:CTCT:CT
NM_018136.5(ASPM):c.9730C>T (p.Arg3244Ter)	ASPM	R3244*, R1659*	Primary autosomal recessive microcephaly 5|not provided	Pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, multiple submitters, no conflicts	VCV000021635	1	197059425	1	197090295	21635	34487	rs199422195	NC_000001.11:197090294:G:A
NM_018136.5(ASPM):c.9697C>T (p.Arg3233Ter)	ASPM	R3233*, R1648*	Primary autosomal recessive microcephaly 5|not provided	Pathogenic(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000021634	1	197059458	1	197090328	21634	34486	rs199422194	NC_000001.11:197090327:G:A
NM_018136.5(ASPM):c.4795C>T (p.Arg1599Ter)	ASPM	R1599*	Primary autosomal recessive microcephaly 5|not provided	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000021588	1	197073586	1	197104456	21588	34440	rs199422165	NC_000001.11:197104455:G:A
NM_018136.5(ASPM):c.1955_1958CAAA[1] (p.Asn653fs)	ASPM		Primary autosomal recessive microcephaly 5|not provided	Pathogenic(Last reviewed: May 9, 2014)	criteria provided, multiple submitters, no conflicts	VCV000021560	1	197108961 - 197108964	1	197139831 - 197139834	21560	34412	rs199422147	NC_000001.11:197139830:TTTGTTTGTTT:TTTGTTT
NM_018136.5(ASPM):c.1366G>T (p.Glu456Ter)	ASPM	E456*	Primary autosomal recessive microcephaly 5	Pathogenic	criteria provided, single submitter	VCV000021554	1	197112016	1	197142886	21554	34406	rs199422141	NC_000001.11:197142885:C:A
NM_018136.5(ASPM):c.4195dup (p.Thr1399fs)	ASPM		Primary autosomal recessive microcephaly 5	Pathogenic	criteria provided, single submitter	VCV000004964	1	197074185 - 197074186	1	197105055 - 197105056	4964	20003	rs199422163	NC_000001.11:197105055:T:TT
NM_018136.5(ASPM):c.6189T>G (p.Tyr2063Ter)	ASPM	Y2063*	Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000004963	1	197072192	1	197103062	4963	20002	rs137852997	NC_000001.11:197103061:A:C
NM_001204.6(BMPR2):c.(?_-63)_(76_?)+61del	BMPR2		Idiopathic and/or familial pulmonary arterial hypertension	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000517622	2	203242135 - 203242334	2	202377412 - 202377611	517622	496630		
NM_001204.7(BMPR2):c.200A>G (p.Tyr67Cys)	BMPR2	Y67C	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic	no assertion criteria provided	VCV000425719	2	203329655	2	202464932	425719	414107	rs1085307177	NC_000002.12:202464931:A:G
NM_001204.7(BMPR2):c.1128+1G>A	BMPR2		not provided|Primary pulmonary hypertension	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000212811	2	203395678	2	202530955	212811	209589	rs863223420	NC_000002.12:202530954:G:A
NM_001204.6(BMPR2):c.77-?_247+?del (p.A26_Q82del)	BMPR2		Pulmonary venoocclusive disease 1|Primary pulmonary hypertension	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000008816	2	203329532 - 203329702	2	202464809 - 202464979	8816	23855		
NM_001204.7(BMPR2):c.367T>C (p.Cys123Arg)	BMPR2	C123R	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000008808	2	203332361	2	202467638	8808	23847	rs137852750	NC_000002.12:202467637:T:C
NM_000642.3(AGL):c.1571G>A (p.Arg524His)	AGL	R508H, R524H	Glycogen storage disease type III	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000844261	1	100343344	1	99877788	844261	824583		NC_000001.11:99877787:G:A
NM_000642.3(AGL):c.4525C>T (p.Gln1509Ter)	AGL	Q1493*, Q1509*	Glycogen storage disease type III	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000656738	1	100387133	1	99921577	656738	628361		NC_000001.11:99921576:C:T
NM_000642.3(AGL):c.3613C>T (p.Gln1205Ter)	AGL	Q1205*, Q1189*	not provided|Glycogen storage disease type III	Pathogenic/Likely pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000557206	1	100368263	1	99902707	557206	541376	rs775498547	NC_000001.11:99902706:C:T
NM_000642.3(AGL):c.3911dup (p.Asn1304fs)	AGL		Glycogen storage disease type III	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000370832	1	100378027 - 100378028	1	99912471 - 99912472	370832	357222	rs745757264	NC_000001.11:99912471:AAAAAAAA:AAAAAAAAA
NM_000329.3(RPE65):c.95-2A>T	RPE65		not provided|Leber congenital amaurosis|Retinitis pigmentosa 20|Leber congenital amaurosis 2|Retinal dystrophy	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000098899	1	68912545	1	68446862	98899	104789	rs61751279	NC_000001.11:68446861:T:A
NM_014874.3(MFN2):c.313A>G (p.Thr105Ala)	MFN2	T105A	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000543234	1	12056214	1	11996157	543234	515078	rs1553142428	NC_000001.11:11996156:A:G
NM_014874.3(MFN2):c.730G>A (p.Val244Met)	MFN2	V244M	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, type 2A2A	Pathogenic(Last reviewed: Jul 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000243066	1	12059066	1	11999009	243066	244149	rs879253777	NC_000001.11:11999008:G:A
NM_018136.5(ASPM):c.6916_6919del (p.Leu2306fs)	ASPM	L2306fs	not provided|Primary autosomal recessive microcephaly 5	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000422700	1	197071462 - 197071465	1	197102332 - 197102335	422700	404996	rs1064795945	NC_000001.11:197102331:GTAAGT:GT
NM_018136.5(ASPM):c.1727_1728AG[1] (p.Ser577fs)	ASPM		Primary autosomal recessive microcephaly 5|Microcephaly|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000402179	1	197111652 - 197111653	1	197142522 - 197142523	402179	389113	rs199422146	NC_000001.11:197142521:CTCT:CT
NM_018136.5(ASPM):c.1138C>T (p.Gln380Ter)	ASPM	Q380*	not provided|Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157777	1	197112244	1	197143114	157777	167624	rs587783215	NC_000001.11:197143113:G:A
NM_018136.5(ASPM):c.2389C>T (p.Arg797Ter)	ASPM	R797*	Primary autosomal recessive microcephaly 5	Pathogenic	criteria provided, single submitter	VCV000004965	1	197102510	1	197133380	4965	20004	rs145489194	NC_000001.11:197133379:G:A
NM_000478.6(ALPL):c.1001G>A (p.Gly334Asp)	ALPL	G317D, G334D, G257D, G279D	Hypophosphatasia|Adult hypophosphatasia|not provided|Adult hypophosphatasia|Infantile hypophosphatasia|Childhood hypophosphatasia|Infantile hypophosphatasia	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013672	1	21902229	1	21575736	13672	28711	rs121918009	NC_000001.11:21575735:G:A
NM_000530.8(MPZ):c.116A>C (p.His39Pro)	MPZ	H39P	not provided|Charcot-Marie-Tooth disease, type I|not specified|Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217232	1	161277166	1	161307376	217232	213794	rs371856018	NC_000001.11:161307375:T:G
NM_001278344.1(ACTN2):c.-467G>A	ACTN2	A119T	Dilated cardiomyopathy 1AA|Primary dilated cardiomyopathy|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 23	Pathogenic(Last reviewed: Feb 6, 2014)	criteria provided, single submitter	VCV000162727	1	236882307	1	236719007	162727	172928	rs727502886	NC_000001.11:236719006:G:A
NM_000642.3(AGL):c.3682C>T (p.Arg1228Ter)	AGL	R1228*, R1212*	not provided|Glycogen storage disease type III	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000021216	1	100368332	1	99902776	21216	34068	rs113994131	NC_000001.11:99902775:C:T
NM_000393.5(COL5A2):c.2919dup (p.Asp974fs)	COL5A2		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000863014	2	189916057 - 189916058	2	189051331 - 189051332	863014	825499		NC_000002.12:189051331:TT:TTT
NM_000393.5(COL5A2):c.690+5G>T	COL5A2		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000641300	2	189951447	2	189086721	641300	650905		NC_000002.12:189086720:C:A
NM_000393.5(COL5A2):c.1924-4C>G	COL5A2		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: May 6, 2018)	criteria provided, single submitter	VCV000576400	2	189927648	2	189062922	576400	559504	rs1559085578	NC_000002.12:189062921:G:C
NM_000393.5(COL5A2):c.1617+4A>G	COL5A2		Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Pathogenic(Last reviewed: Apr 5, 2018)	no assertion criteria provided	VCV000518428	2	189929726	2	189065000	518428	509020	rs1553515517	NC_000002.12:189064999:T:C
NM_000393.5(COL5A2):c.3148-2A>G	COL5A2		Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Pathogenic(Last reviewed: Apr 5, 2018)	no assertion criteria provided	VCV000518427	2	189912990	2	189048264	518427	509019	rs1553513971	NC_000002.12:189048263:T:C
NM_000393.5(COL5A2):c.4298del (p.Ile1433fs)	COL5A2	I1433fs	Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Pathogenic(Last reviewed: Apr 5, 2018)	no assertion criteria provided	VCV000518426	2	189899697	2	189034971	518426	509018	rs1553512393	NC_000002.12:189034970:A:
NM_000393.5(COL5A2):c.2553+2del	COL5A2		Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Pathogenic(Last reviewed: Apr 5, 2018)	no assertion criteria provided	VCV000518425	2	189918148	2	189053422	518425	509017	rs1553514506	NC_000002.12:189053421:A:
NM_000393.5(COL5A2):c.3445G>C (p.Gly1149Arg)	COL5A2	G934R, G1149R	Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000017198	2	189907903	2	189043177	17198	32237	rs121912930	NC_000002.12:189043176:C:G
NM_000393.5(COL5A2):c.2031+1G>T	COL5A2		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000017197	2	189926287	2	189061561	17197	32236	rs786205104	NC_000002.12:189061560:C:A
NM_000393.5(COL5A2):c.1924-2_1928del	COL5A2		Ehlers-Danlos syndrome, classic type	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000017196	2	189927640 - 189927646	2	189062914 - 189062920	17196	32235	rs786205103	NC_000002.12:189062913:GCTCCCT:
NM_005026.5(PIK3CD):c.3061G>A (p.Glu1021Lys)	PIK3CD	E1021K, E992K, E1020K	Inherited Immunodeficiency Diseases|Immunodeficiency 14|not specified|not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000088675	1	9787030	1	9726972	88675	94255	rs397518423	NC_000001.11:9726971:G:A
NM_001204.7(BMPR2):c.1259G>A (p.Cys420Tyr)	BMPR2	C420Y	Primary pulmonary hypertension	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000425907	2	203397438	2	202532715	425907	414274	rs1085307325	NC_000002.12:202532714:G:A
NM_001204.7(BMPR2):c.1129-3C>G	BMPR2		Primary pulmonary hypertension	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000425878	2	203397305	2	202532582	425878	414247	rs748230358	NC_000002.12:202532581:C:G
NM_001204.7(BMPR2):c.48G>A (p.Trp16Ter)	BMPR2	W16*	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000425685	2	203242245	2	202377522	425685	414080	rs1085307154	NC_000002.12:202377521:G:A
NM_001204.7(BMPR2):c.1398G>A (p.Trp466Ter)	BMPR2	W466*	Primary pulmonary hypertension|Pulmonary venoocclusive disease 1, autosomal dominant|Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000409813	2	203407155	2	202542432	409813	392288	rs1060502576	NC_000002.12:202542431:G:A
NM_001204.7(BMPR2):c.853-2A>G	BMPR2		not provided|Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	VCV000212815	2	203384808	2	202520085	212815	209588	rs863223424	NC_000002.12:202520084:A:G
NC_000001.10:g.17375249_17390927del15679	SDHB		Paragangliomas 4	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000018455	1	17375249 - 17390927	1	17048754 - 17064432	18455	33494		
NM_000642.3(AGL):c.3652C>T (p.Arg1218Ter)	AGL	R1218*, R1202*	not provided|Glycogen storage disease type III	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000456492	1	100368302	1	99902746	456492	448447	rs771853367	NC_000001.11:99902745:C:T
NM_000642.3(AGL):c.2929C>T (p.Arg977Ter)	AGL	R977*, R961*	Glycogen storage disease type III	Pathogenic/Likely pathogenic(Last reviewed: Jun 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370992	1	100356892	1	99891336	370992	357213	rs531425980	NC_000001.11:99891335:C:T
NM_000642.3(AGL):c.2681+1G>A	AGL		Glycogen storage disease type III|not provided	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000281229	1	100350260	1	99884704	281229	265466	rs201201443	NC_000001.11:99884703:G:A
NM_000642.3(AGL):c.664+3A>G	AGL		Glycogen storage disease IIIa|Glycogen storage disease type III	Pathogenic/Likely pathogenic(Last reviewed: Apr 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000188994	1	100330148	1	99864592	188994	186640	rs370792293	NC_000001.11:99864591:A:G
NM_000642.3(AGL):c.1222C>T (p.Arg408Ter)	AGL	R408*, R392*	Glycogen storage disease IIIa|Glycogen storage disease type III	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000001106	1	100340950	1	99875394	1106	16145	rs113994128	NC_000001.11:99875393:C:T
NM_000642.3(AGL):c.3965del (p.Val1322fs)	AGL	V1306fs, V1322fs	Glycogen storage disease type III|Glycogen storage disease IIIa|not provided	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001103	1	100379098	1	99913542	1103	16142	rs113994132	NC_000001.11:99913541:T:
NM_003742.4(ABCB11):c.3213+1del	ABCB11		Inborn genetic diseases	Pathogenic(Last reviewed: Mar 16, 2016)	criteria provided, single submitter	VCV000521014	2	169788886	2	168932376	521014	511358	rs1553546495	NC_000002.12:168932375:CCC:CC
NM_002529.3(NTRK1):c.253C>A (p.Arg85Ser)	NTRK1	R55S, R85S	Charcot-Marie-Tooth disease|Hereditary insensitivity to pain with anhidrosis|Familial medullary thyroid carcinoma	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000584593	1	156834186	1	156864394	584593	575643	rs543320028	NC_000001.11:156864393:C:A
NM_002529.3(NTRK1):c.851-33T>A	NTRK1		Hereditary insensitivity to pain with anhidrosis|Inborn genetic diseases	Pathogenic(Last reviewed: Jan 21, 2014)	criteria provided, single submitter	VCV000021308	1	156843392	1	156873600	21308	34160	rs80356674	NC_000001.11:156873599:T:A
NM_014795.4(ZEB2):c.1027C>T (p.Arg343Ter)	ZEB2	R343*, R319*	not provided|Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189281	2	145157727	2	144400160	189281	187166	rs786204815	NC_000002.12:144400159:G:A
NM_001365999.1(SZT2):c.8826-2A>G	SZT2		not provided	Pathogenic(Last reviewed: Mar 4, 2016)	criteria provided, single submitter	VCV000280379	1	43911563	1	43445892	280379	263992	rs886041594	NC_000001.11:43445891:A:G
NM_001365999.1(SZT2):c.4396C>T (p.Arg1466Ter)	SZT2	R1409*, R1466*	not provided	Pathogenic(Last reviewed: Mar 4, 2016)	criteria provided, single submitter	VCV000280377	1	43895769	1	43430098	280377	263991	rs766090540	NC_000001.11:43430097:C:T
NM_001365999.1(SZT2):c.5146C>T (p.Gln1716Ter)	SZT2	Q1659*, Q1716*	not provided	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000862373	1	43897444	1	43431773	862373	824048		NC_000001.11:43431772:C:T
NM_001365999.1(SZT2):c.7019del (p.Pro2340fs)	SZT2	P2340fs, P2283fs	not provided	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000852970	1	43905415	1	43439744	852970	824080		NC_000001.11:43439743:CCC:CC
NC_000001.11:g.(?_43389949)_(43450500_?)del	SZT2		not provided	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000831281	1	43855620 - 43916171			831281	818970		
NM_001365999.1(SZT2):c.8639_8640del (p.Pro2880fs)	SZT2	P2823fs, P2880fs	not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000660423	1	43909281 - 43909282	1	43443610 - 43443611	660423	627999		NC_000001.11:43443609:CT:
NM_001365999.1(SZT2):c.8811del (p.Ser2938fs)	SZT2	S2881fs, S2938fs	not provided	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000644467	1	43909448	1	43443777	644467	628003		NC_000001.11:43443776:CCCCCC:CCCCC
NM_001365999.1(SZT2):c.8995C>T (p.Gln2999Ter)	SZT2	Q2999*, Q2942*	not provided	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000640608	1	43911928	1	43446257	640608	628006		NC_000001.11:43446256:C:T
NM_001365999.1(SZT2):c.8939C>T (p.Thr2980Ile)	SZT2	T2923I, T2980I	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433096	1	43911872	1	43446201	433096	426659	rs766294629	NC_000001.11:43446200:C:T
NM_001365999.1(SZT2):c.8803C>T (p.Arg2935Trp)	SZT2	R2878W, R2935W	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433095	1	43909445	1	43443774	433095	426658	rs1553154643	NC_000001.11:43443773:C:T
NM_001365999.1(SZT2):c.7112A>T (p.Glu2371Val)	SZT2	E2314V, E2371V	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433093	1	43905621	1	43439950	433093	426656	rs1306918506	NC_000001.11:43439949:A:T
NM_001365999.1(SZT2):c.5938G>A (p.Val1980Met)	SZT2	V1923M, V1980M	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433092	1	43900904	1	43435233	433092	426655	rs780805483	NC_000001.11:43435232:G:A
NM_001365999.1(SZT2):c.4135C>T (p.Arg1379Trp)	SZT2	R1322W, R1379W	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433089	1	43894126	1	43428455	433089	426652	rs752473314	NC_000001.11:43428454:C:T
NM_001365999.1(SZT2):c.3977C>T (p.Ala1326Val)	SZT2	A1269V, A1326V	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433088	1	43893968	1	43428297	433088	426651	rs747241860	NC_000001.11:43428296:C:T
NM_001365999.1(SZT2):c.105C>G (p.Phe35Leu)	SZT2	F35L	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433086	1	43868925	1	43403254	433086	426649	rs1553138299	NC_000001.11:43403253:C:G
NM_001365999.1(SZT2):c.1496G>T (p.Ser499Ile)	SZT2	S499I	Early infantile epileptic encephalopathy 18	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000066998	1	43886654	1	43420983	66998	77883	rs886041034	NC_000001.11:43420982:G:T
NM_001365999.1(SZT2):c.2092C>T (p.Gln698Ter)	SZT2	Q698*	Early infantile epileptic encephalopathy 18	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000066997	1	43888824	1	43423153	66997	77882	rs397515490	NC_000001.11:43423152:C:T
NM_001365999.1(SZT2):c.73C>T (p.Arg25Ter)	SZT2	R25*	Early infantile epileptic encephalopathy 18	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000066996	1	43868893	1	43403222	66996	77881	rs397515489	NC_000001.11:43403221:C:T
NM_001365999.1(SZT2):c.5872C>T (p.Arg1958Ter)	SZT2	R1901*, R1958*	not provided	Pathogenic/Likely pathogenic(Last reviewed: May 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620537	1	43900124	1	43434453	620537	611522	rs145577757	NC_000001.11:43434452:C:T
NM_001365999.1(SZT2):c.2363C>G (p.Ser788Ter)	SZT2	S788*	not provided	Pathogenic(Last reviewed: Oct 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000430047	1	43889995	1	43424324	430047	421246	rs769366055	NC_000001.11:43424323:C:G
NM_001365999.1(SZT2):c.880-1G>C	SZT2		not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000851104	1	43885404	1	43419733	851104	850773		NC_000001.11:43419732:G:C
NM_001204.7(BMPR2):c.2580del (p.Asn861fs)	BMPR2	N861fs	Primary pulmonary hypertension	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000425996	2	203420967	2	202556244	425996	414359	rs1085307395	NC_000002.12:202556243:TT:T
NM_001204.7(BMPR2):c.637C>T (p.Arg213Ter)	BMPR2	R213*	not provided|Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic(Last reviewed: Jun 7, 2016)	criteria provided, single submitter	VCV000280019	2	203383560	2	202518837	280019	264058	rs886041324	NC_000002.12:202518836:C:T
NM_001204.7(BMPR2):c.377A>G (p.Asn126Ser)	BMPR2	N126S	not provided|Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic(Last reviewed: Sep 3, 2014)	criteria provided, single submitter	VCV000212817	2	203332371	2	202467648	212817	209585	rs863223426	NC_000002.12:202467647:A:G
NM_014874.3(MFN2):c.493C>T (p.His165Tyr)	MFN2	H165Y	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease|not specified	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000439897	1	12057372	1	11997315	439897	433691	rs119103262	NC_000001.11:11997314:C:T
NM_014625.3(NPHS2):c.538G>A (p.Val180Met)	NPHS2	V180M	Nephrotic syndrome, idiopathic, steroid-resistant|not provided	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005368	1	179526362	1	179557227	5368	20407	rs74315347	NC_000001.11:179557226:C:T
NM_000642.3(AGL):c.853C>T (p.Arg285Ter)	AGL	R285*, R269*	Glycogen storage disease type III	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550128	1	100336320	1	99870764	550128	541433	rs755747010	NC_000001.11:99870763:C:T
NM_000642.3(AGL):c.118C>T (p.Gln40Ter)	AGL	Q40*, Q24*	not provided|Glycogen storage disease type III	Pathogenic/Likely pathogenic(Last reviewed: May 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189045	1	100327094	1	99861538	189045	186639	rs771961377	NC_000001.11:99861537:C:T
NM_000642.3(AGL):c.100C>T (p.Arg34Ter)	AGL	R34*, R18*	Glycogen storage disease type III	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188743	1	100327076	1	99861520	188743	186638	rs781580050	NC_000001.11:99861519:C:T
NM_002617.3(PEX10):c.704dup (p.Leu236fs)	PEX10		not provided|Peroxisome biogenesis disorders, Zellweger syndrome spectrum|Peroxisome biogenesis disorder, complementation group 7|Peroxisome biogenesis disorder 6A|Peroxisome biogenesis disorder 6B	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006774	1	2338230 - 2338231	1	2406791 - 2406792	6774	21813	rs61750435	NC_000001.11:2406791:T:TT
NM_003000.2(SDHB):c.70C>T (p.Gln24Ter)	SDHB	Q24*	Pheochromocytoma|Paragangliomas 4|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000664893	1	17380445	1	17053950	664893	627115		NC_000001.11:17053949:G:A
NM_003000.2(SDHB):c.653G>A (p.Trp218Ter)	SDHB	W218*	Pheochromocytoma|Paragangliomas 4|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000664580	1	17349215	1	17022720	664580	627088		NC_000001.11:17022719:C:T
NM_003000.2(SDHB):c.656_707dup (p.Pro237_Phe238insAspTer)	SDHB		Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000662440	1	17349160 - 17349161	1	17022665 - 17022666	662440	627083		
NM_003000.3(SDHB):c.63dup (p.Cys22fs)	SDHB		Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000658395	1	17380451 - 17380452	1	17053956 - 17053957	658395	627116		NC_000001.11:17053956:GG:GGG
NM_003000.2(SDHB):c.143_144dup (p.Pro49fs)	SDHB		Pheochromocytoma|Paragangliomas 4|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000656223	1	17371311 - 17371312	1	17044816 - 17044817	656223	627109		NC_000001.11:17044816:GT:GTGT
NC_000001.10:g.(?_17345366)_(17345463_?)del	SDHB		Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000649062	1	17345366 - 17345463	1	17018871 - 17018968	649062	650564		
NM_003000.2(SDHB):c.609_622dup (p.Gly208fs)	SDHB		Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000642173	1	17350487 - 17350488	1	17023992 - 17023993	642173	627089		NC_000001.11:17023992:CCAGATATTTGTCTCC:CCAGATATTTGTCTCCAGATATTTGTCTCC
NM_003000.2(SDHB):c.148_151dup (p.Lys51fs)	SDHB		Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000642012	1	17371304 - 17371305	1	17044809 - 17044810	642012	627107		NC_000001.11:17044809:TGTCTG:TGTCTGTCTG
NM_003000.2(SDHB):c.399dup (p.Tyr134fs)	SDHB		Pheochromocytoma|Paragangliomas 4|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000579501	1	17355118 - 17355119	1	17028623 - 17028624	579501	556747	rs1557741425	NC_000001.11:17028623:C:CC
NM_003000.2(SDHB):c.608del (p.Gly203fs)	SDHB	G203fs	Pheochromocytoma|Paragangliomas 4|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000528737	1	17350502	1	17024007	528737	515287	rs1553177436	NC_000001.11:17024006:CC:C
NM_003000.2(SDHB):c.505C>T (p.Gln169Ter)	SDHB	Q169*	Pheochromocytoma|Paragangliomas 4|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, single submitter	VCV000528736	1	17354279	1	17027784	528736	515290	rs1553177676	NC_000001.11:17027783:G:A
NM_003000.2(SDHB):c.697A>T (p.Lys233Ter)	SDHB	K233*	Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000468235	1	17349171	1	17022676	468235	447379	rs1553177285	NC_000001.11:17022675:T:A
NC_000001.10:g.(?_17371256)_(17371383_?)del	SDHB		Pheochromocytoma|Paragangliomas 4|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Dec 9, 2016)	criteria provided, single submitter	VCV000417581	1	17371256 - 17371383	1	17044761 - 17044888	417581	390721		
NM_003000.2(SDHB):c.441T>G (p.Tyr147Ter)	SDHB	Y147*	Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Jul 30, 2016)	criteria provided, single submitter	VCV000412476	1	17354343	1	17027848	412476	390924	rs1060503763	NC_000001.11:17027847:A:C
NM_003000.2(SDHB):c.141G>A (p.Trp47Ter)	SDHB	W47*	Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Oct 9, 2016)	criteria provided, single submitter	VCV000412474	1	17371315	1	17044820	412474	390935	rs1060503762	NC_000001.11:17044819:C:T
NM_003000.2(SDHB):c.602G>A (p.Trp201Ter)	SDHB	W201*	Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000412470	1	17350508	1	17024013	412470	390910	rs1060503759	NC_000001.11:17024012:C:T
NM_003000.2(SDHB):c.499A>T (p.Lys167Ter)	SDHB	K167*	Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000412456	1	17354285	1	17027790	412456	390913	rs1060503753	NC_000001.11:17027789:T:A
NM_003000.2(SDHB):c.374C>G (p.Ser125Ter)	SDHB	S125*	Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000412455	1	17355144	1	17028649	412455	390921	rs786203506	NC_000001.11:17028648:G:C
NM_003000.2(SDHB):c.620_621del (p.Leu207fs)	SDHB	L207fs	Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Jul 2, 2016)	criteria provided, single submitter	VCV000412454	1	17350489 - 17350490	1	17023994 - 17023995	412454	390891	rs1060503752	NC_000001.11:17023993:CA:
NM_003000.2(SDHB):c.126del (p.Phe42fs)	SDHB	F42fs	Paragangliomas 4|Gastrointestinal stromal tumor|Pheochromocytoma	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000239421	1	17371330	1	17044835	239421	238189	rs878854572	NC_000001.11:17044834:AAA:AA
NM_003000.2(SDHB):c.-151_*159del	SDHB		Paragangliomas 4|Gastrointestinal stromal tumor|Pheochromocytoma	Pathogenic(Last reviewed: Sep 15, 2016)	criteria provided, single submitter	VCV000239419	1	17345217 - 17380665	1	17018722 - 17054170	239419	238109		
NM_000143.4(FH):c.140_147del (p.Gln47fs)	FH	Q47fs	not provided	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000817022	1	241680602 - 241680609	1	241517302 - 241517309	817022	805214		NC_000001.11:241517301:GGAATTTTGG:GG
NM_000143.3(FH):c.443dup (p.Thr149fs)	FH		not provided	Pathogenic(Last reviewed: Feb 10, 2017)	criteria provided, single submitter	VCV000545767	1	241675378 - 241675379	1	241512078 - 241512079	545767	536228	rs1553341610	NC_000001.11:241512078:T:TT
NM_000143.3(FH):c.675del (p.Phe225fs)	FH	F225fs	not provided	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000503955	1	241671966	1	241508666	503955	495074	rs1553341337	NC_000001.11:241508665:AAA:AA
NM_000143.3(FH):c.221dup (p.Ser75fs)	FH		not provided	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000503756	1	241680527 - 241680528	1	241517227 - 241517228	503756	495078	rs1553341951	NC_000001.11:241517227:C:CC
NM_000143.3(FH):c.879del (p.Ala294fs)	FH	A294fs	not provided	Pathogenic(Last reviewed: Sep 16, 2015)	criteria provided, single submitter	VCV000429833	1	241669328	1	241506028	429833	421231	rs1131691622	NC_000001.11:241506027:AA:A
NM_000143.3(FH):c.268-2A>G	FH		not provided	Pathogenic(Last reviewed: Jun 9, 2015)	criteria provided, single submitter	VCV000419237	1	241677015	1	241513715	419237	405129	rs1064793741	NC_000001.11:241513714:T:C
NM_000143.3(FH):c.944_945del (p.Leu315fs)	FH	L315fs	not provided	Pathogenic(Last reviewed: Oct 7, 2016)	criteria provided, single submitter	VCV000280929	1	241667505 - 241667506	1	241504205 - 241504206	280929	263989	rs886042044	NC_000001.11:241504204:CA:
NM_000143.3(FH):c.668_669del (p.Lys223fs)	FH	K223fs	not provided	Pathogenic(Last reviewed: Apr 7, 2015)	criteria provided, single submitter	VCV000265147	1	241671972 - 241671973	1	241508672 - 241508673	265147	259663	rs886039364	NC_000001.11:241508671:TTT:T
NM_000143.3(FH):c.295_301del (p.Leu99fs)	FH	L99fs	not provided	Pathogenic(Last reviewed: Nov 14, 2014)	criteria provided, single submitter	VCV000214435	1	241676980 - 241676986	1	241513680 - 241513686	214435	210702	rs863224017	NC_000001.11:241513679:GCTTCAAG:G
NM_000143.3(FH):c.937G>T (p.Glu313Ter)	FH	E313*	not provided	Pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000214415	1	241667513	1	241504213	214415	210679	rs863224001	NC_000001.11:241504212:C:A
NM_000143.3(FH):c.736C>T (p.Gln246Ter)	FH	Q246*	not provided	Pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	VCV000214411	1	241671905	1	241508605	214411	210690	rs863223998	NC_000001.11:241508604:G:A
NM_000143.3(FH):c.1400dup (p.Ala468fs)	FH		not provided	Pathogenic(Last reviewed: Dec 19, 2013)	criteria provided, single submitter	VCV000214406	1	241661260 - 241661261	1	241497960 - 241497961	214406	210650	rs863223993	NC_000001.11:241497960:TT:TTT
NM_000143.3(FH):c.1355_1356CT[1] (p.Leu453fs)	FH		not provided	Pathogenic(Last reviewed: Dec 13, 2013)	criteria provided, single submitter	VCV000214404	1	241663769 - 241663770	1	241500469 - 241500470	214404	210655	rs863223991	NC_000001.11:241500468:AGAGA:AGA
NM_000143.3(FH):c.1345_1348ATGA[1] (p.Asn450fs)	FH		not provided	Pathogenic(Last reviewed: Sep 5, 2013)	criteria provided, single submitter	VCV000214403	1	241663775 - 241663778	1	241500475 - 241500478	214403	210656	rs863223990	NC_000001.11:241500474:TCATTCAT:TCAT
NM_000143.3(FH):c.1263del (p.Arg421fs)	FH	R421fs	not provided	Pathogenic(Last reviewed: Jan 15, 2014)	criteria provided, single submitter	VCV000214402	1	241663864	1	241500564	214402	210661	rs863223989	NC_000001.11:241500563:CC:C
NM_000143.3(FH):c.1139_1142del (p.Met380fs)	FH	M380fs	not provided	Pathogenic(Last reviewed: Nov 19, 2014)	criteria provided, single submitter	VCV000214401	1	241665837 - 241665840	1	241502537 - 241502540	214401	210666	rs863223988	NC_000001.11:241502536:GTCA:
NM_000143.3(FH):c.816_836del (p.Ala273_Val279del)	FH		not provided	Pathogenic(Last reviewed: Aug 12, 2013)	criteria provided, single submitter	VCV000214397	1	241669371 - 241669391	1	241506071 - 241506091	214397	210686	rs863223985	NC_000001.11:241506070:ACAGCAGTGCCTCCAGCTGCGA:A
NM_000143.3(FH):c.797dup (p.Met266fs)	FH		not provided	Pathogenic(Last reviewed: Dec 23, 2014)	criteria provided, single submitter	VCV000214392	1	241669409 - 241669410	1	241506109 - 241506110	214392	210688	rs863223981	NC_000001.11:241506109:A:AA
NM_000143.3(FH):c.7C>T (p.Arg3Ter)	FH	R3*	not provided	Pathogenic(Last reviewed: Apr 17, 2013)	criteria provided, single submitter	VCV000214391	1	241683016	1	241519716	214391	210710	rs202166344	NC_000001.11:241519715:G:A
NM_000143.3(FH):c.556-1G>C	FH		not provided	Pathogenic(Last reviewed: Dec 3, 2014)	criteria provided, single submitter	VCV000197631	1	241672086	1	241508786	197631	194792	rs794727698	NC_000001.11:241508785:C:G
NM_000143.3(FH):c.1446_1449del (p.Glu484fs)	FH	E484fs	not provided	Pathogenic(Last reviewed: Aug 1, 2012)	criteria provided, single submitter	VCV000092454	1	241661212 - 241661215	1	241497912 - 241497915	92454	98363	rs398123165	NC_000001.11:241497911:CTTT:
NM_000143.3(FH):c.1200del (p.Asn400fs)	FH	N400fs	not provided	Pathogenic(Last reviewed: Jan 9, 2013)	criteria provided, single submitter	VCV000092450	1	241665779	1	241502479	92450	98359	rs398123162	NC_000001.11:241502478:A:
NM_000143.4(FH):c.663dup (p.Ser222fs)	FH		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000826525	1	241671977 - 241671978	1	241508677 - 241508678	826525	806551		NC_000001.11:241508677:TTTT:TTTTT
NM_000143.4(FH):c.434C>G (p.Ser145Ter)	FH	S145*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000824814	1	241675388	1	241512088	824814	806559		NC_000001.11:241512087:G:C
NM_000143.4(FH):c.243del (p.Ile81fs)	FH	I81fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000821277	1	241680506	1	241517206	821277	806571		NC_000001.11:241517205:AA:A
NM_000143.4(FH):c.201T>A (p.Tyr67Ter)	FH	Y67*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000820543	1	241680548	1	241517248	820543	806575		NC_000001.11:241517247:A:T
NM_000143.4(FH):c.1298dup (p.Asn433fs)	FH		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000818714	1	241663828 - 241663829	1	241500528 - 241500529	818714	806525		NC_000001.11:241500528:TTTT:TTTTT
NM_000143.4(FH):c.1240A>T (p.Lys414Ter)	FH	K414*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000818688	1	241663887	1	241500587	818688	806528		NC_000001.11:241500586:T:A
NM_000143.3(FH):c.563del (p.Asn188fs)	FH	N188fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 10, 2016)	criteria provided, single submitter	VCV000429187	1	241672078	1	241508778	429187	421013	rs1131691248	NC_000001.11:241508777:TTT:TT
NM_000143.3(FH):c.1439C>G (p.Ser480Ter)	FH	S480*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000429184	1	241661222	1	241497922	429184	420999	rs1131691245	NC_000001.11:241497921:G:C
NM_000143.3(FH):c.757C>T (p.Gln253Ter)	FH	Q253*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 16, 2015)	criteria provided, single submitter	VCV000429177	1	241669450	1	241506150	429177	421008	rs1131691239	NC_000001.11:241506149:G:A
NM_000143.3(FH):c.134del (p.Ala45fs)	FH	A45fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 9, 2015)	criteria provided, single submitter	VCV000429173	1	241680615	1	241517315	429173	421020	rs1131691237	NC_000001.11:241517314:G:
NM_000143.3(FH):c.1345_1348ATGA[3] (p.Ser452_Leu453insTer)	FH		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 3, 2014)	criteria provided, single submitter	VCV000429170	1	241663774 - 241663775	1	241500474 - 241500475	429170	421001	rs863223990	NC_000001.11:241500474:TCATTCAT:TCATTCATTCAT
NM_000143.3(FH):c.793G>A (p.Ala265Thr)	FH	A265T	Fumarase deficiency	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000016230	1	241669414	1	241506114	16230	31269	rs387906545	NC_000001.11:241506113:C:T
NM_000143.4(FH):c.1169A>G (p.Asn390Ser)	FH	N390S	Fumarase deficiency	Pathogenic(Last reviewed: Jan 1, 2020)	criteria provided, single submitter	VCV000864859	1	241665810	1	241502510	864859	855105		NC_000001.11:241502509:T:C
NM_000143.4(FH):c.780_781del (p.Arg261fs)	FH	R261fs	Fumarase deficiency	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000845546	1	241669426 - 241669427	1	241506126 - 241506127	845546	823787		NC_000001.11:241506125:TT:
NM_000143.4(FH):c.376G>T (p.Glu126Ter)	FH	E126*	Fumarase deficiency	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000841019	1	241676905	1	241513605	841019	823793		NC_000001.11:241513604:C:A
NM_000143.3(FH):c.564_587delinsG (p.Asn188fs)	FH		Fumarase deficiency	Pathogenic(Last reviewed: Jul 8, 2018)	criteria provided, single submitter	VCV000665363	1	241672054 - 241672077	1	241508754 - 241508777	665363	627655		NC_000001.11:241508753:TGCATTGCTGTGGGAAAAGTATCA:C
NM_000143.4(FH):c.344del (p.Lys115fs)	FH	K115fs	Fumarase deficiency	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000661429	1	241676937	1	241513637	661429	627666		NC_000001.11:241513636:TTT:TT
NM_000143.3(FH):c.1165_1174del (p.Gly389fs)	FH	G389fs	Fumarase deficiency	Pathogenic(Last reviewed: Dec 30, 2018)	criteria provided, single submitter	VCV000654732	1	241665805 - 241665814	1	241502505 - 241502514	654732	627635		NC_000001.11:241502504:CATGGTTCCCCATG:CATG
NM_000143.3(FH):c.175G>T (p.Glu59Ter)	FH	E59*	Fumarase deficiency	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000652242	1	241680574	1	241517274	652242	627674		NC_000001.11:241517273:C:A
NM_000143.3(FH):c.424C>T (p.Gln142Ter)	FH	Q142*	Fumarase deficiency	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000644761	1	241675398	1	241512098	644761	627660		NC_000001.11:241512097:G:A
NM_000143.3(FH):c.185_188dup (p.Asn64fs)	FH		Fumarase deficiency	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000583198	1	241680560 - 241680561	1	241517260 - 241517261	583198	557228	rs1558402255	NC_000001.11:241517260:GGCA:GGCAGGCA
NM_000143.3(FH):c.1205del (p.His402fs)	FH	H402fs	Fumarase deficiency	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000578880	1	241665774	1	241502474	578880	557212	rs1558397011	NC_000001.11:241502473:T:
NM_000143.3(FH):c.442C>T (p.Gln148Ter)	FH	Q148*	Fumarase deficiency	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000578830	1	241675380	1	241512080	578830	558451	rs1558400571	NC_000001.11:241512079:G:A
NM_000143.3(FH):c.201T>G (p.Tyr67Ter)	FH	Y67*	Fumarase deficiency	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000576558	1	241680548	1	241517248	576558	557273	rs1558402241	NC_000001.11:241517247:A:C
NM_000143.3(FH):c.1351G>T (p.Glu451Ter)	FH	E451*	Fumarase deficiency	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000575998	1	241663776	1	241500476	575998	558433	rs1558396320	NC_000001.11:241500475:C:A
NM_000143.3(FH):c.1138del (p.Ala379_Met380insTer)	FH		Fumarase deficiency	Pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000572058	1	241665841	1	241502541	572058	557263	rs781466938	NC_000001.11:241502540:TT:T
NM_000143.3(FH):c.919del (p.Thr307fs)	FH	T307fs	Fumarase deficiency	Pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	VCV000529816	1	241667531	1	241504231	529816	515810	rs1553341049	NC_000001.11:241504230:T:
NM_000143.3(FH):c.1082del (p.Asn361fs)	FH	N361fs	Fumarase deficiency	Pathogenic(Last reviewed: Oct 8, 2017)	criteria provided, single submitter	VCV000529815	1	241667368	1	241504068	529815	515748	rs1553341012	NC_000001.11:241504067:TTTT:TTT
NM_000143.3(FH):c.1028del (p.Arg343fs)	FH	R343fs	Fumarase deficiency	Pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	VCV000529809	1	241667422	1	241504122	529809	515835	rs1553341026	NC_000001.11:241504121:C:
NM_000143.3(FH):c.991dup (p.Thr331fs)	FH		Fumarase deficiency	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000529808	1	241667458 - 241667459	1	241504158 - 241504159	529808	515763	rs1553341034	NC_000001.11:241504158:T:TT
NM_000143.3(FH):c.999C>A (p.Cys333Ter)	FH	C333*	Fumarase deficiency	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000529804	1	241667451	1	241504151	529804	515723	rs1553341031	NC_000001.11:241504150:G:T
NM_000143.3(FH):c.634C>T (p.Gln212Ter)	FH	Q212*	Fumarase deficiency	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000460367	1	241672007	1	241508707	460367	447702	rs1553341353	NC_000001.11:241508706:G:A
NM_000143.3(FH):c.379-2A>G	FH		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 16, 2015)	criteria provided, single submitter	VCV000429178	1	241675445	1	241512145	429178	421017	rs1131691240	NC_000001.11:241512144:T:C
NC_000001.10:g.(?_241660857)_(241667545_?)del	FH		Fumarase deficiency	Pathogenic(Last reviewed: Nov 9, 2016)	criteria provided, single submitter	VCV000417362	1	241660857 - 241667545	1	241497557 - 241504245	417362	390724		
NC_000001.10:g.(?_241660857)_(241683085_?)del	FH		Fumarase deficiency	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000417361	1	241660857 - 241683085	1	241497557 - 241519785	417361	390727		
NM_000143.3(FH):c.560C>A (p.Ser187Ter)	FH	S187*	Fumarase deficiency	Pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, single submitter	VCV000405935	1	241672081	1	241508781	405935	391296	rs398123166	NC_000001.11:241508780:G:T
NM_000143.3(FH):c.1112del (p.Lys371fs)	FH	K371fs	Fumarase deficiency	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000405928	1	241665867	1	241502567	405928	391117	rs1060500904	NC_000001.11:241502566:TT:T
NM_000143.3(FH):c.1347del (p.Met449fs)	FH	M449fs	Fumarase deficiency	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000405924	1	241663780	1	241500480	405924	391254	rs1060500903	NC_000001.11:241500479:C:
NM_000143.3(FH):c.679C>T (p.Gln227Ter)	FH	Q227*	Fumarase deficiency	Pathogenic(Last reviewed: Oct 21, 2016)	criteria provided, single submitter	VCV000405913	1	241671962	1	241508662	405913	391174	rs11545658	NC_000001.11:241508661:G:A
NM_000143.3(FH):c.1052C>A (p.Ser351Ter)	FH	S351*	Fumarase deficiency	Pathogenic(Last reviewed: May 23, 2016)	criteria provided, single submitter	VCV000405912	1	241667398	1	241504098	405912	391121	rs1060500896	NC_000001.11:241504097:G:T
NM_000143.3(FH):c.439A>G (p.Thr147Ala)	FH	T147A	Fumarase deficiency	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000214395	1	241675383	1	241512083	214395	210699	rs863223983	NC_000001.11:241512082:T:C
NM_000143.3(FH):c.1327G>T (p.Glu443Ter)	FH	E443*	Fumarase deficiency	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000214385	1	241663800	1	241500500	214385	210658		NC_000001.11:241500499:C:A
FH, DEL	FH		Fumarase deficiency	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000029706					29706	38661		
NM_000143.3(FH):c.1084G>C (p.Glu362Gln)	FH	E319Q, E362Q	Fumarase deficiency	Pathogenic(Last reviewed: Jun 1, 1994)	no assertion criteria provided	VCV000016231	1	241667366	1	241504066	16231	31270	rs121913119	NC_000001.11:241504065:C:G
NM_000143.4(FH):c.556-3_562del	FH		Fumarase deficiency	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000857120	1	241672079 - 241672088	1	241508779 - 241508788	857120	850770		NC_000001.11:241508778:TTGAGCTCTGTTG:TTG
NC_000001.11:g.(?_241497818)_(241512153_?)del	FH		Fumarase deficiency	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000833090	1	241661118 - 241675453			833090	818950		
NC_000001.11:g.(?_241505993)_(241506183_?)del	FH		Fumarase deficiency	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000832434	1	241669293 - 241669483			832434	818952		
NM_000143.4(FH):c.893_904+7del	FH		Hereditary leiomyomatosis and renal cell cancer	Pathogenic	no assertion criteria provided	VCV000827768	1	241669296 - 241669314	1	241505996 - 241506014	827768	815966		NC_000001.11:241505995:CACTAACCTGTAAGTGCAGC:C
NC_000001.10:g.(?_241661118)_(241672095_?)del	FH		Fumarase deficiency	Pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, single submitter	VCV000662851	1	241661118 - 241672095	1	241497818 - 241508795	662851	650578		
NM_000143.3(FH):c.1435G>T (p.Gly479Ter)	FH	G479*	Fumarase deficiency	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000658197	1	241661226	1	241497926	658197	627628		NC_000001.11:241497925:C:A
NM_000143.4(FH):c.418del (p.Val140fs)	FH	V140fs	Fumarase deficiency	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000641584	1	241675404	1	241512104	641584	627661		NC_000001.11:241512103:CC:C
NC_000001.10:g.(?_241669293)_(241669478_?)del	FH		Fumarase deficiency	Pathogenic(Last reviewed: Aug 11, 2019)	criteria provided, single submitter	VCV000583507	1	241669293 - 241669478	1	241505993 - 241506178	583507	556529		
Single allele	FH		Fumarase deficiency	Pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	VCV000460334			1	241505997 - 241506174	460334	446934		
NM_000143.3(FH):c.556_557delAG	FH		not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 27, 2015)	criteria provided, multiple submitters, no conflicts	VCV000429169	1	241672084 - 241672085	1	241508784 - 241508785	429169	421014	rs1131691235	NC_000001.11:241508783:CTCT:CT
NM_000143.3(FH):c.1298_1340dup (p.Met449fs)	FH		Hereditary leiomyomatosis and renal cell cancer	Pathogenic(Last reviewed: Jan 17, 2017)	criteria provided, single submitter	VCV000393581	1	241663786 - 241663787	1	241500486 - 241500487	393581	380448	rs1553340681	NC_000001.11:241500486:TTGTTGATCCTTTCTGTATTGGCCTGGATTCCCACCACGCAGTTT:TTGTTGATCCTTTCTGTATTGGCCTGGATTCCCACCACGCAGTTTGTTGATCCTTTCTGTATTGGCCTGGATTCCCACCACGCAGTTT
NM_000143.3(FH):c.808del (p.Tyr270fs)	FH	Y270fs	Hereditary leiomyomatosis and renal cell cancer	Pathogenic(Last reviewed: Jan 17, 2017)	criteria provided, single submitter	VCV000393572	1	241669399	1	241506099	393572	380457	rs1060499637	NC_000001.11:241506098:A:
NM_000143.3(FH):c.524del (p.Val175fs)	FH	V175fs	Hereditary leiomyomatosis and renal cell cancer	Pathogenic(Last reviewed: Jan 17, 2017)	criteria provided, single submitter	VCV000393564	1	241675298	1	241511998	393564	380465	rs1060499634	NC_000001.11:241511997:A:
NM_000143.3(FH):c.395del (p.Lys131_Leu132insTer)	FH		Hereditary leiomyomatosis and renal cell cancer	Pathogenic(Last reviewed: Jan 17, 2017)	criteria provided, single submitter	VCV000393561	1	241675427	1	241512127	393561	380468	rs1060499631	NC_000001.11:241512126:AA:A
NM_000143.3(FH):c.267+1_267+10del	FH		Hereditary leiomyomatosis and renal cell cancer	Pathogenic(Last reviewed: Jan 17, 2017)	criteria provided, single submitter	VCV000393559	1	241680472 - 241680481	1	241517172 - 241517181	393559	380470	rs1060499629	NC_000001.11:241517171:TGCCACTTACTG:TG
NM_000143.3(FH):c.157G>T (p.Glu53Ter)	FH	E53*	Hereditary leiomyomatosis and renal cell cancer	Pathogenic(Last reviewed: Jan 17, 2017)	criteria provided, single submitter	VCV000393557	1	241680592	1	241517292	393557	380472	rs863224013	NC_000001.11:241517291:C:A
NM_000143.3(FH):c.1390+1G>T	FH		Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265150	1	241663736	1	241500436	265150	259660	rs886039367	NC_000001.11:241500435:C:A
NM_000143.3(FH):c.1056dup (p.Leu353fs)	FH		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Nov 18, 2016)	criteria provided, multiple submitters, no conflicts	VCV000214434	1	241667393 - 241667394	1	241504093 - 241504094	214434	210672	rs863224016	NC_000001.11:241504093:A:AA
NM_000143.3(FH):c.133-1G>A	FH		Hereditary leiomyomatosis and renal cell cancer	Pathogenic(Last reviewed: Jan 17, 2017)	criteria provided, single submitter	VCV000214426	1	241680617	1	241517317	214426	210707	rs863224011	NC_000001.11:241517316:C:T
NM_000143.3(FH):c.1210G>T (p.Glu404Ter)	FH	E404*	Hereditary leiomyomatosis and renal cell cancer	Pathogenic(Last reviewed: Aug 20, 2015)	no assertion criteria provided	VCV000208375	1	241665769	1	241502469	208375	204603	rs797044974	NC_000001.11:241502468:C:A
NC_000001.11:g.(?_241519581)_(241519732_?)del	FH		Fumarase deficiency	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000831658	1	241682881 - 241683032			831658	818955		
NM_000143.3(FH):c.127C>T (p.Arg43Ter)	FH	R43*	Fumarase deficiency	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000644260	1	241682896	1	241519596	644260	627678		NC_000001.11:241519595:G:A
NM_000143.4(FH):c.5dup (p.Tyr2Ter)	FH		Fumarase deficiency	Pathogenic(Last reviewed: Dec 8, 2018)	criteria provided, single submitter	VCV000643704	1	241683017 - 241683018	1	241519717 - 241519718	643704	627683		NC_000001.11:241519717:T:TT
NM_000143.3(FH):c.120_130del (p.Ala41fs)	FH	A41fs	Fumarase deficiency	Pathogenic(Last reviewed: Dec 2, 2018)	criteria provided, single submitter	VCV000642622	1	241682893 - 241682903	1	241519593 - 241519603	642622	627677		NC_000001.11:241519592:TTCGAGCCGCGTTCG:TTCG
NC_000001.10:g.(?_241682885)_(241683028_?)del	FH		Fumarase deficiency	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000584410	1	241682885 - 241683028	1	241519585 - 241519728	584410	556499		
NM_000143.3(FH):c.65T>A (p.Leu22Ter)	FH	L22*	Fumarase deficiency	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000573460	1	241682958	1	241519658	573460	556938	rs1031919395	NC_000001.11:241519657:A:T
NM_000143.3(FH):c.1236+1G>A	FH		Fumarase deficiency	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000529817	1	241665742	1	241502442	529817	515829	rs1131691249	NC_000001.11:241502441:C:T
NM_000143.3(FH):c.379-1G>A	FH		Fumarase deficiency	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000460352	1	241675444	1	241512144	460352	448033	rs1553341623	NC_000001.11:241512143:C:T
NM_000143.3(FH):c.1445T>G (p.Leu482Ter)	FH	L482*	not provided|Fumarase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000423941	1	241661216	1	241497916	423941	405120	rs1064796708	NC_000001.11:241497915:A:C
NM_000143.3(FH):c.504del (p.Glu168fs)	FH	E168fs	Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000422293	1	241675318	1	241512018	422293	405128	rs776190273	NC_000001.11:241512017:TT:T
NM_000143.3(FH):c.1479_1483AGCAG[1] (p.Glu495fs)	FH		Fumarase deficiency	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000405937	1	241661173 - 241661177	1	241497873 - 241497877	405937	391231	rs1060500907	NC_000001.11:241497872:CTGCTCTGCT:CTGCT
NM_000143.3(FH):c.1391-1G>A	FH		Fumarase deficiency	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000405909	1	241661271	1	241497971	405909	391095	rs863223978	NC_000001.11:241497970:C:T
NM_000143.3(FH):c.1391-2A>T	FH		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000214423	1	241661272	1	241497972	214423	210653	rs863224008	NC_000001.11:241497971:T:A
NM_000143.3(FH):c.737del (p.Gln246fs)	FH	Q246fs	not provided|Fumarase deficiency	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000167067	1	241671904	1	241508604	167067	177706	rs727503928	NC_000001.11:241508603:T:
NM_000143.3(FH):c.669_670AG[1] (p.Glu224fs)	FH		Hereditary leiomyomatosis and renal cell cancer	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000016234	1	241671969 - 241671970	1	241508669 - 241508670	16234	31273	rs780001199	NC_000001.11:241508668:CTCT:CT
NM_000329.3(RPE65):c.272G>A (p.Arg91Gln)	RPE65	R91Q	not provided|Retinitis pigmentosa 20|Leber congenital amaurosis 2	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000098857	1	68910540	1	68444857	98857	104747	rs61752873	NC_000001.11:68444856:C:T
NM_000329.3(RPE65):c.11+5G>A	RPE65		Retinitis pigmentosa 20|Retinal dystrophy|Leber congenital amaurosis 2|Retinitis pigmentosa 20|Leber congenital amaurosis 2|not provided	Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000098825	1	68915573	1	68449890	98825	104715	rs61751276	NC_000001.11:68449889:C:T
NM_000143.3(FH):c.353del (p.Asn118fs)	FH	N118fs	Hereditary cancer-predisposing syndrome|Fumarase deficiency	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000576345	1	241676928	1	241513628	576345	557222	rs1558401064	NC_000001.11:241513627:TT:T
NM_000143.3(FH):c.301_319del (p.Arg101fs)	FH	R101fs	Hereditary cancer-predisposing syndrome|Fumarase deficiency	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000569195	1	241676962 - 241676980	1	241513662 - 241513680	569195	557224	rs1558401094	NC_000001.11:241513661:TTACTTCAGCGGCCGCTCG:
NM_000143.3(FH):c.237dup (p.Lys80Ter)	FH		Fumarase deficiency|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480830	1	241680511 - 241680512	1	241517211 - 241517212	480830	472375	rs1553341945	NC_000001.11:241517211:AAA:AAAA
NM_000143.3(FH):c.583A>G (p.Met195Val)	FH	M195V	Fumarase deficiency	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000460368	1	241672058	1	241508758	460368	448046	rs1553341364	NC_000001.11:241508757:T:C
NM_000143.3(FH):c.174_177dup (p.Leu60Ter)	FH		Fumarase deficiency|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429185	1	241680571 - 241680572	1	241517271 - 241517272	429185	421019	rs1131691246	NC_000001.11:241517271:TTCA:TTCATTCA
NM_000143.3(FH):c.739G>T (p.Glu247Ter)	FH	E247*	Fumarase deficiency|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429182	1	241669468	1	241506168	429182	421009	rs1131691243	NC_000001.11:241506167:C:A
NM_000143.3(FH):c.1052C>G (p.Ser351Ter)	FH	S351*	Fumarase deficiency|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429168	1	241667398	1	241504098	429168	421006	rs1060500896	NC_000001.11:241504097:G:C
NM_000143.3(FH):c.805del (p.Ile269fs)	FH	I269fs	Fumarase deficiency|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429167	1	241669402	1	241506102	429167	421007	rs1131691234	NC_000001.11:241506101:TT:T
NM_000143.3(FH):c.267+1G>A	FH		Fumarase deficiency	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000405927	1	241680481	1	241517181	405927	391147	rs878853691	NC_000001.11:241517180:C:T
NM_000143.3(FH):c.204T>A (p.Tyr68Ter)	FH	Y68*	Fumarase deficiency|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 4, 2016)	criteria provided, multiple submitters, no conflicts	VCV000405883	1	241680545	1	241517245	405883	391202	rs1060500883	NC_000001.11:241517244:A:T
NM_000143.3(FH):c.439dup (p.Thr147fs)	FH		not provided|Hereditary leiomyomatosis and renal cell cancer	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000393563	1	241675382 - 241675383	1	241512082 - 241512083	393563	380466	rs1060499633	NC_000001.11:241512082:TT:TTT
NM_000143.3(FH):c.390_394TAAAT[1] (p.Lys131_Leu132insTer)	FH		Hereditary leiomyomatosis and renal cell cancer|not provided	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000214408	1	241675423 - 241675427	1	241512123 - 241512127	214408	210701	rs863223995	NC_000001.11:241512122:ATTTAATTTA:ATTTA
NM_000143.3(FH):c.1339A>T (p.Lys447Ter)	FH	K447*	Hereditary cancer-predisposing syndrome|Fumarase deficiency	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000214386	1	241663788	1	241500488	214386	210657	rs863223977	NC_000001.11:241500487:T:A
NM_000143.3(FH):c.786_806del (p.Lys263_Ile269del)	FH		Fumarase deficiency|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000185496	1	241669401 - 241669421	1	241506101 - 241506121	185496	181631	rs786202220	NC_000001.11:241506100:ATTCTTGGCATGGCAGCTTTTATTCTTG:ATTCTTG
NM_000143.3(FH):c.1126C>T (p.Gln376Ter)	FH	Q376*	not provided|Hereditary leiomyomatosis and renal cell cancer	Pathogenic(Last reviewed: Jan 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000092448	1	241665853	1	241502553	92448	98357	rs398123160	NC_000001.11:241502552:G:A
NM_000016.5(ACADM):c.600-18G>A	ACADM		Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000226084	1	76211473	1	75745788	226084	227889	rs370523609	NC_000001.11:75745787:G:A
NM_000016.5(ACADM):c.583G>A (p.Gly195Arg)	ACADM	G170R, G195R, G199R, G6R, G228R, G159R	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003594	1	76205779	1	75740094	3594	18633	rs121434278	NC_000001.11:75740093:G:A
NM_000143.3(FH):c.568_569del (p.Thr190fs)	FH	T190fs	Fumarase deficiency|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000529823	1	241672072 - 241672073	1	241508772 - 241508773	529823	515731	rs1553341367	NC_000001.11:241508771:GT:
NM_000143.3(FH):c.1209del (p.Phe403fs)	FH	F403fs	Hereditary cancer-predisposing syndrome|Hereditary leiomyomatosis and renal cell cancer	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000393580	1	241665770	1	241502470	393580	380449	rs1060499644	NC_000001.11:241502469:AAAA:AAA
NM_000143.3(FH):c.349G>C (p.Ala117Pro)	FH	A117P	Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265146	1	241676932	1	241513632	265146	259664	rs886039363	NC_000001.11:241513631:C:G
NM_000143.3(FH):c.132G>A (p.Met44Ile)	FH	M44I	Hereditary cancer-predisposing syndrome|Fumarase deficiency	Pathogenic(Last reviewed: Oct 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000214393	1	241682891	1	241519591	214393	210708	rs863223982	NC_000001.11:241519590:C:T
NM_000143.3(FH):c.1391-1G>C	FH		Fumarase deficiency|not provided	Pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000214387	1	241661271	1	241497971	214387	210652	rs863223978	NC_000001.11:241497970:C:G
NM_000143.3(FH):c.584T>C (p.Met195Thr)	FH	M195T	not provided|Fumarase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000214373	1	241672057	1	241508757	214373	210695	rs863223965	NC_000001.11:241508756:A:G
NM_000143.3(FH):c.760C>T (p.Gln254Ter)	FH	Q254*	Fumarase deficiency|not provided	Pathogenic(Last reviewed: Mar 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092457	1	241669447	1	241506147	92457	98366	rs398123167	NC_000001.11:241506146:G:A
NM_201253.3(CRB1):c.3122T>C (p.Met1041Thr)	CRB1	M1041T, M1017T, M929T	Retinitis pigmentosa 12|Retinal dystrophy|CRB1-Related Disorders|Leber congenital amaurosis 8|Retinitis pigmentosa 12|not provided	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005730	1	197404115	1	197434985	5730	20769	rs62635656	NC_000001.11:197434984:T:C
NM_014874.3(MFN2):c.776G>A (p.Arg259His)	MFN2	R259H	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000577496	1	12059112	1	11999055	577496	556905	rs755065651	NC_000001.11:11999054:G:A
NM_014874.3(MFN2):c.707C>T (p.Thr236Met)	MFN2	T236M	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, type 2|Distal muscle weakness|Peripheral axonal neuropathy|Distal lower limb amyotrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217165	1	12058934	1	11998877	217165	213789	rs773159585	NC_000001.11:11998876:C:T
NM_014874.3(MFN2):c.647T>C (p.Phe216Ser)	MFN2	F216S	not provided|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B	Pathogenic/Likely pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000030736	1	12058874	1	11998817	30736	39693	rs387906990	NC_000001.11:11998816:T:C
NC_000001.11:g.(?_241497818)_(241502580_?)del	FH		Fumarase deficiency	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000833143	1	241661118 - 241665880			833143	818949		
NC_000001.10:g.(?_241661118)_(241683032_?)del	FH		Fumarase deficiency	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000665629	1	241661118 - 241683032	1	241497818 - 241519732	665629	650573		
NM_000143.3(FH):c.1328_1331dup (p.Ile445fs)	FH		Fumarase deficiency	Pathogenic(Last reviewed: Aug 26, 2018)	criteria provided, single submitter	VCV000662311	1	241663795 - 241663796	1	241500495 - 241500496	662311	627632		NC_000001.11:241500495:CTTTCT:CTTTCTTTCT
NM_000143.3(FH):c.1251dup (p.His418fs)	FH		Fumarase deficiency	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000460337	1	241663875 - 241663876	1	241500575 - 241500576	460337	447919	rs1553340708	NC_000001.11:241500575:T:TT
NM_000143.3(FH):c.1236+1G>C	FH		Fumarase deficiency|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429188	1	241665742	1	241502442	429188	421003	rs1131691249	NC_000001.11:241502441:C:G
NM_000143.3(FH):c.738+2T>C	FH		Fumarase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000405921	1	241671901	1	241508601	405921	391136	rs1060500901	NC_000001.11:241508600:A:G
NM_000143.3(FH):c.1063G>T (p.Glu355Ter)	FH	E355*	Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency	Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000393577	1	241667387	1	241504087	393577	380452	rs1060499642	NC_000001.11:241504086:C:A
NM_000143.3(FH):c.578_583del (p.Thr193_Ala194del)	FH		Hereditary leiomyomatosis and renal cell cancer|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000393568	1	241672058 - 241672063	1	241508758 - 241508763	393568	380461	rs1060499635	NC_000001.11:241508757:TTGCTGT:T
NM_000143.3(FH):c.478A>G (p.Arg160Gly)	FH	R160G	Fumarase deficiency|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237116	1	241675344	1	241512044	237116	238260	rs878853694	NC_000001.11:241512043:T:C
NM_000143.3(FH):c.316del (p.Glu105_Val106insTer)	FH		Hereditary cancer-predisposing syndrome|not provided|Fumarase deficiency	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000230443	1	241676965	1	241513665	230443	232195	rs876658569	NC_000001.11:241513664:C:
NM_000143.3(FH):c.1370_1371insTCAC (p.Ala458fs)	FH		Hereditary cancer-predisposing syndrome|Fumarase deficiency|not provided	Pathogenic(Last reviewed: Mar 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000214405	1	241663756 - 241663757	1	241500456 - 241500457	214405	210654	rs863223992	NC_000001.11:241500456:GT:GTGAGT
NM_000143.3(FH):c.1067T>A (p.Leu356Ter)	FH	L356*	not provided|Hereditary leiomyomatosis and renal cell cancer	Pathogenic/Likely pathogenic(Last reviewed: May 17, 2016)	criteria provided, multiple submitters, no conflicts	VCV000167066	1	241667383	1	241504083	167066	177061	rs727503927	NC_000001.11:241504082:A:T
NM_001276345.2(TNNT2):c.891G>A (p.Trp297Ter)	TNNT2	W287*, W294*, W284*, W281*, W254*, W297*	Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Cardiovascular phenotype|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000181636	1	201328344	1	201359216	181636	178913	rs730881116	NC_000001.11:201359215:C:T
NM_198576.4(AGRN):c.5023G>A (p.Gly1675Ser)	AGRN	G1675S, G1570S	Congenital myasthenic syndrome	Pathogenic(Last reviewed: Jul 14, 2016)	no assertion criteria provided	VCV000243039	1	985853	1	1050473	243039	244113	rs764160563	NC_000001.11:1050472:G:A
NM_198576.4(AGRN):c.1362dup (p.Ser455fs)	AGRN		Congenital myasthenic syndrome	Pathogenic(Last reviewed: Jul 14, 2016)	no assertion criteria provided	VCV000243038	1	977516 - 977517	1	1042136 - 1042137	243038	244112	rs879253788	NC_000001.11:1042136:CCCC:CCCCC
NM_198576.4(AGRN):c.1036_1039dup (p.Glu347fs)	AGRN		Myasthenic syndrome, congenital, 8	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000654968	1	976939 - 976940	1	1041559 - 1041560	654968	626508		NC_000001.11:1041559:GCCCG:GCCCGCCCG
NM_198576.4(AGRN):c.902_912del (p.Arg301fs)	AGRN	R301fs, R196fs	Myasthenic syndrome, congenital, 8	Pathogenic(Last reviewed: Aug 11, 2018)	criteria provided, single submitter	VCV000654128	1	976719 - 976729	1	1041339 - 1041349	654128	626505		NC_000001.11:1041338:CCTGCGCCGCGCCTGCGCC:CCTGCGCC
NM_198576.4(AGRN):c.1275C>G (p.Tyr425Ter)	AGRN	Y320*, Y425*	Myasthenic syndrome, congenital, 8	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000644955	1	977433	1	1042053	644955	626510		NC_000001.11:1042052:C:G
NM_198576.4(AGRN):c.914_947del (p.Arg305fs)	AGRN	R305fs, R200fs	Myasthenic syndrome, congenital, 8	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000574478	1	976735 - 976768	1	1041355 - 1041388	574478	556892	rs1557700705	NC_000001.11:1041354:GCCCGCCAGGAGAATGTCTTCAAGAAGTTCGACGGCCC:GCCC
1p36.33 deletion (0.48 Mb)	AGRN		Congenital myasthenic syndrome	Pathogenic(Last reviewed: Jul 14, 2016)	no assertion criteria provided	VCV000243041					243041	244122		
NM_198576.4(AGRN):c.314A>T (p.Asn105Ile)	AGRN	N105I	Congenital myasthenic syndrome	Pathogenic(Last reviewed: Jul 14, 2016)	no assertion criteria provided	VCV000243037	1	957693	1	1022313	243037	244111	rs879253787	NC_000001.11:1022312:A:T
NM_198576.4(AGRN):c.226G>A (p.Gly76Ser)	AGRN	G76S	Congenital myasthenic syndrome	Pathogenic(Last reviewed: Jul 14, 2016)	no assertion criteria provided	VCV000243036	1	957605	1	1022225	243036	244110	rs756623659	NC_000001.11:1022224:G:A
NM_198576.4(AGRN):c.1057C>T (p.Gln353Ter)	AGRN	Q353*, Q248*	Myasthenic syndrome, congenital, 8|Congenital myasthenic syndrome	Pathogenic(Last reviewed: Jul 14, 2016)	no assertion criteria provided	VCV000126556	1	976962	1	1041582	126556	132069	rs587777299	NC_000001.11:1041581:C:T
NM_198576.4(AGRN):c.5179G>T (p.Val1727Phe)	AGRN	V1727F, V1622F	Myasthenic syndrome, congenital, 8|Congenital myasthenic syndrome	Pathogenic(Last reviewed: Jul 14, 2016)	no assertion criteria provided	VCV000126555	1	986143	1	1050763	126555	132068	rs587777298	NC_000001.11:1050762:G:T
NM_198576.4(AGRN):c.5125G>C (p.Gly1709Arg)	AGRN	G1709R, G1604R	Myasthenic syndrome, congenital, 8|Congenital myasthenic syndrome	Pathogenic(Last reviewed: Jul 14, 2016)	no assertion criteria provided	VCV000018241	1	985955	1	1050575	18241	33280	rs199476396	NC_000001.11:1050574:G:C
NC_000001.10:g.(?_241661118)_(241667555_?)del	FH		Fumarase deficiency	Pathogenic(Last reviewed: Nov 17, 2018)	criteria provided, single submitter	VCV000647960	1	241661118 - 241667555	1	241497818 - 241504255	647960	650559		
NM_000143.3(FH):c.1294_1336dup (p.Asn446fs)	FH		Fumarase deficiency|not provided	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000422542	1	241663790 - 241663791	1	241500490 - 241500491	422542	405122	rs1553340686	NC_000001.11:241500490:TGATCCTTTCTGTATTGGCCTGGATTCCCACCACGCAGTTTTCTG:TGATCCTTTCTGTATTGGCCTGGATTCCCACCACGCAGTTTTCTGATCCTTTCTGTATTGGCCTGGATTCCCACCACGCAGTTTTCTG
NM_000143.3(FH):c.1138dup (p.Met380fs)	FH		Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000393579	1	241665840 - 241665841	1	241502540 - 241502541	393579	380450	rs781466938	NC_000001.11:241502540:TT:TTT
NM_000143.3(FH):c.1500G>A (p.Trp500Ter)	FH	W500*	Hereditary leiomyomatosis and renal cell cancer|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000265151	1	241661161	1	241497861	265151	259659	rs886039368	NC_000001.11:241497860:C:T
NM_000143.3(FH):c.267+1G>C	FH		Fumarase deficiency|Hereditary leiomyomatosis and renal cell cancer	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237112	1	241680481	1	241517181	237112	238262	rs878853691	NC_000001.11:241517180:C:G
NC_000001.10:g.(?_17371246)_(17371393_?)del	SDHB		Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, single submitter	VCV000649629	1	17371246 - 17371393	1	17044751 - 17044898	649629	650566		
NC_000001.10:g.(?_17359545)_(17359650_?)del	SDHB		Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000583569	1	17359545 - 17359650	1	17033050 - 17033155	583569	556521		
NC_000001.10:g.(?_17359549)_(17359646_?)del	SDHB		Pheochromocytoma|Paragangliomas 4|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000528762	1	17359549 - 17359646	1	17033054 - 17033151	528762	514882		
NM_003000.2(SDHB):c.491del (p.Gln164fs)	SDHB	Q164fs	Pheochromocytoma|Paragangliomas 4|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000528750	1	17354293	1	17027798	528750	515362	rs1553177678	NC_000001.11:17027797:T:
NM_003000.2(SDHB):c.112del (p.Arg38fs)	SDHB	R38fs	Pheochromocytoma|Paragangliomas 4|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000528741	1	17371344	1	17044849	528741	515373	rs398123690	NC_000001.11:17044848:GGGG:GGG
NM_003000.2(SDHB):c.685_686insCGCTTCACAGAGG (p.Glu229fs)	SDHB		Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, single submitter	VCV000468238	1	17349182 - 17349183	1	17022687 - 17022688	468238	447490	rs1209914140	NC_000001.11:17022687:CCTCTGTGAAG:CCTCTGTGAAGCGCCTCTGTGAAG
NM_001301365.1(LYST):c.3310C>T (p.Arg1104Ter)	LYST	R1103*, R1104*	Chediak-Higashi syndrome, adult type|not provided|Chédiak-Higashi syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003809	1	235969126	1	235805826	3809	18848	rs80338652	NC_000001.11:235805825:G:A
NM_000642.3(AGL):c.4456del (p.Ser1486fs)	AGL	S1470fs, S1486fs	Glycogen storage disease type III|Glycogen storage disease IIIa|not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001098	1	100382260	1	99916704	1098	16137	rs113994134	NC_000001.11:99916703:TTT:TT
NM_000642.3(AGL):c.2039G>A (p.Trp680Ter)	AGL	W680*, W664*	Glycogen storage disease type III|Glycogen storage disease IIIb|not provided	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001096	1	100346885	1	99881329	1096	16135	rs113994129	NC_000001.11:99881328:G:A
NM_000642.3(AGL):c.16C>T (p.Gln6Ter)	AGL	Q6*	Glycogen storage disease IIIb|Glycogen storage disease type III|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001095	1	100316614	1	99851058	1095	16134	rs113994126	NC_000001.11:99851057:C:T
NM_000310.3(PPT1):c.29T>A (p.Leu10Ter)	PPT1	L10*	|not provided|History of neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008903	1	40562882	1	40097210	8903	23942	rs137852699	NC_000001.11:40097209:A:T
NM_213653.3(HJV):c.959G>T (p.Gly320Val)	HJV	G320V, G207V, G94V	Hemochromatosis type 1|Hemochromatosis type 2A|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002365	1	145416614	1	146018399	2365	17404	rs74315323	NC_000001.11:146018398:C:A
NM_014795.4(ZEB2):c.2761C>T (p.Arg921Ter)	ZEB2	R921*, R897*	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000160323	2	145155993	2	144398426	160323	168023	rs587784566	NC_000002.12:144398425:G:A
NM_000143.3(FH):c.1041del (p.Gly348fs)	FH	G348fs	Hereditary leiomyomatosis and renal cell cancer|Hereditary cancer-predisposing syndrome|Fumarase deficiency	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000393576	1	241667409	1	241504109	393576	380453	rs1060499641	NC_000001.11:241504108:A:
NM_000143.3(FH):c.556-2A>T	FH		Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000393566	1	241672087	1	241508787	393566	380463	rs750273092	NC_000001.11:241508786:T:A
NM_000143.3(FH):c.1108+1G>T	FH		Hereditary cancer-predisposing syndrome|not provided|Fumarase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372365	1	241667341	1	241504041	372365	359309	rs1057517734	NC_000001.11:241504040:C:A
NM_000143.3(FH):c.1473_1474TC[1] (p.Leu492fs)	FH		Fumarase deficiency|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279807	1	241661185 - 241661186	1	241497885 - 241497886	279807	264011	rs886041201	NC_000001.11:241497884:GAGA:GA
NM_000143.3(FH):c.1430_1437dup (p.Ser480fs)	FH		not provided|Fumarase deficiency	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000214407	1	241661223 - 241661224	1	241497923 - 241497924	214407	210648	rs863223994	NC_000001.11:241497923:TCCATTTTT:TCCATTTTTCCATTTTT
NM_002354.2(EPCAM):c.904-?_945+?del	EPCAM		Lynch syndrome	Pathogenic(Last reviewed: Dec 15, 2015)	criteria provided, single submitter	VCV000433577	2	47613711 - 47613752			433577	427589		
NM_014874.3(MFN2):c.1091G>A (p.Arg364Gln)	MFN2	R364Q	Charcot-Marie-Tooth disease, type 2|not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000245944	1	12062091	1	12002034	245944	244195	rs879254011	NC_000001.11:12002033:G:A
NM_001204.7(BMPR2):c.961C>T (p.Arg321Ter)	BMPR2	R321*	not specified|Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic(Last reviewed: Jun 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000409826	2	203384918	2	202520195	409826	392462	rs1060502581	NC_000002.12:202520194:C:T
NM_000143.3(FH):c.722_738+3del	FH		Hereditary cancer-predisposing syndrome|Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000393570	1	241671900 - 241671919	1	241508600 - 241508619	393570	380458	rs1064792900	NC_000001.11:241508599:TACCTGCCCAAGAGTAAGTG:
NM_000143.3(FH):c.322C>T (p.Gln108Ter)	FH	Q108*	Hereditary leiomyomatosis and renal cell cancer|Cutaneous leiomyoma|Uterine leiomyoma|Fumarase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jun 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000393560	1	241676959	1	241513659	393560	380469	rs1060499630	NC_000001.11:241513658:G:A
NM_001040142.2(SCN2A):c.2581del (p.Ala861fs)	SCN2A	A861fs	not provided	Pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, single submitter	VCV000817420	2	166201082	2	165344572	817420	805251		NC_000002.12:165344571:GG:G
NM_001040142.2(SCN2A):c.4267G>T (p.Gly1423Ter)	SCN2A	G1423*	not provided	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000620576	2	166234119	2	165377609	620576	611537	rs1553461660	NC_000002.12:165377608:G:T
NM_001040142.2(SCN2A):c.4517C>A (p.Ser1506Ter)	SCN2A	S1506*	not provided	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000620445	2	166237673	2	165381163	620445	611538	rs1287017958	NC_000002.12:165381162:C:A
NM_001040142.2(SCN2A):c.1747C>T (p.Arg583Ter)	SCN2A	R583*	not provided	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000620152	2	166179741	2	165323231	620152	611535	rs1553571901	NC_000002.12:165323230:C:T
NM_001040142.2(SCN2A):c.4980_4983del (p.Phe1661fs)	SCN2A	F1661fs	History of neurodevelopmental disorder	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000588387	2	166245294 - 166245297	2	165388784 - 165388787	588387	578940	rs1558885691	NC_000002.12:165388783:TTGTTT:TT
NM_001040142.2(SCN2A):c.3577_3578CT[1] (p.Trp1194fs)	SCN2A		not provided	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, single submitter	VCV000524019	2	166223783 - 166223784	2	165367273 - 165367274	524019	514439	rs1553590192	NC_000002.12:165367272:CTCT:CT
NM_001040142.2(SCN2A):c.2354del (p.Glu785fs)	SCN2A	E785fs	not provided	Pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, single submitter	VCV000523993	2	166188044	2	165331534	523993	514438	rs1553574729	NC_000002.12:165331533:A:
NM_001040142.2(SCN2A):c.4691_4692del (p.Tyr1564fs)	SCN2A	Y1564fs	not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000503894	2	166243395 - 166243396	2	165386885 - 165386886	503894	495095	rs1553463074	NC_000002.12:165386884:AC:
NM_001040142.2(SCN2A):c.4591C>T (p.Gln1531Ter)	SCN2A	Q1531*	not provided	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000489345	2	166243295	2	165386785	489345	481612	rs1553463032	NC_000002.12:165386784:C:T
NM_001040142.2(SCN2A):c.3892G>T (p.Glu1298Ter)	SCN2A	E1298*	not provided	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	VCV000489238	2	166229777	2	165373267	489238	481611	rs1553593030	NC_000002.12:165373266:G:T
NM_001040142.2(SCN2A):c.517A>T (p.Lys173Ter)	SCN2A	K173*	not provided	Pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	VCV000489024	2	166165216	2	165308706	489024	481610	rs1553567304	NC_000002.12:165308705:A:T
NM_001040142.2(SCN2A):c.4494del (p.Tyr1497_Tyr1498insTer)	SCN2A		not provided	Pathogenic(Last reviewed: Oct 18, 2017)	criteria provided, single submitter	VCV000452919	2	166237650	2	165381140	452919	442999	rs1553462224	NC_000002.12:165381139:C:
NM_001040142.2(SCN2A):c.5644C>T (p.Arg1882Ter)	SCN2A	R1882*	not provided	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000450533	2	166245960	2	165389450	450533	443004	rs796053166	NC_000002.12:165389449:C:T
NM_001040142.2(SCN2A):c.2942dup (p.Leu981fs)	SCN2A		not provided	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000450121	2	166210722 - 166210723	2	165354212 - 165354213	450121	442992	rs1553583550	NC_000002.12:165354212:TT:TTT
NM_001040142.2(SCN2A):c.386+2T>C	SCN2A		not provided	Pathogenic(Last reviewed: Nov 1, 2015)	criteria provided, single submitter	VCV000449290	2	166153647	2	165297137	449290	442981	rs1553564400	NC_000002.12:165297136:T:C
NM_001040142.2(SCN2A):c.719C>T (p.Ala240Val)	SCN2A	A240V	not provided	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000449164	2	166166854	2	165310344	449164	442985	rs1553567864	NC_000002.12:165310343:C:T
NM_001040142.2(SCN2A):c.2810G>A (p.Arg937His)	SCN2A	R937H	not provided	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000432034	2	166201312	2	165344802	432034	425417	rs1553579488	NC_000002.12:165344801:G:A
NM_001040142.2(SCN2A):c.4371dup (p.Ile1458fs)	SCN2A		not provided	Pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000429399	2	166237162 - 166237163	2	165380652 - 165380653	429399	421294	rs1131691361	NC_000002.12:165380652:TT:TTT
NM_001040142.2(SCN2A):c.3703C>T (p.Arg1235Ter)	SCN2A	R1235*	not provided	Pathogenic(Last reviewed: Apr 26, 2017)	criteria provided, single submitter	VCV000426208	2	166226663	2	165370153	426208	414831	rs1085307500	NC_000002.12:165370152:C:T
NM_001040142.2(SCN2A):c.2823dup (p.Glu942fs)	SCN2A		not provided	Pathogenic(Last reviewed: Oct 13, 2017)	criteria provided, single submitter	VCV000423628	2	166201324 - 166201325	2	165344814 - 165344815	423628	405350	rs1553579500	NC_000002.12:165344814:A:AA
NM_001040142.2(SCN2A):c.3391del (p.Ser1131fs)	SCN2A	S1131fs	not provided	Pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, single submitter	VCV000423061	2	166211171	2	165354661	423061	405351	rs1064796203	NC_000002.12:165354660:AAA:AA
NM_001040142.2(SCN2A):c.5272A>C (p.Ser1758Arg)	SCN2A	S1758R	not provided	Pathogenic(Last reviewed: Jul 30, 2015)	criteria provided, single submitter	VCV000419634	2	166245588	2	165389078	419634	405359	rs1064794005	NC_000002.12:165389077:A:C
NM_001040142.2(SCN2A):c.2622_2631del (p.Ile874fs)	SCN2A	I874fs	not provided	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000419405	2	166201123 - 166201132	2	165344613 - 165344622	419405	405349	rs1064793850	NC_000002.12:165344612:TTGGCAATTCT:T
NM_001040142.2(SCN2A):c.1028A>T (p.Asp343Val)	SCN2A	D343V	not provided	Pathogenic(Last reviewed: Dec 23, 2016)	criteria provided, single submitter	VCV000391613	2	166168592	2	165312082	391613	365782	rs1057524164	NC_000002.12:165312081:A:T
NM_001040142.2(SCN2A):c.3985G>T (p.Ala1329Ser)	SCN2A	A1329S	not provided	Pathogenic(Last reviewed: Dec 20, 2016)	criteria provided, single submitter	VCV000391368	2	166231207	2	165374697	391368	365822	rs1057524059	NC_000002.12:165374696:G:T
NM_001040142.2(SCN2A):c.4904G>A (p.Arg1635Gln)	SCN2A	R1635Q	not provided	Pathogenic(Last reviewed: Dec 29, 2016)	criteria provided, single submitter	VCV000380389	2	166245220	2	165388710	380389	365825	rs1057520844	NC_000002.12:165388709:G:A
NM_001040142.2(SCN2A):c.3956G>T (p.Arg1319Leu)	SCN2A	R1319L	not provided	Pathogenic(Last reviewed: Mar 26, 2015)	criteria provided, single submitter	VCV000379254	2	166229841	2	165373331	379254	365821	rs121917753	NC_000002.12:165373330:G:T
NM_001040142.2(SCN2A):c.3697G>T (p.Glu1233Ter)	SCN2A	E1233*	Mental retardation, autosomal dominant	Pathogenic(Last reviewed: Mar 16, 2015)	no assertion criteria provided	VCV000377394	2	166226657	2	165370147	377394	364279	rs1057519617	NC_000002.12:165370146:G:T
NM_001040142.2(SCN2A):c.1027G>C (p.Asp343His)	SCN2A	D343H	not provided	Pathogenic(Last reviewed: Sep 9, 2016)	criteria provided, single submitter	VCV000280832	2	166168591	2	165312081	280832	264016	rs796053175	NC_000002.12:165312080:G:C
NM_001040142.2(SCN2A):c.4777G>A (p.Gly1593Arg)	SCN2A	G1593R	not provided	Pathogenic(Last reviewed: Aug 29, 2016)	criteria provided, single submitter	VCV000279927	2	166243481	2	165386971	279927	264041	rs886041259	NC_000002.12:165386970:G:A
NM_001040142.2(SCN2A):c.1649del (p.Lys550fs)	SCN2A	K550fs	not provided	Pathogenic(Last reviewed: Aug 19, 2016)	criteria provided, single submitter	VCV000265662	2	166172243	2	165315733	265662	259700	rs886039710	NC_000002.12:165315732:AAAA:AAA
NM_001040142.2(SCN2A):c.4308+1G>A	SCN2A		not provided	Pathogenic(Last reviewed: Jun 2, 2016)	criteria provided, single submitter	VCV000265589	2	166234161	2	165377651	265589	259702	rs886039648	NC_000002.12:165377650:G:A
GRCh37/hg19 2q24.3(chr2:166094617-166246621)x3	SCN2A		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253453	2	166094617 - 166246621			253453	247901		
NM_001040142.2(SCN2A):c.1154del (p.Phe385fs)	SCN2A	F385fs	Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Jul 2, 2015)	no assertion criteria provided	VCV000242977	2	166170248	2	165313738	242977	244064	rs879253767	NC_000002.12:165313737:TT:T
NM_001040142.2(SCN2A):c.4726G>A (p.Gly1576Arg)	SCN2A	G1576R	Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: May 8, 2014)	criteria provided, single submitter	VCV000224078	2	166243430	2	165386920	224078	225808	rs869312664	NC_000002.12:165386919:G:A
NM_001040142.2(SCN2A):c.708del (p.Ile237fs)	SCN2A	I237fs	not provided	Pathogenic(Last reviewed: May 23, 2014)	criteria provided, single submitter	VCV000207081	2	166166842	2	165310332	207081	201284	rs796053198	NC_000002.12:165310331:CC:C
NM_001040142.2(SCN2A):c.425del (p.Asn142fs)	SCN2A	N142fs	not provided	Pathogenic(Last reviewed: Jun 6, 2014)	criteria provided, single submitter	VCV000207079	2	166164395	2	165307885	207079	201280	rs796053196	NC_000002.12:165307884:AA:A
NM_001040142.2(SCN2A):c.4474_4476GAA[1] (p.Glu1493del)	SCN2A	E1493del	not provided	Pathogenic(Last reviewed: Nov 6, 2013)	criteria provided, single submitter	VCV000207077	2	166237629 - 166237631	2	165381119 - 165381121	207077	201379	rs796053194	NC_000002.12:165381118:AGAAGAA:AGAA
NM_001040142.2(SCN2A):c.3401del (p.Lys1134fs)	SCN2A	K1134fs	not provided	Pathogenic(Last reviewed: Jun 18, 2014)	criteria provided, single submitter	VCV000207075	2	166221653	2	165365143	207075	201354	rs796053192	NC_000002.12:165365142:AA:A
NM_001040142.2(SCN2A):c.1289A>C (p.Glu430Ala)	SCN2A	E430A	not provided	Pathogenic(Last reviewed: May 7, 2013)	criteria provided, single submitter	VCV000207055	2	166170524	2	165314014	207055	201302	rs796053183	NC_000002.12:165314013:A:C
NM_001040142.2(SCN2A):c.1271T>C (p.Val424Ala)	SCN2A	V424A	not provided	Pathogenic(Last reviewed: Nov 20, 2012)	criteria provided, single submitter	VCV000207053	2	166170506	2	165313996	207053	201300	rs796053181	NC_000002.12:165313995:T:C
NM_001040142.2(SCN2A):c.1027G>T (p.Asp343Tyr)	SCN2A	D343Y	not provided	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000207046	2	166168591	2	165312081	207046	201293	rs796053175	NC_000002.12:165312080:G:T
NM_001040142.2(SCN2A):c.605+1G>T	SCN2A		not provided	Pathogenic(Last reviewed: Jan 25, 2017)	criteria provided, single submitter	VCV000207039	2	166165305	2	165308795	207039	201282	rs796053171	NC_000002.12:165308794:G:T
NM_001040142.2(SCN2A):c.387-2A>G	SCN2A		not provided	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	VCV000207037	2	166164356	2	165307846	207037	201279	rs796053169	NC_000002.12:165307845:A:G
NM_001040142.2(SCN2A):c.5645G>T (p.Arg1882Leu)	SCN2A	R1882L	not provided	Pathogenic(Last reviewed: Jun 7, 2016)	criteria provided, single submitter	VCV000207029	2	166245961	2	165389451	207029	201408	rs794727444	NC_000002.12:165389450:G:T
NM_001040142.2(SCN2A):c.5644C>G (p.Arg1882Gly)	SCN2A	R1882G	not provided	Pathogenic(Last reviewed: Aug 4, 2016)	criteria provided, single submitter	VCV000207028	2	166245960	2	165389450	207028	201407	rs796053166	NC_000002.12:165389449:C:G
NM_001040142.2(SCN2A):c.4718T>C (p.Leu1573Pro)	SCN2A	L1573P	not provided	Pathogenic(Last reviewed: Mar 27, 2013)	criteria provided, single submitter	VCV000207014	2	166243422	2	165386912	207014	201388	rs796053152	NC_000002.12:165386911:T:C
NM_001040142.2(SCN2A):c.4036A>G (p.Ile1346Val)	SCN2A	I1346V	not provided	Pathogenic(Last reviewed: Jun 12, 2014)	criteria provided, single submitter	VCV000206997	2	166231258	2	165374748	206997	201368	rs796053135	NC_000002.12:165374747:A:G
NM_001040142.2(SCN2A):c.3977T>A (p.Val1326Asp)	SCN2A	V1326D	not provided	Pathogenic(Last reviewed: Dec 20, 2012)	criteria provided, single submitter	VCV000206993	2	166231199	2	165374689	206993	201364	rs796053131	NC_000002.12:165374688:T:A
NM_001040142.2(SCN2A):c.3944G>A (p.Arg1315Lys)	SCN2A	R1315K	not provided	Pathogenic(Last reviewed: Oct 23, 2013)	criteria provided, single submitter	VCV000206990	2	166229829	2	165373319	206990	201361	rs796053129	NC_000002.12:165373318:G:A
NM_001040142.2(SCN2A):c.2715G>C (p.Lys905Asn)	SCN2A	K905N	not provided	Pathogenic(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	VCV000206973	2	166201217	2	165344707	206973	201341	rs796053119	NC_000002.12:165344706:G:C
NM_001040142.2(SCN2A):c.2635G>A (p.Gly879Arg)	SCN2A	G879R	Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000206969	2	166201137	2	165344627	206969	201335	rs796053115	NC_000002.12:165344626:G:A
NM_001040142.2(SCN2A):c.2562+1G>T	SCN2A		not provided	Pathogenic(Last reviewed: Dec 31, 2012)	criteria provided, single submitter	VCV000206967	2	166198980	2	165342470	206967	201333	rs796053113	NC_000002.12:165342469:G:T
NC_000002.12:g.165331497A>G	SCN2A		Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000816922					816922	805077		
NM_001040142.2(SCN2A):c.4343_4346dup (p.Met1449fs)	SCN2A		Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Apr 19, 2016)	criteria provided, single submitter	VCV000813736	2	166237134 - 166237135	2	165380624 - 165380625	813736	801977		NC_000002.12:165380624:TACAT:TACATACAT
NM_001040142.2(SCN2A):c.507del (p.Glu169fs)	SCN2A	E169fs	Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801775	2	166165205	2	165308695	801775	790072		NC_000002.12:165308694:AA:A
NM_001040142.2(SCN2A):c.4865C>G (p.Pro1622Arg)	SCN2A	P1622R	not provided	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000633560	2	166245181	2	165388671	633560	621944	rs1558885489	NC_000002.12:165388670:C:G
NM_001040142.2(SCN2A):c.605+1G>A	SCN2A		Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000619986	2	166165305	2	165308795	619986	611460	rs796053171	NC_000002.12:165308794:G:A
NM_001040142.2(SCN2A):c.882del (p.Phe295fs)	SCN2A	F295fs	Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Jan 17, 2017)	criteria provided, single submitter	VCV000496673	2	166167016	2	165310506	496673	488153	rs1553568045	NC_000002.12:165310505:CC:C
NM_001040142.2(SCN2A):c.11C>G (p.Ser4Ter)	SCN2A	S4*	Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, single submitter	VCV000436659	2	166152344	2	165295834	436659	427920	rs1553564144	NC_000002.12:165295833:C:G
NM_001040142.2(SCN2A):c.2182T>C (p.Cys728Arg)	SCN2A	C728R	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433097	2	166187872	2	165331362	433097	426660	rs1553574522	NC_000002.12:165331361:T:C
NM_001040142.2(SCN2A):c.3967A>G (p.Met1323Val)	SCN2A	M1323V	Malignant migrating partial seizures of infancy	Pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, single submitter	VCV000375505	2	166229852	2	165373342	375505	362319	rs1057519523	NC_000002.12:165373341:A:G
NM_001040142.2(SCN2A):c.2229_2230del (p.Lys743fs)	SCN2A	K743fs	Autistic disorder of childhood onset	Pathogenic(Last reviewed: Mar 13, 2015)	no assertion criteria provided	VCV000374268	2	166187919 - 166187920	2	165331409 - 165331410	374268	361168	rs1057518658	NC_000002.12:165331408:AC:
NM_001040142.2(SCN2A):c.4419A>G (p.Ile1473Met)	SCN2A	I1473M	Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Sep 29, 2009)	no assertion criteria provided	VCV000029887	2	166237212	2	165380702	29887	38842	rs387906685	NC_000002.12:165380701:A:G
NM_000642.3(AGL):c.753_756del (p.Asp251fs)	AGL	D235fs, D251fs	Glycogen storage disease type III|not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370509	1	100336041 - 100336044	1	99870485 - 99870488	370509	357199	rs748789700	NC_000001.11:99870484:AGACAGA:AGA
NM_000642.3(AGL):c.256C>T (p.Gln86Ter)	AGL	Q86*, Q70*	Glycogen storage disease type III|not provided|Glycogen storage disease IIIa	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000196286	1	100327232	1	99861676	196286	193447	rs193186112	NC_000001.11:99861675:C:T
NM_000642.3(AGL):c.4529dup (p.Tyr1510Ter)	AGL		Glycogen storage disease type III|Glycogen storage disease IIIa	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001094	1	100387136 - 100387137	1	99921580 - 99921581	1094	16133	rs387906244	NC_000001.11:99921580:A:AA
NM_001040142.2(SCN2A):c.4389dup (p.Thr1464fs)	SCN2A		Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000857716	2	166237179 - 166237180	2	165380669 - 165380670	857716	825085		NC_000002.12:165380669:TTT:TTTT
NM_001040142.2(SCN2A):c.1019dup (p.Asn340fs)	SCN2A		Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000848371	2	166168581 - 166168582	2	165312071 - 165312072	848371	825055		NC_000002.12:165312071:AA:AAA
NM_001040142.2(SCN2A):c.1530_1531del (p.Lys511fs)	SCN2A	K511fs	Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000848365	2	166172126 - 166172127	2	165315616 - 165315617	848365	825059		NC_000002.12:165315615:AGA:A
NM_001040142.2(SCN2A):c.4350T>G (p.Tyr1450Ter)	SCN2A	Y1450*	Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000665987	2	166237143	2	165380633	665987	628784		NC_000002.12:165380632:T:G
NM_001040142.2(SCN2A):c.4844_4845del (p.Ile1615fs)	SCN2A	I1615fs	Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000650150	2	166245159 - 166245160	2	165388649 - 165388650	650150	628785		NC_000002.12:165388648:ATA:A
NM_001040142.2(SCN2A):c.1600A>T (p.Arg534Ter)	SCN2A	R534*	Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000620037	2	166172197	2	165315687	620037	611377	rs1553569789	NC_000002.12:165315686:A:T
NM_001040142.2(SCN2A):c.962_970+1del	SCN2A		Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000579666	2	166167096 - 166167105	2	165310586 - 165310595	579666	558821	rs1559353540	NC_000002.12:165310585:GAGGATAAAAG:G
NM_001040142.2(SCN2A):c.5316del (p.Ile1772fs)	SCN2A	I1772fs	Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: Oct 20, 2018)	criteria provided, single submitter	VCV000575820	2	166245632	2	165389122	575820	557643	rs1558886168	NC_000002.12:165389121:C:
NM_001040142.2(SCN2A):c.658A>G (p.Arg220Gly)	SCN2A	R220G	Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000567919	2	166165914	2	165309404	567919	559304	rs1559352550	NC_000002.12:165309403:A:G
NM_001040142.2(SCN2A):c.4727del (p.Gly1576fs)	SCN2A	G1576fs	SCN2A-related disorder|not provided	Pathogenic(Last reviewed: May 9, 2018)	criteria provided, single submitter	VCV000545912	2	166243430	2	165386920	545912	536235	rs1553463096	NC_000002.12:165386919:GG:G
NM_001040142.2(SCN2A):c.4270dup (p.Trp1424fs)	SCN2A		Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000533497	2	166234121 - 166234122	2	165377611 - 165377612	533497	516513	rs1553461662	NC_000002.12:165377611:T:TT
NM_001040142.2(SCN2A):c.3036del (p.Gly1013fs)	SCN2A	G1013fs	Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000533484	2	166210816	2	165354306	533484	516592	rs1553583659	NC_000002.12:165354305:AAA:AA
NM_001040142.2(SCN2A):c.1529_1532AGAA[1] (p.Lys511fs)	SCN2A		Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000533483	2	166172126 - 166172129	2	165315616 - 165315619	533483	516614	rs1553569662	NC_000002.12:165315615:AGAAAGAA:AGAA
NM_001040142.2(SCN2A):c.606-159A>G	SCN2A	N212D	Early infantile epileptic encephalopathy 11	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488391	2	166165703	2	165309193	488391	481228	rs1553567473	NC_000002.12:165309192:A:G
NM_001040142.2(SCN2A):c.1342C>T (p.Gln448Ter)	SCN2A	Q448*	Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Jun 3, 2017)	criteria provided, single submitter	VCV000464901	2	166170577	2	165314067	464901	449085	rs1553569054	NC_000002.12:165314066:C:T
NM_001040142.2(SCN2A):c.4876C>T (p.Arg1626Ter)	SCN2A	R1626*	Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: Sep 22, 2016)	criteria provided, single submitter	VCV000410985	2	166245192	2	165388682	410985	391638	rs1060503102	NC_000002.12:165388681:C:T
NM_001040142.2(SCN2A):c.2877C>A (p.Cys959Ter)	SCN2A	C959*	Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: Aug 16, 2016)	criteria provided, single submitter	VCV000410979	2	166201379	2	165344869	410979	391458	rs746163041	NC_000002.12:165344868:C:A
NM_001040142.2(SCN2A):c.1198dup (p.Thr400fs)	SCN2A		Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000410976	2	166170429 - 166170430	2	165313919 - 165313920	410976	391571	rs1553568927	NC_000002.12:165313919:AAAA:AAAAA
NM_001040142.2(SCN2A):c.647T>G (p.Leu216Trp)	SCN2A	L216W	not provided	Pathogenic/Likely pathogenic(Last reviewed: May 18, 2016)	criteria provided, multiple submitters, no conflicts	VCV000207088	2	166165903	2	165309393	207088	201283	rs796053203	NC_000002.12:165309392:T:G
NM_001040142.2(SCN2A):c.3374del (p.Glu1125fs)	SCN2A	E1125fs	Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: Dec 10, 2013)	criteria provided, single submitter	VCV000130220	2	166211156	2	165354646	130220	135667	rs587780450	NC_000002.12:165354645:A:
NM_001040142.2(SCN2A):c.754A>G (p.Met252Val)	SCN2A	M252V	Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: May 1, 2010)	no assertion criteria provided	VCV000029889	2	166166889	2	165310379	29889	38844	rs387906687	NC_000002.12:165310378:A:G
NM_001040142.2(SCN2A):c.3007C>A (p.Leu1003Ile)	SCN2A	L1003I	Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000012881	2	166210789	2	165354279	12881	27920	rs121917754	NC_000002.12:165354278:C:A
NM_001040142.2(SCN2A):c.3988C>T (p.Leu1330Phe)	SCN2A	L1330F	Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: Sep 14, 2002)	no assertion criteria provided	VCV000012876	2	166231210	2	165374700	12876	27915	rs121917749	NC_000002.12:165374699:C:T
NM_001040142.2(SCN2A):c.573G>T (p.Trp191Cys)	SCN2A	W191C	Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000643515	2	166165272	2	165308762	643515	628770		NC_000002.12:165308761:G:T
NC_000002.11:g.(?_166221633)_(166246354_?)del	SCN2A		Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000583829	2	166221633 - 166246354	2	165365123 - 165389844	583829	557420		
NM_001040142.2(SCN2A):c.2687C>T (p.Ala896Val)	SCN2A	A896V	Early infantile epileptic encephalopathy 11|Epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000375508	2	166201189	2	165344679	375508	362318	rs1057519526	NC_000002.12:165344678:C:T
NM_001040142.2(SCN2A):c.2567G>A (p.Arg856Gln)	SCN2A	R856Q	not provided|Seizures	Pathogenic/Likely pathogenic(Last reviewed: Jul 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000212125	2	166201069	2	165344559	212125	206877	rs797045942	NC_000002.12:165344558:G:A
NM_001040142.2(SCN2A):c.3947C>T (p.Ala1316Val)	SCN2A	A1316V	not provided|Epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000206991	2	166229832	2	165373322	206991	201362	rs796053130	NC_000002.12:165373321:C:T
NM_201253.3(CRB1):c.2688T>A (p.Cys896Ter)	CRB1	C896*, C872*, C784*	Retinal dystrophy|Leber congenital amaurosis 8|Retinitis pigmentosa 12|Macular dystrophy|not provided	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000099888	1	197398590	1	197429460	99888	105777	rs62636273	NC_000001.11:197429459:T:A
NM_001040142.2(SCN2A):c.4976C>T (p.Ala1659Val)	SCN2A	A1659V	Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures|Seizures	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000410984	2	166245292	2	165388782	410984	391639	rs1060503101	NC_000002.12:165388781:C:T
NM_001040142.2(SCN2A):c.2809C>T (p.Arg937Cys)	SCN2A	R937C	Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000207080	2	166201311	2	165344801	207080	201344	rs796053197	NC_000002.12:165344800:C:T
NM_001040142.2(SCN2A):c.1147C>G (p.Gln383Glu)	SCN2A	Q383E	Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures|not provided	Pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000207050	2	166170242	2	165313732	207050	201297	rs796053178	NC_000002.12:165313731:C:G
NM_001040142.2(SCN2A):c.823C>T (p.Arg275Ter)	SCN2A	R275*	Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures|not provided	Pathogenic(Last reviewed: Feb 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000207041	2	166166958	2	165310448	207041	201287	rs181327458	NC_000002.12:165310447:C:T
NM_003000.3(SDHB):c.677del (p.Phe226fs)	SDHB	F226fs	Pheochromocytoma|Paragangliomas 4|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000840440	1	17349191	1	17022696	840440	822996		NC_000001.11:17022695:AA:A
NC_000001.11:g.(?_17018881)_(17054019_?)del	SDHB		Pheochromocytoma|Paragangliomas 4|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000832529	1	17345376 - 17380514			832529	818867		
NC_000001.10:g.(?_17345366)_(17380524_?)del	SDHB		Pheochromocytoma|Paragangliomas 4|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000646398	1	17345366 - 17380524	1	17018871 - 17054029	646398	650537		
NM_003000.2(SDHB):c.605dup (p.Asn202fs)	SDHB		Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428922	1	17350504 - 17350505	1	17024009 - 17024010	428922	420743	rs1131691053	NC_000001.11:17024009:TT:TTT
NM_003000.2(SDHB):c.374C>A (p.Ser125Ter)	SDHB	S125*	Pheochromocytoma|Paragangliomas 4|Gastrointestinal stromal tumor|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000187145	1	17355144	1	17028649	187145	181617	rs786203506	NC_000001.11:17028648:G:T
NM_005270.4(GLI2):c.322delG (p.Ala108Leufs)	GLI2	A108fs	Holoprosencephaly 9|Culler-Jones syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000520904	2	121708885	2	120951309	520904	511313	rs1553471273	NC_000002.12:120951308:GG:G
NM_001040142.2(SCN2A):c.4886G>T (p.Arg1629Leu)	SCN2A	R1629L	Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000660961	2	166245202	2	165388692	660961	628786		NC_000002.12:165388691:G:T
NM_001040142.2(SCN2A):c.2548C>T (p.Arg850Ter)	SCN2A	R850*	Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000493288	2	166198965	2	165342455	493288	486251	rs1553578503	NC_000002.12:165342454:C:T
NM_001040142.2(SCN2A):c.4468A>G (p.Met1490Val)	SCN2A	M1490V	Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11	Pathogenic/Likely pathogenic(Last reviewed: Feb 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000224077	2	166237624	2	165381114	224077	225807	rs869312663	NC_000002.12:165381113:A:G
NM_001040142.2(SCN2A):c.304C>T (p.Arg102Ter)	SCN2A	R102*	Early infantile epileptic encephalopathy 11|not provided	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000029885	2	166153563	2	165297053	29885	38840	rs387906683	NC_000002.12:165297052:C:T
NM_001040142.2(SCN2A):c.4687C>G (p.Leu1563Val)	SCN2A	L1563V	not provided|Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000012877	2	166243391	2	165386881	12877	27916	rs121917750	NC_000002.12:165386880:C:G
NM_000784.4(CYP27A1):c.1214G>A (p.Arg405Gln)	CYP27A1	R372Q, R405Q	Cholestanol storage disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004260	2	219679132	2	218814409	4260	19299	rs121908099	NC_000002.12:218814408:G:A
NM_018136.5(ASPM):c.9178C>T (p.Gln3060Ter)	ASPM	Q3060*, Q1475*	not provided|Primary autosomal recessive microcephaly 5	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004960	1	197062298	1	197093168	4960	19999	rs137852994	NC_000001.11:197093167:G:A
NM_005373.3(MPL):c.79+2T>A	MPL		Thrombocytopenia|not specified|MPL-Related Disorders|essential thrombocytemia|Congenital amegakaryocytic thrombocytopenia|Thrombocytosis, benign familial microcytic|Myelofibrosis|Congenital amegakaryocytic thrombocytopenia|Congenital amegakaryocytic thrombocytopenia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000135563	1	43803600	1	43337929	135563	139302	rs146249964	NC_000001.11:43337928:T:A
NM_005373.2(MPL):c.305G>C (p.Arg102Pro)	MPL	R102P	Congenital amegakaryocytic thrombocytopenia|Congenital amegakaryocytic thrombocytopenia|essential thrombocytemia|Thrombocytopenia|not specified	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014158	1	43804305	1	43338634	14158	29197	rs28928907	NC_000001.11:43338633:G:C
NM_006343.3(MERTK):c.2189+1G>T	MERTK		Retinal dystrophy|Inborn genetic diseases|Retinitis pigmentosa 38	Pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005403	2	112777100	2	112019523	5403	20442	rs371956016	NC_000002.12:112019522:G:T
NM_001040142.2(SCN2A):c.4766A>G (p.Tyr1589Cys)	SCN2A	Y1589C	Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000464912	2	166243470	2	165386960	464912	448802	rs1553463119	NC_000002.12:165386959:A:G
NM_001040142.2(SCN2A):c.2627A>G (p.Asn876Ser)	SCN2A	N876S	Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449958	2	166201129	2	165344619	449958	442991	rs1553579282	NC_000002.12:165344618:A:G
NM_001040142.2(SCN2A):c.2960G>T (p.Ser987Ile)	SCN2A	S987I	not provided|Early infantile epileptic encephalopathy 11|Episodic ataxia|Vertigo|Seizures	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000206978	2	166210742	2	165354232	206978	201345	rs796053124	NC_000002.12:165354231:G:T
NM_003001.3(SDHC):c.1A>T (p.Met1Leu)	SDHC	M1L	Paragangliomas 3|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000653751	1	161284196	1	161314406	653751	627029		NC_000001.11:161314405:A:T
NM_001040142.2(SCN2A):c.3956G>A (p.Arg1319Gln)	SCN2A	R1319Q	not provided|Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012880	2	166229841	2	165373331	12880	27919	rs121917753	NC_000002.12:165373330:G:A
NM_000143.3(FH):c.700A>G (p.Thr234Ala)	FH	T234A	Fumarase deficiency|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000184555	1	241671941	1	241508641	184555	181633	rs372505976	NC_000001.11:241508640:T:C
NM_000143.3(FH):c.560C>G (p.Ser187Ter)	FH	S187*	not provided|Fumarase deficiency|Hereditary leiomyomatosis and renal cell cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092456	1	241672081	1	241508781	92456	98365	rs398123166	NC_000001.11:241508780:G:C
NM_001692.4(ATP6V1B1):c.1155dup (p.Ile386fs)	ATP6V1B1		not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000520772	2	71191572 - 71191573	2	70964442 - 70964443	520772	511435	rs781969081	NC_000002.12:70964442:CCCCCCC:CCCCCCCC
NM_001040142.2(SCN2A):c.2566C>T (p.Arg856Ter)	SCN2A	R856*	Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures|Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000436662	2	166201068	2	165344558	436662	427924	rs1553579225	NC_000002.12:165344557:C:T
NM_001040142.2(SCN2A):c.781G>A (p.Val261Met)	SCN2A	V261M	Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11|not provided	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000378927	2	166166916	2	165310406	378927	366036	rs1057520413	NC_000002.12:165310405:G:A
NM_001040142.2(SCN2A):c.668G>A (p.Arg223Gln)	SCN2A	R223Q	Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000012879	2	166165924	2	165309414	12879	27918	rs121917752	NC_000002.12:165309413:G:A
NM_001079866.2(BCS1L):c.166C>T (p.Arg56Ter)	BCS1L	R56*	BCS1L-Related Disorders|Leigh syndrome|Pili torti-deafness syndrome|GRACILE syndrome|Mitochondrial complex III deficiency, nuclear type 1|GRACILE syndrome|not provided|Mitochondrial complex III deficiency, nuclear type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006169	2	219525876	2	218661153	6169	21208	rs121908576	NC_000002.12:218661152:C:T
NM_001079866.2(BCS1L):c.232A>G (p.Ser78Gly)	BCS1L	S78G	Leigh syndrome|Pili torti-deafness syndrome|GRACILE syndrome|Mitochondrial complex III deficiency, nuclear type 1|GRACILE syndrome|not provided|Mitochondrial complex III deficiency, nuclear type 1	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006167	2	219525942	2	218661219	6167	21206	rs28937590	NC_000002.12:218661218:A:G
NM_014874.3(MFN2):c.1126A>G (p.Met376Val)	MFN2	M376V	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, type 2A2A	Pathogenic/Likely pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217161	1	12062126	1	12002069	217161	213790	rs863224967	NC_000001.11:12002068:A:G
NM_004895.4(NLRP3):c.1049C>T (p.Thr350Met)	NLRP3	T350M, T348M	not provided|Familial cold urticaria|Familial amyloid nephropathy with urticaria AND deafness|Cryopyrin associated periodic syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000097909	1	247587794	1	247424492	97909	103801	rs151344629	NC_000001.11:247424491:C:T
NM_000642.3(AGL):c.3214_3215GA[1] (p.Glu1072fs)	AGL		Glycogen storage disease IIIa|not provided|Glycogen storage disease type III	Pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000432008	1	100358118 - 100358119	1	99892562 - 99892563	432008	425390	rs771069887	NC_000001.11:99892561:GAGA:GA
NM_000642.3(AGL):c.2590C>T (p.Arg864Ter)	AGL	R864*, R848*	not provided|Glycogen storage disease type III	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021215	1	100350168	1	99884612	21215	34067	rs113994130	NC_000001.11:99884611:C:T
NM_170707.4(LMNA):c.1524_1534dup (p.Leu512fs)	LMNA		not provided	Pathogenic(Last reviewed: Feb 28, 2018)	criteria provided, single submitter	VCV000504373	1	156106936 - 156106937	1	156137145 - 156137146	504373	495131	rs1553266098	NC_000001.11:156137145:CCCCCTACCGACC:CCCCCTACCGACCCCCTACCGACC
NM_170707.4(LMNA):c.978dup (p.Leu327fs)	LMNA		not provided	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000503978	1	156105732 - 156105733	1	156135941 - 156135942	503978	495081	rs1553265630	NC_000001.11:156135941:A:AA
NM_170707.4(LMNA):c.1582A>C (p.Thr528Pro)	LMNA	T528P, T416P, T447P	not provided	Pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, single submitter	VCV000500663	1	156106997	1	156137206	500663	492087	rs1187380696	NC_000001.11:156137205:A:C
NM_170707.4(LMNA):c.1078C>T (p.Gln360Ter)	LMNA	Q360*, Q248*, Q279*	not provided	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000423883	1	156105833	1	156136042	423883	404950	rs1064796677	NC_000001.11:156136041:C:T
NM_170707.4(LMNA):c.835del (p.Glu279fs)	LMNA	E167fs, E279fs, E198fs	not provided	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000421186	1	156105002	1	156135211	421186	404949	rs1064794966	NC_000001.11:156135210:G:
NM_170707.4(LMNA):c.1629_1636del (p.Val544fs)	LMNA	V463fs, V432fs, V544fs	not provided	Pathogenic(Last reviewed: Jun 14, 2015)	criteria provided, single submitter	VCV000419142	1	156107462 - 156107469	1	156137671 - 156137678	419142	404951	rs1064793674	NC_000001.11:156137670:GCTGGTGCGCT:GCT
NM_170707.4(LMNA):c.65_66delinsT (p.Ser22fs)	LMNA		not provided	Pathogenic(Last reviewed: Apr 29, 2016)	criteria provided, single submitter	VCV000287839	1	156084774 - 156084775	1	156114983 - 156114984	287839	272076	rs886043745	NC_000001.11:156114982:CG:T
NM_170707.4(LMNA):c.784del (p.Glu262fs)	LMNA	E262fs, E150fs, E181fs	not provided	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000279840	1	156104739	1	156134948	279840	263984	rs886041211	NC_000001.11:156134947:GG:G
NM_170707.4(LMNA):c.1566C>A (p.Cys522Ter)	LMNA	C522*, C410*, C441*	Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, single submitter	VCV000263601	1	156106981	1	156137190	263601	257928	rs149339264	NC_000001.11:156137189:C:A
NM_170707.4(LMNA):c.1540T>C (p.Trp514Arg)	LMNA	W514R, W433R, W402R	not provided	Pathogenic(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	VCV000246077	1	156106955	1	156137164	246077	244235	rs879254082	NC_000001.11:156137163:T:C
NM_170707.4(LMNA):c.1157+1G>T	LMNA		not provided	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000246075	1	156105913	1	156136122	246075	244228	rs267607590	NC_000001.11:156136121:G:T
NM_170707.4(LMNA):c.513+1G>A	LMNA		not provided	Pathogenic(Last reviewed: Apr 21, 2015)	criteria provided, single submitter	VCV000245721	1	156100565	1	156130774	245721	244219	rs397517904	NC_000001.11:156130773:G:A
NM_170707.4(LMNA):c.1150del (p.Glu384fs)	LMNA	E272fs, E303fs, E384fs	not provided	Pathogenic(Last reviewed: Apr 3, 2015)	criteria provided, single submitter	VCV000245715	1	156105904	1	156136113	245715	244227	rs879253913	NC_000001.11:156136112:GG:G
NM_170707.4(LMNA):c.967_968del (p.Leu323fs)	LMNA	L242fs, L211fs, L323fs	not provided	Pathogenic(Last reviewed: Dec 28, 2011)	no assertion criteria provided	VCV000235005	1	156105722 - 156105723	1	156135931 - 156135932	235005	236737	rs876661352	NC_000001.11:156135930:CT:
NM_170707.4(LMNA):c.949G>T (p.Glu317Ter)	LMNA	E317*, E236*, E205*	not provided	Pathogenic(Last reviewed: Jun 14, 2013)	no assertion criteria provided	VCV000235004	1	156105704	1	156135913	235004	236736	rs56816490	NC_000001.11:156135912:G:T
NM_170707.4(LMNA):c.1401G>A (p.Trp467Ter)	LMNA	W467*, W355*, W386*	not provided	Pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000200965	1	156106732	1	156136941	200965	196480	rs794728613	NC_000001.11:156136940:G:A
NM_170707.4(LMNA):c.978_979del (p.Leu327fs)	LMNA	L215fs, L327fs, L246fs	not provided	Pathogenic(Last reviewed: Jul 31, 2013)	criteria provided, single submitter	VCV000200961	1	156105732 - 156105733	1	156135941 - 156135942	200961	196475	rs794728610	NC_000001.11:156135940:CAC:C
NM_170707.4(LMNA):c.973dup (p.Asp325fs)	LMNA		not provided	Pathogenic(Last reviewed: Jan 17, 2017)	criteria provided, single submitter	VCV000200960	1	156105726 - 156105727	1	156135935 - 156135936	200960	196474	rs794728609	NC_000001.11:156135935:GG:GGG
NM_170707.4(LMNA):c.586_596del (p.Arg196fs)	LMNA	R196fs, R84fs, R115fs	not provided	Pathogenic(Last reviewed: Mar 13, 2014)	criteria provided, single submitter	VCV000200958	1	156104264 - 156104274	1	156134473 - 156134483	200958	196466	rs794728607	NC_000001.11:156134472:ACAGGCTGCAGAC:AC
NM_170707.4(LMNA):c.522del (p.Ala175fs)	LMNA	A94fs, A63fs, A175fs	not provided	Pathogenic(Last reviewed: Jul 1, 2014)	criteria provided, single submitter	VCV000200957	1	156104202	1	156134411	200957	196464	rs794728606	NC_000001.11:156134410:A:
NM_170707.4(LMNA):c.1560G>A (p.Trp520Ter)	LMNA	W520*, W408*, W439*	not provided	Pathogenic(Last reviewed: May 25, 2016)	criteria provided, single submitter	VCV000200944	1	156106975	1	156137184	200944	196481	rs794728595	NC_000001.11:156137183:G:A
NM_170707.4(LMNA):c.871G>A (p.Glu291Lys)	LMNA	E291K, E210K, E179K	not provided	Pathogenic(Last reviewed: Apr 9, 2015)	criteria provided, single submitter	VCV000200942	1	156105038	1	156135247	200942	196473	rs794728594	NC_000001.11:156135246:G:A
NM_170707.4(LMNA):c.48del (p.Ser17fs)	LMNA	S17fs	not provided	Pathogenic(Last reviewed: Jan 20, 2015)	criteria provided, single submitter	VCV000193316	1	156084756	1	156114965	193316	190480	rs794726921	NC_000001.11:156114964:CC:C
NM_170707.4(LMNA):c.917T>G (p.Leu306Arg)	LMNA	L306R, L225R, L194R	Hutchinson-Gilford progeria syndrome, childhood-onset|Right ventricular cardiomyopathy	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000183362	1	156105084	1	156135293	183362	181469	rs730882262	NC_000001.11:156135292:T:G
NM_170707.4(LMNA):c.711_729delinsCC (p.Glu238fs)	LMNA		Dilated cardiomyopathy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000691647	1	156104667 - 156104685	1	156134876 - 156134894	691647	679362		NC_000001.11:156134875:TGAGAGCCGGCTGGCGGAT:CC
NM_170707.4(LMNA):c.1142_1157+1del	LMNA		not provided	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000496992	1	156105895 - 156105911	1	156136104 - 156136120	496992	488416	rs1553265755	NC_000001.11:156136103:GGAGGGCGAGGAGGAGAGG:GG
NM_170707.4(LMNA):c.840_845del (p.Arg280_Asn281del)	LMNA		Muscular dystrophy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000435777	1	156105005 - 156105010	1	156135214 - 156135219	435777	427649	rs1553265436	NC_000001.11:156135213:AGGAACAG:AG
NM_170707.4(LMNA):c.832G>C (p.Ala278Pro)	LMNA	A278P, A197P, A166P	Muscular dystrophy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000435769	1	156104999	1	156135208	435769	427648	rs1553265433	NC_000001.11:156135207:G:C
NM_170707.4(LMNA):c.162_163del (p.Asn56fs)	LMNA	N56fs	not provided	Pathogenic(Last reviewed: Jul 12, 2016)	criteria provided, multiple submitters, no conflicts	VCV000245757	1	156084871 - 156084872	1	156115080 - 156115081	245757	244210	rs879253932	NC_000001.11:156115079:GG:
NM_170707.4(LMNA):c.899A>G (p.Asp300Gly)	LMNA	D300G, D188G, D219G	Hutchinson-Gilford progeria syndrome, atypical	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000217451	1	156105066	1	156135275	217451	214091	rs79907212	NC_000001.11:156135274:A:G
NM_170707.4(LMNA):c.3G>T (p.Met1Ile)	LMNA	M1I	not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000200949	1	156084712	1	156114921	200949	196446	rs794728598	NC_000001.11:156114920:G:T
NM_170707.4(LMNA):c.1968+5G>C	LMNA		Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000162416	1	156108553	1	156138762	162416	172118	rs797044488	NC_000001.11:156138761:G:C
NM_170707.4(LMNA):c.1968+2T>C	LMNA		Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000162415	1	156108550	1	156138759	162415	172116	rs113860699	NC_000001.11:156138758:T:C
NM_170707.4(LMNA):c.1968+2T>A	LMNA		Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000162414	1	156108550	1	156138759	162414	172115	rs113860699	NC_000001.11:156138758:T:A
NM_170707.4(LMNA):c.1968+1G>C	LMNA		Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000162413	1	156108549	1	156138758	162413	172114	rs113436208	NC_000001.11:156138757:G:C
NM_170707.4(LMNA):c.1620G>A (p.Met540Ile)	LMNA	M540I, M459I, M428I	Mandibuloacral dysplasia with type A lipodystrophy	Pathogenic(Last reviewed: Apr 30, 2016)	criteria provided, single submitter	VCV000100690	1	156107456	1	156137665	100690	106555	rs483352811	NC_000001.11:156137664:G:A
NM_170707.4(LMNA):c.427T>C (p.Ser143Pro)	LMNA	S143P, S31P, S62P	not provided	Pathogenic(Last reviewed: Jan 10, 2017)	criteria provided, single submitter	VCV000066899	1	156100478	1	156130687	66899	77796	rs61661343	NC_000001.11:156130686:T:C
NM_170707.4(LMNA):c.412G>A (p.Glu138Lys)	LMNA	E138K, E26K, E57K	not provided	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000066897	1	156100463	1	156130672	66897	77794	rs267607649	NC_000001.11:156130671:G:A
NM_170707.4(LMNA):c.1488+1G>A	LMNA		not provided	Pathogenic(Last reviewed: Feb 16, 2016)	criteria provided, single submitter	VCV000066831	1	156106820	1	156137029	66831	77728	rs267607640	NC_000001.11:156137028:G:A
NM_170707.4(LMNA):c.1368C>A (p.Asn456Lys)	LMNA	N456K, N375K, N344K	not provided	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000066813	1	156106215	1	156136424	66813	77710	rs61235244	NC_000001.11:156136423:C:A
NM_170707.4(LMNA):c.3G>C (p.Met1Ile)	LMNA	M1I	not specified|not provided	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000245838	1	156084712	1	156114921	245838	244206	rs794728598	NC_000001.11:156114920:G:C
NM_170707.4(LMNA):c.513+45T>G	LMNA		Emery-Dreifuss muscular dystrophy 2, autosomal dominant	Pathogenic(Last reviewed: Apr 26, 2016)	no assertion criteria provided	VCV000236201	1	156100609	1	156130818	236201	237758	rs878853220	NC_000001.11:156130817:T:G
NM_170707.4(LMNA):c.1771T>A (p.Cys591Ser)	LMNA	C561S, C591S, C479S	Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000162411	1	156108351	1	156138560	162411	172112	rs797044486	NC_000001.11:156138559:T:A
NM_170707.4(LMNA):c.1700_1968+1del	LMNA		Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000162410	1	156108274 - 156108543	1	156138483 - 156138752	162410	172111	rs1553266460	
NM_170707.4(LMNA):c.667G>A (p.Glu223Lys)	LMNA	E223K, E142K, E111K	Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000162409	1	156104623	1	156134832	162409	172110	rs797044485	NC_000001.11:156134831:G:A
NM_170707.4(LMNA):c.736C>T (p.Gln246Ter)	LMNA	Q246*, Q165*, Q134*	not provided	Pathogenic(Last reviewed: Jan 14, 2013)	criteria provided, single submitter	VCV000066927	1	156104692	1	156134901	66927	77824	rs267607587	NC_000001.11:156134900:C:T
NM_170707.4(LMNA):c.611del (p.Leu204fs)	LMNA	L123fs, L204fs, L92fs	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000864423	1	156104291	1	156134500	864423	822801		NC_000001.11:156134499:T:
NM_170707.4(LMNA):c.210del (p.Ser71fs)	LMNA	S71fs	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000842353	1	156084919	1	156115128	842353	822791		NC_000001.11:156115127:C:
NM_170707.4(LMNA):c.1606del (p.Glu536fs)	LMNA	E536fs, E424fs, E455fs	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000842305	1	156107018	1	156137227	842305	822809		NC_000001.11:156137226:GGGG:GGG
NM_170707.4(LMNA):c.1264G>T (p.Glu422Ter)	LMNA	E310*, E341*, E422*	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000665384	1	156106111	1	156136320	665384	626922		NC_000001.11:156136319:G:T
NM_170707.4(LMNA):c.1030del (p.Glu344fs)	LMNA	E232fs, E263fs, E344fs	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000656120	1	156105783	1	156135992	656120	626919		NC_000001.11:156135991:GGG:GG
NM_170707.4(LMNA):c.94A>T (p.Lys32Ter)	LMNA	K32*	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000655996	1	156084803	1	156115012	655996	626903		NC_000001.11:156115011:A:T
NM_170707.4(LMNA):c.601A>T (p.Lys201Ter)	LMNA	K120*, K201*, K89*	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000650067	1	156104281	1	156134490	650067	626912		NC_000001.11:156134489:A:T
NM_170707.4(LMNA):c.1580_1586del (p.Arg527fs)	LMNA	R415fs, R446fs, R527fs	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000649493	1	156106993 - 156106999	1	156137202 - 156137208	649493	626925		NC_000001.11:156137201:GCGTACGGC:GC
NM_170707.4(LMNA):c.11dup (p.Ser5fs)	LMNA		Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000640649	1	156084716 - 156084717	1	156114925 - 156114926	640649	626901		NC_000001.11:156114925:CCCC:CCCCC
NM_170707.4(LMNA):c.1657dup (p.Asp553fs)	LMNA		Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000640296	1	156107492 - 156107493	1	156137701 - 156137702	640296	626926		NC_000001.11:156137701:G:GG
NM_170707.4(LMNA):c.1184C>A (p.Ser395Ter)	LMNA	S395*, S314*, S283*	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000582238	1	156106031	1	156136240	582238	556677	rs267607561	NC_000001.11:156136239:C:A
NM_170707.4(LMNA):c.1516del (p.His506fs)	LMNA	H394fs, H425fs, H506fs	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000582185	1	156106929	1	156137138	582185	556622	rs1558133157	NC_000001.11:156137137:CCC:CC
NM_170707.4(LMNA):c.73del (p.Arg25fs)	LMNA	R25fs	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000573981	1	156084780	1	156114989	573981	556671	rs1558115970	NC_000001.11:156114988:CCC:CC
NM_170707.4(LMNA):c.810+32_1323del	LMNA		Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000572141	1	156104795 - 156106167	1	156135004 - 156136376	572141	556965		
NM_170707.4(LMNA):c.4G>T (p.Glu2Ter)	LMNA	E2*	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000568051	1	156084713	1	156114922	568051	556669	rs1558115754	NC_000001.11:156114921:G:T
NC_000001.10:g.(?_156084690)_(156109650_?)del	LMNA		Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000543301	1	156084690 - 156109650	1	156114899 - 156139859	543301	514862		
NM_170707.4(LMNA):c.248_251dup (p.Glu84fs)	LMNA		Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000543229	1	156084956 - 156084957	1	156115165 - 156115166	543229	515112	rs1553261982	NC_000001.11:156115165:CCGA:CCGACCGA
NM_170707.4(LMNA):c.391C>T (p.Gln131Ter)	LMNA	Q131*, Q19*, Q50*	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000543228	1	156100442	1	156130651	543228	515114	rs1553264593	NC_000001.11:156130650:C:T
NM_170707.4(LMNA):c.991_992del (p.Arg331fs)	LMNA	R219fs, R250fs, R331fs	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000543224	1	156105745 - 156105746	1	156135954 - 156135955	543224	515162	rs1553265647	NC_000001.11:156135953:GCG:G
NM_170707.4(LMNA):c.729dup (p.Ala244fs)	LMNA		Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000543223	1	156104684 - 156104685	1	156134893 - 156134894	543223	515159	rs1553265328	NC_000001.11:156134893:T:TT
NM_170707.4(LMNA):c.936+1G>A	LMNA		Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	VCV000476836	1	156105104	1	156135313	476836	447315	rs267607588	NC_000001.11:156135312:G:A
NM_170707.4(LMNA):c.877C>T (p.Gln293Ter)	LMNA	Q293*, Q212*, Q181*	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000476834	1	156105044	1	156135253	476834	447253	rs1553265455	NC_000001.11:156135252:C:T
NM_170707.4(LMNA):c.592C>T (p.Gln198Ter)	LMNA	Q198*, Q117*, Q86*	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000476831	1	156104272	1	156134481	476831	447230	rs1553265165	NC_000001.11:156134480:C:T
NM_170707.4(LMNA):c.928C>T (p.Gln310Ter)	LMNA	Q310*, Q229*, Q198*	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Mar 11, 2016)	criteria provided, single submitter	VCV000242005	1	156105095	1	156135304	242005	238147	rs878855234	NC_000001.11:156135303:C:T
NM_170707.4(LMNA):c.1622G>C (p.Arg541Pro)	LMNA	R541P, R460P, R429P	not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000066861	1	156107458	1	156137667	66861	77758	rs61444459	NC_000001.11:156137666:G:C
NM_170707.4(LMNA):c.1458G>T (p.Lys486Asn)	LMNA	K486N, K374N, K405N	not provided|Familial partial lipodystrophy 2	Pathogenic(Last reviewed: Jan 29, 2015)	criteria provided, single submitter	VCV000066829	1	156106789	1	156136998	66829	77726	rs59981161	NC_000001.11:156136997:G:T
NM_170707.4(LMNA):c.1081G>A (p.Glu361Lys)	LMNA	E361K, E249K, E280K	Muscular dystrophy|not provided	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000066772	1	156105836	1	156136045	66772	77669	rs267607634	NC_000001.11:156136044:G:A
NM_170707.4(LMNA):c.1585G>A (p.Ala529Thr)	LMNA	A529T, A417T, A448T	not provided|Mandibuloacral dysplasia with type A lipodystrophy	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000014522	1	156107000	1	156137209	14522	29561	rs121912494	NC_000001.11:156137208:G:A
NM_170707.4(LMNA):c.688G>A (p.Asp230Asn)	LMNA	D230N, D118N, D149N	not provided|Familial partial lipodystrophy 2	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000014518	1	156104644	1	156134853	14518	29557	rs61214927	NC_000001.11:156134852:G:A
NM_170707.4(LMNA):c.1626G>C (p.Lys542Asn)	LMNA	K542N, K430N, K461N	not provided|Mandibuloacral dysplasia with type A lipodystrophy	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000014509	1	156107462	1	156137671	14509	29548	rs56673169	NC_000001.11:156137670:G:C
NM_170707.4(LMNA):c.121C>A (p.Arg41Ser)	LMNA	R41S	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000648598	1	156084830	1	156115039	648598	626905		NC_000001.11:156115038:C:A
NM_170707.4(LMNA):c.1119C>G (p.Ile373Met)	LMNA	I373M, I261M, I292M	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000580670	1	156105874	1	156136083	580670	556616	rs1340894696	NC_000001.11:156136082:C:G
NC_000001.10:g.(?_156084690)_(156096034_?)del	LMNA		Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000543299	1	156084690 - 156096034	1	156114899 - 156126243	543299	514876		
NM_170707.4(LMNA):c.52_53dup (p.Thr19fs)	LMNA		Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000543212	1	156084759 - 156084760	1	156114968 - 156114969	543212	515102	rs1553261855	NC_000001.11:156114968:CTC:CTCTC
NM_170707.4(LMNA):c.988G>T (p.Glu330Ter)	LMNA	E330*, E218*, E249*	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000408988	1	156105743	1	156135952	408988	390839	rs1060502211	NC_000001.11:156135951:G:T
NM_170707.4(LMNA):c.1157G>C (p.Arg386Thr)	LMNA	R386T, R274T, R305T	Cardiovascular phenotype	Pathogenic(Last reviewed: Feb 16, 2016)	criteria provided, single submitter	VCV000264271	1	156105912	1	156136121	264271	257932	rs267607545	NC_000001.11:156136120:G:C
NM_170707.4(LMNA):c.810+1G>C	LMNA		Congenital muscular dystrophy, LMNA-related|Limb-girdle muscular dystrophy, type 1B|Emery-Dreifuss muscular dystrophy 2, autosomal dominant	Pathogenic(Last reviewed: Jul 29, 2014)	criteria provided, single submitter	VCV000216958	1	156104767	1	156134976	216958	213515	rs267607632	NC_000001.11:156134975:G:C
NM_170707.4(LMNA):c.1908C>T (p.Ser636=)	LMNA		Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Apr 30, 2015)	no assertion criteria provided	VCV000066875	1	156108488	1	156138697	66875	77772	rs80356814	NC_000001.11:156138696:C:T
NM_170707.4(LMNA):c.1868C>G (p.Thr623Ser)	LMNA	T593S, T623S, T511S	not provided|Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066869	1	156108448	1	156138657	66869	77766	rs59267781	NC_000001.11:156138656:C:G
NM_170707.4(LMNA):c.1609-12T>G	LMNA		Heart-hand syndrome, Slovenian type|not provided	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000066855	1	156107433	1	156137642	66855	77752	rs267607582	NC_000001.11:156137641:T:G
NM_170707.4(LMNA):c.1157+1G>A	LMNA		Cardiovascular phenotype|not provided	Pathogenic(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	VCV000066781	1	156105913	1	156136122	66781	77678	rs267607590	NC_000001.11:156136121:G:A
NM_170707.4(LMNA):c.674G>A (p.Arg225Gln)	LMNA	R225Q, R113Q, R144Q	Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Emery-Dreifuss muscular dystrophy 2, autosomal dominant	Pathogenic(Last reviewed: Jan 17, 2013)	no assertion criteria provided	VCV000041234	1	156104630	1	156134839	41234	49658	rs199474724	NC_000001.11:156134838:G:A
NM_170707.4(LMNA):c.176T>G (p.Leu59Arg)	LMNA	L59R	not provided|Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome	Pathogenic(Last reviewed: Feb 15, 2009)	no assertion criteria provided	VCV000018457	1	156084885	1	156115094	18457	33496	rs58922911	NC_000001.11:156115093:T:G
NM_170707.4(LMNA):c.1139T>C (p.Leu380Ser)	LMNA	L380S, L268S, L299S	not provided|Congenital muscular dystrophy, LMNA-related	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000014523	1	156105894	1	156136103	14523	29562	rs121912495	NC_000001.11:156136102:T:C
NM_170707.4(LMNA):c.1586C>T (p.Ala529Val)	LMNA	A529V, A417V, A448V	not provided|Mandibuloacral dysplasia with type A lipodystrophy	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000014513	1	156107001	1	156137210	14513	29552	rs60580541	NC_000001.11:156137209:C:T
NM_170707.4(LMNA):c.419T>G (p.Leu140Arg)	LMNA	L140R, L28R, L59R	not provided|Hutchinson-Gilford progeria syndrome, childhood-onset	Pathogenic(Last reviewed: Aug 9, 2003)	no assertion criteria provided	VCV000014507	1	156100470	1	156130679	14507	29546	rs60652225	NC_000001.11:156130678:T:G
NM_170707.4(LMNA):c.1589T>C (p.Leu530Pro)	LMNA	L530P, L418P, L449P	not provided|Emery-Dreifuss muscular dystrophy 2, autosomal dominant	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000014482	1	156107004	1	156137213	14482	29521	rs60934003	NC_000001.11:156137212:T:C
NM_014946.3(SPAST):c.1245+1G>A	SPAST		Spastic paraplegia 4, autosomal dominant|not provided	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000226113	2	32353549	2	32128480	226113	227916	rs875989878	NC_000002.12:32128479:G:A
NM_014946.3(SPAST):c.1291C>T (p.Arg431Ter)	SPAST	R431*, R399*, R430*, R398*	Spastic paraplegia 4, autosomal dominant|not provided	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000188179	2	32361677	2	32136608	188179	185966	rs786204126	NC_000002.12:32136607:C:T
NM_000143.3(FH):c.553_554insTG (p.Gln185fs)	FH		not provided|Hereditary cancer-predisposing syndrome|Fumarase deficiency|Hereditary leiomyomatosis and renal cell cancer	Pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000393565	1	241675268 - 241675269	1	241511968 - 241511969	393565	380464	rs768182640	NC_000001.11:241511968::CA
NM_170707.4(LMNA):c.357-2A>G	LMNA		Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000652066	1	156100406	1	156130615	652066	650588		NC_000001.11:156130614:A:G
NM_170707.4(LMNA):c.1142del (p.Glu381fs)	LMNA	E300fs, E269fs, E381fs	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	VCV000543194	1	156105897	1	156136106	543194	515166	rs1553265760	NC_000001.11:156136105:A:
NM_170707.4(LMNA):c.1558T>C (p.Trp520Arg)	LMNA	W520R, W408R, W439R	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000476824	1	156106973	1	156137182	476824	447237	rs267607557	NC_000001.11:156137181:T:C
NM_170707.4(LMNA):c.1436del (p.Leu479fs)	LMNA	L367fs, L398fs, L479fs	Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000476823	1	156106767	1	156136976	476823	447258	rs1553266024	NC_000001.11:156136975:T:
NM_170707.4(LMNA):c.158A>G (p.Glu53Gly)	LMNA	E53G	Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000424915	1	156084867	1	156115076	424915	413249	rs60290646	NC_000001.11:156115075:A:G
NM_170707.4(LMNA):c.381_383delinsTGGTCACCTGAGAG (p.Ile128fs)	LMNA		Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000200956	1	156100432 - 156100434	1	156130641 - 156130643	200956	196460	rs794728605	NC_000001.11:156130640:GAT:TGGTCACCTGAGAG
NM_170707.4(LMNA):c.886_887insA (p.Arg296fs)	LMNA		not provided|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000197776	1	156105053 - 156105054	1	156135262 - 156135263	197776	194937	rs797044758	NC_000001.11:156135262::A
NM_170707.4(LMNA):c.710T>C (p.Phe237Ser)	LMNA	F237S, F156S, F125S	not provided|Primary dilated cardiomyopathy	Pathogenic(Last reviewed: Mar 3, 2019)	criteria provided, single submitter	VCV000180404	1	156104666	1	156134875	180404	178431	rs730880132	NC_000001.11:156134874:T:C
NM_170707.4(LMNA):c.266G>T (p.Arg89Leu)	LMNA	R89L	Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	VCV000066884	1	156084975	1	156115184	66884	77781	rs59040894	NC_000001.11:156115183:G:T
NM_170707.4(LMNA):c.1488+5G>C	LMNA		not provided|Familial partial lipodystrophy 2	Pathogenic(Last reviewed: Oct 3, 2016)	criteria provided, single submitter	VCV000066833	1	156106824	1	156137033	66833	77730	rs267607543	NC_000001.11:156137032:G:C
NM_170707.4(LMNA):c.1063C>T (p.Gln355Ter)	LMNA	Q355*, Q274*, Q243*	Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Jun 16, 2016)	criteria provided, single submitter	VCV000066767	1	156105818	1	156136027	66767	77664	rs267607617	NC_000001.11:156136026:C:T
NM_170707.4(LMNA):c.1821G>A (p.Val607=)	LMNA	V607V	not provided|Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000014516	1	156108401	1	156138610	14516	29555	rs59886214	NC_000001.11:156138609:G:A
NM_170707.4(LMNA):c.428C>T (p.Ser143Phe)	LMNA	S143F, S31F, S62F	not provided|Congenital muscular dystrophy, LMNA-related	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000014510	1	156100479	1	156130688	14510	29549	rs58912633	NC_000001.11:156130687:C:T
NM_170707.4(LMNA):c.169G>C (p.Ala57Pro)	LMNA	A57P	not provided|Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome	Pathogenic(Last reviewed: Feb 15, 2009)	no assertion criteria provided	VCV000014506	1	156084878	1	156115087	14506	29545	rs28928903	NC_000001.11:156115086:G:C
NM_003000.2(SDHB):c.3G>A (p.Met1Ile)	SDHB	M1I	Paragangliomas 4|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000428932	1	17380512	1	17054017	428932	420754	rs1131691061	NC_000001.11:17054016:C:T
NM_003000.2(SDHB):c.329_330CT[1] (p.Leu111fs)	SDHB		Hereditary Paraganglioma-Pheochromocytoma Syndromes|Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000412453	1	17355186 - 17355187	1	17028691 - 17028692	412453	390920	rs1060503751	NC_000001.11:17028690:AGAG:AG
NM_003000.2(SDHB):c.271A>T (p.Arg91Ter)	SDHB	R91*	Hereditary Paraganglioma-Pheochromocytoma Syndromes|Paragangliomas 4|Gastrointestinal stromal tumor|Pheochromocytoma	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000239427	1	17359570	1	17033075	239427	238183	rs878854575	NC_000001.11:17033074:T:A
NM_000530.8(MPZ):c.487G>C (p.Gly163Arg)	MPZ	G163R	Charcot-Marie-Tooth disease, demyelinating, type 1b|not provided|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000041022	1	161276216	1	161306426	41022	49444	rs281865128	NC_000001.11:161306425:C:G
NC_000001.10:g.(?_156084700)_(156085075_?)del	LMNA		Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000655760	1	156084700 - 156085075	1	156114909 - 156115284	655760	650534		
NM_170707.4(LMNA):c.1541G>A (p.Trp514Ter)	LMNA	W433*, W402*, W514*	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000649746	1	156106956	1	156137165	649746	626924		NC_000001.11:156137164:G:A
NM_170707.4(LMNA):c.1559G>A (p.Trp520Ter)	LMNA	W520*, W408*, W439*	Dilated cardiomyopathy 1A	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000520407	1	156106974	1	156137183	520407	511003	rs58362413	NC_000001.11:156137182:G:A
NM_170707.3(LMNA):c.(?_1)_(356_?)del (p.(?))	LMNA		Primary dilated cardiomyopathy|Laminopathy	Pathogenic(Last reviewed: Nov 25, 2014)	criteria provided, single submitter	VCV000180106	1	156084710 - 156085065	1	156114919 - 156115274	180106	172880		
NM_170707.4(LMNA):c.1968+5G>A	LMNA		Hutchinson-Gilford progeria syndrome, atypical|Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Aug 1, 2015)	no assertion criteria provided	VCV000162417	1	156108553	1	156138762	162417	172117	rs797044488	NC_000001.11:156138761:G:A
NM_170707.4(LMNA):c.1968G>A (p.Gln656=)	LMNA	Q656Q	Hutchinson-Gilford syndrome|Hutchinson-Gilford progeria syndrome, atypical	Pathogenic(Last reviewed: Aug 1, 2015)	no assertion criteria provided	VCV000162412	1	156108548	1	156138757	162412	172113	rs797044487	NC_000001.11:156138756:G:A
NM_170707.4(LMNA):c.1619T>C (p.Met540Thr)	LMNA	M540T, M459T, M428T	Hutchinson-Gilford syndrome|not provided	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000066858	1	156107455	1	156137664	66858	77755	rs267607547	NC_000001.11:156137663:T:C
NM_170707.4(LMNA):c.1296_1299GCAC[4] (p.Ser437fs)	LMNA		Cardiomyopathy|not provided	Pathogenic(Last reviewed: Oct 27, 2014)	no assertion criteria provided	VCV000066803	1	156106142 - 156106143	1	156136351 - 156136352	66803	77700	rs267607577	NC_000001.11:156136351:GCACGCACGCAC:GCACGCACGCACGCAC
NM_170707.4(LMNA):c.1157G>A (p.Arg386Lys)	LMNA	R386K, R274K, R305K	not provided	Pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, single submitter	VCV000066782	1	156105912	1	156136121	66782	77679	rs267607545	NC_000001.11:156136120:G:A
NM_170707.4(LMNA):c.1114del (p.Glu372fs)	LMNA	E260fs, E372fs, E291fs	Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000066777	1	156105868	1	156136077	66777	77674	rs267607575	NC_000001.11:156136076:GG:G
NM_170707.4(LMNA):c.1477C>T (p.Gln493Ter)	LMNA	Q493*, Q381*, Q412*	not provided|Emery-Dreifuss muscular dystrophy 2, autosomal dominant	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000014514	1	156106808	1	156137017	14514	29553	rs56699480	NC_000001.11:156137016:C:T
NM_170707.4(LMNA):c.433G>A (p.Glu145Lys)	LMNA	E145K, E33K, E64K	not provided|Hutchinson-Gilford progeria syndrome, atypical|Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000014502	1	156100484	1	156130693	14502	29541	rs60310264	NC_000001.11:156130692:G:A
NM_170707.4(LMNA):c.1822G>A (p.Gly608Ser)	LMNA	G608S, G578S, G496S	not provided|Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000014501	1	156108402	1	156138611	14501	29540	rs61064130	NC_000001.11:156138610:G:A
NM_170707.4(LMNA):c.1394G>A (p.Gly465Asp)	LMNA	G465D, G353D, G384D	not provided|Familial partial lipodystrophy 2	Pathogenic(Last reviewed: Jan 22, 2016)	criteria provided, single submitter	VCV000014493	1	156106725	1	156136934	14493	29532	rs61282106	NC_000001.11:156136933:G:A
NM_170707.4(LMNA):c.664C>T (p.His222Tyr)	LMNA	H222Y, H141Y, H110Y	not provided|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Emery-Dreifuss muscular dystrophy 3, autosomal recessive	Pathogenic(Last reviewed: Jan 17, 2013)	no assertion criteria provided	VCV000014492	1	156104620	1	156134829	14492	29531	rs28928901	NC_000001.11:156134828:C:T
NM_001201543.2(FAM161A):c.1309A>T (p.Arg437Ter)	FAM161A	R437*	Retinitis pigmentosa 28|Retinal dystrophy|Retinitis pigmentosa|Cone-rod dystrophy|not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000036	2	62066830	2	61839695	36	15075	rs200691042	NC_000002.12:61839694:T:A
NM_022089.4(ATP13A2):c.1459C>T (p.Arg487Ter)	ATP13A2	R487*, R482*	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 5, 2015)	criteria provided, single submitter	VCV000520750	1	17322554	1	16996059	520750	511191	rs1303653650	NC_000001.11:16996058:G:A
NM_170707.4(LMNA):c.91G>A (p.Glu31Lys)	LMNA	E31K	Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000573778	1	156084800	1	156115009	573778	556955	rs1228406418	NC_000001.11:156115008:G:A
NM_170707.4(LMNA):c.1494G>A (p.Trp498Ter)	LMNA	W498*, W386*, W417*	Charcot-Marie-Tooth disease, type 2|Familial dilated cardiomyopathy	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000520447	1	156106909	1	156137118	520447	511044	rs57730570	NC_000001.11:156137117:G:A
NM_170707.4(LMNA):c.1228C>T (p.Gln410Ter)	LMNA	Q410*, Q298*, Q329*	Dilated cardiomyopathy 1A	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000222001	1	156106075	1	156136284	222001	223685	rs1057515421	NC_000001.11:156136283:C:T
NM_170707.4(LMNA):c.859del (p.Ala287fs)	LMNA	A287fs, A175fs, A206fs	not provided|Primary dilated cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2015)	criteria provided, multiple submitters, no conflicts	VCV000200959	1	156105022	1	156135231	200959	196472	rs59564495	NC_000001.11:156135230:GGGGG:GGGG
NM_170707.4(LMNA):c.1608+5G>C	LMNA		not provided|Emery-Dreifuss muscular dystrophy 2, autosomal dominant	Pathogenic(Last reviewed: May 22, 2000)	no assertion criteria provided	VCV000066854	1	156107028	1	156137237	66854	77751	rs267607539	NC_000001.11:156137236:G:C
NM_170707.4(LMNA):c.1346G>A (p.Gly449Asp)	LMNA	G449D, G337D, G368D	Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000066806	1	156106193	1	156136402	66806	77703	rs267607637	NC_000001.11:156136401:G:A
NM_170707.4(LMNA):c.11C>G (p.Pro4Arg)	LMNA	P4R	Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000066795	1	156084720	1	156114929	66795	77692	rs267607620	NC_000001.11:156114928:C:G
NM_170707.4(LMNA):c.644T>C (p.Leu215Pro)	LMNA	L215P, L103P, L134P	not provided|Dilated cardiomyopathy 1A	Pathogenic(Last reviewed: Sep 19, 2013)	no assertion criteria provided	VCV000065764	1	156104600	1	156134809	65764	76672	rs61295588	NC_000001.11:156134808:T:C
NM_170707.4(LMNA):c.1444C>T (p.Arg482Trp)	LMNA	R482W, R401W, R370W	not provided|Familial partial lipodystrophy 2	Pathogenic(Last reviewed: Nov 14, 2014)	criteria provided, single submitter	VCV000014489	1	156106775	1	156136984	14489	29528	rs57920071	NC_000001.11:156136983:C:T
NM_201253.3(CRB1):c.613_619del (p.Ile205fs)	CRB1	I136fs, I205fs	Leber congenital amaurosis 8|Retinitis pigmentosa 12|Leber congenital amaurosis|not provided|Retinal dystrophy|Retinitis pigmentosa|Leber congenital amaurosis 1	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000099913	1	197298091 - 197298097	1	197328961 - 197328967	99913	105802	rs62645752	NC_000001.11:197328960:GAAATAGGAA:GAA
NM_001040142.2(SCN2A):c.4303C>T (p.Arg1435Ter)	SCN2A	R1435*	not provided|Early infantile epileptic encephalopathy 11|Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419721	2	166234155	2	165377645	419721	405354	rs796053138	NC_000002.12:165377644:C:T
NM_000016.5(ACADM):c.797A>G (p.Asp266Gly)	ACADM	D266G, D270G, D299G, D77G, D230G	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203540	1	76215192	1	75749507	203540	199977	rs201375579	NC_000001.11:75749506:A:G
NM_015100.4(POGZ):c.2883dup (p.Gly962fs)	POGZ		Inborn genetic diseases	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000521504	1	151378627 - 151378628	1	151406151 - 151406152	521504	511168	rs1553212626	NC_000001.11:151406151:A:AA
NM_015100.4(POGZ):c.2712dup (p.Ala905fs)	POGZ		Inborn genetic diseases	Pathogenic(Last reviewed: Mar 29, 2017)	criteria provided, single submitter	VCV000521423	1	151378798 - 151378799	1	151406322 - 151406323	521423	511170	rs1553212978	NC_000001.11:151406322:T:TT
NM_015100.4(POGZ):c.2729C>A (p.Ser910Ter)	POGZ	S910*, S857*, S848*, S815*, S901*	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, single submitter	VCV000521284	1	151378782	1	151406306	521284	511169	rs1313319892	NC_000001.11:151406305:G:T
NM_015100.4(POGZ):c.2989C>T (p.Arg997Ter)	POGZ	R997*, R935*, R988*, R902*, R944*	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 13, 2016)	criteria provided, single submitter	VCV000521279	1	151378522	1	151406046	521279	511167	rs1553212545	NC_000001.11:151406045:G:A
NM_003742.4(ABCB11):c.890A>G (p.Glu297Gly)	ABCB11	E297G	Progressive familial intrahepatic cholestasis||not provided|Progressive familial intrahepatic cholestasis 2|Cholestasis, intrahepatic, of pregnancy 3	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006590	2	169847329	2	168990819	6590	21629	rs11568372	NC_000002.12:168990818:T:C
NM_000104.3(CYP1B1):c.1159G>A (p.Glu387Lys)	CYP1B1	E387K	Glaucoma 3, primary congenital, A|Congenital glaucoma|not provided	Pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000007735	2	38298338	2	38071195	7735	22774	rs55989760	NC_000002.12:38071194:C:T
NM_001204.7(BMPR2):c.2617C>T (p.Arg873Ter)	BMPR2	R873*	Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000008805	2	203421005	2	202556282	8805	23844	rs137852748	NC_000002.12:202556281:C:T
NM_001276345.2(TNNT2):c.547C>T (p.Arg183Trp)	TNNT2	R173W, R183W, R143W, R168W	Familial hypertrophic cardiomyopathy 2|Familial restrictive cardiomyopathy 3|Left ventricular noncompaction 6|not provided|Primary dilated cardiomyopathy	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228409	1	201332477	1	201363349	228409	228285	rs727503512	NC_000001.11:201363348:G:A
NM_170707.4(LMNA):c.356+1G>C	LMNA		not provided|Primary dilated cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2016)	criteria provided, multiple submitters, no conflicts	VCV000228271	1	156085066	1	156115275	228271	228273	rs794728589	NC_000001.11:156115274:G:C
NM_170707.4(LMNA):c.1086del (p.Leu363fs)	LMNA	L363fs, L282fs, L251fs	Primary dilated cardiomyopathy|not provided	Pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, single submitter	VCV000155806	1	156105840	1	156136049	155806	165558	rs58389804	NC_000001.11:156136048:TT:T
NM_170707.4(LMNA):c.82C>T (p.Arg28Trp)	LMNA	R28W	Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Sep 4, 2017)	criteria provided, single submitter	VCV000066946	1	156084791	1	156115000	66946	77843	rs59914820	NC_000001.11:156114999:C:T
NM_170707.4(LMNA):c.621_623GAA[1] (p.Lys208del)	LMNA	K208del	Emery-Dreifuss muscular dystrophy 2, autosomal dominant|not provided	Pathogenic(Last reviewed: May 22, 2000)	no assertion criteria provided	VCV000066918	1	156104300 - 156104302	1	156134509 - 156134511	66918	77815	rs267607540	NC_000001.11:156134508:AGAAGAA:AGAA
NM_170707.4(LMNA):c.1621C>G (p.Arg541Gly)	LMNA	R541G, R460G, R429G	not provided|Dilated cardiomyopathy 1A	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000029775	1	156107457	1	156137666	29775	38730	rs56984562	NC_000001.11:156137665:C:G
NM_170707.4(LMNA):c.254T>G (p.Leu85Arg)	LMNA	L85R	not provided|Dilated cardiomyopathy 1A	Pathogenic(Last reviewed: Dec 2, 1999)	no assertion criteria provided	VCV000014480	1	156084963	1	156115172	14480	29519	rs28933090	NC_000001.11:156115171:T:G
NM_020451.3(SELENON):c.1397G>A (p.Arg466Gln)	SELENON	R466Q, R432Q	not provided|Eichsfeld type congenital muscular dystrophy|SEPN1-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004492	1	26140381	1	25813890	4492	19531	rs121908185	NC_000001.11:25813889:G:A
NM_003001.3(SDHC):c.405+1G>C	SDHC		Gastrointestinal stromal tumor|Paragangliomas 3|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428934	1	161326631	1	161356841	428934	420736	rs587776653	NC_000001.11:161356840:G:C
NM_000143.3(FH):c.689A>G (p.Lys230Arg)	FH	K230R	Fumarase deficiency|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429176	1	241671952	1	241508652	429176	421011	rs752232718	NC_000001.11:241508651:T:C
NM_000143.3(FH):c.1189G>A (p.Gly397Arg)	FH	G397R	Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency|not provided	Pathogenic(Last reviewed: Jul 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000214422	1	241665790	1	241502490	214422	210663	rs863224007	NC_000001.11:241502489:C:T
NM_000143.3(FH):c.1097G>A (p.Ser366Asn)	FH	S366N	Hereditary cancer-predisposing syndrome|Fumarase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000214419	1	241667353	1	241504053	214419	210669	rs863224004	NC_000001.11:241504052:C:T
NM_000143.3(FH):c.912_918del (p.Phe305fs)	FH	F305fs	Hereditary cancer-predisposing syndrome|Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency|not provided	Pathogenic(Last reviewed: Sep 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000198391	1	241667532 - 241667538	1	241504232 - 241504238	198391	195552	rs794727836	NC_000001.11:241504231:GACAAAAG:G
NM_170707.4(LMNA):c.91_93del (p.Glu31del)	LMNA	E31del	Charcot-Marie-Tooth disease, type 2|Congenital muscular dystrophy, LMNA-related	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000218376	1	156084798 - 156084800	1	156115007 - 156115009	218376	215103	rs864309525	NC_000001.11:156115006:AGGAG:AG
NM_170707.4(LMNA):c.356+1G>A	LMNA		not provided|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000200933	1	156085066	1	156115275	200933	196457	rs794728589	NC_000001.11:156115274:G:A
NM_170707.4(LMNA):c.1609-1G>A	LMNA		Primary dilated cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000179809	1	156107444	1	156137653	179809	172349	rs111569862	NC_000001.11:156137652:G:A
NM_170707.4(LMNA):c.640-10A>G	LMNA		Dilated cardiomyopathy 1A|not provided	Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000066921	1	156104586	1	156134795	66921	77818	rs80356807	NC_000001.11:156134794:A:G
NM_170707.4(LMNA):c.1968+1G>A	LMNA		Hutchinson-Gilford syndrome|not provided|Lethal tight skin contracture syndrome	Pathogenic(Last reviewed: Aug 1, 2015)	no assertion criteria provided	VCV000066879	1	156108549	1	156138758	66879	77776	rs113436208	NC_000001.11:156138757:G:A
NM_014874.3(MFN2):c.1091G>C (p.Arg364Pro)	MFN2	R364P	Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000572157	1	12062091	1	12002034	572157	558090	rs879254011	NC_000001.11:12002033:G:C
NM_014874.3(MFN2):c.494A>G (p.His165Arg)	MFN2	H165R	Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217164	1	12057373	1	11997316	217164	213788	rs863224970	NC_000001.11:11997315:A:G
NM_001040142.2(SCN2A):c.2674G>A (p.Val892Ile)	SCN2A	V892I	Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures|not provided|Benign familial neonatal-infantile seizures	Pathogenic/Likely pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012878	2	166201176	2	165344666	12878	27917	rs121917751	NC_000002.12:165344665:G:A
NM_018136.5(ASPM):c.7782_7783del (p.Lys2595fs)	ASPM	K2595fs	Primary autosomal recessive microcephaly 5|Primary autosomal recessive microcephaly 1|not provided	Pathogenic(Last reviewed: Sep 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021606	1	197070598 - 197070599	1	197101468 - 197101469	21606	34458	rs199422173	NC_000001.11:197101467:TCT:T
NM_005857.4(ZMPSTE24):c.1085dupT (p.Leu362Phefs)	ZMPSTE24		Lethal tight skin contracture syndrome|Mandibuloacral dysplasia with type B lipodystrophy|ZMPSTE24-Related Disorders|not provided	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004271	1	40756542 - 40756543	1	40290870 - 40290871	4271	19310	rs137854889	NC_000001.11:40290870:TTTTTTTTT:TTTTTTTTTT
NM_003000.2(SDHB):c.607_616del (p.Gly203fs)	SDHB	G203fs	Hereditary cancer-predisposing syndrome|not provided|Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000142653	1	17350494 - 17350503	1	17023999 - 17024008	142653	152367	rs587782617	NC_000001.11:17023998:ATTTGTCTCC:
NM_170707.4(LMNA):c.3G>A (p.Met1Ile)	LMNA	M1I	not provided|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488705	1	156084712	1	156114921	488705	481568	rs794728598	NC_000001.11:156114920:G:A
NM_170707.4(LMNA):c.1057C>T (p.Gln353Ter)	LMNA	Q353*, Q241*, Q272*	Cardiovascular phenotype|Charcot-Marie-Tooth disease, type 2|not provided|Autosomal dominant distal hereditary motor neuropathy	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000200939	1	156105812	1	156136021	200939	196476	rs267607623	NC_000001.11:156136020:C:T
NM_170707.4(LMNA):c.73C>G (p.Arg25Gly)	LMNA	R25G	Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066928	1	156084782	1	156114991	66928	77825	rs58327533	NC_000001.11:156114990:C:G
NM_170707.4(LMNA):c.1380+1G>A	LMNA		Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066817	1	156106228	1	156136437	66817	77714	rs267607552	NC_000001.11:156136436:G:A
NM_001040142.2(SCN2A):c.2995G>A (p.Glu999Lys)	SCN2A	E999K	not provided|Early infantile epileptic encephalopathy 11|Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures	Pathogenic/Likely pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000206981	2	166210777	2	165354267	206981	201348	rs796053126	NC_000002.12:165354266:G:A
NM_001040142.2(SCN2A):c.3631G>A (p.Glu1211Lys)	SCN2A	E1211K	Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000029886	2	166223837	2	165367327	29886	38841	rs387906684	NC_000002.12:165367326:G:A
NM_001204.7(BMPR2):c.1472G>A (p.Arg491Gln)	BMPR2	R491Q	not specified|Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic(Last reviewed: Jun 22, 2019)	criteria provided, single submitter	VCV000008806	2	203417497	2	202552774	8806	23845	rs137852749	NC_000002.12:202552773:G:A
NM_000143.3(FH):c.239dup (p.Ile81fs)	FH		not provided|Hereditary cancer-predisposing syndrome|Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000393558	1	241680509 - 241680510	1	241517209 - 241517210	393558	380471	rs1553341942	NC_000001.11:241517209:TT:TTT
NM_000143.3(FH):c.1255T>C (p.Ser419Pro)	FH	S419P	not provided|Fumarase deficiency|Hereditary cancer-predisposing syndrome|Hereditary leiomyomatosis and renal cell cancer	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092451	1	241663872	1	241500572	92451	98360	rs200004220	NC_000001.11:241500571:A:G
NM_024529.4(CDC73):c.2T>C (p.Met1Thr)	CDC73	M1T	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000521635	1	193091332	1	193122202	521635	511204	rs1553277483	NC_000001.11:193122201:T:C
NM_201253.3(CRB1):c.2401A>T (p.Lys801Ter)	CRB1	K801*, K732*, K689*	Retinitis pigmentosa 12|Retinal dystrophy|Retinitis pigmentosa|Leber congenital amaurosis 8|Retinitis pigmentosa 12|not provided	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005736	1	197396856	1	197427726	5736	20775	rs137853137	NC_000001.11:197427725:A:T
NM_201253.3(CRB1):c.2234C>T (p.Thr745Met)	CRB1	T745M, T633M, T676M	Retinitis pigmentosa 12|Retinal dystrophy|Retinitis pigmentosa|Leber congenital amaurosis 8|Retinitis pigmentosa 12|not provided	Pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005733	1	197396689	1	197427559	5733	20772	rs28939720	NC_000001.11:197427558:C:T
NM_006912.6(RIT1):c.247A>C (p.Thr83Pro)	RIT1	T83P, T100P, T47P	Inborn genetic diseases|Noonan syndrome 1|not provided|Noonan syndrome	Pathogenic(Last reviewed: Dec 7, 2016)	criteria provided, multiple submitters, no conflicts	VCV000183409	1	155874284	1	155904493	183409	181507	rs869025195	NC_000001.11:155904492:T:G
NM_170707.4(LMNA):c.475G>T (p.Glu159Ter)	LMNA	E159*, E47*, E78*	Charcot-Marie-Tooth disease, type 2|Dilated cardiomyopathy 1A	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000694069	1	156100526	1	156130735	694069	681874		NC_000001.11:156130734:G:T
NM_170707.4(LMNA):c.398G>A (p.Arg133Gln)	LMNA	R133Q, R21Q, R52Q	not provided|Charcot-Marie-Tooth disease, type 2	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200934	1	156100449	1	156130658	200934	196461	rs60864230	NC_000001.11:156130657:G:A
NM_170707.4(LMNA):c.178C>G (p.Arg60Gly)	LMNA	R60G	not provided|Familial partial lipodystrophy 2|Dilated cardiomyopathy 1A	Pathogenic(Last reviewed: Aug 27, 2002)	no assertion criteria provided	VCV000014479	1	156084887	1	156115096	14479	29518	rs28928900	NC_000001.11:156115095:C:G
NM_015506.3(MMACHC):c.440G>C (p.Gly147Ala)	MMACHC	G147A, G90A	not provided|Methylmalonic aciduria|Homocystinuria|Disorders of Intracellular Cobalamin Metabolism|Methylmalonic acidemia with homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203828	1	45974478	1	45508806	203828	199952	rs140522266	NC_000001.11:45508805:G:C
NM_001276345.2(TNNT2):c.566C>T (p.Ser189Phe)	TNNT2	S179F, S189F, S149F, S174F	Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Familial hypertrophic cardiomyopathy 2|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177634	1	201332458	1	201363330	177634	172499	rs727504246	NC_000001.11:201363329:G:A
NM_001276345.2(TNNT2):c.422G>A (p.Arg141Gln)	TNNT2	R131Q, R141Q, R101Q, R126Q	Familial restrictive cardiomyopathy 3|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|not provided|Primary dilated cardiomyopathy	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043637	1	201333493	1	201364365	43637	52806	rs397516464	NC_000001.11:201364364:C:T
NM_017837.3(PIGV):c.1022C>A (p.Ala341Glu)	PIGV	A341E	Hyperphosphatasia with mental retardation syndrome 1|Hyperphosphatasia-intellectual disability syndrome|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001284	1	27121547	1	26795056	1284	16323	rs139073416	NC_000001.11:26795055:C:A
NM_000384.3(APOB):c.2786del (p.Pro929fs)	APOB	P929fs	Familial hypobetalipoproteinemia	Pathogenic	no assertion criteria provided	VCV000440527	2	21245733	2	21022861	440527	434177	rs1553385404	NC_000002.12:21022860:GGGG:GGG
NM_000384.3(APOB):c.3614_3625delinsCTTAGG (p.His1205_Asn1209delinsProTer)	APOB		Familial hypobetalipoproteinemia	Pathogenic	no assertion criteria provided	VCV000440526	2	21238016 - 21238027	2	21015144 - 21015155	440526	434176	rs1553384441	NC_000002.12:21015143:TAGCATACATAT:CCTAAG
NM_000384.3(APOB):c.4089C>G (p.Tyr1363Ter)	APOB	Y1363*	Familial hypobetalipoproteinemia	Pathogenic	no assertion criteria provided	VCV000440525	2	21236159	2	21013287	440525	434175	rs1553384177	NC_000002.12:21013286:G:C
NM_000384.3(APOB):c.5238T>G (p.Tyr1746Ter)	APOB	Y1746*	Familial hypobetalipoproteinemia	Pathogenic	no assertion criteria provided	VCV000440524	2	21234502	2	21011630	440524	434174	rs1553383898	NC_000002.12:21011629:A:C
NM_000384.3(APOB):c.10633G>T (p.Glu3545Ter)	APOB	E3545*	Familial hypobetalipoproteinemia	Pathogenic	no assertion criteria provided	VCV000440522	2	21229107	2	21006235	440522	434172	rs759934326	NC_000002.12:21006234:C:A
NM_000384.3(APOB):c.4089C>A (p.Tyr1363Ter)	APOB	Y1363*	Hypobetalipoproteinemia, familial, 1	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000477784	2	21236159	2	21013287	477784	450483	rs1553384177	NC_000002.12:21013286:G:T
NM_000384.3(APOB):c.1830-1G>A	APOB		Hypobetalipoproteinemia, familial, 1	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000477783	2	21250938	2	21028066	477783	450492	rs1399892057	NC_000002.12:21028065:C:T
NM_000384.3(APOB):c.5116dup (p.Thr1706fs)	APOB		Hypobetalipoproteinemia, familial, 1	Pathogenic(Last reviewed: Jul 31, 2016)	criteria provided, single submitter	VCV000404409	2	21234623 - 21234624	2	21011751 - 21011752	404409	392554	rs1553383931	NC_000002.12:21011751:T:TT
NM_000384.3(APOB):c.9523del (p.Ala3175fs)	APOB	A3175fs	Hypobetalipoproteinemia, familial, 1	Pathogenic(Last reviewed: Jun 18, 2016)	criteria provided, single submitter	VCV000237754	2	21230217	2	21007345	237754	238606	rs878853973	NC_000002.12:21007344:C:
NM_000384.3(APOB):c.1672C>T (p.Arg558Ter)	APOB	R558*	Hypobetalipoproteinemia, familial, 1	Pathogenic(Last reviewed: Jan 11, 2016)	criteria provided, single submitter	VCV000237741	2	21251356	2	21028484	237741	238618	rs878853970	NC_000002.12:21028483:G:A
NM_000384.3(APOB):c.905-1_905dup	APOB		Familial hypobetalipoproteinemia	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000029608	2	21256389 - 21256390	2	21033517 - 21033518	29608	38562	rs606231236	NC_000002.12:21033517:CC:CCCC
NM_000384.3(APOB):c.3600T>A (p.Tyr1200Ter)	APOB	Y1173*, Y1200*	Hypobetalipoproteinemia, normotriglyceridemic	Pathogenic(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000017901	2	21238041	2	21015169	17901	32940	rs121918391	NC_000002.12:21015168:A:T
APOB, 1-BP DEL, 4432T	APOB		Familial hypobetalipoproteinemia	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000017899					17899	32938		
NM_000384.3(APOB):c.819-2A>G	APOB		Familial hypobetalipoproteinemia	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000017898	2	21257775	2	21034903	17898	32937		NC_000002.12:21034902:T:C
NM_000384.3(APOB):c.4429C>T (p.Gln1477Ter)	APOB	Q1450*, Q1477*	Familial hypobetalipoproteinemia	Pathogenic(Last reviewed: Apr 14, 1992)	no assertion criteria provided	VCV000017894	2	21235311	2	21012439	17894	32933	rs121918389	NC_000002.12:21012438:G:A
NM_000384.3(APOB):c.9200del (p.Lys3067fs)	APOB	L3041*, K3067fs	Familial hypobetalipoproteinemia	Pathogenic(Last reviewed: May 1, 1991)	no assertion criteria provided	VCV000017892	2	21230540	2	21007668	17892	32931	rs121918387	NC_000002.12:21007667:TT:T
NM_000384.2(APOB):c.11905del (p.Glu3969Asnfs)	APOB		Familial hypobetalipoproteinemia	Pathogenic(Last reviewed: Sep 1, 1996)	no assertion criteria provided	VCV000017888	2	21227323	2	21004451	17888	32927	rs387906569	NC_000002.12:21004450:CCC:CC
APOB, EX21DEL	APOB		Familial hypobetalipoproteinemia	Pathogenic(Last reviewed: Jul 5, 1989)	no assertion criteria provided	VCV000017886					17886	32925		
NM_000384.3(APOB):c.3997C>T (p.Arg1333Ter)	APOB	R1306*, R1333*	Familial hypobetalipoproteinemia	Pathogenic(Last reviewed: Sep 12, 1988)	no assertion criteria provided	VCV000017883	2	21236251	2	21013379	17883	32922	rs121918383	NC_000002.12:21013378:G:A
NM_000384.3(APOB):c.5463del (p.His1822fs)	APOB	H1822fs	Familial hypobetalipoproteinemia	Pathogenic(Last reviewed: Sep 12, 1988)	no assertion criteria provided	VCV000017882	2	21234277	2	21011405	17882	32921	rs397514255	NC_000002.12:21011404:C:
NM_000384.3(APOB):c.9180dup (p.Pro3061fs)	APOB		Hypobetalipoproteinemia, familial, 1|Familial hypercholesterolemia 2	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000853099	2	21230559 - 21230560	2	21007687 - 21007688	853099	825620		NC_000002.12:21007687:AAAA:AAAAA
NM_000384.3(APOB):c.8392G>T (p.Glu2798Ter)	APOB	E2798*	Hypobetalipoproteinemia, familial, 1|Familial hypercholesterolemia 2	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000843259	2	21231348	2	21008476	843259	825622		NC_000002.12:21008475:C:A
NM_000384.3(APOB):c.5316del (p.Asn1772fs)	APOB	N1772fs	Hypobetalipoproteinemia, familial, 1|Familial hypercholesterolemia 2	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000838558	2	21234424	2	21011552	838558	825630		NC_000002.12:21011551:G:
NM_000384.3(APOB):c.671del (p.Pro224fs)	APOB	P224fs	Hypobetalipoproteinemia, familial, 1|Familial hypercholesterolemia 2	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000648832	2	21259994	2	21037122	648832	629347		NC_000002.12:21037121:GGG:GG
NM_000384.3(APOB):c.7605C>A (p.Tyr2535Ter)	APOB	Y2535*	Hypobetalipoproteinemia, familial, 1|Familial hypercholesterolemia 2	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000544071	2	21232135	2	21009263	544071	517828	rs1553383473	NC_000002.12:21009262:G:T
NM_000384.3(APOB):c.7537C>T (p.Arg2513Ter)	APOB	R2513*	Hypobetalipoproteinemia, familial, 1|Familial hypercholesterolemia 2	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000069511	2	21232203	2	21009331	69511	80402		NC_000002.12:21009330:G:A
APOB, 4-BP DEL, NT36491	APOB		Hypobetalipoproteinemia, normotriglyceridemic	Pathogenic(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000017900					17900	32939		
NM_000384.3(APOB):c.11712del (p.Asn3904fs)	APOB	N3904fs	Familial hypobetalipoproteinemia	Pathogenic(Last reviewed: Dec 1, 1992)	no assertion criteria provided	VCV000017896	2	21228028	2	21005156	17896	32935	rs587776852	NC_000002.12:21005155:G:
NM_000384.3(APOB):c.4352del (p.Gly1451fs)	APOB	G1451fs	Familial hypobetalipoproteinemia	Pathogenic(Last reviewed: Mar 1, 1990)	no assertion criteria provided	VCV000017889	2	21235388	2	21012516	17889	32928	rs397514256	NC_000002.12:21012515:CC:C
NM_000384.3(APOB):c.6253C>T (p.Arg2085Ter)	APOB	R2058*, R2085*	Familial hypobetalipoproteinemia	Pathogenic(Last reviewed: Jun 15, 1989)	no assertion criteria provided	VCV000017887	2	21233487	2	21010615	17887	32926	rs121918386	NC_000002.12:21010614:G:A
NM_000384.3(APOB):c.5566_5567del (p.Val1856fs)	APOB	V1829C, V1856fs	Familial hypobetalipoproteinemia	Pathogenic(Last reviewed: Aug 1, 1992)	no assertion criteria provided	VCV000017884	2	21234173 - 21234174	2	21011301 - 21011302	17884	32923	rs121918384	NC_000002.12:21011300:ACA:A
NM_000384.3(APOB):c.4006C>T (p.Gln1336Ter)	APOB	Q1336*	Hypobetalipoproteinemia, familial, 1|Familial hypercholesterolemia 2	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000855100	2	21236242	2	21013370	855100	825636		NC_000002.12:21013369:G:A
NM_000384.3(APOB):c.6543del (p.Phe2181fs)	APOB	F2181fs	Hypobetalipoproteinemia, familial, 1|Familial hypercholesterolemia 2	Pathogenic(Last reviewed: Jun 10, 2018)	criteria provided, single submitter	VCV000569699	2	21233197	2	21010325	569699	560768	rs1558564161	NC_000002.12:21010324:AAA:AA
NM_000384.3(APOB):c.12181del (p.Glu4061fs)	APOB	E4034R, E4061fs	Familial hypobetalipoproteinemia	Pathogenic(Last reviewed: Aug 1, 1992)	no assertion criteria provided	VCV000017885	2	21226113	2	21003241	17885	32924	rs121918385	NC_000002.12:21003240:C:
NM_000384.3(APOB):c.4503T>G (p.Tyr1501Ter)	APOB	Y1501*	Hypobetalipoproteinemia, familial, 1|Familial hypercholesterolemia 2	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000577519	2	21235237	2	21012365	577519	560798	rs368825685	NC_000002.12:21012364:A:C
NM_000384.3(APOB):c.9110_9114TTTTC[1] (p.Phe3039fs)	APOB		Hypobetalipoproteinemia, familial, 1|Familial hypercholesterolemia 2	Pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	VCV000544076	2	21230621 - 21230625	2	21007749 - 21007753	544076	517705	rs1215189537	NC_000002.12:21007748:GAAAAGAAAAGA:GAAAAGA
NM_000384.3(APOB):c.7564C>T (p.Arg2522Ter)	APOB	R2495*, R2522*	Familial hypobetalipoproteinemia|Hypobetalipoproteinemia, familial, 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2018)	no assertion criteria provided	VCV000017895	2	21232176	2	21009304	17895	32934	rs121918390	NC_000002.12:21009303:G:A
NM_000384.3(APOB):c.5263_5266del (p.Asn1755fs)	APOB	N1755fs	Familial hypobetalipoproteinemia	Pathogenic(Last reviewed: Dec 1, 1992)	no assertion criteria provided	VCV000017881	2	21234474 - 21234477	2	21011602 - 21011605	17881	32920	rs281865425	NC_000002.12:21011601:TGTTTGT:TGT
NM_014874.3(MFN2):c.314C>T (p.Thr105Met)	MFN2	T105M	Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000214652	1	12056215	1	11996158	214652	210585	rs863224069	NC_000001.11:11996157:C:T
NM_000384.3(APOB):c.409G>T (p.Glu137Ter)	APOB	E137*	Hypobetalipoproteinemia, familial, 1|Familial hypercholesterolemia 2|Hypobetalipoproteinemia, familial, 1	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000404400	2	21260958	2	21038086	404400	392301	rs766243954	NC_000002.12:21038085:C:A
NM_000384.3(APOB):c.10238del (p.Thr3413fs)	APOB	T3413fs	Familial hypercholesterolemia 2|Hypobetalipoproteinemia, familial, 1|Hypobetalipoproteinemia	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000434252	2	21229502	2	21006630	434252	427986	rs756209187	NC_000002.12:21006629:G:
NM_000384.3(APOB):c.6835C>T (p.Gln2279Ter)	APOB	Q2252*, Q2279*	Hypobetalipoproteinemia, normotriglyceridemic	Pathogenic(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000017893	2	21232905	2	21010033	17893	32932	rs121918388	NC_000002.12:21010032:G:A
NM_170707.3(LMNA):c.1961dupG (p.Thr655Asnfs)	LMNA		Charcot-Marie-Tooth disease, type 2|Familial partial lipodystrophy 2|not provided	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066878	1	156108541	1	156138749 - 156138750	66878	77775	rs863225024	NC_000001.11:156138749:G:GG
NM_170707.4(LMNA):c.778_780AAG[1] (p.Lys261del)	LMNA	K261del	not provided|Primary dilated cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000048080	1	156104734 - 156104736	1	156134943 - 156134945	48080	57244	rs58978449	NC_000001.11:156134942:AAGAAG:AAG
NM_170707.4(LMNA):c.1112_1115dup (p.Glu372fs)	LMNA		not provided|Charcot-Marie-Tooth disease, type 2|Primary dilated cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048030	1	156105865 - 156105866	1	156136074 - 156136075	48030	57194	rs397517888	NC_000001.11:156136074:ATGGA:ATGGATGGA
NM_005572.3(LMNA):c.959delT (p.Arg321Glufs)	LMNA	R240fs, R321fs, R209fs	not provided|Dilated cardiomyopathy 1A|Emery-Dreifuss muscular dystrophy 2, autosomal dominant	Pathogenic(Last reviewed: Sep 19, 2013)	no assertion criteria provided	VCV000014491	1	156105714	1	156135923	14491	29530	rs56771886	NC_000001.11:156135922:TT:T
NM_003000.2(SDHB):c.717dup (p.Leu240fs)	SDHB		Hereditary cancer-predisposing syndrome|Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000412481	1	17349150 - 17349151	1	17022655 - 17022656	412481	390877	rs1060503764	NC_000001.11:17022655:A:AA
NM_003000.2(SDHB):c.210dup (p.Met71fs)	SDHB		Hereditary cancer-predisposing syndrome|Pheochromocytoma|Paragangliomas 4|Gastrointestinal stromal tumor|not provided	Pathogenic(Last reviewed: Sep 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000201604	1	17359630 - 17359631	1	17033135 - 17033136	201604	196494	rs794728947	NC_000001.11:17033135:GGGG:GGGGG
NM_000143.3(FH):c.139C>T (p.Gln47Ter)	FH	Q47*	Fumarase deficiency|Hereditary leiomyomatosis and renal cell cancer|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000214389	1	241680610	1	241517310	214389	210706	rs863223980	NC_000001.11:241517309:G:A
NM_000143.3(FH):c.905-1G>A	FH		Hereditary cancer-predisposing syndrome|Fumarase deficiency|Hereditary leiomyomatosis and renal cell cancer	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208374	1	241667546	1	241504246	208374	204604	rs797044973	NC_000001.11:241504245:C:T
NM_022787.4(NMNAT1):c.769G>A (p.Glu257Lys)	NMNAT1	E257K	Leber congenital amaurosis 9|not provided|Retinal dystrophy|Global developmental delay|Severe visual impairment|Nystagmus|Diarrhea|Gastrointestinal dysmotility|Developmental regression|Leber congenital amaurosis|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000037134	1	10042688	1	9982630	37134	45795	rs150726175	NC_000001.11:9982629:G:A
NM_001204.7(BMPR2):c.439C>T (p.Arg147Ter)	BMPR2	R147*	not provided|Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic(Last reviewed: Aug 31, 2015)	criteria provided, multiple submitters, no conflicts	VCV000222513	2	203378462	2	202513739	222513	224249	rs869025366	NC_000002.12:202513738:C:T
NM_000642.3(AGL):c.18_19del (p.Gln6fs)	AGL	Q6fs	Glycogen storage disease IIIb|Glycogen storage disease type III|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000195097	1	100316615 - 100316616	1	99851059 - 99851060	195097	192258	rs113994127	NC_000001.11:99851058:AGA:A
NM_000530.8(MPZ):c.233C>T (p.Ser78Leu)	MPZ	S49L, S78L	Charcot-Marie-Tooth disease, type 1b, with focally folded myelin sheaths|Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|not provided	Pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014188	1	161277049	1	161307259	14188	29227	rs121913601	NC_000001.11:161307258:G:A
NM_000090.4(COL3A1):c.1859dup (p.Gly621fs)	COL3A1		not provided	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000817234	2	189862100 - 189862101	2	188997374 - 188997375	817234	805280		NC_000002.12:188997374:CCCCC:CCCCCC
NM_000090.3(COL3A1):c.2102del (p.Pro701fs)	COL3A1	P701fs	not provided	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000618031	2	189864086	2	188999360	618031	609464	rs1559058551	NC_000002.12:188999359:CCCCC:CCCC
NM_000090.3(COL3A1):c.2096G>T (p.Gly699Val)	COL3A1	G699V	not provided	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000618030	2	189864084	2	188999358	618030	609463	rs587779706	NC_000002.12:188999357:G:T
NM_000090.3(COL3A1):c.712C>T (p.Arg238Ter)	COL3A1	R238*	Cardiovascular phenotype	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000519603	2	189854843	2	188990117	519603	509438	rs1393544920	NC_000002.12:188990116:C:T
NM_000090.3(COL3A1):c.3966_3972delinsTT (p.Glu1322fs)	COL3A1		Cardiovascular phenotype	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000519602	2	189875046 - 189875052	2	189010320 - 189010326	519602	509454	rs1553509869	NC_000002.12:189010319:GAAGAAA:TT
NM_000090.3(COL3A1):c.2392-2A>C	COL3A1		Cardiovascular phenotype	Pathogenic(Last reviewed: Feb 16, 2016)	criteria provided, single submitter	VCV000519598	2	189867022	2	189002296	519598	509448	rs1553508957	NC_000002.12:189002295:A:C
NM_000090.3(COL3A1):c.1222G>A (p.Gly408Arg)	COL3A1	G408R	not provided	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000420551	2	189858987	2	188994261	420551	405503	rs1064794552	NC_000002.12:188994260:G:A
NM_000090.3(COL3A1):c.3499G>A (p.Gly1167Ser)	COL3A1	G1167S	not provided	Pathogenic(Last reviewed: Aug 4, 2015)	criteria provided, single submitter	VCV000419652	2	189872842	2	189008116	419652	405509	rs587779609	NC_000002.12:189008115:G:A
NM_000090.3(COL3A1):c.1106G>A (p.Gly369Glu)	COL3A1	G369E	not provided	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000384345	2	189858142	2	188993416	384345	365927	rs1057521930	NC_000002.12:188993415:G:A
NM_000090.3(COL3A1):c.897+1G>A	COL3A1		not provided	Pathogenic(Last reviewed: Nov 15, 2016)	criteria provided, single submitter	VCV000373363	2	189856258	2	188991532	373363	359446	rs1057518372	NC_000002.12:188991531:G:A
NM_000090.3(COL3A1):c.3544G>C (p.Gly1182Arg)	COL3A1	G1182R	not provided	Pathogenic(Last reviewed: Feb 26, 2016)	criteria provided, single submitter	VCV000280350	2	189873668	2	189008942	280350	264087	rs587779683	NC_000002.12:189008941:G:C
NM_000090.3(COL3A1):c.3500_3501delinsAA (p.Gly1167Glu)	COL3A1		Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 10, 2014)	criteria provided, single submitter	VCV000263793	2	189872843 - 189872844	2	189008117 - 189008118	263793	258218	rs886038925	NC_000002.12:189008116:GT:AA
NM_000090.3(COL3A1):c.2642del (p.Pro881fs)	COL3A1	P881fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 1, 2013)	criteria provided, single submitter	VCV000263774	2	189868493	2	189003767	263774	258220	rs886038920	NC_000002.12:189003766:CC:C
NM_000090.3(COL3A1):c.4180_4189del (p.Gly1394fs)	COL3A1	G1394fs	not provided	Pathogenic(Last reviewed: May 12, 2014)	criteria provided, single submitter	VCV000199750	2	189875539 - 189875548	2	189010813 - 189010822	199750	196822	rs794728059	NC_000002.12:189010812:ATGGGGTCAAATG:ATG
NM_000090.3(COL3A1):c.4072C>T (p.Arg1358Ter)	COL3A1	R1358*	not provided	Pathogenic(Last reviewed: Aug 25, 2014)	criteria provided, single submitter	VCV000199747	2	189875434	2	189010708	199747	196820	rs794728057	NC_000002.12:189010707:C:T
NM_000090.3(COL3A1):c.2338-2A>G	COL3A1		not provided	Pathogenic(Last reviewed: Aug 5, 2013)	criteria provided, single submitter	VCV000199729	2	189866260	2	189001534	199729	196796	rs794728050	NC_000002.12:189001533:A:G
NM_000090.3(COL3A1):c.2057del (p.Pro686fs)	COL3A1	P686fs	POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME	Pathogenic(Last reviewed: Mar 5, 2019)	no assertion criteria provided	VCV000619226	2	189864044	2	188999318	619226	610624	rs1559058482	NC_000002.12:188999317:CC:C
NM_000090.3(COL3A1):c.2410G>A (p.Gly804Ser)	COL3A1	G637S, G804S	EHLERS-DANLOS SYNDROME, NONVASCULAR VARIANT	Pathogenic(Last reviewed: Sep 1, 1994)	no assertion criteria provided	VCV000017221	2	189867042	2	189002316	17221	32260	rs121912920	NC_000002.12:189002315:G:A
NM_170707.4(LMNA):c.1608+1G>A	LMNA		Charcot-Marie-Tooth disease, type 2|Neuromuscular disease|not provided	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000066853	1	156107024	1	156137233	66853	77750	rs267607592	NC_000001.11:156137232:G:A
NM_170707.4(LMNA):c.116A>G (p.Asn39Ser)	LMNA	N39S	Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066791	1	156084825	1	156115034	66791	77688	rs57983345	NC_000001.11:156115033:A:G
NM_170707.4(LMNA):c.799T>C (p.Tyr267His)	LMNA	Y267H, Y186H, Y155H	not provided|Primary dilated cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000048084	1	156104755	1	156134964	48084	57248	rs267607593	NC_000001.11:156134963:T:C
NM_170707.4(LMNA):c.1745G>A (p.Arg582His)	LMNA	R582H, R552H, R470H	not provided|Familial partial lipodystrophy 2|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000014494	1	156108325	1	156138534	14494	29533	rs57830985	NC_000001.11:156138533:G:A
NM_170707.4(LMNA):c.16C>T (p.Gln6Ter)	LMNA	Q6*	not provided|Primary dilated cardiomyopathy|Emery-Dreifuss muscular dystrophy 2, autosomal dominant	Pathogenic(Last reviewed: Jun 2, 2011)	criteria provided, single submitter	VCV000014477	1	156084725	1	156114934	14477	29516	rs61046466	NC_000001.11:156114933:C:T
NM_000090.3(COL3A1):c.1282C>T (p.Arg428Ter)	COL3A1	R428*	POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME	Pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, single submitter	VCV000619225	2	189859047	2	188994321	619225	610623		NC_000002.12:188994320:C:T
NM_000090.3(COL3A1):c.536del (p.Pro179fs)	COL3A1	P179fs	Thoracic aortic aneurysm and aortic dissection	Pathogenic	no assertion criteria provided	VCV000517127	2	189852809	2	188988083	517127	508706	rs1553507180	NC_000002.12:188988082:CCCCCC:CCCCC
NM_000090.3(COL3A1):c.479dup (p.Lys161fs)	COL3A1		POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000029638	2	189851815 - 189851816	2	188987089 - 188987090	29638	38592	rs397509377	NC_000002.12:188987089:T:TT
NM_020919.4(ALS2):c.3415C>T (p.Arg1139Ter)	ALS2	R1139*	Inborn genetic diseases|not provided|Amyotrophic lateral sclerosis type 2	Pathogenic/Likely pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000393199	2	202589115	2	201724392	393199	366307	rs767350733	NC_000002.12:201724391:G:A
NM_000090.3(COL3A1):c.2221G>T (p.Gly741Cys)	COL3A1	G741C	not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000429978	2	189864295	2	188999569	429978	421347	rs587779685	NC_000002.12:188999568:G:T
NM_001615.4(ACTG2):c.769C>T (p.Arg257Cys)	ACTG2	R257C, R214C	Visceral neuropathy, familial, autosomal dominant|not provided|Chronic intestinal pseudoobstruction|Megacystis|Chronic intestinal pseudoobstruction|Inborn genetic diseases|Visceral myopathy	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000132803	2	74141962	2	73914835	132803	136552	rs587777387	NC_000002.12:73914834:C:T
NM_001111.5(ADAR):c.2433_2434del (p.Ala813fs)	ADAR	A822fs, A813fs, A518fs	Inborn genetic diseases|Symmetrical dyschromatosis of extremities|Aicardi-Goutieres syndrome 6	Pathogenic(Last reviewed: Jun 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000521470	1	154562722 - 154562723	1	154590246 - 154590247	521470	511176	rs779357448	NC_000001.11:154590245:CT:
NM_015506.3(MMACHC):c.394C>T (p.Arg132Ter)	MMACHC	R132*, R75*	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|not provided|Methylmalonic acidemia with homocystinuria	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001423	1	45974001	1	45508329	1423	16462	rs121918241	NC_000001.11:45508328:C:T
NM_000090.4(COL3A1):c.724C>T (p.Arg242Ter)	COL3A1	R242*	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801840	2	189854855	2	188990129	801840	790137		NC_000002.12:188990128:C:T
NM_000090.3(COL3A1):c.1762-2A>G (p.Gly588_Gln605del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101495	2	189861889	2	188997163	101495	107242	rs587779722	NC_000002.12:188997162:A:G
NM_000090.3(COL3A1):c.1347+5G>C (p.Arg449_Gly450insValSerPheThrAlaThrAspLeu+)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101494	2	189859325	2	188994599	101494	107241	rs587779721	NC_000002.12:188994598:G:C
NM_000090.3(COL3A1):c.3410G>A (p.Gly1137Asp)	COL3A1	G1137D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101493	2	189872657	2	189007931	101493	107240	rs587779720	NC_000002.12:189007930:G:A
NM_000090.3(COL3A1):c.582+5G>T (p.Gly177_Pro194del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101492	2	189852865	2	188988139	101492	107239	rs587779671	NC_000002.12:188988138:G:T
NM_000090.3(COL3A1):c.4286_4287del (p.Val1428_Phe1429insTer)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101491	2	189876384 - 189876385	2	189011658 - 189011659	101491	107238	rs587779719	NC_000002.12:189011657:TTT:T
NM_000090.3(COL3A1):c.2022G>T (p.Lys674Asn)	COL3A1	K674N	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101490	2	189863444	2	188998718	101490	107237	rs587779643	NC_000002.12:188998717:G:T
NM_000090.3(COL3A1):c.799G>A (p.Gly267Ser)	COL3A1	G267S	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101489	2	189855730	2	188991004	101489	107236	rs587779718	NC_000002.12:188991003:G:A
NM_000090.3(COL3A1):c.2573G>T (p.Gly858Val)	COL3A1	G858V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101488	2	189868156	2	189003430	101488	107235	rs587779717	NC_000002.12:189003429:G:T
NM_000090.3(COL3A1):c.3482G>A (p.Gly1161Glu)	COL3A1	G1161E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101487	2	189872825	2	189008099	101487	107234	rs587779473	NC_000002.12:189008098:G:A
NM_000090.3(COL3A1):c.2735G>A (p.Gly912Asp)	COL3A1	G912D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101486	2	189868781	2	189004055	101486	107233	rs587779716	NC_000002.12:189004054:G:A
NM_000090.3(COL3A1):c.539G>A (p.Gly180Asp)	COL3A1	G180D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101483	2	189852817	2	188988091	101483	107230	rs587779714	NC_000002.12:188988090:G:A
NM_000090.3(COL3A1):c.2553+3A>T (p.Gly816_Ala851del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101482	2	189867791	2	189003065	101482	107229	rs587779713	NC_000002.12:189003064:A:T
NM_000090.3(COL3A1):c.3417+1G>T (p.Gly1122_Arg1139del+)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101480	2	189872665	2	189007939	101480	107227	rs587779444	NC_000002.12:189007938:G:T
NM_000090.3(COL3A1):c.2553+1G>C (p.Gly816_Ala851del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101479	2	189867789	2	189003063	101479	107226	rs587779664	NC_000002.12:189003062:G:C
NM_000090.3(COL3A1):c.1347+1G>T (p.Arg449_Gly450insValSerPheThrAlaThrAspLeu+)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101473	2	189859321	2	188994595	101473	107220	rs397509370	NC_000002.12:188994594:G:T
NM_000090.3(COL3A1):c.2815G>A (p.Gly939Ser)	COL3A1	G939S	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101472	2	189868861	2	189004135	101472	107219	rs587779550	NC_000002.12:189004134:G:A
NM_000090.3(COL3A1):c.3572G>A (p.Gly1191Asp)	COL3A1	G1191D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101466	2	189873696	2	189008970	101466	107213	rs587779703	NC_000002.12:189008969:G:A
NM_000090.3(COL3A1):c.3490G>C (p.Gly1164Arg)	COL3A1	G1164R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101465	2	189872833	2	189008107	101465	107212	rs587779553	NC_000002.12:189008106:G:C
NM_000090.3(COL3A1):c.1456-10T>G (p.Arg485_Gly486insTyrPheGln)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101463	2	189859762	2	188995036	101463	107210	rs587779701	NC_000002.12:188995035:T:G
NM_000090.3(COL3A1):c.1978-6_1981del (p.Gly660_Lys662del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101462	2	189863392 - 189863401	2	188998666 - 188998675	101462	107209	rs587779700	NC_000002.12:188998665:TCTCCCAGGGTC:TC
NM_000090.3(COL3A1):c.3499G>T (p.Gly1167Cys)	COL3A1	G1167C	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101461	2	189872842	2	189008116	101461	107208	rs587779609	NC_000002.12:189008115:G:T
NM_000090.3(COL3A1):c.2177G>A (p.Gly726Glu)	COL3A1	G726E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101458	2	189864251	2	188999525	101458	107205	rs587779698	NC_000002.12:188999524:G:A
NM_000090.3(COL3A1):c.1096G>A (p.Gly366Arg)	COL3A1	G366R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101456	2	189858132	2	188993406	101456	107203	rs587779696	NC_000002.12:188993405:G:A
NM_000090.3(COL3A1):c.2284G>C (p.Gly762Arg)	COL3A1	G762R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101454	2	189866123	2	189001397	101454	107201	rs587779694	NC_000002.12:189001396:G:C
NM_000090.3(COL3A1):c.2402G>A (p.Gly801Asp)	COL3A1	G801D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101449	2	189867034	2	189002308	101449	107196	rs587779689	NC_000002.12:189002307:G:A
NM_000090.3(COL3A1):c.2221G>A (p.Gly741Ser)	COL3A1	G741S	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101444	2	189864295	2	188999569	101444	107191	rs587779685	NC_000002.12:188999568:G:A
NM_000090.3(COL3A1):c.1861G>C (p.Gly621Arg)	COL3A1	G621R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101442	2	189862107	2	188997381	101442	107189	rs587779616	NC_000002.12:188997380:G:C
NM_000090.3(COL3A1):c.3544G>A (p.Gly1182Arg)	COL3A1	G1182R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101441	2	189873668	2	189008942	101441	107188	rs587779683	NC_000002.12:189008941:G:A
NM_000090.3(COL3A1):c.631_636+6delinsTACTAAATATA (p.Gly195_Ser212del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101439	2	189853364 - 189853375	2	188988638 - 188988649	101439	107186	rs587779681	NC_000002.12:188988637:CCTTCAGTAAGT:TACTAAATATA
NM_000090.3(COL3A1):c.2186G>A (p.Gly729Glu)	COL3A1	G729E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101438	2	189864260	2	188999534	101438	107185	rs587779680	NC_000002.12:188999533:G:A
NM_000090.3(COL3A1):c.2141G>A (p.Gly714Glu)	COL3A1	G714E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101436	2	189864215	2	188999489	101436	107183	rs587779678	NC_000002.12:188999488:G:A
NM_000090.3(COL3A1):c.30G>A (p.Trp10Ter)	COL3A1	W10*	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101435	2	189839245	2	188974519	101435	107182	rs587779677	NC_000002.12:188974518:G:A
NM_000090.3(COL3A1):c.636+1G>A (p.Gly195_Ser212del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101433	2	189853370	2	188988644	101433	107180	rs587779676	NC_000002.12:188988643:G:A
NM_000090.3(COL3A1):c.2121+1G>C (p.Gly675_Lys707del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101432	2	189864110	2	188999384	101432	107179	rs587779675	NC_000002.12:188999383:G:C
NM_000090.3(COL3A1):c.2860G>A (p.Gly954Arg)	COL3A1	G954R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101431	2	189869019	2	189004293	101431	107178	rs587779674	NC_000002.12:189004292:G:A
NM_000090.3(COL3A1):c.728G>A (p.Gly243Glu)	COL3A1	G243E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101428	2	189854859	2	188990133	101428	107175	rs587779629	NC_000002.12:188990132:G:A
NM_000090.3(COL3A1):c.764G>A (p.Gly255Glu)	COL3A1	G255E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101426	2	189855052	2	188990326	101426	107173	rs587779605	NC_000002.12:188990325:G:A
NM_000090.3(COL3A1):c.1870-2A>G (p.Gly624_Gln641del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101424	2	189862424	2	188997698	101424	107171	rs587779575	NC_000002.12:188997697:A:G
NM_000090.3(COL3A1):c.997-10A>G (p.Pro332_Gly333insFFQ)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101423	2	189857603	2	188992877	101423	107170	rs587779670	NC_000002.12:188992876:A:G
NM_000090.3(COL3A1):c.3418-2A>G (p.Arg1139_Gly1140insVSSTERYYRSTCFRCLHFRKIFWHCDVMILSW)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101422	2	189872759	2	189008033	101422	107169	rs587779502	NC_000002.12:189008032:A:G
NM_000090.3(COL3A1):c.3527_3528GC>AA	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101421	2	189873651 - 189873652	2	189008925 - 189008926	101421	107168	rs587779669	NC_000002.12:189008924:GC:AA
NM_000090.3(COL3A1):c.3093+2T>G (p.Gly1014_Lys1031del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101420	2	189870987	2	189006261	101420	107167	rs587779503	NC_000002.12:189006260:T:G
NM_000090.3(COL3A1):c.1915G>A (p.Gly639Arg)	COL3A1	G639R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101419	2	189862471	2	188997745	101419	107166	rs587779435	NC_000002.12:188997744:G:A
NM_000090.3(COL3A1):c.3275G>T (p.Gly1092Val)	COL3A1	G1092V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101416	2	189872245	2	189007519	101416	107163	rs587779666	NC_000002.12:189007518:G:T
NM_000090.3(COL3A1):c.3039+154_3525+223del	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101415	2	189870336 - 189873090	2	189005610 - 189008364	101415	107162		
NM_000090.3(COL3A1):c.3417+4_3417+5del	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101412	2	189872668 - 189872669	2	189007942 - 189007943	101412	107159	rs1553509630	NC_000002.12:189007941:AG:
NM_000090.3(COL3A1):c.2887G>C (p.Gly963Arg)	COL3A1	G963R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101411	2	189869046	2	189004320	101411	107158	rs587779640	NC_000002.12:189004319:G:C
NM_000090.3(COL3A1):c.1925G>T (p.Gly642Val)	COL3A1	G642V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101406	2	189862993	2	188998267	101406	107152	rs587779661	NC_000002.12:188998266:G:T
NM_000090.3(COL3A1):c.3023G>A (p.Gly1008Asp)	COL3A1	G1008D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101403	2	189870167	2	189005441	101403	107149	rs587779659	NC_000002.12:189005440:G:A
NM_000090.3(COL3A1):c.2142_2168del (p.Pro715_Gly723del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101400	2	189864209 - 189864235	2	188999483 - 188999509	101400	107146	rs587779657	NC_000002.12:188999482:CTCCTGGGCCACCTGGTGCTGCTGGTACTCCTGG:CTCCTGG
NM_000090.3(COL3A1):c.701G>A (p.Gly234Asp)	COL3A1	G234D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101399	2	189854832	2	188990106	101399	107145	rs587779656	NC_000002.12:188990105:G:A
NM_000090.3(COL3A1):c.2870G>A (p.Gly957Asp)	COL3A1	G957D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101397	2	189869029	2	189004303	101397	107143	rs587779654	NC_000002.12:189004302:G:A
NM_000090.3(COL3A1):c.665G>A (p.Gly222Asp)	COL3A1	G222D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101393	2	189854150	2	188989424	101393	107139	rs587779518	NC_000002.12:188989423:G:A
NM_000090.3(COL3A1):c.583G>C (p.Gly195Arg)	COL3A1	G195R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101392	2	189853316	2	188988590	101392	107138	rs267599120	NC_000002.12:188988589:G:C
NM_000090.3(COL3A1):c.3157G>C (p.Gly1053Arg)	COL3A1	G1053R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101389	2	189871134	2	189006408	101389	107135	rs587779651	NC_000002.12:189006407:G:C
NM_000090.3(COL3A1):c.996+2T>A (p.Gly318_Pro332del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101387	2	189856956	2	188992230	101387	107133	rs587779649	NC_000002.12:188992229:T:A
NM_000090.3(COL3A1):c.2995G>A (p.Gly999Ser)	COL3A1	G999S	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101386	2	189870139	2	189005413	101386	107132	rs587779548	NC_000002.12:189005412:G:A
NM_000090.3(COL3A1):c.3419G>A (p.Gly1140Glu)	COL3A1	G1140E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101385	2	189872762	2	189008036	101385	107131	rs587779648	NC_000002.12:189008035:G:A
NM_000090.3(COL3A1):c.548G>C (p.Gly183Ala)	COL3A1	G183A	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101384	2	189852826	2	188988100	101384	107130	rs587779420	NC_000002.12:188988099:G:C
NM_000090.3(COL3A1):c.3989del (p.Glu1330fs)	COL3A1	E1330fs	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101383	2	189875069	2	189010343	101383	107129	rs587779647	NC_000002.12:189010342:A:
NM_000090.3(COL3A1):c.3417+1G>C (p.Gly1122_Arg1139del+)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101380	2	189872665	2	189007939	101380	107126	rs587779444	NC_000002.12:189007938:G:C
NM_000090.3(COL3A1):c.827G>A (p.Gly276Asp)	COL3A1	G276D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101378	2	189855758	2	188991032	101378	107124	rs587779644	NC_000002.12:188991031:G:A
NM_000090.3(COL3A1):c.2285G>A (p.Gly762Asp)	COL3A1	G762D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101377	2	189866124	2	189001398	101377	107123	rs587779541	NC_000002.12:189001397:G:A
NM_000090.3(COL3A1):c.3518G>T (p.Gly1173Val)	COL3A1	G1173V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101375	2	189872861	2	189008135	101375	107121	rs121912918	NC_000002.12:189008134:G:T
NM_000090.3(COL3A1):c.2501G>A (p.Gly834Asp)	COL3A1	G834D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101374	2	189867736	2	189003010	101374	107120	rs587779642	NC_000002.12:189003009:G:A
NM_000090.3(COL3A1):c.2887G>T (p.Gly963Cys)	COL3A1	G963C	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101372	2	189869046	2	189004320	101372	107118	rs587779640	NC_000002.12:189004319:G:T
NM_000090.3(COL3A1):c.1844G>A (p.Gly615Glu)	COL3A1	G615E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101366	2	189862090	2	188997364	101366	107112	rs587779634	NC_000002.12:188997363:G:A
NM_000090.3(COL3A1):c.1384G>A (p.Gly462Ser)	COL3A1	G462S	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101365	2	189859486	2	188994760	101365	107111	rs587779633	NC_000002.12:188994759:G:A
NM_000090.3(COL3A1):c.1511G>T (p.Gly504Val)	COL3A1	G504V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101363	2	189860419	2	188995693	101363	107109	rs587779632	NC_000002.12:188995692:G:T
NM_000090.3(COL3A1):c.2105G>T (p.Gly702Val)	COL3A1	G702V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101362	2	189864093	2	188999367	101362	107108	rs587779512	NC_000002.12:188999366:G:T
NM_000090.3(COL3A1):c.656G>A (p.Gly219Asp)	COL3A1	G219D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101360	2	189854141	2	188989415	101360	107106	rs587779441	NC_000002.12:188989414:G:A
NM_000090.3(COL3A1):c.2293G>A (p.Gly765Ser)	COL3A1	G765S	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101359	2	189866132	2	189001406	101359	107105	rs587779630	NC_000002.12:189001405:G:A
NM_000090.3(COL3A1):c.1149+1G>T (p.Gly351_Pro383del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101358	2	189858186	2	188993460	101358	107104	rs587779443	NC_000002.12:188993459:G:T
NM_000090.3(COL3A1):c.1923+2_1923+5del (p.Gly624_Gln641del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101357	2	189862478 - 189862481	2	188997752 - 188997755	101357	107103	rs786200946	NC_000002.12:188997751:AAGTAAG:AAG
NM_000090.3(COL3A1):c.2212G>T (p.Gly738Cys)	COL3A1	G738C	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101355	2	189864286	2	188999560	101355	107101	rs121912925	NC_000002.12:188999559:G:T
NM_000090.3(COL3A1):c.3545G>T (p.Gly1182Val)	COL3A1	G1182V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101354	2	189873669	2	189008943	101354	107100	rs111505097	NC_000002.12:189008942:G:T
NM_000090.3(COL3A1):c.615_629dup (p.Gly207_Pro211dup)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101353	2	189853347 - 189853348	2	188988621 - 188988622	101353	107099	rs587779628	NC_000002.12:188988621:ACCTGGGCAAGCTGG:ACCTGGGCAAGCTGGACCTGGGCAAGCTGG
NM_000090.3(COL3A1):c.3536G>T (p.Gly1179Val)	COL3A1	G1179V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101352	2	189873660	2	189008934	101352	107098	rs587779627	NC_000002.12:189008933:G:T
NM_000090.3(COL3A1):c.1761+2T>G (p.Gly555_Asp587del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101350	2	189861224	2	188996498	101350	107096	rs587779530	NC_000002.12:188996497:T:G
NM_000090.3(COL3A1):c.3040-127_3255+107del	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101348	2	189870803 - 189871821	2	189006077 - 189007095	101348	107094		
NM_000090.3(COL3A1):c.2113G>A (p.Gly705Arg)	COL3A1	G705R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101346	2	189864101	2	188999375	101346	107092	rs587779623	NC_000002.12:188999374:G:A
NM_000090.3(COL3A1):c.1862G>A (p.Gly621Glu)	COL3A1	G621E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101344	2	189862108	2	188997382	101344	107090	rs587779539	NC_000002.12:188997381:G:A
NM_000090.3(COL3A1):c.1358G>A (p.Gly453Asp)	COL3A1	G453D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101343	2	189859460	2	188994734	101343	107089	rs587779621	NC_000002.12:188994733:G:A
NM_000090.3(COL3A1):c.1961G>A (p.Gly654Glu)	COL3A1	G654E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101342	2	189863029	2	188998303	101342	107088	rs587779620	NC_000002.12:188998302:G:A
NM_000090.3(COL3A1):c.3176G>T (p.Gly1059Val)	COL3A1	G1059V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101341	2	189871153	2	189006427	101341	107087	rs587779619	NC_000002.12:189006426:G:T
NM_000090.3(COL3A1):c.1475G>T (p.Gly492Val)	COL3A1	G492V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101340	2	189859791	2	188995065	101340	107086	rs587779500	NC_000002.12:188995064:G:T
NM_000090.3(COL3A1):c.951+4_951+5del	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101339	2	189856451 - 189856452	2	188991725 - 188991726	101339	107085	rs1559055162	NC_000002.12:188991724:GAG:G
NM_000090.3(COL3A1):c.4399T>C (p.Ter1467Gln)	COL3A1	*1467Q	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101338	2	189876498	2	189011772	101338	107084	rs587779618	NC_000002.12:189011771:T:C
NM_000090.3(COL3A1):c.1861G>T (p.Gly621Trp)	COL3A1	G621W	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101336	2	189862107	2	188997381	101336	107082	rs587779616	NC_000002.12:188997380:G:T
NM_000090.3(COL3A1):c.1816G>C (p.Gly606Arg)	COL3A1	G606R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101333	2	189862062	2	188997336	101333	107079	rs587779613	NC_000002.12:188997335:G:C
NM_000090.3(COL3A1):c.1898G>A (p.Gly633Glu)	COL3A1	G633E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101331	2	189862454	2	188997728	101331	107077	rs587779611	NC_000002.12:188997727:G:A
NM_000090.3(COL3A1):c.1761+4_1761+5del	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101330	2	189861225 - 189861226	2	188996499 - 188996500	101330	107076	rs1559057346	NC_000002.12:188996498:GAG:G
NM_000090.3(COL3A1):c.1330G>C (p.Gly444Arg)	COL3A1	G444R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101329	2	189859303	2	188994577	101329	107075	rs587779489	NC_000002.12:188994576:G:C
NM_000090.3(COL3A1):c.3284G>A (p.Gly1095Asp)	COL3A1	G1095D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101328	2	189872254	2	189007528	101328	107074	rs587779610	NC_000002.12:189007527:G:A
NM_000090.3(COL3A1):c.3499G>C (p.Gly1167Arg)	COL3A1	G1167R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101327	2	189872842	2	189008116	101327	107073	rs587779609	NC_000002.12:189008115:G:C
NM_000090.3(COL3A1):c.764G>T (p.Gly255Val)	COL3A1	G255V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101322	2	189855052	2	188990326	101322	107068	rs587779605	NC_000002.12:188990325:G:T
NM_000090.3(COL3A1):c.1662+1G>C (p.Gly537_Pro554del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101321	2	189860905	2	188996179	101321	107067	rs587779535	NC_000002.12:188996178:G:C
NM_000090.3(COL3A1):c.791G>A (p.Gly264Glu)	COL3A1	G264E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101320	2	189855079	2	188990353	101320	107066	rs587779604	NC_000002.12:188990352:G:A
NM_000090.3(COL3A1):c.1977+2T>G (p.Gly642_Pro659del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101319	2	189863047	2	188998321	101319	107065	rs587779603	NC_000002.12:188998320:T:G
NM_000090.3(COL3A1):c.997-2A>G (p.Gly333_Lys350del+)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101317	2	189857611	2	188992885	101317	107063	rs587779602	NC_000002.12:188992884:A:G
NM_000090.3(COL3A1):c.2770G>A (p.Gly924Ser)	COL3A1	G924S	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101316	2	189868816	2	189004090	101316	107062	rs587779471	NC_000002.12:189004089:G:A
NM_000090.3(COL3A1):c.592G>A (p.Gly198Arg)	COL3A1	G198R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101315	2	189853325	2	188988599	101315	107061	rs587779601	NC_000002.12:188988598:G:A
NM_000090.3(COL3A1):c.1869+1G>C (p.Gly606_Thr623del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101314	2	189862116	2	188997390	101314	107060	rs587779600	NC_000002.12:188997389:G:C
NM_000090.3(COL3A1):c.951+4A>T (p.Gly300_Ala317del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101312	2	189856452	2	188991726	101312	107058	rs587779598	NC_000002.12:188991725:A:T
NM_000090.3(COL3A1):c.2024G>T (p.Gly675Val)	COL3A1	G675V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101311	2	189864012	2	188999286	101311	107057	rs587779597	NC_000002.12:188999285:G:T
NM_000090.3(COL3A1):c.647G>A (p.Gly216Glu)	COL3A1	G216E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101310	2	189854132	2	188989406	101310	107056	rs587779596	NC_000002.12:188989405:G:A
NM_000090.3(COL3A1):c.836G>A (p.Gly279Asp)	COL3A1	G279D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101307	2	189855767	2	188991041	101307	107053	rs587779593	NC_000002.12:188991040:G:A
NM_000090.3(COL3A1):c.620G>T (p.Gly207Val)	COL3A1	G207V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101306	2	189853353	2	188988627	101306	107052	rs587779592	NC_000002.12:188988626:G:T
NM_000090.3(COL3A1):c.2087G>A (p.Gly696Asp)	COL3A1	G696D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101305	2	189864075	2	188999349	101305	107051	rs587779591	NC_000002.12:188999348:G:A
NM_000090.3(COL3A1):c.2681G>C (p.Gly894Ala)	COL3A1	G894A	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101303	2	189868727	2	189004001	101303	107049	rs587779589	NC_000002.12:189004000:G:C
NM_000090.3(COL3A1):c.2051G>T (p.Gly684Val)	COL3A1	G684V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101301	2	189864039	2	188999313	101301	107047	rs587779587	NC_000002.12:188999312:G:T
NM_000090.3(COL3A1):c.3104G>T (p.Gly1035Val)	COL3A1	G1035V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101294	2	189871081	2	189006355	101294	107040	rs587779582	NC_000002.12:189006354:G:T
NM_000090.3(COL3A1):c.1194+1G>A (p.Gly384_Met398del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101293	2	189858809	2	188994083	101293	107039	rs587779459	NC_000002.12:188994082:G:A
NM_000090.3(COL3A1):c.2905G>A (p.Gly969Arg)	COL3A1	G969R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101291	2	189869064	2	189004338	101291	107037	rs587779580	NC_000002.12:189004337:G:A
NM_000090.3(COL3A1):c.1068_1069insGACCCTGCA (p.Ala356_Gly357insDPA)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101290	2	189858098 - 189858099	2	188993372 - 188993373	101290	107036	rs587779579	NC_000002.12:188993372:CCTGCAG:CCTGCAGACCCTGCAG
NM_000090.3(COL3A1):c.3500G>T (p.Gly1167Val)	COL3A1	G1167V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101289	2	189872843	2	189008117	101289	107035	rs587779578	NC_000002.12:189008116:G:T
NM_000090.3(COL3A1):c.2059G>C (p.Gly687Arg)	COL3A1	G687R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101288	2	189864047	2	188999321	101288	107034	rs587779577	NC_000002.12:188999320:G:C
NM_000090.3(COL3A1):c.737G>A (p.Gly246Glu)	COL3A1	G246E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101281	2	189854868	2	188990142	101281	107027	rs587779570	NC_000002.12:188990141:G:A
NM_000090.3(COL3A1):c.1124G>A (p.Gly375Glu)	COL3A1	G375E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101280	2	189858160	2	188993434	101280	107026	rs587779569	NC_000002.12:188993433:G:A
NM_000090.3(COL3A1):c.3039+5G>A (p.Asp1013_Gly1014insVNSSFYSTSQ)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101279	2	189870188	2	189005462	101279	107025	rs587779568	NC_000002.12:189005461:G:A
NM_000090.3(COL3A1):c.2833G>A (p.Gly945Ser)	COL3A1	G945S	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101278	2	189868992	2	189004266	101278	107024	rs587779567	NC_000002.12:189004265:G:A
NG_007404.1:g.32133_36640del	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101275			2	189001505 - 189006012	101275	107021		
NM_000090.3(COL3A1):c.2357G>T (p.Gly786Val)	COL3A1	G786V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101274	2	189866281	2	189001555	101274	107020	rs587779564	NC_000002.12:189001554:G:T
NM_000090.3(COL3A1):c.3418-1G>T (p.Arg1139_Gly1140insVSSTERYYRSTCFRCLHFRKIFWHCDVMILSY)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101272	2	189872760	2	189008034	101272	107018	rs587779562	NC_000002.12:189008033:G:T
NM_000090.3(COL3A1):c.1509+224_1510-71delinsNM_000090.3:c.799-118_852+62 (p.Lys503_Gly504insGFDGRNGEKGETGAPGLK)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101271					101271	107017		
NM_000090.3(COL3A1):c.2771G>T (p.Gly924Val)	COL3A1	G924V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101270	2	189868817	2	189004091	101270	107016	rs587779450	NC_000002.12:189004090:G:T
NM_000090.3(COL3A1):c.2122_2148del (p.Gly708_Pro716del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101266	2	189864196 - 189864222	2	188999470 - 188999496	101266	107012	rs587779560	NC_000002.12:188999469:GGTGCTGCTGGTCCTCCTGGGCCACCTGGTGCTGCTGGT:GGTGCTGCTGGT
NM_000090.3(COL3A1):c.2915G>A (p.Gly972Asp)	COL3A1	G972D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101265	2	189869074	2	189004348	101265	107011	rs587779559	NC_000002.12:189004347:G:A
NM_000090.3(COL3A1):c.2284-2A>G (p.Gly762_Lys779del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101263	2	189866121	2	189001395	101263	107009	rs587779558	NC_000002.12:189001394:A:G
NM_000090.3(COL3A1):c.637G>A (p.Gly213Ser)	COL3A1	G213S	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101262	2	189854122	2	188989396	101262	107008	rs587779557	NC_000002.12:188989395:G:A
NM_000090.3(COL3A1):c.898-1G>C (p.Gly300_Ala317del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101261	2	189856394	2	188991668	101261	107007	rs587779556	NC_000002.12:188991667:G:C
NM_000090.3(COL3A1):c.582+6T>A (p.Gly177_Pro194del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101260	2	189852866	2	188988140	101260	107006	rs397509375	NC_000002.12:188988139:T:A
NM_000090.3(COL3A1):c.3220G>A (p.Gly1074Ser)	COL3A1	G1074S	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101258	2	189871681	2	189006955	101258	107004	rs587779554	NC_000002.12:189006954:G:A
NM_000090.3(COL3A1):c.3490G>T (p.Gly1164Trp)	COL3A1	G1164W	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101257	2	189872833	2	189008107	101257	107003	rs587779553	NC_000002.12:189008106:G:T
NM_000090.3(COL3A1):c.3203G>T (p.Gly1068Val)	COL3A1	G1068V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101255	2	189871664	2	189006938	101255	107001	rs587779551	NC_000002.12:189006937:G:T
NM_000090.3(COL3A1):c.2815G>T (p.Gly939Cys)	COL3A1	G939C	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101254	2	189868861	2	189004135	101254	107000	rs587779550	NC_000002.12:189004134:G:T
NM_000090.3(COL3A1):c.2150G>A (p.Gly717Asp)	COL3A1	G717D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101253	2	189864224	2	188999498	101253	106999	rs587779549	NC_000002.12:188999497:G:A
NM_000090.3(COL3A1):c.1115G>T (p.Gly372Val)	COL3A1	G372V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101251	2	189858151	2	188993425	101251	106997	rs587779547	NC_000002.12:188993424:G:T
NM_000090.3(COL3A1):c.3140G>A (p.Gly1047Asp)	COL3A1	G1047D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101249	2	189871117	2	189006391	101249	106995	rs587779545	NC_000002.12:189006390:G:A
NM_000090.3(COL3A1):c.1142G>A (p.Gly381Asp)	COL3A1	G381D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101248	2	189858178	2	188993452	101248	106994	rs587779544	NC_000002.12:188993451:G:A
NM_000090.3(COL3A1):c.2185G>A (p.Gly729Arg)	COL3A1	G729R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101247	2	189864259	2	188999533	101247	106993	rs587779543	NC_000002.12:188999532:G:A
NM_000090.3(COL3A1):c.2285G>T (p.Gly762Val)	COL3A1	G762V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101245	2	189866124	2	189001398	101245	106991	rs587779541	NC_000002.12:189001397:G:T
NM_000090.3(COL3A1):c.3167G>A (p.Gly1056Asp)	COL3A1	G1056D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101244	2	189871144	2	189006418	101244	106990	rs587779540	NC_000002.12:189006417:G:A
NM_000090.3(COL3A1):c.1862G>T (p.Gly621Val)	COL3A1	G621V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101243	2	189862108	2	188997382	101243	106989	rs587779539	NC_000002.12:188997381:G:T
NM_000090.3(COL3A1):c.951+6T>A (p.Gly300_Ala317del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101242	2	189856454	2	188991728	101242	106988	rs587779423	NC_000002.12:188991727:T:A
NM_000090.3(COL3A1):c.1149+5G>A (p.Gly351_Pro383del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101241	2	189858190	2	188993464	101241	106987	rs587779538	NC_000002.12:188993463:G:A
NM_000090.3(COL3A1):c.1662+2dup	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101240	2	189860905 - 189860906	2	188996179 - 188996180	101240	106986	rs587779537	NC_000002.12:188996179:T:TT
NM_000090.3(COL3A1):c.3391G>A (p.Gly1131Ser)	COL3A1	G1131S	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101239	2	189872638	2	189007912	101239	106985	rs587779536	NC_000002.12:189007911:G:A
NM_000090.3(COL3A1):c.1662+1G>T (p.Gly537_Pro554del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101238	2	189860905	2	188996179	101238	106984	rs587779535	NC_000002.12:188996178:G:T
NM_000090.3(COL3A1):c.844G>A (p.Gly282Arg)	COL3A1	G282R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101234	2	189855775	2	188991049	101234	106980	rs587779531	NC_000002.12:188991048:G:A
NM_000090.3(COL3A1):c.1808G>A (p.Gly603Asp)	COL3A1	G603D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101233	2	189861937	2	188997211	101233	106979	rs587779477	NC_000002.12:188997210:G:A
NM_000090.3(COL3A1):c.1761+2T>C (p.Gly555_Asp587del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101232	2	189861224	2	188996498	101232	106978	rs587779530	NC_000002.12:188996497:T:C
NM_000090.3(COL3A1):c.3062_3064del (p.Leu1021del)	COL3A1	K1021del, L1021del	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101231	2	189870952 - 189870954	2	189006226 - 189006228	101231	106977	rs587779529	NC_000002.12:189006225:TCTTC:TC
NM_000090.3(COL3A1):c.1701_2391+367del (p.Gly555_Pro797del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101230					101230	106976		
NG_007404.1:g.31358_38084del	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101228					101228	106973		
NM_000090.3(COL3A1):c.582+5_582+11delinsACA	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101227	2	189852865 - 189852871	2	188988139 - 188988145	101227	106972	rs1559053784	NC_000002.12:188988138:GTATAGC:ACA
NM_000090.3(COL3A1):c.2510G>A (p.Gly837Asp)	COL3A1	G837D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101226	2	189867745	2	189003019	101226	106971	rs587779526	NC_000002.12:189003018:G:A
NM_000090.3(COL3A1):c.1100_1117del (p.Gln367_Gly372del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101225	2	189858129 - 189858146	2	188993403 - 188993420	101225	106970	rs587779525	NC_000002.12:188993402:CCTGGACAAAGAGGAGAACCTGGAC:CCTGGAC
NM_000090.3(COL3A1):c.582+2dup	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101224	2	189852861 - 189852862	2	188988135 - 188988136	101224	106969	rs587779524	NC_000002.12:188988135:T:TT
NM_000090.3(COL3A1):c.3517G>A (p.Gly1173Arg)	COL3A1	G1173R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101221	2	189872860	2	189008134	101221	106966	rs587779521	NC_000002.12:189008133:G:A
NM_000090.3(COL3A1):c.665G>T (p.Gly222Val)	COL3A1	G222V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101218	2	189854150	2	188989424	101218	106963	rs587779518	NC_000002.12:188989423:G:T
NM_000090.3(COL3A1):c.629G>T (p.Gly210Val)	COL3A1	G210V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101215	2	189853362	2	188988636	101215	106960	rs587779515	NC_000002.12:188988635:G:T
NM_000090.3(COL3A1):c.2553+1del	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101214	2	189867789	2	189003063	101214	106959	rs587779514	NC_000002.12:189003062:G:
NM_000090.3(COL3A1):c.2105G>A (p.Gly702Asp)	COL3A1	G702D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101212	2	189864093	2	188999367	101212	106957	rs587779512	NC_000002.12:188999366:G:A
NM_000090.3(COL3A1):c.2608-?_3255+?del (p.Gly870_Pro1085del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101211					101211	106956		
NM_000090.3(COL3A1):c.2888G>A (p.Gly963Asp)	COL3A1	G963D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101210	2	189869047	2	189004321	101210	106955	rs587779511	NC_000002.12:189004320:G:A
NM_000090.3(COL3A1):c.1763_1769delinsTAAG (p.Gly588_Pro590delinsValSer)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101208	2	189861892 - 189861898	2	188997166 - 188997172	101208	106953	rs587779510	NC_000002.12:188997165:GTGCTCC:TAAG
NM_000090.3(COL3A1):c.3223_3240del (p.Ala1075_Gly1080del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101207	2	189871675 - 189871692	2	189006949 - 189006966	101207	106952	rs587779509	NC_000002.12:189006948:CCTGCTGGTGCTCCCGGTCCTGCTGGT:CCTGCTGGT
NM_000090.3(COL3A1):c.565G>C (p.Gly189Arg)	COL3A1	G189R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101205	2	189852843	2	188988117	101205	106950	rs587779507	NC_000002.12:188988116:G:C
NM_000090.3(COL3A1):c.3255+5G>A (p.Gly1068_Pro1085del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101198	2	189871721	2	189006995	101198	106943	rs587779501	NC_000002.12:189006994:G:A
NM_000090.3(COL3A1):c.1475G>A (p.Gly492Glu)	COL3A1	G492E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101197	2	189859791	2	188995065	101197	106942	rs587779500	NC_000002.12:188995064:G:A
NM_000090.3(COL3A1):c.1087G>A (p.Gly363Ser)	COL3A1	G363S	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101196	2	189858123	2	188993397	101196	106941	rs587779499	NC_000002.12:188993396:G:A
NM_000090.3(COL3A1):c.547G>C (p.Gly183Arg)	COL3A1	G183R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101191	2	189852825	2	188988099	101191	106936	rs121912926	NC_000002.12:188988098:G:C
NM_000090.3(COL3A1):c.2555G>A (p.Gly852Asp)	COL3A1	G852D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101190	2	189868138	2	189003412	101190	106935	rs587779494	NC_000002.12:189003411:G:A
NM_000090.3(COL3A1):c.2294G>T (p.Gly765Val)	COL3A1	G765V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101188	2	189866133	2	189001407	101188	106933	rs587779492	NC_000002.12:189001406:G:T
NM_000090.3(COL3A1):c.3122G>T (p.Gly1041Val)	COL3A1	G1041V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101187	2	189871099	2	189006373	101187	106932	rs587779491	NC_000002.12:189006372:G:T
NM_000090.3(COL3A1):c.3966del (p.Lys1323fs)	COL3A1	K1323fs	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101186	2	189875046	2	189010320	101186	106931	rs587779490	NC_000002.12:189010319:G:
NM_000090.3(COL3A1):c.944G>C (p.Gly315Ala)	COL3A1	G315A	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101183	2	189856441	2	188991715	101183	106928	rs587779487	NC_000002.12:188991714:G:C
NM_000090.3(COL3A1):c.1240G>T (p.Gly414Cys)	COL3A1	G414C	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101180	2	189859005	2	188994279	101180	106925	rs587779485	NC_000002.12:188994278:G:T
NM_000090.3(COL3A1):c.2203G>A (p.Gly735Arg)	COL3A1	G735R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101179	2	189864277	2	188999551	101179	106924	rs587779484	NC_000002.12:188999550:G:A
NM_000090.3(COL3A1):c.3508G>A (p.Gly1170Ser)	COL3A1	G1170S	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101177	2	189872851	2	189008125	101177	106922	rs587779482	NC_000002.12:189008124:G:A
NM_000090.3(COL3A1):c.809G>A (p.Gly270Glu)	COL3A1	G270E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101173	2	189855740	2	188991014	101173	106918	rs587779478	NC_000002.12:188991013:G:A
NM_000090.3(COL3A1):c.1808G>T (p.Gly603Val)	COL3A1	G603V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101172	2	189861937	2	188997211	101172	106917	rs587779477	NC_000002.12:188997210:G:T
NM_000090.3(COL3A1):c.1974_1977+4del	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101169	2	189863041 - 189863048	2	188998315 - 188998322	101169	106914	rs587779475	NC_000002.12:188998314:AACCAGTAA:A
NM_000090.3(COL3A1):c.2068G>A (p.Gly690Arg)	COL3A1	G690R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101168	2	189864056	2	188999330	101168	106913	rs587779474	NC_000002.12:188999329:G:A
NM_000090.3(COL3A1):c.3473G>A (p.Gly1158Asp)	COL3A1	G1158D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101166	2	189872816	2	189008090	101166	106911	rs587779472	NC_000002.12:189008089:G:A
NM_000090.3(COL3A1):c.3491G>T (p.Gly1164Val)	COL3A1	G1164V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101164	2	189872834	2	189008108	101164	106909	rs587779431	NC_000002.12:189008107:G:T
NM_000090.3(COL3A1):c.682G>C (p.Gly228Arg)	COL3A1	G228R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101163	2	189854167	2	188989441	101163	106908	rs587779470	NC_000002.12:188989440:G:C
NM_000090.3(COL3A1):c.3239G>A (p.Gly1080Asp)	COL3A1	G1080D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101162	2	189871700	2	189006974	101162	106907	rs587779469	NC_000002.12:189006973:G:A
NM_000090.3(COL3A1):c.2869G>T (p.Gly957Cys)	COL3A1	G957C	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101159	2	189869028	2	189004302	101159	106904	rs121912913	NC_000002.12:189004301:G:T
NM_000090.3(COL3A1):c.2564G>A (p.Gly855Asp)	COL3A1	G855D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101158	2	189868147	2	189003421	101158	106903	rs587779466	NC_000002.12:189003420:G:A
NM_000090.3(COL3A1):c.2337G>A (p.Lys779=)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101153	2	189866176	2	189001450	101153	106898	rs587779461	NC_000002.12:189001449:G:A
NM_000090.3(COL3A1):c.2114G>A (p.Gly705Glu)	COL3A1	G705E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101152	2	189864102	2	188999376	101152	106897	rs587779460	NC_000002.12:188999375:G:A
NM_000090.3(COL3A1):c.1194+1G>C (p.Gly384_Met398del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101151	2	189858809	2	188994083	101151	106896	rs587779459	NC_000002.12:188994082:G:C
NM_000090.3(COL3A1):c.2069G>T (p.Gly690Val)	COL3A1	G690V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101150	2	189864057	2	188999331	101150	106895	rs587779458	NC_000002.12:188999330:G:T
NM_000090.3(COL3A1):c.2978G>A (p.Gly993Asp)	COL3A1	G993D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101148	2	189870122	2	189005396	101148	106893	rs587779456	NC_000002.12:189005395:G:A
NM_000090.3(COL3A1):c.2941G>A (p.Gly981Arg)	COL3A1	G981R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101147	2	189870085	2	189005359	101147	106892	rs587779449	NC_000002.12:189005358:G:A
NM_000090.3(COL3A1):c.1988G>A (p.Gly663Asp)	COL3A1	G663D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101145	2	189863410	2	188998684	101145	106890	rs587779454	NC_000002.12:188998683:G:A
NM_000090.3(COL3A1):c.1347+3A>C (p.Arg449_Gly450insValSerPheThrAlaThrAspLeu+)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101144	2	189859323	2	188994597	101144	106889	rs587779453	NC_000002.12:188994596:A:C
NM_000090.3(COL3A1):c.899G>A (p.Gly300Asp)	COL3A1	G300D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101143	2	189856396	2	188991670	101143	106888	rs587779440	NC_000002.12:188991669:G:A
NM_000090.3(COL3A1):c.951+2T>C (p.Gly300_Ala317del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101140	2	189856450	2	188991724	101140	106885	rs587779426	NC_000002.12:188991723:T:C
NM_000090.3(COL3A1):c.2771G>A (p.Gly924Asp)	COL3A1	G924D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101139	2	189868817	2	189004091	101139	106884	rs587779450	NC_000002.12:189004090:G:A
NM_000090.3(COL3A1):c.2941G>C (p.Gly981Arg)	COL3A1	G981R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101138	2	189870085	2	189005359	101138	106883	rs587779449	NC_000002.12:189005358:G:C
NM_000090.3(COL3A1):c.556G>A (p.Gly186Ser)	COL3A1	G186S	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101135	2	189852834	2	188988108	101135	106880	rs587779446	NC_000002.12:188988107:G:A
NM_000090.3(COL3A1):c.3347G>T (p.Gly1116Val)	COL3A1	G1116V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101133	2	189872317	2	189007591	101133	106878	rs587779445	NC_000002.12:189007590:G:T
NM_000090.3(COL3A1):c.656G>C (p.Gly219Ala)	COL3A1	G219A	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101128	2	189854141	2	188989415	101128	106873	rs587779441	NC_000002.12:188989414:G:C
NM_000090.3(COL3A1):c.899G>T (p.Gly300Val)	COL3A1	G300V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101127	2	189856396	2	188991670	101127	106872	rs587779440	NC_000002.12:188991669:G:T
NM_000090.3(COL3A1):c.3301G>A (p.Gly1101Arg)	COL3A1	G1101R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101126	2	189872271	2	189007545	101126	106871	rs587779439	NC_000002.12:189007544:G:A
NM_000090.3(COL3A1):c.2140G>A (p.Gly714Arg)	COL3A1	G714R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101124	2	189864214	2	188999488	101124	106869	rs587779437	NC_000002.12:188999487:G:A
NM_000090.3(COL3A1):c.1915G>C (p.Gly639Arg)	COL3A1	G639R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101122	2	189862471	2	188997745	101122	106867	rs587779435	NC_000002.12:188997744:G:C
NM_000090.3(COL3A1):c.2861G>A (p.Gly954Glu)	COL3A1	G954E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101121	2	189869020	2	189004294	101121	106866	rs587779434	NC_000002.12:189004293:G:A
NM_000090.3(COL3A1):c.2780G>A (p.Gly927Asp)	COL3A1	G927D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101119	2	189868826	2	189004100	101119	106864	rs587779432	NC_000002.12:189004099:G:A
NM_000090.3(COL3A1):c.1189_1194+23del (p.Gly384_Met398del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101117	2	189858801 - 189858829	2	188994075 - 188994103	101117	106862	rs587779430	NC_000002.12:188994074:GCGAAATGGTAAGCTGTCCCCACTCCTCAGC:GC
NM_000090.3(COL3A1):c.951+2T>A (p.Gly300_Ala317del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101112	2	189856450	2	188991724	101112	106857	rs587779426	NC_000002.12:188991723:T:A
NM_000090.3(COL3A1):c.951+6T>C (p.Gly300_Ala317del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101109	2	189856454	2	188991728	101109	106854	rs587779423	NC_000002.12:188991727:T:C
NM_000090.3(COL3A1):c.951+5G>A (p.Gly300_Ala317del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101108	2	189856453	2	188991727	101108	106853	rs587779422	NC_000002.12:188991726:G:A
NM_000090.3(COL3A1):c.1916G>A (p.Gly639Glu)	COL3A1	G639E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101107	2	189862472	2	188997746	101107	106852	rs587779421	NC_000002.12:188997745:G:A
NM_000090.3(COL3A1):c.2222G>A (p.Gly741Asp)	COL3A1	G741D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101106	2	189864296	2	188999570	101106	106851	rs553203474	NC_000002.12:188999569:G:A
NM_000090.3(COL3A1):c.2276G>A (p.Gly759Asp)	COL3A1	G759D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101103	2	189864614	2	188999888	101103	106848	rs587779418	NC_000002.12:188999887:G:A
NM_000090.3(COL3A1):c.2600G>A (p.Gly867Asp)	COL3A1	G867D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101102	2	189868183	2	189003457	101102	106847	rs587779417	NC_000002.12:189003456:G:A
NM_000090.3(COL3A1):c.2977G>T (p.Gly993Cys)	COL3A1	G993C	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101101	2	189870121	2	189005395	101101	106846	rs587779416	NC_000002.12:189005394:G:T
NM_000143.3(FH):c.1083_1086del (p.Glu362fs)	FH	E362fs	Hereditary leiomyomatosis and renal cell cancer|Hereditary cancer-predisposing syndrome|Fumarase deficiency|not provided	Pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000214399	1	241667364 - 241667367	1	241504064 - 241504067	214399	210671	rs756469140	NC_000001.11:241504063:TTCATT:TT
NM_000143.3(FH):c.1020T>A (p.Asn340Lys)	FH	N340K	Hereditary leiomyomatosis and renal cell cancer|not provided|Fumarase deficiency|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092447	1	241667430	1	241504130	92447	98356	rs398123159	NC_000001.11:241504129:A:T
NM_000478.6(ALPL):c.346G>A (p.Ala116Thr)	ALPL	A99T, A116T, A39T, A61T	Adult hypophosphatasia|Odontohypophosphatasia|Hypophosphatasia|Childhood hypophosphatasia|not provided|Infantile hypophosphatasia	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013677	1	21889651	1	21563158	13677	28716	rs121918013	NC_000001.11:21563157:G:A
NM_000478.6(ALPL):c.979T>C (p.Phe327Leu)	ALPL	F310L, F327L, F250L, F272L	Hypophosphatasia|Adult hypophosphatasia|not provided|Infantile hypophosphatasia	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013673	1	21900274	1	21573781	13673	28712	rs121918010	NC_000001.11:21573780:T:C
NM_000329.3(RPE65):c.271C>T (p.Arg91Trp)	RPE65	R91W	Retinitis pigmentosa|Retinal dystrophy|Leber congenital amaurosis 2|Retinitis pigmentosa 20|Retinitis pigmentosa 20|not provided	Pathogenic(Last reviewed: Jun 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013115	1	68910541	1	68444858	13115	28154	rs61752871	NC_000001.11:68444857:G:A
NM_003000.2(SDHB):c.311delinsGG (p.Asn104fs)	SDHB		Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000184177	1	17355207	1	17028712	184177	181618	rs786201316	NC_000001.11:17028711:T:CC
NM_001284214.2(TRIP12):c.3901_3902AG[1] (p.Gly1302fs)	TRIP12		Inborn genetic diseases	Pathogenic(Last reviewed: Jul 21, 2016)	criteria provided, single submitter	VCV000521198	2	230657845 - 230657846	2	229793129 - 229793130	521198	511402	rs1553610329	NC_000002.12:229793128:CTCT:CT
NM_001284214.2(TRIP12):c.486del (p.Gln162fs)	TRIP12	Q120fs, Q162fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	VCV000520711	2	230724029	2	229859313	520711	511404	rs1553704696	NC_000002.12:229859312:TT:T
NM_001284214.2(TRIP12):c.5110_5113del (p.Thr1704fs)	TRIP12	T1697fs, T1704fs, T1731fs, T1386fs, T1732fs, T1656fs, T1657fs, T1684fs, T1705fs, T1727fs, T1689fs, T1726fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 9, 2015)	criteria provided, single submitter	VCV000520615	2	230643607 - 230643610	2	229778891 - 229778894	520615	511401	rs1553591922	NC_000002.12:229778890:GAGT:
NM_000090.4(COL3A1):c.1910_1911CA[1] (p.Gln638fs)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV000805951	2	189862466 - 189862467	2	188997740 - 188997741	805951	794279		NC_000002.12:188997739:CACA:CA
NM_000090.3(COL3A1):c.937_938dup (p.Pro314fs)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000650847	2	189856433 - 189856434	2	188991707 - 188991708	650847	629190		NC_000002.12:188991707:CT:CTCT
NC_000002.11:g.(?_189839196)_(189839314_?)dup	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000583627	2	189839196 - 189839314	2	188974470 - 188974588	583627	558637		
NM_000090.3(COL3A1):c.1684C>T (p.Arg562Ter)	COL3A1	R562*	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000577225	2	189861145	2	188996419	577225	557831	rs375737772	NC_000002.12:188996418:C:T
NM_000090.3(COL3A1):c.134G>A (p.Trp45Ter)	COL3A1	W45*	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000575406	2	189849540	2	188984814	575406	559482	rs1559052609	NC_000002.12:188984813:G:A
NM_000090.3(COL3A1):c.3527G>A (p.Gly1176Asp)	COL3A1	G1176D	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547274	2	189873651	2	189008925	547274	537705	rs1553509726	NC_000002.12:189008924:G:A
NM_000090.3(COL3A1):c.2828del (p.Ala943fs)	COL3A1	A943fs	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000529321	2	189868987	2	189004261	529321	517439	rs1553509208	NC_000002.12:189004260:C:
NM_000090.3(COL3A1):c.4267G>T (p.Glu1423Ter)	COL3A1	E1423*	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000520518	2	189876366	2	189011640	520518	511070	rs1553510000	NC_000002.12:189011639:G:T
NM_000090.3(COL3A1):c.608del (p.Pro203fs)	COL3A1	P203fs	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Jan 27, 2017)	criteria provided, single submitter	VCV000459794	2	189853337	2	188988611	459794	450284	rs1553507265	NC_000002.12:188988610:CCCCC:CCCC
NM_000090.3(COL3A1):c.3500G>A (p.Gly1167Asp)	COL3A1	G1167D	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000459787	2	189872843	2	189008117	459787	450325	rs587779578	NC_000002.12:189008116:G:A
NM_000090.3(COL3A1):c.3257G>T (p.Gly1086Val)	COL3A1	G1086V	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, single submitter	VCV000404304	2	189872227	2	189007501	404304	392416	rs1060500203	NC_000002.12:189007500:G:T
NM_000090.3(COL3A1):c.81del (p.Val28fs)	COL3A1	V28fs	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Mar 6, 2017)	criteria provided, single submitter	VCV000404300	2	189849487	2	188984761	404300	392392	rs1060500200	NC_000002.12:188984760:T:
NM_000090.3(COL3A1):c.1652del (p.Pro551fs)	COL3A1	P551fs	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Feb 14, 2017)	criteria provided, single submitter	VCV000404299	2	189860893	2	188996167	404299	392332	rs1060500199	NC_000002.12:188996166:CC:C
NM_000090.3(COL3A1):c.3833G>A (p.Trp1278Ter)	COL3A1	W1278*	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Dec 11, 2016)	criteria provided, single submitter	VCV000404267	2	189874913	2	189010187	404267	392351	rs1060500187	NC_000002.12:189010186:G:A
NM_000090.3(COL3A1):c.3575_3576insAGGG (p.Pro1193fs)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101481	2	189873699 - 189873700	2	189008973 - 189008974	101481	107228	rs587779712	NC_000002.12:189008973::AGGG
NM_000090.3(COL3A1):c.575G>T (p.Gly192Val)	COL3A1	G192V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101477	2	189852853	2	188988127	101477	107224	rs587779710	NC_000002.12:188988126:G:T
NM_000090.3(COL3A1):c.1970G>A (p.Gly657Glu)	COL3A1	G657E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101459	2	189863038	2	188998312	101459	107206	rs587779699	NC_000002.12:188998311:G:A
NM_000090.3(COL3A1):c.2231G>T (p.Gly744Val)	COL3A1	G744V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101457	2	189864569	2	188999843	101457	107204	rs587779697	NC_000002.12:188999842:G:T
NM_000090.3(COL3A1):c.2131G>A (p.Gly711Ser)	COL3A1	G711S	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101455	2	189864205	2	188999479	101455	107202	rs587779695	NC_000002.12:188999478:G:A
NM_000090.3(COL3A1):c.1556G>A (p.Gly519Glu)	COL3A1	G519E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101453	2	189860464	2	188995738	101453	107200	rs587779693	NC_000002.12:188995737:G:A
NM_000090.3(COL3A1):c.2554G>T (p.Gly852Cys)	COL3A1	G852C	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101450	2	189868137	2	189003411	101450	107197	rs587779690	NC_000002.12:189003410:G:T
NM_000090.3(COL3A1):c.1105_1107delGGA (p.Gly369del)	COL3A1	G369del	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101445	2	189858139 - 189858141	2	188993413 - 188993415	101445	107192	rs587779686	NC_000002.12:188993412:GAGGAG:GAG
NM_000090.3(COL3A1):c.1646G>A (p.Gly549Glu)	COL3A1	G549E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101437	2	189860888	2	188996162	101437	107184	rs587779679	NC_000002.12:188996161:G:A
NM_000090.3(COL3A1):c.3266G>A (p.Gly1089Asp)	COL3A1	G1089D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101429	2	189872236	2	189007510	101429	107176	rs587779672	NC_000002.12:189007509:G:A
NM_000090.3(COL3A1):c.2095G>C (p.Gly699Arg)	COL3A1	G699R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101418	2	189864083	2	188999357	101418	107165	rs587779668	NC_000002.12:188999356:G:C
NM_000090.3(COL3A1):c.1410del (p.Gly471fs)	COL3A1	G471fs	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101414	2	189859512	2	188994786	101414	107161	rs587779665	NC_000002.12:188994785:T:
NM_000090.3(COL3A1):c.2753G>A (p.Gly918Glu)	COL3A1	G918E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101407	2	189868799	2	189004073	101407	107153	rs587779662	NC_000002.12:189004072:G:A
NM_000090.3(COL3A1):c.3863A>T (p.Asp1288Val)	COL3A1	D1288V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101401	2	189874943	2	189010217	101401	107147	rs587779658	NC_000002.12:189010216:A:T
NM_000090.4(COL3A1):c.955_974delinsTTTACATCGAGGGTTTTAAAGTTTACA (p.Ala319fs)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101398	2	189856913 - 189856932	2	188992187 - 188992206	101398	107144	rs587779655	NC_000002.12:188992186:GCTCGGGGTAATGACGGTGC:TTTACATCGAGGGTTTTAAAGTTTACA
NM_000090.3(COL3A1):c.3496C>T (p.Arg1166Ter)	COL3A1	R1166*	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101382	2	189872839	2	189008113	101382	107128	rs587779646	NC_000002.12:189008112:C:T
NM_000090.3(COL3A1):c.3545G>A (p.Gly1182Glu)	COL3A1	G1182E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101381	2	189873669	2	189008943	101381	107127	rs111505097	NC_000002.12:189008942:G:A
NM_000090.3(COL3A1):c.2636G>T (p.Gly879Val)	COL3A1	G879V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101379	2	189868488	2	189003762	101379	107125	rs587779645	NC_000002.12:189003761:G:T
NM_000090.3(COL3A1):c.2176G>A (p.Gly726Arg)	COL3A1	G726R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101370	2	189864250	2	188999524	101370	107116	rs587779638	NC_000002.12:188999523:G:A
NM_000090.3(COL3A1):c.1249G>A (p.Gly417Arg)	COL3A1	G417R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101369	2	189859014	2	188994288	101369	107115	rs587779637	NC_000002.12:188994287:G:A
NM_000090.3(COL3A1):c.728G>T (p.Gly243Val)	COL3A1	G243V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101356	2	189854859	2	188990133	101356	107102	rs587779629	NC_000002.12:188990132:G:T
NM_000090.3(COL3A1):c.2645G>A (p.Gly882Asp)	COL3A1	G882D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101345	2	189868497	2	189003771	101345	107091	rs587779622	NC_000002.12:189003770:G:A
NM_000090.3(COL3A1):c.2824-1G>A (p.Gly942Glufs*294)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101337	2	189868982	2	189004256	101337	107083	rs587779617	NC_000002.12:189004255:G:A
NM_000090.3(COL3A1):c.2213G>T (p.Gly738Val)	COL3A1	G738V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101335	2	189864287	2	188999561	101335	107081	rs587779615	NC_000002.12:188999560:G:T
NM_000090.3(COL3A1):c.3293G>T (p.Gly1098Val)	COL3A1	G1098V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101334	2	189872263	2	189007537	101334	107080	rs587779614	NC_000002.12:189007536:G:T
NM_000090.3(COL3A1):c.2915G>C (p.Gly972Ala)	COL3A1	G972A	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101326	2	189869074	2	189004348	101326	107072	rs587779559	NC_000002.12:189004347:G:C
NM_000090.3(COL3A1):c.1773dupT (p.Lys592Terfs)	COL3A1	K592*	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101325	2	189861901 - 189861902	2	188997175 - 188997176	101325	107071	rs587779608	NC_000002.12:188997175:T:TT
NM_000090.3(COL3A1):c.2950_2951delinsAC (p.Gly984Thr)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101318	2	189870094 - 189870095	2	189005368 - 189005369	101318	107064	rs1559061242	NC_000002.12:189005367:GG:AC
NM_000090.3(COL3A1):c.2699G>A (p.Gly900Asp)	COL3A1	G900D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101313	2	189868745	2	189004019	101313	107059	rs587779599	NC_000002.12:189004018:G:A
NM_000090.3(COL3A1):c.1808del (p.Gly603fs)	COL3A1	G603fs	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101308	2	189861936	2	188997210	101308	107054	rs587779594	NC_000002.12:188997209:GG:G
NM_000090.3(COL3A1):c.2655_2661+7delinsGACCTGAGAC (p.Ser886Thrfs*2)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101304	2	189868507 - 189868520	2	189003781 - 189003794	101304	107050	rs587779590	NC_000002.12:189003780:TAGTAATGTAAGTA:GACCTGAGAC
NM_000090.3(COL3A1):c.962G>T (p.Gly321Val)	COL3A1	G321V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101302	2	189856920	2	188992194	101302	107048	rs587779588	NC_000002.12:188992193:G:T
NM_000090.3(COL3A1):c.1761+15_1870-100del (p.Gly588_Thr623del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101300	2	189861234 - 189862323	2	188996508 - 188997597	101300	107046		
NM_000090.3(COL3A1):c.4294C>T (p.Arg1432Ter)	COL3A1	R1432*	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101298	2	189876393	2	189011667	101298	107044	rs587779585	NC_000002.12:189011666:C:T
NM_000090.3(COL3A1):c.746G>T (p.Gly249Val)	COL3A1	G249V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101295	2	189855034	2	188990308	101295	107041	rs121912927	NC_000002.12:188990307:G:T
NM_000090.3(COL3A1):c.2987G>A (p.Gly996Glu)	COL3A1	G996E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101287	2	189870131	2	189005405	101287	107033	rs587779576	NC_000002.12:189005404:G:A
NM_000090.3(COL3A1):c.1870-2A>T (p.Gly624_Gln641del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101286	2	189862424	2	188997698	101286	107032	rs587779575	NC_000002.12:188997697:A:T
NM_000090.3(COL3A1):c.1923+1G>A (p.Gly624_Gln641del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101284	2	189862480	2	188997754	101284	107030	rs587779573	NC_000002.12:188997753:G:A
NM_000090.3(COL3A1):c.2445+2dup	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101283	2	189867078 - 189867079	2	189002352 - 189002353	101283	107029	rs587779572	NC_000002.12:189002352:T:TT
NM_000090.3(COL3A1):c.2897G>T (p.Gly966Val)	COL3A1	G966V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101282	2	189869056	2	189004330	101282	107028	rs587779571	NC_000002.12:189004329:G:T
NM_000090.3(COL3A1):c.755G>A (p.Gly252Asp)	COL3A1	G252D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101264	2	189855043	2	188990317	101264	107010	rs587779464	NC_000002.12:188990316:G:A
NM_000090.3(COL3A1):c.3032G>A (p.Gly1011Glu)	COL3A1	G1011E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101256	2	189870176	2	189005450	101256	107002	rs587779552	NC_000002.12:189005449:G:A
NM_000090.3(COL3A1):c.2995G>C (p.Gly999Arg)	COL3A1	G999R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101252	2	189870139	2	189005413	101252	106998	rs587779548	NC_000002.12:189005412:G:C
NM_000090.3(COL3A1):c.2924G>T (p.Gly975Val)	COL3A1	G975V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101246	2	189869083	2	189004357	101246	106992	rs587779542	NC_000002.12:189004356:G:T
NM_000090.3(COL3A1):c.674G>T (p.Gly225Val)	COL3A1	G225V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101236	2	189854159	2	188989433	101236	106982	rs587779533	NC_000002.12:188989432:G:T
NM_000090.3(COL3A1):c.3039+6T>C (p.Asp1013_Gly1014insVSSSFYSTSQ)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101235	2	189870189	2	189005463	101235	106981	rs587779532	NC_000002.12:189005462:T:C
NM_000090.3(COL3A1):c.2554-1G>A (p.Gly852Valfs*384)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101219	2	189868136	2	189003410	101219	106964	rs587779519	NC_000002.12:189003409:G:A
NM_000090.3(COL3A1):c.2825G>A (p.Gly942Glu)	COL3A1	G942E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101217	2	189868984	2	189004258	101217	106962	rs587779517	NC_000002.12:189004257:G:A
NM_000090.3(COL3A1):c.996+1G>A (p.Gly318_Pro332del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101216	2	189856955	2	188992229	101216	106961	rs587779516	NC_000002.12:188992228:G:A
NM_000090.3(COL3A1):c.2708G>A (p.Gly903Glu)	COL3A1	G903E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101203	2	189868754	2	189004028	101203	106948	rs587779505	NC_000002.12:189004027:G:A
NM_000090.3(COL3A1):c.3562G>A (p.Gly1188Arg)	COL3A1	G1188R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101202	2	189873686	2	189008960	101202	106947	rs587779504	NC_000002.12:189008959:G:A
NM_000090.3(COL3A1):c.3509G>T (p.Gly1170Val)	COL3A1	G1170V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101199	2	189872852	2	189008126	101199	106944	rs587779465	NC_000002.12:189008125:G:T
NM_000090.3(COL3A1):c.1294-3T>G (p.Gly432_Arg449del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101193	2	189859264	2	188994538	101193	106938	rs587779496	NC_000002.12:188994537:T:G
NM_000090.3(COL3A1):c.1979G>A (p.Gly660Asp)	COL3A1	G660D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101189	2	189863401	2	188998675	101189	106934	rs587779493	NC_000002.12:188998674:G:A
NM_000090.3(COL3A1):c.2935G>T (p.Glu979Ter)	COL3A1	E979*	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101184	2	189870079	2	189005353	101184	106929	rs587779488	NC_000002.12:189005352:G:T
NM_000090.3(COL3A1):c.2482G>T (p.Gly828Trp)	COL3A1	G828W	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101181	2	189867717	2	189002991	101181	106926	rs587779486	NC_000002.12:189002990:G:T
NM_000090.3(COL3A1):c.2726G>T (p.Gly909Val)	COL3A1	G909V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101178	2	189868772	2	189004046	101178	106923	rs587779483	NC_000002.12:189004045:G:T
NM_000090.3(COL3A1):c.1466G>A (p.Gly489Glu)	COL3A1	G489E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101170	2	189859782	2	188995056	101170	106915	rs587779476	NC_000002.12:188995055:G:A
NM_000090.3(COL3A1):c.3482G>T (p.Gly1161Val)	COL3A1	G1161V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101167	2	189872825	2	189008099	101167	106912	rs587779473	NC_000002.12:189008098:G:T
NM_000090.3(COL3A1):c.2770G>T (p.Gly924Cys)	COL3A1	G924C	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101165	2	189868816	2	189004090	101165	106910	rs587779471	NC_000002.12:189004089:G:T
NM_000090.3(COL3A1):c.718G>C (p.Gly240Arg)	COL3A1	G240R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101161	2	189854849	2	188990123	101161	106906	rs587779468	NC_000002.12:188990122:G:C
NM_000090.3(COL3A1):c.3847C>T (p.Gln1283Ter)	COL3A1	Q1283*	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101160	2	189874927	2	189010201	101160	106905	rs587779467	NC_000002.12:189010200:C:T
NM_000090.3(COL3A1):c.3509G>A (p.Gly1170Asp)	COL3A1	G1170D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101157	2	189872852	2	189008126	101157	106902	rs587779465	NC_000002.12:189008125:G:A
NM_000090.3(COL3A1):c.798+1G>A (p.Phe268Leufs*10)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101155	2	189855087	2	188990361	101155	106900	rs587779463	NC_000002.12:188990360:G:A
NM_000090.3(COL3A1):c.766del (p.Ile256fs)	COL3A1	I256fs	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101146	2	189855054	2	188990328	101146	106891	rs587779455	NC_000002.12:188990327:A:
NM_000090.3(COL3A1):c.3417+5G>A (p.Gly1122_Arg1139del+)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101137	2	189872669	2	189007943	101137	106882	rs587779448	NC_000002.12:189007942:G:A
NM_000090.3(COL3A1):c.2842G>A (p.Gly948Arg)	COL3A1	G948R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101136	2	189869001	2	189004275	101136	106881	rs587779447	NC_000002.12:189004274:G:A
NM_000090.3(COL3A1):c.907G>A (p.Gly303Arg)	COL3A1	G303R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101131	2	189856404	2	188991678	101131	106876	rs121912919	NC_000002.12:188991677:G:A
NM_000090.3(COL3A1):c.1987G>C (p.Gly663Arg)	COL3A1	G663R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101120	2	189863409	2	188998683	101120	106865	rs587779433	NC_000002.12:188998682:G:C
NM_000090.3(COL3A1):c.1744G>C (p.Gly582Arg)	COL3A1	G582R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101116	2	189861205	2	188996479	101116	106861	rs121912923	NC_000002.12:188996478:G:C
NM_000090.3(COL3A1):c.3095G>T (p.Gly1032Val)	COL3A1	G1032V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101114	2	189871072	2	189006346	101114	106859	rs587779428	NC_000002.12:189006345:G:T
NM_000090.3(COL3A1):c.2823+1G>A (p.Gly942Valfs*28)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101110	2	189868870	2	189004144	101110	106855	rs587779424	NC_000002.12:189004143:G:A
NM_000090.3(COL3A1):c.548G>A (p.Gly183Asp)	COL3A1	G183D	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101105	2	189852826	2	188988100	101105	106850	rs587779420	NC_000002.12:188988099:G:A
NM_000090.3(COL3A1):c.3302G>A (p.Gly1101Glu)	COL3A1	G934E, G1101E	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000017226	2	189872272	2	189007546	17226	32265	rs121912924	NC_000002.12:189007545:G:A
NM_000090.3(COL3A1):c.1869+5G>A	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000017222	2	189862120	2	188997394	17222	32261	rs397509376	NC_000002.12:188997393:G:A
NM_000090.3(COL3A1):c.582+6T>C	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: May 1, 1993)	no assertion criteria provided	VCV000017220	2	189852866	2	188988140	17220	32259	rs397509375	NC_000002.12:188988139:T:C
COL3A1, GLY373ARG	COL3A1	G373R	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Mar 9, 2000)	no assertion criteria provided	VCV000017210					17210	32249		
NM_000090.3(COL3A1):c.2553+5G>T	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Jan 1, 1993)	no assertion criteria provided	VCV000017206	2	189867793	2	189003067	17206	32245	rs397509371	NC_000002.12:189003066:G:T
NM_000090.3(COL3A1):c.3093+1G>A	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Jul 15, 1990)	no assertion criteria provided	VCV000017204	2	189870986	2	189006260	17204	32243	rs869312034	NC_000002.12:189006259:G:A
NM_000090.3(COL3A1):c.3149G>A (p.Gly1050Asp)	COL3A1	G883D, G1050D	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Dec 21, 2017)	no assertion criteria provided	VCV000017201	2	189871126	2	189006400	17201	32240	rs121912914	NC_000002.12:189006399:G:A
NM_170707.4(LMNA):c.744_745delinsTT (p.Arg249Trp)	LMNA		Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000543181	1	156104700 - 156104701	1	156134909 - 156134910	543181	515161	rs1553265342	NC_000001.11:156134908:GC:TT
NM_170707.4(LMNA):c.1583C>G (p.Thr528Arg)	LMNA	T528R, T416R, T447R	Charcot-Marie-Tooth disease, type 2|Familial partial lipodystrophy 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066850	1	156106998	1	156137207	66850	77747	rs57629361	NC_000001.11:156137206:C:G
NM_170707.4(LMNA):c.958del (p.Leu320fs)	LMNA	L208fs, L320fs, L239fs	Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048095	1	156105713	1	156135922	48095	57259	rs397517915	NC_000001.11:156135921:C:
NM_170707.4(LMNA):c.348dup (p.Lys117fs)	LMNA		not provided|Charcot-Marie-Tooth disease, type 2|Primary dilated cardiomyopathy	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000048061	1	156085056 - 156085057	1	156115265 - 156115266	48061	57225	rs267607646	NC_000001.11:156115265:G:GG
NM_000090.3(COL3A1):c.2392-3_2395del	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000580085	2	189867021 - 189867027	2	189002295 - 189002301	580085	559488	rs1559059873	NC_000002.12:189002294:CAGGGTG:
NM_000090.3(COL3A1):c.4011+1G>T	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000575052	2	189875092	2	189010366	575052	557790	rs112532745	NC_000002.12:189010365:G:T
NM_000090.3(COL3A1):c.2569C>T (p.Gln857Ter)	COL3A1	Q857*	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000566570	2	189868152	2	189003426	566570	559490	rs1559060412	NC_000002.12:189003425:C:T
NM_000090.3(COL3A1):c.1471C>T (p.Arg491Ter)	COL3A1	R491*	not provided|Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000372921	2	189859787	2	188995061	372921	359399	rs1057518075	NC_000002.12:188995060:C:T
NM_000090.3(COL3A1):c.610G>A (p.Gly204Ser)	COL3A1	G204S	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101478	2	189853343	2	188988617	101478	107225	rs587779711	NC_000002.12:188988616:G:A
NM_000090.3(COL3A1):c.3212G>T (p.Gly1071Val)	COL3A1	G1071V	Ehlers-Danlos syndrome, type 4	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2013)	no assertion criteria provided	VCV000101476	2	189871673	2	189006947	101476	107223	rs587779709	NC_000002.12:189006946:G:T
NM_000090.3(COL3A1):c.2023-1G>A (p.Gly675Valfs*116)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101475	2	189864010	2	188999284	101475	107222	rs587779708	NC_000002.12:188999283:G:A
NM_000090.3(COL3A1):c.413del (p.Pro138fs)	COL3A1	P138fs	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101474	2	189850465	2	188985739	101474	107221	rs587779707	NC_000002.12:188985738:CCCCCC:CCCCC
NM_000090.3(COL3A1):c.754G>C (p.Gly252Arg)	COL3A1	G252R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101470	2	189855042	2	188990316	101470	107217	rs587779705	NC_000002.12:188990315:G:C
NM_000090.3(COL3A1):c.1456-13_1499del (p.Gly486_Lys503del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101468	2	189859759 - 189859815	2	188995033 - 188995089	101468	107215	rs1553508025	
NM_000090.3(COL3A1):c.1923+1G>C (p.Gly624_Gln641del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101460	2	189862480	2	188997754	101460	107207	rs587779573	NC_000002.12:188997753:G:C
NM_000090.3(COL3A1):c.2553+2T>C (p.Gly816_Ala851del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101443	2	189867790	2	189003064	101443	107190	rs587779684	NC_000002.12:189003063:T:C
NM_000090.3(COL3A1):c.2553+1G>A (p.Gly816_Ala851del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Nov 10, 2015)	criteria provided, single submitter	VCV000101413	2	189867789	2	189003063	101413	107160	rs587779664	NC_000002.12:189003062:G:A
NM_000090.3(COL3A1):c.2337+1G>A (p.Gly762_Lys779del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101410	2	189866177	2	189001451	101410	107157	rs587779663	NC_000002.12:189001450:G:A
NM_000090.3(COL3A1):c.2607+5G>A (p.Gly852_Pro869del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101409	2	189868195	2	189003469	101409	107156	rs587779457	NC_000002.12:189003468:G:A
NM_000090.3(COL3A1):c.690+1G>A (p.Gly213_Asp230del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101404	2	189854176	2	188989450	101404	107150	rs587779660	NC_000002.12:188989449:G:A
NM_000090.3(COL3A1):c.3490G>A (p.Gly1164Arg)	COL3A1	G1164R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101402	2	189872833	2	189008107	101402	107148	rs587779553	NC_000002.12:189008106:G:A
NM_000090.3(COL3A1):c.2534dup (p.Gly846fs)	COL3A1		not specified|Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: May 17, 2019)	criteria provided, single submitter	VCV000101396	2	189867764 - 189867765	2	189003038 - 189003039	101396	107142	rs587779653	NC_000002.12:189003038:CCCCC:CCCCCC
NM_000090.3(COL3A1):c.582+55_798+320delinsTATGCAAAATCAAAC	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101394	2	189852915 - 189855406	2	188988189 - 188990680	101394	107140		
NM_000090.3(COL3A1):c.951+1G>A (p.Gly300_Ala317del)	COL3A1		COL3A1-Related Disorder|Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101391	2	189856449	2	188991723	101391	107137	rs587779652	NC_000002.12:188991722:G:A
NM_000090.3(COL3A1):c.2022G>A (p.Lys674=)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101376	2	189863444	2	188998718	101376	107122	rs587779643	NC_000002.12:188998717:G:A
NM_000090.3(COL3A1):c.782G>A (p.Gly261Asp)	COL3A1	G261D	not provided|Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, single submitter	VCV000101367	2	189855070	2	188990344	101367	107113	rs587779635	NC_000002.12:188990343:G:A
NM_000090.3(COL3A1):c.655G>T (p.Gly219Cys)	COL3A1	G219C	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101347	2	189854140	2	188989414	101347	107093	rs587779624	NC_000002.12:188989413:G:T
NM_000090.4(COL3A1):c.1150-1_1166delinsCCGTCCTGGGCCCTGGTGGTATACAAACCTGGTATACCACC	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101332	2	189858763 - 189858780	2	188994037 - 188994054	101332	107078	rs587779612	NC_000002.12:188994036:GGGCCCTCCTGGGATTAA:CCGTCCTGGGCCCTGGTGGTATACAAACCTGGTATACCACC
NM_000090.3(COL3A1):c.1268G>A (p.Gly423Asp)	COL3A1	G423D	Ehlers-Danlos syndrome, type 4|not provided	Pathogenic(Last reviewed: May 6, 2015)	criteria provided, single submitter	VCV000101299	2	189859033	2	188994307	101299	107045	rs587779586	NC_000002.12:188994306:G:A
NM_000090.3(COL3A1):c.3535G>C (p.Gly1179Arg)	COL3A1	G1179R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101285	2	189873659	2	189008933	101285	107031	rs587779574	NC_000002.12:189008932:G:C
NM_000090.3(COL3A1):c.2806G>C (p.Gly936Arg)	COL3A1	G936R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101277	2	189868852	2	189004126	101277	107023	rs587779566	NC_000002.12:189004125:G:C
NM_000090.3(COL3A1):c.4254G>A (p.Thr1418=)	COL3A1		not provided|Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, single submitter	VCV000101276	2	189875616	2	189010890	101276	107022	rs587779565	NC_000002.12:189010889:G:A
NM_000090.3(COL3A1):c.690+2T>A (p.Gly213_Asp230del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101268	2	189854177	2	188989451	101268	107014	rs587779497	NC_000002.12:188989450:T:A
NM_000090.3(COL3A1):c.683G>A (p.Gly228Glu)	COL3A1	G228E	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101259	2	189854168	2	188989442	101259	107005	rs587779555	NC_000002.12:188989441:G:A
NM_000090.3(COL3A1):c.3364-2A>C (p.Gly1122_Arg1139del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101250	2	189872609	2	189007883	101250	106996	rs587779546	NC_000002.12:189007882:A:C
NM_000090.3(COL3A1):c.1501G>A (p.Gly501Arg)	COL3A1	G501R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101223	2	189859817	2	188995091	101223	106968	rs587779523	NC_000002.12:188995090:G:A
NM_000090.3(COL3A1):c.1906G>C (p.Gly636Arg)	COL3A1	G636R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101222	2	189862462	2	188997736	101222	106967	rs587779522	NC_000002.12:188997735:G:C
NM_000090.3(COL3A1):c.582+1G>C (p.Gly177_Pro194del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101206	2	189852861	2	188988135	101206	106951	rs587779508	NC_000002.12:188988134:G:C
NM_000090.3(COL3A1):c.3039+1G>A (p.Asp1013_Gly1014insMSSSFYSTSQ)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101204	2	189870184	2	189005458	101204	106949	rs587779506	NC_000002.12:189005457:G:A
NM_000090.3(COL3A1):c.3093+2T>C (p.Gly1014_Lys1031del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101201	2	189870987	2	189006261	101201	106946	rs587779503	NC_000002.12:189006260:T:C
NM_000090.3(COL3A1):c.3418-2A>T (p.Arg1139_Gly1140insVSSTERYYRSTCFRCLHFRKIFWHCDVMILSL)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101200	2	189872759	2	189008033	101200	106945	rs587779502	NC_000002.12:189008032:A:T
NM_000090.3(COL3A1):c.690+2T>G (p.Gly213_Asp230del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101194	2	189854177	2	188989451	101194	106939	rs587779497	NC_000002.12:188989450:T:G
NM_000090.3(COL3A1):c.3554G>T (p.Gly1185Val)	COL3A1	G1185V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101182	2	189873678	2	189008952	101182	106927	rs121912917	NC_000002.12:189008951:G:T
NM_000090.3(COL3A1):c.547G>T (p.Gly183Cys)	COL3A1	G183C	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101171	2	189852825	2	188988099	101171	106916	rs121912926	NC_000002.12:188988098:G:T
NM_000090.3(COL3A1):c.755G>T (p.Gly252Val)	COL3A1	G252V	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101156	2	189855043	2	188990317	101156	106901	rs587779464	NC_000002.12:188990316:G:T
NM_000090.3(COL3A1):c.1831_1832del (p.Asn611fs)	COL3A1	N611fs	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101154	2	189862077 - 189862078	2	188997351 - 188997352	101154	106899	rs587779462	NC_000002.12:188997350:AA:
NM_000090.3(COL3A1):c.2607+5G>T (p.Gly852_Pro869del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101149	2	189868195	2	189003469	101149	106894	rs587779457	NC_000002.12:189003468:G:T
NM_000090.3(COL3A1):c.601G>C (p.Gly201Arg)	COL3A1	G201R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101123	2	189853334	2	188988608	101123	106868	rs587779436	NC_000002.12:188988607:G:C
NM_000090.3(COL3A1):c.2022+2T>C (p.Gly660_Lys674del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000101115	2	189863446	2	188998720	101115	106860	rs587779429	NC_000002.12:188998719:T:C
NM_000090.3(COL3A1):c.951_951+14del (p.Gly300_Ala317del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101111	2	189856443 - 189856457	2	188991717 - 188991731	101111	106856	rs587779425	NC_000002.12:188991716:GCTGCAGTGAGTATAGCTGC:GCTGC
NM_000090.3(COL3A1):c.1033G>A (p.Gly345Arg)	COL3A1	G345R	Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101104	2	189857649	2	188992923	101104	106849	rs587779419	NC_000002.12:188992922:G:A
NM_000090.3(COL3A1):c.2879G>T (p.Gly960Val)	COL3A1	G793V, G960V	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000017224	2	189869038	2	189004312	17224	32263	rs121912922	NC_000002.12:189004311:G:T
NM_000090.3(COL3A1):c.2490_2516del (p.Glu832_Gly840del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000017214	2	189867721 - 189867747	2	189002995 - 189003021	17214	32253	rs397509374	NC_000002.12:189002994:CTCCGGGTGAGAAAGGTGAAGGAGGCCCTCC:CTCC
NM_000090.3(COL3A1):c.1761+5G>T	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Mar 15, 1991)	no assertion criteria provided	VCV000017212	2	189861227	2	188996501	17212	32251	rs397509372	NC_000002.12:188996500:G:T
NM_000090.3(COL3A1):c.1655G>A (p.Gly552Glu)	COL3A1	G385E, G552E	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Mar 9, 2000)	no assertion criteria provided	VCV000017211	2	189860897	2	188996171	17211	32250	rs121912928	NC_000002.12:188996170:G:A
NM_000090.3(COL3A1):c.746G>A (p.Gly249Asp)	COL3A1	G82D, G249D	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Mar 9, 2000)	no assertion criteria provided	VCV000017208	2	189855034	2	188990308	17208	32247	rs121912927	NC_000002.12:188990307:G:A
NM_000642.3(AGL):c.1000dup (p.Thr334fs)	AGL		Inborn genetic diseases	Pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, single submitter	VCV000521450	1	100340283 - 100340284	1	99874727 - 99874728	521450	511307	rs1553185302	NC_000001.11:99874727:A:AA
NM_012222.2(MUTYH):c.1438dup (p.Thr480fs)	MUTYH		not provided	Pathogenic(Last reviewed: Oct 17, 2014)	criteria provided, single submitter	VCV000418345	1	45796882 - 45796883	1	45331210 - 45331211	418345	405187	rs1553124893	NC_000001.11:45331210:T:TT
NM_001128425.1(MUTYH):c.1187-32_1199del	MUTYH		not provided	Pathogenic(Last reviewed: Dec 21, 2015)	criteria provided, single submitter	VCV000265534	1	45797216 - 45797260	1	45331544 - 45331588	265534	259672	rs886039606	NC_000001.11:45331543:CCTGCCAGCAGACCTGAGAGGGAGGGCAGCCAGGCAGGGGTCAGGCCT:CCT
NM_001128425.2(MUTYH):c.471_473delinsAA (p.Thr158fs)	MUTYH		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000825116	1	45798621 - 45798623	1	45332949 - 45332951	825116	806672		NC_000001.11:45332948:GTA:TT
NM_001128425.2(MUTYH):c.444C>G (p.Tyr148Ter)	MUTYH	Y135*, Y120*, Y148*, Y28*, Y121*, Y131*, Y145*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 22, 2018)	criteria provided, single submitter	VCV000824899	1	45798787	1	45333115	824899	806674		NC_000001.11:45333114:G:C
NM_001128425.2(MUTYH):c.877C>T (p.Gln293Ter)	MUTYH	Q276*, Q150*, Q290*, Q293*, Q173*, Q265*, Q266*, Q280*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000822727	1	45797894	1	45332222	822727	806646		NC_000001.11:45332221:G:A
NM_001128425.2(MUTYH):c.1371del (p.Leu458fs)	MUTYH	L445fs, L338fs, L431fs, L430fs, L441fs, L315fs, L455fs, L458fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000819034	1	45796959	1	45331287	819034	806613		NC_000001.11:45331286:CCC:CC
NM_001128425.2(MUTYH):c.1267del (p.Glu423fs)	MUTYH	E420fs, E303fs, E396fs, E423fs, E280fs, E406fs, E410fs, E395fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000818740	1	45797148	1	45331476	818740	806624		NC_000001.11:45331475:CC:C
NM_001128425.2(MUTYH):c.1135C>T (p.Gln379Ter)	MUTYH	Q376*, Q362*, Q379*, Q351*, Q352*, Q366*, Q236*, Q259*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000818408	1	45797384	1	45331712	818408	806633		NC_000001.11:45331711:G:A
NM_012222.2(MUTYH):c.1288del (p.Ala430fs)	MUTYH	A405fs, A419fs, A430fs, A416fs, A290fs, A313fs, A406fs, A420fs, A433fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 23, 2016)	criteria provided, single submitter	VCV000485896	1	45797118	1	45331446	485896	472340	rs1553125622	NC_000001.11:45331445:C:
NM_001350650.1(MUTYH):c.33+120del	MUTYH	V132fs, V118fs, V12fs, V104fs, V115fs, V105fs, V119fs, V129fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000483932	1	45798837	1	45333165	483932	472399	rs1553129676	NC_000001.11:45333164:CCC:CC
NM_012222.2(MUTYH):c.954del (p.Ser319fs)	MUTYH	S179fs, S202fs, S308fs, S319fs, S305fs, S295fs, S294fs, S309fs, S322fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, single submitter	VCV000479983	1	45797729	1	45332057	479983	472382	rs776362892	NC_000001.11:45332056:CCC:CC
NM_001128425.1(MUTYH):c.1125T>A (p.Cys375Ter)	MUTYH	C375*, C347*, C348*, C362*, C232*, C358*, C372*, C255*, C361*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 11, 2013)	criteria provided, single submitter	VCV000428282	1	45797394	1	45331722	428282	419300	rs1114167685	NC_000001.11:45331721:A:T
NM_001128425.1(MUTYH):c.421C>T (p.Gln141Ter)	MUTYH	Q141*, Q113*, Q114*, Q124*, Q127*, Q128*, Q21*, Q138*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	VCV000232217	1	45798810	1	45333138	232217	232270	rs876659625	NC_000001.11:45333137:G:A
NM_012222.2(MUTYH):c.1541_1542delinsAG (p.Cys514Ter)	MUTYH		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 4, 2014)	criteria provided, single submitter	VCV000142786	1	45795077 - 45795078	1	45329405 - 45329406	142786	152500	rs587782716	NC_000001.11:45329404:GC:CT
NM_001128425.2(MUTYH):c.294del (p.Ser99fs)	MUTYH	S71fs, S82fs, S86fs, S96fs, S72fs, S85fs, S99fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000631361	1	45799139	1	45333467	631361	616123	rs1557486313	NC_000001.11:45333466:CCC:CC
NM_012222.2(MUTYH):c.1393_1394del (p.Thr465fs)	MUTYH	T441fs, T451fs, T468fs, T325fs, T348fs, T454fs, T465fs, T440fs, T455fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000486917	1	45796927 - 45796928	1	45331255 - 45331256	486917	472337	rs1553125075	NC_000001.11:45331254:GTG:G
NM_012222.2(MUTYH):c.1092_1110del (p.Arg365fs)	MUTYH	R340fs, R341fs, R354fs, R225fs, R248fs, R351fs, R355fs, R365fs, R368fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	VCV000224537	1	45797400 - 45797418	1	45331728 - 45331746	224537	226293	rs869312771	NC_000001.11:45331727:GGCAGAGCTCTCCTCCCTGGG:GG
NM_012222.2(MUTYH):c.1232A>G (p.Gln411Arg)	MUTYH	Q400R, Q414R, Q271R, Q294R, Q397R, Q401R, Q386R, Q387R, Q411R	Neoplasm of stomach	Pathogenic(Last reviewed: Sep 2, 2004)	no assertion criteria provided	VCV000005299	1	45797174	1	45331502	5299	20338	rs121908383	NC_000001.11:45331501:T:C
NM_012222.2(MUTYH):c.1204C>T (p.Pro402Ser)	MUTYH	P391S, P405S, P378S, P392S, P402S, P262S, P285S, P377S, P388S	Neoplasm of stomach	Pathogenic(Last reviewed: Sep 2, 2004)	no assertion criteria provided	VCV000005298	1	45797202	1	45331530	5298	20337	rs121908382	NC_000001.11:45331529:G:A
NM_001128425.2(MUTYH):c.522G>A (p.Trp174Ter)	MUTYH	W171*, W146*, W157*, W174*, W54*, W147*, W31*, W161*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000825571	1	45798489	1	45332817	825571	806666		NC_000001.11:45332816:C:T
NM_001128425.2(MUTYH):c.521G>A (p.Trp174Ter)	MUTYH	W171*, W146*, W157*, W174*, W54*, W160*, W161*, W147*, W31*	not provided	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000801228	1	45798490	1	45332818	801228	789410		NC_000001.11:45332817:C:T
NM_001128425.1(MUTYH):c.338G>A (p.Trp113Ter)	MUTYH	W113*, W86*, W85*, W96*, W99*, W100*, W110*	MUTYH-associated polyposis|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000630488	1	45799095	1	45333423	630488	616121	rs888691362	NC_000001.11:45333422:C:T
NM_000530.8(MPZ):c.293G>A (p.Arg98His)	MPZ	R98H	Charcot-Marie-Tooth disease, demyelinating, type 1b|not provided|Decreased nerve conduction velocity|Pes cavus|Distal muscle weakness|Sensory neuropathy|Distal lower limb amyotrophy|Charcot-Marie-Tooth disease, type I	Pathogenic/Likely pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000014176	1	161276653	1	161306863	14176	29215	rs121913589	NC_000001.11:161306862:C:T
NM_000530.8(MPZ):c.188C>G (p.Ser63Cys)	MPZ	S63C	Dejerine-Sottas syndrome, autosomal dominant|not provided|Dejerine-Sottas disease|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014169	1	161277094	1	161307304	14169	29208	rs121913585	NC_000001.11:161307303:G:C
NM_012222.2(MUTYH):c.1092del (p.Arg365fs)	MUTYH	R368fs, R225fs, R340fs, R341fs, R248fs, R351fs, R354fs, R355fs, R365fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000491999	1	45797418	1	45331746	491999	483124	rs768130289	NC_000001.11:45331745:GGGGGG:GGGGG
NM_001130987.2(DYSF):c.4768del (p.Ile1590fs)	DYSF	I1537fs, I1559fs, I1572fs, I1589fs, I1551fs, I1568fs, I1583fs, I1569fs, I1573fs, I1590fs, I1538fs, I1552fs, I1558fs, I1582fs	not provided	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000598034	2	71886017	2	71658887	598034	589095	rs1179051248	NC_000002.12:71658886:AAAA:AAA
NM_001130987.2(DYSF):c.1589_1592dup (p.Phe532fs)	DYSF		not provided	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000596644	2	71778182 - 71778183	2	71551052 - 71551053	596644	587705	rs1559136308	NC_000002.12:71551052:TGGG:TGGGTGGG
NM_001130987.2(DYSF):c.2378G>A (p.Trp793Ter)	DYSF	W793*, W775*, W792*, W806*, W776*, W807*, W761*, W762*	not provided	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000596406	2	71789043	2	71561913	596406	587467	rs1559162681	NC_000002.12:71561912:G:A
NM_001130987.2(DYSF):c.1260del (p.Glu421fs)	DYSF	E389fs, E420fs, E390fs, E421fs	not provided	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000596405	2	71753459	2	71526329	596405	587466	rs1559079887	NC_000002.12:71526328:CC:C
NM_001130987.2(DYSF):c.3786_3787del (p.Ile1262fs)	DYSF	I1230fs, I1244fs, I1261fs, I1262fs, I1276fs, I1231fs, I1245fs, I1275fs	not provided	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000596079	2	71827860 - 71827861	2	71600730 - 71600731	596079	587140	rs1558583697	NC_000002.12:71600729:TCT:T
NM_001130987.2(DYSF):c.1493G>A (p.Trp498Ter)	DYSF	W466*, W498*, W467*, W497*	not provided	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000595797	2	71762441	2	71535311	595797	586859	rs1559100639	NC_000002.12:71535310:G:A
NM_001130987.2(DYSF):c.4843C>T (p.Gln1615Ter)	DYSF	Q1615*, Q1576*, Q1577*, Q1593*, Q1598*, Q1614*, Q1563*, Q1584*, Q1597*, Q1608*, Q1607*, Q1562*, Q1583*, Q1594*	not provided	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000595745	2	71886095	2	71658965	595745	586807	rs1163488527	NC_000002.12:71658964:C:T
NM_001130987.2(DYSF):c.5437dup (p.Leu1813fs)	DYSF		not provided	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000595345	2	71894620 - 71894621	2	71667490 - 71667491	595345	586407	rs769873428	NC_000002.12:71667490:CCCCC:CCCCCC
NM_001130987.2(DYSF):c.2760dup (p.Lys921fs)	DYSF		not provided	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000592961	2	71795360 - 71795361	2	71568230 - 71568231	592961	584025	rs1559177278	NC_000002.12:71568230:CCCC:CCCCC
NM_001130987.2(DYSF):c.5763del (p.Val1922fs)	DYSF	V1869fs, V1891fs, V1900fs, V1890fs, V1921fs, V1922fs, V1884fs, V1914fs, V1870fs, V1883fs, V1901fs, V1904fs, V1905fs, V1915fs	not provided	Pathogenic(Last reviewed: Apr 13, 2017)	criteria provided, single submitter	VCV000501302	2	71896854	2	71669724	501302	492726	rs1553416197	NC_000002.12:71669723:AA:A
NM_001130987.2(DYSF):c.6139G>T (p.Glu2047Ter)	DYSF	E2008*, E2047*, E1995*, E2009*, E2016*, E2025*, E2029*, E2039*, E2040*, E2046*, E2015*, E1994*, E2026*, E2030*	not provided	Pathogenic(Last reviewed: Mar 28, 2017)	criteria provided, single submitter	VCV000501041	2	71908206	2	71681076	501041	492465	rs886043489	NC_000002.12:71681075:G:T
NM_001130987.2(DYSF):c.889-2A>G	DYSF		not provided	Pathogenic(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	VCV000500814	2	71743308	2	71516178	500814	492238	rs934428561	NC_000002.12:71516177:A:G
NM_001130987.2(DYSF):c.1093_1094del (p.Ala365fs)	DYSF	A334fs, A333fs, A364fs, A365fs	not provided	Pathogenic(Last reviewed: Mar 5, 2017)	criteria provided, single submitter	VCV000500700	2	71747978 - 71747979	2	71520848 - 71520849	500700	492124	rs1553525756	NC_000002.12:71520847:GC:
NM_001130987.2(DYSF):c.4317dup (p.Ile1440fs)	DYSF		not provided	Pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, single submitter	VCV000500404	2	71839864 - 71839865	2	71612734 - 71612735	500404	491828	rs1553383144	NC_000002.12:71612734:CC:CCC
NM_001130987.2(DYSF):c.2826G>A (p.Trp942Ter)	DYSF	W924*, W942*, W941*, W910*, W925*, W911*, W955*, W956*	not provided	Pathogenic(Last reviewed: Dec 28, 2016)	criteria provided, single submitter	VCV000499543	2	71795430	2	71568300	499543	490967	rs1553553888	NC_000002.12:71568299:G:A
NM_001130987.2(DYSF):c.3824G>A (p.Trp1275Ter)	DYSF	W1257*, W1275*, W1289*, W1244*, W1274*, W1258*, W1288*, W1243*	not provided	Pathogenic(Last reviewed: Dec 10, 2016)	criteria provided, single submitter	VCV000498955	2	71827899	2	71600769	498955	490379	rs1553376538	NC_000002.12:71600768:G:A
NM_001130987.2(DYSF):c.2864+2T>A	DYSF		not provided	Pathogenic(Last reviewed: Dec 28, 2016)	criteria provided, single submitter	VCV000498750	2	71795470	2	71568340	498750	490174	rs1553553943	NC_000002.12:71568339:T:A
NM_001130987.2(DYSF):c.2948G>A (p.Trp983Ter)	DYSF	W965*, W983*, W966*, W996*, W952*, W982*, W997*, W951*	not provided	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000498353	2	71797033	2	71569903	498353	489777	rs1268594965	NC_000002.12:71569902:G:A
NM_001130987.2(DYSF):c.2088del (p.Ile699fs)	DYSF	I682fs, I698fs, I699fs, I681fs, I667fs, I668fs, I712fs, I713fs	not provided	Pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, single submitter	VCV000497135	2	71781040	2	71553910	497135	274466	rs886044390	NC_000002.12:71553909:G:
NM_001130987.2(DYSF):c.995del (p.Glu332fs)	DYSF	E332fs, E301fs, E300fs, E331fs	not provided	Pathogenic(Last reviewed: Aug 10, 2016)	criteria provided, single submitter	VCV000497134	2	71744162	2	71517032	497134	274458	rs886044386	NC_000002.12:71517031:A:
NM_001130987.1(DYSF):c.1696dup (p.Glu566Glyfs)	DYSF		not provided	Pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, single submitter	VCV000497132	2	71778735 - 71778736	2	71551605 - 71551606	497132	488556	rs398123772	NC_000002.12:71551605:GGGGG:GGGGGG
NM_001130987.2(DYSF):c.1267_1276+4dup	DYSF		not provided	Pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, single submitter	VCV000497129	2	71753465 - 71753466	2	71526335 - 71526336	497129	488553	rs1553529974	NC_000002.12:71526335:CTTGCCGCAGAGTGC:CTTGCCGCAGAGTGCTTGCCGCAGAGTGC
NM_001130987.2(DYSF):c.3941C>G (p.Ser1314Ter)	DYSF	S1296*, S1314*, S1297*, S1313*, S1327*, S1328*, S1282*, S1283*	not provided	Pathogenic(Last reviewed: Nov 4, 2016)	criteria provided, single submitter	VCV000497116	2	71829919	2	71602789	497116	488540	rs1553377740	NC_000002.12:71602788:C:G
NM_001130987.2(DYSF):c.5546+2T>A	DYSF		not provided	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000489283	2	71895974	2	71668844	489283	481661	rs1553415233	NC_000002.12:71668843:T:A
NM_001130987.2(DYSF):c.6021G>A (p.Trp2007Ter)	DYSF	W1968*, W2007*, W1954*, W1955*, W1969*, W1989*, W1990*, W1975*, W1986*, W2000*, W1985*, W1999*, W1976*, W2006*	not provided	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000489098	2	71906323	2	71679193	489098	481662	rs1553420848	NC_000002.12:71679192:G:A
NM_001130987.2(DYSF):c.1149+5G>A	DYSF		not provided	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000488834	2	71748039	2	71520909	488834	481660	rs1023002894	NC_000002.12:71520908:G:A
NM_001130987.2(DYSF):c.1273C>T (p.Gln425Ter)	DYSF	Q393*, Q425*, Q424*, Q394*	not provided	Pathogenic(Last reviewed: Jun 10, 2016)	criteria provided, single submitter	VCV000429885	2	71753473	2	71526343	429885	421399	rs1131691651	NC_000002.12:71526342:C:T
NM_001130987.2(DYSF):c.1577-1655C>G	DYSF	S506*, S507*, S537*, S538*	not provided	Pathogenic(Last reviewed: Aug 11, 2016)	criteria provided, single submitter	VCV000290283	2	71776516	2	71549386	290283	274520	rs886044410	NC_000002.12:71549385:C:G
NM_001130987.2(DYSF):c.757C>T (p.Gln253Ter)	DYSF	Q221*, Q253*, Q222*, Q252*	not provided	Pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, single submitter	VCV000290209	2	71741049	2	71513919	290209	274446	rs886044381	NC_000002.12:71513918:C:T
NM_001130987.2(DYSF):c.2217-1G>T	DYSF		not provided	Pathogenic(Last reviewed: Aug 18, 2016)	criteria provided, single submitter	VCV000290204	2	71788881	2	71561751	290204	274441	rs886044379	NC_000002.12:71561750:G:T
NM_001130987.2(DYSF):c.1167del (p.Ser390fs)	DYSF	S390fs, S358fs, S359fs, S389fs	not provided	Pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, single submitter	VCV000290141	2	71753364	2	71526234	290141	274378	rs886044355	NC_000002.12:71526233:CCCC:CCC
NM_001130987.2(DYSF):c.1576+1G>A	DYSF		not provided	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000289768	2	71766370	2	71539240	289768	274005	rs886044258	NC_000002.12:71539239:G:A
NM_001130987.2(DYSF):c.2344G>T (p.Glu782Ter)	DYSF	E764*, E782*, E751*, E765*, E781*, E796*, E750*, E795*	not provided	Pathogenic(Last reviewed: Jun 3, 2016)	criteria provided, single submitter	VCV000288442	2	71789009	2	71561879	288442	272679	rs886043901	NC_000002.12:71561878:G:T
NM_001130987.2(DYSF):c.6333del (p.Ala2111_Met2112insTer)	DYSF		not provided	Pathogenic(Last reviewed: May 31, 2016)	criteria provided, single submitter	VCV000288397	2	71913594	2	71686464	288397	272634	rs886043884	NC_000002.12:71686463:CC:C
NM_001130987.2(DYSF):c.1450-3_1450-2del	DYSF		not provided	Pathogenic(Last reviewed: Feb 9, 2016)	criteria provided, single submitter	VCV000286171	2	71762395 - 71762396	2	71535265 - 71535266	286171	270408	rs886043328	NC_000002.12:71535264:CA:
NM_001130987.2(DYSF):c.5004-1G>A	DYSF		not provided	Pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	VCV000285665	2	71891397	2	71664267	285665	269902	rs886043170	NC_000002.12:71664266:G:A
NM_001130987.2(DYSF):c.3757-2A>G	DYSF		not provided	Pathogenic(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	VCV000285590	2	71827830	2	71600700	285590	269827	rs886043149	NC_000002.12:71600699:A:G
NM_001130987.2(DYSF):c.888+2T>A	DYSF		not provided	Pathogenic(Last reviewed: Dec 14, 2015)	criteria provided, single submitter	VCV000284882	2	71742883	2	71515753	284882	269119	rs886042970	NC_000002.12:71515752:T:A
NM_001130987.2(DYSF):c.5458-1G>A	DYSF		not provided	Pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	VCV000284470	2	71895883	2	71668753	284470	268707	rs886042879	NC_000002.12:71668752:G:A
NM_001130987.2(DYSF):c.3421_3422del (p.Lys1141fs)	DYSF	K1124fs, K1141fs, K1154fs, K1123fs, K1140fs, K1155fs, K1109fs, K1110fs	not provided	Pathogenic(Last reviewed: Nov 11, 2015)	criteria provided, single submitter	VCV000284027	2	71816741 - 71816742	2	71589611 - 71589612	284027	268264	rs748542672	NC_000002.12:71589610:AA:
NM_001130987.2(DYSF):c.682dup (p.His228fs)	DYSF		not provided	Pathogenic(Last reviewed: Oct 9, 2015)	criteria provided, single submitter	VCV000283667	2	71740970 - 71740971	2	71513840 - 71513841	283667	267904	rs886042680	NC_000002.12:71513840:CCCC:CCCCC
NM_001130987.2(DYSF):c.6064-1G>C	DYSF		not provided	Pathogenic(Last reviewed: Sep 23, 2015)	criteria provided, single submitter	VCV000283475	2	71908130	2	71681000	283475	267712	rs886042636	NC_000002.12:71680999:G:C
NM_001130987.2(DYSF):c.4576G>T (p.Glu1526Ter)	DYSF	E1508*, E1526*, E1487*, E1509*, E1518*, E1495*, E1519*, E1473*, E1474*, E1494*, E1505*, E1488*, E1504*, E1525*	not provided	Pathogenic(Last reviewed: Sep 22, 2015)	criteria provided, single submitter	VCV000283471	2	71871143	2	71644013	283471	267708	rs886042635	NC_000002.12:71644012:G:T
NM_001130987.2(DYSF):c.1762C>T (p.Gln588Ter)	DYSF	Q570*, Q588*, Q587*, Q556*, Q557*, Q601*, Q571*, Q602*	not provided	Pathogenic(Last reviewed: Sep 22, 2015)	criteria provided, single submitter	VCV000283466	2	71778806	2	71551676	283466	267703	rs886042633	NC_000002.12:71551675:C:T
NM_001130987.2(DYSF):c.3483del (p.Cys1162fs)	DYSF	C1130fs, C1131fs, C1175fs, C1145fs, C1161fs, C1162fs, C1176fs, C1144fs	not provided	Pathogenic(Last reviewed: Sep 22, 2015)	criteria provided, single submitter	VCV000283465	2	71816802	2	71589672	283465	267702	rs886042632	NC_000002.12:71589671:CC:C
NM_001130987.2(DYSF):c.1033+2T>C	DYSF		not provided	Pathogenic(Last reviewed: Oct 6, 2015)	criteria provided, single submitter	VCV000283412	2	71747340	2	71520210	283412	267649	rs886042617	NC_000002.12:71520209:T:C
NM_001130987.2(DYSF):c.951+2T>G	DYSF		not provided	Pathogenic(Last reviewed: Sep 11, 2015)	criteria provided, single submitter	VCV000283267	2	71743374	2	71516244	283267	267504	rs886042590	NC_000002.12:71516243:T:G
NM_001130987.2(DYSF):c.5174+1G>A	DYSF		not provided	Pathogenic(Last reviewed: Sep 4, 2015)	criteria provided, single submitter	VCV000283233	2	71891569	2	71664439	283233	267470	rs886042581	NC_000002.12:71664438:G:A
NM_003494.3(DYSF):c.3504dup (p.Lys1169Glnfs)	DYSF		not provided	Pathogenic(Last reviewed: Aug 25, 2015)	criteria provided, single submitter	VCV000282861	2	71817401 - 71817402	2	71590271 - 71590272	282861	267098	rs886042504	NC_000002.12:71590271:C:CC
NM_001130987.2(DYSF):c.4911+1G>T	DYSF		not provided	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000282513	2	71886164	2	71659034	282513	266750	rs777216777	NC_000002.12:71659033:G:T
NM_001130987.2(DYSF):c.6099_6106dup (p.His2036fs)	DYSF		not provided	Pathogenic(Last reviewed: Jul 23, 2015)	criteria provided, single submitter	VCV000282134	2	71908165 - 71908166	2	71681035 - 71681036	282134	266371	rs886042318	NC_000002.12:71681035:GAGTGAGC:GAGTGAGCGAGTGAGC
NM_001130987.2(DYSF):c.4144C>T (p.Gln1382Ter)	DYSF	Q1364*, Q1382*, Q1381*, Q1365*, Q1350*, Q1351*, Q1395*, Q1396*	not provided	Pathogenic(Last reviewed: Jan 26, 2016)	criteria provided, single submitter	VCV000281072	2	71838679	2	71611549	281072	265309	rs886042095	NC_000002.12:71611548:C:T
NM_001130987.2(DYSF):c.1372G>A (p.Gly458Arg)	DYSF	G426R, G458R, G427R, G457R	not provided	Pathogenic(Last reviewed: Jan 15, 2016)	criteria provided, single submitter	VCV000281067	2	71755523	2	71528393	281067	265304	rs886042093	NC_000002.12:71528392:G:A
NM_001130987.2(DYSF):c.3284G>A (p.Trp1095Ter)	DYSF	W1077*, W1095*, W1094*, W1078*, W1109*, W1063*, W1064*, W1108*	not provided	Pathogenic(Last reviewed: Nov 20, 2014)	criteria provided, single submitter	VCV000196625	2	71801383	2	71574253	196625	193786	rs794727534	NC_000002.12:71574252:G:A
NM_001130987.2(DYSF):c.2010G>A (p.Trp670Ter)	DYSF	W652*, W670*, W683*, W639*, W653*, W669*, W638*, W684*	not provided	Pathogenic(Last reviewed: Mar 17, 2015)	criteria provided, single submitter	VCV000195597	2	71780962	2	71553832	195597	192758	rs794727343	NC_000002.12:71553831:G:A
NM_001130987.2(DYSF):c.1985-2del	DYSF		not provided	Pathogenic(Last reviewed: Apr 13, 2015)	criteria provided, single submitter	VCV000195596	2	71780935	2	71553805	195596	192757	rs774047700	NC_000002.12:71553804:A:
NM_001130987.2(DYSF):c.6063+1G>A	DYSF		not provided	Pathogenic(Last reviewed: Jun 14, 2013)	criteria provided, single submitter	VCV000094349	2	71906366	2	71679236	94349	100249	rs398123798	NC_000002.12:71679235:G:A
NM_001130987.2(DYSF):c.5761C>T (p.Gln1921Ter)	DYSF	Q1882*, Q1903*, Q1921*, Q1900*, Q1904*, Q1868*, Q1920*, Q1883*, Q1889*, Q1899*, Q1914*, Q1869*, Q1890*, Q1913*	not provided	Pathogenic(Last reviewed: Oct 30, 2013)	criteria provided, single submitter	VCV000094342	2	71896853	2	71669723	94342	100242	rs398123795	NC_000002.12:71669722:C:T
NM_001130987.2(DYSF):c.5614G>T (p.Glu1872Ter)	DYSF	E1833*, E1854*, E1872*, E1819*, E1851*, E1855*, E1864*, E1865*, E1871*, E1841*, E1850*, E1834*, E1840*, E1820*	not provided	Pathogenic(Last reviewed: Jun 14, 2013)	criteria provided, single submitter	VCV000094339	2	71896309	2	71669179	94339	100239	rs201592500	NC_000002.12:71669178:G:T
NM_001130987.2(DYSF):c.5546+1G>T	DYSF		not provided	Pathogenic(Last reviewed: Oct 16, 2015)	criteria provided, single submitter	VCV000094337	2	71895973	2	71668843	94337	100237	rs398123793	NC_000002.12:71668842:G:T
NM_001130987.2(DYSF):c.5458-2A>C	DYSF		not provided	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000094336	2	71895882	2	71668752	94336	100236	rs398123792	NC_000002.12:71668751:A:C
NM_001130987.2(DYSF):c.5011G>T (p.Glu1671Ter)	DYSF	E1632*, E1653*, E1671*, E1650*, E1619*, E1639*, E1664*, E1618*, E1640*, E1654*, E1670*, E1633*, E1649*, E1663*	not provided	Pathogenic(Last reviewed: Dec 10, 2012)	criteria provided, single submitter	VCV000094333	2	71891405	2	71664275	94333	100233	rs398123790	NC_000002.12:71664274:G:T
NM_001130987.2(DYSF):c.396_397del (p.Leu133fs)	DYSF	L133fs, L132fs	not provided	Pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, single submitter	VCV000094313	2	71738985 - 71738986	2	71511855 - 71511856	94313	100213	rs398123784	NC_000002.12:71511854:CCCC:CC
NM_001130987.2(DYSF):c.3695del (p.Pro1232fs)	DYSF	P1201fs, P1200fs, P1215fs, P1232fs, P1245fs, P1214fs, P1231fs, P1246fs	not provided	Pathogenic(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	VCV000094309	2	71825813	2	71598683	94309	100209	rs398123783	NC_000002.12:71598682:CC:C
NM_001130987.2(DYSF):c.3379_3380GT[1] (p.Phe1128fs)	DYSF		not provided	Pathogenic(Last reviewed: Oct 17, 2012)	criteria provided, single submitter	VCV000094303	2	71801477 - 71801478	2	71574347 - 71574348	94303	100203	rs398123780	NC_000002.12:71574346:TGTGT:TGT
NM_001130987.2(DYSF):c.2924_2928del (p.Gln975fs)	DYSF	Q943fs, Q975fs, Q988fs, Q989fs, Q944fs, Q958fs, Q957fs, Q974fs	not provided	Pathogenic(Last reviewed: Apr 8, 2013)	criteria provided, single submitter	VCV000094296	2	71797006 - 71797010	2	71569876 - 71569880	94296	100196	rs398123777	NC_000002.12:71569875:ACCAGACC:ACC
NM_001130987.2(DYSF):c.2923C>T (p.Gln975Ter)	DYSF	Q957*, Q975*, Q974*, Q988*, Q943*, Q989*, Q944*, Q958*	not provided	Pathogenic(Last reviewed: Jun 19, 2013)	criteria provided, single submitter	VCV000094295	2	71797008	2	71569878	94295	100195	rs398123776	NC_000002.12:71569877:C:T
NM_001130987.2(DYSF):c.2406_2409+1del	DYSF		not provided	Pathogenic(Last reviewed: Oct 8, 2013)	criteria provided, single submitter	VCV000094287	2	71789071 - 71789075	2	71561941 - 71561945	94287	100187	rs398123774	NC_000002.12:71561940:GGAGG:
NM_001130987.2(DYSF):c.2365C>T (p.Gln789Ter)	DYSF	Q771*, Q789*, Q757*, Q788*, Q802*, Q803*, Q758*, Q772*	not provided	Pathogenic(Last reviewed: Apr 8, 2013)	criteria provided, single submitter	VCV000094286	2	71789030	2	71561900	94286	100186	rs398123773	NC_000002.12:71561899:C:T
NM_003494.3(DYSF):c.1642delG (p.Glu548Lysfs)	DYSF		not provided	Pathogenic(Last reviewed: Sep 5, 2012)	criteria provided, single submitter	VCV000094277	2	71778740	2	71551606	94277	100177	rs398123772	
NM_001130987.2(DYSF):c.1692+2T>A	DYSF		not provided	Pathogenic(Last reviewed: Sep 5, 2012)	criteria provided, single submitter	VCV000094276	2	71778288	2	71551158	94276	100176	rs398123771	NC_000002.12:71551157:T:A
NM_001130987.2(DYSF):c.1494-2A>G	DYSF		not provided	Pathogenic(Last reviewed: Dec 10, 2012)	criteria provided, single submitter	VCV000094273	2	71766285	2	71539155	94273	100173	rs398123769	NC_000002.12:71539154:A:G
NM_001130987.2(DYSF):c.2524del (p.Cys842fs)	DYSF	C810fs, C811fs, C841fs, C855fs, C825fs, C824fs, C842fs, C856fs	Absent muscle fiber dysferlin|Distal lower limb muscle weakness|Peroneal muscle atrophy|Foot dorsiflexor weakness	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523461	2	71791302	2	71564172	523461	513931	rs1553551006	NC_000002.12:71564171:T:
NM_001130987.2(DYSF):c.2302C>T (p.Gln768Ter)	DYSF	Q750*, Q768*, Q737*, Q781*, Q782*, Q751*, Q767*, Q736*	not provided	Pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000498566	2	71788967	2	71561837	498566	489990	rs1027145211	NC_000002.12:71561836:C:T
NM_001130987.2(DYSF):c.2550_2553del (p.Thr851fs)	DYSF	T819fs, T820fs, T834fs, T851fs, T864fs, T833fs, T850fs, T865fs	not provided	Pathogenic(Last reviewed: Apr 19, 2017)	criteria provided, single submitter	VCV000496872	2	71791325 - 71791328	2	71564195 - 71564198	496872	488296	rs755849745	NC_000002.12:71564194:ACAGACA:ACA
NM_001130987.2(DYSF):c.5646G>A (p.Trp1882Ter)	DYSF	W1882*, W1843*, W1829*, W1850*, W1860*, W1851*, W1864*, W1861*, W1865*, W1874*, W1875*, W1881*, W1830*, W1844*	not provided	Pathogenic(Last reviewed: Nov 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000288647	2	71896738	2	71669608	288647	272884	rs886043966	NC_000002.12:71669607:G:A
NM_001130987.2(DYSF):c.2442G>A (p.Trp814Ter)	DYSF	W813*, W782*, W783*, W797*, W796*, W814*, W827*, W828*	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000864338	2	71791220	2	71564090	864338	826942		NC_000002.12:71564089:G:A
NM_001130987.2(DYSF):c.306del (p.Phe102fs)	DYSF	F102fs, F101fs	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000863635	2	71730410	2	71503280	863635	826928		NC_000002.12:71503279:C:
NM_001130987.2(DYSF):c.2648dup (p.Glu884fs)	DYSF		Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000856589	2	71795161 - 71795162	2	71568031 - 71568032	856589	826944		NC_000002.12:71568031:AA:AAA
NM_001130987.2(DYSF):c.2986G>T (p.Glu996Ter)	DYSF	E965*, E1009*, E996*, E1010*, E964*, E978*, E995*, E979*	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000850419	2	71797365	2	71570235	850419	826948		NC_000002.12:71570234:G:T
NM_001130987.2(DYSF):c.1117del (p.Leu373fs)	DYSF	L373fs, L341fs, L342fs, L372fs	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000848060	2	71748001	2	71520871	848060	826934		NC_000002.12:71520870:CC:C
NM_001130987.2(DYSF):c.1213_1250del (p.Gly405fs)	DYSF	G374fs, G373fs, G404fs, G405fs	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, single submitter	VCV000841065	2	71753413 - 71753450	2	71526283 - 71526320	841065	826935		NC_000002.12:71526282:GGCGTAGCCCTGCGAGGAGCCCACTTCTGCCTGAAGGT:
NM_001130987.2(DYSF):c.6166del (p.Asp2056fs)	DYSF	D2035fs, D2004fs, D2034fs, D2038fs, D2049fs, D2003fs, D2017fs, D2018fs, D2024fs, D2048fs, D2056fs, D2025fs, D2039fs, D2055fs	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000666025	2	71908232	2	71681102	666025	630468		NC_000002.12:71681101:GG:G
NM_001130987.2(DYSF):c.4444G>T (p.Glu1482Ter)	DYSF	E1465*, E1464*, E1481*, E1482*, E1450*, E1451*, E1495*, E1496*	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000665762	2	71840520	2	71613390	665762	630456		NC_000002.12:71613389:G:T
NC_000002.11:g.(?_71708003)_(71709110_?)del	DYSF		Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV000659607	2	71708003 - 71709110	2	71480873 - 71481980	659607	650880		
NC_000002.11:g.(?_71795071)_(71797474_?)del	DYSF		Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000655241	2	71795071 - 71797474	2	71567941 - 71570344	655241	650882		
NM_001130987.2(DYSF):c.1922del (p.Lys641fs)	DYSF	K609fs, K640fs, K655fs, K610fs, K624fs, K623fs, K641fs, K654fs	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000654135	2	71780255	2	71553125	654135	630429		NC_000002.12:71553124:AA:A
NM_001130987.2(DYSF):c.3270_3271CT[2] (p.Leu1092fs)	DYSF		Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000653601	2	71801369 - 71801370	2	71574239 - 71574240	653601	630442		NC_000002.12:71574238:CTCTCT:CTCT
NM_001130987.2(DYSF):c.4153C>T (p.Gln1385Ter)	DYSF	Q1399*, Q1368*, Q1384*, Q1385*, Q1398*, Q1353*, Q1354*, Q1367*	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Jan 6, 2019)	criteria provided, single submitter	VCV000647109	2	71838688	2	71611558	647109	630449		NC_000002.12:71611557:C:T
NM_001130987.2(DYSF):c.4418_4419dup (p.Val1474fs)	DYSF		Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000644959	2	71840493 - 71840494	2	71613363 - 71613364	644959	630453		NC_000002.12:71613363:AC:ACAC
NM_001130987.2(DYSF):c.2070del (p.Ile690fs)	DYSF	I659fs, I703fs, I704fs, I658fs, I672fs, I673fs, I690fs, I689fs	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Jul 21, 2018)	criteria provided, single submitter	VCV000642604	2	71781022	2	71553892	642604	630430		NC_000002.12:71553891:C:
NM_001130987.2(DYSF):c.3361A>T (p.Lys1121Ter)	DYSF	K1103*, K1121*, K1134*, K1090*, K1120*, K1089*, K1135*, K1104*	not provided	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000597804	2	71801460	2	71574330	597804	588865	rs1558513494	NC_000002.12:71574329:A:T
NM_001130987.2(DYSF):c.1834_1835del (p.Leu612fs)	DYSF	L594fs, L581fs, L580fs, L595fs, L612fs, L611fs, L625fs, L626fs	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Mar 2, 2018)	criteria provided, single submitter	VCV000579639	2	71780168 - 71780169	2	71553038 - 71553039	579639	558632	rs1559141367	NC_000002.12:71553037:CT:
NM_001130987.2(DYSF):c.4909A>T (p.Lys1637Ter)	DYSF	K1598*, K1637*, K1605*, K1606*, K1616*, K1636*, K1599*, K1620*, K1630*, K1584*, K1619*, K1585*, K1615*, K1629*	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, single submitter	VCV000574900	2	71886161	2	71659031	574900	561929	rs1558750788	NC_000002.12:71659030:A:T
NM_001130987.2(DYSF):c.5086G>T (p.Glu1696Ter)	DYSF	E1657*, E1696*, E1664*, E1678*, E1679*, E1695*, E1643*, E1644*, E1665*, E1674*, E1675*, E1688*, E1658*, E1689*	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000574059	2	71891480	2	71664350	574059	561931	rs368142107	NC_000002.12:71664349:G:T
NM_001130987.2(DYSF):c.6141_6151del (p.Pro2048_Asn2049insTer)	DYSF		Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: May 20, 2018)	criteria provided, single submitter	VCV000573478	2	71908204 - 71908214	2	71681074 - 71681084	573478	558640	rs1558817973	NC_000002.12:71681073:ATGAGCCCAACATGA:ATGA
NM_001130987.2(DYSF):c.730del (p.Leu244fs)	DYSF	L244fs, L212fs, L213fs, L243fs	Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Dec 18, 2017)	no assertion criteria provided	VCV000523646	2	71741022	2	71513892	523646	514294	rs1553521119	NC_000002.12:71513891:C:
NM_001130987.2(DYSF):c.5976_5977inv (p.Glu1993Ter)	DYSF		Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, single submitter	VCV000471321	2	71906278 - 71906279	2	71679148 - 71679149	471321	451765		NC_000002.12:71679147:AG:CT
NM_001130987.2(DYSF):c.5467C>T (p.Gln1823Ter)	DYSF	Q1784*, Q1823*, Q1791*, Q1792*, Q1801*, Q1802*, Q1806*, Q1822*, Q1770*, Q1771*, Q1815*, Q1816*, Q1785*, Q1805*	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000471317	2	71895893	2	71668763	471317	451762	rs1553415109	NC_000002.12:71668762:C:T
NM_001130987.2(DYSF):c.4590C>A (p.Cys1530Ter)	DYSF	C1491*, C1530*, C1477*, C1512*, C1523*, C1478*, C1498*, C1499*, C1508*, C1509*, C1492*, C1513*, C1522*, C1529*	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000471307	2	71871157	2	71644027	471307	451607	rs778185705	NC_000002.12:71644026:C:A
NM_001130987.2(DYSF):c.1766_1767insTTCT (p.Lys589fs)	DYSF		Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000471281	2	71778810 - 71778811	2	71551680 - 71551681	471281	451565	rs1553542773	NC_000002.12:71551680::TTCT
NM_001130987.2(DYSF):c.5642G>A (p.Gly1881Asp)	DYSF	G1828D, G1842D, G1881D, G1860D, G1863D, G1880D, G1843D, G1849D, G1864D, G1873D, G1874D, G1829D, G1850D, G1859D	Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: May 29, 2017)	no assertion criteria provided	VCV000430739	2	71896337	2	71669207	430739	424285	rs1131692158	NC_000002.12:71669206:G:A
NM_001130987.2(DYSF):c.1576G>T (p.Val526Leu)	DYSF	V526L, E494*, E525*, V495L, E495*, E526*, V494L, V525L	not provided	Pathogenic(Last reviewed: Sep 27, 2016)	criteria provided, multiple submitters, no conflicts	VCV000290700	2	71766369	2	71539239	290700	274937	rs886044537	NC_000002.12:71539238:G:T
NM_001130987.2(DYSF):c.4614del (p.Phe1538fs)	DYSF	F1485fs, F1531fs, F1506fs, F1530fs, F1486fs, F1516fs, F1517fs, F1520fs, F1521fs, F1499fs, F1500fs, F1507fs, F1537fs, F1538fs	not provided	Pathogenic(Last reviewed: Mar 4, 2017)	criteria provided, single submitter	VCV000283205	2	71871178	2	71644048	283205	267442	rs886042578	NC_000002.12:71644047:TTTT:TTT
NM_001130987.2(DYSF):c.5383C>T (p.Gln1795Ter)	DYSF	Q1756*, Q1795*, Q1764*, Q1778*, Q1787*, Q1794*, Q1757*, Q1773*, Q1774*, Q1743*, Q1763*, Q1777*, Q1788*, Q1742*	not provided	Pathogenic(Last reviewed: Feb 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000167026	2	71894571	2	71667441	167026	177085	rs727503912	NC_000002.12:71667440:C:T
NM_001130987.2(DYSF):c.3756T>A (p.Tyr1252Ter)	DYSF	Y1265*, Y1234*, Y1252*, Y1220*, Y1221*, Y1251*, Y1235*, Y1266*	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, single submitter	VCV000857602	2	71825875	2	71598745	857602	826954		NC_000002.12:71598744:T:A
NM_001130987.2(DYSF):c.148-1G>A	DYSF		Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV000856717	2	71709008	2	71481878	856717	850875		NC_000002.12:71481877:G:A
NM_001130987.2(DYSF):c.5311G>T (p.Glu1771Ter)	DYSF	E1719*, E1749*, E1754*, E1770*, E1771*, E1753*, E1733*, E1750*, E1718*, E1732*, E1739*, E1740*, E1763*, E1764*	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000853605	2	71892428	2	71665298	853605	826964		NC_000002.12:71665297:G:T
NM_001130987.2(DYSF):c.4248C>A (p.Cys1416Ter)	DYSF	C1399*, C1385*, C1416*, C1415*, C1429*, C1384*, C1398*, C1430*	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000841556	2	71839797	2	71612667	841556	826959		NC_000002.12:71612666:C:A
NM_001130987.2(DYSF):c.1965C>A (p.Tyr655Ter)	DYSF	Y624*, Y654*, Y655*, Y669*, Y623*, Y638*, Y668*, Y637*	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000837580	2	71780299	2	71553169	837580	826939		NC_000002.12:71553168:C:A
NM_001130987.2(DYSF):c.5850G>A (p.Trp1950Ter)	DYSF	W1919*, W1932*, W1933*, W1942*, W1949*, W1918*, W1928*, W1929*, W1943*, W1950*, W1912*, W1897*, W1898*, W1911*	Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Sep 27, 2019)	criteria provided, single submitter	VCV000694065	2	71901392	2	71674262	694065	681871		NC_000002.12:71674261:G:A
NM_001130987.2(DYSF):c.4216G>T (p.Glu1406Ter)	DYSF	E1375*, E1389*, E1420*, E1374*, E1419*, E1388*, E1405*, E1406*	Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000694000	2	71838751	2	71611621	694000	681819		NC_000002.12:71611620:G:T
NM_001130987.2(DYSF):c.1000del (p.Arg334fs)	DYSF	R334fs, R302fs, R303fs, R333fs	Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000693997	2	71744166	2	71517036	693997	681816		NC_000002.12:71517035:CC:C
NM_001130987.2(DYSF):c.5757del (p.Glu1920fs)	DYSF	E1867fs, E1868fs, E1881fs, E1882fs, E1888fs, E1889fs, E1898fs, E1899fs, E1902fs, E1903fs, E1912fs, E1913fs, E1919fs, E1920fs	Miyoshi muscular dystrophy 1	Pathogenic	criteria provided, single submitter	VCV000689493	2	71896849	2	71669719	689493	677130		NC_000002.12:71669718:T:
NM_001130987.2(DYSF):c.3859dup (p.Glu1287fs)	DYSF		Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000646166	2	71827929 - 71827930	2	71600799 - 71600800	646166	630447		NC_000002.12:71600799:GGGGG:GGGGGG
NC_000002.11:g.(?_71906177)_(71906375_?)del	DYSF		Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV000640452	2	71906177 - 71906375	2	71679047 - 71679245	640452	650888		
NM_001130987.2(DYSF):c.2473C>T (p.Gln825Ter)	DYSF	Q807*, Q825*, Q793*, Q808*, Q824*, Q838*, Q794*, Q839*	Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic	criteria provided, single submitter	VCV000638644	2	71791251	2	71564121	638644	626417		NC_000002.12:71564120:C:T
NM_001130987.2(DYSF):c.1149+3G>C	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000638642	2	71748037	2	71520907	638642	626412		NC_000002.12:71520906:G:C
NM_001130987.2(DYSF):c.5516_5517dup (p.Phe1840fs)	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000632557	2	71895940 - 71895941	2	71668810 - 71668811	632557	620944	rs1558783870	NC_000002.12:71668810:CCC:CCCCC
NM_001130987.2(DYSF):c.1560del (p.Gly521fs)	DYSF	G521fs, G490fs, G520fs, G489fs	Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623388	2	71766353	2	71539223	623388	612261	rs1456182703	NC_000002.12:71539222:T:
NM_001130987.2(DYSF):c.1562del (p.Gly521fs)	DYSF	G490fs, G521fs, G489fs, G520fs	Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623361	2	71766354	2	71539224	623361	612262	rs1559109621	NC_000002.12:71539223:GG:G
NM_001130987.2(DYSF):c.3741C>A (p.Tyr1247Ter)	DYSF	Y1229*, Y1247*, Y1215*, Y1260*, Y1216*, Y1246*, Y1230*, Y1261*	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Feb 19, 2018)	criteria provided, single submitter	VCV000575305	2	71825860	2	71598730	575305	558636	rs375160101	NC_000002.12:71598729:C:A
NM_001130987.2(DYSF):c.5724G>A (p.Trp1908Ter)	DYSF	W1908*, W1869*, W1856*, W1890*, W1876*, W1887*, W1870*, W1891*, W1901*, W1855*, W1877*, W1886*, W1900*, W1907*	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000571837	2	71896816	2	71669686	571837	561942	rs1558787893	NC_000002.12:71669685:G:A
NM_001130987.2(DYSF):c.361C>T (p.Gln121Ter)	DYSF	Q120*, Q121*	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000567525	2	71738952	2	71511822	567525	560915	rs1423123313	NC_000002.12:71511821:C:T
NM_001130987.2(DYSF):c.3859G>T (p.Glu1287Ter)	DYSF	E1287*, E1269*, E1300*, E1256*, E1270*, E1301*, E1255*, E1286*	Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: May 9, 2018)	criteria provided, single submitter	VCV000558274	2	71827934	2	71600804	558274	542357	rs763674597	NC_000002.12:71600803:G:T
NM_001130987.2(DYSF):c.4042C>T (p.Gln1348Ter)	DYSF	Q1348*, Q1330*, Q1316*, Q1317*, Q1362*, Q1331*, Q1347*, Q1361*	Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Sep 24, 2017)	criteria provided, single submitter	VCV000554013	2	71838459	2	71611329	554013	542269	rs778092738	NC_000002.12:71611328:C:T
NM_001130987.2(DYSF):c.1577-2A>G	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000552023	2	71778169	2	71551039	552023	542335	rs1553542142	NC_000002.12:71551038:A:G
NM_001130987.2(DYSF):c.2548C>T (p.Gln850Ter)	DYSF	Q850*, Q832*, Q833*, Q818*, Q819*, Q849*, Q863*, Q864*	Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000551845	2	71791326	2	71564196	551845	542174	rs199543257	NC_000002.12:71564195:C:T
NM_001130987.2(DYSF):c.951+1del	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000006684	2	71743372	2	71516242	6684	21723	rs786200898	NC_000002.12:71516241:GG:G
NM_001130987.2(DYSF):c.1381-2A>G	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000006683	2	71762149	2	71535019	6683	21722	rs786200897	NC_000002.12:71535018:A:G
NM_001130987.2(DYSF):c.3497-33A>G	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Apr 11, 2006)	no assertion criteria provided	VCV000006680	2	71817308	2	71590178	6680	21719	rs786205083	NC_000002.12:71590177:A:G
NM_001130987.2(DYSF):c.5318A>G (p.Glu1773Gly)	DYSF	E1734G, E1755G, E1773G, E1741G, E1742G, E1751G, E1720G, E1721G, E1766G, E1772G, E1756G, E1765G, E1735G, E1752G	Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Apr 17, 2007)	no assertion criteria provided	VCV000006678	2	71894506	2	71667376	6678	21717	rs121908961	NC_000002.12:71667375:A:G
NM_001130987.2(DYSF):c.1927G>T (p.Asp643Tyr)	DYSF	D625Y, D643Y, D626Y, D611Y, D612Y, D642Y, D656Y, D657Y	Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Apr 17, 2007)	no assertion criteria provided	VCV000006677	2	71780261	2	71553131	6677	21716	rs121908960	NC_000002.12:71553130:G:T
NM_001130987.2(DYSF):c.5174+5G>A	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Apr 10, 2000)	no assertion criteria provided	VCV000006672	2	71891573	2	71664443	6672	21711	rs745891180	NC_000002.12:71664442:G:A
NM_001130987.2(DYSF):c.5405del (p.Glu1802fs)	DYSF	E1749fs, E1763fs, E1781fs, E1794fs, E1795fs, E1770fs, E1750fs, E1764fs, E1784fs, E1801fs, E1771fs, E1780fs, E1785fs, E1802fs	Autosomal recessive limb-girdle muscular dystrophy type 2B|Myopathy, distal, with anterior tibial onset|Miyoshi muscular dystrophy 1	Pathogenic(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV000834073	2	71894593	2	71667463	834073	822324		NC_000002.12:71667462:A:
NM_001130987.2(DYSF):c.4179del (p.Lys1394fs)	DYSF	K1376fs, K1408fs, K1362fs, K1377fs, K1394fs, K1407fs, K1393fs, K1363fs	Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000638577	2	71838713	2	71611583	638577	626364		NC_000002.12:71611582:GG:G
NM_001130987.2(DYSF):c.3655C>T (p.Gln1219Ter)	DYSF	Q1201*, Q1219*, Q1202*, Q1187*, Q1218*, Q1233*, Q1188*, Q1232*	Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000557310	2	71825774	2	71598644	557310	542266	rs1380642629	NC_000002.12:71598643:C:T
NM_001130987.2(DYSF):c.2698-2A>G	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000556235	2	71795300	2	71568170	556235	542176	rs1420930684	NC_000002.12:71568169:A:G
NM_001130987.2(DYSF):c.4221+1G>C	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000555431	2	71838757	2	71611627	555431	542105	rs1474151297	NC_000002.12:71611626:G:C
NM_001130987.2(DYSF):c.6252G>A (p.Trp2084Ter)	DYSF	W2045*, W2084*, W2053*, W2062*, W2066*, W2046*, W2076*, W2077*, W2031*, W2032*, W2052*, W2063*, W2067*, W2083*	Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000554672	2	71909738	2	71682608	554672	542298	rs1553422723	NC_000002.12:71682607:G:A
NM_001130987.2(DYSF):c.1350del (p.Phe451fs)	DYSF	F420fs, F451fs, F419fs, F450fs	Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, single submitter	VCV000551669	2	71755498	2	71528368	551669	542162	rs766936914	NC_000002.12:71528367:CCCC:CCC
NM_003494.3(DYSF):c.3383dup (p.Met1128Ilefs)	DYSF		Qualitative or quantitative defects of dysferlin|not provided	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000502211	2	71816756 - 71816757	2	71589626 - 71589627	502211	493635	rs1553370437	NC_000002.12:71589626:T:TT
NM_001130987.2(DYSF):c.5938A>T (p.Lys1980Ter)	DYSF	K1941*, K1980*, K1927*, K1948*, K1958*, K1962*, K1972*, K1963*, K1928*, K1942*, K1949*, K1959*, K1973*, K1979*	Qualitative or quantitative defects of dysferlin|not provided	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000501036	2	71906240	2	71679110	501036	492460	rs1553420738	NC_000002.12:71679109:A:T
NM_001130987.2(DYSF):c.4135T>C (p.Cys1379Arg)	DYSF	C1361R, C1379R, C1393R, C1347R, C1362R, C1348R, C1378R, C1392R	not provided	Pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000500922	2	71838670	2	71611540	500922	492346	rs776472879	NC_000002.12:71611539:T:C
NM_001130987.1(DYSF):c.3105dup(p.Ile1036Hisfs)	DYSF		not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic/Likely pathogenic(Last reviewed: May 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000498619	2	71797746 - 71797747	2	71570616 - 71570617	498619	490043	rs756118312	NC_000002.12:71570616:CC:CCC
NM_001130987.2(DYSF):c.1812C>G (p.Tyr604Ter)	DYSF	Y586*, Y604*, Y587*, Y572*, Y573*, Y603*, Y617*, Y618*	not provided	Pathogenic(Last reviewed: Jan 17, 2017)	criteria provided, single submitter	VCV000447282	2	71780146	2	71553016	447282	440725	rs1553543506	NC_000002.12:71553015:C:G
NM_001130987.2(DYSF):c.5200C>T (p.Gln1734Ter)	DYSF	Q1695*, Q1734*, Q1681*, Q1727*, Q1682*, Q1716*, Q1726*, Q1696*, Q1712*, Q1717*, Q1702*, Q1703*, Q1713*, Q1733*	Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000290310	2	71892317	2	71665187	290310	274547	rs886044422	NC_000002.12:71665186:C:T
NM_001130987.2(DYSF):c.2426dup (p.Asp810fs)	DYSF		Qualitative or quantitative defects of dysferlin|not provided	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000285647	2	71791202 - 71791203	2	71564072 - 71564073	285647	269884	rs752479889	NC_000002.12:71564072:CC:CCC
NM_001130987.2(DYSF):c.4282C>T (p.Gln1428Ter)	DYSF	Q1410*, Q1428*, Q1396*, Q1397*, Q1427*, Q1441*, Q1411*, Q1442*	Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided	Pathogenic(Last reviewed: Dec 7, 2015)	criteria provided, single submitter	VCV000285153	2	71839831	2	71612701	285153	269390	rs769721856	NC_000002.12:71612700:C:T
NM_001130987.2(DYSF):c.2409+1G>A	DYSF		not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Aug 17, 2015)	criteria provided, single submitter	VCV000282771	2	71789075	2	71561945	282771	267008	rs151317754	NC_000002.12:71561944:G:A
NM_001130987.2(DYSF):c.1263_1276+1dup	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Jun 27, 2013)	criteria provided, single submitter	VCV000217221	2	71753462 - 71753463	2	71526332 - 71526333	217221	213807	rs863225019	NC_000002.12:71526332:GGACTTGCCGCAGAG:GGACTTGCCGCAGAGGGACTTGCCGCAGAG
NM_001130987.2(DYSF):c.886G>T (p.Glu296Ter)	DYSF	E264*, E296*, E265*, E295*	not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: May 13, 2015)	criteria provided, single submitter	VCV000198458	2	71742879	2	71515749	198458	195619	rs794727851	NC_000002.12:71515748:G:T
NM_001130987.2(DYSF):c.5156_5174+4dup	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000006670	2	71891547 - 71891548	2	71664417 - 71664418	6670	21709	rs786205082	NC_000002.12:71664417:ACTCCCACAGACCTACTGTGTGTAC:ACTCCCACAGACCTACTGTGTGTACTCCCACAGACCTACTGTGTGTAC
NM_000384.3(APOB):c.13059C>A (p.Cys4353Ter)	APOB	C4353*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000828175	2	21225235	2	21002363	828175	816444		NC_000002.12:21002362:G:T
NM_000384.3(APOB):c.2297_2298del (p.Lys766fs)	APOB	K766fs	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440529	2	21247943 - 21247944	2	21025071 - 21025072	440529	434179	rs1553385715	NC_000002.12:21025070:TTT:T
NM_000384.3(APOB):c.2786dup (p.Arg931fs)	APOB		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440528	2	21245732 - 21245733	2	21022860 - 21022861	440528	434178	rs1553385404	NC_000002.12:21022860:GGGG:GGGGG
NM_000384.3(APOB):c.10580G>T (p.Arg3527Leu)	APOB	R3527L	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440523	2	21229160	2	21006288	440523	434173	rs5742904	NC_000002.12:21006287:C:A
NM_000384.3(APOB):c.10724G>A (p.Gly3575Asp)	APOB	G3575D	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440519	2	21229016	2	21006144	440519	434169	rs1418775778	NC_000002.12:21006143:C:T
NM_000384.3(APOB):c.10739A>G (p.Asn3580Ser)	APOB	N3580S	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440518	2	21229001	2	21006129	440518	434168	rs762028704	NC_000002.12:21006128:T:C
NM_000384.3(APOB):c.10768G>A (p.Glu3590Lys)	APOB	E3590K	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440516	2	21228972	2	21006100	440516	434166	rs747606537	NC_000002.12:21006099:C:T
NM_000384.3(APOB):c.10808A>G (p.His3603Arg)	APOB	H3603R	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440515	2	21228932	2	21006060	440515	434165	rs370481987	NC_000002.12:21006059:T:C
NM_000384.3(APOB):c.13114C>T (p.Gln4372Ter)	APOB	Q4372*	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440512	2	21225180	2	21002308	440512	434162	rs1442815965	NC_000002.12:21002307:G:A
NM_000384.3(APOB):c.13126C>T (p.Gln4376Ter)	APOB	Q4376*	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440511	2	21225168	2	21002296	440511	434161	rs1553382326	NC_000002.12:21002295:G:A
NM_000384.3(APOB):c.13129_13130del (p.Ile4377fs)	APOB	I4377fs	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440510	2	21225164 - 21225165	2	21002292 - 21002293	440510	434160	rs1553382325	NC_000002.12:21002291:AT:
NM_000384.3(APOB):c.13135C>T (p.Gln4379Ter)	APOB	Q4379*	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440509	2	21225159	2	21002287	440509	434159	rs1553382319	NC_000002.12:21002286:G:A
NM_000384.3(APOB):c.13151T>C (p.Leu4384Pro)	APOB	L4384P	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440508	2	21225143	2	21002271	440508	434158	rs1339117465	NC_000002.12:21002270:A:G
NM_000384.3(APOB):c.13168G>C (p.Asp4390His)	APOB	D4390H	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440507	2	21225126	2	21002254	440507	434157	rs771015234	NC_000002.12:21002253:C:G
NM_000384.3(APOB):c.13196A>C (p.Lys4399Thr)	APOB	K4399T	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440506	2	21225098	2	21002226	440506	434156	rs1553382300	NC_000002.12:21002225:T:G
NM_000384.3(APOB):c.13220T>C (p.Ile4407Thr)	APOB	I4407T	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440505	2	21225074	2	21002202	440505	434155	rs1553382295	NC_000002.12:21002201:A:G
NM_000090.3(COL3A1):c.691-2A>G	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000651878	2	189854820	2	188990094	651878	650921		NC_000002.12:188990093:A:G
NM_000090.3(COL3A1):c.1610delG	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000101464	2	189860850	2	188996124	101464	107211	rs587779702	NC_000002.12:188996123:GGG:GG
NM_000090.3(COL3A1):c.2284-109_3489del (p.Gly762_Glu1175del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101405					101405	107151		
NM_000090.3(COL3A1):c.2933G>A (p.Gly978Asp)	COL3A1	G978D	Ehlers-Danlos syndrome, type 4|Seizures|Connective tissue nevi	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000101309	2	189870077	2	189005351	101309	107055	rs587779595	NC_000002.12:189005350:G:A
NM_000090.3(COL3A1):c.1150-1G>C (p.Gly384_Met398del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101220	2	189858763	2	188994037	101220	106965	rs587779520	NC_000002.12:188994036:G:C
NM_000090.3(COL3A1):c.2337+2T>C (p.Gly762_Lys779del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101213	2	189866178	2	189001452	101213	106958	rs587779513	NC_000002.12:189001451:T:C
NM_000090.3(COL3A1):c.3255+1G>A (p.Gly1068_Pro1085del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101175	2	189871717	2	189006991	101175	106920	rs587779480	NC_000002.12:189006990:G:A
NM_000090.3(COL3A1):c.951+3G>T (p.Gly300_Ala317del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic	no assertion criteria provided	VCV000101142	2	189856451	2	188991725	101142	106887	rs587779452	NC_000002.12:188991724:G:T
NM_000090.3(COL3A1):c.3149G>T (p.Gly1050Val)	COL3A1	G883V, G1050V	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000017231	2	189871126	2	189006400	17231	32270	rs121912914	NC_000002.12:189006399:G:T
NM_000090.3(COL3A1):c.3230G>T (p.Gly1077Val)	COL3A1	G910V, G1077V	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Jun 1, 1992)	no assertion criteria provided	VCV000017209	2	189871691	2	189006965	17209	32248	rs121912915	NC_000002.12:189006964:G:T
NM_000090.3(COL3A1):c.2437G>A (p.Gly813Ser)	COL3A1	G790S, G813S	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Jan 25, 1989)	no assertion criteria provided	VCV000017199	2	189867069	2	189002343	17199	32238	rs397509369	NC_000002.12:189002342:G:A
NM_001130987.2(DYSF):c.895_896del (p.Phe299fs)	DYSF	F267fs, F298fs, F268fs, F299fs	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000639814	2	71743314 - 71743315	2	71516184 - 71516185	639814	630422		NC_000002.12:71516183:TTTT:TT
NM_001130987.2(DYSF):c.5200del (p.Gln1734fs)	DYSF	Q1733fs, Q1695fs, Q1702fs, Q1703fs, Q1712fs, Q1716fs, Q1717fs, Q1734fs, Q1681fs, Q1696fs, Q1726fs, Q1727fs, Q1682fs, Q1713fs	Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000619218	2	71892316	2	71665186	619218	610613	rs1558771348	NC_000002.12:71665185:CC:C
NM_001130987.2(DYSF):c.5884+1G>A	DYSF		not provided|Qualitative or quantitative defects of dysferlin	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000597680	2	71901427	2	71674297	597680	588741	rs756689063	NC_000002.12:71674296:G:A
NM_001130987.2(DYSF):c.622C>T (p.Gln208Ter)	DYSF	Q208*, Q176*, Q207*, Q177*	Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000556201	2	71740914	2	71513784	556201	542037	rs1553521017	NC_000002.12:71513783:C:T
NM_001130987.2(DYSF):c.890_891CT[1] (p.Leu298fs)	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, single submitter	VCV000555171	2	71743311 - 71743312	2	71516181 - 71516182	555171	542209	rs1553522104	NC_000002.12:71516180:CTCT:CT
NM_001130987.2(DYSF):c.1449+1G>A	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000554978	2	71762220	2	71535090	554978	542238	rs1553535902	NC_000002.12:71535089:G:A
NM_001130987.2(DYSF):c.4941del (p.Lys1648fs)	DYSF	K1595fs, K1616fs, K1626fs, K1631fs, K1641fs, K1609fs, K1610fs, K1617fs, K1596fs, K1627fs, K1630fs, K1648fs, K1640fs, K1647fs	Proximal muscle weakness|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Dec 22, 2017)	criteria provided, single submitter	VCV000369690	2	71887719	2	71660587	369690	353882	rs1057516051	NC_000002.12:71660586:GGG:GG
NM_001130987.2(DYSF):c.2217-2A>G	DYSF		not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000290309	2	71788880	2	71561750	290309	274546	rs747289205	NC_000002.12:71561749:A:G
NM_001130987.2(DYSF):c.2865-2A>C	DYSF		not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, single submitter	VCV000288644	2	71796948	2	71569818	288644	272881	rs886043964	NC_000002.12:71569817:A:C
NM_001130987.2(DYSF):c.4802dup (p.Met1601fs)	DYSF		not provided|Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000286729	2	71886053 - 71886054	2	71658923 - 71658924	286729	270966	rs778065845	NC_000002.12:71658923:T:TT
NM_001130987.2(DYSF):c.4353C>G (p.Tyr1451Ter)	DYSF	Y1433*, Y1451*, Y1420*, Y1434*, Y1464*, Y1450*, Y1465*, Y1419*	Qualitative or quantitative defects of dysferlin|not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000285584	2	71839902	2	71612772	285584	269821	rs886043145	NC_000002.12:71612771:C:G
NM_001130987.2(DYSF):c.1577-1G>A	DYSF		Qualitative or quantitative defects of dysferlin|not provided	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000285177	2	71778170	2	71551040	285177	269414	rs189923208	NC_000002.12:71551039:G:A
NM_001130987.2(DYSF):c.1494-1G>A	DYSF		not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000094272	2	71766286	2	71539156	94272	100172	rs398123768	NC_000002.12:71539155:G:A
NM_001130987.2(DYSF):c.1380+2T>C	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided	Pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000094266	2	71755533	2	71528403	94266	100166	rs398123765	NC_000002.12:71528402:T:C
NM_001130987.2(DYSF):c.991G>T (p.Gly331Trp)	DYSF	G299W, G331W, G300W, G330W	not provided|Miyoshi muscular dystrophy 1	Pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, single submitter	VCV000006682	2	71744158	2	71517028	6682	21721	rs121908963	NC_000002.12:71517027:G:T
NM_001130987.2(DYSF):c.1867C>T (p.Gln623Ter)	DYSF	Q605*, Q623*, Q636*, Q606*, Q591*, Q592*, Q622*, Q637*	Miyoshi muscular dystrophy 1|not provided	Pathogenic(Last reviewed: Aug 17, 2015)	criteria provided, single submitter	VCV000006665	2	71780201	2	71553071	6665	21704	rs121908953	NC_000002.12:71553070:C:T
NM_001130987.2(DYSF):c.922del (p.Glu308fs)	DYSF	E277fs, E308fs, E276fs, E307fs	Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000499095	2	71743340	2	71516210	499095	490519	rs1553522133	NC_000002.12:71516209:GGGG:GGG
NM_001130987.2(DYSF):c.4462C>T (p.Gln1488Ter)	DYSF	Q1488*, Q1470*, Q1456*, Q1457*, Q1501*, Q1502*, Q1487*, Q1471*	Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000290284	2	71840538	2	71613408	290284	274521	rs886044411	NC_000002.12:71613407:C:T
NM_001130987.2(DYSF):c.3564_3565CT[1] (p.Ser1189fs)	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided	Pathogenic(Last reviewed: Oct 23, 2015)	criteria provided, single submitter	VCV000284251	2	71817408 - 71817409	2	71590278 - 71590279	284251	268488	rs886042827	NC_000002.12:71590277:CTCT:CT
NM_001130987.2(DYSF):c.3498T>A (p.Tyr1166Ter)	DYSF	Y1166*, Y1148*, Y1165*, Y1134*, Y1149*, Y1135*, Y1179*, Y1180*	Qualitative or quantitative defects of dysferlin|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000283206	2	71817342	2	71590212	283206	267443	rs758944159	NC_000002.12:71590211:T:A
NM_001130987.2(DYSF):c.5003+1249G>T	DYSF		not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Jul 11, 2016)	criteria provided, single submitter	VCV000281197	2	71889030	2	71661900	281197	265434	rs886042110	NC_000002.12:71661899:G:T
NM_001130987.2(DYSF):c.3532C>T (p.Gln1178Ter)	DYSF	Q1178*, Q1160*, Q1146*, Q1177*, Q1161*, Q1147*, Q1191*, Q1192*	not provided	Pathogenic(Last reviewed: Jan 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000281063	2	71817376	2	71590246	281063	265300	rs886042091	NC_000002.12:71590245:C:T
NM_001130987.2(DYSF):c.110_111del (p.Lys37fs)	DYSF	K36fs, K37fs	Qualitative or quantitative defects of dysferlin|not provided	Pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094263	2	71708030 - 71708031	2	71480900 - 71480901	94263	100163	rs398123764	NC_000002.12:71480899:AAA:A
NM_014874.3(MFN2):c.775C>T (p.Arg259Cys)	MFN2	R259C	Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000155730	1	12059111	1	11999054	155730	165484	rs587777875	NC_000001.11:11999053:C:T
NM_014874.3(MFN2):c.227T>C (p.Leu76Pro)	MFN2	L76P	not provided|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, type 2A2A	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002270	1	12052663	1	11992606	2270	17309	rs28940293	NC_000001.11:11992605:T:C
NM_000143.3(FH):c.952C>T (p.His318Tyr)	FH	H318Y	Fumarase deficiency|Fumarase deficiency|Hereditary leiomyomatosis and renal cell cancer|not provided|Hereditary leiomyomatosis and renal cell cancer	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092458	1	241667498	1	241504198	92458	98367	rs398123168	NC_000001.11:241504197:G:A
NM_001130987.2(DYSF):c.991G>C (p.Gly331Arg)	DYSF	G299R, G300R, G330R, G331R	Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000837557	2	71744158	2	71517028	837557	826933		NC_000002.12:71517027:G:C
NM_003494.3(DYSF):c.2512-1496_3149del	DYSF		Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000655612			2	71566455 - 71570716	655612	651005		
NM_003494.3(DYSF):c.2512-1495_3148del	DYSF		Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000573415	2	71793586 - 71797845	2	71566456 - 71570715	573415	560919		
NM_001130987.2(DYSF):c.5139del (p.Phe1713fs)	DYSF	F1675fs, F1682fs, F1692fs, F1695fs, F1696fs, F1661fs, F1681fs, F1660fs, F1705fs, F1706fs, F1712fs, F1713fs, F1674fs, F1691fs	Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000374503	2	71891531	2	71664401	374503	361389	rs1057519132	NC_000002.12:71664400:TTT:TT
NM_001130987.2(DYSF):c.159G>A (p.Trp53Ter)	DYSF	W53*, W52*	not provided|Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000283497	2	71709020	2	71481890	283497	267734	rs886042641	NC_000002.12:71481889:G:A
NM_001130987.2(DYSF):c.334C>T (p.Gln112Ter)	DYSF	Q111*, Q112*	Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265108	2	71730438	2	71503308	265108	259743	rs746315830	NC_000002.12:71503307:C:T
NM_001130987.2(DYSF):c.5642+1G>A	DYSF		Qualitative or quantitative defects of dysferlin|not provided	Pathogenic(Last reviewed: May 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000167030	2	71896338	2	71669208	167030	177691	rs727503915	NC_000002.12:71669207:G:A
NM_001130987.2(DYSF):c.203_204delinsAT (p.Val68Asp)	DYSF	V67D	Miyoshi muscular dystrophy 1|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Dec 26, 2000)	no assertion criteria provided	VCV000006673	2	71709064 - 71709065	2	71481934 - 71481935	6673	21712	rs121908957	NC_000002.12:71481933:TG:AT
NM_152263.4(TPM3):c.503G>A (p.Arg168His)	TPM3	R168H, R131H, R65H, R41H	Nemaline myopathy 1|Congenital myopathy with fiber type disproportion|Nemaline myopathy 1|not provided|Congenital myopathy with fiber type disproportion|Cap myopathy 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012450	1	154145447	1	154172971	12450	27489	rs121964852	NC_000001.11:154172970:C:T
NC_000001.10:g.(?_156104184)_(156108907_?)del	LMNA		Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000662281	1	156104184 - 156108907	1	156134393 - 156139116	662281	650538		
NM_170707.4(LMNA):c.184C>G (p.Arg62Gly)	LMNA	R62G	not provided|Familial partial lipodystrophy 2|Cardiomyopathy|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066868	1	156084893	1	156115102	66868	77765	rs56793579	NC_000001.11:156115101:C:G
NM_170707.4(LMNA):c.1366A>G (p.Asn456Asp)	LMNA	N456D, N344D, N375D	Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000066811	1	156106213	1	156136422	66811	77708	rs267607599	NC_000001.11:156136421:A:G
NM_170707.4(LMNA):c.1294C>T (p.Gln432Ter)	LMNA	Q432*, Q320*, Q351*	Charcot-Marie-Tooth disease, type 2|Primary dilated cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000066800	1	156106141	1	156136350	66800	77697	rs267607618	NC_000001.11:156136349:C:T
NM_170707.4(LMNA):c.398G>T (p.Arg133Leu)	LMNA	R133L, R21L, R52L	Charcot-Marie-Tooth disease|not provided|Hutchinson-Gilford progeria syndrome, childhood-onset|Familial partial lipodystrophy 2	Pathogenic(Last reviewed: Apr 30, 2015)	no assertion criteria provided	VCV000014488	1	156100449	1	156130658	14488	29527	rs60864230	NC_000001.11:156130657:G:T
NM_170707.4(LMNA):c.1579C>T (p.Arg527Cys)	LMNA	R527C, R415C, R446C	Charcot-Marie-Tooth disease|not provided|Hutchinson-Gilford syndrome|Mandibuloacral dysplasia with type A lipodystrophy	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000014487	1	156106994	1	156137203	14487	29526	rs57318642	NC_000001.11:156137202:C:T
NC_000001.11:g.(?_17053938)_(17054019_?)del	SDHB		Gastrointestinal stromal tumor|Pheochromocytoma|Paragangliomas 4	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000831621	1	17380433 - 17380514			831621	818870		
NC_000001.10:g.(?_17380433)_(17380524_?)del	SDHB		Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000583582	1	17380433 - 17380524	1	17053938 - 17054029	583582	556492		
NC_000001.10:g.(?_17380437)_(17380520_?)del	SDHB		Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000468232	1	17380437 - 17380520			468232	446940		
NM_000090.3(COL3A1):c.3255+1G>C	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000651201	2	189871717	2	189006991	651201	650901		NC_000002.12:189006990:G:C
NM_000090.3(COL3A1):c.2096G>A (p.Gly699Asp)	COL3A1	G699D	Cardiovascular phenotype|Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, single submitter	VCV000101471	2	189864084	2	188999358	101471	107218	rs587779706	NC_000002.12:188999357:G:A
NM_000090.3(COL3A1):c.611G>A (p.Gly204Asp)	COL3A1	G204D	Cardiovascular phenotype|Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Oct 11, 2016)	criteria provided, single submitter	VCV000101351	2	189853344	2	188988618	101351	107097	rs587779626	NC_000002.12:188988617:G:A
NM_000090.3(COL3A1):c.976C>T (p.Arg326Ter)	COL3A1	R326*	Ehlers-Danlos syndrome, type 4|not provided	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000101324	2	189856934	2	188992208	101324	107070	rs587779607	NC_000002.12:188992207:C:T
NM_000090.3(COL3A1):c.555del (p.Gly186fs)	COL3A1	G186fs	not provided|Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000101141	2	189852833	2	188988107	101141	106886	rs587779451	NC_000002.12:188988106:T:
NM_000090.3(COL3A1):c.3417+1G>A (p.Gly1122_Arg1139del+)	COL3A1		Ehlers-Danlos syndrome, type 4|not provided	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000101132	2	189872665	2	189007939	101132	106877	rs587779444	NC_000002.12:189007938:G:A
NM_000090.3(COL3A1):c.1997G>A (p.Gly666Asp)	COL3A1	G499D, G666D	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Mar 9, 2000)	no assertion criteria provided	VCV000017223	2	189863419	2	188998693	17223	32262	rs121912921	NC_000002.12:188998692:G:A
NM_000090.3(COL3A1):c.406G>C (p.Gly136Arg)	COL3A1	G136R	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Jun 1, 1993)	no assertion criteria provided	VCV000017219	2	189850463	2	188985737	17219	32258	rs387906557	NC_000002.12:188985736:G:C
NM_000090.3(COL3A1):c.3563G>A (p.Gly1188Glu)	COL3A1	G1021E, G1188E	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Mar 9, 2000)	no assertion criteria provided	VCV000017218	2	189873687	2	189008961	17218	32257	rs112456072	NC_000002.12:189008960:G:A
NM_000090.3(COL3A1):c.3041G>A (p.Gly1014Glu)	COL3A1	G847E, G1014E	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000017215	2	189870933	2	189006207	17215	32254	rs121912916	NC_000002.12:189006206:G:A
NM_000090.3(COL3A1):c.2356G>A (p.Gly786Arg)	COL3A1	G619R, G786R	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Nov 1, 1991)	no assertion criteria provided	VCV000017200	2	189866280	2	189001554	17200	32239	rs113485686	NC_000002.12:189001553:G:A
NM_001130987.2(DYSF):c.2864+1G>A	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic/Likely pathogenic(Last reviewed: Dec 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000443997	2	71795469	2	71568339	443997	437659	rs199954546	NC_000002.12:71568338:G:A
NM_001130987.2(DYSF):c.3085+2T>C	DYSF		not provided|Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000284804	2	71797466	2	71570336	284804	269041	rs886042951	NC_000002.12:71570335:T:C
NM_001130987.2(DYSF):c.342del (p.Ala116fs)	DYSF	A115fs, A116fs	not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B|Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000282316	2	71730446	2	71503316	282316	266553	rs886042379	NC_000002.12:71503315:A:
NM_001130987.2(DYSF):c.5953_5956del (p.Gln1985fs)	DYSF	Q1946fs, Q1968fs, Q1977fs, Q1978fs, Q1985fs, Q1947fs, Q1964fs, Q1984fs, Q1932fs, Q1953fs, Q1954fs, Q1967fs, Q1933fs, Q1963fs	not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Dec 22, 2016)	criteria provided, multiple submitters, no conflicts	VCV000094347	2	71906254 - 71906257	2	71679124 - 71679127	94347	100247	rs398123797	NC_000002.12:71679123:CCAGC:C
NM_001130987.2(DYSF):c.1488dup (p.Asp497fs)	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided	Pathogenic(Last reviewed: Feb 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000094271	2	71762435 - 71762436	2	71535305 - 71535306	94271	100171	rs398123767	NC_000002.12:71535305:A:AA
NM_001130987.2(DYSF):c.5711del (p.Gly1904fs)	DYSF	G1851fs, G1866fs, G1887fs, G1897fs, G1903fs, G1852fs, G1883fs, G1896fs, G1904fs, G1865fs, G1873fs, G1882fs, G1886fs, G1872fs	Qualitative or quantitative defects of dysferlin|Myopathy, distal, with anterior tibial onset	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000006666	2	71896802	2	71669672	6666	21705	rs786205081	NC_000002.12:71669671:GG:G
NM_003001.3(SDHC):c.1A>G (p.Met1Val)	SDHC	M1V	Hereditary cancer-predisposing syndrome|Paragangliomas 3|Gastrointestinal stromal tumor|Paragangliomas 3	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000407060	1	161284196	1	161314406	407060	390864	rs755235380	NC_000001.11:161314405:A:G
NM_003001.3(SDHC):c.380A>G (p.His127Arg)	SDHC	H127R, H74R, H93R	Hereditary cancer-predisposing syndrome|not provided|Paragangliomas 3|Gastrointestinal stromal tumor	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000187084	1	161326605	1	161356815	187084	181599	rs786203457	NC_000001.11:161356814:A:G
NM_015100.4(POGZ):c.2935C>T (p.Arg979Ter)	POGZ	R979*, R884*, R926*, R917*, R970*	Inborn genetic diseases|White-sutton syndrome	Pathogenic(Last reviewed: Dec 1, 2014)	criteria provided, single submitter	VCV000218149	1	151378576	1	151406100	218149	214794	rs864321674	NC_000001.11:151406099:G:A
NM_001204.7(BMPR2):c.1471C>T (p.Arg491Trp)	BMPR2	R491W	not provided|Pulmonary arterial hypertension|Primary pulmonary hypertension	Pathogenic(Last reviewed: Aug 27, 2015)	criteria provided, single submitter	VCV000008802	2	203417496	2	202552773	8802	23841	rs137852746	NC_000002.12:202552772:C:T
NM_014795.4(ZEB2):c.2609C>A (p.Ser870Ter)	ZEB2	S870*, S846*	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000521378	2	145156145	2	144398578	521378	511320	rs1553961516	NC_000002.12:144398577:G:T
NM_014795.4(ZEB2):c.1537del (p.Leu513fs)	ZEB2	L513fs, L489fs	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 9, 2016)	criteria provided, single submitter	VCV000520971	2	145157217	2	144399650	520971	511321	rs1553961697	NC_000002.12:144399649:G:
NM_000384.3(APOB):c.11789-2A>C	APOB		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000431502	2	21227549	2	21004677	431502	425002	rs1135402766	NC_000002.12:21004676:T:G
NM_000384.3(APOB):c.4651C>T (p.Gln1551Ter)	APOB	Q1551*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000431499	2	21235089	2	21012217	431499	425005	rs142017360	NC_000002.12:21012216:G:A
NM_000384.3(APOB):c.4590del (p.Asn1531fs)	APOB	N1531fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000431498	2	21235150	2	21012278	431498	425006	rs1135402765	NC_000002.12:21012277:GG:G
NM_000384.3(APOB):c.3012del (p.Glu1004fs)	APOB	E1004fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000431494	2	21241973	2	21019101	431494	425010	rs1135402764	NC_000002.12:21019100:TT:T
NM_000384.3(APOB):c.13158del (p.Glu4387fs)	APOB	E4387fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000265895	2	21225136	2	21002264	265895	260628	rs886039829	NC_000002.12:21002263:TT:T
NM_001128425.1(MUTYH):c.1418C>A (p.Ala473Asp)	MUTYH	A473D, A353D, A470D, A445D, A446D, A330D, A456D, A459D, A460D	MYH-associated polyposis	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000041041	1	45796912	1	45331240	41041	49463	rs200844166	NC_000001.11:45331239:G:T
NM_001130987.2(DYSF):c.1471dup (p.Met491fs)	DYSF		Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000550946	2	71762413 - 71762414	2	71535283 - 71535284	550946	542254	rs1236367931	NC_000002.12:71535283:AAAAAA:AAAAAAA
NM_001130987.2(DYSF):c.5317+1G>A	DYSF		Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000538631	2	71892435	2	71665305	538631	518541	rs773386253	NC_000002.12:71665304:G:A
NM_001130987.2(DYSF):c.6001C>T (p.Gln2001Ter)	DYSF	Q1962*, Q2001*, Q1963*, Q1969*, Q1949*, Q1980*, Q1983*, Q1993*, Q1948*, Q1970*, Q1984*, Q1994*, Q2000*, Q1979*	not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B|Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Mar 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419655	2	71906303	2	71679173	419655	406010	rs1064794020	NC_000002.12:71679172:C:T
NM_001130987.2(DYSF):c.1906G>C (p.Gly636Arg)	DYSF	G618R, G636R, G649R, G619R, G635R, G604R, G605R, G650R	Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 2, 2016)	criteria provided, multiple submitters, no conflicts	VCV000217224	2	71780240	2	71553110	217224	213809	rs201049092	NC_000002.12:71553109:G:C
NM_001130987.2(DYSF):c.4551G>A (p.Trp1517Ter)	DYSF	W1478*, W1517*, W1465*, W1486*, W1510*, W1516*, W1479*, W1499*, W1509*, W1485*, W1495*, W1500*, W1464*, W1496*	Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000197433	2	71871118	2	71643988	197433	194594	rs766016391	NC_000002.12:71643987:G:A
NM_001130987.2(DYSF):c.759+1G>C	DYSF		not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000094355	2	71741052	2	71513922	94355	100255	rs398123800	NC_000002.12:71513921:G:C
NM_001130987.2(DYSF):c.356del (p.Val119fs)	DYSF	V119fs, V118fs	not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000094308	2	71738947	2	71511817	94308	100208	rs398123782	NC_000002.12:71511816:T:
NM_001130987.2(DYSF):c.1577-1692G>A	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000094274	2	71776479	2	71549349	94274	100174	rs398123770	NC_000002.12:71549348:G:A
NM_001130987.2(DYSF):c.5546G>A (p.Arg1849Lys)	DYSF	R1810K, R1831K, R1849K, R1818K, R1832K, R1797K, R1817K, R1842K, R1848K, R1841K, R1796K, R1811K, R1827K, R1828K	not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000018443	2	71895972	2	71668842	18443	33482	rs786205084	NC_000002.12:71668841:G:A
NM_000642.3(AGL):c.3980G>A (p.Trp1327Ter)	AGL	W1327*, W1311*	Glycogen storage disease IIIa|Glycogen storage disease type III|not provided	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001108	1	100379113	1	99913557	1108	16147	rs267606640	NC_000001.11:99913556:G:A
NM_000090.3(COL3A1):c.4087C>T (p.Arg1363Ter)	COL3A1	R1363*	not provided|Ehlers-Danlos syndrome, type 4	Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000199753	2	189875449	2	189010723	199753	196821	rs794728060	NC_000002.12:189010722:C:T
NM_000090.3(COL3A1):c.1869+5G>T (p.Gly606_Thr623del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000101485	2	189862120	2	188997394	101485	107232	rs397509376	NC_000002.12:188997393:G:T
NM_000090.3(COL3A1):c.997-1G>C (p.Gly333_Lys350del+)	COL3A1		Cardiovascular phenotype|Ehlers-Danlos syndrome, type 4|not provided	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000101447	2	189857612	2	188992886	101447	107194	rs587779687	NC_000002.12:188992885:G:C
NM_000090.3(COL3A1):c.3325C>T (p.Arg1109Ter)	COL3A1	R1109*	Cardiovascular phenotype|Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000101427	2	189872295	2	189007569	101427	107174	rs112371422	NC_000002.12:189007568:C:T
NM_000090.3(COL3A1):c.3070C>T (p.Arg1024Ter)	COL3A1	R1024*	Cardiovascular phenotype|Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, single submitter	VCV000101174	2	189870962	2	189006236	101174	106919	rs587779479	NC_000002.12:189006235:C:T
NM_000090.3(COL3A1):c.2212G>A (p.Gly738Ser)	COL3A1	G571S, G738S	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Nov 26, 2016)	criteria provided, single submitter	VCV000017227	2	189864286	2	188999560	17227	32266	rs121912925	NC_000002.12:188999559:G:A
NM_000090.3(COL3A1):c.2931+1G>A (p.Gly942_Lys977del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Dec 1, 1991)	no assertion criteria provided	VCV000017213	2	189869091	2	189004365	17213	32252	rs397509373	NC_000002.12:189004364:G:A
NM_001128425.2(MUTYH):c.252C>A (p.Tyr84Ter)	MUTYH	Y56*, Y67*, Y71*, Y81*, Y57*, Y84*	MYH-associated polyposis	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000859310	1	45799181	1	45333509	859310	824191		NC_000001.11:45333508:G:T
NM_001128425.2(MUTYH):c.132_135del (p.Ser44fs)	MUTYH	S44fs, S30fs	MYH-associated polyposis	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000854670	1	45800085 - 45800088	1	45334413 - 45334416	854670	824196		NC_000001.11:45334412:CTGACTG:CTG
NM_001128425.2(MUTYH):c.1218del (p.Ser406_Val407insTer)	MUTYH		MYH-associated polyposis	Pathogenic(Last reviewed: Aug 25, 2018)	criteria provided, single submitter	VCV000663501	1	45797197	1	45331525	663501	628071		NC_000001.11:45331524:GG:G
NM_012222.2(MUTYH):c.624_651del (p.Leu209fs)	MUTYH	L92fs, L184fs, L195fs, L198fs, L199fs, L212fs, L69fs, L209fs, L185fs	MYH-associated polyposis	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000662131	1	45798276 - 45798303	1	45332604 - 45332631	662131	628090		NC_000001.11:45332603:AGCTGTGTAGCGCCCCACGCCAGGCAGGAGCTG:AGCTG
NM_001128425.2(MUTYH):c.276dup (p.Val93fs)	MUTYH		MYH-associated polyposis	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000657663	1	45799156 - 45799157	1	45333484 - 45333485	657663	628102		NC_000001.11:45333484:TT:TTT
NM_001128425.1(MUTYH):c.1264C>T (p.Gln422Ter)	MUTYH	Q419*, Q409*, Q422*, Q302*, Q394*, Q405*, Q279*, Q395*, Q408*	MYH-associated polyposis	Pathogenic(Last reviewed: Jul 8, 2018)	criteria provided, single submitter	VCV000654529	1	45797151	1	45331479	654529	628070		NC_000001.11:45331478:G:A
NM_001128425.1(MUTYH):c.37-95_84delinsC	MUTYH		MYH-associated polyposis	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000648550	1	45800136 - 45800278	1	45334464 - 45334606	648550	650682		
NM_001128425.1(MUTYH):c.788G>A (p.Trp263Ter)	MUTYH	W236*, W250*, W143*, W246*, W120*, W249*, W260*, W263*, W235*	MYH-associated polyposis	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000641274	1	45798063	1	45332391	641274	628087		NC_000001.11:45332390:C:T
NM_012222.2(MUTYH):c.1501_1508delinsCCAACAGCCCA (p.Thr501_Met503delinsProThrAlaGln)	MUTYH		MYH-associated polyposis	Pathogenic(Last reviewed: Jun 1, 2018)	no assertion criteria provided	VCV000587356	1	45796189 - 45796196	1	45330517 - 45330524	587356	578304	rs1557451154	NC_000001.11:45330516:ATACAGGT:TGGGCTGTTGG
NM_001128425.1(MUTYH):c.178G>T (p.Glu60Ter)	MUTYH	E60*, E43*, E57*	MYH-associated polyposis	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000582666	1	45799255	1	45333583	582666	558551	rs1557487793	NC_000001.11:45333582:C:A
NM_001128425.1(MUTYH):c.971C>A (p.Ser324Ter)	MUTYH	S324*, S181*, S307*, S310*, S204*, S297*, S311*, S321*, S296*	MYH-associated polyposis	Pathogenic(Last reviewed: May 19, 2018)	criteria provided, single submitter	VCV000569689	1	45797721	1	45332049	569689	557077	rs558173961	NC_000001.11:45332048:G:T
NM_001128425.1(MUTYH):c.789G>A (p.Trp263Ter)	MUTYH	W263*, W143*, W246*, W249*, W260*, W250*, W120*, W235*, W236*	MYH-associated polyposis	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000565890	1	45797982	1	45332310	565890	557300	rs1338038953	NC_000001.11:45332309:C:T
NM_012222.2(MUTYH):c.800delinsAG (p.Val267fs)	MUTYH		MYH-associated polyposis	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000533305	1	45797962	1	45332290	533305	515955	rs1553127825	NC_000001.11:45332289:A:CT
NC_000001.10:g.(?_45794978)_(45798996_?)del	MUTYH		MYH-associated polyposis	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, single submitter	VCV000437842	1	45794978 - 45798996	1	45329306 - 45333324	437842	420988		
NM_001293192.1(MUTYH):c.-153del	MUTYH	R36fs, R22fs	MYH-associated polyposis	Pathogenic(Last reviewed: May 13, 2016)	criteria provided, single submitter	VCV000406847	1	45800118	1	45334446	406847	391516	rs1060501336	NC_000001.11:45334445:TT:T
NM_001350650.1(MUTYH):c.33+119_33+132dup	MUTYH		MYH-associated polyposis	Pathogenic(Last reviewed: Oct 2, 2016)	criteria provided, single submitter	VCV000406838	1	45798824 - 45798825	1	45333152 - 45333153	406838	391322	rs1553129652	NC_000001.11:45333152:TGACCTCTGAGACC:TGACCTCTGAGACCTGACCTCTGAGACC
NM_001128425.1(MUTYH):c.1267G>T (p.Glu423Ter)	MUTYH	E423*, E396*, E406*, E409*, E280*, E395*, E410*, E420*, E303*	MYH-associated polyposis	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000406823	1	45797148	1	45331476	406823	391345	rs1060501321	NC_000001.11:45331475:C:A
NM_001293192.1(MUTYH):c.-28dup	MUTYH		MYH-associated polyposis	Pathogenic(Last reviewed: Nov 24, 2015)	criteria provided, single submitter	VCV000238345	1	45799099 - 45799100	1	45333427 - 45333428	238345	238329	rs878854189	NC_000001.11:45333427:T:TT
NM_001128425.1(MUTYH):c.1474A>T (p.Lys492Ter)	MUTYH	K492*, K464*, K489*, K349*, K479*, K372*, K478*, K465*, K475*	MYH-associated polyposis	Pathogenic(Last reviewed: Jun 24, 2015)	criteria provided, single submitter	VCV000216081	1	45796856	1	45331184	216081	212090	rs863224502	NC_000001.11:45331183:T:A
MUTYH, 2-BP INS, 1186GG	MUTYH		MYH-associated polyposis	Pathogenic(Last reviewed: Apr 15, 2005)	no assertion criteria provided	VCV000005300					5300	20339		
NM_012222.2(MUTYH):c.1452del (p.Thr485fs)	MUTYH	T368fs, T460fs, T461fs, T475fs, T485fs, T345fs, T471fs, T488fs, T474fs	MYH-associated polyposis	Pathogenic(Last reviewed: Feb 27, 2003)	no assertion criteria provided	VCV000005295	1	45796869	1	45331197	5295	20334	rs146331482	NC_000001.11:45331196:GG:G
NM_001130987.2(DYSF):c.1693-6T>A	DYSF		not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265488	2	71778731	2	71551601	265488	259745	rs886039573	NC_000002.12:71551600:T:A
NM_001130987.2(DYSF):c.167dup (p.Ile58fs)	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217222	2	71709026 - 71709027	2	71481896 - 71481897	217222	213806	rs863225020	NC_000002.12:71481896:AA:AAA
NM_001130987.2(DYSF):c.3403-2A>G	DYSF		not provided|Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000196694	2	71816721	2	71589591	196694	193855	rs370874727	NC_000002.12:71589590:A:G
NM_001130987.2(DYSF):c.3886C>T (p.Gln1296Ter)	DYSF	Q1278*, Q1296*, Q1264*, Q1310*, Q1295*, Q1265*, Q1279*, Q1309*	Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000167025	2	71827961	2	71600831	167025	177216	rs727503911	NC_000002.12:71600830:C:T
NM_001130987.2(DYSF):c.5813_5814AG[1] (p.Ser1939fs)	DYSF		Qualitative or quantitative defects of dysferlin|not provided	Pathogenic(Last reviewed: Oct 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094344	2	71901354 - 71901355	2	71674224 - 71674225	94344	100244	rs398123796	NC_000002.12:71674223:GAGAG:GAG
NM_000143.3(FH):c.1293del (p.Glu432fs)	FH	E432fs	Hereditary leiomyomatosis and renal cell cancer|Hereditary cancer-predisposing syndrome|Fumarase deficiency|not provided	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092452	1	241663834	1	241500534	92452	98361	rs398123163	NC_000001.11:241500533:T:
NM_000143.3(FH):c.1127A>C (p.Gln376Pro)	FH	Q376P	Fumarase deficiency|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000042094	1	241665852	1	241502552	42094	51260	rs200796606	NC_000001.11:241502551:T:G
NM_000143.3(FH):c.1027C>T (p.Arg343Ter)	FH	R300*, R343*	not provided|Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016235	1	241667423	1	241504123	16235	31274	rs121913122	NC_000001.11:241504122:G:A
NM_000530.8(MPZ):c.292C>T (p.Arg98Cys)	MPZ	R98C	Charcot-Marie-Tooth disease, demyelinating, type 1b|not provided|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Oct 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014175	1	161276654	1	161306864	14175	29214	rs121913590	NC_000001.11:161306863:G:A
NM_004958.4(MTOR):c.4447T>C (p.Cys1483Arg)	MTOR	C1483R	Glioblastoma|Hemimegalencephaly|Neoplasm of the breast|Renal cell carcinoma, papillary, 1	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000374796	1	11217231	1	11157174	374796	361700	rs1057519914	NC_000001.11:11157173:A:G
NM_004958.4(MTOR):c.6644C>T (p.Ser2215Phe)	MTOR	S2215F	Neoplasm of the large intestine|not provided|Malignant melanoma of skin|Glioblastoma|Uterine cervical neoplasms|Papillary renal cell carcinoma, sporadic|Malignant neoplasm of body of uterus|Focal cortical dysplasia type II|Renal cell carcinoma, papillary, 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 18, 2018)	no assertion criteria provided	VCV000156703	1	11184573	1	11124516	156703	166563	rs587777894	NC_000001.11:11124515:G:A
NM_170707.4(LMNA):c.700C>T (p.Gln234Ter)	LMNA	Q234*, Q153*, Q122*	Primary dilated cardiomyopathy|Cardiovascular phenotype|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048075	1	156104656	1	156134865	48075	57239	rs267607573	NC_000001.11:156134864:C:T
NM_170707.4(LMNA):c.608A>G (p.Glu203Gly)	LMNA	E203G, E122G, E91G	not provided|Primary dilated cardiomyopathy|Dilated cardiomyopathy 1A	Pathogenic(Last reviewed: Aug 21, 2015)	criteria provided, single submitter	VCV000014484	1	156104288	1	156134497	14484	29523	rs28933092	NC_000001.11:156134496:A:G
NM_006593.4(TBR1):c.667G>C (p.Glu223Gln)	TBR1	E223Q	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 17, 2015)	criteria provided, single submitter	VCV000520662	2	162273588	2	161417077	520662	511334	rs1553510215	NC_000002.12:161417076:G:C
NM_015120.4(ALMS1):c.4937C>A (p.Ser1646Ter)	ALMS1	S1645*, S1646*	Retinal dystrophy	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000867044	2	73678588	2	73451461	867044	856191		NC_000002.12:73451460:C:A
NM_015120.4(ALMS1):c.7534C>T (p.Arg2512Ter)	ALMS1	R2512*, R2511*	Retinal dystrophy	Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000866836	2	73681185	2	73454058	866836	856195		NC_000002.12:73454057:C:T
NM_001378454.1(ALMS1):c.1006_1007TG[1] (p.Cys336_Asp337delinsTer)	ALMS1		Retinal dystrophy	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000865951	2	73651799 - 73651800	2	73424671 - 73424672	865951	856188		NC_000002.12:73424670:TGTG:TG
NM_015120.4(ALMS1):c.11416C>T (p.Arg3806Ter)	ALMS1	R3805*, R3806*	Retinal dystrophy	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000865871	2	73800417	2	73573290	865871	856202		NC_000002.12:73573289:C:T
NM_001378454.1(ALMS1):c.3011_3012CA[1] (p.Ser1004_His1005insTer)	ALMS1		not provided	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000817572	2	73676665 - 73676666	2	73449538 - 73449539	817572	805318		NC_000002.12:73449537:CACA:CA
NM_015120.4(ALMS1):c.5005del (p.Arg1669fs)	ALMS1	R1668fs, R1669fs	not provided	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000817439	2	73678656	2	73451529	817439	805319		NC_000002.12:73451528:A:
NM_015120.4(ALMS1):c.2620C>T (p.Gln874Ter)	ALMS1	Q874*, Q873*	not provided	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000816972	2	73676271	2	73449144	816972	805317		NC_000002.12:73449143:C:T
NM_015120.4(ALMS1):c.808C>T (p.Arg270Ter)	ALMS1	R270*	Cone-rod degeneration	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812221	2	73651598	2	73424470	812221	800474		NC_000002.12:73424469:C:T
NM_015120.4(ALMS1):c.12208C>T (p.Gln4070Ter)	ALMS1	Q4070*	not provided	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000620395	2	73829402	2	73602275	620395	611576	rs1558712413	NC_000002.12:73602274:C:T
NM_015120.4(ALMS1):c.928C>T (p.Gln310Ter)	ALMS1	Q310*	not provided	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000620384	2	73651718	2	73424590	620384	611574	rs1558639213	NC_000002.12:73424589:C:T
NM_015120.4(ALMS1):c.800G>A (p.Trp267Ter)	ALMS1	W267*	not provided	Pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000620305	2	73651590	2	73424462	620305	611573	rs1558639105	NC_000002.12:73424461:G:A
NM_015120.4(ALMS1):c.7657del (p.Arg2553fs)	ALMS1	R2553fs	not provided	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000500499	2	73682401	2	73455274	500499	491923	rs1553404662	NC_000002.12:73455273:AA:A
NM_015120.4(ALMS1):c.11395_11396AG[1] (p.Arg3799fs)	ALMS1		not provided	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000451082	2	73800396 - 73800397	2	73573269 - 73573270	451082	443307	rs1553418598	NC_000002.12:73573268:AGAG:AG
NM_015120.4(ALMS1):c.11311_11312del (p.Thr3770_Asp3771insTer)	ALMS1		not provided	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000432813	2	73800311 - 73800312	2	73573184 - 73573185	432813	425512	rs1553418578	NC_000002.12:73573183:AGA:A
NM_015120.4(ALMS1):c.3902C>A (p.Ser1301Ter)	ALMS1	S1301*	not provided	Pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000264657	2	73677553	2	73450426	264657	248730	rs769219669	NC_000002.12:73450425:C:A
NM_015120.4(ALMS1):c.1604dup (p.Thr535_Asp536insTer)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Apr 15, 2019)	no assertion criteria provided	VCV000829836	2	73675254 - 73675255	2	73448127 - 73448128	829836	818217		NC_000002.12:73448127:C:CC
NM_015120.4(ALMS1):c.9254del (p.Asn3085fs)	ALMS1	N3085fs	Alstrom syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801723	2	73718336	2	73491209	801723	790293		NC_000002.12:73491208:AA:A
NM_015120.4(ALMS1):c.9194T>G (p.Leu3065Ter)	ALMS1	L3065*	Alstrom syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801722	2	73718277	2	73491150	801722	790292		NC_000002.12:73491149:T:G
NM_015120.4(ALMS1):c.2329C>T (p.Gln777Ter)	ALMS1	Q777*	Alstrom syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801721	2	73675980	2	73448853	801721	790291		NC_000002.12:73448852:C:T
NM_015120.4(ALMS1):c.1730C>G (p.Ser577Ter)	ALMS1	S577*	Alstrom syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801720	2	73675381	2	73448254	801720	790290		NC_000002.12:73448253:C:G
NM_015120.4(ALMS1):c.7316C>A (p.Ser2439Ter)	ALMS1	S2439*	Alstrom syndrome	Pathogenic(Last reviewed: Aug 27, 2018)	no assertion criteria provided	VCV000560536	2	73680967	2	73453840	560536	551615	rs1558651680	NC_000002.12:73453839:C:A
NM_015120.4(ALMS1):c.3014C>G (p.Ser1005Ter)	ALMS1	S1005*, S1004*	Alstrom syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000861254	2	73676665	2	73449538	861254	826986		NC_000002.12:73449537:C:G
NM_015120.4(ALMS1):c.12376C>T (p.Gln4126Ter)	ALMS1	Q4126*, Q4125*	Alstrom syndrome	Pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, single submitter	VCV000849501	2	73835612	2	73608485	849501	827027		NC_000002.12:73608484:C:T
NM_001378454.1(ALMS1):c.11574_11575CT[1] (p.Ser3859fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000848177	2	73826554 - 73826555	2	73599427 - 73599428	848177	827023		NC_000002.12:73599426:CTCT:CT
NM_015120.4(ALMS1):c.9977C>G (p.Ser3326Ter)	ALMS1	S3325*, S3326*	Alstrom syndrome	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000846651	2	73777460	2	73550333	846651	827017		NC_000002.12:73550332:C:G
NM_015120.4(ALMS1):c.550G>T (p.Glu184Ter)	ALMS1	E184*, E183*	Alstrom syndrome	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000838357	2	73646347	2	73419219	838357	826976		NC_000002.12:73419218:G:T
NM_015120.4(ALMS1):c.9193_9194insA (p.Leu3065fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000835398	2	73718276 - 73718277	2	73491149 - 73491150	835398	827013		NC_000002.12:73491149::A
NC_000002.11:g.(?_73612987)_(73836749_?)del	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000830940	2	73612987 - 73836749			830940	819020		
NC_000002.12:g.(?_73489624)_(73603314_?)del	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000830711	2	73716751 - 73830441			830711	819274		
NM_015120.4(ALMS1):c.10679del (p.Val3560fs)	ALMS1	V3560fs	Alstrom syndrome	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000663965	2	73799680	2	73572553	663965	630512		NC_000002.12:73572552:T:
NM_015120.4(ALMS1):c.5906C>G (p.Ser1969Ter)	ALMS1	S1969*	Alstrom syndrome	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000662562	2	73679557	2	73452430	662562	630494		NC_000002.12:73452429:C:G
NM_015120.4(ALMS1):c.301G>T (p.Glu101Ter)	ALMS1	E101*	Alstrom syndrome	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000661135	2	73613294	2	73386166	661135	630481		NC_000002.12:73386165:G:T
NM_015120.4(ALMS1):c.9832_9835dup (p.Tyr3279fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000660080	2	73761997 - 73761998	2	73534870 - 73534871	660080	630510		NC_000002.12:73534870:TATT:TATTTATT
NM_015120.4(ALMS1):c.8766C>A (p.Cys2922Ter)	ALMS1	C2922*	Alstrom syndrome	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000659575	2	73717849	2	73490722	659575	630505		NC_000002.12:73490721:C:A
NM_015120.4(ALMS1):c.11647_11648del (p.Met3883fs)	ALMS1	M3883fs	Alstrom syndrome	Pathogenic(Last reviewed: Oct 21, 2018)	criteria provided, single submitter	VCV000659336	2	73826624 - 73826625	2	73599497 - 73599498	659336	630517		NC_000002.12:73599496:AT:
NM_015120.4(ALMS1):c.2273del (p.Pro758fs)	ALMS1	P758fs	Alstrom syndrome	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000655483	2	73675923	2	73448796	655483	630484		NC_000002.12:73448795:CC:C
NM_015120.4(ALMS1):c.60_61insTAGGAG (p.Glu21Ter)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000653256	2	73613048 - 73613049	2	73385920 - 73385921	653256	630479		NC_000002.12:73385920:AGGAG:AGGAGTAGGAG
NM_015120.4(ALMS1):c.11450_11451AG[1] (p.Arg3818fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000652293	2	73800451 - 73800452	2	73573324 - 73573325	652293	630515		NC_000002.12:73573323:AGAG:AG
NM_015120.4(ALMS1):c.3870T>G (p.Tyr1290Ter)	ALMS1	Y1290*	Alstrom syndrome	Pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, single submitter	VCV000648250	2	73677521	2	73450394	648250	630487		NC_000002.12:73450393:T:G
NM_015120.4(ALMS1):c.5735del (p.Pro1912fs)	ALMS1	P1912fs	Alstrom syndrome	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000646515	2	73679385	2	73452258	646515	630493		NC_000002.12:73452257:CC:C
NM_015120.4(ALMS1):c.11726del (p.Thr3909fs)	ALMS1	T3909fs	Alstrom syndrome	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000645734	2	73827859	2	73600732	645734	630519		NC_000002.12:73600731:C:
NM_015120.4(ALMS1):c.6850dup (p.Leu2284fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000583303	2	73680497 - 73680498	2	73453370 - 73453371	583303	558652	rs1558651349	NC_000002.12:73453370:CCCC:CCCCC
NM_015120.4(ALMS1):c.9422_9423del (p.Gln3141fs)	ALMS1	Q3141fs	Alstrom syndrome	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000566263	2	73718505 - 73718506	2	73491378 - 73491379	566263	562025	rs1558667882	NC_000002.12:73491377:AG:
NM_015120.4(ALMS1):c.7090del (p.Leu2364fs)	ALMS1	L2364fs	Alstrom syndrome	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000559893	2	73680741	2	73453614	559893	550590	rs1553404395	NC_000002.12:73453613:C:
NM_015120.4(ALMS1):c.6411_6412insCCTA (p.Ala2138fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000559892	2	73680061 - 73680062	2	73452934 - 73452935	559892	550589	rs1553404233	NC_000002.12:73452934:A:ACCTA
NM_015120.4(ALMS1):c.11385del (p.Phe3795fs)	ALMS1	F3795fs	Alstrom syndrome	Pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000551457	2	73800383	2	73573256	551457	542762	rs768759374	NC_000002.12:73573255:TTTT:TTT
NM_015120.4(ALMS1):c.8394dup (p.Leu2799fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000550848	2	73717472 - 73717473	2	73490345 - 73490346	550848	542611	rs1553409715	NC_000002.12:73490345:AAAAA:AAAAAA
NM_015120.4(ALMS1):c.11651_11652insGTTA (p.Asn3885fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Feb 8, 2017)	criteria provided, single submitter	VCV000550627	2	73826628 - 73826629	2	73599501 - 73599502	550627	542856	rs760264695	NC_000002.12:73599501::GTTA
NM_015120.4(ALMS1):c.5630dup (p.Gly1878fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	VCV000550511	2	73679280 - 73679281	2	73452153 - 73452154	550511	542513	rs1553404109	NC_000002.12:73452153:T:TT
NM_015120.4(ALMS1):c.11787G>A (p.Trp3929Ter)	ALMS1	W3929*	Alstrom syndrome	Pathogenic(Last reviewed: Apr 19, 2017)	criteria provided, single submitter	VCV000545448	2	73827920	2	73600793	545448	535698	rs1318520999	NC_000002.12:73600792:G:A
NM_015120.4(ALMS1):c.7674+1G>A	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Apr 19, 2017)	criteria provided, single submitter	VCV000545447	2	73682423	2	73455296	545447	535697	rs1417025395	NC_000002.12:73455295:G:A
NM_015120.4(ALMS1):c.4393C>T (p.Gln1465Ter)	ALMS1	Q1465*	Alstrom syndrome	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000529397	2	73678044	2	73450917	529397	518655	rs904289501	NC_000002.12:73450916:C:T
NM_015120.4(ALMS1):c.6375del (p.Pro2126fs)	ALMS1	P2126fs	Alstrom syndrome	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000529396	2	73680025	2	73452898	529396	518744	rs1553404220	NC_000002.12:73452897:TT:T
NM_015120.4(ALMS1):c.563dup (p.Ser190fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000529371	2	73646358 - 73646359	2	73419230 - 73419231	529371	518715	rs1439541639	NC_000002.12:73419230:TT:TTT
NM_015120.4(ALMS1):c.4183C>T (p.Gln1395Ter)	ALMS1	Q1395*	Alstrom syndrome	Pathogenic(Last reviewed: Apr 10, 2017)	criteria provided, single submitter	VCV000459866	2	73677834	2	73450707	459866	451643	rs969786171	NC_000002.12:73450706:C:T
NM_015120.4(ALMS1):c.1819G>T (p.Gly607Ter)	ALMS1	G607*	Alstrom syndrome	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000459853	2	73675470	2	73448343	459853	451845	rs1553403321	NC_000002.12:73448342:G:T
NM_015120.4(ALMS1):c.11418_11422AATTA[1] (p.Lys3808fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Apr 10, 2017)	criteria provided, single submitter	VCV000459849	2	73800419 - 73800423	2	73573292 - 73573296	459849	451668	rs1553418609	NC_000002.12:73573291:AATTAAATTA:AATTA
NM_015120.4(ALMS1):c.9116del (p.Pro3039fs)	ALMS1	P3039fs	Alstrom syndrome	Pathogenic(Last reviewed: Dec 21, 2016)	no assertion criteria provided	VCV000438278	2	73718198	2	73491071	438278	431905	rs1425609364	NC_000002.12:73491070:CC:C
NM_015120.4(ALMS1):c.3300_3301del (p.Lys1103fs)	ALMS1	K1103fs	Alstrom syndrome	Pathogenic(Last reviewed: Dec 21, 2016)	no assertion criteria provided	VCV000438277	2	73676950 - 73676951	2	73449823 - 73449824	438277	431904	rs1553403653	NC_000002.12:73449822:AAA:A
NM_015120.4(ALMS1):c.4648dup (p.Arg1550fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Sep 6, 2017)	no assertion criteria provided	VCV000437922	2	73678298 - 73678299	2	73451171 - 73451172	437922	431545	rs1553403917	NC_000002.12:73451171:A:AA
NM_015120.4(ALMS1):c.363_366dup (p.Tyr123fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Dec 27, 2016)	criteria provided, single submitter	VCV000403953	2	73635784 - 73635785	2	73408656 - 73408657	403953	393242	rs753301358	NC_000002.12:73408656:AGTA:AGTAAGTA
NM_015120.4(ALMS1):c.7247C>A (p.Ser2416Ter)	ALMS1	S2416*	Alstrom syndrome	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000403943	2	73680898	2	73453771	403943	393090	rs1060500039	NC_000002.12:73453770:C:A
NM_015120.4(ALMS1):c.10303delinsGA (p.Gln3435fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Oct 9, 2016)	criteria provided, single submitter	VCV000403929	2	73786185	2	73559058	403929	393112	rs1060500034	NC_000002.12:73559057:C:GA
NM_015120.4(ALMS1):c.5590C>T (p.Gln1864Ter)	ALMS1	Q1864*	Alstrom syndrome	Pathogenic(Last reviewed: Oct 9, 2016)	criteria provided, single submitter	VCV000403915	2	73679241	2	73452114	403915	393456	rs769440001	NC_000002.12:73452113:C:T
NM_015120.4(ALMS1):c.9433dup (p.Thr3145fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Dec 25, 2015)	criteria provided, single submitter	VCV000241016	2	73718512 - 73718513	2	73491385 - 73491386	241016	239006	rs878855003	NC_000002.12:73491385:AAAA:AAAAA
ALMS1, 333-BP ALU INS, EX16	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000037246					37246	45839		
NM_015120.4(ALMS1):c.10992G>A (p.Trp3664Ter)	ALMS1	W3664*	Alstrom syndrome	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000003974	2	73799993	2	73572866	3974	19013	rs193919339	NC_000002.12:73572865:G:A
NM_015120.4(ALMS1):c.8383C>T (p.Gln2795Ter)	ALMS1	E2795*, Q2795*	Alstrom syndrome	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000003970	2	73717466	2	73490339	3970	19009	rs193919338	NC_000002.12:73490338:C:T
NM_015120.4(ALMS1):c.7402G>T (p.Glu2468Ter)	ALMS1	E2467*, E2468*	Alstrom syndrome	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000858665	2	73681053	2	73453926	858665	827006		NC_000002.12:73453925:G:T
NM_015120.4(ALMS1):c.3054G>A (p.Trp1018Ter)	ALMS1	W1017*, W1018*	Alstrom syndrome	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV000851909	2	73676705	2	73449578	851909	826987		NC_000002.12:73449577:G:A
NM_015120.4(ALMS1):c.7436C>G (p.Ser2479Ter)	ALMS1	S2478*, S2479*	Alstrom syndrome	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000849601	2	73681087	2	73453960	849601	827009		NC_000002.12:73453959:C:G
NM_015120.4(ALMS1):c.4823dup (p.Thr1609fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000842644	2	73678467 - 73678468	2	73451340 - 73451341	842644	826995		NC_000002.12:73451340:AAAAAAA:AAAAAAAA
NM_015120.4(ALMS1):c.10674_10677del (p.Lys3558_Glu3559insTer)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000835838	2	73799673 - 73799676	2	73572546 - 73572549	835838	827021		NC_000002.12:73572545:AAAGAA:AA
NM_015120.4(ALMS1):c.3575del (p.Phe1192fs)	ALMS1	F1192fs	Alstrom syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000599289	2	73677225	2	73450098	599289	590553	rs1558648759	NC_000002.12:73450097:TT:T
NM_015120.4(ALMS1):c.9541C>T (p.Arg3181Ter)	ALMS1	R3181*	Alstrom syndrome	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000583154	2	73718624	2	73491497	583154	558277	rs563393715	NC_000002.12:73491496:C:T
NM_015120.4(ALMS1):c.806_808del (p.Ser269_Arg270delinsTer)	ALMS1		Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000558330	2	73651596 - 73651598	2	73424468 - 73424470	558330	542388	rs758952057	NC_000002.12:73424467:CTC:
NM_015120.4(ALMS1):c.362_363del (p.Ile121fs)	ALMS1	I121fs	Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557521	2	73635783 - 73635784	2	73408655 - 73408656	557521	542360	rs1553398842	NC_000002.12:73408654:ATA:A
NM_015120.4(ALMS1):c.9900dup (p.Ser3301fs)	ALMS1		Alstrom syndrome|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000556350	2	73762065 - 73762066	2	73534938 - 73534939	556350	542576	rs754702823	NC_000002.12:73534938:C:CC
NM_015120.4(ALMS1):c.10788_10789TG[1] (p.Val3597fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000556135	2	73799789 - 73799790	2	73572662 - 73572663	556135	542747	rs1218465638	NC_000002.12:73572661:TGTG:TG
NM_015120.4(ALMS1):c.712G>T (p.Glu238Ter)	ALMS1	E238*	Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555777	2	73650047	2	73422919	555777	542190	rs989080548	NC_000002.12:73422918:G:T
NM_015120.4(ALMS1):c.10134dup (p.Gln3379fs)	ALMS1		Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000555428	2	73784393 - 73784394	2	73557266 - 73557267	555428	542600	rs1553416867	NC_000002.12:73557266:AAAAAA:AAAAAAA
NM_015120.4(ALMS1):c.10800_10803del	ALMS1		Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553426	2	73799797 - 73799800	2	73572670 - 73572673	553426	542632	rs1553418500	NC_000002.12:73572669:TGAATGAA:TGAA
NM_015120.4(ALMS1):c.10829_10830AG[1] (p.Arg3611fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, single submitter	VCV000552413	2	73799830 - 73799831	2	73572703 - 73572704	552413	542754	rs755616266	NC_000002.12:73572702:AGAG:AG
NM_015120.4(ALMS1):c.8144_8151del (p.Ser2715fs)	ALMS1	S2715fs	Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552097	2	73717225 - 73717232	2	73490098 - 73490105	552097	542481	rs1553409686	NC_000002.12:73490097:CTCCATCACT:CT
NM_015120.4(ALMS1):c.3690_3691del (p.Gly1231fs)	ALMS1	G1231fs	Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551692	2	73677341 - 73677342	2	73450214 - 73450215	551692	542331	rs1296683633	NC_000002.12:73450213:TG:
NM_015120.4(ALMS1):c.430C>T (p.Gln144Ter)	ALMS1	Q144*	Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551028	2	73635852	2	73408724	551028	542158	rs150825781	NC_000002.12:73408723:C:T
NM_015120.4(ALMS1):c.4913_4916TAAA[1] (p.Asn1639fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Mar 22, 2017)	criteria provided, single submitter	VCV000550038	2	73678564 - 73678567	2	73451437 - 73451440	550038	542501	rs779366889	NC_000002.12:73451436:TAAATAAA:TAAA
NM_015120.4(ALMS1):c.6167_6168AT[3] (p.Leu2058fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000529393	2	73679817 - 73679818	2	73452690 - 73452691	529393	518583	rs759603306	NC_000002.12:73452690:ATAT:ATATAT
NM_015120.4(ALMS1):c.10825C>T (p.Arg3609Ter)	ALMS1	R3609*	not provided|Alstrom syndrome	Pathogenic(Last reviewed: Oct 20, 2017)	criteria provided, single submitter	VCV000488677	2	73799826	2	73572699	488677	481663	rs1192396248	NC_000002.12:73572698:C:T
NM_015120.4(ALMS1):c.7302_7303AG[1] (p.Glu2435fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000459884	2	73680953 - 73680954	2	73453826 - 73453827	459884	451654	rs1246023978	NC_000002.12:73453825:AGAG:AG
NM_015120.4(ALMS1):c.3019dup (p.Arg1007fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000240992	2	73676669 - 73676670	2	73449542 - 73449543	240992	238986	rs878854998	NC_000002.12:73449542:A:AA
NM_015120.4(ALMS1):c.10945G>T (p.Glu3649Ter)	ALMS1	E3649*	Alstrom syndrome	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000039748	2	73799946	2	73572819	39748	48347	rs397514576	NC_000002.12:73572818:G:T
NM_001128425.1(MUTYH):c.43A>G (p.Met15Val)	MUTYH	M15V, M1V	MYH-associated polyposis	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000641313	1	45800177	1	45334505	641313	628112		NC_000001.11:45334504:T:C
NM_001048171.1(MUTYH):c.517C>T (p.Gln173Ter)	MUTYH	Q187*, Q173*, Q170*, Q184*, Q159*, Q174*, Q67*, Q160*, Q44*	MYH-associated polyposis	Pathogenic/Likely pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000554017	1	45798452	1	45332780	554017	541068	rs1553128813	NC_000001.11:45332779:G:A
NM_012222.2(MUTYH):c.1271_1280del (p.Trp424fs)	MUTYH	W307fs, W284fs, W400fs, W410fs, W414fs, W424fs, W399fs, W427fs, W413fs	MYH-associated polyposis	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000533306	1	45797126 - 45797135	1	45331454 - 45331463	533306	516064	rs1553125677	NC_000001.11:45331453:GGCCCAGCCC:
NM_001350650.1(MUTYH):c.33+147del	MUTYH	Q114fs, Q138fs, Q141fs, Q113fs, Q127fs, Q128fs, Q124fs, Q21fs	MYH-associated polyposis	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000464719	1	45798810	1	45333138	464719	448163	rs1553129638	NC_000001.11:45333137:GGG:GG
NM_001128425.1(MUTYH):c.348+33_*210delinsTA	MUTYH		MYH-associated polyposis	Pathogenic(Last reviewed: Sep 24, 2015)	no assertion criteria provided	VCV000030441	1	45794768 - 45799052	1	45329096 - 45333380	30441	39398		
NM_015120.4(ALMS1):c.2090C>A (p.Ser697Ter)	ALMS1	S696*, S697*	Alstrom syndrome	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000863290	2	73675741	2	73448614	863290	826982		NC_000002.12:73448613:C:A
NM_015120.4(ALMS1):c.592C>T (p.Gln198Ter)	ALMS1	Q197*, Q198*	Alstrom syndrome	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000854725	2	73646389	2	73419261	854725	826978		NC_000002.12:73419260:C:T
NM_015120.4(ALMS1):c.6800T>A (p.Leu2267Ter)	ALMS1	L2267*	Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000554903	2	73680451	2	73453324	554903	542399	rs761071372	NC_000002.12:73453323:T:A
NM_015120.4(ALMS1):c.11314_11315AG[1] (p.Glu3773fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550797	2	73800315 - 73800318	2	73573188 - 73573191	550797	542838	rs747272625	NC_000002.12:73573187:AGAGAG:AG
NM_015120.4(ALMS1):c.5200C>T (p.Gln1734Ter)	ALMS1	Q1734*	not provided|Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000529398	2	73678851	2	73451724	529398	518733	rs750136202	NC_000002.12:73451723:C:T
NM_015120.4(ALMS1):c.2822T>A (p.Leu941Ter)	ALMS1	L941*	Alstrom syndrome	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000224801	2	73676473	2	73449346	224801	226620	rs539612316	NC_000002.12:73449345:T:A
NM_015120.4(ALMS1):c.1900C>T (p.Gln634Ter)	ALMS1	Q634*, Q633*	not provided|Alstrom syndrome	Pathogenic	criteria provided, single submitter	VCV000092240	2	73675551	2	73448424	92240	98152	rs398122995	NC_000002.12:73448423:C:T
NM_015120.4(ALMS1):c.5926del (p.Glu1976fs)	ALMS1	E1976fs	not provided|Alstrom syndrome	Pathogenic	criteria provided, single submitter	VCV000092193	2	73679577	2	73452450	92193	97583	rs398122994	NC_000002.12:73452449:G:
NM_015120.4(ALMS1):c.4292_4293CA[2] (p.His1432fs)	ALMS1		Alstrom syndrome|not provided	Pathogenic	criteria provided, single submitter	VCV000092192	2	73677943 - 73677946	2	73450816 - 73450819	92192	97582	rs398122993	NC_000002.12:73450815:CACACACA:CACA
NM_015120.4(ALMS1):c.11116_11134del (p.Arg3706fs)	ALMS1	R3706fs	not provided|Alstrom syndrome	Pathogenic	criteria provided, single submitter	VCV000092191	2	73800117 - 73800135	2	73572990 - 73573008	92191	97581	rs398122992	NC_000002.12:73572989:AGGTCTAATCAAATTAAAA:
NM_015120.4(ALMS1):c.8164C>T (p.Arg2722Ter)	ALMS1	R2722*	Alstrom syndrome	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000003975	2	73717247	2	73490120	3975	19014	rs193919340	NC_000002.12:73490119:C:T
NM_015120.4(ALMS1):c.2137_2138CT[2] (p.Ser714fs)	ALMS1		not provided|Alstrom syndrome	Pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, single submitter	VCV000003972	2	73675788 - 73675789	2	73448661 - 73448662	3972	19011	rs387906313	NC_000002.12:73448660:CTCTCT:CTCT
ALMS1, 19-BP INS	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000003969					3969	19008		
NM_001276345.2(TNNT2):c.548G>A (p.Arg183Gln)	TNNT2	R173Q, R183Q, R143Q, R168Q	not provided|Familial restrictive cardiomyopathy 3|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Primary dilated cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043649	1	201332476	1	201363348	43649	52818	rs397516471	NC_000001.11:201363347:C:T
NM_001130987.2(DYSF):c.1116C>A (p.Ser372Arg)	DYSF	S372R, S340R, S371R, S341R	Autosomal recessive limb-girdle muscular dystrophy type 2B|Qualitative or quantitative defects of dysferlin	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551891	2	71748001	2	71520871	551891	542153	rs766891289	NC_000002.12:71520870:C:A
NM_001130987.2(DYSF):c.1264G>A (p.Asp422Asn)	DYSF	D422N, D390N, D391N, D421N	not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B|Qualitative or quantitative defects of dysferlin	Pathogenic/Likely pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000282410	2	71753464	2	71526334	282410	266647	rs886042389	NC_000002.12:71526333:G:A
NM_001130987.2(DYSF):c.268C>T (p.Arg90Ter)	DYSF	R89*, R90*	not provided|Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000197217	2	71730372	2	71503242	197217	194378	rs794727636	NC_000002.12:71503241:C:T
NM_001130987.2(DYSF):c.5626G>A (p.Asp1876Asn)	DYSF	D1837N, D1858N, D1876N, D1823N, D1824N, D1845N, D1875N, D1844N, D1854N, D1855N, D1859N, D1868N, D1869N, D1838N	Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000094340	2	71896321	2	71669191	94340	100240	rs398123794	NC_000002.12:71669190:G:A
NM_015120.4(ALMS1):c.1199_1205del (p.Thr400fs)	ALMS1	T400fs	Alstrom syndrome|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000555656	2	73651986 - 73651992	2	73424858 - 73424864	555656	542490	rs761292021	NC_000002.12:73424857:GGACACAGGA:GGA
NM_015120.4(ALMS1):c.358C>T (p.Gln120Ter)	ALMS1	Q120*	Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000550543	2	73635780	2	73408652	550543	542438	rs751804613	NC_000002.12:73408651:C:T
NM_015120.4(ALMS1):c.6571_6574del (p.Ser2191fs)	ALMS1	S2191fs	Alstrom syndrome	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000434133	2	73680220 - 73680223	2	73453093 - 73453096	434133	428091	rs1034630858	NC_000002.12:73453092:ACTCAC:AC
NM_015120.4(ALMS1):c.11207C>A (p.Ser3736Ter)	ALMS1	S3736*	Alstrom syndrome|not provided	Pathogenic(Last reviewed: Apr 5, 2016)	criteria provided, single submitter	VCV000280474	2	73800208	2	73573081	280474	264140	rs367877017	NC_000002.12:73573080:C:A
NM_003036.4(SKI):c.100G>T (p.Gly34Cys)	SKI	G34C	Inborn genetic diseases|Shprintzen-Goldberg syndrome	Pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000037262	1	2160305	1	2228866	37262	45852	rs387907306	NC_000001.11:2228865:G:T
NM_000090.4(COL3A1):c.1654G>A (p.Gly552Arg)	COL3A1	G552R	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000847405	2	189860896	2	188996170	847405	825473		NC_000002.12:188996169:G:A
NM_000090.3(COL3A1):c.845G>T (p.Gly282Val)	COL3A1	G282V	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000664376	2	189855776	2	188991050	664376	629189		NC_000002.12:188991049:G:T
NM_000090.3(COL3A1):c.826G>A (p.Gly276Ser)	COL3A1	G276S	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000659067	2	189855757	2	188991031	659067	629186		NC_000002.12:188991030:G:A
NM_000090.3(COL3A1):c.2051G>A (p.Gly684Glu)	COL3A1	G684E	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000650784	2	189864039	2	188999313	650784	629197		NC_000002.12:188999312:G:A
NM_000090.3(COL3A1):c.619G>T (p.Gly207Trp)	COL3A1	G207W	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000459795	2	189853352	2	188988626	459795	450408	rs1553507274	NC_000002.12:188988625:G:T
NM_000090.3(COL3A1):c.3194G>A (p.Gly1065Glu)	COL3A1	G1065E	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000459785	2	189871171	2	189006445	459785	450431	rs1553509430	NC_000002.12:189006444:G:A
NM_000090.3(COL3A1):c.811C>T (p.Arg271Ter)	COL3A1	R271*	not provided|Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000381616	2	189855742	2	188991016	381616	365926	rs1057521106	NC_000002.12:188991015:C:T
NM_000090.3(COL3A1):c.1149+1G>A (p.Gly351_Pro383del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000017203	2	189858186	2	188993460	17203	32242	rs587779443	NC_000002.12:188993459:G:A
NM_003000.2(SDHB):c.88del (p.Gln30fs)	SDHB	Q30fs	Hereditary cancer-predisposing syndrome|Pheochromocytoma|Paragangliomas 4|Gastrointestinal stromal tumor|Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000186518	1	17371368	1	17044873	186518	181625	rs747198089	NC_000001.11:17044872:GGG:GG
NM_001204.7(BMPR2):c.994C>T (p.Arg332Ter)	BMPR2	R332*	not specified|Pulmonary arterial hypertension|not provided|Primary pulmonary hypertension	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008810	2	203395543	2	202530820	8810	23849	rs137852751	NC_000002.12:202530819:C:T
NM_015120.4(ALMS1):c.11449C>T (p.Gln3817Ter)	ALMS1	Q3817*	not provided|Alstrom syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620477	2	73800450	2	73573323	620477	611575	rs940576720	NC_000002.12:73573322:C:T
NM_015120.4(ALMS1):c.7375_7376del (p.Thr2458_Asp2459insTer)	ALMS1		Retinal dystrophy|Alstrom syndrome	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000550572	2	73681025 - 73681026	2	73453898 - 73453899	550572	542420	rs1225343345	NC_000002.12:73453897:AGA:A
NM_015120.4(ALMS1):c.1054C>T (p.Arg352Ter)	ALMS1	R352*	Alstrom syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000459845	2	73651844	2	73424716	459845	451767	rs1275113273	NC_000002.12:73424715:C:T
NM_015120.4(ALMS1):c.10885C>T (p.Arg3629Ter)	ALMS1	R3629*	Alstrom syndrome	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000434136	2	73799886	2	73572759	434136	428097	rs1473611414	NC_000002.12:73572758:C:T
NM_015120.4(ALMS1):c.4156dup (p.Thr1386fs)	ALMS1		Alstrom syndrome	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000210127	2	73677806 - 73677807	2	73450679 - 73450680	210127	207020	rs797045228	NC_000002.12:73450679:A:AA
NM_015120.4(ALMS1):c.1794_1801dup (p.Lys601delinsArgLeuTer)	ALMS1		not provided|Retinal dystrophy|Alstrom syndrome	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092190	2	73675442 - 73675443	2	73448315 - 73448316	92190	97580	rs398122991	NC_000002.12:73448315:GAGGCTTTGA:GAGGCTTTGAGGCTTTGA
NM_000478.6(ALPL):c.407G>A (p.Arg136His)	ALPL	R119H, R136H, R59H, R81H	Hypophosphatasia|Adult hypophosphatasia|Childhood hypophosphatasia|not provided|Infantile hypophosphatasia	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013675	1	21889712	1	21563219	13675	28714	rs121918011	NC_000001.11:21563218:G:A
NM_000329.3(RPE65):c.1102T>C (p.Tyr368His)	RPE65	Y368H	Leber congenital amaurosis 2|Retinitis pigmentosa 20|RPE65-Related Disorders|Retinitis pigmentosa|Leber congenital amaurosis 2|Retinitis pigmentosa 20|not provided	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000029870	1	68903896	1	68438213	29870	38825	rs62653011	NC_000001.11:68438212:A:G
NM_015120.4(ALMS1):c.6590del (p.Lys2197fs)	ALMS1	K2197fs	Alstrom syndrome	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000557712	2	73680240	2	73453113	557712	542582	rs1553404283	NC_000002.12:73453112:AA:A
NM_015120.4(ALMS1):c.8008C>T (p.Arg2670Ter)	ALMS1	R2670*	Alstrom syndrome|not provided	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000529386	2	73717091	2	73489964	529386	518587	rs549857076	NC_000002.12:73489963:C:T
NM_015120.4(ALMS1):c.10483C>T (p.Gln3495Ter)	ALMS1	Q3495*	Alstrom syndrome	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000210122	2	73799484	2	73572357	210122	207024	rs772624348	NC_000002.12:73572356:C:T
NM_031844.3(HNRNPU):c.2085dup (p.Gly696fs)	HNRNPU		Inborn genetic diseases|History of neurodevelopmental disorder	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000521108	1	245019287 - 245019288	1	244855985 - 244855986	521108	511259	rs1553282235	NC_000001.11:244855985:A:AA
NM_012222.2(MUTYH):c.1015_1037del (p.Cys339fs)	MUTYH	C222fs, C314fs, C315fs, C328fs, C329fs, C339fs, C342fs, C199fs, C325fs	MYH-associated polyposis	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000533319	1	45797473 - 45797495	1	45331801 - 45331823	533319	515947	rs1553126848	NC_000001.11:45331800:CAGGGCTCCGAGGGAGGCAGGCACAGG:CAGG
NM_012222.2(MUTYH):c.1312del (p.Glu438fs)	MUTYH	E424fs, E438fs, E413fs, E298fs, E414fs, E441fs, E321fs, E427fs, E428fs	not provided|MYH-associated polyposis	Pathogenic/Likely pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000421975	1	45797094	1	45331422	421975	405190	rs1064795480	NC_000001.11:45331421:CCCC:CCC
NM_012222.2(MUTYH):c.707_712delinsCAGCTGCT (p.Val236fs)	MUTYH		MYH-associated polyposis|not provided	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000418342	1	45798130 - 45798135	1	45332458 - 45332463	418342	405197	rs1064793197	NC_000001.11:45332457:GTGCTA:AGCAGCTG
NM_001128425.1(MUTYH):c.1281G>A (p.Trp427Ter)	MUTYH	W427*, W413*, W307*, W400*, W414*, W424*, W284*, W410*, W399*	MYH-associated polyposis|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000406830	1	45797134	1	45331462	406830	391443	rs1060501325	NC_000001.11:45331461:C:T
NM_001130987.2(DYSF):c.4076T>C (p.Leu1359Pro)	DYSF	L1341P, L1359P, L1328P, L1342P, L1327P, L1372P, L1358P, L1373P	Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555968	2	71838611	2	71611481	555968	542183	rs757917335	NC_000002.12:71611480:T:C
NM_001130987.2(DYSF):c.1225C>T (p.Arg409Ter)	DYSF	R377*, R409*, R378*, R408*	Qualitative or quantitative defects of dysferlin|not provided|DYSF- Related Disorder|Miyoshi muscular dystrophy 1|Myopathy, distal, with anterior tibial onset|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265487	2	71753425	2	71526295	265487	259744	rs758180890	NC_000002.12:71526294:C:T
NM_001130987.2(DYSF):c.3095A>G (p.Tyr1032Cys)	DYSF	Y1014C, Y1032C, Y1015C, Y1031C, Y1046C, Y1000C, Y1001C, Y1045C	Qualitative or quantitative defects of dysferlin|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000196175	2	71797738	2	71570608	196175	193336	rs756328339	NC_000002.12:71570607:A:G
NM_001130987.2(DYSF):c.4873C>T (p.Arg1625Ter)	DYSF	R1586*, R1607*, R1625*, R1572*, R1594*, R1603*, R1604*, R1608*, R1624*, R1587*, R1573*, R1593*, R1617*, R1618*	Qualitative or quantitative defects of dysferlin|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094330	2	71886125	2	71658995	94330	100230	rs398123789	NC_000002.12:71658994:C:T
NM_001130987.2(DYSF):c.991G>A (p.Gly331Arg)	DYSF	G299R, G331R, G300R, G330R	not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000006681	2	71744158	2	71517028	6681	21720	rs121908963	NC_000002.12:71517027:G:A
NM_001130987.2(DYSF):c.3051G>T (p.Trp1017Cys)	DYSF	W999C, W1017C, W1000C, W1030C, W1031C, W1016C, W985C, W986C	not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B|Miyoshi muscular dystrophy 1	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000006674	2	71797430	2	71570300	6674	21713	rs28937581	NC_000002.12:71570299:G:T
NM_001130987.2(DYSF):c.2426C>G (p.Pro809Arg)	DYSF	P791R, P809R, P792R, P822R, P808R, P777R, P778R, P823R	Miyoshi muscular dystrophy 1|Qualitative or quantitative defects of dysferlin|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006671	2	71791204	2	71564074	6671	21710	rs121908956	NC_000002.12:71564073:C:G
NM_001130987.2(DYSF):c.4989_4993delinsCCCC (p.Glu1663fs)	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006669	2	71887767 - 71887771	2	71660637 - 71660641	6669	21708	rs786200896	NC_000002.12:71660636:GCCCG:CCCC
NM_015120.4(ALMS1):c.11618_11619del	ALMS1		Alstrom syndrome|Retinal dystrophy	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000553694	2	73826593 - 73826594	2	73599466 - 73599467	553694	542799	rs1476205467	NC_000002.12:73599465:CTCT:CT
NM_170707.4(LMNA):c.94_96del (p.Lys32del)	LMNA	K32del	Congenital muscular dystrophy, LMNA-related|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000066960	1	156084801 - 156084803	1	156115010 - 156115012	66960	77857	rs60872029	NC_000001.11:156115009:AGAAG:AG
NM_000090.3(COL3A1):c.1502G>A (p.Gly501Glu)	COL3A1	G501E	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Feb 18, 2018)	criteria provided, single submitter	VCV000581735	2	189859818	2	188995092	581735	559007	rs1559056621	NC_000002.12:188995091:G:A
NM_000090.3(COL3A1):c.953G>A (p.Gly318Asp)	COL3A1	G318D	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000529315	2	189856911	2	188992185	529315	517425	rs1553507614	NC_000002.12:188992184:G:A
NM_000090.3(COL3A1):c.1786C>T (p.Arg596Ter)	COL3A1	R596*	POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME|not provided|Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000242648	2	189861915	2	188997189	242648	106974	rs587779527	NC_000002.12:188997188:C:T
NM_000090.3(COL3A1):c.2870G>T (p.Gly957Val)	COL3A1	G957V	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000101446	2	189869029	2	189004303	101446	107193	rs587779654	NC_000002.12:189004302:G:T
NM_000090.3(COL3A1):c.2168G>A (p.Gly723Asp)	COL3A1	G723D	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000101292	2	189864242	2	188999516	101292	107038	rs587779581	NC_000002.12:188999515:G:A
NM_000090.3(COL3A1):c.3193G>A (p.Gly1065Arg)	COL3A1	G1065R	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000101273	2	189871170	2	189006444	101273	107019	rs587779563	NC_000002.12:189006443:G:A
NM_015120.4(ALMS1):c.6436C>T (p.Arg2146Ter)	ALMS1	R2146*	Retinal dystrophy|Alstrom syndrome	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000210129	2	73680087	2	73452960	210129	207022	rs770558150	NC_000002.12:73452959:C:T
NM_000702.4(ATP1A2):c.1778G>A (p.Arg593Gln)	ATP1A2	R593Q	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 4, 2016)	criteria provided, single submitter	VCV000520985	1	160100338	1	160130548	520985	511185	rs1553245178	NC_000001.11:160130547:G:A
NM_000702.4(ATP1A2):c.879C>G (p.Ile293Met)	ATP1A2	I293M	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 8, 2015)	criteria provided, single submitter	VCV000520908	1	160097472	1	160127682	520908	511184	rs1553244746	NC_000001.11:160127681:C:G
NC_000001.10:g.(?_45794968)_(45799006_?)del	MUTYH		MYH-associated polyposis	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV000639376	1	45794968 - 45799006	1	45329296 - 45333334	639376	650593		
NM_001048171.1(MUTYH):c.85C>T (p.Gln29Ter)	MUTYH	Q29*, Q15*	Hereditary cancer-predisposing syndrome|MYH-associated polyposis	Pathogenic/Likely pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000555262	1	45800135	1	45334463	555262	541078	rs768386527	NC_000001.11:45334462:G:A
NC_000001.10:g.(?_45794972)_(45799281_?)del	MUTYH		MYH-associated polyposis	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000533333	1	45794972 - 45799281	1	45329300 - 45333609	533333	514878		
NM_001048171.1(MUTYH):c.1005G>A (p.Trp335Ter)	MUTYH	W349*, W335*, W206*, W332*, W336*, W346*, W229*, W321*, W322*	MYH-associated polyposis|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000406829	1	45797472	1	45331800	406829	391291	rs1060501324	NC_000001.11:45331799:C:T
NM_201253.3(CRB1):c.3172G>T (p.Glu1058Ter)	CRB1	E1058*, E1034*, E946*	Inborn genetic diseases|Leber congenital amaurosis 8|Retinitis pigmentosa 12|Stargardt disease	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521051	1	197404165	1	197435035	521051	511211	rs564754426	NC_000001.11:197435034:G:T
NM_001130987.2(DYSF):c.3028T>C (p.Trp1010Arg)	DYSF	W1010R, W992R, W993R, W978R, W979R, W1009R, W1023R, W1024R	Myopathy, distal, with anterior tibial onset|Miyoshi muscular dystrophy 1|Autosomal recessive limb-girdle muscular dystrophy type 2B|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000551236	2	71797407	2	71570277	551236	542336	rs750028300	NC_000002.12:71570276:T:C
NM_001130987.2(DYSF):c.3571dup (p.Ser1191fs)	DYSF		Qualitative or quantitative defects of dysferlin|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370730	2	71817410 - 71817411	2	71590280 - 71590281	370730	357265	rs766341386	NC_000002.12:71590280:TTTTT:TTTTTT
NM_001130987.2(DYSF):c.1033+1G>A	DYSF		not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B|Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094367	2	71747339	2	71520209	94367	100267	rs201869739	NC_000002.12:71520208:G:A
NM_001130987.2(DYSF):c.1464C>A (p.Cys488Ter)	DYSF	C456*, C488*, C457*, C487*	Qualitative or quantitative defects of dysferlin|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000094269	2	71762412	2	71535282	94269	100169	rs202044973	NC_000002.12:71535281:C:A
NM_001276345.2(TNNT2):c.890G>A (p.Trp297Ter)	TNNT2	W287*, W294*, W281*, W284*, W254*, W297*	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|not provided|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Familial hypertrophic cardiomyopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177636	1	201328345	1	201359217	177636	172354	rs727504247	NC_000001.11:201359216:C:T
NM_001276345.2(TNNT2):c.311G>A (p.Arg104His)	TNNT2	R104H, R94H, R89H	Hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype|Familial restrictive cardiomyopathy 3|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043628	1	201334419	1	201365291	43628	52797	rs397516457	NC_000001.11:201365290:C:T
NC_000001.11:g.(?_17018871)_(17033155_?)del	SDHB		Gastrointestinal stromal tumor|Pheochromocytoma|Paragangliomas 4	Pathogenic(Last reviewed: Jun 29, 2019)	criteria provided, single submitter	VCV000830735	1	17345366 - 17359650			830735	818863		
NC_000001.10:g.(?_17345370)_(17359646_?)del	SDHB		Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, single submitter	VCV000583909	1	17345370 - 17359646	1	17018875 - 17033151	583909	556517		
NM_003000.2(SDHB):c.724C>A (p.Arg242Ser)	SDHB	R242S	not provided|Paragangliomas 4|Gastrointestinal stromal tumor|Pheochromocytoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000239443	1	17349144	1	17022649	239443	238171	rs786203251	NC_000001.11:17022648:G:T
NM_001204.7(BMPR2):c.2695C>T (p.Arg899Ter)	BMPR2	R899*	Pulmonary arterial hypertension|Primary pulmonary hypertension|Pulmonary venoocclusive disease 1, autosomal dominant|Primary pulmonary hypertension	Pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008796	2	203421083	2	202556360	8796	23835	rs137852741	NC_000002.12:202556359:C:T
NM_015120.4(ALMS1):c.1735del (p.Arg579fs)	ALMS1	R579fs	Alstrom syndrome|Leukodystrophy|Hearing impairment|Visual impairment|Stage 5 chronic kidney disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000374506	2	73675386	2	73448259	374506	361392	rs777476179	NC_000002.12:73448258:A:
NM_015120.4(ALMS1):c.5145T>G (p.Tyr1715Ter)	ALMS1	Y1715*	not provided|Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000212728	2	73678796	2	73451669	212728	209346	rs772136379	NC_000002.12:73451668:T:G
NM_000642.3(AGL):c.4260-12A>G	AGL		Glycogen storage disease type III|Glycogen storage disease IIIb|Glycogen storage disease IIIa|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001099	1	100381954	1	99916398	1099	16138	rs369973784	NC_000001.11:99916397:A:G
NM_000090.3(COL3A1):c.3112G>C (p.Gly1038Arg)	COL3A1	G1038R	not provided|Ehlers-Danlos syndrome, type 4	Pathogenic/Likely pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000573925	2	189871089	2	189006363	573925	557837	rs1559061706	NC_000002.12:189006362:G:C
NM_000090.3(COL3A1):c.582+5G>A (p.Gly177_Pro194del)	COL3A1		not provided|Ehlers-Danlos syndrome, type 4	Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000101425	2	189852865	2	188988139	101425	107172	rs587779671	NC_000002.12:188988138:G:A
NM_000090.3(COL3A1):c.1347+1G>A (p.Arg449_Gly450insValSerPheThrAlaThrAspLeu+)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000017202	2	189859321	2	188994595	17202	32241	rs397509370	NC_000002.12:188994594:G:A
NM_000478.6(ALPL):c.1133A>T (p.Asp378Val)	ALPL	D378V, D301V, D323V	Hypophosphatasia|Adult hypophosphatasia|not provided|Adult hypophosphatasia|Infantile hypophosphatasia|Childhood hypophosphatasia|Infantile hypophosphatasia	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013671	1	21902361	1	21575868	13671	28710	rs121918008	NC_000001.11:21575867:A:T
NM_000784.4(CYP27A1):c.1016C>T (p.Thr339Met)	CYP27A1	T339M	Cholestanol storage disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004266	2	219677818	2	218813095	4266	19305	rs121908102	NC_000002.12:218813094:C:T
NM_170707.4(LMNA):c.904_905CT[2] (p.Ser303fs)	LMNA		Charcot-Marie-Tooth disease, type 2|not provided|Dilated cardiomyopathy 1A|Dilated cardiomyopathy 1S	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000066955	1	156105071 - 156105072	1	156135280 - 156135281	66955	77852	rs59684335	NC_000001.11:156135279:CTCTCT:CTCT
NM_170707.4(LMNA):c.244G>A (p.Glu82Lys)	LMNA	E82K	Charcot-Marie-Tooth disease, type 2|Primary dilated cardiomyopathy|not provided	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066882	1	156084953	1	156115162	66882	77779	rs59270054	NC_000001.11:156115161:G:A
NM_014946.3(SPAST):c.1495C>T (p.Arg499Cys)	SPAST	R499C, R467C, R498C, R466C	not provided|Spastic paraplegia 4, autosomal dominant|Spastic paraparesis	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000005660	2	32366974	2	32141905	5660	20699	rs121908511	NC_000002.12:32141904:C:T
NM_001128425.1(MUTYH):c.688C>T (p.Gln230Ter)	MUTYH	Q230*, Q203*, Q87*, Q213*, Q216*, Q202*, Q217*, Q110*, Q227*	MYH-associated polyposis|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000423786	1	45798248	1	45332576	423786	405200	rs1064796630	NC_000001.11:45332575:G:A
NM_001128425.1(MUTYH):c.463-1G>A	MUTYH		MYH-associated polyposis|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000379599	1	45798632	1	45332960	379599	365260	rs1057520660	NC_000001.11:45332959:C:T
NM_001128425.1(MUTYH):c.463A>T (p.Lys155Ter)	MUTYH	K155*, K128*, K152*, K35*, K12*, K142*, K127*, K138*, K141*	Hereditary cancer-predisposing syndrome|MYH-associated polyposis|not provided	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000234000	1	45798631	1	45332959	234000	232267	rs876660787	NC_000001.11:45332958:T:A
NM_000143.3(FH):c.1093A>G (p.Ser365Gly)	FH	S365G	not provided|Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000214374	1	241667357	1	241504057	214374	210670	rs863223966	NC_000001.11:241504056:T:C
NM_000143.3(FH):c.301C>T (p.Arg101Ter)	FH	R58*, R101*	not provided|Fumarase deficiency|Hereditary cancer-predisposing syndrome|Hereditary leiomyomatosis and renal cell cancer	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016232	1	241676980	1	241513680	16232	31271	rs121913120	NC_000001.11:241513679:G:A
NM_001130987.2(DYSF):c.5419C>T (p.Arg1807Trp)	DYSF	R1768W, R1807W, R1785W, R1769W, R1775W, R1800W, R1806W, R1754W, R1755W, R1790W, R1776W, R1786W, R1789W, R1799W	not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B|Qualitative or quantitative defects of dysferlin	Pathogenic/Likely pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000286151	2	71894607	2	71667477	286151	270388	rs746243052	NC_000002.12:71667476:C:T
NM_001130987.2(DYSF):c.4254dup (p.Ile1419fs)	DYSF		not provided|Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094320	2	71839796 - 71839797	2	71612666 - 71612667	94320	100220	rs398123786	NC_000002.12:71612666:CCCCCCC:CCCCCCCC
NM_006920.6(SCN1A):c.1354A>T (p.Lys452Ter)	SCN1A	K452*	not provided	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000620251	2	166903303	2	166046793	620251	611542	rs1553546668	NC_000002.12:166046792:T:A
NM_006920.6(SCN1A):c.1378C>T (p.Gln460Ter)	SCN1A	Q460*	not provided	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000620092	2	166901837	2	166045327	620092	611541	rs1559221910	NC_000002.12:166045326:G:A
NM_006920.6(SCN1A):c.1118T>A (p.Leu373Ter)	SCN1A	L373*	History of neurodevelopmental disorder	Pathogenic(Last reviewed: Dec 9, 2016)	criteria provided, single submitter	VCV000590199	2	166904189	2	166047679	590199	578980	rs1553547448	NC_000002.12:166047678:A:T
NM_006920.6(SCN1A):c.1462_1466del (p.Lys488fs)	SCN1A	K487fs, K488fs	not provided	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000504041	2	166901749 - 166901753	2	166045239 - 166045243	504041	495351	rs1553545742	NC_000002.12:166045238:AACTTA:A
NM_006920.6(SCN1A):c.607_611del (p.Val203fs)	SCN1A	V203fs	not provided	Pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	VCV000504036	2	166909445 - 166909449	2	166052935 - 166052939	504036	495354	rs1553550625	NC_000002.12:166052934:GTGACGT:GT
NM_006920.6(SCN1A):c.1177del (p.Arg393fs)	SCN1A	R393fs	not provided	Pathogenic(Last reviewed: Dec 1, 2016)	criteria provided, single submitter	VCV000498238	2	166903480	2	166046970	498238	489662	rs1553546981	NC_000002.12:166046969:G:
NM_006920.6(SCN1A):c.2784C>A (p.His928Gln)	SCN1A	H928Q, H939Q, H125Q, H911Q, H910Q, H927Q	not provided	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000451108	2	166894415	2	166037905	451108	443030	rs121918795	NC_000002.12:166037904:G:T
NM_006920.6(SCN1A):c.549dup (p.Thr184fs)	SCN1A		not provided	Pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	VCV000449096	2	166911200 - 166911201	2	166054690 - 166054691	449096	443040	rs1553551425	NC_000002.12:166054690:AAAA:AAAAA
NM_006920.6(SCN1A):c.327C>G (p.Tyr109Ter)	SCN1A	Y109*	Febrile seizures	Pathogenic(Last reviewed: Sep 28, 2016)	criteria provided, single submitter	VCV000437911	2	166915136	2	166058626	437911	431539	rs1553553485	NC_000002.12:166058625:G:C
NM_006920.6(SCN1A):c.695-2_697delinsCCACAA	SCN1A		not provided	Pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, single submitter	VCV000432885	2	166908496 - 166908500	2	166051986 - 166051990	432885	425433	rs1553549997	NC_000002.12:166051985:GGCCT:TTGTGG
NM_006920.6(SCN1A):c.1151G>A (p.Trp384Ter)	SCN1A	W384*	not provided	Pathogenic(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000432265	2	166904156	2	166047646	432265	425430	rs1553547380	NC_000002.12:166047645:C:T
NM_006920.6(SCN1A):c.1662+2T>C	SCN1A		not provided	Pathogenic(Last reviewed: May 20, 2016)	criteria provided, single submitter	VCV000429711	2	166901551	2	166045041	429711	421312	rs1131691545	NC_000002.12:166045040:A:G
NM_006920.6(SCN1A):c.1663-2A>C	SCN1A		not provided	Pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, single submitter	VCV000426241	2	166900561	2	166044051	426241	414843	rs1085307520	NC_000002.12:166044050:T:G
NM_006920.6(SCN1A):c.1230del (p.Ser411fs)	SCN1A	S411fs	not provided	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000422912	2	166903427	2	166046917	422912	405405	rs1064796087	NC_000002.12:166046916:G:
NM_006920.6(SCN1A):c.185_189dup (p.Ile64fs)	SCN1A		not provided	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000421351	2	166929942 - 166929943	2	166073432 - 166073433	421351	405412	rs1064795078	NC_000002.12:166073432:AAATG:AAATGAAATG
NM_006920.6(SCN1A):c.2301_2302insTTCCCCTTGTATT (p.Val768fs)	SCN1A		not provided	Pathogenic(Last reviewed: Feb 18, 2016)	criteria provided, single submitter	VCV000420478	2	166897821 - 166897822	2	166041311 - 166041312	420478	405395	rs1064794503	NC_000002.12:166041311:AATACA:AATACAAGGGGAAAATACA
NM_006920.6(SCN1A):c.891_892TG[1] (p.Val298fs)	SCN1A		not provided	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000420039	2	166908299 - 166908300	2	166051789 - 166051790	420039	405406	rs1064794252	NC_000002.12:166051788:CACA:CA
NM_006920.6(SCN1A):c.1347del (p.Glu449fs)	SCN1A	E449fs	not provided	Pathogenic(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	VCV000419847	2	166903310	2	166046800	419847	405403	rs1064794147	NC_000002.12:166046799:TT:T
NM_006920.6(SCN1A):c.1344dup (p.Glu449Ter)	SCN1A		not provided	Pathogenic(Last reviewed: Jul 10, 2015)	criteria provided, single submitter	VCV000419340	2	166903312 - 166903313	2	166046802 - 166046803	419340	405404	rs1064793803	NC_000002.12:166046802:AA:AAA
NM_006920.6(SCN1A):c.637_650delinsCACA (p.Ser213fs)	SCN1A		not provided	Pathogenic(Last reviewed: May 22, 2015)	criteria provided, single submitter	VCV000419148	2	166909406 - 166909419	2	166052896 - 166052909	419148	405407	rs1064793678	NC_000002.12:166052895:GTTCTCAATGCCGA:TGTG
NM_006920.6(SCN1A):c.2913+1_2913+2dup	SCN1A		not provided	Pathogenic(Last reviewed: Mar 9, 2015)	criteria provided, single submitter	VCV000418648	2	166894283 - 166894284	2	166037773 - 166037774	418648	405390	rs1064793341	NC_000002.12:166037773:AC:ACAC
NM_006920.6(SCN1A):c.1170+1G>A	SCN1A		not provided	Pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	VCV000381570	2	166904136	2	166047626	381570	365652	rs794726765	NC_000002.12:166047625:C:T
NM_006920.6(SCN1A):c.235G>A (p.Asp79Asn)	SCN1A	D79N	not provided	Pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	VCV000379355	2	166929897	2	166073387	379355	366161	rs121917982	NC_000002.12:166073386:C:T
NM_006920.6(SCN1A):c.2913+5G>A	SCN1A		not provided	Pathogenic(Last reviewed: Aug 10, 2015)	criteria provided, single submitter	VCV000379071	2	166894281	2	166037771	379071	365646	rs1057520486	NC_000002.12:166037770:C:T
NM_006920.6(SCN1A):c.1034G>T (p.Cys345Phe)	SCN1A	C345F	not provided	Pathogenic(Last reviewed: Nov 14, 2016)	criteria provided, single submitter	VCV000373136	2	166904273	2	166047763	373136	359324	rs1057518243	NC_000002.12:166047762:C:A
NM_006920.6(SCN1A):c.1662G>C (p.Gln554His)	SCN1A	Q554H, Q553H	not provided	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000373008	2	166901553	2	166045043	373008	359322	rs796052977	NC_000002.12:166045042:C:G
NM_006920.6(SCN1A):c.1377+1del	SCN1A		not provided	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000372999	2	166903279	2	166046769	372999	359427	rs1057518129	NC_000002.12:166046768:CC:C
NM_006920.6(SCN1A):c.2556+1G>T	SCN1A		not provided	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, single submitter	VCV000372551	2	166895932	2	166039422	372551	359321	rs1057517849	NC_000002.12:166039421:C:A
NM_006920.6(SCN1A):c.2818del (p.Glu940fs)	SCN1A	E922fs, E951fs, E923fs, E939fs, E940fs, E137fs	not provided	Pathogenic(Last reviewed: Sep 19, 2016)	criteria provided, single submitter	VCV000280877	2	166894381	2	166037871	280877	264043	rs886042004	NC_000002.12:166037870:CCCC:CCC
NM_006920.6(SCN1A):c.1028+1del	SCN1A		not provided	Pathogenic(Last reviewed: Sep 19, 2016)	criteria provided, single submitter	VCV000280846	2	166905395	2	166048885	280846	264051	rs886041980	NC_000002.12:166048884:CCC:CC
NM_006920.6(SCN1A):c.2298del (p.Ile765_Cys766insTer)	SCN1A		not provided	Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	VCV000280831	2	166897825	2	166041315	280831	264032	rs886041969	NC_000002.12:166041314:A:
NM_006920.6(SCN1A):c.763_764GT[1] (p.Phe256fs)	SCN1A		not provided	Pathogenic(Last reviewed: Sep 6, 2016)	criteria provided, single submitter	VCV000280823	2	166908427 - 166908428	2	166051917 - 166051918	280823	264062	rs886041961	NC_000002.12:166051916:ACACA:ACA
NM_006920.6(SCN1A):c.1119del (p.Leu373fs)	SCN1A	L373fs	not provided	Pathogenic(Last reviewed: Oct 12, 2016)	criteria provided, single submitter	VCV000280797	2	166904188	2	166047678	280797	264071	rs886041939	NC_000002.12:166047677:C:
NM_006920.6(SCN1A):c.2465dup (p.Asn822fs)	SCN1A		not provided	Pathogenic(Last reviewed: Aug 16, 2016)	criteria provided, single submitter	VCV000280794	2	166896023 - 166896024	2	166039513 - 166039514	280794	264059	rs886041937	NC_000002.12:166039513:TT:TTT
NM_006920.6(SCN1A):c.323dup (p.Tyr109fs)	SCN1A		not provided	Pathogenic(Last reviewed: Aug 10, 2016)	criteria provided, single submitter	VCV000280781	2	166915139 - 166915140	2	166058629 - 166058630	280781	264054	rs886041926	NC_000002.12:166058629:A:AA
NM_006920.6(SCN1A):c.2942dup (p.Ser982fs)	SCN1A		not provided	Pathogenic(Last reviewed: Jul 20, 2016)	criteria provided, single submitter	VCV000280695	2	166893011 - 166893012	2	166036501 - 166036502	280695	264056	rs886041852	NC_000002.12:166036501:A:AA
NM_006920.6(SCN1A):c.600dup (p.Ala201fs)	SCN1A		not provided	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000280547	2	166911149 - 166911150	2	166054639 - 166054640	280547	264036	rs886041733	NC_000002.12:166054639:AAA:AAAA
NM_006920.6(SCN1A):c.2764C>T (p.His922Tyr)	SCN1A	H922Y, H933Y, H921Y, H119Y, H904Y, H905Y	not provided	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	VCV000280527	2	166894435	2	166037925	280527	264045	rs886041716	NC_000002.12:166037924:G:A
NM_006920.6(SCN1A):c.1853_1854del (p.Arg618fs)	SCN1A	R618fs, R617fs	not provided	Pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, single submitter	VCV000280436	2	166900368 - 166900369	2	166043858 - 166043859	280436	264047	rs886041644	NC_000002.12:166043857:GCG:G
NM_006920.6(SCN1A):c.644T>A (p.Leu215Ter)	SCN1A	L215*	not provided	Pathogenic(Last reviewed: Mar 16, 2016)	criteria provided, single submitter	VCV000280390	2	166909412	2	166052902	280390	264034	rs886041604	NC_000002.12:166052901:A:T
NM_006920.6(SCN1A):c.384dup (p.Leu129fs)	SCN1A		not provided	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000280265	2	166913009 - 166913010	2	166056499 - 166056500	280265	264052	rs886041501	NC_000002.12:166056499:T:TT
NM_006920.6(SCN1A):c.705del (p.Ile236fs)	SCN1A	I236fs	not provided	Pathogenic(Last reviewed: Dec 18, 2015)	criteria provided, single submitter	VCV000280191	2	166908488	2	166051978	280191	264083	rs886041442	NC_000002.12:166051977:GG:G
NM_006920.6(SCN1A):c.2382+1G>C	SCN1A		not provided	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000279972	2	166897740	2	166041230	279972	264024	rs886041292	NC_000002.12:166041229:C:G
NM_006920.6(SCN1A):c.707T>C (p.Ile236Thr)	SCN1A	I236T	not provided	Pathogenic(Last reviewed: Jul 29, 2016)	criteria provided, single submitter	VCV000265308	2	166908486	2	166051976	265308	259709	rs886039464	NC_000002.12:166051975:A:G
GRCh37/hg19 2q24.3(chr2:166847469-166931348)x1	SCN1A		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253464	2	166847469 - 166931348			253464	247912		
GRCh37/hg19 2q24.3(chr2:166847469-166930620)x1	SCN1A		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253421	2	166847469 - 166930620			253421	247869		
GRCh37/hg19 2q24.3(chr2:166894421-166903728)x1	SCN1A		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253414	2	166894421 - 166903728			253414	247862		
NM_006920.6(SCN1A):c.2913+2T>G	SCN1A		not provided	Pathogenic(Last reviewed: Feb 1, 2012)	criteria provided, single submitter	VCV000208412	2	166894284	2	166037774	208412	204633	rs797044985	NC_000002.12:166037773:A:C
NM_006920.6(SCN1A):c.2653_2661del (p.Val885_Ala887del)	SCN1A		not provided	Pathogenic(Last reviewed: Jun 29, 2012)	criteria provided, single submitter	VCV000208408	2	166894538 - 166894546	2	166038028 - 166038036	208408	204634	rs797044981	NC_000002.12:166038027:GGCCAAGACG:G
NM_006920.6(SCN1A):c.1053dup (p.Val352fs)	SCN1A		not provided	Pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	VCV000206951	2	166904253 - 166904254	2	166047743 - 166047744	206951	201596	rs796053106	NC_000002.12:166047743:A:AA
NM_006920.6(SCN1A):c.942del (p.Asp313_Trp314insTer)	SCN1A		not provided	Pathogenic(Last reviewed: Nov 17, 2014)	criteria provided, single submitter	VCV000206950	2	166908251	2	166051741	206950	201605	rs796053105	NC_000002.12:166051740:CC:C
NM_006920.6(SCN1A):c.2144-1G>T	SCN1A		not provided	Pathogenic(Last reviewed: Sep 17, 2014)	criteria provided, single submitter	VCV000206937	2	166897980	2	166041470	206937	201556	rs763400390	NC_000002.12:166041469:C:A
NM_006920.6(SCN1A):c.739C>G (p.Leu247Val)	SCN1A	L247V	not provided	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000206931	2	166908454	2	166051944	206931	201612	rs796053092	NC_000002.12:166051943:G:C
NM_006920.6(SCN1A):c.677C>G (p.Thr226Arg)	SCN1A	T226R	not provided	Pathogenic(Last reviewed: Oct 23, 2014)	criteria provided, single submitter	VCV000206930	2	166909379	2	166052869	206930	201613	rs121917984	NC_000002.12:166052868:G:C
NM_006920.6(SCN1A):c.314C>T (p.Thr105Ile)	SCN1A	T105I	not provided	Pathogenic(Last reviewed: Jan 7, 2015)	criteria provided, single submitter	VCV000206927	2	166915149	2	166058639	206927	201628	rs796053089	NC_000002.12:166058638:G:A
NM_006920.6(SCN1A):c.141del (p.Asn47fs)	SCN1A	N47fs	not provided	Pathogenic(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	VCV000206914	2	166929991	2	166073481	206914	201636	rs796053076	NC_000002.12:166073480:A:
NM_006920.6(SCN1A):c.140del (p.Asn47fs)	SCN1A	N47fs	not provided	Pathogenic(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	VCV000206913	2	166929992	2	166073482	206913	201637	rs796053075	NC_000002.12:166073481:TTTT:TTT
NM_006920.6(SCN1A):c.2961del (p.Asp987fs)	SCN1A	D184fs, D969fs, D970fs, D986fs, D987fs, D998fs	not provided	Pathogenic(Last reviewed: Jan 15, 2014)	criteria provided, single submitter	VCV000206905	2	166892993	2	166036483	206905	201536	rs796053067	NC_000002.12:166036482:G:
NM_006920.6(SCN1A):c.2306_2307insTAT (p.Leu769delinsPheIle)	SCN1A		not provided	Pathogenic(Last reviewed: Jan 10, 2014)	criteria provided, single submitter	VCV000206904	2	166897816 - 166897817	2	166041306 - 166041307	206904	201554	rs796053066	NC_000002.12:166041306:A:ATAA
NM_006920.6(SCN1A):c.2536del (p.Val846fs)	SCN1A	V43fs, V828fs, V846fs, V829fs, V857fs, V845fs	not provided	Pathogenic(Last reviewed: Jun 10, 2014)	criteria provided, single submitter	VCV000206903	2	166895953	2	166039443	206903	201549	rs796053065	NC_000002.12:166039442:C:
NM_006920.6(SCN1A):c.1852del (p.Arg618fs)	SCN1A	R617fs, R618fs	not provided	Pathogenic(Last reviewed: Dec 15, 2014)	criteria provided, single submitter	VCV000206902	2	166900370	2	166043860	206902	201561	rs796053064	NC_000002.12:166043859:G:
NM_006920.6(SCN1A):c.1819del (p.Ser607fs)	SCN1A	S607fs, S606fs	not provided	Pathogenic(Last reviewed: Jan 14, 2013)	criteria provided, single submitter	VCV000206900	2	166900403	2	166043893	206900	201563	rs796053062	NC_000002.12:166043892:AA:A
NM_006920.6(SCN1A):c.1739_1742dup (p.Lys582fs)	SCN1A		not provided	Pathogenic(Last reviewed: Jan 23, 2014)	criteria provided, single submitter	VCV000206898	2	166900479 - 166900480	2	166043969 - 166043970	206898	201569	rs796053060	NC_000002.12:166043969:GCTCGC:GCTCGCTCGC
NM_006920.6(SCN1A):c.1537dup (p.Glu513fs)	SCN1A		not provided	Pathogenic(Last reviewed: Aug 28, 2014)	criteria provided, single submitter	VCV000206897	2	166901677 - 166901678	2	166045167 - 166045168	206897	201574	rs796053059	NC_000002.12:166045167:CCCC:CCCCC
NM_006920.6(SCN1A):c.1518_1522del (p.Lys507fs)	SCN1A	K506fs, K507fs	not provided	Pathogenic(Last reviewed: Jan 2, 2015)	criteria provided, single submitter	VCV000206896	2	166901693 - 166901697	2	166045183 - 166045187	206896	201575	rs796053058	NC_000002.12:166045182:CTTTC:
NM_006920.6(SCN1A):c.1430del (p.Gly477fs)	SCN1A	G476fs, G477fs	not provided	Pathogenic(Last reviewed: Aug 15, 2014)	criteria provided, single submitter	VCV000206895	2	166901785	2	166045275	206895	201578	rs796053057	NC_000002.12:166045274:CC:C
NM_006920.6(SCN1A):c.1247_1248insGTAGA (p.Asn416delinsLysTer)	SCN1A		not provided	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000206894	2	166903409 - 166903410	2	166046899 - 166046900	206894	201584	rs796053056	NC_000002.12:166046899:T:TCTACT
NM_006920.6(SCN1A):c.1192del (p.Thr398fs)	SCN1A	T398fs	not provided	Pathogenic(Last reviewed: May 8, 2012)	criteria provided, single submitter	VCV000206893	2	166903465	2	166046955	206893	201588	rs796053055	NC_000002.12:166046954:TTTT:TTT
NM_006920.6(SCN1A):c.476del (p.Tyr159fs)	SCN1A	Y159fs	not provided	Pathogenic(Last reviewed: Mar 19, 2014)	criteria provided, single submitter	VCV000206891	2	166911274	2	166054764	206891	201623	rs796053053	NC_000002.12:166054763:T:
NM_006920.6(SCN1A):c.368del (p.Lys123fs)	SCN1A	K123fs	not provided	Pathogenic(Last reviewed: Oct 21, 2013)	criteria provided, single submitter	VCV000206890	2	166915095	2	166058585	206890	201627	rs796053052	NC_000002.12:166058584:TT:T
NM_006920.6(SCN1A):c.305dup (p.Ser103fs)	SCN1A		not provided	Pathogenic(Last reviewed: Oct 14, 2013)	criteria provided, single submitter	VCV000206889	2	166915157 - 166915158	2	166058647 - 166058648	206889	201630	rs796053051	NC_000002.12:166058647:AA:AAA
NM_006920.6(SCN1A):c.292del (p.Ala98fs)	SCN1A	A98fs	not provided	Pathogenic(Last reviewed: Oct 14, 2013)	criteria provided, single submitter	VCV000206888	2	166915171	2	166058661	206888	201631	rs796053050	NC_000002.12:166058660:CC:C
NM_006920.6(SCN1A):c.1139del (p.Thr380fs)	SCN1A	T380fs	not provided	Pathogenic(Last reviewed: Jul 2, 2013)	criteria provided, single submitter	VCV000206879	2	166904168	2	166047658	206879	201591	rs796053047	NC_000002.12:166047657:G:
NM_006920.6(SCN1A):c.82C>T (p.Arg28Cys)	SCN1A	R28C	not provided	Pathogenic(Last reviewed: May 29, 2013)	criteria provided, single submitter	VCV000206802	2	166930050	2	166073540	206802	201638	rs754032480	NC_000002.12:166073539:G:A
NM_006920.6(SCN1A):c.2844T>A (p.Cys948Ter)	SCN1A	C948*, C959*, C930*, C931*, C947*, C145*	not provided	Pathogenic(Last reviewed: Apr 9, 2013)	criteria provided, single submitter	VCV000206791	2	166894355	2	166037845	206791	201540	rs775214722	NC_000002.12:166037844:A:T
NM_006920.6(SCN1A):c.2773G>T (p.Asp925Tyr)	SCN1A	D925Y, D936Y, D122Y, D924Y, D907Y, D908Y	not provided	Pathogenic(Last reviewed: Nov 8, 2013)	criteria provided, single submitter	VCV000206790	2	166894426	2	166037916	206790	201542	rs796052988	NC_000002.12:166037915:C:A
NM_006920.6(SCN1A):c.2749C>T (p.Gln917Ter)	SCN1A	Q917*, Q928*, Q114*, Q900*, Q899*, Q916*	not provided	Pathogenic(Last reviewed: Apr 9, 2014)	criteria provided, single submitter	VCV000206787	2	166894450	2	166037940	206787	201544	rs796052985	NC_000002.12:166037939:G:A
NM_006920.6(SCN1A):c.1662G>A (p.Gln554=)	SCN1A		not provided	Pathogenic(Last reviewed: Jun 10, 2014)	criteria provided, single submitter	VCV000206771	2	166901553	2	166045043	206771	201571	rs796052977	NC_000002.12:166045042:C:T
NM_006920.6(SCN1A):c.1348C>T (p.Gln450Ter)	SCN1A	Q450*	not provided	Pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, single submitter	VCV000206766	2	166903309	2	166046799	206766	201580	rs796052976	NC_000002.12:166046798:G:A
NM_006920.6(SCN1A):c.1195T>G (p.Tyr399Asp)	SCN1A	Y399D	not provided	Pathogenic(Last reviewed: Sep 5, 2012)	criteria provided, single submitter	VCV000206763	2	166903462	2	166046952	206763	201586	rs796052974	NC_000002.12:166046951:A:C
NM_006920.6(SCN1A):c.1076A>T (p.Asn359Ile)	SCN1A	N359I	not provided	Pathogenic(Last reviewed: Feb 25, 2014)	criteria provided, single submitter	VCV000206757	2	166904231	2	166047721	206757	201594	rs794726713	NC_000002.12:166047720:T:A
NM_006920.6(SCN1A):c.842C>T (p.Pro281Leu)	SCN1A	P281L	not provided	Pathogenic(Last reviewed: Apr 15, 2013)	criteria provided, single submitter	VCV000206750	2	166908351	2	166051841	206750	201607	rs796052964	NC_000002.12:166051840:G:A
NM_006920.6(SCN1A):c.662T>C (p.Leu221Pro)	SCN1A	L221P	not provided	Pathogenic(Last reviewed: May 14, 2014)	criteria provided, single submitter	VCV000206745	2	166909394	2	166052884	206745	201615	rs796052961	NC_000002.12:166052883:A:G
NM_006920.6(SCN1A):c.434T>A (p.Met145Lys)	SCN1A	M145K	not provided	Pathogenic(Last reviewed: Sep 11, 2012)	criteria provided, single submitter	VCV000206739	2	166912960	2	166056450	206739	201625	rs121918631	NC_000002.12:166056449:A:T
NM_006920.6(SCN1A):c.830del (p.Cys277fs)	SCN1A	C277fs	not provided	Pathogenic(Last reviewed: Dec 30, 2014)	criteria provided, single submitter	VCV000198126	2	166908363	2	166051853	198126	195287	rs794727786	NC_000002.12:166051852:C:
NM_006920.6(SCN1A):c.2387dup (p.Thr797fs)	SCN1A		not provided	Pathogenic(Last reviewed: Dec 10, 2013)	no assertion criteria provided	VCV000167644	2	166896101 - 166896102	2	166039591 - 166039592	167644	178044	rs786200989	NC_000002.12:166039591:AAAA:AAAAA
NM_006920.6(SCN1A):c.2557-2A>G	SCN1A		not provided	Pathogenic(Last reviewed: Apr 29, 2014)	criteria provided, single submitter	VCV000167643	2	166894644	2	166038134	167643	178043	rs727504140	NC_000002.12:166038133:T:C
NM_006920.6(SCN1A):c.1162del (p.Tyr388fs)	SCN1A	Y388fs	not provided	Pathogenic(Last reviewed: Nov 19, 2012)	criteria provided, single submitter	VCV000093627	2	166904145	2	166047635	93627	99531	rs398123580	NC_000002.12:166047634:AAA:AA
NM_006920.6(SCN1A):c.1029-1G>C	SCN1A		not provided	Pathogenic(Last reviewed: Dec 21, 2012)	criteria provided, single submitter	VCV000093625	2	166904279	2	166047769	93625	99529	rs398123579	NC_000002.12:166047768:C:G
NM_006920.6(SCN1A):c.2928del (p.Leu977fs)	SCN1A	L977fs, L959fs, L988fs, L174fs, L960fs, L976fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000860829	2	166893026	2	166036516	860829	850488		NC_000002.12:166036515:AAA:AA
NM_006920.6(SCN1A):c.1463del (p.Lys488fs)	SCN1A	K487fs, K488fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Mar 23, 2019)	criteria provided, single submitter	VCV000858532	2	166901752	2	166045242	858532	850448		NC_000002.12:166045241:TT:T
NM_006920.6(SCN1A):c.2197_2198AT[1] (p.Phe734fs)	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000857116	2	166897923 - 166897924	2	166041413 - 166041414	857116	850464		NC_000002.12:166041412:ATAT:AT
NM_006920.6(SCN1A):c.1796_1803dup (p.Glu602fs)	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000852890	2	166900418 - 166900419	2	166043908 - 166043909	852890	850452		NC_000002.12:166043908:GTTATCCT:GTTATCCTGTTATCCT
NM_006920.6(SCN1A):c.1047T>G (p.Tyr349Ter)	SCN1A	Y349*	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000851618	2	166904260	2	166047750	851618	850440		NC_000002.12:166047749:A:C
NM_006920.6(SCN1A):c.238dup (p.Leu80fs)	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jan 5, 2020)	criteria provided, single submitter	VCV000850219	2	166929893 - 166929894	2	166073383 - 166073384	850219	850603		NC_000002.12:166073383:GG:GGG
NM_006920.6(SCN1A):c.694+5G>A	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000847623	2	166909357	2	166052847	847623	851109		NC_000002.12:166052846:C:T
NM_006920.6(SCN1A):c.2233A>T (p.Lys745Ter)	SCN1A	K744*, K745*, K728*, K727*, K756*	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000847338	2	166897890	2	166041380	847338	850466		NC_000002.12:166041379:T:A
NM_006920.6(SCN1A):c.184_187del (p.Pro62fs)	SCN1A	P62fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000841107	2	166929945 - 166929948	2	166073435 - 166073438	841107	850602		NC_000002.12:166073434:ATGGA:A
NM_006920.6(SCN1A):c.487_496del (p.Gly163fs)	SCN1A	G163fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: May 18, 2019)	criteria provided, single submitter	VCV000840761	2	166911254 - 166911263	2	166054744 - 166054753	840761	850614		NC_000002.12:166054743:TATATATTCCT:T
NM_006920.6(SCN1A):c.2139del (p.Glu714fs)	SCN1A	E696fs, E697fs, E713fs, E725fs, E714fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000839859	2	166898806	2	166042296	839859	850463		NC_000002.12:166042295:T:
NM_006920.6(SCN1A):c.2427dup (p.Ala810fs)	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000838723	2	166896061 - 166896062	2	166039551 - 166039552	838723	850471		NC_000002.12:166039551:AA:AAA
NC_000002.12:g.(?_166052832)_(166053034_?)del	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000831753	2	166909342 - 166909544			831753	819076		
NC_000002.12:g.(?_166042272)_(166044069_?)del	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000831555	2	166898782 - 166900579			831555	819075		
NC_000002.12:g.(?_165995993)_(166073641_?)del	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000831240	2	166852503 - 166930151			831240	819072		
NM_006920.6(SCN1A):c.842C>G (p.Pro281Arg)	SCN1A	P281R	Generalized epilepsy with febrile seizures plus, type 2	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000807675	2	166908351	2	166051841	807675	798489		NC_000002.12:166051840:G:C
NM_006920.6(SCN1A):c.2546C>A (p.Ser849Ter)	SCN1A	S46*, S831*, S832*, S849*, S860*, S848*	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000660812	2	166895943	2	166039433	660812	628848		NC_000002.12:166039432:G:T
NM_006920.6(SCN1A):c.1278C>A (p.Tyr426Ter)	SCN1A	Y426*	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000659903	2	166903379	2	166046869	659903	628860		NC_000002.12:166046868:G:T
NM_006920.6(SCN1A):c.1840_1852delinsGATTCCTTGTTTGTGCACTCAGGT (p.His614fs)	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000658077	2	166900370 - 166900382	2	166043860 - 166043872	658077	628856		NC_000002.12:166043859:GTCTCTCTCCGTG:ACCTGAGTGCACAAACAAGGAATC
NM_006920.6(SCN1A):c.1539del (p.Glu514fs)	SCN1A	E514fs, E513fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000657792	2	166901676	2	166045166	657792	628858		NC_000002.12:166045165:TT:T
NM_006920.6(SCN1A):c.2462G>A (p.Trp821Ter)	SCN1A	W804*, W820*, W18*, W832*, W803*, W821*	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000651494	2	166896027	2	166039517	651494	628850		NC_000002.12:166039516:C:T
NM_006920.6(SCN1A):c.905del (p.Gly302fs)	SCN1A	G302fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000648952	2	166908288	2	166051778	648952	628869		NC_000002.12:166051777:CC:C
NM_006920.6(SCN1A):c.2360_2378del (p.Asn787fs)	SCN1A	N770fs, N786fs, N769fs, N787fs, N798fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000648064	2	166897745 - 166897763	2	166041235 - 166041253	648064	628852		NC_000002.12:166041234:TTTCCTACTGTAAGCACATT:T
NM_006920.6(SCN1A):c.1170+5G>A	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000646111	2	166904132	2	166047622	646111	650914		NC_000002.12:166047621:C:T
NM_001165963.1(SCN1A):c.964+424_2022del	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, single submitter	VCV000645614			2	166043690 - 166051295	645614	650857		
NM_006920.6(SCN1A):c.1566dup (p.Ser523fs)	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000644741	2	166901648 - 166901649	2	166045138 - 166045139	644741	628857		NC_000002.12:166045138:TTTTT:TTTTTT
NM_006920.6(SCN1A):c.1426del (p.Ala476fs)	SCN1A	A475fs, A476fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000642461	2	166901789	2	166045279	642461	628859		NC_000002.12:166045278:C:
NM_006920.6(SCN1A):c.295_301del (p.Ile99fs)	SCN1A	I99fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000641010	2	166915162 - 166915168	2	166058652 - 166058658	641010	628880		NC_000002.12:166058651:GGAAGATGG:GG
Single allele	SCN1A		Epilepsy	Pathogenic(Last reviewed: Apr 9, 2019)	no assertion criteria provided	VCV000635922	2	166818453 - 166939516			635922	623735		
NM_006920.6(SCN1A):c.1306G>T (p.Glu436Ter)	SCN1A	E436*	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000582155	2	166903351	2	166046841	582155	559344	rs1553546763	NC_000002.12:166046840:C:A
NM_006920.6(SCN1A):c.655_964+402del	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000579103	2	166907827 - 166909401	2	166051317 - 166052891	579103	559346		
NM_006920.6(SCN1A):c.1844_1845GA[5] (p.Arg618fs)	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, single submitter	VCV000577287	2	166900370 - 166900371	2	166043860 - 166043861	577287	558855	rs1559216338	NC_000002.12:166043860:TCTCTCTC:TCTCTCTCTC
NM_006920.6(SCN1A):c.1118dup (p.Leu373fs)	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000571560	2	166904188 - 166904189	2	166047678 - 166047679	571560	557687	rs794726695	NC_000002.12:166047678:AAAAAA:AAAAAAA
NM_006920.6(SCN1A):c.1518_1519del (p.Lys507fs)	SCN1A	K506fs, K507fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000569861	2	166901696 - 166901697	2	166045186 - 166045187	569861	557685	rs1559220874	NC_000002.12:166045185:TCT:T
NM_006920.6(SCN1A):c.2632del (p.Ala878fs)	SCN1A	A877fs, A75fs, A860fs, A878fs, A861fs, A889fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, single submitter	VCV000568302	2	166894567	2	166038057	568302	557632	rs1559200672	NC_000002.12:166038056:CCCCC:CCCC
NM_006920.6(SCN1A):c.1738dup (p.Arg580fs)	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000568242	2	166900483 - 166900484	2	166043973 - 166043974	568242	557683	rs1559217391	NC_000002.12:166043973:G:GG
NM_006920.6(SCN1A):c.1269del (p.Met424fs)	SCN1A	M424fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000566661	2	166903388	2	166046878	566661	557640	rs1559225495	NC_000002.12:166046877:GG:G
NM_006920.6(SCN1A):c.2235del (p.Lys745_Val746insTer)	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000565992	2	166897888	2	166041378	565992	557636	rs1559210063	NC_000002.12:166041377:TTTT:TTT
NM_006920.6(SCN1A):c.1296del (p.Thr433fs)	SCN1A	T433fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000530505	2	166903361	2	166046851	530505	516663	rs1553546789	NC_000002.12:166046850:GG:G
NM_006920.6(SCN1A):c.1795G>T (p.Glu599Ter)	SCN1A	E599*, E598*	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Nov 18, 2017)	criteria provided, single submitter	VCV000530469	2	166900427	2	166043917	530469	516584	rs1553544821	NC_000002.12:166043916:C:A
NM_006920.6(SCN1A):c.1584_1588del (p.Ser528fs)	SCN1A	S528fs, S527fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000530468	2	166901627 - 166901631	2	166045117 - 166045121	530468	516644	rs1553545522	NC_000002.12:166045116:TGATG:
NM_006920.6(SCN1A):c.1278C>G (p.Tyr426Ter)	SCN1A	Y426*	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000530464	2	166903379	2	166046869	530464	516646	rs146515561	NC_000002.12:166046868:G:C
NM_006920.6(SCN1A):c.1958T>A (p.Leu653Ter)	SCN1A	L653*, L652*	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000530404	2	166900264	2	166043754	530404	516579	rs1553544559	NC_000002.12:166043753:A:T
NM_006920.6(SCN1A):c.938_941del (p.Asp313fs)	SCN1A	D313fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, single submitter	VCV000461285	2	166908252 - 166908255	2	166051742 - 166051745	461285	449131	rs1553549483	NC_000002.12:166051741:CAGTCA:CA
NM_006920.6(SCN1A):c.566del (p.Pro189fs)	SCN1A	P189fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000461282	2	166911184	2	166054674	461282	448842	rs1553551385	NC_000002.12:166054673:GG:G
NM_006920.6(SCN1A):c.454dup (p.Asp152fs)	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jun 3, 2017)	criteria provided, single submitter	VCV000461273	2	166912939 - 166912940	2	166056429 - 166056430	461273	449145	rs1553552319	NC_000002.12:166056429:C:CC
NM_006920.6(SCN1A):c.2532_2535dup (p.Val846fs)	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000461253	2	166895953 - 166895954	2	166039443 - 166039444	461253	449124	rs1553542199	NC_000002.12:166039443:AGATA:AGATAGATA
NM_006920.6(SCN1A):c.2228G>A (p.Trp743Ter)	SCN1A	W743*, W754*, W725*, W726*, W742*	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Mar 4, 2017)	criteria provided, single submitter	VCV000461248	2	166897895	2	166041385	461248	449138	rs794726743	NC_000002.12:166041384:C:T
NM_006920.6(SCN1A):c.1931_1939delinsA (p.Thr644fs)	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000461246	2	166900283 - 166900291	2	166043773 - 166043781	461246	448839	rs1553544579	NC_000002.12:166043772:AATCCACAG:T
NM_006920.6(SCN1A):c.559_602+6del	SCN1A		not provided	Pathogenic(Last reviewed: Sep 28, 2016)	criteria provided, single submitter	VCV000448259	2	166911142 - 166911191	2	166054632 - 166054681	448259	440561	rs1553551304	NC_000002.12:166054631:ACTTACGCAAATGTAATGACAGTGAAATCGAGCCAGTTCCATGGATCCCGA:A
NM_006920.6(SCN1A):c.302G>T (p.Arg101Leu)	SCN1A	R101L	not provided	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000448251	2	166915161	2	166058651	448251	440562	rs121917918	NC_000002.12:166058650:C:A
NM_006920.6(SCN1A):c.312del (p.Thr105fs)	SCN1A	T105fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Sep 26, 2016)	criteria provided, single submitter	VCV000408929	2	166915151	2	166058641	408929	391484	rs1060502187	NC_000002.12:166058640:GG:G
NM_006920.6(SCN1A):c.1848G>C (p.Glu616Asp)	SCN1A	E616D, E615D	Epileptic encephalopathy	Pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, single submitter	VCV000375511	2	166900374	2	166043864	375511	362325	rs1057519529	NC_000002.12:166043863:C:G
NM_006920.6(SCN1A):c.1377+1G>C	SCN1A		not provided	Pathogenic(Last reviewed: Jun 7, 2016)	criteria provided, single submitter	VCV000288314	2	166903279	2	166046769	288314	272551	rs886043864	NC_000002.12:166046768:C:G
NM_006920.6(SCN1A):c.1277A>G (p.Tyr426Cys)	SCN1A	Y426C	not provided	Pathogenic(Last reviewed: Sep 2, 2015)	criteria provided, multiple submitters, no conflicts	VCV000206761	2	166903380	2	166046870	206761	201582	rs796052973	NC_000002.12:166046869:T:C
GRCh38/hg38 2q24.3(chr2:166044436-166079787)x1	SCN1A		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000060251	2	166900946 - 166936297	2	166044436 - 166079787	60251	74846		
NM_006920.6(SCN1A):c.575G>A (p.Trp192Ter)	SCN1A	W192*	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000861602	2	166911175	2	166054665	861602	850427		NC_000002.12:166054664:C:T
NM_006920.6(SCN1A):c.974A>G (p.Tyr325Cys)	SCN1A	Y325C	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000855077	2	166905450	2	166048940	855077	850437		NC_000002.12:166048939:T:C
NM_006920.6(SCN1A):c.2210G>A (p.Trp737Ter)	SCN1A	W737*, W720*, W719*, W736*, W748*	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000848223	2	166897913	2	166041403	848223	850465		NC_000002.12:166041402:C:T
NM_006920.6(SCN1A):c.539T>A (p.Leu180Ter)	SCN1A	L180*	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000836613	2	166911211	2	166054701	836613	850425		NC_000002.12:166054700:A:T
NC_000002.12:g.(?_165995993)_(165998195_?)del	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000832910	2	166852503 - 166854705			832910	819071		
NC_000002.12:g.(?_165991225)_(166041489_?)del	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000832193	2	166847735 - 166897999			832193	819067		
NC_000002.12:g.(?_166073338)_(166073641_?)del	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000830988	2	166929848 - 166930151			830988	819077		
NM_006920.6(SCN1A):c.2262del (p.Met755fs)	SCN1A	M737fs, M754fs, M755fs, M766fs, M738fs	Generalized epilepsy with febrile seizures plus, type 2	Pathogenic(Last reviewed: Sep 4, 2017)	criteria provided, single submitter	VCV000813760	2	166897861	2	166041351	813760	801982		NC_000002.12:166041350:C:
NM_006920.6(SCN1A):c.2723_2724GT[1] (p.Val909fs)	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000807489	2	166894473 - 166894474	2	166037963 - 166037964	807489	798488		NC_000002.12:166037962:ACACA:ACA
NM_006920.6(SCN1A):c.1034G>A (p.Cys345Tyr)	SCN1A	C345Y	not provided	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000805380	2	166904273	2	166047763	805380	792920		NC_000002.12:166047762:C:T
NM_006920.6(SCN1A):c.126dup (p.Asp43fs)	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801826	2	166930005 - 166930006	2	166073495 - 166073496	801826	790123		NC_000002.12:166073495:TTTTTT:TTTTTTT
NM_006920.6(SCN1A):c.207del (p.Pro70fs)	SCN1A	P70fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801825	2	166929925	2	166073415	801825	790122		NC_000002.12:166073414:A:
NM_006920.6(SCN1A):c.262_264+1del	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801824	2	166929867 - 166929870	2	166073357 - 166073360	801824	790121		NC_000002.12:166073356:CTTTCTT:CTT
NM_006920.6(SCN1A):c.684del (p.Val229fs)	SCN1A	V229fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801819	2	166909372	2	166052862	801819	790116		NC_000002.12:166052861:T:
NC_000002.12:g.166051989del	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801818	2	166908498	2	166051988	801818	790115		NC_000002.12:166051987:CC:C
NM_006920.6(SCN1A):c.1028+1G>A	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801815	2	166905395	2	166048885	801815	790112		NC_000002.12:166048884:C:T
NM_006920.6(SCN1A):c.1543A>T (p.Lys515Ter)	SCN1A	K515*, K514*	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801812	2	166901672	2	166045162	801812	790109		NC_000002.12:166045161:T:A
NM_006920.6(SCN1A):c.2098C>T (p.Gln700Ter)	SCN1A	Q682*, Q683*, Q700*, Q699*, Q711*	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801808	2	166898847	2	166042337	801808	790105		NC_000002.12:166042336:G:A
NM_006920.6(SCN1A):c.2114_2117del (p.Ile705fs)	SCN1A	I716fs, I687fs, I704fs, I705fs, I688fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801807	2	166898828 - 166898831	2	166042318 - 166042321	801807	790104		NC_000002.12:166042317:GCTA:
NM_006920.6(SCN1A):c.2382+1G>A	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801805	2	166897740	2	166041230	801805	790102		NC_000002.12:166041229:C:T
NM_006920.6(SCN1A):c.2658G>T (p.Leu886Phe)	SCN1A	L885F, L886F, L869F, L83F, L868F, L897F	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801803	2	166894541	2	166038031	801803	790100		NC_000002.12:166038030:C:A
NM_006920.6(SCN1A):c.2636T>C (p.Leu879Pro)	SCN1A	L890P, L879P, L878P, L76P, L862P, L861P	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000461256	2	166894563	2	166038053	461256	449018	rs1553541473	NC_000002.12:166038052:A:G
NC_000002.12:g.(?_165991225)_(166073641_?)del	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000832530	2	166847735 - 166930151			832530	819069		
NC_000002.12:g.(?_166009699)_(166015748_?)del	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000831474	2	166866209 - 166872258			831474	819073		
NM_006920.6(SCN1A):c.2846T>C (p.Met949Thr)	SCN1A	M146T, M931T, M949T, M932T, M948T, M960T	Generalized epilepsy with febrile seizures plus, type 2	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000813803	2	166894353	2	166037843	813803	801981		NC_000002.12:166037842:A:G
NM_006920.6(SCN1A):c.2769G>A (p.Met923Ile)	SCN1A	M120I, M905I, M906I, M922I, M923I, M934I	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000665440	2	166894430	2	166037920	665440	628845		NC_000002.12:166037919:C:T
NM_006920.6(SCN1A):c.811_815dup (p.Asn272fs)	SCN1A		not provided|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000643783	2	166908377 - 166908378	2	166051867 - 166051868	643783	628870		NC_000002.12:166051867:TTGCC:TTGCCTTGCC
NM_006920.6(SCN1A):c.1153G>C (p.Glu385Gln)	SCN1A	E385Q	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000569331	2	166904154	2	166047644	569331	557642	rs796052972	NC_000002.12:166047643:C:G
NM_006920.6(SCN1A):c.3G>A (p.Met1Ile)	SCN1A	M1I	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	VCV000530490	2	166930129	2	166073619	530490	516733	rs1553561016	NC_000002.12:166073618:C:T
NM_006920.6(SCN1A):c.264_264+5delinsTGCC	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000530484	2	166929863 - 166929868	2	166073353 - 166073358	530484	516667	rs1553560676	NC_000002.12:166073352:CTCACT:GGCA
NM_006920.6(SCN1A):c.580G>T (p.Asp194Tyr)	SCN1A	D194Y	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000461284	2	166911170	2	166054660	461284	449143	rs121917935	NC_000002.12:166054659:C:A
NM_006920.6(SCN1A):c.2T>C (p.Met1Thr)	SCN1A	M1T	not provided|Early infantile epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000461262	2	166930130	2	166073620	461262	449140	rs1553561023	NC_000002.12:166073619:A:G
NM_006920.6(SCN1A):c.2914G>A (p.Val972Ile)	SCN1A	V972I, V983I, V971I, V169I, V954I, V955I	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000461261	2	166893040	2	166036530	461261	449114	rs1553540503	NC_000002.12:166036529:C:T
NM_006920.6(SCN1A):c.1506_1510GAAAA[1] (p.Arg504fs)	SCN1A		Early infantile epileptic encephalopathy|not provided	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000461242	2	166901700 - 166901704	2	166045190 - 166045194	461242	449139	rs1553545660	NC_000002.12:166045189:TTTTCTTTTCTT:TTTTCTT
NM_006920.6(SCN1A):c.278_279dup (p.Asn94Ter)	SCN1A		Early infantile epileptic encephalopathy|not provided	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000423081	2	166915183 - 166915184	2	166058673 - 166058674	423081	405411	rs1064796213	NC_000002.12:166058673:CA:CACA
NM_006920.6(SCN1A):c.603-2A>G	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, single submitter	VCV000375513	2	166909455	2	166052945	375513	362327	rs1057519531	NC_000002.12:166052944:T:C
NM_006920.4(SCN1A):c.384_473del (p.Leu129_Glu158del)	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190030	2	166912921 - 166913010	2	166056411 - 166056500	190030	187871	rs1553552270	
NM_001165963.1(SCN1A):c.384_1662dup	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190027					190027	187889		
NM_006920.6(SCN1A):c.433A>G (p.Met145Val)	SCN1A	M145V	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190024	2	166912961	2	166056451	190024	187872	rs794726849	NC_000002.12:166056450:T:C
NM_006920.6(SCN1A):c.70G>A (p.Ala24Thr)	SCN1A	A24T	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190023	2	166930062	2	166073552	190023	187883	rs794726848	NC_000002.12:166073551:C:T
NM_001165963.1(SCN1A):c.1663_2176del	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190022					190022	187888		
NM_006920.6(SCN1A):c.826A>C (p.Lys276Gln)	SCN1A	K276Q	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190021	2	166908367	2	166051857	190021	187858	rs794726847	NC_000002.12:166051856:T:G
NM_006920.6(SCN1A):c.930_931dup (p.Glu311fs)	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190020	2	166908261 - 166908262	2	166051751 - 166051752	190020	187856	rs794726846	NC_000002.12:166051751:CA:CACA
NM_006920.6(SCN1A):c.1046A>G (p.Tyr349Cys)	SCN1A	Y349C	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190018	2	166904261	2	166047751	190018	187849	rs794726844	NC_000002.12:166047750:T:C
NM_006920.6(SCN1A):c.1024G>T (p.Ala342Ser)	SCN1A	A342S	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190017	2	166905400	2	166048890	190017	187852	rs794726843	NC_000002.12:166048889:C:A
NM_006920.6(SCN1A):c.2903G>A (p.Gly968Glu)	SCN1A	G968E, G979E, G951E, G165E, G950E, G967E	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190016	2	166894296	2	166037786	190016	187787	rs794726842	NC_000002.12:166037785:C:T
NM_001165963.1(SCN1A):c.4338_6030del	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190015					190015	187887		
NM_006920.6(SCN1A):c.473+1G>C	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190012	2	166912920	2	166056410	190012	187870	rs794726840	NC_000002.12:166056409:C:G
NM_006920.6(SCN1A):c.1970C>T (p.Pro657Leu)	SCN1A	P657L, P656L	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190010	2	166900252	2	166043742	190010	187820	rs794726838	NC_000002.12:166043741:G:A
NM_006920.6(SCN1A):c.964+14T>G	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190009	2	166908215	2	166051705	190009	187855	rs794726837	NC_000002.12:166051704:A:C
NM_006920.6(SCN1A):c.1804G>T (p.Glu602Ter)	SCN1A	E602*, E601*	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190006	2	166900418	2	166043908	190006	187822	rs794726834	NC_000002.12:166043907:C:A
NM_006920.6(SCN1A):c.602+3A>C	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190004	2	166911145	2	166054635	190004	187866	rs794726833	NC_000002.12:166054634:T:G
NM_006920.6(SCN1A):c.380A>T (p.His127Leu)	SCN1A	H127L	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190002	2	166915083	2	166058573	190002	187875	rs794726831	NC_000002.12:166058572:T:A
NM_006920.6(SCN1A):c.2947_2948del (p.Ser983fs)	SCN1A	S180fs, S982fs, S965fs, S966fs, S983fs, S994fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190001	2	166893006 - 166893007	2	166036496 - 166036497	190001	187783	rs794726830	NC_000002.12:166036495:GAG:G
NM_006920.6(SCN1A):c.1442_1445del (p.Asp481fs)	SCN1A	D481fs, D480fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000190000	2	166901770 - 166901773	2	166045260 - 166045263	190000	187830	rs794726829	NC_000002.12:166045259:CTGTCTG:CTG
NM_006920.6(SCN1A):c.2896G>A (p.Val966Met)	SCN1A	V966M, V977M, V163M, V949M, V965M, V948M	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189999	2	166894303	2	166037793	189999	187788	rs794726828	NC_000002.12:166037792:C:T
NM_006920.6(SCN1A):c.602+1G>T	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189997	2	166911147	2	166054637	189997	187867	rs794726827	NC_000002.12:166054636:C:A
NM_006920.6(SCN1A):c.1259C>T (p.Ala420Val)	SCN1A	A420V	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189996	2	166903398	2	166046888	189996	187834	rs794726826	NC_000002.12:166046887:G:A
NM_001165963.1(SCN1A):c.4285_4476del	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189995					189995	187886		
NM_006920.6(SCN1A):c.2870G>T (p.Cys957Phe)	SCN1A	C957F, C968F, C154F, C956F, C940F, C939F	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189992	2	166894329	2	166037819	189992	187789	rs794726823	NC_000002.12:166037818:C:A
NM_006920.6(SCN1A):c.2285_2286insT (p.Ile763fs)	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189989	2	166897837 - 166897838	2	166041327 - 166041328	189989	187810	rs794726820	NC_000002.12:166041327::A
NM_006920.6(SCN1A):c.1197_1198del (p.Met400fs)	SCN1A	M400fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189987	2	166903459 - 166903460	2	166046949 - 166046950	189987	187836	rs794726818	NC_000002.12:166046948:TGT:T
NM_006920.6(SCN1A):c.2645T>A (p.Leu882Ter)	SCN1A	L882*, L893*, L79*, L865*, L864*, L881*	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189984	2	166894554	2	166038044	189984	187799	rs794726815	NC_000002.12:166038043:A:T
NM_006920.6(SCN1A):c.747T>G (p.Asp249Glu)	SCN1A	D249E	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189982	2	166908446	2	166051936	189982	187862	rs773407463	NC_000002.12:166051935:A:C
NM_001165963.1(SCN1A):c.384_964del	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189981					189981	187885		
NM_006920.6(SCN1A):c.2984del (p.Asp995fs)	SCN1A	D978fs, D995fs, D1006fs, D192fs, D977fs, D994fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189980	2	166892970	2	166036460	189980	187781	rs794726813	NC_000002.12:166036459:T:
NM_006920.6(SCN1A):c.825_826insGTATA (p.Lys276delinsValTer)	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189979	2	166908367 - 166908368	2	166051857 - 166051858	189979	187859	rs794726812	NC_000002.12:166051857::TATAC
NM_006920.6(SCN1A):c.2747G>T (p.Cys916Phe)	SCN1A	C916F, C927F, C898F, C899F, C113F, C915F	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189978	2	166894452	2	166037942	189978	187796	rs794726811	NC_000002.12:166037941:C:A
NM_006920.6(SCN1A):c.1301del (p.Leu434fs)	SCN1A	L434fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189977	2	166903356	2	166046846	189977	187832	rs794726810	NC_000002.12:166046845:AA:A
NM_006920.6(SCN1A):c.2839_2848del (p.Asp947fs)	SCN1A	D144fs, D929fs, D947fs, D930fs, D946fs, D958fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189974	2	166894351 - 166894360	2	166037841 - 166037850	189974	187791	rs794726808	NC_000002.12:166037840:CCATACAGTCCCA:CCA
NM_006920.6(SCN1A):c.1345G>T (p.Glu449Ter)	SCN1A	E449*	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189973	2	166903312	2	166046802	189973	187831	rs794726807	NC_000002.12:166046801:C:A
NM_006920.6(SCN1A):c.2067del (p.Met690fs)	SCN1A	M689fs, M701fs, M690fs, M672fs, M673fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189972	2	166898878	2	166042368	189972	187818	rs794726806	NC_000002.12:166042367:GG:G
NM_006920.6(SCN1A):c.2446T>G (p.Tyr816Asp)	SCN1A	Y816D, Y827D, Y13D, Y799D, Y798D, Y815D	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189971	2	166896043	2	166039533	189971	187808	rs794726805	NC_000002.12:166039532:A:C
NM_006920.6(SCN1A):c.2759G>C (p.Arg920Pro)	SCN1A	R920P, R931P, R903P, R902P, R919P, R117P	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189961	2	166894440	2	166037930	189961	187794	rs794726718	NC_000002.12:166037929:C:G
NM_006920.6(SCN1A):c.1025C>T (p.Ala342Val)	SCN1A	A342V	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189960	2	166905399	2	166048889	189960	187851	rs794726797	NC_000002.12:166048888:G:A
NM_006920.6(SCN1A):c.289_292del (p.Lys97fs)	SCN1A	K97fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189959	2	166915171 - 166915174	2	166058661 - 166058664	189959	187879	rs794726796	NC_000002.12:166058660:CCTTCC:CC
NM_006920.6(SCN1A):c.2143+3T>A	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189958	2	166898799	2	166042289	189958	187816	rs794726795	NC_000002.12:166042288:A:T
NM_006920.6(SCN1A):c.2504A>G (p.Glu835Gly)	SCN1A	E835G, E846G, E817G, E818G, E32G, E834G	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189957	2	166895985	2	166039475	189957	187806	rs794726794	NC_000002.12:166039474:T:C
NM_006920.6(SCN1A):c.323T>C (p.Leu108Pro)	SCN1A	L108P	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189956	2	166915140	2	166058630	189956	187877	rs794726793	NC_000002.12:166058629:A:G
NM_006920.6(SCN1A):c.1096_1115del (p.Asp366fs)	SCN1A	D366fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189955	2	166904192 - 166904211	2	166047682 - 166047701	189955	187844	rs794726792	NC_000002.12:166047681:AAAGCCCAACTGAAGGTATCAAAGC:AAAGC
NM_006920.6(SCN1A):c.185del (p.Pro62fs)	SCN1A	P62fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189954	2	166929947	2	166073437	189954	187881	rs35595680	NC_000002.12:166073436:GG:G
NM_006920.6(SCN1A):c.1516C>T (p.Gln506Ter)	SCN1A	Q506*, Q505*	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189953	2	166901699	2	166045189	189953	187829	rs794726790	NC_000002.12:166045188:G:A
NM_006920.6(SCN1A):c.896_905del (p.Asn299fs)	SCN1A	N299fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189951	2	166908288 - 166908297	2	166051778 - 166051787	189951	187857	rs794726788	NC_000002.12:166051777:CCATTATAAT:
NM_006920.6(SCN1A):c.2570del (p.Lys857fs)	SCN1A	K839fs, K868fs, K857fs, K54fs, K840fs, K856fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189950	2	166894629	2	166038119	189950	187801	rs794726787	NC_000002.12:166038118:TT:T
NM_006920.6(SCN1A):c.2582C>A (p.Ser861Tyr)	SCN1A	S861Y, S872Y, S58Y, S843Y, S844Y, S860Y	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189949	2	166894617	2	166038107	189949	187800	rs794726786	NC_000002.12:166038106:G:T
NM_006920.6(SCN1A):c.1033T>C (p.Cys345Arg)	SCN1A	C345R	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189945	2	166904274	2	166047764	189945	187850	rs794726782	NC_000002.12:166047763:A:G
NM_006920.6(SCN1A):c.1182_1183insA (p.Ala395fs)	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189940	2	166903474 - 166903475	2	166046964 - 166046965	189940	187838	rs794726777	NC_000002.12:166046964::T
NM_006920.6(SCN1A):c.1183_1184del (p.Ala395fs)	SCN1A	A395fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189939	2	166903473 - 166903474	2	166046963 - 166046964	189939	187837	rs794726776	NC_000002.12:166046962:GC:
NM_006920.6(SCN1A):c.1662+3A>G	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189936	2	166901550	2	166045040	189936	187825	rs794726773	NC_000002.12:166045039:T:C
NM_006920.6(SCN1A):c.1048A>G (p.Met350Val)	SCN1A	M350V	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189931	2	166904259	2	166047749	189931	187848	rs794726768	NC_000002.12:166047748:T:C
NM_006920.6(SCN1A):c.1049_1050TG[3] (p.Val352fs)	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189930	2	166904251 - 166904252	2	166047741 - 166047742	189930	187847	rs794726767	NC_000002.12:166047740:CACACACA:CACACA
NM_006920.6(SCN1A):c.2270C>T (p.Pro757Leu)	SCN1A	P757L, P768L, P756L, P739L, P740L	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189929	2	166897853	2	166041343	189929	187811	rs794726766	NC_000002.12:166041342:G:A
NM_006920.6(SCN1A):c.384-1C>G	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189927	2	166913011	2	166056501	189927	187873	rs794726764	NC_000002.12:166056500:G:C
NM_006920.6(SCN1A):c.264+5G>C	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189925	2	166929863	2	166073353	189925	187880	rs794726762	NC_000002.12:166073352:C:G
NM_006920.6(SCN1A):c.2657T>C (p.Leu886Ser)	SCN1A	L886S, L897S, L869S, L868S, L83S, L885S	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189924	2	166894542	2	166038032	189924	187798	rs794726761	NC_000002.12:166038031:A:G
NM_006920.6(SCN1A):c.1265T>C (p.Val422Ala)	SCN1A	V422A	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189920	2	166903392	2	166046882	189920	187833	rs121917989	NC_000002.12:166046881:A:G
NM_006920.6(SCN1A):c.3029_3033del (p.Lys1010fs)	SCN1A	K993fs, K1009fs, K1010fs, K1021fs, K207fs, K992fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189916	2	166892921 - 166892925	2	166036411 - 166036415	189916	187780	rs794726756	NC_000002.12:166036410:TCCTTT:T
NM_006920.6(SCN1A):c.728C>A (p.Ser243Tyr)	SCN1A	S243Y	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189915	2	166908465	2	166051955	189915	187863	rs794726755	NC_000002.12:166051954:G:T
NM_006920.6(SCN1A):c.1146C>A (p.Asp382Glu)	SCN1A	D382E	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189913	2	166904161	2	166047651	189913	187840	rs794726753	NC_000002.12:166047650:G:T
NM_006920.6(SCN1A):c.751del (p.Val250_Met251insTer)	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189910	2	166908442	2	166051932	189910	187861	rs794726751	NC_000002.12:166051931:TT:T
NM_006920.6(SCN1A):c.2266_2269dup (p.Pro757fs)	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189909	2	166897853 - 166897854	2	166041343 - 166041344	189909	187812	rs794726750	NC_000002.12:166041343:GGTC:GGTCGGTC
NM_006920.6(SCN1A):c.1662+1G>T	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189908	2	166901552	2	166045042	189908	187826	rs794726749	NC_000002.12:166045041:C:A
NM_006920.6(SCN1A):c.2038A>T (p.Lys680Ter)	SCN1A	K680*, K691*, K663*, K662*, K679*	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189906	2	166898907	2	166042397	189906	187819	rs794726747	NC_000002.12:166042396:T:A
NM_006920.6(SCN1A):c.530G>T (p.Gly177Val)	SCN1A	G177V	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189904	2	166911220	2	166054710	189904	187869	rs121918770	NC_000002.12:166054709:C:A
NM_006920.6(SCN1A):c.2228G>T (p.Trp743Leu)	SCN1A	W743L, W754L, W726L, W725L, W742L	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189901	2	166897895	2	166041385	189901	187813	rs794726743	NC_000002.12:166041384:C:A
NM_006920.6(SCN1A):c.2180G>T (p.Trp727Leu)	SCN1A	W727L, W738L, W726L, W709L, W710L	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189900	2	166897943	2	166041433	189900	187814	rs794726742	NC_000002.12:166041432:C:A
NM_006920.6(SCN1A):c.308G>T (p.Ser103Ile)	SCN1A	S103I	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189899	2	166915155	2	166058645	189899	187878	rs760361423	NC_000002.12:166058644:C:A
NM_006920.6(SCN1A):c.2490_2491del (p.Thr830_Leu831insTer)	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189895	2	166895998 - 166895999	2	166039488 - 166039489	189895	187807	rs794726738	NC_000002.12:166039487:GCG:G
NM_006920.6(SCN1A):c.121A>T (p.Lys41Ter)	SCN1A	K41*	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189894	2	166930011	2	166073501	189894	187882	rs764444350	NC_000002.12:166073500:T:A
NM_006920.6(SCN1A):c.1136T>A (p.Met379Lys)	SCN1A	M379K	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189888	2	166904171	2	166047661	189888	187841	rs794726732	NC_000002.12:166047660:A:T
NM_006920.6(SCN1A):c.2804G>C (p.Arg935Pro)	SCN1A	R935P, R946P, R918P, R132P, R934P, R917P	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189882	2	166894395	2	166037885	189882	187793	rs121917971	NC_000002.12:166037884:C:G
NM_006920.6(SCN1A):c.1199T>A (p.Met400Lys)	SCN1A	M400K	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189880	2	166903458	2	166046948	189880	187835	rs794726725	NC_000002.12:166046947:A:T
NM_006920.6(SCN1A):c.659_662del (p.Val220fs)	SCN1A	V220fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189878	2	166909394 - 166909397	2	166052884 - 166052887	189878	187865	rs794726724	NC_000002.12:166052883:AGAA:
NM_006920.6(SCN1A):c.474_602del (p.Thr160_Tyr202del)	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189875	2	166911148 - 166911276	2	166054638 - 166054766	189875	187868	rs1553551314	
NM_006920.6(SCN1A):c.2695C>A (p.Gln899Lys)	SCN1A	Q899K, Q910K, Q881K, Q96K, Q898K, Q882K	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189874	2	166894504	2	166037994	189874	187797	rs794726721	NC_000002.12:166037993:G:T
NM_006920.6(SCN1A):c.1072C>T (p.Pro358Ser)	SCN1A	P358S	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189872	2	166904235	2	166047725	189872	187846	rs121917923	NC_000002.12:166047724:G:A
NM_006920.6(SCN1A):c.1660dup (p.Gln554fs)	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189868	2	166901554 - 166901555	2	166045044 - 166045045	189868	187827	rs794726717	NC_000002.12:166045044:GG:GGG
NM_006920.6(SCN1A):c.2913+1_2913+2del	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189865	2	166894284 - 166894285	2	166037774 - 166037775	189865	187784	rs794726714	NC_000002.12:166037773:AC:
NM_006920.6(SCN1A):c.2555T>G (p.Leu852Trp)	SCN1A	L852W, L863W, L834W, L835W, L851W, L49W	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189863	2	166895934	2	166039424	189863	187804	rs794726712	NC_000002.12:166039423:A:C
NM_006920.6(SCN1A):c.2846T>G (p.Met949Arg)	SCN1A	M949R, M960R, M931R, M948R, M932R, M146R	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189858	2	166894353	2	166037843	189858	187790	rs794726708	NC_000002.12:166037842:A:C
NM_006920.6(SCN1A):c.1667del (p.Leu556fs)	SCN1A	L556fs, L555fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189853	2	166900555	2	166044045	189853	187824	rs794726704	NC_000002.12:166044044:AAA:AA
NM_001165963.1(SCN1A):c.2044_6030del	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189852					189852	187884		
NM_006920.6(SCN1A):c.1118del (p.Leu373fs)	SCN1A	L373fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000189842	2	166904189	2	166047679	189842	187843	rs794726695	NC_000002.12:166047678:AAAAAA:AAAAA
NM_006920.6(SCN1A):c.2551C>G (p.Arg851Gly)	SCN1A	R862G, R851G, R850G, R834G, R48G, R833G	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Jul 26, 2011)	no assertion criteria provided	VCV000029884	2	166895938	2	166039428	29884	38839	rs397514459	NC_000002.12:166039427:G:C
SCN1A, 6.5-KB DEL	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Sep 26, 2006)	no assertion criteria provided	VCV000012900					12900	27939		
SCN1A, EX21-26DEL	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Sep 26, 2006)	no assertion criteria provided	VCV000012899					12899	27938		
NM_006920.6(SCN1A):c.655_656AG[1] (p.Arg219fs)	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000012888	2	166909398 - 166909399	2	166052888 - 166052889	12888	27927		NC_000002.12:166052887:CTCT:CT
NM_006920.6(SCN1A):c.338C>T (p.Pro113Leu)	SCN1A	P113L	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000855453	2	166915125	2	166058615	855453	850608		NC_000002.12:166058614:G:A
NM_006920.6(SCN1A):c.2767A>G (p.Met923Val)	SCN1A	M934V, M923V, M120V, M906V, M905V, M922V	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Feb 7, 2018)	criteria provided, single submitter	VCV000574036	2	166894432	2	166037922	574036	557628	rs1559199628	NC_000002.12:166037921:T:C
NM_006920.6(SCN1A):c.971_973ATT[1] (p.Tyr325del)	SCN1A	Y325del	not provided|Obesity|Seizures|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000503736	2	166905448 - 166905450	2	166048938 - 166048940	503736	495097	rs1553548194	NC_000002.12:166048937:AATAAT:AAT
NM_006920.6(SCN1A):c.2786C>T (p.Ser929Phe)	SCN1A	S929F, S940F, S126F, S911F, S912F, S928F	Early infantile epileptic encephalopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000381569	2	166894413	2	166037903	381569	366118	rs1057521080	NC_000002.12:166037902:G:A
NM_006920.6(SCN1A):c.354G>T (p.Arg118Ser)	SCN1A	R118S	not provided|Severe myoclonic epilepsy in infancy	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280476	2	166915109	2	166058599	280476	264048	rs121917959	NC_000002.12:166058598:C:A
NM_006920.6(SCN1A):c.992dup (p.Leu331fs)	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Jul 13, 2015)	criteria provided, single submitter	VCV000217249	2	166905431 - 166905432	2	166048921 - 166048922	217249	213803	rs863225038	NC_000002.12:166048921:AAAAAA:AAAAAAA
NM_006920.6(SCN1A):c.249C>A (p.Tyr83Ter)	SCN1A	Y83*	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000217241	2	166929883	2	166073373	217241	213805	rs863225031	NC_000002.12:166073372:G:T
NM_006920.6(SCN1A):c.2181G>A (p.Trp727Ter)	SCN1A	W727*, W738*, W726*, W710*, W709*	Generalized epilepsy with febrile seizures plus, type 2|not provided	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000190225	2	166897942	2	166041432	190225	188046	rs786205214	NC_000002.12:166041431:C:T
NM_006920.6(SCN1A):c.1007G>A (p.Cys336Tyr)	SCN1A	C336Y	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189962	2	166905417	2	166048907	189962	187853	rs794726798	NC_000002.12:166048906:C:T
NM_006920.6(SCN1A):c.2542C>T (p.Arg848Cys)	SCN1A	R848C, R859C, R847C, R45C, R830C, R831C	not provided|Generalized epilepsy with febrile seizures plus, type 1	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000068592	2	166895947	2	166039437	68592	79484	rs121918784	NC_000002.12:166039436:G:A
NM_006920.6(SCN1A):c.1162T>C (p.Tyr388His)	SCN1A	Y388H	not provided|Generalized epilepsy with febrile seizures plus, type 1	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000068586	2	166904145	2	166047635	68586	79478	rs121918781	NC_000002.12:166047634:A:G
NM_006920.6(SCN1A):c.2759G>T (p.Arg920Leu)	SCN1A	R902L, R931L, R117L, R919L, R903L, R920L	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, single submitter	VCV000837128	2	166894440	2	166037930	837128	850479		NC_000002.12:166037929:C:A
NC_000002.12:g.(?_165991225)_(166048969_?)del	SCN1A		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000832804	2	166847735 - 166905479			832804	819068		
NM_006920.6(SCN1A):c.2915T>A (p.Val972Asp)	SCN1A	V972D, V983D, V955D, V169D, V971D, V954D	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000568075	2	166893039	2	166036529	568075	557626	rs121918756	NC_000002.12:166036528:A:T
NM_006920.6(SCN1A):c.2317_2318del (p.Phe773fs)	SCN1A	F772fs, F755fs, F756fs, F773fs, F784fs	Severe myoclonic epilepsy in infancy|Early infantile epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000461250	2	166897805 - 166897806	2	166041295 - 166041296	461250	449127	rs1553543215	NC_000002.12:166041294:AAAA:AA
NM_006920.6(SCN1A):c.1028+1G>T	SCN1A		Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Jun 15, 2015)	criteria provided, single submitter	VCV000217240	2	166905395	2	166048885	217240	213802	rs863225030	NC_000002.12:166048884:C:A
NM_006920.6(SCN1A):c.265-1G>A	SCN1A		Early infantile epileptic encephalopathy|not provided	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000206735	2	166915199	2	166058689	206735	201632	rs796052953	NC_000002.12:166058688:C:T
NM_006920.6(SCN1A):c.2180G>A (p.Trp727Ter)	SCN1A	W727*, W738*, W726*, W709*, W710*	Severe myoclonic epilepsy in infancy|not provided	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189969	2	166897943	2	166041433	189969	187815	rs794726742	NC_000002.12:166041432:C:T
NM_006920.6(SCN1A):c.2913+1G>T	SCN1A		not provided|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Jun 20, 2016)	criteria provided, multiple submitters, no conflicts	VCV000189935	2	166894285	2	166037775	189935	187785	rs794726772	NC_000002.12:166037774:C:A
NM_006920.6(SCN1A):c.769T>C (p.Cys257Arg)	SCN1A	C257R	not provided|Severe myoclonic epilepsy in infancy	Pathogenic/Likely pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189934	2	166908424	2	166051914	189934	187860	rs794726771	NC_000002.12:166051913:A:G
NM_006920.6(SCN1A):c.1170+1G>T	SCN1A		not provided|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000189928	2	166904136	2	166047626	189928	187839	rs794726765	NC_000002.12:166047625:C:A
NM_006920.6(SCN1A):c.675G>C (p.Lys225Asn)	SCN1A	K225N	Severe myoclonic epilepsy in infancy|not provided	Pathogenic(Last reviewed: Jun 24, 2015)	criteria provided, multiple submitters, no conflicts	VCV000189871	2	166909381	2	166052871	189871	187864	rs794726719	NC_000002.12:166052870:C:G
NM_006920.6(SCN1A):c.2843G>A (p.Cys948Tyr)	SCN1A	C948Y, C959Y, C931Y, C930Y, C947Y, C145Y	not provided|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Jun 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000189867	2	166894356	2	166037846	189867	187792	rs794726716	NC_000002.12:166037845:C:T
NM_001165963.2(SCN1A):c.2947del (p.Val983Serfs)	SCN1A		not provided|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189866	2	166894286	2	166037775	189866	187786	rs794726715	
NM_006920.6(SCN1A):c.2902G>A (p.Gly968Arg)	SCN1A	G968R, G979R, G165R, G951R, G967R, G950R	Severe myoclonic epilepsy in infancy|not provided	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000068609	2	166894297	2	166037787	68609	79501	rs121918754	NC_000002.12:166037786:C:T
NM_006920.6(SCN1A):c.2821T>G (p.Trp941Gly)	SCN1A	W941G, W952G, W940G, W138G, W923G, W924G	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000068605	2	166894378	2	166037868	68605	79497	rs121918737	NC_000002.12:166037867:A:C
NM_006920.6(SCN1A):c.2782C>T (p.His928Tyr)	SCN1A	H928Y, H939Y, H911Y, H125Y, H910Y, H927Y	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000068600	2	166894417	2	166037907	68600	79492	rs121918736	NC_000002.12:166037906:G:A
NM_006920.6(SCN1A):c.2816G>A (p.Gly939Glu)	SCN1A	G939E, G950E, G136E, G922E, G938E, G921E	not provided|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Mar 30, 2015)	criteria provided, single submitter	VCV000068524	2	166894383	2	166037873	68524	79416	rs121917972	NC_000002.12:166037872:C:T
SCN1A, 1-BP DEL, 2528G	SCN1A		Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2	Pathogenic(Last reviewed: Feb 28, 2006)	no assertion criteria provided	VCV000012898					12898	27937		
NM_004958.4(MTOR):c.6644C>A (p.Ser2215Tyr)	MTOR	S2215Y	Papillary renal cell carcinoma, sporadic|Uterine cervical neoplasms|Malignant melanoma of skin|Kidney Carcinoma|Glioblastoma|Renal cell carcinoma, papillary, 1|Neoplasm of the large intestine|Focal cortical dysplasia type II|Malignant neoplasm of body of uterus	Pathogenic/Likely pathogenic(Last reviewed: Apr 18, 2018)	no assertion criteria provided	VCV000376129	1	11184573	1	11124516	376129	363008	rs587777894	NC_000001.11:11124515:G:T
NM_004958.4(MTOR):c.4448G>T (p.Cys1483Phe)	MTOR	C1483F	Smith-Kingsmore syndrome|Neoplasm of the breast|Renal cell carcinoma, papillary, 1|Glioblastoma|not provided	Pathogenic(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	VCV000190121	1	11217230	1	11157173	190121	187953	rs786205165	NC_000001.11:11157172:C:A
NM_005465.7(AKT3):c.1393C>T (p.Arg465Trp)	AKT3	R465W	Inborn genetic diseases|Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2|Global developmental delay|Macrocephalus|Polymicrogyria|Capillary hemangiomas	Pathogenic/Likely pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000039814	1	243668598	1	243505296	39814	48413	rs587776935	NC_000001.11:243505295:G:A
NM_006920.6(SCN1A):c.126del (p.Asp43fs)	SCN1A	D43fs	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Jan 25, 2017)	criteria provided, single submitter	VCV000496115	2	166930006	2	166073496	496115	486946	rs1553560831	NC_000002.12:166073495:TTTTTT:TTTTT
NM_006920.6(SCN1A):c.1662+1G>A	SCN1A		Early infantile epileptic encephalopathy|not provided	Pathogenic(Last reviewed: Mar 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449097	2	166901552	2	166045042	449097	443035	rs794726749	NC_000002.12:166045041:C:T
NM_006920.6(SCN1A):c.1702C>T (p.Arg568Ter)	SCN1A	R568*, R567*	not provided|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2|Familial hemiplegic migraine type 3	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000265254	2	166900520	2	166044010	265254	259708	rs886039430	NC_000002.12:166044009:G:A
NM_006920.6(SCN1A):c.602+1G>C	SCN1A		Early infantile epileptic encephalopathy|not provided	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000206742	2	166911147	2	166054637	206742	201620	rs794726827	NC_000002.12:166054636:C:G
NM_006920.6(SCN1A):c.2320A>G (p.Met774Val)	SCN1A	M774V, M785V, M757V, M773V, M756V	Early infantile epileptic encephalopathy|Severe myoclonic epilepsy in infancy	Pathogenic/Likely pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189917	2	166897803	2	166041293	189917	187809	rs767045134	NC_000002.12:166041292:T:C
NM_006920.6(SCN1A):c.2551C>T (p.Arg851Ter)	SCN1A	R851*, R862*, R833*, R834*, R850*, R48*	not provided|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, multiple submitters, no conflicts	VCV000189857	2	166895938	2	166039428	189857	187805	rs397514459	NC_000002.12:166039427:G:A
NM_006920.6(SCN1A):c.838T>C (p.Trp280Arg)	SCN1A	W280R	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000068583	2	166908355	2	166051845	68583	79475	rs121917938	NC_000002.12:166051844:A:G
NM_006920.6(SCN1A):c.715G>A (p.Ala239Thr)	SCN1A	A239T	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000068580	2	166908478	2	166051968	68580	79472	rs121917985	NC_000002.12:166051967:C:T
NM_006920.6(SCN1A):c.1876A>G (p.Ser626Gly)	SCN1A	S626G, S625G	Generalized epilepsy|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000068512	2	166900346	2	166043836	68512	79404	rs121917990	NC_000002.12:166043835:T:C
NM_006920.6(SCN1A):c.434T>C (p.Met145Thr)	SCN1A	M145T	not provided|Generalized epilepsy with febrile seizures plus, type 2|Febrile seizures, familial, 3a	Pathogenic(Last reviewed: Jun 8, 2016)	criteria provided, single submitter	VCV000012896	2	166912960	2	166056450	12896	27935	rs121918631	NC_000002.12:166056449:A:G
NM_001791.4(CDC42):c.68A>G (p.Tyr23Cys)	CDC42	Y23C	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000208731	1	22405039	1	22078546	208731	205217	rs797044916	NC_000001.11:22078545:A:G
NM_006920.6(SCN1A):c.603-1G>A	SCN1A		Early infantile epileptic encephalopathy|not provided	Pathogenic(Last reviewed: Jun 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000206743	2	166909454	2	166052944	206743	201617	rs796052959	NC_000002.12:166052943:C:T
NM_006920.6(SCN1A):c.1834C>T (p.Arg612Ter)	SCN1A	R612*, R611*	Early infantile epileptic encephalopathy|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189941	2	166900388	2	166043878	189941	187821	rs794726778	NC_000002.12:166043877:G:A
NM_006920.6(SCN1A):c.777C>A (p.Ser259Arg)	SCN1A	S259R	Seizures|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Dec 20, 2014)	criteria provided, single submitter	VCV000068673	2	166908416	2	166051906	68673	79565	rs121918735	NC_000002.12:166051905:G:T
NM_006920.6(SCN1A):c.568T>C (p.Trp190Arg)	SCN1A	W190R	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000068668	2	166911182	2	166054672	68668	79560	rs121918773	NC_000002.12:166054671:A:G
NM_006920.6(SCN1A):c.2827G>A (p.Glu943Lys)	SCN1A	E943K, E954K, E925K, E942K, E926K, E140K	Severe myoclonic epilepsy in infancy|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000068606	2	166894372	2	166037862	68606	79498	rs121918786	NC_000002.12:166037861:C:T
NM_006920.6(SCN1A):c.2798T>C (p.Val933Ala)	SCN1A	V933A, V944A, V916A, V932A, V130A, V915A	Severe myoclonic epilepsy in infancy|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, single submitter	VCV000068602	2	166894401	2	166037891	68602	79494	rs121917969	NC_000002.12:166037890:A:G
NM_201253.3(CRB1):c.2290C>T (p.Arg764Cys)	CRB1	R764C, R652C, R695C	Macular dystrophy|Retinitis pigmentosa 12|Retinitis pigmentosa|Retinal dystrophy|Leber congenital amaurosis 8|Retinitis pigmentosa 12|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005732	1	197396745	1	197427615	5732	20771	rs62635654	NC_000001.11:197427614:C:T
NM_000090.4(COL3A1):c.2932G>A (p.Gly978Ser)	COL3A1	G978S	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000853303	2	189870076	2	189005350	853303	825484		NC_000002.12:189005349:G:A
NM_000090.4(COL3A1):c.2267G>A (p.Gly756Glu)	COL3A1	G756E	Ehlers-Danlos syndrome, type 4	Pathogenic/Likely pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000667403	2	189864605	2	188999879	667403	654237		NC_000002.12:188999878:G:A
NM_000090.3(COL3A1):c.1024G>A (p.Gly342Arg)	COL3A1	G342R	not provided|Ehlers-Danlos syndrome, type 4	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000199715	2	189857640	2	188992914	199715	196772	rs794728040	NC_000002.12:188992913:G:A
NM_000090.3(COL3A1):c.962G>A (p.Gly321Asp)	COL3A1	G321D	not provided|Ehlers-Danlos syndrome, type 4	Pathogenic/Likely pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000101390	2	189856920	2	188992194	101390	107136	rs587779588	NC_000002.12:188992193:G:A
NM_000090.3(COL3A1):c.970G>A (p.Gly324Ser)	COL3A1	G324S	Cardiovascular phenotype|Ehlers-Danlos syndrome, type 4	Pathogenic/Likely pathogenic(Last reviewed: May 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000101388	2	189856928	2	188992202	101388	107134	rs587779650	NC_000002.12:188992201:G:A
NM_000090.3(COL3A1):c.800G>T (p.Gly267Val)	COL3A1	G267V	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000101113	2	189855731	2	188991005	101113	106858	rs587779427	NC_000002.12:188991004:G:T
NM_001204.7(BMPR2):c.631C>T (p.Arg211Ter)	BMPR2	R211*	not provided|Pulmonary arterial hypertension|Pulmonary hypertension, primary, dexfenfluramine-associated|Primary pulmonary hypertension	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008812	2	203383554	2	202518831	8812	23851	rs137852753	NC_000002.12:202518830:C:T
NC_000001.11:g.(?_17018871)_(17044898_?)del	SDHB		Pheochromocytoma|Paragangliomas 4|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000833509	1	17345366 - 17371393			833509	818864		
NC_000001.11:g.(?_17018881)_(17044898_?)del	SDHB		Gastrointestinal stromal tumor|Pheochromocytoma|Paragangliomas 4	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000831498	1	17345376 - 17371393			831498	818866		
NM_003000.2(SDHB):c.683_684delAG	SDHB		Hereditary cancer-predisposing syndrome|Gastrointestinal stromal tumor|Pheochromocytoma|Paragangliomas 4|Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic(Last reviewed: Nov 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000438428	1	17349184 - 17349185	1	17022689 - 17022690	438428	432026	rs762812025	NC_000001.11:17022688:CTCT:CT
NM_003000.2(SDHB):c.286+1G>A	SDHB		Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183757	1	17359554	1	17033059	183757	181619	rs786201063	NC_000001.11:17033058:C:T
NM_003000.3(SDHB):c.600G>A (p.Trp200Ter)	SDHB	W200*	Paragangliomas 4|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000044646	1	17350510	1	17024015	44646	53813	rs397516836	NC_000001.11:17024014:C:T
NM_003000.2(SDHB):c.136C>G (p.Arg46Gly)	SDHB	R46G	Pheochromocytoma|Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012785	1	17371320	1	17044825	12785	27824	rs74315370	NC_000001.11:17044824:G:C
NC_000001.10:g.(?_45798240)_(45800189_?)del	MUTYH		MYH-associated polyposis	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000533332	1	45798240 - 45800189	1	45332568 - 45334517	533332	514857		
NM_001128425.1(MUTYH):c.308G>A (p.Trp103Ter)	MUTYH	W103*, W86*, W90*, W76*, W89*, W75*, W100*	Hereditary cancer-predisposing syndrome|not provided|MYH-associated polyposis	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000485909	1	45799125	1	45333453	485909	472477	rs1553130185	NC_000001.11:45333452:C:T
NM_001048171.1(MUTYH):c.206C>G (p.Ser69Ter)	MUTYH	S83*, S69*, S56*, S80*, S66*, S70*, S55*	Hereditary cancer-predisposing syndrome|not provided|MYH-associated polyposis	Pathogenic/Likely pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000485907	1	45799185	1	45333513	485907	472441	rs370124822	NC_000001.11:45333512:G:C
NM_001128425.1(MUTYH):c.37-1317_667del	MUTYH		MYH-associated polyposis	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000464717	1	45798269 - 45801500	1	45332597 - 45335828	464717	448022		
NM_012222.2(MUTYH):c.1347del (p.Tyr450fs)	MUTYH	Y436fs, Y310fs, Y425fs, Y440fs, Y453fs, Y333fs, Y426fs, Y450fs, Y439fs	Hereditary cancer-predisposing syndrome|MYH-associated polyposis	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000464690	1	45796974	1	45331302	464690	447967	rs1553125243	NC_000001.11:45331301:T:
NM_006920.6(SCN1A):c.1150T>A (p.Trp384Arg)	SCN1A	W384R	not provided|Early infantile epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000390676	2	166904157	2	166047647	390676	365899	rs1057523858	NC_000002.12:166047646:A:T
NM_006920.6(SCN1A):c.1738C>T (p.Arg580Ter)	SCN1A	R580*, R579*	Severe myoclonic epilepsy in infancy|Early infantile epileptic encephalopathy|not provided	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000189892	2	166900484	2	166043974	189892	187823	rs794726736	NC_000002.12:166043973:G:A
NM_006920.6(SCN1A):c.2560C>T (p.Arg854Ter)	SCN1A	R854*, R865*, R836*, R837*, R51*, R853*	Severe myoclonic epilepsy in infancy|Early infantile epileptic encephalopathy|not provided	Pathogenic(Last reviewed: Feb 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000189844	2	166894639	2	166038129	189844	187802	rs794726697	NC_000002.12:166038128:G:A
NM_006920.6(SCN1A):c.523G>A (p.Ala175Thr)	SCN1A	A175T	Severe myoclonic epilepsy in infancy|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000068656	2	166911227	2	166054717	68656	79548	rs121918767	NC_000002.12:166054716:C:T
NM_006920.6(SCN1A):c.1130G>A (p.Arg377Gln)	SCN1A	R377Q	not provided|Generalized epilepsy with febrile seizures plus, type 1|Severe myoclonic epilepsy in infancy	Pathogenic/Likely pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000068502	2	166904177	2	166047667	68502	79394	rs121917957	NC_000002.12:166047666:C:T
NM_003036.4(SKI):c.100G>A (p.Gly34Ser)	SKI	G34S	Shprintzen-Goldberg syndrome|Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000037261	1	2160305	1	2228866	37261	45851	rs387907306	NC_000001.11:2228865:G:A
NM_001130987.2(DYSF):c.5785-7G>A	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B|Qualitative or quantitative defects of dysferlin|not provided	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000283474	2	71901320	2	71674190	283474	267711	rs753861836	NC_000002.12:71674189:G:A
NM_001130987.2(DYSF):c.3191G>A (p.Arg1064His)	DYSF	R1046H, R1064H, R1033H, R1047H, R1078H, R1063H, R1032H, R1077H	Miyoshi muscular dystrophy 1|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B|Myopathy, distal, with anterior tibial onset|Miyoshi muscular dystrophy 1|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006675	2	71797834	2	71570704	6675	21714	rs121908958	NC_000002.12:71570703:G:A
NM_018328.4(MBD5):c.75G>A (p.Trp25Ter)	MBD5	W25*	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 20, 2016)	criteria provided, single submitter	VCV000521204	2	149216402	2	148458833	521204	511322	rs1553517456	NC_000002.12:148458832:G:A
NM_170707.4(LMNA):c.695G>A (p.Gly232Glu)	LMNA	G232E, G151E, G120E	Charcot-Marie-Tooth disease, type 2|not provided|Emery-Dreifuss muscular dystrophy 2, autosomal dominant	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066925	1	156104651	1	156134860	66925	77822	rs57207746	NC_000001.11:156134859:G:A
NM_003001.3(SDHC):c.405+1G>T	SDHC		not provided|Paragangliomas 3|Paragangliomas 3|Gastrointestinal stromal tumor|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007242	1	161326631	1	161356841	7242	22281	rs587776653	NC_000001.11:161356840:G:T
NM_206933.4(USH2A):c.4576G>A (p.Gly1526Arg)	USH2A	G1526R	Retinal dystrophy	Pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000867207	1	216348645	1	216175303	867207	855988		NC_000001.11:216175302:C:T
NM_206933.4(USH2A):c.4707T>G (p.Tyr1569Ter)	USH2A	Y1569*	Retinal dystrophy	Pathogenic(Last reviewed: Jun 6, 2019)	criteria provided, single submitter	VCV000867170	1	216270476	1	216097134	867170	855986		NC_000001.11:216097133:A:C
NM_206933.4(USH2A):c.11548+2T>G	USH2A		Retinal dystrophy	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, single submitter	VCV000867169	1	215916517	1	215743175	867169	857125		NC_000001.11:215743174:A:C
NM_206933.4(USH2A):c.3317-2A>G	USH2A		Retinal dystrophy	Pathogenic(Last reviewed: Dec 22, 2017)	criteria provided, single submitter	VCV000866916	1	216373465	1	216200123	866916	857131		NC_000001.11:216200122:T:C
NM_206933.4(USH2A):c.4133T>C (p.Leu1378Pro)	USH2A	L1378P	Retinal dystrophy	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000866375	1	216370013	1	216196671	866375	855990		NC_000001.11:216196670:A:G
NM_206933.4(USH2A):c.773_774AG[1] (p.Ser259fs)	USH2A		Retinal dystrophy	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000866168	1	216538303 - 216538304	1	216364961 - 216364962	866168	856012		NC_000001.11:216364960:CTCT:CT
NM_206933.4(USH2A):c.7468del (p.Ser2490fs)	USH2A	S2490fs	Retinal dystrophy	Pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, single submitter	VCV000865988	1	216073543	1	215900201	865988	855968		NC_000001.11:215900200:AA:A
NM_206933.4(USH2A):c.4384del (p.Thr1462fs)	USH2A	T1462fs	Retinal dystrophy	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000865950	1	216363577	1	216190235	865950	855989		NC_000001.11:216190234:TTT:TT
NM_206933.4(USH2A):c.12703C>T (p.Gln4235Ter)	USH2A	Q4235*	Retinal dystrophy	Pathogenic(Last reviewed: May 12, 2019)	criteria provided, single submitter	VCV000865933	1	215848550	1	215675208	865933	855928		NC_000001.11:215675207:G:A
NM_206933.4(USH2A):c.98C>A (p.Ser33Ter)	USH2A	S33*	Retinal dystrophy	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000865905	1	216595581	1	216422239	865905	856019		NC_000001.11:216422238:G:T
NM_206933.4(USH2A):c.11216_11223del (p.Leu3739fs)	USH2A	L3739fs	not provided	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000818063	1	215933010 - 215933017	1	215759668 - 215759675	818063	805202		NC_000001.11:215759667:GGGCTCCAGG:GG
NM_206933.4(USH2A):c.13587del (p.Ser4530fs)	USH2A	S4530fs	not provided	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, single submitter	VCV000817690	1	215847666	1	215674324	817690	805200		NC_000001.11:215674323:GGGG:GGG
NM_206933.4(USH2A):c.2815del (p.Tyr939fs)	USH2A	Y939fs	not provided	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000817432	1	216405473	1	216232131	817432	805203		NC_000001.11:216232130:AAAAA:AAAA
NM_206933.4(USH2A):c.14365C>T (p.Gln4789Ter)	USH2A	Q4789*	not provided	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000816987	1	215822087	1	215648745	816987	805199		NC_000001.11:215648744:G:A
NM_206933.4(USH2A):c.2073C>A (p.Cys691Ter)	USH2A	C691*	not provided	Pathogenic(Last reviewed: Mar 20, 2019)	criteria provided, single submitter	VCV000816945	1	216424339	1	216250997	816945	805204		NC_000001.11:216250996:G:T
NC_000001.11:g.216323502_216323503delinsAT	USH2A		not provided	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000813117	1	216496844 - 216496845	1	216323502 - 216323503	813117	801305		NC_000001.11:216323501:CA:AT
NM_206933.2:c.8932_8933insAlu	USH2A		not provided	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000801009					801009	789395		
GRCh37/hg19 1q41(chr1:216212155-216234471)x1	USH2A		not provided	Pathogenic(Last reviewed: Apr 20, 2017)	no assertion criteria provided	VCV000688085	1	216212155 - 216234471			688085	675677		
GRCh37/hg19 1q41(chr1:216355508-216417771)x1	USH2A		not provided	Pathogenic(Last reviewed: Jul 12, 2018)	no assertion criteria provided	VCV000687497	1	216355508 - 216417771			687497	675089		
NM_206933.3(USH2A):c.2293C>T (p.Gln765Ter)	USH2A	Q765*	not provided	Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, single submitter	VCV000620284	1	216420443	1	216247101	620284	611512	rs777629750	NC_000001.11:216247100:G:A
NM_206933.3(USH2A):c.7999G>T (p.Glu2667Ter)	USH2A	E2667*	not provided	Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, single submitter	VCV000620283	1	216061992	1	215888650	620283	611511	rs1301139848	NC_000001.11:215888649:C:A
NM_206933.3(USH2A):c.11065C>T (p.Arg3689Ter)	USH2A	R3689*	not provided	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000620107	1	215933168	1	215759826	620107	611510	rs41314534	NC_000001.11:215759825:G:A
NM_206933.3(USH2A):c.3296_3297del (p.Thr1099fs)	USH2A	T1099fs	not provided	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000592698	1	216380634 - 216380635	1	216207292 - 216207293	592698	583763	rs748369458	NC_000001.11:216207291:TGT:T
NM_206933.3(USH2A):c.12093C>A (p.Tyr4031Ter)	USH2A	Y4031*	not provided	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000546112	1	215853692	1	215680350	546112	536573	rs55921307	NC_000001.11:215680349:G:T
NM_206933.3(USH2A):c.13695T>G (p.Tyr4565Ter)	USH2A	Y4565*	not provided	Pathogenic(Last reviewed: Nov 15, 2016)	criteria provided, single submitter	VCV000498010	1	215847558	1	215674216	498010	489434	rs1553252343	NC_000001.11:215674215:A:C
NM_206933.3(USH2A):c.10684G>T (p.Glu3562Ter)	USH2A	E3562*	not provided	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, single submitter	VCV000430065	1	215955440	1	215782098	430065	421206	rs749702843	NC_000001.11:215782097:C:A
NM_206933.3(USH2A):c.8546G>T (p.Gly2849Val)	USH2A	G2849V	not provided	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	VCV000419673	1	216052118	1	215878776	419673	405036	rs1064794034	NC_000001.11:215878775:C:A
NM_206933.3(USH2A):c.4125del (p.Tyr1376fs)	USH2A	Y1376fs	not provided	Pathogenic(Last reviewed: Apr 13, 2015)	criteria provided, single submitter	VCV000418896	1	216370021	1	216196679	418896	405040	rs1064793506	NC_000001.11:216196678:C:
NM_206933.3(USH2A):c.3086del (p.Gly1029fs)	USH2A	G1029fs	not provided	Pathogenic(Last reviewed: Jul 19, 2016)	criteria provided, single submitter	VCV000289013	1	216390800	1	216217458	289013	273250	rs886044060	NC_000001.11:216217457:CC:C
NM_206933.3(USH2A):c.9390G>A (p.Trp3130Ter)	USH2A	W3130*	not provided	Pathogenic(Last reviewed: Oct 27, 2015)	criteria provided, single submitter	VCV000284006	1	215990519	1	215817177	284006	268243	rs886042766	NC_000001.11:215817176:C:T
NM_206933.3(USH2A):c.14175G>A (p.Trp4725Ter)	USH2A	W4725*	not provided	Pathogenic(Last reviewed: Oct 3, 2015)	criteria provided, single submitter	VCV000283856	1	215824102	1	215650760	283856	268093	rs886042722	NC_000001.11:215650759:C:T
NM_206933.3(USH2A):c.9685del (p.Glu3229fs)	USH2A	E3229fs	Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236049	1	215987132	1	215813790	236049	237597	rs878853233	NC_000001.11:215813789:CC:C
NM_206933.3(USH2A):c.14500_14501TC[1] (p.Pro4835fs)	USH2A		not provided	Pathogenic(Last reviewed: Nov 17, 2014)	criteria provided, single submitter	VCV000198365	1	215821949 - 215821950	1	215648607 - 215648608	198365	195526	rs794727830	NC_000001.11:215648606:GAGAG:GAG
NM_206933.4(USH2A):c.9304C>T (p.Gln3102Ter)	USH2A	Q3102*	Rare genetic deafness	Pathogenic(Last reviewed: Mar 11, 2013)	no assertion criteria provided	VCV000048621	1	216011400	1	215838058	48621	57783	rs397518046	NC_000001.11:215838057:G:A
NM_206933.4(USH2A):c.11048-1G>A	USH2A		Rare genetic deafness	Pathogenic(Last reviewed: Jun 13, 2010)	no assertion criteria provided	VCV000048365	1	215933186	1	215759844	48365	57527	rs111033414	NC_000001.11:215759843:C:T
NM_206933.4(USH2A):c.7023dup (p.Ser2342fs)	USH2A		not provided	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000862635	1	216138755 - 216138756	1	215965413 - 215965414	862635	823412		NC_000001.11:215965413:T:TT
NM_206933.4(USH2A):c.10074C>A (p.Cys3358Ter)	USH2A	C3358*	not provided	Pathogenic(Last reviewed: May 31, 2019)	criteria provided, single submitter	VCV000859991	1	215963509	1	215790167	859991	823376		NC_000001.11:215790166:G:T
NM_206933.4(USH2A):c.3372_3373del (p.Tyr1124_Ile1125insTer)	USH2A		not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000859369	1	216373407 - 216373408	1	216200065 - 216200066	859369	823444		NC_000001.11:216200064:TGT:T
NM_206933.4(USH2A):c.803del (p.Gly268fs)	USH2A	G268fs	not provided	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000856681	1	216500978	1	216327636	856681	823462		NC_000001.11:216327635:CC:C
NM_206933.4(USH2A):c.9441G>A (p.Trp3147Ter)	USH2A	W3147*	not provided	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000856307	1	215990468	1	215817126	856307	823387		NC_000001.11:215817125:C:T
NM_206933.4(USH2A):c.11824dup (p.Val3942fs)	USH2A		not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000854044	1	215901613 - 215901614	1	215728271 - 215728272	854044	823355		NC_000001.11:215728271:CCC:CCCC
NM_206933.4(USH2A):c.2146A>T (p.Lys716Ter)	USH2A	K716*	not provided	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000853403	1	216424266	1	216250924	853403	823457		NC_000001.11:216250923:T:A
NM_206933.4(USH2A):c.12202G>T (p.Gly4068Ter)	USH2A	G4068*	not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000850746	1	215853583	1	215680241	850746	823351		NC_000001.11:215680240:C:A
NM_206933.4(USH2A):c.2599C>T (p.Gln867Ter)	USH2A	Q867*	not provided	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000850436	1	216420137	1	216246795	850436	823455		NC_000001.11:216246794:G:A
NM_206933.4(USH2A):c.13598C>G (p.Ser4533Ter)	USH2A	S4533*	not provided	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000846146	1	215847655	1	215674313	846146	823341		NC_000001.11:215674312:G:C
NM_206933.4(USH2A):c.7075_7076del (p.Leu2359fs)	USH2A	L2359fs	not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000834543	1	216138703 - 216138704	1	215965361 - 215965362	834543	823409		NC_000001.11:215965360:AA:
NC_000001.11:g.(?_215813726)_(215817205_?)del	USH2A		not provided	Pathogenic(Last reviewed: Feb 23, 2019)	criteria provided, single submitter	VCV000833296	1	215987068 - 215990547			833296	818908		
NC_000001.11:g.(?_215867007)_(215993167_?)del	USH2A		not provided	Pathogenic(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV000833168	1	216040349 - 216166509			833168	818913		
NC_000001.11:g.(?_216217387)_(216292370_?)del	USH2A		not provided	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000833029	1	216390729 - 216465712			833029	818920		
NC_000001.11:g.(?_215670962)_(215671303_?)del	USH2A		not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000831414	1	215844304 - 215844645			831414	818902		
NC_000001.11:g.(?_215993010)_(215993177_?)del	USH2A		not provided	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000831328	1	216166352 - 216166519			831328	818914		
NC_000001.11:g.(?_216250893)_(216251108_?)del	USH2A		not provided	Pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000830744	1	216424235 - 216424450			830744	818921		
NM_206933.4(USH2A):c.409dup (p.Ser137fs)	USH2A		Retinitis pigmentosa 39	Pathogenic(Last reviewed: Jul 18, 2019)	no assertion criteria provided	VCV000829992	1	216595269 - 216595270	1	216421927 - 216421928	829992	818169		NC_000001.11:216421927:AAAA:AAAAA
NC_000001.11:g.215675578dup	USH2A		not provided	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000813108	1	215848919 - 215848920	1	215675577 - 215675578	813108	801286		NC_000001.11:215675577:A:AA
NC_000001.11:g.215786848del	USH2A	P3404fs	Usher syndrome type 2	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812452	1	215960188	1	215786846	812452	800433		NC_000001.11:215786845:GGG:GG
NC_000001.11:g.215680329del	USH2A	Y4039fs	Usher syndrome type 2	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812450	1	215853671	1	215680329	812450	800431		NC_000001.11:215680328:T:
NC_000001.11:g.215671082T>A	USH2A	R4675*	Usher syndrome type 2	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812448	1	215844424	1	215671082	812448	800429		NC_000001.11:215671081:T:A
NM_206933.3(USH2A):c.3384_3417del (p.Asn1129fs)	USH2A	N1129fs	not provided	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000663600	1	216373363 - 216373396	1	216200021 - 216200054	663600	627365		NC_000001.11:216200020:GACAGCTACACTCCTTGTTGAACCATGCACATTGG:G
NM_206933.3(USH2A):c.12854G>A (p.Trp4285Ter)	USH2A	W4285*	not provided	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000657539	1	215848399	1	215675057	657539	627354		NC_000001.11:215675056:C:T
NM_206933.3(USH2A):c.12794del (p.Gly4265fs)	USH2A	G4265fs	not provided	Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000656749	1	215848459	1	215675117	656749	627355		NC_000001.11:215675116:CC:C
NM_206933.3(USH2A):c.15403del (p.Thr5135fs)	USH2A	T5135fs	not provided	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000655791	1	215802272	1	215628930	655791	627353		NC_000001.11:215628929:TT:T
NM_007123.5(USH2A):c.3004del (p.Cys1002fs)	USH2A	C1002fs	not provided	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000653649	1	216390882	1	216217540	653649	627367		NC_000001.11:216217539:AA:A
NM_206933.3(USH2A):c.10318del (p.Ile3440fs)	USH2A	I3440fs	not provided	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000645735	1	215960081	1	215786739	645735	627358		NC_000001.11:215786738:TT:T
NM_206933.3(USH2A):c.8584C>T (p.Gln2862Ter)	USH2A	Q2862*	not provided	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000645172	1	216051197	1	215877855	645172	627360		NC_000001.11:215877854:G:A
NM_206933.3(USH2A):c.1228G>T (p.Glu410Ter)	USH2A	E410*	not provided	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000643680	1	216497610	1	216324268	643680	627368		NC_000001.11:216324267:C:A
NM_007123.5(USH2A):c.3224_3225dup (p.Pro1076fs)	USH2A		not provided	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000640716	1	216380705 - 216380706	1	216207363 - 216207364	640716	627366		NC_000001.11:216207363:AC:ACAC
NM_206933.3(USH2A):c.3788G>A (p.Trp1263Ter)	USH2A	W1263*	not provided	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000640289	1	216372992	1	216199650	640289	627364		NC_000001.11:216199649:C:T
NM_206933.3(USH2A):c.8271T>G (p.Tyr2757Ter)	USH2A	Y2757*	USH2A-Related Disorders	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000638304	1	216052393	1	215879051	638304	626104		NC_000001.11:215879050:A:C
NM_007123.5(USH2A):c.667dup (p.Ile223fs)	USH2A		Retinitis pigmentosa 39	Pathogenic(Last reviewed: Oct 16, 2017)	no assertion criteria provided	VCV000522527	1	216538411 - 216538412	1	216365069 - 216365070	522527	513013	rs1553253747	NC_000001.11:216365069:TTTTT:TTTTTT
NM_206933.3(USH2A):c.10388-1G>C	USH2A		Retinitis pigmentosa 39	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522485	1	215956278	1	215782936	522485	513010	rs1553261478	NC_000001.11:215782935:C:G
NM_206933.2:c.(?_4628)_(9371_?)del	USH2A		Usher syndrome	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000503557	1	216011333 - 216270555			503557	494979		
NM_007123.5(USH2A):c.1803del (p.Gly602fs)	USH2A	G602fs	Usher syndrome	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000503555	1	216465554	1	216292212	503555	494954	rs1553327452	NC_000001.11:216292211:T:
NM_206933.3(USH2A):c.6639del (p.Lys2213fs)	USH2A	K2213fs	Rare genetic deafness	Pathogenic(Last reviewed: Feb 26, 2016)	criteria provided, single submitter	VCV000228415	1	216172247	1	215998905	228415	228328	rs876657732	NC_000001.11:215998904:TTT:TT
NM_206933.4(USH2A):c.13711G>T (p.Glu4571Ter)	USH2A	E4571*	Rare genetic deafness	Pathogenic(Last reviewed: Jun 16, 2015)	criteria provided, single submitter	VCV000228412	1	215847542	1	215674200	228412	228300	rs751411512	NC_000001.11:215674199:C:A
NC_000001.10:g.(?_216061768)_(216074247_?)del	USH2A		Rare genetic deafness	Pathogenic(Last reviewed: Jul 15, 2015)	criteria provided, single submitter	VCV000228410	1	216061768 - 216074247	1	215888426 - 215900905	228410	228251		
NM_206933.2(USH2A):c.(?_8682)_(8845_?)del (p.(?))	USH2A		Rare genetic deafness	Pathogenic(Last reviewed: Jan 3, 2014)	criteria provided, single submitter	VCV000179512	1	216040349 - 216040512	1	215867007 - 215867170	179512	172463		
NM_206933.4(USH2A):c.632G>A (p.Trp211Ter)	USH2A	W211*	Rare genetic deafness	Pathogenic(Last reviewed: Dec 23, 2013)	criteria provided, single submitter	VCV000179482	1	216591875	1	216418533	179482	172924	rs727504893	NC_000001.11:216418532:C:T
NM_206933.4(USH2A):c.14248C>T (p.Gln4750Ter)	USH2A	Q4750*	Rare genetic deafness	Pathogenic(Last reviewed: Dec 12, 2013)	criteria provided, single submitter	VCV000179439	1	215824029	1	215650687	179439	172515	rs727504867	NC_000001.11:215650686:G:A
NM_206933.4(USH2A):c.11145T>A (p.Tyr3715Ter)	USH2A	Y3715*	Rare genetic deafness	Pathogenic(Last reviewed: Jun 11, 2013)	criteria provided, single submitter	VCV000179075	1	215933088	1	215759746	179075	172750	rs727504608	NC_000001.11:215759745:A:T
NM_007123.5(USH2A):c.1992dup (p.Lys665Ter)	USH2A		Rare genetic deafness	Pathogenic(Last reviewed: May 31, 2013)	criteria provided, single submitter	VCV000178971	1	216424419 - 216424420	1	216251077 - 216251078	178971	172778	rs730880349	NC_000001.11:216251077:A:AA
NM_206933.4(USH2A):c.2541C>A (p.Cys847Ter)	USH2A	C847*	Rare genetic deafness	Pathogenic(Last reviewed: Dec 5, 2013)	criteria provided, single submitter	VCV000166516	1	216420195	1	216246853	166516	172916	rs727503736	NC_000001.11:216246852:G:T
NM_206933.4(USH2A):c.6398G>A (p.Trp2133Ter)	USH2A	W2133*	Rare genetic deafness	Pathogenic(Last reviewed: Apr 8, 2010)	criteria provided, single submitter	VCV000166484	1	216173832	1	216000490	166484	172768	rs727503725	NC_000001.11:216000489:C:T
NM_206933.4(USH2A):c.9159T>G (p.Tyr3053Ter)	USH2A	Y3053*	Rare genetic deafness	Pathogenic(Last reviewed: Mar 12, 2012)	criteria provided, single submitter	VCV000048613	1	216017735	1	215844393	48613	57775	rs397518042	NC_000001.11:215844392:A:C
NM_206933.4(USH2A):c.7244C>G (p.Ser2415Ter)	USH2A	S2415*	Rare genetic deafness	Pathogenic(Last reviewed: Jun 14, 2012)	criteria provided, single submitter	VCV000048579	1	216108014	1	215934672	48579	57741	rs397518029	NC_000001.11:215934671:G:C
NM_007123.5(USH2A):c.4129_4130TC[4] (p.Asn1379fs)	USH2A		Rare genetic deafness	Pathogenic(Last reviewed: Sep 17, 2011)	criteria provided, single submitter	VCV000048512	1	216370011 - 216370012	1	216196669 - 216196670	48512	57674	rs397518015	NC_000001.11:216196669:GAGAGAG:GAGAGAGAG
NM_206933.3(USH2A):c.14031dup (p.Ala4678fs)	USH2A		Rare genetic deafness	Pathogenic(Last reviewed: Nov 5, 2012)	criteria provided, single submitter	VCV000048426	1	215844415 - 215844416	1	215671073 - 215671074	48426	57588	rs397517988	NC_000001.11:215671073:T:TT
NM_206933.4(USH2A):c.12714T>G (p.Tyr4238Ter)	USH2A	Y4238*	Rare genetic deafness	Pathogenic(Last reviewed: Nov 30, 2011)	criteria provided, single submitter	VCV000048405	1	215848539	1	215675197	48405	57567	rs397517981	NC_000001.11:215675196:A:C
NM_206933.4(USH2A):c.1143+1G>A	USH2A		Rare genetic deafness	Pathogenic(Last reviewed: Feb 16, 2011)	criteria provided, single submitter	VCV000048376	1	216498646	1	216325304	48376	57538	rs397517974	NC_000001.11:216325303:C:T
NM_206933.4(USH2A):c.6931del (p.Ala2311fs)	USH2A	A2311fs	not provided	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000860964	1	216143993	1	215970651	860964	823413		NC_000001.11:215970650:CC:C
NM_206933.4(USH2A):c.612dup (p.Arg205fs)	USH2A		not provided	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000855548	1	216591894 - 216591895	1	216418552 - 216418553	855548	823464		NC_000001.11:216418552:CCCC:CCCCC
NM_206933.4(USH2A):c.7231C>T (p.Gln2411Ter)	USH2A	Q2411*	not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000853660	1	216108027	1	215934685	853660	823408		NC_000001.11:215934684:G:A
NM_206933.4(USH2A):c.8231G>A (p.Trp2744Ter)	USH2A	W2744*	not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000835276	1	216052433	1	215879091	835276	823398		NC_000001.11:215879090:C:T
NC_000001.11:g.(?_215837991)_(215846033_?)del	USH2A		not provided	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000833182	1	216011333 - 216019375			833182	818912		
NC_000001.11:g.(?_216364943)_(216365095_?)del	USH2A		not provided	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000832482	1	216538285 - 216538437			832482	818924		
NC_000001.11:g.(?_216097073)_(216097223_?)del	USH2A		not provided	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000832380	1	216270415 - 216270565			832380	818918		
NC_000001.11:g.(?_216321873)_(216327664_?)del	USH2A		not provided	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000832261	1	216495215 - 216501006			832261	818923		
NC_000001.11:g.(?_216364953)_(216365085_?)del	USH2A		not provided	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000831966	1	216538295 - 216538427			831966	818925		
NC_000001.11:g.(?_215837981)_(215846043_?)del	USH2A		not provided	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000831595	1	216011323 - 216019385			831595	818910		
NC_000001.11:g.(?_215837991)_(215844496_?)dup	USH2A		not provided	Pathogenic(Last reviewed: Sep 25, 2019)	criteria provided, single submitter	VCV000830964	1	216011333 - 216017838			830964	818911		
NM_007123.5(USH2A):c.402del (p.Cys135fs)	USH2A	C135fs	Usher syndrome, type 2A	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801623	1	216595277	1	216421935	801623	789931		NC_000001.11:216421934:G:
NM_007123.5(USH2A):c.999_1000dup (p.Arg334fs)	USH2A		Usher syndrome, type 2A	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801621	1	216498789 - 216498790	1	216325447 - 216325448	801621	789929		NC_000001.11:216325447:GTG:GTGTG
NM_007123.5(USH2A):c.1312_1327dup (p.Asn443fs)	USH2A		Usher syndrome, type 2A	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801620	1	216497510 - 216497511	1	216324168 - 216324169	801620	789928		NC_000001.11:216324168:TGGAAAGCTGAAGACA:TGGAAAGCTGAAGACATGGAAAGCTGAAGACA
NM_007123.5(USH2A):c.1829A>C (p.His610Pro)	USH2A	H610P	Usher syndrome, type 2A	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801618	1	216465528	1	216292186	801618	789926		NC_000001.11:216292185:T:G
NM_007123.5(USH2A):c.2534del (p.Leu845fs)	USH2A	L845fs	Usher syndrome, type 2A	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801617	1	216420202	1	216246860	801617	789925		NC_000001.11:216246859:A:
NM_007123.5(USH2A):c.4603dup (p.His1535fs)	USH2A		Usher syndrome, type 2A	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801614	1	216348617 - 216348618	1	216175275 - 216175276	801614	789922		NC_000001.11:216175275:G:GG
NM_206933.3(USH2A):c.9827C>A (p.Ser3276Ter)	USH2A	S3276*	Usher syndrome, type 2A	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801612	1	215972380	1	215799038	801612	789920		NC_000001.11:215799037:G:T
NM_206933.3(USH2A):c.11174del (p.Phe3725fs)	USH2A	F3725fs	Usher syndrome, type 2A	Pathogenic(Last reviewed: Nov 28, 2018)	no assertion criteria provided	VCV000635525	1	215933059	1	215759717	635525	623244		NC_000001.11:215759716:AAAA:AAA
NM_206933.3(USH2A):c.8089G>T (p.Glu2697Ter)	USH2A	E2697*	Retinitis pigmentosa 39	Pathogenic(Last reviewed: May 20, 2016)	criteria provided, single submitter	VCV000620588	1	216061902	1	215888560	620588	611974	rs1558146243	NC_000001.11:215888559:C:A
NM_206933.3(USH2A):c.9372-1G>A	USH2A		Usher syndrome, type 2A	Pathogenic(Last reviewed: Jun 25, 2018)	no assertion criteria provided	VCV000599145	1	215990538	1	215817196	599145	590236	rs1558111861	NC_000001.11:215817195:C:T
NM_206933.3(USH2A):c.7501C>T (p.Gln2501Ter)	USH2A	Q2501*	Usher syndrome, type 2A	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560525	1	216073510	1	215900168	560525	551511	rs1558151555	NC_000001.11:215900167:G:A
NM_007123.5(USH2A):c.2279_2280del (p.Asn760fs)	USH2A	N760fs	Usher syndrome, type 2A	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522464	1	216420456 - 216420457	1	216247114 - 216247115	522464	513012	rs1553320542	NC_000001.11:216247113:AT:
NM_206933.3(USH2A):c.12954C>A (p.Tyr4318Ter)	USH2A	Y4318*	Usher syndrome	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000438009	1	215848299	1	215674957	438009	431579	rs762159022	NC_000001.11:215674956:G:T
NM_007123.5(USH2A):c.485+3A>T	USH2A		Usher syndrome, type 2A	Pathogenic(Last reviewed: May 9, 2017)	no assertion criteria provided	VCV000427861	1	216595191	1	216421849	427861	418816	rs1553258031	NC_000001.11:216421848:T:A
NM_206933.3(USH2A):c.12152_12153insTT (p.Glu4051fs)	USH2A		Retinal dystrophy|not provided	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000418537	1	215853632 - 215853633	1	215680290 - 215680291	418537	405033	rs1064793289	NC_000001.11:215680290::AA
NM_206933.3(USH2A):c.12691C>T (p.Gln4231Ter)	USH2A	Q4231*	Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000372544	1	215848562	1	215675220	372544	359227	rs1057517844	NC_000001.11:215675219:G:A
NM_206933.3(USH2A):c.2304C>A (p.Cys768Ter)	USH2A	C768*	Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265286	1	216420432	1	216247090	265286	259653	rs886039449	NC_000001.11:216247089:G:T
NM_206933.3(USH2A):c.2983C>T (p.Gln995Ter)	USH2A	Q995*	Usher syndrome, type 2A	Pathogenic	no assertion criteria provided	VCV000143180	1	216405305	1	216231963	143180	152898	rs527236135	NC_000001.11:216231962:G:A
NM_206933.4(USH2A):c.11146C>T (p.Gln3716Ter)	USH2A	Q3716*	not provided	Pathogenic(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV000860045	1	215933087	1	215759745	860045	823362		NC_000001.11:215759744:G:A
NM_206933.4(USH2A):c.9811del (p.Met3271fs)	USH2A	M3271fs	not provided	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000853741	1	215972396	1	215799054	853741	823382		NC_000001.11:215799053:TT:T
NM_206933.4(USH2A):c.14038C>T (p.Gln4680Ter)	USH2A	Q4680*	Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000851480	1	215844409	1	215671067	851480	823339		NC_000001.11:215671066:G:A
NM_206933.4(USH2A):c.4046del (p.Ser1349fs)	USH2A	S1349fs	not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000843266	1	216371692	1	216198350	843266	823439		NC_000001.11:216198349:G:
NC_000001.11:g.(?_216289280)_(216292370_?)del	USH2A		not provided	Pathogenic(Last reviewed: Nov 24, 2019)	criteria provided, single submitter	VCV000832899	1	216462622 - 216465712			832899	818922		
NC_000001.11:g.(?_216089003)_(216097223_?)del	USH2A		not provided	Pathogenic(Last reviewed: Jun 23, 2019)	criteria provided, single submitter	VCV000832567	1	216262345 - 216270565			832567	818917		
NC_000001.11:g.(?_216086709)_(216097223_?)del	USH2A		not provided	Pathogenic(Last reviewed: Oct 26, 2019)	criteria provided, single submitter	VCV000832001	1	216260051 - 216270565			832001	818916		
NC_000001.11:g.(?_215837981)_(215838113_?)del	USH2A		not provided	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000831310	1	216011323 - 216011455			831310	818909		
NC_000001.11:g.(?_216175228)_(216175492_?)del	USH2A		not provided	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000830853	1	216348570 - 216348834			830853	818919		
NC_000001.11:g.(?_216070101)_(216097213_?)del	USH2A		not provided	Pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV000830583	1	216243443 - 216270555			830583	818915		
NC_000001.11:g.216418633dup	USH2A		Usher syndrome, type 2A	Pathogenic	criteria provided, single submitter	VCV000813346	1	216591974 - 216591975	1	216418632 - 216418633	813346	801592		NC_000001.11:216418632:T:TT
NC_000001.11:g.215728342C>T	USH2A	W3918*	Usher syndrome, type 2A	Pathogenic	criteria provided, single submitter	VCV000813344	1	215901684	1	215728342	813344	801590		NC_000001.11:215728341:C:T
NC_000001.11:g.216421960del	USH2A	S126fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812463	1	216595302	1	216421960	812463	800444		NC_000001.11:216421959:C:
NC_000001.11:g.215741387T>C	USH2A	Y3900C	Usher syndrome, type 2A	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812117	1	215914729	1	215741387	812117	800348		NC_000001.11:215741386:T:C
NC_000001.11:g.215680377C>T	USH2A		Usher syndrome, type 2A	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812105	1	215853719	1	215680377	812105	800366		NC_000001.11:215680376:C:T
NC_000001.11:g.215998886C>T	USH2A		Usher syndrome, type 2A	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812103	1	216172228	1	215998886	812103	800367		NC_000001.11:215998885:C:T
NC_000001.11:g.(215728385_215741374)_(215759844_215766680)dup	USH2A		Usher syndrome, type 2A	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000812102	1	215901727 - 215940022			812102	800365		
NC_000001.10:g.(?_215914707)_(215933195_?)dup	USH2A		not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000656809	1	215914707 - 215933195	1	215741365 - 215759853	656809	650574		
NM_206933.4(USH2A):c.2809+2T>A	USH2A		not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000504388	1	216419925	1	216246583	504388	495068	rs1553320397	NC_000001.11:216246582:A:T
NM_206933.3(USH2A):c.4474G>T (p.Glu1492Ter)	USH2A	E1492*	Usher syndrome, type 2A	Pathogenic(Last reviewed: Mar 3, 2015)	no assertion criteria provided	VCV000224745	1	216348747	1	216175405	224745	226521	rs869312179	NC_000001.11:216175404:C:A
NM_206933.3(USH2A):c.9751T>C (p.Cys3251Arg)	USH2A	C3251R	Retinitis pigmentosa	Pathogenic	no assertion criteria provided	VCV000143185	1	215972456	1	215799114	143185	152903	rs527236118	NC_000001.11:215799113:A:G
NM_206933.3(USH2A):c.10544A>G (p.Asp3515Gly)	USH2A	D3515G	Retinitis pigmentosa	Pathogenic	no assertion criteria provided	VCV000143169	1	215956121	1	215782779	143169	152887	rs527236119	NC_000001.11:215782778:T:C
NM_206933.4(USH2A):c.13313G>A (p.Trp4438Ter)	USH2A	W4438*	Rare genetic deafness|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048416	1	215847940	1	215674598	48416	57578	rs111033417	NC_000001.11:215674597:C:T
NM_206933.3(USH2A):c.8890dup (p.Trp2964fs)	USH2A		Usher syndrome, type 2A	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000030724	1	216019330 - 216019331	1	215845988 - 215845989	30724	39681	rs786205116	NC_000001.11:215845988:AAAAAA:AAAAAAA
NM_007123.5(USH2A):c.3129dup (p.Val1044fs)	USH2A		Usher syndrome, type 2A	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000030723	1	216390756 - 216390757	1	216217414 - 216217415	30723	39680	rs786205115	NC_000001.11:216217414:A:AA
NM_007123.5(USH2A):c.779T>G (p.Leu260Ter)	USH2A	L260*	Usher syndrome, type 2A	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000002354	1	216538300	1	216364958	2354	17393	rs121912598	NC_000001.11:216364957:A:C
NM_018136.5(ASPM):c.7581_7585del (p.Tyr2527_Arg2529delinsTer)	ASPM		Inborn genetic diseases	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000522025	1	197070796 - 197070800	1	197101666 - 197101670	522025	511206	rs765530357	NC_000001.11:197101665:TGATAT:T
NM_018136.5(ASPM):c.6152del (p.Gln2051fs)	ASPM	Q2051fs	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000521724	1	197072229	1	197103099	521724	511207	rs1189399471	NC_000001.11:197103098:T:
NM_018136.5(ASPM):c.1386C>G (p.Tyr462Ter)	ASPM	Y462*	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 30, 2015)	criteria provided, single submitter	VCV000520789	1	197111996	1	197142866	520789	511210	rs1553227742	NC_000001.11:197142865:G:C
NM_006920.6(SCN1A):c.1178G>C (p.Arg393Pro)	SCN1A	R393P	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000530476	2	166903479	2	166046969	530476	516664	rs121917927	NC_000002.12:166046968:C:G
NM_006920.6(SCN1A):c.264+5G>A	SCN1A		Severe myoclonic epilepsy in infancy|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217242	2	166929863	2	166073353	217242	213804	rs794726762	NC_000002.12:166073352:C:T
NM_006920.6(SCN1A):c.337C>A (p.Pro113Thr)	SCN1A	P113T	Early infantile epileptic encephalopathy|not provided|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000189862	2	166915126	2	166058616	189862	187876	rs794726711	NC_000002.12:166058615:G:T
NM_006920.6(SCN1A):c.2543G>A (p.Arg848His)	SCN1A	R848H, R859H, R45H, R830H, R831H, R847H	Autosomal dominant epilepsy|Early infantile epileptic encephalopathy|not provided	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000093639	2	166895946	2	166039436	93639	99543	rs398123588	NC_000002.12:166039435:C:T
NM_006920.6(SCN1A):c.269T>C (p.Phe90Ser)	SCN1A	F90S	not provided|Severe myoclonic epilepsy in infancy	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2015)	criteria provided, multiple submitters, no conflicts	VCV000068596	2	166915194	2	166058684	68596	79488	rs121918733	NC_000002.12:166058683:A:G
NM_006920.6(SCN1A):c.1177C>A (p.Arg393Ser)	SCN1A	R393S	Severe myoclonic epilepsy in infancy|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000068504	2	166903480	2	166046970	68504	79396	rs121917929	NC_000002.12:166046969:G:T
NM_206933.4(USH2A):c.12525G>T (p.Trp4175Cys)	USH2A	W4175C	not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000856772	1	215848728	1	215675386	856772	823350		NC_000001.11:215675385:C:A
NM_206933.4(USH2A):c.6616C>T (p.Gln2206Ter)	USH2A	Q2206*	Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000847796	1	216172270	1	215998928	847796	823415		NC_000001.11:215998927:G:A
NM_206933.3(USH2A):c.2809+1G>A	USH2A		Retinal dystrophy|Usher syndrome, type 2A	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000801616	1	216419926	1	216246584	801616	789924		NC_000001.11:216246583:C:T
NM_206933.3(USH2A):c.7932G>A (p.Trp2644Ter)	USH2A	W2644*	Retinal dystrophy|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000801613	1	216062059	1	215888717	801613	789921		NC_000001.11:215888716:C:T
NM_206933.3(USH2A):c.9676C>T (p.Arg3226Ter)	USH2A	R3226*	not provided	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000663131	1	215987141	1	215813799	663131	627359		NC_000001.11:215813798:G:A
NM_206933.2:c.(11711+1_11712-1)_(*1_?)del	USH2A		Retinitis pigmentosa	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636141					636141	624026		
NM_206933.3(USH2A):c.9056-2A>G	USH2A		Retinitis pigmentosa	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636128	1	216017840	1	215844498	636128	623920		NC_000001.11:215844497:T:C
NM_206933.3(USH2A):c.3661C>T (p.Gln1221Ter)	USH2A	Q1221*	Deafness|not provided	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000560919	1	216373119	1	216199777	560919	551994	rs767797828	NC_000001.11:216199776:G:A
NM_206933.3(USH2A):c.10388-1G>A	USH2A		Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000557493	1	215956278	1	215782936	557493	540823	rs1553261478	NC_000001.11:215782935:C:T
NM_206933.2(USH2A):c.3368A>G	USH2A	Y1123C	Retinal dystrophy|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000242397	1	216373412	1	216200070	242397	237598	rs775177930	NC_000001.11:216200069:T:C
NM_206933.4(USH2A):c.8681+1G>A	USH2A		Retinitis pigmentosa 39|Rare genetic deafness|Usher syndrome	Pathogenic(Last reviewed: Nov 3, 2015)	criteria provided, single submitter	VCV000228416	1	216051099	1	215877757	228416	228321	rs876657733	NC_000001.11:215877756:C:T
NM_206933.4(USH2A):c.4405C>T (p.Gln1469Ter)	USH2A	Q1469*	Usher syndrome, type 2A	Pathogenic(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	VCV000208625	1	216348816	1	216175474	208625	205129	rs797045113	NC_000001.11:216175473:G:A
NM_206933.3(USH2A):c.6601C>T (p.Gln2201Ter)	USH2A	Q2201*	not specified|Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000196933	1	216172285	1	215998943	196933	194094	rs794727579	NC_000001.11:215998942:G:A
NM_206933.4(USH2A):c.10724G>A (p.Cys3575Tyr)	USH2A	C3575Y	Rare genetic deafness|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000048356	1	215955400	1	215782058	48356	57518	rs111033265	NC_000001.11:215782057:C:T
NM_206933.4(USH2A):c.4732C>T (p.Arg1578Cys)	USH2A	R1578C	not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000861348	1	216270451	1	216097109	861348	823434		NC_000001.11:216097108:G:A
NM_206933.4(USH2A):c.14787del (p.Glu4930fs)	USH2A	E4930fs	Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000817032	1	215820868	1	215647526	817032	805198		NC_000001.11:215647525:TTTTT:TTTT
NM_206933.3(USH2A):c.15089C>A (p.Ser5030Ter)	USH2A	S5030*	not provided|Retinal dystrophy	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000620106	1	215808009	1	215634667	620106	611509	rs758660532	NC_000001.11:215634666:G:T
NM_206933.3(USH2A):c.8834G>A (p.Trp2945Ter)	USH2A	W2945*	Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	VCV000557801	1	216040360	1	215867018	557801	540937	rs760302201	NC_000001.11:215867017:C:T
NM_206933.3(USH2A):c.1972-1G>A	USH2A		Retinitis pigmentosa 39|Usher syndrome, type 2A|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556200	1	216424441	1	216251099	556200	541074	rs372927796	NC_000001.11:216251098:C:T
NM_206933.3(USH2A):c.13700del (p.Leu4567fs)	USH2A	L4567fs	Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000555701	1	215847553	1	215674211	555701	540809	rs1212608410	NC_000001.11:215674210:A:
NM_206933.3(USH2A):c.10388-2A>G	USH2A		Retinitis pigmentosa 39|Usher syndrome, type 2A|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000554721	1	215956279	1	215782937	554721	540930	rs1553261479	NC_000001.11:215782936:T:C
NM_206933.3(USH2A):c.2023C>T (p.Gln675Ter)	USH2A	Q675*	Usher syndrome, type 2A|Retinitis pigmentosa 39	Pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, single submitter	VCV000553607	1	216424389	1	216251047	553607	541094	rs868562952	NC_000001.11:216251046:G:A
NM_206933.2(USH2A):c.8179dup (p.Val2727Glyfs)	USH2A		Usher syndrome, type 2A|Retinitis pigmentosa 39|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000496920	1	216061811 - 216061812	1	215888469 - 215888470	496920	488344	rs774573692	NC_000001.11:215888469:CCCC:CCCCC
NM_206933.3(USH2A):c.8681G>A (p.Arg2894Lys)	USH2A	R2894K	Retinitis pigmentosa 39|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000495329	1	216051100	1	215877758	495329	486824	rs1369414978	NC_000001.11:215877757:C:T
NM_206933.3(USH2A):c.11389+3A>T	USH2A		Retinal dystrophy|Usher syndrome, type 2A	Pathogenic(Last reviewed: Aug 7, 2019)	criteria provided, single submitter	VCV000427867	1	215931934	1	215758592	427867	418815	rs753886165	NC_000001.11:215758591:T:A
NM_206933.3(USH2A):c.3158-2A>G	USH2A		Retinal dystrophy|Usher syndrome, type 2A	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000236533	1	216380775	1	216207433	236533	237990	rs878853404	NC_000001.11:216207432:T:C
NM_206933.2(USH2A):c.(?_1645)_(1840_?)del (p.(?))	USH2A		Rare genetic deafness	Pathogenic(Last reviewed: Jun 9, 2012)	criteria provided, single submitter	VCV000178657	1	216465517 - 216465712	1	216292175 - 216292370	178657	172881		
NC_000001.10:g.(?_216465517)_(216500996_?)del	USH2A		Rare genetic deafness	Pathogenic(Last reviewed: Jun 2, 2012)	criteria provided, single submitter	VCV000178656	1	216465517 - 216500996	1	216292175 - 216327654	178656	172741		
NM_206933.3(USH2A):c.7475C>A (p.Ser2492Ter)	USH2A	S2492*	not provided|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Mar 24, 2015)	criteria provided, multiple submitters, no conflicts	VCV000133313	1	216073536	1	215900194	133313	137050	rs483353056	NC_000001.11:215900193:G:T
NM_007123.5(USH2A):c.3435del (p.Val1147fs)	USH2A	V1147fs	Rare genetic deafness|Usher syndrome, type 2A	Pathogenic(Last reviewed: Aug 19, 2010)	criteria provided, single submitter	VCV000048502	1	216373345	1	216200003	48502	57664	rs397518012	NC_000001.11:216200002:T:
NC_000001.11:g.(?_215670962)_(215675626_?)del	USH2A		not provided	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000832301	1	215844304 - 215848968			832301	818903		
NM_206933.3(USH2A):c.6325+1G>A	USH2A		not provided	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000648680	1	216219772	1	216046430	648680	650618		NC_000001.11:216046429:C:T
NM_206933.3(USH2A):c.11431_11434del (p.Leu3811fs)	USH2A	L3811fs	not provided|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000558490	1	215916633 - 215916636	1	215743291 - 215743294	558490	540885	rs1553257705	NC_000001.11:215743290:TGAGT:T
NM_206933.3(USH2A):c.13822C>T (p.Arg4608Ter)	USH2A	R4608*	Retinal dystrophy|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000557745	1	215844625	1	215671283	557745	540847	rs367674026	NC_000001.11:215671282:G:A
NM_206933.3(USH2A):c.3920C>G (p.Ser1307Ter)	USH2A	S1307*	Usher syndrome, type 2A|Retinitis pigmentosa 39	Pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	VCV000553983	1	216371818	1	216198476	553983	541048	rs756623509	NC_000001.11:216198475:G:C
NM_206933.3(USH2A):c.2797C>T (p.Gln933Ter)	USH2A	Q933*	Usher syndrome, type 2A|Retinitis pigmentosa 39	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000553620	1	216419939	1	216246597	553620	541083	rs1394737087	NC_000001.11:216246596:G:A
NM_206933.3(USH2A):c.828C>G (p.Tyr276Ter)	USH2A	Y276*	Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000551646	1	216500953	1	216327611	551646	541101	rs1553250952	NC_000001.11:216327610:G:C
NM_206933.2(USH2A):c.11048-?_11711+?dup	USH2A		Rare genetic deafness|not provided	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000503553	1	215914717 - 215933185			503553	494951		
NM_206933.3(USH2A):c.3507G>A (p.Trp1169Ter)	USH2A	W1169*	Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419244	1	216373273	1	216199931	419244	405043	rs1064793745	NC_000001.11:216199930:C:T
NM_206933.4(USH2A):c.12067-1G>C	USH2A		Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000048389	1	215853719	1	215680377	48389	57551	rs397517977	NC_000001.11:215680376:C:G
NM_001040142.2(SCN2A):c.2558G>A (p.Arg853Gln)	SCN2A	R853Q	Early infantile epileptic encephalopathy 11|Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000194555	2	166198975	2	165342465	194555	191718	rs794727152	NC_000002.12:165342464:G:A
NM_206933.4(USH2A):c.8232G>C (p.Trp2744Cys)	USH2A	W2744C	Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000848662	1	216052432	1	215879090	848662	823397		NC_000001.11:215879089:C:G
NM_206933.3(USH2A):c.2168-2A>G	USH2A		Retinal dystrophy|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000556562	1	216420570	1	216247228	556562	540964	rs993185407	NC_000001.11:216247227:T:C
NM_206933.3(USH2A):c.14131C>T (p.Gln4711Ter)	USH2A	Q4711*	Retinal dystrophy|Usher syndrome, type 2A|Retinitis pigmentosa 39	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000554236	1	215844316	1	215670974	554236	540843	rs747063294	NC_000001.11:215670973:G:A
NM_206933.3(USH2A):c.8079G>A (p.Trp2693Ter)	USH2A	W2693*	Retinal dystrophy|Usher syndrome, type 2A|Retinitis pigmentosa 39	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000553648	1	216061912	1	215888570	553648	540876	rs1553273330	NC_000001.11:215888569:C:T
NM_206933.2(USH2A):c.852_853delGA (p.Glu284Aspfs)	USH2A		Usher syndrome, type 2A|Retinitis pigmentosa 39|Retinal dystrophy	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553452	1	216498937 - 216498938	1	216325595 - 216325596	553452	541092	rs1188025733	NC_000001.11:216325594:TCTCTCT:TCTCT
NM_206933.3(USH2A):c.236_239dup (p.Gln81fs)	USH2A		Usher syndrome type 2|Usher syndrome, type 2A|Retinitis pigmentosa 39	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000552849	1	216595439 - 216595440	1	216422097 - 216422098	552849	541109	rs1553258097	NC_000001.11:216422097:GTAC:GTACGTAC
NM_206933.3(USH2A):c.13898del (p.Pro4632_Leu4633insTer)	USH2A		Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551736	1	215844549	1	215671207	551736	540846	rs1553252052	NC_000001.11:215671206:AAA:AA
NM_206933.3(USH2A):c.11241C>A (p.Tyr3747Ter)	USH2A	Y3747*	not provided|Usher syndrome|Rare genetic deafness	Pathogenic(Last reviewed: Sep 17, 2018)	reviewed by expert panel	VCV000506273	1	215932085	1	215758743	506273	496182	rs777465132	NC_000001.11:215758742:G:T
NM_206933.3(USH2A):c.12819T>A (p.Tyr4273Ter)	USH2A	Y4273*	Retinitis pigmentosa 39|Usher syndrome, type 2A|Usher syndrome	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000438008	1	215848434	1	215675092	438008	431580	rs1362058696	NC_000001.11:215675091:A:T
NM_206933.3(USH2A):c.8522G>A (p.Trp2841Ter)	USH2A	W2841*	not provided|Usher syndrome, type 2A|Retinitis pigmentosa 39	Pathogenic/Likely pathogenic(Last reviewed: May 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000424934	1	216052142	1	215878800	424934	413268	rs1064797134	NC_000001.11:215878799:C:T
NM_206933.4(USH2A):c.11440G>T (p.Gly3814Ter)	USH2A	G3814*	Rare genetic deafness|Retinitis pigmentosa	Pathogenic(Last reviewed: Nov 12, 2014)	criteria provided, single submitter	VCV000180084	1	215916627	1	215743285	180084	172889	rs727505337	NC_000001.11:215743284:C:A
NM_206933.3(USH2A):c.6795_6797del (p.Glu2265_Tyr2266delinsAsp)	USH2A		Retinal dystrophy|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000166478	1	216166370 - 216166372	1	215993028 - 215993030	166478	172765	rs727503723	NC_000001.11:215993027:TATT:T
NM_206933.3(USH2A):c.12232_12233GA[1] (p.Asn4079fs)	USH2A		not provided|Retinitis pigmentosa 39|Retinal dystrophy	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096665	1	215853550 - 215853551	1	215680208 - 215680209	96665	102558	rs398124618	NC_000001.11:215680207:TCTCT:TCT
NM_206933.4(USH2A):c.6224G>A (p.Trp2075Ter)	USH2A	W2075*	not provided|Rare genetic deafness|Retinal dystrophy	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048554	1	216219874	1	216046532	48554	57716	rs111033386	NC_000001.11:216046531:C:T
NM_206933.4(USH2A):c.14180G>A (p.Trp4727Ter)	USH2A	W4727*	Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000048429	1	215824097	1	215650755	48429	57591	rs397517989	NC_000001.11:215650754:C:T
NM_206933.3(USH2A):c.240_241insGATC (p.Gln81fs)	USH2A		Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000002360	1	216595438 - 216595439	1	216422096 - 216422097	2360	17399	rs587776538	NC_000001.11:216422096:G:GATCG
NM_006920.6(SCN1A):c.965-1G>A	SCN1A		Severe myoclonic epilepsy in infancy|Early infantile epileptic encephalopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189993	2	166905460	2	166048950	189993	187854	rs794726824	NC_000002.12:166048949:C:T
NM_015120.4(ALMS1):c.10775del (p.Thr3592fs)	ALMS1	T3592fs	not provided|Alstrom syndrome|Retinal dystrophy	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003971	2	73799776	2	73572649	3971	19010	rs387906312	NC_000002.12:73572648:C:
NC_000001.10:g.(?_216465507)_(216501006_?)del	USH2A		not provided	Pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, single submitter	VCV000659606	1	216465507 - 216501006	1	216292165 - 216327664	659606	650575		
NM_206933.3(USH2A):c.13207_13208del (p.Gly4403fs)	USH2A	G4403fs	Retinitis pigmentosa 39|Usher syndrome, type 2A|Retinal dystrophy	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000558124	1	215848045 - 215848046	1	215674703 - 215674704	558124	540859	rs746447649	NC_000001.11:215674702:CCC:C
NM_206933.3(USH2A):c.10636G>A (p.Gly3546Arg)	USH2A	G3546R	Retinitis pigmentosa 39|Usher syndrome, type 2A|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000557692	1	215955488	1	215782146	557692	540891	rs1553261372	NC_000001.11:215782145:C:T
NM_206933.3(USH2A):c.15200del (p.Ile5067fs)	USH2A	I5067fs	Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: May 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556916	1	215807898	1	215634556	556916	540830	rs1295968274	NC_000001.11:215634555:A:
NM_206933.3(USH2A):c.387del (p.Phe129fs)	USH2A	F129fs	Retinitis pigmentosa 39|Usher syndrome, type 2A|Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556037	1	216595292	1	216421950	556037	541107	rs1484339054	NC_000001.11:216421949:AAAAA:AAAA
NM_206933.3(USH2A):c.8557A>T (p.Arg2853Ter)	USH2A	R2853*	Retinal dystrophy|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555751	1	216052107	1	215878765	555751	540873	rs749452910	NC_000001.11:215878764:T:A
NM_206933.3(USH2A):c.8167C>T (p.Arg2723Ter)	USH2A	R2723*	Usher syndrome, type 2A|Retinitis pigmentosa 39|not provided	Pathogenic(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000419282	1	216061824	1	215888482	419282	405037	rs200712760	NC_000001.11:215888481:G:A
NM_206933.3(USH2A):c.11105G>A (p.Trp3702Ter)	USH2A	W3702*	not provided|Retinal dystrophy|Usher syndrome, type 2A|Retinitis pigmentosa 39	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000374674	1	215933128	1	215759786	374674	361560	rs1057519193	NC_000001.11:215759785:C:T
NM_206933.4(USH2A):c.486-1G>C	USH2A		Retinitis pigmentosa 39|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000228413	1	216592022	1	216418680	228413	228352	rs876657730	NC_000001.11:216418679:C:G
NM_206933.3(USH2A):c.14792-2A>G	USH2A		not provided|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000100610	1	215814078	1	215640736	100610	106487	rs137853923	NC_000001.11:215640735:T:C
NM_206933.4(USH2A):c.820C>T (p.Arg274Ter)	USH2A	R274*	Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic(Last reviewed: Oct 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000048595	1	216500961	1	216327619	48595	57757	rs397518036	NC_000001.11:216327618:G:A
NM_206933.4(USH2A):c.11954G>A (p.Trp3985Ter)	USH2A	W3985*	Rare genetic deafness|Retinal dystrophy|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000048388	1	215901484	1	215728142	48388	57550	rs397517976	NC_000001.11:215728141:C:T
NM_206933.3(USH2A):c.10190_10191del (p.Lys3397fs)	USH2A	K3397fs	not provided|Rare genetic deafness|Retinitis pigmentosa 39	Pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, multiple submitters, no conflicts	VCV000048343	1	215960208 - 215960209	1	215786866 - 215786867	48343	57505	rs397517964	NC_000001.11:215786865:TTT:T
NM_206933.3(USH2A):c.14020A>G (p.Arg4674Gly)	USH2A	R4674G	Retinitis pigmentosa|Retinitis pigmentosa 39	Pathogenic/Likely pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000002362	1	215844427	1	215671085	2362	17401	rs80338904	NC_000001.11:215671084:T:C
NM_000090.3(COL3A1):c.1258G>A (p.Gly420Ser)	COL3A1	G420S	Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000101452	2	189859023	2	188994297	101452	107199	rs587779692	NC_000002.12:188994296:G:A
NM_001048171.1(MUTYH):c.310G>T (p.Glu104Ter)	MUTYH	E104*, E118*, E101*, E91*, E105*, E115*, E90*	Hereditary cancer-predisposing syndrome|MYH-associated polyposis	Pathogenic/Likely pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000487453	1	45798993	1	45333321	487453	480495	rs1553129892	NC_000001.11:45333320:C:A
NM_012222.2(MUTYH):c.850del (p.Ala284fs)	MUTYH	A273fs, A274fs, A270fs, A144fs, A260fs, A287fs, A167fs, A259fs, A284fs	Hereditary cancer-predisposing syndrome|MYH-associated polyposis	Pathogenic/Likely pathogenic(Last reviewed: Sep 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000433934	1	45797912	1	45332240	433934	427132	rs761468459	NC_000001.11:45332239:CCCC:CCC
NM_001128425.1(MUTYH):c.200del (p.Gly67fs)	MUTYH	G40fs, G50fs, G64fs, G54fs, G67fs	not provided|MYH-associated polyposis|MUTYH-associated polyposis|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419735	1	45799233	1	45333561	419735	405207	rs746449748	NC_000001.11:45333560:CC:C
NM_001128425.1(MUTYH):c.1240C>T (p.Gln414Ter)	MUTYH	Q414*, Q401*, Q386*, Q387*, Q397*, Q271*, Q294*, Q411*, Q400*	MYH-associated polyposis|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000406824	1	45797175	1	45331503	406824	391354	rs766420907	NC_000001.11:45331502:G:A
NM_001293192.1(MUTYH):c.-164del	MUTYH	A17fs, A31fs	not provided|MYH-associated polyposis|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141379	1	45800129	1	45334457	141379	151093	rs587781704	NC_000001.11:45334456:C:
NM_001128425.1(MUTYH):c.940C>T (p.Gln314Ter)	MUTYH	Q314*, Q194*, Q311*, Q171*, Q297*, Q301*, Q300*, Q286*, Q287*	MYH-associated polyposis|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000140876	1	45797752	1	45332080	140876	150590	rs587781338	NC_000001.11:45332079:G:A
NM_001128425.1(MUTYH):c.1186+1G>A	MUTYH		MYH-associated polyposis|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000140874	1	45797332	1	45331660	140874	150588	rs587781337	NC_000001.11:45331659:C:T
NM_001130987.2(DYSF):c.4307G>A (p.Gly1436Asp)	DYSF	G1418D, G1436D, G1419D, G1404D, G1435D, G1449D, G1450D, G1405D	Qualitative or quantitative defects of dysferlin|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094321	2	71839856	2	71612726	94321	100221	rs398123787	NC_000002.12:71612725:G:A
NM_001130987.2(DYSF):c.3498_3499delinsAA (p.Tyr1166_Gly1167delinsTer)	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B|Qualitative or quantitative defects of dysferlin|Myopathy, distal, with anterior tibial onset|Autosomal recessive limb-girdle muscular dystrophy type 2B|Miyoshi muscular dystrophy 1|not provided	Pathogenic(Last reviewed: Sep 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094305	2	71817342 - 71817343	2	71590212 - 71590213	94305	100205	rs398123781	NC_000002.12:71590211:TG:AA
NM_001130987.2(DYSF):c.1149+1G>A	DYSF		not provided|Myopathy, distal, with anterior tibial onset|Autosomal recessive limb-girdle muscular dystrophy type 2B|Miyoshi muscular dystrophy 1|Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000094262	2	71748035	2	71520905	94262	100162	rs398123763	NC_000002.12:71520904:G:A
NM_206933.3(USH2A):c.9270C>A (p.Cys3090Ter)	USH2A	C3090*	Retinitis pigmentosa 39|Usher syndrome, type 2A|Retinal dystrophy	Pathogenic(Last reviewed: Jul 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557177	1	216011434	1	215838092	557177	540850	rs779572631	NC_000001.11:215838091:G:T
NM_206933.3(USH2A):c.2168-1G>C	USH2A		Retinal dystrophy|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000556842	1	216420569	1	216247227	556842	541088	rs748961218	NC_000001.11:216247226:C:G
NM_206933.3(USH2A):c.3883C>T (p.Arg1295Ter)	USH2A	R1295*	not provided|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556829	1	216371855	1	216198513	556829	541050	rs764797292	NC_000001.11:216198512:G:A
NM_206933.3(USH2A):c.13621C>T (p.Gln4541Ter)	USH2A	Q4541*	Usher syndrome, type 2A|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000555195	1	215847632	1	215674290	555195	540766	rs765476745	NC_000001.11:215674289:G:A
NM_206933.3(USH2A):c.3589del (p.Ser1197fs)	USH2A	S1197fs	Usher syndrome, type 2A|Retinitis pigmentosa 39|Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000552496	1	216373191	1	216199849	552496	540940	rs1553313810	NC_000001.11:216199848:AAA:AA
NM_206933.3(USH2A):c.9258+1G>A	USH2A		Retinal dystrophy|Usher syndrome, type 2A|Usher syndrome, type 2A|Retinitis pigmentosa 39	Pathogenic/Likely pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265980	1	216017635	1	215844293	265980	260776	rs748810737	NC_000001.11:215844292:C:T
NM_206933.3(USH2A):c.1558del (p.Cys520fs)	USH2A	C520fs	not provided|Retinal dystrophy|Usher syndrome, type 2A|Retinitis pigmentosa 39	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000236541	1	216495311	1	216321969	236541	237993	rs878853410	NC_000001.11:216321968:A:
NM_206933.3(USH2A):c.11549-1G>A	USH2A		Retinal dystrophy|Usher syndrome, type 2A|Retinitis pigmentosa 39	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000236536	1	215914880	1	215741538	236536	237981	rs878853407	NC_000001.11:215741537:C:T
NM_206933.4(USH2A):c.8740C>T (p.Arg2914Ter)	USH2A	R2914*	Retinitis pigmentosa 39|Retinal dystrophy|Rare genetic deafness	Pathogenic(Last reviewed: Jul 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228417	1	216040454	1	215867112	228417	228320	rs766590491	NC_000001.11:215867111:G:A
NM_006920.6(SCN1A):c.383+1A>G	SCN1A		Early infantile epileptic encephalopathy|History of neurodevelopmental disorder|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189967	2	166915079	2	166058569	189967	187874	rs794726803	NC_000002.12:166058568:T:C
NM_006920.6(SCN1A):c.1129C>T (p.Arg377Ter)	SCN1A	R377*	Early infantile epileptic encephalopathy|not provided|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189963	2	166904178	2	166047668	189963	187842	rs794726799	NC_000002.12:166047667:G:A
NM_006920.6(SCN1A):c.2923C>T (p.Leu975Phe)	SCN1A	L986F, L975F, L974F, L172F, L957F, L958F	Early infantile epileptic encephalopathy|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000012890	2	166893031	2	166036521	12890	27929	rs121918625	NC_000002.12:166036520:G:A
NM_003000.2(SDHB):c.640C>T (p.Gln214Ter)	SDHB	Q214*	Hereditary cancer-predisposing syndrome|Pheochromocytoma|Carney-Stratakis syndrome|Paragangliomas 4|Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|not provided|Paragangliomas 4	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000230243	1	17350470	1	17023975	230243	232175	rs876658461	NC_000001.11:17023974:G:A
NM_001276345.2(TNNT2):c.310C>T (p.Arg104Cys)	TNNT2	R104C, R94C, R89C	Restrictive cardiomyopathy|not provided|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000165549	1	201334420	1	201365292	165549	172503	rs727503513	NC_000001.11:201365291:G:A
NM_170707.4(LMNA):c.497G>C (p.Arg166Pro)	LMNA	R166P, R85P, R54P	Charcot-Marie-Tooth disease, type 2|Dilated cardiomyopathy 1A|Cardiovascular phenotype|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066901	1	156100548	1	156130757	66901	77798	rs267607570	NC_000001.11:156130756:G:C
NM_005572.3(LMNA):c.1526dupC (p.Thr510Tyrfs)	LMNA		Cardiovascular phenotype|Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000048041	1	156106935 - 156106936	1	156137144 - 156137145	48041	57205	rs58013325	NC_000001.11:156137144:CCCCCC:CCCCCCC
NM_014795.4(ZEB2):c.823C>T (p.Gln275Ter)	ZEB2	Q275*, Q251*	Mowat-Wilson syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000160328	2	145158859	2	144401292	160328	168032	rs587784570	NC_000002.12:144401291:G:A
NM_206933.3(USH2A):c.11389+1G>A	USH2A		not provided|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000801610	1	215931936	1	215758594	801610	789918		NC_000001.11:215758593:C:T
NM_206933.3(USH2A):c.13112_13115del (p.Gln4371fs)	USH2A	Q4371fs	not provided|Retinitis pigmentosa 39|Usher syndrome, type 2A|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000558585	1	215848138 - 215848141	1	215674796 - 215674799	558585	540772	rs768161313	NC_000001.11:215674795:ATTT:
NM_206933.3(USH2A):c.6967C>T (p.Arg2323Ter)	USH2A	R2323*	not provided|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000558501	1	216138812	1	215965470	558501	540886	rs1485173724	NC_000001.11:215965469:G:A
NM_007123.5(USH2A):c.545_546del (p.Lys182fs)	USH2A	K182fs	Retinitis pigmentosa 39|Usher syndrome, type 2A|Retinal dystrophy|not provided	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000556324	1	216591961 - 216591962	1	216418619 - 216418620	556324	540979	rs780779563	NC_000001.11:216418618:TTT:T
NM_206933.3(USH2A):c.14977_14978del (p.Phe4993fs)	USH2A	F4993fs	Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided|Retinal dystrophy	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555201	1	215812571 - 215812572	1	215639229 - 215639230	555201	540827	rs747160949	NC_000001.11:215639228:AAAAA:AAA
NM_206933.3(USH2A):c.12232G>T (p.Glu4078Ter)	USH2A	E4078*	Usher syndrome, type 2A|Retinitis pigmentosa 39|not provided|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553479	1	215853553	1	215680211	553479	540933	rs988693758	NC_000001.11:215680210:C:A
NM_206933.3(USH2A):c.6159del (p.Glu2054fs)	USH2A	E2054fs	Retinitis pigmentosa 39|Retinal dystrophy|not provided|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Jul 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000497726	1	216221880	1	216048538	497726	489150	rs769838859	NC_000001.11:216048537:TT:T
NM_206933.3(USH2A):c.13335_13347delinsCTTG (p.Glu4445_Ser4449delinsAspLeu)	USH2A		Retinal dystrophy|not provided|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: May 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000438013	1	215847906 - 215847918	1	215674564 - 215674576	438013	431575	rs1553252388	NC_000001.11:215674563:AGAGTCCATGTTC:CAAG
NM_206933.4(USH2A):c.9459C>A (p.Cys3153Ter)	USH2A	C3153*	Retinitis pigmentosa 39|Usher syndrome, type 2A|Rare genetic deafness|Retinal dystrophy	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048628	1	215990450	1	215817108	48628	57790	rs73090721	NC_000001.11:215817107:G:T
NM_206933.4(USH2A):c.10450C>T (p.Arg3484Ter)	USH2A	R3484*	Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000048348	1	215956215	1	215782873	48348	57510	rs111033379	NC_000001.11:215782872:G:A
NM_000143.3(FH):c.697C>T (p.Arg233Cys)	FH	R233C	Fumarase deficiency|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141355	1	241671944	1	241508644	141355	151069	rs587781682	NC_000001.11:241508643:G:A
NM_000784.4(CYP27A1):c.1183C>T (p.Arg395Cys)	CYP27A1	R362C, R395C	Cholestanol storage disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004255	2	219678909	2	218814186	4255	19294	rs121908096	NC_000002.12:218814185:C:T
NM_020451.3(SELENON):c.943G>A (p.Gly315Ser)	SELENON	G315S, G281S	Eichsfeld type congenital muscular dystrophy|Congenital myopathy with fiber type disproportion|SEPN1-Related Disorders|not provided|Eichsfeld type congenital muscular dystrophy|Congenital myopathy with fiber type disproportion	Pathogenic/Likely pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004496	1	26136244	1	25809753	4496	19535	rs121908188	NC_000001.11:25809752:G:A
NM_001128425.1(MUTYH):c.713A>G (p.Asn238Ser)	MUTYH	N238S, N235S, N95S, N211S, N118S, N221S, N225S, N210S, N224S	MYH-associated polyposis|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372416	1	45798138	1	45332466	372416	359363	rs1057517765	NC_000001.11:45332465:T:C
NM_001128425.1(MUTYH):c.526_535del (p.Gly176fs)	MUTYH	G159fs, G56fs, G162fs, G148fs, G149fs, G163fs, G173fs, G176fs, G33fs	MYH-associated polyposis|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371677	1	45798476 - 45798485	1	45332804 - 45332813	371677	357090	rs1057517457	NC_000001.11:45332803:AGCCCAGGCCAGCCCAG:AGCCCAG
NM_001128425.1(MUTYH):c.628C>T (p.Gln210Ter)	MUTYH	Q210*, Q193*, Q196*, Q207*, Q90*, Q182*, Q183*, Q197*, Q67*	not provided|MYH-associated polyposis|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000233460	1	45798308	1	45332636	233460	232257	rs376561094	NC_000001.11:45332635:G:A
NM_206933.3(USH2A):c.8254G>A (p.Gly2752Arg)	USH2A	G2752R	Retinal dystrophy|Usher syndrome, type 2A|Retinitis pigmentosa	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000636127	1	216052410	1	215879068	636127	623803		NC_000001.11:215879067:C:T
NM_206933.3(USH2A):c.7524del (p.Arg2509fs)	USH2A	R2509fs	Retinal dystrophy|Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic(Last reviewed: May 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000517494	1	216073487	1	215900145	517494	508746	rs751176116	NC_000001.11:215900144:AAA:AA
NM_206933.3(USH2A):c.9976C>T (p.Gln3326Ter)	USH2A	Q3326*	Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000438038	1	215963607	1	215790265	438038	431587	rs1288381992	NC_000001.11:215790264:G:A
NM_206933.3(USH2A):c.9343_9344AC[1] (p.Pro3116fs)	USH2A		Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371686	1	216011358 - 216011359	1	215838016 - 215838017	371686	357073	rs536593247	NC_000001.11:215838015:GTGT:GT
NM_206933.3(USH2A):c.3558del (p.Cys1186fs)	USH2A	C1186fs	Usher syndrome, type 2A|Rare genetic deafness|Retinal dystrophy|Retinitis pigmentosa 39	Pathogenic/Likely pathogenic(Last reviewed: May 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048504	1	216373222	1	216199880	48504	57666	rs397518014	NC_000001.11:216199879:A:
NM_206933.3(USH2A):c.11411del (p.Pro3804fs)	USH2A	P3804fs	not provided|Rare genetic deafness|Retinal dystrophy|Retinitis pigmentosa 39	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048375	1	215916656	1	215743314	48375	57537	rs397517973	NC_000001.11:215743313:GG:G
NM_001130987.2(DYSF):c.706C>T (p.Arg236Ter)	DYSF	R204*, R236*, R205*, R235*	Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094352	2	71740998	2	71513868	94352	100252	rs373585652	NC_000002.12:71513867:C:T
NM_001791.4(CDC42):c.196A>G (p.Arg66Gly)	CDC42	R66G	Takenouchi-Kosaki syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000208668	1	22412949	1	22086456	208668	205218	rs797044870	NC_000001.11:22086455:A:G
NM_206933.3(USH2A):c.9469C>T (p.Gln3157Ter)	USH2A	Q3157*	Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000555916	1	215990440	1	215817098	555916	541020	rs772100045	NC_000001.11:215817097:G:A
NM_206933.3(USH2A):c.15017C>T (p.Thr5006Met)	USH2A	T5006M	Usher syndrome, type 2A|Retinitis pigmentosa 39|not provided|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: May 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553406	1	215812532	1	215639190	553406	540825	rs757676723	NC_000001.11:215639189:G:A
NM_206933.3(USH2A):c.4174G>T (p.Gly1392Ter)	USH2A	G1392*	Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551604	1	216369972	1	216196630	551604	541070	rs1177198729	NC_000001.11:216196629:C:A
NM_206933.3(USH2A):c.11047+1G>A	USH2A		Retinitis pigmentosa 39|Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000501315	1	215940022	1	215766680	501315	492739	rs201730567	NC_000001.11:215766679:C:T
NM_206933.3(USH2A):c.7950dup (p.Asn2651fs)	USH2A		Retinal dystrophy|Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280266	1	216062040 - 216062041	1	215888698 - 215888699	280266	263977	rs886041502	NC_000001.11:215888698:GGGG:GGGGG
NM_206933.4(USH2A):c.9371+1G>C	USH2A		Usher syndrome, type 2A|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048624	1	216011332	1	215837990	48624	57786	rs41308425	NC_000001.11:215837989:C:G
NM_206933.4(USH2A):c.3309C>A (p.Tyr1103Ter)	USH2A	Y1103*	Rare genetic deafness|Usher syndrome, type 2A|Retinitis pigmentosa 39|Usher syndrome, type 2A|Retinal dystrophy	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048499	1	216380622	1	216207280	48499	57661	rs397518011	NC_000001.11:216207279:G:T
NM_206933.4(USH2A):c.12868C>T (p.Gln4290Ter)	USH2A	Q4290*	not provided|Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome, type 2A|Retinal dystrophy	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000048408	1	215848385	1	215675043	48408	57570	rs397517983	NC_000001.11:215675042:G:A
NM_007123.5(USH2A):c.2898del (p.Thr967fs)	USH2A	T967fs	Usher syndrome, type 2A|Retinitis pigmentosa 39|Rare genetic deafness|Usher syndrome, type 2A	Pathogenic(Last reviewed: Dec 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000002352	1	216405390	1	216232048	2352	17391	rs397518008	NC_000001.11:216232047:C:
NM_170707.4(LMNA):c.569G>A (p.Arg190Gln)	LMNA	R190Q, R109Q, R78Q	Charcot-Marie-Tooth disease, type 2|not provided|Cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066910	1	156104249	1	156134458	66910	77807	rs267607571	NC_000001.11:156134457:G:A
NM_170707.4(LMNA):c.1146C>T (p.Gly382=)	LMNA		Neuromuscular disease|Primary dilated cardiomyopathy|not provided|Cardiovascular phenotype|Charcot-Marie-Tooth disease, type 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048032	1	156105901	1	156136110	48032	57196	rs57508089	NC_000001.11:156136109:C:T
NM_170707.4(LMNA):c.1580G>A (p.Arg527His)	LMNA	R527H, R415H, R446H	not provided|Mandibuloacral dysplasia|Mandibuloacral dysplasia with type A lipodystrophy, atypical|Mandibuloacral dysplasia with type A lipodystrophy|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014499	1	156106995	1	156137204	14499	29538	rs57520892	NC_000001.11:156137203:G:A
NM_003000.3(SDHB):c.343C>T (p.Arg115Ter)	SDHB	R115*	Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|not provided|Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic(Last reviewed: Aug 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000197210	1	17355175	1	17028680	197210	194371	rs751000085	NC_000001.11:17028679:G:A
NM_003000.2(SDHB):c.716_719delCTCT	SDHB		Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Paragangliomas 4	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012782	1	17349149 - 17349152	1	17022654 - 17022657	12782	27821	rs587781266	NC_000001.11:17022653:AGAGAGA:AGA
NM_001035.3(RYR2):c.506G>T (p.Arg169Leu)	RYR2	R169L	not provided	Pathogenic(Last reviewed: Mar 16, 2015)	criteria provided, single submitter	VCV000372582	1	237540665	1	237377365	372582	359247	rs397516539	NC_000001.11:237377364:G:T
NM_001035.3(RYR2):c.12271_12272delinsAG (p.Ala4091Arg)	RYR2		not provided	Pathogenic(Last reviewed: Sep 8, 2011)	criteria provided, single submitter	VCV000201410	1	237947283 - 237947284	1	237783983 - 237783984	201410	196701	rs794728837	NC_000001.11:237783982:GC:AG
NM_001035.3(RYR2):c.11995A>T (p.Met3999Leu)	RYR2	M3999L	not provided	Pathogenic(Last reviewed: Nov 8, 2011)	criteria provided, single submitter	VCV000201400	1	237947007	1	237783707	201400	196696	rs794728780	NC_000001.11:237783706:A:T
NM_001035.3(RYR2):c.568A>G (p.Arg190Gly)	RYR2	R190G	not provided	Pathogenic(Last reviewed: Jul 22, 2011)	criteria provided, single submitter	VCV000201369	1	237540727	1	237377427	201369	196516	rs794728814	NC_000001.11:237377426:A:G
NM_001035.3(RYR2):c.184C>T (p.Leu62Phe)	RYR2	L62F	not provided	Pathogenic(Last reviewed: Aug 15, 2011)	criteria provided, single submitter	VCV000201368	1	237494193	1	237330893	201368	196505	rs794728813	NC_000001.11:237330892:C:T
NM_001035.3(RYR2):c.14704C>T (p.Pro4902Ser)	RYR2	P4902S	not provided	Pathogenic(Last reviewed: Aug 7, 2012)	criteria provided, single submitter	VCV000201361	1	237993878	1	237830578	201361	196747	rs794728808	NC_000001.11:237830577:C:T
NM_001035.3(RYR2):c.12372C>A (p.Ser4124Arg)	RYR2	S4124R	not provided	Pathogenic(Last reviewed: Jun 5, 2012)	criteria provided, single submitter	VCV000201330	1	237947384	1	237784084	201330	196707	rs771994461	NC_000001.11:237784083:C:A
NM_001035.3(RYR2):c.11965A>G (p.Asn3989Asp)	RYR2	N3989D	not provided	Pathogenic(Last reviewed: Nov 9, 2012)	criteria provided, single submitter	VCV000201319	1	237946977	1	237783677	201319	196694	rs794728779	NC_000001.11:237783676:A:G
NM_001035.3(RYR2):c.11965A>C (p.Asn3989His)	RYR2	N3989H	not provided	Pathogenic(Last reviewed: Dec 9, 2014)	criteria provided, single submitter	VCV000201318	1	237946977	1	237783677	201318	196693	rs794728779	NC_000001.11:237783676:A:C
NM_001035.3(RYR2):c.7202G>T (p.Arg2401Leu)	RYR2	R2401L	not provided	Pathogenic(Last reviewed: Jun 23, 2014)	criteria provided, single submitter	VCV000201280	1	237804283	1	237640983	201280	196636	rs794728756	NC_000001.11:237640982:G:T
NM_001035.3(RYR2):c.7189G>T (p.Asp2397Tyr)	RYR2	D2397Y	not provided	Pathogenic(Last reviewed: Apr 30, 2012)	criteria provided, single submitter	VCV000201278	1	237804270	1	237640970	201278	196634	rs794728755	NC_000001.11:237640969:G:T
NM_001035.3(RYR2):c.6916G>C (p.Val2306Leu)	RYR2	V2306L	not provided	Pathogenic(Last reviewed: Mar 18, 2013)	criteria provided, single submitter	VCV000201268	1	237801780	1	237638480	201268	196623	rs794728746	NC_000001.11:237638479:G:C
NM_001035.3(RYR2):c.5170G>A (p.Glu1724Lys)	RYR2	E1724K	not provided	Pathogenic(Last reviewed: Apr 27, 2015)	criteria provided, single submitter	VCV000201254	1	237777598	1	237614298	201254	196603	rs794728740	NC_000001.11:237614297:G:A
NM_001035.3(RYR2):c.689G>A (p.Gly230Asp)	RYR2	G230D	not provided	Pathogenic(Last reviewed: Oct 11, 2013)	criteria provided, single submitter	VCV000201197	1	237551399	1	237388099	201197	196518	rs794728710	NC_000001.11:237388098:G:A
NM_001035.3(RYR2):c.11837G>A (p.Gly3946Asp)	RYR2	G3946D	Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000644207	1	237942027	1	237778727	644207	627594		NC_000001.11:237778726:G:A
GRCh37/hg19 1q43(chr1:237413038-237540797)	RYR2		Arrhythmogenic right ventricular dysplasia, familial, 2	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625614	1	237413038 - 237540797			625614	613918		
NM_001035.3(RYR2):c.14586A>G (p.Ile4862Met)	RYR2	I4862M	Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Apr 7, 2018)	criteria provided, single submitter	VCV000566084	1	237982488	1	237819188	566084	557208	rs1558481148	NC_000001.11:237819187:A:G
NM_001035.3(RYR2):c.6916G>A (p.Val2306Ile)	RYR2	V2306I	Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Mar 13, 2016)	criteria provided, single submitter	VCV000201387	1	237801780	1	237638480	201387	196622	rs794728746	NC_000001.11:237638479:G:A
NM_001035.3(RYR2):c.7157A>T (p.Asn2386Ile)	RYR2	N2386I	Arrhythmogenic right ventricular dysplasia, familial, 2	Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	VCV000012958	1	237804238	1	237640938	12958	27997	rs121918601	NC_000001.11:237640937:A:T
NM_001035.3(RYR2):c.14590G>T (p.Gly4864Cys)	RYR2	G4864C	Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000463579	1	237982492	1	237819192	463579	448004	rs1553339086	NC_000001.11:237819191:G:T
NM_001035.3(RYR2):c.11934G>A (p.Met3978Ile)	RYR2	M3978I	not provided|Cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 8, 2015)	criteria provided, multiple submitters, no conflicts	VCV000201398	1	237944918	1	237781618	201398	196690	rs794728826	NC_000001.11:237781617:G:A
NM_001035.3(RYR2):c.14251A>C (p.Lys4751Gln)	RYR2	K4751Q	Cardiovascular phenotype|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000201355	1	237969536	1	237806236	201355	196740	rs794728802	NC_000001.11:237806235:A:C
NM_001035.3(RYR2):c.11836G>A (p.Gly3946Ser)	RYR2	G3946S	not provided|Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000201315	1	237942026	1	237778726	201315	196687	rs794728777	NC_000001.11:237778725:G:A
NM_001276345.2(TNNT2):c.418C>T (p.Arg140Cys)	TNNT2	R130C, R140C, R125C, R100C	Cardiovascular phenotype|not provided|Familial restrictive cardiomyopathy 3|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043636	1	201333497	1	201364369	43636	52805	rs397516463	NC_000001.11:201364368:G:A
NM_001035.3(RYR2):c.230C>T (p.Ala77Val)	RYR2	A77V	Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000404190	1	237494239	1	237330939	404190	391039	rs1060500142	NC_000001.11:237330938:C:T
NM_001128425.1(MUTYH):c.799C>T (p.Gln267Ter)	MUTYH	Q267*, Q239*, Q240*, Q147*, Q253*, Q254*, Q264*, Q124*, Q250*	Hereditary cancer-predisposing syndrome|MYH-associated polyposis	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000186651	1	45797972	1	45332300	186651	181687	rs786203115	NC_000001.11:45332299:G:A
NM_001035.3(RYR2):c.7160C>T (p.Ala2387Val)	RYR2	A2387V	Catecholaminergic polymorphic ventricular tachycardia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000201277	1	237804241	1	237640941	201277	196633	rs794728754	NC_000001.11:237640940:C:T
NM_001035.3(RYR2):c.12312C>G (p.Asn4104Lys)	RYR2	N4104K	Catecholaminergic polymorphic ventricular tachycardia type 1	Pathogenic(Last reviewed: Jan 16, 2001)	no assertion criteria provided	VCV000012956	1	237947324	1	237784024	12956	27995	rs121918599	NC_000001.11:237784023:C:G
NM_001035.3(RYR2):c.7422G>C (p.Arg2474Ser)	RYR2	R2474S	Catecholaminergic polymorphic ventricular tachycardia type 1	Pathogenic(Last reviewed: Jan 16, 2001)	no assertion criteria provided	VCV000012955	1	237811823	1	237648523	12955	27994	rs121918598	NC_000001.11:237648522:G:C
NM_000090.3(COL3A1):c.2194G>A (p.Gly732Arg)	COL3A1	G732R	Ehlers-Danlos syndrome, type 4	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000101323	2	189864268	2	188999542	101323	107069	rs587779606	NC_000002.12:188999541:G:A
NM_000090.3(COL3A1):c.2959G>A (p.Gly987Ser)	COL3A1	G987S	Cardiovascular phenotype|Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000101296	2	189870103	2	189005377	101296	107042	rs587779583	NC_000002.12:189005376:G:A
NM_000090.3(COL3A1):c.1330G>A (p.Gly444Arg)	COL3A1	G444R	not provided|Ehlers-Danlos syndrome, type 4	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000101185	2	189859303	2	188994577	101185	106930	rs587779489	NC_000002.12:188994576:G:A
NM_000090.3(COL3A1):c.547G>A (p.Gly183Ser)	COL3A1	G16S, G183S	Ehlers-Danlos syndrome, type 4|not provided	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000017228	2	189852825	2	188988099	17228	32267	rs121912926	NC_000002.12:188988098:G:A
NM_001130987.2(DYSF):c.5194C>T (p.Arg1732Trp)	DYSF	R1693W, R1732W, R1701W, R1724W, R1725W, R1679W, R1680W, R1700W, R1711W, R1731W, R1694W, R1715W, R1710W, R1714W	Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Qualitative or quantitative defects of dysferlin	Pathogenic/Likely pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217227	2	71892311	2	71665181	217227	213811	rs863225021	NC_000002.12:71665180:C:T
NM_003494.3(DYSF):c.3516_3517delTT	DYSF		Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217226	2	71817411 - 71817412	2	71590281 - 71590282	217226	213540	rs766341386	NC_000002.12:71590280:TTTTT:TTT
NM_006920.6(SCN1A):c.251A>G (p.Tyr84Cys)	SCN1A	Y84C	Early infantile epileptic encephalopathy|not provided|Severe myoclonic epilepsy in infancy|Familial hemiplegic migraine type 3|Generalized epilepsy with febrile seizures plus, type 2|Severe myoclonic epilepsy in infancy	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000068520	2	166929881	2	166073371	68520	79412	rs121917964	NC_000002.12:166073370:T:C
NM_206933.3(USH2A):c.6937G>T (p.Gly2313Cys)	USH2A	G2313C	Retinitis pigmentosa|not provided|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000384319	1	216143987	1	215970645	384319	364867	rs199840367	NC_000001.11:215970644:C:A
NM_206933.3(USH2A):c.1227G>A (p.Trp409Ter)	USH2A	W409*	Usher syndrome, type 2A|Retinitis pigmentosa 39|Retinitis pigmentosa 39|not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000379205	1	216497611	1	216324269	379205	364778	rs397517979	NC_000001.11:216324268:C:T
NM_206933.3(USH2A):c.5877del (p.Ser1961fs)	USH2A	S1961fs	Rare genetic deafness|Retinitis pigmentosa 39|Retinal dystrophy|not provided|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000180092	1	216243615	1	216070273	180092	172522	rs727505343	NC_000001.11:216070272:A:
NM_206933.4(USH2A):c.5858-1G>A	USH2A		not provided|Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048545	1	216243635	1	216070293	48545	57707	rs397518023	NC_000001.11:216070292:C:T
NM_206933.4(USH2A):c.14911C>T (p.Arg4971Ter)	USH2A	R4971*	Cone-rod dystrophy|Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic(Last reviewed: Jan 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000048449	1	215813957	1	215640615	48449	57611	rs397517994	NC_000001.11:215640614:G:A
NM_206933.4(USH2A):c.14287G>A (p.Gly4763Arg)	USH2A	G4763R	Retinitis pigmentosa 39|Usher syndrome, type 2A|Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048433	1	215823990	1	215650648	48433	57595	rs397517990	NC_000001.11:215650647:C:T
NM_206933.4(USH2A):c.10759C>T (p.Gln3587Ter)	USH2A	Q3587*	Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048357	1	215953365	1	215780023	48357	57519	rs111033418	NC_000001.11:215780022:G:A
NM_001035.3(RYR2):c.1069G>A (p.Gly357Ser)	RYR2	G357S	Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000519533	1	237604682	1	237441382	519533	509173	rs1401116572	NC_000001.11:237441381:G:A
NM_001035.3(RYR2):c.169-198_273+820del	RYR2		Catecholaminergic polymorphic ventricular tachycardia type 1	Pathogenic(Last reviewed: Nov 24, 2009)	no assertion criteria provided	VCV000029879	1	237493979 - 237495101	1	237330679 - 237331801	29879	38834		
NM_001035.3(RYR2):c.14579C>G (p.Ala4860Gly)	RYR2	A4860G	Catecholaminergic polymorphic ventricular tachycardia type 1	Pathogenic(Last reviewed: Nov 13, 2007)	no assertion criteria provided	VCV000012963	1	237982481	1	237819181	12963	28002	rs121918606	NC_000001.11:237819180:C:G
NM_000341.4(SLC3A1):c.1400T>C (p.Met467Thr)	SLC3A1	M467T	not provided|Cystinuria	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000018115	2	44539792	2	44312653	18115	33154	rs121912691	NC_000002.12:44312652:T:C
NM_001035.3(RYR2):c.14864G>A (p.Gly4955Glu)	RYR2	G4955E	not provided|Catecholaminergic polymorphic ventricular tachycardia type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449306	1	237995907	1	237832607	449306	442781	rs1553343100	NC_000001.11:237832606:G:A
NM_001035.3(RYR2):c.6982C>T (p.Pro2328Ser)	RYR2	P2328S	Catecholaminergic polymorphic ventricular tachycardia type 1	Pathogenic(Last reviewed: Feb 16, 2012)	no assertion criteria provided	VCV000012960	1	237802368	1	237639068	12960	27999	rs121918603	NC_000001.11:237639067:C:T
NM_001271208.2(NEB):c.15781G>T (p.Glu5261Ter)	NEB	E5261*	not provided	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000817518	2	152440163	2	151583649	817518	805244		NC_000002.12:151583648:C:A
NM_001271208.2(NEB):c.7966A>T (p.Lys2656Ter)	NEB	K2656*	not provided	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000816962	2	152499858	2	151643344	816962	805245		NC_000002.12:151643343:T:A
GRCh37/hg19 2q23.3(chr2:152434811-152466339)x1	NEB		not provided	Pathogenic(Last reviewed: Aug 23, 2017)	no assertion criteria provided	VCV000688549	2	152434811 - 152466339			688549	676141		
NM_001271208.2(NEB):c.12221dup (p.Thr4075fs)	NEB		not provided	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000499820	2	152466431 - 152466432	2	151609917 - 151609918	499820	491244	rs1553883480	NC_000002.12:151609917:T:TT
NM_001271208.2(NEB):c.11184del (p.Lys3728fs)	NEB	K3728fs, K3485fs	not provided	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, single submitter	VCV000498809	2	152472621	2	151616107	498809	490233	rs1553901624	NC_000002.12:151616106:TTT:TT
NM_001271208.2(NEB):c.18830_18831del (p.Thr6277fs)	NEB	T6277fs, T4576fs	not provided	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000432818	2	152419185 - 152419186	2	151562671 - 151562672	432818	425405	rs1553762626	NC_000002.12:151562670:CG:
NM_001271208.2(NEB):c.8265+1G>A	NEB		not provided	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000429723	2	152499278	2	151642764	429723	421284	rs1131691547	NC_000002.12:151642763:C:T
NM_001271208.2(NEB):c.17262G>A (p.Trp5754Ter)	NEB	W5754*, W4053*	not provided	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000373081	2	152426763	2	151570249	373081	359277	rs1057518200	NC_000002.12:151570248:C:T
NM_001271208.2(NEB):c.17557_17558del (p.Glu5853fs)	NEB	E4152fs, E5853fs	not provided	Pathogenic(Last reviewed: Jul 12, 2016)	criteria provided, single submitter	VCV000288778	2	152425208 - 152425209	2	151568694 - 151568695	288778	273015	rs886044005	NC_000002.12:151568693:TCT:T
NM_001271208.2(NEB):c.17541dup (p.Tyr5848fs)	NEB		not provided	Pathogenic(Last reviewed: May 25, 2016)	criteria provided, single submitter	VCV000287419	2	152425224 - 152425225	2	151568710 - 151568711	287419	271656	rs886043631	NC_000002.12:151568710:TTTTTT:TTTTTTT
NM_001271208.2(NEB):c.18862_18872del (p.Val6288fs)	NEB	V6288fs, V4587fs	not provided	Pathogenic(Last reviewed: Jun 11, 2015)	criteria provided, single submitter	VCV000281369	2	152419144 - 152419154	2	151562630 - 151562640	281369	265606	rs886042141	NC_000002.12:151562629:GCGTTTCGGACGCGT:GCGT
NM_001271208.2(NEB):c.16620T>A (p.Tyr5540Ter)	NEB	Y5540*	not provided	Pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, single submitter	VCV000280871	2	152435936	2	151579422	280871	264053	rs886041998	NC_000002.12:151579421:A:T
NM_001271208.2(NEB):c.11806-1G>A	NEB		not provided	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000280692	2	152467381	2	151610867	280692	264035	rs886041851	NC_000002.12:151610866:C:T
NM_001271208.2(NEB):c.6184-2A>G	NEB		not provided	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000805081	2	152512980	2	151656466	805081	794003		NC_000002.12:151656465:T:C
NM_001271208.2(NEB):c.1471-1G>A	NEB		Nemaline myopathy 2, autosomal recessive	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000435970	2	152553250	2	151696736	435970	427917	rs1553605995	NC_000002.12:151696735:C:T
NM_001271208.2(NEB):c.3774+1G>A	NEB		Nemaline myopathy 2, autosomal recessive	Pathogenic(Last reviewed: Dec 1, 2014)	criteria provided, single submitter	VCV000211588	2	152534078	2	151677564	211588	206868	rs111293259	NC_000002.12:151677563:C:T
NM_001271208.2(NEB):c.18597del (p.Tyr6200fs)	NEB	Y6200fs, Y4499fs	Nemaline myopathy 2, autosomal recessive	Pathogenic(Last reviewed: Jan 20, 2015)	criteria provided, single submitter	VCV000211583	2	152420216	2	151563702	211583	206865	rs797045735	NC_000002.12:151563701:T:
NM_001271208.2(NEB):c.3567+1G>A	NEB		Nemaline myopathy 2, autosomal recessive	Pathogenic(Last reviewed: Mar 31, 2014)	criteria provided, single submitter	VCV000129741	2	152534389	2	151677875	129741	135187	rs587780399	NC_000002.12:151677874:C:T
NM_001271208.2(NEB):c.19712_19716delinsGAG (p.Ala6571fs)	NEB		Nemaline myopathy 2, autosomal recessive	Pathogenic(Last reviewed: Feb 7, 2014)	criteria provided, single submitter	VCV000129704	2	152409927 - 152409931	2	151553413 - 151553417	129704	135150	rs587780397	NC_000002.12:151553412:ATAAG:CTC
GRCh37/hg19 2q23.3(chr2:152502644-152502748)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000813318	2	152502644 - 152502748			813318	801567		
NM_001271208.2(NEB):c.19800C>G (p.Tyr6600Ter)	NEB	Y4899*, Y6600*	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000807448	2	152409222	2	151552708	807448	798485		NC_000002.12:151552707:G:C
NM_001271208.2(NEB):c.20808T>A (p.Tyr6936Ter)	NEB	Y5235*, Y6936*	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000807447	2	152396942	2	151540428	807447	798484		NC_000002.12:151540427:A:T
NM_001271208.2(NEB):c.20467-2A>C	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801768	2	152402514	2	151546000	801768	790061		NC_000002.12:151545999:T:G
NM_001271208.2(NEB):c.12991C>T (p.Gln4331Ter)	NEB	Q4331*	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000864424	2	152461142	2	151604628	864424	824880		NC_000002.12:151604627:G:A
NM_001271208.2(NEB):c.1558C>T (p.Gln520Ter)	NEB	Q520*	Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000863778	2	152553162	2	151696648	863778	824962		NC_000002.12:151696647:G:A
NM_001271208.2(NEB):c.17653_17654del (p.Trp5885fs)	NEB	W4184fs, W5885fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000862121	2	152424912 - 152424913	2	151568398 - 151568399	862121	824871		NC_000002.12:151568397:CA:
NM_001271208.2(NEB):c.7892G>A (p.Trp2631Ter)	NEB	W2631*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000861741	2	152500396	2	151643882	861741	824920		NC_000002.12:151643881:C:T
NM_001271208.2(NEB):c.5977dup (p.Tyr1993fs)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000861713	2	152515676 - 152515677	2	151659162 - 151659163	861713	824935		NC_000002.12:151659162:A:AA
NM_001271208.2(NEB):c.11613del (p.Lys3871fs)	NEB	K3628fs, K3871fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000860942	2	152468892	2	151612378	860942	824892		NC_000002.12:151612377:TTT:TT
NM_001271208.2(NEB):c.21194_21195CT[2] (p.Tyr7067fs)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000860448	2	152393654 - 152393655	2	151537140 - 151537141	860448	824852		NC_000002.12:151537139:AGAGAG:AGAG
NM_001271208.2(NEB):c.12648C>G (p.Tyr4216Ter)	NEB	Y4216*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000859915	2	152463219	2	151606705	859915	824881		NC_000002.12:151606704:G:C
NM_001271208.2(NEB):c.13420C>T (p.Arg4474Ter)	NEB	R4474*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 10, 2020)	criteria provided, single submitter	VCV000856764	2	152458471	2	151601957	856764	824879		NC_000002.12:151601956:G:A
NM_001271208.2(NEB):c.9954T>G (p.Tyr3318Ter)	NEB	Y3318*, Y3075*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000856292	2	152484226	2	151627712	856292	824904		NC_000002.12:151627711:A:C
NM_001271208.2(NEB):c.6542G>A (p.Trp2181Ter)	NEB	W2181*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000856160	2	152512491	2	151655977	856160	824932		NC_000002.12:151655976:C:T
NM_001271208.2(NEB):c.6753del (p.Met2251fs)	NEB	M2251fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000854267	2	152511838	2	151655324	854267	824929		NC_000002.12:151655323:C:
NM_001271208.2(NEB):c.493C>T (p.Gln165Ter)	NEB	Q165*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000854027	2	152581385	2	151724871	854027	824969		NC_000002.12:151724870:G:A
NM_001271208.2(NEB):c.17781del (p.Gly5926_Tyr5927insTer)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000852024	2	152424648	2	151568134	852024	824870		NC_000002.12:151568133:G:
NM_001271208.2(NEB):c.12182del (p.Pro4061fs)	NEB	P3818fs, P4061fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000851515	2	152466471	2	151609957	851515	824884		NC_000002.12:151609956:GGG:GG
NM_001271208.2(NEB):c.5245_5254del (p.Tyr1749fs)	NEB	Y1749fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000846712	2	152521362 - 152521371	2	151664848 - 151664857	846712	824939		NC_000002.12:151664847:TTTCAGTGTA:
NM_001271208.2(NEB):c.6993del (p.Val2332fs)	NEB	V2332fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000843176	2	152507322	2	151650808	843176	824927		NC_000002.12:151650807:AA:A
NM_001271208.2(NEB):c.13537A>T (p.Lys4513Ter)	NEB	K4513*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000840725	2	152457207	2	151600693	840725	824878		NC_000002.12:151600692:T:A
NM_001271208.2(NEB):c.7984del (p.Trp2661_Leu2662insTer)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000840577	2	152499840	2	151643326	840577	824917		NC_000002.12:151643325:G:
NM_001271208.2(NEB):c.13780C>T (p.Gln4594Ter)	NEB	Q4594*	Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000836763	2	152456964	2	151600450	836763	824877		NC_000002.12:151600449:G:A
NM_001271208.2(NEB):c.12555del (p.Ala4184_Trp4185insTer)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000835568	2	152464102	2	151607588	835568	824882		NC_000002.12:151607587:CC:C
NM_001271208.2(NEB):c.937C>T (p.Gln313Ter)	NEB	Q313*	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	VCV000692009	2	152566268	2	151709754	692009	679740		NC_000002.12:151709753:G:A
NM_001271208.2(NEB):c.11054dup (p.Asn3685fs)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000665171	2	152474810 - 152474811	2	151618296 - 151618297	665171	628584		NC_000002.12:151618296:TTTTTT:TTTTTTT
NM_001271208.2(NEB):c.9217_9218del (p.Arg3073fs)	NEB	R3073fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000662889	2	152490364 - 152490365	2	151633850 - 151633851	662889	628601		NC_000002.12:151633849:CT:
NM_001271208.2(NEB):c.17986del (p.Thr5996fs)	NEB	T4295fs, T5996fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000662876	2	152423852	2	151567338	662876	628551		NC_000002.12:151567337:TTTT:TTT
NM_001271208.2(NEB):c.20503C>T (p.Arg6835Ter)	NEB	R6835*, R5134*	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000662526	2	152402476	2	151545962	662526	628530		NC_000002.12:151545961:G:A
NM_001271208.2(NEB):c.19711_19714del (p.Ala6571fs)	NEB	A6571fs, A4870fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000660184	2	152409929 - 152409932	2	151553415 - 151553418	660184	628535		NC_000002.12:151553414:AAGCA:A
NM_001271208.2(NEB):c.1676del (p.Asn559fs)	NEB	N559fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000660081	2	152551142	2	151694628	660081	628661		NC_000002.12:151694627:TT:T
NM_001271208.2(NEB):c.21052del (p.Asp7018fs)	NEB	D5317fs, D7018fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000658225	2	152394436	2	151537922	658225	628524		NC_000002.12:151537921:C:
NM_001271208.2(NEB):c.1333del (p.His445fs)	NEB	H445fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000657235	2	152553896	2	151697382	657235	628665		NC_000002.12:151697381:G:
NM_001271208.2(NEB):c.7253G>A (p.Trp2418Ter)	NEB	W2418*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000656677	2	152506868	2	151650354	656677	628618		NC_000002.12:151650353:C:T
NM_001271208.2(NEB):c.13773C>A (p.Tyr4591Ter)	NEB	Y4591*	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000656253	2	152456971	2	151600457	656253	628569		NC_000002.12:151600456:G:T
NM_001271208.2(NEB):c.2065dup (p.Tyr689fs)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000653699	2	152548613 - 152548614	2	151692099 - 151692100	653699	628657		NC_000002.12:151692099:A:AA
NM_001271208.2(NEB):c.17196_17200del (p.Ile5732fs)	NEB	I4031fs, I5732fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000651742	2	152426825 - 152426829	2	151570311 - 151570315	651742	628560		NC_000002.12:151570310:AGCGGA:A
NM_001271208.2(NEB):c.724del (p.Tyr242fs)	NEB	Y242fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000648486	2	152574028	2	151717514	648486	628670		NC_000002.12:151717513:A:
NM_001271208.2(NEB):c.496_499del (p.Gln166fs)	NEB	Q166fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000647587	2	152581379 - 152581382	2	151724865 - 151724868	647587	628671		NC_000002.12:151724864:CTTGCT:CT
NM_001271208.2(NEB):c.6108_6111AAAG[1] (p.Lys2038fs)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000645659	2	152514565 - 152514568	2	151658051 - 151658054	645659	628628		NC_000002.12:151658050:CTTTCTTT:CTTT
NM_001271208.2(NEB):c.10493del (p.Gly3498fs)	NEB	G3498fs, G3255fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000645208	2	152477500	2	151620986	645208	628590		NC_000002.12:151620985:CC:C
NM_001271208.2(NEB):c.17415C>A (p.Tyr5805Ter)	NEB	Y4104*, Y5805*	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000644721	2	152426610	2	151570096	644721	628556		NC_000002.12:151570095:G:T
NM_001271208.2(NEB):c.8458_8459del (p.Ser2820fs)	NEB	S2820fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000644503	2	152497095 - 152497096	2	151640581 - 151640582	644503	628608		NC_000002.12:151640580:GA:
NM_001271208.2(NEB):c.8425del (p.Arg2809fs)	NEB	R2809fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000644459	2	152497129	2	151640615	644459	628609		NC_000002.12:151640614:GGG:GG
NM_001271208.2(NEB):c.6341_6342AC[3] (p.Ala2117fs)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000640888	2	152512817 - 152512818	2	151656303 - 151656304	640888	628625		NC_000002.12:151656303:GTGTG:GTGTGTG
NM_001271208.2(NEB):c.4623del (p.Ala1542fs)	NEB	A1542fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000582645	2	152524414	2	151667900	582645	558797	rs1559039815	NC_000002.12:151667899:TTT:TT
NM_001271208.2(NEB):c.17828del (p.Asn5943fs)	NEB	N4242fs, N5943fs	Nemaline myopathy 2	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000581901	2	152424601	2	151568087	581901	557603	rs1560031341	NC_000002.12:151568086:TT:T
NM_001271208.2(NEB):c.10899G>A (p.Trp3633Ter)	NEB	W3633*, W3390*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000581881	2	152474966	2	151618452	581881	559254	rs780343350	NC_000002.12:151618451:C:T
NM_001271208.2(NEB):c.5364G>A (p.Trp1788Ter)	NEB	W1788*	Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000580393	2	152521102	2	151664588	580393	558791	rs201636991	NC_000002.12:151664587:C:T
NM_001271208.2(NEB):c.13756C>T (p.Gln4586Ter)	NEB	Q4586*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000574810	2	152456988	2	151600474	574810	557558	rs1560283028	NC_000002.12:151600473:G:A
NM_001271208.2(NEB):c.13704T>A (p.Tyr4568Ter)	NEB	Y4568*	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000534017	2	152457040	2	151600526	534017	516517	rs1553862274	NC_000002.12:151600525:A:T
NM_001271208.2(NEB):c.4652del (p.Gly1551fs)	NEB	G1551fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000533982	2	152524385	2	151667871	533982	516564	rs1553502168	NC_000002.12:151667870:CCC:CC
NM_001271208.2(NEB):c.10872+1G>T	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 2, 2018)	no assertion criteria provided	VCV000506287	2	152475964	2	151619450	506287	497912	rs1336053002	NC_000002.12:151619449:C:A
NM_001271208.2(NEB):c.9726_9727insAT (p.Leu3243fs)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000465655	2	152486157 - 152486158	2	151629643 - 151629644	465655	448711	rs1553934562	NC_000002.12:151629643:A:ATA
NM_001271208.2(NEB):c.5722del (p.Ser1908fs)	NEB	S1908fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000465618	2	152520103	2	151663589	465618	448722	rs1553484601	NC_000002.12:151663588:T:
NM_001271208.2(NEB):c.12684T>G (p.Tyr4228Ter)	NEB	Y4228*	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000465462	2	152463183	2	151606669	465462	448912	rs1553875421	NC_000002.12:151606668:A:C
NM_001271208.2(NEB):c.11585_11586delinsC (p.Tyr3862fs)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 9, 2016)	criteria provided, single submitter	VCV000465439	2	152470805 - 152470806	2	151614291 - 151614292	465439	448931	rs1553896522	NC_000002.12:151614290:AT:G
NEB, 2-BP DEL, GA, EX181	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 2, 1999)	no assertion criteria provided	VCV000014049					14049	29088	rs1559154278	
NM_001271208.2(NEB):c.17845-2A>T	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000847448	2	152423995	2	151567481	847448	850793		NC_000002.12:151567480:T:A
NM_001271208.2(NEB):c.12639+1G>A	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000845691	2	152464017	2	151607503	845691	851085		NC_000002.12:151607502:C:T
NM_001271208.2(NEB):c.3879+2T>C	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000845647	2	152531799	2	151675285	845647	850836		NC_000002.12:151675284:A:G
NM_001271208.2(NEB):c.10612C>T (p.Arg3538Ter)	NEB	R3295*, R3538*	Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000801770	2	152476225	2	151619711	801770	790063		NC_000002.12:151619710:G:A
NC_000002.11:g.(?_152502624)_(152502768_?)del	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000665633	2	152502624 - 152502768	2	151646110 - 151646254	665633	650713		
NM_001271208.2(NEB):c.18124C>T (p.Gln6042Ter)	NEB	Q6042*, Q4341*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000652416	2	152423714	2	151567200	652416	628550		NC_000002.12:151567199:G:A
NM_001271208.2(NEB):c.1674+1G>A	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000651953	2	152552091	2	151695577	651953	650855		NC_000002.12:151695576:C:T
NM_001271208.2(NEB):c.12160del (p.Trp4054fs)	NEB	W3811fs, W4054fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000639479	2	152466493	2	151609979	639479	628576		NC_000002.12:151609978:A:
NM_001271208.2(NEB):c.1570-2A>G	NEB		not provided|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: May 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000558305	2	152552198	2	151695684	558305	541707	rs1553603958	NC_000002.12:151695683:T:C
NM_001271208.2(NEB):c.18676C>T (p.Gln6226Ter)	NEB	Q6226*, Q4525*	Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000557505	2	152420137	2	151563623	557505	541640	rs1475648900	NC_000002.12:151563622:G:A
NM_001271208.2(NEB):c.18808C>T (p.Arg6270Ter)	NEB	R6270*, R4569*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000553116	2	152419208	2	151562694	553116	541657	rs754369875	NC_000002.12:151562693:G:A
NM_001271208.2(NEB):c.37-1G>A	NEB		Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000552631	2	152586171	2	151729657	552631	541665	rs1428597732	NC_000002.12:151729656:C:T
NM_001271208.2(NEB):c.1674+2T>C	NEB		Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000550050	2	152552090	2	151695576	550050	541632	rs1553603437	NC_000002.12:151695575:A:G
NM_001271208.2(NEB):c.17845-1G>A	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000534004	2	152423994	2	151567480	534004	516435	rs1371849916	NC_000002.12:151567479:C:T
NM_001271208.2(NEB):c.13788+1G>A	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000465492	2	152456955	2	151600441	465492	448648	rs1553862061	NC_000002.12:151600440:C:T
NM_001271208.2(NEB):c.19405C>T (p.Arg6469Ter)	NEB	R6469*, R4768*	Nemaline myopathy 2|not provided	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000451764	2	152411468	2	151554954	451764	442947	rs1553740233	NC_000002.12:151554953:G:A
NEB, 2-BP DEL, AG, EX172	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000014048					14048	29087		
NM_003590.5(CUL3):c.1651C>T (p.Gln551Ter)	CUL3	Q551*, Q485*, Q557*	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	VCV000521839	2	225362526	2	224497809	521839	511399	rs1553602498	NC_000002.12:224497808:G:A
NM_003590.5(CUL3):c.1347_1348CT[1] (p.Asp449_Ser450insTer)	CUL3		Inborn genetic diseases	Pathogenic(Last reviewed: Jan 2, 2015)	criteria provided, single submitter	VCV000520612	2	225368396 - 225368397	2	224503679 - 224503680	520612	511400	rs1553521389	NC_000002.12:224503678:AGAG:AG
NM_001271208.2(NEB):c.17118+1G>A	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000841709	2	152427010	2	151570496	841709	851338		NC_000002.12:151570495:C:T
NM_001271208.2(NEB):c.13147C>T (p.Gln4383Ter)	NEB	Q4383*	Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000813958	2	152460199	2	151603685	813958	802126		NC_000002.12:151603684:G:A
NM_001271208.2(NEB):c.1623del (p.Asp542fs)	NEB	D542fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000575054	2	152552143	2	151695629	575054	559286	rs772366030	NC_000002.12:151695628:A:
NM_001271208.2(NEB):c.3880-2A>G	NEB		Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000556861	2	152531100	2	151674586	556861	541664	rs1342507012	NC_000002.12:151674585:T:C
NM_001271208.2(NEB):c.3879+1G>A	NEB		Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000554705	2	152531800	2	151675286	554705	541667	rs746999970	NC_000002.12:151675285:C:T
NM_001271208.2(NEB):c.2943+1G>A	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551899	2	152539175	2	151682661	551899	541687	rs113091511	NC_000002.12:151682660:C:T
NM_001271208.2(NEB):c.20845dup (p.Thr6949fs)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551753	2	152396904 - 152396905	2	151540390 - 151540391	551753	541602	rs1553695209	NC_000002.12:151540390:T:TT
NM_001271208.2(NEB):c.11164C>T (p.Arg3722Ter)	NEB	R3722*, R3479*	Nemaline myopathy|Nemaline myopathy 2	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000496131	2	152473895	2	151617381	496131	486874	rs928945364	NC_000002.12:151617380:G:A
NM_001271208.2(NEB):c.3858C>A (p.Cys1286Ter)	NEB	C1286*	not provided|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000444521	2	152531822	2	151675308	444521	438161	rs1386238241	NC_000002.12:151675307:G:T
NM_001271208.2(NEB):c.9046C>T (p.Arg3016Ter)	NEB	R3016*	not provided|Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000372773	2	152492797	2	151636283	372773	359394	rs1057517977	NC_000002.12:151636282:G:A
NM_001271208.2(NEB):c.412C>T (p.Arg138Ter)	NEB	R138*	Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371551	2	152581466	2	151724952	371551	357235	rs1057517360	NC_000002.12:151724951:G:A
NM_001271208.2(NEB):c.3987+1G>A	NEB		Nemaline myopathy|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371210	2	152530990	2	151674476	371210	357230	rs780022652	NC_000002.12:151674475:C:T
NM_002074.5(GNB1):c.239T>C (p.Ile80Thr)	GNB1	I80T	Myelodysplastic syndrome|LEUKEMIA, CHRONIC LYMPHOCYTIC, SOMATIC|Mental retardation, autosomal dominant 42|not provided|Inborn genetic diseases|Cleft palate|Hypothyroidism|Dystonia|Intellectual disability|Infantile axial hypotonia|Growth delay|Upper limb hypertonia|Neurodevelopmental Disability|hypotonia|Seizures|Global developmental delay|Inability to walk|Limb hypertonia|Nystagmus|Multifocal epileptiform discharges|Muscular hypotonia|Strabismus|Expressive language delay|Developmental regression|Seizures|Growth delay|Failure to thrive|EEG with generalized epileptiform discharges	Pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208722	1	1737942	1	1806503	208722	205216	rs752746786	NC_000001.11:1806502:A:G
NC_000002.11:g.(?_152502634)_(152502758_?)del	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000652395	2	152502634 - 152502758	2	151646120 - 151646244	652395	650770		
NC_000002.11:g.(?_152502272)_(152504773_?)del	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000652384	2	152502272 - 152504773	2	151645758 - 151648259	652384	650711		
NM_001271208.2(NEB):c.1161C>G (p.Tyr387Ter)	NEB	Y387*	Nemaline myopathy 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000586164	2	152554154	2	151697640	586164	576568	rs1259297878	NC_000002.12:151697639:G:C
NM_001271208.2(NEB):c.5574C>G (p.Tyr1858Ter)	NEB	Y1858*	not provided|Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449501	2	152520251	2	151663737	449501	442966	rs781185019	NC_000002.12:151663736:G:C
NM_001271208.2(NEB):c.6078del (p.Lys2026fs)	NEB	K2026fs	Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370777	2	152514602	2	151658088	370777	357228	rs1057516758	NC_000002.12:151658087:TTT:TT
NM_001271208.2(NEB):c.6385C>T (p.Gln2129Ter)	NEB	Q2129*	Nemaline myopathy 2|not provided	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000282373	2	152512777	2	151656263	282373	266610	rs80344795	NC_000002.12:151656262:G:A
NM_001271208.2(NEB):c.8031_8041del (p.Lys2677fs)	NEB	K2677fs	Nemaline myopathy 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000095138	2	152499783 - 152499793	2	151643269 - 151643279	95138	101038	rs398124172	NC_000002.12:151643268:CTCGTTTATTT:
NC_000001.11:g.(?_237330868)_(237330992_?)del	RYR2		Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000832865	1	237494168 - 237494292			832865	818941		
NM_206933.3(USH2A):c.8558+1G>T	USH2A		Retinitis pigmentosa 39|Usher syndrome, type 2A|Usher syndrome type 2|not provided|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jun 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555522	1	216052105	1	215878763	555522	540961	rs770383273	NC_000001.11:215878762:C:A
NM_206933.3(USH2A):c.9815C>T (p.Pro3272Leu)	USH2A	P3272L	Usher syndrome, type 2A|Retinitis pigmentosa 39|Retinal dystrophy|Usher syndrome, type 2A|Retinitis pigmentosa 39	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553424	1	215972392	1	215799050	553424	540841	rs764182950	NC_000001.11:215799049:G:A
NM_206933.4(USH2A):c.14453C>T (p.Pro4818Leu)	USH2A	P4818L	not provided|Usher syndrome, type 2A|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Dec 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000504509	1	215821999	1	215648657	504509	496179	rs143344549	NC_000001.11:215648656:G:A
NM_206933.3(USH2A):c.1111_1112del (p.Ile371fs)	USH2A	I371fs	Usher syndrome, type 2A|Retinal dystrophy|Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000495336	1	216498678 - 216498679	1	216325336 - 216325337	495336	486831	rs1366496013	NC_000001.11:216325335:ATA:A
NM_206933.3(USH2A):c.1679del (p.Pro560fs)	USH2A	P560fs	not provided|Retinal dystrophy|Retinitis pigmentosa 39	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000286104	1	216465678	1	216292336	286104	270341	rs773539640	NC_000001.11:216292335:GG:G
NM_206933.3(USH2A):c.13374del (p.Glu4458fs)	USH2A	E4458fs	Retinal dystrophy|Retinitis pigmentosa 39|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000166428	1	215847879	1	215674537	166428	172517	rs727503715	NC_000001.11:215674536:TT:T
NM_206933.3(USH2A):c.6862G>T (p.Glu2288Ter)	USH2A	E2288*	not provided|Retinal dystrophy|Usher syndrome, type 2A|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096666	1	216144062	1	215970720	96666	102559	rs398124619	NC_000001.11:215970719:C:A
NM_206933.4(USH2A):c.13130C>A (p.Ser4377Ter)	USH2A	S4377*	not provided|Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000048412	1	215848123	1	215674781	48412	57574	rs111033385	NC_000001.11:215674780:G:T
NM_201253.3(CRB1):c.3307G>A (p.Gly1103Arg)	CRB1	G1103R, G1079R, G991R	Retinitis pigmentosa 12|Leber congenital amaurosis 8|Retinal dystrophy|Leber congenital amaurosis 8|Retinitis pigmentosa 12|Leber congenital amaurosis|Early-onset retinal dystrophy|not provided	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005739	1	197404300	1	197435170	5739	20778	rs62636275	NC_000001.11:197435169:G:A
NM_006920.6(SCN1A):c.2556+3A>T	SCN1A		Early infantile epileptic encephalopathy|not provided|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000189938	2	166895930	2	166039420	189938	187803	rs794726775	NC_000002.12:166039419:T:A
NM_006920.6(SCN1A):c.2758C>T (p.Arg920Cys)	SCN1A	R920C, R931C, R117C, R902C, R903C, R919C	Severe myoclonic epilepsy in infancy|not provided|Early infantile epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000068598	2	166894441	2	166037931	68598	79490	rs121918788	NC_000002.12:166037930:G:A
NM_006920.6(SCN1A):c.580G>A (p.Asp194Asn)	SCN1A	D194N	Severe myoclonic epilepsy in infancy|not provided|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068575	2	166911170	2	166054660	68575	79467	rs121917935	NC_000002.12:166054659:C:T
NM_003000.2(SDHB):c.1A>T (p.Met1Leu)	SDHB	M1L	Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428918	1	17380514	1	17054019	428918	420755	rs1131691049	NC_000001.11:17054018:T:A
NM_003000.2(SDHB):c.689G>T (p.Arg230Leu)	SDHB	R230L	Hereditary cancer-predisposing syndrome|not provided|Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000184933	1	17349179	1	17022684	184933	181607	rs587782604	NC_000001.11:17022683:C:A
NM_003000.2(SDHB):c.600G>T (p.Trp200Cys)	SDHB	W200C	Hereditary Paraganglioma-Pheochromocytoma Syndromes|Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183747	1	17350510	1	17024015	183747	181610	rs397516836	NC_000001.11:17024014:C:A
NC_000002.12:g.(?_151614266)_(151697658_?)del	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV000831138	2	152470780 - 152554172			831138	819055		
NM_001271208.2(NEB):c.2920C>T (p.Arg974Ter)	NEB	R974*	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000465594	2	152539199	2	151682685	465594	449009	rs1553548666	NC_000002.12:151682684:G:A
NM_001271208.2(NEB):c.11627G>A (p.Trp3876Ter)	NEB	W3876*, W3633*	not provided|Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000450119	2	152468878	2	151612364	450119	442955	rs776569219	NC_000002.12:151612363:C:T
NM_001271208.1(NEB):c.7523_7526del	NEB	I2508fs	Nemaline myopathy 2|not provided	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000242434	2	152502654 - 152502657	2	151646140 - 151646143	242434	226443	rs878854368	NC_000002.12:151646139:TTGATT:TT
NM_001271208.2(NEB):c.7431+1919_7536+374del	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 15, 2012)	no assertion criteria provided	VCV000014052	2	152502270 - 152504771	2	151645756 - 151648257	14052	29091		
NC_000001.11:g.(?_45329306)_(45333334_?)del	MUTYH		MYH-associated polyposis	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000832371	1	45794978 - 45799006			832371	818974		
NM_001128425.1(MUTYH):c.586G>T (p.Glu196Ter)	MUTYH	E196*, E76*, E53*, E169*, E179*, E182*, E183*, E168*, E193*	MYH-associated polyposis|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000406822	1	45798350	1	45332678	406822	391331	rs745921592	NC_000001.11:45332677:C:A
NM_001276345.2(TNNT2):c.311G>T (p.Arg104Leu)	TNNT2	R104L, R94L, R89L	Cardiovascular phenotype|not provided|Familial restrictive cardiomyopathy 3|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043629	1	201334419	1	201365291	43629	52798	rs397516457	NC_000001.11:201365290:C:A
NM_014795.4(ZEB2):c.2083C>T (p.Arg695Ter)	ZEB2	R695*, R671*	not provided|Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004755	2	145156671	2	144399104	4755	19794	rs137852981	NC_000002.12:144399103:G:A
NM_001130987.2(DYSF):c.2929C>T (p.Arg977Trp)	DYSF	R959W, R977W, R976W, R990W, R946W, R945W, R960W, R991W	not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B|Myopathy, distal, with anterior tibial onset|Miyoshi muscular dystrophy 1|Autosomal recessive limb-girdle muscular dystrophy type 2B|Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000284254	2	71797014	2	71569884	284254	268491	rs202218890	NC_000002.12:71569883:C:T
NM_003494.3(DYSF):c.2779del (p.Ala927Leufs)	DYSF	A914fs, A928fs, A944fs, A959fs, A913fs, A927fs, A945fs, A958fs	Miyoshi muscular dystrophy 1|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B|Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006685	2	71795435	2	71568305	6685	21724	rs727503909	NC_000002.12:71568304:GGG:GG
NM_001271208.2(NEB):c.3255+1G>T	NEB		Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000552035	2	152536234	2	151679720	552035	541733	rs375628303	NC_000002.12:151679719:C:A
NM_001271208.2(NEB):c.78+1G>A	NEB		Nemaline myopathy 2|Nemaline myopathy	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000552018	2	152586128	2	151729614	552018	541761	rs778593702	NC_000002.12:151729613:C:T
NM_001271208.2(NEB):c.3987+1_3987+2delinsTG	NEB		not provided|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188944	2	152530989 - 152530990	2	151674475 - 151674476	188944	186648	rs786204576	NC_000002.12:151674474:AC:CA
NM_001271208.2(NEB):c.2784del (p.Asp929fs)	NEB	D929fs	Nemaline myopathy 2|Nemaline myopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188731	2	152541343	2	151684829	188731	186649	rs786204430	NC_000002.12:151684828:A:
NM_000090.3(COL3A1):c.1763G>A (p.Gly588Asp)	COL3A1	G588D	Ehlers-Danlos syndrome, type 4|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000101451	2	189861892	2	188997166	101451	107198	rs587779691	NC_000002.12:188997165:G:A
NM_000090.3(COL3A1):c.636+5G>A (p.Gly195_Ser212del)	COL3A1		Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000101448	2	189853374	2	188988648	101448	107195	rs587779688	NC_000002.12:188988647:G:A
NM_001172509.2(SATB2):c.808_809del (p.Gln270fs)	SATB2	Q270fs	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 9, 2016)	criteria provided, single submitter	VCV000521394	2	200213788 - 200213789	2	199349065 - 199349066	521394	511387	rs1553551705	NC_000002.12:199349064:TGT:T
NM_001172509.2(SATB2):c.1196del (p.Arg399fs)	SATB2	R399fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 5, 2016)	criteria provided, single submitter	VCV000521185	2	200193611	2	199328888	521185	511386	rs1553547906	NC_000002.12:199328887:C:
NM_000143.3(FH):c.698G>A (p.Arg233His)	FH	R190H, R233H	not provided|Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016236	1	241671943	1	241508643	16236	31275	rs121913123	NC_000001.11:241508642:C:T
NM_001035.3(RYR2):c.13957G>T (p.Val4653Phe)	RYR2	V4653F	Catecholaminergic polymorphic ventricular tachycardia type 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 10, 2014)	no assertion criteria provided	VCV000012961	1	237961337	1	237798037	12961	28000	rs121918604	NC_000001.11:237798036:G:T
NM_001271208.2(NEB):c.3255+1G>A	NEB		not provided|Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449502	2	152536234	2	151679720	449502	442968	rs375628303	NC_000002.12:151679719:C:T
NM_001271208.2(NEB):c.1152+1G>A	NEB		Nemaline myopathy 2|not provided	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000095104	2	152563394	2	151706880	95104	101004	rs398124167	NC_000002.12:151706879:C:T
NM_014946.3(SPAST):c.1378C>T (p.Arg460Cys)	SPAST	R460C, R427C, R459C, R428C	not provided|Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000240948	2	32362002	2	32136933	240948	238765	rs878854990	NC_000002.12:32136932:C:T
NM_022893.4(BCL11A):c.385+2T>C	BCL11A		Intellectual developmental disorder with persistence of fetal hemoglobin|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000521857	2	60773104	2	60545969	521857	511432	rs1553352926	NC_000002.12:60545968:A:G
NM_206933.3(USH2A):c.1724G>A (p.Cys575Tyr)	USH2A	C575Y	Retinal dystrophy|Usher syndrome, type 2A|Retinitis pigmentosa 39|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552511	1	216465633	1	216292291	552511	540966	rs483353054	NC_000001.11:216292290:C:T
NM_206933.3(USH2A):c.11873_11874CA[1] (p.Gln3959fs)	USH2A		Retinal dystrophy|Usher syndrome, type 2A|Retinitis pigmentosa 39|Retinitis pigmentosa|not provided	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000198318	1	215901562 - 215901563	1	215728220 - 215728221	198318	195479	rs779791079	NC_000001.11:215728219:TGTGT:TGT
NM_006920.6(SCN1A):c.302G>A (p.Arg101Gln)	SCN1A	R101Q	not provided|Severe myoclonic epilepsy in infancy|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Mar 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000068528	2	166915161	2	166058651	68528	79420	rs121917918	NC_000002.12:166058650:C:T
NM_001271208.2(NEB):c.19097G>T (p.Ser6366Ile)	NEB	S6366I, S4665I	Nemaline myopathy|Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000496132	2	152417726	2	151561212	496132	486940	rs191579691	NC_000002.12:151561211:C:A
NM_001271208.2(NEB):c.294+2T>C	NEB		not provided|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000287422	2	152584203	2	151727689	287422	271659	rs773952935	NC_000002.12:151727688:A:G
NM_001271208.2(NEB):c.12018+1G>A	NEB		not provided|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265494	2	152467029	2	151610515	265494	259697	rs762278237	NC_000002.12:151610514:C:T
NM_001035.3(RYR2):c.506G>A (p.Arg169Gln)	RYR2	R169Q	Cardiovascular phenotype|not provided|Catecholaminergic polymorphic ventricular tachycardia	Pathogenic/Likely pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043801	1	237540665	1	237377365	43801	52970	rs397516539	NC_000001.11:237377364:G:A
NM_000310.3(PPT1):c.364A>T (p.Arg122Trp)	PPT1	R122W	|not provided|Neuronal ceroid lipofuscinosis|Inborn genetic diseases	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008899	1	40557070	1	40091398	8899	23938	rs137852695	NC_000001.11:40091397:T:A
NM_170707.4(LMNA):c.1609-3C>G	LMNA		Dilated cardiomyopathy 1A|Neuromuscular disease|Primary dilated cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000066856	1	156107442	1	156137651	66856	77753	rs267607581	NC_000001.11:156137650:C:G
NM_170707.4(LMNA):c.949G>A (p.Glu317Lys)	LMNA	E317K, E236K, E205K	Cardiomyopathy|not provided|Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease, type 2|not specified	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048093	1	156105704	1	156135913	48093	57257	rs56816490	NC_000001.11:156135912:G:A
NM_001048171.1(MUTYH):c.425G>A (p.Trp142Ter)	MUTYH	W156*, W142*, W139*, W143*, W153*, W36*, W128*, W129*, W13*	not provided|Hereditary cancer-predisposing syndrome|MYH-associated polyposis	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000230971	1	45798627	1	45332955	230971	232266	rs762307622	NC_000001.11:45332954:C:T
NM_001128425.1(MUTYH):c.393G>A (p.Trp131Ter)	MUTYH	W131*, W104*, W118*, W117*, W114*, W128*, W103*, W11*	MUTYH-associated polyposis|Hereditary cancer-predisposing syndrome|not provided|MYH-associated polyposis	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000140811	1	45798838	1	45333166	140811	150525	rs587781295	NC_000001.11:45333165:C:T
NM_001271208.2(NEB):c.9619-2A>G	NEB		Nemaline myopathy 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000379231	2	152487335	2	151630821	379231	365720	rs375145370	NC_000002.12:151630820:T:C
NM_001271208.2(NEB):c.21076C>T (p.Arg7026Ter)	NEB	R7026*, R5325*	Nemaline myopathy 2|Nemaline myopathy|Non-immune hydrops fetalis	Pathogenic/Likely pathogenic(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000190457	2	152394412	2	151537898	190457	188272	rs769345284	NC_000002.12:151537897:G:A
NM_003000.2(SDHB):c.166_170del (p.Pro56fs)	SDHB	P56fs	not specified|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185342	1	17371286 - 17371290	1	17044791 - 17044795	185342	181622	rs786202100	NC_000001.11:17044790:TGAGGT:T
NM_003000.2(SDHB):c.286+2T>A	SDHB		Hereditary Paraganglioma-Pheochromocytoma Syndromes|Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|Paragangliomas 4|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000140773	1	17359553	1	17033058	140773	150487	rs587781270	NC_000001.11:17033057:A:T
NM_003494.3(DYSF):c.3113G>A	DYSF	R1038Q, R1056Q, R1024Q, R1055Q, R1069Q, R1070Q, R1025Q, R1039Q	Autosomal recessive limb-girdle muscular dystrophy type 2B|Qualitative or quantitative defects of dysferlin|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000242418	2	71797810	2	71570680	242418	226470	rs150877497	NC_000002.12:71570679:G:A
NM_001130987.2(DYSF):c.3166C>T (p.Arg1056Ter)	DYSF	R1038*, R1056*, R1039*, R1024*, R1025*, R1069*, R1070*, R1055*	Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217225	2	71797809	2	71570679	217225	213810	rs369607332	NC_000002.12:71570678:C:T
NM_000016.5(ACADM):c.799G>A (p.Gly267Arg)	ACADM	G267R, G271R, G300R, G78R, G231R	not provided|Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003588	1	76215194	1	75749509	3588	18627	rs121434274	NC_000001.11:75749508:G:A
NM_000090.3(COL3A1):c.1618G>A (p.Gly540Arg)	COL3A1	G540R	not provided|Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000101297	2	189860860	2	188996134	101297	107043	rs587779584	NC_000002.12:188996133:G:A
NM_000090.3(COL3A1):c.1662+1G>A (p.Gly537_Pro554del)	COL3A1		Ehlers-Danlos syndrome, type 4|Cardiovascular phenotype|not provided	Pathogenic(Last reviewed: Sep 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000101269	2	189860905	2	188996179	101269	107015	rs587779535	NC_000002.12:188996178:G:A
NM_206933.3(USH2A):c.2610C>A (p.Cys870Ter)	USH2A	C870*	Usher syndrome|Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome, type 2A|Retinal dystrophy	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000557167	1	216420126	1	216246784	557167	541060	rs767078782	NC_000001.11:216246783:G:T
NM_206933.3(USH2A):c.13576C>T (p.Arg4526Ter)	USH2A	R4526*	Retinal dystrophy|Retinitis pigmentosa 39|Retinitis pigmentosa|not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000438014	1	215847677	1	215674335	438014	431574	rs1003869920	NC_000001.11:215674334:G:A
NM_206933.3(USH2A):c.8682-9A>G	USH2A		Retinitis pigmentosa 39|not provided|Usher syndrome|Retinal dystrophy	Pathogenic(Last reviewed: Sep 24, 2018)	reviewed by expert panel	VCV000197510	1	216040521	1	215867179	197510	194671	rs372347027	NC_000001.11:215867178:T:C
NM_206933.3(USH2A):c.1214del (p.Asn405fs)	USH2A	N405fs	Usher syndrome, type 2A|Retinal dystrophy|Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189250	1	216497624	1	216324282	189250	187108	rs750228923	NC_000001.11:216324281:TTTT:TTT
NM_206933.4(USH2A):c.12295-2A>G	USH2A		Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided|Rare genetic deafness|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000048392	1	215848960	1	215675618	48392	57554	rs151148854	NC_000001.11:215675617:T:C
NM_000143.3(FH):c.320A>C (p.Asn107Thr)	FH	N107T, N64T	Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092455	1	241676961	1	241513661	92455	98364	rs121913121	NC_000001.11:241513660:T:G
NM_201548.4(CERKL):c.769C>T	CERKL	R257*, R283*, R239*	Cone-rod degeneration|Retinal dystrophy|Retinal pigment epithelial atrophy|Cone/cone-rod dystrophy|Retinitis pigmentosa|Cone-rod dystrophy|Retinitis pigmentosa 26|not provided	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002364	2	182423344	2	181558617	2364	17403	rs121909398	NC_000002.12:181558616:G:A
NM_170707.4(LMNA):c.1580G>C (p.Arg527Pro)	LMNA	R527P, R446P, R415P	not provided|Familial partial lipodystrophy 2|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000014481	1	156106995	1	156137204	14481	29520	rs57520892	NC_000001.11:156137203:G:C
NM_001128425.1(MUTYH):c.847A>G (p.Met283Val)	MUTYH	M283V, M140V, M163V, M256V, M269V, M255V, M266V, M270V, M280V	MYH-associated polyposis|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000232291	1	45797924	1	45332252	232291	232244	rs876659676	NC_000001.11:45332251:T:C
NM_001130987.2(DYSF):c.1888C>T (p.Gln630Ter)	DYSF	Q612*, Q630*, Q598*, Q599*, Q613*, Q629*, Q644*, Q643*	Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B|Myopathy, distal, with anterior tibial onset|Miyoshi muscular dystrophy 1|Qualitative or quantitative defects of dysferlin	Pathogenic(Last reviewed: Jul 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217223	2	71780222	2	71553092	217223	213808	rs746873768	NC_000002.12:71553091:C:T
NM_206933.4(USH2A):c.4645C>T (p.Arg1549Ter)	USH2A	R1549*	Usher syndrome, type 2A|Usher syndrome, type 2A|Retinitis pigmentosa 39|Rare genetic deafness	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000504513	1	216270538	1	216097196	504513	496156	rs199679165	NC_000001.11:216097195:G:A
NM_206933.3(USH2A):c.908G>A (p.Arg303His)	USH2A	R303H	Hearing impairment|Retinal dystrophy|Retinitis pigmentosa 39|not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000284411	1	216498882	1	216325540	284411	268648	rs371777049	NC_000001.11:216325539:C:T
NM_206933.4(USH2A):c.9570+1G>A	USH2A		Retinal dystrophy|Retinitis pigmentosa 39|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228418	1	215990338	1	215816996	228418	228312	rs760225886	NC_000001.11:215816995:C:T
NM_006920.6(SCN1A):c.1624C>T (p.Arg542Ter)	SCN1A	R542*, R541*	Severe myoclonic epilepsy in infancy|Early infantile epileptic encephalopathy|not provided|Generalized epilepsy with febrile seizures plus, type 2|History of neurodevelopmental disorder	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189848	2	166901591	2	166045081	189848	187828	rs138877187	NC_000002.12:166045080:G:A
NM_006920.6(SCN1A):c.301C>T (p.Arg101Trp)	SCN1A	R101W	not provided|Severe myoclonic epilepsy in infancy|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000068527	2	166915162	2	166058652	68527	79419	rs121917965	NC_000002.12:166058651:G:A
NM_006920.6(SCN1A):c.2591C>T (p.Thr864Met)	SCN1A	T875M, T864M, T61M, T846M, T863M, T847M	Generalized epilepsy with febrile seizures plus, type 1|History of neurodevelopmental disorder|Generalized epilepsy with febrile seizures plus, type 2|Early infantile epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012883	2	166894608	2	166038098	12883	27922	rs121918623	NC_000002.12:166038097:G:A
NM_001172509.2(SATB2):c.868C>T (p.Gln290Ter)	SATB2	Q290*	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Dec 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000373586	2	200213729	2	199349006	373586	359455	rs1057518496	NC_000002.12:199349005:G:A
NM_018136.4(ASPM):c.10168C>T	ASPM	R3390*, R1805*	Primary autosomal recessive microcephaly 5|Inborn genetic diseases	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000157773	1	197056096	1	197086966	157773	165918	rs587783211	NC_000001.11:197086965:G:A
NM_001035.3(RYR2):c.12602A>G (p.Gln4201Arg)	RYR2	Q4201R	Catecholaminergic polymorphic ventricular tachycardia|Catecholaminergic polymorphic ventricular tachycardia type 1	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000012962	1	237947614	1	237784314	12962	28001	rs121918605	NC_000001.11:237784313:A:G
NM_206933.3(USH2A):c.187C>T (p.Arg63Ter)	USH2A	R63*	not provided|Retinal dystrophy|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556744	1	216595492	1	216422150	556744	541115	rs781223647	NC_000001.11:216422149:G:A
NM_206933.4(USH2A):c.1876C>T (p.Arg626Ter)	USH2A	R626*	not provided|Retinal dystrophy|Rare genetic deafness	Pathogenic(Last reviewed: Oct 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000497414	1	216462717	1	216289375	497414	488838	rs534534437	NC_000001.11:216289374:G:A
NM_206933.3(USH2A):c.486-14G>A	USH2A		Retinitis pigmentosa 39|Retinal dystrophy|Usher syndrome, type 2A|Retinitis pigmentosa 39|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372543	1	216592035	1	216418693	372543	359230	rs374536346	NC_000001.11:216418692:C:T
NM_206933.4(USH2A):c.8981G>A (p.Trp2994Ter)	USH2A	W2994*	Retinitis pigmentosa 39|Usher syndrome, type 2A|Rare genetic deafness|not provided|Retinal dystrophy|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048611	1	216019240	1	215845898	48611	57773	rs397518041	NC_000001.11:215845897:C:T
NM_001128425.1(MUTYH):c.389-1G>A	MUTYH		MYH-associated polyposis|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000186819	1	45798843	1	45333171	186819	181724	rs372267274	NC_000001.11:45333170:C:T
NM_170707.4(LMNA):c.745C>T (p.Arg249Trp)	LMNA	R249W, R137W, R168W	not provided|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Congenital muscular dystrophy, LMNA-related|Charcot-Marie-Tooth disease, type 2	Pathogenic/Likely pathogenic(Last reviewed: Apr 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014524	1	156104701	1	156134910	14524	29563	rs121912496	NC_000001.11:156134909:C:T
NM_001130987.2(DYSF):c.1717C>T (p.Arg573Trp)	DYSF	R555W, R573W, R541W, R556W, R587W, R542W, R572W, R586W	Autosomal recessive limb-girdle muscular dystrophy type 2B|DYSF-Related Disorders|not provided	Pathogenic(Last reviewed: Mar 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000094278	2	71778761	2	71551631	94278	100178	rs377735262	NC_000002.12:71551630:C:T
NM_006920.6(SCN1A):c.602+1G>A	SCN1A		not provided|Generalized epilepsy with febrile seizures plus, type 2|Severe myoclonic epilepsy in infancy|Familial hemiplegic migraine type 3|Global developmental delay|Seizures|Autistic disorder of childhood onset|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2	Pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000197187	2	166911147	2	166054637	197187	194348	rs794726827	NC_000002.12:166054636:C:T
NM_006920.6(SCN1A):c.2101C>T (p.Arg701Ter)	SCN1A	R701*, R712*, R683*, R700*, R684*	Early infantile epileptic encephalopathy|not provided|Generalized epilepsy with febrile seizures plus, type 2|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189886	2	166898844	2	166042334	189886	187817	rs794726730	NC_000002.12:166042333:G:A
NM_006920.6(SCN1A):c.677C>T (p.Thr226Met)	SCN1A	T226M	Severe myoclonic epilepsy in infancy|not provided|Familial hemiplegic migraine type 3|Generalized epilepsy with febrile seizures plus, type 2|Severe myoclonic epilepsy in infancy|Seizures|Global developmental delay|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000068578	2	166909379	2	166052869	68578	79470	rs121917984	NC_000002.12:166052868:G:A
NM_001035.3(RYR2):c.7159G>A (p.Ala2387Thr)	RYR2	A2387T	Catecholaminergic polymorphic ventricular tachycardia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000201276	1	237804240	1	237640940	201276	196632	rs794728753	NC_000001.11:237640939:G:A
NM_001035.3(RYR2):c.1259G>A (p.Arg420Gln)	RYR2	R420Q	Cardiovascular phenotype|Long QT syndrome|not provided	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000201215	1	237608789	1	237445489	201215	196541	rs794728721	NC_000001.11:237445488:G:A
NM_003000.2(SDHB):c.574T>C (p.Cys192Arg)	SDHB	C192R	Hereditary Paraganglioma-Pheochromocytoma Syndromes|not provided|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000186150	1	17350536	1	17024041	186150	181611	rs786202732	NC_000001.11:17024040:A:G
NM_003000.2(SDHB):c.541-2A>G	SDHB		Hereditary cancer-predisposing syndrome|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|SDHB-Related Disorders|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183925	1	17350571	1	17024076	183925	181613	rs786201161	NC_000001.11:17024075:T:C
NM_000251.3(MSH2):c.2382del (p.Pro795fs)	MSH2	P729fs, P795fs	Colon cancer	Pathogenic	no assertion criteria provided	VCV000637008	2	47705582	2	47478443	637008	624831		NC_000002.12:47478442:A:
NM_000251.2(MSH2):c.2267_2268insGTAG (p.Tyr757_Asp758insTer)	MSH2		Ovarian Neoplasms	Pathogenic(Last reviewed: Dec 1, 2018)	no assertion criteria provided	VCV000634745	2	47705467 - 47705468	2	47478328 - 47478329	634745	622524	rs1558521605	NC_000002.12:47478328::GTAG
NM_000251.2(MSH2):c.495T>G (p.Tyr165Ter)	MSH2	Y165*, Y99*	not provided	Pathogenic(Last reviewed: Aug 29, 2016)	criteria provided, single submitter	VCV000545986	2	47637361	2	47410222	545986	536245	rs63749949	NC_000002.12:47410221:T:G
NM_000251.2(MSH2):c.1566C>A (p.Tyr522Ter)	MSH2	Y522*, Y456*	not provided	Pathogenic(Last reviewed: Jul 26, 2016)	criteria provided, single submitter	VCV000545985	2	47693852	2	47466713	545985	536248	rs63750224	NC_000002.12:47466712:C:A
NM_000251.2(MSH2):c.2079T>A (p.Cys693Ter)	MSH2	C693*, C627*	not provided	Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	VCV000545977	2	47703579	2	47476440	545977	536251	rs1553369089	NC_000002.12:47476439:T:A
NM_000251.2(MSH2):c.1144del (p.Arg382fs)	MSH2	R316fs, R382fs	not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000545850	2	47656948	2	47429809	545850	536246	rs1553356605	NC_000002.12:47429808:C:
NM_000251.2(MSH2):c.2045_2047delinsTT (p.Thr682fs)	MSH2		not provided	Pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, single submitter	VCV000545780	2	47703545 - 47703547	2	47476406 - 47476408	545780	536250	rs1553369034	NC_000002.12:47476405:CTG:TT
NM_000251.2(MSH2):c.1812_1819dup (p.Ser607fs)	MSH2		not provided	Pathogenic(Last reviewed: Feb 6, 2017)	criteria provided, single submitter	VCV000545764	2	47702215 - 47702216	2	47475076 - 47475077	545764	536249	rs1553368570	NC_000002.12:47475076:TGTTGTCA:TGTTGTCATGTTGTCA
NM_000251.2(MSH2):c.839del (p.Leu280fs)	MSH2	L280fs, L214fs	not provided	Pathogenic	no assertion criteria provided	VCV000492700	2	47641453	2	47414314	492700	485588	rs63750091	NC_000002.12:47414313:TT:T
NM_000251.2(MSH2):c.999T>G (p.Cys333Trp)	MSH2	C333W, C267W	not provided	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000450154	2	47643491	2	47416352	450154	443257	rs1553353167	NC_000002.12:47416351:T:G
NM_000251.2(MSH2):c.1176_1177del (p.Lys393fs)	MSH2	K327fs, K393fs	not provided	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, single submitter	VCV000449969	2	47656979 - 47656980	2	47429840 - 47429841	449969	443259	rs1553356643	NC_000002.12:47429839:AGA:A
NM_000251.2(MSH2):c.1307_1308dup (p.Val437fs)	MSH2		not specified	Pathogenic(Last reviewed: Oct 12, 2016)	criteria provided, single submitter	VCV000439909	2	47672713 - 47672714	2	47445574 - 47445575	439909	432990	rs1060502035	NC_000002.12:47445574:TTTTT:TTTTTTT
NM_001258281.1(MSH2):c.-31+55_-31+64del	MSH2	S13fs	not provided	Pathogenic(Last reviewed: Jul 6, 2016)	criteria provided, single submitter	VCV000421632	2	47630366 - 47630375	2	47403227 - 47403236	421632	405745	rs1064795264	NC_000002.12:47403226:GAGCGCGGCCGAG:GAG
NM_000251.2(MSH2):c.1666_1672del (p.Leu556_Thr557insTer)	MSH2		not provided	Pathogenic(Last reviewed: Aug 25, 2015)	criteria provided, single submitter	VCV000419730	2	47698108 - 47698114	2	47470969 - 47470975	419730	405796	rs1064794071	NC_000002.12:47470968:TTGACTT:
NM_000251.2(MSH2):c.1465G>T (p.Glu489Ter)	MSH2	E489*, E423*	not provided	Pathogenic(Last reviewed: Jul 5, 2015)	criteria provided, single submitter	VCV000419345	2	47690248	2	47463109	419345	405789	rs876658187	NC_000002.12:47463108:G:T
NM_000251.2(MSH2):c.1158_1167del (p.Asn388fs)	MSH2	N388fs, N322fs	not provided	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000372411	2	47656960 - 47656969	2	47429821 - 47429830	372411	359392	rs1057517762	NC_000002.12:47429820:GATCTTAACCGA:GA
NM_000251.2(MSH2):c.2629del (p.Arg877fs)	MSH2	R811fs, R877fs	not provided	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000280399	2	47708003	2	47480864	280399	264118	rs886041613	NC_000002.12:47480863:AAA:AA
NM_000251.2(MSH2):c.1867del (p.Ala623fs)	MSH2	A557fs, A623fs	not provided	Pathogenic(Last reviewed: Jan 25, 2016)	criteria provided, single submitter	VCV000246322	2	47702271	2	47475132	246322	244388	rs879254204	NC_000002.12:47475131:G:
NM_000251.2(MSH2):c.294T>A (p.Tyr98Ter)	MSH2	Y98*, Y32*	not provided	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000246229	2	47635622	2	47408483	246229	244369	rs763872353	NC_000002.12:47408482:T:A
NM_000251.2(MSH2):c.352_358del (p.Tyr118fs)	MSH2	Y118fs, Y52fs	not provided	Pathogenic(Last reviewed: Sep 28, 2015)	criteria provided, single submitter	VCV000245970	2	47635676 - 47635682	2	47408537 - 47408543	245970	244371	rs879254025	NC_000002.12:47408536:TTGGTATTTGG:TTGG
NM_000251.2(MSH2):c.1394dup (p.Asn465fs)	MSH2		not provided	Pathogenic	no assertion criteria provided	VCV000218036	2	47690173 - 47690174	2	47463034 - 47463035	218036	214585	rs863225390	NC_000002.12:47463034:AAAA:AAAAA
NM_000251.2(MSH2):c.1277-?_1386+?dup	MSH2		not provided	Pathogenic	no assertion criteria provided	VCV000218033					218033	214574		
NM_000251.2(MSH2):c.1916_1919del (p.His639fs)	MSH2	H639fs, H573fs	not provided	Pathogenic(Last reviewed: Sep 8, 2014)	criteria provided, single submitter	VCV000182593	2	47702318 - 47702321	2	47475179 - 47475182	182593	180018	rs730881776	NC_000002.12:47475178:GCATGC:GC
NM_000251.2(MSH2):c.1157dup (p.Asp386fs)	MSH2		not provided	Pathogenic(Last reviewed: Jun 24, 2014)	criteria provided, single submitter	VCV000182591	2	47656960 - 47656961	2	47429821 - 47429822	182591	180006	rs730881774	NC_000002.12:47429821:A:AA
NM_000251.2(MSH2):c.1525A>T (p.Lys509Ter)	MSH2	K509*, K443*	not provided	Pathogenic(Last reviewed: Oct 1, 2014)	criteria provided, single submitter	VCV000182562	2	47693811	2	47466672	182562	180013	rs730881758	NC_000002.12:47466671:A:T
NM_000251.2(MSH2):c.1744del (p.Val582fs)	MSH2	V582fs, V516fs	not provided	Pathogenic(Last reviewed: Dec 31, 2013)	criteria provided, single submitter	VCV000127635	2	47698186	2	47471047	127635	133092	rs587779964	NC_000002.12:47471046:G:
NM_000251.3(MSH2):c.955_959del (p.Asp319fs)	MSH2	D253fs, D319fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV000860226	2	47643447 - 47643451	2	47416308 - 47416312	860226	826574		NC_000002.12:47416307:GATAC:
NM_000251.3(MSH2):c.2156dup (p.Leu719fs)	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000859819	2	47703654 - 47703655	2	47476515 - 47476516	859819	826616		NC_000002.12:47476515:TT:TTT
NM_000251.3(MSH2):c.958_959del (p.Thr320fs)	MSH2	T320fs, T254fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000852960	2	47643450 - 47643451	2	47416311 - 47416312	852960	826575		NC_000002.12:47416310:AC:
NM_000251.3(MSH2):c.1704del (p.Glu569fs)	MSH2	E569fs, E503fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: May 23, 2019)	criteria provided, single submitter	VCV000847505	2	47698146	2	47471007	847505	826601		NC_000002.12:47471006:A:
NM_000251.3(MSH2):c.463del (p.Val155fs)	MSH2	V155fs, V89fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000847146	2	47637329	2	47410190	847146	826561		NC_000002.12:47410189:G:
NM_000251.3(MSH2):c.1927del (p.Glu643fs)	MSH2	E643fs, E577fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000845713	2	47702331	2	47475192	845713	826607		NC_000002.12:47475191:G:
NM_000251.3(MSH2):c.1929dup (p.Val644fs)	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000844976	2	47702331 - 47702332	2	47475192 - 47475193	844976	826608		NC_000002.12:47475192:AA:AAA
NM_000251.3(MSH2):c.867del (p.Phe289fs)	MSH2	F223fs, F289fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000840984	2	47641480	2	47414341	840984	826570		NC_000002.12:47414340:TTT:TT
NM_000251.3(MSH2):c.173_174delinsAA (p.Phe58Ter)	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 26, 2019)	criteria provided, single submitter	VCV000839057	2	47630503 - 47630504	2	47403364 - 47403365	839057	826552		NC_000002.12:47403363:TC:AA
NC_000002.12:g.(?_47425835)_(47471072_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: May 19, 2019)	criteria provided, single submitter	VCV000833452	2	47652974 - 47698211			833452	819220		
NC_000002.12:g.(?_47463021)_(47471072_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 27, 2019)	criteria provided, single submitter	VCV000831677	2	47690160 - 47698211			831677	819230		
NM_000251.3(MSH2):c.721del (p.Leu241fs)	MSH2	L175fs, L241fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000826916	2	47639627	2	47412488	826916	806981		NC_000002.12:47412487:CC:C
NM_000251.3(MSH2):c.714T>G (p.Tyr238Ter)	MSH2	Y172*, Y238*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000826866	2	47639621	2	47412482	826866	806979		NC_000002.12:47412481:T:G
NM_000251.3(MSH2):c.643_644del (p.Gln215fs)	MSH2	Q149fs, Q215fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000826399	2	47637508 - 47637509	2	47410369 - 47410370	826399	806976		NC_000002.12:47410368:ACA:A
NM_000251.3(MSH2):c.636dup (p.Leu213fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000826356	2	47637499 - 47637500	2	47410360 - 47410361	826356	806975		NC_000002.12:47410360:AAA:AAAA
NM_000251.3(MSH2):c.466del (p.Asp156fs)	MSH2	D90fs, D156fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV000825085	2	47637332	2	47410193	825085	806965		NC_000002.12:47410192:G:
NM_000251.3(MSH2):c.98del (p.Thr33fs)	MSH2	T33fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 3, 2019)	criteria provided, single submitter	VCV000823546	2	47630428	2	47403289	823546	806940		NC_000002.12:47403288:C:
NM_000251.3(MSH2):c.887_891delinsACTTTTTCAGTATATGACTACTTTTGACTACTTTTT (p.Phe296_Ser297delinsTyrPhePheSerIleTer)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000822788	2	47641502 - 47641506	2	47414363 - 47414367	822788	806989		NC_000002.12:47414362:TCAGC:ACTTTTTCAGTATATGACTACTTTTGACTACTTTTT
NM_000251.3(MSH2):c.874_875del (p.Thr292fs)	MSH2	T226fs, T292fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000822699	2	47641489 - 47641490	2	47414350 - 47414351	822699	806988		NC_000002.12:47414349:AC:
NM_000251.3(MSH2):c.2584G>T (p.Gly862Ter)	MSH2	G796*, G862*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000821523	2	47707960	2	47480821	821523	807086		NC_000002.12:47480820:G:T
NM_000251.3(MSH2):c.2533A>T (p.Lys845Ter)	MSH2	K779*, K845*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000821408	2	47707909	2	47480770	821408	807084		NC_000002.12:47480769:A:T
NM_000251.3(MSH2):c.2220_2223dup (p.Asp742fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000820916	2	47705419 - 47705420	2	47478280 - 47478281	820916	807060		NC_000002.12:47478280:CAAA:CAAACAAA
NM_000251.3(MSH2):c.19G>T (p.Glu7Ter)	MSH2	E7*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000820493	2	47630349	2	47403210	820493	806933		NC_000002.12:47403209:G:T
NM_000251.3(MSH2):c.1968_1969delinsAC (p.Tyr656_Phe657delinsTer)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000820426	2	47702372 - 47702373	2	47475233 - 47475234	820426	807043		NC_000002.12:47475232:CT:AC
NM_000251.3(MSH2):c.1921del (p.Cys641fs)	MSH2	C641fs, C575fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 24, 2018)	criteria provided, single submitter	VCV000820343	2	47702324	2	47475185	820343	807040		NC_000002.12:47475184:TT:T
NM_000251.3(MSH2):c.1897_1898AT[1] (p.Leu634fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 22, 2018)	criteria provided, single submitter	VCV000820261	2	47702300 - 47702301	2	47475161 - 47475162	820261	807039		NC_000002.12:47475160:TATAT:TAT
NM_000251.3(MSH2):c.1850_1851dup (p.Pro618fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000820181	2	47702253 - 47702254	2	47475114 - 47475115	820181	807033		NC_000002.12:47475114:TT:TTTT
NM_000251.3(MSH2):c.1854_1857del (p.Val620fs)	MSH2	V554fs, V620fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 9, 2019)	criteria provided, single submitter	VCV000820161	2	47702258 - 47702261	2	47475119 - 47475122	820161	807036		NC_000002.12:47475118:ATAT:
NM_000251.3(MSH2):c.1792_1796del (p.Val598fs)	MSH2	V598fs, V532fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000820088	2	47702195 - 47702199	2	47475056 - 47475060	820088	807028		NC_000002.12:47475055:TGTGTT:T
NM_000251.3(MSH2):c.1728dup (p.Ile577fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000819922	2	47698168 - 47698169	2	47471029 - 47471030	819922	807027		NC_000002.12:47471029:CC:CCC
NM_000251.3(MSH2):c.1618del (p.Ser540fs)	MSH2	S474fs, S540fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 29, 2018)	criteria provided, single submitter	VCV000819674	2	47693904	2	47466765	819674	807021		NC_000002.12:47466764:A:
NM_000251.3(MSH2):c.1534A>T (p.Lys512Ter)	MSH2	K446*, K512*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000819483	2	47693820	2	47466681	819483	807014		NC_000002.12:47466680:A:T
NM_000251.3(MSH2):c.1486_1487dup (p.Leu496fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000819343	2	47690268 - 47690269	2	47463129 - 47463130	819343	807010		NC_000002.12:47463129:TT:TTTT
NM_000251.3(MSH2):c.1415dup (p.Ser473fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000819157	2	47690196 - 47690197	2	47463057 - 47463058	819157	807007		NC_000002.12:47463057:CC:CCC
NM_000251.3(MSH2):c.1401dup (p.Phe468fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000819093	2	47690182 - 47690183	2	47463043 - 47463044	819093	807006		NC_000002.12:47463043:AA:AAA
NM_000251.3(MSH2):c.1316del (p.Pro439fs)	MSH2	P439fs, P373fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000818889	2	47672725	2	47445586	818889	807002		NC_000002.12:47445585:CC:C
NM_000251.2(MSH2):c.1939G>T (p.Glu647Ter)	MSH2	E581*, E647*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000664359	2	47702343	2	47475204	664359	630154		NC_000002.12:47475203:G:T
NM_000251.3(MSH2):c.1770del (p.Glu590fs)	MSH2	E590fs, E524fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000663530	2	47702173	2	47475034	663530	630141		NC_000002.12:47475033:AA:A
NM_000251.2(MSH2):c.2307C>G (p.Tyr769Ter)	MSH2	Y703*, Y769*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000662590	2	47705507	2	47478368	662590	630173		NC_000002.12:47478367:C:G
NM_000251.3(MSH2):c.1959del (p.Asn653fs)	MSH2	N653fs, N587fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000660405	2	47702363	2	47475224	660405	630155		NC_000002.12:47475223:T:
NM_000251.3(MSH2):c.2179del (p.Ala727fs)	MSH2	A727fs, A661fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000660012	2	47703678	2	47476539	660012	630168		NC_000002.12:47476538:GG:G
NM_000251.3(MSH2):c.2010dup (p.Asn671fs)	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000654057	2	47703506 - 47703507	2	47476367 - 47476368	654057	630158		NC_000002.12:47476367:CCCC:CCCCC
NM_000251.3(MSH2):c.191del (p.Ile64fs)	MSH2	I64fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000652472	2	47630521	2	47403382	652472	630082		NC_000002.12:47403381:T:
NM_000251.3(MSH2):c.2060del (p.Leu687fs)	MSH2	L621fs, L687fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000650765	2	47703560	2	47476421	650765	630160		NC_000002.12:47476420:T:
NM_000251.3(MSH2):c.2474del (p.Ser825fs)	MSH2	S759fs, S825fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000650316	2	47707850	2	47480711	650316	630181		NC_000002.12:47480710:G:
NM_000251.3(MSH2):c.1151dup (p.Asp386fs)	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000650315	2	47656953 - 47656954	2	47429814 - 47429815	650315	630118		NC_000002.12:47429814:TT:TTT
NM_000251.3(MSH2):c.2003del (p.Thr668fs)	MSH2	T602fs, T668fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000650202	2	47702407	2	47475268	650202	630157		NC_000002.12:47475267:C:
NC_000002.11:g.(?_47637223)_(47657090_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000643150	2	47637223 - 47657090	2	47410084 - 47429951	643150	650792		
NM_000251.2(MSH2):c.1273G>T (p.Glu425Ter)	MSH2	E425*, E359*	not provided	Pathogenic(Last reviewed: Oct 11, 2017)	criteria provided, single submitter	VCV000619690	2	47657077	2	47429938	619690	611019	rs1064795063	NC_000002.12:47429937:G:T
NM_000251.2(MSH2):c.1958_1965del (p.Asn653fs)	MSH2	N653fs, N587fs	Glioblastoma	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000590849	2	47702360 - 47702367	2	47475221 - 47475228	590849	581781	rs1558518449	NC_000002.12:47475220:TAATGACGTA:TA
NC_000002.11:g.(?_47705401)_(47708020_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000583456	2	47705401 - 47708020	2	47478262 - 47480881	583456	558659		
NM_000251.2(MSH2):c.437_438GT[3] (p.Val148fs)	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000579730	2	47637302 - 47637303	2	47410163 - 47410164	579730	560665	rs1558459096	NC_000002.12:47410163:GTGT:GTGTGT
NM_000251.2(MSH2):c.2034T>A (p.Tyr678Ter)	MSH2	Y678*, Y612*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000579638	2	47703534	2	47476395	579638	558516	rs1558519611	NC_000002.12:47476394:T:A
NM_000251.2(MSH2):c.1201_1204del (p.Leu401fs)	MSH2	L401fs, L335fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000577983	2	47657003 - 47657006	2	47429864 - 47429867	577983	561621	rs1558478567	NC_000002.12:47429863:ACTTAC:AC
NM_001258281.1(MSH2):c.1067_1071delinsGAAAAG (p.Glu356fs)	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000576490	2	47657069 - 47657073	2	47429930 - 47429934	576490	560683	rs63751667	NC_000002.12:47429929:AAAAA:GAAAAG
NM_000251.2(MSH2):c.643del (p.Gln215fs)	MSH2	Q215fs, Q149fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000575233	2	47637509	2	47410370	575233	561592	rs1558459882	NC_000002.12:47410369:C:
NM_000251.2(MSH2):c.655dup (p.Arg219fs)	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000574635	2	47639559 - 47639560	2	47412420 - 47412421	574635	558498	rs1558461615	NC_000002.12:47412420:AAA:AAAA
NM_000251.2(MSH2):c.1396del (p.His466fs)	MSH2	H466fs, H400fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000574231	2	47690178	2	47463039	574231	558149	rs1558508067	NC_000002.12:47463038:CC:C
NM_000251.2(MSH2):c.2369del (p.Leu790fs)	MSH2	L724fs, L790fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Feb 4, 2018)	criteria provided, single submitter	VCV000572242	2	47705568	2	47478429	572242	558526	rs1558521949	NC_000002.12:47478428:TT:T
NM_000251.2(MSH2):c.1111G>T (p.Glu371Ter)	MSH2	E371*, E305*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000566113	2	47656915	2	47429776	566113	560677	rs1060501994	NC_000002.12:47429775:G:T
NM_000251.2(MSH2):c.979del (p.Ala327fs)	MSH2	A261fs, A327fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000565926	2	47643470	2	47416331	565926	558504	rs1558466434	NC_000002.12:47416330:GG:G
NM_000251.2(MSH2):c.1491_1492insTT (p.Ser498fs)	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000565456	2	47690274 - 47690275	2	47463135 - 47463136	565456	558153	rs1558508343	NC_000002.12:47463135::TT
NM_000251.2(MSH2):c.475del (p.Arg159fs)	MSH2	R159fs, R93fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, single submitter	VCV000525842	2	47637341	2	47410202	525842	518401	rs1553350758	NC_000002.12:47410201:A:
NM_000251.2(MSH2):c.217A>T (p.Lys73Ter)	MSH2	K73*, K7*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000525834	2	47635545	2	47408406	525834	518395	rs770110491	NC_000002.12:47408405:A:T
NM_000251.2(MSH2):c.367-525_493del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000525792	2	47636707 - 47637358	2	47409568 - 47410219	525792	518399	rs1553350466	
NM_000251.2(MSH2):c.934del (p.Leu312fs)	MSH2	L312fs, L246fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000525780	2	47641548	2	47414409	525780	518294	rs267607937	NC_000002.12:47414408:CC:C
NM_000251.2(MSH2):c.1139T>G (p.Leu380Ter)	MSH2	L380*, L314*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000525748	2	47656943	2	47429804	525748	518337	rs730881755	NC_000002.12:47429803:T:G
NM_000251.2(MSH2):c.1339_1340del (p.Phe447fs)	MSH2	F381fs, F447fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000525597	2	47672749 - 47672750	2	47445610 - 47445611	525597	518309	rs1553361231	NC_000002.12:47445609:TT:
NM_000251.2(MSH2):c.2013del (p.Asn671fs)	MSH2	N605fs, N671fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	VCV000486887	2	47703513	2	47476374	486887	472859	rs1553368988	NC_000002.12:47476373:T:
NM_000251.2(MSH2):c.1784dup (p.Asn596fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000486886	2	47702187 - 47702188	2	47475048 - 47475049	486886	472933	rs1553368518	NC_000002.12:47475048:T:TT
NM_000251.2(MSH2):c.1942_1945del (p.Ile648fs)	MSH2	I648fs, I582fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 2, 2016)	criteria provided, single submitter	VCV000486875	2	47702346 - 47702349	2	47475207 - 47475210	486875	472856	rs1553368675	NC_000002.12:47475206:ATTG:
NM_000251.2(MSH2):c.2551_2552insCA (p.Leu851fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000486872	2	47707927 - 47707928	2	47480788 - 47480789	486872	472993	rs1553370381	NC_000002.12:47480788::CA
NM_000251.2(MSH2):c.1350del (p.Gln451fs)	MSH2	Q385fs, Q451fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 21, 2017)	criteria provided, single submitter	VCV000485844	2	47672758	2	47445619	485844	472885	rs1553361261	NC_000002.12:47445618:TTT:TT
NM_000251.2(MSH2):c.1208del (p.Asp403fs)	MSH2	D403fs, D337fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 29, 2016)	criteria provided, single submitter	VCV000483695	2	47657012	2	47429873	483695	472778	rs1553356678	NC_000002.12:47429872:A:
NM_000251.2(MSH2):c.2593dup (p.Ile865fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 15, 2016)	criteria provided, single submitter	VCV000483692	2	47707968 - 47707969	2	47480829 - 47480830	483692	472908	rs1553370443	NC_000002.12:47480829:A:AA
NM_000251.2(MSH2):c.1794_1803del (p.Val598_Leu599insTer)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 19, 2016)	criteria provided, single submitter	VCV000480906	2	47702198 - 47702207	2	47475059 - 47475068	480906	472836	rs1553368540	NC_000002.12:47475058:GTTAGCTCAG:
NM_000251.2(MSH2):c.443del (p.Val148fs)	MSH2	V82fs, V148fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000480905	2	47637309	2	47410170	480905	472867	rs1553350721	NC_000002.12:47410169:T:
NM_000251.2(MSH2):c.729dup (p.Leu244fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 17, 2017)	criteria provided, single submitter	VCV000479852	2	47639634 - 47639635	2	47412495 - 47412496	479852	472793	rs1553351651	NC_000002.12:47412495:GG:GGG
NM_000251.2(MSH2):c.2246_2250del (p.Glu749fs)	MSH2	E683fs, E749fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 10, 2017)	criteria provided, single submitter	VCV000479849	2	47705444 - 47705448	2	47478305 - 47478309	479849	472864	rs1553369665	NC_000002.12:47478304:TGAATTG:TG
NM_000251.2(MSH2):c.1579dup (p.Cys527fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000479833	2	47693864 - 47693865	2	47466725 - 47466726	479833	472821	rs1553366583	NC_000002.12:47466725:T:TT
NM_000251.2(MSH2):c.939del (p.Gln314fs)	MSH2	Q314fs, Q248fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, single submitter	VCV000455625	2	47641550	2	47414411	455625	451305	rs796532309	NC_000002.12:47414410:TTTTT:TTTT
NM_000251.2(MSH2):c.2563C>T (p.Gln855Ter)	MSH2	Q855*, Q789*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000455569	2	47707939	2	47480800	455569	451191	rs1553370404	NC_000002.12:47480799:C:T
NM_000251.2(MSH2):c.2532dup (p.Lys845Ter)	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 16, 2017)	criteria provided, single submitter	VCV000455568	2	47707907 - 47707908	2	47480768 - 47480769	455568	451119	rs1553370371	NC_000002.12:47480768:T:TT
NM_000251.2(MSH2):c.2116del (p.Asp706fs)	MSH2	D640fs, D706fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000455545	2	47703615	2	47476476	455545	451385	rs1553369131	NC_000002.12:47476475:GG:G
NM_000251.2(MSH2):c.2085dup (p.Pro696fs)	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000455541	2	47703584 - 47703585	2	47476445 - 47476446	455541	451359	rs1553369100	NC_000002.12:47476445:G:GG
NM_000251.2(MSH2):c.206del (p.Pro69fs)	MSH2	P3fs, P69fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000455539	2	47630535	2	47403396	455539	451255	rs1553348904	NC_000002.12:47403395:CC:C
NM_000251.2(MSH2):c.193_194insTC (p.Lys65fs)	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000455534	2	47630523 - 47630524	2	47403384 - 47403385	455534	450972	rs1553348898	NC_000002.12:47403384::TC
NM_001258281.1(MSH2):c.-30-16dup	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	VCV000455505	2	47630482 - 47630483	2	47403343 - 47403344	455505	451252	rs1553348842	NC_000002.12:47403343:G:GG
NM_000251.2(MSH2):c.1478del (p.Gln493fs)	MSH2	Q427fs, Q493fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000455495	2	47690261	2	47463122	455495	451130	rs1553365799	NC_000002.12:47463121:A:
NM_001258281.1(MSH2):c.-30-54del	MSH2	R39fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000455473	2	47630444	2	47403305	455473	450949	rs1553348794	NC_000002.12:47403304:CC:C
NM_000251.2(MSH2):c.1007dup (p.Gln337fs)	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000455468	2	47643495 - 47643496	2	47416356 - 47416357	455468	451307	rs587779064	NC_000002.12:47416356:CCCC:CCCCC
Single allele	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000455064			2	47478266 - 47482955	455064	448579		
NC_000002.11:g.(?_47702158)_(47708016_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000455062	2	47702158 - 47708016	2	47475019 - 47480877	455062	448654		
Single allele	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, single submitter	VCV000455060			2	47470959 - 47482955	455060	448649		
Single allele	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, single submitter	VCV000455047			2	47410088 - 47412566	455047	448526		
NC_000002.11:g.(?_47630325)_(47637517_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, single submitter	VCV000455041	2	47630325 - 47637517	2	47403186 - 47410378	455041	448400		
NM_000251.2(MSH2):c.1747_1748del (p.Asn583fs)	MSH2	N517fs, N583fs	not provided	Pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000439187	2	47698189 - 47698190	2	47471050 - 47471051	439187	432517	rs1553367687	NC_000002.12:47471049:AA:
NM_000251.2(MSH2):c.1576dup (p.Thr526fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	VCV000428565	2	47693860 - 47693861	2	47466721 - 47466722	428565	419366	rs63750094	NC_000002.12:47466721:AA:AAA
NM_000251.2(MSH2):c.646-1G>C	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, single submitter	VCV000428564	2	47639552	2	47412413	428564	419333	rs1114167888	NC_000002.12:47412412:G:C
NM_000251.2(MSH2):c.656_664delGAGGAGGAAins13 (p.?)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 30, 2010)	criteria provided, single submitter	VCV000428562	2	47639563 - 47639571	2	47412424 - 47412432	428562	419334		
NM_000251.2(MSH2):c.563del (p.Glu188fs)	MSH2	E122fs, E188fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 28, 2012)	criteria provided, single submitter	VCV000428561	2	47637429	2	47410290	428561	419326	rs1114167885	NC_000002.12:47410289:A:
NM_000251.2(MSH2):c.465_466delinsA (p.Asp156fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000428560	2	47637331 - 47637332	2	47410192 - 47410193	428560	419320	rs1114167884	NC_000002.12:47410191:TG:A
NM_000251.2(MSH2):c.1924_1928delinsTTTC (p.Val642fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 12, 2012)	criteria provided, single submitter	VCV000428558	2	47702328 - 47702332	2	47475189 - 47475193	428558	419386	rs1114167882	NC_000002.12:47475188:GTTGA:TTTC
NM_000251.2(MSH2):c.2668A>T (p.Lys890Ter)	MSH2	K890*, K824*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 21, 2016)	criteria provided, single submitter	VCV000428555	2	47709951	2	47482812	428555	419426	rs1114167880	NC_000002.12:47482811:A:T
NM_000251.2(MSH2):c.1834del (p.Ser612fs)	MSH2	S546fs, S612fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 16, 2016)	criteria provided, single submitter	VCV000428554	2	47702238	2	47475099	428554	419378	rs1114167879	NC_000002.12:47475098:T:
NM_000251.2(MSH2):c.1809dup (p.Ala604fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 5, 2016)	criteria provided, single submitter	VCV000428548	2	47702212 - 47702213	2	47475073 - 47475074	428548	419377	rs1114167876	NC_000002.12:47475073:T:TT
NM_000251.2(MSH2):c.309del (p.Val102_Tyr103insTer)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 22, 2015)	criteria provided, single submitter	VCV000428544	2	47635637	2	47408498	428544	419313	rs1114167874	NC_000002.12:47408497:T:
NM_000251.2(MSH2):c.535_536del (p.Phe178_Pro179insTer)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 24, 2015)	criteria provided, single submitter	VCV000428543	2	47637400 - 47637401	2	47410261 - 47410262	428543	419324	rs1114167812	NC_000002.12:47410260:CCC:C
NM_000251.2(MSH2):c.2333_2334delinsT (p.Cys778fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 4, 2015)	criteria provided, single submitter	VCV000428541	2	47705533 - 47705534	2	47478394 - 47478395	428541	419407	rs1114167872	NC_000002.12:47478393:GC:T
NM_000251.2(MSH2):c.1068del (p.Ile356fs)	MSH2	I290fs, I356fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 8, 2015)	criteria provided, single submitter	VCV000428535	2	47643560	2	47416421	428535	419351	rs1114167867	NC_000002.12:47416420:A:
NM_000251.2(MSH2):c.1888G>T (p.Gly630Ter)	MSH2	G630*, G564*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 23, 2016)	criteria provided, single submitter	VCV000428534	2	47702292	2	47475153	428534	419384	rs1114167866	NC_000002.12:47475152:G:T
NM_000251.2(MSH2):c.2128del (p.Ala710fs)	MSH2	A710fs, A644fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000428532	2	47703628	2	47476489	428532	419398	rs1114167864	NC_000002.12:47476488:G:
NM_000251.2(MSH2):c.217_227del (p.Lys73fs)	MSH2	K73fs, K7fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 8, 2015)	criteria provided, single submitter	VCV000428530	2	47635542 - 47635552	2	47408403 - 47408413	428530	419310	rs1114167863	NC_000002.12:47408402:GCAAAGAATCTGCA:GCA
NM_000251.2(MSH2):c.2314del (p.Thr772fs)	MSH2	T772fs, T706fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000428529	2	47705513	2	47478374	428529	419406	rs1114167862	NC_000002.12:47478373:AA:A
NM_000251.2(MSH2):c.850dup (p.Ser284fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 6, 2014)	criteria provided, single submitter	VCV000428525	2	47641463 - 47641464	2	47414324 - 47414325	428525	419341	rs1114167860	NC_000002.12:47414324:TT:TTT
NM_000251.2(MSH2):c.1075_1076dup (p.Leu360Aspfs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000428523	2	47643567 - 47643568	2	47416424 - 47416425	428523	419352	rs1114167858	
NM_000251.2(MSH2):c.1843_1844del (p.Ala615fs)	MSH2	A549fs, A615fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 25, 2014)	criteria provided, single submitter	VCV000428521	2	47702247 - 47702248	2	47475108 - 47475109	428521	419381	rs1114167856	NC_000002.12:47475107:GC:
NM_000251.2(MSH2):c.565_566dup (p.Leu191fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 8, 2014)	criteria provided, single submitter	VCV000428520	2	47637430 - 47637431	2	47410291 - 47410292	428520	419327	rs1114167855	NC_000002.12:47410291:GC:GCGC
NM_000251.2(MSH2):c.1533del (p.Lys512fs)	MSH2	K446fs, K512fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 16, 2014)	criteria provided, single submitter	VCV000428518	2	47693818	2	47466679	428518	419365	rs1114167853	NC_000002.12:47466678:TT:T
NM_000251.2(MSH2):c.1354_1355insT (p.Glu452fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 20, 2014)	criteria provided, single submitter	VCV000428514	2	47672764 - 47672765	2	47445625 - 47445626	428514	419359	rs1114167850	NC_000002.12:47445625::T
NM_000251.2(MSH2):c.1950dup (p.Ile651fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2013)	criteria provided, single submitter	VCV000428506	2	47702351 - 47702352	2	47475212 - 47475213	428506	419389	rs1114167844	NC_000002.12:47475212:TTT:TTTT
NM_000251.2(MSH2):c.602T>A (p.Leu201Ter)	MSH2	L201*, L135*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 13, 2013)	criteria provided, single submitter	VCV000428501	2	47637468	2	47410329	428501	419329	rs1114167839	NC_000002.12:47410328:T:A
NM_000251.2(MSH2):c.2413dup (p.Leu805fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 12, 2013)	criteria provided, single submitter	VCV000428499	2	47705612 - 47705613	2	47478473 - 47478474	428499	419415	rs1114167837	NC_000002.12:47478473:C:CC
NM_000251.2(MSH2):c.2562del (p.Gln855fs)	MSH2	Q789fs, Q855fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 21, 2017)	criteria provided, single submitter	VCV000428495	2	47707936	2	47480797	428495	419421	rs1114167836	NC_000002.12:47480796:TTT:TT
NM_000251.2(MSH2):c.1247_1257dup (p.Ala420fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, single submitter	VCV000428491	2	47657050 - 47657051	2	47429911 - 47429912	428491	419355	rs1553356720	NC_000002.12:47429911:ATGTTATACAG:ATGTTATACAGATGTTATACAG
NM_000251.2(MSH2):c.2381_2385dup (p.Thr796fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 27, 2016)	criteria provided, single submitter	VCV000428488	2	47705579 - 47705580	2	47478440 - 47478441	428488	419412	rs1114167832	NC_000002.12:47478440:ATACCA:ATACCATACCA
NM_000251.2(MSH2):c.1252dup (p.Ile418fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000428486	2	47657055 - 47657056	2	47429916 - 47429917	428486	419356	rs1114167830	NC_000002.12:47429916:A:AA
NM_000251.2(MSH2):c.365delinsCGG (p.Lys122fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 20, 2011)	criteria provided, single submitter	VCV000428484	2	47635693	2	47408554	428484	419315	rs1114167829	NC_000002.12:47408553:A:CGG
NM_000251.2(MSH2):c.1394del (p.Asn465fs)	MSH2	N465fs, N399fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 18, 2014)	criteria provided, single submitter	VCV000428482	2	47690174	2	47463035	428482	419361	rs863225390	NC_000002.12:47463034:AAAA:AAA
NM_000251.2(MSH2):c.2393_2396del (p.Asn798fs)	MSH2	N732fs, N798fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 9, 2016)	criteria provided, single submitter	VCV000428481	2	47705592 - 47705595	2	47478453 - 47478456	428481	419413	rs1114167826	NC_000002.12:47478452:AATAA:A
NM_000251.2(MSH2):c.175A>T (p.Lys59Ter)	MSH2	K59*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 7, 2016)	criteria provided, single submitter	VCV000428480	2	47630505	2	47403366	428480	419307	rs771255106	NC_000002.12:47403365:A:T
NM_000251.2(MSH2):c.959_962del (p.Thr320fs)	MSH2	T254fs, T320fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 16, 2016)	criteria provided, single submitter	VCV000428479	2	47643451 - 47643454	2	47416312 - 47416315	428479	419346	rs1114167825	NC_000002.12:47416311:CCAC:
NM_000251.2(MSH2):c.2269dup (p.Tyr757fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000428478	2	47705468 - 47705469	2	47478329 - 47478330	428478	419403	rs1114167824	NC_000002.12:47478329:T:TT
NM_000251.2(MSH2):c.1930del (p.Val644fs)	MSH2	V644fs, V578fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 10, 2016)	criteria provided, single submitter	VCV000428476	2	47702334	2	47475195	428476	419387	rs1114167823	NC_000002.12:47475194:G:
NM_000251.2(MSH2):c.1587_1597delinsT (p.Glu529fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000428471	2	47693873 - 47693883	2	47466734 - 47466744	428471	419367	rs1114167820	NC_000002.12:47466733:AGAAAAAGTCC:T
NM_000251.2(MSH2):c.425C>A (p.Ser142Ter)	MSH2	S142*, S76*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 28, 2015)	criteria provided, single submitter	VCV000428470	2	47637291	2	47410152	428470	419318	rs63750910	NC_000002.12:47410151:C:A
NM_000251.2(MSH2):c.790dup (p.Gln264fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 17, 2014)	criteria provided, single submitter	VCV000428460	2	47639696 - 47639697	2	47412557 - 47412558	428460	419339	rs1114167814	NC_000002.12:47412557:C:CC
NM_000251.2(MSH2):c.536del (p.Pro179fs)	MSH2	P113fs, P179fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 16, 2013)	criteria provided, single submitter	VCV000428456	2	47637400	2	47410261	428456	419325	rs1114167812	NC_000002.12:47410260:CCC:CC
NM_000251.2(MSH2):c.1043del (p.Gln348fs)	MSH2	Q282fs, Q348fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000428453	2	47643535	2	47416396	428453	419350	rs1114167809	NC_000002.12:47416395:A:
NM_000251.2(MSH2):c.289del (p.Gln97fs)	MSH2	Q31fs, Q97fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	VCV000428451	2	47635617	2	47408478	428451	419312	rs1114167808	NC_000002.12:47408477:C:
NM_000251.2(MSH2):c.710_716del (p.Ile237fs)	MSH2	I171fs, I237fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 12, 2012)	criteria provided, single submitter	VCV000428449	2	47639615 - 47639621	2	47412476 - 47412482	428449	419338	rs1114167807	NC_000002.12:47412475:CATTTATCA:CA
NM_000251.2(MSH2):c.1453_1456ATGA[3] (p.Asp487delinsGluTer)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 10, 2012)	criteria provided, single submitter	VCV000428448	2	47690234 - 47690235	2	47463095 - 47463096	428448	419363	rs1114167806	NC_000002.12:47463095:AATGAATGA:AATGAATGAATGA
NM_000251.2(MSH2):c.1308dup (p.Val437fs)	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000408551	2	47672713 - 47672714	2	47445574 - 47445575	408551	392733	rs1060502035	NC_000002.12:47445574:TTTTT:TTTTTT
NM_000251.2(MSH2):c.2640_2656del (p.Glu881fs)	MSH2	E815fs, E881fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 21, 2017)	criteria provided, single submitter	VCV000408510	2	47709920 - 47709936	2	47482781 - 47482797	408510	392930	rs1064792951	NC_000002.12:47482780:AGGTGAAAAAATTATTCAGG:AGG
NM_000251.2(MSH2):c.731del (p.Leu244fs)	MSH2	L178fs, L244fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 10, 2015)	criteria provided, single submitter	VCV000233811	2	47639637	2	47412498	233811	232541	rs876660655	NC_000002.12:47412497:TT:T
NM_000251.2(MSH2):c.212-1_221delinsCAC	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 26, 2015)	criteria provided, single submitter	VCV000233629	2	47635539 - 47635549	2	47408400 - 47408410	233629	232518	rs876660533	NC_000002.12:47408399:GGAGCAAAGAA:CAC
NM_001258281.1(MSH2):c.-30-9del	MSH2	A54fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 26, 2015)	criteria provided, single submitter	VCV000233547	2	47630490	2	47403351	233547	232514	rs876660480	NC_000002.12:47403350:G:
NM_000251.2(MSH2):c.2004delinsCA (p.Gly669fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, single submitter	VCV000232739	2	47702408	2	47475269	232739	232614	rs876659961	NC_000002.12:47475268:T:CA
NM_000251.2(MSH2):c.1390G>T (p.Glu464Ter)	MSH2	E464*, E398*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 7, 2015)	criteria provided, single submitter	VCV000229827	2	47690173	2	47463034	229827	232582	rs876658223	NC_000002.12:47463033:G:T
NM_000251.2(MSH2):c.1803dup (p.Leu602fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 3, 2014)	criteria provided, single submitter	VCV000187400	2	47702206 - 47702207	2	47475067 - 47475068	187400	181962	rs786203704	NC_000002.12:47475067:G:GG
NM_000251.2(MSH2):c.913dup (p.Ala305fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 3, 2014)	criteria provided, single submitter	VCV000187273	2	47641527 - 47641528	2	47414388 - 47414389	187273	181926	rs786203604	NC_000002.12:47414388:G:GG
NM_000251.2(MSH2):c.830T>G (p.Leu277Ter)	MSH2	L277*, L211*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 2, 2014)	criteria provided, single submitter	VCV000187038	2	47641445	2	47414306	187038	181923	rs786203424	NC_000002.12:47414305:T:G
NM_000251.2(MSH2):c.1125_1126insAT (p.Leu376fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 25, 2014)	criteria provided, single submitter	VCV000186955	2	47656928 - 47656929	2	47429789 - 47429790	186955	181932	rs786203350	NC_000002.12:47429789:T:TAT
NM_000251.2(MSH2):c.1442T>G (p.Leu481Ter)	MSH2	L481*, L415*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 9, 2014)	criteria provided, single submitter	VCV000186554	2	47690225	2	47463086	186554	181945	rs786203036	NC_000002.12:47463085:T:G
NM_000251.2(MSH2):c.1793del (p.Val598fs)	MSH2	V598fs, V532fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000186224	2	47702197	2	47475058	186224	181961	rs786202790	NC_000002.12:47475057:T:
NM_000251.2(MSH2):c.251del (p.Asn84fs)	MSH2	N18fs, N84fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000185257	2	47635578	2	47408439	185257	181905	rs786202037	NC_000002.12:47408438:AA:A
NM_000251.2(MSH2):c.592G>T (p.Glu198Ter)	MSH2	E198*, E132*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000182584	2	47637458	2	47410319	182584	179995	rs587779166	NC_000002.12:47410318:G:T
NM_000251.2(MSH2):c.1210del (p.Cys404fs)	MSH2	C404fs, C338fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 16, 2014)	criteria provided, single submitter	VCV000142864	2	47657013	2	47429874	142864	152578	rs587782777	NC_000002.12:47429873:TT:T
NM_001258281.1(MSH2):c.-30-45_-30-42dup	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 8, 2013)	criteria provided, single submitter	VCV000142580	2	47630453 - 47630454	2	47403314 - 47403315	142580	152294	rs587782561	NC_000002.12:47403314:TTCT:TTCTTTCT
NM_000251.3(MSH2):c.1440dup (p.Leu481fs)	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000859379	2	47690221 - 47690222	2	47463082 - 47463083	859379	826590		NC_000002.12:47463082:AA:AAA
NM_000251.3(MSH2):c.1753del (p.Ser585fs)	MSH2	S519fs, S585fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000848811	2	47698193	2	47471054	848811	826604		NC_000002.12:47471053:TTT:TT
NM_000251.3(MSH2):c.2352del (p.His785fs)	MSH2	H719fs, H785fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000844726	2	47705549	2	47478410	844726	826620		NC_000002.12:47478409:TTTT:TTT
NM_000251.3(MSH2):c.968_971dup (p.Gln324fs)	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 20, 2019)	criteria provided, single submitter	VCV000838837	2	47643459 - 47643460	2	47416320 - 47416321	838837	826576		NC_000002.12:47416320:CTCA:CTCACTCA
NC_000002.12:g.(?_47403011)_(47414428_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV000833332	2	47630150 - 47641567			833332	819201		
NC_000002.12:g.(?_47475015)_(47480881_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000832898	2	47702154 - 47708020			832898	819236		
NC_000002.12:g.(?_47412404)_(47429951_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000832077	2	47639543 - 47657090			832077	819217		
NC_000002.12:g.(?_47478262)_(47482981_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV000831789	2	47705401 - 47710120			831789	819237		
NC_000002.12:g.(?_47466648)_(47466818_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000831305	2	47693787 - 47693957			831305	819233		
NM_000251.3(MSH2):c.2245G>T (p.Glu749Ter)	MSH2	E749*, E683*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000820955	2	47705445	2	47478306	820955	807063		NC_000002.12:47478305:G:T
NM_000251.3(MSH2):c.1673del (p.Ser558fs)	MSH2	S492fs, S558fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000819796	2	47698115	2	47470976	819796	807022		NC_000002.12:47470975:C:
NM_000251.3(MSH2):c.1935del (p.Asp646fs)	MSH2	D580fs, D646fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000658665	2	47702338	2	47475199	658665	630152		NC_000002.12:47475198:AA:A
NM_000251.3(MSH2):c.2481del (p.Ile828fs)	MSH2	I828fs, I762fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000656659	2	47707855	2	47480716	656659	630182		NC_000002.12:47480715:GGG:GG
NC_000002.11:g.(?_47635530)_(47639709_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 13, 2019)	criteria provided, single submitter	VCV000653518	2	47635530 - 47639709	2	47408391 - 47412570	653518	650854		
NM_000251.3(MSH2):c.679del (p.Arg227fs)	MSH2	R161fs, R227fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000649850	2	47639584	2	47412445	649850	630101		NC_000002.12:47412444:AAA:AA
NC_000002.11:g.(?_47702154)_(47710098_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000646957	2	47702154 - 47710098	2	47475015 - 47482959	646957	650799		
NM_000251.3(MSH2):c.882del (p.Phe294fs)	MSH2	F294fs, F228fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000629194	2	47641494	2	47414355	629194	616615	rs63751115	NC_000002.12:47414354:TTTT:TTT
NM_000251.2(MSH2):c.1648A>T (p.Lys550Ter)	MSH2	K550*, K484*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000628672	2	47693934	2	47466795	628672	616640	rs1558511191	NC_000002.12:47466794:A:T
NM_000251.2(MSH2):c.1071_1072dup (p.Glu358fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000628341	2	47643562 - 47643563	2	47416423 - 47416424	628341	616622	rs1558466769	NC_000002.12:47416423:GG:GGGG
NM_000251.2(MSH2):c.(1661+1_1662-1)_(*1_?)del	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000584579					584579	575636		
NC_000002.11:g.(?_47630321)_(47641567_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000584387	2	47630321 - 47641567	2	47403182 - 47414428	584387	559142		
NC_000002.11:g.(?_47705401)_(47710098_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000583660	2	47705401 - 47710098	2	47478262 - 47482959	583660	557450		
NC_000002.11:g.(?_47635534)_(47641563_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000525999	2	47635534 - 47641563	2	47408395 - 47414424	525999	516231		
NM_000251.2(MSH2):c.2557G>T (p.Glu853Ter)	MSH2	E853*, E787*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000525849	2	47707933	2	47480794	525849	518381	rs1553370397	NC_000002.12:47480793:G:T
NM_000251.2(MSH2):c.1413del (p.Lys471fs)	MSH2	K471fs, K405fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000525760	2	47690193	2	47463054	525760	518351	rs1553365719	NC_000002.12:47463053:AAAA:AAA
NM_000251.2(MSH2):c.1373del (p.Thr457_Leu458insTer)	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000525710	2	47672781	2	47445642	525710	518425	rs1553361289	NC_000002.12:47445641:TTT:TT
NM_001258281.1(MSH2):c.94_95TA[1] (p.Tyr32_Arg33delinsTer)	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000525647	2	47635620 - 47635621	2	47408481 - 47408482	525647	518281	rs1553350167	NC_000002.12:47408480:TATA:TA
NM_000251.2(MSH2):c.858del (p.Phe286fs)	MSH2	F220fs, F286fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 29, 2016)	criteria provided, single submitter	VCV000491844	2	47641471	2	47414332	491844	483310	rs1553352474	NC_000002.12:47414331:TTT:TT
NM_000251.2(MSH2):c.454dup (p.Met152fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, single submitter	VCV000491828	2	47637316 - 47637317	2	47410177 - 47410178	491828	483300	rs63751449	NC_000002.12:47410177:AAAA:AAAAA
NM_000251.2(MSH2):c.1225C>T (p.Gln409Ter)	MSH2	Q409*, Q343*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 14, 2016)	criteria provided, single submitter	VCV000491756	2	47657029	2	47429890	491756	483364	rs151244108	NC_000002.12:47429889:C:T
NM_000251.2(MSH2):c.1143del (p.Arg382fs)	MSH2	R316fs, R382fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 24, 2016)	criteria provided, single submitter	VCV000491749	2	47656946	2	47429807	491749	483353	rs1553356594	NC_000002.12:47429806:TT:T
NM_000251.2(MSH2):c.2421_2422delinsCT (p.Glu808Ter)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, single submitter	VCV000479848	2	47705621 - 47705622	2	47478482 - 47478483	479848	472879	rs1553369812	NC_000002.12:47478481:TG:CT
NM_000251.2(MSH2):c.2635-1G>A	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000428556	2	47709917	2	47482778	428556	419424	rs267608020	NC_000002.12:47482777:G:A
NM_000251.2(MSH2):c.646-4_655del	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000428516	2	47639543 - 47639556	2	47412404 - 47412417	428516	419332	rs1114167851	NC_000002.12:47412403:TTCAAAATAGATAATTCAAA:TTCAAA
NM_000251.2(MSH2):c.870_874del (p.Glu290fs)	MSH2	E290fs, E224fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 23, 2019)	criteria provided, single submitter	VCV000428511	2	47641482 - 47641486	2	47414343 - 47414347	428511	419342	rs1114167848	NC_000002.12:47414342:TGAACTGA:TGA
NM_000251.2(MSH2):c.942+2T>A	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 27, 2016)	criteria provided, single submitter	VCV000428474	2	47641559	2	47414420	428474	419345	rs587779195	NC_000002.12:47414419:T:A
NM_000251.2(MSH2):c.633del (p.Lys212fs)	MSH2	K146fs, K212fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, single submitter	VCV000428472	2	47637496	2	47410357	428472	419331	rs1114167821	NC_000002.12:47410356:GGGG:GGG
NM_000251.2(MSH2):c.989dup (p.Asn331fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 6, 2016)	criteria provided, single submitter	VCV000428458	2	47643480 - 47643481	2	47416341 - 47416342	428458	419348	rs1114167813	NC_000002.12:47416341:T:TT
NM_000251.2(MSH2):c.806_807insTGTACCGCAGATT (p.Leu270fs)	MSH2		not provided	Pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419425	2	47641421 - 47641422	2	47414282 - 47414283	419425	405770	rs1064793863	NC_000002.12:47414282::TGTACCGCAGATT
NM_000251.2(MSH2):c.1782dup (p.Leu595fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000231072	2	47702185 - 47702186	2	47475046 - 47475047	231072	232599	rs876658940	NC_000002.12:47475046:A:AA
NM_000251.2(MSH2):c.1697del (p.Asn566fs)	MSH2	N500fs, N566fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 31, 2015)	criteria provided, single submitter	VCV000141147	2	47698135	2	47470996	141147	150861	rs63750737	NC_000002.12:47470995:AAAAA:AAAA
NC_000002.12:g.(?_47463021)_(47475280_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: May 31, 2019)	criteria provided, single submitter	VCV000832022	2	47690160 - 47702419			832022	819231		
NC_000002.12:g.(?_47429732)_(47445667_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000831396	2	47656871 - 47672806			831396	819222		
NC_000002.12:g.(?_47470955)_(47482981_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Aug 18, 2019)	criteria provided, single submitter	VCV000830658	2	47698094 - 47710120			830658	819234		
NM_000251.3(MSH2):c.942+1G>A	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000823244	2	47641558	2	47414419	823244	815236		NC_000002.12:47414418:G:A
NM_000251.2(MSH2):c.812_813del (p.Ser271fs)	MSH2	S271fs, S205fs	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000651451	2	47641426 - 47641427	2	47414287 - 47414288	651451	630106		NC_000002.12:47414286:TCT:T
NC_000002.11:g.(?_47643425)_(47643578_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 7, 2019)	criteria provided, single submitter	VCV000644266	2	47643425 - 47643578	2	47416286 - 47416439	644266	650795		
NC_000002.11:g.(?_47639543)_(47643578_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000639368	2	47639543 - 47643578	2	47412404 - 47416439	639368	650771		
NC_000002.11:g.(?_47705401)_(47705668_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, single submitter	VCV000583953	2	47705401 - 47705668	2	47478262 - 47478529	583953	558657		
NM_000251.2(MSH2):c.1229del (p.Gly410fs)	MSH2	G344fs, G410fs	Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000545842	2	47657031	2	47429892	545842	536247	rs1553356700	NC_000002.12:47429891:GGG:GG
NC_000002.11:g.(?_47690164)_(47702415_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000525986	2	47690164 - 47702415	2	47463025 - 47475276	525986	516204		
NM_000251.3(MSH2):c.1387-10=	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Aug 21, 2017)	criteria provided, single submitter	VCV000525690	2	47690160 - 47690179	2	47463021 - 47463040	525690	518310		NC_000002.12:47463020:CTGTTTGCAGGTGGAAAACC:CTGTTTGCAGGTGGAAAACC
NM_000251.2(MSH2):c.1681G>T (p.Glu561Ter)	MSH2	E561*, E495*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, single submitter	VCV000486879	2	47698123	2	47470984	486879	472835	rs63750328	NC_000002.12:47470983:G:T
Single allele	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: May 9, 2018)	criteria provided, single submitter	VCV000455063			2	47478266 - 47478525	455063	448536		
Single allele	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000455053			2	47429736 - 47445663	455053	448575		
NM_000251.2(MSH2):c.2520_2521delinsT (p.Val840_Ile841insTer)	MSH2		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000428469	2	47707896 - 47707897	2	47480757 - 47480758	428469	419420	rs587779147	NC_000002.12:47480756:AA:T
NM_000251.2(MSH2):c.1933C>T (p.Gln645Ter)	MSH2	Q645*, Q579*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000428446	2	47702337	2	47475198	428446	419388	rs267607982	NC_000002.12:47475197:C:T
NM_000251.2(MSH2):c.1570del (p.Arg524fs)	MSH2	R458fs, R524fs	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jan 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000422243	2	47693856	2	47466717	422243	405793	rs1064795653	NC_000002.12:47466716:C:
NM_000251.2(MSH2):c.876dup (p.Thr293fs)	MSH2		not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000421500	2	47641490 - 47641491	2	47414351 - 47414352	421500	405773	rs1553352505	NC_000002.12:47414351:T:TT
NM_000251.2(MSH2):c.1883del (p.Gly628fs)	MSH2	G628fs, G562fs	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Nov 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000421423	2	47702286	2	47475147	421423	405806	rs1064795127	NC_000002.12:47475146:GG:G
NM_000251.2(MSH2):c.1796del (p.Val598_Leu599insTer)	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000408559	2	47702199	2	47475060	408559	392775	rs1060502039	NC_000002.12:47475059:TT:T
NM_000251.2(MSH2):c.2027C>G (p.Ser676Ter)	MSH2	S676*, S610*	Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: May 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000379791	2	47703527	2	47476388	379791	367439	rs1057520735	NC_000002.12:47476387:C:G
NM_000251.2(MSH2):c.2295_2296insTA (p.Ile766Ter)	MSH2		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 31, 2015)	criteria provided, single submitter	VCV000218043	2	47705495 - 47705496	2	47478356 - 47478357	218043	214592	rs863225393	NC_000002.12:47478356::TA
NM_000251.2(MSH2):c.2236dup (p.Ile746fs)	MSH2		Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000218042	2	47705434 - 47705435	2	47478295 - 47478296	218042	214591	rs863225392	NC_000002.12:47478295:AA:AAA
NM_000251.2(MSH2):c.1481C>G (p.Ser494Ter)	MSH2	S494*, S428*	not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000218037	2	47690264	2	47463125	218037	214586	rs370970617	NC_000002.12:47463124:C:G
NM_001258281.1(MSH2):c.488_489del (p.Lys163fs)	MSH2	K163fs, K229fs	Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000127650	2	47639588 - 47639589	2	47412449 - 47412450	127650	133107	rs63749897	NC_000002.12:47412448:AAAAAAA:AAAAA
NM_000251.3(MSH2):c.2629A>T (p.Arg877Ter)	MSH2	R811*, R877*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000858125	2	47708005	2	47480866	858125	826628		NC_000002.12:47480865:A:T
NC_000002.12:g.(?_47442337)_(47445667_?)dup	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 6, 2019)	criteria provided, single submitter	VCV000832736	2	47669476 - 47672806			832736	819225		
NM_000251.2(MSH2):c.198C>A (p.Tyr66Ter)	MSH2	Y66*	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000645593	2	47630528	2	47403389	645593	630084		NC_000002.12:47403388:C:A
NM_000251.2(MSH2):c.380dup (p.Asn127fs)	MSH2		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000619869	2	47637244 - 47637245	2	47410105 - 47410106	619869	611016	rs1558458884	NC_000002.12:47410105:AA:AAA
NM_001258281.1(MSH2):c.-31+27_-31+28delinsC	MSH2		Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000569035	2	47630341 - 47630342	2	47403202 - 47403203	569035	561555	rs1558451119	NC_000002.12:47403201:AG:C
NM_000251.2(MSH2):c.192dup (p.Lys65fs)	MSH2		Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000486874	2	47630521 - 47630522	2	47403382 - 47403383	486874	472849	rs1553348896	NC_000002.12:47403382:C:CC
NM_000251.2(MSH2):c.1042del (p.Gln348fs)	MSH2	Q282fs, Q348fs	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000483705	2	47643534	2	47416395	483705	472845	rs1553353233	NC_000002.12:47416394:C:
NM_000251.2(MSH2):c.2585dup (p.Tyr863fs)	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000455576	2	47707959 - 47707960	2	47480820 - 47480821	455576	451133	rs1553370431	NC_000002.12:47480820:GG:GGG
NM_001258281.1(MSH2):c.763_808del (p.Thr255fs)	MSH2	T255fs, T321fs	not provided|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000439197	2	47643451 - 47643496	2	47416312 - 47416357	439197	432514	rs1553353114	NC_000002.12:47416311:CCACTGGCTCTCAGTCTCTGGCTGCCTTGCTGAATAAGTGTAAAACCC:CC
NM_000251.2(MSH2):c.525_532del (p.Cys176fs)	MSH2	C110fs, C176fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428549	2	47637390 - 47637397	2	47410251 - 47410258	428549	419323	rs1114167877	NC_000002.12:47410250:TGTGTGAAT:T
NM_000251.2(MSH2):c.1757C>G (p.Ser586Ter)	MSH2	S586*, S520*	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000428519	2	47698199	2	47471060	428519	419374	rs1114167854	NC_000002.12:47471059:C:G
NM_000251.2(MSH2):c.1042C>T (p.Gln348Ter)	MSH2	Q348*, Q282*	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000428496	2	47643534	2	47416395	428496	419349	rs979212552	NC_000002.12:47416394:C:T
NM_000251.2(MSH2):c.1649_1650del (p.Lys550fs)	MSH2	K550fs, K484fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428492	2	47693934 - 47693935	2	47466795 - 47466796	428492	419368	rs1114167835	NC_000002.12:47466794:AAA:A
NM_000251.2(MSH2):c.680_683delGAAA	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000428475	2	47639582 - 47639585	2	47412443 - 47412446	428475	419335	rs587782537	NC_000002.12:47412442:AGAAAGAAA:AGAAA
NM_000251.2(MSH2):c.1684G>T (p.Glu562Ter)	MSH2	E562*, E496*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428466	2	47698126	2	47470987	428466	419372	rs1114167816	NC_000002.12:47470986:G:T
NM_000251.2(MSH2):c.420dup (p.Met141fs)	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000428454	2	47637285 - 47637286	2	47410146 - 47410147	428454	419317	rs1114167810	NC_000002.12:47410146:T:TT
NM_000251.2(MSH2):c.1968del (p.Phe657fs)	MSH2	F591fs, F657fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428447	2	47702372	2	47475233	428447	419390	rs1114167805	NC_000002.12:47475232:C:
NM_000251.2(MSH2):c.871del (p.Glu290_Leu291insTer)	MSH2		not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000420949	2	47641486	2	47414347	420949	405772	rs1064794809	NC_000002.12:47414346:C:
NM_000251.2(MSH2):c.2459-2A>G	MSH2		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419555	2	47707833	2	47480694	419555	405816	rs267608011	NC_000002.12:47480693:A:G
NM_000251.2(MSH2):c.897T>G (p.Tyr299Ter)	MSH2	Y299*, Y233*	Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000246110	2	47641512	2	47414373	246110	244379	rs879254104	NC_000002.12:47414372:T:G
NM_000251.2(MSH2):c.2634+2T>G	MSH2		not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000233647	2	47708012	2	47480873	233647	232645	rs876660546	NC_000002.12:47480872:T:G
NM_000251.2(MSH2):c.1462_1463del (p.Leu488fs)	MSH2	L488fs, L422fs	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000230906	2	47690245 - 47690246	2	47463106 - 47463107	230906	232586	rs876658834	NC_000002.12:47463105:TT:
NM_000251.2(MSH2):c.748G>T (p.Gly250Ter)	MSH2	G250*, G184*	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000219627	2	47639655	2	47412516	219627	221216	rs864622183	NC_000002.12:47412515:G:T
NM_018328.4(MBD5):c.973C>T (p.Arg325Ter)	MBD5	R325*	Inborn genetic diseases|Autism spectrum disorder	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000521004	2	149226485	2	148468916	521004	511323	rs1553518509	NC_000002.12:148468915:C:T
NM_000251.3(MSH2):c.321del (p.Gly108fs)	MSH2	G108fs, G42fs	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000801210	2	47635649	2	47408510	801210	789423		NC_000002.12:47408509:T:
NM_000251.2(MSH2):c.2626G>T (p.Glu876Ter)	MSH2	E876*, E810*	Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000644894	2	47708002	2	47480863	644894	630185		NC_000002.12:47480862:G:T
NC_000002.11:g.(?_47637223)_(47710098_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000642053	2	47637223 - 47710098	2	47410084 - 47482959	642053	650860		
NM_000251.2(MSH2):c.832G>T (p.Glu278Ter)	MSH2	E278*, E212*	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000641057	2	47641447	2	47414308	641057	630107		NC_000002.12:47414307:G:T
NM_000251.3(MSH2):c.1985dup (p.Met663fs)	MSH2		Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000640005	2	47702388 - 47702389	2	47475249 - 47475250	640005	630156		NC_000002.12:47475249:A:AA
NM_000251.2(MSH2):c.2523dup (p.Glu842fs)	MSH2		Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000525814	2	47707898 - 47707899	2	47480759 - 47480760	525814	518379	rs1553370366	NC_000002.12:47480759:A:AA
NM_001258281.1(MSH2):c.-17del	MSH2	Q61fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000455527	2	47630512	2	47403373	455527	450955	rs1553348882	NC_000002.12:47403372:A:
NM_000251.2(MSH2):c.1285del (p.Gln429fs)	MSH2	Q363fs, Q429fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428490	2	47672694	2	47445555	428490	419357	rs1114167833	NC_000002.12:47445554:CC:C
NM_000251.2(MSH2):c.1759G>T (p.Gly587Cys)	MSH2	G587C, G521C	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000428463	2	47698201	2	47471062	428463	419375	rs63751140	NC_000002.12:47471061:G:T
NM_000251.2(MSH2):c.830T>A (p.Leu277Ter)	MSH2	L277*, L211*	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000408494	2	47641445	2	47414306	408494	392848	rs786203424	NC_000002.12:47414305:T:A
NM_000251.2(MSH2):c.1344del (p.Lys449fs)	MSH2	K449fs, K383fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000231037	2	47672753	2	47445614	231037	232580	rs876658918	NC_000002.12:47445613:CC:C
NM_000251.2(MSH2):c.1237C>T (p.Gln413Ter)	MSH2	Q413*, Q347*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000218030	2	47657041	2	47429902	218030	214580	rs863225387	NC_000002.12:47429901:C:T
NM_000251.2(MSH2):c.942+2T>C	MSH2		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000142750	2	47641559	2	47414420	142750	152464	rs587779195	NC_000002.12:47414419:T:C
NM_000251.3(MSH2):c.2005+255_2089del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000844780	2	47702661 - 47703586	2	47475522 - 47476447	844780	851188		
NC_000002.12:g.(?_47445538)_(47482959_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 26, 2019)	criteria provided, single submitter	VCV000833191	2	47672677 - 47710098			833191	819228		
NC_000002.12:g.(?_47403011)_(47416439_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000832286	2	47630150 - 47643578			832286	819202		
NC_000002.12:g.(?_47403113)_(47416439_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000831625	2	47630252 - 47643578			831625	819205		
NC_000002.12:g.(?_47403182)_(47410382_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000831237	2	47630321 - 47637521			831237	819207		
NC_000002.12:g.(?_47403011)_(47403412_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000830589	2	47630150 - 47630551			830589	819199		
NC_000002.11:g.(?_47669476)_(47710098_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 8, 2019)	criteria provided, single submitter	VCV000664457	2	47669476 - 47710098	2	47442337 - 47482959	664457	650841		
NM_000251.2(MSH2):c.680_681del (p.Arg227fs)	MSH2	R227fs, R161fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000630493	2	47639586 - 47639587	2	47412447 - 47412448	630493	616612	rs1558461683	NC_000002.12:47412446:AGA:A
NC_000002.11:g.(?_47630321)_(47643578_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 23, 2019)	criteria provided, single submitter	VCV000583865	2	47630321 - 47643578	2	47403182 - 47416439	583865	559144		
NM_000251.2(MSH2):c.2588dup (p.Tyr863Ter)	MSH2		not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000546053	2	47707963 - 47707964	2	47480824 - 47480825	546053	536252	rs1553370435	NC_000002.12:47480824:A:AA
NM_000251.2(MSH2):c.1661G>A (p.Ser554Asn)	MSH2	S554N, S488N	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000483664	2	47693947	2	47466808	483664	472825	rs63750597	NC_000002.12:47466807:G:A
NM_000251.2(MSH2):c.628_629del (p.Met210fs)	MSH2	M144fs, M210fs	not provided|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000455603	2	47637494 - 47637495	2	47410355 - 47410356	455603	451296	rs1553350966	NC_000002.12:47410354:AT:
NM_000251.2(MSH2):c.940C>T (p.Gln314Ter)	MSH2	Q314*, Q248*	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428507	2	47641555	2	47414416	428507	419344	rs1114167845	NC_000002.12:47414415:C:T
NM_000251.2(MSH2):c.2459-6_2459-2del	MSH2		Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428503	2	47707829 - 47707833	2	47480690 - 47480694	428503	419417	rs1114167841	NC_000002.12:47480689:TTATA:
NM_000251.2(MSH2):c.2074G>A (p.Gly692Arg)	MSH2	G692R, G626R	Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428477	2	47703574	2	47476435	428477	419394	rs63750232	NC_000002.12:47476434:G:A
NM_000251.2(MSH2):c.1565_1568del (p.Tyr522fs)	MSH2	Y522fs, Y456fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000418979	2	47693849 - 47693852	2	47466710 - 47466713	418979	405791	rs1064793561	NC_000002.12:47466709:TTACTT:TT
NM_000251.2(MSH2):c.350G>A (p.Trp117Ter)	MSH2	W117*, W51*	Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000408504	2	47635678	2	47408539	408504	392724	rs786202083	NC_000002.12:47408538:G:A
NM_000251.2(MSH2):c.1563T>A (p.Tyr521Ter)	MSH2	Y521*, Y455*	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000220417	2	47693849	2	47466710	220417	221231	rs63750330	NC_000002.12:47466709:T:A
NM_000251.2(MSH2):c.842C>G (p.Ser281Ter)	MSH2	S281*, S215*	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000219909	2	47641457	2	47414318	219909	221219	rs63749991	NC_000002.12:47414317:C:G
NM_000251.2(MSH2):c.11dup (p.Pro5fs)	MSH2		not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000182592	2	47630340 - 47630341	2	47403201 - 47403202	182592	179979	rs730881775	NC_000002.12:47403201:A:AA
NM_000251.2(MSH2):c.70C>T (p.Gln24Ter)	MSH2	Q24*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jun 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000127652	2	47630400	2	47403261	127652	133109	rs587779976	NC_000002.12:47403260:C:T
NM_000251.2(MSH2):c.2006-5T>A	MSH2		Turcot syndrome	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000090849	2	47703501	2	47476362	90849	96324	rs267607990	NC_000002.12:47476361:T:A
NC_000002.12:g.(?_47403192)_(47408555_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000833349	2	47630331 - 47635694			833349	819209		
NC_000002.12:g.(?_47403113)_(47429951_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000832839	2	47630252 - 47657090			832839	819206		
NC_000002.11:g.(?_47630321)_(47657090_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000654663	2	47630321 - 47657090	2	47403182 - 47429951	654663	650838		
NC_000002.11:g.(?_47630321)_(47635704_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000584057	2	47630321 - 47635704	2	47403182 - 47408565	584057	557501		
Single allele	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000455043			2	47403186 - 47429947	455043	448415		
NM_000251.2(MSH2):c.2635-1G>C	MSH2		Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428547	2	47709917	2	47482778	428547	419425	rs267608020	NC_000002.12:47482777:G:C
NM_000251.2(MSH2):c.362del (p.Tyr121fs)	MSH2	Y121fs, Y55fs	Hereditary nonpolyposis colon cancer|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000428487	2	47635690	2	47408551	428487	419314	rs1114167831	NC_000002.12:47408550:A:
NM_000251.2(MSH2):c.792+1delG	MSH2		Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000419862	2	47639699	2	47412560	419862	405769	rs1064794155	NC_000002.12:47412559:GG:G
NM_000251.2(MSH2):c.790C>T (p.Gln264Ter)	MSH2	Q264*, Q198*	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000237408	2	47639697	2	47412558	237408	238823	rs878853824	NC_000002.12:47412557:C:T
NM_000251.2(MSH2):c.421_422delAT	MSH2		not provided|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000220510	2	47637285 - 47637286	2	47410146 - 47410147	220510	221205	rs1553350680	NC_000002.12:47410145:ATAT:AT
NM_000251.2(MSH2):c.2300C>G (p.Ser767Ter)	MSH2	S767*, S701*	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000218045	2	47705500	2	47478361	218045	214594	rs863225395	NC_000002.12:47478360:C:G
NC_000002.12:g.(?_47482769)_(47482981_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000833320	2	47709908 - 47710120			833320	819238		
NC_000002.12:g.(?_47412404)_(47482981_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 28, 2019)	criteria provided, single submitter	VCV000832977	2	47639543 - 47710120			832977	819218		
NC_000002.12:g.(?_47414259)_(47414428_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000832870	2	47641398 - 47641567			832870	819219		
NC_000002.12:g.(?_47403011)_(47482981_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 19, 2019)	criteria provided, single submitter	VCV000831693	2	47630150 - 47710120			831693	819204		
NC_000002.12:g.(?_47412404)_(47414428_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Aug 16, 2019)	criteria provided, single submitter	VCV000830910	2	47639543 - 47641567			830910	819216		
NC_000002.11:g.(?_47630321)_(47710098_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000656820	2	47630321 - 47710098	2	47403182 - 47482959	656820	650850		
NC_000002.11:g.(?_47709908)_(47710098_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000652971	2	47709908 - 47710098	2	47482769 - 47482959	652971	650807		
NM_000251.2(MSH2):c.2297del (p.Ile766fs)	MSH2	I766fs, I700fs	Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000218044	2	47705497	2	47478358	218044	214593	rs863225394	NC_000002.12:47478357:T:
NM_000251.2(MSH2):c.1351C>T (p.Gln451Ter)	MSH2	Q451*, Q385*	not provided|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000183761	2	47672761	2	47445622	183761	181940	rs786201066	NC_000002.12:47445621:C:T
NM_206933.3(USH2A):c.9571-2A>G	USH2A		Retinal dystrophy|Retinitis pigmentosa 39|Usher syndrome, type 2A|Retinitis pigmentosa|not provided	Pathogenic(Last reviewed: Oct 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000438033	1	215987248	1	215813906	438033	431592	rs751111524	NC_000001.11:215813905:T:C
NM_206933.3(USH2A):c.4222C>T (p.Gln1408Ter)	USH2A	Q1408*	Retinal dystrophy|not specified|not provided|Retinitis pigmentosa|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000438021	1	216369924	1	216196582	438021	431601	rs746551311	NC_000001.11:216196581:G:A
NM_206933.3(USH2A):c.100C>T (p.Arg34Ter)	USH2A	R34*	Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000438000	1	216595579	1	216422237	438000	431610	rs772808534	NC_000001.11:216422236:G:A
NM_001128425.1(MUTYH):c.453_458dup (p.Met153_Gln154insIleTrp)	MUTYH		MYH-associated polyposis|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233094	1	45798772 - 45798773	1	45333100 - 45333101	233094	232268	rs876660190	NC_000001.11:45333100:ATCCAT:ATCCATATCCAT
NM_001128425.1(MUTYH):c.391T>A (p.Trp131Arg)	MUTYH	W131R, W104R, W114R, W118R, W117R, W128R, W103R, W11R	MYH-associated polyposis|not provided|MUTYH-associated polyposis|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000182688	1	45798840	1	45333168	182688	179938	rs730881832	NC_000001.11:45333167:A:T
NM_000251.2(MSH2):c.645+2T>G	MSH2		Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000231167	2	47637513	2	47410374	231167	232536	rs876658996	NC_000002.12:47410373:T:G
NM_000251.2(MSH2):c.932del (p.Asn311fs)	MSH2	N245fs, N311fs	Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000127655	2	47641546	2	47414407	127655	133112	rs587779979	NC_000002.12:47414406:AA:A
NM_014874.3(MFN2):c.1090C>T (p.Arg364Trp)	MFN2	R364W	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease type 4|not provided|Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease, type 2A2A	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002278	1	12062090	1	12002033	2278	17317	rs119103265	NC_000001.11:12002032:C:T
NM_001130987.2(DYSF):c.6096dup (p.Glu2033fs)	DYSF		not provided|Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094351	2	71908162 - 71908163	2	71681032 - 71681033	94351	100251	rs398123799	NC_000002.12:71681032:A:AA
NM_170707.4(LMNA):c.1072G>A (p.Glu358Lys)	LMNA	E358K, E246K, E277K	Muscular dystrophy|not provided|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Congenital muscular dystrophy, LMNA-related|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014525	1	156105827	1	156136036	14525	29564	rs60458016	NC_000001.11:156136035:G:A
NM_006920.6(SCN1A):c.1837C>T (p.Arg613Ter)	SCN1A	R613*, R612*	Generalized epilepsy with febrile seizures plus, type 2|Familial hemiplegic migraine type 3|Severe myoclonic epilepsy in infancy|Early infantile epileptic encephalopathy|not provided|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000093635	2	166900385	2	166043875	93635	99539	rs398123585	NC_000002.12:166043874:G:A
NM_006920.6(SCN1A):c.1177C>T (p.Arg393Cys)	SCN1A	R393C	not provided|Severe myoclonic epilepsy in infancy|Early infantile epileptic encephalopathy|Seizures|Intellectual disability, mild	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068505	2	166903480	2	166046970	68505	79397	rs121917929	NC_000002.12:166046969:G:A
NC_000002.11:g.(?_47630321)_(47632584_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000642047	2	47630321 - 47632584	2	47403182 - 47405445	642047	650789		
NC_000002.11:g.(?_47630321)_(47630551_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jul 16, 2019)	criteria provided, single submitter	VCV000583862	2	47630321 - 47630551	2	47403182 - 47403412	583862	557499		
NC_000002.11:g.(?_47635534)_(47657086_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000525976	2	47635534 - 47657086	2	47408395 - 47429947	525976	516235		
NM_000251.2(MSH2):c.1023del (p.Val342fs)	MSH2	V342fs, V276fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000220006	2	47643514	2	47416375	220006	221222	rs864622340	NC_000002.12:47416374:TT:T
NM_003000.2(SDHB):c.591del (p.Ser198fs)	SDHB	S198fs	Gastrointestinal stromal tumor|Cowden syndrome|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000412462	1	17350519	1	17024024	412462	390893	rs1060503757	NC_000001.11:17024023:GGGG:GGG
NM_001276345.2(TNNT2):c.508_510GAG[3] (p.Glu173del)	TNNT2	E163del, E173del	Cardiovascular phenotype|not provided|Familial restrictive cardiomyopathy 3|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043648	1	201332505 - 201332507	1	201363377 - 201363379	43648	52817	rs397516470	NC_000001.11:201363376:CTCCTCCTCCTC:CTCCTCCTC
NM_000478.6(ALPL):c.571G>A (p.Glu191Lys)	ALPL	E174K, E191K, E114K, E136K	Adult hypophosphatasia|Infantile hypophosphatasia|Hypophosphatasia|Childhood hypophosphatasia|not provided|Adult hypophosphatasia|Infantile hypophosphatasia|Childhood hypophosphatasia	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013670	1	21890632	1	21564139	13670	28709	rs121918007	NC_000001.11:21564138:G:A
NM_003001.5(SDHC):c.43C>T (p.Arg15Ter)	SDHC	R15*	Hereditary cancer-predisposing syndrome|Paragangliomas 3|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Gastrointestinal stromal tumor|Paragangliomas 3|not provided	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000041776	1	161293426	1	161323636	41776	50215	rs201286421	NC_000001.11:161323635:C:T
NC_000002.12:g.(?_47463021)_(47482959_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 8, 2019)	criteria provided, single submitter	VCV000832300	2	47690160 - 47710098			832300	819232		
NM_000251.2(MSH2):c.1968C>A (p.Tyr656Ter)	MSH2	Y656*, Y590*	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419473	2	47702372	2	47475233	419473	405810	rs63751317	NC_000002.12:47475232:C:A
NM_001035.2(RYR2):c.(?_169)_(273_?)del (p.(?))	RYR2		Catecholaminergic polymorphic ventricular tachycardia	Pathogenic/Likely pathogenic(Last reviewed: Jan 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000228290	1	237494178 - 237494282	1	237330878 - 237330982	228290	228252		
NM_001035.3(RYR2):c.14876G>A (p.Arg4959Gln)	RYR2	R4959Q	Catecholaminergic polymorphic ventricular tachycardia type 1|not provided|Catecholaminergic polymorphic ventricular tachycardia	Pathogenic/Likely pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000201365	1	237995919	1	237832619	201365	196751	rs794728811	NC_000001.11:237832618:G:A
NM_001128425.1(MUTYH):c.1435G>T (p.Glu479Ter)	MUTYH	E479*, E359*, E452*, E451*, E462*, E466*, E476*, E336*, E465*	Hereditary cancer-predisposing syndrome|MUTYH-associated polyposis|not provided|MYH-associated polyposis	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000238337	1	45796895	1	45331223	238337	238314	rs376790729	NC_000001.11:45331222:C:A
NM_012222.2(MUTYH):c.1092dup (p.Arg365fs)	MUTYH		Hereditary cancer-predisposing syndrome|MYH-associated polyposis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000185770	1	45797417 - 45797418	1	45331745 - 45331746	185770	181673	rs768130289	NC_000001.11:45331745:GGGGGG:GGGGGGG
NM_006920.6(SCN1A):c.680T>G (p.Ile227Ser)	SCN1A	I227S	Severe myoclonic epilepsy in infancy|not provided|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: May 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000068579	2	166909376	2	166052866	68579	79471	rs121917937	NC_000002.12:166052865:A:C
NC_000002.12:g.(?_47410084)_(47414428_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000832094	2	47637223 - 47641567			832094	819215		
NM_014874.3(MFN2):c.310C>T (p.Arg104Trp)	MFN2	R104W	Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B|Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2|not provided|Charcot-Marie-Tooth disease, type 2A2A|Hereditary motor and sensory neuropathy with optic atrophy	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002281	1	12052746	1	11992689	2281	17320	rs119103268	NC_000001.11:11992688:C:T
NM_170707.4(LMNA):c.1583C>A (p.Thr528Lys)	LMNA	T528K, T416K, T447K	Hutchinson-Gilford syndrome|Charcot-Marie-Tooth disease, type 2|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066849	1	156106998	1	156137207	66849	77746	rs57629361	NC_000001.11:156137206:C:A
NM_170707.4(LMNA):c.961C>T (p.Arg321Ter)	LMNA	R321*, R240*, R209*	Primary dilated cardiomyopathy|Cardiovascular phenotype|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048096	1	156105716	1	156135925	48096	57260	rs267607554	NC_000001.11:156135924:C:T
NM_170707.4(LMNA):c.892C>T (p.Arg298Cys)	LMNA	R298C, R186C, R217C	Charcot-Marie-Tooth disease|not provided|Hutchinson-Gilford syndrome|Autosomal recessive axonal hereditary motor and sensory neuropathy|Charcot-Marie-Tooth disease type 2B1|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014498	1	156105059	1	156135268	14498	29537	rs59885338	NC_000001.11:156135267:C:T
NM_003000.2(SDHB):c.724C>T (p.Arg242Cys)	SDHB	R242C	Pheochromocytoma|Paragangliomas 4|Gastrointestinal stromal tumor|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000186827	1	17349144	1	17022649	186827	181605	rs786203251	NC_000001.11:17022648:G:A
NM_000251.2(MSH2):c.793-1G>A	MSH2		Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000218048	2	47641407	2	47414268	218048	214577	rs863225397	NC_000002.12:47414267:G:A
NM_000251.2(MSH2):c.997T>C (p.Cys333Arg)	MSH2	C333R, C267R	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000091272	2	47643489	2	47416350	91272	96747	rs63750468	NC_000002.12:47416349:T:C
NM_206933.3(USH2A):c.2167+5G>A	USH2A		Usher syndrome, type 2A|Retinitis pigmentosa 39|Retinal dystrophy|not provided|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552447	1	216424240	1	216250898	552447	541090	rs771583281	NC_000001.11:216250897:C:T
NM_206933.4(USH2A):c.1055C>T (p.Thr352Ile)	USH2A	T352I	Retinal dystrophy|Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome|not provided	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000438002	1	216498735	1	216325393	438002	431606	rs780308389	NC_000001.11:216325392:G:A
NM_206933.3(USH2A):c.7595-3C>G	USH2A		not provided|Usher syndrome|Retinal dystrophy|Usher syndrome, type 2A|Retinitis pigmentosa 39	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000197447	1	216062399	1	215889057	197447	194608	rs201657446	NC_000001.11:215889056:G:C
NM_001035.3(RYR2):c.1298T>C (p.Leu433Pro)	RYR2	L433P	Cardiovascular phenotype|Arrhythmogenic right ventricular dysplasia, familial, 2|Long QT syndrome|Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000012959	1	237617696	1	237454396	12959	27998	rs121918602	NC_000001.11:237454395:T:C
NM_001128425.1(MUTYH):c.504+19_504+31del	MUTYH		MYH-associated polyposis|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000406825	1	45798559 - 45798571	1	45332887 - 45332899	406825	391385	rs781222233	NC_000001.11:45332886:CCTATTTCCCCTACC:CC
NM_001048171.1(MUTYH):c.502C>T (p.Arg168Cys)	MUTYH	R182C, R168C, R179C, R62C, R39C, R155C, R165C, R169C, R154C	MYH-associated polyposis|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000187280	1	45798467	1	45332795	187280	181710	rs747993448	NC_000001.11:45332794:G:A
NM_001130987.2(DYSF):c.6241C>T (p.Arg2081Cys)	DYSF	R2042C, R2063C, R2081C, R2028C, R2029C, R2049C, R2059C, R2060C, R2073C, R2080C, R2064C, R2043C, R2050C, R2074C	Miyoshi muscular dystrophy 1|Qualitative or quantitative defects of dysferlin|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006668	2	71909727	2	71682597	6668	21707	rs121908955	NC_000002.12:71682596:C:T
NC_000002.12:g.(?_47410084)_(47412570_?)del	MSH2		Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000831722	2	47637223 - 47639709			831722	819214		
NM_170707.4(LMNA):c.1622G>A (p.Arg541His)	LMNA	R541H, R429H, R460H	Charcot-Marie-Tooth disease, type 2|Cardiovascular phenotype|Primary dilated cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066860	1	156107458	1	156137667	66860	77757	rs61444459	NC_000001.11:156137666:G:A
NM_170707.4(LMNA):c.585C>G (p.Asn195Lys)	LMNA	N195K, N114K, N83K	not provided|Primary dilated cardiomyopathy|Dilated cardiomyopathy 1A|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000014483	1	156104265	1	156134474	14483	29522	rs28933091	NC_000001.11:156134473:C:G
NM_000090.3(COL3A1):c.1744G>A (p.Gly582Ser)	COL3A1	G415S, G582S	Thoracic aortic aneurysm and aortic dissection|not provided|Ehlers-Danlos syndrome, type 4	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017225	2	189861205	2	188996479	17225	32264	rs121912923	NC_000002.12:188996478:G:A
NM_003000.2(SDHB):c.79C>T (p.Arg27Ter)	SDHB	R27*	Pheochromocytoma|Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|Hereditary cancer-predisposing syndrome|not provided|Paragangliomas 4|Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic(Last reviewed: Sep 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012783	1	17371377	1	17044882	12783	27822	rs74315369	NC_000001.11:17044881:G:A
NM_000228.3(LAMB3):c.1903C>T (p.Arg635Ter)	LAMB3	R635*	not provided|Junctional epidermolysis bullosa gravis of Herlitz|Amelogenesis imperfecta, type IA|Junctional epidermolysis bullosa gravis of Herlitz|Adult junctional epidermolysis bullosa||Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014539	1	209799066	1	209625721	14539	29578	rs80356682	NC_000001.11:209625720:G:A
NM_206933.3(USH2A):c.3187_3188del (p.Gln1063fs)	USH2A	Q1063fs	Retinal dystrophy|Usher syndrome, type 2A|Retinitis pigmentosa 39|not provided|Usher syndrome	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265288	1	216380743 - 216380744	1	216207401 - 216207402	265288	259652	rs886039450	NC_000001.11:216207400:TGT:T
NM_206933.4(USH2A):c.14803C>T (p.Arg4935Ter)	USH2A	R4935*	not provided|Retinal dystrophy|Retinitis pigmentosa 39|Usher syndrome, type 2A|Rare genetic deafness	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177760	1	215814065	1	215640723	177760	172511	rs146733615	NC_000001.11:215640722:G:A
NM_000251.2(MSH2):c.943-1G>T	MSH2		Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000408461	2	47643434	2	47416295	408461	392853	rs12476364	NC_000002.12:47416294:G:T
NM_000251.2(MSH2):c.989T>C (p.Leu330Pro)	MSH2	L330P, L264P	Lynch syndrome	Pathogenic(Last reviewed: Jun 21, 2019)	reviewed by expert panel	VCV000091270	2	47643481	2	47416342	91270	96745	rs63750630	NC_000002.12:47416341:T:C
NM_000251.2(MSH2):c.973dup (p.Ser325fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091266	2	47643464 - 47643465	2	47416325 - 47416326	91266	96741	rs63749945	NC_000002.12:47416325:T:TT
NM_000251.1(MSH2):c.972_973insNM_002133.2:c.737-1292_737-1109	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091265					91265	96740		
NM_000251.2(MSH2):c.970_971ins4	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091263	2	47643462 - 47643463	2	47416323 - 47416324	91263	96738		
NM_000251.2(MSH2):c.970_971del (p.Gln324fs)	MSH2	Q258fs, Q324fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091262	2	47643462 - 47643463	2	47416323 - 47416324	91262	96737	rs63751044	NC_000002.12:47416322:CA:
NM_000251.2(MSH2):c.958dup (p.Thr320fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091258	2	47643449 - 47643450	2	47416310 - 47416311	91258	96733	rs63749852	NC_000002.12:47416310:A:AA
NM_000251.2(MSH2):c.94_103del (p.Thr32fs)	MSH2	T32fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091257	2	47630423 - 47630432	2	47403284 - 47403293	91257	96732	rs63750728	NC_000002.12:47403283:CACCACAGTGC:C
NM_000251.1(MSH2):c.943-926_1077-1449del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091255	2	47642509 - 47655432	2	47415370 - 47428293	91255	96730		
NM_000251.2(MSH2):c.942G>A (p.Gln314=)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091251	2	47641557	2	47414418	91251	96726	rs587779197	NC_000002.12:47414417:G:A
NM_000251.2(MSH2):c.915_922dup (p.Arg308fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091244	2	47641529 - 47641530	2	47414390 - 47414391	91244	96719	rs63750046	NC_000002.12:47414390:AGCAGTCA:AGCAGTCAAGCAGTCA
NM_000251.2(MSH2):c.901A>T (p.Lys301Ter)	MSH2	K301*, K235*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091241	2	47641516	2	47414377	91241	96716	rs63749915	NC_000002.12:47414376:A:T
NM_000251.2(MSH2):c.888del (p.Phe296fs)	MSH2	F230fs, F296fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091238	2	47641503	2	47414364	91238	96713	rs587779192	NC_000002.12:47414363:C:
NM_000251.2(MSH2):c.881_882del (p.Thr293_Phe294insTer)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091237	2	47641494 - 47641495	2	47414355 - 47414356	91237	96712	rs63751115	NC_000002.12:47414354:TTTT:TT
NM_000251.2(MSH2):c.863del (p.Gln288fs)	MSH2	Q222fs, Q288fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091234	2	47641478	2	47414339	91234	96709	rs587779189	NC_000002.12:47414338:A:
NM_000251.2(MSH2):c.854del (p.Asn285fs)	MSH2	N285fs, N219fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091231	2	47641468	2	47414329	91231	96706	rs63750701	NC_000002.12:47414328:AA:A
NM_000251.2(MSH2):c.842C>A (p.Ser281Ter)	MSH2	S281*, S215*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091229	2	47641457	2	47414318	91229	96704	rs63749991	NC_000002.12:47414317:C:A
NM_000251.2(MSH2):c.839dup (p.Leu280fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091228	2	47641452 - 47641453	2	47414313 - 47414314	91228	96703	rs63750091	NC_000002.12:47414313:TT:TTT
NM_000251.2(MSH2):c.836del (p.Leu279fs)	MSH2	L213fs, L279fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091227	2	47641451	2	47414312	91227	96702	rs63751159	NC_000002.12:47414311:T:
NM_000251.2(MSH2):c.82del (p.Glu28fs)	MSH2	E28fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091226	2	47630411	2	47403272	91226	96701	rs587779188	NC_000002.12:47403271:GG:G
NM_000251.2(MSH2):c.810_811del (p.Ser271fs)	MSH2	S271fs, S205fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091221	2	47641424 - 47641425	2	47414285 - 47414286	91221	96696	rs63751133	NC_000002.12:47414284:TGT:T
NM_000251.2(MSH2):c.795del (p.Ala266fs)	MSH2	A200fs, A266fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091219	2	47641409	2	47414270	91219	96694	rs63749902	NC_000002.12:47414269:TT:T
NM_000251.2(MSH2):c.793-?_942+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091217					91217	96692		
NM_000251.2(MSH2):c.793-?_1386+?deldel594	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091216					91216	96691		
NM_000251.2(MSH2):c.793-?_1276+?del484	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091215					91215	96690		
NM_000251.2(MSH2):c.793-6_942+450del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091212	2	47641402 - 47642007	2	47414263 - 47414868	91212	96687	rs1553352366	
NM_000251.2(MSH2):c.792+10_943-448del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091207	2	47639707 - 47642985	2	47412568 - 47415846	91207	96682		
NM_000251.2(MSH2):c.788_789del (p.Asn263fs)	MSH2	N263fs, N197fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091204	2	47639695 - 47639696	2	47412556 - 47412557	91204	96679	rs63751614	NC_000002.12:47412555:AT:
NM_000251.2(MSH2):c.767_768dup (p.Val257fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091202	2	47639673 - 47639674	2	47412534 - 47412535	91202	96677	rs587779181	NC_000002.12:47412534:CT:CTCT
NM_000251.2(MSH2):c.763_766delinsTT (p.Ser255fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091201	2	47639670 - 47639673	2	47412531 - 47412534	91201	96676	rs63750329	NC_000002.12:47412530:AGTG:TT
NM_000251.2(MSH2):c.761del (p.Asn254fs)	MSH2	N254fs, N188fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091199	2	47639667	2	47412528	91199	96674	rs587779179	NC_000002.12:47412527:AA:A
NM_000251.2(MSH2):c.759del (p.Met253fs)	MSH2	M253fs, M187fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091198	2	47639666	2	47412527	91198	96673	rs63751160	NC_000002.12:47412526:G:
NM_000251.2(MSH2):c.759_762del (p.Met253fs)	MSH2	M187fs, M253fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091197	2	47639664 - 47639667	2	47412525 - 47412528	91197	96672	rs267607931	NC_000002.12:47412524:ATGAAT:AT
NM_000251.2(MSH2):c.73_74insC (p.Gly25fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091193	2	47630403 - 47630404	2	47403264 - 47403265	91193	96668	rs587779177	NC_000002.12:47403264::C
NM_000251.2(MSH2):c.736A>T (p.Lys246Ter)	MSH2	K246*, K180*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091192	2	47639643	2	47412504	91192	96667	rs63750881	NC_000002.12:47412503:A:T
NM_000251.2(MSH2):c.735dup (p.Lys246fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091190	2	47639641 - 47639642	2	47412502 - 47412503	91190	96665	rs63750107	NC_000002.12:47412502:G:GG
NM_000251.2(MSH2):c.725dup (p.Asn242fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091188	2	47639630 - 47639631	2	47412491 - 47412492	91188	96663	rs587779176	NC_000002.12:47412491:AA:AAA
NM_000251.2(MSH2):c.71dup (p.Met26fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091187	2	47630400 - 47630401	2	47403261 - 47403262	91187	96662	rs587779175	NC_000002.12:47403261:A:AA
NM_000251.2(MSH2):c.717_721delinsTTA (p.Gln239fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091186	2	47639624 - 47639628	2	47412485 - 47412489	91186	96661	rs63750690	NC_000002.12:47412484:GGACC:TTA
NM_000251.2(MSH2):c.711_714del (p.Tyr238fs)	MSH2	Y238fs, Y172fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091184	2	47639616 - 47639619	2	47412477 - 47412480	91184	96659	rs63751288	NC_000002.12:47412476:ATTTAT:AT
NM_000251.2(MSH2):c.696_697del (p.Ser233fs)	MSH2	S167fs, S233fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091180	2	47639601 - 47639602	2	47412462 - 47412463	91180	96655	rs63750426	NC_000002.12:47412461:TTTT:TT
NM_000251.2(MSH2):c.691del (p.Asp231fs)	MSH2	D165fs, D231fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091179	2	47639598	2	47412459	91179	96654	rs587779174	NC_000002.12:47412458:G:
NM_000251.2(MSH2):c.685A>T (p.Lys229Ter)	MSH2	K229*, K163*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091176	2	47639592	2	47412453	91176	96651	rs587779173	NC_000002.12:47412452:A:T
NM_000251.2(MSH2):c.675_679delinsTAAT (p.Glu226fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091175	2	47639582 - 47639586	2	47412443 - 47412447	91175	96650	rs587779172	NC_000002.12:47412442:AGAAA:TAAT
NM_000251.2(MSH2):c.646-?_942+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091170					91170	96645		
NM_000251.2(MSH2):c.646-?_792+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091169					91169	96644		
NM_000251.2(MSH2):c.646-?_1386+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091168					91168	96643		
NM_000251.2(MSH2):c.646-?_1276+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091167					91167	96642		
NM_000251.2(MSH2):c.646-?_1076+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091165					91165	96640		
NM_000251.2(MSH2):c.646-?_*(272_?)del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091164	2	47639553 - 47710360	2	47412414 - 47483221	91164	96639		
NM_000251.1(MSH2):c.645+967_1076+5075del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091160	2	47638478 - 47648643	2	47411339 - 47421504	91160	96635		
NM_000251.1(MSH2):c.645+791_1076+4894del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091159	2	47638302 - 47648462	2	47411163 - 47421323	91159	96634		
NM_000251.1(MSH2):c.645+539_1077-3451del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091158	2	47638050 - 47653430	2	47410911 - 47426291	91158	96633		
NM_000251.2(MSH2):c.642_645delACAG (p.Gln215Terfs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091153	2	47637508 - 47637511	2	47410367 - 47410370	91153	96628	rs63751695	
NM_000251.2(MSH2):c.616dup (p.Thr206fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091151	2	47637481 - 47637482	2	47410342 - 47410343	91151	96626	rs63750995	NC_000002.12:47410342:A:AA
NM_000251.2(MSH2):c.613G>T (p.Glu205Ter)	MSH2	E205*, E139*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091150	2	47637479	2	47410340	91150	96625	rs63749984	NC_000002.12:47410339:G:T
NM_000251.2(MSH2):c.595T>C (p.Cys199Arg)	MSH2	C199R, C133R	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091146	2	47637461	2	47410322	91146	96621	rs63751110	NC_000002.12:47410321:T:C
NM_000251.2(MSH2):c.592dup (p.Glu198fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091144	2	47637456 - 47637457	2	47410317 - 47410318	91144	96619	rs63750786	NC_000002.12:47410317:GG:GGG
NM_001258281.1(MSH2):c.363_371del (p.Glu122_Leu124del)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Oct 10, 2014)	reviewed by expert panel	VCV000091136	2	47637424 - 47637432	2	47410285 - 47410293	91136	96611	rs63750088	NC_000002.12:47410284:TCTTGAGGCTCT:TCT
NM_000251.2(MSH2):c.530_531del (p.Glu177fs)	MSH2	E111fs, E177fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091129	2	47637396 - 47637397	2	47410257 - 47410258	91129	96604	rs63750551	NC_000002.12:47410256:AA:
NM_000251.2(MSH2):c.529G>T (p.Glu177Ter)	MSH2	E177*, E111*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091128	2	47637395	2	47410256	91128	96603	rs63750382	NC_000002.12:47410255:G:T
NM_000251.2(MSH2):c.518del (p.Leu173fs)	MSH2	L173fs, L107fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091123	2	47637384	2	47410245	91123	96598	rs63750069	NC_000002.12:47410244:T:
NM_000251.3(MSH2):c.511_583dup (p.Gly195delinsGluGluThrArgThrValTer)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091118	2	47637375 - 47637376	2	47410236 - 47410237	91118	96593	rs1553350789	
NM_000251.2(MSH2):c.506_509del (p.Ile169fs)	MSH2	I103fs, I169fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091116	2	47637370 - 47637373	2	47410231 - 47410234	91116	96591	rs63751013	NC_000002.12:47410230:CATACA:CA
NM_000251.2(MSH2):c.472C>T (p.Gln158Ter)	MSH2	Q158*, Q92*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091102	2	47637338	2	47410199	91102	96577	rs63751226	NC_000002.12:47410198:C:T
NM_000251.2(MSH2):c.416del (p.Asn139fs)	MSH2	N139fs, N73fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091095	2	47637281	2	47410142	91095	96570	rs63750401	NC_000002.12:47410141:AA:A
NM_000251.2(MSH2):c.399del (p.Asp133fs)	MSH2	D133fs, D67fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091093	2	47637265	2	47410126	91093	96568	rs63751290	NC_000002.12:47410125:C:
NM_000251.2(MSH2):c.380_381del (p.Asn127fs)	MSH2	N61fs, N127fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091088	2	47637246 - 47637247	2	47410107 - 47410108	91088	96563	rs63751227	NC_000002.12:47410106:AT:
NM_000251.2(MSH2):c.368del (p.Ala123fs)	MSH2	A123fs, A57fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091086	2	47637234	2	47410095	91086	96561	rs63750210	NC_000002.12:47410094:C:
NM_000251.2(MSH2):c.367-?_942+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091085					91085	96560		
NM_000251.2(MSH2):c.367-?_1759+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091083					91083	96558		
NM_000251.2(MSH2):c.367-681_646-956del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091079	2	47636551 - 47638596	2	47409412 - 47411457	91079	96554		
NM_000251.2(MSH2):c.367-466_645+658del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091078	2	47636753 - 47638155	2	47409614 - 47411016	91078	96553		
NM_000251.2(MSH2):c.367-452_646-722del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091077	2	47636768 - 47638818	2	47409629 - 47411679	91077	96552		
NM_000251.2(MSH2):c.367-371_646-513del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091076	2	47636841 - 47639019	2	47409702 - 47411880	91076	96551		
NM_000251.2(MSH2):c.352dup (p.Tyr118fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091069	2	47635679 - 47635680	2	47408540 - 47408541	91069	96544	rs587779159	NC_000002.12:47408540:T:TT
NM_000251.2(MSH2):c.347_350del (p.Asp116fs)	MSH2	D50fs, D116fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091067	2	47635673 - 47635676	2	47408534 - 47408537	91067	96542	rs63750501	NC_000002.12:47408533:TGATTG:TG
NM_000251.2(MSH2):c.344del (p.Asn115fs)	MSH2	N115fs, N49fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091066	2	47635671	2	47408532	91066	96541	rs63751195	NC_000002.12:47408531:AA:A
NM_000251.2(MSH2):c.29dup (p.Leu11fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091058	2	47630358 - 47630359	2	47403219 - 47403220	91058	96533	rs63750589	NC_000002.12:47403219:A:AA
NM_000251.2(MSH2):c.278_279del (p.Leu93fs)	MSH2	L93fs, L27fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091046	2	47635606 - 47635607	2	47408467 - 47408468	91046	96521	rs63749872	NC_000002.12:47408466:TT:
NM_000251.2(MSH2):c.2635-?_*(272_?)del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091027	2	47709918 - 47710360	2	47482779 - 47483221	91027	96502		
NM_000251.2(MSH2):c.2622T>A (p.Tyr874Ter)	MSH2	Y874*, Y808*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091014	2	47707998	2	47480859	91014	96489	rs587779152	NC_000002.12:47480858:T:A
NM_000251.2(MSH2):c.2620_2621ins115 (p.?)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091013	2	47707996 - 47707997	2	47480857 - 47480858	91013	96488		
NM_000251.2(MSH2):c.2593_2597del (p.Ile865fs)	MSH2	I799fs, I865fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091009	2	47707967 - 47707971	2	47480828 - 47480832	91009	96484	rs587779151	NC_000002.12:47480827:ATATCAT:AT
NM_000251.2(MSH2):c.255dup (p.Glu86Ter)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091002	2	47635579 - 47635580	2	47408440 - 47408441	91002	96477	rs63751158	NC_000002.12:47408440:TTTT:TTTTT
NM_000251.2(MSH2):c.255_256del (p.Phe85fs)	MSH2	F19fs, F85fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091001	2	47635583 - 47635584	2	47408444 - 47408445	91001	96476	rs267607921	NC_000002.12:47408443:TG:
NM_000251.2(MSH2):c.2545del (p.Leu849fs)	MSH2	L783fs, L849fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090997	2	47707919	2	47480780	90997	96472	rs587779149	NC_000002.12:47480779:CCC:CC
NM_000251.2(MSH2):c.2527_2528TG[1] (p.Cys843_Ala844insTer)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090994	2	47707902 - 47707903	2	47480763 - 47480764	90994	96469	rs63749975	NC_000002.12:47480762:GTGTG:GTG
NM_000251.2(MSH2):c.2521del (p.Val840_Ile841insTer)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090992	2	47707896	2	47480757	90992	96467	rs587779147	NC_000002.12:47480756:AA:A
NM_000251.2(MSH2):c.2507del (p.Phe836fs)	MSH2	F836fs, F770fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090989	2	47707881	2	47480742	90989	96464	rs63750008	NC_000002.12:47480741:TTT:TT
NM_000251.2(MSH2):c.2485_2498dup (p.Ala834fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090984	2	47707859 - 47707860	2	47480720 - 47480721	90984	96459	rs587779146	NC_000002.12:47480720:TCATGTTGCAGAGCT:TCATGTTGCAGAGCTCATGTTGCAGAGCT
NM_000251.2(MSH2):c.2459-?_2634+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090979					90979	96454		
NM_000251.2(MSH2):c.2459-?_*(272_?)del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090978	2	47707835 - 47710360	2	47480696 - 47483221	90978	96453		
NM_000251.2(MSH2):c.244A>T (p.Lys82Ter)	MSH2	K82*, K16*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090975	2	47635572	2	47408433	90975	96450	rs587779145	NC_000002.12:47408432:A:T
NM_000251.2(MSH2):c.243_273delinsCTGACAAGCGCCTATAGCACTCGAATAATTCTTCTCACCCTAACAGGTCAGCCTCGCTTCCCAGCCCTCACTAACATTAACGAAAACAACCCACCCACTAAACCCCATTAAACGCCTAACAATCGGAAGCCTATTTTGCAGGGTTTCTCCATCACCAACAGCATTCTCCCCACATCCACCCCCCAAATGACAATCCCACTTTACTTAAAACTCACAG (p.Lys82_Asp91delinsTer)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090973	2	47635571 - 47635601	2	47408432 - 47408462	90973	96448		
NM_000251.2(MSH2):c.2432T>G (p.Leu811Ter)	MSH2	L811*, L745*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090971	2	47705632	2	47478493	90971	96446	rs63751018	NC_000002.12:47478492:T:G
NM_000251.2(MSH2):c.2427dup (p.Thr810fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090970	2	47705626 - 47705627	2	47478487 - 47478488	90970	96445	rs63751079	NC_000002.12:47478487:G:GG
NM_000251.2(MSH2):c.2422G>T (p.Glu808Ter)	MSH2	E808*, E742*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090969	2	47705622	2	47478483	90969	96444	rs34986638	NC_000002.12:47478482:G:T
NM_000251.2(MSH2):c.2418dup (p.Thr807fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090967	2	47705616 - 47705617	2	47478477 - 47478478	90967	96442	rs587779144	NC_000002.12:47478477:CC:CCC
NM_000251.2(MSH2):c.2406_2407CA[1] (p.Thr803fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090966	2	47705606 - 47705607	2	47478467 - 47478468	90966	96441	rs63750060	NC_000002.12:47478466:CACA:CA
NM_000251.2(MSH2):c.2361dup (p.Thr788fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090961	2	47705559 - 47705560	2	47478420 - 47478421	90961	96436	rs63750803	NC_000002.12:47478420:TT:TTT
NM_000251.2(MSH2):c.2360_2361dup (p.Thr788fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090960	2	47705559 - 47705560	2	47478420 - 47478421	90960	96435	rs63750803	NC_000002.12:47478420:TT:TTTT
NM_000251.2(MSH2):c.2347del (p.His783fs)	MSH2	H783fs, H717fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090959	2	47705545	2	47478406	90959	96434	rs63750233	NC_000002.12:47478405:CCC:CC
NM_000251.2(MSH2):c.2305del (p.Tyr769fs)	MSH2	Y703fs, Y769fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090954	2	47705505	2	47478366	90954	96429	rs63750896	NC_000002.12:47478365:T:
NM_000251.2(MSH2):c.2295del (p.Ile766fs)	MSH2	I700fs, I766fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090952	2	47705495	2	47478356	90952	96427	rs63751143	NC_000002.12:47478355:T:
NM_000251.2(MSH2):c.2294del (p.Ala765fs)	MSH2	A765fs, A699fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090951	2	47705494	2	47478355	90951	96426	rs63750346	NC_000002.12:47478354:C:
NM_000251.2(MSH2):c.2290del (p.Trp764fs)	MSH2	W764fs, W698fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090947	2	47705490	2	47478351	90947	96422	rs63749913	NC_000002.12:47478350:T:
NM_000251.2(MSH2):c.2261del (p.Thr754fs)	MSH2	T754fs, T688fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090944	2	47705461	2	47478322	90944	96419	rs267608009	NC_000002.12:47478321:C:
NM_000251.2(MSH2):c.2240_2241del (p.Ile747fs)	MSH2	I681fs, I747fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090940	2	47705439 - 47705440	2	47478300 - 47478301	90940	96415	rs63751036	NC_000002.12:47478299:ATA:A
NM_000251.2(MSH2):c.223_224del (p.Leu75fs)	MSH2	L75fs, L9fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090939	2	47635550 - 47635551	2	47408411 - 47408412	90939	96414	rs63750712	NC_000002.12:47408410:TCT:T
NM_000251.2(MSH2):c.2237_2238insA (p.Ile747fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090938	2	47705437 - 47705438	2	47478298 - 47478299	90938	96413	rs1553369641	NC_000002.12:47478298::A
NM_000251.2(MSH2):c.2231T>G (p.Leu744Ter)	MSH2	L744*, L678*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090935	2	47705431	2	47478292	90935	96410	rs63750403	NC_000002.12:47478291:T:G
NM_000251.2(MSH2):c.2228_2231del (p.Asp742_Ser743insTer)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090934	2	47705425 - 47705428	2	47478286 - 47478289	90934	96409	rs63751156	NC_000002.12:47478285:ATTCATT:ATT
NM_000251.2(MSH2):c.2211-?_2458+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090931					90931	96406		
NM_000251.1(MSH2):c.2210+116_2562del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090920	2	47703826 - 47707938	2	47476687 - 47480799	90920	96395		
NM_000251.2(MSH2):c.21dup (p.Thr8fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090918	2	47630350 - 47630351	2	47403211 - 47403212	90918	96393	rs1553348668	NC_000002.12:47403211:G:GG
NM_000251.2(MSH2):c.2191G>T (p.Glu731Ter)	MSH2	E731*, E665*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090915	2	47703691	2	47476552	90915	96390	rs63749802	NC_000002.12:47476551:G:T
NM_000251.2(MSH2):c.2167dup (p.Ser723fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090912	2	47703666 - 47703667	2	47476527 - 47476528	90912	96387	rs587779140	NC_000002.12:47476527:T:TT
NM_000251.2(MSH2):c.2160_2163del (p.Gly721fs)	MSH2	G655fs, G721fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090911	2	47703659 - 47703662	2	47476520 - 47476523	90911	96386	rs63750722	NC_000002.12:47476519:AAGGA:A
NM_000251.2(MSH2):c.2141dup (p.Gly715fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090908	2	47703640 - 47703641	2	47476501 - 47476502	90908	96383	rs63750545	NC_000002.12:47476501:C:CC
NM_000251.2(MSH2):c.212-?_645+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090901					90901	96376		
NM_000251.2(MSH2):c.212-?_366+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090900					90900	96375		
NM_000251.2(MSH2):c.212-?_2458+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090899					90899	96374		
NM_000251.2(MSH2):c.212-?_1510+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090898					90898	96373		
NM_000251.2(MSH2):c.212-?_1386+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090897					90897	96372		
NM_000251.2(MSH2):c.212-?_1276+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090896					90896	96371		
NM_000251.1(MSH2):c.211+1566_1277-3954del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090889	2	47632107 - 47668733	2	47404968 - 47441594	90889	96364		
NM_000251.2(MSH2):c.2074_2081del (p.Gly692fs)	MSH2	G692fs, G626fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090879	2	47703572 - 47703579	2	47476433 - 47476440	90879	96354	rs587779135	NC_000002.12:47476432:TTGGGTGTTT:TT
NM_000251.2(MSH2):c.2071dup (p.Ile691fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090877	2	47703568 - 47703569	2	47476429 - 47476430	90877	96352	rs63749878	NC_000002.12:47476429:AAA:AAAA
NM_000251.2(MSH2):c.2048_2111dup (p.Ile704Metfs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090870	2	47703547 - 47703548	2	47476408 - 47476409	90870	96345	rs1553369051	
NM_000251.2(MSH2):c.2031_2032AT[2] (p.Ile679fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090865	2	47703531 - 47703532	2	47476392 - 47476393	90865	96340	rs587779129	NC_000002.12:47476391:ATATAT:ATAT
NM_000251.2(MSH2):c.2021_2022del (p.Gly674fs)	MSH2	G674fs, G608fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090862	2	47703521 - 47703522	2	47476382 - 47476383	90862	96337	rs267608000	NC_000002.12:47476381:GT:
NM_000251.2(MSH2):c.2015del (p.Met672fs)	MSH2	M606fs, M672fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090859	2	47703515	2	47476376	90859	96334	rs63751161	NC_000002.12:47476375:T:
NM_000251.2(MSH2):c.2005+2T>C	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090839	2	47702411	2	47475272	90839	96314	rs267607987	NC_000002.12:47475271:T:C
NM_000251.2(MSH2):c.1996_1997del (p.Ile666fs)	MSH2	I666fs, I600fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090831	2	47702400 - 47702401	2	47475261 - 47475262	90831	96306	rs63751700	NC_000002.12:47475260:AT:
NM_000251.2(MSH2):c.1986del (p.Met663fs)	MSH2	M597fs, M663fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090830	2	47702390	2	47475251	90830	96305	rs63749929	NC_000002.12:47475250:G:
NM_000251.2(MSH2):c.1986_1987del (p.Gln662fs)	MSH2	Q596fs, Q662fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090829	2	47702389 - 47702390	2	47475250 - 47475251	90829	96304	rs587779122	NC_000002.12:47475249:AGA:A
NM_000251.2(MSH2):c.1984_1985del (p.Gln662fs)	MSH2	Q596fs, Q662fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090828	2	47702387 - 47702388	2	47475248 - 47475249	90828	96303	rs587779121	NC_000002.12:47475247:ACA:A
NM_000251.2(MSH2):c.1980_1981del (p.Asp660fs)	MSH2	D660fs, D594fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090826	2	47702383 - 47702384	2	47475244 - 47475245	90826	96301	rs587779119	NC_000002.12:47475243:ATA:A
NM_000251.2(MSH2):c.1922_1923GT[1] (p.Cys641_Val642insTer)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090821	2	47702325 - 47702326	2	47475186 - 47475187	90821	96296	rs587779117	NC_000002.12:47475185:TGTGT:TGT
NM_000251.2(MSH2):c.1897dup (p.Ile633fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090814	2	47702300 - 47702301	2	47475161 - 47475162	90814	96289	rs587779114	NC_000002.12:47475161:A:AA
NM_000251.2(MSH2):c.1889_1892del (p.Gly630fs)	MSH2	G564fs, G630fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090813	2	47702290 - 47702293	2	47475151 - 47475154	90813	96288	rs63750960	NC_000002.12:47475150:AAGGAAG:AAG
NM_000251.2(MSH2):c.1858_1859dup (p.Arg621fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090803	2	47702260 - 47702261	2	47475121 - 47475122	90803	96278	rs63750806	NC_000002.12:47475121:TGT:TGTGT
NM_000251.2(MSH2):c.1809del (p.Asp603fs)	MSH2	D537fs, D603fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090792	2	47702213	2	47475074	90792	96267	rs63751129	NC_000002.12:47475073:T:
NM_000251.2(MSH2):c.1788_1789del (p.Asn596fs)	MSH2	N596fs, N530fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090788	2	47702192 - 47702193	2	47475053 - 47475054	90788	96263	rs63750495	NC_000002.12:47475052:TG:
NM_000251.2(MSH2):c.1781_1782insCT (p.Leu595fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090785	2	47702185 - 47702186	2	47475046 - 47475047	90785	96260	rs267607691	NC_000002.12:47475046::CT
NM_000251.2(MSH2):c.1779_1782del (p.Gln593fs)	MSH2	Q527fs, Q593fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090784	2	47702181 - 47702184	2	47475042 - 47475045	90784	96259	rs63750113	NC_000002.12:47475041:CAGACA:CA
NM_000251.2(MSH2):c.1764T>G (p.Tyr588Ter)	MSH2	Y588*, Y522*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090780	2	47702168	2	47475029	90780	96255	rs63750844	NC_000002.12:47475028:T:G
NM_000251.2(MSH2):c.1760delG (p.Gly587Alafs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090779	2	47702164	2	47475024	90779	96254	rs63750103	
NM_000251.2(MSH2):c.1760-?_2210+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090778					90778	96253		
NM_000251.2(MSH2):c.1760-?_2005+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090777					90777	96252		
NM_000251.2(MSH2):c.1760-?_*(272_?)del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090776	2	47702164 - 47710360	2	47475025 - 47483221	90776	96251		
NM_000251.1(MSH2):c.1760-361_2634+838del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090774	2	47701803 - 47708848	2	47474664 - 47481709	90774	96249		
NM_000251.1(MSH2):c.1759+305_2006-34del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090769	2	47698506 - 47703472	2	47471367 - 47476333	90769	96244		
NM_000251.2(MSH2):c.1720del (p.Gln574fs)	MSH2	Q574fs, Q508fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090761	2	47698160	2	47471021	90761	96236	rs63751299	NC_000002.12:47471020:CCC:CC
NM_000251.2(MSH2):c.1720C>T (p.Gln574Ter)	MSH2	Q574*, Q508*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090760	2	47698162	2	47471023	90760	96235	rs63751298	NC_000002.12:47471022:C:T
NM_000251.2(MSH2):c.1717del (p.Ala573fs)	MSH2	A507fs, A573fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090759	2	47698159	2	47471020	90759	96234	rs267607974	NC_000002.12:47471019:G:
NM_000251.2(MSH2):c.1705_1706insT (p.Glu569fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090758	2	47698147 - 47698148	2	47471008 - 47471009	90758	96233	rs587779106	NC_000002.12:47471008::T
NM_000251.2(MSH2):c.1705_1706dup (p.Tyr570fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090757	2	47698145 - 47698146	2	47471006 - 47471007	90757	96232	rs63750393	NC_000002.12:47471006:AGA:AGAGA
NM_000251.2(MSH2):c.1699A>T (p.Lys567Ter)	MSH2	K567*, K501*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090753	2	47698141	2	47471002	90753	96228	rs63751149	NC_000002.12:47471001:A:T
NM_000251.2(MSH2):c.1696_1697del (p.Lys565_Asn566insTer)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090752	2	47698135 - 47698136	2	47470996 - 47470997	90752	96227	rs63750737	NC_000002.12:47470995:AAAAA:AAA
NM_000251.2(MSH2):c.1693A>T (p.Lys565Ter)	MSH2	K565*, K499*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090751	2	47698135	2	47470996	90751	96226	rs587779104	NC_000002.12:47470995:A:T
NM_000251.2(MSH2):c.1683del (p.Glu562fs)	MSH2	E562fs, E496fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090746	2	47698124	2	47470985	90746	96221	rs63750406	NC_000002.12:47470984:AA:A
NM_000251.2(MSH2):c.1676del (p.Ser558_Leu559insTer)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090743	2	47698116	2	47470977	90743	96218	rs63750633	NC_000002.12:47470976:TTT:TT
NM_000251.2(MSH2):c.166del (p.Glu56fs)	MSH2	E56fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090742	2	47630494	2	47403355	90742	96217	rs63750087	NC_000002.12:47403354:GGG:GG
NM_000251.2(MSH2):c.166G>T (p.Glu56Ter)	MSH2	E56*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090741	2	47630496	2	47403357	90741	96216	rs587779102	NC_000002.12:47403356:G:T
NM_000251.2(MSH2):c.1667_1668insA (p.Thr557fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090738	2	47698109 - 47698110	2	47470970 - 47470971	90738	96213	rs1553367587	NC_000002.12:47470970::A
NM_000251.2(MSH2):c.1665del (p.Lys555fs)	MSH2	K489fs, K555fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090736	2	47698105	2	47470966	90736	96211	rs63751120	NC_000002.12:47470965:AAA:AA
NM_000251.2(MSH2):c.1662-?_2458+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090735					90735	96210		
NM_000251.2(MSH2):c.1662-?_*(272_?)del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090731	2	47698104 - 47710360	2	47470965 - 47483221	90731	96206		
NM_000251.1(MSH2):c.1662-374_2458+467del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090729	2	47697730 - 47706125	2	47470591 - 47478986	90729	96204		
NM_000251.2(MSH2):c.1660A>T (p.Ser554Cys)	MSH2	S554C, S488C	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090718	2	47693946	2	47466807	90718	96193	rs63751656	NC_000002.12:47466806:A:T
NM_000251.2(MSH2):c.1638_1639dup (p.Asn547fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090711	2	47693922 - 47693923	2	47466783 - 47466784	90711	96186	rs63750662	NC_000002.12:47466783:AGA:AGAGA
NM_000251.2(MSH2):c.1627del (p.Asp543fs)	MSH2	D543fs, D477fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090710	2	47693913	2	47466774	90710	96185	rs63750675	NC_000002.12:47466773:G:
NM_000251.2(MSH2):c.1594dup (p.Val532fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090706	2	47693879 - 47693880	2	47466740 - 47466741	90706	96181	rs63750104	NC_000002.12:47466740:G:GG
NM_000251.2(MSH2):c.1587del (p.Glu530fs)	MSH2	E464fs, E530fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090704	2	47693872	2	47466733	90704	96179	rs63750845	NC_000002.12:47466732:AA:A
NM_000251.2(MSH2):c.1566C>G (p.Tyr522Ter)	MSH2	Y522*, Y456*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090699	2	47693852	2	47466713	90699	96174	rs63750224	NC_000002.12:47466712:C:G
NM_000251.2(MSH2):c.154_155insG (p.Leu52fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090695	2	47630484 - 47630485	2	47403345 - 47403346	90695	96170	rs63750352	NC_000002.12:47403345::G
NM_000251.2(MSH2):c.1511-?_2005+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090690					90690	96165		
NM_000251.2(MSH2):c.1500dup (p.Arg501fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090683	2	47690281 - 47690282	2	47463142 - 47463143	90683	96158	rs587779094	NC_000002.12:47463142:CC:CCC
NM_000251.2(MSH2):c.1497del (p.Ala500fs)	MSH2	A500fs, A434fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090681	2	47690280	2	47463141	90681	96156	rs63749963	NC_000002.12:47463140:A:
NM_000251.2(MSH2):c.1494dup (p.Ala499fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090680	2	47690276 - 47690277	2	47463137 - 47463138	90680	96155	rs63750362	NC_000002.12:47463137:T:TT
NM_000251.2(MSH2):c.1487T>A (p.Leu496Ter)	MSH2	L496*, L430*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090678	2	47690270	2	47463131	90678	96153	rs587779093	NC_000002.12:47463130:T:A
NM_000251.2(MSH2):c.1476_1477delinsCT (p.Met492_Gln493delinsIleTer)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090676	2	47690259 - 47690260	2	47463120 - 47463121	90676	96151	rs63750583	NC_000002.12:47463119:GC:CT
NM_000251.2(MSH2):c.145del (p.Asp49fs)	MSH2	D49fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090673	2	47630474	2	47403335	90673	96148	rs63750644	NC_000002.12:47403334:GG:G
NM_000251.2(MSH2):c.145_146del (p.Asp49fs)	MSH2	D49fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090672	2	47630475 - 47630476	2	47403336 - 47403337	90672	96147	rs63750334	NC_000002.12:47403335:GA:
NM_000251.2(MSH2):c.1457del (p.Asn486fs)	MSH2	N486fs, N420fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090671	2	47690239	2	47463100	90671	96146	rs63750986	NC_000002.12:47463099:AA:A
NM_000251.2(MSH2):c.1445_1446GA[1] (p.Glu483fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090669	2	47690227 - 47690228	2	47463088 - 47463089	90669	96144	rs63750161	NC_000002.12:47463087:AGAGA:AGA
NM_000251.2(MSH2):c.1445_1449del (p.Arg482fs)	MSH2	R416fs, R482fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090667	2	47690226 - 47690230	2	47463087 - 47463091	90667	96142	rs267607961	NC_000002.12:47463086:AAGAGAA:AA
NM_000251.2(MSH2):c.1444del (p.Arg482fs)	MSH2	R416fs, R482fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090665	2	47690226	2	47463087	90665	96140	rs63750068	NC_000002.12:47463086:AA:A
NM_000251.2(MSH2):c.1431_1432TC[3] (p.Glu480fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090663	2	47690213 - 47690214	2	47463074 - 47463075	90663	96138	rs587779091	NC_000002.12:47463074:TCTC:TCTCTC
NM_000251.2(MSH2):c.1418C>G (p.Ser473Ter)	MSH2	S473*, S407*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090659	2	47690201	2	47463062	90659	96134	rs63751403	NC_000002.12:47463061:C:G
NM_000251.2(MSH2):c.1390del (p.Glu464fs)	MSH2	E464fs, E398fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090655	2	47690172	2	47463033	90655	96130	rs587779088	NC_000002.12:47463032:GG:G
NM_000251.2(MSH2):c.1387-?_2458+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090653					90653	96128		
NM_000251.2(MSH2):c.1387-?_1661+?dup275	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090652					90652	96127		
NM_000251.2(MSH2):c.1387-?_1510+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090650					90650	96125		
NM_000251.2(MSH2):c.1387-?_*(272_?)del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090649	2	47690170 - 47710360	2	47463031 - 47483221	90649	96124		
NM_000251.1(MSH2):c.1387-3976_1662-364del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090647	2	47686194 - 47697740	2	47459055 - 47470601	90647	96122		
NM_000251.2(MSH2):c.1358T>A (p.Met453Lys)	MSH2	M453K, M387K	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090638	2	47672768	2	47445629	90638	96113	rs63750697	NC_000002.12:47445628:T:A
NM_000251.2(MSH2):c.1345_1348del (p.Lys449fs)	MSH2	K383fs, K449fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090633	2	47672755 - 47672758	2	47445616 - 47445619	90633	96108	rs267607955	NC_000002.12:47445615:AAGT:
NM_000251.2(MSH2):c.1345A>T (p.Lys449Ter)	MSH2	K449*, K383*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090632	2	47672755	2	47445616	90632	96107	rs63749920	NC_000002.12:47445615:A:T
NM_000251.2(MSH2):c.1340_1341insGG (p.Phe447fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090631	2	47672750 - 47672751	2	47445611 - 47445612	90631	96106	rs267607696	NC_000002.12:47445611::GG
NM_000251.2(MSH2):c.1311_1334del24insNM_000251.1:c.1338_1361inv24 (p.Thr438_Ser445delinsPheSerLysPheGlnGluMetIle)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090622	2	47672721 - 47672744	2	47445582 - 47445605	90622	96097		
NM_000251.2(MSH2):c.129T>G (p.Tyr43Ter)	MSH2	Y43*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090621	2	47630459	2	47403320	90621	96096	rs63750894	NC_000002.12:47403319:T:G
NM_000251.2(MSH2):c.1292T>A (p.Leu431Ter)	MSH2	L431*, L365*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090620	2	47672702	2	47445563	90620	96095	rs63751315	NC_000002.12:47445562:T:A
NM_000251.2(MSH2):c.1288A>T (p.Lys430Ter)	MSH2	K430*, K364*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090618	2	47672698	2	47445559	90618	96093	rs63751646	NC_000002.12:47445558:A:T
NM_000251.2(MSH2):c.1287dup (p.Lys430fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090617	2	47672696 - 47672697	2	47445557 - 47445558	90617	96092	rs63751626	NC_000002.12:47445557:G:GG
NM_000251.2(MSH2):c.1277-?_1759+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090614					90614	96089		
NM_000251.2(MSH2):c.1277-?_1386+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090612					90612	96087		
NM_000251.2(MSH2):c.1277-?_*(272_?)inv	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090611	2	47672687 - 47710360	2	47445548 - 47483221	90611	96086		
NM_000251.2(MSH2):c.1277-?_*(272_?)del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090610	2	47672687 - 47710360	2	47445548 - 47483221	90610	96085		
NM_000251.2(MSH2):c.1277-571_1386+2327del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090606	2	47672110 - 47675117	2	47444971 - 47447978	90606	96081		
NM_000251.1(MSH2):c.1276+232_1386+3798del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090593	2	47657312 - 47676594	2	47430173 - 47449455	90593	96068		
NM_000251.2(MSH2):c.1269dup (p.His424fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090588	2	47657068 - 47657069	2	47429929 - 47429930	90588	96063	rs63751667	NC_000002.12:47429929:AAAAA:AAAAAA
NM_000251.2(MSH2):c.1264G>T (p.Glu422Ter)	MSH2	E422*, E356*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090587	2	47657068	2	47429929	90587	96062	rs63751712	NC_000002.12:47429928:G:T
NM_000251.2(MSH2):c.1249del (p.Val417fs)	MSH2	V351fs, V417fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090582	2	47657053	2	47429914	90582	96057	rs63751059	NC_000002.12:47429913:G:
NM_000251.2(MSH2):c.1249_1253del (p.Val417fs)	MSH2	V351fs, V417fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090581	2	47657051 - 47657055	2	47429912 - 47429916	90581	96056	rs587779079	NC_000002.12:47429911:ATGTTAT:AT
NM_000251.2(MSH2):c.1243_1246del (p.Pro415fs)	MSH2	P349fs, P415fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090580	2	47657044 - 47657047	2	47429905 - 47429908	90580	96055	rs63751206	NC_000002.12:47429904:CTACCTA:CTA
NM_000251.2(MSH2):c.1216_1219dup (p.Leu407fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090568	2	47657017 - 47657018	2	47429878 - 47429879	90568	96043	rs63751192	NC_000002.12:47429878:ACCGAC:ACCGACCGAC
NM_000251.2(MSH2):c.1215C>A (p.Tyr405Ter)	MSH2	Y405*, Y339*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090567	2	47657019	2	47429880	90567	96042	rs63751271	NC_000002.12:47429879:C:A
NM_000251.2(MSH2):c.1196_1197dup (p.Asn400fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090562	2	47656999 - 47657000	2	47429860 - 47429861	90562	96037	rs63749850	NC_000002.12:47429860:CA:CACA
NM_000251.2(MSH2):c.1192dup (p.Ala398fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090561	2	47656995 - 47656996	2	47429856 - 47429857	90561	96036	rs63751169	NC_000002.12:47429856:G:GG
NM_000251.2(MSH2):c.1183C>T (p.Gln395Ter)	MSH2	Q395*, Q329*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090558	2	47656987	2	47429848	90558	96033	rs63750302	NC_000002.12:47429847:C:T
NM_000251.2(MSH2):c.1144dup (p.Arg382fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090552	2	47656947 - 47656948	2	47429808 - 47429809	90552	96027	rs63750496	NC_000002.12:47429808:C:CC
NM_000251.2(MSH2):c.1139del (p.Leu380fs)	MSH2	L314fs, L380fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090551	2	47656941	2	47429802	90551	96026	rs63750039	NC_000002.12:47429801:TTT:TT
NM_000251.2(MSH2):c.1127_1128dup (p.Gln377fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090549	2	47656930 - 47656931	2	47429791 - 47429792	90549	96024	rs63751219	NC_000002.12:47429791:TA:TATA
NM_000251.2(MSH2):c.1119del (p.Arg373fs)	MSH2	R373fs, R307fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090547	2	47656922	2	47429783	90547	96022	rs63750516	NC_000002.12:47429782:GG:G
NM_000251.2(MSH2):c.110del (p.Phe37fs)	MSH2	F37fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090546	2	47630437	2	47403298	90546	96021	rs63751056	NC_000002.12:47403297:TTTT:TTT
NM_000251.2(MSH2):c.1108del (p.Ala370fs)	MSH2	A304fs, A370fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090545	2	47656912	2	47429773	90545	96020	rs63749814	NC_000002.12:47429772:G:
NM_000251.2(MSH2):c.1099del (p.Phe366_Val367insTer)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090544	2	47656903	2	47429764	90544	96019	rs587779073	NC_000002.12:47429763:G:
NM_000251.2(MSH2):c.1097_1098insA (p.Phe366fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090543	2	47656901 - 47656902	2	47429762 - 47429763	90543	96018	rs267607693	NC_000002.12:47429762::A
NM_000251.2(MSH2):c.1077_1078ins173 (p.?)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090540	2	47656881 - 47656882	2	47429742 - 47429743	90540	96015		
NM_000251.2(MSH2):c.1077A>T (p.Arg359Ser)	MSH2	R359S, R293S	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090539	2	47656881	2	47429742	90539	96014	rs63751617	NC_000002.12:47429741:A:T
NM_000251.2(MSH2):c.1077-?_2005+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090538					90538	96013		
NM_000251.2(MSH2):c.1077-?_1661+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090537					90537	96012		
NM_000251.2(MSH2):c.1077-?_1386+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090535					90535	96010		
NM_000251.2(MSH2):c.1077-?_1276+?dup200	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090534					90534	96009	rs1553356518	
NM_000251.2(MSH2):c.1077-?_1276+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090533					90533	96008		
NM_000251.2(MSH2):c.1077-?_*(272_?)del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090532	2	47656881 - 47710360	2	47429742 - 47483221	90532	96007		
NM_000251.2(MSH2):c.1077-220_1276+6245del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090527	2	47656661 - 47663325	2	47429522 - 47436186	90527	96002		
NM_000251.3(MSH2):c.1077-135_1276+119dup	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090523	2	47656744 - 47656745	2	47429605 - 47429606	90523	95998	rs1553356484	
NM_000251.2(MSH2):c.1075A>T (p.Arg359Ter)	MSH2	R359*, R293*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090517	2	47643567	2	47416428	90517	95992	rs587779070	NC_000002.12:47416427:A:T
NM_000251.2(MSH2):c.1059del (p.Asn354fs)	MSH2	N288fs, N354fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090515	2	47643551	2	47416412	90515	95990	rs587779068	NC_000002.12:47416411:G:
NM_000251.2(MSH2):c.1037_1038dup (p.Lys347fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090511	2	47643528 - 47643529	2	47416389 - 47416390	90511	95986	rs63751483	NC_000002.12:47416389:TT:TTTT
NM_000251.2(MSH2):c.1017_1018del (p.Arg340fs)	MSH2	R274fs, R340fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090505	2	47643508 - 47643509	2	47416369 - 47416370	90505	95980	rs63750703	NC_000002.12:47416368:AAA:A
NM_000251.2(MSH2):c.1013G>A (p.Gly338Glu)	MSH2	G338E, G272E	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090504	2	47643505	2	47416366	90504	95979	rs587779065	NC_000002.12:47416365:G:A
NM_000251.2(MSH2):c.1007del (p.Pro336fs)	MSH2	P336fs, P270fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090501	2	47643496	2	47416357	90501	95976	rs587779064	NC_000002.12:47416356:CCCC:CCC
NM_000251.2(MSH2):c.1000A>T (p.Lys334Ter)	MSH2	K334*, K268*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090498	2	47643492	2	47416353	90498	95973	rs587779063	NC_000002.12:47416352:A:T
NM_000251.1(MSH2):c.-956_1077-5607del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090497	2	47629375 - 47651274	2	47402236 - 47424135	90497	95972		
NM_000251.1(MSH2):c.-75398_1759+1708del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090493					90493	95968		
NM_000251.1(MSH2):c.-4729_367-353del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090492	2	47625602 - 47636880	2	47398463 - 47409741	90492	95967		
NM_000251.1(MSH2):c.-47156_1277-4980del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090491					90491	95966		
NM_000251.1(MSH2):c.-35298_1276+5697del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090489					90489	95964		
NM_000251.1(MSH2):c.-1753_645+922del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090486	2	47628578 - 47638433	2	47401439 - 47411294	90486	95961		
NM_000251.1(MSH2):c.-11844_1077-6021delins155	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090484					90484	95959		
NM_000251.2(MSH2):c.(?_-68)_942+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090477	2	47630263 - 47641557	2	47403124 - 47414418	90477	95952		
NM_000251.2(MSH2):c.(?_-68)_792+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090476	2	47630263 - 47639699	2	47403124 - 47412560	90476	95951		
NM_000251.2(MSH2):c.(?_-68)_645+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090474	2	47630263 - 47637511	2	47403124 - 47410372	90474	95949		
NM_000251.2(MSH2):c.(?_-68)_366+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090473	2	47630263 - 47635694	2	47403124 - 47408555	90473	95948		
NM_000251.2(MSH2):c.(?_-68)_2634+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090472	2	47630263 - 47708010	2	47403124 - 47480871	90472	95947		
NM_000251.2(MSH2):c.(?_-68)_211+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090471	2	47630263 - 47630541	2	47403124 - 47403402	90471	95946		
NM_000251.2(MSH2):c.(?_-68)_1759+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090470	2	47630263 - 47698201	2	47403124 - 47471062	90470	95945		
NM_000251.2(MSH2):c.(?_-68)_1661+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090469	2	47630263 - 47693947	2	47403124 - 47466808	90469	95944		
NM_000251.2(MSH2):c.(?_-68)_1386+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090468	2	47630263 - 47672796	2	47403124 - 47445657	90468	95943		
NM_000251.2(MSH2):c.(?_-68)_1276+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090467	2	47630263 - 47657080	2	47403124 - 47429941	90467	95942		
NM_000251.1(MSH2):c.(?_-68)_(*272_?)del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090464					90464	95939		
NM_006920.6(SCN1A):c.2803C>T (p.Arg935Cys)	SCN1A	R935C, R946C, R918C, R934C, R132C, R917C	Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2|not provided|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000068604	2	166894396	2	166037886	68604	79496	rs121918775	NC_000002.12:166037885:G:A
NM_014874.3(MFN2):c.2219G>C (p.Trp740Ser)	MFN2	W740S	Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B|Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease|not specified|not provided|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease, type 2A2A	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002269	1	12071567	1	12011510	2269	17308	rs28940292	NC_000001.11:12011509:G:C
NM_014874.3(MFN2):c.281G>A (p.Arg94Gln)	MFN2	R94Q	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2|not provided|Charcot-Marie-Tooth disease, type 2A2A	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002268	1	12052717	1	11992660	2268	17307	rs28940291	NC_000001.11:11992659:G:A
NM_004974.4(KCNA2):c.890G>A (p.Arg297Gln)	KCNA2	R297Q	not provided|Inborn genetic diseases|Epileptic encephalopathy, early infantile, 32	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000190328	1	111146515	1	110603893	190328	188155	rs786205232	NC_000001.11:110603892:C:T
NM_170707.4(LMNA):c.568C>T (p.Arg190Trp)	LMNA	R190W, R109W, R78W	Charcot-Marie-Tooth disease, type 2|not provided|Dilated cardiomyopathy 1S|Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066908	1	156104248	1	156134457	66908	77805	rs59026483	NC_000001.11:156134456:C:T
NM_170707.4(LMNA):c.1130G>A (p.Arg377His)	LMNA	R377H, R265H, R296H	Muscular dystrophy|not provided|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014495	1	156105885	1	156136094	14495	29534	rs61672878	NC_000001.11:156136093:G:A
NM_000251.2(MSH2):c.2634+2T>C	MSH2		Lynch syndrome	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000619571	2	47708012	2	47480873	619571	610975	rs876660546	NC_000002.12:47480872:T:C
NM_000251.2(MSH2):c.366+2T>C	MSH2		Lynch syndrome	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000619527	2	47635696	2	47408557	619527	610970	rs1558457533	NC_000002.12:47408556:T:C
NM_000251.2(MSH2):c.1637dup (p.Asn547fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	VCV000517418	2	47693921 - 47693922	2	47466782 - 47466783	517418	496760	rs1553366642	NC_000002.12:47466782:AA:AAA
NM_000251.2(MSH2):c.1293dup (p.Leu432fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	VCV000517330	2	47672702 - 47672703	2	47445563 - 47445564	517330	496704	rs1553361162	NC_000002.12:47445563:A:AA
NM_000251.2(MSH2):c.2484dup (p.His829fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	VCV000433903	2	47707858 - 47707859	2	47480719 - 47480720	433903	427166	rs1553370324	NC_000002.12:47480719:TT:TTT
NM_000251.2(MSH2):c.2472_2473del (p.Ser825fs)	MSH2	S825fs, S759fs	Lynch syndrome	Pathogenic	criteria provided, single submitter	VCV000433902	2	47707847 - 47707848	2	47480708 - 47480709	433902	427165	rs1553370310	NC_000002.12:47480707:AAA:A
NM_000251.2(MSH2):c.2148del (p.Asp716fs)	MSH2	D650fs, D716fs	Lynch syndrome	Pathogenic(Last reviewed: Feb 16, 2015)	criteria provided, single submitter	VCV000433897	2	47703648	2	47476509	433897	427160	rs1553369165	NC_000002.12:47476508:C:
NM_000251.2(MSH2):c.2145del (p.Asp716fs)	MSH2	D650fs, D716fs	Lynch syndrome	Pathogenic(Last reviewed: Mar 18, 2012)	criteria provided, single submitter	VCV000433896	2	47703645	2	47476506	433896	427159	rs1553369164	NC_000002.12:47476505:T:
NM_000251.2(MSH2):c.2100del (p.Glu701fs)	MSH2	E701fs, E635fs	Lynch syndrome	Pathogenic(Last reviewed: Jan 16, 2014)	criteria provided, single submitter	VCV000433895	2	47703600	2	47476461	433895	427158	rs1553369113	NC_000002.12:47476460:A:
NM_000251.2(MSH2):c.1882G>T (p.Gly628Ter)	MSH2	G628*, G562*	Lynch syndrome	Pathogenic	criteria provided, single submitter	VCV000433891	2	47702286	2	47475147	433891	427154	rs371776176	NC_000002.12:47475146:G:T
NM_000251.2(MSH2):c.1681_1682dup (p.Glu562fs)	MSH2		Lynch syndrome	Pathogenic	criteria provided, single submitter	VCV000433888	2	47698122 - 47698123	2	47470983 - 47470984	433888	427151	rs1553367608	NC_000002.12:47470983:GA:GAGA
NM_000251.2(MSH2):c.1560dup (p.Tyr521fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Oct 2, 2015)	criteria provided, single submitter	VCV000433886	2	47693845 - 47693846	2	47466706 - 47466707	433886	427149	rs1553366561	NC_000002.12:47466706:A:AA
NM_000251.2(MSH2):c.1557del (p.Phe519fs)	MSH2	F453fs, F519fs	Lynch syndrome	Pathogenic	criteria provided, single submitter	VCV000433885	2	47693841	2	47466702	433885	427148	rs1553366554	NC_000002.12:47466701:TTT:TT
NM_000251.2(MSH2):c.1534_1543del (p.Lys512fs)	MSH2	K512fs, K446fs	Lynch syndrome	Pathogenic	criteria provided, single submitter	VCV000433884	2	47693816 - 47693825	2	47466677 - 47466686	433884	427147	rs1553366522	NC_000002.12:47466676:GATTAAACTGGATT:GATT
NM_000251.2(MSH2):c.1215C>G (p.Tyr405Ter)	MSH2	Y405*, Y339*	Lynch syndrome	Pathogenic(Last reviewed: Jul 31, 2012)	criteria provided, single submitter	VCV000433881	2	47657019	2	47429880	433881	427143	rs63751271	NC_000002.12:47429879:C:G
NM_001258281.1(MSH2):c.448-1_450del	MSH2		Lynch syndrome	Pathogenic	criteria provided, single submitter	VCV000433877	2	47639549 - 47639552	2	47412410 - 47412413	433877	427138	rs1553351549	NC_000002.12:47412409:ATAGATA:ATA
NM_000251.2(MSH2):c.611_612GA[5] (p.Thr206fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Dec 14, 2012)	criteria provided, single submitter	VCV000433876	2	47637476 - 47637477	2	47410337 - 47410338	433876	427137	rs1553350946	NC_000002.12:47410337:GAGAGA:GAGAGAGAGA
NM_001258281.1(MSH2):c.15_168+1del	MSH2		Lynch syndrome	Pathogenic	criteria provided, single submitter	VCV000433875	2	47635536 - 47635690	2	47408397 - 47408551	433875	427136	rs1553350052	
NM_000251.2(MSH2):c.1760-?_2458+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: May 7, 2013)	criteria provided, single submitter	VCV000433586	2	47702164 - 47705658			433586	427134		
NM_000251.2:c.1760-?_2802+?del	MSH2		Lynch syndrome	Pathogenic	criteria provided, single submitter	VCV000433584	2	47702164 - 47710085			433584	427593		
NM_001258281.1:c.595-?_2607+?del	MSH2		Lynch syndrome	Pathogenic	criteria provided, single submitter	VCV000433582	2	47641408 - 47710088			433582	427591		
NM_000251.2:c.1-?_1076+?dup	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Feb 5, 2016)	criteria provided, single submitter	VCV000433581	2	47630331 - 47643568			433581	427590		
NM_000251.2(MSH2):c.1277-?_1386+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Oct 3, 2016)	criteria provided, single submitter	VCV000417809			2	47445548 - 47445657	417809	391390		
NM_000251.2(MSH2):c.367-?_1076+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Nov 13, 2016)	criteria provided, single submitter	VCV000417807			2	47410094 - 47416429	417807	391478		
NM_000251.2(MSH2):c.1277-?_2634+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Jan 15, 2017)	criteria provided, single submitter	VCV000417806			2	47445548 - 47480871	417806	391557		
NC_000002.11:g.(?_47630206)_(47710367_?)del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Oct 12, 2016)	criteria provided, single submitter	VCV000417444	2	47630206 - 47710367	2	47403067 - 47483228	417444	391472		
NM_000251.2(MSH2):c.212-?_366+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000417440	2	47635540 - 47635694	2	47408401 - 47408555	417440	391477		
NM_000251.2(MSH2):c.2006-?_2210+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Oct 27, 2016)	criteria provided, single submitter	VCV000417439	2	47703506 - 47703710	2	47476367 - 47476571	417439	391393		
NC_000002.11:g.(?_47630206)_(47635694_?)del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Dec 20, 2016)	criteria provided, single submitter	VCV000417437	2	47630206 - 47635694	2	47403067 - 47408555	417437	391470		
NC_000002.11:g.(?_47639553)_(47710367_?)del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Nov 6, 2016)	criteria provided, single submitter	VCV000417436	2	47639553 - 47710367	2	47412414 - 47483228	417436	391490		
NC_000002.11:g.(?_47630206)_(47630541_?)del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Dec 26, 2016)	criteria provided, single submitter	VCV000417434	2	47630206 - 47630541	2	47403067 - 47403402	417434	391362		
NM_000251.2(MSH2):c.1277-?_1661+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: May 20, 2016)	criteria provided, single submitter	VCV000417433	2	47672687 - 47693947	2	47445548 - 47466808	417433	391555		
NM_000251.2(MSH2):c.2161G>T (p.Gly721Ter)	MSH2	G721*, G655*	Lynch syndrome	Pathogenic(Last reviewed: May 12, 2016)	criteria provided, single submitter	VCV000408548	2	47703661	2	47476522	408548	392808	rs1060502032	NC_000002.12:47476521:G:T
NM_000251.2(MSH2):c.1470_1473delinsAAA (p.Met492fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Nov 25, 2016)	criteria provided, single submitter	VCV000408543	2	47690253 - 47690256	2	47463114 - 47463117	408543	392884	rs1060502029	NC_000002.12:47463113:GAAG:AAA
NM_000251.2(MSH2):c.1405del (p.Leu469_Val470insTer)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000408538	2	47690187	2	47463048	408538	393116	rs1060502027	NC_000002.12:47463047:CC:C
NM_000251.2(MSH2):c.510dup (p.Arg171fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Jul 21, 2016)	criteria provided, single submitter	VCV000408515	2	47637375 - 47637376	2	47410236 - 47410237	408515	392728	rs1553350787	NC_000002.12:47410236:G:GG
NM_000251.2(MSH2):c.85A>T (p.Lys29Ter)	MSH2	K29*	Lynch syndrome	Pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000408478	2	47630415	2	47403276	408478	392837	rs1060502001	NC_000002.12:47403275:A:T
NM_001258281.1(MSH2):c.-30-82_-30-79del	MSH2	T31fs	Lynch syndrome	Pathogenic(Last reviewed: May 12, 2016)	criteria provided, single submitter	VCV000408477	2	47630417 - 47630420	2	47403278 - 47403281	408477	392839	rs1060502000	NC_000002.12:47403277:GCCG:
NM_000251.2(MSH2):c.1667dup (p.Leu556fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Oct 29, 2016)	criteria provided, single submitter	VCV000408462	2	47698107 - 47698108	2	47470968 - 47470969	408462	392764	rs267607694	NC_000002.12:47470968:TT:TTT
NM_000251.2(MSH2):c.1387-?_1510+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: May 27, 2016)	criteria provided, single submitter	VCV000267343	2	47690170 - 47690293	2	47463031 - 47463154	267343	262401		
NM_000251.2(MSH2):c.1077-?_1276+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Mar 31, 2016)	criteria provided, single submitter	VCV000267341	2	47656881 - 47657080	2	47429742 - 47429941	267341	262400		
NM_000251.2(MSH2):c.367-?_645+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Nov 23, 2016)	criteria provided, single submitter	VCV000267340	2	47637233 - 47637511	2	47410094 - 47410372	267340	262399		
NM_000251.2(MSH2):c.-125_1076+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Jan 15, 2017)	criteria provided, single submitter	VCV000254090	2	47630206 - 47643568	2	47403067 - 47416429	254090	248480		
NM_000251.2(MSH2):c.-125_645+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Jun 2, 2016)	criteria provided, single submitter	VCV000254072	2	47630206 - 47637511	2	47403067 - 47410372	254072	248481		
NM_000251.2(MSH2):c.2150_2153del (p.Ser717fs)	MSH2	S651fs, S717fs	Lynch syndrome	Pathogenic(Last reviewed: Dec 14, 2015)	criteria provided, single submitter	VCV000237383	2	47703648 - 47703651	2	47476509 - 47476512	237383	238855	rs878853809	NC_000002.12:47476508:CAGTCA:CA
NM_000251.2(MSH2):c.1404_1410del (p.Phe468fs)	MSH2	F468fs, F402fs	Lynch syndrome	Pathogenic(Last reviewed: Mar 26, 2016)	criteria provided, single submitter	VCV000237369	2	47690187 - 47690193	2	47463048 - 47463054	237369	238843	rs878853802	NC_000002.12:47463047:CCTTGTA:
NM_000251.2(MSH2):c.1201_1202dup (p.Leu401fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	VCV000224533	2	47657004 - 47657005	2	47429865 - 47429866	224533	226297	rs869312768	NC_000002.12:47429865:TT:TTTT
NM_000251.2(MSH2):c.819_821delinsTG (p.Ile274fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	criteria provided, single submitter	VCV000219810	2	47641434 - 47641436	2	47414295 - 47414297	219810	221218	rs864622261	NC_000002.12:47414294:AAT:TG
NM_000251.2(MSH2):c.1963_1964del (p.Val655fs)	MSH2	V655fs, V589fs	Lynch syndrome	Pathogenic(Last reviewed: Jul 12, 2015)	criteria provided, single submitter	VCV000219499	2	47702367 - 47702368	2	47475228 - 47475229	219499	221240	rs864622121	NC_000002.12:47475227:GT:
NM_000251.2(MSH2):c.1662-?_*(1_?)del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Mar 19, 2015)	criteria provided, single submitter	VCV000216053	2	47698104 - 47710089	2	47470965 - 47482950	216053	212115		
NM_001258281.1(MSH2):c.-30-28_-30-15del	MSH2	E48fs	Lynch syndrome	Pathogenic(Last reviewed: Jul 8, 2015)	criteria provided, single submitter	VCV000216052	2	47630471 - 47630484	2	47403332 - 47403345	216052	212180	rs863224481	NC_000002.12:47403331:CGAGGACGCGCTGC:
NM_000251.2(MSH2):c.(?_-1)_1076+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Aug 27, 2015)	criteria provided, single submitter	VCV000216051	2	47630330 - 47643568	2	47403191 - 47416429	216051	212113		
NM_000251.2(MSH2):c.475dup (p.Arg159fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Mar 5, 2013)	criteria provided, single submitter	VCV000188513	2	47637341	2	47410201 - 47410202	188513	186310	rs786204319	NC_000002.12:47410201:A:AA
NM_000251.2(MSH2):c.264dup (p.Val89fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Nov 11, 2014)	criteria provided, single submitter	VCV000188399	2	47635588 - 47635589	2	47408449 - 47408450	188399	185976	rs267607920	NC_000002.12:47408449:TTTT:TTTTT
NM_000251.2(MSH2):c.1442T>A (p.Leu481Ter)	MSH2	L481*, L415*	Lynch syndrome	Pathogenic(Last reviewed: Dec 3, 2014)	criteria provided, single submitter	VCV000188274	2	47690225	2	47463086	188274	185981	rs786203036	NC_000002.12:47463085:T:A
NM_000251.2(MSH2):c.782_783insA (p.Met261fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Nov 1, 2014)	criteria provided, single submitter	VCV000188205	2	47639689 - 47639690	2	47412550 - 47412551	188205	185978	rs786204144	NC_000002.12:47412550::A
NM_000251.2(MSH2):c.2283del (p.Gly761_Leu762insTer)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 10, 2014)	criteria provided, single submitter	VCV000188073	2	47705481	2	47478342	188073	185985	rs786204050	NC_000002.12:47478341:GGG:GG
NM_000251.2(MSH2):c.212-478T>G	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090894	2	47635062	2	47407923	90894	96369	rs587779138	NC_000002.12:47407922:T:G
NM_206933.3(USH2A):c.11156G>A (p.Arg3719His)	USH2A	R3719H	Retinitis pigmentosa 39|Usher syndrome, type 2A|Retinitis pigmentosa|Retinal dystrophy|not provided|Usher syndrome, type 2A|Retinitis pigmentosa 39	Pathogenic/Likely pathogenic(Last reviewed: May 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143170	1	215933077	1	215759735	143170	152888	rs527236139	NC_000001.11:215759734:C:T
NM_206933.4(USH2A):c.9799T>C (p.Cys3267Arg)	USH2A	C3267R	Rare genetic deafness|Retinitis pigmentosa|Retinal dystrophy|Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048634	1	215972408	1	215799066	48634	57796	rs111033263	NC_000001.11:215799065:A:G
NM_206933.4(USH2A):c.2209C>T (p.Arg737Ter)	USH2A	R737*	Usher syndrome type 2|Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002361	1	216420527	1	216247185	2361	17400	rs111033334	NC_000001.11:216247184:G:A
NM_006920.6(SCN1A):c.2759G>A (p.Arg920His)	SCN1A	R920H, R931H, R902H, R919H, R903H, R117H	Early infantile epileptic encephalopathy|not provided|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2|Severe myoclonic epilepsy in infancy|Familial hemiplegic migraine type 3	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189869	2	166894440	2	166037930	189869	187795	rs794726718	NC_000002.12:166037929:C:T
NM_000530.8(MPZ):c.371C>T (p.Thr124Met)	MPZ	T124M, T134M	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease|Congenital hypomyelinating neuropathy 1, autosomal recessive||Dejerine-Sottas disease|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease, demyelinating, type 1b|Roussy-Lévy syndrome|not provided|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014181	1	161276575	1	161306785	14181	29220	rs121913595	NC_000001.11:161306784:G:A
NM_001172509.2(SATB2):c.847C>T (p.Arg283Ter)	SATB2	R283*	Chromosome 2q32-q33 deletion syndrome|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208673	2	200213750	2	199349027	208673	205228	rs797044874	NC_000002.12:199349026:G:A
NM_201253.3(CRB1):c.2843G>A (p.Cys948Tyr)	CRB1	C948Y, C836Y, C924Y	Leber congenital amaurosis 8|Retinitis pigmentosa 12|CRB1-Related Disorders|Retinitis pigmentosa 12|Leber congenital amaurosis 8|Retinal dystrophy|not provided|Leber congenital amaurosis 1|Leber congenital amaurosis 8|Retinitis pigmentosa 12|Pigmented paravenous chorioretinal atrophy|Retinitis pigmentosa	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039614	1	197403836	1	197434706	39614	48213	rs62645748	NC_000001.11:197434705:G:A
NM_001130987.2(DYSF):c.5830C>T (p.Arg1944Ter)	DYSF	R1905*, R1926*, R1944*, R1922*, R1923*, R1936*, R1891*, R1892*, R1906*, R1913*, R1937*, R1943*, R1912*, R1927*	Miyoshi muscular dystrophy 1|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B|Qualitative or quantitative defects of dysferlin|Myopathy, distal, with anterior tibial onset	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006676	2	71901372	2	71674242	6676	21715	rs121908959	NC_000002.12:71674241:C:T
NM_000251.3(MSH2):c.2332dup (p.Cys778fs)	MSH2		Lynch syndrome I	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801692	2	47705527 - 47705528	2	47478388 - 47478389	801692	790261		NC_000002.12:47478388:TTTTT:TTTTTT
NM_000251.3(MSH2):c.2299del (p.Ser767fs)	MSH2	S767fs, S701fs	Lynch syndrome I	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801691	2	47705499	2	47478360	801691	790260		NC_000002.12:47478359:T:
NM_000251.3(MSH2):c.1058del (p.Lys353fs)	MSH2	K353fs, K287fs	Lynch syndrome I	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801688	2	47643549	2	47416410	801688	790257		NC_000002.12:47416409:AA:A
NM_000251.3(MSH2):c.198C>G (p.Tyr66Ter)	MSH2	Y66*	Lynch syndrome I	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801677	2	47630528	2	47403389	801677	790246		NC_000002.12:47403388:C:G
NM_000251.2(MSH2):c.1077_1276del200 (p.Leu360Lysfs)	MSH2		Lynch syndrome	Pathogenic	criteria provided, single submitter	VCV000433906	2	47656879 - 47657078	2	47429740 - 47429939	433906	427142	rs1553356518	
NM_000251.2(MSH2):c.2425G>T (p.Glu809Ter)	MSH2	E809*, E743*	Lynch syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000433901	2	47705625	2	47478486	433901	427164	rs202145681	NC_000002.12:47478485:G:T
NM_000251.2(MSH2):c.1708del (p.Tyr570fs)	MSH2	Y504fs, Y570fs	Lynch syndrome I	Pathogenic(Last reviewed: Nov 4, 2014)	criteria provided, single submitter	VCV000430964	2	47698150	2	47471011	430964	424486	rs1131692279	NC_000002.12:47471010:T:
NM_000251.2(MSH2):c.1277-4076_1386+1819del	MSH2		Lynch syndrome I	Pathogenic(Last reviewed: Apr 20, 2016)	reviewed by expert panel	VCV000427611	2	47668611 - 47674615	2	47441472 - 47447476	427611	416958		
NM_000251.2(MSH2):c.1277-6224_1386+4836del	MSH2		Lynch syndrome I	Pathogenic(Last reviewed: Apr 20, 2016)	reviewed by expert panel	VCV000427610	2	47666463 - 47677632	2	47439324 - 47450493	427610	416957		
NM_000251.2(MSH2):c.1277-6284_1386+4776del	MSH2		Lynch syndrome I	Pathogenic(Last reviewed: Apr 20, 2016)	reviewed by expert panel	VCV000427609	2	47666403 - 47677572	2	47439264 - 47450433	427609	416956		
NM_000251.2(MSH2):c.793-?_1076+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091213					91213	96688		
NM_000251.2(MSH2):c.643C>T (p.Gln215Ter)	MSH2	Q215*, Q149*	not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091154	2	47637509	2	47410370	91154	96629	rs63751274	NC_000002.12:47410369:C:T
NM_000251.2(MSH2):c.551del (p.Phe184fs)	MSH2	F118fs, F184fs	not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091132	2	47637416	2	47410277	91132	96607	rs267607928	NC_000002.12:47410276:TT:T
NM_000251.2(MSH2):c.488T>G (p.Val163Gly)	MSH2	V163G, V97G	Lynch syndrome I	Pathogenic(Last reviewed: Mar 18, 2015)	reviewed by expert panel	VCV000091108	2	47637354	2	47410215	91108	96583	rs63750214	NC_000002.12:47410214:T:G
NM_000251.2(MSH2):c.367-?_645+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091084					91084	96559		
NM_000251.2(MSH2):c.367-?_1276+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091081					91081	96556		
NM_000251.2(MSH2):c.263_264del (p.Phe88fs)	MSH2	F88fs, F22fs	not specified|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091029	2	47635589 - 47635590	2	47408450 - 47408451	91029	96504	rs267607920	NC_000002.12:47408449:TTTT:TT
NM_000251.2(MSH2):c.2536C>T (p.Gln846Ter)	MSH2	Q846*, Q780*	not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090996	2	47707912	2	47480773	90996	96471	rs63750857	NC_000002.12:47480772:C:T
NM_000251.2(MSH2):c.212-?_1076+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090895					90895	96370		
NM_000251.2(MSH2):c.2091T>A (p.Cys697Ter)	MSH2	C697*, C631*	not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090884	2	47703591	2	47476452	90884	96359	rs63750872	NC_000002.12:47476451:T:A
NM_000251.2(MSH2):c.2089T>C (p.Cys697Arg)	MSH2	C697R, C631R	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090882	2	47703589	2	47476450	90882	96357	rs63750961	NC_000002.12:47476449:T:C
NM_000251.2(MSH2):c.1982_1985del (p.Lys661fs)	MSH2	K595fs, K661fs	not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090827	2	47702385 - 47702388	2	47475246 - 47475249	90827	96302	rs587779120	NC_000002.12:47475245:AAACA:A
NM_000251.2(MSH2):c.1967_1970dup (p.Phe657fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090824	2	47702369 - 47702370	2	47475230 - 47475231	90824	96299	rs587779118	NC_000002.12:47475230:TACTT:TACTTACTT
NM_000251.2(MSH2):c.1853del (p.Pro618fs)	MSH2	P618fs, P552fs	not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090800	2	47702256	2	47475117	90800	96275	rs267607984	NC_000002.12:47475116:CC:C
NM_000251.2(MSH2):c.1667del (p.Lys555_Leu556insTer)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090739	2	47698108	2	47470969	90739	96214	rs267607694	NC_000002.12:47470968:TT:T
NM_000251.2(MSH2):c.1662-?_1759+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090733					90733	96208		
NM_000251.2(MSH2):c.1576del (p.Thr526fs)	MSH2	T526fs, T460fs	not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090702	2	47693861	2	47466722	90702	96177	rs63750094	NC_000002.12:47466721:AA:A
NM_000251.2(MSH2):c.1528C>T (p.Gln510Ter)	MSH2	Q510*, Q444*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090693	2	47693814	2	47466675	90693	96168	rs587779097	NC_000002.12:47466674:C:T
NM_000251.2(MSH2):c.1444A>T (p.Arg482Ter)	MSH2	R482*, R416*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090664	2	47690227	2	47463088	90664	96139	rs587779092	NC_000002.12:47463087:A:T
NM_000251.2(MSH2):c.1387-?_1661+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090651					90651	96126		
NM_000251.2(MSH2):c.1277-?_2634+?del	MSH2		not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090615					90615	96090		
NM_000251.2(MSH2):c.1277-?_1661+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090613					90613	96088		
NM_000251.2(MSH2):c.1018dup (p.Arg340fs)	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090506	2	47643507 - 47643508	2	47416368 - 47416369	90506	95981	rs63750703	NC_000002.12:47416368:AAA:AAAA
NM_000251.2(MSH2):c.(?_-68)_1076+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090465	2	47630263 - 47643568	2	47403124 - 47416429	90465	95940		
NM_170707.4(LMNA):c.607G>A (p.Glu203Lys)	LMNA	E203K, E91K, E122K	Dilated cardiomyopathy 1A|not provided|Primary dilated cardiomyopathy|Cardiovascular phenotype|Charcot-Marie-Tooth disease, type 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000048070	1	156104287	1	156134496	48070	57234	rs61195471	NC_000001.11:156134495:G:A
NM_170707.4(LMNA):c.481G>A (p.Glu161Lys)	LMNA	E161K, E80K, E49K	not provided|Primary dilated cardiomyopathy|Dilated cardiomyopathy 1A|Charcot-Marie-Tooth disease, type 2	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014504	1	156100532	1	156130741	14504	29543	rs28933093	NC_000001.11:156130740:G:A
NM_170707.4(LMNA):c.1357C>T (p.Arg453Trp)	LMNA	R453W, R341W, R372W	Muscular dystrophy|not provided|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Limb-girdle muscular dystrophy, type 1B|Charcot-Marie-Tooth disease, type 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014478	1	156106204	1	156136413	14478	29517	rs58932704	NC_000001.11:156136412:C:T
NM_001276345.2(TNNT2):c.266T>A (p.Ile89Asn)	TNNT2	I79N, I89N, I74N, I88N	Cardiovascular phenotype|not provided|Familial hypertrophic cardiomyopathy 2|Familial restrictive cardiomyopathy 3|Left ventricular noncompaction 6|Left ventricular noncompaction 6|Hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy 3|Familial hypertrophic cardiomyopathy 2	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012408	1	201334766	1	201365638	12408	27447	rs121964855	NC_000001.11:201365637:A:T
NM_003000.3(SDHB):c.287-1G>C	SDHB		Paragangliomas 4|Pheochromocytoma|Paragangliomas 4|Gastrointestinal stromal tumor|Hereditary cancer-predisposing syndrome|not provided|Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic/Likely pathogenic(Last reviewed: Jul 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000044642	1	17355232	1	17028737	44642	53809	rs397516833	NC_000001.11:17028736:C:G
NM_003001.5(SDHC):c.397C>T (p.Arg133Ter)	SDHC	R133*, R80*, R99*	not provided|Gastrointestinal stromal tumor|Paragangliomas 3|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Hereditary cancer-predisposing syndrome|Paragangliomas 3	Pathogenic(Last reviewed: Dec 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183753	1	161326622	1	161356832	183753	181600	rs764575966	NC_000001.11:161356831:C:T
NM_001035.3(RYR2):c.6737C>T (p.Ser2246Leu)	RYR2	S2246L	not provided|Catecholaminergic polymorphic ventricular tachycardia|Catecholaminergic polymorphic ventricular tachycardia type 1	Pathogenic(Last reviewed: Aug 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012954	1	237798237	1	237634937	12954	27993	rs121918597	NC_000001.11:237634936:C:T
NM_206933.4(USH2A):c.13010C>T (p.Thr4337Met)	USH2A	T4337M	not provided|Retinitis pigmentosa 39|Usher syndrome, type 2A|Rare genetic deafness|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143172	1	215848243	1	215674901	143172	152890	rs527236137	NC_000001.11:215674900:G:A
NM_000251.2(MSH2):c.2083G>A (p.Val695Met)	MSH2	V695M, V629M	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Oct 18, 2018)	reviewed by expert panel	VCV000633496	2	47703583	2	47476444	633496	621925	rs772491283	NC_000002.12:47476443:G:A
NM_000251.2(MSH2):c.1511-1G>A	MSH2		Lynch syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000619529	2	47693796	2	47466657	619529	610972	rs267607964	NC_000002.12:47466656:G:A
NM_000251.2(MSH2):c.1224T>G (p.Tyr408Ter)	MSH2	Y408*, Y342*	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000486881	2	47657028	2	47429889	486881	472813	rs63750132	NC_000002.12:47429888:T:G
NM_001258281.1(MSH2):c.-31+91del	MSH2	M26fs	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000483722	2	47630405	2	47403266	483722	472715	rs1553348760	NC_000002.12:47403265:C:
NM_000251.3(MSH2):c.645+2T>C	MSH2		Lynch syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000450032	2	47637513	2	47410374	450032	443255	rs876658996	NC_000002.12:47410373:T:C
NM_000251.2(MSH2):c.1692_1693del (p.Lys565_Asn566insTer)	MSH2		Lynch syndrome I	Pathogenic(Last reviewed: Jan 24, 2013)	no assertion criteria provided	VCV000438795	2	47698134 - 47698135	2	47470995 - 47470996	438795	432377	rs1553367635	NC_000002.12:47470994:CA:
NM_000251.2:c.1760-?_2805+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: May 20, 2015)	criteria provided, single submitter	VCV000433585	2	47702164 - 47710088			433585	427594		
NM_000251.2(MSH2):c.2459_2460GT[1] (p.Val821fs)	MSH2		Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428483	2	47707835 - 47707836	2	47480696 - 47480697	428483	419418	rs1114167828	NC_000002.12:47480695:GTGT:GT
NM_000251.2(MSH2):c.388C>T (p.Gln130Ter)	MSH2	Q130*, Q64*	not provided|Lynch syndrome	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000408452	2	47637254	2	47410115	408452	393062	rs1060501989	NC_000002.12:47410114:C:T
NM_000251.2(MSH2):c.912dup (p.Ala305fs)	MSH2		Lynch syndrome|not provided	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000216863	2	47641525 - 47641526	2	47414386 - 47414387	216863	212189	rs863224833	NC_000002.12:47414386:TT:TTT
NM_000251.2(MSH2):c.746del (p.Lys249fs)	MSH2	K249fs, K183fs	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091195	2	47639649	2	47412510	91195	96670	rs63749832	NC_000002.12:47412509:AAAAA:AAAA
NM_000251.2(MSH2):c.652C>T (p.Gln218Ter)	MSH2	Q218*, Q152*	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091173	2	47639559	2	47412420	91173	96648	rs587779170	NC_000002.12:47412419:C:T
NM_000251.2(MSH2):c.490G>A (p.Gly164Arg)	MSH2	G164R, G98R	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091109	2	47637356	2	47410217	91109	96584	rs63750582	NC_000002.12:47410216:G:A
NM_000251.2(MSH2):c.478C>T (p.Gln160Ter)	MSH2	Q160*, Q94*	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091103	2	47637344	2	47410205	91103	96578	rs63751426	NC_000002.12:47410204:C:T
NM_000251.2(MSH2):c.2204del (p.Ile735fs)	MSH2	I669fs, I735fs	Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090919	2	47703704	2	47476565	90919	96394	rs63750572	NC_000002.12:47476564:T:
NM_000251.2(MSH2):c.186_187dup (p.Val63fs)	MSH2		Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090806	2	47630512 - 47630513	2	47403373 - 47403374	90806	96281	rs63750160	NC_000002.12:47403373:GGGGG:GGGGGGG
NM_000251.2(MSH2):c.1857T>G (p.Tyr619Ter)	MSH2	Y619*, Y553*	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090802	2	47702261	2	47475122	90802	96277	rs63750312	NC_000002.12:47475121:T:G
NM_000251.2(MSH2):c.1787dup (p.Asn596fs)	MSH2		Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090787	2	47702189 - 47702190	2	47475050 - 47475051	90787	96262	rs587779111	NC_000002.12:47475050:AA:AAA
NM_000251.2(MSH2):c.1777C>T (p.Gln593Ter)	MSH2	Q593*, Q527*	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090783	2	47702181	2	47475042	90783	96258	rs63750200	NC_000002.12:47475041:C:T
NM_000251.2(MSH2):c.1578del (p.Cys527fs)	MSH2	C461fs, C527fs	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090703	2	47693863	2	47466724	90703	96178	rs63750738	NC_000002.12:47466723:CC:C
NM_001258281.1(MSH2):c.1118_1119CT[1] (p.Leu374fs)	MSH2		Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090624	2	47672726 - 47672727	2	47445587 - 47445588	90624	96099	rs587779083	NC_000002.12:47445586:CTCT:CT
MSH2, 3.5-KB DEL AND 15-BP INS	MSH2		Lynch syndrome I	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000041413					41413	49845		
NM_000251.2(MSH2):c.1077-66_1146del	MSH2		Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000036563	2	47656812 - 47656947	2	47429673 - 47429808	36563	45225	rs193922372	
nsv513794	MSH2		Lynch syndrome I	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000001769					1769	16808		
MSH2, 24-BP INS	MSH2		Lynch syndrome I	Pathogenic(Last reviewed: Feb 17, 2000)	no assertion criteria provided	VCV000001765					1765	16804		
NM_014874.3(MFN2):c.674_680del (p.Leu225fs)	MFN2	L225fs	Inborn genetic diseases|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jul 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000408319	1	12058899 - 12058905	1	11998842 - 11998848	408319	390816	rs1060501915	NC_000001.11:11998841:GCTGGTGGC:GC
NM_014874.3(MFN2):c.839G>A (p.Arg280His)	MFN2	R280H	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 2|not provided|Charcot-Marie-Tooth disease, type 2A2A	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002271	1	12061480	1	12001423	2271	17310	rs28940294	NC_000001.11:12001422:G:A
NM_206933.3(USH2A):c.4510dup (p.Arg1504fs)	USH2A		Retinitis pigmentosa|Retinal dystrophy|Usher syndrome, type 2A|Retinitis pigmentosa 39|Rare genetic deafness|Usher syndrome|not provided	Pathogenic(Last reviewed: Sep 10, 2018)	reviewed by expert panel	VCV000166504	1	216348710 - 216348711	1	216175368 - 216175369	166504	172390	rs727503731	NC_000001.11:216175368:TTT:TTTT
NM_206933.4(USH2A):c.802G>A (p.Gly268Arg)	USH2A	G268R	Usher syndrome|Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided|Usher syndrome type 2|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048592	1	216500979	1	216327637	48592	57754	rs111033280	NC_000001.11:216327636:C:T
NM_206933.4(USH2A):c.1606T>C (p.Cys536Arg)	USH2A	C536R	Usher syndrome, type 2A|Rare genetic deafness|not provided|Retinitis pigmentosa|Retinal dystrophy|Retinitis pigmentosa 39	Pathogenic(Last reviewed: Sep 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048471	1	216495263	1	216321921	48471	57633	rs111033273	NC_000001.11:216321920:A:G
NM_206933.4(USH2A):c.10712C>T (p.Thr3571Met)	USH2A	T3571M	not provided|Rare genetic deafness|Retinal dystrophy|Retinitis pigmentosa 39|Usher syndrome, type 2A|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000048355	1	215955412	1	215782070	48355	57517	rs202175091	NC_000001.11:215782069:G:A
NM_206933.3(USH2A):c.7595-2144A>G	USH2A		not provided|Usher syndrome, type 2A|Retinal dystrophy|Usher syndrome type 2|Retinitis pigmentosa 39|Usher syndrome, type 2A|Usher syndrome|Retinitis pigmentosa	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030722	1	216064540	1	215891198	30722	39679	rs786200928	NC_000001.11:215891197:T:C
NM_206933.3(USH2A):c.4334_4335CT[2] (p.Cys1447fs)	USH2A		Usher syndrome|USH2A-Related Disorders|Retinal dystrophy|Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided	Pathogenic(Last reviewed: Sep 25, 2018)	reviewed by expert panel	VCV000002353	1	216363622 - 216363623	1	216190280 - 216190281	2353	17392	rs111033367	NC_000001.11:216190279:AGAGAG:AGAG
NM_001172509.2(SATB2):c.1165C>T (p.Arg389Cys)	SATB2	R389C	Inborn genetic diseases|Chromosome 2q32-q33 deletion syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000381575	2	200213432	2	199348709	381575	366251	rs1057521083	NC_000002.12:199348708:G:A
NM_000251.2(MSH2):c.354T>G (p.Tyr118Ter)	MSH2	Y118*, Y52*	Lynch syndrome I|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000548765	2	47635682	2	47408543	548765	539204	rs1553350250	NC_000002.12:47408542:T:G
NM_000251.2(MSH2):c.1656del (p.Asn553fs)	MSH2	N487fs, N553fs	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 20, 2015)	criteria provided, multiple submitters, no conflicts	VCV000428467	2	47693941	2	47466802	428467	419370	rs1114167817	NC_000002.12:47466801:CC:C
NM_000251.2(MSH2):c.1838dup (p.Asn613fs)	MSH2		Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428465	2	47702239 - 47702240	2	47475100 - 47475101	428465	419379	rs1114167815	NC_000002.12:47475100:AAA:AAAA
NM_000251.2(MSH2):c.687_688insT (p.Ala230fs)	MSH2		Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 4, 2014)	criteria provided, multiple submitters, no conflicts	VCV000428462	2	47639594 - 47639595	2	47412455 - 47412456	428462	419336	rs63750364	NC_000002.12:47412455::T
NM_000251.2(MSH2):c.1510+2T>C	MSH2		Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 30, 2016)	criteria provided, multiple submitters, no conflicts	VCV000408532	2	47690295	2	47463156	408532	393119	rs1060502023	NC_000002.12:47463155:T:C
NM_000251.2(MSH2):c.896_897AT[3] (p.Met300fs)	MSH2		Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091240	2	47641509 - 47641510	2	47414370 - 47414371	91240	96715	rs63750885	NC_000002.12:47414370:TATAT:TATATAT
NM_000251.2(MSH2):c.82G>T (p.Glu28Ter)	MSH2	E28*	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091225	2	47630412	2	47403273	91225	96700	rs63751246	NC_000002.12:47403272:G:T
NM_000251.2(MSH2):c.705del (p.Asp236fs)	MSH2	D236fs, D170fs	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091183	2	47639609	2	47412470	91183	96658	rs281864944	NC_000002.12:47412469:AAAA:AAA
NM_000251.2(MSH2):c.650_654del (p.Ile217fs)	MSH2	I151fs, I217fs	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091172	2	47639555 - 47639559	2	47412416 - 47412420	91172	96647	rs63751602	NC_000002.12:47412415:AATTCAA:AA
NM_000251.2(MSH2):c.646-3T>G	MSH2		Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091162	2	47639550	2	47412411	91162	96637	rs267607930	NC_000002.12:47412410:T:G
NM_000251.2(MSH2):c.638_639del (p.Leu213fs)	MSH2	L147fs, L213fs	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091152	2	47637504 - 47637505	2	47410365 - 47410366	91152	96627	rs63751622	NC_000002.12:47410364:TG:
NM_000251.2(MSH2):c.513del (p.Lys172fs)	MSH2	K172fs, K106fs	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091120	2	47637378	2	47410239	91120	96595	rs63750933	NC_000002.12:47410238:GG:G
NM_000251.3(MSH2):c.2581C>T (p.Gln861Ter)	MSH2	Q861*, Q795*	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091007	2	47707957	2	47480818	91007	96482	rs63750291	NC_000002.12:47480817:C:T
NM_001258281.1(MSH2):c.2266_2267TG[1] (p.Cys756_Asp757delinsTer)	MSH2		Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090981	2	47707840 - 47707841	2	47480701 - 47480702	90981	96456	rs63751621	NC_000002.12:47480700:TGTG:TG
NM_000251.2(MSH2):c.2292G>A (p.Trp764Ter)	MSH2	W764*, W698*	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090949	2	47705492	2	47478353	90949	96424	rs63751105	NC_000002.12:47478352:G:A
NM_000251.2(MSH2):c.2046_2047del (p.Val684fs)	MSH2	V618fs, V684fs	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090867	2	47703546 - 47703547	2	47476407 - 47476408	90867	96342	rs587779131	NC_000002.12:47476406:TG:
NM_000251.2(MSH2):c.2010del (p.Asn671fs)	MSH2	N605fs, N671fs	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090856	2	47703507	2	47476368	90856	96331	rs63751123	NC_000002.12:47476367:CCCC:CCC
NM_000251.2(MSH2):c.2006-?_2210+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090851					90851	96326		
NM_000251.2(MSH2):c.187dup (p.Val63fs)	MSH2		Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090809	2	47630512 - 47630513	2	47403373 - 47403374	90809	96284	rs63750160	NC_000002.12:47403373:GGGGG:GGGGGG
NM_000251.2(MSH2):c.1702dup (p.Thr568fs)	MSH2		Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090756	2	47698140 - 47698141	2	47471001 - 47471002	90756	96231	rs587779105	NC_000002.12:47471001:AAAA:AAAAA
NM_000251.2(MSH2):c.1399G>T (p.Glu467Ter)	MSH2	E467*, E401*	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090656	2	47690182	2	47463043	90656	96131	rs587779089	NC_000002.12:47463042:G:T
NM_000251.2(MSH2):c.1387-9T>A	MSH2		Hereditary nonpolyposis colon cancer|Lynch syndrome I	Pathogenic(Last reviewed: Oct 10, 2014)	reviewed by expert panel	VCV000090648	2	47690161	2	47463022	90648	96123	rs587779087	NC_000002.12:47463021:T:A
NM_001258281.1(MSH2):c.-30-33_-30-5del	MSH2	H46fs	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090639	2	47630464 - 47630492	2	47403325 - 47403353	90639	96114	rs63751482	NC_000002.12:47403324:CGCACGGCGAGGACGCGCTGCTGGCCGCCCG:CG
NM_000251.2(MSH2):c.1129C>T (p.Gln377Ter)	MSH2	Q377*, Q311*	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090550	2	47656933	2	47429794	90550	96025	rs63750267	NC_000002.12:47429793:C:T
MSH2, 19.28-KB DEL	MSH2		Lynch syndrome I	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000041414					41414	49846		
MSH2, DEL 50 CODONS	MSH2		Lynch syndrome I	Pathogenic(Last reviewed: Dec 17, 1993)	no assertion criteria provided	VCV000001754					1754	16793		
NM_014874.3(MFN2):c.280C>T (p.Arg94Trp)	MFN2	R94W	Charcot-Marie-Tooth disease, type 2|not provided|Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease, type 2A2A|Abnormality of dental enamel|Decreased body weight|Nail dystrophy|Scarring alopecia of scalp|Microcephaly|EMG abnormality|Scarring|Hyperpigmentation of the skin|Abnormal blistering of the skin|Abnormality of the dentition|Alopecia of scalp|Failure to thrive|Distal muscle weakness|Short stature	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002276	1	12052716	1	11992659	2276	17315	rs119103263	NC_000001.11:11992658:C:T
NM_001128425.1(MUTYH):c.857G>A (p.Gly286Glu)	MUTYH	G286E, G258E, G283E, G143E, G272E, G273E, G166E, G259E, G269E	MYH-associated polyposis|not provided|MUTYH-associated polyposis|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000182691	1	45797914	1	45332242	182691	179933	rs730881833	NC_000001.11:45332241:C:T
NM_025216.3(WNT10A):c.321C>A (p.Cys107Ter)	WNT10A	C107*	Schopf-Schulz-Passarge syndrome|Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4|Odonto-onycho-dermal dysplasia|Inborn genetic diseases|not provided|WNT10A-Related Disorders|Tooth agenesis, selective, 4|Tooth agenesis, selective, 4|Odonto-onycho-dermal dysplasia|Schopf-Schulz-Passarge syndrome	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004461	2	219747090	2	218882368	4461	19500	rs121908119	NC_000002.12:218882367:C:A
NM_003000.2(SDHB):c.688C>T (p.Arg230Cys)	SDHB	R230C	Hereditary Paraganglioma-Pheochromocytoma Syndromes|Paragangliomas 4|not provided|Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000185077	1	17349180	1	17022685	185077	181608	rs138996609	NC_000001.11:17022684:G:A
NM_003000.2(SDHB):c.423+1G>A	SDHB		Paragangliomas 4|Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|Carney-Stratakis syndrome|Pheochromocytoma|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Paragangliomas 4|Hereditary cancer-predisposing syndrome|not specified|not provided	Pathogenic(Last reviewed: Nov 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000029896	1	17355094	1	17028599	29896	38851	rs398122805	NC_000001.11:17028598:C:T
NM_001035.3(RYR2):c.527G>A (p.Arg176Gln)	RYR2	R176Q	Catecholaminergic polymorphic ventricular tachycardia type 1|not provided|Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000201194	1	237540686	1	237377386	201194	196513	rs794728708	NC_000001.11:237377385:G:A
NM_001035.3(RYR2):c.13489C>T (p.Arg4497Cys)	RYR2	R4497C	Cardiovascular phenotype|not provided|Catecholaminergic polymorphic ventricular tachycardia|Catecholaminergic polymorphic ventricular tachycardia type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012957	1	237954741	1	237791441	12957	27996	rs121918600	NC_000001.11:237791440:C:T
NM_153759.3(DNMT3A):c.1969C>T (p.Gln657Ter)	DNMT3A	Q657*, Q846*, Q694*	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000521889	2	25458637	2	25235768	521889	511415	rs781139634	NC_000002.12:25235767:G:A
NM_000251.2(MSH2):c.1801_1805del (p.Gln601fs)	MSH2	Q601fs, Q535fs	Lynch syndrome I|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000656413	2	47702201 - 47702205	2	47475062 - 47475066	656413	630144		NC_000002.12:47475061:AGCTCAGCT:AGCT
NM_000251.2(MSH2):c.644del (p.Gln215fs)	MSH2	Q149fs, Q215fs	Lynch syndrome I|Lynch syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000584606	2	47637510	2	47410371	584606	575670	rs1558459885	NC_000002.12:47410370:A:
NM_000251.2(MSH2):c.1520del (p.Pro507fs)	MSH2	P441fs, P507fs	Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000455503	2	47693804	2	47466665	455503	451137	rs1553366510	NC_000002.12:47466664:CCC:CC
NM_000251.2(MSH2):c.1401del (p.Glu467fs)	MSH2	E401fs, E467fs	Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000455489	2	47690183	2	47463044	455489	451314	rs1553365711	NC_000002.12:47463043:AA:A
NM_000251.2(MSH2):c.1901T>G (p.Leu634Ter)	MSH2	L634*, L568*	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428455	2	47702305	2	47475166	428455	419385	rs1114167811	NC_000002.12:47475165:T:G
NM_001258281.1(MSH2):c.810del (p.Gln271fs)	MSH2	Q271fs, Q337fs	Lynch syndrome|not provided	Pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000245686	2	47643500	2	47416361	245686	244380	rs879253899	NC_000002.12:47416360:T:
NM_000251.3(MSH2):c.1984C>T (p.Gln662Ter)	MSH2	Q662*, Q596*	not provided|Lynch syndrome	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188516	2	47702388	2	47475249	188516	186313	rs786204321	NC_000002.12:47475248:C:T
NM_000251.2(MSH2):c.862C>T (p.Gln288Ter)	MSH2	Q288*, Q222*	not provided|Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091233	2	47641477	2	47414338	91233	96708	rs63750097	NC_000002.12:47414337:C:T
NM_000251.2(MSH2):c.610G>T (p.Gly204Ter)	MSH2	G204*, G138*	Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091149	2	47637476	2	47410337	91149	96624	rs63750574	NC_000002.12:47410336:G:T
NM_000251.2(MSH2):c.587del (p.Pro196fs)	MSH2	P196fs, P130fs	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091142	2	47637452	2	47410313	91142	96617	rs63750682	NC_000002.12:47410312:CC:C
NM_000251.2(MSH2):c.547C>T (p.Gln183Ter)	MSH2	Q183*, Q117*	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091130	2	47637413	2	47410274	91130	96605	rs63750037	NC_000002.12:47410273:C:T
NM_000251.2(MSH2):c.1661G>C (p.Ser554Thr)	MSH2	S554T, S488T	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090724	2	47693947	2	47466808	90724	96199	rs63750597	NC_000002.12:47466807:G:C
NM_000251.2(MSH2):c.1321dup (p.Thr441fs)	MSH2		Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090629	2	47672730 - 47672731	2	47445591 - 47445592	90629	96104	rs63750807	NC_000002.12:47445591:A:AA
NM_000251.2(MSH2):c.1319T>C (p.Leu440Pro)	MSH2	L440P, L374P	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090625	2	47672729	2	47445590	90625	96100	rs587779084	NC_000002.12:47445589:T:C
NM_000251.2(MSH2):c.1277-2A>G	MSH2		Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090605	2	47672685	2	47445546	90605	96080	rs267607949	NC_000002.12:47445545:A:G
NM_000251.2(MSH2):c.454del (p.Met152fs)	MSH2	M86fs, M152fs	Lynch syndrome|Turcot syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000001768	2	47637317	2	47410178	1768	16807	rs63751449	NC_000002.12:47410177:AAAA:AAA
NM_000251.2(MSH2):c.269_290dup (p.Tyr98fs)	MSH2		Lynch syndrome|Muir-Torré syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000001761	2	47635595 - 47635596	2	47408456 - 47408457	1761	16800	rs1553350126	NC_000002.12:47408456:AAAGATCTTCTTCTGGTTCGTCA:AAAGATCTTCTTCTGGTTCGTCAAAGATCTTCTTCTGGTTCGTCA
NM_006920.6(SCN1A):c.2804G>A (p.Arg935His)	SCN1A	R935H, R946H, R132H, R934H, R917H, R918H	Generalized epilepsy with febrile seizures plus, type 2|not provided|Severe myoclonic epilepsy in infancy|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000068523	2	166894395	2	166037885	68523	79415	rs121917971	NC_000002.12:166037884:C:T
NM_006920.6(SCN1A):c.1178G>A (p.Arg393His)	SCN1A	R393H	Early infantile epileptic encephalopathy|not provided|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068506	2	166903479	2	166046969	68506	79398	rs121917927	NC_000002.12:166046968:C:T
NM_001276345.2(TNNT2):c.421C>T (p.Arg141Trp)	TNNT2	R131W, R141W, R126W, R101W	Cardiovascular phenotype|not provided|Familial hypertrophic cardiomyopathy 2|Familial restrictive cardiomyopathy 3|Left ventricular noncompaction 6|Left ventricular noncompaction 6|Primary dilated cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012415	1	201333494	1	201364366	12415	27454	rs74315380	NC_000001.11:201364365:G:A
NM_001276345.2(TNNT2):c.451C>T (p.Arg151Trp)	TNNT2	R141W, R151W, R111W, R136W	Primary dilated cardiomyopathy|Hypertrophic cardiomyopathy|not provided|Familial hypertrophic cardiomyopathy 2|Familial restrictive cardiomyopathy 3|Left ventricular noncompaction 6|Familial isolated dilated cardiomyopathy|Primary dilated cardiomyopathy|Left ventricular noncompaction 6	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012414	1	201333464	1	201364336	12414	27453	rs74315379	NC_000001.11:201364335:G:A
NM_003494.3(DYSF):c.2643+1G>A	DYSF		not provided|Miyoshi muscular dystrophy 1|Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy type 2B|Myopathy, distal, with anterior tibial onset|Autosomal recessive limb-girdle muscular dystrophy type 2B|Miyoshi muscular dystrophy 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094291	2	71795213	2	71568083	94291	100191	rs140108514	NC_000002.12:71568082:G:A
NM_170707.4(LMNA):c.673C>T (p.Arg225Ter)	LMNA	R225*, R113*, R144*	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1A|not provided|Limb-girdle muscular dystrophy, type 1B|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Sep 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048074	1	156104629	1	156134838	48074	57238	rs60682848	NC_000001.11:156134837:C:T
NM_007123.5(USH2A):c.99_100insT (p.Arg34fs)	USH2A		Inborn genetic diseases	Pathogenic(Last reviewed: Mar 19, 2015)	criteria provided, single submitter	VCV000520636	1	216595579 - 216595580	1	216422237 - 216422238	520636	511226	rs141672841	NC_000001.11:216422237::A
NM_206933.3(USH2A):c.13316C>T (p.Thr4439Ile)	USH2A	T4439I	Usher syndrome, type 2A|not provided|Retinal dystrophy|Usher syndrome, type 2A|Retinitis pigmentosa 39|Retinitis pigmentosa	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000198344	1	215847937	1	215674595	198344	195505	rs753330544	NC_000001.11:215674594:G:A
NM_000251.2(MSH2):c.2211-2A>G	MSH2		Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000433899	2	47705409	2	47478270	433899	427162	rs267608001	NC_000002.12:47478269:A:G
NM_000251.2(MSH2):c.2082del (p.Phe694fs)	MSH2	F628fs, F694fs	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000433894	2	47703579	2	47476440	433894	427157	rs63750689	NC_000002.12:47476439:TTTT:TTT
NM_000251.2(MSH2):c.1271dup (p.His424fs)	MSH2		Lynch syndrome I	Pathogenic(Last reviewed: Jul 24, 2014)	no assertion criteria provided	VCV000156506	2	47657074 - 47657075	2	47429935 - 47429936	156506	166271	rs587783055	NC_000002.12:47429935:A:AA
NM_000251.2(MSH2):c.943-?_1076+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091256					91256	96731		
NM_000251.2(MSH2):c.905T>A (p.Leu302Ter)	MSH2	L302*, L236*	Lynch syndrome I|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091242	2	47641520	2	47414381	91242	96717	rs63749914	NC_000002.12:47414380:T:A
NM_000251.2(MSH2):c.792+1G>A	MSH2		Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091205	2	47639700	2	47412561	91205	96680	rs267607934	NC_000002.12:47412560:G:A
NM_000251.2(MSH2):c.599T>A (p.Val200Asp)	MSH2	V200D, V134D	Lynch syndrome I|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 10, 2014)	reviewed by expert panel	VCV000091148	2	47637465	2	47410326	91148	96623	rs587779167	NC_000002.12:47410325:T:A
NM_000251.2(MSH2):c.518T>G (p.Leu173Arg)	MSH2	L173R, L107R	Lynch syndrome I|Lynch syndrome	Pathogenic(Last reviewed: Mar 9, 2018)	reviewed by expert panel	VCV000091122	2	47637384	2	47410245	91122	96597	rs63750070	NC_000002.12:47410244:T:G
NM_000251.2(MSH2):c.1552C>T (p.Gln518Ter)	MSH2	Q518*, Q452*	not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090696	2	47693838	2	47466699	90696	96171	rs63750780	NC_000002.12:47466698:C:T
NM_000251.2(MSH2):c.1352_1353del (p.Gln451fs)	MSH2	Q385fs, Q451fs	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090635	2	47672762 - 47672763	2	47445623 - 47445624	90635	96110	rs63750957	NC_000002.12:47445622:AG:
NM_000251.2(MSH2):c.1189C>T (p.Gln397Ter)	MSH2	Q397*, Q331*	Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090559	2	47656993	2	47429854	90559	96034	rs63750611	NC_000002.12:47429853:C:T
NM_000251.2(MSH2):c.1120C>T (p.Gln374Ter)	MSH2	Q374*, Q308*	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090548	2	47656924	2	47429785	90548	96023	rs63750558	NC_000002.12:47429784:C:T
NM_000251.2(MSH2):c.1077-2A>C	MSH2		Lynch syndrome I|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 10, 2014)	reviewed by expert panel	VCV000090528	2	47656879	2	47429740	90528	96003	rs267607943	NC_000002.12:47429739:A:C
NM_000310.3(PPT1):c.451C>T (p.Arg151Ter)	PPT1	R151*, R48*	|not provided|History of neurodevelopmental disorder|Neuronal Ceroid-Lipofuscinosis, Recessive|Neuronal ceroid lipofuscinosis	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008904	1	40555167	1	40089495	8904	23943	rs137852700	NC_000001.11:40089494:G:A
NM_001048171.1(MUTYH):c.842C>T (p.Pro281Leu)	MUTYH	P295L, P281L, P292L, P268L, P152L, P175L, P278L, P282L, P267L	not provided|MYH-associated polyposis|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000185242	1	45797887	1	45332215	185242	181683	rs374950566	NC_000001.11:45332214:G:A
NM_001048171.1(MUTYH):c.247C>T (p.Arg83Ter)	MUTYH	R97*, R83*, R69*, R70*, R80*, R94*, R84*	MUTYH-associated polyposis|not provided|MYH-associated polyposis|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000140827	1	45799144	1	45333472	140827	150541	rs138775799	NC_000001.11:45333471:G:A
NM_003000.2(SDHB):c.136C>T (p.Arg46Ter)	SDHB	R46*	Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|not provided|Paragangliomas 4|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000142763	1	17371320	1	17044825	142763	152477	rs74315370	NC_000001.11:17044824:G:A
NM_170707.4(LMNA):c.1045C>T (p.Arg349Trp)	LMNA	R349W, R237W, R268W	Charcot-Marie-Tooth disease, type 2|Familial partial lipodystrophy 2|Limb-girdle muscular dystrophy, type 1B|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Charcot-Marie-Tooth disease type 2B1|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Dilated cardiomyopathy 1A|Congenital muscular dystrophy, LMNA-related|Hutchinson-Gilford syndrome|Monogenic diabetes|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066762	1	156105800	1	156136009	66762	77659	rs267607555	NC_000001.11:156136008:C:T
NM_000251.2(MSH2):c.1759+1G>T	MSH2		Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000566832	2	47698202	2	47471063	566832	561641	rs587779108	NC_000002.12:47471062:G:T
NM_000251.2(MSH2):c.2656G>T (p.Glu886Ter)	MSH2	E886*, E820*	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000433904	2	47709939	2	47482800	433904	427167	rs1230083633	NC_000002.12:47482799:G:T
NM_000251.2(MSH2):c.1251_1268delinsAGTT (p.Ile418fs)	MSH2		Lynch syndrome|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000218031	2	47657055 - 47657072	2	47429916 - 47429933	218031	214581	rs863225388	NC_000002.12:47429915:TATACAGGCTCTGGAAAA:AGTT
NM_000251.2(MSH2):c.859G>T (p.Gly287Ter)	MSH2	G287*, G221*	Lynch syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091232	2	47641474	2	47414335	91232	96707	rs63750276	NC_000002.12:47414334:G:T
NM_000251.2(MSH2):c.577C>T (p.Gln193Ter)	MSH2	Q193*, Q127*	Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091141	2	47637443	2	47410304	91141	96616	rs63751326	NC_000002.12:47410303:C:T
NM_000251.2(MSH2):c.488T>A (p.Val163Asp)	MSH2	V163D, V97D	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091107	2	47637354	2	47410215	91107	96582	rs63750214	NC_000002.12:47410214:T:A
NM_000251.2(MSH2):c.367-?_1076+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091080					91080	96555		
NM_000251.2(MSH2):c.301G>T (p.Glu101Ter)	MSH2	E101*, E35*	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091059	2	47635629	2	47408490	91059	96534	rs63750318	NC_000002.12:47408489:G:T
NM_000251.2(MSH2):c.28C>T (p.Gln10Ter)	MSH2	Q10*	Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091055	2	47630358	2	47403219	91055	96530	rs63751099	NC_000002.12:47403218:C:T
NM_000251.2(MSH2):c.1687dup (p.Tyr563fs)	MSH2		Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090748	2	47698128 - 47698129	2	47470989 - 47470990	90748	96223	rs587779103	NC_000002.12:47470989:T:TT
NM_000251.2(MSH2):c.1354G>T (p.Glu452Ter)	MSH2	E452*, E386*	Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090636	2	47672764	2	47445625	90636	96111	rs267607954	NC_000002.12:47445624:G:T
NM_000251.2(MSH2):c.1255C>T (p.Gln419Ter)	MSH2	Q419*, Q353*	Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090584	2	47657059	2	47429920	90584	96059	rs63750006	NC_000002.12:47429919:C:T
NM_000251.2(MSH2):c.119del (p.Gly40fs)	MSH2	G40fs	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090563	2	47630446	2	47403307	90563	96038	rs63750984	NC_000002.12:47403306:GGGG:GGG
NM_000251.2(MSH2):c.1034G>A (p.Trp345Ter)	MSH2	W345*, W279*	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090509	2	47643526	2	47416387	90509	95984	rs63751027	NC_000002.12:47416386:G:A
NM_000251.1(MSH2):c.-823_1076+5984del	MSH2		Lynch syndrome|Lynch syndrome I	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090496	2	47629508 - 47649552	2	47402369 - 47422413	90496	95971		
MSH2, EX1-6 DEL	MSH2		Turcot syndrome|Lynch syndrome I	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000001767					1767	16806		
NM_206933.4(USH2A):c.1000C>T (p.Arg334Trp)	USH2A	R334W	Usher syndrome type 2|Retinal dystrophy|Rare genetic deafness|not provided|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000228411	1	216498790	1	216325448	228411	228349	rs397517963	NC_000001.11:216325447:G:A
NM_206933.4(USH2A):c.12067-2A>G	USH2A		not provided|Usher syndrome type 2|Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome, type 2A|Retinal dystrophy|Retinitis pigmentosa 39	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048390	1	215853720	1	215680378	48390	57552	rs397517978	NC_000001.11:215680377:T:C
NM_206933.4(USH2A):c.10561T>C (p.Trp3521Arg)	USH2A	W3521R	Usher syndrome, type 2A|not provided|Retinitis pigmentosa 39|Usher syndrome, type 2A|Rare genetic deafness|Usher syndrome|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048352	1	215956104	1	215782762	48352	57514	rs111033264	NC_000001.11:215782761:A:G
NM_153759.3(DNMT3A):c.1745G>A (p.Arg582Gln)	DNMT3A	R582Q, R771Q, R619Q	Tatton-Brown-rahman syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, single submitter	VCV000438287	2	25463181	2	25240312	438287	431903	rs757823678	NC_000002.12:25240311:C:T
NM_000447.3(PSEN2):c.422A>T (p.Asn141Ile)	PSEN2	N141I	not provided|Alzheimer disease, type 4	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008845	1	227073304	1	226885603	8845	23884	rs63750215	NC_000001.11:226885602:A:T
NM_006920.6(SCN1A):c.664C>T (p.Arg222Ter)	SCN1A	R222*	Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2|Severe myoclonic epilepsy in infancy|Familial hemiplegic migraine type 3|History of neurodevelopmental disorder|not provided|Early infantile epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Jan 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000012889	2	166909392	2	166052882	12889	27928	rs121918624	NC_000002.12:166052881:G:A
NM_003000.2(SDHB):c.587G>A (p.Cys196Tyr)	SDHB	C196Y	Paragangliomas 4|Hereditary cancer-predisposing syndrome|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|not provided	Pathogenic(Last reviewed: Aug 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000230070	1	17350523	1	17024028	230070	232176	rs876658367	NC_000001.11:17024027:C:T
NM_003000.2(SDHB):c.72+1G>T	SDHB		Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|Hereditary cancer-predisposing syndrome|not specified|Carney-Stratakis syndrome|not provided|Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000142764	1	17380442	1	17053947	142764	152478	rs587782703	NC_000001.11:17053946:C:A
NM_001128425.2(MUTYH):c.721C>T (p.Arg241Trp)	MUTYH	R241W, R227W, R214W, R224W, R121W, R213W, R228W, R238W, R98W	MYH-associated polyposis|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000185274	1	45798130	1	45332458	185274	181693	rs34126013	NC_000001.11:45332457:G:A
NM_000251.3(MSH2):c.1384C>T (p.Gln462Ter)	MSH2	Q462*, Q396*	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000228365	2	47672794	2	47445655	228365	228967	rs876657701	NC_000002.12:47445654:C:T
NM_000251.2(MSH2):c.408del (p.Phe136fs)	MSH2	F136fs, F70fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091094	2	47637272	2	47410133	91094	96569	rs63750408	NC_000002.12:47410132:TTT:TT
NM_000251.2(MSH2):c.367-?_1386+?del	MSH2		Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091082					91082	96557		
NM_001258281.1(MSH2):c.2190del (p.Val731fs)	MSH2	V731fs, V797fs	not provided|Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090963	2	47705588	2	47478449	90963	96438	rs63749983	NC_000002.12:47478448:T:
NM_000251.2(MSH2):c.2335dup (p.Met779fs)	MSH2		Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090957	2	47705534 - 47705535	2	47478395 - 47478396	90957	96432	rs63750149	NC_000002.12:47478395:A:AA
NM_000251.2(MSH2):c.2228C>A (p.Ser743Ter)	MSH2	S743*, S677*	not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090932	2	47705428	2	47478289	90932	96407	rs63751155	NC_000002.12:47478288:C:A
NM_000251.2(MSH2):c.2090G>T (p.Cys697Phe)	MSH2	C697F, C631F	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090883	2	47703590	2	47476451	90883	96358	rs63750398	NC_000002.12:47476450:G:T
NM_000251.3(MSH2):c.204del (p.Pro69fs)	MSH2	P69fs, P3fs	not provided|Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090871	2	47630534	2	47403392	90871	96346	rs63750199	NC_000002.12:47403391:GGGG:GGG
NM_000251.2(MSH2):c.1885C>T (p.Gln629Ter)	MSH2	Q629*, Q563*	Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090811	2	47702289	2	47475150	90811	96286	rs63750203	NC_000002.12:47475149:C:T
NM_000251.2(MSH2):c.1827del (p.His610fs)	MSH2	H544fs, H610fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090796	2	47702231	2	47475092	90796	96271	rs587779112	NC_000002.12:47475091:T:
NM_000251.2(MSH2):c.1660A>G (p.Ser554Gly)	MSH2	S554G, S488G	not provided|Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 21, 2019)	reviewed by expert panel	VCV000090717	2	47693946	2	47466807	90717	96192	rs63751656	NC_000002.12:47466806:A:G
NM_000251.2(MSH2):c.163del (p.Arg55fs)	MSH2	R55fs	Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090712	2	47630491	2	47403352	90712	96187	rs63750337	NC_000002.12:47403351:CCC:CC
NM_000251.2(MSH2):c.1447G>T (p.Glu483Ter)	MSH2	E483*, E417*	Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090668	2	47690230	2	47463091	90668	96143	rs63749947	NC_000002.12:47463090:G:T
NM_000251.2(MSH2):c.1009C>T (p.Gln337Ter)	MSH2	Q337*, Q271*	not provided|Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090502	2	47643501	2	47416362	90502	95977	rs63750778	NC_000002.12:47416361:C:T
NM_000251.2(MSH2):c.860dup (p.Gln288fs)	MSH2		Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036579	2	47641473 - 47641474	2	47414334 - 47414335	36579	45241	rs193922375	NC_000002.12:47414334:GG:GGG
NM_015506.2(MMACHC):c.482G>A	MMACHC	R161Q, R104Q	not provided|Methylmalonic acidemia with homocystinuria|Inborn genetic diseases|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001425	1	45974520	1	45508848	1425	16464	rs121918243	NC_000001.11:45508847:G:A
NM_001271208.2(NEB):c.1849del (p.Asp617fs)	NEB	D617fs	Nemaline myopathy|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000520693	2	152550884	2	151694370	520693	511331	rs755531536	NC_000002.12:151694369:C:
NM_001128425.2(MUTYH):c.389-1G>C	MUTYH		Hereditary cancer-predisposing syndrome|Pilomatrixoma|MYH-associated polyposis|Neoplasm of stomach|MUTYH-associated polyposis|not provided|MYH-associated polyposis	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000234229	1	45798843	1	45333171	234229	232272	rs372267274	NC_000001.11:45333170:C:G
NM_001048171.1(MUTYH):c.1435G>T (p.Val479Phe)	MUTYH	V493F, V479F, V373F, V465F, V466F, V350F, V480F, V476F, V490F	Hereditary cancer-predisposing syndrome|MUTYH-associated polyposis|MYH-associated polyposis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000219953	1	45796229	1	45330557	219953	221097	rs587782228	NC_000001.11:45330556:C:A
NM_001048171.1(MUTYH):c.970C>T (p.Gln324Ter)	MUTYH	Q338*, Q310*, Q324*, Q311*, Q325*, Q195*, Q321*, Q218*, Q335*	MYH-associated polyposis|not provided|MUTYH-associated polyposis|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000127835	1	45797507	1	45331835	127835	133292	rs587780082	NC_000001.11:45331834:G:A
NM_170707.4(LMNA):c.746G>A (p.Arg249Gln)	LMNA	R249Q, R168Q, R137Q	Charcot-Marie-Tooth disease type 2B1|Charcot-Marie-Tooth disease, type 2|not provided|Dilated cardiomyopathy 1A|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Muscular dystrophy	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066931	1	156104702	1	156134911	66931	77828	rs59332535	NC_000001.11:156134910:G:A
NM_170707.4(LMNA):c.1412G>A (p.Arg471His)	LMNA	R471H, R359H, R390H	Dilated cardiomyopathy 1A|Cardiovascular phenotype|not provided|Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease, type 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036476	1	156106743	1	156136952	36476	45138	rs267607578	NC_000001.11:156136951:G:A
NM_152263.4(TPM3):c.502C>T (p.Arg168Cys)	TPM3	R168C, R131C, R41C, R65C	not provided|Congenital myopathy with fiber type disproportion|Nemaline myopathy 1|Congenital myopathy with fiber type disproportion|Inborn genetic diseases|Cap myopathy 1	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012454	1	154145448	1	154172972	12454	27493	rs121964854	NC_000001.11:154172971:G:A
NM_000251.2:c.904-?_1386+?del	MSH2		Lynch syndrome	Pathogenic	criteria provided, single submitter	VCV000433583	2	47641519 - 47672796			433583	427592		
NM_001258281.1(MSH2):c.1080_1188+1del	MSH2		Lynch syndrome	Pathogenic	criteria provided, single submitter	VCV000188515	2	47672685 - 47672794	2	47445546 - 47445655	188515	186312	rs1553361141	
NM_000251.2(MSH2):c.560T>G (p.Leu187Arg)	MSH2	L187R, L121R	Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091135	2	47637426	2	47410287	91135	96610	rs63751444	NC_000002.12:47410286:T:G
NM_000251.2(MSH2):c.2291G>A (p.Trp764Ter)	MSH2	W764*, W698*	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090948	2	47705491	2	47478352	90948	96423	rs587779143	NC_000002.12:47478351:G:A
NM_000251.2(MSH2):c.2251G>A (p.Gly751Arg)	MSH2	G751R, G685R	Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090943	2	47705451	2	47478312	90943	96418	rs63751119	NC_000002.12:47478311:G:A
NM_000251.2(MSH2):c.2135dup (p.Gly713fs)	MSH2		Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090904	2	47703634 - 47703635	2	47476495 - 47476496	90904	96379	rs63751453	NC_000002.12:47476495:T:TT
NM_000251.2(MSH2):c.1759G>C (p.Gly587Arg)	MSH2	G587R, G521R	Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090771	2	47698201	2	47471062	90771	96246	rs63751140	NC_000002.12:47471061:G:C
NM_000251.2(MSH2):c.1700_1704del (p.Lys567fs)	MSH2	K501fs, K567fs	not provided|Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090755	2	47698141 - 47698145	2	47471002 - 47471006	90755	96230	rs63750474	NC_000002.12:47471001:AAAACA:A
NM_000251.2(MSH2):c.1511-2A>G	MSH2		Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090688	2	47693795	2	47466656	90688	96163	rs267607962	NC_000002.12:47466655:A:G
NM_000251.2(MSH2):c.1444dup (p.Arg482fs)	MSH2		Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090666	2	47690225 - 47690226	2	47463086 - 47463087	90666	96141	rs63750068	NC_000002.12:47463086:AA:AAA
NM_000251.2(MSH2):c.1219_1220CT[1] (p.Tyr408fs)	MSH2		Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090572	2	47657023 - 47657024	2	47429884 - 47429885	90572	96047	rs587779076	NC_000002.12:47429883:CTCT:CT
NM_000251.2(MSH2):c.1204del (p.Gln402fs)	MSH2	Q402fs, Q336fs	Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090566	2	47657008	2	47429869	90566	96041	rs63751413	NC_000002.12:47429868:C:
NM_000251.2(MSH2):c.1204C>T (p.Gln402Ter)	MSH2	Q402*, Q336*	Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090565	2	47657008	2	47429869	90565	96040	rs63751412	NC_000002.12:47429868:C:T
MSH2, 32-KB DEL, EX1-6	MSH2		Lynch syndrome I|Muir-Torré syndrome	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000001774					1774	16813		
NM_206933.3(USH2A):c.14698C>T (p.Gln4900Ter)	USH2A	Q4900*	not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521389	1	215820957	1	215647615	521389	511221	rs1553250072	NC_000001.11:215647614:G:A
NM_014946.3(SPAST):c.1168A>G (p.Met390Val)	SPAST	M390V, M358V, M357V, M389V	not provided|Inborn genetic diseases|Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000208644	2	32352086	2	32127017	208644	205235	rs797044850	NC_000002.12:32127016:A:G
NM_006920.6(SCN1A):c.812del (p.Gly271fs)	SCN1A	G271fs	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 12, 2015)	criteria provided, single submitter	VCV000520813	2	166908381	2	166051871	520813	511355	rs1553549717	NC_000002.12:166051870:CCC:CC
NM_001128425.2(MUTYH):c.325C>T (p.Arg109Trp)	MUTYH	R109W, R95W, R96W, R106W, R81W, R82W, R92W	MYH-associated polyposis|MUTYH-associated polyposis|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183896	1	45799108	1	45333436	183896	181726	rs765123255	NC_000001.11:45333435:G:A
NM_001128425.2(MUTYH):c.545G>A (p.Arg182His)	MUTYH	R182H, R62H, R154H, R165H, R168H, R179H, R39H, R155H, R169H	not provided|not specified|MYH-associated polyposis|MUTYH-associated polyposis|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000182689	1	45798466	1	45332794	182689	179937	rs143353451	NC_000001.11:45332793:C:T
NM_000251.2(MSH2):c.2041C>T (p.Gln681Ter)	MSH2	Q681*, Q615*	Hereditary nonpolyposis colon cancer|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428498	2	47703541	2	47476402	428498	419392	rs730881762	NC_000002.12:47476401:C:T
NM_000251.2(MSH2):c.340G>T (p.Glu114Ter)	MSH2	E114*, E48*	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided|Lynch syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237395	2	47635668	2	47408529	237395	238810	rs878853815	NC_000002.12:47408528:G:T
NM_000251.2(MSH2):c.970C>T (p.Gln324Ter)	MSH2	Q324*, Q258*	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091261	2	47643462	2	47416323	91261	96736	rs63750502	NC_000002.12:47416322:C:T
NM_000251.2(MSH2):c.873_876del (p.Thr292fs)	MSH2	T226fs, T292fs	Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091236	2	47641485 - 47641488	2	47414346 - 47414349	91236	96711	rs587779191	NC_000002.12:47414345:ACTGACT:ACT
NM_000251.2(MSH2):c.482T>A (p.Val161Asp)	MSH2	V161D, V95D	Hereditary cancer-predisposing syndrome|Lynch syndrome I	Pathogenic(Last reviewed: Mar 9, 2018)	reviewed by expert panel	VCV000091104	2	47637348	2	47410209	91104	96579	rs63750126	NC_000002.12:47410208:T:A
NM_000251.2(MSH2):c.363T>G (p.Tyr121Ter)	MSH2	Y121*, Y55*	Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091070	2	47635691	2	47408552	91070	96545	rs63750458	NC_000002.12:47408551:T:G
NM_000251.2(MSH2):c.2634G>A (p.Glu878=)	MSH2		Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091021	2	47708010	2	47480871	91021	96496	rs63751624	NC_000002.12:47480870:G:A
NM_000251.2(MSH2):c.2575G>T (p.Glu859Ter)	MSH2	E859*, E793*	Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091004	2	47707951	2	47480812	91004	96479	rs63749830	NC_000002.12:47480811:G:T
NM_000251.2(MSH2):c.2446C>T (p.Gln816Ter)	MSH2	Q816*, Q750*	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090974	2	47705646	2	47478507	90974	96449	rs63749917	NC_000002.12:47478506:C:T
NM_000251.2(MSH2):c.2362dup (p.Thr788fs)	MSH2		not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090962	2	47705561 - 47705562	2	47478422 - 47478423	90962	96437	rs63750463	NC_000002.12:47478422:A:AA
NM_000251.2(MSH2):c.1771_1772insA (p.Pro591fs)	MSH2		Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090781	2	47702175 - 47702176	2	47475036 - 47475037	90781	96256	rs267607977	NC_000002.12:47475036::A
NM_000251.2(MSH2):c.1408del (p.Leu469_Val470insTer)	MSH2		Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090657	2	47690191	2	47463052	90657	96132	rs63750384	NC_000002.12:47463051:G:
NM_003000.2(SDHB):c.689G>A (p.Arg230His)	SDHB	R230H	Hereditary cancer-predisposing syndrome|not provided|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|Pheochromocytoma|Carney-Stratakis syndrome|Paragangliomas 4|Paragangliomas 4	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000142637	1	17349179	1	17022684	142637	152351	rs587782604	NC_000001.11:17022683:C:T
NM_170707.4(LMNA):c.1129C>T (p.Arg377Cys)	LMNA	R377C, R296C, R265C	not provided|Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease, type 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048031	1	156105884	1	156136093	48031	57195	rs397517889	NC_000001.11:156136092:C:T
NM_012222.2(MUTYH):c.724C>T (p.Arg242Cys)	MUTYH	R245C, R231C, R242C, R125C, R217C, R218C, R232C, R102C, R228C	not provided|MUTYH-associated polyposis|Hereditary cancer-predisposing syndrome|MYH-associated polyposis|Familial colorectal cancer	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000041761	1	45798118	1	45332446	41761	50200	rs200495564	NC_000001.11:45332445:G:A
NM_000251.2(MSH2):c.929T>C (p.Leu310Pro)	MSH2	L310P, L244P	Hereditary nonpolyposis colon cancer|Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091245	2	47641544	2	47414405	91245	96720	rs63750640	NC_000002.12:47414404:T:C
NM_000251.2(MSH2):c.868G>T (p.Glu290Ter)	MSH2	E290*, E224*	Hereditary cancer-predisposing syndrome|Lynch syndrome I|Turcot syndrome|Muir-Torré syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091235	2	47641483	2	47414344	91235	96710	rs587779190	NC_000002.12:47414343:G:T
NM_000251.2(MSH2):c.754C>T (p.Gln252Ter)	MSH2	Q252*, Q186*	Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091196	2	47639661	2	47412522	91196	96671	rs63750347	NC_000002.12:47412521:C:T
NM_000251.2(MSH2):c.687dup (p.Ala230fs)	MSH2		Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091178	2	47639587 - 47639588	2	47412448 - 47412449	91178	96653	rs63749897	NC_000002.12:47412448:AAAAAAA:AAAAAAAA
NM_000251.2(MSH2):c.34dup (p.Glu12fs)	MSH2		Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091068	2	47630362 - 47630363	2	47403223 - 47403224	91068	96543	rs63750614	NC_000002.12:47403223:GG:GGG
NM_000251.2(MSH2):c.2653C>T (p.Gln885Ter)	MSH2	Q885*, Q819*	Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome I	Pathogenic(Last reviewed: Jun 13, 2018)	reviewed by expert panel	VCV000091033	2	47709936	2	47482797	91033	96508	rs63750808	NC_000002.12:47482796:C:T
NM_000251.2(MSH2):c.2647del (p.Ile883fs)	MSH2	I817fs, I883fs	Lynch syndrome I|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 13, 2018)	reviewed by expert panel	VCV000091030	2	47709925	2	47482786	91030	96505	rs63750084	NC_000002.12:47482785:AAAAAA:AAAAA
NM_000251.2(MSH2):c.2485del (p.His829fs)	MSH2	H763fs, H829fs	Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090985	2	47707861	2	47480722	90985	96460	rs63751117	NC_000002.12:47480721:C:
NM_000251.2(MSH2):c.2470C>T (p.Gln824Ter)	MSH2	Q824*, Q758*	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090983	2	47707846	2	47480707	90983	96458	rs63750623	NC_000002.12:47480706:C:T
NM_000251.2(MSH2):c.2275G>T (p.Gly759Ter)	MSH2	G759*, G693*	Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090946	2	47705475	2	47478336	90946	96421	rs63749854	NC_000002.12:47478335:G:T
NM_000251.2(MSH2):c.20del (p.Glu7fs)	MSH2	E7fs	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090886	2	47630350	2	47403211	90886	96361	rs267607915	NC_000002.12:47403210:A:
NM_000251.2(MSH2):c.187del (p.Gly62_Val63insTer)	MSH2		not provided|Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090808	2	47630513	2	47403374	90808	96283	rs63750160	NC_000002.12:47403373:GGGGG:GGGG
NM_000251.2(MSH2):c.1835C>G (p.Ser612Ter)	MSH2	S612*, S546*	not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090799	2	47702239	2	47475100	90799	96274	rs63750493	NC_000002.12:47475099:C:G
NM_000251.2(MSH2):c.1759+2T>A	MSH2		Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090767	2	47698203	2	47471064	90767	96242	rs267607976	NC_000002.12:47471063:T:A
NM_000251.3(MSH2):c.1662-1G>A	MSH2		Hereditary cancer-predisposing syndrome|Turcot syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090727	2	47698103	2	47470964	90727	96202	rs267607970	NC_000002.12:47470963:G:A
NM_000251.2(MSH2):c.1203dup (p.Gln402fs)	MSH2		Lynch syndrome|Hereditary nonpolyposis colon cancer|Lynch syndrome I	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090564	2	47657006 - 47657007	2	47429867 - 47429868	90564	96039	rs63750586	NC_000002.12:47429867:A:AA
NM_206933.3(USH2A):c.1036A>C (p.Asn346His)	USH2A	N346H	Rare genetic deafness|Usher syndrome, type 2A|not provided|Usher syndrome|Retinal dystrophy|Retinitis pigmentosa 39	Pathogenic(Last reviewed: Sep 14, 2018)	reviewed by expert panel	VCV000048347	1	216498754	1	216325412	48347	57509	rs369522997	NC_000001.11:216325411:T:G
NM_001276345.2(TNNT2):c.305G>A (p.Arg102Gln)	TNNT2	R92Q, R102Q, R87Q	Cardiovascular phenotype|not provided|Familial hypertrophic cardiomyopathy 2|Familial restrictive cardiomyopathy 3|Left ventricular noncompaction 6|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012409	1	201334425	1	201365297	12409	27448	rs121964856	NC_000001.11:201365296:C:T
NM_001048171.1(MUTYH):c.697C>T (p.Arg233Ter)	MUTYH	R247*, R233*, R220*, R219*, R244*, R104*, R127*, R230*, R234*	Carcinoma of colon|MYH-associated polyposis|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143003	1	45798112	1	45332440	143003	152717	rs587782885	NC_000001.11:45332439:G:A
NM_000251.2(MSH2):c.425C>G (p.Ser142Ter)	MSH2	S142*, S76*	not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091096	2	47637291	2	47410152	91096	96571	rs63750910	NC_000002.12:47410151:C:G
NM_000251.2(MSH2):c.2502_2508del (p.Asn835fs)	MSH2	N835fs, N769fs	Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090987	2	47707877 - 47707883	2	47480738 - 47480744	90987	96462	rs63751447	NC_000002.12:47480737:CTAATTTC:C
NM_000251.2(MSH2):c.2096C>G (p.Ser699Ter)	MSH2	S699*, S633*	Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090885	2	47703596	2	47476457	90885	96360	rs587779136	NC_000002.12:47476456:C:G
NM_000251.2(MSH2):c.1968C>G (p.Tyr656Ter)	MSH2	Y656*, Y590*	Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090825	2	47702372	2	47475233	90825	96300	rs63751317	NC_000002.12:47475232:C:G
NM_000251.2(MSH2):c.1911del (p.Arg638fs)	MSH2	R572fs, R638fs	not provided|Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090816	2	47702314	2	47475175	90816	96291	rs63750893	NC_000002.12:47475174:CC:C
NM_000251.2(MSH2):c.1373T>G (p.Leu458Ter)	MSH2	L458*, L392*	Lynch syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090640	2	47672783	2	47445644	90640	96115	rs63750521	NC_000002.12:47445643:T:G
NM_000251.2(MSH2):c.1046C>G (p.Pro349Arg)	MSH2	P349R, P283R	Lynch syndrome I|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Oct 10, 2014)	reviewed by expert panel	VCV000090513	2	47643538	2	47416399	90513	95988	rs587779067	NC_000002.12:47416398:C:G
NM_000251.2(MSH2):c.1035G>A (p.Trp345Ter)	MSH2	W345*, W279*	not provided|Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090510	2	47643527	2	47416388	90510	95985	rs63750396	NC_000002.12:47416387:G:A
NM_000251.2(MSH2):c.1030C>T (p.Gln344Ter)	MSH2	Q344*, Q278*	not provided|Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000036561	2	47643522	2	47416383	36561	45223	rs63750245	NC_000002.12:47416382:C:T
NM_206933.3(USH2A):c.2802T>G (p.Cys934Trp)	USH2A	C934W	not provided|Retinitis pigmentosa 39|Usher syndrome type 2|Retinal dystrophy|Usher syndrome, type 2A|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143179	1	216419934	1	216246592	143179	152897	rs201527662	NC_000001.11:216246591:A:C
NM_206933.4(USH2A):c.1841-2A>G	USH2A		not provided|Rare genetic deafness|USH2A-Related Disorders|Retinitis pigmentosa 39|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048476	1	216462754	1	216289412	48476	57638	rs397518003	NC_000001.11:216289411:T:C
NM_170707.4(LMNA):c.1621C>T (p.Arg541Cys)	LMNA	R541C, R460C, R429C	Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|not provided|Cardiovascular phenotype|Charcot-Marie-Tooth disease, type 2	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048046	1	156107457	1	156137666	48046	57210	rs56984562	NC_000001.11:156137665:C:T
NM_001128425.1(MUTYH):c.55C>T (p.Arg19Ter)	MUTYH	R19*, R5*	not provided|Hereditary cancer-predisposing syndrome|Carcinoma of colon|MYH-associated polyposis|Pilomatrixoma|MYH-associated polyposis|Neoplasm of stomach	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000127845	1	45800165	1	45334493	127845	133302	rs587780088	NC_000001.11:45334492:G:A
NM_000251.2(MSH2):c.211+1G>T	MSH2		Hereditary nonpolyposis colon cancer|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428559	2	47630542	2	47403403	428559	419309	rs1114167883	NC_000002.12:47403402:G:T
NM_000251.2(MSH2):c.704_705del (p.Lys235fs)	MSH2	K169fs, K235fs	not provided|Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091182	2	47639609 - 47639610	2	47412470 - 47412471	91182	96657	rs281864944	NC_000002.12:47412469:AAAA:AA
NM_000251.2(MSH2):c.2006G>T (p.Gly669Val)	MSH2	G669V, G603V	not specified|Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090854	2	47703506	2	47476367	90854	96329	rs63751640	NC_000002.12:47476366:G:T
NM_206933.4(USH2A):c.949C>A (p.Arg317=)	USH2A	R317R	Usher syndrome, type 2A|Retinitis pigmentosa 39|Retinal dystrophy|Pigmentary retinopathy|Rod-cone dystrophy|Retinal pigment epithelial atrophy|Abnormal macular morphology|Blindness|Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002358	1	216498841	1	216325499	2358	17397	rs111033272	NC_000001.11:216325498:G:T
NM_001267550.2(TTN):c.2370+2T>C	TTN		Limb-girdle muscular dystrophy, type 2J	Pathogenic	no assertion criteria provided	VCV000816835	2	179650573	2	178785846	816835	805058		NC_000002.12:178785845:A:G
NM_001267550.2(TTN):c.22145_22146del (p.Val7381_Phe7382insTer)	TTN		not provided	Pathogenic(Last reviewed: Dec 10, 2015)	criteria provided, single submitter	VCV000198657	2	179587480 - 179587481	2	178722753 - 178722754	198657	195818	rs794727888	NC_000002.12:178722752:AAAAA:AAA
NM_001267550.2(TTN):c.35041G>T (p.Glu11681Ter)	TTN	E10380*, E11681*, E11307*	Limb-girdle muscular dystrophy, type 2J	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000813976	2	179536884	2	178672157	813976	802130		NC_000002.12:178672156:C:A
NM_001267550.2(TTN):c.669+1G>A	TTN		Dilated cardiomyopathy 1G	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801836	2	179664551	2	178799824	801836	790133		NC_000002.12:178799823:C:T
NM_001267550.2(TTN):c.19156C>T (p.Gln6386Ter)	TTN	Q5142*, Q6069*, Q6386*	Dilated cardiomyopathy 1G	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801834	2	179593497	2	178728770	801834	790131		NC_000002.12:178728769:G:A
NM_001267550.2(TTN):c.27607G>T (p.Glu9203Ter)	TTN	E7959*, E8886*, E9203*	Dilated cardiomyopathy 1G	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801833	2	179577042	2	178712315	801833	790130		NC_000002.12:178712314:C:A
NM_001267550.2(TTN):c.29619_29620AG[1] (p.Glu9874fs)	TTN		Limb-girdle muscular dystrophy, type 2J	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000635051	2	179569674 - 179569677	2	178704947 - 178704950	635051	622865		NC_000002.12:178704946:CTCTCT:CT
NM_001267550.2(TTN):c.29963-1G>C	TTN		Myopathy, early-onset, with fatal cardiomyopathy|Congenital titinopathy	Pathogenic(Last reviewed: Feb 11, 2019)	no assertion criteria provided	VCV000619187	2	179569135	2	178704408	619187	610585	rs1560513651	NC_000002.12:178704407:C:G
NM_001267550.2(TTN):c.20836+1G>A	TTN		Noncompaction cardiomyopathy	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523428	2	179590094	2	178725367	523428	513913	rs1553915256	NC_000002.12:178725366:C:T
NM_001267550.2(TTN):c.42482_42485TTGT[1] (p.Cys14163fs)	TTN		Muscular Diseases	Pathogenic(Last reviewed: Jun 5, 2014)	criteria provided, single submitter	VCV000212468	2	179498737 - 179498740	2	178634010 - 178634013	212468	206924	rs797046064	NC_000002.12:178634009:ACAAACAAA:ACAAA
NM_001267550.2(TTN):c.23903_23904delinsA (p.Gly7968fs)	TTN		Muscular Diseases	Pathogenic(Last reviewed: Aug 5, 2014)	criteria provided, single submitter	VCV000212463	2	179584315 - 179584316	2	178719588 - 178719589	212463	206928	rs797046060	NC_000002.12:178719587:GC:T
NM_001267550.2(TTN):c.29092_29093CT[1] (p.Phe9700fs)	TTN		Dilated cardiomyopathy 1G	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000437408	2	179571628 - 179571629	2	178706901 - 178706902	437408	430961	rs1553882262	NC_000002.12:178706900:AGAG:AG
NM_001267550.2(TTN):c.45316_45320dup (p.Arg15108fs)	TTN		Cardiovascular phenotype|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000202537	2	179486230 - 179486231	2	178621503 - 178621504	202537	199332	rs794729390	NC_000002.12:178621503:GAGCT:GAGCTGAGCT
NM_001267550.2(TTN):c.13108C>T (p.Gln4370Ter)	TTN	Q4053*, Q4370*, Q4007*, Q4132*, Q4199*	Dilated cardiomyopathy 1G	Pathogenic(Last reviewed: Feb 22, 2002)	no assertion criteria provided	VCV000012657	2	179604852	2	178740125	12657	27696	rs267607158	NC_000002.12:178740124:G:A
NM_001267550.2(TTN):c.160G>A (p.Val54Met)	TTN	V54M	Dilated cardiomyopathy 1G	Pathogenic(Last reviewed: Feb 22, 2002)	no assertion criteria provided	VCV000012656	2	179667000	2	178802273	12656	27695	rs139517732	NC_000002.12:178802272:C:T
NM_001267550.2(TTN):c.2228C>T (p.Ala743Val)	TTN	A743V, A697V	Dilated cardiomyopathy 1G	Pathogenic(Last reviewed: Feb 22, 2002)	no assertion criteria provided	VCV000012655	2	179650717	2	178785990	12655	27694	rs267607157	NC_000002.12:178785989:G:A
NM_001267550.2(TTN):c.2219G>T (p.Arg740Leu)	TTN	R740L, R694L	Familial hypertrophic cardiomyopathy 9	Pathogenic(Last reviewed: Aug 27, 1999)	no assertion criteria provided	VCV000012649	2	179650726	2	178785999	12649	27688	rs28933405	NC_000002.12:178785998:C:A
TTN, 2-BP INS, 43628AT	TTN		Dilated cardiomyopathy 1G	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000012650					12650	27689		
NM_001276345.2(TNNT2):c.650_652AGA[3] (p.Lys220del)	TNNT2	K210del, K217del, K177del, K204del, K207del, K220del	Cardiovascular phenotype|not provided|Left ventricular noncompaction 6|Primary dilated cardiomyopathy|Familial restrictive cardiomyopathy 3|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043659	1	201331099 - 201331101	1	201361971 - 201361973	43659	52828	rs45578238	NC_000001.11:201361970:TCTTCTTCTTCTT:TCTTCTTCTT
NM_000251.2(MSH2):c.715C>T (p.Gln239Ter)	MSH2	Q239*, Q173*	Lynch syndrome I|Hereditary nonpolyposis colon cancer|Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091185	2	47639622	2	47412483	91185	96660	rs63750488	NC_000002.12:47412482:C:T
NM_000251.2(MSH2):c.2662del (p.Leu888fs)	MSH2	L822fs, L888fs	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|Lynch syndrome I	Pathogenic(Last reviewed: Jun 13, 2018)	reviewed by expert panel	VCV000091035	2	47709944	2	47482805	91035	96510	rs63751007	NC_000002.12:47482804:CC:C
NM_000251.2(MSH2):c.2635C>T (p.Gln879Ter)	MSH2	Q879*, Q813*	Lynch syndrome I|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Jun 13, 2018)	reviewed by expert panel	VCV000091028	2	47709918	2	47482779	91028	96503	rs63751469	NC_000002.12:47482778:C:T
NM_001258281.1(MSH2):c.2325_2326AG[1] (p.Glu776fs)	MSH2		Hereditary nonpolyposis colon cancer|Lynch syndrome|Lynch syndrome I	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090993	2	47707899 - 47707900	2	47480760 - 47480761	90993	96468	rs587779148	NC_000002.12:47480759:AGAG:AG
NM_000251.2(MSH2):c.2334C>A (p.Cys778Ter)	MSH2	C778*, C712*	Lynch syndrome I|Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090956	2	47705534	2	47478395	90956	96431	rs63750618	NC_000002.12:47478394:C:A
NM_000251.2(MSH2):c.2228C>G (p.Ser743Ter)	MSH2	S743*, S677*	Lynch syndrome I|Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090933	2	47705428	2	47478289	90933	96408	rs63751155	NC_000002.12:47478288:C:G
NM_000251.2(MSH2):c.2047G>A (p.Gly683Arg)	MSH2	G683R, G617R	not specified|Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090868	2	47703547	2	47476408	90868	96343	rs267607995	NC_000002.12:47476407:G:A
NM_000251.2(MSH2):c.181C>T (p.Gln61Ter)	MSH2	Q61*	not provided|Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090794	2	47630511	2	47403372	90794	96269	rs63750951	NC_000002.12:47403371:C:T
NM_000251.2(MSH2):c.1285C>T (p.Gln429Ter)	MSH2	Q429*, Q363*	Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090616	2	47672695	2	47445556	90616	96091	rs63751693	NC_000002.12:47445555:C:T
NM_170707.4(LMNA):c.1824C>T (p.Gly608=)	LMNA	G608G	not provided|Lethal tight skin contracture syndrome|Primary dilated cardiomyopathy|Hutchinson-Gilford syndrome|Hutchinson-Gilford syndrome|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000014500	1	156108404	1	156138613	14500	29539	rs58596362	NC_000001.11:156138612:C:T
NM_206933.4(USH2A):c.8559-2A>G	USH2A		Usher syndrome, type 2A|Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided|Retinitis pigmentosa|Rare genetic deafness|Retinal dystrophy|Usher syndrome|Retinitis pigmentosa 39	Pathogenic(Last reviewed: Oct 9, 2018)	reviewed by expert panel	VCV000048604	1	216051224	1	215877882	48604	57766	rs397518039	NC_000001.11:215877881:T:C
NM_001128425.2(MUTYH):c.1438G>T (p.Glu480Ter)	MUTYH	E466*, E480*, E360*, E467*, E452*, E463*, E477*, E337*, E453*	not provided|MYH-associated polyposis|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005297	1	45796892	1	45331220	5297	20336	rs121908381	NC_000001.11:45331219:C:A
NM_003000.2(SDHB):c.418G>T (p.Val140Phe)	SDHB	V140F	not provided|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Pheochromocytoma|Paragangliomas 4|Gastrointestinal stromal tumor|Hereditary cancer-predisposing syndrome|Paragangliomas 4	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000018454	1	17355100	1	17028605	18454	33493	rs267607032	NC_000001.11:17028604:C:A
NM_001276345.2(TNNT2):c.304C>T (p.Arg102Trp)	TNNT2	R102W, R92W, R87W	Hypertrophic cardiomyopathy|Cardiovascular phenotype|Primary familial hypertrophic cardiomyopathy|not provided|Familial restrictive cardiomyopathy 3|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043627	1	201334426	1	201365298	43627	52796	rs397516456	NC_000001.11:201365297:G:A
NM_001035.3(RYR2):c.1258C>T (p.Arg420Trp)	RYR2	R420W	Catecholaminergic polymorphic ventricular tachycardia type 1|Arrhythmogenic right ventricular dysplasia, familial, 2|Ventricular fibrillation|Catecholaminergic polymorphic ventricular tachycardia|not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000201214	1	237608788	1	237445488	201214	196540	rs190140598	NC_000001.11:237445487:C:T
NM_000251.2(MSH2):c.560T>C (p.Leu187Pro)	MSH2	L187P, L121P	Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091134	2	47637426	2	47410287	91134	96609	rs63751444	NC_000002.12:47410286:T:C
NM_000251.2(MSH2):c.2634+5G>C	MSH2		Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091019	2	47708015	2	47480876	91019	96494	rs267608017	NC_000002.12:47480875:G:C
NM_000251.2(MSH2):c.2579C>A (p.Ser860Ter)	MSH2	S860*, S794*	Hereditary cancer-predisposing syndrome|Lynch syndrome I|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091005	2	47707955	2	47480816	91005	96480	rs63750849	NC_000002.12:47480815:C:A
NM_001128425.2(MUTYH):c.1187-2A>G	MUTYH		not provided|Hereditary cancer-predisposing syndrome|Pilomatrixoma|MYH-associated polyposis|Neoplasm of stomach|Carcinoma of colon|MYH-associated polyposis	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141282	1	45797230	1	45331558	141282	150996	rs587781628	NC_000001.11:45331557:T:C
NM_000251.2(MSH2):c.687del (p.Ala230fs)	MSH2	A230fs, A164fs	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|Lynch syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091177	2	47639588	2	47412449	91177	96652	rs63749897	NC_000002.12:47412448:AAAAAAA:AAAAAA
NM_000251.2(MSH2):c.645+1G>A	MSH2		Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091155	2	47637512	2	47410373	91155	96630	rs267607689	NC_000002.12:47410372:G:A
NM_000251.2(MSH2):c.571_573delCTC	MSH2	L191del	Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091139	2	47637434 - 47637436	2	47410295 - 47410297	91139	96614	rs587779165	NC_000002.12:47410294:CTCCTC:CTC
NM_000251.2(MSH2):c.528_529delTG	MSH2		Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|Lynch syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091126	2	47637390 - 47637391	2	47410251 - 47410252	91126	96601	rs587779164	NC_000002.12:47410250:TGTGTG:TGTG
NM_000251.2(MSH2):c.212-1G>A	MSH2		Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090892	2	47635539	2	47408400	90892	96367	rs267607914	NC_000002.12:47408399:G:A
NM_000251.2(MSH2):c.2063T>G (p.Met688Arg)	MSH2	M688R, M622R	Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090874	2	47703563	2	47476424	90874	96349	rs63749993	NC_000002.12:47476423:T:G
NM_001258281.1(MSH2):c.1352_1353CA[1] (p.Gln452fs)	MSH2		Lynch syndrome|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090697	2	47693836 - 47693837	2	47466697 - 47466698	90697	96172	rs63749930	NC_000002.12:47466696:CACA:CA
NM_000251.2(MSH2):c.1276+1G>A	MSH2		Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090590	2	47657081	2	47429942	90590	96065	rs267607950	NC_000002.12:47429941:G:A
NM_000251.2(MSH2):c.1222dup (p.Tyr408fs)	MSH2		Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colon cancer|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090573	2	47657025 - 47657026	2	47429886 - 47429887	90573	96048	rs63751142	NC_000002.12:47429886:T:TT
NM_003000.2(SDHB):c.725G>A (p.Arg242His)	SDHB	R242H	Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|Pheochromocytoma|Hereditary cancer-predisposing syndrome|not provided|Paragangliomas 4|Gastrointestinal stromal tumor|Hereditary Paraganglioma-Pheochromocytoma Syndromes	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012781	1	17349143	1	17022648	12781	27820	rs74315368	NC_000001.11:17022647:C:T
NM_001040142.2(SCN2A):c.2356C>T (p.Gln786Ter)	SCN2A	Q786*	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 13, 2017)	criteria provided, single submitter	VCV000522022	2	166188046	2	165331536	522022	511342	rs1553574733	NC_000002.12:165331535:C:T
NM_001040142.2(SCN2A):c.3067_3068del (p.Glu1023fs)	SCN2A	E1023fs	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 15, 2016)	criteria provided, single submitter	VCV000521387	2	166210849 - 166210850	2	165354339 - 165354340	521387	511344	rs1553583712	NC_000002.12:165354338:GA:
NM_001040142.2(SCN2A):c.5318C>T (p.Ala1773Val)	SCN2A	A1773V	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 10, 2015)	criteria provided, single submitter	VCV000520893	2	166245634	2	165389124	520893	511350	rs1553463602	NC_000002.12:165389123:C:T
NM_001040142.2(SCN2A):c.4967C>T (p.Ser1656Phe)	SCN2A	S1656F	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 23, 2015)	criteria provided, single submitter	VCV000520884	2	166245283	2	165388773	520884	511346	rs1553463464	NC_000002.12:165388772:C:T
NM_001040142.2(SCN2A):c.5308A>T (p.Met1770Leu)	SCN2A	M1770L	Inborn genetic diseases	Pathogenic(Last reviewed: May 29, 2015)	criteria provided, single submitter	VCV000520713	2	166245624	2	165389114	520713	511349	rs1553463594	NC_000002.12:165389113:A:T
NM_001040142.2(SCN2A):c.2645G>A (p.Gly882Glu)	SCN2A	G882E	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 8, 2014)	criteria provided, single submitter	VCV000520571	2	166201147	2	165344637	520571	511343	rs1553579305	NC_000002.12:165344636:G:A
NM_206933.4(USH2A):c.10073G>A (p.Cys3358Tyr)	USH2A	C3358Y	Retinitis pigmentosa 39|Usher syndrome, type 2A|Retinitis pigmentosa|Rare genetic deafness|Retinal dystrophy|Usher syndrome, type 2A|Retinitis pigmentosa 39|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000197932	1	215963510	1	215790168	197932	195093	rs148660051	NC_000001.11:215790167:C:T
NM_206933.4(USH2A):c.1256G>T (p.Cys419Phe)	USH2A	C419F	Usher syndrome|USH2A-Related Disorders|Retinal dystrophy|Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002359	1	216497582	1	216324240	2359	17398	rs121912600	NC_000001.11:216324239:C:A
NM_000251.2(MSH2):c.366+1G>A	MSH2		Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000245947	2	47635695	2	47408556	245947	244372	rs267607924	NC_000002.12:47408555:G:A
NM_000251.2(MSH2):c.508C>T (p.Gln170Ter)	MSH2	Q170*, Q104*	Ovarian Neoplasms|not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091117	2	47637374	2	47410235	91117	96592	rs63750843	NC_000002.12:47410234:C:T
NM_000251.2(MSH2):c.2087C>T (p.Pro696Leu)	MSH2	P696L, P630L	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|Lynch syndrome|not specified	Pathogenic(Last reviewed: Jun 21, 2019)	reviewed by expert panel	VCV000090881	2	47703587	2	47476448	90881	96356	rs267607994	NC_000002.12:47476447:C:T
NM_001035.3(RYR2):c.14311G>A (p.Val4771Ile)	RYR2	V4771I	Inborn genetic diseases|Catecholaminergic polymorphic ventricular tachycardia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000201357	1	237972213	1	237808913	201357	196743	rs794728804	NC_000001.11:237808912:G:A
NM_000251.2(MSH2):c.1276+2T>C	MSH2		Lynch syndrome I|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colon cancer	Pathogenic/Likely pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000218032	2	47657082	2	47429943	218032	214582	rs267607953	NC_000002.12:47429942:T:C
NM_000251.2(MSH2):c.229_230delAG	MSH2		Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090953	2	47635555 - 47635556	2	47408416 - 47408417	90953	96428	rs63749848	NC_000002.12:47408415:AGAG:AG
NM_000251.2(MSH2):c.226C>T (p.Gln76Ter)	MSH2	Q76*, Q10*	Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090945	2	47635554	2	47408415	90945	96420	rs63750042	NC_000002.12:47408414:C:T
NM_000251.2(MSH2):c.1738G>T (p.Glu580Ter)	MSH2	E580*, E514*	Ovarian Neoplasms|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|Lynch syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090763	2	47698180	2	47471041	90763	96238	rs63751411	NC_000002.12:47471040:G:T
NM_000251.2(MSH2):c.1477C>T (p.Gln493Ter)	MSH2	Q493*, Q427*	Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090677	2	47690260	2	47463121	90677	96152	rs63750936	NC_000002.12:47463120:C:T
NM_170707.4(LMNA):c.305T>C (p.Leu102Pro)	LMNA	L102P	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 9, 2015)	criteria provided, single submitter	VCV000520647	1	156085014	1	156115223	520647	511179	rs1553262007	NC_000001.11:156115222:T:C
NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp)	LMNA	R335W, R223W, R254W	Primary dilated cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy|Laminopathy|Primary dilated cardiomyopathy|Cardiovascular phenotype|Dilated cardiomyopathy 1A|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Mandibuloacral dysplasia with type A lipodystrophy|Lethal tight skin contracture syndrome|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Congenital muscular dystrophy, LMNA-related|Hutchinson-Gilford syndrome|Familial partial lipodystrophy 2|Limb-girdle muscular dystrophy, type 1B|Heart-hand syndrome, Slovenian type|Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome|Charcot-Marie-Tooth disease type 2B1|not provided|Left ventricular noncompaction|Heart-hand syndrome, Slovenian type|Charcot-Marie-Tooth disease, type 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036473	1	156105758	1	156135967	36473	45135	rs386134243	NC_000001.11:156135966:C:T
NM_000251.2(MSH2):c.289C>T (p.Gln97Ter)	MSH2	Q97*, Q31*	Lynch syndrome I|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|Lynch syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091054	2	47635617	2	47408478	91054	96529	rs63750970	NC_000002.12:47408477:C:T
NM_000251.2(MSH2):c.2647dup (p.Ile883fs)	MSH2		Lynch syndrome I|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jun 13, 2018)	reviewed by expert panel	VCV000091031	2	47709924 - 47709925	2	47482785 - 47482786	91031	96506	rs63750084	NC_000002.12:47482785:AAAAAA:AAAAAAA
NM_000251.2(MSH2):c.1046C>T (p.Pro349Leu)	MSH2	P349L, P283L	not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090514	2	47643538	2	47416399	90514	95989	rs587779067	NC_000002.12:47416398:C:T
NM_000251.2(MSH2):c.1801C>T (p.Gln601Ter)	MSH2	Q601*, Q535*	Hereditary cancer-predisposing syndrome|Lynch syndrome|not provided|Muir-Torré syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000001758	2	47702205	2	47475066	1758	16797	rs63750047	NC_000002.12:47475065:C:T
NM_000251.2(MSH2):c.1915C>T (p.His639Tyr)	MSH2	H639Y, H573Y	Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome|Lynch syndrome I	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000001756	2	47702319	2	47475180	1756	16795	rs28929484	NC_000002.12:47475179:C:T
NM_003000.2(SDHB):c.380T>G (p.Ile127Ser)	SDHB	I127S	not provided|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Paragangliomas 4|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Gastrointestinal stromal tumor|Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|Carney triad|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183814	1	17355138	1	17028643	183814	181616	rs786201095	NC_000001.11:17028642:A:C
NM_003000.3(SDHB):c.137G>A (p.Arg46Gln)	SDHB	R46Q	Pheochromocytoma|Carney-Stratakis syndrome|Paragangliomas 4|Paragangliomas 4|Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|not provided|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Hereditary cancer-predisposing syndrome|SDHB-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183793	1	17371319	1	17044824	183793	181624	rs772551056	NC_000001.11:17044823:C:T
NM_001128425.2(MUTYH):c.1171C>T (p.Gln391Ter)	MUTYH	Q391*, Q377*, Q271*, Q364*, Q374*, Q378*, Q388*, Q363*, Q248*	Carcinoma of colon|MYH-associated polyposis|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000156509	1	45797348	1	45331676	156509	166274	rs587783057	NC_000001.11:45331675:G:A
NM_001048171.1(MUTYH):c.270C>A (p.Tyr90Ter)	MUTYH	Y90*, Y104*, Y77*, Y87*, Y101*, Y76*, Y91*	not provided|MUTYH-associated polyposis|Hereditary cancer-predisposing syndrome|Familial colorectal cancer|MYH-associated polyposis	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005296	1	45799121	1	45333449	5296	20335	rs121908380	NC_000001.11:45333448:G:T
NM_007123.5(USH2A):c.920_923dup (p.His308fs)	USH2A		Rare genetic deafness|not provided|Retinitis pigmentosa|Usher syndrome|Retinal dystrophy|Retinitis pigmentosa 39|Usher syndrome, type 2A	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048615	1	216498866 - 216498867	1	216325524 - 216325525	48615	57777	rs397518043	NC_000001.11:216325524:TGGCTG:TGGCTGGCTG
NM_000251.2(MSH2):c.892C>T (p.Gln298Ter)	MSH2	Q298*, Q232*	not provided|Malignant tumor of sigmoid colon|Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091239	2	47641507	2	47414368	91239	96714	rs63750934	NC_000002.12:47414367:C:T
NM_000251.2(MSH2):c.387_388delTC	MSH2		not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091089	2	47637247 - 47637248	2	47410108 - 47410109	91089	96564	rs63750924	NC_000002.12:47410107:TCTCTCTC:TCTCTC
NM_001048171.1(MUTYH):c.692G>A (p.Arg231His)	MUTYH	R245H, R231H, R102H, R125H, R217H, R242H, R218H, R228H, R232H	MUTYH-associated polyposis|Pilomatrixoma|MYH-associated polyposis|Neoplasm of stomach|not provided|MYH-associated polyposis|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000140877	1	45798117	1	45332445	140877	150591	rs140342925	NC_000001.11:45332444:C:T
NM_000251.2(MSH2):c.142G>T (p.Glu48Ter)	MSH2	E48*	Hereditary nonpolyposis colon cancer|not provided|Hereditary cancer-predisposing syndrome|Lynch syndrome|Lynch syndrome I|not specified	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090662	2	47630472	2	47403333	90662	96137	rs63750615	NC_000002.12:47403332:G:T
NM_014874.3(MFN2):c.2119C>T (p.Arg707Trp)	MFN2	R707W	Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B|Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B|Charcot-Marie-Tooth disease, type 2|not provided|MFN2-Related Disorders|Inborn genetic diseases|Charcot-Marie-Tooth disease, type 2A2A	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002280	1	12069698	1	12009641	2280	17319	rs119103267	NC_000001.11:12009640:C:T
NM_000251.2(MSH2):c.811_814del (p.Ser271fs)	MSH2	S205fs, S271fs	Hereditary cancer-predisposing syndrome|not specified|Lynch syndrome|Lynch syndrome I|Hereditary nonpolyposis colon cancer|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091222	2	47641423 - 47641426	2	47414284 - 47414287	91222	96697	rs587779185	NC_000002.12:47414283:CTGTCTG:CTG
NM_000251.2(MSH2):c.388_389del (p.Gln130fs)	MSH2	Q64fs, Q130fs	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided|Lynch syndrome I|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091090	2	47637254 - 47637255	2	47410115 - 47410116	91090	96565	rs63750704	NC_000002.12:47410114:CA:
NM_003000.3(SDHB):c.268C>T (p.Arg90Ter)	SDHB	R90*	Pheochromocytoma|Gastrointestinal stromal tumor|Paragangliomas 4|Hereditary cancer-predisposing syndrome|not provided|Pheochromocytoma|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Pheochromocytoma|Paragangliomas 4|Carney-Stratakis syndrome|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Paragangliomas 4	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012778	1	17359573	1	17033078	12778	27817	rs74315366	NC_000001.11:17033077:G:A
NM_000251.2(MSH2):c.2113del (p.Val705fs)	MSH2	V639fs, V705fs	Hereditary cancer-predisposing syndrome|Lynch syndrome|not provided|Lynch syndrome I|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000001760	2	47703613	2	47476474	1760	16799	rs63749811	NC_000002.12:47476473:G:
NM_000251.3(MSH2):c.2152C>T (p.Gln718Ter)	MSH2	Q718*, Q652*	not provided|Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090909	2	47703652	2	47476513	90909	96384	rs587779139	NC_000002.12:47476512:C:T
NM_000251.2(MSH2):c.1076+1G>A	MSH2		not provided|Muir-Torré syndrome|Lynch syndrome I|Turcot syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090519	2	47643569	2	47416430	90519	95994	rs267607940	NC_000002.12:47416429:G:A
NM_206933.4(USH2A):c.9424G>T (p.Gly3142Ter)	USH2A	G3142*	Usher syndrome|Rare genetic deafness|Usher syndrome type 2|Retinal dystrophy|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000048626	1	215990485	1	215817143	48626	57788	rs397518048	NC_000001.11:215817142:C:A
NM_206933.4(USH2A):c.11864G>A (p.Trp3955Ter)	USH2A	W3955*	Rare genetic deafness|Usher syndrome|Retinal dystrophy|Hearing impairment|Usher syndrome type 2|Retinitis pigmentosa|Retinitis pigmentosa 39|not provided|Usher syndrome, type 2A|Congenital sensorineural hearing impairment	Pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002357	1	215901574	1	215728232	2357	17396	rs111033364	NC_000001.11:215728231:C:T
NM_012222.2(MUTYH):c.1425_1427GGA[1] (p.Glu477del)	MUTYH	E480del, E453del, E466del	MYH-associated polyposis|not specified|not provided|Hereditary cancer-predisposing syndrome|MUTYH-associated polyposis	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000127838	1	45796891 - 45796893	1	45331219 - 45331221	127838	133295	rs587778541	NC_000001.11:45331218:TCCTCCT:TCCT
NM_012222.2(MUTYH):c.1218_1219dup (p.Glu407fs)	MUTYH		MYH-associated polyposis|Hereditary cancer-predisposing syndrome|not provided|MUTYH-associated polyposis|Carcinoma of colon	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000127831	1	45797186 - 45797187	1	45331514 - 45331515	127831	133288	rs587780078	NC_000001.11:45331514:CCC:CCCCC
NM_170707.4(LMNA):c.1445G>A (p.Arg482Gln)	LMNA	R482Q, R370Q, R401Q	Partial lipodystrophy, Dunnigan|not provided|Monogenic diabetes|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Mandibuloacral dysplasia with type A lipodystrophy|Lethal tight skin contracture syndrome|Charcot-Marie-Tooth disease type 2B1|Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome|Dilated cardiomyopathy 1A|Congenital muscular dystrophy, LMNA-related|Heart-hand syndrome, Slovenian type|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Hutchinson-Gilford syndrome|Familial partial lipodystrophy 2|Familial partial lipodystrophy 2|Laminopathy|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014486	1	156106776	1	156136985	14486	29525	rs11575937	NC_000001.11:156136984:G:A
NM_001048171.1(MUTYH):c.1172C>T (p.Pro391Leu)	MUTYH	P405L, P391L, P262L, P378L, P388L, P285L, P377L, P392L, P402L	Hereditary cancer-predisposing syndrome|Carcinoma of colon|B lymphoblastic leukemia lymphoma, no ICD-O subtype|not provided|MYH-associated polyposis	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000142604	1	45797201	1	45331529	142604	152318	rs529008617	NC_000001.11:45331528:G:A
NM_170707.4(LMNA):c.29C>T (p.Thr10Ile)	LMNA	T10I	Inborn genetic diseases|Familial partial lipodystrophy 2|Dilated cardiomyopathy 1A|not provided|Lipodystrophy (disease)	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000066888	1	156084738	1	156114947	66888	77785	rs57077886	NC_000001.11:156114946:C:T
NM_000251.2(MSH2):c.1865C>T (p.Pro622Leu)	MSH2	P622L, P556L	Hereditary cancer-predisposing syndrome|Lynch syndrome|Lynch syndrome I|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000001753	2	47702269	2	47475130	1753	16792	rs28929483	NC_000002.12:47475129:C:T
NM_000251.2(MSH2):c.1457_1460delATGA	MSH2		Colon cancer|Hereditary cancer-predisposing syndrome|Lynch syndrome I|not provided|Lynch syndrome|Carcinoma of colon	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090670	2	47690235 - 47690238	2	47463096 - 47463099	90670	96145	rs1114167806	NC_000002.12:47463095:AATGAATGA:AATGA
NM_000251.2(MSH2):c.484G>A (p.Gly162Arg)	MSH2	G162R, G96R	not provided|Lynch syndrome I|Hereditary nonpolyposis colon cancer|Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091105	2	47637350	2	47410211	91105	96580	rs63750624	NC_000002.12:47410210:G:A
NM_012222.2(MUTYH):c.1138del (p.Ala382fs)	MUTYH	A357fs, A358fs, A371fs, A372fs, A385fs, A242fs, A265fs, A382fs, A368fs	MYH-associated polyposis|not provided|Carcinoma of colon|Familial colorectal cancer|MUTYH-associated polyposis|Hereditary cancer-predisposing syndrome|not specified	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000134860	1	45797372	1	45331700	134860	138599	rs587778536	NC_000001.11:45331699:GGG:GG
NM_000251.2(MSH2):c.2633_2634delAG	MSH2		Lynch syndrome I|Hereditary cancer-predisposing syndrome|not specified|not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091015	2	47708009 - 47708010	2	47480866 - 47480867	91015	96490	rs63751618	NC_000002.12:47480865:AGAGAG:AGAG
NM_000251.2(MSH2):c.998G>A (p.Cys333Tyr)	MSH2	C333Y, C267Y	Hereditary cancer-predisposing syndrome|Lynch syndrome I|not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Nov 3, 2016)	reviewed by expert panel	VCV000091273	2	47643490	2	47416351	91273	96748	rs63750828	NC_000002.12:47416350:G:A
NM_000251.2(MSH2):c.1226_1227del (p.Gln409fs)	MSH2	Q343fs, Q409fs	Lynch syndrome I|Hereditary nonpolyposis colon cancer|not provided|Lynch syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090577	2	47657030 - 47657031	2	47429891 - 47429892	90577	96052	rs63750086	NC_000002.12:47429890:AG:
NM_000251.2(MSH2):c.1705_1706del (p.Glu569fs)	MSH2	E503fs, E569fs	Lynch syndrome I|not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000036569	2	47698146 - 47698147	2	47471007 - 47471008	36569	45231	rs63750393	NC_000002.12:47471006:AGA:A
NM_000251.3(MSH2):c.1165C>T (p.Arg389Ter)	MSH2	R389*, R323*	not provided|Lynch syndrome|Hereditary nonpolyposis colon cancer|Lynch syndrome I|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090557	2	47656969	2	47429830	90557	96032	rs587779075	NC_000002.12:47429829:C:T
NM_000251.3(MSH2):c.1147C>T (p.Arg383Ter)	MSH2	R383*, R317*	Lynch syndrome I|not provided|Muir-Torré syndrome|Lynch syndrome I|Turcot syndrome|Lynch syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090554	2	47656951	2	47429812	90554	96029	rs63749849	NC_000002.12:47429811:C:T
NM_000251.3(MSH2):c.2131C>T (p.Arg711Ter)	MSH2	R711*, R645*	not specified|not provided|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|Lynch syndrome I|Turcot syndrome|Muir-Torré syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090903	2	47703631	2	47476492	90903	96378	rs63750636	NC_000002.12:47476491:C:T
NM_000251.2(MSH2):c.1861C>T (p.Arg621Ter)	MSH2	R621*, R555*	not provided|Hereditary cancer-predisposing syndrome|Lynch syndrome|Lynch syndrome I|Turcot syndrome|Muir-Torré syndrome|Lynch syndrome I|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090804	2	47702265	2	47475126	90804	96279	rs63750508	NC_000002.12:47475125:C:T
NM_000251.3(MSH2):c.1786_1788del (p.Asn596del)	MSH2	N596del, N530del	Hereditary cancer-predisposing syndrome|Lynch syndrome|not provided|Lynch syndrome I|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000001757	2	47702190 - 47702192	2	47475051 - 47475053	1757	16796	rs63749831	NC_000002.12:47475050:AAT:
NM_000251.2(MSH2):c.1906G>C (p.Ala636Pro)	MSH2	A636P, A570P	Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome|Lynch syndrome I|Turcot syndrome|Muir-Torré syndrome|Lynch syndrome I|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000001764	2	47702310	2	47475171	1764	16803	rs63750875	NC_000002.12:47475170:G:C
NM_001128425.2(MUTYH):c.536A>G (p.Tyr179Cys)	MUTYH	Y165C, Y179C, Y59C, Y176C, Y151C, Y162C, Y36C, Y152C, Y166C	Carcinoma of colon|Pilomatrixoma|MYH-associated polyposis|Neoplasm of stomach|not provided|MUTYH-associated polyposis|not specified|MYH-associated polyposis|Endometrial carcinoma|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005293	1	45798475	1	45332803	5293	20332	rs34612342	NC_000001.11:45332802:T:C
NM_206933.4(USH2A):c.2276G>T (p.Cys759Phe)	USH2A	C759F	Usher syndrome|USH2A-Related Disorders|Inborn genetic diseases|Retinal dystrophy|Retinitis pigmentosa|Retinitis pigmentosa 39|not provided|Usher syndrome, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Jan 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002356	1	216420460	1	216247118	2356	17395	rs80338902	NC_000001.11:216247117:C:A
NM_000251.3(MSH2):c.2038C>T (p.Arg680Ter)	MSH2	R680*, R614*	Lynch syndrome I|not provided|Lynch syndrome|Malignant tumor of ascending colon|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000036572	2	47703538	2	47476399	36572	45234	rs63749932	NC_000002.12:47476398:C:T
NM_000251.2(MSH2):c.1216C>T (p.Arg406Ter)	MSH2	R406*, R340*	Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome|Lynch syndrome I|Turcot syndrome|Muir-Torré syndrome|Carcinoma of colon|Lynch syndrome I|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000001755	2	47657020	2	47429881	1755	16794	rs63751108	NC_000002.12:47429880:C:T
NM_007123.5(USH2A):c.2299del (p.Glu767fs)	USH2A	E767fs	Rare genetic deafness|Usher syndrome|Macular dystrophy|Inborn genetic diseases|Retinal dystrophy|Distal arthrogryposis|Chronic pain|Multiple joint contractures|Brisk reflexes|Dysautonomia|Cognitive impairment|High palate|Dislocated radial head|Abnormality of the upper limb|Abnormality of upper limb joint|Anxiety|Abnormality of upper limb bone|Short stature|Congenital stationary night blindness|not specified|Retinitis pigmentosa|Cone-rod dystrophy|Retinitis pigmentosa 39|Usher syndrome, type 2A|not provided|Usher syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002351	1	216420437	1	216247095	2351	17390	rs80338903	NC_000001.11:216247094:C:
NM_001128425.2(MUTYH):c.1187G>A (p.Gly396Asp)	MUTYH	G382D, G396D, G276D, G393D, G369D, G368D, G383D, G253D, G379D	Carcinoma of colon|MYH-associated polyposis|Neoplasm of stomach|Small intestine carcinoid|not provided|Pilomatrixoma|MYH-associated polyposis|Neoplasm of stomach|not specified|MYH-associated polyposis|Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas|MUTYH-associated polyposis|Hereditary cancer-predisposing syndrome|endometrial cancer	Pathogenic/Likely pathogenic(Last reviewed: Jan 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005294	1	45797228	1	45331556	5294	20333	rs36053993	NC_000001.11:45331555:C:T
NM_000251.3(MSH2):c.942+3A>T	MSH2		Hereditary cancer-predisposing syndrome|Lynch syndrome|Lynch syndrome I|not provided|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000036580	2	47641560	2	47414421	36580	45242	rs193922376	NC_000002.12:47414420:A:T
